Index of Molecular Images
To facilitate comparison of similar structures, the images are listed by clan and family.
| Clan | MEROPS ID | Peptidase | Comment | PDB Entry |
|---|---|---|---|---|
| AA | A01.003 | gastricsin | activation intermediate 2 | 1AVF |
| AA | A01.003 | gastricsin | precursor | 1HTR |
| AA | A01.004 | BACE1 g.p. (Homo sapiens) | protease domain; complex with Glu-Val-Asn-leucinol-2-methyl-propionyl-Ala-Glu-Phe inhibitor | 1FKN_A |
| AA | A01.004 | BACE1 g.p. (Homo sapiens) | complex with inhibitor OM00-3 | 1M4H |
| AA | A01.004 | BACE1 g.p. (Homo sapiens) | unbound catalytic domain | 1SGZ |
| AA | A01.004 | BACE1 g.p. (Homo sapiens) | complex with inhibitor | 1TQF_A |
| AA | A01.004 | BACE1 g.p. (Homo sapiens) | 1W50 | |
| AA | A01.004 | BACE1 g.p. (Homo sapiens) | complex with 3-[((1S,2R)-1-benzyl-2-hydroxy-3-[(3-methoxybenzyl)amino]propylamino)(hydroxy)methyl]-N,N-dipropylbenzamide | 1W51 |
| AA | A01.004 | BACE1 g.p. (Homo sapiens) | complex with nvp-aur200 | 1YM2_A |
| AA | A01.004 | BACE1 g.p. (Homo sapiens) | complex with nvp-amk640 | 1YM4_A |
| AA | A01.004 | BACE1 g.p. (Homo sapiens) | complex with inhibitor | 2B8L_A |
| AA | A01.004 | BACE1 g.p. (Homo sapiens) | complex with l- l000430,469 | 2B8V_A |
| AA | A01.004 | BACE1 g.p. (Homo sapiens) | complex with axq093, a macrocyclic inhibitor | 2F3E_A |
| AA | A01.004 | BACE1 g.p. (Homo sapiens) | complex with bdf488, a macrocyclic inhibitor | 2F3F_A |
| AA | A01.004 | BACE1 g.p. (Homo sapiens) | complex with inhibitor | 2HIZ_A |
| AA | A01.004 | BACE1 g.p. (Homo sapiens) | complex with inhibitor | 2IRZ_A |
| AA | A01.004 | BACE1 g.p. (Homo sapiens) | complex with inhibitor | 2IS0_A |
| AA | A01.004 | BACE1 g.p. (Homo sapiens) | complex with inhibitor | 2NTR_A |
| AA | A01.004 | BACE1 g.p. (Homo sapiens) | complex with inhibitor | 2OAH_A |
| AA | A01.004 | BACE1 g.p. (Homo sapiens) | complex with isophthalamide s2 hydroxyethylamine inhibitor | 2P83_A |
| AA | A01.004 | BACE1 g.p. (Homo sapiens) | complex with inhibitor | 2P8H_A |
| AA | A01.004 | BACE1 g.p. (Homo sapiens) | complex with inhibitor | 2PH6_A |
| AA | A01.004 | BACE1 g.p. (Homo sapiens) | complex with inhibitor | 2PH8_A |
| AA | A01.004 | BACE1 g.p. (Homo sapiens) | complex with compound 1 | 2Q11_A |
| AA | A01.004 | BACE1 g.p. (Homo sapiens) | complex with compound 3a | 2Q15_A |
| AA | A01.004 | BACE1 g.p. (Homo sapiens) | complex with compound 1 | 2QU2_A |
| AA | A01.004 | BACE1 g.p. (Homo sapiens) | complex with compound 2 | 2QU3_A |
| AA | A01.004 | BACE1 g.p. (Homo sapiens) | complex with i21 | 2QZK_A |
| AA | A01.004 | BACE1 g.p. (Homo sapiens) | complex with ixs | 2QZL_A |
| AA | A01.004 | BACE1 g.p. (Homo sapiens) | human bace-1 in complex with n-((1s,2r)-1-benzyl-2-hydroxy-3-((1,1,5- trimethylhexyl)amino)propyl)-3-(ethylamino)-5-(2-oxopyrrolidin-1-yl) benzamide | 2VIE_A |
| AA | A01.004 | BACE1 g.p. (Homo sapiens) | complex with 3-(1,1-dioxidotetrahydro-2h-1,2-thiazin- 2-yl)-5-(ethylamino)-n-((1s,2r)-2-hydroxy-1-(phenylmethyl)-3-(1,2,3, 4- tetrahydro-1-naphthalenylamino)propyl)benzamide | 2VIJ_A |
| AA | A01.004 | BACE1 g.p. (Homo sapiens) | complex with n-((1s,2r)-3-(((1s)-2-(cyclohexylamino)- 1-methyl-2-oxoethyl)amino)-2-hydroxy-1-(phenylmethyl)propyl)-3- (pentylsulfonyl)benzamide | 2VIY_A |
| AA | A01.004 | BACE1 g.p. (Homo sapiens) | complex with n-((1s,2r)-3-(((1s)-2-(cyclohexylamino)- 1-methyl-2-oxoethyl)amino)-2-hydroxy-1-(phenylmethyl)propyl)-3-(2- oxo- 1-pyrrolidinyl)-5-(propyloxy)benzamide | 2VIZ_A |
| AA | A01.004 | BACE1 g.p. (Homo sapiens) | complex with n-((1s,2r)-3-(((1s)-2-(cyclohexylamino)- 1-methyl-2-oxoethyl)amino)-2-hydroxy-1-(phenylmethyl)propyl)-3- (ethylamino)-5-(2-oxo-1-pyrrolidinyl)benzamide | 2VJ6_A |
| AA | A01.004 | BACE1 g.p. (Homo sapiens) | human bace-1 in complex with 3-(ethylamino)-n-((1s,2r)-2-hydroxy-1- (phenylmethyl)-3-(((3-(trifluoromethyl)phenyl)methyl)amino)propyl)-5-(2-oxo-1-pyrrolidinyl)benzamide | 2VJ7_A |
| AA | A01.004 | BACE1 g.p. (Homo sapiens) | human bace-1 in complex with n-((1s,2r)-3-(cyclohexylamino)-2-hydroxy-1-(phenylmethyl)propyl)-3-(ethylamino)-5-(2-oxo-1-pyrrolidinyl) benzamide | 2VJ9_A |
| AA | A01.004 | BACE1 g.p. (Homo sapiens) | human bace-1 in complex with 3-(1,1-dioxidotetrahydro-2h-1,2-thiazin- 2-yl)-5-(ethylamino)-n-((1s,2r)-2-hydroxy-1-(phenylmethyl)-3-(((3- (trifluoromethyl)phenyl)methyl)amino)propyl)benzamide | 2VNM_A |
| AA | A01.004 | BACE1 g.p. (Homo sapiens) | human bace-1 in complex with 7-ethyl-n-((1s,2r)-2-hydroxy-1- (phenylmethyl)-3-(((3-(trifluoromethyl)phenyl)methyl)amino)propyl)-1-methyl-3,4-dihydro-1h-(1,2,5)thiadiazepino(3,4,5-hi)indole-9- carboxamide 2,2-dioxide | 2VNN_A |
| AA | A01.004 | BACE1 g.p. (Homo sapiens) | human bace-1 in complex with 1-ethyl-n-((1s,2r)-2-hydroxy-3-(((3- (methyloxy)phenyl)methyl)amino)-1-(phenylmethyl)propyl)-4-(2-oxo-1- pyrrolidinyl)-1h-indole-6-carboxamide | 2WEZ_A |
| AA | A01.004 | BACE1 g.p. (Homo sapiens) | human bace-1 in complex with 4-ethyl-n-((1s,2r)-2-hydroxy-1- (phenylmethyl)-3-(((3-(trifluoromethyl)phenyl)methyl)amino)propyl)-8-(2-oxo-1-pyrrolidinyl)-6-quinolinecarboxamide | 2WF0_A |
| AA | A01.004 | BACE1 g.p. (Homo sapiens) | human bace-1 in complex with 7-ethyl-n-((1s,2r)-2-hydroxy-3-(((3- (methyloxy)phenyl(methyl)amino)-1-(phenylmethyl)propyl)-1-methyl-3,4-dihydro-1h-(1,2,5)thiadiazepino(3,4,5-hi)indole-9-carboxamide 2,2- dioxide | 2WF1_A |
| AA | A01.004 | BACE1 g.p. (Homo sapiens) | human bace-1 in complex with 8-ethyl-n-((1s,2r)-2-hydroxy-3-(((3- (methyloxy)phenyl)methyl)amino)-1-(phenylmethyl)propyl)-1-methyl-3,4,7, 8-tetrahydro-1h,6h-(1,2,5)thiadiazepino(5,4,3-de)quinoxaline-10- carboxamide 2,2-dioxide | 2WF2_A |
| AA | A01.004 | BACE1 g.p. (Homo sapiens) | human bace-1 in complex with 6-(ethylamino)-n-((1s,2r)-2-hydroxy-3- (((3-(methyloxy)phenyl)methyl)amino)-1-(phenylmethyl)propyl)-1- methyl-1, 3,4,5-tetrahydro-2,1-benzothiazepine-8-carboxamide 2,2- dioxide | 2WF3_A |
| AA | A01.004 | BACE1 g.p. (Homo sapiens) | human bace-1 in complex with 6-ethyl-1-methyl-n-((1s)-2-oxo-1- (phenylmethyl)-3-(tetrahydro-2h-pyran-4-ylamino)propyl)-1,3,4,6- tetrahydro(1,2)thiazepino(5,4,3-cd)indole-8-carboxamide 2,2-dioxide | 2WF4_A |
| AA | A01.004 | BACE1 g.p. (Homo sapiens) | human bace-1 in complex with n-((1s,2r)-3-(((1s)-2-(cyclohexylamino)- 1-methyl-2-oxoethyl)amino)-2-hydroxy-1-(phenylmethyl)propyl)-3- ((methylsulfonyl)(phenyl)amino)benzamide | 2XFI_A |
| AA | A01.004 | BACE1 g.p. (Homo sapiens) | human bace-1 in complex with n-((1s,2r)-3-(((1s)-2-(cyclohexylamino)- 1-methyl-2-oxoethyl)amino)-2-hydroxy-1-(phenylmethyl)propyl)-3- (ethylamino)-5-(2-oxo-1-pyrrolidinyl)benzamide | 2XFJ_A |
| AA | A01.004 | BACE1 g.p. (Homo sapiens) | human bace-1 in complex with n-((1s,2r)-3-(((1s)-2-(cyclohexylamino)- 1-methyl-2-oxoethyl)amino)-2-hydroxy-1-(phenylmethyl)propyl)-3- (ethylamino)-5-((methylsulfonyl)(phenyl)amino)benzamide | 2XFK_A |
| AA | A01.004 | BACE1 g.p. (Homo sapiens) | complex with compound 3.b.10 | 2ZDZ_A |
| AA | A01.004 | BACE1 g.p. (Homo sapiens) | complex with compound 6g | 2ZE1_A |
| AA | A01.004 | BACE1 g.p. (Homo sapiens) | complex with inhibitor OM99-2 at pH 5.0 | 2ZHR |
| AA | A01.004 | BACE1 g.p. (Homo sapiens) | at pH 4.0 | 2ZHS |
| AA | A01.004 | BACE1 g.p. (Homo sapiens) | at pH 4.5 | 2ZHT |
| AA | A01.004 | BACE1 g.p. (Homo sapiens) | at pH 5.0 | 2ZHU |
| AA | A01.004 | BACE1 g.p. (Homo sapiens) | at pH 7.0 | 2ZHV |
| AA | A01.004 | BACE1 g.p. (Homo sapiens) | catalytic domain; complex with 4-(4-fluoro-benzyl)-piperazine-2-carboxylic acid(3-mercapto-propyl)-amide | 2ZJK_A |
| AA | A01.004 | BACE1 g.p. (Homo sapiens) | catalytic domain; complex with n-[1-(5-chloro-2-isopropoxy-3-methoxy-benzyl)- piperidin-4-yl]-2-(4-sulfamoyl-phenoxy)-acetamide | 2ZJM_A |
| AA | A01.004 | BACE1 g.p. (Homo sapiens) | catalytic domain; complex with n-[1-(5-chloro-2-isopropoxy-3-methoxy-benzyl)- piperidin-4-yl]-2-(2-methyl-4-sulfamoyl-phenoxy)-acetamide | 2ZJN_A |
| AA | A01.004 | BACE1 g.p. (Homo sapiens) | complex with compound 1 | 3BRA_A |
| AA | A01.004 | BACE1 g.p. (Homo sapiens) | complex with compound 2 | 3BUF_A |
| AA | A01.004 | BACE1 g.p. (Homo sapiens) | complex with compound 3 | 3BUG_A |
| AA | A01.004 | BACE1 g.p. (Homo sapiens) | complex with compound 4 | 3BUH_A |
| AA | A01.004 | BACE1 g.p. (Homo sapiens) | complex with statine-based inhibitor | 3DM6_A |
| AA | A01.004 | BACE1 g.p. (Homo sapiens) | complex with nvp-afj144 | 3DUY_A |
| AA | A01.004 | BACE1 g.p. (Homo sapiens) | complex with nvp-arv999 | 3DV1_A |
| AA | A01.004 | BACE1 g.p. (Homo sapiens) | complex with nvp-bav544 | 3DV5_A |
| AA | A01.004 | BACE1 g.p. (Homo sapiens) | complex with inhibitor | 3EXO_A |
| AA | A01.004 | BACE1 g.p. (Homo sapiens) | complex with spiropiperdine iminohydantoin inhibitor | 3FKT_A |
| AA | A01.004 | BACE1 g.p. (Homo sapiens) | discovery of aminoheterocycles as a novel beta-secretase inhibitor class | 3H0B_A |
| AA | A01.004 | BACE1 g.p. (Homo sapiens) | complex with ev0 | 3HVG_A |
| AA | A01.004 | BACE1 g.p. (Homo sapiens) | complex with ligand ev2 | 3HW1_A |
| AA | A01.004 | BACE1 g.p. (Homo sapiens) | potent beta-secretase 1 hydroxyethylene inhibitor | 3I25_A |
| AA | A01.004 | BACE1 g.p. (Homo sapiens) | complex with compound 3 | 3IGB_A |
| AA | A01.004 | BACE1 g.p. (Homo sapiens) | complex with compound 30 | 3IN3_A |
| AA | A01.004 | BACE1 g.p. (Homo sapiens) | complex with compound 38 | 3IN4_A |
| AA | A01.004 | BACE1 g.p. (Homo sapiens) | complex with the aminohydantoin compound 29 | 3IND_A |
| AA | A01.004 | BACE1 g.p. (Homo sapiens) | complex with the aminohydantoin compound s-34 | 3INE_A |
| AA | A01.004 | BACE1 g.p. (Homo sapiens) | complex with the aminohydantoin compound 37 | 3INF_A |
| AA | A01.004 | BACE1 g.p. (Homo sapiens) | complex with the aminohydantoin compound r-58 | 3INH_A |
| AA | A01.004 | BACE1 g.p. (Homo sapiens) | potent beta-secretase 1 inhibitor | 3IXK_A |
| AA | A01.004 | BACE1 g.p. (Homo sapiens) | human bace-1 complex with nb-216 | 3K5C_A |
| AA | A01.004 | BACE1 g.p. (Homo sapiens) | complex with ahm178 | 3K5D_A |
| AA | A01.004 | BACE1 g.p. (Homo sapiens) | human bace-1 complex with ayh011 | 3K5F_A |
| AA | A01.004 | BACE1 g.p. (Homo sapiens) | human bace-1 complex with bjc060 | 3K5G_A |
| AA | A01.004 | BACE1 g.p. (Homo sapiens) | complex with a norstatine type inhibitor | 3KYR_A |
| AA | A01.004 | BACE1 g.p. (Homo sapiens) | complex with the aminopyridine compound 44 | 3L38_A |
| AA | A01.004 | BACE1 g.p. (Homo sapiens) | complex with the aminopyridine compound 32 | 3L3A_A |
| AA | A01.004 | BACE1 g.p. (Homo sapiens) | complex with sch589432 | 3L58_A |
| AA | A01.004 | BACE1 g.p. (Homo sapiens) | complex with sch710413 | 3L59_A |
| AA | A01.004 | BACE1 g.p. (Homo sapiens) | complex with sch713601 | 3L5B_A |
| AA | A01.004 | BACE1 g.p. (Homo sapiens) | complex with sch723871 | 3L5C_A |
| AA | A01.004 | BACE1 g.p. (Homo sapiens) | complex with sch723873 | 3L5D_A |
| AA | A01.004 | BACE1 g.p. (Homo sapiens) | complex with sch736062 | 3L5E_A |
| AA | A01.004 | BACE1 g.p. (Homo sapiens) | complex with sch736201 | 3L5F_A |
| AA | A01.004 | BACE1 g.p. (Homo sapiens) | complex with the aminohydantoin compound 4g | 3LHG_A |
| AA | A01.004 | BACE1 g.p. (Homo sapiens) | complex with sch745132 | 3LPI_A |
| AA | A01.004 | BACE1 g.p. (Homo sapiens) | complex with sch743641 | 3LPJ_A |
| AA | A01.004 | BACE1 g.p. (Homo sapiens) | complex with sch747123 | 3LPK_A |
| AA | A01.004 | BACE1 g.p. (Homo sapiens) | complex with inhibitor | 3MSJ_A |
| AA | A01.004 | BACE1 g.p. (Homo sapiens) | fragment based discovery and optimisation of bace-1 inhibitors | 3MSK_A |
| AA | A01.004 | BACE1 g.p. (Homo sapiens) | fragment based discovery and optimisation of bace-1 inhibitors | 3MSL_A |
| AA | A01.004 | BACE1 g.p. (Homo sapiens) | complex with bms-655295 aka n~3~-((1s,2r)-1- benzyl-2-hydroxy-3-((3- methoxybenzyl)amino)propyl)-n~1~, n~1~-dibutyl-1h-indole-1,3- dicarboxamide | 3OHF_A |
| AA | A01.004 | BACE1 g.p. (Homo sapiens) | complex with bms-681889 aka n~1~-butyl-5-cyano- n~3~-((1s,2r)-1-(3,5- difluorobenzyl)-2-hydroxy-3-((3- methoxybenzyl)amino)propyl)-n~1~- methyl-1h-indole-1,3- dicarboxamide | 3OHH_A |
| AA | A01.004 | BACE1 g.p. (Homo sapiens) | complex with the aminohydantoin compound 102 | 3OOZ_A |
| AA | A01.004 | BACE1 g.p. (Homo sapiens) | complex with bfg356 | 3PI5_A |
| AA | A01.004 | BACE1 g.p. (Homo sapiens) | structure based design, synthesis and sar of cyclic hydroxyethylamine (hea) bace-1 inhibitors | 3QBH_A |
| AA | A01.004 | BACE1 g.p. (Homo sapiens) | design and synthesis of hydroxyethylamine (hea) bace-1 inhibitors: prime side chromane-containing inhibitors | 3QI1_A |
| AA | A01.004 | BACE1 g.p. (Homo sapiens) | complex with bms-693391 aka (2s)-2-((3r)-3-acetamido-3-isobutyl-2-oxo-1- pyrrolidinyl)-n-((1s,2r)-1-(3,5-difluorobenzyl)-2-hydroxy-2-((2r,4r)-4-propoxy-2-pyrrolidinyl)ethyl)-4-phenylbutanamide | 3R2F_A |
| AA | A01.004 | BACE1 g.p. (Homo sapiens) | complex with 3-(2- aminoquinolin-3-yl)-n-(cyclohexylmethyl)propanamide | 3RU1_A |
| AA | A01.004 | BACE1 g.p. (Homo sapiens) | complex with 2-((2-amino-6-o- tolylquinolin-3-yl)methyl)-n-(cyclohexylmethyl)pentanamide | 3RVI_A |
| AA | A01.004 | BACE1 g.p. (Homo sapiens) | fragment based discovery and optimisation of bace-1 inhibitors | 3S2O_A |
| AA | A01.004 | BACE1 g.p. (Homo sapiens) | pyrazolyl and thienyl aminohydantoins as potent bace1 inhibitors | 3S7L_A |
| AA | A01.004 | BACE1 g.p. (Homo sapiens) | pyrazolyl and thienyl aminohydantoins as potent bace1 inhibitors | 3S7M_A |
| AA | A01.004 | BACE1 g.p. (Homo sapiens) | complex with (2s)-2-((3s)-3-(acetylamino)-3-(butan-2-yl)-2-oxopyrrolidin-1- yl)-n-((2s,3r)-3-hydroxy-4-((3-methoxybenzyl)amino)-1-phenylbutan-2- yl)-4-phenylbutanamide | 3SKF_A |
| AA | A01.004 | BACE1 g.p. (Homo sapiens) | complex with (2s)-2-((3r)-3-acetamido-3-isobutyl-2-oxo-1-pyrrolidinyl)-n- ((1s,2r)-1-(3,5-difluorobenzyl)-2-hydroxy-2-(1,2,3,4-tetrahydro-3- isoquinolinyl)ethyl)-4-phenylbutanamide | 3SKG_A |
| AA | A01.004 | BACE1 g.p. (Homo sapiens) | apo form | 3TPJ_A |
| AA | A01.004 | BACE1 g.p. (Homo sapiens) | apo form | 3TPL_A |
| AA | A01.004 | BACE1 g.p. (Homo sapiens) | complex with an inhibitor | 3TPP_A |
| AA | A01.004 | BACE1 g.p. (Homo sapiens) | complex with an inhibitor | 3TPR_A |
| AA | A01.004 | BACE1 g.p. (Homo sapiens) | rational design and synthesis of aminopiperazinones as beta secretase (bace) inhibitors | 3U6A_A |
| AA | A01.004 | BACE1 g.p. (Homo sapiens) | complex with an inhibitor | 3UQP_A |
| AA | A01.004 | BACE1 g.p. (Homo sapiens) | complex with an inhibitor | 3UQR_A |
| AA | A01.004 | BACE1 g.p. (Homo sapiens) | complex with an inhibitor | 3UQU_A |
| AA | A01.004 | BACE1 g.p. (Homo sapiens) | complex with an inhibitor | 3UQW_A |
| AA | A01.004 | BACE1 g.p. (Homo sapiens) | complex with an inhibitor | 3UQX_A |
| AA | A01.004 | BACE1 g.p. (Homo sapiens) | complex with nvp-avi326 | 3VEU_A |
| AA | A01.004 | BACE1 g.p. (Homo sapiens) | complex with nvp-bqq711 | 3VF3_A |
| AA | A01.004 | BACE1 g.p. (Homo sapiens) | complex with nvp-bur436, derived from a soaking experiment | 3VG1_A |
| AA | A01.004 | BACE1 g.p. (Homo sapiens) | complex with 2-amino-3-methyl-6-((1s, 2r)-2-phenylcyclopropyl)pyrimidin-4(3h)-one | 3VV6_A |
| AA | A01.004 | BACE1 g.p. (Homo sapiens) | complex with 2-amino-3,6- dimethyl-6-(2-phenylethyl)-3,4,5,6-tetrahydropyrimidin-4-one | 3WB4_A |
| AA | A01.004 | BACE1 g.p. (Homo sapiens) | complex with (6s)-2-amino-3,6- dimethyl-6-[(1r,2r)-2-phenylcyclopropyl]-3,4,5,6-tetrahydropyrimidin-4-one | 3WB5_A |
| AA | A01.004 | BACE1 g.p. (Homo sapiens) | complex with chemical ligand | 3ZMG_A |
| AA | A01.004 | BACE1 g.p. (Homo sapiens) | complex with chemical ligand | 3ZOV_A |
| AA | A01.004 | BACE1 g.p. (Homo sapiens) | complex with compound 14 | 4ACU_A |
| AA | A01.004 | BACE1 g.p. (Homo sapiens) | complex with compound 23 | 4ACX_A |
| AA | A01.004 | BACE1 g.p. (Homo sapiens) | design and synthesis of bace1 inhibitors with in vivo brain reduction of beta-amyloid peptides (compound 10) | 4AZY_A |
| AA | A01.004 | BACE1 g.p. (Homo sapiens) | design and synthesis of bace1 inhibitors with in vivo brain reduction of beta-amyloid peptides (compound (r)-41) | 4B00_A |
| AA | A01.004 | BACE1 g.p. (Homo sapiens) | complex with azd3839 | 4B05_A |
| AA | A01.004 | BACE1 g.p. (Homo sapiens) | new aminoimidazoles as bace-1 inhibitors: from rational design to ab- lowering in brain | 4B1C_A |
| AA | A01.004 | BACE1 g.p. (Homo sapiens) | aminoimidazoles as bace-1 inhibitors: from de novo design to ab-lowering in brain | 4B70_A |
| AA | A01.004 | BACE1 g.p. (Homo sapiens) | aminoimidazoles as bace-1 inhibitors: from de novo design to ab-lowering in brain | 4B72_A |
| AA | A01.004 | BACE1 g.p. (Homo sapiens) | aminoimidazoles as bace-1 inhibitors: from de novo design to ab-lowering in brain | 4B77_A |
| AA | A01.004 | BACE1 g.p. (Homo sapiens) | aminoimidazoles as bace-1 inhibitors: from de novo design to ab-lowering in brain | 4B78_A |
| AA | A01.004 | BACE1 g.p. (Homo sapiens) | complex with chemical ligand | 4BEK_A |
| AA | A01.004 | BACE1 g.p. (Homo sapiens) | complex with chemical ligand | 4BFD_A |
| AA | A01.004 | BACE1 g.p. (Homo sapiens) | complex with nvp-bur436, derived from a co-crystallization experiment | 4D83_A |
| AA | A01.004 | BACE1 g.p. (Homo sapiens) | complex with nvp-bvi151 | 4D85_A |
| AA | A01.004 | BACE1 g.p. (Homo sapiens) | complex with nvp-bxq490 | 4D88_A |
| AA | A01.004 | BACE1 g.p. (Homo sapiens) | complex with nvp-bxd552, derived from a soaking experiment | 4D89_A |
| AA | A01.004 | BACE1 g.p. (Homo sapiens) | complex with nvp-bxd552, derived from a co-crystallization experiment | 4D8C_A |
| AA | A01.004 | BACE1 g.p. (Homo sapiens) | complex with hydroxyethylamine inhibitor37 | 4DI2_A |
| AA | A01.004 | BACE1 g.p. (Homo sapiens) | complex with 2-imino-3-methyl-5,5-diphenylimidazolidin- 4-one | 4DJU_A |
| AA | A01.004 | BACE1 g.p. (Homo sapiens) | complex with 2-imino-3-methyl-5-phenyl-5-(3-(pyridin-3- yl)phenyl)imidazolidin-4-one | 4DJW_A |
| AA | A01.004 | BACE1 g.p. (Homo sapiens) | complex with 5-(3-(5-chloropyridin-3-yl)phenyl)-5- cyclopropyl-2-imino-3-methylimidazolidin-4-one | 4DJX_A |
| AA | A01.004 | BACE1 g.p. (Homo sapiens) | complex with (r)-5-cyclopropyl-2-imino-3-methyl-5-(3-(5-(prop-1-yn-1-yl)pyridin-3-yl)phenyl)imidazolidin-4-one | 4DJY_A |
| AA | A01.004 | BACE1 g.p. (Homo sapiens) | complex with a hea-macrocyclic type inhibitor | 4DPF_A |
| AA | A01.004 | BACE1 g.p. (Homo sapiens) | complex with hea-macrocyclic inhibitor, mv078512 | 4DPI_A |
| AA | A01.004 | BACE1 g.p. (Homo sapiens) | complex with an inhibitor | 4DV9_A |
| AA | A01.004 | BACE1 g.p. (Homo sapiens) | complex with an inhibitor | 4DVF_A |
| AA | A01.004 | BACE1 g.p. (Homo sapiens) | design and synthesis of potent hydroxyethylamine (hea) bace-1 inhibitors | 4EWO_A |
| AA | A01.004 | BACE1 g.p. (Homo sapiens) | design and synthesis of potent hydroxyethylamine (hea) bace-1 inhibitors | 4EXG_A |
| AA | A01.004 | BACE1 g.p. (Homo sapiens) | complex with an inhibitor | 4FCO_A |
| AA | A01.004 | BACE1 g.p. (Homo sapiens) | complex with an inhibitor | 4FGX_A |
| AA | A01.004 | BACE1 g.p. (Homo sapiens) | complex with compound 14g | 4FM7_A |
| AA | A01.004 | BACE1 g.p. (Homo sapiens) | complex with compound 12a | 4FM8_A |
| AA | A01.004 | BACE1 g.p. (Homo sapiens) | complex with biarylspiro aminooxazoline 6 | 4FRI_A |
| AA | A01.004 | BACE1 g.p. (Homo sapiens) | complex with aminooxazoline xanthene 9l | 4FRJ_A |
| AA | A01.004 | BACE1 g.p. (Homo sapiens) | complex with aminooxazoline xanthene 11a | 4FRK_A |
| AA | A01.004 | BACE1 g.p. (Homo sapiens) | complex with (s)-4-(3-chloro-5-(5-(prop-1-yn-1- yl)pyridin-3-yl)thiophen-2-yl)-1,4-dimethyl-6-oxotetrahydropyrimidin-2(1h)-iminium | 4FRS_A |
| AA | A01.004 | BACE1 g.p. (Homo sapiens) | complex with n-(n-(4-amino-3,5- dichlorobenzyl)carbamimidoyl)-3-(4- methoxyphenyl)-5- methyl-4-isothiazolecarboxamide | 4FSE_A |
| AA | A01.004 | BACE1 g.p. (Homo sapiens) | bace-db-mutant; complex with n-(n-(4- acetamido-3-chloro-5-methylbenzyl) carbamimidoyl)-3-(4- methoxyphenyl)-5-methyl-4-isothiazolecarboxamide | 4FSL_A |
| AA | A01.004 | BACE1 g.p. (Homo sapiens) | complex with inhibitor | 4GID_A |
| AA | A01.004 | BACE1 g.p. (Homo sapiens) | complex with hea-type macrocyclic inhibitor, mv078571 | 4GMI_A |
| AA | A01.004 | BACE1 g.p. (Homo sapiens) | complex with (7ar)-6-benzoyl-7a-(4-(3-cyanophenyl) thiophen-2-yl)-3-methyl-4-oxohexahydro-1h-pyrrolo[3,4-d]pyrimidin- 2(3h)-iminium | 4H1E_A |
| AA | A01.004 | BACE1 g.p. (Homo sapiens) | complex with 3-(5-((7ar)-2-imino-6-(6-methoxypyridin-2- yl)-3-methyl-4-oxooctahydro-1h-pyrrolo[3,4-d]pyrimidin-7a-yl) thiophen-3-yl)benzonitrile | 4H3F_A |
| AA | A01.004 | BACE1 g.p. (Homo sapiens) | complex with 2-((7ar)-7a-(4-(3-cyanophenyl)thiophen-2- yl)-2-imino-3-methyl-4-oxohexahydro-1h-pyrrolo[3,4-d]pyrimidin-6(2h)-yl)nicotinonitrile | 4H3G_A |
| AA | A01.004 | BACE1 g.p. (Homo sapiens) | complex with 3-(5-((7ar)-2-imino-6-(3-methoxypyridin-2- yl)-3-methyl-4-oxooctahydro-1h-pyrrolo[3,4-d]pyrimidin-7a-yl) thiophen-3-yl)benzonitrile | 4H3I_A |
| AA | A01.004 | BACE1 g.p. (Homo sapiens) | complex with 2-fluoro-5-(5-(2-imino-3-methyl-4-oxo-6- phenyloctahydro-1h-pyrrolo[3,4-d]pyrimidin-7a-yl)thiophen-2-yl) benzonitrile | 4H3J_A |
| AA | A01.004 | BACE1 g.p. (Homo sapiens) | complex with (s)-3-(5-(2-imino-1,4-dimethyl-6- oxohexahydropyrimidin-4-yl)thiophen-3-yl)benzonitrile | 4HA5_A |
| AA | A01.004 | BACE1 g.p. (Homo sapiens) | structure-based design of novel dihydroisoquinoline bace-1 inhibitors that do not engage the catalytic aspartates | 4HZT_A |
| AA | A01.004 | BACE1 g.p. (Homo sapiens) | design and synthesis of thiophene dihydroisoquinolins as novel bace-1 inhibitors ***caveat 4i0d a his 423 ca has chirality not corresponding to the amino ***caveat 2 4i0d acid definition. some close contacts | 4I0D_A |
| AA | A01.004 | BACE1 g.p. (Homo sapiens) | design and synthesis of thiophene dihydroisoquinolins as novel bace-1 inhibitors ***caveat 4i0e several close contacts | 4I0E_A |
| AA | A01.004 | BACE1 g.p. (Homo sapiens) | design and synthesis of thiophene dihydroisoquinolins as novel bace-1 inhibitors | 4I0F_A |
| AA | A01.004 | BACE1 g.p. (Homo sapiens) | design and synthesis of thiophene dihydroisoquinolins as novel bace-1 inhibitors ***caveat 4i0g few water molecules are involved in close contacts | 4I0G_A |
| AA | A01.004 | BACE1 g.p. (Homo sapiens) | spr and structural analysis yield insight towards mechanism of inhibition of bace inhibitors. | 4I0H_A |
| AA | A01.004 | BACE1 g.p. (Homo sapiens) | spr and structural analysis yield insight towards mechanism of inhibition of bace inhibitors | 4I0I_A |
| AA | A01.004 | BACE1 g.p. (Homo sapiens) | spr and structural analysis yield insight towards mechanism of inhibition of bace inhibitors | 4I0J_A |
| AA | A01.004 | BACE1 g.p. (Homo sapiens) | structure-based design of novel dihydroisoquinoline bace-1 inhibitors that do not engage the catalytic aspartates | 4I0Z_A |
| AA | A01.004 | BACE1 g.p. (Homo sapiens) | structure-based design of novel dihydroisoquinoline bace-1 inhibitors that do not engage the catalytic aspartates | 4I10_A |
| AA | A01.004 | BACE1 g.p. (Homo sapiens) | structure-based design of novel dihydroisoquinoline bace-1 inhibitors that do not engage the catalytic aspartates. | 4I11_A |
| AA | A01.004 | BACE1 g.p. (Homo sapiens) | design and synthesis of thiophene dihydroisoquinolins as novel bace-1 inhibitors | 4I12_A |
| AA | A01.004 | BACE1 g.p. (Homo sapiens) | design and synthesis of thiophene dihydroisoquinolins as novel bace-1 inhibitors | 4I1C_A |
| AA | A01.004 | BACE1 g.p. (Homo sapiens) | complex with an inhibitor | 4IVS_A |
| AA | A01.004 | BACE1 g.p. (Homo sapiens) | complex with an inhibitor | 4IVT_A |
| AA | A01.004 | BACE1 g.p. (Homo sapiens) | complex with 5-cyano-pyridine-2- carboxylic acid [3-((s)-2-amino-4-methyl-5,6-dihydro-4h-[1,3]oxazin- 4-yl)-4-fluoro-phenyl]-amide | 4J0P_A |
| AA | A01.004 | BACE1 g.p. (Homo sapiens) | complex with 5-ethoxy-pyridine-2- carboxylic acid [3-((r)-2-amino-5,5-difluoro-4-methyl-5,6-dihydro-4h-[1,3]oxazin-4-yl)-4-fluoro-phenyl]-amide | 4J0T_A |
| AA | A01.004 | BACE1 g.p. (Homo sapiens) | complex with 5-cyano-pyridine-2- carboxylic acid [3-((4r,5r)-2-amino-5-fluoro-4-methyl-5,6-dihydro-4h-[1,3]oxazin-4-yl)-4-fluoro-phenyl]-amide | 4J0V_A |
| AA | A01.004 | BACE1 g.p. (Homo sapiens) | complex with 5-cyano-pyridine-2- carboxylic acid [3-((4r,5s)-2-amino-5-fluoro-4-methyl-5,6-dihydro-4h-[1,3]oxazin-4-yl)-4-fluoro-phenyl]-amide | 4J0Y_A |
| AA | A01.004 | BACE1 g.p. (Homo sapiens) | complex with 5-cyano-pyridine-2- carboxylic acid [3-((4s,5r)-2-amino-5-fluoro-4-fluoromethyl-5,6- dihydro-4h-[1,3]oxazin-4-yl)-4-fluoro-phenyl]-amide | 4J0Z_A |
| AA | A01.004 | BACE1 g.p. (Homo sapiens) | complex with 5-cyano-pyridine-2- carboxylic acid [3-((s)-2-amino-4-difluoromethyl-5,6-dihydro-4h-[1, 3]oxazin-4-yl)-4-fluoro-phenyl]-amide | 4J17_A |
| AA | A01.004 | BACE1 g.p. (Homo sapiens) | complex with 5-cyano-pyridine-2- carboxylic acid [3-((s)-2-amino-5,5-difluoro-4-fluoromethyl-5,6- dihydro-4h-[1,3]oxazin-4-yl)-4-fluoro-phenyl]-amide | 4J1C_A |
| AA | A01.004 | BACE1 g.p. (Homo sapiens) | complex with 5-cyano-pyridine-2- carboxylic acid [3-((4s,6s)-2-amino-4-fluoromethyl-6-trifluoromethyl-5,6-dihydro-4h-[1,3]oxazin-4-yl)-4-fluoro-phenyl]-amide | 4J1E_A |
| AA | A01.004 | BACE1 g.p. (Homo sapiens) | complex with 5-cyano-pyridine-2- carboxylic acid [3-((4s,6s)-2-amino-4-methyl-6-trifluoromethyl-5,6- dihydro-4h-[1,3]oxazin-4-yl)-4-fluoro-phenyl]-amide | 4J1F_A |
| AA | A01.004 | BACE1 g.p. (Homo sapiens) | complex with 5-cyano-pyridine-2- carboxylic acid [3-((4s,6r)-2-amino-4-methyl-6-trifluoromethyl-5,6- dihydro-4h-[1,3]oxazin-4-yl)-4-fluoro-phenyl]-amide | 4J1H_A |
| AA | A01.004 | BACE1 g.p. (Homo sapiens) | complex with 5-cyano-pyridine-2- carboxylic acid [3-((4r,5r,6r)-2-amino-5-fluoro-4-methyl-6- trifluoromethyl-5,6-dihydro-4h-[1,3]oxazin-4-yl)-4-fluoro-phenyl]- amide | 4J1I_A |
| AA | A01.004 | BACE1 g.p. (Homo sapiens) | complex with 5-cyano-pyridine-2- carboxylic acid [3-((4r,5r,6s)-2-amino-5-fluoro-4-methyl-6- trifluoromethyl-5,6-dihydro-4h-[1,3]oxazin-4-yl)-4-fluoro-phenyl]- amide | 4J1K_A |
| AA | A01.004 | BACE1 g.p. (Homo sapiens) | spirocyclic beta-site amyloid precursor protein cleaving enzyme 1 (bace1) inhibitors | 4JOO_A |
| AA | A01.004 | BACE1 g.p. (Homo sapiens) | spirocyclic beta-site amyloid precursor protein cleaving enzyme 1 (bace1) inhibitors | 4JP9_A |
| AA | A01.004 | BACE1 g.p. (Homo sapiens) | spirocyclic beta-site amyloid precursor protein cleaving enzyme 1 (bace1) inhibitors | 4JPC_A |
| AA | A01.004 | BACE1 g.p. (Homo sapiens) | spirocyclic beta-site amyloid precursor protein cleaving enzyme 1 (bace1) inhibitors | 4JPE_A |
| AA | A01.004 | BACE1 g.p. (Homo sapiens) | hydroxyethylamine-based inhibitors of bace1: p1-p3 macrocyclization can improve potency, selectivity, and cell activity | 4K8S_A |
| AA | A01.004 | BACE1 g.p. (Homo sapiens) | complex with inhibitor | 4K9H_A |
| AA | A01.004 | BACE1 g.p. (Homo sapiens) | complex with hydroxyethylamine- macrocyclic inhibitor 13 | 4KE0_A |
| AA | A01.004 | BACE1 g.p. (Homo sapiens) | complex with hydroxyethylamine- macrocyclic inhibitor 19 | 4KE1_A |
| AA | A01.004 | BACE1 g.p. (Homo sapiens) | diethylaminosulfur trifluoride-mediated intramolecular cyclization of 2-hydroxy-benzylureas to fused bicyclic aminooxazoline compounds and evaluation of their biochemical activity against beta-secretase-1 (bace1) | 4L7G_A |
| AA | A01.004 | BACE1 g.p. (Homo sapiens) | diethylaminosulfur trifluoride-mediated intramolecular cyclization of 2-hydroxy-benzylureas to fused bicyclic aminooxazoline compounds and evaluation of their biochemical activity against beta-secretase-1 (bace-1) | 4L7H_A |
| AA | A01.004 | BACE1 g.p. (Homo sapiens) | diethylaminosulfur trifluoride-mediated intramolecular cyclization of 2-hydroxy-benzylureas to fused bicyclic aminooxazoline compounds and evaluation of their biochemical activity against beta-secretase-1 (bace-1) | 4L7J_A |
| AA | A01.004 | BACE1 g.p. (Homo sapiens) | aminooxazoline inhibitor of bace-1 | 4LC7_A |
| AA | A01.004 | BACE1 g.p. (Homo sapiens) | complex with compound 11a | 4LXA_A |
| AA | A01.004 | BACE1 g.p. (Homo sapiens) | complex with compound 11d | 4LXK_A |
| AA | A01.004 | BACE1 g.p. (Homo sapiens) | complex with compound 12a | 4LXM_A |
| AA | A01.004 | BACE1 g.p. (Homo sapiens) | discovery of 7-thp chromans: bace1 inhibitors that reduce a-beta in the cns | 4N00_A |
| AA | A01.004 | BACE1 g.p. (Homo sapiens) | synthesis, characterization and pk/pd studies of a series of spirocyclic pyranochromene bace1 inhibitors | 4PZW_A |
| AA | A01.004 | BACE1 g.p. (Homo sapiens) | synthesis, characterization and pk/pd studies of a series of spirocyclic pyranochromene bace1 inhibitors | 4PZX_A |
| AA | A01.004 | BACE1 g.p. (Homo sapiens) | 8-tetrahydropyran-2-yl chromans: highly selective beta-site amyloid precursor protein cleaving enzyme 1 (bace1) inhibitors | 4R5N_A |
| AA | A01.004 | BACE1 g.p. (Homo sapiens) | complex with (r)-4-(2-cyclohexylethyl)-4-(((r)-1-(2- cyclopentylacetyl)pyrrolidin-3-yl)methyl)-1-methyl-5-oxoimidazolidin-2-iminium | 4R8Y_A |
| AA | A01.004 | BACE1 g.p. (Homo sapiens) | complex with (r)-4-(2-cyclohexylethyl)-4-(((1s,3r)-3- (cyclopentylamino)cyclohexyl)methyl)-1-methyl-5-oxoimidazolidin-2- iminium | 4R91_A |
| AA | A01.004 | BACE1 g.p. (Homo sapiens) | complex with (r)-4-(2-cyclohexylethyl)-4-(((1s,3r)-3- (isonicotinamido)cyclohexyl)methyl)-1-methyl-5-oxoimidazolidin-2- iminium | 4R92_A |
| AA | A01.004 | BACE1 g.p. (Homo sapiens) | complex with (r)-4-(2-cyclohexylethyl)-1-methyl-5-oxo-4- (((1s,3r)-3-(3-phenylureido)cyclohexyl)methyl)imidazolidin-2-iminium | 4R93_A |
| AA | A01.004 | BACE1 g.p. (Homo sapiens) | complex with 2-(((1r,3s)-3-(((r)-4-(2-cyclohexylethyl)-2- iminio-1-methyl-5-oxoimidazolidin-4-yl)methyl)cyclohexyl)amino) quinolin-1-ium | 4R95_A |
| AA | A01.004 | BACE1 g.p. (Homo sapiens) | complex with a 2-aminooxazoline 4- azaxanthene inhibitor | 4RCD_A |
| AA | A01.004 | BACE1 g.p. (Homo sapiens) | complex with aminooxazoline xanthene inhibitor 2 | 4RCE_A |
| AA | A01.004 | BACE1 g.p. (Homo sapiens) | complex with 2-aminooxazoline 4- fluoroxanthene inhibitor 49 | 4RCF_A |
| AA | A01.004 | BACE1 g.p. (Homo sapiens) | 8-tetrahydropyran-2-yl chromans: highly selective beta-site amyloid precursor protein cleaving enzyme 1 (bace1) inhibitors | 4RRN_A |
| AA | A01.004 | BACE1 g.p. (Homo sapiens) | 8-tetrahydropyran-2-yl chromans: highly selective beta-site amyloid precursor protein cleaving enzyme 1 (bace1) inhibitors | 4RRO_A |
| AA | A01.004 | BACE1 g.p. (Homo sapiens) | 8-tetrahydropyran-2-yl chromans: highly selective beta-site amyloid precursor protein cleaving enzyme 1 (bace1) inhibitors | 4RRS_A |
| AA | A01.004 | BACE1 g.p. (Homo sapiens) | complex with a syn-hea-type inhibitor | 4TRW_A |
| AA | A01.004 | BACE1 g.p. (Homo sapiens) | complex with a hea-type inhibitor | 4TRY_A |
| AA | A01.004 | BACE1 g.p. (Homo sapiens) | complex with 2-thiophenyl hea-type inhibitor | 4TRZ_A |
| AA | A01.004 | BACE1 g.p. (Homo sapiens) | complex with 2-aminooxazoline 3-aza-4- fluoro-xanthene inhibitor 22 | 4WTU_A |
| AA | A01.004 | BACE1 g.p. (Homo sapiens) | complex with compound 24b | 4WY1_A |
| AA | A01.004 | BACE1 g.p. (Homo sapiens) | complex with compound 36 | 4WY6_A |
| AA | A01.004 | BACE1 g.p. (Homo sapiens) | complex with compound 6 | 4X2L_A |
| AA | A01.004 | BACE1 g.p. (Homo sapiens) | complex with amino thiazine inhibitor ly2886721 | 4X7I_A |
| AA | A01.004 | BACE1 g.p. (Homo sapiens) | complex with 2-aminooxazoline 3- azaxanthene inhibitor 28 | 4XKX_A |
| AA | A01.004 | BACE1 g.p. (Homo sapiens) | complex with a pyrazole-substituted tetrahydropyranthioamidine | 4XXS_A |
| AA | A01.004 | BACE1 g.p. (Homo sapiens) | complex with amino thiazine inhibitor ly2811376 | 4YBI_A |
| AA | A01.004 | BACE1 g.p. (Homo sapiens) | complex with 4-(cyclohexylamino)-1-(3-fluorophenyl)-8-(3- isopropoxybenzyl)-1,3,8-triazaspiro[4.5]dec-3-en-2-one | 4ZPE_A |
| AA | A01.004 | BACE1 g.p. (Homo sapiens) | complex with 8-(3-((1-aminopropan-2-yl)oxy)benzyl)-4- (cyclohexylamino)-1-(3-fluorophenyl)-1,3,8-triazaspiro[4.5]dec-3-en- 2-one | 4ZPF_A |
| AA | A01.004 | BACE1 g.p. (Homo sapiens) | complex with 8-benzyl-4-(cyclohexylamino)-1-(3-fluorophenyl)-7-methyl-1,3,8-triazaspiro[4.5]dec-3-en-2-one | 4ZPG_A |
| AA | A01.004 | BACE1 g.p. (Homo sapiens) | complex with bicyclic aminothiazine fragment | 4ZSM_A |
| AA | A01.004 | BACE1 g.p. (Homo sapiens) | complex with bicyclic aminothiazine inhibitor | 4ZSP_A |
| AA | A01.004 | BACE1 g.p. (Homo sapiens) | complex with tricyclic aminothiazine inhibitor | 4ZSQ_A |
| AA | A01.004 | BACE1 g.p. (Homo sapiens) | complex with tricyclic aminothiazine inhibitor | 4ZSR_A |
| AA | A01.004 | BACE1 g.p. (Homo sapiens) | 1,4-oxazine bace1 inhibitors | 5CLM_A |
| AA | A01.004 | BACE1 g.p. (Homo sapiens) | complex with compound 0211 | 5DQC_A |
| AA | A01.004 | BACE1 g.p. (Homo sapiens) | complex with compound 18 | 5ENK_A |
| AA | A01.004 | BACE1 g.p. (Homo sapiens) | complex with compound 10 | 5ENM_A |
| AA | A01.004 | BACE1 g.p. (Homo sapiens) | complex with (1r,2r)-2-[(r)-2-amino-4-(4-difluoromethoxy-phenyl)-4,5-dihydro-oxazol-4-yl]-cyclopropyl-(5- chloro-pyridin-3-yl)-methanone | 5EZX_A |
| AA | A01.004 | BACE1 g.p. (Homo sapiens) | complex with (4s)-4-[3-(5-chloro-3- pyridyl)phenyl]-4-[4-(difluoromethoxy)-3-methyl-phenyl]-5h-oxazol-2- amine | 5EZZ_A |
| AA | A01.004 | BACE1 g.p. (Homo sapiens) | complex with 5-[3-[(3-chloro-8- quinolyl)amino]phenyl]-5-methyl-2,6-dihydro-1,4-oxazin-3-amine | 5F00_A |
| AA | A01.004 | BACE1 g.p. (Homo sapiens) | complex with (1sr,2sr)-2-((r)-2-amino- 5,5-difluoro-4-methyl-5,6-dihydro-4h-1,3-oxazin-4-yl)-n-(3- chloroquinolin-8-yl)cyclopropanecarboxamide | 5F01_A |
| AA | A01.004 | BACE1 g.p. (Homo sapiens) | complex with (7ar)-7a-(4-(3-cyanophenyl)thiophen-2-yl)-6-(5-fluoropyrimidin-2-yl)-3-methyl-4-oxooctahydro-2h-pyrrolo[3,4- d]pyrimidin-2-iminium | 5HD0_A |
| AA | A01.004 | BACE1 g.p. (Homo sapiens) | complex with (7ar)-7a-(4-(3-cyanophenyl)thiophen-2-yl)-6-(5- fluoro-4-methoxypyrimidin-2-yl)-3-methyl-4-oxooctahydro-2h-pyrrolo[3,4-d]pyrimidin-2-iminium | 5HDU_A |
| AA | A01.004 | BACE1 g.p. (Homo sapiens) | complex with (7ar)-7a-(5-cyanothiophen-2-yl)-6-(5-fluoro-4- methoxy-6-methylpyrimidin-2-yl)-3-methyl-4-oxooctahydro-2h-pyrrolo[3,4-d]pyrimidin-2-iminium | 5HDV_A |
| AA | A01.004 | BACE1 g.p. (Homo sapiens) | complex with (7ar)-7a-(5-cyanothiophen-2-yl)-6-(4-ethoxy-5- fluoro-6-methylpyrimidin-2-yl)-3-methyl-4-oxooctahydro-2h-pyrrolo[3, 4-d]pyrimidin-2-iminium | 5HDX_A |
| AA | A01.004 | BACE1 g.p. (Homo sapiens) | complex with (7ar)-7a-(5-cyanothiophen-2-yl)-6-(5-fluoro-4- methyl-6-(methylthio)pyrimidin-2-yl)-3-methyl-4-oxooctahydro-2h- pyrrolo[3,4-d]pyrimidin-2-iminium | 5HDZ_A |
| AA | A01.004 | BACE1 g.p. (Homo sapiens) | complex with (4ar,7as)-7a-(2,6-difluorophenyl)-6-(5-fluoro- 4-methoxy-6-methylpyrimidin-2-yl)-3-methyl-4-oxooctahydro-2h- pyrrolo[3,4-d]pyrimidin-2-iminium | 5HE4_A |
| AA | A01.004 | BACE1 g.p. (Homo sapiens) | complex with (7ar)-7a-(5-cyanothiophen-2-yl)-6-(5-fluoro-4- methyl-6-(methylamino)pyrimidin-2-yl)-3-methyl-4-oxooctahydro-2h- pyrrolo[3,4-d]pyrimidin-2-iminium | 5HE5_A |
| AA | A01.004 | BACE1 g.p. (Homo sapiens) | complex with (4ar,7as)-7a-(2,4-difluorophenyl)-6-(5-fluoro- 4-methoxy-6-methylpyrimidin-2-yl)-2-imino-3-methyloctahydro-4h- pyrrolo[3,4-d]pyrimidin-4-one | 5HE7_A |
| AA | A01.004 | BACE1 g.p. (Homo sapiens) | complex with (s)-5-(3-chloro-5-(5-(prop-1-yn-1-yl)pyridin-3- yl)thiophen-2-yl)-2,5-dimethyl-1,2,4-thiadiazinan-3-iminium 1,1- dioxide | 5HTZ_A |
| AA | A01.004 | BACE1 g.p. (Homo sapiens) | complex with 4-(3-(furan-2-carboxamido)phenyl)-1-methyl-5- oxo-4-phenylimidazolidin-2-iminium | 5HU0_A |
| AA | A01.004 | BACE1 g.p. (Homo sapiens) | complex with (r)-n-(3-(3-amino-2,5-dimethyl-1,1-dioxido-5,6- dihydro-2h-1,2,4-thiadiazin-5-yl)-4-fluorophenyl)-5- fluoropicolinamide | 5HU1_A |
| AA | A01.004 | BACE1 g.p. (Homo sapiens) | complex with aminoquinoline compound 1 | 5I3V_A |
| AA | A01.004 | BACE1 g.p. (Homo sapiens) | complex with 2-aminooxazoline-3- azaxanthene inhibitor 2 | 5I3W_A |
| AA | A01.004 | BACE1 g.p. (Homo sapiens) | complex with aminoquinoline inhibitor 6 | 5I3X_A |
| AA | A01.004 | BACE1 g.p. (Homo sapiens) | complex with aminoquinoline inhibitor 9 | 5I3Y_A |
| AA | A01.004 | BACE1 g.p. (Homo sapiens) | complex with 3-(2-amino-6-(o-tolyl) quinolin-3-yl)-n-(3,3-dimethylbutyl)propanamide | 5IE1_A |
| AA | A01.004 | BACE1 g.p. (Homo sapiens) | (4~s,6~s)-4-[2,4-bis(fluoranyl)phenyl]-4-methyl-6-pyrimidin-5-yl- 5,6-dihydro-1,3-thiazin-2-amine (compound 12) bound to bace1 | 5KQF_A |
| AA | A01.004 | BACE1 g.p. (Homo sapiens) | (4~s,6~s)-4-[2,4-bis(fluoranyl)phenyl]-6-(3,5-dimethyl-1,2-oxazol-4-yl)-4-methyl-5,6-dihydro-1,3-thiazin-2-amine (compound 5) bound to bace1 | 5KR8_A |
| AA | A01.004 | BACE1 g.p. (Homo sapiens) | complex with active site inhibitor GRL-8234 and exosite peptide | 5MCO_A |
| AA | A01.004 | BACE1 g.p. (Homo sapiens) | complex with active site and exosite binding peptide inhibitor | 5MCQ_A |
| AA | A01.004 | BACE1 g.p. (Homo sapiens) | complex with ligand 32397778 | 5MXD_A |
| AA | A01.004 | BACE1 g.p. (Homo sapiens) | aminomethyl-derived beta secretase (bace1) inhibitors: engaging gly230without an anilide functionality | 5T1U_A |
| AA | A01.004 | BACE1 g.p. (Homo sapiens) | aminomethyl-derived beta secretase (bace1) inhibitors: engaging gly230without an anilide functionality | 5T1W_A |
| AA | A01.004 | BACE1 g.p. (Homo sapiens) | complex with n-(3-((4as,7as)-2-amino-4,4a,5,6-tetrahydro-7ah-furo[2,3-d][1, 3]thiazin-7a-yl)-4-fluorophenyl)-5-bromo-2-pyridinecarboxamide | 5TOL_A |
| AA | A01.004 | BACE1 g.p. (Homo sapiens) | complex with 2-aminooxazoline-3- azaxanthene compound 12 | 5UYU_A |
| AA | A01.004 | BACE1 g.p. (Homo sapiens) | complex with inhibitor 5g | 5V0N_A |
| AA | A01.004 | BACE1 g.p. (Homo sapiens) | complex with n-(3-((4r,5r,6s)-2-amino-6-(1,1- difluoroethyl)-5-fluoro-4-methyl-5,6-dihydro-4h-1,3-oxazin-4-yl)-4- fluorophenyl)-5-(fluoromethoxy)pyrazine-2-carboxamide | 5YGX_A |
| AA | A01.004 | BACE1 g.p. (Homo sapiens) | complex with (s)-n-(3-(2-amino-6- (fluoromethyl)-4 -methyl-4h-1,3-oxazin-4-yl)-4-fluorophenyl)-5- cyanopicolinamide | 5YGY_A |
| AA | A01.004 | BACE1 g.p. (Homo sapiens) | complex with hydroxy pyrrolidine inhibitor | 6BFD_A |
| AA | A01.004 | BACE1 g.p. (Homo sapiens) | complex with hydroxy pyrrolidine inhibitor | 6BFE_A |
| AA | A01.004 | BACE1 g.p. (Homo sapiens) | complex with hydroxy morpholine inhibitor | 6BFW_A |
| AA | A01.004 | BACE1 g.p. (Homo sapiens) | complex with hydroxy pyrrolidine inhibitor | 6BFX_A |
| AA | A01.004 | BACE1 g.p. (Homo sapiens) | complex with : n-(3-((1r,5s, 6r)-3-amino-5-methyl-2-oxa-4-azabicyclo[4.1.0]hept-3-en-5-yl)-4- fluorophenyl)-5-methoxypyrazine-2-carboxamide | 6C2I_A |
| AA | A01.004 | BACE1 g.p. (Homo sapiens) | complex with a bicyclic isoxazoline carboxamide as the p3 ligand | 6DHC_A |
| AA | A01.004 | BACE1 g.p. (Homo sapiens) | complex with a multiconformer ligand 5t5 | 6DMI_A |
| AA | A01.004 | BACE1 g.p. (Homo sapiens) | complex with compound 28 | 6EJ2_A |
| AA | A01.004 | BACE1 g.p. (Homo sapiens) | complex with B7T ((1r,4r)-4-methoxy-6'-(5-methyl-3-pyridinyl)-3'H-dispiro[cyclohexane-1,2'-indene-1',4''-[1,3]oxazol]-2''-amine) | 6EJ3_A |
| AA | A01.004 | BACE1 g.p. (Homo sapiens) | complex with cnp520 | 6EQM_A |
| AA | A01.004 | BACE1 g.p. (Homo sapiens) | complex with amino-1,4-oxazine compound 4 | 6FGY_A |
| AA | A01.006 | chymosin | recombinant | 1CMS |
| AA | A01.006 | chymosin | complex with inhibitor CP-113972 | 1CZI |
| AA | A01.006 | chymosin | Val111Phe mutant | 3CMS |
| AA | A01.006 | chymosin | 4AA8 | |
| AA | A01.006 | chymosin | complex with pepstatin | 4AUC |
| AA | A01.006 | chymosin | 4CMS | |
| AA | A01.006 | chymosin | camel chymosin at 1.6a resolution | 4AA9_A |
| AA | A01.007 | renin | recombinant glycosylated form | 1BBS |
| AA | A01.007 | renin | complex with butanediamide inhibitor BILA 1908 | 1BIL |
| AA | A01.007 | renin | complex with butanediamide inhibitor BILA 2151 | 1BIM |
| AA | A01.007 | renin | complex with polyhydroxymonoamide inhibitor BILA 980 | 1HRN |
| AA | A01.007 | renin | complex with CGP 38,560 | 1RNE |
| AA | A01.007 | renin | complex with PF00074777 | 2BKS_A |
| AA | A01.007 | renin | complex with PF00257567 | 2BKT_A |
| AA | A01.007 | renin | ketopiperazine-based renin inhibitors: optimization of the c ring | 2FS4_A |
| AA | A01.007 | renin | ketopiperazine-based renin inhibitors: optimization of the "c" ring | 2G1N_A |
| AA | A01.007 | renin | ketopiperazine-based renin inhibitors: optimization of the "c" ring | 2G1O_A |
| AA | A01.007 | renin | ketopiperazine-based renin inhibitors: optimization of the c ring | 2G1R_A |
| AA | A01.007 | renin | ketopiperazine-based renin inhibitors: optimization of the c ring | 2G1S_A |
| AA | A01.007 | renin | ketopiperazine-based renin inhibitors: optimization of the "c" ring | 2G1Y_A |
| AA | A01.007 | renin | ketopiperazine-based renin inhibitors: optimization of the c ring | 2G20_A |
| AA | A01.007 | renin | ketopiperazine-based renin inhibitors: optimization of the "c" ring | 2G21_A |
| AA | A01.007 | renin | ketopiperazine-based renin inhibitors: optimization of the "c" ring | 2G22_A |
| AA | A01.007 | renin | ketopiperazine-based renin inhibitors: optimization of the "c" ring | 2G24_A |
| AA | A01.007 | renin | ketopiperazine-based renin inhibitors: optimization of the "c" ring | 2G26_A |
| AA | A01.007 | renin | ketopiperazine-based renin inhibitors: optimization of the "c" ring | 2G27_A |
| AA | A01.007 | renin | complex with PF02342674 | 2I4Q_A |
| AA | A01.007 | renin | complex with 5-4-[(3,5-difluorobenzyl)amino]phenyl-6-ethylpyrimidine-2,4-diamine | 2IKO_A |
| AA | A01.007 | renin | complex with 6-ethyl-5-[(2S)-1-(3-methoxypropyl)-2-phenyl-1,2,3,4-tetrahydroquinolin-7-yl]pyrimidine-2,4-diamine | 2IKU_A |
| AA | A01.007 | renin | complex with N-[2-(2-amino-6-ethyl-5-[4-(3-methoxypropyl)-2,2-dimethyl-3-oxo-3,4-dihydro-2H-1,4-benzoxazin-6-yl]pyrimidin-4-ylamino)ethyl]naphthalene-2-sulfonamide | 2IL2_A |
| AA | A01.007 | renin | recombinant | 2REN |
| AA | A01.007 | renin | complex with inhibitor 10 (aliskiren) | 2V0Z_C |
| AA | A01.007 | renin | complex with inhibitor 9 ((2R,4S,5S,7S)-5-amino-N-butyl-4-hydroxy-7-[4-methoxy-3-(3-methoxypropoxy)benzyl]-2,8-dimethylnonanamide) | 2V10_C |
| AA | A01.007 | renin | complex with inhibitor 6 ((2S,4S,5R,7R)-4-amino-8-(butylamino)-5-hydroxy-2,7-dimethyl-8-oxooctyl 1-benzyl-1H-indole-3-carboxylate) | 2V11_C |
| AA | A01.007 | renin | complex with inhibitor 8 (N-[(2S,4S,5S,7R)-4-amino-8-(butylamino)-5-hydroxy-7-methyl-2-(1-methylethyl)-8-oxooctyl]-2-(3-methoxypropoxy)benzamide) | 2V12_C |
| AA | A01.007 | renin | complex with inhibitor 7 (N-[(2R,4S,5S,7R)-4-amino-8-(butylamino)-5-hydroxy-2,7-dimethyl-8-oxooctyl]-2-(3-methoxypropoxy)benzamide) | 2V13_A |
| AA | A01.007 | renin | complex with inhibitor 3 | 2V16_A |
| AA | A01.007 | renin | complex with inhibitor 3 | 2V16_C |
| AA | A01.007 | renin | complex with human angiotensinogen | 2X0B_A |
| AA | A01.007 | renin | complex with remikiren | 3D91 |
| AA | A01.007 | renin | 3G6Z | |
| AA | A01.007 | renin | 3G70 | |
| AA | A01.007 | renin | 3G72 | |
| AA | A01.007 | renin | 3GW5 | |
| AA | A01.007 | renin | 3K1W | |
| AA | A01.007 | renin | 3KM4 | |
| AA | A01.007 | renin | 3O9L | |
| AA | A01.007 | renin | 3OAD | |
| AA | A01.007 | renin | complex with piperidine inhibitor | 3OAG |
| AA | A01.007 | renin | 3OOT | |
| AA | A01.007 | renin | 3OQF | |
| AA | A01.007 | renin | 3OQK | |
| AA | A01.007 | renin | 3OWN | |
| AA | A01.007 | renin | 3Q3T | |
| AA | A01.007 | renin | 3Q4B | |
| AA | A01.007 | renin | 3Q5H | |
| AA | A01.007 | renin | 3SFC | |
| AA | A01.007 | renin | 3VCM | |
| AA | A01.007 | renin | 3VSW | |
| AA | A01.007 | renin | 3VSX | |
| AA | A01.007 | renin | 3VUC | |
| AA | A01.007 | renin | 3VYD | |
| AA | A01.007 | renin | 3VYE | |
| AA | A01.007 | renin | 3VYF | |
| AA | A01.007 | renin | 4AMT | |
| AA | A01.007 | renin | 4GJ5 | |
| AA | A01.007 | renin | 4GJ6 | |
| AA | A01.007 | renin | 4GJ7 | |
| AA | A01.007 | renin | 4GJ8 | |
| AA | A01.007 | renin | 4GJ9 | |
| AA | A01.007 | renin | 4GJA | |
| AA | A01.007 | renin | 4GJB | |
| AA | A01.007 | renin | 4GJC | |
| AA | A01.007 | renin | 4GJD | |
| AA | A01.007 | renin | 4PYV | |
| AA | A01.007 | renin | 4Q1N | |
| AA | A01.007 | renin | 4RYC | |
| AA | A01.007 | renin | 4RYG | |
| AA | A01.007 | renin | 4RZ1 | |
| AA | A01.007 | renin | 4S1G | |
| AA | A01.007 | renin | 4XX3 | |
| AA | A01.007 | renin | 4XX4 | |
| AA | A01.007 | renin | discovery of tak-272: a novel, potent and orally active renin in- hibitor ***caveat 5koq nag b 401 has wrong chirality at atom c1 | 5KOQ_A |
| AA | A01.007 | renin | discovery of tak-272: a novel, potent and orally active renin in- hibitor | 5KOS_A |
| AA | A01.007 | renin | discovery of tak-272: a novel, potent and orally active renin in- hibitor | 5KOT_A |
| AA | A01.007 | renin | structure-based design of a new series of n-piperidin-3-ylpyrimidine- 5-carboxamides as renin inhibitors | 5SXN_A |
| AA | A01.007 | renin | structure-based design of a new series of n-piperidin-3-ylpyrimidine- 5-carboxamides as renin inhibitors | 5SY2_A |
| AA | A01.007 | renin | structure-based design of a new series of n-piperidin-3-ylpyrimidine- 5-carboxamides as renin inhibitors | 5SY3_A |
| AA | A01.007 | renin | structure-based design of a new series of n-piperidin-3-ylpyrimidine- 5-carboxamides as renin inhibitors | 5SZ9_A |
| AA | A01.007 | renin | novel approach of fragment-based lead discovery applied to renin inhibitors | 5T4S_A |
| AA | A01.007 | renin | optimization of 3,5-disubstitued piperidine: discovery of non-peptide mimetics as an orally active renin inhibitor | 5TMG_A |
| AA | A01.007 | renin | optimization of 3,5-disubstitued piperidine: discovery of non-peptide mimetics as an orally active renin inhibitor | 5TMK_A |
| AA | A01.007 | renin | complex with a biphenylpipderidinylcarbinol | 5V8V_A |
| AA | A01.007 | renin | complex with a biphenylpipderidinylcarbinol | 5VPM_A |
| AA | A01.007 | renin | complex with a biphenylpipderidinylcarbinol | 5VRP_A |
| AA | A01.007 | renin | complex with human angiotensinogen | 6I3F_B |
| AA | A01.008 | renin-2 | complex with inhibitor CH-66 | 1SMR_A |
| AA | A01.008 | renin-2 | precursor | 5MLG_A |
| AA | A01.009 | cathepsin D | 1LYA | |
| AA | A01.009 | cathepsin D | complex with pepstatin | 1LYB |
| AA | A01.009 | cathepsin D | pH 7.5 | 1LYW_A |
| AA | A01.009 | cathepsin D | 4OBZ | |
| AA | A01.009 | cathepsin D | 4OC6 | |
| AA | A01.009 | cathepsin D | 4OD9 | |
| AA | A01.010 | cathepsin E | theoretical model | 1LCG |
| AA | A01.010 | cathepsin E | activation intermediate | 1TZS |
| AA | A01.011 | penicillopepsin | complex with isoval-Val-Val-Lysta-O-Et | 1APT |
| AA | A01.011 | penicillopepsin | complex with isoval-Val-Val-Sta-O-Et | 1APU |
| AA | A01.011 | penicillopepsin | complex with isoval-Val-Val-hydrated difluorostatone-N-methylamide | 1APV |
| AA | A01.011 | penicillopepsin | complex with isoval-Val-Val-difluorostatone-N-methylamide | 1APW |
| AA | A01.011 | penicillopepsin | complex with ethyl cyclo[(2S)-2-[[(1R)-1-(N-(l-N-(3-methylbutanoyl)valyl-L-aspartyl)amino)-3-methylbutyl]hydroxyphosphinyloxy]-3-(3-aminomethyl)phenylpropanoate | 1BXO |
| AA | A01.011 | penicillopepsin | complex with phosphonate inhibitor | 1BXQ |
| AA | A01.011 | penicillopepsin | complex with isoval-Val-Val-Sta(P)-O-Et | 1PPK |
| AA | A01.011 | penicillopepsin | complex with isoval-Val-Val-Leu(P)-O(Phe)-OME | 1PPL |
| AA | A01.011 | penicillopepsin | complex with CBZ-Ala-Ala-Leu(P)-(O)Phe-OME | 1PPM |
| AA | A01.011 | penicillopepsin | complex with phosphonate inhibitor methyl[cyclo-7[(2R)-((N-valyl)amino)-2-(hydroxyl-(1S)-1-methyloxycarbonyl-2-phenylethoxy)phosphinyloxy-ethyl]-1-naphthaleneacetamide] | 2WEA |
| AA | A01.011 | penicillopepsin | complex with phosphonate inhibitor methyl (2S)-[1-((N-formyl)-l-valyl)amino-2-(2-naphthyl)ethyl)hydroxyphosphinyloxy]-3-phenyl propanoate | 2WEB |
| AA | A01.011 | penicillopepsin | complex with phosphonate inhibitor methyl (2S)-[1-((N-(naphthaleneacetyl))-L-valyl)aminomethyl)hydroxyphosphinyloxy]-3-phenyl propanoate | 2WEC |
| AA | A01.011 | penicillopepsin | complex with phosphonate macrocyclic inhibitor | 2WED |
| AA | A01.011 | penicillopepsin | 3APP | |
| AA | A01.012 | rhizopuspepsin | pH 4.6 | 1UH7 |
| AA | A01.012 | rhizopuspepsin | pH 8.0 | 1UH8 |
| AA | A01.012 | rhizopuspepsin | pH 7.0 | 1UH9 |
| AA | A01.012 | rhizopuspepsin | 2APR | |
| AA | A01.012 | rhizopuspepsin | complex with psi-(CH2-NH)-D-His-Pro-Phe-His-Phe-Phe-Val-Tyr | 3APR |
| AA | A01.012 | rhizopuspepsin | complex with a pepstatin-like renin inhibitor | 4APR |
| AA | A01.012 | rhizopuspepsin | complex with a pepstatin-like renin inhibitor | 5APR |
| AA | A01.012 | rhizopuspepsin | complex with pepstatin | 6APR |
| AA | A01.013 | mucorpepsin | 2ASI | |
| AA | A01.013 | mucorpepsin | complex with pepstatin A | 2RMP_A |
| AA | A01.013 | mucorpepsin | 1MPP | |
| AA | A01.014 | candidapepsin SAP1 | 2QZW | |
| AA | A01.016 | aspergillopepsin I | 1IZD | |
| AA | A01.016 | aspergillopepsin I | 1IZE | |
| AA | A01.016 | aspergillopepsin I | 1IBQ_A | |
| AA | A01.017 | endothiapepsin | complex with inhibitor DB2 | 1E5O |
| AA | A01.017 | endothiapepsin | complex with renin inhibitor Merck-KGAA-EMD56133 | 1E80 |
| AA | A01.017 | endothiapepsin | complex with renin inhibitor Merck-KGAA-EMD61395 | 1E81 |
| AA | A01.017 | endothiapepsin | complex with renin inhibitor Merck-KGAA-EMD59601 | 1E82 |
| AA | A01.017 | endothiapepsin | complex with cyclohexyl renin inhibitor PD125754 | 1EED |
| AA | A01.017 | endothiapepsin | complex with inhibitor PD130328 | 1ENT |
| AA | A01.017 | endothiapepsin | complex with PS1 (Pro-Leu-Glu-PSA-Arg-Leu) | 1EPL |
| AA | A01.017 | endothiapepsin | complex with PS2 (Thr-Phe-Gln-Ala-PSA-Leu-Arg-Glu) | 1EPM |
| AA | A01.017 | endothiapepsin | complex with CP-80,794 (MOR-Phe-Cys-CH3-NOR) | 1EPN |
| AA | A01.017 | endothiapepsin | complex with CP-81,282 (MOR-Phe-Nle-CHF-NME) | 1EPO |
| AA | A01.017 | endothiapepsin | complex with PD-130,693 (MAS-Phe-Lys-MTF-Sta-MBA) | 1EPP |
| AA | A01.017 | endothiapepsin | complex with PD-133,450 (SOT-Phe-Gly-SCC-GCL) | 1EPQ |
| AA | A01.017 | endothiapepsin | complex with PD-135,040 (TSM-DPH-His-CHF-EMR) | 1EPR |
| AA | A01.017 | endothiapepsin | complex with H-77 (D-His-Pro-Phe-His-Leu-Leu-Val-Tyr) | 1ER8_E |
| AA | A01.017 | endothiapepsin | complex with transition state analogue inhibitor H261 | 1GKT |
| AA | A01.017 | endothiapepsin | complex with CP-80,794 (N-carbonylmorphine-Phe-S-methyl-Cys-cyclohexyl-norstatine) inhibitor | 1GVT |
| AA | A01.017 | endothiapepsin | complex with inhibitor H189 | 1GVU |
| AA | A01.017 | endothiapepsin | complex with Glu-statine-Leu-meta-di(aminomethyl)benzene inhibitor | 1GVV |
| AA | A01.017 | endothiapepsin | complex with PD-130,328 inhibitor | 1GVW |
| AA | A01.017 | endothiapepsin | complex with inhibitor H256 | 1GVX |
| AA | A01.017 | endothiapepsin | complex with PD135,040 | 1OD1 |
| AA | A01.017 | endothiapepsin | 1OEW | |
| AA | A01.017 | endothiapepsin | complex with transition state analogue inhibitor H261 | 1OEX |
| AA | A01.017 | endothiapepsin | complex with L364,099 (IVA-His-Pro-Phe-His-CHS-Leu-Phe-NH2) | 2ER0 |
| AA | A01.017 | endothiapepsin | complex with H-256 (Pro-Thr-Glu-Phe-Phe-Arg-Glu) | 2ER6 |
| AA | A01.017 | endothiapepsin | complex with H-261 | 2ER7_E |
| AA | A01.017 | endothiapepsin | complex with L636,564 | 2ER9 |
| AA | A01.017 | endothiapepsin | complex with gem-diol inhibitor PD-135.040 | 2JJI_A |
| AA | A01.017 | endothiapepsin | 2JJJ | |
| AA | A01.017 | endothiapepsin | complex with compound 1 | 2V00 |
| AA | A01.017 | endothiapepsin | neutron diffraction structure; complex with gem-diol inhibitor PD-135.040 . | 2VS2_A |
| AA | A01.017 | endothiapepsin | complex with CP-71,362 | 3ER3 |
| AA | A01.017 | endothiapepsin | complex with H-189 | 3ER5_E |
| AA | A01.017 | endothiapepsin | 3LZY | |
| AA | A01.017 | endothiapepsin | 3PB5 | |
| AA | A01.017 | endothiapepsin | 3PBD | |
| AA | A01.017 | endothiapepsin | 3PBZ | |
| AA | A01.017 | endothiapepsin | 3PCW | |
| AA | A01.017 | endothiapepsin | 3PCZ | |
| AA | A01.017 | endothiapepsin | 3PGI | |
| AA | A01.017 | endothiapepsin | 3PI0 | |
| AA | A01.017 | endothiapepsin | 3PLD | |
| AA | A01.017 | endothiapepsin | 3PLL | |
| AA | A01.017 | endothiapepsin | 3PM4 | |
| AA | A01.017 | endothiapepsin | 3PMU | |
| AA | A01.017 | endothiapepsin | 3PMY | |
| AA | A01.017 | endothiapepsin | 3PRS | |
| AA | A01.017 | endothiapepsin | 3PSY | |
| AA | A01.017 | endothiapepsin | 3PWW | |
| AA | A01.017 | endothiapepsin | 3Q6Y | |
| AA | A01.017 | endothiapepsin | 3T6I | |
| AA | A01.017 | endothiapepsin | 3T7P | |
| AA | A01.017 | endothiapepsin | 3T7Q | |
| AA | A01.017 | endothiapepsin | 3T7X | |
| AA | A01.017 | endothiapepsin | 3URI | |
| AA | A01.017 | endothiapepsin | 3URJ | |
| AA | A01.017 | endothiapepsin | 3URL | |
| AA | A01.017 | endothiapepsin | 3WZ6 | |
| AA | A01.017 | endothiapepsin | 3WZ7 | |
| AA | A01.017 | endothiapepsin | 3WZ8 | |
| AA | A01.017 | endothiapepsin | 4APE | |
| AA | A01.017 | endothiapepsin | complex with PD125967 (BNA-His-CAL-DCI) | 4ER1 |
| AA | A01.017 | endothiapepsin | complex with pepstatin | 4ER2 |
| AA | A01.017 | endothiapepsin | complex with Pro-His-Pro-Phe-His-Leu-Val-Ile-His-Lys | 4ER4 |
| AA | A01.017 | endothiapepsin | 4KUP | |
| AA | A01.017 | endothiapepsin | 4L6B | |
| AA | A01.017 | endothiapepsin | 4LAP | |
| AA | A01.017 | endothiapepsin | 4LBT | |
| AA | A01.017 | endothiapepsin | 4LHH | |
| AA | A01.017 | endothiapepsin | 4LP9 | |
| AA | A01.017 | endothiapepsin | complex with BW624 (LOL-CH2-Val-Ile-Phe-OMe) | 5ER1 |
| AA | A01.017 | endothiapepsin | complex with CP-69,799 (BOC-Phe-His-AHS-Lys-Phe) | 5ER2 |
| AA | A01.017 | endothiapepsin | endothiapepsin in complex with biacylhydrazone | 5HCT_A |
| AA | A01.017 | endothiapepsin | treated with fragment 115 | 5P1W_A |
| AA | A01.017 | endothiapepsin | treated with fragment 116 | 5P1X_A |
| AA | A01.017 | endothiapepsin | treated with fragment 117 | 5P1Y_A |
| AA | A01.017 | endothiapepsin | treated with fragment 118 | 5P1Z_A |
| AA | A01.017 | endothiapepsin | treated with fragment 119 | 5P20_A |
| AA | A01.017 | endothiapepsin | treated with fragment 120 | 5P22_A |
| AA | A01.017 | endothiapepsin | treated with fragment 121 | 5P23_A |
| AA | A01.017 | endothiapepsin | treated with fragment 122 | 5P24_A |
| AA | A01.017 | endothiapepsin | treated with fragment 123 | 5P25_A |
| AA | A01.017 | endothiapepsin | treated with fragment 124 | 5P26_A |
| AA | A01.017 | endothiapepsin | treated with fragment 125 | 5P27_A |
| AA | A01.017 | endothiapepsin | treated with fragment 126 | 5P28_A |
| AA | A01.017 | endothiapepsin | treated with fragment 127 | 5P29_A |
| AA | A01.017 | endothiapepsin | treated with fragment 128 | 5P2A_A |
| AA | A01.017 | endothiapepsin | treated with fragment 129 | 5P2B_A |
| AA | A01.017 | endothiapepsin | treated with fragment 130 | 5P2C_A |
| AA | A01.017 | endothiapepsin | treated with fragment 131 | 5P2D_A |
| AA | A01.017 | endothiapepsin | treated with fragment 132 | 5P2E_A |
| AA | A01.017 | endothiapepsin | treated with fragment 133 | 5P2F_A |
| AA | A01.017 | endothiapepsin | treated with fragment 134 | 5P2G_A |
| AA | A01.017 | endothiapepsin | treated with fragment 135 | 5P2H_A |
| AA | A01.017 | endothiapepsin | treated with fragment 136 | 5P2I_A |
| AA | A01.017 | endothiapepsin | treated with fragment 137 | 5P2J_A |
| AA | A01.017 | endothiapepsin | treated with fragment 138 | 5P2K_A |
| AA | A01.017 | endothiapepsin | treated with fragment 139 | 5P2L_A |
| AA | A01.017 | endothiapepsin | treated with fragment 140 | 5P2M_A |
| AA | A01.017 | endothiapepsin | treated with fragment 141 | 5P2N_A |
| AA | A01.017 | endothiapepsin | treated with fragment 142 | 5P2O_A |
| AA | A01.017 | endothiapepsin | treated with fragment 143 | 5P2Q_A |
| AA | A01.017 | endothiapepsin | treated with fragment 144 | 5P2R_A |
| AA | A01.017 | endothiapepsin | treated with fragment 145 | 5P2S_A |
| AA | A01.017 | endothiapepsin | treated with fragment 146 | 5P2T_A |
| AA | A01.017 | endothiapepsin | treated with fragment 147 | 5P2U_A |
| AA | A01.017 | endothiapepsin | treated with fragment 148 | 5P2V_A |
| AA | A01.017 | endothiapepsin | treated with fragment 149 | 5P2W_A |
| AA | A01.017 | endothiapepsin | treated with fragment 150 | 5P2X_A |
| AA | A01.017 | endothiapepsin | treated with fragment 151 | 5P2Y_A |
| AA | A01.017 | endothiapepsin | treated with fragment 152 | 5P2Z_A |
| AA | A01.017 | endothiapepsin | treated with fragment 153 | 5P30_A |
| AA | A01.017 | endothiapepsin | treated with fragment 154 | 5P31_A |
| AA | A01.017 | endothiapepsin | treated with fragment 155 | 5P32_A |
| AA | A01.017 | endothiapepsin | treated with fragment 156 | 5P33_A |
| AA | A01.017 | endothiapepsin | treated with fragment 157 | 5P34_A |
| AA | A01.017 | endothiapepsin | treated with fragment 158 | 5P35_A |
| AA | A01.017 | endothiapepsin | treated with fragment 159 | 5P36_A |
| AA | A01.017 | endothiapepsin | treated with fragment 160 | 5P37_A |
| AA | A01.017 | endothiapepsin | treated with fragment 161 | 5P38_A |
| AA | A01.017 | endothiapepsin | treated with fragment 162 | 5P39_A |
| AA | A01.017 | endothiapepsin | treated with fragment 163 | 5P3A_A |
| AA | A01.017 | endothiapepsin | treated with fragment 164 | 5P3B_A |
| AA | A01.017 | endothiapepsin | treated with fragment 165 | 5P3C_A |
| AA | A01.017 | endothiapepsin | treated with fragment 166 | 5P3D_A |
| AA | A01.017 | endothiapepsin | treated with fragment 167 | 5P3E_A |
| AA | A01.017 | endothiapepsin | treated with fragment 168 | 5P3F_A |
| AA | A01.017 | endothiapepsin | treated with fragment 169 | 5P3G_A |
| AA | A01.017 | endothiapepsin | treated with fragment 170 | 5P3H_A |
| AA | A01.017 | endothiapepsin | treated with fragment 171 | 5P3I_A |
| AA | A01.017 | endothiapepsin | treated with fragment 172 | 5P3J_A |
| AA | A01.017 | endothiapepsin | treated with fragment 173 | 5P3K_A |
| AA | A01.017 | endothiapepsin | treated with fragment 174 | 5P3L_A |
| AA | A01.017 | endothiapepsin | treated with fragment 175 | 5P3M_A |
| AA | A01.017 | endothiapepsin | treated with fragment 176 | 5P3N_A |
| AA | A01.017 | endothiapepsin | treated with fragment 177 | 5P3O_A |
| AA | A01.017 | endothiapepsin | treated with fragment 178 | 5P3P_A |
| AA | A01.017 | endothiapepsin | treated with fragment 179 | 5P3Q_A |
| AA | A01.017 | endothiapepsin | treated with fragment 180 | 5P3R_A |
| AA | A01.017 | endothiapepsin | treated with fragment 181 | 5P3S_A |
| AA | A01.017 | endothiapepsin | treated with fragment 182 | 5P3T_A |
| AA | A01.017 | endothiapepsin | treated with fragment 183 | 5P3U_A |
| AA | A01.017 | endothiapepsin | treated with fragment 184 | 5P3V_A |
| AA | A01.017 | endothiapepsin | treated with fragment 185 | 5P3W_A |
| AA | A01.017 | endothiapepsin | treated with fragment 186 | 5P3X_A |
| AA | A01.017 | endothiapepsin | treated with fragment 187 | 5P3Y_A |
| AA | A01.017 | endothiapepsin | treated with fragment 188 | 5P3Z_A |
| AA | A01.017 | endothiapepsin | treated with fragment 189 | 5P40_A |
| AA | A01.017 | endothiapepsin | treated with fragment 190 | 5P41_A |
| AA | A01.017 | endothiapepsin | treated with fragment 191 | 5P42_A |
| AA | A01.017 | endothiapepsin | treated with fragment 192 | 5P43_A |
| AA | A01.017 | endothiapepsin | treated with fragment 193 | 5P44_A |
| AA | A01.017 | endothiapepsin | treated with fragment 194 | 5P45_A |
| AA | A01.017 | endothiapepsin | treated with fragment 195 | 5P46_A |
| AA | A01.017 | endothiapepsin | treated with fragment 196 | 5P47_A |
| AA | A01.017 | endothiapepsin | treated with fragment 197 | 5P48_A |
| AA | A01.017 | endothiapepsin | treated with fragment 198 | 5P49_A |
| AA | A01.017 | endothiapepsin | treated with fragment 199 | 5P4A_A |
| AA | A01.017 | endothiapepsin | treated with fragment 200 | 5P4B_A |
| AA | A01.017 | endothiapepsin | treated with fragment 201 | 5P4C_A |
| AA | A01.017 | endothiapepsin | treated with fragment 202 | 5P4D_A |
| AA | A01.017 | endothiapepsin | treated with fragment 203 | 5P4E_A |
| AA | A01.017 | endothiapepsin | treated with fragment 204 | 5P4F_A |
| AA | A01.017 | endothiapepsin | treated with fragment 205 | 5P4G_A |
| AA | A01.017 | endothiapepsin | treated with fragment 206 | 5P4H_A |
| AA | A01.017 | endothiapepsin | treated with fragment 207 | 5P4I_A |
| AA | A01.017 | endothiapepsin | treated with fragment 208 | 5P4J_A |
| AA | A01.017 | endothiapepsin | treated with fragment 209 | 5P4K_A |
| AA | A01.017 | endothiapepsin | treated with fragment 210 | 5P4L_A |
| AA | A01.017 | endothiapepsin | treated with fragment 211 | 5P4M_A |
| AA | A01.017 | endothiapepsin | treated with fragment 212 | 5P4N_A |
| AA | A01.017 | endothiapepsin | treated with fragment 213 | 5P4O_A |
| AA | A01.017 | endothiapepsin | treated with fragment 214 | 5P4P_A |
| AA | A01.017 | endothiapepsin | treated with fragment 215 | 5P4Q_A |
| AA | A01.017 | endothiapepsin | treated with fragment 216 | 5P4R_A |
| AA | A01.017 | endothiapepsin | treated with fragment 217 | 5P4S_A |
| AA | A01.017 | endothiapepsin | treated with fragment 218 | 5P4T_A |
| AA | A01.017 | endothiapepsin | treated with fragment 219 | 5P4U_A |
| AA | A01.017 | endothiapepsin | treated with fragment 220 | 5P4V_A |
| AA | A01.017 | endothiapepsin | treated with fragment 221 | 5P4W_A |
| AA | A01.017 | endothiapepsin | treated with fragment 222 | 5P4X_A |
| AA | A01.017 | endothiapepsin | treated with fragment 223 | 5P4Y_A |
| AA | A01.017 | endothiapepsin | treated with fragment 224 | 5P4Z_A |
| AA | A01.017 | endothiapepsin | treated with fragment 225 | 5P50_A |
| AA | A01.017 | endothiapepsin | treated with fragment 226 | 5P51_A |
| AA | A01.017 | endothiapepsin | treated with fragment 227 | 5P52_A |
| AA | A01.017 | endothiapepsin | treated with fragment 228 | 5P53_A |
| AA | A01.017 | endothiapepsin | treated with fragment 229 | 5P54_A |
| AA | A01.017 | endothiapepsin | treated with fragment 230 | 5P55_A |
| AA | A01.017 | endothiapepsin | treated with fragment 231 | 5P56_A |
| AA | A01.017 | endothiapepsin | treated with fragment 232 | 5P57_A |
| AA | A01.017 | endothiapepsin | treated with fragment 233 | 5P58_A |
| AA | A01.017 | endothiapepsin | treated with fragment 234 | 5P59_A |
| AA | A01.017 | endothiapepsin | treated with fragment 235 | 5P5A_A |
| AA | A01.017 | endothiapepsin | treated with fragment 236 | 5P5B_A |
| AA | A01.017 | endothiapepsin | treated with fragment 237 | 5P5C_A |
| AA | A01.017 | endothiapepsin | treated with fragment 238 | 5P5D_A |
| AA | A01.017 | endothiapepsin | treated with fragment 239 | 5P5E_A |
| AA | A01.017 | endothiapepsin | treated with fragment 240 | 5P5F_A |
| AA | A01.017 | endothiapepsin | treated with fragment 241 | 5P5G_A |
| AA | A01.017 | endothiapepsin | treated with fragment 242 | 5P5H_A |
| AA | A01.017 | endothiapepsin | treated with fragment 243 | 5P5I_A |
| AA | A01.017 | endothiapepsin | treated with fragment 244 | 5P5J_A |
| AA | A01.017 | endothiapepsin | treated with fragment 245 | 5P5K_A |
| AA | A01.017 | endothiapepsin | treated with fragment 246 | 5P5L_A |
| AA | A01.017 | endothiapepsin | treated with fragment 247 | 5P5M_A |
| AA | A01.017 | endothiapepsin | treated with fragment 248 | 5P5N_A |
| AA | A01.017 | endothiapepsin | treated with fragment 249 | 5P5O_A |
| AA | A01.017 | endothiapepsin | treated with fragment 250 | 5P5P_A |
| AA | A01.017 | endothiapepsin | treated with fragment 251 | 5P5Q_A |
| AA | A01.017 | endothiapepsin | treated with fragment 252 | 5P5R_A |
| AA | A01.017 | endothiapepsin | treated with fragment 253 | 5P5S_A |
| AA | A01.017 | endothiapepsin | treated with fragment 254 | 5P5T_A |
| AA | A01.017 | endothiapepsin | treated with fragment 255 | 5P5U_A |
| AA | A01.017 | endothiapepsin | treated with fragment 256 | 5P5V_A |
| AA | A01.017 | endothiapepsin | treated with fragment 257 | 5P5W_A |
| AA | A01.017 | endothiapepsin | treated with fragment 258 | 5P5X_A |
| AA | A01.017 | endothiapepsin | treated with fragment 259 | 5P5Y_A |
| AA | A01.017 | endothiapepsin | treated with fragment 260 | 5P5Z_A |
| AA | A01.017 | endothiapepsin | treated with fragment 261 | 5P60_A |
| AA | A01.017 | endothiapepsin | treated with fragment 262 | 5P61_A |
| AA | A01.017 | endothiapepsin | treated with fragment 263 | 5P62_A |
| AA | A01.017 | endothiapepsin | treated with fragment 264 | 5P63_A |
| AA | A01.017 | endothiapepsin | treated with fragment 265 | 5P64_A |
| AA | A01.017 | endothiapepsin | treated with fragment 266 | 5P65_A |
| AA | A01.017 | endothiapepsin | treated with fragment 267 | 5P66_A |
| AA | A01.017 | endothiapepsin | treated with fragment 268 | 5P67_A |
| AA | A01.017 | endothiapepsin | treated with fragment 269 | 5P68_A |
| AA | A01.017 | endothiapepsin | treated with fragment 270 | 5P69_A |
| AA | A01.017 | endothiapepsin | treated with fragment 271 | 5P6A_A |
| AA | A01.017 | endothiapepsin | treated with fragment 272 | 5P6B_A |
| AA | A01.017 | endothiapepsin | treated with fragment 273 | 5P6C_A |
| AA | A01.017 | endothiapepsin | treated with fragment 274 | 5P6D_A |
| AA | A01.017 | endothiapepsin | treated with fragment 275 | 5P6E_A |
| AA | A01.017 | endothiapepsin | treated with fragment 276 | 5P6F_A |
| AA | A01.017 | endothiapepsin | treated with fragment 277 | 5P6G_A |
| AA | A01.017 | endothiapepsin | treated with fragment 278 | 5P6H_A |
| AA | A01.017 | endothiapepsin | treated with fragment 279 | 5P6I_A |
| AA | A01.017 | endothiapepsin | treated with fragment 280 | 5P6J_A |
| AA | A01.017 | endothiapepsin | treated with fragment 281 | 5P6K_A |
| AA | A01.017 | endothiapepsin | treated with fragment 282 | 5P6L_A |
| AA | A01.017 | endothiapepsin | treated with fragment 283 | 5P6M_A |
| AA | A01.017 | endothiapepsin | treated with fragment 284 | 5P6N_A |
| AA | A01.017 | endothiapepsin | treated with fragment 285 | 5P6O_A |
| AA | A01.017 | endothiapepsin | treated with fragment 286 | 5P6P_A |
| AA | A01.017 | endothiapepsin | treated with fragment 287 | 5P6Q_A |
| AA | A01.017 | endothiapepsin | treated with fragment 288 | 5P6R_A |
| AA | A01.017 | endothiapepsin | treated with fragment 289 | 5P6S_A |
| AA | A01.017 | endothiapepsin | treated with fragment 290 | 5P6T_A |
| AA | A01.017 | endothiapepsin | treated with fragment 291 | 5P6U_A |
| AA | A01.017 | endothiapepsin | treated with fragment 292 | 5P6V_A |
| AA | A01.017 | endothiapepsin | treated with fragment 293 | 5P6W_A |
| AA | A01.017 | endothiapepsin | treated with fragment 294 | 5P6X_A |
| AA | A01.017 | endothiapepsin | treated with fragment 295 | 5P6Y_A |
| AA | A01.017 | endothiapepsin | treated with fragment 296 | 5P6Z_A |
| AA | A01.017 | endothiapepsin | treated with fragment 297 | 5P70_A |
| AA | A01.017 | endothiapepsin | treated with fragment 298 | 5P71_A |
| AA | A01.017 | endothiapepsin | treated with fragment 299 | 5P72_A |
| AA | A01.017 | endothiapepsin | treated with fragment 300 | 5P73_A |
| AA | A01.017 | endothiapepsin | treated with fragment 301 | 5P74_A |
| AA | A01.017 | endothiapepsin | treated with fragment 302 | 5P75_A |
| AA | A01.017 | endothiapepsin | treated with fragment 303 | 5P76_A |
| AA | A01.017 | endothiapepsin | treated with fragment 304 | 5P77_A |
| AA | A01.017 | endothiapepsin | treated with fragment 305 | 5P78_A |
| AA | A01.017 | endothiapepsin | treated with fragment 306 | 5P79_A |
| AA | A01.017 | endothiapepsin | treated with fragment 307 | 5P7A_A |
| AA | A01.017 | endothiapepsin | treated with fragment 308 | 5P7B_A |
| AA | A01.017 | endothiapepsin | treated with fragment 309 | 5P7C_A |
| AA | A01.017 | endothiapepsin | treated with fragment 310 | 5P7D_A |
| AA | A01.017 | endothiapepsin | treated with fragment 311 | 5P7E_A |
| AA | A01.017 | endothiapepsin | treated with fragment 312 | 5P7F_A |
| AA | A01.017 | endothiapepsin | treated with fragment 313 | 5P7G_A |
| AA | A01.017 | endothiapepsin | treated with fragment 314 | 5P7H_A |
| AA | A01.017 | endothiapepsin | treated with fragment 315 | 5P7I_A |
| AA | A01.017 | endothiapepsin | treated with fragment 316 | 5P7J_A |
| AA | A01.017 | endothiapepsin | treated with fragment 317 | 5P7K_A |
| AA | A01.017 | endothiapepsin | treated with fragment 318 | 5P7L_A |
| AA | A01.017 | endothiapepsin | treated with fragment 319 | 5P7M_A |
| AA | A01.017 | endothiapepsin | treated with fragment 320 | 5P7N_A |
| AA | A01.017 | endothiapepsin | treated with fragment 321 | 5P7O_A |
| AA | A01.017 | endothiapepsin | treated with fragment 322 | 5P7P_A |
| AA | A01.017 | endothiapepsin | treated with fragment 323 | 5P7Q_A |
| AA | A01.017 | endothiapepsin | treated with fragment 324 | 5P7R_A |
| AA | A01.017 | endothiapepsin | treated with fragment 325 | 5P7S_A |
| AA | A01.017 | endothiapepsin | treated with fragment 326 | 5P7T_A |
| AA | A01.017 | endothiapepsin | treated with fragment 327 | 5P7U_A |
| AA | A01.017 | endothiapepsin | treated with fragment 328 | 5P7V_A |
| AA | A01.017 | endothiapepsin | treated with fragment 329 | 5P7W_A |
| AA | A01.017 | endothiapepsin | treated with fragment 330 | 5P7X_A |
| AA | A01.017 | endothiapepsin | treated with fragment 331 | 5P7Y_A |
| AA | A01.017 | endothiapepsin | treated with fragment 332 | 5P7Z_A |
| AA | A01.017 | endothiapepsin | treated with fragment 333 | 5P80_A |
| AA | A01.017 | endothiapepsin | treated with fragment 334 | 5P81_A |
| AA | A01.017 | endothiapepsin | treated with fragment 335 | 5P82_A |
| AA | A01.017 | endothiapepsin | treated with fragment 336 | 5P83_A |
| AA | A01.017 | endothiapepsin | treated with fragment 337 | 5P84_A |
| AA | A01.017 | endothiapepsin | treated with fragment 338 | 5P85_A |
| AA | A01.017 | endothiapepsin | treated with fragment 339 | 5P86_A |
| AA | A01.017 | endothiapepsin | treated with fragment 340 | 5P87_A |
| AA | A01.017 | endothiapepsin | treated with fragment 341 | 5P88_A |
| AA | A01.017 | endothiapepsin | treated with fragment 342 | 5P89_A |
| AA | A01.017 | endothiapepsin | treated with fragment 343 | 5P8A_A |
| AA | A01.017 | endothiapepsin | treated with fragment 344 | 5P8B_A |
| AA | A01.017 | endothiapepsin | treated with fragment 345 | 5P8C_A |
| AA | A01.017 | endothiapepsin | treated with fragment 346 | 5P8D_A |
| AA | A01.017 | endothiapepsin | treated with fragment 347 | 5P8E_A |
| AA | A01.017 | endothiapepsin | treated with fragment 348 | 5P8F_A |
| AA | A01.017 | endothiapepsin | treated with fragment 349 | 5P8G_A |
| AA | A01.017 | endothiapepsin | treated with fragment 350 | 5P8H_A |
| AA | A01.017 | endothiapepsin | treated with fragment 351 | 5P8I_A |
| AA | A01.017 | endothiapepsin | treated with fragment 352 | 5P8J_A |
| AA | A01.017 | endothiapepsin | treated with fragment 353 | 5P8K_A |
| AA | A01.017 | endothiapepsin | treated with fragment 354 | 5P8L_A |
| AA | A01.017 | endothiapepsin | treated with fragment 355 | 5P8M_A |
| AA | A01.017 | endothiapepsin | treated with fragment 356 | 5P8N_A |
| AA | A01.017 | endothiapepsin | treated with fragment 357 | 5P8O_A |
| AA | A01.017 | endothiapepsin | treated with fragment 358 | 5P8P_A |
| AA | A01.017 | endothiapepsin | treated with fragment 359 | 5P8Q_A |
| AA | A01.017 | endothiapepsin | treated with fragment 360 | 5P8R_A |
| AA | A01.017 | endothiapepsin | treated with fragment 361 | 5P8S_A |
| AA | A01.017 | endothiapepsin | treated with fragment 362 | 5P8T_A |
| AA | A01.017 | endothiapepsin | treated with fragment 363 | 5P8U_A |
| AA | A01.017 | endothiapepsin | treated with fragment 364 | 5P8V_A |
| AA | A01.018 | saccharopepsin | complex with IA3 mutant inhibitor | 1DP5_A |
| AA | A01.018 | saccharopepsin | complex with IA3 inhibitor | 1DPJ_A |
| AA | A01.018 | saccharopepsin | 1FMU | |
| AA | A01.018 | saccharopepsin | 1FMX | |
| AA | A01.018 | saccharopepsin | complex with hydroxythylene inhibitor CP-108,420 | 1FQ4 |
| AA | A01.018 | saccharopepsin | complex with cyclic statine inhibitor PD-129,541 | 1FQ5 |
| AA | A01.018 | saccharopepsin | complex with glycol inhibitor PD-133,450 | 1FQ6 |
| AA | A01.018 | saccharopepsin | complex with inhibitor CP-72,647 | 1FQ7 |
| AA | A01.018 | saccharopepsin | complex with difluorostatine inhibitor CP81,198 | 1FQ8 |
| AA | A01.018 | saccharopepsin | complex with proteinase A inhibitor 3 mutant | 1G0V_A |
| AA | A01.018 | saccharopepsin | complex with N-carbonylmorpholine-Phe-norLeu-cyclohexylfluorostatone-methylamine | 2JXR |
| AA | A01.019 | polyporopepsin | 1WKR | |
| AA | A01.020 | phytepsin | zymogen | 1QDM |
| AA | A01.020 | phytepsin | 1B5F_A | |
| AA | A01.020 | phytepsin | 5NFG_A | |
| AA | A01.021 | plasmepsin (Plasmodium sp.) | 1MIQ | |
| AA | A01.021 | plasmepsin (Plasmodium sp.) | complex with pepstatin A inhibitor | 1QS8 |
| AA | A01.021 | plasmepsin (Plasmodium sp.) | complex with allophenylnorstatine inhibitor KNI-764 | 2ANL |
| AA | A01.021 | plasmepsin (Plasmodium sp.) | theoretical model | 1KBX |
| AA | A01.022 | plasmepsin-1 | theoretical model | 1LCR |
| AA | A01.022 | plasmepsin-1 | 1LDU | |
| AA | A01.022 | plasmepsin-1 | 3QRV | |
| AA | A01.022 | plasmepsin-1 | complex with KNI-10006 inhibitor | 3QS1 |
| AA | A01.023 | plasmepsin-2 | theoretical model | 1J8J |
| AA | A01.023 | plasmepsin-2 | complex with inhibitor RS367 | 1LEE |
| AA | A01.023 | plasmepsin-2 | complex with inhibitor RS370 | 1LF2 |
| AA | A01.023 | plasmepsin-2 | complex with EH58 inhibitor | 1LF3 |
| AA | A01.023 | plasmepsin-2 | 1LF4 | |
| AA | A01.023 | plasmepsin-2 | complex with pepstatin A | 1M43 |
| AA | A01.023 | plasmepsin-2 | complex with a statine based inhibitor | 1ME6 |
| AA | A01.023 | plasmepsin-2 | precursor | 1PFZ |
| AA | A01.023 | plasmepsin-2 | complex with pepstatin A | 1SME |
| AA | A01.023 | plasmepsin-2 | complex with TIT inhibitor | 1W6H |
| AA | A01.023 | plasmepsin-2 | complex with pepstatin A | 1W6I |
| AA | A01.023 | plasmepsin-2 | complex with pepstatin A | 1XDH |
| AA | A01.023 | plasmepsin-2 | complex with a pepstatin analogue | 1XE5 |
| AA | A01.023 | plasmepsin-2 | complex with a pepstatin analogue | 1XE6 |
| AA | A01.023 | plasmepsin-2 | complex with N-(R-carboxy-ethyl)-alpha-(S)-(2-phenylethyl) | 2BJU |
| AA | A01.023 | plasmepsin-2 | 2BL3 | |
| AA | A01.023 | plasmepsin-2 | achiral, cheap and potent inhibitors of plasmepsins ii | 2IGX_A |
| AA | A01.023 | plasmepsin-2 | achiral, cheap and potent inhibitors of plasmepsins ii | 2IGY_A |
| AA | A01.023 | plasmepsin-2 | complex with KPFS-(CH2-NH)-LQF | 2R9B_A |
| AA | A01.023 | plasmepsin-2 | re-refinement of uncomplexed plasmepsin ii from plasmodium falciparum. | 3F9Q_A |
| AA | A01.023 | plasmepsin-2 | 4CKU | |
| AA | A01.023 | plasmepsin-2 | 4Y6M | |
| AA | A01.023 | plasmepsin-2 | 4YA8 | |
| AA | A01.027 | trichodermapepsin | 3C9X | |
| AA | A01.027 | trichodermapepsin | complex with pepstatin A | 3C9Y |
| AA | A01.027 | trichodermapepsin | complex with pepstatin A | 3EMY |
| AA | A01.030 | yapsin-1 | theoretical model | 1YPS |
| AA | A01.037 | canditropsin | Complex with Thr-Ile-Thr-Ser | 1J71 |
| AA | A01.038 | candiparapsin | complex with pepstatin | 3FV3 |
| AA | A01.038 | candiparapsin | 3TNE | |
| AA | A01.041 | BACE2 g.p. (Homo sapiens) | complex with hydroxyethylenamine transition-state inhibitor N-(1S,2R)-1-benzyl-2-hydroxy-3-[(3-methylbenzyl)amino]propyldibenzo[B,F]oxepine-10-carboxamide | 2EWY_A |
| AA | A01.041 | BACE2 g.p. (Homo sapiens) | 3ZKG | |
| AA | A01.041 | BACE2 g.p. (Homo sapiens) | 3ZKI | |
| AA | A01.041 | BACE2 g.p. (Homo sapiens) | 3ZKM | |
| AA | A01.041 | BACE2 g.p. (Homo sapiens) | 3ZKN | |
| AA | A01.041 | BACE2 g.p. (Homo sapiens) | 3ZKQ | |
| AA | A01.041 | BACE2 g.p. (Homo sapiens) | 3ZKS | |
| AA | A01.041 | BACE2 g.p. (Homo sapiens) | 3ZKX | |
| AA | A01.041 | BACE2 g.p. (Homo sapiens) | 3ZL7 | |
| AA | A01.041 | BACE2 g.p. (Homo sapiens) | 3ZLQ | |
| AA | A01.041 | BACE2 g.p. (Homo sapiens) | 4BEL | |
| AA | A01.041 | BACE2 g.p. (Homo sapiens) | 4BFB | |
| AA | A01.043 | histoaspartic peptidase (Plasmodium falciparum) | ON HOLD; apoenzyme | 3FNS |
| AA | A01.043 | histoaspartic peptidase (Plasmodium falciparum) | complex with pepstatin A | 3FNT |
| AA | A01.043 | histoaspartic peptidase (Plasmodium falciparum) | complex with inhibitor KNI-10006 | 3FNU |
| AA | A01.043 | histoaspartic peptidase (Plasmodium falciparum) | 3QVC_A | |
| AA | A01.043 | histoaspartic peptidase (Plasmodium falciparum) | complex with kni-10395 | 3QVI_A |
| AA | A01.055 | Mername-AA047 peptidase | 1AM5 | |
| AA | A01.059 | plasmepsin-4 | complex with pepstatin A | 1LS5_A |
| AA | A01.060 | candidapepsin SAP2 | complex with A70450 | 1EAG_A |
| AA | A01.060 | candidapepsin SAP2 | complex with N-ethyl-N-[(4-methylpiperazin-1-yl)carbonyl]- D-phenylalanyl-N-[(1S,2S,4R)-4-(butylcarbamoyl)- 1-(cyclohexylmethyl)-2-hydroxy-5-methylhexyl]- L-norleucinamide | 1ZAP |
| AA | A01.061 | candidapepsin SAP3 | secreted aspartic proteinase (sap) 3 from candida albicans | 2H6S_A |
| AA | A01.061 | candidapepsin SAP3 | complex with pepstatin A | 2H6T_A |
| AA | A01.063 | candidapepsin SAP5 | complex with pepstatin A | 2QZX |
| AA | A01.070 | pepsin A4 | Uropepsin | 1FLH |
| AA | A01.070 | pepsin A4 | pepsin 3A | 1PSN |
| AA | A01.070 | pepsin A4 | pepsin 3A; complex with pepstatin | 1PSO |
| AA | A01.070 | pepsin A4 | complex with phosphonate inhibitor Iva-Val-Val-Leu(P)-(O)Phe-Ala-Ala-Ome | 1QRP |
| AA | A01.070 | pepsin A4 | 3UTL | |
| AA | A01.075 | plasmepsin-5 (Plasmodium sp.) | plasmepsin v from plasmodium vivax bound to a transition state mimetic(wehi-842) | 4ZL4_A |
| AA | A01.075 | plasmepsin-5 (Plasmodium sp.) | plasmepsin v from plasmodium vivax bound to a transition state mimetic(wehi-601) | 6C4G_A |
| AA | A01.076 | Sapp2p peptidase (Candida parapsilosis) | aspartic proteinase sapp2 secreted from candida parapsilosis at 0.82 aresolution. | 4Y9W_A |
| AA | A01.076 | Sapp2p peptidase (Candida parapsilosis) | aspartic proteinase sapp2 secreted from candida parapsilosis at 1.25 aresolution | 4YBF_A |
| AA | A01.950 | cockroach allergen | Asn93Gln mutant | 1YG9 |
| AA | A01.950 | cockroach allergen | Asn93Gln mutant; complex with monoclonal antibody | 2NR6_A |
| AA | A01.950 | cockroach allergen | 3LIZ | |
| AA | A01.950 | cockroach allergen | 4RLD | |
| AA | A01.974 | xylanase inhibitor precursor | 1T6E_X | |
| AA | A01.974 | xylanase inhibitor precursor | complex with Aspergillus niger xylanase-I | 1T6G_A |
| AA | A01.974 | xylanase inhibitor precursor | complex with Bacillus subtilis xylanase | 2B42_A |
| AA | A01.974 | xylanase inhibitor precursor | complex with bacillus subtilis xylanase | 3HD8_A |
| AA | A01.UNB | subfamily A1B non-peptidase homologues | 3VLA_A | |
| AA | A01.UNB | subfamily A1B non-peptidase homologues | 3VLB_A | |
| AA | A01.UNB | subfamily A1B non-peptidase homologues | 4PPH_A | |
| AA | A01.UNB | subfamily A1B non-peptidase homologues | 3AUP | |
| AA | A01.UPA | subfamily A1A unassigned peptidases | 1IZD | |
| AA | A01.UPA | subfamily A1A unassigned peptidases | 1IZE | |
| AA | A01.UPA | subfamily A1A unassigned peptidases | complex with the n-terminal octapeptide of the propeptid | 5N70_A |
| AA | A01.UPA | subfamily A1A unassigned peptidases | 5N71_A | |
| AA | A01.UPA | subfamily A1A unassigned peptidases | zymogen | 5N7N_A |
| AA | A01.UPA | subfamily A1A unassigned peptidases | complex with the inhibitor pepstatin a | 5N7Q_A |
| AA | A01.UPA | subfamily A1A unassigned peptidases | complex with kni-10343 | 5YIA_A |
| AA | A01.UPA | subfamily A1A unassigned peptidases | complex with kni-10743 | 5YIB_A |
| AA | A01.UPA | subfamily A1A unassigned peptidases | complex with kni-10333 | 5YIC_A |
| AA | A01.UPA | subfamily A1A unassigned peptidases | complex with kni-10395 | 5YID_A |
| AA | A01.UPA | subfamily A1A unassigned peptidases | complex with kni-10742 | 5YIE_A |
| AA | A01.UPA | subfamily A1A unassigned peptidases | precursor | 5MKT_A |
| AA | A02.001 | HIV-1 retropepsin | complex with Glu-Asp-Leu inhibitor | 1A30 |
| AA | A02.001 | HIV-1 retropepsin | complex with SDZ283-910 inhibitor | 1A8G |
| AA | A02.001 | HIV-1 retropepsin | complex with CA-P2 peptide substrate analogue | 1A8K |
| AA | A02.001 | HIV-1 retropepsin | complex with Arg-Val-Leu-Phe-Glu-Ala-norLeu-NH2 | 1A94 |
| AA | A02.001 | HIV-1 retropepsin | complex with U-89360E inhibitor | 1A9M |
| AA | A02.001 | HIV-1 retropepsin | complex with methyl N-(4S,5S)-5-[(L-alanyl-L-alanyl)amino]- 4-hydroxy-6-phenylhexanoyl-L-valyl-L-valinate | 1AAQ |
| AA | A02.001 | HIV-1 retropepsin | complex with UCSF8 inhibitor | 1AID |
| AA | A02.001 | HIV-1 retropepsin | complex with AHA006 inhibitor | 1AJV |
| AA | A02.001 | HIV-1 retropepsin | complex with AHA001 inhibitor | 1AJX |
| AA | A02.001 | HIV-1 retropepsin | Ala28Ser mutant | 1AXA |
| AA | A02.001 | HIV-1 retropepsin | complex with macrocyclic peptidomimetic inhibitor 1 | 1B6J |
| AA | A02.001 | HIV-1 retropepsin | complex with macrocyclic peptidomimetic inhibitor 5 | 1B6K |
| AA | A02.001 | HIV-1 retropepsin | complex with macrocyclic peptidomimetic inhibitor 4 | 1B6L |
| AA | A02.001 | HIV-1 retropepsin | complex with macrocyclic peptidomimetic inhibitor 6 | 1B6M |
| AA | A02.001 | HIV-1 retropepsin | complex with macrocyclic peptidomimetic inhibitor 3 | 1B6N |
| AA | A02.001 | HIV-1 retropepsin | complex with macrocyclic peptidomimetic inhibitor 2 | 1B6O |
| AA | A02.001 | HIV-1 retropepsin | complex with macrocyclic peptidomimetic inhibitor 7 | 1B6P |
| AA | A02.001 | HIV-1 retropepsin | mutant; complex with SB203386 inhibitor | 1BDL |
| AA | A02.001 | HIV-1 retropepsin | complex with SB203386 inhibitor | 1BDQ |
| AA | A02.001 | HIV-1 retropepsin | mutant; complex with SB203386 inhibitor | 1BDR |
| AA | A02.001 | HIV-1 retropepsin | Val3Ile, Ile64Val, Val77Ile mutant; complex with cyclic urea amide XV638 | 1BV7 |
| AA | A02.001 | HIV-1 retropepsin | mutant; complex with XV638 (Dupont Pharmaceuticals) | 1BV9 |
| AA | A02.001 | HIV-1 retropepsin | NMR structure; complex with DMP323 | 1BVE |
| AA | A02.001 | HIV-1 retropepsin | NMR structure; complex with DMP323 | 1BVG |
| AA | A02.001 | HIV-1 retropepsin | Val82Phe and Ile84Val double mutant; complex with XV638 (Dupont Pharmaceuticals) | 1BWA |
| AA | A02.001 | HIV-1 retropepsin | Val82Phe and Ile84Val double mutant; complex with SD146 (Dupont Pharmaceuticals) | 1BWB |
| AA | A02.001 | HIV-1 retropepsin | complex with L-739,622 inhibitor | 1C6X |
| AA | A02.001 | HIV-1 retropepsin | complex with L-735,524 inhibitor | 1C6Y |
| AA | A02.001 | HIV-1 retropepsin | complex with ROC 505 inhibitor | 1C6Z |
| AA | A02.001 | HIV-1 retropepsin | complex with L-756,423 inhibitor | 1C70 |
| AA | A02.001 | HIV-1 retropepsin | complex with a cyclic peptide inhibitor | 1CPI |
| AA | A02.001 | HIV-1 retropepsin | complex with inhibitor BEA435 | 1D4H |
| AA | A02.001 | HIV-1 retropepsin | complex with inhibitor BEA425 | 1D4I |
| AA | A02.001 | HIV-1 retropepsin | complex with inhibitor MSL370 | 1D4J |
| AA | A02.001 | HIV-1 retropepsin | complex with N-13-[(10S,13S)-9,12-dioxo-10-(2-butyl)-2-oxa-8,11-diazabicyclo [13.2.2] nonadeca-15,17,18-triene] (2R)-benzyl-(4S)-hydroxy-5-aminopentanoic (1R)- hydroxy-(2S)-indaneamide | 1D4K |
| AA | A02.001 | HIV-1 retropepsin | complex with (10S,13S,1'R)-13-[1'-hydroxy-2'-(N-P-aminobenzenesulfonyl-1''-amino-3''-methylbutyl)ethyl]-8,11-dioxo-10-isopropyl-2-oxa-9,12-diazabicyclo [13.2.2]nonadeca-15,17,18-triene | 1D4L |
| AA | A02.001 | HIV-1 retropepsin | Val82Phe, Ile84Val double mutant; complex with tipranavir inhibitor | 1D4S |
| AA | A02.001 | HIV-1 retropepsin | Gln7Lys, Leu33Ile, Leu63Ile mutant: complex with tipranavir | 1D4Y |
| AA | A02.001 | HIV-1 retropepsin | drug resistant mutant; complex with peptide inhibitor | 1DAZ |
| AA | A02.001 | HIV-1 retropepsin | complex with a difluoroketone containing inhibitor A79285 | 1DIF |
| AA | A02.001 | HIV-1 retropepsin | complex with DMP450 (Dupont-Merck) | 1DMP |
| AA | A02.001 | HIV-1 retropepsin | complex with inhibitor analogue of CA-P2 processing site | 1DW6 |
| AA | A02.001 | HIV-1 retropepsin | drug-resistant mutant | 1EBK |
| AA | A02.001 | HIV-1 retropepsin | complex with inhibitor BEA322 | 1EBW |
| AA | A02.001 | HIV-1 retropepsin | complex with inhibitor BEA369 | 1EBY |
| AA | A02.001 | HIV-1 retropepsin | complex with inhibitor BEA388 | 1EBZ |
| AA | A02.001 | HIV-1 retropepsin | complex with inhibitor BEA403 | 1EC0 |
| AA | A02.001 | HIV-1 retropepsin | complex with inhibitor BEA409 | 1EC1 |
| AA | A02.001 | HIV-1 retropepsin | complex with inhibitor BEA428 | 1EC2 |
| AA | A02.001 | HIV-1 retropepsin | complex with inhibitor MSA367 | 1EC3 |
| AA | A02.001 | HIV-1 retropepsin | complex with Lys-Ala-Arg-Val-Leu-Ala-Glu-Ala-Met-Ser substrate | 1F7A |
| AA | A02.001 | HIV-1 retropepsin | Val48Gly, Met90Leu mutant; complex with saquinavir | 1FB7 |
| AA | A02.001 | HIV-1 retropepsin | complex with substrate acetyl-Thr-Ile-norLeu-norLeu-Gln-Arg | 1FEJ |
| AA | A02.001 | HIV-1 retropepsin | engineered; complex with acetyl-Thr-Ile-norLeu-norLeu-Gln-Arg inhibitor | 1FF0 |
| AA | A02.001 | HIV-1 retropepsin | engineered; complex with Arg-Val-2-amino-4-methyl-pentan-1-ol-Phe-Glu-Ala-norLeu-NH2 inhibitor | 1FFF |
| AA | A02.001 | HIV-1 retropepsin | engineered; complex with acetyl-Thr-Ile-norLeu-norLeu-Gln-Arg inhibitor | 1FFI |
| AA | A02.001 | HIV-1 retropepsin | engineered; complex with acetyl-Thr-Ile-norLeu-norLeu-Gln-Arg inhibitor | 1FG6 |
| AA | A02.001 | HIV-1 retropepsin | engineered; complex with Arg-Val-2-amino-4-methyl-pentan-1-ol-Phe-Glu-Ala-norLeu-NH2 inhibitor | 1FG8 |
| AA | A02.001 | HIV-1 retropepsin | engineered; complex with acetyl-Thr-Ile-norLeu-norLeu-Gln-Arg inhibitor | 1FGC |
| AA | A02.001 | HIV-1 retropepsin | complex with Boc-3(S)-amino-4-phenyl-butan-2(S)-yl-Phe-Glu-Phe-NH2 inhibitor | 1FQX |
| AA | A02.001 | HIV-1 retropepsin | complex with cyclic sulfamide inhibitor AHA047 | 1G2K |
| AA | A02.001 | HIV-1 retropepsin | complex with AHA024 inhibitor | 1G35 |
| AA | A02.001 | HIV-1 retropepsin | homodimer covalently linked through engineered pentapeptide linker | 1G6L |
| AA | A02.001 | HIV-1 retropepsin | Val82Asp mutant; complex with U89360E inhibitor | 1GNM |
| AA | A02.001 | HIV-1 retropepsin | Val82Asn mutant; complex with U89360E inhibitor | 1GNN |
| AA | A02.001 | HIV-1 retropepsin | complex with U89360E inhibitor | 1GNO |
| AA | A02.001 | HIV-1 retropepsin | complex with SB203238 | 1HBV |
| AA | A02.001 | HIV-1 retropepsin | recombinant | 1HEF |
| AA | A02.001 | HIV-1 retropepsin | recombinant | 1HEG |
| AA | A02.001 | HIV-1 retropepsin | recombinant | 1HHP |
| AA | A02.001 | HIV-1 retropepsin | complex with CGP 53820 | 1HIH |
| AA | A02.001 | HIV-1 retropepsin | 1HIV | |
| AA | A02.001 | HIV-1 retropepsin | complex with SB204144 | 1HOS |
| AA | A02.001 | HIV-1 retropepsin | mutant form; complex with benzenesulfonamide inhibitor U103265 | 1HPO |
| AA | A02.001 | HIV-1 retropepsin | 1HPS | |
| AA | A02.001 | HIV-1 retropepsin | complex with VX-478 | 1HPV |
| AA | A02.001 | HIV-1 retropepsin | complex with inhibitor KNI-272 | 1HPX |
| AA | A02.001 | HIV-1 retropepsin | complex with L-735,524 | 1HSG |
| AA | A02.001 | HIV-1 retropepsin | complex with GR123976 | 1HTE |
| AA | A02.001 | HIV-1 retropepsin | complex with GR126045 | 1HTF |
| AA | A02.001 | HIV-1 retropepsin | complex with GR137615 | 1HTG |
| AA | A02.001 | HIV-1 retropepsin | complex with A-76928 | 1HVC |
| AA | A02.001 | HIV-1 retropepsin | complex with Q8261 inhibitor | 1HVH |
| AA | A02.001 | HIV-1 retropepsin | complex with A77003 | 1HVI |
| AA | A02.001 | HIV-1 retropepsin | complex with A78791 | 1HVJ |
| AA | A02.001 | HIV-1 retropepsin | complex with A-76928 | 1HVK |
| AA | A02.001 | HIV-1 retropepsin | complex with A76889 | 1HVL |
| AA | A02.001 | HIV-1 retropepsin | theoretical model | 1HVP |
| AA | A02.001 | HIV-1 retropepsin | complex with XK263 | 1HVR |
| AA | A02.001 | HIV-1 retropepsin | Val82Ala mutant; complex with A77003 | 1HVS |
| AA | A02.001 | HIV-1 retropepsin | complex with synthetic cyclic urea inhibitor XK216 | 1HWR |
| AA | A02.001 | HIV-1 retropepsin | complex with RO 31-8959 | 1HXB |
| AA | A02.001 | HIV-1 retropepsin | complex with A-84538 | 1HXW |
| AA | A02.001 | HIV-1 retropepsin | 1IHV | |
| AA | A02.001 | HIV-1 retropepsin | 1IHW | |
| AA | A02.001 | HIV-1 retropepsin | complex with hydroxyethylamine peptidomimetic inhibitor Boc-Pso-Phe-Gln-Phe-NH2 | 1IIQ |
| AA | A02.001 | HIV-1 retropepsin | complex with inhibitor Q50 | 1IZH |
| AA | A02.001 | HIV-1 retropepsin | complex with inhibitor Q50 | 1IZI |
| AA | A02.001 | HIV-1 retropepsin | engineered multiple mutant form | 1K1T |
| AA | A02.001 | HIV-1 retropepsin | engineered multiple mutant form | 1K1U |
| AA | A02.001 | HIV-1 retropepsin | engineered multiple mutant form | 1K2B |
| AA | A02.001 | HIV-1 retropepsin | engineered multiple mutant form | 1K2C |
| AA | A02.001 | HIV-1 retropepsin | complex with inhibitor MK1 | 1K6C |
| AA | A02.001 | HIV-1 retropepsin | complex with inhibitor XN3 | 1K6P |
| AA | A02.001 | HIV-1 retropepsin | complex with inhibitor XN1 | 1K6T |
| AA | A02.001 | HIV-1 retropepsin | complex with inhibitor XN2 | 1K6V |
| AA | A02.001 | HIV-1 retropepsin | complex with GAG protein fragment | 1KJ4 |
| AA | A02.001 | HIV-1 retropepsin | complex with GAG protein fragment | 1KJ7 |
| AA | A02.001 | HIV-1 retropepsin | complex with GAG protein fragment | 1KJF |
| AA | A02.001 | HIV-1 retropepsin | complex with decapeptide substrate | 1KJG |
| AA | A02.001 | HIV-1 retropepsin | complex with POL protein fragment | 1KJH |
| AA | A02.001 | HIV-1 retropepsin | complex with inhibitor JE-2147 | 1KZK |
| AA | A02.001 | HIV-1 retropepsin | engineered tethered dimer | 1LV1 |
| AA | A02.001 | HIV-1 retropepsin | Ala71Val, Val82Thr, Ile84Val mutant; complex with Boc-Phe-Psi[CH2CH2NH]-Phe-Glu-Phe-NH2 | 1LZQ |
| AA | A02.001 | HIV-1 retropepsin | complex with Boc-Phe-Psi[CH2CH2NH]-Phe-Glu-Phe-NH2 | 1M0B_A |
| AA | A02.001 | HIV-1 retropepsin | complex with DMP450 | 1MER |
| AA | A02.001 | HIV-1 retropepsin | Ile84Val mutant; complex with DMP323 | 1MES |
| AA | A02.001 | HIV-1 retropepsin | Val82Phe mutant; complex with DMP323 | 1MET |
| AA | A02.001 | HIV-1 retropepsin | Val82Phe, Ile84Val mutant; complex with DMP323 | 1MEU |
| AA | A02.001 | HIV-1 retropepsin | Gln7lys/Leu33Ile/Leu63Ile mutant; complex with kni-577 | 1MRW_A |
| AA | A02.001 | HIV-1 retropepsin | mutant q7k l33i l63i v82f i84v; complex with kni-577 | 1MRX_A |
| AA | A02.001 | HIV-1 retropepsin | Gln7Lys, Leu33Ile, Leu63Ile mutant; complex with KNI-764 inhibitor | 1MSM_A |
| AA | A02.001 | HIV-1 retropepsin | Gln7Lys, Leu33Ile, Leu63Ile, Val82Phe, Ile84Valmutant; complex with KNI-764 inhibitor | 1MSN_A |
| AA | A02.001 | HIV-1 retropepsin | complex with GAG protein fragment | 1MT7 |
| AA | A02.001 | HIV-1 retropepsin | complex with GAG protein fragment | 1MT8 |
| AA | A02.001 | HIV-1 retropepsin | complex with GAG protein fragment | 1MT9 |
| AA | A02.001 | HIV-1 retropepsin | complex with Saquinavir | 1MTB |
| AA | A02.001 | HIV-1 retropepsin | complex with a cyclic Phe-Ile-Val peptidomimetic inhibitor | 1MTR |
| AA | A02.001 | HIV-1 retropepsin | complex with lopinavir | 1MUI |
| AA | A02.001 | HIV-1 retropepsin | complex with Ritonavir | 1N49 |
| AA | A02.001 | HIV-1 retropepsin | 1.03 a structure of hiv-1 protease: inhibitor binding inside and outside the active site | 1NH0_A |
| AA | A02.001 | HIV-1 retropepsin | complex with LDC271 | 1NPV |
| AA | A02.001 | HIV-1 retropepsin | complex with inhibitor LGZ479 | 1NPW |
| AA | A02.001 | HIV-1 retropepsin | 1ODW | |
| AA | A02.001 | HIV-1 retropepsin | Ala71Thr, Val82Ala mutant | 1ODX |
| AA | A02.001 | HIV-1 retropepsin | complex with inhibitor LP-130 | 1ODY |
| AA | A02.001 | HIV-1 retropepsin | complex with nelfinavir mesylate AG1343 inhibitor | 1OHR |
| AA | A02.001 | HIV-1 retropepsin | dimer; complex with A-98881 | 1PRO |
| AA | A02.001 | HIV-1 retropepsin | complex with inhibitor XV638 | 1QBR |
| AA | A02.001 | HIV-1 retropepsin | complex with inhibitor DMP323 | 1QBS |
| AA | A02.001 | HIV-1 retropepsin | complex with inhibitor SD146 | 1QBT |
| AA | A02.001 | HIV-1 retropepsin | complex with inhibitor Q8467 (Dupont-Merck) | 1QBU |
| AA | A02.001 | HIV-1 retropepsin | resistant strain (Val82Ala mutant); complex with ritonavir | 1RL8_A |
| AA | A02.001 | HIV-1 retropepsin | multidrug-resistant hiv-1 protease | 1RV7_A |
| AA | A02.001 | HIV-1 retropepsin | complex with SB203386 | 1SBG |
| AA | A02.001 | HIV-1 retropepsin | Val82Ala and Ile90Met mutant; complex with indinavir | 1SDT_A |
| AA | A02.001 | HIV-1 retropepsin | Val82Ala and Ile90Met mutant | 1SDU_A |
| AA | A02.001 | HIV-1 retropepsin | Val82Ala and Ile90Met mutant | 1SDV_A |
| AA | A02.001 | HIV-1 retropepsin | comparing the accumulation of active site and non-active site mutations in the hiv-1 protease | 1SGU_A |
| AA | A02.001 | HIV-1 retropepsin | comparing the accumulation of active site and non-active site mutations in the hiv-1 protease | 1SH9_A |
| AA | A02.001 | HIV-1 retropepsin | complex with a product of autoproteolysis | 1SP5_A |
| AA | A02.001 | HIV-1 retropepsin | complex with TMC114 inhibitor | 1T3R_A |
| AA | A02.001 | HIV-1 retropepsin | triple mutant; complex with SB203386 | 1TCX |
| AA | A02.001 | HIV-1 retropepsin | Val82Ala/Asp25Asn mutant; complex with AP2V substrate variant of NC-P1 decamer peptide | 1TSQ_A |
| AA | A02.001 | HIV-1 retropepsin | Val82Ala/Asp25Asn mutant; complex with AP2V substrate variant of NC-P1 decamer peptide | 1TSQ_P |
| AA | A02.001 | HIV-1 retropepsin | wild-type Asp25Asn variant; complex with decamer NCP1 substrate peptide | 1TSU_A |
| AA | A02.001 | HIV-1 retropepsin | wild-type Asp25Asn variant; complex with decamer NCP1 substrate peptide | 1TSU_P |
| AA | A02.001 | HIV-1 retropepsin | peptidase domain only; multi-drug resistant isolate | 1TW7 |
| AA | A02.001 | HIV-1 retropepsin | complex with peptidomimetic inhibitor KI2-Phe-Glu-Glu-NH2 | 1U8G_A |
| AA | A02.001 | HIV-1 retropepsin | complex with [3-[1-(4-bromophenyl)isobutyl]-4-hydroxycoumarin (U095438) | 1UPJ |
| AA | A02.001 | HIV-1 retropepsin | complex with HOE/BAY 793 inhibitor | 1VIJ |
| AA | A02.001 | HIV-1 retropepsin | compex with HOE/BAY 793 inhibitor, orthorhombic form | 1VIK |
| AA | A02.001 | HIV-1 retropepsin | complex with fluoro substituted diol- based c2-symmetric inhibitor N,N-[2,5-O-di-3-fluoro-benzyl-glucaryl]-di-[1-amino-indan-2-ol] | 1W5V_A |
| AA | A02.001 | HIV-1 retropepsin | complex with fluoro substituted diol- based c2-symmetric inhibitor (2R,3R,4R,5R)-2,5-bis[(2,4-difluorobenzyl)oxy]-3,4-dihydroxy-N,N'-bis[(1R,2S)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]hexanediamide | 1W5W_A |
| AA | A02.001 | HIV-1 retropepsin | complex with fluoro substituted diol- based c2-symmetric inhibitor (2R,3R,4R,5R)-2,5-bis[(2,3-difluorobenzyl)oxy]-3,4-dihydroxy-N,N'-bis[(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]hexanediamide | 1W5X_A |
| AA | A02.001 | HIV-1 retropepsin | complex with fluoro substituted diol- based c2-symmetric inhibitor (2R,3R,4R,5R)-2,5-bis[(2,5-difluorobenzyl)oxy]-3,4-dihydroxy-N,N'-bis[(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]hexanediamide | 1W5Y_A |
| AA | A02.001 | HIV-1 retropepsin | complex with asymmetric inhibitor BEA568 | 1WBK_A |
| AA | A02.001 | HIV-1 retropepsin | complex with symmetric inhibitor BEA450 | 1WBM_A |
| AA | A02.001 | HIV-1 retropepsin | complex with pyrrolidinmethanamine | 1XL2_A |
| AA | A02.001 | HIV-1 retropepsin | complex with amidhyroxysulfone | 1XL5_A |
| AA | A02.001 | HIV-1 retropepsin | complex with Pro-Ile-Val-NH2 peptide product | 1YTG |
| AA | A02.001 | HIV-1 retropepsin | complex with ac-Ser-Leu-Asn-Phe peptide product | 1YTH |
| AA | A02.001 | HIV-1 retropepsin | complex with macrocyclic peptidomimetic inhibitor 3 | 1Z1H_A |
| AA | A02.001 | HIV-1 retropepsin | complex with macrocyclic peptidomimetic inhibitor 2 | 1Z1R_A |
| AA | A02.001 | HIV-1 retropepsin | lle63Pro, Ala71Val, Val82Thr, Ile84Val mutant; complex with a hydroxyethylamine peptidomimetic inhibitor Boc-Phe-psi[r-CH(OH)CH2NH]-Phe-Glu-Phe-NH2 | 1Z8C_A |
| AA | A02.001 | HIV-1 retropepsin | Ala71Val, Val82Thr, Ile84Val mutant; complex with a hydroxyethylamine peptidomimetic inhibitor Boc-Phe-psi[r-CH(OH)CH2NH]-Phe-Glu-Phe-NH2 | 1ZBG_A |
| AA | A02.001 | HIV-1 retropepsin | Ala71Val, Val82Thr, Ile84Val mutant; complex with a hydroxyethylamine peptidomimetic inhibitor Boc-Phe-psi[r-CH(OH)CH2NH]-Phe-Glu-Phe-NH2 | 1ZJ7_A |
| AA | A02.001 | HIV-1 retropepsin | Ala71Val, Val82Thr, Ile84Val mutant; complex with a hydroxyethylamine peptidomimetic inhibitor | 1ZLF_A |
| AA | A02.001 | HIV-1 retropepsin | Ala71Val, Val82Thr, Ile84Val mutant; complex with a hydroxyethylamine peptidomimetic inhibitor Boc-Phe-psi[r-CH(OH)CH2NH]-Phe-Glu-Phe-NH2 | 1ZPK_A |
| AA | A02.001 | HIV-1 retropepsin | complex with a hydroxyethylamine inhibitor N-(2R,3S)-3-[(tert-butoxycarbonyl)amino]-2-hydroxy-4-phenylbutyl-L-phenylalanyl-L-alpha-glutamyl-L-phenylalaninamide | 1ZSF_A |
| AA | A02.001 | HIV-1 retropepsin | complex with a hydroxyethylamine peptidomimetic inhibitor Boc-Phe-psi[r-CH(OH)CH2NH]-Phe-Glu-Phe-NH2 | 1ZSR_A |
| AA | A02.001 | HIV-1 retropepsin | complex with cobalt bis(1,2-dicarbollide) | 1ZTZ_A |
| AA | A02.001 | HIV-1 retropepsin | complex with ts-126 | 2A1E_A |
| AA | A02.001 | HIV-1 retropepsin | synthesis and activity of n-axyl azacyclic urea hiv-1 protease inhibitors with high potency against multiple drug resistant viral strains. | 2A4F_A |
| AA | A02.001 | HIV-1 retropepsin | complex with UCSF8 inhibitor | 2AID |
| AA | A02.001 | HIV-1 retropepsin | Ile84Val mutant; complex with a substrate analog p2-nc | 2AOC_A |
| AA | A02.001 | HIV-1 retropepsin | complex with a substrate analog p2-nc | 2AOD_A |
| AA | A02.001 | HIV-1 retropepsin | Val82Ala mutant; complex with a substrate analog ca-p2 | 2AOE_A |
| AA | A02.001 | HIV-1 retropepsin | Val82Ala mutant; complex with a substrate analog p1-p6 | 2AOF_A |
| AA | A02.001 | HIV-1 retropepsin | Val82Ala mutant; complex with a substrate analog p2-nc | 2AOG_A |
| AA | A02.001 | HIV-1 retropepsin | Val82Ala mutant; complex with a substrate analog p6-pr | 2AOH_A |
| AA | A02.001 | HIV-1 retropepsin | complex with a substrate analog p1-p6 | 2AOI_A |
| AA | A02.001 | HIV-1 retropepsin | complex with a substrate analog p6-pr | 2AOJ_A |
| AA | A02.001 | HIV-1 retropepsin | complex with atazanavir | 2AQU_A |
| AA | A02.001 | HIV-1 retropepsin | kinetics, stability, and structural changes in high resolution crystalstructures of hiv-1 protease with drug resistant mutations l24i, i50v, and g73s | 2AVM_A |
| AA | A02.001 | HIV-1 retropepsin | kinetics, stability, and structural changes in high resolution crystalstructures of hiv-1 protease with drug resistant mutations l24i, i50v, and g73s | 2AVO_A |
| AA | A02.001 | HIV-1 retropepsin | kinetics, stability, and structural changes in high resolution crystalstructures of hiv-1 protease with drug resistant mutations l24i, i50v, and g73s | 2AVQ_A |
| AA | A02.001 | HIV-1 retropepsin | kinetics, stability, and structural changes in high resolution crystal structures of hiv-1 protease with drug resistant mutations l24i, i50v, and g73s | 2AVS_A |
| AA | A02.001 | HIV-1 retropepsin | kinetics, stability, and structural changes in high resolution crystal structures of hiv-1 protease with drug resistant mutations l24i, i50v, and g73s | 2AVV_A |
| AA | A02.001 | HIV-1 retropepsin | ML4-3 mutant; complex with inhibitorTL3 | 2AZ8_A |
| AA | A02.001 | HIV-1 retropepsin | hiv-1 protease nl4-3 1x mutant | 2AZ9_A |
| AA | A02.001 | HIV-1 retropepsin | NL4-3 3X mutant; complex with inhibitorTL-3 | 2AZB_A |
| AA | A02.001 | HIV-1 retropepsin | hiv-1 protease nl4-3 6x mutant ***caveat 2azc incorrect chirality at ca of ala j 201 | 2AZC_A |
| AA | A02.001 | HIV-1 retropepsin | complex with ritonavir | 2B60_A |
| AA | A02.001 | HIV-1 retropepsin | mutant; complex with indinavir | 2B7Z_B |
| AA | A02.001 | HIV-1 retropepsin | complex with akc4p_133a | 2BB9_A |
| AA | A02.001 | HIV-1 retropepsin | complex with hh1_173_3a | 2BBB_A |
| AA | A02.001 | HIV-1 retropepsin | complex with L-738,317 inhibitor | 2BPV |
| AA | A02.001 | HIV-1 retropepsin | complex with L-738,317 inhibitor | 2BPW |
| AA | A02.001 | HIV-1 retropepsin | complex with L-735,524 inhibitor | 2BPX |
| AA | A02.001 | HIV-1 retropepsin | complex with L-739,622 inhibitor | 2BPY |
| AA | A02.001 | HIV-1 retropepsin | complex with L-739,622 inhibitor | 2BPZ |
| AA | A02.001 | HIV-1 retropepsin | complex with inhibitor AHA455 | 2BQV_A |
| AA | A02.001 | HIV-1 retropepsin | wild-type; complex with r01 | 2F3K_A |
| AA | A02.001 | HIV-1 retropepsin | Asp30Asn mutant; complex with inhibitor TMC114 | 2F80_A |
| AA | A02.001 | HIV-1 retropepsin | Leu90Met mutant; complex with inhibitor TMC114 | 2F81_A |
| AA | A02.001 | HIV-1 retropepsin | Ile50Val mutant; complex with inhibitor TMC114 | 2F8G_A |
| AA | A02.001 | HIV-1 retropepsin | Thr80Ser variant; complex with the inhibitor saquinavir | 2FGU_A |
| AA | A02.001 | HIV-1 retropepsin | Thrt80Asn variant; complex with the inhibitor saquinavir | 2FGV_A |
| AA | A02.001 | HIV-1 retropepsin | Asp25Asn mutant; complex with wild-type HIV-1 NC-P1 substrate. | 2FNS_A |
| AA | A02.001 | HIV-1 retropepsin | drug-resistant (Val82Ala) inactive (Asp25Asn) mutant; complex with AP2V variant of hiv-1 NC-P1 substrate. | 2FNT_A |
| AA | A02.001 | HIV-1 retropepsin | structure of hiv protease 6x mutant in apo form | 2HB2_A |
| AA | A02.001 | HIV-1 retropepsin | complex with potent inhibitor GRL06579 | 2HB3_A |
| AA | A02.001 | HIV-1 retropepsin | structure of hiv protease nl4-3 in an unliganded state | 2HB4_A |
| AA | A02.001 | HIV-1 retropepsin | 6x mutant; complex with AB-2. | 2HC0_A |
| AA | A02.001 | HIV-1 retropepsin | recombinant | 2HVP |
| AA | A02.001 | HIV-1 retropepsin | complex with KB-19 | 2I0A_A |
| AA | A02.001 | HIV-1 retropepsin | complex with AD-81 | 2I0D_A |
| AA | A02.001 | HIV-1 retropepsin | complex with inhibitor jg-365 | 2J9J_A |
| AA | A02.001 | HIV-1 retropepsin | complex with inhibitor MVT-101 | 2J9K_A |
| AA | A02.001 | HIV-1 retropepsin | complex with jg-365 | 2JE4_A |
| AA | A02.001 | HIV-1 retropepsin | Val82Ala mutant; complex with a inhibitor saquinavir | 2NMY_A |
| AA | A02.001 | HIV-1 retropepsin | Val82Ala mutant; complex with a inhibitor saquinavir | 2NMZ_A |
| AA | A02.001 | HIV-1 retropepsin | Ile84Val mutant; complex with a inhibitor saquinavir | 2NNK_A |
| AA | A02.001 | HIV-1 retropepsin | Ile84Val mutant; complex with a inhibitor saquinavir | 2NNP_A |
| AA | A02.001 | HIV-1 retropepsin | complex with product in situ | 2NPH_A |
| AA | A02.001 | HIV-1 retropepsin | Asp25Asn mutant; complex with rt-rh analogue peptide gly-ala-asp-ile-phe*tyr-leu-asp-gly-ala | 2NXD_A |
| AA | A02.001 | HIV-1 retropepsin | Asp25Asn mutant; complex with peptide Gly-Ala-Glu-Val-Phe*Tyr-Val-Asp-Gly-Ala | 2NXL_A |
| AA | A02.001 | HIV-1 retropepsin | Asp25Asn mutant; complex with the rt-rh analogue peptide gly-ala-gln-thr-phe*tyr-val-asp-gly-ala | 2NXM_A |
| AA | A02.001 | HIV-1 retropepsin | Gln7Lys mutant; complex with Atazanavir | 2O4K_A |
| AA | A02.001 | HIV-1 retropepsin | Gln7Lys, Ile50Val mutant; complex with Tipranavir | 2O4L_A |
| AA | A02.001 | HIV-1 retropepsin | TRM mutant; complex with Tipranavir | 2O4N_A |
| AA | A02.001 | HIV-1 retropepsin | Gln7Lys mutant; complex with Tipranavir | 2O4P_A |
| AA | A02.001 | HIV-1 retropepsin | Gln7Lys mutant; complex with Lopinavir | 2O4S_A |
| AA | A02.001 | HIV-1 retropepsin | complex with TL-3 inhibitor | 2P3B_A |
| AA | A02.001 | HIV-1 retropepsin | subtype F; complex with TL-3 inhibitor | 2P3C_A |
| AA | A02.001 | HIV-1 retropepsin | multi-drug resistant mutant subtype F; complex with TL-3 inhibitor | 2P3D_A |
| AA | A02.001 | HIV-1 retropepsin | apo wild-type hiv protease in the open conformation | 2PC0_A |
| AA | A02.001 | HIV-1 retropepsin | Gln7Lys, Leu33Ile, Leu63Ile mutant; complex with KNI-10075 | 2PK5_A |
| AA | A02.001 | HIV-1 retropepsin | Gln7Lys, Leu33Ile, Leu63Ile mutant; complex with KNI-10033 | 2PK6_A |
| AA | A02.001 | HIV-1 retropepsin | complex with N,N'-(3S,4S)-pyrrolidine-3,4-diylbis(N-benzylbenzenesulfonamide) | 2PQZ_A |
| AA | A02.001 | HIV-1 retropepsin | complex with CARB-AD37 | 2PSU_A |
| AA | A02.001 | HIV-1 retropepsin | complex with CARB-KB45 | 2PSV_A |
| AA | A02.001 | HIV-1 retropepsin | complex with N,N'-(3S,4S)-pyrrolidine-3,4-diylbis(4-amino-N-benzylbenzenesulfonamide) | 2PWC_A |
| AA | A02.001 | HIV-1 retropepsin | complex with 4,4'-(3S,4S)-pyrrolidine-3,4-diylbis[(benzylimino)sulfonyl]dibenzamide | 2PWR_A |
| AA | A02.001 | HIV-1 retropepsin | mutant; complex with nelfinavir | 2PYM_A |
| AA | A02.001 | HIV-1 retropepsin | mutant; complex with Nelfinavir | 2PYN_A |
| AA | A02.001 | HIV-1 retropepsin | complex with a lysine sulfonamide inhibitor | 2Q3K_A |
| AA | A02.001 | HIV-1 retropepsin | complex with KB73 | 2Q54_A |
| AA | A02.001 | HIV-1 retropepsin | complex with KK44 | 2Q55_A |
| AA | A02.001 | HIV-1 retropepsin | complex with lopinavir | 2Q5K_A |
| AA | A02.001 | HIV-1 retropepsin | mutant; complex with nelfinavir | 2Q63_A |
| AA | A02.001 | HIV-1 retropepsin | mutant; complex with nelfinavir | 2Q64_A |
| AA | A02.001 | HIV-1 retropepsin | mutant; complex with nelfinavir | 2QAK_A |
| AA | A02.001 | HIV-1 retropepsin | hiv-1 protease mutant d30n with potent antiviral inhibitor grl-98065 | 2QCI_A |
| AA | A02.001 | HIV-1 retropepsin | hiv-1 protease mutant i50v with potent antiviral inhibitor grl-98065 | 2QD6_A |
| AA | A02.001 | HIV-1 retropepsin | hiv-1 protease mutant v82a with potent antiviral inhibitor grl-98065 | 2QD7_A |
| AA | A02.001 | HIV-1 retropepsin | hiv-1 protease mutant i84v with potent antiviral inhibitor grl-98065 | 2QD8_A |
| AA | A02.001 | HIV-1 retropepsin | the influence of i47a mutation on reduced susceptibility to the protease inhibitor lopinavir | 2QHC_A |
| AA | A02.001 | HIV-1 retropepsin | complex with inhibitor MIT-1-AC6 | 2QHY_A |
| AA | A02.001 | HIV-1 retropepsin | complex with inhibitor MIT-1-AC87 | 2QHZ_A |
| AA | A02.001 | HIV-1 retropepsin | complex with inhibitor MIT-1-KK80 | 2QI0_A |
| AA | A02.001 | HIV-1 retropepsin | complex with inhibitor MIT-1-KK81 | 2QI1_A |
| AA | A02.001 | HIV-1 retropepsin | complex with inhibitor MIT-2-AD94 | 2QI3_A |
| AA | A02.001 | HIV-1 retropepsin | complex with inhibitor MIT-2-AD93 | 2QI4_A |
| AA | A02.001 | HIV-1 retropepsin | complex with inhibitor MIT-2-KC08 | 2QI5_A |
| AA | A02.001 | HIV-1 retropepsin | complex with inhibitor MIT-2-KB98 | 2QI6_A |
| AA | A02.001 | HIV-1 retropepsin | complex with inhibitor MIT-2-AD86 | 2QI7_A |
| AA | A02.001 | HIV-1 retropepsin | complex with PL-100 | 2QMP_A |
| AA | A02.001 | HIV-1 retropepsin | complex with 4,4'-[(3S,4S)-pyrrolidine-3,4-diylbis([4- (trifluoromethyl)benzyl]iminosulfonyl)]dibenzamide | 2QNN_A |
| AA | A02.001 | HIV-1 retropepsin | complex with | 2QNP_A |
| AA | A02.001 | HIV-1 retropepsin | complex with a chloro decorated pyrrolidine-based inhibitor | 2QNQ_A |
| AA | A02.001 | HIV-1 retropepsin | i84v hiv-1 protease mutant in complex with a carbamoyl decorated pyrrolidine-based inhibitor | 2R38_A |
| AA | A02.001 | HIV-1 retropepsin | Ile50Val mutant; complex with a carbamoyl decorated pyrrolidine-based inhibitor | 2R3T_A |
| AA | A02.001 | HIV-1 retropepsin | Ile84Val mutant; complex with a amino decorated pyrrolidine-based inhibitor | 2R3W_A |
| AA | A02.001 | HIV-1 retropepsin | i50v hiv-1 protease in complex with an amino decorated pyrrolidine-based inhibitor | 2R43_A |
| AA | A02.001 | HIV-1 retropepsin | subtype c protease; complex with indinavir | 2R5P_A |
| AA | A02.001 | HIV-1 retropepsin | subtype c; complex with nelfinavir | 2R5Q_A |
| AA | A02.001 | HIV-1 retropepsin | subtype C | 2R8N |
| AA | A02.001 | HIV-1 retropepsin | complex with U100313 | 2UPJ |
| AA | A02.001 | HIV-1 retropepsin | two-carbon-elongated hiv-1 protease inhibitors with a tertiary-alcohol-containing transition-state mimic | 2UXZ_A |
| AA | A02.001 | HIV-1 retropepsin | two-carbon-elongated hiv-1 protease inhibitors with a tertiary-alcohol-containing transition-state mimic | 2UY0_A |
| AA | A02.001 | HIV-1 retropepsin | hiv-1 protease inhibitors containing a tertiary alcohol in the transition-state mimic with improved cell-based antiviral activity | 2WKZ_A |
| AA | A02.001 | HIV-1 retropepsin | wild type hiv-1 protease with potent antiviral inhibitor grl-98065 | 2Z4O_A |
| AA | A02.001 | HIV-1 retropepsin | Ile47Ala mutant on reduced susceptibility to the protease inhibitor lopinavir | 2Z54_A |
| AA | A02.001 | HIV-1 retropepsin | complex with (3S,4S),-3,4-Bis-[(4-carbamoyl-benzensulfonyl)- (3-methyl-but-2-enyl)-amino]-pyrrolidine | 2ZGA_A |
| AA | A02.001 | HIV-1 retropepsin | complex with potent inhibitor KNI-272 | 2ZYE_A |
| AA | A02.001 | HIV-1 retropepsin | complex with kni-1689 | 3A2O_A |
| AA | A02.001 | HIV-1 retropepsin | complex with benzoylamino-benzyl-methyl-[2-hydroxy-3-[1-methyl-ethyl-oxy-N-formamidyl]-4-phenyl-butyl]-ammonium | 3AID |
| AA | A02.001 | HIV-1 retropepsin | complex with gem-diol-amine tetrahedral intermediate nlltqi | 3B7V_A |
| AA | A02.001 | HIV-1 retropepsin | Ile54Val mutant; complex with gem-diol-amine intermediate nlltqi | 3B80_A |
| AA | A02.001 | HIV-1 retropepsin | Ile84Val mutant; complex with a pyrrolidine diester | 3BC4_A |
| AA | A02.001 | HIV-1 retropepsin | complex with N,N'-(iminodiethane-2,1-diyl)bis[4-amino- N-(2-methylpropyl)benzenesulfonamide] | 3BGB_A |
| AA | A02.001 | HIV-1 retropepsin | complex with N,N'-(iminodiethane-2,1-diyl)bis(4-amino- N-benzylbenzenesulfonamide) | 3BGC_A |
| AA | A02.001 | HIV-1 retropepsin | complex with a three armed pyrrolidine derivative | 3BHE_A |
| AA | A02.001 | HIV-1 retropepsin | Asp25Asn mutant; complex with p2-nc analog inhibitor | 3BVA_A |
| AA | A02.001 | HIV-1 retropepsin | cystal structure of hiv-1 active site mutant d25n and inhibitor darunavir | 3BVB_A |
| AA | A02.001 | HIV-1 retropepsin | crystal structures of highly constrained substrate and hydrolysis products bound to hiv-1 protease. implications for catalytic mechanism | 3BXR_A |
| AA | A02.001 | HIV-1 retropepsin | crystal structures of highly constrained substrate and hydrolysis products bound to hiv-1 protease. implications for catalytic mechanism | 3BXS_A |
| AA | A02.001 | HIV-1 retropepsin | complex with (3S,4S),-3,4-Bis-[(4-carbamoyl-benzensulfonyl)- (3-methyl-but-2-enyl)-amino]-pyrrolidine (orthorhombic space group) | 3CKT_A |
| AA | A02.001 | HIV-1 retropepsin | effect of flap mutations inhibition by saquinavir and darunavir | 3CYW_A |
| AA | A02.001 | HIV-1 retropepsin | Ile50Val mutant; complex with inhibitor saquinavir | 3CYX_A |
| AA | A02.001 | HIV-1 retropepsin | Ile54Met mutant; complex with inhibitor saquinavir | 3D1X_A |
| AA | A02.001 | HIV-1 retropepsin | Ile54Val mutant; complex with inhibitor saquinavir | 3D1Y_A |
| AA | A02.001 | HIV-1 retropepsin | Ile54Met mutant; complex with inhibitor darunavir | 3D1Z_A |
| AA | A02.001 | HIV-1 retropepsin | Ile54Val mutant; complex with inhibitor darunavia | 3D20_A |
| AA | A02.001 | HIV-1 retropepsin | complex with substrate p1-p6 | 3D3T_A |
| AA | A02.001 | HIV-1 retropepsin | wild type hiv-1 protease with potent antiviral inhibitor grl-0255a | 3DJK_A |
| AA | A02.001 | HIV-1 retropepsin | wild type hiv-1 protease with potent antiviral inhibitor grl-0105a | 3DK1_A |
| AA | A02.001 | HIV-1 retropepsin | multidrug resistant variant (Leu10Ile/Gly48Val/Ile54Val/Val64Ile/Val82Ala); complex with inhibitor amprenavir (apv) | 3EKP_A |
| AA | A02.001 | HIV-1 retropepsin | multi-drug resistant form (Leu63Pro/Val82Thr/Ile84Val); complex with inhibitor saquinavir (sqv) | 3EKQ_A |
| AA | A02.001 | HIV-1 retropepsin | multi-drug resistant variant (Leu10Phe/Gly48Val/Ile54Val/Val64Ile/Val82Ala); complex with darunavir (drv) | 3EKT_A |
| AA | A02.001 | HIV-1 retropepsin | wild type; complex with the inhibitor, amprenavir | 3EKV_A |
| AA | A02.001 | HIV-1 retropepsin | multi-drug resistance variant (Leu10Ile/Gly48Val/Ile54Val/Val64Ile/Val82Ala); complex with the inhibitor atazanavir (atv) in complex with a refer: flap+ in citation. | 3EKW_A |
| AA | A02.001 | HIV-1 retropepsin | wild-type; complex with the inhibitor nelfinavir | 3EKX_A |
| AA | A02.001 | HIV-1 retropepsin | wild-type; complex with the inhibitor, atazanavir | 3EKY_A |
| AA | A02.001 | HIV-1 retropepsin | multi-drug resistant variant (Leu10Ile/Gly48Val/Ile54Val/Val64Ile/Val82Ala); in complex with inhibitor nelfinavir (nfv) | 3EL0_A |
| AA | A02.001 | HIV-1 retropepsin | wild-type; complex with the inhibitor, atazanavir | 3EL1_A |
| AA | A02.001 | HIV-1 retropepsin | drug resistant Ile50Leu/Ala71Val variant; complex with amprenavir (apv) | 3EM3_A |
| AA | A02.001 | HIV-1 retropepsin | drug- resistant Ile50Val/Ala71Val variant; complex with the protease inhibitor atazanavir | 3EM4_A |
| AA | A02.001 | HIV-1 retropepsin | Ile50Leu/Ala71val mutant; complex with inhibitor darunavir | 3EM6_A |
| AA | A02.001 | HIV-1 retropepsin | complex with potent inhibitor KNI-272 | 3FX5_A |
| AA | A02.001 | HIV-1 retropepsin | hiv protease inhibitors with pseudo-symmetric cores | 3GGA_G |
| AA | A02.001 | HIV-1 retropepsin | hiv protease, pseudo-symmetric inhibitors | 3GGV_B |
| AA | A02.001 | HIV-1 retropepsin | hiv protease, pseudo-symmetric inhibitors | 3GGX_A |
| AA | A02.001 | HIV-1 retropepsin | wild type; complex with inhibitor kb60 | 3GI4_A |
| AA | A02.001 | HIV-1 retropepsin | wild type; complex with inhibitor kb62 | 3GI5_A |
| AA | A02.001 | HIV-1 retropepsin | wild type; complex with inhibitor ad78 | 3GI6_A |
| AA | A02.001 | HIV-1 retropepsin | Cys replaced with alpha-amino-N-butyric acid | 3HVP |
| AA | A02.001 | HIV-1 retropepsin | complex with mutant resistant inhibitor uic-98038 | 3I7E_A |
| AA | A02.001 | HIV-1 retropepsin | complex with saquinavir | 3K4V_A |
| AA | A02.001 | HIV-1 retropepsin | complex with darunavir | 3LZS_A |
| AA | A02.001 | HIV-1 retropepsin | nelfinavir resistant variant (Asn88Ser); complex with the protease inhibitor darunavir. | 3LZU_B |
| AA | A02.001 | HIV-1 retropepsin | nelfinavir-resistant variant (Asp30Asn/Asn88Asp); complex with darunavir. | 3LZV_A |
| AA | A02.001 | HIV-1 retropepsin | wild-type; complex with inhibitor kc53 | 3MXD_A |
| AA | A02.001 | HIV-1 retropepsin | wild-type; complex with inhibitor kc32 | 3MXE_A |
| AA | A02.001 | HIV-1 retropepsin | complex with saquinavir:ritonavir 1:1 | 3NDT_A |
| AA | A02.001 | HIV-1 retropepsin | complex with saquinavir:ritonavir 1:5 | 3NDU_A |
| AA | A02.001 | HIV-1 retropepsin | complex with saquinavir:ritonavir 1:15 | 3NDW_A |
| AA | A02.001 | HIV-1 retropepsin | complex with saquinavir:ritonavir 1:50 | 3NDX_A |
| AA | A02.001 | HIV-1 retropepsin | wild-type; complex with antiviral drug amprenavir | 3NU3_A |
| AA | A02.001 | HIV-1 retropepsin | Val32Ile mutant; complex with antiviral drug amprenavir | 3NU4_A |
| AA | A02.001 | HIV-1 retropepsin | Ile50Val mutant; complex with antiviral drug amprenavir | 3NU5_A |
| AA | A02.001 | HIV-1 retropepsin | Ile54Met mutant; complex with antiviral drug amprenavir | 3NU6_A |
| AA | A02.001 | HIV-1 retropepsin | Ile54Val mutant; complex with antiviral drug amprenavir | 3NU9_A |
| AA | A02.001 | HIV-1 retropepsin | Ile54Val mutant; complex with antiviral drug amprenavir | 3NUJ_A |
| AA | A02.001 | HIV-1 retropepsin | Ile90Met mutant; complex with antiviral drug amprenavir | 3NUO_A |
| AA | A02.001 | HIV-1 retropepsin | wild-type; complex with kd13 | 3O99_A |
| AA | A02.001 | HIV-1 retropepsin | wild-type; complex with kd14 | 3O9A_A |
| AA | A02.001 | HIV-1 retropepsin | wild-type; complex with kd25 | 3O9B_A |
| AA | A02.001 | HIV-1 retropepsin | wild-type; complex with kd20 | 3O9C_A |
| AA | A02.001 | HIV-1 retropepsin | wild-type; complex with kd19 | 3O9D_A |
| AA | A02.001 | HIV-1 retropepsin | wild-type; complex with af60 | 3O9E_A |
| AA | A02.001 | HIV-1 retropepsin | wild-type; complex with kd27 | 3O9F_A |
| AA | A02.001 | HIV-1 retropepsin | wild-type; complex with af53 | 3O9G_A |
| AA | A02.001 | HIV-1 retropepsin | wild-type; complex with kd26 | 3O9H_A |
| AA | A02.001 | HIV-1 retropepsin | wild-type; complex with af61 | 3O9I_A |
| AA | A02.001 | HIV-1 retropepsin | wild-type; complex with oxatricyclic designed inhibitor GRL-0519a | 3OK9_A |
| AA | A02.001 | HIV-1 retropepsin | complex with saquinavir | 3OXC_A |
| AA | A02.001 | HIV-1 retropepsin | Ile50Val, Ala71 variant; complex with the protease inhibitor amprenavir. | 3OXV_B |
| AA | A02.001 | HIV-1 retropepsin | Ile50Val/Ala71Val variant; complex with the protease inhibitor darunavir | 3OXW_B |
| AA | A02.001 | HIV-1 retropepsin | drug- resistant Ile50Val/Ala71Val variant; complex with the protease inhibitor atazanavir | 3OXX_B |
| AA | A02.001 | HIV-1 retropepsin | Leu76Val variant; complex with the protease inhibitor darunavir. | 3OY4_A |
| AA | A02.001 | HIV-1 retropepsin | recombinant | 3PHV |
| AA | A02.001 | HIV-1 retropepsin | wild type; complex with a substituted bis-tetrahydrofuran inhibitor, GRL-044-10a | 3QAA_A |
| AA | A02.001 | HIV-1 retropepsin | wild-type; complex with tmc310911 | 3R4B_A |
| AA | A02.001 | HIV-1 retropepsin | Val32Ile/Ile47Val/Val82Ile mutant; complex with antiviral drug amprenavir | 3S43_A |
| AA | A02.001 | HIV-1 retropepsin | triple mutant Val32Ile/Ile47Val/Val82Ile; complex with antiviral drug darunavir in space group p212121 | 3S53_A |
| AA | A02.001 | HIV-1 retropepsin | triple mutant Val32Ile/Ile47Val/Val82Ile; complex with antiviral drug darunavir in space group p21212 | 3S54_A |
| AA | A02.001 | HIV-1 retropepsin | triple mutants Val32Ile, Ile47Val, Val82Ile with antiviral drug saquinavir | 3S56_A |
| AA | A02.001 | HIV-1 retropepsin | discovery of new hiv protease inhibitors with potential for convenientdosing and reduced side effects: a-790742 and a-792611. | 3S85_A |
| AA | A02.001 | HIV-1 retropepsin | wild-type; complex with ag23 | 3SA3_A |
| AA | A02.001 | HIV-1 retropepsin | wild-type; complex with af72 | 3SA4_A |
| AA | A02.001 | HIV-1 retropepsin | wild-type; complex with af69 | 3SA5_A |
| AA | A02.001 | HIV-1 retropepsin | wild-type; complex with af71 | 3SA6_A |
| AA | A02.001 | HIV-1 retropepsin | wild-type; complex with af55 | 3SA7_A |
| AA | A02.001 | HIV-1 retropepsin | wild-type; complex with kb83 | 3SA8_A |
| AA | A02.001 | HIV-1 retropepsin | wild-type; complex with af68 | 3SA9_A |
| AA | A02.001 | HIV-1 retropepsin | wild-type; complex with af77 | 3SAA_A |
| AA | A02.001 | HIV-1 retropepsin | wild-type; complex with af78 | 3SAB_A |
| AA | A02.001 | HIV-1 retropepsin | wild-type; complex with af80 | 3SAC_A |
| AA | A02.001 | HIV-1 retropepsin | complex with TL-3-093 inhibitor | 3TLH |
| AA | A02.001 | HIV-1 retropepsin | South African wild type subtype c | 3U71_A |
| AA | A02.001 | HIV-1 retropepsin | wild-type; complex with mkp56 | 4DJO_A |
| AA | A02.001 | HIV-1 retropepsin | wild-type; complex with mkp73 | 4DJP_A |
| AA | A02.001 | HIV-1 retropepsin | wild-type; complex with mkp86 | 4DJQ_A |
| AA | A02.001 | HIV-1 retropepsin | wild-type; complex with mkp97 | 4DJR_A |
| AA | A02.001 | HIV-1 retropepsin | hiv protease (pr) dimer with acetate in exo site and peptide in activesite | 4E43_A |
| AA | A02.001 | HIV-1 retropepsin | apo hiv protease (pr) dimer in closed form with fragment 1f1 in the outside/top of flap | 4EJ8_A |
| AA | A02.001 | HIV-1 retropepsin | dimer in closed form with pepstatin in active site and fragment 1f1 in the outside/top of flap | 4EJD_A |
| AA | A02.001 | HIV-1 retropepsin | dimer in closed form with pepstatin in active site and fragment 1f1-n in the outside/top of flap | 4EJK_A |
| AA | A02.001 | HIV-1 retropepsin | apo hiv protease (pr) dimer in closed form with fragment 1f1-n in the outside/top of flap | 4EJL_A |
| AA | A02.001 | HIV-1 retropepsin | inactive single chain wild-type; complex with the substrate rt-rh | 4EP2_A |
| AA | A02.001 | HIV-1 retropepsin | inactive single chain wild-type; complex with the substrate rt-rh | 4EP2_B |
| AA | A02.001 | HIV-1 retropepsin | inactive single chain variant; complex with the substrate ca-p2 | 4EP3_A |
| AA | A02.001 | HIV-1 retropepsin | inactive single chain variant; complex with the substrate p2-nc | 4EPJ_A |
| AA | A02.001 | HIV-1 retropepsin | inactive single chain variant; complex with the substrate p2-nc | 4EQ0_A |
| AA | A02.001 | HIV-1 retropepsin | inactive single chain variant; complex with the substrate rt-rh | 4EQJ_A |
| AA | A02.001 | HIV-1 retropepsin | inactive single chain variant; complex with the substrate rt-rh | 4EQJ_G |
| AA | A02.001 | HIV-1 retropepsin | complex with the n terminal product of ca-p2 cleavage site | 4F73_A |
| AA | A02.001 | HIV-1 retropepsin | complex with the n terminal product of the substrate ma-ca. | 4F74_A |
| AA | A02.001 | HIV-1 retropepsin | complex with the n terminal product of the substrate rh-in | 4F75_A |
| AA | A02.001 | HIV-1 retropepsin | complex with the products of p1-p6 substrate | 4F76_A |
| AA | A02.001 | HIV-1 retropepsin | complex with N-Ac-Thr-Ile-Nle-PSI(CH2-NH)-Nle-Gln-Arg amide | 4HVP |
| AA | A02.001 | HIV-1 retropepsin | tl-3 inhibited trp6ala hiv protease | 4K4P_A |
| AA | A02.001 | HIV-1 retropepsin | tl-3 inhibited trp6ala hiv protease with 3-bromo-2,6-dimethoxybenzoic acid bound in flap site ***caveat 4k4q chirality error on c10 center of 3tl 108 a | 4K4Q_A |
| AA | A02.001 | HIV-1 retropepsin | tl-3 inhibited trp6ala hiv protease with 1-bromo-2-napthoic acid boundin exosite | 4K4R_A |
| AA | A02.001 | HIV-1 retropepsin | wild-type; complex with novel tricyclic p2-ligands GRL-0739a | 4KB9_A |
| AA | A02.001 | HIV-1 retropepsin | wild-type; complex with darunavir | 4LL3_A |
| AA | A02.001 | HIV-1 retropepsin | gs-8374, a novel phosphonate-containing inhibitor of hiv-1 protease, effectively inhibits hiv pr mutants with amino acid insertions | 4M8X_A |
| AA | A02.001 | HIV-1 retropepsin | multidrug-resistant clinical isolate; complex with non-peptidic inhibitor, GRL008 | 4NJS_A |
| AA | A02.001 | HIV-1 retropepsin | multidrug-resistant clinical isolate; complex with darunavir | 4NJT_A |
| AA | A02.001 | HIV-1 retropepsin | multidrug-resistant clinical isolate; complex with tipranavir | 4NJU_A |
| AA | A02.001 | HIV-1 retropepsin | multidrug-resistant clinical isolate; complex with ritonavir | 4NJV_A |
| AA | A02.001 | HIV-1 retropepsin | nelfinavir-resistant, inactive Asp30Asn/Asn88Asp; complex with the p1-p6 substrate variant (Leu449Phe/Ser451Asn) | 4OBD_A |
| AA | A02.001 | HIV-1 retropepsin | nelfinavir-resistant, inactive Asp30Asn/Asn88Asp; complex with the p1-p6 substrate variant (Ser451Asn) | 4OBF_A |
| AA | A02.001 | HIV-1 retropepsin | nelfinavir-resistant, inactive Asp30Asn/Asn88Asp; complex with the p1-p6 substrate. | 4OBG_A |
| AA | A02.001 | HIV-1 retropepsin | complex with N,N-bis(2(R)-hydroxy-1(S)-indanyl)-2,6-(R,R)-diphenylmethyl-4-hydroxy-1,7,-heptandiamide | 4PHV |
| AA | A02.001 | HIV-1 retropepsin | multidrug-resistant clinical isolate; complex with non-peptidic inhibitor, GRL0519 | 4RVI_A |
| AA | A02.001 | HIV-1 retropepsin | multidrug-resistant clinical isolate; complex with amprenavir | 4RVJ_A |
| AA | A02.001 | HIV-1 retropepsin | multidrug-resistant clinical isolate; complex with non-peptidic inhibitor, GRL079 | 4RVX_A |
| AA | A02.001 | HIV-1 retropepsin | dimer in closed form with pepstatin in active site and fragment ak-2097 in the outside/top of flap | 4TVG_A |
| AA | A02.001 | HIV-1 retropepsin | hiv protease (pr) dimer in closed form with tl-3 in active site and fragment ak-2097 in the outside/top of flap ***caveat 4tvh chiral center atom c10 of 3tl a 200 has sp2 hybridization ***caveat 2 4tvh instead of sp3 | 4TVH_A |
| AA | A02.001 | HIV-1 retropepsin | wild type; complex with GRL-050-10a (a gem-difluoro-bis- tetrahydrofuran as p2-ligand) | 4U8W_A |
| AA | A02.001 | HIV-1 retropepsin | multidrug resistant clinical isolate pr20; complex with inhibitor GRL-4410a | 4YE3_A |
| AA | A02.001 | HIV-1 retropepsin | multidrug resistant clinical isolate pr20; complex with inhibitor GRL-5010a | 4YHQ_A |
| AA | A02.001 | HIV-1 retropepsin | multidrug resistant clinical isolate pr20d25n with open flap | 4Z4X_A |
| AA | A02.001 | HIV-1 retropepsin | crystal structure of multidrug resistant hiv-1 protease clinical isolate pr20d25n with tucked flap | 4Z50_A |
| AA | A02.001 | HIV-1 retropepsin | wild type; complex with GRL-0648a (a isophthalamide-derived p2- ligand) | 4ZIP_A |
| AA | A02.001 | HIV-1 retropepsin | wild type; complex with GRL-096-13a (a boc-derivative p2-ligand,3,-5-dimethylbiphenyl p1-ligand) | 4ZLS_A |
| AA | A02.001 | HIV-1 retropepsin | wild type; complex with GRL-011-11a (a methylamine bis- tetrahydrofuran p2-ligand, sulfonamide isostere derivate) | 5BRY_A |
| AA | A02.001 | HIV-1 retropepsin | wild type; complex with GRL-047-11a (a methylamine bis- tetrahydrofuran p2-ligand, 4-amino sulfonamide derivative) | 5BS4_A |
| AA | A02.001 | HIV-1 retropepsin | complex with inhibitor GRL-004-11a containing substituted fused-tetrahydropyranyl tetrahydrofuran as P2-ligand | 5DGU_A |
| AA | A02.001 | HIV-1 retropepsin | complex with inhibitor GRL-105-11a containing substituted fused-tetrahydropyranyl tetrahydrofuran as p2-ligand | 5DGW_A |
| AA | A02.001 | HIV-1 retropepsin | triple mutant (Val32Ile/Ile47Val/Val82Ile); complex with darunavir at ph 6.0 | 5E5J_A |
| AA | A02.001 | HIV-1 retropepsin | complex with acetyl-pepstatin | 5HVP |
| AA | A02.001 | HIV-1 retropepsin | complex with methyl n-[(1s)-1- benzhydryl-2-(3-morpholin-4-ium-2-ylpropylamino)-2-oxo- ethyl]carbamate | 5IVQ_A |
| AA | A02.001 | HIV-1 retropepsin | complex with methyl n-[(1s)-1-[[2-[(3s)-3-[(4-aminophenyl)methylamino]-4-hydroxy- butyl]phenyl]carbamoyl]-2,2-diphenyl-ethyl]carbamate | 5IVR_A |
| AA | A02.001 | HIV-1 retropepsin | complex with methyl n-[(1s)-1- benzhydryl-2-[2-[2-[(2r,5s)-5-(benzylcarbamoyloxymethyl)morpholin-2- yl]ethyl]anilino]-2-oxo-ethyl]carbamate | 5IVS_A |
| AA | A02.001 | HIV-1 retropepsin | wild type; complex with GRL- 10413 | 5KAO_A |
| AA | A02.001 | HIV-1 retropepsin | Val32Ile/Ile47Val/Val82Ile mutant; complex with amprenavir at ph 6.0 | 5T8H_A |
| AA | A02.001 | HIV-1 retropepsin | wild type; complex with GRL-09510 | 5V4Y_A |
| AA | A02.001 | HIV-1 retropepsin | hiv protease (pr) with tl-3 in active site and 4-methylbenzene-1,2- diamine in exosite | 5VEA_A |
| AA | A02.001 | HIV-1 retropepsin | hiv protease (pr) in open form with mg2+ in active site and hive-9 in eye site | 5VJ3_A |
| AA | A02.001 | HIV-1 retropepsin | hiv protease (pr) in open form with mg2+ in active site and hive-9 in eye site | 5W5W_A |
| AA | A02.001 | HIV-1 retropepsin | complex with (s)-n-(3-fluoro-2-(2-(1-(phenylsulfonyl)piperazin-2-yl)ethyl)phenyl)-3,3-bis(4- fluorophenyl)propanamide | 6B36_A |
| AA | A02.001 | HIV-1 retropepsin | complex with n-(3-fluoro-2-(2- ((2s,6r)-6-methyl-1-(phenylsulfonyl)piperazin-2-yl)ethyl)phenyl)-3,3-bis(4-fluorophenyl)propanamide | 6B38_A |
| AA | A02.001 | HIV-1 retropepsin | complex with n-(3-fluoro-2-(2- ((2s,6r)-6-methyl-1-(phenylsulfonyl)piperazin-2-yl)ethyl)phenyl)-3,3-bis(4-fluorophenyl)propanamide | 6B3C_A |
| AA | A02.001 | HIV-1 retropepsin | complex with n-(3-fluoro-2-(2- ((2s,5s)-5-methyl-1-(phenylsulfonyl)piperazin-2-yl)ethyl)phenyl)-3,3-bis(4-fluorophenyl)propanamide | 6B3F_A |
| AA | A02.001 | HIV-1 retropepsin | complex with n-(3-fluoro-2-(2- ((2s,6s)-6-methyl-1-(phenylsulfonyl)piperazin-2-yl)ethyl)phenyl)-3,3-bis(4-fluorophenyl)propanamide | 6B3G_A |
| AA | A02.001 | HIV-1 retropepsin | complex with n-(2-(2-((6r,9s)-2,2-dioxido-2-thia-1,7-diazabicyclo[4.3.1]decan-9-yl)ethyl)-3- fluorophenyl)-3,3-bis(4-fluorophenyl)propanamide | 6B3H_A |
| AA | A02.001 | HIV-1 retropepsin | nl4-3 wt; complex with darunavir | 6DGX_B |
| AA | A02.001 | HIV-1 retropepsin | nl4-3 wt; complex with umass1 | 6DGY_B |
| AA | A02.001 | HIV-1 retropepsin | nl4-3 wt; complex with umass6 | 6DGZ_B |
| AA | A02.001 | HIV-1 retropepsin | nl4-3 v82i mutant; complex with darunavir | 6DH3_B |
| AA | A02.001 | HIV-1 retropepsin | nl4-3 Val82Ile mutant; complex with umass1 | 6DH4_B |
| AA | A02.001 | HIV-1 retropepsin | nl4-3 Val82Ile mutant; complex with umass6 | 6DH5_B |
| AA | A02.001 | HIV-1 retropepsin | nl4-3 i50v mutant; complex with darunavir | 6DH6_B |
| AA | A02.001 | HIV-1 retropepsin | nl4-3 Ile50Val mutant; complex with umass1 | 6DH7_B |
| AA | A02.001 | HIV-1 retropepsin | nl4-3 Ile50Val mutant; complex with umass6 | 6DH8_B |
| AA | A02.001 | HIV-1 retropepsin | wild-type hiv-1 protease in complex with tipranavir | 6DIF_A |
| AA | A02.001 | HIV-1 retropepsin | Leu76Val mutant; complex with tipranavir | 6DIL_A |
| AA | A02.001 | HIV-1 retropepsin | wild-type; complex with lopinavir | 6DJ1_A |
| AA | A02.001 | HIV-1 retropepsin | Leu76Val mutant; complex with lopinavir | 6DJ2_A |
| AA | A02.001 | HIV-1 retropepsin | Leu76Val mutant; complex with GRL-0519 (tris- tetrahydrofuran as p2 ligand) | 6DJ5_A |
| AA | A02.001 | HIV-1 retropepsin | Leu76Val mutant; complex with GRL-5010 (gem- difluoro-bis-tetrahydrofuran as p2 ligand) | 6DJ7_A |
| AA | A02.001 | HIV-1 retropepsin | wild type; complex with GRL-02815a, a thiochroman heterocycle with (s)-boc-amine functionality as the p2 ligand | 6DV0_A |
| AA | A02.001 | HIV-1 retropepsin | wild type; complex with GRL-04315a, a tetrahydronaphthalene carboxamide with (r)-boc-amine and (s)-hydroxyl functionalities as the p2 ligand | 6DV4_A |
| AA | A02.001 | HIV-1 retropepsin | wild type; complex with GRL-042-17a, 3-phenylhexahydro-2h- cyclopenta[d]oxazol-2-one with a bicyclic oxazolidinone scaffold as the p2 ligand | 6E7J_A |
| AA | A02.001 | HIV-1 retropepsin | wild type; complex with GRL-034-17a, (3as, 5r, 6ar)-2-oxohexahydcyclopenta[d]-5-oxazolyl urethane with a bicyclic oxazolidinone scaffas the p2 ligand | 6E9A_A |
| AA | A02.001 | HIV-1 retropepsin | complex with bpi-11 | 6IXD_A |
| AA | A02.001 | HIV-1 retropepsin | wild type; complex with GRL-001 | 6MCR_A |
| AA | A02.001 | HIV-1 retropepsin | wild type; complex with GRL-003 | 6MCS_A |
| AA | A02.001 | HIV-1 retropepsin | wild-type hiv-1 protease in complex with a substrate analog ca-p2 | 6O48_A |
| AA | A02.001 | HIV-1 retropepsin | Val32Ile/Ile47Val/Val82Ile mutant; complex with GRL-011-11a (a methylamine bis-tetrahydrofuran p2-ligand, sulfonamide isostere derivate) | 6OTG_A |
| AA | A02.001 | HIV-1 retropepsin | complex with ACE-Ser-Leu-Asn-Phe-PSI(CH(OH)-CH2)-Pro-Ile-Val-OME | 7HVP |
| AA | A02.001 | HIV-1 retropepsin | complex with U101935 | 7UPJ |
| AA | A02.001 | HIV-1 retropepsin | complex with Val-Ser-Gln-Asn-Leu-PSI(CH(OH)-CH2)-Val-Ile-Val | 8HVP |
| AA | A02.001 | HIV-1 retropepsin | complex with A-74704l | 9HVP |
| AA | A02.002 | HIV-2 retropepsin | complex with inhibitor CGP 53820 | 1HII |
| AA | A02.002 | HIV-2 retropepsin | 1HSH | |
| AA | A02.002 | HIV-2 retropepsin | 1HSI | |
| AA | A02.002 | HIV-2 retropepsin | complex with BILA 1906 | 1IDA |
| AA | A02.002 | HIV-2 retropepsin | complex with BILA 2450 | 1IDB |
| AA | A02.002 | HIV-2 retropepsin | Lys57Leu mutant; complex with NOA-His-CHA-PSI[CH(OH)CH(OH)]Val-Ile-APY | 1IVP |
| AA | A02.002 | HIV-2 retropepsin | Lys57Leu mutant; complex with QNC-Asn-CHA-PSI[CH(OH)CH(OH)]Val-NPT | 1IVQ |
| AA | A02.002 | HIV-2 retropepsin | complex with inhibitor containing an (hydroxyethyl) amide isostere | 1JLD |
| AA | A02.002 | HIV-2 retropepsin | theoretical model; complex with N-ac-Val-Val-Sta-Ala-Sta | 1PHV |
| AA | A02.002 | HIV-2 retropepsin | Lys57Leu mutant | 2HPE |
| AA | A02.002 | HIV-2 retropepsin | Lys57Leu mutant | 2HPF |
| AA | A02.002 | HIV-2 retropepsin | complex with Phe-Val-Phe-PSI(CH2NH)-Leu-Glu-Ile amide inhibitor | 2MIP |
| AA | A02.002 | HIV-2 retropepsin | theoretical model; complex with renin inhibitor H261 | 2PHV |
| AA | A02.002 | HIV-2 retropepsin | complex with clinical drug darunavir | 3EBZ_A |
| AA | A02.002 | HIV-2 retropepsin | complex with antiviral inhibitor GRL-06579a | 3EC0_A |
| AA | A02.002 | HIV-2 retropepsin | complex with antiviral inhibitor GRL-98065 | 3ECG_A |
| AA | A02.002 | HIV-2 retropepsin | wild-type; complex with antiviral drug amprenavir | 3S45_A |
| AA | A02.002 | HIV-2 retropepsin | complex with U096333 | 3UPJ |
| AA | A02.002 | HIV-2 retropepsin | complex with U097410 | 4UPJ |
| AA | A02.002 | HIV-2 retropepsin | complex with U99283 | 5UPJ |
| AA | A02.002 | HIV-2 retropepsin | complex with U99294 | 6UPJ |
| AA | A02.004 | equine infectious anaemia virus retropepsin | theoretical model | 1EQI |
| AA | A02.004 | equine infectious anaemia virus retropepsin | complex with inhibitor HBY-793 | 1FMB |
| AA | A02.004 | equine infectious anaemia virus retropepsin | complex with inhibitor LP-130 | 2FMB |
| AA | A02.005 | bovine immunodeficiency virus retropepsin | 3KKR | |
| AA | A02.005 | bovine immunodeficiency virus retropepsin | 3KKS | |
| AA | A02.006 | Visna lentivirus-type retropepsin | 3HPG | |
| AA | A02.006 | Visna lentivirus-type retropepsin | 3HPH | |
| AA | A02.007 | feline immunodeficiency virus retropepsin | complex with TL-3-093 inhibitor | 1B11 |
| AA | A02.007 | feline immunodeficiency virus retropepsin | complex with acAla-Val-Sta-Glu-Ala-NH2 | 1FIV |
| AA | A02.007 | feline immunodeficiency virus retropepsin | complex with Ac-naphylAla-Val-Sta-Glu-naphthylaminoAla substrate | 2FIV |
| AA | A02.007 | feline immunodeficiency virus retropepsin | complex with tl-3 | 2HAH_A |
| AA | A02.007 | feline immunodeficiency virus retropepsin | complex with Ac-naphthylAla-Val-Leu-Ala-Glu-naphthylaminoAla substrate | 3FIV |
| AA | A02.007 | feline immunodeficiency virus retropepsin | complex with darunavir | 3OGP_A |
| AA | A02.007 | feline immunodeficiency virus retropepsin | complex with lopinavir | 3OGQ_A |
| AA | A02.007 | feline immunodeficiency virus retropepsin | complex with LP-130 inhibitor | 4FIV |
| AA | A02.007 | feline immunodeficiency virus retropepsin | complex with TL-3-093 inhibitor | 5FIV |
| AA | A02.007 | feline immunodeficiency virus retropepsin | complex with TL-3-093 inhibitor | 6FIV |
| AA | A02.008 | murine leukemia virus-type retropepsin | 1D0E | |
| AA | A02.008 | murine leukemia virus-type retropepsin | 1D1U | |
| AA | A02.008 | murine leukemia virus-type retropepsin | 1I6J | |
| AA | A02.008 | murine leukemia virus-type retropepsin | 1MML | |
| AA | A02.008 | murine leukemia virus-type retropepsin | 1N4L | |
| AA | A02.008 | murine leukemia virus-type retropepsin | 1NND | |
| AA | A02.008 | murine leukemia virus-type retropepsin | 1QAI | |
| AA | A02.008 | murine leukemia virus-type retropepsin | 1QAJ | |
| AA | A02.008 | murine leukemia virus-type retropepsin | 1ZTT | |
| AA | A02.008 | murine leukemia virus-type retropepsin | 1ZTW | |
| AA | A02.008 | murine leukemia virus-type retropepsin | 2FJV | |
| AA | A02.008 | murine leukemia virus-type retropepsin | 2FJW | |
| AA | A02.008 | murine leukemia virus-type retropepsin | 2FJX | |
| AA | A02.008 | murine leukemia virus-type retropepsin | 2FVP | |
| AA | A02.008 | murine leukemia virus-type retropepsin | 2FVQ | |
| AA | A02.008 | murine leukemia virus-type retropepsin | 2FVR | |
| AA | A02.008 | murine leukemia virus-type retropepsin | 2FVS | |
| AA | A02.008 | murine leukemia virus-type retropepsin | 2HB5 | |
| AA | A02.008 | murine leukemia virus-type retropepsin | 2M9U | |
| AA | A02.008 | murine leukemia virus-type retropepsin | 2MQV | |
| AA | A02.008 | murine leukemia virus-type retropepsin | 2MS0 | |
| AA | A02.008 | murine leukemia virus-type retropepsin | 2MS1 | |
| AA | A02.008 | murine leukemia virus-type retropepsin | 2R2R | |
| AA | A02.008 | murine leukemia virus-type retropepsin | 2R2S | |
| AA | A02.008 | murine leukemia virus-type retropepsin | 2R2T | |
| AA | A02.008 | murine leukemia virus-type retropepsin | 2R2U | |
| AA | A02.008 | murine leukemia virus-type retropepsin | 3FSI | |
| AA | A02.008 | murine leukemia virus-type retropepsin | 3NNQ | |
| AA | A02.008 | murine leukemia virus-type retropepsin | peptidase domain only; complex with TL-3 | 3SLZ |
| AA | A02.008 | murine leukemia virus-type retropepsin | peptidase domain only; complex with pepstatin | 3SM1 |
| AA | A02.008 | murine leukemia virus-type retropepsin | peptidase domain only; complex with amprenavir | 3SM2 |
| AA | A02.008 | murine leukemia virus-type retropepsin | complex with acetyl-pepstatin | 4EXH_A |
| AA | A02.008 | murine leukemia virus-type retropepsin | 4M94 | |
| AA | A02.008 | murine leukemia virus-type retropepsin | 4M95 | |
| AA | A02.008 | murine leukemia virus-type retropepsin | 4MH8 | |
| AA | A02.008 | murine leukemia virus-type retropepsin | 4NZG | |
| AA | A02.008 | murine leukemia virus-type retropepsin | 4XO0 | |
| AA | A02.008 | murine leukemia virus-type retropepsin | 4XPC | |
| AA | A02.008 | murine leukemia virus-type retropepsin | 4XPE | |
| AA | A02.008 | murine leukemia virus-type retropepsin | 3NR6_A | |
| AA | A02.008 | murine leukemia virus-type retropepsin | 3P1G | |
| AA | A02.008 | murine leukemia virus-type retropepsin | 4E89 | |
| AA | A02.008 | murine leukemia virus-type retropepsin | 4HKQ | |
| AA | A02.009 | Mason-Pfizer leukemia virus retropepsin | 1NSO | |
| AA | A02.009 | Mason-Pfizer leukemia virus retropepsin | 2D4L | |
| AA | A02.009 | Mason-Pfizer leukemia virus retropepsin | 2D4M | |
| AA | A02.009 | Mason-Pfizer leukemia virus retropepsin | 2D4N | |
| AA | A02.009 | Mason-Pfizer leukemia virus retropepsin | 3SQF | |
| AA | A02.009 | Mason-Pfizer leukemia virus retropepsin | 3TP1 | |
| AA | A02.009 | Mason-Pfizer leukemia virus retropepsin | 3TPW | |
| AA | A02.012 | retropepsin (human T-cell leukemia virus) | 2B7F | |
| AA | A02.012 | retropepsin (human T-cell leukemia virus) | complex with the inhibitor, kni- 10562 | 3LIN_A |
| AA | A02.012 | retropepsin (human T-cell leukemia virus) | complex with the inhibitor, kni- 10673 | 3LIQ_A |
| AA | A02.012 | retropepsin (human T-cell leukemia virus) | complex with the inhibitor kni-10681 | 3LIT_A |
| AA | A02.012 | retropepsin (human T-cell leukemia virus) | complex with the inhibitor kni- 10683 | 3LIV_A |
| AA | A02.012 | retropepsin (human T-cell leukemia virus) | complex with the inhibitor kni- 10729 | 3LIX_A |
| AA | A02.012 | retropepsin (human T-cell leukemia virus) | complex with statine-containing peptide inhibitor | 3LIY_A |
| AA | A02.012 | retropepsin (human T-cell leukemia virus) | complex with the hiv-1 protease inhibitor indinavir | 3WSJ_A |
| AA | A02.012 | retropepsin (human T-cell leukemia virus) | complex with compound 9 | 4YDF_A |
| AA | A02.013 | bovine leukemia virus retropepsin | 2IM6 | |
| AA | A02.013 | bovine leukemia virus retropepsin | 2IM7 | |
| AA | A02.015 | Rous sarcoma virus retropepsin | NMR structure | 1A6S |
| AA | A02.015 | Rous sarcoma virus retropepsin | complex with Arg-Val-Leu-Phe-Glu-Ala-norLeu-NH2 inhibitor | 1BAI |
| AA | A02.015 | Rous sarcoma virus retropepsin | 1EM9 | |
| AA | A02.015 | Rous sarcoma virus retropepsin | 1EOQ | |
| AA | A02.015 | Rous sarcoma virus retropepsin | 1P7N | |
| AA | A02.015 | Rous sarcoma virus retropepsin | 2IHX | |
| AA | A02.015 | Rous sarcoma virus retropepsin | 2RSP_B | |
| AA | A02.015 | Rous sarcoma virus retropepsin | 2X8Q | |
| AA | A02.015 | Rous sarcoma virus retropepsin | 3G0V | |
| AA | A02.015 | Rous sarcoma virus retropepsin | 3G1G | |
| AA | A02.015 | Rous sarcoma virus retropepsin | 3G1I | |
| AA | A02.015 | Rous sarcoma virus retropepsin | 3G21 | |
| AA | A02.015 | Rous sarcoma virus retropepsin | 3G26 | |
| AA | A02.015 | Rous sarcoma virus retropepsin | 3G28 | |
| AA | A02.015 | Rous sarcoma virus retropepsin | 3G29 | |
| AA | A02.015 | Rous sarcoma virus retropepsin | 5A9E | |
| AA | A02.018 | simian T-cell lymphotropic virus retropepsin | 1JVR | |
| AA | A02.022 | Ty3 transposon peptidase | 4OL8 | |
| AA | A02.UPA | subfamily A2A unassigned peptidases | open conformation | 1AZ5 |
| AA | A02.UPA | subfamily A2A unassigned peptidases | 1C6V | |
| AA | A02.UPA | subfamily A2A unassigned peptidases | 1ECW | |
| AA | A02.UPA | subfamily A2A unassigned peptidases | 1ED1 | |
| AA | A02.UPA | subfamily A2A unassigned peptidases | 1SIP | |
| AA | A02.UPA | subfamily A2A unassigned peptidases | complex with SKF107457 | 1SIV |
| AA | A02.UPA | subfamily A2A unassigned peptidases | complex with SB203386 | 1TCW |
| AA | A02.UPA | subfamily A2A unassigned peptidases | complex with Phe-Leu-Glu-Lys peptide product | 1YTI |
| AA | A02.UPA | subfamily A2A unassigned peptidases | complex with p-nitroPhe-Glu-Ala-norLeu-Ser peptide product | 1YTJ |
| AA | A02.UPA | subfamily A2A unassigned peptidases | mutant Ser4His | 2SAM |
| AA | A02.UPA | subfamily A2A unassigned peptidases | 3JTS | |
| AA | A02.UPW | family A2 unassigned peptidases | 1MVP | |
| AA | A02.UPW | family A2 unassigned peptidases | theoretical model | 2MVP |
| AA | A02.UPW | family A2 unassigned peptidases | 1BV7_A | |
| AA | A02.UPW | family A2 unassigned peptidases | 1BV9_A | |
| AA | A02.UPW | family A2 unassigned peptidases | 1BVE_A | |
| AA | A02.UPW | family A2 unassigned peptidases | 1BVG_A | |
| AA | A02.UPW | family A2 unassigned peptidases | 1BWA_A | |
| AA | A02.UPW | family A2 unassigned peptidases | 1BWB_A | |
| AA | A02.UPW | family A2 unassigned peptidases | 1C0T | |
| AA | A02.UPW | family A2 unassigned peptidases | 1C0U | |
| AA | A02.UPW | family A2 unassigned peptidases | 1C1B | |
| AA | A02.UPW | family A2 unassigned peptidases | 1C1C | |
| AA | A02.UPW | family A2 unassigned peptidases | 1DMP_A | |
| AA | A02.UPW | family A2 unassigned peptidases | 1DTQ | |
| AA | A02.UPW | family A2 unassigned peptidases | 1DTT | |
| AA | A02.UPW | family A2 unassigned peptidases | 1E6J | |
| AA | A02.UPW | family A2 unassigned peptidases | 1EP4 | |
| AA | A02.UPW | family A2 unassigned peptidases | 1ESK | |
| AA | A02.UPW | family A2 unassigned peptidases | 1EX4 | |
| AA | A02.UPW | family A2 unassigned peptidases | 1EXQ | |
| AA | A02.UPW | family A2 unassigned peptidases | Val48Gly, Met90Leu mutant; complex with saquinavir | 1FB7 |
| AA | A02.UPW | family A2 unassigned peptidases | 1FK9 | |
| AA | A02.UPW | family A2 unassigned peptidases | 1FKO | |
| AA | A02.UPW | family A2 unassigned peptidases | 1FKP | |
| AA | A02.UPW | family A2 unassigned peptidases | 1G6L_A | |
| AA | A02.UPW | family A2 unassigned peptidases | 1HIV_A | |
| AA | A02.UPW | family A2 unassigned peptidases | 1HVH_A | |
| AA | A02.UPW | family A2 unassigned peptidases | 1HVR_A | |
| AA | A02.UPW | family A2 unassigned peptidases | 1HWR_A | |
| AA | A02.UPW | family A2 unassigned peptidases | 1HXB_A | |
| AA | A02.UPW | family A2 unassigned peptidases | 1JKH | |
| AA | A02.UPW | family A2 unassigned peptidases | 1JLA | |
| AA | A02.UPW | family A2 unassigned peptidases | 1JLB | |
| AA | A02.UPW | family A2 unassigned peptidases | 1JLC | |
| AA | A02.UPW | family A2 unassigned peptidases | 1JLE | |
| AA | A02.UPW | family A2 unassigned peptidases | 1JLF | |
| AA | A02.UPW | family A2 unassigned peptidases | 1JLG | |
| AA | A02.UPW | family A2 unassigned peptidases | 1JLQ | |
| AA | A02.UPW | family A2 unassigned peptidases | 1KLM | |
| AA | A02.UPW | family A2 unassigned peptidases | 1LV1_A | |
| AA | A02.UPW | family A2 unassigned peptidases | 1LW0 | |
| AA | A02.UPW | family A2 unassigned peptidases | 1LW2 | |
| AA | A02.UPW | family A2 unassigned peptidases | 1LWC | |
| AA | A02.UPW | family A2 unassigned peptidases | 1LWE | |
| AA | A02.UPW | family A2 unassigned peptidases | 1LWF | |
| AA | A02.UPW | family A2 unassigned peptidases | 1NCP_N | |
| AA | A02.UPW | family A2 unassigned peptidases | 1O1W | |
| AA | A02.UPW | family A2 unassigned peptidases | 1ODW_A | |
| AA | A02.UPW | family A2 unassigned peptidases | complex with inhibitor LP-130 | 1ODY |
| AA | A02.UPW | family A2 unassigned peptidases | 1QBR_A | |
| AA | A02.UPW | family A2 unassigned peptidases | 1QBS_A | |
| AA | A02.UPW | family A2 unassigned peptidases | 1QBT_A | |
| AA | A02.UPW | family A2 unassigned peptidases | 1QBU_A | |
| AA | A02.UPW | family A2 unassigned peptidases | 1REV | |
| AA | A02.UPW | family A2 unassigned peptidases | 1RT1 | |
| AA | A02.UPW | family A2 unassigned peptidases | 1RT2 | |
| AA | A02.UPW | family A2 unassigned peptidases | 1RT3 | |
| AA | A02.UPW | family A2 unassigned peptidases | 1RT4 | |
| AA | A02.UPW | family A2 unassigned peptidases | 1RT5 | |
| AA | A02.UPW | family A2 unassigned peptidases | 1RT6 | |
| AA | A02.UPW | family A2 unassigned peptidases | 1RT7 | |
| AA | A02.UPW | family A2 unassigned peptidases | 1RTD | |
| AA | A02.UPW | family A2 unassigned peptidases | 1RTH | |
| AA | A02.UPW | family A2 unassigned peptidases | 1RTI | |
| AA | A02.UPW | family A2 unassigned peptidases | 1RTJ | |
| AA | A02.UPW | family A2 unassigned peptidases | 1S1T | |
| AA | A02.UPW | family A2 unassigned peptidases | 1S1U | |
| AA | A02.UPW | family A2 unassigned peptidases | 1S1V | |
| AA | A02.UPW | family A2 unassigned peptidases | 1S1W | |
| AA | A02.UPW | family A2 unassigned peptidases | 1S1X | |
| AA | A02.UPW | family A2 unassigned peptidases | 1T05 | |
| AA | A02.UPW | family A2 unassigned peptidases | 1TAM | |
| AA | A02.UPW | family A2 unassigned peptidases | 1TKT | |
| AA | A02.UPW | family A2 unassigned peptidases | 1TKX | |
| AA | A02.UPW | family A2 unassigned peptidases | 1TKZ | |
| AA | A02.UPW | family A2 unassigned peptidases | 1TL1 | |
| AA | A02.UPW | family A2 unassigned peptidases | 1TL3 | |
| AA | A02.UPW | family A2 unassigned peptidases | 1VRT | |
| AA | A02.UPW | family A2 unassigned peptidases | 1VRU | |
| AA | A02.UPW | family A2 unassigned peptidases | 2HND | |
| AA | A02.UPW | family A2 unassigned peptidases | 2HNY | |
| AA | A02.UPW | family A2 unassigned peptidases | 2HNZ | |
| AA | A02.UPW | family A2 unassigned peptidases | 2KOD | |
| AA | A02.UPW | family A2 unassigned peptidases | 2NPH | |
| AA | A02.UPW | family A2 unassigned peptidases | 2OPP | |
| AA | A02.UPW | family A2 unassigned peptidases | 2OPQ | |
| AA | A02.UPW | family A2 unassigned peptidases | 2OPR | |
| AA | A02.UPW | family A2 unassigned peptidases | 2OPS | |
| AA | A02.UPW | family A2 unassigned peptidases | 2RF2 | |
| AA | A02.UPW | family A2 unassigned peptidases | 2RKI | |
| AA | A02.UPW | family A2 unassigned peptidases | 2WHH | |
| AA | A02.UPW | family A2 unassigned peptidases | 2WOM | |
| AA | A02.UPW | family A2 unassigned peptidases | 2WON | |
| AA | A02.UPW | family A2 unassigned peptidases | 2YNF | |
| AA | A02.UPW | family A2 unassigned peptidases | 2YNG | |
| AA | A02.UPW | family A2 unassigned peptidases | 2YNH | |
| AA | A02.UPW | family A2 unassigned peptidases | 2YNI | |
| AA | A02.UPW | family A2 unassigned peptidases | 3AO2 | |
| AA | A02.UPW | family A2 unassigned peptidases | 3C6T | |
| AA | A02.UPW | family A2 unassigned peptidases | 3C6U | |
| AA | A02.UPW | family A2 unassigned peptidases | 3DI6 | |
| AA | A02.UPW | family A2 unassigned peptidases | 3DLE | |
| AA | A02.UPW | family A2 unassigned peptidases | 3DLG | |
| AA | A02.UPW | family A2 unassigned peptidases | 3DM2 | |
| AA | A02.UPW | family A2 unassigned peptidases | 3DMJ | |
| AA | A02.UPW | family A2 unassigned peptidases | 3DOK | |
| AA | A02.UPW | family A2 unassigned peptidases | 3DOL | |
| AA | A02.UPW | family A2 unassigned peptidases | 3DOX | |
| AA | A02.UPW | family A2 unassigned peptidases | 3DRP | |
| AA | A02.UPW | family A2 unassigned peptidases | 3DRR | |
| AA | A02.UPW | family A2 unassigned peptidases | 3DRS | |
| AA | A02.UPW | family A2 unassigned peptidases | 3DYA | |
| AA | A02.UPW | family A2 unassigned peptidases | 3E01 | |
| AA | A02.UPW | family A2 unassigned peptidases | 3FFI | |
| AA | A02.UPW | family A2 unassigned peptidases | 3I0R | |
| AA | A02.UPW | family A2 unassigned peptidases | 3I0S | |
| AA | A02.UPW | family A2 unassigned peptidases | 3KJV | |
| AA | A02.UPW | family A2 unassigned peptidases | 3KK1 | |
| AA | A02.UPW | family A2 unassigned peptidases | 3KK2 | |
| AA | A02.UPW | family A2 unassigned peptidases | 3KK3 | |
| AA | A02.UPW | family A2 unassigned peptidases | 3KT2 | |
| AA | A02.UPW | family A2 unassigned peptidases | 3KT5 | |
| AA | A02.UPW | family A2 unassigned peptidases | 3LAK | |
| AA | A02.UPW | family A2 unassigned peptidases | 3LAL | |
| AA | A02.UPW | family A2 unassigned peptidases | 3LAM | |
| AA | A02.UPW | family A2 unassigned peptidases | 3LAN | |
| AA | A02.UPW | family A2 unassigned peptidases | 3LP0 | |
| AA | A02.UPW | family A2 unassigned peptidases | 3LP1 | |
| AA | A02.UPW | family A2 unassigned peptidases | 3LP2 | |
| AA | A02.UPW | family A2 unassigned peptidases | 3M8P | |
| AA | A02.UPW | family A2 unassigned peptidases | 3M8Q | |
| AA | A02.UPW | family A2 unassigned peptidases | 3MEC | |
| AA | A02.UPW | family A2 unassigned peptidases | 3MED | |
| AA | A02.UPW | family A2 unassigned peptidases | 3MEE | |
| AA | A02.UPW | family A2 unassigned peptidases | 3MEG | |
| AA | A02.UPW | family A2 unassigned peptidases | 3MIM | |
| AA | A02.UPW | family A2 unassigned peptidases | 3N3I | |
| AA | A02.UPW | family A2 unassigned peptidases | 3NBP | |
| AA | A02.UPW | family A2 unassigned peptidases | 3PHV_A | |
| AA | A02.UPW | family A2 unassigned peptidases | 3QIN | |
| AA | A02.UPW | family A2 unassigned peptidases | 3QIO | |
| AA | A02.UPW | family A2 unassigned peptidases | 3QIP | |
| AA | A02.UPW | family A2 unassigned peptidases | 3T19 | |
| AA | A02.UPW | family A2 unassigned peptidases | 3T1A | |
| AA | A02.UPW | family A2 unassigned peptidases | 3TAM | |
| AA | A02.UPW | family A2 unassigned peptidases | 4B3O | |
| AA | A02.UPW | family A2 unassigned peptidases | 4B3P | |
| AA | A02.UPW | family A2 unassigned peptidases | 4B3Q | |
| AA | A02.UPW | family A2 unassigned peptidases | 4I7F | |
| AA | A02.UPW | family A2 unassigned peptidases | 4KSE | |
| AA | A02.UPW | family A2 unassigned peptidases | 4KV8 | |
| AA | A02.UPW | family A2 unassigned peptidases | 4NCG | |
| AA | A02.UPW | family A2 unassigned peptidases | 4Q1W | |
| AA | A02.UPW | family A2 unassigned peptidases | 4Q1X | |
| AA | A02.UPW | family A2 unassigned peptidases | 4Q1Y | |
| AA | A02.UPW | family A2 unassigned peptidases | 4Q5M | |
| AA | A02.UPW | family A2 unassigned peptidases | 4QLH | |
| AA | A02.UPW | family A2 unassigned peptidases | 4U1H | |
| AA | A02.UPW | family A2 unassigned peptidases | 4U1I | |
| AA | A02.UPW | family A2 unassigned peptidases | 4U1J | |
| AA | A02.UPW | family A2 unassigned peptidases | 4U7Q | |
| AA | A02.UPW | family A2 unassigned peptidases | 4U7V | |
| AA | A02.UPW | family A2 unassigned peptidases | x-ray snapshot of hiv-1 protease in action: observation of tetrahedralintermediate and its sihb with catalytic aspartate | 5YRS_A |
| AC | A08.UPW | family A8 unassigned peptidases | 5DIR | |
| AC | A08.UPW | family A8 unassigned peptidases | imisx-ep of se-lspa | 6FMS_A |
| AA | A09.001 | spumapepsin | 2LSN | |
| AA | A09.001 | spumapepsin | 2X6N | |
| AA | A09.001 | spumapepsin | 2X6S | |
| AA | A09.001 | spumapepsin | 2X74 | |
| AA | A09.001 | spumapepsin | 2X78 | |
| AA | A09.001 | spumapepsin | 3DLR | |
| AA | A09.001 | spumapepsin | 3L2Q | |
| AA | A09.001 | spumapepsin | 3L2R | |
| AA | A09.001 | spumapepsin | 3L2U | |
| AA | A09.001 | spumapepsin | 3L2V | |
| AA | A09.001 | spumapepsin | 3L2W | |
| AA | A09.001 | spumapepsin | 3OS0 | |
| AA | A09.001 | spumapepsin | 3OS1 | |
| AA | A09.001 | spumapepsin | 3OS2 | |
| AA | A09.001 | spumapepsin | 3OY9 | |
| AA | A09.001 | spumapepsin | 3OYA | |
| AA | A09.001 | spumapepsin | 3OYB | |
| AA | A09.001 | spumapepsin | 3OYC | |
| AA | A09.001 | spumapepsin | 3OYD | |
| AA | A09.001 | spumapepsin | 3OYE | |
| AA | A09.001 | spumapepsin | 3OYF | |
| AA | A09.001 | spumapepsin | 3OYG | |
| AA | A09.001 | spumapepsin | 3OYH | |
| AA | A09.001 | spumapepsin | 3OYI | |
| AA | A09.001 | spumapepsin | 3OYJ | |
| AA | A09.001 | spumapepsin | 3OYK | |
| AA | A09.001 | spumapepsin | 3OYL | |
| AA | A09.001 | spumapepsin | 3OYM | |
| AA | A09.001 | spumapepsin | 3OYN | |
| AA | A09.001 | spumapepsin | 3S3M | |
| AA | A09.001 | spumapepsin | 3S3N | |
| AA | A09.001 | spumapepsin | 3S3O | |
| AA | A09.001 | spumapepsin | 4BAC | |
| AA | A09.001 | spumapepsin | 4BDY | |
| AA | A09.001 | spumapepsin | 4BDZ | |
| AA | A09.001 | spumapepsin | 4BE0 | |
| AA | A09.001 | spumapepsin | 4BE1 | |
| AA | A09.001 | spumapepsin | 4BE2 | |
| AA | A09.001 | spumapepsin | 4E7H | |
| AA | A09.001 | spumapepsin | 4E7I | |
| AA | A09.001 | spumapepsin | 4E7J | |
| AA | A09.001 | spumapepsin | 4E7K | |
| AA | A09.001 | spumapepsin | 4E7L | |
| AA | A09.001 | spumapepsin | 4IKF | |
| AA | A09.001 | spumapepsin | 4ZTF | |
| AA | A09.001 | spumapepsin | 4ZTJ | |
| AA | A09.001 | spumapepsin | NMR structure | 2JYS |
| AD | A22.001 | presenilin 1 | NMR structure; CTF subunit | 2KR6 |
| AD | A22.001 | presenilin 1 | 4UIS | |
| AD | A22.001 | presenilin 1 | 5A63 | |
| AD | A22.001 | presenilin 1 | 5FN2 | |
| AD | A22.001 | presenilin 1 | 5FN3 | |
| AD | A22.001 | presenilin 1 | 5FN4 | |
| AD | A22.001 | presenilin 1 | 5FN5 | |
| AD | A22.001 | presenilin 1 | complex with a notch fragment | 6IDF_B |
| AD | A22.001 | presenilin 1 | recognition of the amyloid precursor protein by human gamma-secretase | 6IYC_B |
| AD | A22.007 | signal peptide peptidase-like protein 2A | 2FC7 | |
| AD | A22.007 | signal peptide peptidase-like protein 2A | 2YUM | |
| AD | A22.015 | intramembrane aspartyl peptidase (Methanoculleus marisnigri JR1) | 4HYC | |
| AD | A22.015 | intramembrane aspartyl peptidase (Methanoculleus marisnigri JR1) | 4HYD | |
| AD | A22.015 | intramembrane aspartyl peptidase (Methanoculleus marisnigri JR1) | 4HYG | |
| AD | A22.015 | intramembrane aspartyl peptidase (Methanoculleus marisnigri JR1) | complex with an inhibitor | 4Y6K_A |
| AD | A24.016 | FlaK peptidase | 3S0X | |
| AE | A25.001 | gpr peptidase | precursor | 1C8B_A |
| AF | A26.001 | omptin | 1I78_A | |
| AF | A26.003 | plasminogen activator Pla | Ala106Asp mutant | 2X4M |
| AF | A26.003 | plasminogen activator Pla | 2X55 | |
| AF | A26.003 | plasminogen activator Pla | 2X56 | |
| AF | A26.003 | plasminogen activator Pla | 4DCB_A | |
| AA | A28.001 | DNA-damage inducible protein 1 | 2I1A | |
| AA | A28.001 | DNA-damage inducible protein 1 | 2MR9 | |
| AA | A28.001 | DNA-damage inducible protein 1 | 2MRO | |
| AA | A28.001 | DNA-damage inducible protein 1 | 2MRP | |
| AA | A28.001 | DNA-damage inducible protein 1 | 2MWS | |
| AA | A28.001 | DNA-damage inducible protein 1 | 4Z2Z | |
| AA | A28.001 | DNA-damage inducible protein 1 | 3S8I_A | |
| AA | A28.003 | DNA-damage inducible protein 2 | human dna damage-inducible protein: from protein chemistry and 3d structure to deciphering its cellular role | 4RGH_A |
| AA | A28.A01 | gene name 1700011N24Rik (Mus musculus) | NMR structure | 1V5O |
| AA | A28.UPA | subfamily A28A unassigned peptidases | protease-like domain | 5YQ8_A |
| AA | A28.UPA | subfamily A28A unassigned peptidases | protease-like domain | 5YS4_A |
| AE | A31.001 | HybD peptidase | 1CFZ_A | |
| AE | A31.001 | HybD peptidase | NMR structure | 2KML |
| AE | A31.003 | HycI peptidase | 3PU6_A | |
| AE | A31.007 | TK2004 peptidase | 5ZBY | |
| AE | A31.008 | TK2066 peptidase | 5IJA | |
| AE | A31.UPW | family A31 unassigned peptidases | 5TTX_A | |
| AE | A31.UPW | family A31 unassigned peptidases | 2E85_A | |
| AA | A32.002 | RC1339 g.p. (Rickettsia conorii) | 5C9B | |
| AA | A32.002 | RC1339 g.p. (Rickettsia conorii) | 5C9D | |
| AA | A32.002 | RC1339 g.p. (Rickettsia conorii) | 5C9F | |
| CA | C01.001 | papain | complex with carbobenzyloxy-Leu-leucinal inhibitor | 1BP4 |
| CA | C01.001 | papain | complex with carboxybenzyloxy-Leu-Leu-methoxymethylketone | 1BQI |
| CA | C01.001 | papain | complex with inhibitor CLIK148 | 1CVZ |
| CA | C01.001 | papain | theoretical model; complex with N-acetyl-p-benzoquinone imine | 1EFF |
| CA | C01.001 | papain | complex with Z-Leu-Phe-Gly-diazomethylketone inhibitor | 1KHP |
| CA | C01.001 | papain | complex with Z-Leu-Phe-Gly-diazomethylketone inhibitor (orthorhombic form) | 1KHQ |
| CA | C01.001 | papain | Cys25Ac-Ala-Ala-Phe-methylenylAla derivative | 1PAD |
| CA | C01.001 | papain | complex with E64C | 1PE6 |
| CA | C01.001 | papain | complex with Suc-Gln-Vla-Val-Ala-Ala-pNA | 1PIP |
| CA | C01.001 | papain | complex with leupeptin | 1POP |
| CA | C01.001 | papain | hydroxyethylthiopapain | 1PPD |
| CA | C01.001 | papain | Cys25 with bound atom | 1PPN |
| CA | C01.001 | papain | complex with E64C | 1PPP |
| CA | C01.001 | papain | complex with cystatin B Cys18Ser | 1STF_E |
| CA | C01.001 | papain | complex with ICP | 2CIO_A |
| CA | C01.001 | papain | cysteinyl derivative of Cys25 | 2PAD |
| CA | C01.001 | papain | complex with chagasin | 3E1Z_B |
| CA | C01.001 | papain | complex with tarocystatin | 3IMA_A |
| CA | C01.001 | papain | complex with CTD of tarocystatin | 3LFY_A |
| CA | C01.001 | papain | precursor; thermostable variant | 3TNX_A |
| CA | C01.001 | papain | precursor; thermostable variant from a crystal soaked at ph 4 | 3USV_A |
| CA | C01.001 | papain | TOS-methylenylLys derivative of Cys25 | 4PAD |
| CA | C01.001 | papain | Ile86Leu mutant | 4QRG_A |
| CA | C01.001 | papain | Ile86Phe mutant | 4QRV_A |
| CA | C01.001 | papain | precursor mutant at ph 4.0 | 4QRX_A |
| CA | C01.001 | papain | benzyloxycarbonyl-Gly-Phe-methylenylGly derivative | 5PAD |
| CA | C01.001 | papain | modified by achiral ru(ii)complex | 6H8T_A |
| CA | C01.001 | papain | benzyloxycarbonyl-Gly-Phe-methylenylGly derivative | 6PAD |
| CA | C01.001 | papain | Cys25 oxidized | 9PAP |
| CA | C01.002 | chymopapain | 1YAL | |
| CA | C01.003 | caricain | theoretical model; Asp158Glu mutant; complex with carbobenzoxy-Phe-3-amino-butan-2-one | 1C7X |
| CA | C01.003 | caricain | theoretical model; Asp158Glu mutant in complex with E64c | 1EUX |
| CA | C01.003 | caricain | theoretical model; Asp158Glu mutant in complex with leupeptin | 1F1I |
| CA | C01.003 | caricain | Asp185Glu mutant; complex with E64 | 1MEG |
| CA | C01.003 | caricain | precursor | 1PCI |
| CA | C01.003 | caricain | Cys25 with bound mercury | 1PPO |
| CA | C01.004 | glycyl endopeptidase | complex with benzyloxycarbonyl-Leu-Val-Gly-methylene bound to Cys25 | 1GEC |
| CA | C01.005 | stem bromelain | 1W0Q | |
| CA | C01.007 | actinidin | complex with E64 | 1AEC |
| CA | C01.007 | actinidin | theoretical model; complex with ZPACK (Z-Phe-Ala-Ala-chloromethyl ketone) | 1F3Q |
| CA | C01.007 | actinidin | theoretical model; complex with leupeptin | 1FOG |
| CA | C01.007 | actinidin | theoretical model; complex with E64c | 1FTV |
| CA | C01.007 | actinidin | 2ACT | |
| CA | C01.009 | cathepsin V | complex with 4-methylpiperazin-1-ylcarbonyl-Phe-3-amino-5-phenylpentane inhibitor | 1FH0 |
| CA | C01.009 | cathepsin V | complex with clitocypin | 3H6S_A |
| CA | C01.010 | vignain | complex with D-Val-Leu-dexoxy-methyl-Lys. | 1S4V_A |
| CA | C01.011 | calotropain | 0CDI | |
| CA | C01.013 | cathepsin X | precursor | 1DEU |
| CA | C01.013 | cathepsin X | 1EF7 | |
| CA | C01.017 | zingipain | tetramer | 1CQD |
| CA | C01.018 | cathepsin F | theoretical model | 1D5U |
| CA | C01.018 | cathepsin F | 1M6D_A | |
| CA | C01.024 | endopeptidase-B (Hordeum-type) | isoform 2 (EP-B2); complex with leupeptin | 2FO5_A |
| CA | C01.026 | ananain | complex with E-64 | 6MIS_A |
| CA | C01.026 | ananain | native ananain from ananas comosus | 6OKJ_A |
| CA | C01.032 | cathepsin L | precursor | 1CJL |
| CA | C01.032 | cathepsin L | procathepsin L | 1CJL_P |
| CA | C01.032 | cathepsin L | precursor | 1CS8_A |
| CA | C01.032 | cathepsin L | procathepsin L | 1CS8_P |
| CA | C01.032 | cathepsin L | complex with MHC class II associated P41 II fragment | 1ICF_A |
| CA | C01.032 | cathepsin L | complex with propeptide-based inhibitor biphenyl-4-yl-acetaldehyde-Cys-D-Arg-Tyr-2-phenylethylamine | 1MHW |
| CA | C01.032 | cathepsin L | complex with chagasin | 2NQD_B |
| CA | C01.032 | cathepsin L | cathsilicatein, a chimera | 2VHS_A |
| CA | C01.032 | cathepsin L | complex with a nitrile inhibitor | 2XU1_A |
| CA | C01.032 | cathepsin L | complex with a nitrile inhibitor | 2XU3_A |
| CA | C01.032 | cathepsin L | complex with a nitrile inhibitor | 2XU4_A |
| CA | C01.032 | cathepsin L | complex with a nitrile inhibitor | 2XU5_A |
| CA | C01.032 | cathepsin L | complex with a nitrile inhibitor | 2YJ2_A |
| CA | C01.032 | cathepsin L | complex with a nitrile inhibitor | 2YJ8_A |
| CA | C01.032 | cathepsin L | complex with a nitrile inhibitor | 2YJ9_A |
| CA | C01.032 | cathepsin L | complex with a nitrile inhibitor | 2YJB_A |
| CA | C01.032 | cathepsin L | complex with a nitrile inhibitor | 2YJC_A |
| CA | C01.032 | cathepsin L | exploring inhibitor binding at the s subsites of cathepsin l | 3BC3_A |
| CA | C01.032 | cathepsin L | complex with retro-binding inhibitor compound 4 | 3H89_A |
| CA | C01.032 | cathepsin L | complex with retro-binding inhibitor compound 9 | 3H8B_A |
| CA | C01.032 | cathepsin L | complex with retro-binding inhibitor compound 14 | 3H8C_A |
| CA | C01.032 | cathepsin L | complex with az12878478 | 3HHA_A |
| CA | C01.032 | cathepsin L | cathepsin l with az13010160 | 3HWN_A |
| CA | C01.032 | cathepsin L | Cys25Ala mutant | 3IV2_A |
| CA | C01.032 | cathepsin L | Cys25Ala mutant; complex with Gln-Leu-Ala peptide | 3K24_A |
| CA | C01.032 | cathepsin L | complex with dipeptidyl glyoxal and diazomethylketone inhibitors | 3OF8_A |
| CA | C01.032 | cathepsin L | complex with adiazomethylketone inhibitor | 3OF9_A |
| CA | C01.032 | cathepsin L | human cathepsin l apo form with zn | 4AXL_A |
| CA | C01.032 | cathepsin L | triazine cathepsin inhibitor complex | 4AXM_A |
| CA | C01.032 | cathepsin L | complex with (2s,4r)-4-(2-chloro-4-methoxy- benzenesulfonyl)-1-[3-(5-chloro-pyridin-2-yl)-azetidine-3-carbonyl]- pyrrolidine-2-carboxylic acid (1-cyano-cyclopropyl)-amide | 5F02_A |
| CA | C01.032 | cathepsin L | cleaved cathepsin L bound to the active site of cathepsin L | 5I4H_A |
| CA | C01.032 | cathepsin L | complex with (2s,4r)-4-(2-chloro-4-methoxy- benzenesulfonyl)-1-[3-(5-chloro-pyridin-2-yl)-azetidine-3-carbonyl]- pyrrolidine-2-car boxylic acid (1-cyano-cyclopropyl)-amide | 5MAE_A |
| CA | C01.032 | cathepsin L | complex with 4-[cyclopentyl(imidazo[1,2-a]pyridin-2- ylmethyl)amino]-6-morpholino-1,3,5-triazine-2-carbonitrile | 5MAJ_A |
| CA | C01.032 | cathepsin L | complex with 4-[1,3-benzodioxol-5-ylmethyl(2- phenoxyethyl)amino]-5-fluoropyrimidine-2-carbonitrile | 5MQY_A |
| CA | C01.032 | cathepsin L | complex with (3s,14e)-19-chloro-n-(1-cyanocyclopropyl)-5-oxo-12,17-dioxa-4-azatricyclo[16.2.2.06,11]docosa-1(21),6(11),7,9, 14,18(22),19-heptaene-3-carboxamide | 6EZP_A |
| CA | C01.032 | cathepsin L | complex with (3s,14e)-19-chloro-n-(1-cyanocyclopropyl)-5-oxo-17-oxa-4-azatricyclo[16.2.2.06,11]docosa-1(21),6,8,10,14, 18(22),19-heptaene-3-carboxamide | 6EZX_A |
| CA | C01.032 | cathepsin L | complex with (3s,14e)-8-(azetidin-3-yl)-19-chloro-n-(1-cyanocyclopropyl)-5-oxo-12,17-dioxa-4-azatricyclo[16.2.2.06, 11]docosa-1(21),6,8,10,14,18(22),19-heptaene-3-carboxamide | 6F06_A |
| CA | C01.032 | cathepsin L | theoretical model | 1MVV |
| CA | C01.033 | cathepsin L1 (Fasciola sp.) | precursor | 2O6X |
| CA | C01.034 | cathepsin S | theoretical model | 1BXF |
| CA | C01.034 | cathepsin S | Cys25Ser mutant | 1GLO |
| CA | C01.034 | cathepsin S | complex with dipeptide nitrile inhibitor BLN | 1MS6 |
| CA | C01.034 | cathepsin S | complex with inhibitor C1P | 1NPZ |
| CA | C01.034 | cathepsin S | complex with inhibitor C4P | 1NQC |
| CA | C01.034 | cathepsin S | precursor Cys25Ala mutant | 2C0Y_A |
| CA | C01.034 | cathepsin S | complex with non-covalent 2-(benzoxazol-2- ylamino)-acetamide | 2F1G_A |
| CA | C01.034 | cathepsin S | complex with CRA-27934, a nitrile inhibitor | 2FRA_A |
| CA | C01.034 | cathepsin S | complex with inhibitor CRA-26871 | 2FRQ_A |
| CA | C01.034 | cathepsin S | complex with inhibitor CRA-29728 | 2FT2_A |
| CA | C01.034 | cathepsin S | complex with inhibitor CRA-27566 | 2FUD_A |
| CA | C01.034 | cathepsin S | complex with irreversible inhibitor CRA-14013 | 2FYE_A |
| CA | C01.034 | cathepsin S | complex with vinyl sulfone inhibitor CRA-14009 | 2G6D_A |
| CA | C01.034 | cathepsin S | complex with inhibitor CRA-16981 | 2G7Y_A |
| CA | C01.034 | cathepsin S | complex with N-[(1S)-1-1-[(1R,3E)-1-acetylpent-3-en-1-yl]-1H-1,2,3-triazol-4-yl-1,2-dimethylpropyl]benzamide | 2H7J_A |
| CA | C01.034 | cathepsin S | complex with N-[(1R)-1-[(benzylsulfonyl)methyl]-2-[(1S)-1-methyl-2-[4-(trifluoromethoxy)phenyl]aminoethyl]amino-2-oxoethyl]morpholine-4-carboxamide | 2HH5_A |
| CA | C01.034 | cathepsin S | complex with non covalent arylaminoethyl amide. | 2HHN_A |
| CA | C01.034 | cathepsin S | complex with N-[(1S)-1-1-[(1R,3E)-1-acetylpent-3-en-1-yl]-1H-1,2,3-triazol-4-yl-1,2-dimethylpropyl]benzamide | 2HXZ_A |
| CA | C01.034 | cathepsin S | complex with a novel 2- arylphenoxyacetaldehyde inhibitor derived by the substrate activity screening (sas) method | 2OP3_A |
| CA | C01.034 | cathepsin S | complex with compound 15 | 2R9M_A |
| CA | C01.034 | cathepsin S | complex with compound 26 | 2R9N_A |
| CA | C01.034 | cathepsin S | complex with compound 8 | 2R9O_A |
| CA | C01.034 | cathepsin S | complex with a pyrazole-based inhibitor with an arylalkynes as P1 binding element | 3IEJ_A |
| CA | C01.034 | cathepsin S | complex with 4-(3-trifluoromethylphenyl)-pyrimidine-2-carbonitrile | 3N3G_A |
| CA | C01.034 | cathepsin S | complex with 6-phenyl-1h-imidazo[4,5-c]pyridine-4-carbonitrile | 3N4C_A |
| CA | C01.034 | cathepsin S | complex with a covalent inhibitor with an aldehyde warhead | 3OVX_A |
| CA | C01.034 | cathepsin S | complex with a non-covalent inhibitor | 4P6E_A |
| CA | C01.034 | cathepsin S | complex with a non-covalent inhibitor. | 4P6G_A |
| CA | C01.034 | cathepsin S | complex with bound ligand | 5QBU_A |
| CA | C01.034 | cathepsin S | complex with bound ligand | 5QBV_A |
| CA | C01.034 | cathepsin S | complex with bound ligand | 5QBW_A |
| CA | C01.034 | cathepsin S | complex with bound ligand | 5QBX_A |
| CA | C01.034 | cathepsin S | complex with bound ligand | 5QBY_A |
| CA | C01.034 | cathepsin S | complex with bound ligand | 5QBZ_A |
| CA | C01.034 | cathepsin S | complex with bound ligand | 5QC0_A |
| CA | C01.034 | cathepsin S | complex with bound ligand | 5QC1_A |
| CA | C01.034 | cathepsin S | complex with bound ligand | 5QC2_A |
| CA | C01.034 | cathepsin S | complex with bound ligand | 5QC3_A |
| CA | C01.034 | cathepsin S | complex with bound ligand | 5QC4_A |
| CA | C01.034 | cathepsin S | complex with bound ligand | 5QC5_A |
| CA | C01.034 | cathepsin S | complex with bound ligand | 5QC6_A |
| CA | C01.034 | cathepsin S | complex with bound ligand | 5QC7_A |
| CA | C01.034 | cathepsin S | complex with bound ligand | 5QC8_A |
| CA | C01.034 | cathepsin S | complex with bound ligand | 5QC9_A |
| CA | C01.034 | cathepsin S | complex with bound ligand | 5QCA_A |
| CA | C01.034 | cathepsin S | complex with bound ligand | 5QCB_A |
| CA | C01.034 | cathepsin S | complex with bound ligand | 5QCC_A |
| CA | C01.034 | cathepsin S | complex with bound ligand | 5QCE_A |
| CA | C01.034 | cathepsin S | complex with bound ligand | 5QCF_A |
| CA | C01.034 | cathepsin S | complex with bound ligand | 5QCG_A |
| CA | C01.034 | cathepsin S | complex with bound ligand | 5QCH_A |
| CA | C01.034 | cathepsin S | complex with bound ligand | 5QCI_A |
| CA | C01.034 | cathepsin S | complex with bound ligand | 5QCJ_A |
| CA | C01.034 | cathepsin S | theoretical model; precursor | 1M0H |
| CA | C01.034 | cathepsin S | 4BPV | |
| CA | C01.034 | cathepsin S | 4BQV | |
| CA | C01.034 | cathepsin S | 4BS5 | |
| CA | C01.034 | cathepsin S | 4BS6 | |
| CA | C01.034 | cathepsin S | 4BSQ | |
| CA | C01.034 | cathepsin S | 4MZO | |
| CA | C01.034 | cathepsin S | 4MZS | |
| CA | C01.036 | cathepsin K | complex with E64 | 1ATK |
| CA | C01.036 | cathepsin K | complex with a covalent symmetric diacylaminomethyl ketone inhibitor | 1AU0 |
| CA | C01.036 | cathepsin K | complex with a covant propanone inhibitor | 1AU2 |
| CA | C01.036 | cathepsin K | complex with 1-[N[(phenylmethoxy)carbonyl]-l-leucyl-4-[[N/N-[(phenylmethoxy)carbonyl]-/NL-leucyl]amino]-3-pyrrolidinone | 1AU3 |
| CA | C01.036 | cathepsin K | complex with 4-[[N-[(phenylmethoxy)carbonyl]-L-leucyl]amino]-1[(2S)-2-[[[4-(pyridinylmethoxy)carbonyl]amino]-4-methylpentyl]-3-pyrrolidinone | 1AU4 |
| CA | C01.036 | cathepsin K | complex with 1,5-bis(N-benzyloxycarbonyl-L-leucinyl)carbohydrazide | 1AYU |
| CA | C01.036 | cathepsin K | complex with N-[2-[1-(N-benzyloxycarbonylamino)-3-methylbutyl]thiazol-4-ylcarbonyl]-N'-(benzyloxycarbonyl-L-leucinyl)hydrazide | 1AYV |
| CA | C01.036 | cathepsin K | complex with 1-(N-benzyloxycarbonyl-L-leucinyl)-5-(3-benzyloxy benzoyl)carbohydrazide | 1AYW |
| CA | C01.036 | cathepsin K | complex with covalent peptidomimetic inhibitor 1-[2-(3-bipheyl)-4-methylvaleryl)]-amino-3-(2-pyridylsulfonyl)amino-2-propanone | 1BGO |
| CA | C01.036 | cathepsin K | precursor | 1BY8 |
| CA | C01.036 | cathepsin K | Ser149Ala mutant; complex with vinyl sulfone inhibitor | 1MEM |
| CA | C01.036 | cathepsin K | complex with covalent azepanone 5-(2-morpholin-4-ylethoxy)benzofuran-2-carboxylic acid ((S)-3-methyl-1-(S)-3-oxo-1-[2-(3-pyridin-2-ylphenyl)acetyl]azepan-4-ylcarbamoylbutyl)amide | 1NL6 |
| CA | C01.036 | cathepsin K | complex with covalent azepanone benzofuran-2-carboxylic acid (S)-3-methyl-1-[3-oxo-1-(pyridin-2-ylsulfonyl)azepan-4-ylcarbamoyl]butylamide | 1NLJ |
| CA | C01.036 | cathepsin K | complex with T-butyl(1S)-1-cyclohexyl-2- oxoethylcarbamate | 1Q6K_A |
| CA | C01.036 | cathepsin K | complex with N2-([(4-bromophenyl)methyl]oxycarbonyl)-N1-[(1S)-1-formylpentyl]-L-leucinamide | 1SNK |
| CA | C01.036 | cathepsin K | complex with ketoamide inhibitor [1-(4-fluorobenzyl)cyclobutyl]methyl (1S)-1-[oxo(1h-pyrazol-5-ylamino)acetyl]pentylcarbamate | 1TU6 |
| CA | C01.036 | cathepsin K | complex with the covalent inhibitor NVP-ABE854 | 1U9V_A |
| CA | C01.036 | cathepsin K | complex with the covalent inhibitor NVP-ABI491 | 1U9W_A |
| CA | C01.036 | cathepsin K | complex with the covalent inhibitor NVP-ABJ688 | 1U9X_A |
| CA | C01.036 | cathepsin K | complex with N-(2-aminoethyl)-N~2~-(1S)-1-[4'-(aminosulfonyl)biphenyl-4-yl]-2,2,2-trifluoroethyl-L-leucinamide | 1VSN_A |
| CA | C01.036 | cathepsin K | complex with cyanopyrrolidine inhibitor N2-[(benzyloxy)carbonyl]-N1-[(3S)-1-cyanopyrrolidin-3-yl]-L-leucinamide | 1YK7 |
| CA | C01.036 | cathepsin K | complex with cyanamide-based inhibitor tert-butyl 2-cyano-2-methylhydrazinecarboxylate | 1YK8_A |
| CA | C01.036 | cathepsin K | complex with (1R)-2,2-dimethyl-1-(5-[4-(trifluoromethyl)phenyl]-1,3,4-oxadiazol-2-ylmethyl)propyl (1S)-1-oxo[(2-oxo-1,3-oxazolidin-3-yl)amino]acetylpentylcarbamate | 1YT7 |
| CA | C01.036 | cathepsin K | complex with myocrisin | 2ATO_A |
| CA | C01.036 | cathepsin K | complex with semicarbazone inhibitor (1R)-2-methyl-1-(phenylmethyl)propyl[(1S)-1-formylpentyl]carbamate | 2AUX |
| CA | C01.036 | cathepsin K | complex with semicarbazone inhibitor 1-(phenylmethyl)cyclopentyl[(1S)-1-formylpentyl]carbamate | 2AUZ_A |
| CA | C01.036 | cathepsin K | complex with (3S)-1-[(3,5-dimethylisoxazol-4-yl)amino]carbonyl-4,4-dimethylpyrrolidin-3-yl(1s)-1-[1-hydroxy-2-oxo-2-[(1R)-1-phenylethyl]aminoethyl]pentylcarbamate | 2BDL |
| CA | C01.036 | cathepsin K | complex with a pyrrolopyrimidine inhibitor | 2R6N_A |
| CA | C01.036 | cathepsin K | complex with chondroitin sulfate | 3C9E |
| CA | C01.036 | cathepsin K | variant M5; complex with chondroitin-4-sulfate | 3H7D_A |
| CA | C01.036 | cathepsin K | complex with a triazine ligand | 3KW9_A |
| CA | C01.036 | cathepsin K | complex with a dioxo-triazine inhibitor | 3KWB_X |
| CA | C01.036 | cathepsin K | complex with a non-selective 2-cyano-pyrimidine inhibitor | 3KWZ_A |
| CA | C01.036 | cathepsin K | complex with a selective 2-cyano-pyrimidine inhibitor | 3KX1_A |
| CA | C01.036 | cathepsin K | complex with a cyano-pyrimidine inhibitor | 3O0U_A |
| CA | C01.036 | cathepsin K | complex with a 2-cyano pyrimidine inhibitor with a benzyl p3 group. | 3O1G_A |
| CA | C01.036 | cathepsin K | complex with a covalent inhibitor with a ketoamide warhead | 3OVZ_A |
| CA | C01.036 | cathepsin K | cathepsin k inhibitor | 4DMX_A |
| CA | C01.036 | cathepsin K | cathepsin k inhibitor | 4DMY_A |
| CA | C01.036 | cathepsin K | complex with dermatan sulfate | 4N79_A |
| CA | C01.036 | cathepsin K | complex with chondroitin sulfate | 4N8W_A |
| CA | C01.036 | cathepsin K | development of n-(functionalized benzoyl)-homocycloleucyl- glycinonitriles as potent cathepsin k inhibitors. | 4X6H_A |
| CA | C01.036 | cathepsin K | development of n-(functionalized benzoyl)-homocycloleucyl- glycinonitriles as potent cathepsin k inhibitors. | 4X6I_A |
| CA | C01.036 | cathepsin K | development of n-(functionalized benzoyl)-homocycloleucyl- glycinonitriles as potent cathepsin k inhibitors. | 4X6J_A |
| CA | C01.036 | cathepsin K | complex with lichostatinal | 4YV8_A |
| CA | C01.036 | cathepsin K | co-crystallized with actinomycetes extract | 4YVA_A |
| CA | C01.036 | cathepsin K | Cys25Ser mutant; complex with the allosteric effector nsc13345 | 5J94_A |
| CA | C01.036 | cathepsin K | Cys25Ser mutant; complex with the allosteric effector nsc94914 | 5JA7_A |
| CA | C01.036 | cathepsin K | Cys25Ser mutant | 5JH3_A |
| CA | C01.036 | cathepsin K | complex with a covalently-linked inhibitor | 5TDI_A |
| CA | C01.036 | cathepsin K | 5TUN_A | |
| CA | C01.036 | cathepsin K | pycnonodysostosis disease related Ile249Thr mutant | 5Z5O_A |
| CA | C01.036 | cathepsin K | complex with a non-active site inhibitor | 6ASH_A |
| CA | C01.036 | cathepsin K | complex with n-desmethyl thalassospiramide c | 6HGY_A |
| CA | C01.036 | cathepsin K | complex with an alkyne moiety | 6QBS_A |
| CA | C01.036 | cathepsin K | 7PCK | |
| CA | C01.036 | cathepsin K | 5T6U_A | |
| CA | C01.036 | cathepsin K | Thr101Ala variant | 6BKI_A |
| CA | C01.040 | cathepsin H | theoretical model | 1BZN |
| CA | C01.040 | cathepsin H | precursor | 6CZK_A |
| CA | C01.040 | cathepsin H | Cys26Ser mutant | 6CZS_A |
| CA | C01.040 | cathepsin H | complex with cystatin A | 1NB3_A |
| CA | C01.040 | cathepsin H | complex with cystatin A | 1NB5_A |
| CA | C01.040 | cathepsin H | 8PCH | |
| CA | C01.046 | falcipain-2 | complex with egg-white cystatin | 1YVB_A |
| CA | C01.046 | falcipain-2 | complex with E64 | 3BPF_A |
| CA | C01.046 | falcipain-2 | complex with PBICP-C | 3PNR_A |
| CA | C01.060 | cathepsin B | 1CSB | |
| CA | C01.060 | cathepsin B | 1CSB_A | |
| CA | C01.060 | cathepsin B | complex with a dipeptidyl nitrile inhibitor | 1GMY |
| CA | C01.060 | cathepsin B | 1GMY_A | |
| CA | C01.060 | cathepsin B | 1HUC | |
| CA | C01.060 | cathepsin B | 1HUC_A | |
| CA | C01.060 | cathepsin B | recombinant precursor | 1PBH |
| CA | C01.060 | cathepsin B | recombinant precursor | 1PBH_A |
| CA | C01.060 | cathepsin B | tetragonal form | 2IPP_A |
| CA | C01.060 | cathepsin B | recombinant precursor | 2PBH |
| CA | C01.060 | cathepsin B | recombinant precursor | 2PBH_A |
| CA | C01.060 | cathepsin B | 3AI8 | |
| CA | C01.060 | cathepsin B | complex with chagasin | 3CBJ_A |
| CA | C01.060 | cathepsin B | complex with chagasin | 3CBK_A |
| CA | C01.060 | cathepsin B | 3K9M_A | |
| CA | C01.060 | cathepsin B | recombinant precursor | 3PBH |
| CA | C01.060 | cathepsin B | recombinant precursor | 3PBH_A |
| CA | C01.060 | cathepsin B | complex with darpin 81 | 5MBL_A |
| CA | C01.060 | cathepsin B | complex with covalently linked compound 28 | 6AY2_A |
| CA | C01.060 | cathepsin B | complex with E64c | 1ITO |
| CA | C01.060 | cathepsin B | complex with CA074 inhibitor | 1QDQ |
| CA | C01.060 | cathepsin B | complex with NS-134, a two headed epoxysuccinyl inhibitor | 1SP4_A |
| CA | C01.060 | cathepsin B | 2DC6 | |
| CA | C01.060 | cathepsin B | 2DC7 | |
| CA | C01.060 | cathepsin B | 2DC8 | |
| CA | C01.060 | cathepsin B | 2DC9 | |
| CA | C01.060 | cathepsin B | 2DCA | |
| CA | C01.060 | cathepsin B | 2DCB | |
| CA | C01.060 | cathepsin B | 2DCC | |
| CA | C01.060 | cathepsin B | 2DCD | |
| CA | C01.060 | cathepsin B | Ser115Ala mutant | 1CPJ |
| CA | C01.060 | cathepsin B | 1CTE | |
| CA | C01.060 | cathepsin B | precursor | 1MIR |
| CA | C01.060 | cathepsin B | Ser115Ala mutant; complex with Z-Arg-Ser(OBzl) chloromethylketone | 1THE_B |
| CA | C01.062 | cathepsin B-like peptidase (platyhelminth) | complex with ca074 inhibitor | 3QSD_A |
| CA | C01.062 | cathepsin B-like peptidase (platyhelminth) | complex with k11017 inhibitor | 3S3Q_A |
| CA | C01.062 | cathepsin B-like peptidase (platyhelminth) | complex with k11777 inhibitor | 3S3R_A |
| CA | C01.062 | cathepsin B-like peptidase (platyhelminth) | zymogen | 4I04_A |
| CA | C01.062 | cathepsin B-like peptidase (platyhelminth) | structure of intermediate processing form of cathepsin b1 from schistosoma mansoni | 4I05_A |
| CA | C01.062 | cathepsin B-like peptidase (platyhelminth) | mature form | 4I07_A |
| CA | C01.062 | cathepsin B-like peptidase (platyhelminth) | complex with wrr391 inhibitor | 5OGQ_A |
| CA | C01.062 | cathepsin B-like peptidase (platyhelminth) | complex with wrr286 inhibitor | 5OGR_A |
| CA | C01.062 | cathepsin B-like peptidase (platyhelminth) | theoretical model | 1MF3 |
| CA | C01.063 | falcipain-3 | complex with leupeptin | 3BPM_A |
| CA | C01.063 | falcipain-3 | complex with the vinyl sulfone derived inhibitor K11017 | 3BWK_A |
| CA | C01.068 | vitellogenic cathepsin B | theoretical model | 1MHG |
| CA | C01.070 | dipeptidyl-peptidase I | 1JQP | |
| CA | C01.070 | dipeptidyl-peptidase I | exclusion domain | 1K3B_A |
| CA | C01.070 | dipeptidyl-peptidase I | complex with the inhibitor Gly-Phe-CHN2 | 2DJF_A |
| CA | C01.070 | dipeptidyl-peptidase I | re-refinement of the native structure of human dipeptidyl peptidase i (cathepsin c) | 2DJG_A |
| CA | C01.070 | dipeptidyl-peptidase I | discovery of novel cyanamide-based inhibitors of cathepsin c | 3PDF_A |
| CA | C01.070 | dipeptidyl-peptidase I | human dpp1 in complex with (2s)-2-amino-n-((1s)-1-cyano-2-(4- phenylphenyl)ethyl)butanamide | 4CDC_A |
| CA | C01.070 | dipeptidyl-peptidase I | human dpp1 in complex with (2s)-n-((1s)-1-cyano-2-(4-(4-cyanophenyl) phenyl)ethyl)piperidine-2-carboxamide | 4CDD_A |
| CA | C01.070 | dipeptidyl-peptidase I | human dpp1 in complex with 4-amino-n-((1s)-1-cyano-2-(4-(4- cyanophenyl)phenyl)ethyl)tetrahydropyran-4-carboxamide | 4CDE_A |
| CA | C01.070 | dipeptidyl-peptidase I | human dpp1 in complex with (2s,4s)-n-((1s)-1-cyano-2-(4-(4- cyanophenyl)phenyl)ethyl)-4-hydroxy-piperidine-2-carboxamide | 4CDF_A |
| CA | C01.070 | dipeptidyl-peptidase I | complex with dipeptide substrates | 4OEL_A |
| CA | C01.070 | dipeptidyl-peptidase I | complex with dipeptide substrates | 4OEM_A |
| CA | C01.070 | dipeptidyl-peptidase I | complex with dipeptidyl cyclopropyl nitrile inhibitor 2 | 6IC5_A |
| CA | C01.070 | dipeptidyl-peptidase I | complex with cyclopropyl peptidyl nitrile inhibitor 1 | 6IC6_A |
| CA | C01.070 | dipeptidyl-peptidase I | complex with dipeptidyl cyclopropyl nitrile inhibitor 3 | 6IC7_A |
| CA | C01.070 | dipeptidyl-peptidase I | theoretical model | 1BMU |
| CA | C01.072 | rhodesain | complex with the vinyl sulfone derived inhibitor K11777 | 2P7U_A |
| CA | C01.072 | rhodesain | complex with the vinyl sulfone derived inhibitor K11002 | 2P86_A |
| CA | C01.072 | rhodesain | complex with a macrolactam inhibitor | 6EX8_A |
| CA | C01.072 | rhodesain | complex with a macrolactam inhibitor | 6EXO_A |
| CA | C01.072 | rhodesain | complex with a macrolactam inhibitor | 6EXQ_A |
| CA | C01.073 | peptidase 1 (mite) | precursor; mutant form | 1XKG |
| CA | C01.073 | peptidase 1 (mite) | 2AS8_A | |
| CA | C01.073 | peptidase 1 (mite) | c2 crystal form of mite allergen der p 1 | 3F5V_A |
| CA | C01.073 | peptidase 1 (mite) | 3RVW | |
| CA | C01.073 | peptidase 1 (mite) | 3RVX | |
| CA | C01.073 | peptidase 1 (mite) | 4PP1 | |
| CA | C01.073 | peptidase 1 (mite) | 4PP2 | |
| CA | C01.073 | peptidase 1 (mite) | complex with fab fragment of mab 5h8 | 5VCN_A |
| CA | C01.073 | peptidase 1 (mite) | complex with fab fragment of mab 10b9 | 5VCO_A |
| CA | C01.073 | peptidase 1 (mite) | complex with fab 4c1 | 5VPG_A |
| CA | C01.073 | peptidase 1 (mite) | complex with fab 4c1 | 5VPH_A |
| CA | C01.073 | peptidase 1 (mite) | 3D6S_A | |
| CA | C01.073 | peptidase 1 (mite) | 3RVV | |
| CA | C01.073 | peptidase 1 (mite) | 5VPK_A | |
| CA | C01.073 | peptidase 1 (mite) | complex with fab 4c1 | 5VPL_A |
| CA | C01.074 | CPB peptidase | theoretical model | 1BMJ |
| CA | C01.075 | cruzipain | catalytic domain, Gly213 stop. | 1AIM |
| CA | C01.075 | cruzipain | complex with WRR-99 | 1EWL_A |
| CA | C01.075 | cruzipain | complex with WRR-112 | 1EWM |
| CA | C01.075 | cruzipain | complex with WRR-204 | 1EWO |
| CA | C01.075 | cruzipain | complex with N-carbonylmorpholine-Leu-homophenylalanylmethane inhibitor | 1EWP |
| CA | C01.075 | cruzipain | complex with vinyl sulfone-derived inhibitor VS1 | 1F29 |
| CA | C01.075 | cruzipain | complex with vinyl sulfone-derived inhibitor VS2 | 1F2A |
| CA | C01.075 | cruzipain | complex with vinyl sulfone-derived inhibitor VS3 | 1F2B |
| CA | C01.075 | cruzipain | complex with vinyl sulfone-derived inhibitor VS4 | 1F2C |
| CA | C01.075 | cruzipain | complex with [1-(3-hydroxy-2-oxo-1-phenethyl-propylcarbamoyl)2-phenyl-ethyl]-carbamic acid pyridin-4-ylmethyl ester | 1ME3 |
| CA | C01.075 | cruzipain | complex with [1-(1-benzyl-3-hydroxy-2-oxo-propylcarbamoyl)-2-phenyl-ethyl]-carbamic acid benzyl ester | 1ME4 |
| CA | C01.075 | cruzipain | complex with [1-(1-methyl-4,5-dioxo-pent-2-enylcarbamoyl)-2-phenyl-ethyl]-carbamic acid benzyl ester | 1U9Q_X |
| CA | C01.075 | cruzipain | catalytic domain; complex with Bz-Arg-Ala-fluoromethylketone | 2AIM |
| CA | C01.075 | cruzipain | complex with vinyl sulfone derived inhibitor WR483 | 2EFM_A |
| CA | C01.075 | cruzipain | complex with the vinyl sulfone derived inhibitor K11777 | 2OZ2_A |
| CA | C01.075 | cruzipain | 3HD3 | |
| CA | C01.075 | cruzipain | 3I06 | |
| CA | C01.075 | cruzipain | 3IUT | |
| CA | C01.075 | cruzipain | 3KKU | |
| CA | C01.075 | cruzipain | 3LXS | |
| CA | C01.075 | cruzipain | 4KLB | |
| CA | C01.075 | cruzipain | 4PI3 | |
| CA | C01.075 | cruzipain | 4QH6 | |
| CA | C01.075 | cruzipain | 4W5B | |
| CA | C01.075 | cruzipain | 4W5C | |
| CA | C01.075 | cruzipain | 4XUI | |
| CA | C01.075 | cruzipain | apo-form | 6N3S_A |
| CA | C01.075 | cruzipain | complex with mmts inhibitor | 6O2X_A |
| CA | C01.084 | bleomycin hydrolase (animal) | 1CB5 | |
| CA | C01.084 | bleomycin hydrolase (animal) | Cys73Ser mutant | 2CB5 |
| CA | C01.085 | bleomycin hydrolase (yeast) | Cys73Ala mutant | 1A6R |
| CA | C01.085 | bleomycin hydrolase (yeast) | 1GCB | |
| CA | C01.085 | bleomycin hydrolase (yeast) | Asn392Ala mutant | 2DZY_A |
| CA | C01.085 | bleomycin hydrolase (yeast) | Asn392Val mutant | 2DZZ_A |
| CA | C01.085 | bleomycin hydrolase (yeast) | Asn392Leu mutant | 2E00_A |
| CA | C01.085 | bleomycin hydrolase (yeast) | His369la mutant | 2E01_A |
| CA | C01.085 | bleomycin hydrolase (yeast) | His369Leu mutant | 2E02_A |
| CA | C01.085 | bleomycin hydrolase (yeast) | Asnq67e mutant | 2E03_A |
| CA | C01.085 | bleomycin hydrolase (yeast) | Cys73Ala mutant | 3GCB |
| CA | C01.098 | CPC peptidase | theoretical model | 1MJ6 |
| CA | C01.098 | CPC peptidase | theoretical model | 1BF7 |
| CA | C01.098 | CPC peptidase | complex with ca074 | 3HHI_A |
| CA | C01.098 | CPC peptidase | 3MOR_A | |
| CA | C01.098 | CPC peptidase | 4HWY_A | |
| CA | C01.098 | CPC peptidase | trypanosoma brucei procathepsin b structure solved by serial microcrystallography using synchrotron radiation | 4N4Z_A |
| CA | C01.098 | CPC peptidase | procathepsin b s9 from trypanosoma congolense | 5FPW_A |
| CA | C01.099 | ervatamin B | 1IWD | |
| CA | C01.101 | cathepsin B-like peptidase, nematode | theoretical model | 1MNW |
| CA | C01.116 | ervatamin C | 1O0E_A | |
| CA | C01.116 | ervatamin C | 2PNS_A | |
| CA | C01.125 | Cwp84 peptidase | 4CI7 | |
| CA | C01.125 | Cwp84 peptidase | Cys116Ala mutant; mature protein | 4D59 |
| CA | C01.125 | Cwp84 peptidase | Cys116Ala mutant; mature protein | 4D5A |
| CA | C01.128 | xylellain | 3OIS | |
| CA | C01.134 | mexicain | 2BDZ | |
| CA | C01.137 | ervatamin A | complex with E64 | 2PSC |
| CA | C01.137 | ervatamin A | complex with E64 | 3BCN |
| CA | C01.137 | ervatamin A | 2PNS | |
| CA | C01.137 | ervatamin A | ervatamin-C; complex with E64 | 2PRE_A |
| CA | C01.149 | TgCPL peptidase (Toxoplasma-type) | complex with propeptide | 3F75_A |
| CA | C01.171 | Pd_dinase (Parabacteroides distasonis) | 3PW3 | |
| CA | C01.171 | Pd_dinase (Parabacteroides distasonis) | 5WDK_A | |
| CA | C01.171 | Pd_dinase (Parabacteroides distasonis) | 5WDL_A | |
| CA | C01.984 | serine-repeat antigen (Plasmodium sp.) | 2WBF | |
| CA | C01.984 | serine-repeat antigen (Plasmodium sp.) | 3CH2 | |
| CA | C01.984 | serine-repeat antigen (Plasmodium sp.) | 3CH3 | |
| CA | C01.987 | papain-like protein SPE31 (Pachyrhizus erosus) | 2B1M | |
| CA | C01.987 | papain-like protein SPE31 (Pachyrhizus erosus) | 2B1N | |
| CA | C01.UPA | subfamily C1A unassigned peptidases | complex with N-[(1S)-1-([(3S,4S,7R)-3-hydroxy-7-methyl-1-(pyridin-2-ylsulfonyl)-2,3,4,7-tetrahydro-1H-azepin-4-yl]aminocarbonyl)-3-methylbutyl]-1-benzofuran-2-carboxamide | 2FTD |
| CA | C01.UPA | subfamily C1A unassigned peptidases | structural basis for the limited antibody cross reactivity between themite allergens blo t 1 and der p 1 | 5JT8_A |
| CA | C01.UPA | subfamily C1A unassigned peptidases | structure of digestive procathepsin l2 proteinase from tenebrio molitor larval midgut | 3QJ3_A |
| CA | C01.UPA | subfamily C1A unassigned peptidases | precursor | 5EF4_A |
| CA | C01.UPA | subfamily C1A unassigned peptidases | precursor | 5EGW_A |
| CA | C02.001 | calpain-1 | complex with inhibitor Z-Leu-Leu-Tyr-CH2F | 1ZCM |
| CA | C02.001 | calpain-1 | catalytic domain only | 2ARY |
| CA | C02.001 | calpain-1 | catalytic domain only | 1KXR_A |
| CA | C02.001 | calpain-1 | 1QXP_A | |
| CA | C02.001 | calpain-1 | protease core; complex with leupeptin | 1TL9_A |
| CA | C02.001 | calpain-1 | peptidase unit only; complex with E64 | 1TLO |
| CA | C02.001 | calpain-1 | calpain 1 proteolytic core;ncomplex with snj-1715, a cyclic hemiacetal-type inhibitor | 2G8E_A |
| CA | C02.001 | calpain-1 | proteolytic core; complex with snj-1945, a alpha-ketoamide-type inhibitor. | 2G8J_A |
| CA | C02.001 | calpain-1 | calpain 1 proteolytic core inactivated by wr18(s,s), an epoxysuccinyl-type inhibitor. | 2NQG_A |
| CA | C02.001 | calpain-1 | calpain 1 proteolytic core inactivated by wr13(r,r), an epoxysuccinyl-type inhibitor. | 2NQI_A |
| CA | C02.001 | calpain-1 | calpain 1 proteolytic core inactivated by zlak-3001, an alpha-ketoamide | 2R9C_A |
| CA | C02.001 | calpain-1 | calpain 1 proteolytic core inactivated by zlak-3002, an alpha-ketoamide | 2R9F_A |
| CA | C02.002 | calpain-2 | 1KFU_L | |
| CA | C02.002 | calpain-2 | 1KFX_L | |
| CA | C02.002 | calpain-2 | 2NQA | |
| CA | C02.002 | calpain-2 | Complex with light chain | 1DF0_A |
| CA | C02.002 | calpain-2 | protease core | 1MDW_A |
| CA | C02.002 | calpain-2 | 1QXP_A | |
| CA | C02.002 | calpain-2 | Lys10Thr mutant | 1U5I_A |
| CA | C02.002 | calpain-2 | complex with light chain with calpastatin | 3BOW_A |
| CA | C02.002 | calpain-2 | complex with light chain and calpastatin | 3DF0_A |
| CA | C02.004 | calpain-3 | 1Y9V | |
| CA | C02.004 | calpain-3 | 4OKH | |
| CA | C02.004 | calpain-3 | crystal structure of human calpain-3 protease core mutant-Cys129Ser | 6BDT_A |
| CA | C02.004 | calpain-3 | crystal structure of human calpain-3 protease core mutant-Cys129Ala | 6BGP_A |
| CA | C02.004 | calpain-3 | protease core; complex with E-64 | 6BJD_A |
| CA | C02.004 | calpain-3 | protease core; complex with leupeptin | 6BKJ_A |
| CA | C02.006 | calpain-9 | catalytic domain only | 1ZIV |
| CA | C02.006 | calpain-9 | complex with leupeptin | 2P0R_A |
| CA | C02.011 | calpain-5 | core peptidase domain | 6P3Q |
| CA | C02.020 | calpain-13 | 2I7A | |
| CA | C02.029 | calpain (Plasmodium-type) | C2 domain | 2QFE |
| PA | C03.001 | poliovirus-type picornain 3C | 1L1N_A | |
| PA | C03.001 | poliovirus-type picornain 3C | coxsackievirus Ala24Val mutant; complex with the d1-d2 fragment of icam-1 | 6EIT_3 |
| PA | C03.005 | hepatitis A virus-type picornain 3C | 1HAV_A | |
| PA | C03.005 | hepatitis A virus-type picornain 3C | complex with inhibitor iodoacetyl-Val-Phe-amide | 1QA7 |
| PA | C03.005 | hepatitis A virus-type picornain 3C | complex with peptide-based ketone inhibitor N-acetyl-L-leucyl-L-alanyl-N-[(1S)-4-(dimethylamino)-1-(fluoroacetyl)-4-oxobutyl]-L-alaninamide | 2H6M |
| PA | C03.005 | hepatitis A virus-type picornain 3C | complex with peptide-based ketone inhibitor N-acetyl-L-Leu-L-Ala-N-[(1S)-4-(dimethylamino)-1-(fluoroacetyl)-4-oxobutyl]-L-alaninamide | 2H9H |
| PA | C03.005 | hepatitis A virus-type picornain 3C | complex with peptide-based ketone inhibitor N-acetyl-L-Leu-L-Phe-N-[(1S,2R)-1-(2-carboxyethyl)-3-fluoro-2-hydroxypropyl]-L-phenylalaninamide | 2HAL |
| PA | C03.007 | human rhinovirus 2-type picornain 3C | complex with AG7088 inhibitor | 1CQQ_A |
| PA | C03.007 | human rhinovirus 2-type picornain 3C | 1AYM_4 | |
| PA | C03.007 | human rhinovirus 2-type picornain 3C | 1AYN_4 | |
| PA | C03.007 | human rhinovirus 2-type picornain 3C | 1R1A | |
| PA | C03.007 | human rhinovirus 2-type picornain 3C | 2HWD | |
| PA | C03.007 | human rhinovirus 2-type picornain 3C | 2HWE | |
| PA | C03.007 | human rhinovirus 2-type picornain 3C | 2HWF | |
| PA | C03.008 | foot-and-mouth disease virus picornain 3C | type A10(61); crystal packing mutant (Lys51Gln) | 2J92_A |
| PA | C03.008 | foot-and-mouth disease virus picornain 3C | complex with a decameric peptide corresponding to the vp1-2a cleavage junction | 2WV4_A |
| PA | C03.008 | foot-and-mouth disease virus picornain 3C | complex with a decameric peptide corresponding to the vp1-2a cleavage junction with a gln to glu substitution at p1 | 2WV5_A |
| PA | C03.008 | foot-and-mouth disease virus picornain 3C | crystal structure of the 3c protease from south african territories type 2 foot-and-mouth disease virus | 5HM2_A |
| PA | C03.008 | foot-and-mouth disease virus picornain 3C | 1QMY | |
| PA | C03.008 | foot-and-mouth disease virus picornain 3C | 1QOL_A | |
| PA | C03.008 | foot-and-mouth disease virus picornain 3C | 1QQP | |
| PA | C03.008 | foot-and-mouth disease virus picornain 3C | 2JQF_R | |
| PA | C03.008 | foot-and-mouth disease virus picornain 3C | 2JQG | |
| PA | C03.008 | foot-and-mouth disease virus picornain 3C | 4QBB | |
| PA | C03.008 | foot-and-mouth disease virus picornain 3C | fmdv leader protease bound to substrate isg15 | 6FFA_A |
| PA | C03.011 | Coxsackievirus-type picornain 3C | coxsackievirus b3 coat protein | 1COV_1 |
| PA | C03.011 | Coxsackievirus-type picornain 3C | 2VB0_A | |
| PA | C03.011 | Coxsackievirus-type picornain 3C | complex with epdtc | 2ZTX_A |
| PA | C03.011 | Coxsackievirus-type picornain 3C | space group c2 | 2ZTY_A |
| PA | C03.011 | Coxsackievirus-type picornain 3C | space group p21 | 2ZTZ_A |
| PA | C03.011 | Coxsackievirus-type picornain 3C | Cys147Ala mutant | 2ZU1_A |
| PA | C03.011 | Coxsackievirus-type picornain 3C | 2ZU3_A | |
| PA | C03.011 | Coxsackievirus-type picornain 3C | the novel asymmetric entry intermediate of a picornavirus captured with nanodiscs | 3JD7_1 |
| PA | C03.011 | Coxsackievirus-type picornain 3C | crystal structure of 3c protease of coxsackievirus b3 | 3ZYD_A |
| PA | C03.011 | Coxsackievirus-type picornain 3C | Thr68Ala mutant | 3ZYE_A |
| PA | C03.011 | Coxsackievirus-type picornain 3C | crystal structure of 3c protease mutant (Asn126Tyr) of coxsackievirus b3 | 3ZZ3_A |
| PA | C03.011 | Coxsackievirus-type picornain 3C | Thr68Ala and Asn126Tyr mutant | 3ZZ4_A |
| PA | C03.011 | Coxsackievirus-type picornain 3C | complex with alpha, beta-unsaturated ethyl ester inhibitor 74 | 3ZZ5_A |
| PA | C03.011 | Coxsackievirus-type picornain 3C | complex with michael receptor inhibitor 75 | 3ZZ6_A |
| PA | C03.011 | Coxsackievirus-type picornain 3C | complex with alpha, beta-unsaturated ethyl ester inhibitor 81 | 3ZZ7_A |
| PA | C03.011 | Coxsackievirus-type picornain 3C | complex with alpha, beta-unsaturated ethyl ester inhibitor 82 | 3ZZ8_A |
| PA | C03.011 | Coxsackievirus-type picornain 3C | complex with alpha, beta-unsaturated ethyl ester inhibitor 83 | 3ZZ9_A |
| PA | C03.011 | Coxsackievirus-type picornain 3C | complex with alpha, beta-unsaturated ethyl ester inhibitor 84 | 3ZZA_A |
| PA | C03.011 | Coxsackievirus-type picornain 3C | complex with alpha, beta-unsaturated ethyl ester inhibitor 85 | 3ZZB_A |
| PA | C03.011 | Coxsackievirus-type picornain 3C | Thr68Ala and Asn126Tyr mutant; complex with alpha, beta-unsaturated ethyl ester inhibitor 83 | 3ZZC_A |
| PA | C03.011 | Coxsackievirus-type picornain 3C | Thr68Ala and Asn126Tyr mutant; complex with alpha, beta-unsaturated ethyl ester inhibitor 85 | 3ZZD_A |
| PA | C03.011 | Coxsackievirus-type picornain 3C | echovirus 18 native particle | 6HBG_A |
| PA | C03.011 | Coxsackievirus-type picornain 3C | echovirus 18 a-particle | 6HBH_A |
| PA | C03.011 | Coxsackievirus-type picornain 3C | echovirus 18 empty particle | 6HBJ_A |
| PA | C03.011 | Coxsackievirus-type picornain 3C | echovirus 18 open particle without one pentamer | 6HBK_A |
| PA | C03.011 | Coxsackievirus-type picornain 3C | echovirus 18 open particle without three pentamers | 6HBL_A |
| PA | C03.011 | Coxsackievirus-type picornain 3C | 3ZV8 | |
| PA | C03.011 | Coxsackievirus-type picornain 3C | complex with Michael receptor inhibitor 74 | 3ZV9 |
| PA | C03.011 | Coxsackievirus-type picornain 3C | complex with Michael receptor inhibitor 75 | 3ZVA |
| PA | C03.011 | Coxsackievirus-type picornain 3C | complex with Michael receptor inhibitor 81 | 3ZVB |
| PA | C03.011 | Coxsackievirus-type picornain 3C | complex with Michael receptor inhibitor 82 | 3ZVC |
| PA | C03.011 | Coxsackievirus-type picornain 3C | complex with Michael receptor inhibitor 83 | 3ZVD |
| PA | C03.011 | Coxsackievirus-type picornain 3C | complex with Michael receptor inhibitor 84 | 3ZVE |
| PA | C03.011 | Coxsackievirus-type picornain 3C | complex with Michael receptor inhibitor 85 | 3ZVF |
| PA | C03.011 | Coxsackievirus-type picornain 3C | complex with Michael receptor inhibitor 98 | 3ZVG |
| PA | C03.011 | Coxsackievirus-type picornain 3C | crystal structure of the main protease (3c) from human enterovirus b ev93 | 3Q3X_A |
| PA | C03.011 | Coxsackievirus-type picornain 3C | complex with compound 1 (ag7404) | 3Q3Y_A |
| PA | C03.011 | Coxsackievirus-type picornain 3C | complex with rupintrivir (ag7088) | 3RUO_A |
| PA | C03.014 | human enterovirus 71 3C peptidase | human enterovirus 71 3c protease | 3OSY_A |
| PA | C03.014 | human enterovirus 71 3C peptidase | Glu71Asp mutant; complex with rupintrivir | 3QZQ_A |
| PA | C03.014 | human enterovirus 71 3C peptidase | Glu71Ala mutant; complex with rupintrivir | 3QZR_A |
| PA | C03.014 | human enterovirus 71 3C peptidase | His133Gly mutant; complex with rupintrivir | 3R0F_A |
| PA | C03.014 | human enterovirus 71 3C peptidase | human enterovirus 71 in complex with capsid binding inhibitor win51711 | 3ZFE_A |
| PA | C03.014 | human enterovirus 71 3C peptidase | human enterovirus 71 in complex with capsid binding inhibitor win51711 | 3ZFF_A |
| PA | C03.014 | human enterovirus 71 3C peptidase | human enterovirus 71 in complex with capsid binding inhibitor win51711 | 3ZFG_A |
| PA | C03.014 | human enterovirus 71 3C peptidase | crystal structure of human enterovirus 71 | 4AED_A |
| PA | C03.014 | human enterovirus 71 3C peptidase | cryo-em reconstruction of enterovirus 71 in complex with a neutralizing antibody e18 | 4C0U_A |
| PA | C03.014 | human enterovirus 71 3C peptidase | cryo-em reconstruction of empty enterovirus 71 in complex with a neutralizing antibody e18 | 4C0Y_A |
| PA | C03.014 | human enterovirus 71 3C peptidase | cryo-em reconstruction of empty enterovirus 71 in complex with a neutralizing antibody e19 | 4C10_4 |
| PA | C03.014 | human enterovirus 71 3C peptidase | crystal structure of human enterovirus 71 in complex with the uncoating inhibitor gpp2 | 4CDQ_A |
| PA | C03.014 | human enterovirus 71 3C peptidase | crystal structure of human enterovirus 71 in complex with the uncoating inhibitor gpp3 | 4CDU_A |
| PA | C03.014 | human enterovirus 71 3C peptidase | crystal structure of human enterovirus 71 in complex with the uncoating inhibitor gpp4 | 4CDW_A |
| PA | C03.014 | human enterovirus 71 3C peptidase | crystal structure of human enterovirus 71 in complex with the uncoating inhibitor gpp12 | 4CDX_A |
| PA | C03.014 | human enterovirus 71 3C peptidase | crystal structure of human enterovirus 71 in complex with the uncoating inhibitor ald | 4CEW_A |
| PA | C03.014 | human enterovirus 71 3C peptidase | crystal structure of human enterovirus 71 in complex with the uncoating inhibitor nld | 4CEY_A |
| PA | C03.014 | human enterovirus 71 3C peptidase | Cys110Ala mutant | 4FVB_A |
| PA | C03.014 | human enterovirus 71 3C peptidase | Cys110Ala mutant; complex with substrate | 4FVD_A |
| PA | C03.014 | human enterovirus 71 3C peptidase | 4GHQ_A | |
| PA | C03.014 | human enterovirus 71 3C peptidase | complex with ag7088 | 4GHT_A |
| PA | C03.014 | human enterovirus 71 3C peptidase | human enterovirus 71 uncoating intermediate captured at atomic resolution | 4N43_C |
| PA | C03.014 | human enterovirus 71 3C peptidase | complex with compound xb | 5C1U_A |
| PA | C03.014 | human enterovirus 71 3C peptidase | complex with compound viii | 5C1X_A |
| PA | C03.014 | human enterovirus 71 3C peptidase | complex with compound 1 | 5C1Y_A |
| PA | C03.014 | human enterovirus 71 3C peptidase | complex with compound 2 | 5C20_A |
| PA | C03.014 | human enterovirus 71 3C peptidase | complex with compound 2 | 5DP3_A |
| PA | C03.014 | human enterovirus 71 3C peptidase | complex with compound 3 | 5DP4_A |
| PA | C03.014 | human enterovirus 71 3C peptidase | complex with compound 4 | 5DP5_A |
| PA | C03.014 | human enterovirus 71 3C peptidase | complex with compound 7 | 5DP6_A |
| PA | C03.014 | human enterovirus 71 3C peptidase | complex with compound 5 | 5DP7_A |
| PA | C03.014 | human enterovirus 71 3C peptidase | complex with compound 8 | 5DP8_A |
| PA | C03.014 | human enterovirus 71 3C peptidase | complex with compound 9 | 5DP9_A |
| PA | C03.014 | human enterovirus 71 3C peptidase | complex with compound 6 | 5DPA_A |
| PA | C03.014 | human enterovirus 71 3C peptidase | complex with nk-1.8k | 5GSO_A |
| PA | C03.014 | human enterovirus 71 3C peptidase | complex with n69s 1.8k | 5GSW_A |
| PA | C03.014 | human enterovirus 71 3C peptidase | complex with rupintrivir | 5WQ2_A |
| PA | C03.014 | human enterovirus 71 3C peptidase | cryo-em structure of cva6 vlp | 5YHQ_C |
| PA | C03.020 | enterovirus picornain 2A | 2IJD_1 | |
| PA | C03.020 | enterovirus picornain 2A | poliovirus type 3 (strain saukett) stabilized virus-like particle | 5O5B_4 |
| PA | C03.020 | enterovirus picornain 2A | poliovirus type 3 (strain saukett) stabilized virus-like particle in complex with the pocket factor compound gpp3 | 5O5P_4 |
| PA | C03.020 | enterovirus picornain 2A | complex with antiviral agent sch48973 | 1EAH_1 |
| PA | C03.020 | enterovirus picornain 2A | NMR structure | 1Z8R |
| PA | C03.020 | enterovirus picornain 2A | identification of a druggable vp1-vp3 interprotomer pocket in the capsid of enteroviruses | 6GZV_A |
| PA | C03.020 | enterovirus picornain 2A | 4MG3 | |
| PA | C03.020 | enterovirus picornain 2A | 5C8C | |
| PA | C03.020 | enterovirus picornain 2A | human enterovirus 71 uncoating intermediate captured at atomic resolution | 4N43_B |
| PA | C03.020 | enterovirus picornain 2A | structural model of human decay-accelerating factor bound to echovirus7 from cryo-electron microscopy | 1M11_1 |
| PA | C03.020 | enterovirus picornain 2A | 5X45 | |
| PA | C03.021 | rhinovirus picornain 2A | 2HRV_A | |
| PA | C03.023 | parechovirus picornain 3C | 4UDF | |
| PA | C03.023 | parechovirus picornain 3C | 4Z92 | |
| PA | C03.UNA | subfamily C3A non-peptidase homologues | 1QGC | |
| PA | C03.UNA | subfamily C3A non-peptidase homologues | 4WYL | |
| PA | C03.UNA | subfamily C3A non-peptidase homologues | 4WYW | |
| PA | C03.UNA | subfamily C3A non-peptidase homologues | 4WZM | |
| PA | C03.UNA | subfamily C3A non-peptidase homologues | 4WZQ | |
| PA | C03.UNA | subfamily C3A non-peptidase homologues | 4X2B | |
| PA | C03.UPA | subfamily C3A unassigned peptidases | 1MEC | |
| PA | C03.UPA | subfamily C3A unassigned peptidases | 2M7Y | |
| PA | C03.UPA | subfamily C3A unassigned peptidases | 2MEV | |
| PA | C03.UPA | subfamily C3A unassigned peptidases | 2MMH | |
| PA | C03.UPA | subfamily C3A unassigned peptidases | 2MMI | |
| PA | C03.UPA | subfamily C3A unassigned peptidases | 2MMK | |
| PA | C03.UPA | subfamily C3A unassigned peptidases | 2MML | |
| PA | C03.UPA | subfamily C3A unassigned peptidases | 4NYZ | |
| PA | C03.UPA | subfamily C3A unassigned peptidases | 4NZ0 | |
| PA | C03.UPA | subfamily C3A unassigned peptidases | 4Y2C | |
| PA | C03.UPA | subfamily C3A unassigned peptidases | 4Y3C | |
| PA | C03.UPA | subfamily C3A unassigned peptidases | crystal structure of the 3c protease from coxsackievirus a16 | 3SJ8_A |
| PA | C03.UPA | subfamily C3A unassigned peptidases | Cys147Ala mutant; complex with faglrqavtq peptide | 3SJ9_A |
| PA | C03.UPA | subfamily C3A unassigned peptidases | complex with rupintrivir (ag7088) | 3SJI_A |
| PA | C03.UPC | subfamily C3C unassigned peptidases | 3CJI | |
| PA | C04.004 | tobacco etch virus NIa peptidase | inactive form; complex with substrate | 1LVB_A |
| PA | C04.004 | tobacco etch virus NIa peptidase | complex with product | 1LVM |
| PA | C04.004 | tobacco etch virus NIa peptidase | Cys151Ala mutant | 1Q31 |
| CE | C05.001 | adenain | complex with peptide cofactor | 1AVP_A |
| CE | C05.001 | adenain | complex with 11 amino acid cofactor | 1NLN_A |
| CE | C05.001 | adenain | 4EKF | |
| CE | C05.001 | adenain | complex with N-benzyl-2-[(Z)-iminomethyl]pyrimidine-5- carboxamide | 4PID |
| CE | C05.001 | adenain | complex with N-(2S)-2-(3-chlorophenyl)-2-[(methylsulfonyl)amino]acetyl- L-phenylalanyl-N-[(2Z)-2-iminoethyl]glycinamide | 4PIE |
| CE | C05.001 | adenain | structure of human adenovirus 2 protease with cofactor pvic | 5FGY_A |
| CE | C05.001 | adenain | complex with N-[(3,5-dichlorophenyl)acetyl]-L-threonyl- N-[(2Z)-2-iminoethyl]glycinamide | 4PIQ |
| CE | C05.001 | adenain | complex with N~2~-[(2R)-2-(3,5-dichlorophenyl)-2-(dimethylamino)acetyl]- N-(2-[(Z)-iminomethyl]pyrimidin-4-ylmethyl)- L-isoleucinamide | 4PIS |
| CE | C05.001 | adenain | complex with a nitrile inhibitor | 4WX4_A |
| CE | C05.001 | adenain | crystal structure of human adenovirus 8 protease with an irreversible vinyl sulfone inhibitor | 4WX6_A |
| CE | C05.001 | adenain | crystal structure of adenovirus 8 protease with a nitrile inhibitor | 4WX7_A |
| CA | C06.001 | potato virus Y-type helper component peptidase | 1LVM_A | |
| CA | C06.001 | potato virus Y-type helper component peptidase | 1Q31_A | |
| CA | C06.001 | potato virus Y-type helper component peptidase | 3MMG | |
| CA | C06.001 | potato virus Y-type helper component peptidase | 3RNV | |
| CN | C09.001 | sindbis virus-type nsP2 peptidase | 4GUA | |
| CN | C09.001 | sindbis virus-type nsP2 peptidase | 3GPG | |
| CN | C09.001 | sindbis virus-type nsP2 peptidase | 3GPO | |
| CN | C09.001 | sindbis virus-type nsP2 peptidase | 3GPQ | |
| CN | C09.001 | sindbis virus-type nsP2 peptidase | 3TRK | |
| CN | C09.001 | sindbis virus-type nsP2 peptidase | 4TU0 | |
| CN | C09.001 | sindbis virus-type nsP2 peptidase | 4ZTB | |
| CN | C09.002 | equine encephalitis alphavirus nsP2 peptidase | 2HWK | |
| CN | C09.002 | equine encephalitis alphavirus nsP2 peptidase | venezuelan equine encephalitis virus (veev) nonstructural protein 2 (nsp2) cysteine protease | 5EZQ_A |
| CN | C09.002 | equine encephalitis alphavirus nsP2 peptidase | complex with E64d | 5EZS_A |
| CA | C10.001 | streptopain | precursor; Cys47Ser mutant | 1DKI_A |
| CA | C10.001 | streptopain | complex with inhibitor | 1PVJ |
| CA | C10.001 | streptopain | mature peptidase | 2UZJ |
| CA | C10.004 | interpain A | structure of prevotella intermedia prointerpain a fragment 39-359 (mutant c154a) | 3BB7_A |
| CA | C10.004 | interpain A | structure of active wild-type prevotella intermedia interpain a cysteine protease | 3BBA_A |
| CA | C100.001 | agglutinin peptidase (Marasmius oreades) | complex with trisaccharide Gal-Gla-GlcNAc | 2IHO |
| CA | C100.001 | agglutinin peptidase (Marasmius oreades) | complex with trisaccharide Galalpha(1,3)[Fucalpha(1,2)]Gal | 3EF2 |
| CA | C100.001 | agglutinin peptidase (Marasmius oreades) | complex with Z-Val-Ala-Asp-CH(2)F, direct orientation | 5D61 |
| CA | C100.001 | agglutinin peptidase (Marasmius oreades) | complex with Z-Val-Ala-Asp-CH(2)F, inverted orientation | 5D62 |
| CA | C100.001 | agglutinin peptidase (Marasmius oreades) | complex with Z-Val-Ala-Asp-CH(2)F, dual orientation | 5D63 |
| CA | C100.UNW | family C100 non-peptidase homologues | complex with trisaccharide Neu5Aca2-6Galb1-4GlcNAc | 3PHZ |
| CA | C100.UPW | family C100 unassigned peptidases | complex with E64 | 5MUA |
| CA | C101.001 | OTULIN peptidase | 3ZNV | |
| CA | C101.001 | OTULIN peptidase | 3ZNX | |
| CA | C101.001 | OTULIN peptidase | 3ZNZ | |
| CA | C101.001 | OTULIN peptidase | OTU domain | 4KSJ |
| CA | C101.001 | OTULIN peptidase | complex with ubiquitin | 4KSK |
| CA | C101.001 | OTULIN peptidase | complex with linear di-ubiquitin | 4KSL |
| CA | C101.001 | OTULIN peptidase | 4OYK | |
| CA | C101.001 | OTULIN peptidase | 4P0B | |
| CA | C101.001 | OTULIN peptidase | structure of otulin bound to the met1-linked diubiquitin activity probe | 5OE7_A |
| CA | C101.001 | OTULIN peptidase | structure of the otu domain of otulin g281r mutant | 6I9C_A |
| CA | C101.950 | protein FAM105A | otu domain of fam105a | 6DRM_A |
| CA | C102.001 | GtgE peptidase | 4MI7 | |
| CA | C102.001 | GtgE peptidase | 5KDG | |
| CA | C104.001 | PlyC phage lysin | complex with PlyCB | 4F88 |
| PA | C107.UPW | family C107 unassigned peptidases | semet labeled derivative of cavally virus 3cl protease | 5LAC_A |
| PA | C107.UPW | family C107 unassigned peptidases | ligand-bound structure of cavally virus 3cl protease ***caveat 5lak tyr i 2 has wrong chirality at atom ca tyr k 2 has wrong ***caveat 2 5lak chirality at atom ca | 5LAK_A |
| CR | C108.001 | Prp peptidase (Staphylococcus aureus) | 2P92 | |
| CR | C108.001 | Prp peptidase (Staphylococcus aureus) | 2IDL | |
| CR | C108.001 | Prp peptidase (Staphylococcus aureus) | 2G0I | |
| CR | C108.UPW | family C108 unassigned peptidases | 1S12 | |
| CD | C11.003 | PmC11 peptidase (Parabacteroides merdae) | 3UWS | |
| CD | C11.003 | PmC11 peptidase (Parabacteroides merdae) | complex with peptide inhibitor Ac-VLTK-AOMK | 4YEC |
| CD | C11.004 | fragipain (Bacteroides fragilis) | 5DYN_A | |
| CD | C11.005 | thetapain | ||
| CD | C11.006 | clostripain-related protein (Bacteroides thetaiotaomicron) | complex with biotin-Val-Leu-Thr-Lys-AOMK | 5L20 |
| CD | C11.006 | clostripain-related protein (Bacteroides thetaiotaomicron) | Arg154Ala mutant | 6NAG |
| CD | C11.007 | distapain (Parabacteroides distasonis) | zymogen | 6MZO |
| CA | C111.001 | coagulation factor XIIIa | with bound calcium | 1EVU |
| CA | C111.001 | coagulation factor XIIIa | zymogen; Trp279Phe mutant | 1EX0 |
| CA | C111.001 | coagulation factor XIIIa | recombinant form | 1F13 |
| CA | C111.001 | coagulation factor XIIIa | recombinant form | 1FIE |
| CA | C111.001 | coagulation factor XIIIa | 1GGT | |
| CA | C111.001 | coagulation factor XIIIa | with bound calcium | 1GGU |
| CA | C111.001 | coagulation factor XIIIa | with bound ytterbium | 1GGY |
| CA | C111.001 | coagulation factor XIIIa | with bound strontium | 1QRK |
| CA | C111.001 | coagulation factor XIIIa | complex with peptide-like ligand | 4KTY |
| C- | C116.001 | dermonecrotic toxin (Pasteurella multocida) | 2EBF | |
| C- | C116.001 | dermonecrotic toxin (Pasteurella multocida) | 2EBH | |
| C- | C116.001 | dermonecrotic toxin (Pasteurella multocida) | 2EC5 | |
| CA | C117.001 | SpvD g.p. (Salmonella enterica) | Arg161 variant | 5LQ6 |
| CA | C117.001 | SpvD g.p. (Salmonella enterica) | Gly161 variant | 5LQ7 |
| CA | C12.001 | ubiquitinyl hydrolase-L1 | 2ETL | |
| CA | C12.001 | ubiquitinyl hydrolase-L1 | 2LEN | |
| CA | C12.001 | ubiquitinyl hydrolase-L1 | 3IFW | |
| CA | C12.001 | ubiquitinyl hydrolase-L1 | 3IRT | |
| CA | C12.001 | ubiquitinyl hydrolase-L1 | 3KVF | |
| CA | C12.001 | ubiquitinyl hydrolase-L1 | 3KW5 | |
| CA | C12.001 | ubiquitinyl hydrolase-L1 | 4DM9 | |
| CA | C12.001 | ubiquitinyl hydrolase-L1 | 4JKJ | |
| CA | C12.002 | ubiquitinyl hydrolase-YUH1 | complex with human ubiquitin | 1CMX |
| CA | C12.003 | ubiquitinyl hydrolase-L3 | 1UCH | |
| CA | C12.003 | ubiquitinyl hydrolase-L3 | complex with ubiquitin | 1XD3 |
| CA | C12.003 | ubiquitinyl hydrolase-L3 | complex with Lys27-linked di-ubiquitin | 6ISU_A |
| CA | C12.005 | ubiquitinyl hydrolase-L5 | 3A7S | |
| CA | C12.005 | ubiquitinyl hydrolase-L5 | 3IHR | |
| CA | C12.005 | ubiquitinyl hydrolase-L5 | catalytic domain only | 3RII |
| CA | C12.005 | ubiquitinyl hydrolase-L5 | catalytic domain only | 3RIS |
| CA | C12.005 | ubiquitinyl hydrolase-L5 | 3TB3 | |
| CA | C12.005 | ubiquitinyl hydrolase-L5 | 4UEL | |
| CA | C12.005 | ubiquitinyl hydrolase-L5 | 4UEM | |
| CA | C12.005 | ubiquitinyl hydrolase-L5 | 4UF5 | |
| CA | C12.005 | ubiquitinyl hydrolase-L5 | 4UF6 | |
| CA | C12.005 | ubiquitinyl hydrolase-L5 | 4WLP | |
| CA | C12.005 | ubiquitinyl hydrolase-L5 | 4WLQ | |
| CA | C12.005 | ubiquitinyl hydrolase-L5 | 4WLR | |
| CA | C12.A09 | CG8445 g.p. (Drosophila melanogaster) | complex with pr | 6CGA_A |
| CA | C12.A09 | CG8445 g.p. (Drosophila melanogaster) | complex with DEUBAD of ASX | 6HGC |
| CE | C122.001 | SdeA (Legionella pneumophila) | 5CRA | |
| CE | C122.001 | SdeA (Legionella pneumophila) | 5CRB | |
| CE | C122.001 | SdeA (Legionella pneumophila) | 5CRC | |
| CE | C122.001 | SdeA (Legionella pneumophila) | 5YSI | |
| CE | C122.001 | SdeA (Legionella pneumophila) | 5YSJ | |
| CE | C122.001 | SdeA (Legionella pneumophila) | 5YSK | |
| CE | C122.001 | SdeA (Legionella pneumophila) | 6B7Q | |
| CE | C122.001 | SdeA (Legionella pneumophila) | 6G0C | |
| CD | C13.001 | legumain (plant beta form) | complex with AAN peptide | 6AZT |
| CD | C13.004 | legumain, animal-type | complex with Ac-Tyr-Val-Ala-Asp-chloromethylketone | 4AW9 |
| CD | C13.004 | legumain, animal-type | complex with Ac-Tyr-Val-Ala-Asp-chloromethylketone at pH 5.0 | 4AWA |
| CD | C13.004 | legumain, animal-type | complex with Z-Ala-Ala-AzaAsn-chloromethylketone | 4AWB |
| CD | C13.004 | legumain, animal-type | precursor | 4FGU |
| CD | C13.004 | legumain, animal-type | oxidised form in complex with cystatin E/M | 4N6N_A |
| CD | C13.004 | legumain, animal-type | complex with cystatin E/M | 4N6O_A |
| CD | C13.004 | legumain, animal-type | YVAD-CMK bound form; complex with compound 11b | 5LU8_C |
| CD | C13.004 | legumain, animal-type | YVAD-CMK bound form; complex with compound 11 | 5LU9_C |
| CD | C13.004 | legumain, animal-type | complex with compound 11b | 5LUA_A |
| CD | C13.004 | legumain, animal-type | complex with compound 11 | 5LUB_B |
| CD | C13.004 | legumain, animal-type | activated at pH 3.5 | 4NOJ |
| CD | C13.004 | legumain, animal-type | precxursor at pH 7.5 | 4NOK |
| CD | C13.004 | legumain, animal-type | Asp223Ala mutant; precursor at pH 7.5 | 4NOL |
| CD | C13.004 | legumain, animal-type | activated at pH 4.5 | 4NOM |
| CD | C13.004 | legumain, animal-type | 4D3X | |
| CD | C13.004 | legumain, animal-type | precursor | 4D3Y |
| CD | C13.004 | legumain, animal-type | precursor; trigonal space group | 4D3Z |
| CD | C13.006 | legumain (plant gamma form) | two-chain activation state | 5NIJ |
| CD | C13.006 | legumain (plant gamma form) | isoform gamma in complex with Ac-YVAD-CMK | 5OBT |
| CD | C13.010 | OaAEP1 (Oldenlandia affinis) | 5H0I | |
| CD | C14.001 | caspase-1 | complex with (3S)-N-methanesulfonyl-3-(1-[N-(2-naphtoyl)-Val]-Proamino)-4-oxobutanamide inhibitor | 1BMQ |
| CD | C14.001 | caspase-1 | complex with inhibitor ac-Trp-Glu-His-Asp | 1IBC |
| CD | C14.001 | caspase-1 | complex with inhibitor Ac-Tyr-Val-Ala-Asp-H | 1ICE |
| CD | C14.001 | caspase-1 | complex with 3-(2- mercapto-acetylamino)-4-oxo-pentanoic acid | 1RWK_A |
| CD | C14.001 | caspase-1 | complex with 4-oxo- 3-[2-(5-[4-(quinoxalin-2-ylamino)-benzoylamino]-methyl- thiophen-2-yl)-acetylamino]-pentanoic acid | 1RWM_A |
| CD | C14.001 | caspase-1 | complex with 3-2- ethyl-6-[4-(quinoxalin-2-ylamino)-benzoylamino]- hexanoylamino-4-oxo-butyric acid | 1RWN_A |
| CD | C14.001 | caspase-1 | complex with 4-oxo- 3-6-[4-(quinoxalin-2-ylamino)-benzoylamino]-2-thiophen-2- yl-hexanoylamino-pentanoic acid | 1RWO_A |
| CD | C14.001 | caspase-1 | complex with 3-6- [(8-hydroxy-quinoline-2-carbonyl)-amino]-2-thiophen-2-yl- hexanoylamino-4-oxo-butyric acid | 1RWP_A |
| CD | C14.001 | caspase-1 | complex with 5-[5- (1-carboxymethyl-2-oxo-propylcarbamoyl)-5-phenyl- pentylsulfamoyl]-2-hydroxy-benzoic acid | 1RWV_A |
| CD | C14.001 | caspase-1 | complex with 4-oxo- 3-[(6-[4-(quinoxalin-2-ylamino)-benzoylamino]-methyl- pyridine-3-carbonyl)-amino]-butyric acid | 1RWW_A |
| CD | C14.001 | caspase-1 | complex with 4-oxo- 3-6-[4-(quinoxalin-2-yloxy)-benzoylamino]-2-thiophen-2-yl- hexanoylamino-butyric acid | 1RWX_A |
| CD | C14.001 | caspase-1 | Cys285Ala mutant | 1SC1 |
| CD | C14.001 | caspase-1 | Cys285Ala mutant; complex with malonate | 1SC3 |
| CD | C14.001 | caspase-1 | Cys285Ala mutant; after malonate complex dissociation | 1SC4 |
| CD | C14.001 | caspase-1 | Cys285Ala, Cys362Ala, Cys364Ala, Cys397Ala mutant; complex with 1-methyl-3- trifluoromethyl-1H-thieno[2,3-C]pyrazole-5-carboxylic acid (2-mercapto-ethyl)-amide | 2FQQ_A |
| CD | C14.001 | caspase-1 | Cys362Ala, Cys364Ala, Cys397Ala mutant; complex with 3-[2-(2- benzyloxycarbonylamino-3-methyl-butyrylamino)- propionylamino]-4-oxo-pentanoic acid (z-VAD-FMK) | 2H48_A |
| CD | C14.001 | caspase-1 | Glu390Asp mutant; complex with 3-[2-(2-benzyloxycarbonylamino-3-methyl- butyrylamino)-propionylamino]-4-oxo-pentanoic acid (z-vad- fmk) | 2H4W_A |
| CD | C14.001 | caspase-1 | Arg286Lys mutant; complex with 3-[2-(2-benzyloxycarbonylamino-3-methyl- butyrylamino)-propionylamino]-4-oxo-pentanoic acid (z-vad- fmk) | 2H4Y_A |
| CD | C14.001 | caspase-1 | Glu390Asp, Arg286Lys mutant; complex with 3-[2-(2- benzyloxycarbonylamino-3-methyl-butyrylamino)- propionylamino]-4-oxo-pentanoic acid | 2H51_A |
| CD | C14.001 | caspase-1 | Thr388Ala mutant; complex with 3-[2-(2-benzyloxycarbonylamino-3-methyl- butyrylamino)-propionylamino]-4-oxo-pentanoic acid (z-vad- fmk) | 2H54_A |
| CD | C14.001 | caspase-1 | complex with 3-[2-(2-benzyloxycarbonylamino-3-methyl-butyrylamino)- propionylamino]-4-oxo-pentanoic acid (z-VAD-FMK) | 2HBQ_A |
| CD | C14.001 | caspase-1 | Arg286Ala mutant; complex with 3-[2-(2-benzyloxycarbonylamino-3-methyl- butyrylamino)-propionylamino]-4-oxo-pentanoic acid (z-VAD- FMK) | 2HBR_A |
| CD | C14.001 | caspase-1 | Glu390Ala mutant; complex with 3-[2-(2-benzyloxycarbonylamino-3-methyl- butyrylamino)-propionylamino]-4-oxo-pentanoic acid (z-VAD- FMK) | 2HBY_A |
| CD | C14.001 | caspase-1 | Arg286Ala, Glu390Ala mutant; complex with 3-[2-(2-benzyloxycarbonylamino-3- methyl-butyrylamino)-propionylamino]-4-oxo-pentanoic acid (Z-VAD-FMK) | 2HBZ_A |
| CD | C14.001 | caspase-1 | 3D6F | |
| CD | C14.001 | caspase-1 | 3D6H | |
| CD | C14.001 | caspase-1 | 3D6M | |
| CD | C14.001 | caspase-1 | procaspase-1 zymogen domain crystal strucutre | 3E4C_A |
| CD | C14.001 | caspase-1 | 3NS7 | |
| CD | C14.001 | caspase-1 | crystal structure of human caspase-1 with 2-((2-naphthoyl)-l-valyl)-4-hydroxy-n-((3s)-2-hydroxy-5-oxotetrahydrofuran-3-yl)-2- azabicyclo[2.2.2]octane-3-carboxamide (compound 1) | 5MMV_A |
| CD | C14.001 | caspase-1 | crystal structure of human caspase-1 with (3s,6s,10as)-n-((2s,3s)-2- hydroxy-5-oxotetrahydrofuran-3-yl)-6-(isoquinoline-1-carboxamido)-5- oxodecahydropyrrolo[1,2-a]azocine-3-carboxamide (pge-3935199) | 5MTK_A |
| CD | C14.001 | caspase-1 | complex with ac-fltd-cmk | 6BZ9_A |
| CD | C14.001 | caspase-1 | crystal structure of human caspase-1 with n-3-[1-((s)-2-hydroxy-5- oxo-tetrahydro-furan-3-ylcarbamoyl)-ethyl]-1-methyl-2,4-dioxo-1,2,3, 4-tetrahydro-pyrimidin-5-yl-4-(quinoxalin-2-ylamino)-benzamide | 6F6R_A |
| CD | C14.002 | CED-3 peptidase | 4M9R | |
| CD | C14.003 | caspase-3 | complex with tetrapeptide inhibitor acetyl-Asp-Val-Ala-Asp-fluoromethylketone | 1CP3 |
| CD | C14.003 | caspase-3 | complex with isatin sulfonamide inhibitor 1-methyl-5-(2-phenoxymethyl-pyrrolidine-1-sulfonyl)-1H-indole-2,3-dione | 1GFW |
| CD | C14.003 | caspase-3 | complex with BIRC-4 protein | 1I3O_A |
| CD | C14.003 | caspase-3 | 1NME | |
| CD | C14.003 | caspase-3 | 1NMQ | |
| CD | C14.003 | caspase-3 | 1NMS | |
| CD | C14.003 | caspase-3 | complex with acetyl-Asp-Glu-Val-Asp-CHO | 1PAU_A |
| CD | C14.003 | caspase-3 | 1QX3 | |
| CD | C14.003 | caspase-3 | complex with nicotinic acid aldehyde (3S)-3-[(5-bromopyridin-3-yl)carbonyl]amino-4-oxobutanoic acid | 1RE1_A |
| CD | C14.003 | caspase-3 | complex with pryazinone inhibitor 3-(2-5-tert-butyl-3-[(4-methyl-furazan-3-ylmethyl)-amino]-2-oxo-2H-pyrazin-1-yl-butyrylamino)-5-(hexyl-methyl-amino)-4-oxo-pentanoic acid anion | 1RHJ_A |
| CD | C14.003 | caspase-3 | complex with phenyl- propyl-ketone N-acetyl-L-alpha-aspartyl-L-alpha-glutamyl-N-[(1S)-1-(carboxymethyl)-2-oxo-5-phenylpentyl]-L-valinamide | 1RHK_A |
| CD | C14.003 | caspase-3 | complex with nicotinic acid aldehyde 4-[5-(2-carboxy-1-formyl-ethylcarbamoyl)-pyridin-3-yl]-benzoic acid | 1RHM_A |
| CD | C14.003 | caspase-3 | complex with bromomethoxyphenyl inhibitor 5-S-benzyl-3-(N-[(5-bromo-2-methoxyphenyl)acetyl]- L-valylamino)-2,3-dideoxy-5-thio-D-erythro- pentonic acid | 1RHQ_A |
| CD | C14.003 | caspase-3 | complex with cinnamic acid methyl ester (3S)-5-[(2-chloro-6-fluorobenzyl)sulfanyl]-3-[N-(2-ethoxy-5-[(1E)-3-methoxy-3-oxoprop-1-enyl]phenylacetyl)-D-valyl]amino-4-oxopentanoic acid | 1RHR_A |
| CD | C14.003 | caspase-3 | complex with 5,6,7 tricyclic peptidomimetic inhibitor (3S)-3-[((2S)-5-[(N-acetyl-L-alpha-aspartyl)amino]-4-oxo-1,2,4,5,6,7-hexahydroazepino[3,2,1-hi]indol-2-ylcarbonyl)amino]-5-(benzylsulfanyl)-4-oxopentanoic acid | 1RHU_A |
| CD | C14.003 | caspase-3 | complex with (5S,8R,11S)-8-(2-carboxyethyl)-5-(carboxymethyl)-14-(4-ethoxy-4-oxobutanoyl)-11-(1-methylethyl)-3,6,9,12-tetraoxo-1-phenyl-2-oxa-4,7,10,13,14-pentaazahexadecan-16-oic acid | 2C1E_A |
| CD | C14.003 | caspase-3 | complex with (5S,8R,11S)-8-(2-carboxyethyl)-5-(carboxymethyl)-14-(4-ethoxy-4-oxobutanoyl)-11-(1-methylethyl)-3,6,9,12-tetraoxo-1-phenyl-2-oxa-4,7,10,13,14-pentaazahexadecan-16-oic acid | 2C2K_A |
| CD | C14.003 | caspase-3 | complex with (5S,8R,11S)-14-[4-(benzyloxy)-4-oxobutanoyl]-8-(2-carboxyethyl)-5-(carboxymethyl)-11-(1-methylethyl)-3,6,9,12-tetraoxo-1-phenyl-2-oxa-4,7,10,13,14-pentaazahexadecan-16-oic acid | 2C2M_A |
| CD | C14.003 | caspase-3 | complex with Cbz-Asp-Glu-Val-AAsp-CHCH-CON(CH3)CH2Ph | 2C2O_A |
| CD | C14.003 | caspase-3 | complex with CBZ-Asp-Glu-Val-azaAsp-EP-CO-N(CH2PH)2 | 2CDR_A |
| CD | C14.003 | caspase-3 | extended substrate recognition in caspase-3 revealed by high resolution x-ray structure analysis | 2CJX_A |
| CD | C14.003 | caspase-3 | extended substrate recognition in caspase-3 revealed by high resolution x-ray structure analysis | 2CJY_A |
| CD | C14.003 | caspase-3 | complex with CBZ-Asp-Glu-Val-azaAsp-EP-COO-CH2Ph | 2CNK_A |
| CD | C14.003 | caspase-3 | complex with CBZ-Asp-Glu-Val-azaAsp-EP-CO-NH-CH2Ph | 2CNL_A |
| CD | C14.003 | caspase-3 | complex with CBZ-Ile-Glu-Thr-azaAsp-EP-CO-Ala-NH-CH2-Ph | 2CNN_A |
| CD | C14.003 | caspase-3 | complex with CBZ-Glu-Val-azaAsp-(S,S)EP-CO-NHCH2CH2Ph | 2CNO_A |
| CD | C14.003 | caspase-3 | extended substrate recognition in caspase-3 revealed by high resolution x-ray structure analysis | 2DKO_A |
| CD | C14.003 | caspase-3 | complex with inhibitor Ac-DEVD-CHO | 2H5I_A |
| CD | C14.003 | caspase-3 | complex with inhibitor Ac-DMQD-CHO | 2H5J_A |
| CD | C14.003 | caspase-3 | complex with inhibitor Ac-VDVAD-CHO | 2H65_A |
| CD | C14.003 | caspase-3 | 2J30 | |
| CD | C14.003 | caspase-3 | 2J31 | |
| CD | C14.003 | caspase-3 | 2J32 | |
| CD | C14.003 | caspase-3 | 2J33 | |
| CD | C14.003 | caspase-3 | 2XYG | |
| CD | C14.003 | caspase-3 | 2XYH | |
| CD | C14.003 | caspase-3 | 2XYP | |
| CD | C14.003 | caspase-3 | 2XZD | |
| CD | C14.003 | caspase-3 | 2XZT | |
| CD | C14.003 | caspase-3 | 2Y0B | |
| CD | C14.003 | caspase-3 | 3DEH | |
| CD | C14.003 | caspase-3 | 3DEI | |
| CD | C14.003 | caspase-3 | 3DEJ | |
| CD | C14.003 | caspase-3 | 3DEK | |
| CD | C14.003 | caspase-3 | complex with inhibitor Ac-LDESD-CHO | 3EDQ_A |
| CD | C14.003 | caspase-3 | caspase-3 binds diverse p4 residues in peptides | 3GJQ_A |
| CD | C14.003 | caspase-3 | caspase-3 binds diverse p4 residues in peptides | 3GJR_A |
| CD | C14.003 | caspase-3 | caspase-3 binds diverse p4 residues in peptides | 3GJS_A |
| CD | C14.003 | caspase-3 | caspase-3 binds diverse p4 residues in peptides | 3GJT_A |
| CD | C14.003 | caspase-3 | 3H0E | |
| CD | C14.003 | caspase-3 | 3ITN | |
| CD | C14.003 | caspase-3 | 3KJF | |
| CD | C14.003 | caspase-3 | 3PCX | |
| CD | C14.003 | caspase-3 | 3PD0 | |
| CD | C14.003 | caspase-3 | 3PD1 | |
| CD | C14.003 | caspase-3 | 4DCJ | |
| CD | C14.003 | caspase-3 | 4DCO | |
| CD | C14.003 | caspase-3 | 4DCP | |
| CD | C14.003 | caspase-3 | 4EHA | |
| CD | C14.003 | caspase-3 | 4EHD | |
| CD | C14.003 | caspase-3 | 4EHF | |
| CD | C14.003 | caspase-3 | 4EHH | |
| CD | C14.003 | caspase-3 | 4EHK | |
| CD | C14.003 | caspase-3 | 4EHL | |
| CD | C14.003 | caspase-3 | 4EHN | |
| CD | C14.003 | caspase-3 | 4JJE | |
| CD | C14.003 | caspase-3 | 4JQY | |
| CD | C14.003 | caspase-3 | 4JQZ | |
| CD | C14.003 | caspase-3 | 4JR0 | |
| CD | C14.003 | caspase-3 | 4PRY | |
| CD | C14.003 | caspase-3 | 4PS0 | |
| CD | C14.003 | caspase-3 | 4QTX | |
| CD | C14.003 | caspase-3 | 4QTY | |
| CD | C14.003 | caspase-3 | 4QU0 | |
| CD | C14.003 | caspase-3 | 4QU5 | |
| CD | C14.003 | caspase-3 | 4QU8 | |
| CD | C14.003 | caspase-3 | 4QU9 | |
| CD | C14.003 | caspase-3 | 4QUA | |
| CD | C14.003 | caspase-3 | 4QUB | |
| CD | C14.003 | caspase-3 | 4QUD | |
| CD | C14.003 | caspase-3 | 4QUE | |
| CD | C14.003 | caspase-3 | 4QUG | |
| CD | C14.003 | caspase-3 | 4QUH | |
| CD | C14.003 | caspase-3 | 4QUI | |
| CD | C14.003 | caspase-3 | 4QUJ | |
| CD | C14.003 | caspase-3 | 4QUL | |
| CD | C14.003 | caspase-3 | Val266Ala mutant | 5I9B_A |
| CD | C14.003 | caspase-3 | Val266Cys mutant | 5I9T_A |
| CD | C14.003 | caspase-3 | Val266Asp mutant | 5IAB_A |
| CD | C14.003 | caspase-3 | Val266Phe mutant | 5IAE_A |
| CD | C14.003 | caspase-3 | Val266Gln mutant | 5IAG_A |
| CD | C14.003 | caspase-3 | Val266Leu mutant | 5IAJ_A |
| CD | C14.003 | caspase-3 | Val266Ser mutant | 5IAK_A |
| CD | C14.003 | caspase-3 | Val266Asn mutant | 5IAN_A |
| CD | C14.003 | caspase-3 | Val266Trp mutant | 5IAR_A |
| CD | C14.003 | caspase-3 | Val266Tyr mutant | 5IAS_A |
| CD | C14.003 | caspase-3 | Val266Ile mutant | 5IBC_A |
| CD | C14.003 | caspase-3 | Val266Met mutant | 5IBP_A |
| CD | C14.003 | caspase-3 | Val266Lys mutant | 5IBR_A |
| CD | C14.003 | caspase-3 | complex with DEVE peptide | 5IC4_A |
| CD | C14.003 | caspase-3 | caspase-3 mutant - t245d,s249d | 6BFJ_A |
| CD | C14.003 | caspase-3 | caspase-3 mutant- t245a | 6BFK_A |
| CD | C14.003 | caspase-3 | caspase-3 mutant- d9a,d28a,t245d | 6BFL_A |
| CD | C14.003 | caspase-3 | caspase-3 mutant- t245d | 6BFO_A |
| CD | C14.003 | caspase-3 | Asp9Ala/Asp28Ala/Ser150Asp mutant | 6BG0_A |
| CD | C14.003 | caspase-3 | Asp9Ala/Asp28Ala/Ser150Glu mutant | 6BG1_A |
| CD | C14.003 | caspase-3 | caspase-3 mutant- t152d | 6BG4_A |
| CD | C14.003 | caspase-3 | caspase-3 mutant- d9a,d28a,t152d | 6BGK_A |
| CD | C14.003 | caspase-3 | Ser150Asp mutant | 6BGQ_A |
| CD | C14.003 | caspase-3 | caspase-3 mutant - s150e | 6BGR_A |
| CD | C14.003 | caspase-3 | caspase-3 mutant - s150y | 6BGS_A |
| CD | C14.003 | caspase-3 | caspase-3 mutant - t152a | 6BH9_A |
| CD | C14.003 | caspase-3 | caspase-3 mutant - t152v | 6BHA_A |
| CD | C14.003 | caspase-3 | complex with ac-dw3-ke | 6CKZ_A |
| CD | C14.003 | caspase-3 | complex with ac-ats009-ke | 6CL0_A |
| CD | C14.003 | caspase-3 | zebra fish caspase-3 ***caveat 5jft caspase should be connected to the chloromethyl ketone ***caveat 2 5jft residual terminus of the inhibitor through hemithioacetal ***caveat 3 5jft bond, but the model does not reflect the ideal ***caveat 4 5jft hemithio | 5JFT_A |
| CD | C14.004 | caspase-7 | complex with acetyl-Asp-Glu-Val-Asp-CHO | 1F1J |
| CD | C14.004 | caspase-7 | precursor | 1GQF |
| CD | C14.004 | caspase-7 | complex with XIAP | 1I4O_A |
| CD | C14.004 | caspase-7 | complex with XIAP inhibitor | 1I51_A |
| CD | C14.004 | caspase-7 | 1K86 | |
| CD | C14.004 | caspase-7 | precursor | 1K88 |
| CD | C14.004 | caspase-7 | complex with XIAP-BIR2 | 1KMC_A |
| CD | C14.004 | caspase-7 | theoretical model; complex with AC-DEVD inhibitor | 1MIA |
| CD | C14.004 | caspase-7 | complex with dica allosteric inhibitor | 1SHJ_A |
| CD | C14.004 | caspase-7 | complex with FICA allosteric inhibitor | 1SHL |
| CD | C14.004 | caspase-7 | complex with inhibitor Ac-DMQD-CHO | 2QL5_A |
| CD | C14.004 | caspase-7 | complex with inhibitor Ac-IEPD-CHO | 2QL7_A |
| CD | C14.004 | caspase-7 | complex with inhibitor Ac-DQMD-CHO | 2QL9_A |
| CD | C14.004 | caspase-7 | complex with inhibitor Ac-ESMD-CHO | 2QLB_A |
| CD | C14.004 | caspase-7 | complex with inhibitor Ac-DNLD-CHO | 2QLF_A |
| CD | C14.004 | caspase-7 | complex with inhibitor Ac-WEHD-CHO | 2QLJ_A |
| CD | C14.004 | caspase-7 | complex with acetyl- LDESD-CHO | 3EDR_A |
| CD | C14.004 | caspase-7 | mature caspase-7 i213a with devd-cho inhibitor bound to active site | 3H1P_A |
| CD | C14.004 | caspase-7 | complex with acetyl-yvad- cho | 3IBC_A |
| CD | C14.004 | caspase-7 | crystal structure of unliganded caspase-7 | 3IBF_A |
| CD | C14.004 | caspase-7 | redox-controlled | 3R5K_A |
| CD | C14.004 | caspase-7 | crystal structure of caspase-7 | 4FDL_A |
| CD | C14.004 | caspase-7 | complex with allosteric inhibitor | 4FEA_A |
| CD | C14.004 | caspase-7 | crystal structure of mutant form of caspase-7 | 4HQ0_A |
| CD | C14.004 | caspase-7 | crystal structure of mutant form of caspase-7 | 4HQR_A |
| CD | C14.004 | caspase-7 | complex with darpin c7_16 | 4JB8_A |
| CD | C14.004 | caspase-7 | caspase-3 specific unnatural amino acid peptides | 4JJ8_A |
| CD | C14.004 | caspase-7 | precursor in complex with Ac-DEVD-CMK | 4JR1 |
| CD | C14.004 | caspase-7 | human procaspase-7/caspase-7 heterodimer bound to ac-devd-cmk | 4JR2_A |
| CD | C14.004 | caspase-7 | complex with darpin d7.18 | 4LSZ_A |
| CD | C14.004 | caspase-7 | caspase-7 variant 4 (v4) with reprogrammed substrate specificity due to y230v/w232y/s234v/q276d substitutions bound to veid inhibitor. | 4ZVO_A |
| CD | C14.004 | caspase-7 | caspase-7 variant 2 (v2) with reprogrammed substrate specificity due to y230v/w232m/q276c substitutions bound to devd inhibitor. | 4ZVP_A |
| CD | C14.004 | caspase-7 | caspase-7 variant 2 (v2) with reprogrammed substrate specificity due to y230v/w232m/q276c substitutions bound to veid inhibitor. | 4ZVQ_A |
| CD | C14.004 | caspase-7 | caspase-7 variant 4 (v4) with reprogrammed substrate specificity due to y230v/w232y/s234v/q276d substitutions bound to devd inhibitor. | 4ZVR_A |
| CD | C14.004 | caspase-7 | caspase-7 variant 1 (v1) with reprogrammed substrate specificity due to y230a/w232m/s234n substitutions, bound to devd inhibitor. | 4ZVS_A |
| CD | C14.004 | caspase-7 | caspase-7 variant 1 (v1) with reprogrammed substrate specificity due to y230a/w232m/s234n substitutions, bound to veid inhibitor. | 4ZVT_A |
| CD | C14.004 | caspase-7 | caspase-7 wild-type bound to the caspase-6 cognate tetrapeptide inhibitor ac-veid-cho | 4ZVU_A |
| CD | C14.004 | caspase-7 | complex with DEVE peptide | 5IC6_A |
| CD | C14.004 | caspase-7 | caspase-7 s239e phosphomimetic | 5K20_A |
| CD | C14.004 | caspase-7 | crystal structure of human caspase-7 soaked with allosteric inhibitor 2-[(2-acetylphenyl)sulfanyl]benzoic acid | 5V6U_A |
| CD | C14.004 | caspase-7 | crystal structure of human caspase-7 soaked with allosteric inhibitor 2-[2-(4-chlorophenyl)-2-oxoethyl]sulfanylbenzoic acid | 5V6Z_A |
| CD | C14.004 | caspase-7 | complex with ac-dw3-ke | 6CL1_A |
| CD | C14.004 | caspase-7 | complex with ac-ats009-ke | 6CL2_A |
| CD | C14.005 | caspase-6 | theoretical model; complex with AC-IETD inhibitor | 1MI9 |
| CD | C14.005 | caspase-6 | 2WDP | |
| CD | C14.005 | caspase-6 | 3K7E | |
| CD | C14.005 | caspase-6 | 3NKF | |
| CD | C14.005 | caspase-6 | 3NR2 | |
| CD | C14.005 | caspase-6 | 3OD5 | |
| CD | C14.005 | caspase-6 | 3P45 | |
| CD | C14.005 | caspase-6 | 3P4U | |
| CD | C14.005 | caspase-6 | 3QNW | |
| CD | C14.005 | caspase-6 | 3S70 | |
| CD | C14.005 | caspase-6 | 3S8E | |
| CD | C14.005 | caspase-6 | 3V6L | |
| CD | C14.005 | caspase-6 | 3V6M | |
| CD | C14.005 | caspase-6 | 4EJF | |
| CD | C14.005 | caspase-6 | 4FXO | |
| CD | C14.005 | caspase-6 | 4HVA | |
| CD | C14.005 | caspase-6 | 4IYR | |
| CD | C14.005 | caspase-6 | 4N5D | |
| CD | C14.005 | caspase-6 | 4N6G | |
| CD | C14.005 | caspase-6 | 4N7J | |
| CD | C14.005 | caspase-6 | 4N7M | |
| CD | C14.005 | caspase-6 | 4NBK | |
| CD | C14.005 | caspase-6 | 4NBL | |
| CD | C14.005 | caspase-6 | 4NBN | |
| CD | C14.005 | caspase-6 | Ala109Thr mutant | 6DEU_A |
| CD | C14.005 | caspase-6 | Glu35Lys mutant | 6DEV_A |
| CD | C14.006 | caspase-2 | complex with acetyl-Leu-Asp-Glu-Ser-Asp-CHO | 1PYO_A |
| CD | C14.006 | caspase-2 | inhibition of caspase-2 by a designed ankyrin repeat protein (darpin) | 2P2C_A |
| CD | C14.006 | caspase-2 | crystal structure of active caspase-2 bound with ac-advad-cho | 3R5J_A |
| CD | C14.006 | caspase-2 | crystal structure of active caspase-2 bound with ac-vdvad-cho | 3R6G_A |
| CD | C14.006 | caspase-2 | caspase-2 t380a bound with ac-vdvad-cho | 3R6L_A |
| CD | C14.006 | caspase-2 | complex with one molecule of Ac-DVAD-CHO | 3R7B_A |
| CD | C14.006 | caspase-2 | complex with two molecules of Ac-DVAD-CHO | 3R7N_A |
| CD | C14.006 | caspase-2 | crystal structure of apo caspase2 | 3R7S_A |
| CD | C14.006 | caspase-2 | complex with chdi ligand 33c | 3RJM_A |
| CD | C14.009 | caspase-8 | complex with Z-Asp-Glu-Val-Asp-CHO inhibitor | 1F9E |
| CD | C14.009 | caspase-8 | complex with baculovirus P35 inhibitor | 1I4E_B |
| CD | C14.009 | caspase-8 | complex with tripeptide ketone inhibitor Z-Glu-Val-Asp-dichloromethylketone | 1QDU |
| CD | C14.009 | caspase-8 | complex with acetyl-Ile-Glu-Thr-aspartic aldehyde | 1QTN |
| CD | C14.009 | caspase-8 | complex with | 2C2Z_A |
| CD | C14.009 | caspase-8 | alternative p35-caspase-8 complex | 2FUN_B |
| CD | C14.009 | caspase-8 | complex with darpin-8.4 | 2Y1L_A |
| CD | C14.009 | caspase-8 | zymogen; complex with c-flipl | 3H11_B |
| CD | C14.009 | caspase-8 | complex with a covalent inhibitor | 3KJN_A |
| CD | C14.009 | caspase-8 | complex with a covalent inhibitor | 3KJQ_A |
| CD | C14.009 | caspase-8 | caspase-3 specific unnatural amino acid-based peptides | 4JJ7_A |
| CD | C14.009 | caspase-8 | caspase-8 specific unnatural amino acid peptides | 4PRZ_A |
| CD | C14.009 | caspase-8 | caspase-8 specific unnatural amino acid peptides | 4PS1_A |
| CD | C14.010 | caspase-9 | cleaved form lacking caspase recruitment domain | 1JXQ |
| CD | C14.010 | caspase-9 | complex with BIR-4 protein | 1NW9_B |
| CD | C14.010 | caspase-9 | dimeric form | 2AR9_A |
| CD | C14.010 | caspase-9 | ciap1-bir3 in complex with n-terminal peptide from caspase- 9 (atpfqe) | 3D9T_C |
| CD | C14.010 | caspase-9 | complex with NleF | 3V3K_A |
| CD | C14.010 | caspase-9 | propeptide only; complex with apoptotic protease activating factor 1 | 3YGS |
| CD | C14.015 | caspase (insect 1) | 1M72 | |
| CD | C14.015 | caspase (insect 1) | structure of pro-sf-caspase-1 | 2NN3_C |
| CD | C14.015 | caspase (insect 1) | 3SIP_A | |
| CD | C14.015 | caspase (insect 1) | 3SIR | |
| CD | C14.019 | caspase DRONC (Drosophila melanogaster) | complex with DIAP1 | 1Q4Q_K |
| CD | C14.019 | caspase DRONC (Drosophila melanogaster) | Cys284Arg, Cys318Ala double mutant | 2FP3 |
| CD | C14.019 | caspase DRONC (Drosophila melanogaster) | 3J9K | |
| CD | C14.026 | paracaspase | 2G7R | |
| CD | C14.026 | paracaspase | 3BFO | |
| CD | C14.026 | paracaspase | 3K0W | |
| CD | C14.026 | paracaspase | complex with Val-Arg-Pro-Arg inhibitor | 3UO8 |
| CD | C14.026 | paracaspase | complex with Val-Arg-Pro-Arg inhibitor | 3UOA |
| CD | C14.026 | paracaspase | 3V4O | |
| CD | C14.026 | paracaspase | 3V55 | |
| CD | C14.026 | paracaspase | 4I1P | |
| CD | C14.026 | paracaspase | 4I1R | |
| CD | C14.026 | paracaspase | human malt1(329-728) in complex with mlt-747 | 6F7I_A |
| CD | C14.026 | paracaspase | human malt1(329-728) in complex with mlt-748 | 6H4A_A |
| CD | C14.026 | paracaspase | 3V4L | |
| CD | C14.033 | metacaspase-4 (Arabidopsis-type) | 6W8R | |
| CD | C14.035 | metacaspase Yca1 (Saccharomyces cerevisiae-type) | 4F6O | |
| CD | C14.035 | metacaspase Yca1 (Saccharomyces cerevisiae-type) | 4F6P | |
| CD | C14.044 | metacaspase TbMCA2 | 4AF8 | |
| CD | C14.044 | metacaspase TbMCA2 | in presence of Samarium | 4AFP |
| CD | C14.044 | metacaspase TbMCA2 | Cys213Ala mutant | 4AFR |
| CD | C14.044 | metacaspase TbMCA2 | in presence of calcium chloride | 4AFV |
| CD | C14.048 | bacterial metacaspase | 3BIJ_A | |
| CD | C14.971 | FLIP protein | zymogen; complex with caspase-8 | 3H11_A |
| CD | C14.971 | FLIP protein | c-flipl protease-like domain | 3H13_A |
| CD | C14.UPA | subfamily C14A unassigned peptidases | complex with ACE-DEVD inhibitor | 6WI4 |
| CF | C15.001 | pyroglutamyl-peptidase I (prokaryote) | 1AUG | |
| CF | C15.001 | pyroglutamyl-peptidase I (prokaryote) | 3RNZ | |
| CF | C15.001 | pyroglutamyl-peptidase I (prokaryote) | 3RO0 | |
| CF | C15.001 | pyroglutamyl-peptidase I (prokaryote) | 3GIU_A | |
| CF | C15.001 | pyroglutamyl-peptidase I (prokaryote) | 1A2Z_A | |
| CF | C15.001 | pyroglutamyl-peptidase I (prokaryote) | 1IOF | |
| CF | C15.001 | pyroglutamyl-peptidase I (prokaryote) | Cys142, C188 deletion mutant | 1IOI |
| CF | C15.001 | pyroglutamyl-peptidase I (prokaryote) | structure of mutant pyrrolidone carboxyl peptidase (e192a) from a hyperthermophile, pyrococcus furiosus | 1X10_A |
| CF | C15.001 | pyroglutamyl-peptidase I (prokaryote) | structure of mutant pyrrolidone carboxyl peptidase (e192d) from a hyperthermophile, pyrococcus furiosus | 1X12_A |
| CF | C15.001 | pyroglutamyl-peptidase I (prokaryote) | structure of mutant pyrrolidone carboxyl peptidase (e192q) from a hyperthermophile, pyrococcus furiosus | 1Z8T_A |
| CF | C15.001 | pyroglutamyl-peptidase I (prokaryote) | structure of mutant pyrrolidone carboxyl peptidase (e192i) from a hyperthermophile, pyrococcus furiosus | 1Z8W_A |
| CF | C15.001 | pyroglutamyl-peptidase I (prokaryote) | structure of mutant pyrrolidone carboxyl peptidase (e192v) from a hyperthermophile, pyrococcus furiosus | 1Z8X_A |
| CF | C15.001 | pyroglutamyl-peptidase I (prokaryote) | fragment 1-204 | 2DF5_A |
| CF | C15.001 | pyroglutamyl-peptidase I (prokaryote) | Ala199Pro mutant | 2EO8 |
| CF | C15.001 | pyroglutamyl-peptidase I (prokaryote) | 1IU8 | |
| CF | C15.001 | pyroglutamyl-peptidase I (prokaryote) | crystal structure of pyrrolidone carboxylate peptidase i from deionococcus radiodurans r1 | 5Z40_A |
| CF | C15.001 | pyroglutamyl-peptidase I (prokaryote) | crystal structure of pyrrolidone carboxylate peptidase i with disordered loop a from deinococcus radiodurans r1 | 5Z47_A |
| CF | C15.001 | pyroglutamyl-peptidase I (prokaryote) | crystal structure of pyrrolidone carboxylate peptidase i from deinococcus radiodurans r1 bound to pyroglutamate | 5Z48_A |
| CF | C15.001 | pyroglutamyl-peptidase I (prokaryote) | 3LAC | |
| CF | C15.001 | pyroglutamyl-peptidase I (prokaryote) | 2EBJ | |
| CF | C15.001 | pyroglutamyl-peptidase I (prokaryote) | crystal structure of a pyrrolidone-carboxylate peptidase 1 (target id nysgrc-012831) from xenorhabdus bovienii ss-2004 | 4GXH_A |
| CF | C15.001 | pyroglutamyl-peptidase I (prokaryote) | crystal structure of a pyrrolidone-carboxylate peptidase 1 (target id nysgrc-012831) from xenorhabdus bovienii ss-2004 in space group p21 | 4HPS_A |
| CA | C16.005 | avian infectious bronchitis coronavirus papain-like peptidase | 3EJF | |
| CA | C16.005 | avian infectious bronchitis coronavirus papain-like peptidase | 3EKE | |
| CA | C16.005 | avian infectious bronchitis coronavirus papain-like peptidase | 4X2Z | |
| CA | C16.005 | avian infectious bronchitis coronavirus papain-like peptidase | Cys101Ser mutant; complex with ubiquitin | 5BZ0_A |
| CA | C16.009 | severe acute respiratory syndrome coronavirus papain-like peptidase | 1P76 | |
| CA | C16.009 | severe acute respiratory syndrome coronavirus papain-like peptidase | 1P9T | |
| CA | C16.009 | severe acute respiratory syndrome coronavirus papain-like peptidase | 1PA5 | |
| CA | C16.009 | severe acute respiratory syndrome coronavirus papain-like peptidase | 1PUK | |
| CA | C16.009 | severe acute respiratory syndrome coronavirus papain-like peptidase | 1Q1X | |
| CA | C16.009 | severe acute respiratory syndrome coronavirus papain-like peptidase | 1Q2W | |
| CA | C16.009 | severe acute respiratory syndrome coronavirus papain-like peptidase | 1QZ8 | |
| CA | C16.009 | severe acute respiratory syndrome coronavirus papain-like peptidase | 1UJ1 | |
| CA | C16.009 | severe acute respiratory syndrome coronavirus papain-like peptidase | 1UK2 | |
| CA | C16.009 | severe acute respiratory syndrome coronavirus papain-like peptidase | 1UK3 | |
| CA | C16.009 | severe acute respiratory syndrome coronavirus papain-like peptidase | 1UW7 | |
| CA | C16.009 | severe acute respiratory syndrome coronavirus papain-like peptidase | 1WOF | |
| CA | C16.009 | severe acute respiratory syndrome coronavirus papain-like peptidase | 1YSY | |
| CA | C16.009 | severe acute respiratory syndrome coronavirus papain-like peptidase | 1Z1I | |
| CA | C16.009 | severe acute respiratory syndrome coronavirus papain-like peptidase | 1Z1J | |
| CA | C16.009 | severe acute respiratory syndrome coronavirus papain-like peptidase | 2A5A | |
| CA | C16.009 | severe acute respiratory syndrome coronavirus papain-like peptidase | 2A5I | |
| CA | C16.009 | severe acute respiratory syndrome coronavirus papain-like peptidase | 2A5K | |
| CA | C16.009 | severe acute respiratory syndrome coronavirus papain-like peptidase | 2ACF | |
| CA | C16.009 | severe acute respiratory syndrome coronavirus papain-like peptidase | 2AHM | |
| CA | C16.009 | severe acute respiratory syndrome coronavirus papain-like peptidase | 2AJ5 | |
| CA | C16.009 | severe acute respiratory syndrome coronavirus papain-like peptidase | 2ALV | |
| CA | C16.009 | severe acute respiratory syndrome coronavirus papain-like peptidase | 2AMD | |
| CA | C16.009 | severe acute respiratory syndrome coronavirus papain-like peptidase | 2AMQ | |
| CA | C16.009 | severe acute respiratory syndrome coronavirus papain-like peptidase | 2BX3 | |
| CA | C16.009 | severe acute respiratory syndrome coronavirus papain-like peptidase | 2BX4 | |
| CA | C16.009 | severe acute respiratory syndrome coronavirus papain-like peptidase | 2C3S | |
| CA | C16.009 | severe acute respiratory syndrome coronavirus papain-like peptidase | 2D2D | |
| CA | C16.009 | severe acute respiratory syndrome coronavirus papain-like peptidase | 2DUC | |
| CA | C16.009 | severe acute respiratory syndrome coronavirus papain-like peptidase | 2FAV | |
| CA | C16.009 | severe acute respiratory syndrome coronavirus papain-like peptidase | 2FE8 | |
| CA | C16.009 | severe acute respiratory syndrome coronavirus papain-like peptidase | 2FYG | |
| CA | C16.009 | severe acute respiratory syndrome coronavirus papain-like peptidase | 2G9T | |
| CA | C16.009 | severe acute respiratory syndrome coronavirus papain-like peptidase | 2GA6 | |
| CA | C16.009 | severe acute respiratory syndrome coronavirus papain-like peptidase | 2GDT | |
| CA | C16.009 | severe acute respiratory syndrome coronavirus papain-like peptidase | 2GRI | |
| CA | C16.009 | severe acute respiratory syndrome coronavirus papain-like peptidase | 2GX4 | |
| CA | C16.009 | severe acute respiratory syndrome coronavirus papain-like peptidase | 2GZ7 | |
| CA | C16.009 | severe acute respiratory syndrome coronavirus papain-like peptidase | 2GZ8 | |
| CA | C16.009 | severe acute respiratory syndrome coronavirus papain-like peptidase | 2GZ9 | |
| CA | C16.009 | severe acute respiratory syndrome coronavirus papain-like peptidase | 2H2Z | |
| CA | C16.009 | severe acute respiratory syndrome coronavirus papain-like peptidase | 2HOB | |
| CA | C16.009 | severe acute respiratory syndrome coronavirus papain-like peptidase | 2HSX | |
| CA | C16.009 | severe acute respiratory syndrome coronavirus papain-like peptidase | 2IDY | |
| CA | C16.009 | severe acute respiratory syndrome coronavirus papain-like peptidase | 2KAF | |
| CA | C16.009 | severe acute respiratory syndrome coronavirus papain-like peptidase | 2KQV | |
| CA | C16.009 | severe acute respiratory syndrome coronavirus papain-like peptidase | 2KQW | |
| CA | C16.009 | severe acute respiratory syndrome coronavirus papain-like peptidase | 2KYS | |
| CA | C16.009 | severe acute respiratory syndrome coronavirus papain-like peptidase | 2LIZ | |
| CA | C16.009 | severe acute respiratory syndrome coronavirus papain-like peptidase | 2OP9 | |
| CA | C16.009 | severe acute respiratory syndrome coronavirus papain-like peptidase | Gly11Ala mutant | 2PWX_A |
| CA | C16.009 | severe acute respiratory syndrome coronavirus papain-like peptidase | Asn214Ala mutant | 2QC2_A |
| CA | C16.009 | severe acute respiratory syndrome coronavirus papain-like peptidase | monomeric form of mutant | 2QCY_A |
| CA | C16.009 | severe acute respiratory syndrome coronavirus papain-like peptidase | structure-based design and synthesis and biological evaluation of peptidomimetic sars-3clpro inhibitors | 2QIQ_A |
| CA | C16.009 | severe acute respiratory syndrome coronavirus papain-like peptidase | 2W2G | |
| CA | C16.009 | severe acute respiratory syndrome coronavirus papain-like peptidase | 2WCT | |
| CA | C16.009 | severe acute respiratory syndrome coronavirus papain-like peptidase | 2YY4_A | |
| CA | C16.009 | severe acute respiratory syndrome coronavirus papain-like peptidase | 2Z3C | |
| CA | C16.009 | severe acute respiratory syndrome coronavirus papain-like peptidase | 2Z3D | |
| CA | C16.009 | severe acute respiratory syndrome coronavirus papain-like peptidase | 2Z3E | |
| CA | C16.009 | severe acute respiratory syndrome coronavirus papain-like peptidase | complex with tdt | 2Z94_A |
| CA | C16.009 | severe acute respiratory syndrome coronavirus papain-like peptidase | complex with pma | 2Z9G_A |
| CA | C16.009 | severe acute respiratory syndrome coronavirus papain-like peptidase | complex with epdtc | 2Z9J_A |
| CA | C16.009 | severe acute respiratory syndrome coronavirus papain-like peptidase | complex with jmf1600 | 2Z9K_A |
| CA | C16.009 | severe acute respiratory syndrome coronavirus papain-like peptidase | complex with jmf1586 | 2Z9L_A |
| CA | C16.009 | severe acute respiratory syndrome coronavirus papain-like peptidase | 2ZU4 | |
| CA | C16.009 | severe acute respiratory syndrome coronavirus papain-like peptidase | 2ZU5 | |
| CA | C16.009 | severe acute respiratory syndrome coronavirus papain-like peptidase | 3ATW | |
| CA | C16.009 | severe acute respiratory syndrome coronavirus papain-like peptidase | 3AVZ | |
| CA | C16.009 | severe acute respiratory syndrome coronavirus papain-like peptidase | 3AW0 | |
| CA | C16.009 | severe acute respiratory syndrome coronavirus papain-like peptidase | 3AW1 | |
| CA | C16.009 | severe acute respiratory syndrome coronavirus papain-like peptidase | development of broad-spectrum halomethyl ketone inhibitors against coronavirus main protease 3clpro | 3D62_A |
| CA | C16.009 | severe acute respiratory syndrome coronavirus papain-like peptidase | 3E91 | |
| CA | C16.009 | severe acute respiratory syndrome coronavirus papain-like peptidase | a new class of papain-like protease/deubiquitinase inhibitors blocks sars virus replication | 3E9S_A |
| CA | C16.009 | severe acute respiratory syndrome coronavirus papain-like peptidase | 3EA7 | |
| CA | C16.009 | severe acute respiratory syndrome coronavirus papain-like peptidase | 3EA8 | |
| CA | C16.009 | severe acute respiratory syndrome coronavirus papain-like peptidase | 3EA9 | |
| CA | C16.009 | severe acute respiratory syndrome coronavirus papain-like peptidase | 3EAJ | |
| CA | C16.009 | severe acute respiratory syndrome coronavirus papain-like peptidase | 3EE7 | |
| CA | C16.009 | severe acute respiratory syndrome coronavirus papain-like peptidase | 3F9E | |
| CA | C16.009 | severe acute respiratory syndrome coronavirus papain-like peptidase | 3F9F | |
| CA | C16.009 | severe acute respiratory syndrome coronavirus papain-like peptidase | 3F9G | |
| CA | C16.009 | severe acute respiratory syndrome coronavirus papain-like peptidase | 3F9H | |
| CA | C16.009 | severe acute respiratory syndrome coronavirus papain-like peptidase | 3FZD | |
| CA | C16.009 | severe acute respiratory syndrome coronavirus papain-like peptidase | 3IWM | |
| CA | C16.009 | severe acute respiratory syndrome coronavirus papain-like peptidase | 3M3S | |
| CA | C16.009 | severe acute respiratory syndrome coronavirus papain-like peptidase | 3M3T | |
| CA | C16.009 | severe acute respiratory syndrome coronavirus papain-like peptidase | 3M3V | |
| CA | C16.009 | severe acute respiratory syndrome coronavirus papain-like peptidase | 3MJ5 | |
| CA | C16.009 | severe acute respiratory syndrome coronavirus papain-like peptidase | 3R24 | |
| CA | C16.009 | severe acute respiratory syndrome coronavirus papain-like peptidase | 3SN8 | |
| CA | C16.009 | severe acute respiratory syndrome coronavirus papain-like peptidase | 3SNA | |
| CA | C16.009 | severe acute respiratory syndrome coronavirus papain-like peptidase | 3SNB | |
| CA | C16.009 | severe acute respiratory syndrome coronavirus papain-like peptidase | 3SNC | |
| CA | C16.009 | severe acute respiratory syndrome coronavirus papain-like peptidase | 3SND | |
| CA | C16.009 | severe acute respiratory syndrome coronavirus papain-like peptidase | 3SNE | |
| CA | C16.009 | severe acute respiratory syndrome coronavirus papain-like peptidase | 3SZN | |
| CA | C16.009 | severe acute respiratory syndrome coronavirus papain-like peptidase | 3TIT | |
| CA | C16.009 | severe acute respiratory syndrome coronavirus papain-like peptidase | 3TIU | |
| CA | C16.009 | severe acute respiratory syndrome coronavirus papain-like peptidase | 3TNS | |
| CA | C16.009 | severe acute respiratory syndrome coronavirus papain-like peptidase | 3TNT | |
| CA | C16.009 | severe acute respiratory syndrome coronavirus papain-like peptidase | 3V3M | |
| CA | C16.009 | severe acute respiratory syndrome coronavirus papain-like peptidase | 3VB3 | |
| CA | C16.009 | severe acute respiratory syndrome coronavirus papain-like peptidase | 3VB4 | |
| CA | C16.009 | severe acute respiratory syndrome coronavirus papain-like peptidase | 3VB5 | |
| CA | C16.009 | severe acute respiratory syndrome coronavirus papain-like peptidase | 3VB6 | |
| CA | C16.009 | severe acute respiratory syndrome coronavirus papain-like peptidase | 3VB7 | |
| CA | C16.009 | severe acute respiratory syndrome coronavirus papain-like peptidase | 4HI3 | |
| CA | C16.009 | severe acute respiratory syndrome coronavirus papain-like peptidase | 4M0W | |
| CA | C16.009 | severe acute respiratory syndrome coronavirus papain-like peptidase | 4MDS | |
| CA | C16.009 | severe acute respiratory syndrome coronavirus papain-like peptidase | 4MM3 | |
| CA | C16.009 | severe acute respiratory syndrome coronavirus papain-like peptidase | 4OVZ | |
| CA | C16.009 | severe acute respiratory syndrome coronavirus papain-like peptidase | 4OW0 | |
| CA | C16.009 | severe acute respiratory syndrome coronavirus papain-like peptidase | complex with glycerol | 5Y3E_A |
| CA | C16.009 | severe acute respiratory syndrome coronavirus papain-like peptidase | crystal structure of sars coronavirus papain-like protease conjugated with beta-mercaptoethanol | 5Y3Q_A |
| CA | C16.011 | Middle East respiratory syndrome coronavirus papain-like peptidase | 5KO3 | |
| CA | C16.011 | Middle East respiratory syndrome coronavirus papain-like peptidase | 4P16 | |
| CM | C18.001 | hepatitis C virus peptidase 2 | 2A4G | |
| CM | C18.001 | hepatitis C virus peptidase 2 | 2GVF | |
| CM | C18.001 | hepatitis C virus peptidase 2 | catalytic domain of the NS2 protein only | 2HD0 |
| CM | C18.001 | hepatitis C virus peptidase 2 | 3HKW | |
| CM | C18.001 | hepatitis C virus peptidase 2 | 3KN2 | |
| CM | C18.001 | hepatitis C virus peptidase 2 | avoiding drug resistance against hcv ns3/4a protease inhibitors | 3M5M_C |
| CM | C18.001 | hepatitis C virus peptidase 2 | visualizing atp-dependent rna translocation by the ns3 helicase from hcv | 3O8B_A |
| CM | C18.001 | hepatitis C virus peptidase 2 | visualizing atp-dependent rna translocation by the ns3 helicase from hcv | 3O8C_A |
| CM | C18.001 | hepatitis C virus peptidase 2 | visualizing atp-dependent rna translocation by the ns3 helicase from hcv | 3O8D_A |
| CM | C18.001 | hepatitis C virus peptidase 2 | visualizing atp-dependent rna translocation by the ns3 helicase from hcv | 3O8R_A |
| CM | C18.001 | hepatitis C virus peptidase 2 | 3QGH | |
| CM | C18.001 | hepatitis C virus peptidase 2 | 3QGI | |
| CM | C18.001 | hepatitis C virus peptidase 2 | 3RC4 | |
| CM | C18.001 | hepatitis C virus peptidase 2 | 3RC5 | |
| CM | C18.001 | hepatitis C virus peptidase 2 | crystal structure of hepatitis c virus ns3 helicase inhibitor co- complex with fragment 1 [(5-bromo-1h-indol-3-yl)acetic acid] | 4OJQ_A |
| CM | C18.001 | hepatitis C virus peptidase 2 | crystal structure of hepatitis c virus ns3 helicase inhibitor co- complex with compound 7 [[1-(3-chlorobenzyl)-1h-indol-3-yl]acetic acid] | 4OK3_A |
| CM | C18.001 | hepatitis C virus peptidase 2 | crystal structure of hepatitis c virus ns3 helicase inhibitor co- complex with compound 9 [1-(3-ethynylbenzyl)-1h-indol-3-yl]acetic acid] | 4OK5_A |
| CM | C18.001 | hepatitis C virus peptidase 2 | crystal structure of hepatitis c virus ns3 helicase inhibitor co- complex with compound 13 [[1-(2-methoxy-5-nitrobenzyl)-1h-indol-3- yl]acetic acid] | 4OK6_A |
| CM | C18.001 | hepatitis C virus peptidase 2 | crystal structure of hepatitis c virus ns3 helicase inhibitor co- complex with compound 19 [[6-(3,5-diaminophenyl)-1-(2-methoxy-5- nitrobenzyl)-1h-indol-3-yl]acetic acid] | 4OKS_A |
| CA | C19.001 | ubiquitin-specific peptidase 5 | 2DAG | |
| CA | C19.001 | ubiquitin-specific peptidase 5 | 2DAK | |
| CA | C19.001 | ubiquitin-specific peptidase 5 | 2G43 | |
| CA | C19.001 | ubiquitin-specific peptidase 5 | 2G45 | |
| CA | C19.001 | ubiquitin-specific peptidase 5 | 3IHP | |
| CA | C19.004 | Ubp3 ubiquitin peptidase | 2QIY | |
| CA | C19.010 | ubiquitin-specific peptidase 4 | 2Y6E | |
| CA | C19.010 | ubiquitin-specific peptidase 4 | 3JYU | |
| CA | C19.011 | ubiquitin-specific peptidase 8 | 1WHB | |
| CA | C19.011 | ubiquitin-specific peptidase 8 | N-terminal domain | 2A9U |
| CA | C19.011 | ubiquitin-specific peptidase 8 | catalytic domain only | 2GFO |
| CA | C19.011 | ubiquitin-specific peptidase 8 | complex with RING finger protein 41 | 2GWF |
| CA | C19.011 | ubiquitin-specific peptidase 8 | 3N3K | |
| CA | C19.011 | ubiquitin-specific peptidase 8 | 1UJ0 | |
| CA | C19.012 | ubiquitin-specific peptidase 13 | 2L80 | |
| CA | C19.012 | ubiquitin-specific peptidase 13 | 2LBC | |
| CA | C19.013 | ubiquitin-specific peptidase 2 | complex with ubiquitin | 2HD5 |
| CA | C19.013 | ubiquitin-specific peptidase 2 | complex with ubiquitin | 2IBI |
| CA | C19.013 | ubiquitin-specific peptidase 2 | 3NHE | |
| CA | C19.013 | ubiquitin-specific peptidase 2 | 3V6C | |
| CA | C19.013 | ubiquitin-specific peptidase 2 | 3V6E | |
| CA | C19.013 | ubiquitin-specific peptidase 2 | complex with ubiquitin and 6- thioguanine | 5XU8_A |
| CA | C19.013 | ubiquitin-specific peptidase 2 | Cys276Ser mutant; complex with ubiquitin | 5XVE_A |
| CA | C19.013 | ubiquitin-specific peptidase 2 | ubiquitin variant bound to usp2 | 6DGF_A |
| CA | C19.014 | ubiquitin-specific peptidase 11 | 4MEL | |
| CA | C19.015 | ubiquitin-specific peptidase 14 | 2AYN | |
| CA | C19.015 | ubiquitin-specific peptidase 14 | complex with ubiquitin aldehyde | 2AYO |
| CA | C19.015 | ubiquitin-specific peptidase 14 | 26S proteasome; complex with USP14-UbAl | 5GJQ_x |
| CA | C19.015 | ubiquitin-specific peptidase 14 | usp14 catalytic domain with iu1 | 6IIK_A |
| CA | C19.015 | ubiquitin-specific peptidase 14 | catalytic domain; complex with iu1-47 | 6IIL_A |
| CA | C19.015 | ubiquitin-specific peptidase 14 | usp14 catalytic domain with iu1-206 | 6IIM_A |
| CA | C19.015 | ubiquitin-specific peptidase 14 | usp14 catalytic domain with iu1-248 | 6IIN_A |
| CA | C19.015 | ubiquitin-specific peptidase 14 | 1WGG | |
| CA | C19.016 | ubiquitin-specific peptidase 7 | catalytic domain only | 1NB8_A |
| CA | C19.016 | ubiquitin-specific peptidase 7 | complex with ubiquitin aldehyde | 1NBF |
| CA | C19.016 | ubiquitin-specific peptidase 7 | 1YY6 | |
| CA | C19.016 | ubiquitin-specific peptidase 7 | 1YZE | |
| CA | C19.016 | ubiquitin-specific peptidase 7 | 2F1W | |
| CA | C19.016 | ubiquitin-specific peptidase 7 | 2F1X | |
| CA | C19.016 | ubiquitin-specific peptidase 7 | 2F1Y | |
| CA | C19.016 | ubiquitin-specific peptidase 7 | 2F1Z | |
| CA | C19.016 | ubiquitin-specific peptidase 7 | 2FOJ | |
| CA | C19.016 | ubiquitin-specific peptidase 7 | 2FOO | |
| CA | C19.016 | ubiquitin-specific peptidase 7 | 2FOP | |
| CA | C19.016 | ubiquitin-specific peptidase 7 | 2KVR | |
| CA | C19.016 | ubiquitin-specific peptidase 7 | 2XXN | |
| CA | C19.016 | ubiquitin-specific peptidase 7 | 2YLM | |
| CA | C19.016 | ubiquitin-specific peptidase 7 | 3MQR | |
| CA | C19.016 | ubiquitin-specific peptidase 7 | 3MQS | |
| CA | C19.016 | ubiquitin-specific peptidase 7 | 4JJQ | |
| CA | C19.016 | ubiquitin-specific peptidase 7 | 4KG9 | |
| CA | C19.016 | ubiquitin-specific peptidase 7 | 4M5W | |
| CA | C19.016 | ubiquitin-specific peptidase 7 | 4M5X | |
| CA | C19.016 | ubiquitin-specific peptidase 7 | 4PYZ | |
| CA | C19.016 | ubiquitin-specific peptidase 7 | 4WPH | |
| CA | C19.016 | ubiquitin-specific peptidase 7 | 4WPI | |
| CA | C19.016 | ubiquitin-specific peptidase 7 | 4YOC | |
| CA | C19.016 | ubiquitin-specific peptidase 7 | structure of usp7 with a novel viral protein | 4YSI_A |
| CA | C19.016 | ubiquitin-specific peptidase 7 | 5C56 | |
| CA | C19.016 | ubiquitin-specific peptidase 7 | 5C6D | |
| CA | C19.016 | ubiquitin-specific peptidase 7 | structure of usp7 catalytic domain and three ubl-domains | 5FWI_C |
| CA | C19.016 | ubiquitin-specific peptidase 7 | molecular understanding of usp7 substrate recognition and c-terminal activation | 5J7T_A |
| CA | C19.016 | ubiquitin-specific peptidase 7 | usp7cd-ctp in complex with ubiquitin | 5JTJ_A |
| CA | C19.016 | ubiquitin-specific peptidase 7 | usp7cd-ubl45 in complex with ubiquitin | 5JTV_A |
| CA | C19.016 | ubiquitin-specific peptidase 7 | catalytic domain; Val302Lys mutant | 5KYB_A |
| CA | C19.016 | ubiquitin-specific peptidase 7 | catalytic domain; Val302Lys mutant; complex with ubiquitin (malonate bound) | 5KYC_B |
| CA | C19.016 | ubiquitin-specific peptidase 7 | catalytic domain; Val302Lys mutant; complex with ubiquitin | 5KYD_A |
| CA | C19.016 | ubiquitin-specific peptidase 7 | catalytic domain; His294Glu mutant; complex with ubiquitin | 5KYE_A |
| CA | C19.016 | ubiquitin-specific peptidase 7 | catalytic domain; Leu299Ala mutant; complex with ubiquitin | 5KYF_B |
| CA | C19.016 | ubiquitin-specific peptidase 7 | complex with a potent, selective and reversible small-molecule inhibitor | 5N9R_A |
| CA | C19.016 | ubiquitin-specific peptidase 7 | complex with a potent, selective and reversible small-molecule inhibitor | 5N9T_A |
| CA | C19.016 | ubiquitin-specific peptidase 7 | complex with the non-covalent inhibitor, ft671 | 5NGE_A |
| CA | C19.016 | ubiquitin-specific peptidase 7 | complex with the covalent inhibitor, ft827 | 5NGF_A |
| CA | C19.016 | ubiquitin-specific peptidase 7 | complex with gne6640 (4-(2-amino-4-ethyl-5-(1h-indazol-5-yl) pyridin-3-yl)phenol) | 5UQV_A |
| CA | C19.016 | ubiquitin-specific peptidase 7 | structure of dub complex | 5VS6_A |
| CA | C19.016 | ubiquitin-specific peptidase 7 | structure of dub complex | 5VSB_A |
| CA | C19.016 | ubiquitin-specific peptidase 7 | structure of dub complex | 5VSK_A |
| CA | C19.016 | ubiquitin-specific peptidase 7 | usp7 in complex with cpd2 (4-(3-(1-methylpiperidin-4-yl)-1,2,4- oxadiazol-5-yl)phenol) | 5WHC_A |
| CA | C19.016 | ubiquitin-specific peptidase 7 | complex with a 4-hydroxypiperidine based inhibitor | 6F5H_A |
| CA | C19.017 | ubiquitin-specific peptidase 9X | crystal structure of the catalytic domain of human usp9x | 5WCH_A |
| CA | C19.022 | ubiquitin-specific peptidase 15 | 1W6V | |
| CA | C19.022 | ubiquitin-specific peptidase 15 | 3LMN | |
| CA | C19.022 | ubiquitin-specific peptidase 15 | 3PPA | |
| CA | C19.022 | ubiquitin-specific peptidase 15 | 3PV1 | |
| CA | C19.022 | ubiquitin-specific peptidase 15 | 3T9L | |
| CA | C19.022 | ubiquitin-specific peptidase 15 | 4A3O | |
| CA | C19.022 | ubiquitin-specific peptidase 15 | 4A3P | |
| CA | C19.022 | ubiquitin-specific peptidase 15 | deubiquitinase domain; complex with a third- generation inhibitory ubv | 6CPM_C |
| CA | C19.022 | ubiquitin-specific peptidase 15 | deubiquitinase domain; complex with a high- affinity first-generation ubv | 6CRN_A |
| CA | C19.022 | ubiquitin-specific peptidase 15 | usp15 catalytic domain in complex with small molecule | 6GH9_A |
| CA | C19.022 | ubiquitin-specific peptidase 15 | usp15 catalytic domain structure | 6GHA_A |
| CA | C19.022 | ubiquitin-specific peptidase 15 | deubiquitinase domain; complex with an affinity-matured inhibitory ubv | 6ML1_A |
| CA | C19.030 | ubiquitin-specific peptidase 18 | crystal structure of usp18 | 5CHT_A |
| CA | C19.030 | ubiquitin-specific peptidase 18 | complex with isg15 | 5CHV_A |
| CA | C19.034 | ubiquitin-specific peptidase 21 | 2Y5B | |
| CA | C19.034 | ubiquitin-specific peptidase 21 | 3I3T | |
| CA | C19.034 | ubiquitin-specific peptidase 21 | 3MTN | |
| CA | C19.037 | ubiquitin-specific peptidase 33 | 2UZG | |
| CA | C19.041 | ubiquitin-specific peptidase 25 | crystal structure of human usp25 | 5O71_A |
| CA | C19.041 | ubiquitin-specific peptidase 25 | usp25 catalytic domain | 6H4J_A |
| CA | C19.041 | ubiquitin-specific peptidase 25 | structure of human usp25 | 6HEL_A |
| CA | C19.041 | ubiquitin-specific peptidase 25 | 1VDL | |
| CA | C19.052 | ubiquitin-specific peptidase 46 | 5CVM | |
| CA | C19.052 | ubiquitin-specific peptidase 46 | 5CVN | |
| CA | C19.052 | ubiquitin-specific peptidase 46 | 5CVO | |
| CA | C19.052 | ubiquitin-specific peptidase 46 | structure of usp46-ubvme | 5L8H_A |
| CA | C19.054 | ubiquitin-specific peptidase 28 | 2LVA | |
| CA | C19.054 | ubiquitin-specific peptidase 28 | usp28 catalytic domain variant e593d in complex with ubpa | 6H4H_A |
| CA | C19.054 | ubiquitin-specific peptidase 28 | usp28 catalytic domain apo | 6H4I_A |
| CA | C19.054 | ubiquitin-specific peptidase 28 | structure of the catalytic domain of usp28 (insertion deleted) | 6HEH_A |
| CA | C19.054 | ubiquitin-specific peptidase 28 | structure of the catalytic domain of usp28 (insertion deleted) bound to ubiquitin-pa | 6HEI_A |
| CA | C19.054 | ubiquitin-specific peptidase 28 | structure of human usp28 | 6HEJ_A |
| CA | C19.054 | ubiquitin-specific peptidase 28 | structure of human usp28 bound to ubiquitin-pa | 6HEK_A |
| CA | C19.056 | ubiquitin-specific peptidase 38 | 4RXX | |
| CA | C19.059 | ubiquitin-specific peptidase 35 | Cys450Ser mutant; complex with ubiquitin | 5TXK_A |
| CA | C19.060 | ubiquitin-specific peptidase 30 | complex with ubiquitin propargylamide (high resolution) | 5OHK_A |
| CA | C19.060 | ubiquitin-specific peptidase 30 | complex with ubiquitin propargylamide (low resolution) | 5OHN_A |
| CA | C19.060 | ubiquitin-specific peptidase 30 | Cys77Ala mutant; complex with Lys6-linked diubiquitin | 5OHP_A |
| CA | C19.079 | ubiquitin-specific peptidase 6 (Saccharomyces-type) | 1VJV | |
| CA | C19.079 | ubiquitin-specific peptidase 6 (Saccharomyces-type) | 5A5B | |
| CA | C19.084 | deubiquitinating enzyme 14 (plant) | 1VEK | |
| CA | C19.084 | deubiquitinating enzyme 14 (plant) | 1WIV | |
| CA | C19.087 | ubiquitin-specific peptidase 8 (Saccharomyces cerevisiae) | 3M99 | |
| CA | C19.087 | ubiquitin-specific peptidase 8 (Saccharomyces cerevisiae) | complex with SUS1, SAGA-associated factors 11 and 73. | 3MHH |
| CA | C19.087 | ubiquitin-specific peptidase 8 (Saccharomyces cerevisiae) | complex with SUS1, SAGA-associated factors 11 and 73 bound to ubiquitin aldehyde. | 3MHS |
| CA | C19.087 | ubiquitin-specific peptidase 8 (Saccharomyces cerevisiae) | 4FIP | |
| CA | C19.087 | ubiquitin-specific peptidase 8 (Saccharomyces cerevisiae) | 4FJC | |
| CA | C19.087 | ubiquitin-specific peptidase 8 (Saccharomyces cerevisiae) | 4FK5 | |
| CA | C19.087 | ubiquitin-specific peptidase 8 (Saccharomyces cerevisiae) | 4WA6 | |
| CA | C19.087 | ubiquitin-specific peptidase 8 (Saccharomyces cerevisiae) | saga dub module ubp8/sgf11/sus1/sgf73 bound to ubiqitinated nucleosome | 4ZUX_S |
| CA | C19.087 | ubiquitin-specific peptidase 8 (Saccharomyces cerevisiae) | saga dub module ubp8(c146a)/sgf11/sus1/sgf73 bound to monoubiquitin | 6AQR_A |
| CA | C19.089 | Mername-AA305 putative ubiquitin isopeptidase | 1WHC | |
| CA | C19.972 | ubiquitin-specific endopeptidase 39 [misleading] | 4MSX | |
| CA | C19.972 | ubiquitin-specific endopeptidase 39 [misleading] | u4/u6.u5* tri-snrnp complex | 3JCR_V |
| CA | C19.972 | ubiquitin-specific endopeptidase 39 [misleading] | the cryo-em structure of the precusor of human pre-catalytic spliceosome (pre-b complex) | 6AH0_W |
| CA | C21.001 | tymovirus peptidase | 4A5U | |
| CA | C21.001 | tymovirus peptidase | 5LW5 | |
| CA | C21.001 | tymovirus peptidase | 5LWA_A | |
| PA | C24.003 | sapovirus 3C-like peptidase | 2CKW | |
| PA | C24.003 | sapovirus 3C-like peptidase | 2UUT | |
| PA | C24.003 | sapovirus 3C-like peptidase | 2UUW | |
| PA | C24.003 | sapovirus 3C-like peptidase | 2WK4 | |
| PA | C24.003 | sapovirus 3C-like peptidase | 2MXD | |
| CD | C25.002 | gingipain K | 4RBM | |
| CD | C25.002 | gingipain K | structure of protease | 4TKX_L |
| CD | C25.002 | gingipain K | porphyromonas gingivalis gingipain k (kgp) in complex with inhibitor kyt-36 | 6I9A_A |
| CD | C25.003 | gingipain RgpB | Complex with D-Phe-Phe-Arg-chloromethylketone inhibitor | 1CVR_A |
| CD | C25.003 | gingipain RgpB | 4IEF | |
| CD | C25.UPW | family C25 unassigned peptidases | 2DAI | |
| PC | C26.001 | gamma-glutamyl hydrolase | tetramer | 1L9X_A |
| PC | C26.001 | gamma-glutamyl hydrolase | crystal structure of gamma glutamyl hydrolase (wild-type) from zebrafish | 4L7Q_C |
| PC | C26.001 | gamma-glutamyl hydrolase | complex with mtx | 4L8F_C |
| PC | C26.001 | gamma-glutamyl hydrolase | His218Asn mutant; complex with MTX polyglutamate | 4L8W_D |
| PC | C26.001 | gamma-glutamyl hydrolase | crystal structure of gamma-glutamyl hydrolase (c108a) from zebrafish | 4L8Y_C |
| PC | C26.001 | gamma-glutamyl hydrolase | crystal structure of gamma glutamyl hydrolase (h218n) from zebrafish | 4L95_E |
| PC | C26.950 | guanine 5'-monophosphate synthetase | 2VPI | |
| PC | C26.950 | guanine 5'-monophosphate synthetase | 2VXO | |
| PC | C26.951 | carbamoyl-phosphate synthase (Homo sapiens-type) | 2YVQ | |
| PC | C26.951 | carbamoyl-phosphate synthase (Homo sapiens-type) | 5DOT | |
| PC | C26.951 | carbamoyl-phosphate synthase (Homo sapiens-type) | 5DOU | |
| PC | C26.952 | dihydro-orotase (N-terminal unit) (Homo sapiens-type) | 4BY3 | |
| PC | C26.952 | dihydro-orotase (N-terminal unit) (Homo sapiens-type) | 4C6B | |
| PC | C26.952 | dihydro-orotase (N-terminal unit) (Homo sapiens-type) | 4C6C | |
| PC | C26.952 | dihydro-orotase (N-terminal unit) (Homo sapiens-type) | 4C6D | |
| PC | C26.952 | dihydro-orotase (N-terminal unit) (Homo sapiens-type) | 4C6E | |
| PC | C26.952 | dihydro-orotase (N-terminal unit) (Homo sapiens-type) | 4C6F | |
| PC | C26.952 | dihydro-orotase (N-terminal unit) (Homo sapiens-type) | 4C6I | |
| PC | C26.952 | dihydro-orotase (N-terminal unit) (Homo sapiens-type) | 4C6J | |
| PC | C26.952 | dihydro-orotase (N-terminal unit) (Homo sapiens-type) | 4C6K | |
| PC | C26.952 | dihydro-orotase (N-terminal unit) (Homo sapiens-type) | 4C6L | |
| PC | C26.952 | dihydro-orotase (N-terminal unit) (Homo sapiens-type) | 4C6M | |
| PC | C26.952 | dihydro-orotase (N-terminal unit) (Homo sapiens-type) | 4C6N | |
| PC | C26.952 | dihydro-orotase (N-terminal unit) (Homo sapiens-type) | 4C6O | |
| PC | C26.952 | dihydro-orotase (N-terminal unit) (Homo sapiens-type) | 4C6P | |
| PC | C26.952 | dihydro-orotase (N-terminal unit) (Homo sapiens-type) | 4C6Q | |
| PC | C26.952 | dihydro-orotase (N-terminal unit) (Homo sapiens-type) | crystal structure of the dihydroorotase domain (k1556a) of human cad | 5YNZ_A |
| PC | C26.952 | dihydro-orotase (N-terminal unit) (Homo sapiens-type) | Phe1563Leu mutant; apo structure | 6HFD_A |
| PC | C26.952 | dihydro-orotase (N-terminal unit) (Homo sapiens-type) | Phe1563Leu mutant; apo structure | 6HFE_A |
| PC | C26.952 | dihydro-orotase (N-terminal unit) (Homo sapiens-type) | Phe1563Tyr mutant; apo structure | 6HFF_A |
| PC | C26.952 | dihydro-orotase (N-terminal unit) (Homo sapiens-type) | Phe1563Ala mutant; co-crystallized with carbamoyl aspartate at ph 7.0 | 6HFH_A |
| PC | C26.952 | dihydro-orotase (N-terminal unit) (Homo sapiens-type) | Phe1563Ala mutant; apo structure | 6HFI_A |
| PC | C26.952 | dihydro-orotase (N-terminal unit) (Homo sapiens-type) | Phe1563Ala mutant; co-crystallized with carbamoyl aspartate at ph 7.5 | 6HFJ_A |
| PC | C26.952 | dihydro-orotase (N-terminal unit) (Homo sapiens-type) | Phe1563Leu mutant; co-crystallized with carbamoyl aspartate at ph 6.5 | 6HFK_A |
| PC | C26.952 | dihydro-orotase (N-terminal unit) (Homo sapiens-type) | Phe1563Leu mutant; co-crystallized with carbamoyl aspartate at ph 7.0 | 6HFL_A |
| PC | C26.952 | dihydro-orotase (N-terminal unit) (Homo sapiens-type) | Phe1563Leu mutant; co-crystallized with carbamoyl aspartate at ph 7.5 | 6HFN_A |
| PC | C26.952 | dihydro-orotase (N-terminal unit) (Homo sapiens-type) | Phe1563Thr mutant; co-crystallized with carbamoyl aspartate at ph 7.0 | 6HFP_A |
| PC | C26.952 | dihydro-orotase (N-terminal unit) (Homo sapiens-type) | Phe1563Thr mutant; co-crystallized with carbamoyl aspartate at ph 7.5 | 6HFQ_A |
| PC | C26.952 | dihydro-orotase (N-terminal unit) (Homo sapiens-type) | Phe1563Tyr mutant; co-crystallized with carbamoyl aspartate at ph 7.0 | 6HFR_A |
| PC | C26.952 | dihydro-orotase (N-terminal unit) (Homo sapiens-type) | Phe1563Tyr mutant; co-crystallized with carbamoyl aspartate at ph 6.5 | 6HFS_A |
| PC | C26.952 | dihydro-orotase (N-terminal unit) (Homo sapiens-type) | Phe1563Tyr mutant; co-crystallized with carbamoyl aspartate at ph 7.5 | 6HFU_A |
| PC | C26.952 | dihydro-orotase (N-terminal unit) (Homo sapiens-type) | hybrid dihydroorotase domain of human cad with e. coli flexible loop in apo state | 6HG1_A |
| PC | C26.952 | dihydro-orotase (N-terminal unit) (Homo sapiens-type) | hybrid dihydroorotase domain of human cad with e. coli flexible loop, bound to fluoroorotate | 6HG2_A |
| PC | C26.952 | dihydro-orotase (N-terminal unit) (Homo sapiens-type) | hybrid dihydroorotase domain of human cad with e. coli flexible loop, bound to dihydroorotate | 6HG3_A |
| PC | C26.954 | carA protein | 1A9X | |
| PC | C26.954 | carA protein | 1BXR | |
| PC | C26.954 | carA protein | 1C30 | |
| PC | C26.954 | carA protein | 1C3O | |
| PC | C26.954 | carA protein | 1CE8 | |
| PC | C26.954 | carA protein | 1CS0 | |
| PC | C26.954 | carA protein | 1JDB | |
| PC | C26.954 | carA protein | 1KEE | |
| PC | C26.954 | carA protein | 1M6V | |
| PC | C26.954 | carA protein | 1T36 | |
| PC | C26.956 | carbamyl phosphate synthetase | inactive dihydroorotase-like domain of chaetomium thermophilum cad- like multifunctional protein | 5NNL_A |
| PC | C26.957 | GMP synthase | 1GPM | |
| PC | C26.957 | GMP synthase | crystal structure of a gmp synthase (glutamine-hydrolyzing) from neisseria gonorrhoeae | 5TW7_A |
| PC | C26.960 | TrpD protein (anthranilate synthase component II) | 1I1Q | |
| PC | C26.960 | TrpD protein (anthranilate synthase component II) | 1I7Q | |
| PC | C26.960 | TrpD protein (anthranilate synthase component II) | 1I7S | |
| PC | C26.964 | CTP synthetase | 1S1M | |
| PC | C26.964 | CTP synthetase | 2AD5 | |
| PC | C26.964 | CTP synthetase | "closed" conformation | 5TKV_A |
| PC | C26.964 | CTP synthetase | cryo-em structure of the e. coli ctp synthase tetramer | 5U05_A |
| PC | C26.964 | CTP synthetase | cryoem structure of the ctp synthase filament at 4.6 angstrom resolution | 5U3C_A |
| PC | C26.964 | CTP synthetase | e. coli ctp synthase cc mutant filament (product-bound) | 5U6R_A |
| PC | C26.964 | CTP synthetase | 1VCM_A | |
| PC | C26.964 | CTP synthetase | complex with sulfate anion | 1VCN_A |
| PC | C26.964 | CTP synthetase | complex with glutamine | 1VCO_A |
| PC | C26.965 | imidazole glycerol phosphate synthase subunit HisH | 4GUD | |
| PC | C26.965 | imidazole glycerol phosphate synthase subunit HisH | 1GPW | |
| PC | C26.965 | imidazole glycerol phosphate synthase subunit HisH | 1K9V | |
| PC | C26.965 | imidazole glycerol phosphate synthase subunit HisH | 1KXJ | |
| PC | C26.965 | imidazole glycerol phosphate synthase subunit HisH | 2WJZ | |
| PC | C26.965 | imidazole glycerol phosphate synthase subunit HisH | 3ZR4 | |
| PC | C26.966 | CTP synthase 2 | 2V4U | |
| PC | C26.966 | CTP synthase 2 | 2VKT | |
| PC | C26.966 | CTP synthase 2 | 3IHL | |
| PC | C26.A07 | At1g63660 (Arabidopsis thaliana) | 2YWB_A | |
| PC | C26.A07 | At1g63660 (Arabidopsis thaliana) | complex with xmp | 2YWC_A |
| PC | C26.A31 | GMP synthase (Pyrococcus furiosus) | 2A9V | |
| PC | C26.A31 | GMP synthase (Pyrococcus furiosus) | 1WL8 | |
| PC | C26.A31 | GMP synthase (Pyrococcus furiosus) | 2D7J | |
| PC | C26.A31 | GMP synthase (Pyrococcus furiosus) | 2LXN | |
| PC | C26.A34 | GMPS g.p. (Plasmodium falciparum) | crystal structure of pf10_0123, a gmp synthetase from plasmodium falciparum | 3UOW_A |
| PC | C26.A34 | GMPS g.p. (Plasmodium falciparum) | crystal structure of the gmp synthetase from plasmodium falciparum | 4WIM_A |
| PC | C26.A34 | GMPS g.p. (Plasmodium falciparum) | crystal structure of the gatase domain from plasmodium falciparum gmp synthetase | 4WIN_A |
| PC | C26.A34 | GMPS g.p. (Plasmodium falciparum) | inactive mutant; complex with glutamine | 4WIO_A |
| PC | C26.A35 | pdx2 g.p. (Plasmodium falciparum) | 2ABW | |
| PC | C26.A35 | pdx2 g.p. (Plasmodium falciparum) | 4ADS | |
| PC | C26.A36 | ctps g.p. (Brachydanio rerio) | 2VO1 | |
| PC | C26.A36 | ctps g.p. (Brachydanio rerio) | cryo-em structure of the human ctp synthase filament ***caveat 5u03 residues met 281 and leu 282 are improperly linked in chains ***caveat 2 5u03 a, b, c, and d. residues leu 295 and leu 296 are improperly ***caveat 3 5u03 linked in chains a, b, c, and d. | 5U03_A |
| PC | C26.UPW | family C26 unassigned peptidases | crystal structure of a uncharacterized protein lin1909 | 3FIJ_A |
| PC | C26.UPW | family C26 unassigned peptidases | 1QDL | |
| PC | C26.UPW | family C26 unassigned peptidases | 3D54 | |
| PC | C26.UPW | family C26 unassigned peptidases | 1O1Y_A | |
| PC | C26.UPW | family C26 unassigned peptidases | 1JVN | |
| PC | C26.UPW | family C26 unassigned peptidases | 1OX4 | |
| PC | C26.UPW | family C26 unassigned peptidases | 1OX5 | |
| PC | C26.UPW | family C26 unassigned peptidases | 1OX6 | |
| PC | C26.UPW | family C26 unassigned peptidases | trypanosoma brucei ctps - glutaminase domain with bound acivicin | 2W7T_A |
| PC | C26.UPW | family C26 unassigned peptidases | CTP synthase glutaminase domain:acivicin complex. | 5N29_A |
| PC | C26.UPW | family C26 unassigned peptidases | imidazole glycerol phosphate synthase | 1KA9_H |
| CA | C28.001 | foot-and-mouth disease virus L-peptidase | Cys51Ala, Cys133Ser and Met126Val engineered mutant. | 1QMY_A |
| CA | C28.001 | foot-and-mouth disease virus L-peptidase | Ala51Cys, Val126Met mutant | 1QOL |
| CA | C28.001 | foot-and-mouth disease virus L-peptidase | 2BHG | |
| CA | C28.001 | foot-and-mouth disease virus L-peptidase | 2JQF | |
| PA | C30.001 | coronavirus picornain 3C-like peptidase-1 | complex with an inhibitor | 6JIJ_B |
| PA | C30.002 | avian infectious bronchitis coronavirus 3C-like peptidase | 2Q6D | |
| PA | C30.002 | avian infectious bronchitis coronavirus 3C-like peptidase | complex with Michael acceptor inhibitor N3 | 2Q6F |
| PA | C30.003 | human coronavirus 229E main peptidase | 1P9S_A | |
| PA | C30.003 | human coronavirus 229E main peptidase | 1P9U | |
| PA | C30.003 | human coronavirus 229E main peptidase | complex with epdtc | 2ZU2_A |
| PA | C30.003 | human coronavirus 229E main peptidase | 4XFQ | |
| PA | C30.003 | human coronavirus 229E main peptidase | Cys144Ala mutant complex with a peptide substrate. | 4ZUH_A |
| PA | C30.003 | human coronavirus 229E main peptidase | complex with the alpha-ketoamide tert-butyl ((s)-4-(benzylamino)-3,4-dioxo-1-((s)-2- oxopyrrolidin-3-yl)b- utan-2-yl)carbamate (tert-butyl -glnlactam-co- co-nh-benzyl) | 5NH0_A |
| PA | C30.003 | human coronavirus 229E main peptidase | complex with the alpha-ketoamide (s)-n-((s)-4-(benzylamino)-3,4-dioxo-1-((s)-2- oxopyrrolidin-3-yl)butan-2-yl)-2-cinnamamido-4-methylpentanamide (cinnamoyl-leucine-glnlactam-co-co-nh-benzyl) | 6FV1_A |
| PA | C30.003 | human coronavirus 229E main peptidase | complex with the alpha-ketoamide (s)-n-benzyl-3-((s)-2-cinnamamido-3- phenylpropanamido)-2-oxo-4-((s)-2-oxopyrrolidin-3-yl)butanamide (cinnamoyl-phenylalanine-glnlactam-co-co-nh-benzyl) | 6FV2_A |
| PA | C30.004 | porcine transmissible gastroenteritis virus-type main peptidase | 1LVO_A | |
| PA | C30.004 | porcine transmissible gastroenteritis virus-type main peptidase | complex with an inhibitor N1 | 2AMP_A |
| PA | C30.004 | porcine transmissible gastroenteritis virus-type main peptidase | crystal structure of transmissible gastroenteritis virus papain-like protease 1 | 3MP2_A |
| PA | C30.004 | porcine transmissible gastroenteritis virus-type main peptidase | complex with a covalently bound dipeptidyl inhibitor | 4F49_A |
| PA | C30.004 | porcine transmissible gastroenteritis virus-type main peptidase | complex with N-(tert-butoxycarbonyl)-L-seryl-L-valyl-N-(2S)-5-ethoxy-5-oxo-1-[(3S)-2-oxopyrrolidin-3-yl]pentan-2-yl-L-leucinamide inhibitor | 4ZRO_A |
| PA | C30.005 | SARS coronavirus picornain 3C-like peptidase | 1P9T | |
| PA | C30.005 | SARS coronavirus picornain 3C-like peptidase | 1P9U | |
| PA | C30.005 | SARS coronavirus picornain 3C-like peptidase | 1PA5 | |
| PA | C30.005 | SARS coronavirus picornain 3C-like peptidase | 1Q2W_A | |
| PA | C30.005 | SARS coronavirus picornain 3C-like peptidase | 1UJ1_A | |
| PA | C30.005 | SARS coronavirus picornain 3C-like peptidase | at pH 8 | 1UK2_A |
| PA | C30.005 | SARS coronavirus picornain 3C-like peptidase | at pH 7.6 | 1UK3_A |
| PA | C30.005 | SARS coronavirus picornain 3C-like peptidase | complex with inhibitor Asn-Ser-Thr-Leu-Gln | 1UK4_A |
| PA | C30.005 | SARS coronavirus picornain 3C-like peptidase | complex with inhibitor N1 | 1WOF_A |
| PA | C30.005 | SARS coronavirus picornain 3C-like peptidase | 1Z1I_A | |
| PA | C30.005 | SARS coronavirus picornain 3C-like peptidase | Cys145Ala mutant | 1Z1J_A |
| PA | C30.005 | SARS coronavirus picornain 3C-like peptidase | 2A5A_A | |
| PA | C30.005 | SARS coronavirus picornain 3C-like peptidase | complex with Aza-peptide epoxide | 2A5I_A |
| PA | C30.005 | SARS coronavirus picornain 3C-like peptidase | complex with Aza-peptide epoxide | 2A5K_A |
| PA | C30.005 | SARS coronavirus picornain 3C-like peptidase | complex with N-((3S,6R)-6-((S,E)-4-ethoxycarbonyl-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-ylcarbamoyl)-2,9-dimethyl-4-oxodec-8-en-3-yl)-5-methylisoxazole-3-carboxamide | 2ALV_A |
| PA | C30.005 | SARS coronavirus picornain 3C-like peptidase | complex with an inhibitor N9 | 2AMD_A |
| PA | C30.005 | SARS coronavirus picornain 3C-like peptidase | complex with an inhibitor N3 | 2AMQ_A |
| PA | C30.005 | SARS coronavirus picornain 3C-like peptidase | 2BX3_A | |
| PA | C30.005 | SARS coronavirus picornain 3C-like peptidase | 2BX4_A | |
| PA | C30.005 | SARS coronavirus picornain 3C-like peptidase | at pH 6.5 | 2C3S_A |
| PA | C30.005 | SARS coronavirus picornain 3C-like peptidase | acylated form | 2CGG_A |
| PA | C30.005 | SARS coronavirus picornain 3C-like peptidase | complex with ethyl (2E,4S)-4-[((2R)-2-[N-(tert-butoxycarbonyl)-L-valyl]amino-2-phenylethanoyl)amino]-5-[(3S)-2-oxopyrrolidin-3-yl]pent-2-enoate | 2D2D_A |
| PA | C30.005 | SARS coronavirus picornain 3C-like peptidase | 2DUC_A | |
| PA | C30.005 | SARS coronavirus picornain 3C-like peptidase | at pH 6.0 | 2GT7 |
| PA | C30.005 | SARS coronavirus picornain 3C-like peptidase | 2GT8 | |
| PA | C30.005 | SARS coronavirus picornain 3C-like peptidase | complex with Aza-peptide inhibitor (5S,8S,14R)-ethyl 11-(3-amino-3-oxopropyl)-8-benzyl-14-hydroxy-5-isobutyl-3,6,9,12-tetraoxo-1-phenyl-2-oxa-4,7,10,11-tetraazapentadecan-15-oate | 2GTB |
| PA | C30.005 | SARS coronavirus picornain 3C-like peptidase | complex with inhibitor | 2GX4_A |
| PA | C30.005 | SARS coronavirus picornain 3C-like peptidase | structure-based drug design and structural biology study of novel nonpeptide inhibitors of sars-cov main protease | 2GZ7_A |
| PA | C30.005 | SARS coronavirus picornain 3C-like peptidase | structure-based drug design and structural biology study of novel nonpeptide inhibitors of sars-cov main protease | 2GZ8_A |
| PA | C30.005 | SARS coronavirus picornain 3C-like peptidase | structure-based drug design and structural biology study of novel nonpeptide inhibitors of sars-cov main protease | 2GZ9_A |
| PA | C30.005 | SARS coronavirus picornain 3C-like peptidase | 2H2Z_A | |
| PA | C30.005 | SARS coronavirus picornain 3C-like peptidase | complex with a Michael acceptor N3 | 2HOB_A |
| PA | C30.005 | SARS coronavirus picornain 3C-like peptidase | substrate specificity profiling and identification of a new class of inhibitor for the major protease of the sars coronavirus | 2OP9_A |
| PA | C30.005 | SARS coronavirus picornain 3C-like peptidase | His3281Ala mutant; complex with an N-terminal substrate | 2Q6G |
| PA | C30.005 | SARS coronavirus picornain 3C-like peptidase | crystal structures of the sars-coronavirus main proteinase inactivated by benzotriazole compounds | 2V6N_A |
| PA | C30.005 | SARS coronavirus picornain 3C-like peptidase | a structural view of the inactivation of the sars- coronavirus main proteinase by benzotriazole esters | 2VJ1_A |
| PA | C30.005 | SARS coronavirus picornain 3C-like peptidase | a mechanistic view of enzyme inhibition and peptide hydrolysis in the active site of the sars-cov 3c-like peptidase | 2Z3C_A |
| PA | C30.005 | SARS coronavirus picornain 3C-like peptidase | a mechanistic view of enzyme inhibition and peptide hydrolysis in the active site of the sars-cov 3c-like peptidase | 2Z3D_A |
| PA | C30.005 | SARS coronavirus picornain 3C-like peptidase | a mechanistic view of enzyme inhibition and peptide hydrolysis in the active site of the sars-cov 3c-like peptidase | 2Z3E_A |
| PA | C30.005 | SARS coronavirus picornain 3C-like peptidase | a special dimerization of sars-cov main protease c-terminal domain due to domain-swapping | 3EBN_A |
| PA | C30.005 | SARS coronavirus picornain 3C-like peptidase | complex with a bromobenzoyl (s,r)-n- decalin type inhibitor | 4TWW_A |
| PA | C30.005 | SARS coronavirus picornain 3C-like peptidase | complex with a phenylbenzoyl (s,r)-n- decalin type inhibitor | 4TWY_A |
| PA | C30.005 | SARS coronavirus picornain 3C-like peptidase | complex with a phenylbenzoyl (r,s)-n- decalin type inhibitor | 4WY3_A |
| PA | C30.005 | SARS coronavirus picornain 3C-like peptidase | crystal structure of ms8104 | 5B6O_A |
| PA | C30.005 | SARS coronavirus picornain 3C-like peptidase | complex with a phenyl-beta-alanyl (r, s)-n-decalin type inhibitor | 5C5N_A |
| PA | C30.005 | SARS coronavirus picornain 3C-like peptidase | complex with a phenyl-beta-alanyl (s, r)-n-decalin type inhibitor | 5C5O_A |
| PA | C30.005 | SARS coronavirus picornain 3C-like peptidase | structure of sars plpro bound to a lys48-linked di-ubiquitin activity based probe | 5E6J_A |
| PA | C30.005 | SARS coronavirus picornain 3C-like peptidase | complex with the alpha-ketoamide (s)-n-benzyl-3-((s)-2-cinnamamido-3-phenylpropanamido)-2- oxo-4-((s)-2-oxopyrrolidin-3-yl)butanamide | 5N19_A |
| PA | C30.005 | SARS coronavirus picornain 3C-like peptidase | complex with the alpha-ketoamide (s)-n-benzyl-3-((s)-2-cinnamamido-3- cyclopropylpropanamido)-2-oxo-4-((s)-2-oxopyrrolidin-3-yl)butanamide (cinnamoyl-cyclopropylalanine-glnlactam-co-co-nh-benzyl) | 5N5O_A |
| PA | C30.005 | SARS coronavirus picornain 3C-like peptidase | complex with thec-terminal domain of human isg15 | 5TL6_B |
| PA | C30.005 | SARS coronavirus picornain 3C-like peptidase | complex with c- terminal domain mouse isg15 | 5TL7_B |
| PA | C30.006 | MERS coronavirus picornain 3C-like peptidase | crystal structure of plpro from middle east respiratory syndrome (mers) coronavirus | 4PT5_A |
| PA | C30.006 | MERS coronavirus picornain 3C-like peptidase | crystal structure of plpro from middle east respiratory syndrome (mers) coronavirus | 4RNA_A |
| PA | C30.006 | MERS coronavirus picornain 3C-like peptidase | crystal structure of the middle east respiratory syndrome coronavirus papain-like protease bound to ubiquitin variant me.4 | 5V69_A |
| PA | C30.006 | MERS coronavirus picornain 3C-like peptidase | crystal structure of the middle east respiratory syndrome coronavirus papain-like protease bound to ubiquitin variant me.2 | 5V6A_A |
| PA | C30.006 | MERS coronavirus picornain 3C-like peptidase | complex with human isg15 | 6BI8_A |
| PA | C30.UPW | family C30 unassigned peptidases | 4YO9 | |
| PA | C30.UPW | family C30 unassigned peptidases | 4YOG | |
| PA | C30.UPW | family C30 unassigned peptidases | 4YOI | |
| PA | C30.UPW | family C30 unassigned peptidases | 4YOJ | |
| PA | C30.UPW | family C30 unassigned peptidases | 3ETI | |
| PA | C30.UPW | family C30 unassigned peptidases | 3EW5 | |
| PA | C30.UPW | family C30 unassigned peptidases | 3GZF | |
| PA | C30.UPW | family C30 unassigned peptidases | 3JZT | |
| PA | C30.UPW | family C30 unassigned peptidases | 3UB0 | |
| PA | C30.UPW | family C30 unassigned peptidases | 4ZRO | |
| CA | C31.UPW | family C31 unassigned peptidases | 3IFU | |
| CA | C32.001 | equine arteritis virus-type cysteine peptidase | 3MTV | |
| CA | C33.001 | equine arteritis virus Nsp2-type cysteine peptidase | 1MBM | |
| CA | C33.001 | equine arteritis virus Nsp2-type cysteine peptidase | 2L8K | |
| CA | C33.001 | equine arteritis virus Nsp2-type cysteine peptidase | complex with ubiquitin | 4IUM |
| CA | C33.001 | equine arteritis virus Nsp2-type cysteine peptidase | 4N0N | |
| CA | C33.001 | equine arteritis virus Nsp2-type cysteine peptidase | 4N0O | |
| PA | C37.001 | calicivirin | x-ray structure at 1.75 a resolution of a norovirus protease linked to an active site directed peptide inhibitor | 2IPH_A |
| PA | C37.001 | calicivirin | 2FYQ_A | |
| PA | C37.001 | calicivirin | grown in the presence of AEBSF | 2FYR_A |
| PA | C37.001 | calicivirin | 2LNC | |
| PA | C37.001 | calicivirin | 3UR6 | |
| PA | C37.001 | calicivirin | 3UR9 | |
| PA | C37.001 | calicivirin | 4IMQ | |
| PA | C37.001 | calicivirin | 4IMZ | |
| PA | C37.001 | calicivirin | 4IN1 | |
| PA | C37.001 | calicivirin | 4IN2 | |
| PA | C37.001 | calicivirin | 4INH | |
| PA | C37.001 | calicivirin | 4XBB | |
| PA | C37.001 | calicivirin | 4XBC | |
| PA | C37.001 | calicivirin | 4XBD | |
| PA | C37.001 | calicivirin | complex an oxadiazole-based, cell permeable macrocyclic (21-mer) inhibitor | 5DG6_A |
| PA | C37.001 | calicivirin | complex with an oxadiazole-based, cell permeable macrocyclic (20-mer) inhibitor | 5DGJ_A |
| PA | C37.001 | calicivirin | complex with a triazole-based macrocyclic (17-mer) inhibitor | 5E0G_A |
| PA | C37.001 | calicivirin | complex with a triazole-based macrocyclic (18-mer) inhibitor | 5E0H_A |
| PA | C37.001 | calicivirin | complex with a triazole-based macrocyclic (21-mer) inhibitor | 5E0J_A |
| PA | C37.001 | calicivirin | complex with the dipeptidyl inhibitor 7l (hexagonal form) | 5T6D_A |
| PA | C37.001 | calicivirin | complex with the dipeptidyl inhibitor 7l (orthorhombic p form) | 5T6F_A |
| PA | C37.001 | calicivirin | complex with the dipeptidyl inhibitor 7m (hexagonal form) | 5T6G_A |
| PA | C37.001 | calicivirin | complex with the a m-chlorophenyl substituted macrocyclic inhibitor (17-mer) | 5TG1_A |
| PA | C37.001 | calicivirin | complex with the a n-pentyl substituted macrocyclic inhibitor (17-mer) | 5TG2_A |
| PA | C37.001 | calicivirin | complex with a dipeptidyl oxazolidinone-based inhibitor | 5WEJ_A |
| PA | C37.001 | calicivirin | complex with a triazole-based macrocyclic inhibitor | 6BIB_A |
| PA | C37.001 | calicivirin | complex with a triazole-based macrocyclic inhibitor | 6BIC_A |
| PA | C37.001 | calicivirin | complex with a triazole-based macrocyclic inhibitor | 6BID_A |
| PA | C37.001 | calicivirin | 1WQS_A | |
| PA | C37.001 | calicivirin | 6B6I | |
| PA | C37.003 | murine norovirus NS6 peptidase | 4ASH | |
| PA | C37.003 | murine norovirus NS6 peptidase | Cys139Ala mutant; complex with C-terminus of NS7 | 4X2V |
| PA | C37.003 | murine norovirus NS6 peptidase | Cys139Ala mutant; complex with C-terminus of NS7 | 4X2W |
| PA | C37.003 | murine norovirus NS6 peptidase | Cys139Ala mutant; complex with C-terminus of NS7 | 4X2X |
| PA | C37.003 | murine norovirus NS6 peptidase | Cys139Ala mutant; complex with peptide from NS2-3 junction | 4X2Y |
| CA | C39.001 | bacteriocin-processing peptidase | crystal structure of the peptidase-containing abc transporter pcat1 | 4RY2_A |
| CA | C39.001 | bacteriocin-processing peptidase | crystal structure of the peptidase-containing abc transporter pcat1 e648q mutant complex with atpgs in an occluded conformation | 4S0F_A |
| CA | C39.001 | bacteriocin-processing peptidase | peptidase domain only | 3K8U |
| CA | C39.001 | bacteriocin-processing peptidase | crystal structure of the peptidase domain of streptococcus mutans coma | 5XE8_A |
| CA | C39.001 | bacteriocin-processing peptidase | peptidase domain; complex with a small molecule inhibitor. | 5XE9_A |
| CO | C40.004 | spr peptidase | NMR structure; TOPSAN | 2K1G |
| CO | C40.004 | spr peptidase | N-terminal LysM domain | 4UZ2 |
| CO | C40.004 | spr peptidase | N-terminal LysM domain; complex with N-acteyl-chitohexaose | 4UZ3 |
| CO | C40.004 | spr peptidase | 4XCM | |
| CO | C40.007 | YddH peptidase | crystal structure of a putative cell wall hydrolase (cd630_03720) fromclostridium difficile 630 at 2.38 a resolution | 4HPE_A |
| CO | C40.007 | YddH peptidase | structure of nlpc1 from trichomonas vaginalis | 6BIM_A |
| CO | C40.007 | YddH peptidase | structure of nlpc1 from trichomonas vaginalis | 6BIO_A |
| CO | C40.007 | YddH peptidase | structure of nlpc2 from trichomonas vaginalis | 6BIQ_A |
| CO | C40.009 | NLP/P60 (Nostoc punctiforme)-like putative peptidase | TOPSAN | 2EVR |
| CO | C40.009 | NLP/P60 (Nostoc punctiforme)-like putative peptidase | TOPSAN | 2FG0 |
| CO | C40.009 | NLP/P60 (Nostoc punctiforme)-like putative peptidase | crystal structure of a putative dipeptidyl-peptidase vi (bt_1314) frombacteroides thetaiotaomicron vpi-5482 at 2.10 a resolution | 3PVQ_A |
| CO | C40.009 | NLP/P60 (Nostoc punctiforme)-like putative peptidase | crystal structure of a putative dipeptidyl-peptidase vi (bt_1314) frombacteroides thetaiotaomicron vpi-5482 at 1.75 a resolution | 4R0K_A |
| CO | C40.009 | NLP/P60 (Nostoc punctiforme)-like putative peptidase | TOPSAN | 2HBW |
| CO | C40.009 | NLP/P60 (Nostoc punctiforme)-like putative peptidase | crystal structure of a putative dipeptidyl-peptidase vi (bacova_00612)from bacteroides ovatus at 1.72 a resolution | 3NPF_A |
| CO | C40.012 | RipB peptidoglycan hydrolase | ripd (rv1566c) from mycobacterium tuberculosis: a non-catalytic nlpc/p60 domain protein, adaptation to peptidoglycan-binding function | 4JXB_A |
| CO | C40.012 | RipB peptidoglycan hydrolase | ripd (rv1566c) from mycobacterium tuberculosis: a non-catalytic nlpc/p60 domain protein with two penta-peptide repeat units (pvqqa- pvqpa) | 4LJ1_A |
| CO | C40.012 | RipB peptidoglycan hydrolase | crystal structure of the p60 domain from m. avium paratuberculosis antigen map1272c | 3GT2_A |
| CO | C40.UPW | family C40 unassigned peptidases | crystal structure of the p60 domain from m. avium subspecies paratuberculosis antigen map1204 | 3I86_A |
| CO | C40.UPW | family C40 unassigned peptidases | 3H41_A | |
| PB | C44.001 | amidophosphoribosyltransferase precursor | complex with guanidine monophosphate | 1ECB |
| PB | C44.001 | amidophosphoribosyltransferase precursor | complex with MN-CPRPP and 5-oxo-norLeu | 1ECC |
| PB | C44.001 | amidophosphoribosyltransferase precursor | 1ECF_B | |
| PB | C44.001 | amidophosphoribosyltransferase precursor | 1ECG | |
| PB | C44.001 | amidophosphoribosyltransferase precursor | complex with adenosine monophosphate | 1ECJ |
| PB | C44.001 | amidophosphoribosyltransferase precursor | complex with ppgpp-mg | 6CZF_A |
| PB | C44.001 | amidophosphoribosyltransferase precursor | complex with adenosine monophosphate and adenosine diphosphate | 1AO0 |
| PB | C44.001 | amidophosphoribosyltransferase precursor | 1GPH | |
| PB | C44.003 | glutamate synthase (NADPH) large chain | 1EA0 | |
| PB | C44.003 | glutamate synthase (NADPH) large chain | 2VDC | |
| PB | C44.003 | glutamate synthase (NADPH) large chain | structural studies on the synchronization of catalytic centers in glutamate synthase: complex with 2-oxoglutarate | 1LLW_A |
| PB | C44.003 | glutamate synthase (NADPH) large chain | structural studies on the synchronization of catalytic centers in glutamate synthase: reduced enzyme | 1LLZ_A |
| PB | C44.003 | glutamate synthase (NADPH) large chain | structural studies on the synchronization of catalytic centers in glutamate synthase: native enzyme | 1LM1_A |
| PB | C44.003 | glutamate synthase (NADPH) large chain | glutamate synthase from synechocystis sp in complex with 2-oxoglutarate at 2.0 angstrom resolution | 1OFD_A |
| PB | C44.003 | glutamate synthase (NADPH) large chain | glutamate synthase from synechocystis sp in complex with 2-oxoglutarate and l-don at 2.45 angstrom resolution | 1OFE_A |
| PB | C44.970 | glutamine-fructose-6-phosphate transaminase 1 | 2V4M | |
| PB | C44.970 | glutamine-fructose-6-phosphate transaminase 1 | 2ZJ3 | |
| PB | C44.970 | glutamine-fructose-6-phosphate transaminase 1 | 2ZJ4 | |
| PB | C44.971 | glucosamine-fructose-6-phosphate aminotransferase | complex with glutamate | 1GDO_A |
| PB | C44.971 | glucosamine-fructose-6-phosphate aminotransferase | complex with L-Glu hydroxamate | 1GMS |
| PB | C44.971 | glucosamine-fructose-6-phosphate aminotransferase | complex with glucose 6-phosphate | 1JXA |
| PB | C44.971 | glucosamine-fructose-6-phosphate aminotransferase | glutaminase domain of glucosamine 6-phosphate synthase complexed with glutamate | 1XFF_A |
| PB | C44.971 | glucosamine-fructose-6-phosphate aminotransferase | glutaminase domain of glucosamine 6-phosphate synthase complexed with l-glu hydroxamate | 1XFG_A |
| PB | C44.971 | glucosamine-fructose-6-phosphate aminotransferase | complex with fructose-6P | 2BPL_A |
| PB | C44.971 | glucosamine-fructose-6-phosphate aminotransferase | e. coli glucosamine-6-p synthase in complex with glucose-6p and 5-oxo-l-norleucine | 2J6H_A |
| PB | C44.971 | glucosamine-fructose-6-phosphate aminotransferase | e. coli glucosamine-6-p synthase | 2VF4_X |
| PB | C44.971 | glucosamine-fructose-6-phosphate aminotransferase | glucosamine-6-phosphate synthase in complex with glucosamine-6-phosphate | 2VF5_X |
| PB | C44.971 | glucosamine-fructose-6-phosphate aminotransferase | e.coli glucosamine-6p synthase in complex with fructose-6p | 4AMV_A |
| PB | C44.976 | AsnB protein | 1CT9 | |
| PB | C44.UNW | family C44 non-peptidase homologues | 3TBF | |
| PB | C44.UPW | family C44 unassigned peptidases | 2POC | |
| PB | C44.UPW | family C44 unassigned peptidases | 2PUT | |
| PB | C44.UPW | family C44 unassigned peptidases | 2PUV | |
| PB | C44.UPW | family C44 unassigned peptidases | 2PUW | |
| PB | C44.UPW | family C44 unassigned peptidases | 4ZFJ | |
| PB | C44.UPW | family C44 unassigned peptidases | 4ZFK | |
| PB | C44.UPW | family C44 unassigned peptidases | 4ZFL | |
| PB | C45.001 | acyl-coenzyme A:6-aminopenicillanic acid acyl-transferase precursor | precursor | 2X1C |
| PB | C45.001 | acyl-coenzyme A:6-aminopenicillanic acid acyl-transferase precursor | mature enzyme | 2X1D |
| PB | C45.001 | acyl-coenzyme A:6-aminopenicillanic acid acyl-transferase precursor | complex with 6-aminopenicillanic acid | 2X1E |
| PD | C46.001 | hedgehog protein | autoprocessing domain | 1AT0 |
| PD | C46.001 | hedgehog protein | 2IBG | |
| PD | C46.002 | Sonic hedgehog protein | 3HO5 | |
| PD | C46.002 | Sonic hedgehog protein | 3M1N | |
| PD | C46.002 | Sonic hedgehog protein | 3MXW | |
| PD | C46.002 | Sonic hedgehog protein | amino-terminal domain complexed with zinc | 1VHH |
| PD | C46.002 | Sonic hedgehog protein | 2WFX | |
| PD | C46.002 | Sonic hedgehog protein | 2WG4 | |
| PD | C46.002 | Sonic hedgehog protein | 3D1M | |
| PD | C46.002 | Sonic hedgehog protein | 3N1R | |
| PD | C46.002 | Sonic hedgehog protein | 4C4M | |
| PD | C46.002 | Sonic hedgehog protein | 4C4N | |
| PD | C46.003 | Indian hedgehog protein | 3K7G | |
| PD | C46.003 | Indian hedgehog protein | 3K7H | |
| PD | C46.003 | Indian hedgehog protein | 3K7I | |
| PD | C46.003 | Indian hedgehog protein | 3K7J | |
| PD | C46.003 | Indian hedgehog protein | 3N1F | |
| PD | C46.003 | Indian hedgehog protein | 3N1M | |
| PD | C46.003 | Indian hedgehog protein | 3N1O | |
| PD | C46.003 | Indian hedgehog protein | 3N1P | |
| PD | C46.004 | Desert hedgehog protein | 2WFQ | |
| PD | C46.004 | Desert hedgehog protein | 2WFR | |
| PD | C46.004 | Desert hedgehog protein | 2WG3 | |
| PD | C46.004 | Desert hedgehog protein | 3N1G | |
| PD | C46.004 | Desert hedgehog protein | 3N1Q | |
| CA | C47.001 | staphopain A | complex with E64 | 1CV8 |
| CA | C47.001 | staphopain A | complex with staphostatin | 1PXV_A |
| CA | C47.002 | staphopain B | precursor | 1X9Y |
| CE | C48.001 | Ulp1 peptidase | peptidase unit; complex with ubiquitin-like protein SMT3 | 1EUV_A |
| CE | C48.001 | Ulp1 peptidase | sumo protease ulp1 with the catalytic cysteine oxidized to a sulfenic acid | 2HKP_A |
| CE | C48.001 | Ulp1 peptidase | sumo protease ulp1 with the catalytic cysteine oxidized to a sulfinic acid | 2HL8_A |
| CE | C48.001 | Ulp1 peptidase | sumo protease ulp1 with the catalytic cysteine oxidized to a sulfonic acid | 2HL9_A |
| CE | C48.002 | SENP1 peptidase | complex with sumo2 | 2CKG |
| CE | C48.002 | SENP1 peptidase | complex with sumo2 | 2CKH |
| CE | C48.002 | SENP1 peptidase | Cys603Ser mutant; complex with SUMO-1 | 2G4D_A |
| CE | C48.002 | SENP1 peptidase | senp1 (mutant) sumo1 rangap | 2IY0_A |
| CE | C48.002 | SENP1 peptidase | senp1 (mutant) full length sumo1 | 2IY1_A |
| CE | C48.002 | SENP1 peptidase | senp1 native structure | 2IYC_A |
| CE | C48.002 | SENP1 peptidase | senp1 covalent complex with sumo-2 | 2IYD_A |
| CE | C48.002 | SENP1 peptidase | 2XPH | |
| CE | C48.002 | SENP1 peptidase | 2XRE | |
| CE | C48.002 | SENP1 peptidase | complex with sumo2 | 6NNQ_A |
| CE | C48.005 | Ulp2 peptidase | crystal structure of the de-sumoylating protease | 5LNB_B |
| CE | C48.007 | SENP2 peptidase | Complex with sumo-1 | 1TGZ_A |
| CE | C48.007 | SENP2 peptidase | structure of human senp2 | 1TH0_A |
| CE | C48.007 | SENP2 peptidase | complex with presumo-2 | 2IO0_A |
| CE | C48.007 | SENP2 peptidase | complex with presumo-3 | 2IO1_A |
| CE | C48.007 | SENP2 peptidase | complex with rangap1- sumo-1 | 2IO2_A |
| CE | C48.007 | SENP2 peptidase | complex with rangap1- sumo-2 | 2IO3_A |
| CE | C48.007 | SENP2 peptidase | 3ZO5 | |
| CE | C48.007 | SENP2 peptidase | Cys548Ser mutant; complex with the human sumo1 Lys48Met/Phe66Trp mutant | 5AEK_A |
| CE | C48.009 | SENP7 peptidase | catalytic domain only | 3EAY |
| CE | C48.011 | SENP8 peptidase | complex with ubiquitin-Like Protein Nedd8 | 1XT9 |
| CE | C48.011 | SENP8 peptidase | nedd8 protease | 2BKQ_A |
| CE | C48.011 | SENP8 peptidase | nedd8 nedp1 complex | 2BKR_A |
| CE | C48.023 | XopD peptidase | structural analysis of xanthomonas xopd provides insights into substrate specificity of ubiquitin-like protein proteases | 2OIV_A |
| CE | C48.023 | XopD peptidase | xanthomonas xopd c470a mutant | 2OIX_A |
| CE | C48.023 | XopD peptidase | structure of xanthomonas campestris effector protein xopd bound to tomato sumo | 5JP1_A |
| CE | C48.023 | XopD peptidase | structure of xanthomonas campestris effector protein xopd bound to ubiquitin | 5JP3_A |
| CE | C48.032 | ChlaDub1 peptidase | structure of chlamydia trachomatis effector protein chladub1 | 5HAG_A |
| CE | C48.032 | ChlaDub1 peptidase | structure of chlamydia trachomatis effector protein cdu1 bound to ubiquitin | 6FDK_A |
| CE | C48.032 | ChlaDub1 peptidase | structure of chlamydia trachomatis effector protein cdu1 bound to compound 5 | 6FDQ_A |
| CE | C48.032 | ChlaDub1 peptidase | structure of chlamydia trachomatis effector protein cdu1 bound to compound 3 | 6FDU_A |
| CE | C48.032 | ChlaDub1 peptidase | complex with ubiquitin | 6GZS_A |
| CE | C48.032 | ChlaDub1 peptidase | complex with coenzyme a | 6GZT_A |
| CE | C48.UNW | family C48 non-peptidase homologues | 5B5Q_B | |
| CE | C48.UPW | family C48 unassigned peptidases | 6GZU_A | |
| CE | C48.UPW | family C48 unassigned peptidases | catalytic domain | 6DG4_A |
| CD | C50.001 | separase (yeast-type) | complex with securin | 5U1S |
| CD | C50.001 | separase (yeast-type) | complex with securin | 5U1T |
| CD | C50.004 | SEP-1 peptidase (Nematoda) | complex with securin | 5MZ6_1 |
| CD | C50.UPW | family C50 unassigned peptidases | 5FBY_A | |
| CD | C50.UPW | family C50 unassigned peptidases | complex with a pamk peptide containing a phospho-serine | 5FC2_A |
| CD | C50.UPW | family C50 unassigned peptidases | structural basis of cohesin cleavage by separase | 5FC3_A |
| CA | C51.A01 | fused glutathionylspermidine amidase/glutathionylspermidine synthetase (Escherichia coli) | 2IO7 | |
| CA | C51.A01 | fused glutathionylspermidine amidase/glutathionylspermidine synthetase (Escherichia coli) | 2IO8 | |
| CA | C51.A01 | fused glutathionylspermidine amidase/glutathionylspermidine synthetase (Escherichia coli) | 2IO9 | |
| CA | C51.A01 | fused glutathionylspermidine amidase/glutathionylspermidine synthetase (Escherichia coli) | 2IOA | |
| CA | C51.A01 | fused glutathionylspermidine amidase/glutathionylspermidine synthetase (Escherichia coli) | 2IOB | |
| CA | C51.A01 | fused glutathionylspermidine amidase/glutathionylspermidine synthetase (Escherichia coli) | 3A2Y | |
| CA | C51.A01 | fused glutathionylspermidine amidase/glutathionylspermidine synthetase (Escherichia coli) | 3A2Z | |
| CA | C51.A01 | fused glutathionylspermidine amidase/glutathionylspermidine synthetase (Escherichia coli) | 3A30 | |
| CA | C51.A01 | fused glutathionylspermidine amidase/glutathionylspermidine synthetase (Escherichia coli) | 3O98 | |
| CQ | C53.001 | pestivirus Npro peptidase | 4H9J | |
| CQ | C53.001 | pestivirus Npro peptidase | Cys168Ala mutant | 4H9K |
| CQ | C53.002 | pestivirus strain D32/00_HoBi Npro peptidase | 3ZFN | |
| CQ | C53.002 | pestivirus strain D32/00_HoBi Npro peptidase | Ser169Pro mutant; unprocessed | 3ZFO |
| CQ | C53.002 | pestivirus strain D32/00_HoBi Npro peptidase | with internal His-tag | 3ZFP |
| CQ | C53.002 | pestivirus strain D32/00_HoBi Npro peptidase | with mercury | 3ZFQ |
| CQ | C53.002 | pestivirus strain D32/00_HoBi Npro peptidase | with iridium | 3ZFR |
| CQ | C53.002 | pestivirus strain D32/00_HoBi Npro peptidase | at pH 3 | 3ZFT |
| CQ | C53.002 | pestivirus strain D32/00_HoBi Npro peptidase | Ser169Pro mutant; unprocessed; with sulphate | 3ZFU |
| CA | C54.002 | autophagin-2 | cysteine protease atg4a | 2P82_A |
| CA | C54.003 | autophagin-1 | 2CY7 | |
| CA | C54.003 | autophagin-1 | 2D1I | |
| CA | C54.003 | autophagin-1 | complex with LC3(1-120) | 2Z0D_A |
| CA | C54.003 | autophagin-1 | complex with LC3(1-124) | 2Z0E_A |
| CA | C54.003 | autophagin-1 | the crystal structure of human atg4b(c74s)- lc3(1-124) complex | 2ZZP_A |
| CE | C55.003 | AvrA protein | avra dell154 with ip6, coa | 6BE0_A |
| PC | C56.001 | PfpI peptidase | sav1875 | 4Y0N_A |
| PC | C56.001 | PfpI peptidase | sav1875-c105d | 4Y1E_A |
| PC | C56.001 | PfpI peptidase | sav1875-e17d | 4Y1F_A |
| PC | C56.001 | PfpI peptidase | sav1875-e17n | 4Y1G_A |
| PC | C56.001 | PfpI peptidase | sav1875-cysteinesulfonic acid | 4Y1R_A |
| PC | C56.001 | PfpI peptidase | 1G2I_A | |
| PC | C56.001 | PfpI peptidase | co- cystallized in presence of 10 mm tb-xo4 and ammonium sulfate. | 6F2F_A |
| PC | C56.001 | PfpI peptidase | co-crystallized in presence of 10 mm tb-xo4 and potassium iodide. | 6F2H_A |
| PC | C56.001 | PfpI peptidase | crystal structure of the protease 1 (e29a,e60a,e80a) from pyrococcus horikoshii co-crystallized with tb-xo4. | 6HF6_A |
| PC | C56.001 | PfpI peptidase | at room temperature in chipx microfluidic device | 6Q3T_A |
| PC | C56.001 | PfpI peptidase | TOPSAN | 3FSE_A |
| PC | C56.001 | PfpI peptidase | ton1285, an intracellular protease from thermococcus onnurineus na1 | 3L18_A |
| PC | C56.001 | PfpI peptidase | small cell H3 crystal form | 5TW0 |
| PC | C56.001 | PfpI peptidase | large cell H3 crystal form | 5TXW |
| PC | C56.002 | DJ-1 putative peptidase | 1J42 | |
| PC | C56.002 | DJ-1 putative peptidase | 1P5F | |
| PC | C56.002 | DJ-1 putative peptidase | 1PDV | |
| PC | C56.002 | DJ-1 putative peptidase | 1PDW | |
| PC | C56.002 | DJ-1 putative peptidase | 1PE0 | |
| PC | C56.002 | DJ-1 putative peptidase | 1Q2U | |
| PC | C56.002 | DJ-1 putative peptidase | 1SOA | |
| PC | C56.002 | DJ-1 putative peptidase | 1UCF | |
| PC | C56.002 | DJ-1 putative peptidase | 2OR3 | |
| PC | C56.002 | DJ-1 putative peptidase | 2R1T | |
| PC | C56.002 | DJ-1 putative peptidase | 2R1U | |
| PC | C56.002 | DJ-1 putative peptidase | 2R1V | |
| PC | C56.002 | DJ-1 putative peptidase | 2RK3 | |
| PC | C56.002 | DJ-1 putative peptidase | 2RK4 | |
| PC | C56.002 | DJ-1 putative peptidase | 2RK6 | |
| PC | C56.002 | DJ-1 putative peptidase | 3B36 | |
| PC | C56.002 | DJ-1 putative peptidase | 3B38 | |
| PC | C56.002 | DJ-1 putative peptidase | structure of e163k/r145e dj-1 | 3B3A_A |
| PC | C56.002 | DJ-1 putative peptidase | 3BWE | |
| PC | C56.002 | DJ-1 putative peptidase | 3CY6 | |
| PC | C56.002 | DJ-1 putative peptidase | 3CYF | |
| PC | C56.002 | DJ-1 putative peptidase | 3CZ9 | |
| PC | C56.002 | DJ-1 putative peptidase | 3CZA | |
| PC | C56.002 | DJ-1 putative peptidase | 3EZG | |
| PC | C56.002 | DJ-1 putative peptidase | 3F71 | |
| PC | C56.002 | DJ-1 putative peptidase | 3SF8 | |
| PC | C56.002 | DJ-1 putative peptidase | 4BTE | |
| PC | C56.002 | DJ-1 putative peptidase | 4MNT | |
| PC | C56.002 | DJ-1 putative peptidase | 4MTC | |
| PC | C56.002 | DJ-1 putative peptidase | 4N0M | |
| PC | C56.002 | DJ-1 putative peptidase | 4N12 | |
| PC | C56.002 | DJ-1 putative peptidase | 4OGF | |
| PC | C56.002 | DJ-1 putative peptidase | 4OQ4 | |
| PC | C56.002 | DJ-1 putative peptidase | 4P2G | |
| PC | C56.002 | DJ-1 putative peptidase | 4P34 | |
| PC | C56.002 | DJ-1 putative peptidase | 4P35 | |
| PC | C56.002 | DJ-1 putative peptidase | 4P36 | |
| PC | C56.002 | DJ-1 putative peptidase | 4RKW | |
| PC | C56.002 | DJ-1 putative peptidase | 4RKY | |
| PC | C56.002 | DJ-1 putative peptidase | 4S0Z | |
| PC | C56.002 | DJ-1 putative peptidase | 4ZGG | |
| PC | C56.002 | DJ-1 putative peptidase | complex with na-k-tartrate | 5IP5_A |
| PC | C56.002 | DJ-1 putative peptidase | DTT bound | 5SY6_A |
| PC | C56.002 | DJ-1 putative peptidase | Glu15Gln mutant | 5SY9_A |
| PC | C56.002 | DJ-1 putative peptidase | Asp24Asn mutant | 5SYA_A |
| PC | C56.002 | DJ-1 putative peptidase | dj-1 after backsoaking | 6AF5_A |
| PC | C56.002 | DJ-1 putative peptidase | dj-1 c106s unbound | 6AF7_A |
| PC | C56.002 | DJ-1 putative peptidase | dj-1 with isatin bound (high concentration) | 6AF9_A |
| PC | C56.002 | DJ-1 putative peptidase | dj-1 with isatin (low concentration) | 6AFA_A |
| PC | C56.002 | DJ-1 putative peptidase | dj-1 c106s incubated with isatin | 6AFB_A |
| PC | C56.002 | DJ-1 putative peptidase | dj-1 with compound 4 | 6AFC_A |
| PC | C56.002 | DJ-1 putative peptidase | dj-1 with compound 6 | 6AFD_A |
| PC | C56.002 | DJ-1 putative peptidase | dj-1 with compound 7 | 6AFE_A |
| PC | C56.002 | DJ-1 putative peptidase | dj-1 with compound 8 | 6AFF_A |
| PC | C56.002 | DJ-1 putative peptidase | dj-1 with compound 9 | 6AFG_A |
| PC | C56.002 | DJ-1 putative peptidase | dj-1 with compound 10 | 6AFH_A |
| PC | C56.002 | DJ-1 putative peptidase | dj-1 with compound 11 | 6AFI_A |
| PC | C56.002 | DJ-1 putative peptidase | dj-1 with compound 13 | 6AFJ_A |
| PC | C56.002 | DJ-1 putative peptidase | dj-1 with compound 15 | 6AFL_A |
| PC | C56.002 | DJ-1 putative peptidase | natural modification on Cys106 | 6E5Z_A |
| PC | C56.002 | DJ-1 putative peptidase | without a modification on Cys106 | 6M8Z_A |
| PC | C56.002 | DJ-1 putative peptidase | 4E08_A | |
| PC | C56.004 | YDR533C putative peptidase | 1QVV | |
| PC | C56.004 | YDR533C putative peptidase | 1QVW | |
| PC | C56.004 | YDR533C putative peptidase | 1QVZ | |
| PC | C56.004 | YDR533C putative peptidase | 1RW7_A | |
| PC | C56.004 | YDR533C putative peptidase | 4QYX | |
| PC | C56.006 | Hsp31 peptidase | sav0551 | 5XR2_A |
| PC | C56.006 | Hsp31 peptidase | sav0551 with glyoxylate | 5XR3_A |
| PC | C56.006 | Hsp31 peptidase | 1IZY_A | |
| PC | C56.006 | Hsp31 peptidase | 1IZZ_A | |
| PC | C56.006 | Hsp31 peptidase | 1N57_A | |
| PC | C56.006 | Hsp31 peptidase | 1ONS_A | |
| PC | C56.006 | Hsp31 peptidase | native form 2 e.coli chaperone hsp31 | 1PV2_A |
| PC | C56.975 | ES1 protein homolog, mitochondrial | 5LIR_A | |
| PC | C56.975 | ES1 protein homolog, mitochondrial | 1OY1 | |
| PC | C56.975 | ES1 protein homolog, mitochondrial | 1VHQ | |
| PC | C56.976 | protein deglycase 2 | 1OI4_A | |
| PC | C56.A01 | At3g02720 (Arabidopsis thaliana) | 3UK7 | |
| PC | C56.A01 | At3g02720 (Arabidopsis thaliana) | 4OFW | |
| PC | C56.A01 | At3g02720 (Arabidopsis thaliana) | 4OGG | |
| PC | C56.A03 | chromosome XV reading frame ORF yor391c (Saccharomyces cerevisiae) | 3KKL | |
| PC | C56.A03 | chromosome XV reading frame ORF yor391c (Saccharomyces cerevisiae) | 3MII | |
| PC | C56.A04 | protein SNO4 (Saccharomyces cerevisiae) | 3N7T_A | |
| PC | C56.UNW | family C56 non-peptidase homologues | 2AB0_A | |
| PC | C56.UNW | family C56 non-peptidase homologues | 2VRN | |
| PC | C56.UNW | family C56 non-peptidase homologues | 3OT1_A | |
| PC | C56.UNW | family C56 non-peptidase homologues | crystal structure of c103a mutant of dj-1 superfamily protein stm1931 from salmonella typhimurium | 4K2H_A |
| PC | C56.UNW | family C56 non-peptidase homologues | 3NON_A | |
| PC | C56.UNW | family C56 non-peptidase homologues | 3NOO_A | |
| PC | C56.UNW | family C56 non-peptidase homologues | 3NOQ_A | |
| PC | C56.UNW | family C56 non-peptidase homologues | 3NOR_A | |
| PC | C56.UNW | family C56 non-peptidase homologues | 3NOV_A | |
| PC | C56.UNW | family C56 non-peptidase homologues | 3EWN_A | |
| PC | C56.UNW | family C56 non-peptidase homologues | 3EFE_A | |
| PC | C56.UNW | family C56 non-peptidase homologues | 4GE0 | |
| PC | C56.UNW | family C56 non-peptidase homologues | 4GE3 | |
| PC | C56.UNW | family C56 non-peptidase homologues | 4QYT | |
| PC | C56.UNW | family C56 non-peptidase homologues | 4LRU_A | |
| PC | C56.UNW | family C56 non-peptidase homologues | 4HCJ_A | |
| PC | C56.UNW | family C56 non-peptidase homologues | 4P5P_A | |
| CA | C58.002 | AvrPphB peptidase | 1UKF_A | |
| CA | C58.UPA | subfamily C58A unassigned peptidases | 3N3U | |
| CA | C58.UPA | subfamily C58A unassigned peptidases | 4ITR | |
| PB | C59.001 | penicillin V acylase precursor | 2OQC_A | |
| PB | C59.001 | penicillin V acylase precursor | precursor mutant cys1ser of penicillin v acylase from bacillus sphaericus | 2IWM_A |
| PB | C59.001 | penicillin V acylase precursor | 2PVA_A | |
| PB | C59.001 | penicillin V acylase precursor | truncated mutant asn175ala of penicillin v acylase from bacillus sphaericus | 2QUY_A |
| PB | C59.001 | penicillin V acylase precursor | structure of truncated mutant cys1gly of penicillin v acylase from bacillus sphaericus co-crystallized with penicillin v | 2Z71_A |
| PB | C59.001 | penicillin V acylase precursor | 3MJI | |
| PB | C59.001 | penicillin V acylase precursor | 3PVA_A | |
| PB | C59.951 | choloylglycine hydrolase | 2BJF_A | |
| PB | C59.951 | choloylglycine hydrolase | complex with reaction products taurine and deoxycholate | 2BJG_A |
| PB | C59.951 | choloylglycine hydrolase | mutant | 2RF8_A |
| PB | C59.951 | choloylglycine hydrolase | Arg18Ile variant | 2RG2_A |
| PB | C59.951 | choloylglycine hydrolase | complex with reaction products glycine and cholate | 2RLC_A |
| PB | C59.951 | choloylglycine hydrolase | 4WL3_A | |
| PB | C59.951 | choloylglycine hydrolase | crystal structure determination of cys2ala mutant of bile salt hydrolase from enterococcus feacalis | 5GS7_A |
| PB | C59.951 | choloylglycine hydrolase | 2HEZ_A | |
| PB | C59.951 | choloylglycine hydrolase | 2HF0_A | |
| PB | C59.951 | choloylglycine hydrolase | 5HKE_A | |
| PB | C59.951 | choloylglycine hydrolase | complex with glycocholic acid and cholic acid | 5Y7P_A |
| PB | C59.UPW | family C59 unassigned peptidases | 3HBC_A | |
| PB | C59.UPW | family C59 unassigned peptidases | 4WL2_A | |
| CL | C60.001 | sortase A (Staphylococcus-type) | NMR structure; catalytic domain | 1IJA |
| CL | C60.001 | sortase A (Staphylococcus-type) | Cys184Ala mutant | 1T2O_A |
| CL | C60.001 | sortase A (Staphylococcus-type) | 1T2P_A | |
| CL | C60.001 | sortase A (Staphylococcus-type) | complex with Leu-Pro-Glu-Thr-Gly peptide | 1T2W_A |
| CL | C60.001 | sortase A (Staphylococcus-type) | NMR structure; complex with substrate | 2KID |
| CL | C60.002 | sortase B | 1NG5_A | |
| CL | C60.002 | sortase B | complex with MTSET | 1QWZ |
| CL | C60.002 | sortase B | complex with E-64 | 1QX6 |
| CL | C60.002 | sortase B | complex with Gly-Gly-Gly | 1QXA |
| CL | C60.002 | sortase B | 1RZ2 | |
| CL | C60.002 | sortase B | complex with AAEK1 | 2OQW_A |
| CL | C60.002 | sortase B | complex with AAEK2 | 2OQZ_A |
| CL | C60.002 | sortase B | sortase b from listeria monocytogenes. | 5JCV_A |
| CL | C60.002 | sortase B | 5B23_A | |
| CL | C60.002 | sortase B | Cys232Ser mutant | 5YFK_A |
| CL | C60.002 | sortase B | 4UX7 | |
| CL | C60.002 | sortase B | 5GYJ_A | |
| CL | C60.003 | sortase C2 | 3PSQ_A | |
| CL | C60.006 | sortase A (Streptococcus-type) | 3RCC_A | |
| CL | C60.006 | sortase A (Streptococcus-type) | 3FN5_A | |
| CL | C60.006 | sortase A (Streptococcus-type) | active site cys in its sulphenic acid form | 3FN6_A |
| CL | C60.006 | sortase A (Streptococcus-type) | 3FN7_A | |
| CL | C60.006 | sortase A (Streptococcus-type) | molecular basis of streptococcus mutans sortase a inhibition by chalcone. | 4TQX_A |
| CL | C60.006 | sortase A (Streptococcus-type) | 4O8L_A | |
| CL | C60.006 | sortase A (Streptococcus-type) | structure of sortase a c207a mutant from streptococcus pneumoniae | 4O8T_A |
| CL | C60.007 | sortase C1 (Streptococcus sp.) | the crystal structure of streptococcus pneumoniae sortase c provides novel insights into catalysis as well as pilin substrate specificity | 3G66_A |
| CL | C60.007 | sortase C1 (Streptococcus sp.) | the crystal structure of streptococcus pneumoniae sortase c provides novel insights into catalysis as well as pilin substrate specificity | 3G69_A |
| CL | C60.007 | sortase C1 (Streptococcus sp.) | 3RBI_A | |
| CL | C60.007 | sortase C1 (Streptococcus sp.) | lid-mutant | 3RBJ_A |
| CL | C60.007 | sortase C1 (Streptococcus sp.) | the type ii crystal structure of streptococcus agalactiae sortase c1 | 3RBK_A |
| CL | C60.007 | sortase C1 (Streptococcus sp.) | the type i crystal structure of streptococcus agalactiae sortase c1 | 3TB7_A |
| CL | C60.007 | sortase C1 (Streptococcus sp.) | complex with mtset | 3TBE_A |
| CL | C60.007 | sortase C1 (Streptococcus sp.) | sortase c1 of gbs pilus island 1 | 4G1J_A |
| CL | C60.007 | sortase C1 (Streptococcus sp.) | 2W1J_A | |
| CL | C60.007 | sortase C1 (Streptococcus sp.) | srtf sortase from corynebacterium diphtheriae | 5UUS_A |
| CL | C60.007 | sortase C1 (Streptococcus sp.) | sortase a from corynebacterium diphtheriae | 5K9A_A |
| CL | C60.007 | sortase C1 (Streptococcus sp.) | sortase a from corynebacterium diphtheriae, lid mutant | 6BWE_A |
| CL | C60.UPA | subfamily C60A unassigned peptidases | group b streptococcus pilus island 1 sortase c2 | 4G1H_A |
| CL | C60.UPA | subfamily C60A unassigned peptidases | 2W1K_A | |
| CL | C60.UPA | subfamily C60A unassigned peptidases | 3RE9_A | |
| CL | C60.UPA | subfamily C60A unassigned peptidases | 5GO5_A | |
| CL | C60.UPA | subfamily C60A unassigned peptidases | structure of sortase e t196v mutant from streptomyces avermitilis | 5GO6_A |
| CL | C60.UPA | subfamily C60A unassigned peptidases | complex with tripeptide in the active site | 5CUW_A |
| CL | C60.UPA | subfamily C60A unassigned peptidases | 2XWG_A | |
| CA | C64.001 | Cezanne peptidase | otu domain | 5LRU_A |
| CA | C64.001 | Cezanne peptidase | structure of cezanne/otud7b otu domain bound to lys11-linked diubiquitin | 5LRV_A |
| CA | C64.001 | Cezanne peptidase | otu domain; complex with ubiquitin | 5LRW_A |
| CA | C64.002 | Cezanne-2 peptidase | 2L2D | |
| CA | C64.003 | A20 peptidase | 2EQE | |
| CA | C64.003 | A20 peptidase | 2EQF | |
| CA | C64.003 | A20 peptidase | 2EQG | |
| CA | C64.003 | A20 peptidase | OTU domain only | 2VFJ |
| CA | C64.003 | A20 peptidase | 3DKB_A | |
| CA | C64.003 | A20 peptidase | 3OJ3 | |
| CA | C64.003 | A20 peptidase | 3OJ4 | |
| CA | C64.003 | A20 peptidase | 3VUW | |
| CA | C64.003 | A20 peptidase | 3VUX | |
| CA | C64.003 | A20 peptidase | 3VUY | |
| CA | C64.003 | A20 peptidase | 3ZJD | |
| CA | C64.003 | A20 peptidase | 3ZJE | |
| CA | C64.003 | A20 peptidase | 3ZJF | |
| CA | C64.003 | A20 peptidase | 3ZJG | |
| CA | C64.003 | A20 peptidase | otu domain; complex with ubiquitin | 5LRX_A |
| CA | C64.003 | A20 peptidase | human a20 otu domain (wt) with acetamidylated c103 | 5V3B_A |
| CA | C64.003 | A20 peptidase | human a20 otu domain (i325n) with acetamidylated c103 | 5V3P_A |
| CA | C64.004 | trabid peptidase | 3ZRH | |
| CA | C64.004 | trabid peptidase | 5AF6 | |
| CA | C64.004 | trabid peptidase | 4S1Z | |
| CA | C64.UPW | family C64 unassigned peptidases | 5DQ6 | |
| CA | C65.001 | otubain-1 | 2ZFY | |
| CA | C65.001 | otubain-1 | 3VON | |
| CA | C65.001 | otubain-1 | 4DDG | |
| CA | C65.001 | otubain-1 | 4DDI | |
| CA | C65.001 | otubain-1 | 4DHZ_A | |
| CA | C65.001 | otubain-1 | 4I6L | |
| CA | C65.001 | otubain-1 | 4LDT_A | |
| CA | C65.002 | otubain-2 | 1TFF | |
| CA | C65.002 | otubain-2 | 4FJV | |
| CA | C65.A01 | otub-1 g.p. (Caenorhabditis elegans) | 4DHI | |
| CA | C65.A01 | otub-1 g.p. (Caenorhabditis elegans) | 4DHJ | |
| CA | C65.A01 | otub-1 g.p. (Caenorhabditis elegans) | 4DHZ_A | |
| CA | C65.A01 | otub-1 g.p. (Caenorhabditis elegans) | 4LDT_A | |
| CA | C66.001 | IdeS peptidase | 1Y08 | |
| CA | C66.001 | IdeS peptidase | orthorhombic form | 2AU1 |
| CA | C66.001 | IdeS peptidase | 2AVW | |
| CA | C67.001 | CylD peptidase | 1IXD | |
| CA | C67.001 | CylD peptidase | 1WHL | |
| CA | C67.001 | CylD peptidase | 1WHM | |
| CA | C67.001 | CylD peptidase | USP domain only | 2VHF |
| CA | C67.UPW | family C67 unassigned peptidases | Cys596Ser mutant complex with Met1-linked diubiquitin | 3WXE |
| CA | C67.UPW | family C67 unassigned peptidases | Cys596Ser, Glu674Gln mutant complex with Met1-linked diubiquitin | 3WXF |
| CA | C67.UPW | family C67 unassigned peptidases | Cys596Ala mutant complex with Lys63-linked diubiquitin | 3WXG |
| PA | C74.001 | pestivirus NS2 peptidase | 1S48 | |
| PA | C74.001 | pestivirus NS2 peptidase | 1S49 | |
| PA | C74.001 | pestivirus NS2 peptidase | 1S4F | |
| PA | C74.001 | pestivirus NS2 peptidase | 4ILD | |
| PA | C74.001 | pestivirus NS2 peptidase | 4JNT | |
| PA | C74.UPW | family C74 unassigned peptidases | 4CBG | |
| PA | C74.UPW | family C74 unassigned peptidases | 4CBH | |
| PA | C74.UPW | family C74 unassigned peptidases | 4CBI | |
| PA | C74.UPW | family C74 unassigned peptidases | 4CBL | |
| PA | C74.UPW | family C74 unassigned peptidases | 4CBM | |
| PA | C74.UPW | family C74 unassigned peptidases | crystal structure of full-lengh csfv ns3/4a | 5MZ4_A |
| CA | C76.001 | viral tegument protein deubiquitinylating peptidase | 4TT0 | |
| CA | C76.001 | viral tegument protein deubiquitinylating peptidase | 4TT1 | |
| CA | C76.001 | viral tegument protein deubiquitinylating peptidase | complex with ubiquitin | 27JQ |
| CA | C78.001 | UfSP1 peptidase | 2Z84 | |
| CA | C78.002 | UfSP2 peptidase | 3OQC | |
| CA | C78.A03 | F38A5.1 protein (Caenorhabditis elegans) | 5EJJ_A | |
| CA | C78.A03 | F38A5.1 protein (Caenorhabditis elegans) | structural basis for ufm1 recognition by ufsp | 5XDA_A |
| CE | C79.UPW | family C79 unassigned peptidases | 5HAF_A | |
| CE | C79.UPW | family C79 unassigned peptidases | catalytic domain | 5UBW_A |
| CD | C80.001 | RTX self-cleaving toxin | peptidase domain only | 3EEB |
| CD | C80.001 | RTX self-cleaving toxin | pre-cleavage form of peptidase domain | 3FZY |
| CD | C80.001 | RTX self-cleaving toxin | peptidase domain only; complex with Aza-leucine inhibitor | 3GCD |
| CD | C80.003 | self-cleaving toxin B (Clostridium-type) | catalytic domain only | 2BVL |
| CD | C80.003 | self-cleaving toxin B (Clostridium-type) | 2BVM | |
| CD | C80.003 | self-cleaving toxin B (Clostridium-type) | protease domain; complex with a peptide inhibitor | 3PA8_A |
| CD | C80.003 | self-cleaving toxin B (Clostridium-type) | 3PEE | |
| CL | C82.001 | L,D-transpeptidase (Enterococcus-type) | 1ZAT | |
| CL | C82.001 | L,D-transpeptidase (Enterococcus-type) | Cys442Ser mutant | 2HKL_A |
| CL | C82.003 | ykuD transpeptidase | 1Y7M | |
| CL | C82.003 | ykuD transpeptidase | 2MTZ | |
| CL | C82.003 | ykuD transpeptidase | 3ZQD | |
| CL | C82.003 | ykuD transpeptidase | 4A1I | |
| CL | C82.003 | ykuD transpeptidase | 4A1J | |
| CL | C82.003 | ykuD transpeptidase | 4A1K | |
| CL | C82.003 | ykuD transpeptidase | 4A52 | |
| CL | C82.UPA | subfamily C82A unassigned peptidases | complex with faropenem adduct | 5E51_A |
| CL | C82.UPA | subfamily C82A unassigned peptidases | 5E5L_A | |
| CL | C82.UPA | subfamily C82A unassigned peptidases | 3TUR | |
| CL | C82.UPA | subfamily C82A unassigned peptidases | 3TX4 | |
| CL | C82.UPA | subfamily C82A unassigned peptidases | 3U1P | |
| CL | C82.UPA | subfamily C82A unassigned peptidases | 3U1Q | |
| CL | C82.UPA | subfamily C82A unassigned peptidases | 3VAE | |
| CL | C82.UPA | subfamily C82A unassigned peptidases | n55 truncation mutant (residues 55-408) | 3VYN_A |
| CL | C82.UPA | subfamily C82A unassigned peptidases | n140 truncation mutant (residues 140-408) | 3VYO_A |
| CL | C82.UPA | subfamily C82A unassigned peptidases | ldtmt2-n140 adduct with meropenem | 3VYP_A |
| CL | C82.UPA | subfamily C82A unassigned peptidases | structural basis for the inhibition of mycobacterium tuberculosis l,d-transpeptidase by meropenem, a drug effective against extensively drug-resistant strains | 4GSQ_A |
| CL | C82.UPA | subfamily C82A unassigned peptidases | structural basis for the inhibition of mycobacterium tuberculosis l,d-transpeptidase by meropenem, a drug effective against extensively drug-resistant strains | 4GSR_A |
| CL | C82.UPA | subfamily C82A unassigned peptidases | structural basis for the inhibition of mycobacterium tuberculosis l,d-transpeptidase by meropenem, a drug effective against extensively drug-resistant strains | 4GSU_A |
| CL | C82.UPA | subfamily C82A unassigned peptidases | crystal structure of ldtmt2, a l,d-transpeptidase from mycobacterium tuberculosis: domain b and c | 4HUC_A |
| CL | C82.UPA | subfamily C82A unassigned peptidases | 5D7H_A | |
| CL | C82.UPA | subfamily C82A unassigned peptidases | x-ray crystal structure of a enzymatically degraded biapenem-adduct ofl,d-transpeptidase 2 from mycobacterium tuberculosis | 5DC2_A |
| CL | C82.UPA | subfamily C82A unassigned peptidases | x-ray crystal structure of a tebipenem adduct of l,d transpeptidase 2 from mycobacterium tuberculosis | 5DCC_A |
| CL | C82.UPA | subfamily C82A unassigned peptidases | crystal structure of ldtmt2 at 1.79 angstrom resolution | 5DU7_A |
| CL | C82.UPA | subfamily C82A unassigned peptidases | complex with faropenem adduct | 5DUJ_A |
| CL | C82.UPA | subfamily C82A unassigned peptidases | bc-module with faropenem-derived adduct at the active site cysteine-354 | 5LBG_A |
| CL | C82.UPA | subfamily C82A unassigned peptidases | 5UWV_B | |
| CL | C82.UPA | subfamily C82A unassigned peptidases | crystal structure of l,d-transpeptidase (yku) from stackebrandtia nassauensis | 5BMQ_A |
| CL | C82.UPA | subfamily C82A unassigned peptidases | l,d-transpeptidase from mycobacterium smegmatis | 4XVO_A |
| CL | C82.UPA | subfamily C82A unassigned peptidases | 4K73_A | |
| CL | C82.UPA | subfamily C82A unassigned peptidases | crystal structure of l,d-transpeptidase 3 from mycobacterium tuberculosis at 1.32 a resolution | 6D4K_A |
| CL | C82.UPA | subfamily C82A unassigned peptidases | complex with a faropenem-derived adduct | 6D51_A |
| CL | C82.UPB | subfamily C82B unassigned peptidases | l,d-transpeptidase from klebsiella pneumoniae | 4LZH_A |
| CA | C83.001 | gamma-glutamylcysteine dipeptidyltranspeptidase | 2BTW | |
| CA | C83.001 | gamma-glutamylcysteine dipeptidyltranspeptidase | complex with glutathione | 2BU3 |
| CA | C85.001 | OTUD5 peptidase (Homo sapiens) | catalytic domain only | 3PFY |
| CA | C85.001 | OTUD5 peptidase (Homo sapiens) | catalytic domain only | 3TMO |
| CA | C85.001 | OTUD5 peptidase (Homo sapiens) | catalytic domain only; complex with ubiquitin aldehyde | 3TMP |
| CA | C85.003 | OTUD3 peptidase (Homo sapiens) | 4BOU | |
| CA | C85.004 | OTUD1 peptidase (Homo sapiens) | 4BOP | |
| CA | C85.006 | OTU1 peptidase (Saccharomyces cerevisiae-type) | ovarian tumor (otu) domain; complex with ubiquitin | 3BY4_A |
| CA | C85.006 | OTU1 peptidase (Saccharomyces cerevisiae-type) | complex with ubiquitin | 3C0R |
| CA | C85.006 | OTU1 peptidase (Saccharomyces cerevisiae-type) | 4KDI | |
| CA | C85.006 | OTU1 peptidase (Saccharomyces cerevisiae-type) | 4KDL | |
| CA | C85.007 | YOD1 peptidase | 4BOQ | |
| CA | C85.007 | YOD1 peptidase | 4BOS | |
| CA | C85.007 | YOD1 peptidase | 4BOZ | |
| CA | C85.007 | YOD1 peptidase | 2KZR | |
| CA | C86.001 | ataxin-3 | NMR structure: Josephin domain only | 1YZB |
| CA | C86.001 | ataxin-3 | NMR structure: Josephin domain only | 2AGA |
| CA | C86.001 | ataxin-3 | NMR structure: Josephin domain only | 2DOS |
| CA | C86.002 | ataxin-3-like peptidase | complex with ubiquitin | 3O65_A |
| CA | C87.001 | nairovirus deubiquitinylating peptidase | 4HXD | |
| CA | C87.001 | nairovirus deubiquitinylating peptidase | 3PHU | |
| CA | C87.001 | nairovirus deubiquitinylating peptidase | 3PHW | |
| CA | C87.001 | nairovirus deubiquitinylating peptidase | 3PHX | |
| CA | C87.001 | nairovirus deubiquitinylating peptidase | structural analysis of a viral otu domain protease from the crimean- congo hemorrhagic fever virus in complex with human ubiquitin | 3PRM_A |
| CA | C87.001 | nairovirus deubiquitinylating peptidase | structural analysis of a viral otu domain protease from the crimean- congo hemorrhagic fever virus in complex with human ubiquitin | 3PRP_A |
| CA | C87.001 | nairovirus deubiquitinylating peptidase | complex with interferon-stimulated gene 15 protein | 3PSE_A |
| CA | C87.001 | nairovirus deubiquitinylating peptidase | complex with ubiquitin | 3PT2_A |
| CA | C87.001 | nairovirus deubiquitinylating peptidase | 3ZNH | |
| CA | C87.001 | nairovirus deubiquitinylating peptidase | otu protease of crimean congo hemorrhagic fever virus bound to ubiquitin variant cc.4 | 5V5G_A |
| CA | C87.001 | nairovirus deubiquitinylating peptidase | otu protease of crimean congo hemorrhagic fever virus bound to ubiquitin variant cc.2 | 5V5H_A |
| CA | C87.001 | nairovirus deubiquitinylating peptidase | otu protease of crimean congo hemorrhagic fever virus bound to ubiquitin variant cc.1 | 5V5I_A |
| CA | C87.001 | nairovirus deubiquitinylating peptidase | erve virus viral otu domain protease in complex with mouse isg15 | 5JZE_A |
| PB | C89.001 | acid ceramidase precursor | self-activated | 5U7Z_A |
| PB | C89.001 | acid ceramidase precursor | complex with carmofur | 6MHM_A |
| PB | C89.002 | N-acylethanolamine acid amidase precursor | murine n-acylethanolamine-hydrolyzing acid amidase (naaa) | 6DXY_A |
| PB | C89.002 | N-acylethanolamine acid amidase precursor | precursor; Cys126Ala mutant | 6DXW_A |
| PB | C89.002 | N-acylethanolamine acid amidase precursor | complex with non-covalent benzothiazole-piperazine inhibitor arn19702, in presence of triton x-100 | 6DXX_A |
| PB | C89.002 | N-acylethanolamine acid amidase precursor | caenorhabditis elegans n-acylethanolamine-hydrolyzing acid amidase (naaa) ortholog | 6DY3_A |
| CA | C93.001 | LapG peptidase (Pseudomonas fluorescens) | complex with periplasmic output domain of the legionella pneumophila lapd ortholog cdgs9 | 4U65_E |
| CA | C93.UPW | family C93 unassigned peptidases | calcium-bound form | 4FGO |
| CA | C93.UPW | family C93 unassigned peptidases | EGTA-treated form | 4FGP |
| CA | C93.UPW | family C93 unassigned peptidases | 4FGQ | |
| PB | C95.001 | lysosomal 66.3 kDa protein (Mus musculus-type) | 3FBX | |
| PB | C95.001 | lysosomal 66.3 kDa protein (Mus musculus-type) | 3FGR | |
| PB | C95.001 | lysosomal 66.3 kDa protein (Mus musculus-type) | 3FGT | |
| PB | C95.001 | lysosomal 66.3 kDa protein (Mus musculus-type) | 3FGW | |
| PB | C95.002 | phospholipase B-like protein 1 | 4BWC | |
| CP | C97.001 | desumoylating isopeptidase 1 | 3EBQ | |
| CP | C97.001 | desumoylating isopeptidase 1 | 2WP7 | |
| GA | G01.001 | scytalidoglutamic peptidase | 1S2B | |
| GA | G01.001 | scytalidoglutamic peptidase | complex with Ala-Ile-His | 1S2K |
| GA | G01.001 | scytalidoglutamic peptidase | complex with a transition state inhibitor (Ac-Phe-Lys-Phe-aminophenylpropanol-Ala-Leu-Arg-NH2) | 2IFR |
| GA | G01.001 | scytalidoglutamic peptidase | complex with a transition state inhibitor (Ac-Phe-Lys-Phe-Phe-Leu-Arg-NH2) | 2IFW |
| GA | G01.002 | aspergilloglutamic peptidase | 1Y43_A | |
| GA | G01.002 | aspergilloglutamic peptidase | 3TRS | |
| GB | G02.001 | pre-neck appendage protein (Bacillus phage phi29) | 3GQ7 | |
| GB | G02.001 | pre-neck appendage protein (Bacillus phage phi29) | 3GQ8 | |
| GB | G02.001 | pre-neck appendage protein (Bacillus phage phi29) | 3GQ9 | |
| GB | G02.001 | pre-neck appendage protein (Bacillus phage phi29) | 3GQA | |
| GB | G02.001 | pre-neck appendage protein (Bacillus phage phi29) | 3GQH | |
| GB | G02.001 | pre-neck appendage protein (Bacillus phage phi29) | 3GQK | |
| GB | G02.001 | pre-neck appendage protein (Bacillus phage phi29) | 3GQN | |
| GB | G02.001 | pre-neck appendage protein (Bacillus phage phi29) | 3SUC | |
| G- | G05.004 | microcystinase MlrA | 4CAD | |
| GC | G06.001 | Ras/Rap1-specific peptidase | Glu3930Leu/His4030Leu mutant | 6A7H |
| GC | G06.001 | Ras/Rap1-specific peptidase | 6A8J | |
| I- | I102.001 | roseltide T1 (Hibiscus sabdariffa) | NMR structure | 5GSF |
| I- | I103.UPW | family I103 unassigned peptidase inhibitors | crystal structure of free ubiquitin-specific protease 12 | 5K16_A |
| I- | I103.UPW | family I103 unassigned peptidase inhibitors | complex with uaf1 in c2 space group | 5K1A_A |
| I- | I103.UPW | family I103 unassigned peptidase inhibitors | complex with uaf1 in f222 space group | 5K1B_A |
| I- | I103.UPW | family I103 unassigned peptidase inhibitors | complex with uaf1 and wdr20 | 5K1C_A |
| I- | I103.UPW | family I103 unassigned peptidase inhibitors | structure of usp12-ub-prg/uaf1 | 5L8W_A |
| I- | I103.UPW | family I103 unassigned peptidase inhibitors | complex with an isoform-selective inhibitor, ml349 | 5SYN_A |
| I- | I103.UPW | family I103 unassigned peptidase inhibitors | crystal structure of lysophospholipase a2 conjugated with phenylmethylsulfonyl fluoride | 6BJE_A |
| I- | I103.UPW | family I103 unassigned peptidase inhibitors | 4DLO | |
| I- | I103.UPW | family I103 unassigned peptidase inhibitors | 1PN5 | |
| I- | I103.UPW | family I103 unassigned peptidase inhibitors | 3KAT | |
| I- | I103.UPW | family I103 unassigned peptidase inhibitors | 4IFP | |
| I- | I103.UPW | family I103 unassigned peptidase inhibitors | 4IM6 | |
| I- | I103.UPW | family I103 unassigned peptidase inhibitors | 2P4E | |
| I- | I103.UPW | family I103 unassigned peptidase inhibitors | 2PMW | |
| I- | I103.UPW | family I103 unassigned peptidase inhibitors | 2QTW | |
| I- | I103.UPW | family I103 unassigned peptidase inhibitors | 2W2M | |
| I- | I103.UPW | family I103 unassigned peptidase inhibitors | 2W2N | |
| I- | I103.UPW | family I103 unassigned peptidase inhibitors | 2W2O | |
| I- | I103.UPW | family I103 unassigned peptidase inhibitors | 2W2P | |
| I- | I103.UPW | family I103 unassigned peptidase inhibitors | 2W2Q | |
| I- | I103.UPW | family I103 unassigned peptidase inhibitors | 2XTJ | |
| I- | I103.UPW | family I103 unassigned peptidase inhibitors | 3BPS | |
| I- | I103.UPW | family I103 unassigned peptidase inhibitors | 3GCW | |
| I- | I103.UPW | family I103 unassigned peptidase inhibitors | 3GCX | |
| I- | I103.UPW | family I103 unassigned peptidase inhibitors | 3H42 | |
| I- | I103.UPW | family I103 unassigned peptidase inhibitors | 3M0C | |
| I- | I103.UPW | family I103 unassigned peptidase inhibitors | 3P5B | |
| I- | I103.UPW | family I103 unassigned peptidase inhibitors | 3P5C | |
| I- | I103.UPW | family I103 unassigned peptidase inhibitors | 3SQO | |
| I- | I103.UPW | family I103 unassigned peptidase inhibitors | 4K8R | |
| I- | I103.UPW | family I103 unassigned peptidase inhibitors | 4NE9 | |
| I- | I103.UPW | family I103 unassigned peptidase inhibitors | 4NMX | |
| I- | I103.UPW | family I103 unassigned peptidase inhibitors | 4OV6 | |
| I- | I103.UPW | family I103 unassigned peptidase inhibitors | pcsk9:fab complex with dextran sulfate | 5OCA_A |
| I- | I103.UPW | family I103 unassigned peptidase inhibitors | pcsk9 complex with fab33 | 5VL7_A |
| I- | I103.UPW | family I103 unassigned peptidase inhibitors | pcsk9 complex with ldlr antagonist peptide and fab7g7 | 5VLP_A |
| I- | I103.UPW | family I103 unassigned peptidase inhibitors | complete pcsk9 c-ter domain in complex with vhh p.140 | 6F5G_A |
| I- | I103.UPW | family I103 unassigned peptidase inhibitors | complex with the gm1 glycan | 4ZH1_D |
| I- | I103.UPW | family I103 unassigned peptidase inhibitors | the structure of the tripartite complex between ospe, the c-terminal domains of factor h and c3dg | 5NBQ_D |
| I- | I103.UPW | family I103 unassigned peptidase inhibitors | the structure of complement complex | 5O32_C |
| I- | I103.UPW | family I103 unassigned peptidase inhibitors | structure of complement proteins complex | 5O35_C |
| MA | M01.001 | aminopeptidase N | 4FYQ | |
| MA | M01.001 | aminopeptidase N | 4FYR | |
| MA | M01.001 | aminopeptidase N | 4FYS_A | |
| MA | M01.001 | aminopeptidase N | 4FYT | |
| MA | M01.001 | aminopeptidase N | glycosylated | 5LHD |
| MA | M01.001 | aminopeptidase N | complex with human coronavirus 229e spike protein receptor binding domain | 6ATK_A |
| MA | M01.003 | aminopeptidase A | 4KX7 | |
| MA | M01.003 | aminopeptidase A | complex with amastatin | 4KX8 |
| MA | M01.003 | aminopeptidase A | complex with arginine | 4KX9 |
| MA | M01.003 | aminopeptidase A | complex with aspartate and calcium | 4KXA |
| MA | M01.003 | aminopeptidase A | complex with bestatin | 4KXB |
| MA | M01.003 | aminopeptidase A | complex with glutamate | 4KXC |
| MA | M01.003 | aminopeptidase A | complex with glutamate and calcium | 4KXD |
| MA | M01.004 | leukotriene A4 hydrolase | Asp375Asn mutant | 1GW6 |
| MA | M01.004 | leukotriene A4 hydrolase | Glu271Gln mutant | 1H19 |
| MA | M01.004 | leukotriene A4 hydrolase | complex with bestatin | 1HS6_A |
| MA | M01.004 | leukotriene A4 hydrolase | structure of [r563a] leukotriene a4 hydrolase | 1SQM_A |
| MA | M01.004 | leukotriene A4 hydrolase | leukotriene a4 hydrolase complexed with inhibitor rb3041 | 2R59_A |
| MA | M01.004 | leukotriene A4 hydrolase | 2VJ8 | |
| MA | M01.004 | leukotriene A4 hydrolase | leukotriene a4 hydrolase complexed with inhibitor rb3040 | 3B7R_L |
| MA | M01.004 | leukotriene A4 hydrolase | Glu296Gln mutant; complex with RSR substrate | 3B7S_A |
| MA | M01.004 | leukotriene A4 hydrolase | Glu296Gln mutant; complex with Arg-Ala-Arg substrate | 3B7T_A |
| MA | M01.004 | leukotriene A4 hydrolase | leukotriene a4 hydrolase complexed with kelatorphan | 3B7U_X |
| MA | M01.004 | leukotriene A4 hydrolase | complex with 2-amino-N-[4-(phenylmethoxy)phenyl]-acetamide | 3CHO_A |
| MA | M01.004 | leukotriene A4 hydrolase | complex with (3S)-3-amino-4-oxo-4-[(4-phenylmethoxyphenyl) amino]butanoic acid | 3CHP_A |
| MA | M01.004 | leukotriene A4 hydrolase | complex with N5-[4-(phenylmethoxy)phenyl]-L-glutamine | 3CHQ_A |
| MA | M01.004 | leukotriene A4 hydrolase | complex with 4-amino-N-[4-(phenylmethoxy)phenyl]-butanamide | 3CHR_A |
| MA | M01.004 | leukotriene A4 hydrolase | complex with (2S)-2-amino-5-[[4-[(2S)-2-hydroxy-2-phenyl- ethoxy]phenyl]amino]-5-oxo-pentanoic acid | 3CHS_A |
| MA | M01.004 | leukotriene A4 hydrolase | 3FH5 | |
| MA | M01.004 | leukotriene A4 hydrolase | 3FH7 | |
| MA | M01.004 | leukotriene A4 hydrolase | 3FH8 | |
| MA | M01.004 | leukotriene A4 hydrolase | 3FHE | |
| MA | M01.004 | leukotriene A4 hydrolase | 3FTS | |
| MA | M01.004 | leukotriene A4 hydrolase | 3FTU | |
| MA | M01.004 | leukotriene A4 hydrolase | 3FTV | |
| MA | M01.004 | leukotriene A4 hydrolase | 3FTW | |
| MA | M01.004 | leukotriene A4 hydrolase | 3FTX | |
| MA | M01.004 | leukotriene A4 hydrolase | 3FTY | |
| MA | M01.004 | leukotriene A4 hydrolase | 3FTZ | |
| MA | M01.004 | leukotriene A4 hydrolase | 3FU0 | |
| MA | M01.004 | leukotriene A4 hydrolase | 3FU3 | |
| MA | M01.004 | leukotriene A4 hydrolase | 3FU5 | |
| MA | M01.004 | leukotriene A4 hydrolase | 3FU6 | |
| MA | M01.004 | leukotriene A4 hydrolase | 3FUD | |
| MA | M01.004 | leukotriene A4 hydrolase | 3FUE | |
| MA | M01.004 | leukotriene A4 hydrolase | 3FUF | |
| MA | M01.004 | leukotriene A4 hydrolase | 3FUH | |
| MA | M01.004 | leukotriene A4 hydrolase | 3FUI | |
| MA | M01.004 | leukotriene A4 hydrolase | 3FUJ | |
| MA | M01.004 | leukotriene A4 hydrolase | 3FUK | |
| MA | M01.004 | leukotriene A4 hydrolase | 3FUL | |
| MA | M01.004 | leukotriene A4 hydrolase | 3FUM | |
| MA | M01.004 | leukotriene A4 hydrolase | 3FUN | |
| MA | M01.004 | leukotriene A4 hydrolase | 3U9W | |
| MA | M01.004 | leukotriene A4 hydrolase | 4DPR | |
| MA | M01.004 | leukotriene A4 hydrolase | 4L2L | |
| MA | M01.004 | leukotriene A4 hydrolase | 4MKT | |
| MA | M01.004 | leukotriene A4 hydrolase | 4MS6 | |
| MA | M01.004 | leukotriene A4 hydrolase | 4R7L | |
| MA | M01.004 | leukotriene A4 hydrolase | 4RSY | |
| MA | M01.004 | leukotriene A4 hydrolase | 4RVB | |
| MA | M01.004 | leukotriene A4 hydrolase | 5AEN | |
| MA | M01.004 | leukotriene A4 hydrolase | complex with inhibitor 4az | 5BPP_A |
| MA | M01.004 | leukotriene A4 hydrolase | apo form | 5FWQ_A |
| MA | M01.004 | leukotriene A4 hydrolase | crystal structure of lta4h bound to a selective inhibitor against ltb4generation | 5N3W_A |
| MA | M01.004 | leukotriene A4 hydrolase | lta4h Glu271Ala mutant; complex with lta4 (crystal form I) | 5NI2_A |
| MA | M01.004 | leukotriene A4 hydrolase | lta4h Glu271Ala mutant; complex with lta4 (crystal form II) | 5NI4_A |
| MA | M01.004 | leukotriene A4 hydrolase | Asp375Asn mutant; complex with lta4 | 5NI6_A |
| MA | M01.004 | leukotriene A4 hydrolase | crystal structure of human lta4h mutant d375n in open conformation (crystal form i) | 5NIA_A |
| MA | M01.004 | leukotriene A4 hydrolase | crystal structure of human lta4h mutant d375n in open conformation (crystal form ii) | 5NID_A |
| MA | M01.004 | leukotriene A4 hydrolase | crystal structure of human lta4h mutant r563a in open conformation | 5NIE_A |
| MA | M01.004 | leukotriene A4 hydrolase | lta4 hydrolase (e297q) mutant in complex with pro-gly-pro peptide | 6ENB_A |
| MA | M01.004 | leukotriene A4 hydrolase | lta4 hydrolase in complex with compound11 | 6ENC_A |
| MA | M01.004 | leukotriene A4 hydrolase | lta4 hydrolase in complex with compound15 | 6END_A |
| MA | M01.004 | leukotriene A4 hydrolase | complex with inhibitor bestatin | 4GAA_A |
| MA | M01.005 | alanyl aminopeptidase (bacterial-type) | 2DQ6_A | |
| MA | M01.005 | alanyl aminopeptidase (bacterial-type) | complex with bestatin | 2DQM_A |
| MA | M01.005 | alanyl aminopeptidase (bacterial-type) | structure of aminopeptidase n from e. coli suggests a compartmentalized, gated active site | 2HPO_A |
| MA | M01.005 | alanyl aminopeptidase (bacterial-type) | complex with bestatin | 2HPT_A |
| MA | M01.005 | alanyl aminopeptidase (bacterial-type) | 2ZXG | |
| MA | M01.005 | alanyl aminopeptidase (bacterial-type) | complex with arginine | 3B2P |
| MA | M01.005 | alanyl aminopeptidase (bacterial-type) | complex with lysine | 3B2X |
| MA | M01.005 | alanyl aminopeptidase (bacterial-type) | complex with phenylalanine | 3B34 |
| MA | M01.005 | alanyl aminopeptidase (bacterial-type) | complex with tyrosine | 3B37 |
| MA | M01.005 | alanyl aminopeptidase (bacterial-type) | complex with tryptophan | 3B3B |
| MA | M01.005 | alanyl aminopeptidase (bacterial-type) | 3KED | |
| MA | M01.005 | alanyl aminopeptidase (bacterial-type) | 3PUU | |
| MA | M01.005 | alanyl aminopeptidase (bacterial-type) | 3QJX | |
| MA | M01.005 | alanyl aminopeptidase (bacterial-type) | 4Q4E | |
| MA | M01.005 | alanyl aminopeptidase (bacterial-type) | 4Q4I | |
| MA | M01.005 | alanyl aminopeptidase (bacterial-type) | Met260Ala mutant; complex with l-2,3-diaminopropionic acid | 4XMT_A |
| MA | M01.005 | alanyl aminopeptidase (bacterial-type) | Met260Ala mutant; complex with L-alanine | 4XMU_A |
| MA | M01.005 | alanyl aminopeptidase (bacterial-type) | Met260Ala mutant; complex with l-arginine | 4XMV_A |
| MA | M01.005 | alanyl aminopeptidase (bacterial-type) | Met260Ala mutant; complex with l-aspartic acid | 4XMW_A |
| MA | M01.005 | alanyl aminopeptidase (bacterial-type) | Met260Ala mutant; complex with bestatin | 4XMX_A |
| MA | M01.005 | alanyl aminopeptidase (bacterial-type) | Met260Ala mutant; complex with 2,4-diaminobutyric acid | 4XMZ_A |
| MA | M01.005 | alanyl aminopeptidase (bacterial-type) | Met260Ala mutant; complex with l-glutamate | 4XN1_A |
| MA | M01.005 | alanyl aminopeptidase (bacterial-type) | Met260Ala mutant; complex with l-leucine | 4XN2_A |
| MA | M01.005 | alanyl aminopeptidase (bacterial-type) | Met260Ala mutant; complex with l-methionine | 4XN4_A |
| MA | M01.005 | alanyl aminopeptidase (bacterial-type) | Met260Ala mutant; complex with l-phenylalanine | 4XN5_A |
| MA | M01.005 | alanyl aminopeptidase (bacterial-type) | complex with l-2,3- diaminopropionic acid | 4XN7_A |
| MA | M01.005 | alanyl aminopeptidase (bacterial-type) | complex with l- alanine | 4XN8_A |
| MA | M01.005 | alanyl aminopeptidase (bacterial-type) | complex with beta alanine | 4XN9_A |
| MA | M01.005 | alanyl aminopeptidase (bacterial-type) | complex with l-beta homolysine | 4XNA_A |
| MA | M01.005 | alanyl aminopeptidase (bacterial-type) | complex with l-beta homophenylalanine | 4XNB_A |
| MA | M01.005 | alanyl aminopeptidase (bacterial-type) | complex with l-beta homotryptophan | 4XND_A |
| MA | M01.005 | alanyl aminopeptidase (bacterial-type) | complex with l- leucine | 4XO3_A |
| MA | M01.005 | alanyl aminopeptidase (bacterial-type) | complex with l- methionine | 4XO4_A |
| MA | M01.005 | alanyl aminopeptidase (bacterial-type) | complex with l- glutamate | 4XO5_A |
| MA | M01.005 | alanyl aminopeptidase (bacterial-type) | complex with 7- amino-5,7,8,9-tetrahydrobenzocyclohepten-6-one | 5MFR_A |
| MA | M01.005 | alanyl aminopeptidase (bacterial-type) | complex with 7- amino-4-phenyl-5,7,8,9-tetrahydrobenzocyclohepten-6-one | 5MFS_A |
| MA | M01.005 | alanyl aminopeptidase (bacterial-type) | complex with 7- amino-1-bromo-4-phenyl-5,7,8,9-tetrahydrobenzocyclohepten-6-one | 5MFT_A |
| MA | M01.005 | alanyl aminopeptidase (bacterial-type) | Glu298Ala mutant; complex with puromycin | 5YO1_A |
| MA | M01.005 | alanyl aminopeptidase (bacterial-type) | complex with o-methyl-l-tyrosine | 5YQ1_A |
| MA | M01.005 | alanyl aminopeptidase (bacterial-type) | complex with puromycinaminonucleoside | 5YQ2_A |
| MA | M01.005 | alanyl aminopeptidase (bacterial-type) | complex with puromycin | 5YQB_A |
| MA | M01.005 | alanyl aminopeptidase (bacterial-type) | e. coli aminopeptidase n solved by native sad from a dataset collectedin 60 second with jungfrau detector | 6G8B_A |
| MA | M01.011 | cystinyl aminopeptidase | complex with alanine | 4P8Q |
| MA | M01.011 | cystinyl aminopeptidase | complex with lysine | 4PJ6 |
| MA | M01.011 | cystinyl aminopeptidase | 4Z7I | |
| MA | M01.011 | cystinyl aminopeptidase | 5C97 | |
| MA | M01.011 | cystinyl aminopeptidase | complex with inhibitor DG026 | 5MJ6 |
| MA | M01.018 | endoplasmic reticulum aminopeptidase 1 | soluble domain | 2XDT |
| MA | M01.018 | endoplasmic reticulum aminopeptidase 1 | 2YD0 | |
| MA | M01.018 | endoplasmic reticulum aminopeptidase 1 | complex with bestatin | 3MDJ |
| MA | M01.018 | endoplasmic reticulum aminopeptidase 1 | open state | 3QNF |
| MA | M01.018 | endoplasmic reticulum aminopeptidase 1 | 3RJO | |
| MA | M01.018 | endoplasmic reticulum aminopeptidase 1 | high-resolution crystal structure of erap1 with bound phosphinic transition-state analogue inhibitor | 6Q4R_A |
| MA | M01.021 | tricorn interacting factor F3 | 1Z1W | |
| MA | M01.021 | tricorn interacting factor F3 | 1Z5H | |
| MA | M01.021 | tricorn interacting factor F3 | 3Q7J | |
| MA | M01.024 | ERAP2 aminopeptidase | 3SE6 | |
| MA | M01.024 | ERAP2 aminopeptidase | 4E36 | |
| MA | M01.024 | ERAP2 aminopeptidase | 4JBS | |
| MA | M01.024 | ERAP2 aminopeptidase | 5AB0 | |
| MA | M01.024 | ERAP2 aminopeptidase | 5AB2 | |
| MA | M01.024 | ERAP2 aminopeptidase | 5CU5 | |
| MA | M01.024 | ERAP2 aminopeptidase | complex with a hydroxamic derivative ligand | 5J6S_A |
| MA | M01.024 | ERAP2 aminopeptidase | complex with a diaminobenzoic acid derivative ligand. | 5K1V_A |
| MA | M01.029 | M1 aminopeptidase (Plasmodium spp.) | structure of the m1 alanylaminopeptidase from malaria | 3EBG_A |
| MA | M01.029 | M1 aminopeptidase (Plasmodium spp.) | complex with bestatin | 3EBH_A |
| MA | M01.029 | M1 aminopeptidase (Plasmodium spp.) | complex with the phosphinate dipeptide analog | 3EBI_A |
| MA | M01.029 | M1 aminopeptidase (Plasmodium spp.) | 3Q43 | |
| MA | M01.029 | M1 aminopeptidase (Plasmodium spp.) | 3Q44 | |
| MA | M01.029 | M1 aminopeptidase (Plasmodium spp.) | 3T8V | |
| MA | M01.029 | M1 aminopeptidase (Plasmodium spp.) | 4J3B | |
| MA | M01.029 | M1 aminopeptidase (Plasmodium spp.) | 4K5L | |
| MA | M01.029 | M1 aminopeptidase (Plasmodium spp.) | 4K5M | |
| MA | M01.029 | M1 aminopeptidase (Plasmodium spp.) | 4K5N | |
| MA | M01.029 | M1 aminopeptidase (Plasmodium spp.) | 4K5O | |
| MA | M01.029 | M1 aminopeptidase (Plasmodium spp.) | 4K5P | |
| MA | M01.029 | M1 aminopeptidase (Plasmodium spp.) | 4R5T | |
| MA | M01.029 | M1 aminopeptidase (Plasmodium spp.) | 4R5V | |
| MA | M01.029 | M1 aminopeptidase (Plasmodium spp.) | 4R5X | |
| MA | M01.029 | M1 aminopeptidase (Plasmodium spp.) | 4X2U | |
| MA | M01.029 | M1 aminopeptidase (Plasmodium spp.) | crystal structure of pfa-m1 with virtual ligand inhibitor | 4ZQT_A |
| MA | M01.029 | M1 aminopeptidase (Plasmodium spp.) | complex with hydroxamic acid- based inhibitor 9b | 4ZW3_A |
| MA | M01.029 | M1 aminopeptidase (Plasmodium spp.) | complex with hydroxamic acid- based inhibitor 9f | 4ZW5_A |
| MA | M01.029 | M1 aminopeptidase (Plasmodium spp.) | complex with hydroxamic acid- based inhibitor 9q | 4ZW6_A |
| MA | M01.029 | M1 aminopeptidase (Plasmodium spp.) | complex with hydroxamic acid- based inhibitor 9m | 4ZW7_A |
| MA | M01.029 | M1 aminopeptidase (Plasmodium spp.) | complex with hydroxamic acid- based inhibitor 9r | 4ZW8_A |
| MA | M01.029 | M1 aminopeptidase (Plasmodium spp.) | complex with hydroxamic acid- based inhibitor 10b | 4ZX3_A |
| MA | M01.029 | M1 aminopeptidase (Plasmodium spp.) | complex with hydroxamic acid- based inhibitor 10o | 4ZX4_A |
| MA | M01.029 | M1 aminopeptidase (Plasmodium spp.) | complex with hydroxamic acid- based inhibitor 10q | 4ZX5_A |
| MA | M01.029 | M1 aminopeptidase (Plasmodium spp.) | complex with hydroxamic acid- based inhibitor 10s | 4ZX6_A |
| MA | M01.029 | M1 aminopeptidase (Plasmodium spp.) | complex with (s)-2-((2s,3r)-3-amino-2-hydroxy-4-phenylbutanamido)-n-hydroxy- 4-methylpentanamide | 5XM7_A |
| MA | M01.029 | M1 aminopeptidase (Plasmodium spp.) | complex with (s)-2-((2s,3r)-3-amino-2-hydroxy-4-phenylbutanamido)- n-hydroxy-4-methylpentanamide. ***caveat 5y19 thr a 492 has wrong chirality at atom cb | 5Y19_A |
| MA | M01.029 | M1 aminopeptidase (Plasmodium spp.) | complex with (s)-2-(3-(2,4-difluorobenzyl)ureido)-n-hydroxy-4- methylpentanamide | 5Y1H_A |
| MA | M01.029 | M1 aminopeptidase (Plasmodium spp.) | complex with (s)-2-(3-(2-chlorobenzyl)ureido)-n-hydroxy-4-methylpentanamide | 5Y1K_A |
| MA | M01.029 | M1 aminopeptidase (Plasmodium spp.) | complex with (s)-2-(3-(3-chlorobenzyl)ureido)-n-hydroxy-4-methylpentanamide | 5Y1Q_A |
| MA | M01.029 | M1 aminopeptidase (Plasmodium spp.) | complex with (s)-n-hydroxy-4-methyl-2-(3-( o-tolyl)ureido)pentanamide | 5Y1R_A |
| MA | M01.029 | M1 aminopeptidase (Plasmodium spp.) | complex with (s)-2-(3-(3,4-dimethylbenzyl)ureido)-n-hydroxy-4- methylpentanamide | 5Y1S_A |
| MA | M01.029 | M1 aminopeptidase (Plasmodium spp.) | complex with (s)-2-(3-(2,3-dimethylbenzyl)ureido)-n-hydroxy-4- methylpentanamide | 5Y1T_A |
| MA | M01.029 | M1 aminopeptidase (Plasmodium spp.) | complex with (s)-2-(3-(2,6-diethylphenyl)ureido)- n-hydroxy-4- methylpentanamide | 5Y1V_A |
| MA | M01.029 | M1 aminopeptidase (Plasmodium spp.) | crystal structure of plasmodium falciparum aminopeptidase n with magnesium bound to active site zinc | 5Y1W_A |
| MA | M01.029 | M1 aminopeptidase (Plasmodium spp.) | complex with actinonin | 5Y1X_A |
| MA | M01.029 | M1 aminopeptidase (Plasmodium spp.) | complex with (s)-n-hydroxy-4-methyl-2-(3-(3-methylbenzyl)ureido)pentanamide | 5Y3I_A |
| MA | M01.029 | M1 aminopeptidase (Plasmodium spp.) | complex with inhibitor (6da) and catalytic zinc ion | 6EA1_A |
| MA | M01.029 | M1 aminopeptidase (Plasmodium spp.) | complex with inhibitor (6h) and catalytic zinc ion | 6EA2_A |
| MA | M01.029 | M1 aminopeptidase (Plasmodium spp.) | complex with inhibitor (6i) and catalytic zinc ion | 6EAA_A |
| MA | M01.029 | M1 aminopeptidase (Plasmodium spp.) | complex with inhibitor (6j) and catalytic zinc ion | 6EAB_A |
| MA | M01.029 | M1 aminopeptidase (Plasmodium spp.) | complex with inhibitor (6k) and catalytic zinc ion | 6EE3_A |
| MA | M01.029 | M1 aminopeptidase (Plasmodium spp.) | complex with inhibitor (6m) and catalytic zinc ion | 6EE4_A |
| MA | M01.029 | M1 aminopeptidase (Plasmodium spp.) | complex with inhibitor (6o) and catalytic zinc ion | 6EE6_A |
| MA | M01.029 | M1 aminopeptidase (Plasmodium spp.) | complex with inhibitor (6p) and catalytic zinc ion | 6EED_A |
| MA | M01.031 | cold-active aminopeptidase (Colwellia psychrerythraea)-type peptidase | crystal structure of cold-aminopeptidase from colwellia psychrerythraea ***caveat 3cia incorrect chirality at five calpha leu | 3CIA_A |
| MA | M01.034 | leukotriene A4 hydrolase (Saccharomyces cerevisiae) | P3121 crystal form | 2XPY |
| MA | M01.034 | leukotriene A4 hydrolase (Saccharomyces cerevisiae) | P212121 crystal form | 2XPZ |
| MA | M01.034 | leukotriene A4 hydrolase (Saccharomyces cerevisiae) | complex with bestatin | 2XQ0 |
| MA | M01.035 | LePepA g.p. (Legionella pneumophila) | crystal structure of legionella pneumophila aminopeptidase a | 5ZI5_A |
| MA | M01.035 | LePepA g.p. (Legionella pneumophila) | complex with glutamic acid | 5ZI7_A |
| MA | M01.035 | LePepA g.p. (Legionella pneumophila) | complex with aspartic acid | 5ZIE_A |
| MA | M01.972 | Tata binding protein associated factor | structure of human tfiid-iia bound to core promoter dna | 5FUR_I |
| MA | M01.972 | Tata binding protein associated factor | core | 6MZC_B |
| MA | M01.972 | Tata binding protein associated factor | canonical state | 6MZL_B |
| MA | M01.972 | Tata binding protein associated factor | complex with promoter dna and tfiia | 6MZM_A |
| MA | M02.001 | angiotensin-converting enzyme peptidase unit 1 | 1O8A | |
| MA | M02.001 | angiotensin-converting enzyme peptidase unit 1 | 1UZE | |
| MA | M02.001 | angiotensin-converting enzyme peptidase unit 1 | 1UZF | |
| MA | M02.001 | angiotensin-converting enzyme peptidase unit 1 | N-terminal catalytic domain only | 2C6F_A |
| MA | M02.001 | angiotensin-converting enzyme peptidase unit 1 | 2C6N | |
| MA | M02.001 | angiotensin-converting enzyme peptidase unit 1 | 2IUL | |
| MA | M02.001 | angiotensin-converting enzyme peptidase unit 1 | 2IUX | |
| MA | M02.001 | angiotensin-converting enzyme peptidase unit 1 | 2XY9_A | |
| MA | M02.001 | angiotensin-converting enzyme peptidase unit 1 | 2XYD_A | |
| MA | M02.001 | angiotensin-converting enzyme peptidase unit 1 | 2YDM_A | |
| MA | M02.001 | angiotensin-converting enzyme peptidase unit 1 | testis ace co-crystal structure with ketone ace inhibitor kaf | 3BKK_A |
| MA | M02.001 | angiotensin-converting enzyme peptidase unit 1 | testis ace co-crystal structure with ketone ace inhibitor kaw | 3BKL_A |
| MA | M02.001 | angiotensin-converting enzyme peptidase unit 1 | 3L3N | |
| MA | M02.001 | angiotensin-converting enzyme peptidase unit 1 | 3NXQ_A | |
| MA | M02.001 | angiotensin-converting enzyme peptidase unit 1 | 4APH_A | |
| MA | M02.001 | angiotensin-converting enzyme peptidase unit 1 | 4APJ | |
| MA | M02.001 | angiotensin-converting enzyme peptidase unit 1 | 4BXK | |
| MA | M02.001 | angiotensin-converting enzyme peptidase unit 1 | 4BZR | |
| MA | M02.001 | angiotensin-converting enzyme peptidase unit 1 | 4BZS | |
| MA | M02.001 | angiotensin-converting enzyme peptidase unit 1 | 4C2N | |
| MA | M02.001 | angiotensin-converting enzyme peptidase unit 1 | 4C2O | |
| MA | M02.001 | angiotensin-converting enzyme peptidase unit 1 | 4C2P | |
| MA | M02.001 | angiotensin-converting enzyme peptidase unit 1 | 4C2Q | |
| MA | M02.001 | angiotensin-converting enzyme peptidase unit 1 | 4C2R | |
| MA | M02.001 | angiotensin-converting enzyme peptidase unit 1 | 4CA5 | |
| MA | M02.001 | angiotensin-converting enzyme peptidase unit 1 | 4CA6 | |
| MA | M02.001 | angiotensin-converting enzyme peptidase unit 1 | 4UFA | |
| MA | M02.001 | angiotensin-converting enzyme peptidase unit 1 | 4UFB | |
| MA | M02.001 | angiotensin-converting enzyme peptidase unit 1 | N-domain; complex with amyloid-beta 4-10 | 5AM8_A |
| MA | M02.001 | angiotensin-converting enzyme peptidase unit 1 | N-domain; complex with amyloid-beta 10-16 | 5AM9_A |
| MA | M02.001 | angiotensin-converting enzyme peptidase unit 1 | N-domain; complex with amyloid-beta 1-16 | 5AMA_A |
| MA | M02.001 | angiotensin-converting enzyme peptidase unit 1 | N-domain; complex with amyloid-beta 35-42 | 5AMB_A |
| MA | M02.001 | angiotensin-converting enzyme peptidase unit 1 | N-domain; complex with amyloid-beta fluorogenic fragment 4-10 | 5AMC_A |
| MA | M02.001 | angiotensin-converting enzyme peptidase unit 1 | N-domain; complex with a diprolyl inhibitor. | 6EN5_A |
| MA | M02.001 | angiotensin-converting enzyme peptidase unit 1 | N-domain; complex with a diprolyl inhibitor. | 6EN6_A |
| MA | M02.001 | angiotensin-converting enzyme peptidase unit 1 | N-domain; complex with sampatrilat-asp. | 6F9R_A |
| MA | M02.001 | angiotensin-converting enzyme peptidase unit 1 | complex with sampatrilat. | 6F9T_A |
| MA | M02.001 | angiotensin-converting enzyme peptidase unit 1 | complex with sampatrilat-asp. | 6F9U_A |
| MA | M02.001 | angiotensin-converting enzyme peptidase unit 1 | N-domain; complex with sampatrilat. | 6F9V_A |
| MA | M02.001 | angiotensin-converting enzyme peptidase unit 1 | C-domain complex with omapatrilat. | 6H5W_A |
| MA | M02.001 | angiotensin-converting enzyme peptidase unit 1 | N-domain; complex with omapatrilat. | 6H5X_A |
| MA | M02.001 | angiotensin-converting enzyme peptidase unit 1 | N-domain; complex with bppb | 6QS1_A |
| MA | M02.003 | peptidyl-dipeptidase Ance | 1J36_A | |
| MA | M02.003 | peptidyl-dipeptidase Ance | 1J37_A | |
| MA | M02.003 | peptidyl-dipeptidase Ance | 1J38_A | |
| MA | M02.003 | peptidyl-dipeptidase Ance | 2X8Y | |
| MA | M02.003 | peptidyl-dipeptidase Ance | complex with captopril | 2X8Z |
| MA | M02.003 | peptidyl-dipeptidase Ance | complex with enalaprilat | 2X90 |
| MA | M02.003 | peptidyl-dipeptidase Ance | complex with lisinopril | 2X91 |
| MA | M02.003 | peptidyl-dipeptidase Ance | complex with ramiprilat | 2X92 |
| MA | M02.003 | peptidyl-dipeptidase Ance | complex with trandolaprilat | 2X93 |
| MA | M02.003 | peptidyl-dipeptidase Ance | complex with perindoprilat | 2X94 |
| MA | M02.003 | peptidyl-dipeptidase Ance | complex with lisW-S | 2X95 |
| MA | M02.003 | peptidyl-dipeptidase Ance | complex with RXPA380 | 2X96 |
| MA | M02.003 | peptidyl-dipeptidase Ance | complex with RXP407 | 2X97 |
| MA | M02.003 | peptidyl-dipeptidase Ance | 2XHM | |
| MA | M02.003 | peptidyl-dipeptidase Ance | 3ZQZ | |
| MA | M02.003 | peptidyl-dipeptidase Ance | complex with angiotensin 2 | 4AA1_A |
| MA | M02.003 | peptidyl-dipeptidase Ance | complex with bradykinin potentiating peptide B | 4AA2 |
| MA | M02.003 | peptidyl-dipeptidase Ance | complex with bradykinin | 4ASQ_A |
| MA | M02.003 | peptidyl-dipeptidase Ance | complex with Thr6-bradykinin | 4ASR_A |
| MA | M02.003 | peptidyl-dipeptidase Ance | 4CA7 | |
| MA | M02.003 | peptidyl-dipeptidase Ance | 4CA8 | |
| MA | M02.003 | peptidyl-dipeptidase Ance | 5A2R | |
| MA | M02.004 | angiotensin-converting enzyme peptidase unit 2 | complex with lisinopril. | 1O86_A |
| MA | M02.004 | angiotensin-converting enzyme peptidase unit 2 | 1O8A | |
| MA | M02.004 | angiotensin-converting enzyme peptidase unit 2 | 2C6N | |
| MA | M02.004 | angiotensin-converting enzyme peptidase unit 2 | 2IUL | |
| MA | M02.004 | angiotensin-converting enzyme peptidase unit 2 | 2IUX | |
| MA | M02.004 | angiotensin-converting enzyme peptidase unit 2 | complex with RXPA380 | 2OC2_A |
| MA | M02.004 | angiotensin-converting enzyme peptidase unit 2 | complex with phosphinic tripeptide | 2XY9 |
| MA | M02.004 | angiotensin-converting enzyme peptidase unit 2 | complex with phosphinic tripeptide | 2XYD |
| MA | M02.004 | angiotensin-converting enzyme peptidase unit 2 | complex with a selenium analogue of captopril | 2YDM |
| MA | M02.004 | angiotensin-converting enzyme peptidase unit 2 | engineered form (N9Q, N25Q, N82Q, N117Q, N131Q, N289Q, Q545R, P576L, R629L) | 3NXQ |
| MA | M02.006 | angiotensin-converting enzyme-2 | 1R42 | |
| MA | M02.006 | angiotensin-converting enzyme-2 | inhibitor bound human angiotensin converting enzyme-related carboxypeptidase (ace2) | 1R4L_A |
| MA | M02.006 | angiotensin-converting enzyme-2 | 1XJP | |
| MA | M02.006 | angiotensin-converting enzyme-2 | structure of sars coronavirus spike receptor-binding domain complexed with its receptor | 2AJF_A |
| MA | M02.006 | angiotensin-converting enzyme-2 | crystal structure of spike protein receptor-binding domain from the 2002-2003 sars coronavirus human strain complexed with human-civet chimeric receptor ace2 | 3D0G_A |
| MA | M02.006 | angiotensin-converting enzyme-2 | crystal structure of spike protein receptor-binding domain from the 2002-2003 sars coronavirus civet strain complexed with human-civet chimeric receptor ace2 | 3D0H_A |
| MA | M02.006 | angiotensin-converting enzyme-2 | crystal structure of spike protein receptor-binding domain from the 2005-2006 sars coronavirus civet strain complexed with human-civet chimeric receptor ace2 | 3D0I_A |
| MA | M02.006 | angiotensin-converting enzyme-2 | 3KBH | |
| MA | M02.006 | angiotensin-converting enzyme-2 | 3SCI | |
| MA | M02.006 | angiotensin-converting enzyme-2 | 3SCJ | |
| MA | M02.006 | angiotensin-converting enzyme-2 | 3SCK_A | |
| MA | M02.006 | angiotensin-converting enzyme-2 | 3SCL_A | |
| MA | M02.006 | angiotensin-converting enzyme-2 | trypsin-cleaved and low ph-treated sars-cov spike glycoprotein and ace2 complex, ace2-bound conformation 1 | 6ACG_D |
| MA | M02.006 | angiotensin-converting enzyme-2 | trypsin-cleaved and low ph-treated sars-cov spike glycoprotein and ace2 complex, ace2-bound conformation 2 | 6ACJ_D |
| MA | M02.006 | angiotensin-converting enzyme-2 | trypsin-cleaved and low ph-treated sars-cov spike glycoprotein and ace2 complex, ace2-bound conformation 3 | 6ACK_D |
| MA | M02.006 | angiotensin-converting enzyme-2 | sars spike glycoprotein - human ace2 complex, stabilized variant, all ace2-bound particles | 6CS2_D |
| MA | M03.001 | thimet oligopeptidase | 1S4B | |
| MA | M03.001 | thimet oligopeptidase | engineered with neurolysin specificity for neurotensin cleavage site | 2O36_A |
| MA | M03.002 | neurolysin | 1I1I_P | |
| MA | M03.002 | neurolysin | engineered with thimet oligopeptidase specificity for neurotensin cleavage site | 2O3E_A |
| MA | M03.002 | neurolysin | 4FXY | |
| MA | M03.002 | neurolysin | Glu475Gln mutant; complex with neurotensin peptide products | 5LUZ_A |
| MA | M03.002 | neurolysin | Glu475Gln mutant; complex with amyloid-beta 35-40 peptide product | 5LV0_A |
| MA | M03.005 | peptidyl-dipeptidase Dcp | complex with a tetrapeptide inhibitor Lys-Trp-Gly-Asp | 1Y79 |
| MA | M03.007 | oligopeptidase F | 2QR4_A | |
| MA | M03.010 | Pz-peptidase A | 3SKS | |
| MA | M03.010 | Pz-peptidase A | 2H1J | |
| MA | M03.010 | Pz-peptidase A | 2H1N | |
| MA | M03.010 | Pz-peptidase A | 3AHM | |
| MA | M03.010 | Pz-peptidase A | complex with inhibitor PPI-1 | 3AHN |
| MA | M03.010 | Pz-peptidase A | complex with inhibitor PPI-2 | 3AHO |
| MA | M03.A01 | TOP1 peptidase (Arabidopsis thaliana) | 4KA7 | |
| MA | M03.A01 | TOP1 peptidase (Arabidopsis thaliana) | 4KA8 | |
| MA | M03.A02 | TOP2 peptidase (Arabidopsis thaliana) | 4PUT | |
| MA | M03.UPB | subfamily M3B unassigned peptidases | TOPSAN | 3CE2 |
| MA | M04.001 | thermolysin | 50% acetone soaked crystals | 1FJ3_A |
| MA | M04.001 | thermolysin | 60% acetone soaked crystals | 1FJO_A |
| MA | M04.001 | thermolysin | 1FJQ | |
| MA | M04.001 | thermolysin | 1FJT | |
| MA | M04.001 | thermolysin | 80% acetonitrile soaked crystals | 1FJU_A |
| MA | M04.001 | thermolysin | 1FJV | |
| MA | M04.001 | thermolysin | 50 mm phenol soaked | 1FJW_A |
| MA | M04.001 | thermolysin | crystallized in presence of potassium thiocyanate | 1GXW_A |
| MA | M04.001 | thermolysin | complex with benzylsuccinic acid | 1HYT |
| MA | M04.001 | thermolysin | 1KEI | |
| MA | M04.001 | thermolysin | complex with Z-Thr | 1KJ0 |
| MA | M04.001 | thermolysin | complex with Z-Thr | 1KJO |
| MA | M04.001 | thermolysin | complex with Z-Glu | 1KJP |
| MA | M04.001 | thermolysin | complex with Z-Asp | 1KKK |
| MA | M04.001 | thermolysin | complex with Z-Ala | 1KL6 |
| MA | M04.001 | thermolysin | complex with Z-D-Glu | 1KR6 |
| MA | M04.001 | thermolysin | complex with Z-D-Thr | 1KRO |
| MA | M04.001 | thermolysin | complex with Z-D-Asp | 1KS7 |
| MA | M04.001 | thermolysin | complex with Z-D-Ala | 1KTO |
| MA | M04.001 | thermolysin | 1L3F_E | |
| MA | M04.001 | thermolysin | complex with cobalt | 1LNA |
| MA | M04.001 | thermolysin | complex with iron | 1LNB |
| MA | M04.001 | thermolysin | complex with manganese | 1LNC |
| MA | M04.001 | thermolysin | complex with zinc | 1LND |
| MA | M04.001 | thermolysin | complex with cadmium | 1LNE |
| MA | M04.001 | thermolysin | 1LNF | |
| MA | M04.001 | thermolysin | complex with N-(2R)-3-[(S)-[(1R)-1-amino-2-phenylethyl](hydroxy)phosphoryl]- 2-benzylpropanoyl-L-phenylalanine | 1OS0_A |
| MA | M04.001 | thermolysin | complex with tricyclic inhibitor | 1PE5_A |
| MA | M04.001 | thermolysin | complex with bicyclic inhibitor | 1PE7_A |
| MA | M04.001 | thermolysin | complex with monocyclic inhibitor | 1PE8_A |
| MA | M04.001 | thermolysin | complex with (2-sulphanyl-3-phenylpropanoyl)-Phe-Tyr | 1QF0 |
| MA | M04.001 | thermolysin | complex with (2-sulphanylheptanoyl)-Phe-Ala | 1QF1 |
| MA | M04.001 | thermolysin | complex with (2-sulphanyl-3-phenylpropanoyl)-Gly-(5-phenylPro) | 1QF2 |
| MA | M04.001 | thermolysin | complex with N-(1-(2(R,S)-carboxy-4-phenylbutyl)cyclopentylcarbonyl)-(S)-Trp (CCT) | 1THL |
| MA | M04.001 | thermolysin | 1TLI | |
| MA | M04.001 | thermolysin | complex with phosphoramidon | 1TLP |
| MA | M04.001 | thermolysin | 1TLX | |
| MA | M04.001 | thermolysin | complex with N-(1-carboxy-3-phenylpropyl)-L-Leu-L-Trp | 1TMN |
| MA | M04.001 | thermolysin | NMR structure; fragment 255-316 | 1TRL |
| MA | M04.001 | thermolysin | complex with a silanediol inhibitor (2S)-2-[(aminomethyl)(dihydroxy)silyl]methyl-4-methylpentanal | 1Y3G_E |
| MA | M04.001 | thermolysin | complex with the inhibitor (R)-retro-thiorphan | 1Z9G_E |
| MA | M04.001 | thermolysin | complex with the inhibitor (S)-thiorphan | 1ZDP_E |
| MA | M04.001 | thermolysin | 2A7G_E | |
| MA | M04.001 | thermolysin | 2G4Z_A | |
| MA | M04.001 | thermolysin | 5% isopropanol soaked crystals | 2TLI_A |
| MA | M04.001 | thermolysin | 2TLX | |
| MA | M04.001 | thermolysin | complex with N-phosphoryl-L-leucinamide | 2TMN |
| MA | M04.001 | thermolysin | complex with inducible metalloproteinase inhibitor (Galleria mellonella) | 3SSB_A |
| MA | M04.001 | thermolysin | 10% isopropanol soaked crystals | 3TLI_A |
| MA | M04.001 | thermolysin | complex with Val-Trp | 3TMN |
| MA | M04.001 | thermolysin | 4TLI | |
| MA | M04.001 | thermolysin | complex with L-Leu-hydroxylamine | 4TLN |
| MA | M04.001 | thermolysin | complex with CBZ-Phe-P-Leu-Ala | 4TMN |
| MA | M04.001 | thermolysin | 60% isopropanol soaked crystals | 5TLI_A |
| MA | M04.001 | thermolysin | complex with HONH-benzylmalonyl-L-Ala-Gly-pNA | 5TLN |
| MA | M04.001 | thermolysin | complex with CBZ-Gly-P-Leu-Leu | 5TMN |
| MA | M04.001 | thermolysin | 60% isopropanol soaked crystals | 6TLI_A |
| MA | M04.001 | thermolysin | complex with CBZ-Gly-P-(O)-Leu-Leu | 6TMN |
| MA | M04.001 | thermolysin | 90% isopropanol soaked crystals | 7TLI_A |
| MA | M04.001 | thermolysin | complex with CH2CO(N-OH)Leu-OCH3 | 7TLN |
| MA | M04.001 | thermolysin | theoretical model; complex with Gly-TPH-Leu-Leu | 7TMN |
| MA | M04.001 | thermolysin | 8TLI | |
| MA | M04.001 | thermolysin | complex with Val-Lys | 8TLN |
| MA | M04.001 | thermolysin | sfx structure | 5DLH_A |
| MA | M04.001 | thermolysin | sfx liganded form with oil-based carrier | 5WR2_A |
| MA | M04.001 | thermolysin | sfx liganded form with water-based carrier | 5WR3_A |
| MA | M04.001 | thermolysin | sfx unliganded form with oil-based carrier | 5WR4_A |
| MA | M04.001 | thermolysin | liganded form with cryo condition 1 | 5WR5_A |
| MA | M04.001 | thermolysin | liganded form with cryo condition 2 | 5WR6_A |
| MA | M04.001 | thermolysin | C-terminal fragment; complex with daip | 6FHP_C |
| MA | M04.001 | thermolysin | tce-treated | 6FSM_A |
| MA | M04.001 | thermolysin | Glu144Ser mutant | 1ESP |
| MA | M04.001 | thermolysin | 1NPC | |
| MA | M04.001 | thermolysin | acoustic injectors for drop-on-demand serial femtosecond crystallography | 5HQD_A |
| MA | M04.005 | pseudolysin | 1EZM | |
| MA | M04.005 | pseudolysin | complex with an inhibitor | 1U4G_A |
| MA | M04.005 | pseudolysin | complex with phosphoramidon | 3DBK_A |
| MA | M04.005 | pseudolysin | 4K89_A | |
| MA | M04.005 | pseudolysin | complex with a thiol based inhibitor | 6F8B_A |
| MA | M04.005 | pseudolysin | complex with a hydroxymate inhibitor | 6FZX_A |
| MA | M04.009 | aureolysin | 1BQB | |
| MA | M04.016 | PA peptidase (Aeromonas-type) | 3NQX | |
| MA | M04.016 | PA peptidase (Aeromonas-type) | Glu346Ala mutant; complex with propeptide | 3NQY |
| MA | M04.016 | PA peptidase (Aeromonas-type) | Glu346Ala mutant | 3NQZ |
| MA | M04.018 | stearolysin | crystal structure of gentlyase, the neutral metalloprotease of paenibacillus polymyxa | 4B52_A |
| MA | M04.018 | stearolysin | 4GER | |
| MA | M04.025 | protealysin | precursor of protealysin, metalloproteinase from serratia proteamaculans. | 2VQX_A |
| MA | M06.004 | immune inhibitor A2 peptidase (Bacillus sp.) | zymogen | 4YU5 |
| MA | M06.004 | immune inhibitor A2 peptidase (Bacillus sp.) | zymogen | 4YU6 |
| MA | M07.001 | snapalysin | 1C7K | |
| MA | M07.001 | snapalysin | 1KUH | |
| MA | M07.001 | snapalysin | complex with sermetstatin | 4HX3_A |
| MA | M08.001 | leishmanolysin | 1LML | |
| MA | M09.002 | collagenase G/A (Clostridium histolyticum) | C-terminal collagen-binding domain | 1NQJ |
| MA | M09.002 | collagenase G/A (Clostridium histolyticum) | apo-enzyme | 2Y3U |
| MA | M09.002 | collagenase G/A (Clostridium histolyticum) | 2Y50 | |
| MA | M09.002 | collagenase G/A (Clostridium histolyticum) | complex with isoamylphosphonyl-Gly-Pro-Ala | 2Y6I |
| MA | M09.002 | collagenase G/A (Clostridium histolyticum) | PKD domain only | 2Y72 |
| MA | M09.002 | collagenase G/A (Clostridium histolyticum) | crystal structure of the collagenase unit of collagenase g from clostridium histolyticum at 2.19 angstrom resolution. | 4ARE_A |
| MA | M09.003 | bacterial collagenase H | crystal structure of the peptidase domain of collagenase h from clostridium histolyticum at 2.01 angstrom resolution. | 4AR1_A |
| MA | M09.003 | bacterial collagenase H | peptidase domain; complex with the peptidic inhibitor isoamylphosphonyl-gly-pro-ala | 4ARF_A |
| MA | M09.003 | bacterial collagenase H | peptidase domain; complex with n-aryl mercaptoacetamide- based inhibitor | 5O7E_A |
| MA | M09.005 | collagenase ColT (Clostridium tetani) | peptidase domain; complex with the peptidic inhibitor isoamyl- phosphonyl-gly-pro-ala | 4AR8_A |
| MA | M09.005 | collagenase ColT (Clostridium tetani) | crystal structure of the peptidase domain of collagenase t from clostridium tetani at 1.69 angstrom resolution. | 4AR9_A |
| MA | M10.001 | matrix metallopeptidase-1 | NMR structure of catalytic domain | 1AYK |
| MA | M10.001 | matrix metallopeptidase-1 | complex with stromelysin and PG-117025 inhibitor | 1BQO_B |
| MA | M10.001 | matrix metallopeptidase-1 | recombinant peptidase domain | 1CGE |
| MA | M10.001 | matrix metallopeptidase-1 | catalytic domain binary complex | 1CGF |
| MA | M10.001 | matrix metallopeptidase-1 | recombinant catalytic domain | 1CGL |
| MA | M10.001 | matrix metallopeptidase-1 | recombinant | 1HFC |
| MA | M10.001 | matrix metallopeptidase-1 | precursor | 1SU3 |
| MA | M10.001 | matrix metallopeptidase-1 | catalytic domain; complex with inhibitor | 1TCL |
| MA | M10.001 | matrix metallopeptidase-1 | NMR structure; inhibitor-free catalytic domain | 2AYK |
| MA | M10.001 | matrix metallopeptidase-1 | active form | 2CLT |
| MA | M10.001 | matrix metallopeptidase-1 | catalytic domain; complex with the inhibitory domain of TIMP-1 | 2J0T_A |
| MA | M10.001 | matrix metallopeptidase-1 | catalytic domain; complex with [[1-[N-hydroxy-acetamidyl]-3-methyl-butyl]-carbonyl-leucinyl]-alanine ethyl ester | 2TCL |
| MA | M10.001 | matrix metallopeptidase-1 | NMR structure; catalytic domain; complex with CGS-27023A inhibitor | 3AYK |
| MA | M10.001 | matrix metallopeptidase-1 | 3SHI | |
| MA | M10.001 | matrix metallopeptidase-1 | 4AUO | |
| MA | M10.001 | matrix metallopeptidase-1 | NMR structure; catalytic domain; complex with CGS-27023A inhibitor | 4AYK |
| MA | M10.001 | matrix metallopeptidase-1 | catalytic domain; complex with N-hydroxy-2-[4-(4-phenoxy-benzenesulfonyl)-tetrahydro-pyran-4-yl]-acetamide | 966C |
| MA | M10.001 | matrix metallopeptidase-1 | 1FBL | |
| MA | M10.002 | matrix metallopeptidase-8 | complex with malonic and asparagine based inhibitor | 1A85 |
| MA | M10.002 | matrix metallopeptidase-8 | complex with malonic and aspartate based inhibitor | 1A86 |
| MA | M10.002 | matrix metallopeptidase-8 | complex with HMR2909 inhibitor. | 1BZS |
| MA | M10.002 | matrix metallopeptidase-8 | catalytic domain; complex with Pro-Leu-L-Trp phosphonate | 1I73 |
| MA | M10.002 | matrix metallopeptidase-8 | catalytic domain; complex with 2-(biphenyl-4-sulfonyl)-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid | 1I76 |
| MA | M10.002 | matrix metallopeptidase-8 | catalytic domain; complex with Pro-Leu-Gly-hydroxylamine | 1JAN |
| MA | M10.002 | matrix metallopeptidase-8 | catalytic domain; complex with 3-mercapto-2-benzylpropanoyl-Ala-Gly-NH2 | 1JAO |
| MA | M10.002 | matrix metallopeptidase-8 | catalytic domain; complex with Pro-Leu-Gly-hydroxylamine | 1JAP |
| MA | M10.002 | matrix metallopeptidase-8 | catalytic domain; complex with 1-hydroxylamine-2-isobutylmalonyl-Ala-Gly-NH2 | 1JAQ |
| MA | M10.002 | matrix metallopeptidase-8 | complex with but-3-enyl-[5-(4-chloro-phenyl)-3,6-dihydro-[1,3,4]thiadiazin-2-ylidene]-amine | 1JH1 |
| MA | M10.002 | matrix metallopeptidase-8 | complex with barbiturate | 1JJ9 |
| MA | M10.002 | matrix metallopeptidase-8 | complex with 3-formyl-2-hydroxy-5-methyl-hexanoic acid hydroxyamide | 1KBC |
| MA | M10.002 | matrix metallopeptidase-8 | catalytic domain; complex with BB94 | 1MMB |
| MA | M10.002 | matrix metallopeptidase-8 | catalytic domain | 1MNC |
| MA | M10.002 | matrix metallopeptidase-8 | complex with N-2-[(4'-cyano-1,1'-biphenyl-4-yl)oxy]ethyl-N'-hydroxy-N-methylurea | 1ZP5_A |
| MA | M10.002 | matrix metallopeptidase-8 | complex with phosphonate inhibitor (S-enantiomer) (1S)-1-[(4'-methoxy-1,1'-biphenyl-4-yl)sulfonyl]amino-2-methylpropylphosphonic acid | 1ZS0_A |
| MA | M10.002 | matrix metallopeptidase-8 | complex with phosphonate inhibitor (1R)-1-[(4'-methoxy-1,1'-biphenyl-4-yl)sulfonyl]amino-2-methylpropylphosphonic acid | 1ZVX_A |
| MA | M10.002 | matrix metallopeptidase-8 | complex with peptide IAG | 2OY2_A |
| MA | M10.002 | matrix metallopeptidase-8 | uninhibited human mmp-8 | 2OY4_A |
| MA | M10.002 | matrix metallopeptidase-8 | complex with (5S)-5-(2-amino-2-oxoethyl)-4-oxo-N-[(3-oxo- 3,4-dihydro-2H-1,4-benzoxazin-6-yl)methyl]- 3,4,5,6,7,8-hexahydro[1]benzothieno[2,3-d]pyrimidine- 2-carboxamide | 3DNG_A |
| MA | M10.002 | matrix metallopeptidase-8 | complex with N-[2-(2-amino-3,4-dioxocyclobut-1-en-1-yl)- 1,2,3,4-tetrahydroisoquinolin-7-yl]methyl- 4-oxo-3,5,6,8-tetrahydro-4H-thiopyrano[4',3':4,5]thieno[2,3- d]pyrimidine-2-carboxamide 7,7-dioxide | 3DPE_A |
| MA | M10.002 | matrix metallopeptidase-8 | complex with N-[2-(2-amino-3,4-dioxocyclobut-1-en-1-yl)- 1,2,3,4-tetrahydroisoquinolin-7-yl]methyl- 4-oxo-3,5,6,8-tetrahydro-4H-thiopyrano[4',3':4,5]thieno[2,3- d]pyrimidine-2-carboxamide 7,7-dioxide | 3DPF_A |
| MA | M10.002 | matrix metallopeptidase-8 | 3TT4 | |
| MA | M10.002 | matrix metallopeptidase-8 | 4QKZ | |
| MA | M10.002 | matrix metallopeptidase-8 | complex with bf471 (catechol inhibitor) | 5H8X_A |
| MA | M10.003 | matrix metallopeptidase-2 | 1CK7_A | |
| MA | M10.003 | matrix metallopeptidase-2 | NMR structure; type II fibronectin-like domain 2 | 1CXW |
| MA | M10.003 | matrix metallopeptidase-2 | Glu404Gln mutant; catalytic domain | 1EAK |
| MA | M10.003 | matrix metallopeptidase-2 | C-terminal domain | 1GEN |
| MA | M10.003 | matrix metallopeptidase-2 | precursor; complex with TIMP-2 | 1GXD_A |
| MA | M10.003 | matrix metallopeptidase-2 | NMR structure; catalytic domain; complex with SC-74020 | 1HOV |
| MA | M10.003 | matrix metallopeptidase-2 | NMR structure; fibronectin type II domain 3 | 1J7M |
| MA | M10.003 | matrix metallopeptidase-2 | 1KS0 | |
| MA | M10.003 | matrix metallopeptidase-2 | catalytic domain with fibronectin domain deleted | 1QIB |
| MA | M10.003 | matrix metallopeptidase-2 | haemopexin domain | 1RTG |
| MA | M10.003 | matrix metallopeptidase-2 | 3AYU | |
| MA | M10.004 | matrix metallopeptidase-9 | catalytic domain; complex with reverse hydroxamate inhibitor N~2~-[(2R)-2-[formyl(hydroxy)amino]methyl- 4-methylpentanoyl]-N,3-dimethyl-L-valinamide | 1GKC |
| MA | M10.004 | matrix metallopeptidase-9 | catalytic domain; complex with a reverse hydroxamate inhibitor | 1GKD |
| MA | M10.004 | matrix metallopeptidase-9 | 1ITV | |
| MA | M10.004 | matrix metallopeptidase-9 | 1L6J | |
| MA | M10.004 | matrix metallopeptidase-9 | precursor; theoretical model | 1LKG |
| MA | M10.004 | matrix metallopeptidase-9 | mmp-9 active site mutant with barbiturate inhibitor | 2OVX_A |
| MA | M10.004 | matrix metallopeptidase-9 | mmp-9 active site mutant with phosphinate inhibitor | 2OVZ_A |
| MA | M10.004 | matrix metallopeptidase-9 | mmp-9 active site mutant with iodine-labeled carboxylate inhibitor | 2OW0_A |
| MA | M10.004 | matrix metallopeptidase-9 | mmp-9 active site mutant with trifluoromethyl hydroxamate inhibitor | 2OW1_A |
| MA | M10.004 | matrix metallopeptidase-9 | mmp-9 active site mutant with difluoro butanoic acid inhibitor | 2OW2_A |
| MA | M10.004 | matrix metallopeptidase-9 | 4H1Q | |
| MA | M10.004 | matrix metallopeptidase-9 | 4H2E | |
| MA | M10.004 | matrix metallopeptidase-9 | 4H3X | |
| MA | M10.004 | matrix metallopeptidase-9 | 4H82 | |
| MA | M10.004 | matrix metallopeptidase-9 | 4HMA | |
| MA | M10.004 | matrix metallopeptidase-9 | 4JIJ | |
| MA | M10.004 | matrix metallopeptidase-9 | 4JQG | |
| MA | M10.004 | matrix metallopeptidase-9 | 4WZV | |
| MA | M10.004 | matrix metallopeptidase-9 | 4XCT | |
| MA | M10.004 | matrix metallopeptidase-9 | complex with a constrained hydroxamate based inhibitor lt4 | 5CUH_A |
| MA | M10.004 | matrix metallopeptidase-9 | catalytic domain; complex with a selective sugar-conjugated arylsulfonamide carboxylate water-soluble inhibitor (dc27). | 5I12_A |
| MA | M10.004 | matrix metallopeptidase-9 | structure determination of a potent, selective antibody inhibitor of human mmp9 (apo mmp9) | 5TH6_A |
| MA | M10.004 | matrix metallopeptidase-9 | structure determination of a potent, selective antibody inhibitor of human mmp9 (gs-5745 bound to mmp-9) | 5TH9_L |
| MA | M10.004 | matrix metallopeptidase-9 | prommp-9desfnii | 5UE3_A |
| MA | M10.004 | matrix metallopeptidase-9 | prommp-9desfnii complex to jnj0966 inhibitor | 5UE4_A |
| MA | M10.004 | matrix metallopeptidase-9 | complex with inhibitor be4. | 6ESM_A |
| MA | M10.005 | matrix metallopeptidase-3 | complex with N-[[2-methyl-4-hydroxycarbamoyl]but-4-yl-N]-benzyl-P-[phenyl]-P-[methyl]phosphinamide | 1B3D |
| MA | M10.005 | matrix metallopeptidase-3 | catalytic domain; complex with diphenylpiperidine sulfonamide inhibitor | 1B8Y |
| MA | M10.005 | matrix metallopeptidase-3 | complex with N1-hydroxy-2-(3-hydroxy-propyl)-3-isobutyl-N4-[1-(2-methoxy-ethyl)-2-oxo-azepan-3-yl]-succinamide | 1BIW |
| MA | M10.005 | matrix metallopeptidase-3 | NMR structure; complex with N-HYDROXY-2(R)- [4-METHOXYSULFONYL](3-PICOLYL)AMINO]-3-methylbutaneamide hydrochloride monohydrate inhibitor | 1BM6 |
| MA | M10.005 | matrix metallopeptidase-3 | complex with interstitial collagenase and PG-117025 inhibitor | 1BQO_A |
| MA | M10.005 | matrix metallopeptidase-3 | catalytic domain; complex with RO-26-2812 synthetic inhibitor | 1C3I |
| MA | M10.005 | matrix metallopeptidase-3 | catalytic domain; complex with RO-26-2812 | 1C8T |
| MA | M10.005 | matrix metallopeptidase-3 | catalytic domain; complex with diphenyl piperidine sulfonamide | 1CAQ |
| MA | M10.005 | matrix metallopeptidase-3 | catalytic domain; complex with 3-(1H-indol-3-yl)-2-[4-(4-phenyl-piperidin-1-yl)-benzenesulfonylamino]-propionic acid inhibitor | 1CIZ |
| MA | M10.005 | matrix metallopeptidase-3 | catalytic domain | 1CQR |
| MA | M10.005 | matrix metallopeptidase-3 | complex with N-hydroxy-4-[(4-methoxylphenyl)sulfonyl]-2,2-dimethyl-hexahydro-1,4-thiazepine-3(S)-carboxamide | 1D5J |
| MA | M10.005 | matrix metallopeptidase-3 | complex with N-hydroxy 1N(4-methoxyphenyl)sulfonyl-4-(Z,E-N-methoxyimino)pyrrolidine-2R-carboxamide inhibitor | 1D7X |
| MA | M10.005 | matrix metallopeptidase-3 | complex with N-hydroxy-1-(4-methoxyphenyl)sulfonyl-4-benzyloxycarbonyl-piperazine-2-carboxamide inhibitor | 1D8F |
| MA | M10.005 | matrix metallopeptidase-3 | catalytic domain; complex with 1-benzyl-3-(4-methoxy-benzenesulfonyl)-6-oxo-hexahydro-pyrimidine-4-carboxamide inhibitor | 1D8M |
| MA | M10.005 | matrix metallopeptidase-3 | catalytic domain; complex with heterocycle-based inhibitor | 1G05 |
| MA | M10.005 | matrix metallopeptidase-3 | catalytic domain; complex with carboxylic acid based inhibitor (1N)-4-N-butoxyphenylsulfonyl-(2R)-N-hydroxycarboxamido-(4S)-methanesulfonylamino-pyrrolidine | 1G49 |
| MA | M10.005 | matrix metallopeptidase-3 | catalytic domain; complex with HQQ inhibitor | 1G4K |
| MA | M10.005 | matrix metallopeptidase-3 | catalytic domain; complex with N-carboxy-alkyl inhibitor L-764,004 | 1HFS |
| MA | M10.005 | matrix metallopeptidase-3 | catalytic domain; complex with a carboxylic acid based inhibitor | 1HY7 |
| MA | M10.005 | matrix metallopeptidase-3 | theoretical model | 1M1W |
| MA | M10.005 | matrix metallopeptidase-3 | NMR structure; complex with human stromelysin catalytic domain | 1OO9_A |
| MA | M10.005 | matrix metallopeptidase-3 | catalytic domain | 1QIA |
| MA | M10.005 | matrix metallopeptidase-3 | catalytic domain; complex with diphenylpiperidine inhibitor | 1QIC |
| MA | M10.005 | matrix metallopeptidase-3 | C-truncated proenzyme | 1SLM_A |
| MA | M10.005 | matrix metallopeptidase-3 | catalytic domain; complex with the N-carboxyl-alkyl inhibitor L-702,842 | 1SLN |
| MA | M10.005 | matrix metallopeptidase-3 | catalytic domain; complex with TIMP-1 | 1UEA_A |
| MA | M10.005 | matrix metallopeptidase-3 | NMR structure of catalytic domain; complex with (R,S)-N-[2-[2-(hydroxyamino)-2-oxoethyl]-4-methyl-1-oxopentyl]-Leu-Phe-NH2 inhibitor | 1UMS |
| MA | M10.005 | matrix metallopeptidase-3 | NMR structure; catalytic domain; complex with hydrophobic inhibitor | 1UMT |
| MA | M10.005 | matrix metallopeptidase-3 | catalytic domain; complex with thiadiazole inhibitor PNU-142372 | 1USN |
| MA | M10.005 | matrix metallopeptidase-3 | stromelysin-1 (mmp-3) complexed to a hydroxamic acid inhibitor | 2D1O_A |
| MA | M10.005 | matrix metallopeptidase-3 | 2JNP | |
| MA | M10.005 | matrix metallopeptidase-3 | 2JT5 | |
| MA | M10.005 | matrix metallopeptidase-3 | 2JT6 | |
| MA | M10.005 | matrix metallopeptidase-3 | NMR structure of catalytic domain; complex with N-(R-carboxy-ethyl)-alpha-(S)-(2-phenyl ether) Gly-L-Arg-N-phenylamide | 2SRT |
| MA | M10.005 | matrix metallopeptidase-3 | catalytic domain; complex with thiadiazole inhibitor PNU-141803 | 2USN |
| MA | M10.005 | matrix metallopeptidase-3 | 3OHL | |
| MA | M10.005 | matrix metallopeptidase-3 | 3OHO | |
| MA | M10.005 | matrix metallopeptidase-3 | NMR structure of catalytic domain; complex with thiadiazole inhibitor IPNU-107859 | 3USN |
| MA | M10.005 | matrix metallopeptidase-3 | 4DPE | |
| MA | M10.005 | matrix metallopeptidase-3 | 4G9L | |
| MA | M10.005 | matrix metallopeptidase-3 | 4JA1 | |
| MA | M10.005 | matrix metallopeptidase-3 | catalytic domain; complex with tissue inhibitor of metalloproteinase-1 (timp-1) mutant Leu34Gly | 6MAV_A |
| MA | M10.005 | matrix metallopeptidase-3 | catalytic domain; complex with tissue inhibitor of metalloproteinases-1 (timp-1) mutant (Leu34Gly/Leu133Pro/Leu151Cys/Gly154Ala) | 6N9D_A |
| MA | M10.005 | matrix metallopeptidase-3 | theoretical model | 1L9I |
| MA | M10.006 | matrix metallopeptidase-10 (Homo sapiens-type) | homotrimer; catalytic domain only | 1Q3A |
| MA | M10.006 | matrix metallopeptidase-10 (Homo sapiens-type) | 3V96_B | |
| MA | M10.006 | matrix metallopeptidase-10 (Homo sapiens-type) | 4ILW_D | |
| MA | M10.007 | matrix metallopeptidase-11 | catalytic domain; complex with phosphinic inhibitor R-2-[4'-methoxy-(1,1'-biphenyl)-4-yl]-sulfonyl-amino-6-methoxy-hex-4-ynoic acid | 1HV5 |
| MA | M10.008 | matrix metallopeptidase-7 | complex with 5-methyl-3-(9-oxo-1,8-diaza-tricyclo[10.6.1.013,18]nonadeca-12(19),13,15,17-tetraen-10-ylcarbamoyl)-hexanoic acid | 1MMP |
| MA | M10.008 | matrix metallopeptidase-7 | complex with N4-hydroxy-2-isobutyl-N1-(9-oxo-1,8-diaza-tricyclo[10.6.1.013,18]nonadeca-12(19),13,15,17-tetraen-10-yl)-succinamide | 1MMQ |
| MA | M10.008 | matrix metallopeptidase-7 | complex with 4-methyl-3-(9-oxo-1,8-diaza-tricyclo[10.6.1.0(13,18)]nonadeca-12(19),13(18),15,17-tetraene-10-carbamoyl)penta-methylsulfonediimine | 1MMR |
| MA | M10.008 | matrix metallopeptidase-7 | 2DDY | |
| MA | M10.008 | matrix metallopeptidase-7 | 2MZE | |
| MA | M10.008 | matrix metallopeptidase-7 | 2MZH | |
| MA | M10.008 | matrix metallopeptidase-7 | 2Y6C | |
| MA | M10.008 | matrix metallopeptidase-7 | 2Y6D | |
| MA | M10.009 | matrix metallopeptidase-12 | 1JIZ | |
| MA | M10.009 | matrix metallopeptidase-12 | 1JK3 | |
| MA | M10.009 | matrix metallopeptidase-12 | ternary enzyme-product-inhibitor complexes of human mmp12 | 1OS2_A |
| MA | M10.009 | matrix metallopeptidase-12 | binary enzyme-product complexes of human mmp12 | 1OS9_A |
| MA | M10.009 | matrix metallopeptidase-12 | catalytic domain; complex with the inhibitor NNGH | 1RMZ_A |
| MA | M10.009 | matrix metallopeptidase-12 | complex with 2-(1,3-dioxo-1,3- dihydro-2h-isoindol-2-yl)ethyl-4-(4-ethoxy[1,1-biphenyl]-4- yl)-4-oxobutanoic acid | 1ROS_A |
| MA | M10.009 | matrix metallopeptidase-12 | complex with 2-(1,3-dioxo-1,3- dihydro-2h-isoindol-2-yl)ethyl-4-(4-ethoxy[1,1-biphenyl]-4- yl)-4-oxobutanoic acid | 1UTT_A |
| MA | M10.009 | matrix metallopeptidase-12 | complex with (2R)-3-([4-[(pyri din-4-yl)phenyl]-thien-2-ylcarboxamido)(phenyl)propanoic acid | 1UTZ_A |
| MA | M10.009 | matrix metallopeptidase-12 | catalytic domain; complex with acetohydroxamic acid | 1Y93_A |
| MA | M10.009 | matrix metallopeptidase-12 | 1YCM | |
| MA | M10.009 | matrix metallopeptidase-12 | 1Z3J | |
| MA | M10.009 | matrix metallopeptidase-12 | complex with acetohydroxamic acid and (1S,5S,7R)-N~7~-(biphenyl-4-ylmethyl)-N~3~-hydroxy-6,8-dioxa-3-azabicyclo[3.2.1]octane-3,7-dicarboxamide | 2HU6_A |
| MA | M10.009 | matrix metallopeptidase-12 | 2JXY | |
| MA | M10.009 | matrix metallopeptidase-12 | 2K2G | |
| MA | M10.009 | matrix metallopeptidase-12 | 2K9C | |
| MA | M10.009 | matrix metallopeptidase-12 | 2KRJ | |
| MA | M10.009 | matrix metallopeptidase-12 | 2MLR | |
| MA | M10.009 | matrix metallopeptidase-12 | 2MLS | |
| MA | M10.009 | matrix metallopeptidase-12 | uninhibited form of human mmp-12 | 2OXU_A |
| MA | M10.009 | matrix metallopeptidase-12 | complex with the peptide iag | 2OXW_A |
| MA | M10.009 | matrix metallopeptidase-12 | complex with two peptides pqg and iag | 2OXZ_A |
| MA | M10.009 | matrix metallopeptidase-12 | 2POJ | |
| MA | M10.009 | matrix metallopeptidase-12 | does a fast nuclear magnetic resonance spectroscopy- and x-ray crystallography hybrid approach provide reliable structural information of ligand-protein complexes? a case stud | 2W0D_A |
| MA | M10.009 | matrix metallopeptidase-12 | 2WO8 | |
| MA | M10.009 | matrix metallopeptidase-12 | 2WO9 | |
| MA | M10.009 | matrix metallopeptidase-12 | 2WOA | |
| MA | M10.009 | matrix metallopeptidase-12 | 2Z2D | |
| MA | M10.009 | matrix metallopeptidase-12 | 3BA0 | |
| MA | M10.009 | matrix metallopeptidase-12 | catalytic domain; complex with the inhibitor (r)-2-(biphenyl-4- ylsulfonamido)-4-methylpentanoic acid | 3EHX_A |
| MA | M10.009 | matrix metallopeptidase-12 | catalytic domain; complex with the inhibitor (r)-2-(4- methoxyphenylsulfonamido)propanoic acid | 3EHY_A |
| MA | M10.009 | matrix metallopeptidase-12 | catalytic domain; complex with the inhibitor (s)-n-(2,3-dihydroxypropyl)-4- methoxy-n-(2-nitroso-2-oxoethyl)benzenesulfonamide | 3F15_A |
| MA | M10.009 | matrix metallopeptidase-12 | catalytic domain; complex with the inhibitor (r)-n-(3-hydroxy-1-nitroso-1- oxopropan-2-yl)-4-methoxybenzenesulfonamide | 3F16_A |
| MA | M10.009 | matrix metallopeptidase-12 | catalytic domain; complex with the inhibitor n-(2-nitroso-2-oxoethyl) biphenyl-4-sulfonamide | 3F17_A |
| MA | M10.009 | matrix metallopeptidase-12 | catalytic domain; complex with the inhibitor 4-fluoro-n-(2-hydroxyethyl)-n- (2-nitroso-2-oxoethyl)benzenesulfonamide | 3F18_A |
| MA | M10.009 | matrix metallopeptidase-12 | catalytic domain; complex with the inhibitor 4-fluoro-n-(2-nitroso-2- oxoethyl)benzenesulfonamide | 3F19_A |
| MA | M10.009 | matrix metallopeptidase-12 | catalytic domain; complex with the inhibitor n-(2-nitroso-2-oxoethyl) benzenesulfonamide | 3F1A_A |
| MA | M10.009 | matrix metallopeptidase-12 | 3LIK | |
| MA | M10.009 | matrix metallopeptidase-12 | 3LIL | |
| MA | M10.009 | matrix metallopeptidase-12 | 3LIR | |
| MA | M10.009 | matrix metallopeptidase-12 | 3LJG | |
| MA | M10.009 | matrix metallopeptidase-12 | 3LK8 | |
| MA | M10.009 | matrix metallopeptidase-12 | 3LKA | |
| MA | M10.009 | matrix metallopeptidase-12 | 3N2U | |
| MA | M10.009 | matrix metallopeptidase-12 | 3N2V | |
| MA | M10.009 | matrix metallopeptidase-12 | 3NX7 | |
| MA | M10.009 | matrix metallopeptidase-12 | 3RTS | |
| MA | M10.009 | matrix metallopeptidase-12 | 3RTT | |
| MA | M10.009 | matrix metallopeptidase-12 | 3TS4 | |
| MA | M10.009 | matrix metallopeptidase-12 | 3TSK | |
| MA | M10.009 | matrix metallopeptidase-12 | 3UVC | |
| MA | M10.009 | matrix metallopeptidase-12 | 4EFS | |
| MA | M10.009 | matrix metallopeptidase-12 | 4GQL | |
| MA | M10.009 | matrix metallopeptidase-12 | 4GR0 | |
| MA | M10.009 | matrix metallopeptidase-12 | 4GR3 | |
| MA | M10.009 | matrix metallopeptidase-12 | 4GR8 | |
| MA | M10.009 | matrix metallopeptidase-12 | 4GUY | |
| MA | M10.009 | matrix metallopeptidase-12 | 4H30 | |
| MA | M10.009 | matrix metallopeptidase-12 | 4H49 | |
| MA | M10.009 | matrix metallopeptidase-12 | 4H76 | |
| MA | M10.009 | matrix metallopeptidase-12 | 4H84 | |
| MA | M10.009 | matrix metallopeptidase-12 | 4I03 | |
| MA | M10.009 | matrix metallopeptidase-12 | 4IJO | |
| MA | M10.009 | matrix metallopeptidase-12 | catalytic domain; complex with a carboxylate inhibitor related to rxp470 | 5CXA_A |
| MA | M10.009 | matrix metallopeptidase-12 | mutated catalytic domain; complex with rxp470 | 5CZM_A |
| MA | M10.009 | matrix metallopeptidase-12 | mutated catalytic domain; complex with an hydroxamate analogue of rxp470 | 5D2B_A |
| MA | M10.009 | matrix metallopeptidase-12 | double mutant catalytic domain; complex with an hydroxamate analogue of rxp470 | 5D3C_A |
| MA | M10.009 | matrix metallopeptidase-12 | catalytic domain; complex with a selective sugar-conjugated arylsulfonamide carboxylate water-soluble inhibitor (dc27). | 5I0L_A |
| MA | M10.009 | matrix metallopeptidase-12 | catalytic domain; complex with a selective sugar-conjugated triazole-linked carboxylate chelating water-soluble inhibitor (dc24). | 5I2Z_A |
| MA | M10.009 | matrix metallopeptidase-12 | catalytic domain; complex with a selective sugar-conjugated thiourea-linked carboxylate zinc-chelator water-soluble inhibitor (dc31). | 5I3M_A |
| MA | M10.009 | matrix metallopeptidase-12 | catalytic domain; complex with a selective sugar-conjugated triazole-linked carboxylate chelator water-soluble inhibitor (dc32). | 5I43_A |
| MA | M10.009 | matrix metallopeptidase-12 | catalytic domain; complex with a selective sugar-conjugated triazole-linked carboxylate zinc-chelator water-soluble inhibitor (dc28). | 5I4O_A |
| MA | M10.009 | matrix metallopeptidase-12 | complex with rxp470.1 conjugated with fluorophore cy5,5 in space group p21212. | 5L79_A |
| MA | M10.009 | matrix metallopeptidase-12 | Lys421Ala mutant; complex with rxp470.1 conjugated with fluorophore cy5,5 in space group p21. | 5L7F_A |
| MA | M10.009 | matrix metallopeptidase-12 | catalytic domain; complex with the inhibitor nngh | 5LAB_A |
| MA | M10.009 | matrix metallopeptidase-12 | complex with 3-(5-(1,2-dithiolan-3-yl)pentanamido) propane-1-sulfonate | 5N5J_A |
| MA | M10.009 | matrix metallopeptidase-12 | complex with 5-(1,2-dithiolan-3-yl)-n-(3- hydroxypropyl)pentanamide | 5N5K_A |
| MA | M10.009 | matrix metallopeptidase-12 | complex with inhibitor be7. | 6EKN_A |
| MA | M10.009 | matrix metallopeptidase-12 | complex with inhibitor be4. | 6ELA_A |
| MA | M10.009 | matrix metallopeptidase-12 | complex with hydroxamate inhibitor lp168. | 6ENM_A |
| MA | M10.009 | matrix metallopeptidase-12 | complex with carboxylic inhibitor lp165. | 6EOX_A |
| MA | M10.013 | matrix metallopeptidase-13 | catalytic domain | 1CXV |
| MA | M10.013 | matrix metallopeptidase-13 | NMR structure; catalytic domain; complex with non-peptidic sulfonomide inhibitor | 1EUB |
| MA | M10.013 | matrix metallopeptidase-13 | NMR structure; catalytic domain; complex with inhibitor WAY-151693 | 1FLS |
| MA | M10.013 | matrix metallopeptidase-13 | NMR structure; catalytic domain; complex with inhibitor WAY-151693 | 1FM1 |
| MA | M10.013 | matrix metallopeptidase-13 | C-terminal hemopexin-like domain | 1PEX |
| MA | M10.013 | matrix metallopeptidase-13 | theoretical model | 1UC1 |
| MA | M10.013 | matrix metallopeptidase-13 | matrix metalloproteinase-13 complexed with non-zinc binding inhibitor | 1XUC_A |
| MA | M10.013 | matrix metallopeptidase-13 | matrix metalloproteinase-13 complexed with non-zinc binding inhibitor | 1XUD_A |
| MA | M10.013 | matrix metallopeptidase-13 | matrix metalloproteinase-13 complexed with non-zinc binding inhibitor | 1XUR_A |
| MA | M10.013 | matrix metallopeptidase-13 | catalytic domain; complex with pyrimidinetrione inhibitor 5-(2-ethoxyethyl)-5-[4-(4-fluorophenoxy)phenoxy]pyrimidine-2,4,6(1H,3H,5H)-trione | 1YOU_A |
| MA | M10.013 | matrix metallopeptidase-13 | catalytic domain; complex with WAY-033 | 1ZTQ_A |
| MA | M10.013 | matrix metallopeptidase-13 | catalytic domain; complex with hydroxamic acid inhibitor SM-25453 | 2D1N_A |
| MA | M10.013 | matrix metallopeptidase-13 | complex with TIMP-2 | 2E2D_A |
| MA | M10.013 | matrix metallopeptidase-13 | catalytic domain; complex with benzyl 6-benzyl-5,7-dioxo-6,7-dihydro-5H-[1,3]thiazolo[3,2-C]pyrimidine-2-carboxylate | 2OW9_A |
| MA | M10.013 | matrix metallopeptidase-13 | mmp13 catalytic domain complexed with 4-[1-methyl-2,4- dioxo-6-(3-phenylprop-1-yn-1-yl)-1,4-dihydroquinazolin- 3(2h)-yl]methylbenzoic acid | 2OZR_A |
| MA | M10.013 | matrix metallopeptidase-13 | catalytic domain; complex with WAY-344 | 2PJT_A |
| MA | M10.013 | matrix metallopeptidase-13 | 2YIG | |
| MA | M10.013 | matrix metallopeptidase-13 | 3ELM | |
| MA | M10.013 | matrix metallopeptidase-13 | 3I7G | |
| MA | M10.013 | matrix metallopeptidase-13 | 3I7I | |
| MA | M10.013 | matrix metallopeptidase-13 | 3KEC | |
| MA | M10.013 | matrix metallopeptidase-13 | 3KEJ | |
| MA | M10.013 | matrix metallopeptidase-13 | 3KEK | |
| MA | M10.013 | matrix metallopeptidase-13 | 3KRY | |
| MA | M10.013 | matrix metallopeptidase-13 | 3LJZ | |
| MA | M10.013 | matrix metallopeptidase-13 | 3O2X | |
| MA | M10.013 | matrix metallopeptidase-13 | 3TVC | |
| MA | M10.013 | matrix metallopeptidase-13 | 3WV1 | |
| MA | M10.013 | matrix metallopeptidase-13 | 3WV2 | |
| MA | M10.013 | matrix metallopeptidase-13 | 3WV3 | |
| MA | M10.013 | matrix metallopeptidase-13 | 3ZXH | |
| MA | M10.013 | matrix metallopeptidase-13 | catalytic domain; complex with 2-4-[4-(4-chloro-phenoxy)-benzenesulfonyl]-tetrahydro-pyran-4-yl-N-hydroxy-acetamide | 456C |
| MA | M10.013 | matrix metallopeptidase-13 | 4A7B | |
| MA | M10.013 | matrix metallopeptidase-13 | 4FU4 | |
| MA | M10.013 | matrix metallopeptidase-13 | 4FVL | |
| MA | M10.013 | matrix metallopeptidase-13 | 4G0D | |
| MA | M10.013 | matrix metallopeptidase-13 | 4JP4 | |
| MA | M10.013 | matrix metallopeptidase-13 | 4JPA | |
| MA | M10.013 | matrix metallopeptidase-13 | 4L19 | |
| MA | M10.013 | matrix metallopeptidase-13 | catalytic domain; complex with n- phenyl-4-((4h-1,2,4-triazol-3-ylsulfanyl)methyl)-1,3-thiazol-2-amine | 5B5O_A |
| MA | M10.013 | matrix metallopeptidase-13 | catalytic domain; complex with 4- oxo-n-(3-(2-(1h-1,2,4-triazol-3-ylsulfanyl)ethoxy)benzyl)-3,4- dihydroquinazoline-2-carboxamide | 5B5P_A |
| MA | M10.013 | matrix metallopeptidase-13 | 5BOT | |
| MA | M10.013 | matrix metallopeptidase-13 | 5BOY | |
| MA | M10.013 | matrix metallopeptidase-13 | 5BPA | |
| MA | M10.013 | matrix metallopeptidase-13 | complex with selective inhibitor compound (s)-10a | 5UWK_A |
| MA | M10.013 | matrix metallopeptidase-13 | complex with selective inhibitor compound (s)-17a | 5UWL_A |
| MA | M10.013 | matrix metallopeptidase-13 | complex with selective inhibitor compound (r)-17a | 5UWM_A |
| MA | M10.013 | matrix metallopeptidase-13 | complex with selective inhibitor compound 10d | 5UWN_A |
| MA | M10.013 | matrix metallopeptidase-13 | complex with the peptide imisf | 6HV2_A |
| MA | M10.013 | matrix metallopeptidase-13 | catalytic domain; complex with 4-[4-(4-chloro-phenoxy)-benzenesulfonylmethyl]-tetrahydro-pyran-4-carboxylic acid hydroxyamide | 830C |
| MA | M10.014 | membrane-type matrix metallopeptidase-1 | complex with TIMP2 | 1BQQ_M |
| MA | M10.014 | membrane-type matrix metallopeptidase-1 | complex with TIMP2 | 1BUV_M |
| MA | M10.014 | membrane-type matrix metallopeptidase-1 | 2MQS | |
| MA | M10.014 | membrane-type matrix metallopeptidase-1 | 3C7X | |
| MA | M10.014 | membrane-type matrix metallopeptidase-1 | 3MA2_D | |
| MA | M10.014 | membrane-type matrix metallopeptidase-1 | 3X23 | |
| MA | M10.014 | membrane-type matrix metallopeptidase-1 | 4P3C | |
| MA | M10.014 | membrane-type matrix metallopeptidase-1 | 4P3D | |
| MA | M10.014 | membrane-type matrix metallopeptidase-1 | 4QXU | |
| MA | M10.014 | membrane-type matrix metallopeptidase-1 | crystal structure of the catalytic domain of membrane type 1 matrix metalloproteinase | 5H0U_A |
| MA | M10.016 | membrane-type matrix metallopeptidase-3 | catalytic domain | 1RM8_A |
| MA | M10.019 | matrix metallopeptidase-20 | 2JSD | |
| MA | M10.020 | fragilysin | 3P24 | |
| MA | M10.022 | matrix metallopeptidase-23B | 2K72 | |
| MA | M10.039 | metallopeptidase II (Bacteroides fragilis) | 4ON1 | |
| MA | M10.051 | serralysin | complex with zinc | 1SRP |
| MA | M10.051 | serralysin | complex with CBZ-Leu-hydroxyaminoalanine | 1AF0 |
| MA | M10.051 | serralysin | 1SAT | |
| MA | M10.051 | serralysin | complex with Erwinia chrysanthemi inhibitor | 1SMP_A |
| MA | M10.051 | serralysin | 4I35 | |
| MA | M10.051 | serralysin | crystal structure of serralysin | 5D7W_A |
| MA | M10.054 | peptidase C (Erwinia-type) | Glu189Ala, Met226Leu double mutant | 1GO7 |
| MA | M10.054 | peptidase C (Erwinia-type) | Met226Leu mutant | 1GO8 |
| MA | M10.054 | peptidase C (Erwinia-type) | 1K7G | |
| MA | M10.054 | peptidase C (Erwinia-type) | Tyr228Phe mutant | 1K7I |
| MA | M10.054 | peptidase C (Erwinia-type) | Glu189Ala mutant | 1K7Q |
| MA | M10.054 | peptidase C (Erwinia-type) | ON HOLD | 3HB2 |
| MA | M10.054 | peptidase C (Erwinia-type) | ON HOLD | 3HBU |
| MA | M10.054 | peptidase C (Erwinia-type) | Met226Ala mutant | 3HBV |
| MA | M10.054 | peptidase C (Erwinia-type) | Met226Ala mutant | 3HDA |
| MA | M10.056 | aeruginolysin | 1AKL | |
| MA | M10.056 | aeruginolysin | complex with aprin inhibitor | 1JIW_P |
| MA | M10.056 | aeruginolysin | complex with Gly-Ser-Asn-Ser | 1KAP |
| MA | M10.056 | aeruginolysin | 3VI1 | |
| MA | M10.062 | psychrophilic alkaline metallopeptidase (Pseudomonas sp.) | 1G9K | |
| MA | M10.062 | psychrophilic alkaline metallopeptidase (Pseudomonas sp.) | 1H71 | |
| MA | M10.062 | psychrophilic alkaline metallopeptidase (Pseudomonas sp.) | co-crystallized with 1 mm EDTA | 1O0Q |
| MA | M10.062 | psychrophilic alkaline metallopeptidase (Pseudomonas sp.) | co-crystallized with 5 mm EDTA (5 days) | 1O0T |
| MA | M10.062 | psychrophilic alkaline metallopeptidase (Pseudomonas sp.) | co-crystallized with 5 mm EDTA (2 months) | 1OM6 |
| MA | M10.062 | psychrophilic alkaline metallopeptidase (Pseudomonas sp.) | co-crystallized with 85 mm EDTA | 1OM7 |
| MA | M10.062 | psychrophilic alkaline metallopeptidase (Pseudomonas sp.) | co-crystallized with 10 mm EDTA | 1OM8 |
| MA | M10.062 | psychrophilic alkaline metallopeptidase (Pseudomonas sp.) | 1OMJ | |
| MA | M10.062 | psychrophilic alkaline metallopeptidase (Pseudomonas sp.) | structure analysis of a new psychrophilic marine protease | 3U1R_A |
| MA | M10.066 | karilysin | 2XS3 | |
| MA | M10.066 | karilysin | 2XS4 | |
| MA | M10.066 | karilysin | 4IN9 | |
| MA | M10.066 | karilysin | 4R3V | |
| MA | M100.001 | spartan peptidase | 6MDW | |
| MA | M100.001 | spartan peptidase | 6MDX | |
| MU | M103.001 | TldD peptidase (Escherichia coli) | complex with TldE | 5NJ5_A |
| MU | M103.001 | TldD peptidase (Escherichia coli) | complex with TldE and DRVY angiotensin fragment | 5NJ9_A |
| MU | M103.001 | TldD peptidase (Escherichia coli) | complex with TldE and angiotensin analogue | 5NJA_A |
| MU | M103.001 | TldD peptidase (Escherichia coli) | complex with TldE and actinonin | 5NJB_A |
| MU | M103.001 | TldD peptidase (Escherichia coli) | Glu263Ala mutant; complex with TldE and hexapeptide | 5NJC_A |
| MU | M103.001 | TldD peptidase (Escherichia coli) | His262Ala mutant; complex with TldE and pentapeptide | 5NJF_A |
| MU | M103.002 | peptidase modulator of DNA gyrase (Bacteroides) | TOPSAN | 1VPB |
| MU | M103.003 | TM_0727 g.p. (Thermotoga maritima) | 1VL4 | |
| MU | M103.950 | microcin-processing peptidase 1 homologue | complex with TldD | 5NJ5_B |
| MU | M103.950 | microcin-processing peptidase 1 homologue | complex with TldD and DRVY angiotensin fragment | 5NJ9_B |
| MU | M103.950 | microcin-processing peptidase 1 homologue | complex with TldD and angiotensin analogue | 5NJA_B |
| MU | M103.950 | microcin-processing peptidase 1 homologue | complex with TldD and actinonin | 5NJB_B |
| MU | M103.950 | microcin-processing peptidase 1 homologue | complex with TldD and hexapeptide | 5NJC_B |
| MU | M103.950 | microcin-processing peptidase 1 homologue | complex with TldD and pentapeptide | 5NJF_B |
| MU | M103.UNW | family M103 non-peptidase homologues | 3QTD | |
| MA | M12.001 | astacin | 1AST | |
| MA | M12.001 | astacin | zinc replaced with copper | 1IAA |
| MA | M12.001 | astacin | zinc replaced with cobalt | 1IAB |
| MA | M12.001 | astacin | zinc replaced with mercury | 1IAC |
| MA | M12.001 | astacin | zinc removed | 1IAD |
| MA | M12.001 | astacin | zinc replaced with nickel | 1IAE |
| MA | M12.001 | astacin | 1QJI_A | |
| MA | M12.001 | astacin | complex with Pro-Leu-Gly-hydroxamic acid inhibitor | 1QJJ |
| MA | M12.001 | astacin | precursor | 3LQ0 |
| MA | M12.001 | astacin | complex mouse fetuin-b | 6HT9_A |
| MA | M12.002 | meprin alpha subunit | theoretical model | 1IAF |
| MA | M12.004 | meprin beta subunit | 4GWM | |
| MA | M12.004 | meprin beta subunit | 4GWN | |
| MA | M12.005 | procollagen C-peptidase | peptidase domain only | 3EDG |
| MA | M12.005 | procollagen C-peptidase | complex with partially bound dimethyl sulfoxide (DMSO) | 3EDH |
| MA | M12.005 | procollagen C-peptidase | complex with a reverse hydroxymate - compound 22 | 6BSL_A |
| MA | M12.005 | procollagen C-peptidase | complex with a reverse hydroxamate - compound 4 | 6BSM_A |
| MA | M12.005 | procollagen C-peptidase | complex with a reverse hydroxymate - compound 1 | 6BTN_A |
| MA | M12.005 | procollagen C-peptidase | complex with (2~s)-2-[[(1~r,3~s,4~s)-2-[(2~r)-2-[2- (oxidanylamino)-2-oxidanylidene-ethyl]heptanoyl]-2- azabicyclo[2.2.1]heptan-3-yl]carbonylamino]-2-phenyl-ethanoic acid | 6BTO_A |
| MA | M12.005 | procollagen C-peptidase | complex with a hydroxamate | 6BTP_A |
| MA | M12.005 | procollagen C-peptidase | complex with a hydroxamate - compound 2 | 6BTQ_A |
| MA | M12.007 | choriolysin H | high choriolytic enzyme 1 (hce-1), a hatching enzyme zinc-protease from oryzias latipes (medaka fish) | 3VTG_A |
| MA | M12.007 | choriolysin H | 3LQB | |
| MA | M12.016 | vertebrate tolloid-like 1 protein | peptidase domain only | 3EDI |
| MA | M12.067 | myroilysin | crystal structure of myroilysin | 5CZW_A |
| MA | M12.067 | myroilysin | 5GWD | |
| MA | M12.067 | myroilysin | 5ZJK | |
| MA | M12.131 | acutolysin A | crystallized at pH 7.5 | 1BSW |
| MA | M12.131 | acutolysin A | crystallized at pH 5.0 | 1BUD |
| MA | M12.138 | jararhagin | theoretical model | 1C9G |
| MA | M12.140 | bothropasin | Complex with POL647 inhibitor | 3DSL |
| MA | M12.141 | adamalysin | 1IAG | |
| MA | M12.141 | adamalysin | complex with peptidomimetic inhibitor POL647 | 2AIG |
| MA | M12.141 | adamalysin | complex with peptidomimetic inhibitor POL656 | 3AIG |
| MA | M12.141 | adamalysin | complex with N-[(furan-2-yl)carbonyl]-(S)-leucyl-(R)-[1-amino-2(1H-indol-3-yl)ethyl]-phosphonic acid | 4AIG |
| MA | M12.144 | atrolysin C | 1ATL_A | |
| MA | M12.144 | atrolysin C | form D | 1DTH |
| MA | M12.144 | atrolysin C | form D | 1HTD |
| MA | M12.155 | trimerelysin II | 1WNI_A | |
| MA | M12.155 | trimerelysin II | 1FVL | |
| MA | M12.155 | trimerelysin II | 4J4M | |
| MA | M12.157 | mucrolysin | 1KUF_A | |
| MA | M12.157 | mucrolysin | 1KUG_A | |
| MA | M12.157 | mucrolysin | 1KUI_A | |
| MA | M12.157 | mucrolysin | 1KUK_A | |
| MA | M12.158 | russellysin | 2E3X | |
| MA | M12.159 | cobrin | 3K7L | |
| MA | M12.161 | kistomin (Calloselasma rhodostoma) | 1N4Y | |
| MA | M12.161 | kistomin (Calloselasma rhodostoma) | 1Q7I | |
| MA | M12.161 | kistomin (Calloselasma rhodostoma) | 1Q7J | |
| MA | M12.161 | kistomin (Calloselasma rhodostoma) | 2LJV | |
| MA | M12.161 | kistomin (Calloselasma rhodostoma) | 2M75 | |
| MA | M12.161 | kistomin (Calloselasma rhodostoma) | 2M7F | |
| MA | M12.161 | kistomin (Calloselasma rhodostoma) | 2M7H | |
| MA | M12.161 | kistomin (Calloselasma rhodostoma) | 2PJF | |
| MA | M12.161 | kistomin (Calloselasma rhodostoma) | 2PJG | |
| MA | M12.161 | kistomin (Calloselasma rhodostoma) | 2PJI | |
| MA | M12.161 | kistomin (Calloselasma rhodostoma) | 3UCI | |
| MA | M12.161 | kistomin (Calloselasma rhodostoma) | 4M4C | |
| MA | M12.161 | kistomin (Calloselasma rhodostoma) | 4R5R | |
| MA | M12.161 | kistomin (Calloselasma rhodostoma) | 4R5U | |
| MA | M12.161 | kistomin (Calloselasma rhodostoma) | 4RQG | |
| MA | M12.178 | brevilysin L6 | 2GP2 | |
| MA | M12.186 | vascular apoptosis-inducing protein 1 | orthorhombic crystal form | 2ERO |
| MA | M12.186 | vascular apoptosis-inducing protein 1 | 2ERP | |
| MA | M12.186 | vascular apoptosis-inducing protein 1 | tetragonal crystal form | 2ERQ |
| MA | M12.208 | ADAM8 peptidase | 4DD8 | |
| MA | M12.209 | ADAM9 peptidase | 1M1V | |
| MA | M12.210 | ADAM10 peptidase | 2AO7 | |
| MA | M12.210 | ADAM10 peptidase | D+C domain; complex with a conformation specific mab 8c7. | 5L0Q_A |
| MA | M12.210 | ADAM10 peptidase | 1M1I | |
| MA | M12.210 | ADAM10 peptidase | adam10 extracellular domain bound by the 11g2 fab | 6BDZ_L |
| MA | M12.210 | ADAM10 peptidase | extracellular domain | 6BE6_A |
| MA | M12.217 | ADAM17 peptidase | catalytic domain | 1BKC_A |
| MA | M12.217 | ADAM17 peptidase | 1ZXC | |
| MA | M12.217 | ADAM17 peptidase | 2A8H | |
| MA | M12.217 | ADAM17 peptidase | 2DDF | |
| MA | M12.217 | ADAM17 peptidase | 2FV5 | |
| MA | M12.217 | ADAM17 peptidase | 2FV9 | |
| MA | M12.217 | ADAM17 peptidase | 2I47 | |
| MA | M12.217 | ADAM17 peptidase | 2M2F | |
| MA | M12.217 | ADAM17 peptidase | 2OI0 | |
| MA | M12.217 | ADAM17 peptidase | 3B92 | |
| MA | M12.217 | ADAM17 peptidase | complex with TIMP-3 | 3CKI_A |
| MA | M12.217 | ADAM17 peptidase | 3E8R | |
| MA | M12.217 | ADAM17 peptidase | 3EDZ | |
| MA | M12.217 | ADAM17 peptidase | 3EWJ | |
| MA | M12.217 | ADAM17 peptidase | 3G42 | |
| MA | M12.217 | ADAM17 peptidase | 3KMC | |
| MA | M12.217 | ADAM17 peptidase | 3KME | |
| MA | M12.217 | ADAM17 peptidase | 3L0T | |
| MA | M12.217 | ADAM17 peptidase | 3L0V | |
| MA | M12.217 | ADAM17 peptidase | 3LE9 | |
| MA | M12.217 | ADAM17 peptidase | 3LEA | |
| MA | M12.217 | ADAM17 peptidase | 3LGP | |
| MA | M12.217 | ADAM17 peptidase | 3O64 | |
| MA | M12.221 | ADAMTS4 peptidase | complex with inhibitor N-(4'-[(4-isobutyrylphenoxy)methyl]biphenyl- 4-ylsulfonyl)-D-valine | 2RJP_A |
| MA | M12.221 | ADAMTS4 peptidase | apo form | 3B2Z_A |
| MA | M12.221 | ADAMTS4 peptidase | 4WK7 | |
| MA | M12.221 | ADAMTS4 peptidase | 4WKE | |
| MA | M12.221 | ADAMTS4 peptidase | 4WKI | |
| MA | M12.222 | ADAMTS1 peptidase | catalytic domain and cysteine-rich domain (complex-form) | 2JIH_A |
| MA | M12.222 | ADAMTS1 peptidase | catalytic domain and cysteine-rich domain (apo-form) | 2V4B_A |
| MA | M12.222 | ADAMTS1 peptidase | 3Q2G | |
| MA | M12.222 | ADAMTS1 peptidase | 3Q2H | |
| MA | M12.225 | ADAMTS5 peptidase | complex with inhibitor | 2RJQ_A |
| MA | M12.225 | ADAMTS5 peptidase | high resolution crystal structure of the catalytic domain of adamts-5 (aggrecanase-2) | 3B8Z_A |
| MA | M12.225 | ADAMTS5 peptidase | 3HY7 | |
| MA | M12.225 | ADAMTS5 peptidase | 3HY9 | |
| MA | M12.225 | ADAMTS5 peptidase | 3HYG | |
| MA | M12.225 | ADAMTS5 peptidase | 3LJT | |
| MA | M12.241 | ADAMTS13 peptidase | 3GHM | |
| MA | M12.241 | ADAMTS13 peptidase | 3GHN | |
| MA | M12.241 | ADAMTS13 peptidase | 3VN4 | |
| MA | M12.242 | TM-3 peptidase (Trimeresurus mucrosquamatus) | complex with cadmium | 1KUF |
| MA | M12.242 | TM-3 peptidase (Trimeresurus mucrosquamatus) | complex with inhibitor pGlu-Asn-Trp | 1KUG |
| MA | M12.242 | TM-3 peptidase (Trimeresurus mucrosquamatus) | complex with inhibitor pGlu-Asn-Trp | 1KUI |
| MA | M12.242 | TM-3 peptidase (Trimeresurus mucrosquamatus) | complex with inhibitor pGlu-Asn-Trp | 1KUK |
| MA | M12.244 | ADAM33 peptidase | Catalytic domain only | 1R54_A |
| MA | M12.244 | ADAM33 peptidase | Catalytic domain only | 1R55_A |
| MA | M12.303 | acutolysin C | 1QUA | |
| MA | M12.311 | BaP1 peptidase (Bothrops asper) | 1ND1_A | |
| MA | M12.311 | BaP1 peptidase (Bothrops asper) | complex with a peptidomimetic: insights into inhibitor binding | 2W12_A |
| MA | M12.311 | BaP1 peptidase (Bothrops asper) | complex with a peptidomimetic: insights into inhibitor binding | 2W13_A |
| MA | M12.311 | BaP1 peptidase (Bothrops asper) | complex with a peptidomimetic: insights into inhibitor binding | 2W14_A |
| MA | M12.311 | BaP1 peptidase (Bothrops asper) | complex with a peptidomimetic: insights into inhibitor binding | 2W15_A |
| MA | M12.326 | brevilysin L4 | 1L3X | |
| MA | M12.332 | catrocollastatin | form 2- 1 crystal | 2DW0_A |
| MA | M12.332 | catrocollastatin | form 2- 2 crystal | 2DW1_A |
| MA | M12.332 | catrocollastatin | form 2- 5 crystal | 2DW2_A |
| MA | M12.337 | acutolysin F | 1QUA_A | |
| MA | M12.337 | acutolysin F | 1YP1 | |
| MA | M12.338 | BmooMPalpha-I (Bothrops sp.) | ON HOLD | 3GBO |
| MA | M12.978 | ADAM22 protein | 3G5C | |
| MA | M12.978 | ADAM22 protein | complex with human lgi1 eptp | 5Y2Z_A |
| MA | M12.978 | ADAM22 protein | complex with human lgi1 | 5Y31_A |
| MA | M13.001 | neprilysin | theoretical model of peptidase domain (residues 507-749) | 1DL9 |
| MA | M13.001 | neprilysin | complex with phosphoramidon | 1DMT_A |
| MA | M13.001 | neprilysin | 1QVD | |
| MA | M13.001 | neprilysin | structural analysis of neprilysin with various specific and potent inhibitors | 1R1H_A |
| MA | M13.001 | neprilysin | structural analysis of neprilysin with various specific and potent inhibitors | 1R1I_A |
| MA | M13.001 | neprilysin | structural analysis of neprilysin with various specific and potent inhibitors | 1R1J_A |
| MA | M13.001 | neprilysin | complex with an imidazo[4, 5-C]pyridine inhibitor | 1Y8J_A |
| MA | M13.001 | neprilysin | human nep complexed with a bifunctional nep/dpp iv inhibitor | 2QPJ_A |
| MA | M13.001 | neprilysin | 2YB9 | |
| MA | M13.001 | neprilysin | 4CTH | |
| MA | M13.001 | neprilysin | neprilysin complex with lbq657 | 5JMY_A |
| MA | M13.001 | neprilysin | 6GID | |
| MA | M13.001 | neprilysin | soluble rabbit neprilysin | 4XBH_A |
| MA | M13.001 | neprilysin | complex with phosphoramidon | 4ZR5_A |
| MA | M13.001 | neprilysin | soluble rabbit neprilysin in complex with thiorphan | 5V48_A |
| MA | M13.001 | neprilysin | 2YVC | |
| MA | M13.002 | endothelin-converting enzyme 1 | complex with phosphoramidon | 3DWB |
| MA | M13.003 | endothelin-converting enzyme 2 | 2PXX | |
| MA | M13.009 | Zmp1 peptidase (Mycobacterium-type) | complex with phosphoramidon | 3ZUK |
| MC | M14.001 | carboxypeptidase A1 | 2V77 | |
| MC | M14.001 | carboxypeptidase A1 | complex with carboxypeptidase A inhibitor (Ascaris suum) | 3FJU_A |
| MC | M14.001 | carboxypeptidase A1 | complex with the phosphinic inhibitor acetyl-leu-ala-y(po2ch2)-homophe-oh | 4UEE_A |
| MC | M14.001 | carboxypeptidase A1 | complex with the phosphinic inhibitor acetyl-tyr-ala-y(po2ch2)-homophe-oh | 4UEF_A |
| MC | M14.001 | carboxypeptidase A1 | complex with the phosphinic inhibitor acetyl-leu-phe-y( po2ch2)-phe-oh | 4UEZ_A |
| MC | M14.001 | carboxypeptidase A1 | complex with a thiirane mechanism-based inhibitor | 4UF4_A |
| MC | M14.001 | carboxypeptidase A1 | complex with a thiirane mechanism-based inhibitor | 5OM9_A |
| MC | M14.001 | carboxypeptidase A1 | complex with thephosphinic inhibitor acetyl-tyr-ala-y(po2ch2)-homophe-oh | 6I6Z_A |
| MC | M14.001 | carboxypeptidase A1 | complex with Gly-L-Tyr | 0CPS |
| MC | M14.001 | carboxypeptidase A1 | zinc removed | 1ARL |
| MC | M14.001 | carboxypeptidase A1 | zinc replaced with mercury | 1ARM |
| MC | M14.001 | carboxypeptidase A1 | complex with 2-benzyl-3-iodo-propanoic acid | 1BAV |
| MC | M14.001 | carboxypeptidase A1 | complex with L-benzylsuccinate inhibitor | 1CBX |
| MC | M14.001 | carboxypeptidase A1 | complex with [L-2-carboxy-3-phenylpropyl]methyl-sulfodiimine | 1CPS |
| MC | M14.001 | carboxypeptidase A1 | beta form with two zinc ions in active site | 1CPX |
| MC | M14.001 | carboxypeptidase A1 | cadmium-substituted form at pH 7.5 | 1EE3 |
| MC | M14.001 | carboxypeptidase A1 | cadmium-substituted form at pH 7.5 | 1ELL |
| MC | M14.001 | carboxypeptidase A1 | cadmium-substituted form at pH 5.5 | 1ELM |
| MC | M14.001 | carboxypeptidase A1 | complex with D-cysteine | 1F57 |
| MC | M14.001 | carboxypeptidase A1 | complex with D-N-hydroxyaminocarbonyl-Phe | 1HDQ |
| MC | M14.001 | carboxypeptidase A1 | complex with aminocarbonyl-Phe | 1HDU |
| MC | M14.001 | carboxypeptidase A1 | complex with L-N-hydroxyaminocarbonyl-Phe | 1HEE |
| MC | M14.001 | carboxypeptidase A1 | complex with phenylalanine-N-sulfonamide | 1IY7_A |
| MC | M14.001 | carboxypeptidase A1 | 1M4L | |
| MC | M14.001 | carboxypeptidase A1 | complex of procarboxypeptidase A, proproteinase E and chymotrypsinogen C | 1PYT_AB |
| MC | M14.001 | carboxypeptidase A1 | 1YME | |
| MC | M14.001 | carboxypeptidase A1 | complex with tick carboxypeptidase inhibitor | 1ZLH_A |
| MC | M14.001 | carboxypeptidase A1 | complex with engineered leech metallocarboxypeptidase inhibitor | 2ABZ_A |
| MC | M14.001 | carboxypeptidase A1 | 2CTB | |
| MC | M14.001 | carboxypeptidase A1 | complex with L-phenyl lactate | 2CTC |
| MC | M14.001 | carboxypeptidase A1 | crystal structure analysis of cpa-2-benzyl-3-nitropropanoic acid complex | 2RFH_A |
| MC | M14.001 | carboxypeptidase A1 | complex with glycyl-L-tyrosine | 3CPA |
| MC | M14.001 | carboxypeptidase A1 | crystallogic studies on the complex of carboxypeptidase a with inhibitors using alpha-hydroxy ketone as zinc-binding group | 3FVL_A |
| MC | M14.001 | carboxypeptidase A1 | x-ray crystallographic studies on the complex of carboxypeptidase a with the inhibitor using alpha-nitro ketone as the zinc-binding group | 3FX6_A |
| MC | M14.001 | carboxypeptidase A1 | complex with an organic small-molecule: conformational changes | 3HLP_A |
| MC | M14.001 | carboxypeptidase A1 | complex with an organic small-molecule: conformational changes | 3HUV_A |
| MC | M14.001 | carboxypeptidase A1 | complex with a thiirane mechanism-based inactivator | 3I1U_A |
| MC | M14.001 | carboxypeptidase A1 | complex with an organic small-molecule: conformational changes | 3KGQ_A |
| MC | M14.001 | carboxypeptidase A1 | complex with potato carboxypeptidase A inhibitor | 4CPA_A |
| MC | M14.001 | carboxypeptidase A1 | 5CPA | |
| MC | M14.001 | carboxypeptidase A1 | complex with O-[[(1R)-[[N-phenylmethoxycarbonyl)-L-Ala]amino]ethyl]hydroxyphosphinyl]-L-3-phenyllactate | 6CPA |
| MC | M14.001 | carboxypeptidase A1 | complex with Bz-Phe-Val-P-(O)-Phe | 7CPA |
| MC | M14.001 | carboxypeptidase A1 | complex with BZ-Ala-Gly-(P)-(O)-Phe | 8CPA |
| MC | M14.001 | carboxypeptidase A1 | precursor | 1PCA |
| MC | M14.002 | carboxypeptidase A2 | precursor | 1AYE |
| MC | M14.002 | carboxypeptidase A2 | complex with leech carboxypeptidase inhibitor | 1DTD_A |
| MC | M14.003 | carboxypeptidase B | precursor | 1KWM |
| MC | M14.003 | carboxypeptidase B | complex with tick carboxypeptidase inhibitor | 1ZLI_A |
| MC | M14.003 | carboxypeptidase B | fraction II | 1CPB |
| MC | M14.003 | carboxypeptidase B | procarboxypeptidase activation domain (NMR) | 1PBA |
| MC | M14.003 | carboxypeptidase B | precursor | 1NSA |
| MC | M14.003 | carboxypeptidase B | 1Z5R_A | |
| MC | M14.003 | carboxypeptidase B | complex with 2-(5-[amino(imino)methyl]amino-2- chlorophenyl)-3-sulfanylpropanoic acid | 1ZG7_A |
| MC | M14.003 | carboxypeptidase B | complex with (R)-2-(3-[amino(imino) methyl]aminophenyl)-3-sulfanylpropanoic acid | 1ZG8_A |
| MC | M14.003 | carboxypeptidase B | complex with 5-[amino(imino)methyl]amino-2- (sulfanylmethyl)pentanoic acid | 1ZG9_A |
| MC | M14.003 | carboxypeptidase B | complex with ( (2s)-5-amino-2-((1-N-propyl-1h- imidazol-4-yl)methyl)pentanoic acid) UK396,082 a tafia inhibitor | 2JEW_A |
| MC | M14.003 | carboxypeptidase B | complex with (s)-2-(3-aminomethyl-phenyl)-3-hydroxy- [(r)-2-methyl-1-(3-phenyl-propane-1-sulfonylamino)-propyl]- phosp | 2PIY_A |
| MC | M14.003 | carboxypeptidase B | complex with 2-(3-guanidino-phenyl)-3-[hydroxy-(3- phenyl-propyl)-phosphinoyl]-propionic acid | 2PIZ_A |
| MC | M14.003 | carboxypeptidase B | complex with [((r)-1-benzyloxycarbonylamino-2-methyl- propyl)-hydroxy-phosphinoyloxy]-(3-guanidino-phenyl)- acetic acid | 2PJ0_A |
| MC | M14.003 | carboxypeptidase B | complex with (3-aminomethyl-phenyl)-[((r)-1- benzyloxycarbonylamino-2-methyl-propyl)-hydroxy- phosphinoyloxy]-acetic ac | 2PJ1_A |
| MC | M14.003 | carboxypeptidase B | complex with 2-(3-aminomethyl-phenyl)-3-[((r)-1- benzyloxycarbonylamino-2-methyl-propyl)-hydroxy- phosphinoyl]-propioni | 2PJ2_A |
| MC | M14.003 | carboxypeptidase B | complex with (3-guanidino-phenyl)-hydroxy-[(r)-2- methyl-1-(3-phenyl-propionylamino)-propyl]-phosphinoyloxy- acetic a | 2PJ3_A |
| MC | M14.003 | carboxypeptidase B | complex with [((r)-benzyloxycarbonylamino-cyclohexyl- methyl)-hydroxy-phosphinoyloxy]-(3-guanidino-phenyl)- acetic acid | 2PJ4_A |
| MC | M14.003 | carboxypeptidase B | complex with [((r)-1-benzyloxycarbonylamino-hexyl)- hydroxy-phosphinoyloxy]-(3-guanidino-phenyl)-acetic acid complex | 2PJ5_A |
| MC | M14.003 | carboxypeptidase B | complex with 2-(3-aminomethyl-phenyl)-3-hydroxy- [(r)-2-methyl-1-(2-phenyl-ethanesulfonylamino)-propyl]- phosphinoyl- | 2PJ6_A |
| MC | M14.003 | carboxypeptidase B | complex with 2-(3-aminomethyl-phenyl)-3-[((r)-1- benzenesulfonylamino-2-methyl-propyl)-hydroxy-phosphinoyl]- propionic | 2PJ7_A |
| MC | M14.003 | carboxypeptidase B | complex with 2-(3-aminomethyl-phenyl)-3-[(r)-1- (biphenyl-4-sulfonylamino)-2-methyl-propyl]-hydroxy- phosphinoyl-prop | 2PJ8_A |
| MC | M14.003 | carboxypeptidase B | complex with 2-(3-aminomethyl-phenyl)-3-[(r)-1- (benzo[1,2,5]thiadiazole-4-sulfonylamino)-2-methyl-propyl]- hydroxy-ph | 2PJ9_A |
| MC | M14.003 | carboxypeptidase B | complex with 3-[(r)-1-((s)-2-benzyloxycarbonylamino- 3-phenyl-propionylamino)-2-methyl-propyl]-hydroxy- phosphinoyl-2 | 2PJA_A |
| MC | M14.003 | carboxypeptidase B | complex with 2-(3-aminomethyl-phenyl)-3-[1-((s)-2- benzyloxycarbonylamino-3-phenyl-propane-1-sulfonylamino)-2- methyl- | 2PJB_A |
| MC | M14.003 | carboxypeptidase B | complex with ((r)-1-[(s)-2-benzyloxycarbonylamino-3- (4-hydroxy-phenyl)-propionylamino]-2-methyl-propyl- hydroxy-phos | 2PJC_A |
| MC | M14.003 | carboxypeptidase B | zymogen | 3GLJ_A |
| MC | M14.003 | carboxypeptidase B | in complex with dd2 | 3WAB_A |
| MC | M14.003 | carboxypeptidase B | complex with dd9 | 3WC5_A |
| MC | M14.003 | carboxypeptidase B | complex with 2nd zinc | 3WC6_A |
| MC | M14.003 | carboxypeptidase B | complex with ef6265 | 3WC7_A |
| MC | M14.003 | carboxypeptidase B | complex with tafcpb | 4UIA_A |
| MC | M14.003 | carboxypeptidase B | complex with tafcpb | 4UIB_A |
| MC | M14.003 | carboxypeptidase B | with sulphamoil arginine | 4Z65_A |
| MC | M14.003 | carboxypeptidase B | with sulphamoil phenylalanine | 5J1Q_A |
| MC | M14.003 | carboxypeptidase B | with 2-ND zinc and acetate ion | 5JC6_A |
| MC | M14.003 | carboxypeptidase B | complex with anabaenopeptin B | 5LRG |
| MC | M14.003 | carboxypeptidase B | complex with anabaenopeptin C | 5LRJ |
| MC | M14.003 | carboxypeptidase B | complex with anabaenopeptin F | 5LRK |
| MC | M14.003 | carboxypeptidase B | crystal structure of 1 in complex with tafcpb | 5LYD_A |
| MC | M14.003 | carboxypeptidase B | crystal structure of 1 in complex with tafcpb | 5LYF_A |
| MC | M14.003 | carboxypeptidase B | crystal structure of 1 in complex with tafcpb | 5LYI_A |
| MC | M14.003 | carboxypeptidase B | crystal structure of 1 in complex with tafcpb | 5LYL_A |
| MC | M14.003 | carboxypeptidase B | complex with dd28 | 5ZEQ_A |
| MC | M14.004 | carboxypeptidase N | catalytic domain only | 2NSM |
| MC | M14.006 | carboxypeptidase M | 1UWY | |
| MC | M14.007 | carboxypeptidase T | 1OBR | |
| MC | M14.007 | carboxypeptidase T | 3PRT | |
| MC | M14.007 | carboxypeptidase T | 3QNV | |
| MC | M14.007 | carboxypeptidase T | 3V38 | |
| MC | M14.007 | carboxypeptidase T | complex with 2-guanidinoethylmercapto)succinic acid | 3V7Z |
| MC | M14.007 | carboxypeptidase T | 4DJL | |
| MC | M14.007 | carboxypeptidase T | complex with L-benzylsuccinic acid | 4DUK |
| MC | M14.007 | carboxypeptidase T | 4F8Z | |
| MC | M14.007 | carboxypeptidase T | 4GM5 | |
| MC | M14.007 | carboxypeptidase T | 4IAV | |
| MC | M14.007 | carboxypeptidase T | 4IHM | |
| MC | M14.007 | carboxypeptidase T | 4IK2 | |
| MC | M14.007 | carboxypeptidase T | carboxypeptidase t with n-sulfamoyl-l-glutamic acid | 5MYH_A |
| MC | M14.007 | carboxypeptidase T | carboxypeptidase t mutant l254n with sulphamoil arginine | 6F6Q_A |
| MC | M14.007 | carboxypeptidase T | carboxypeptidase t mutant l254n with sulphamoil leucine | 6F75_A |
| MC | M14.007 | carboxypeptidase T | carboxypeptidase t mutant l211q with sulphamoil arginine | 6F79_A |
| MC | M14.007 | carboxypeptidase T | carboxypeptidase t with n-sulfamoyl-l-leucine | 6GO2_A |
| MC | M14.007 | carboxypeptidase T | carboxypeptidase t mutant l254n with with n-sulfamoyl-l-glutamic acid | 6Q4L_A |
| MC | M14.009 | carboxypeptidase B2 | 3D66_A | |
| MC | M14.009 | carboxypeptidase B2 | crystal structure of thrombin-activatable fibrinolysis inhibitor (tafi); complex with 2-guanidino-ethyl- mercaptosuccinic acid (gemsa) | 3D67_A |
| MC | M14.009 | carboxypeptidase B2 | crystal structure of a t325i/t329i/h333y/h335q mutant of thrombin-activatable fibrinolysis inhibitor (tafi-iiyq) | 3D68_A |
| MC | M14.009 | carboxypeptidase B2 | 3LMS_A | |
| MC | M14.009 | carboxypeptidase B2 | 4P10 | |
| MC | M14.009 | carboxypeptidase B2 | crystal structure of thrombin-activatable fibrinolysis inhibitor in complex with an inhibitory nanobody (vhh-i83) | 5HVF_A |
| MC | M14.009 | carboxypeptidase B2 | crystal structure of thrombin-activatable fibrinolysis inhibitor in complex with an inhibitory nanobody (vhh-a204) | 5HVG_A |
| MC | M14.009 | carboxypeptidase B2 | crystal structure of thrombin-activatable fibrinolysis inhibitor in complex with two inhibitory nanobodies | 5HVH_A |
| MC | M14.009 | carboxypeptidase B2 | complex with tick carboxypeptidase inhibitor | 3D4U_A |
| MC | M14.009 | carboxypeptidase B2 | CRYSTAL STRUCTURE OF THROMBIN ACTIVATABLE FIBRINOLYSIS INHIBITOR TITLE 2 (TAFI) | 3DGV |
| MC | M14.009 | carboxypeptidase B2 | 3OSL_A | |
| MC | M14.011 | metallocarboxypeptidase D peptidase unit 1 | domain II; complex with GEMSA | 1H8L_A |
| MC | M14.011 | metallocarboxypeptidase D peptidase unit 1 | domain II | 1QMU_A |
| MC | M14.017 | carboxypeptidase A4 | complex with human latexin | 2BK7_A |
| MC | M14.017 | carboxypeptidase A4 | complex with human latexin | 2BO9_A |
| MC | M14.017 | carboxypeptidase A4 | 2BOA_A | |
| MC | M14.017 | carboxypeptidase A4 | complex with a cleaved hexapeptide | 2PCU_A |
| MC | M14.021 | metallocarboxypeptidase O | complex with MvCl | 5MRV_A |
| MC | M14.024 | insect gut carboxypeptidase-1 | Mature peptidase | 1JQG |
| MC | M14.032 | insect gut carboxypeptidase-3 | 2C1C_A | |
| MC | M14.034 | murein peptide amidase MpaA | crystal structure of murein-tripeptide amidase mpaa from escherichia coli o157 | 5HXD_A |
| MC | M14.037 | protein Silver domain 1 | structure of drosophila melanogaster carboxypeptidase d isoform 1b short | 3MN8_A |
| MC | M14.950 | metallocarboxypeptidase D non-peptidase unit | the structure of the transthyretin-like domain of the first catalytic domain of the human carboxypeptidase d ***caveat 5aq0 thr a 412 c-beta wrong hand ***caveat 2 5aq0 thr b 412 c-beta wrong hand | 5AQ0_A |
| MC | M14.UND | subfamily M14D non-peptidase homologues | crystal structure of putative carboxypeptidase a (yp_562911.1) from shewanella denitrificans os-217 at 2.39 a resolution | 3L2N_A |
| MC | M14.UND | subfamily M14D non-peptidase homologues | crystal structure of metallo-carboxypeptidase from burkholderia cenocepacia | 4B6Z_A |
| MC | M14.UPW | family M14 unassigned peptidases | 4OKO | |
| MD | M15.001 | zinc D-Ala-D-Ala carboxypeptidase (Streptomyces-type) | 0ZGP | |
| MD | M15.001 | zinc D-Ala-D-Ala carboxypeptidase (Streptomyces-type) | 1LBU | |
| MD | M15.003 | van XYc peptidase | crystal structure of vancomycin resistance d,d-dipeptidase/d,d- pentapeptidase vanxyc d59s mutant | 4MUR_A |
| MD | M15.003 | van XYc peptidase | vancomycin resistant Asp59Ser mutant; complex with D-Ala-D-Ala phosphinate analog | 4MUS_A |
| MD | M15.003 | van XYc peptidase | vancomycin resistant Asp59Ser mutant; complex with D-alanine | 4MUT_A |
| MD | M15.003 | van XYc peptidase | vancomycin resistant Asp59Ser mutant; complex with D-alanine-D-alanine and copper (ii) | 4OAK_A |
| MD | M15.011 | vanX D-Ala-D-Ala dipeptidase | 1R44_A | |
| MD | M15.021 | Ply500 L-Ala-D-Glu peptidase | catalytic domain only | 1XP2_A |
| MD | M15.021 | Ply500 L-Ala-D-Glu peptidase | catalytic domain only | 2VO9 |
| MD | M15.021 | Ply500 L-Ala-D-Glu peptidase | crystal structure of lysb4, the endolysin from bacillus cereus- targeting bacteriophage b4 | 6AKV_A |
| MD | M15.022 | L-alanyl-D-glutamate peptidase (bacteriophage T5) | 2MXZ | |
| MD | M15.024 | DacB metallopeptidase (Streptococcus pneumoniae) | 4NT9 | |
| MD | M15.024 | DacB metallopeptidase (Streptococcus pneumoniae) | 4OX5 | |
| MD | M15.024 | DacB metallopeptidase (Streptococcus pneumoniae) | 4OXD | |
| MD | M15.024 | DacB metallopeptidase (Streptococcus pneumoniae) | 4D0Y | |
| MD | M15.UPB | subfamily M15B unassigned peptidases | 4OX3 | |
| MD | M15.UPB | subfamily M15B unassigned peptidases | crystal structure of vancomycin resistance d,d-dipeptidase vanxyg | 4F78_A |
| MD | M15.UPB | subfamily M15B unassigned peptidases | complex with D-Ala-D-Ala phosphinate analog | 4MUQ_A |
| MD | M15.UPB | subfamily M15B unassigned peptidases | crystal structure of baldcb / vany-like l,d-carboxypeptidase zinc(ii)-bound | 4MPH_A |
| MD | M15.UPB | subfamily M15B unassigned peptidases | vancomycin resistant Glu175Ala mutant; complex with Zn(ii) | 5HNM_A |
| MD | M15.UPB | subfamily M15B unassigned peptidases | structure of vanyb unbound | 5ZHF_A |
| MD | M15.UPB | subfamily M15B unassigned peptidases | vanyb in complex with d-alanine-d-alanine | 5ZHW_A |
| MD | M15.UPB | subfamily M15B unassigned peptidases | vanyb in complex with d-alanine | 6A6A_A |
| MD | M15.UPB | subfamily M15B unassigned peptidases | crystal structure of baldcb / vany-like l,d-carboxypeptidase zinc(ii)-free | 4JID_A |
| MD | M15.UPC | subfamily M15C unassigned peptidases | 4X36 | |
| ME | M16.001 | pitrilysin | 1Q2L_A | |
| ME | M16.002 | insulysin | complex with beta-amyloid(1-40) | 2G47 |
| ME | M16.002 | insulysin | complex with amylin | 2G48 |
| ME | M16.002 | insulysin | complex with glucagon | 2G49 |
| ME | M16.002 | insulysin | complex with oxidized insulin B chain | 2G54 |
| ME | M16.002 | insulysin | complex with oxidized insulin B chain | 2G56 |
| ME | M16.002 | insulysin | Glu111Gln mutant | 2JBU |
| ME | M16.002 | insulysin | Tyr830Phe mutant | 2JG4 |
| ME | M16.002 | insulysin | complex with insulin | 2WBY_A |
| ME | M16.002 | insulysin | complex with iodinated insulin | 2WC0_A |
| ME | M16.002 | insulysin | 2WK3 | |
| ME | M16.002 | insulysin | 2YPU | |
| ME | M16.002 | insulysin | complex with bradykinin | 3CWW |
| ME | M16.002 | insulysin | human ide-inhibitor complex at 2.6 resolution | 3E4A_A |
| ME | M16.002 | insulysin | 3E4Z | |
| ME | M16.002 | insulysin | 3E50 | |
| ME | M16.002 | insulysin | 3H44 | |
| ME | M16.002 | insulysin | 3HGZ | |
| ME | M16.002 | insulysin | 3N56 | |
| ME | M16.002 | insulysin | 3N57 | |
| ME | M16.002 | insulysin | 3OFI | |
| ME | M16.002 | insulysin | 3QZ2 | |
| ME | M16.002 | insulysin | 4DTT | |
| ME | M16.002 | insulysin | 4DWK | |
| ME | M16.002 | insulysin | 4GS8 | |
| ME | M16.002 | insulysin | 4GSC | |
| ME | M16.002 | insulysin | 4GSF | |
| ME | M16.002 | insulysin | 4IFH | |
| ME | M16.002 | insulysin | 4IOF | |
| ME | M16.002 | insulysin | 4LTE | |
| ME | M16.002 | insulysin | 4M1C | |
| ME | M16.002 | insulysin | 4NXO | |
| ME | M16.002 | insulysin | 4PES | |
| ME | M16.002 | insulysin | 4PF7 | |
| ME | M16.002 | insulysin | 4PF9 | |
| ME | M16.002 | insulysin | 4PFC | |
| ME | M16.002 | insulysin | 4Q5Z | |
| ME | M16.002 | insulysin | 4QIA | |
| ME | M16.002 | insulysin | 4RAL | |
| ME | M16.002 | insulysin | 4RE9 | |
| ME | M16.002 | insulysin | elbow-engineered-fab-bound form; complex with insulin | 5CJO_A |
| ME | M16.002 | insulysin | crystal structure analysis of elbow-engineered-fab-bound human insulindegrading enzyme (ide) | 5UOE_A |
| ME | M16.002 | insulysin | fab1-bound form; complex with insulin | 5WOB_A |
| ME | M16.002 | insulysin | complex with insulin | 6B3Q_A |
| ME | M16.002 | insulysin | complex with fab h11-e heavy chain, fab h11-e light chain and insulin | 6B70_A |
| ME | M16.002 | insulysin | 6B7Y_A | |
| ME | M16.002 | insulysin | complex with fab h11 heavy chain and fab h11 light chain | 6B7Z_A |
| ME | M16.002 | insulysin | 6BF6_A | |
| ME | M16.002 | insulysin | complex with fab h11-e heavy chain, fab h11-e light chain | 6BF7_A |
| ME | M16.002 | insulysin | complex with insulin | 6BF8_A |
| ME | M16.002 | insulysin | complex with fab h11-e heavy chain, fab h11-e light chain | 6BF9_A |
| ME | M16.002 | insulysin | complex with insulin | 6BFC_A |
| ME | M16.002 | insulysin | cysteine-free form; complex with substrate-selective macrocyclic inhibitor 37 | 6BYZ_A |
| ME | M16.002 | insulysin | cysteine-free form; complex with glucagon and substrate-selective macrocyclic inhibitor 63 | 6EDS_A |
| ME | M16.002 | insulysin | cysteine-free form; complex with substrate-selective macrocycle inhibitor 63 | 6MQ3_A |
| ME | M16.002 | insulysin | 3P7L | |
| ME | M16.002 | insulysin | 3P7O | |
| ME | M16.002 | insulysin | 3TUV | |
| ME | M16.003 | mitochondrial processing peptidase beta-subunit | complex with alpha subunit | 1HR6_B |
| ME | M16.003 | mitochondrial processing peptidase beta-subunit | Glu73Gln mutant; complex with alpha subunit | 1HR7_B |
| ME | M16.003 | mitochondrial processing peptidase beta-subunit | Glu73Gln mutant; complex with alpha subunit and cytochrome C oxidase IV signal peptide | 1HR8_A |
| ME | M16.003 | mitochondrial processing peptidase beta-subunit | Glu73Gln mutant; complex with alpha subunit and malate dehydrogenase signal peptide | 1HR9_B |
| ME | M16.009 | eupitrilysin | crystal structure of substrate-free human presequence protease | 4L3T_A |
| ME | M16.009 | eupitrilysin | crystal structure of human presequence protease in complex with amyloid-beta (1-40) | 4NGE_A |
| ME | M16.009 | eupitrilysin | crystal structure of human presequence protease in complex with inhibitor mitoblock-60 | 4RPU_A |
| ME | M16.011 | falcilysin | crystal structures of falcilysin, a m16 metalloprotease from the malaria parasite plasmodium falciparum | 3S5H_A |
| ME | M16.011 | falcilysin | crystal structures of falcilysin, a m16 metalloprotease from the malaria parasite plasmodium falciparum | 3S5I_A |
| ME | M16.011 | falcilysin | crystal structures of falcilysin, a m16 metalloprotease from the malaria parasite plasmodium falciparum | 3S5K_A |
| ME | M16.011 | falcilysin | crystal structures of falcilysin, a m16 metalloprotease from the malaria parasite plasmodium falciparum | 3S5M_A |
| ME | M16.012 | PreP1 peptidase (Arabidopsis-type) | 2FGE | |
| ME | M16.019 | YMXG peptidase | apoenzyme | 3AMI_A |
| ME | M16.019 | YMXG peptidase | subunit pa0372 of heterodimeric zinc protease pa0371-pa0372 | 4NNZ_A |
| ME | M16.970 | SPH2682 protein (Sphingomonas sp. strain A1) | complex with SPH2681 | 3AMI_B |
| ME | M16.973 | ubiquinol-cytochrome c reductase core protein I | cytochrome BC1 complex | 1L0L |
| ME | M16.973 | ubiquinol-cytochrome c reductase core protein I | cytochrome BC1 complex | 1L0N |
| ME | M16.973 | ubiquinol-cytochrome c reductase core protein I | mitochondrial cytochrome BC1 complex with antimycin A1 | 1NTK_A |
| ME | M16.973 | ubiquinol-cytochrome c reductase core protein I | mitochondrial cytochrome BC1 complex with ubiquinone | 1NTZ_A |
| ME | M16.973 | ubiquinol-cytochrome c reductase core protein I | mitochondrial cytochrome BC1 complex with 2-nonyl-4-hydroxyquinoline N-oxide | 1NU1_A |
| ME | M16.973 | ubiquinol-cytochrome c reductase core protein I | cytochrome BC1 complex with stigmatellin bound | 1PP9_A |
| ME | M16.973 | ubiquinol-cytochrome c reductase core protein I | cytochrome BC1 complex with stigmatellin and antimycin | 1PPJ_A |
| ME | M16.973 | ubiquinol-cytochrome c reductase core protein I | mitochondrial cytochrome BC1 complex | 1QCR_A |
| ME | M16.973 | ubiquinol-cytochrome c reductase core protein I | cytochrome BC1 complex with azoxystrobin | 1SQB_A |
| ME | M16.973 | ubiquinol-cytochrome c reductase core protein I | cytochrome BC1 complex with myxothiazol | 1SQP_A |
| ME | M16.973 | ubiquinol-cytochrome c reductase core protein I | cytochrome BC1 complex with methoxy acrylate stilbene (moas) | 1SQQ_A |
| ME | M16.973 | ubiquinol-cytochrome c reductase core protein I | cytochrome BC1 complex with UHDBT | 1SQV_A |
| ME | M16.973 | ubiquinol-cytochrome c reductase core protein I | cytochrome BC1 complex with stigmatellin A | 1SQX_A |
| ME | M16.973 | ubiquinol-cytochrome c reductase core protein I | cytochrome BC1 complex with stigmatellin bound | 2A06_A |
| ME | M16.973 | ubiquinol-cytochrome c reductase core protein I | cytochrome BC1 complex with JG144 inhibitor | 2FYU_A |
| ME | M16.974 | ubiquinol-cytochrome c reductase core protein II | cryo-em structure of human respiratory complex iii (cytochrome bc1 complex) | 5XTE_K |
| ME | M16.974 | ubiquinol-cytochrome c reductase core protein II | cytochrome bc1 complex from chicken | 1BCC_B |
| ME | M16.974 | ubiquinol-cytochrome c reductase core protein II | cytochrome BC1 complex | 1BE3_B |
| ME | M16.974 | ubiquinol-cytochrome c reductase core protein II | cytochrome BC1 complex | 1BGY_B |
| ME | M16.974 | ubiquinol-cytochrome c reductase core protein II | cytochrome BC1 complex | 1L0L_B |
| ME | M16.974 | ubiquinol-cytochrome c reductase core protein II | cytochrome BC1 complex | 1L0N_B |
| ME | M16.974 | ubiquinol-cytochrome c reductase core protein II | mitochondrial cytochrome bc1 complex; complex with antimycin A1 | 1NTK_B |
| ME | M16.974 | ubiquinol-cytochrome c reductase core protein II | mitochondrial cytochrome bc1 complex | 1NTM_B |
| ME | M16.974 | ubiquinol-cytochrome c reductase core protein II | mitochondrial cytochrome bc1 complex bound with ubiquinone | 1NTZ_B |
| ME | M16.974 | ubiquinol-cytochrome c reductase core protein II | mitochondrial cytochrome bc1 complex with 2-nonyl-4-hydroxyquinoline N-oxide | 1NU1_B |
| ME | M16.974 | ubiquinol-cytochrome c reductase core protein II | bovine cytochrome bc1 complex with stigmatellin bound | 1PP9_B |
| ME | M16.974 | ubiquinol-cytochrome c reductase core protein II | bovine cytochrome bc1 complex with stigmatellin and antimycin | 1PPJ_B |
| ME | M16.974 | ubiquinol-cytochrome c reductase core protein II | mitochondrial cytochrome BC1 complex | 1QCR_B |
| ME | M16.974 | ubiquinol-cytochrome c reductase core protein II | compex with azoxystrobin | 1SQB_B |
| ME | M16.974 | ubiquinol-cytochrome c reductase core protein II | complex with myxothiazol | 1SQP_B |
| ME | M16.974 | ubiquinol-cytochrome c reductase core protein II | complex with methoxy acrylate stilbene (moas) | 1SQQ_B |
| ME | M16.974 | ubiquinol-cytochrome c reductase core protein II | complex with uhdbt | 1SQV_B |
| ME | M16.974 | ubiquinol-cytochrome c reductase core protein II | complex with stigmatellin A | 1SQX_B |
| ME | M16.974 | ubiquinol-cytochrome c reductase core protein II | bovine cytochrome bc1 complex with stigmatellin bound | 2A06_B |
| ME | M16.974 | ubiquinol-cytochrome c reductase core protein II | 2BCC | |
| ME | M16.974 | ubiquinol-cytochrome c reductase core protein II | 2FYU | |
| ME | M16.974 | ubiquinol-cytochrome c reductase core protein II | complex with JG144 inhibitor | 2FYU_B |
| ME | M16.974 | ubiquinol-cytochrome c reductase core protein II | 2YBB_B | |
| ME | M16.974 | ubiquinol-cytochrome c reductase core protein II | 3BCC | |
| ME | M16.974 | ubiquinol-cytochrome c reductase core protein II | stigmatellin and antimycin bound cytochrome bc1 complex from chicken | 3BCC_B |
| ME | M16.974 | ubiquinol-cytochrome c reductase core protein II | 4D6T_B | |
| ME | M16.974 | ubiquinol-cytochrome c reductase core protein II | 4D6U_B | |
| ME | M16.974 | ubiquinol-cytochrome c reductase core protein II | structure of bos taurus cytochrome bc1 with fenamidone inhibited | 5KLV_B |
| ME | M16.974 | ubiquinol-cytochrome c reductase core protein II | cryo-em of bovine respirasome | 5LUF_m |
| ME | M16.974 | ubiquinol-cytochrome c reductase core protein II | cytochrome bc1 bound to the inhibitor mjm170 ***caveat 5nmi mjm c 503 has wrong chirality at atom c4 pee d 502 has wrong ***caveat 2 5nmi chirality at atom c2 pee e 502 has wrong chirality at atom ***caveat 3 5nmi c2 mjm p 404 has wrong chirality at atom | 5NMI_B |
| ME | M16.974 | ubiquinol-cytochrome c reductase core protein II | crystal structure of bovine cytochrome bc1 in complex with inhibitor scr0911. | 5OKD_B |
| ME | M16.974 | ubiquinol-cytochrome c reductase core protein II | cryoem structure of bovine cytochrome bc1 in complex with the anti- malarial compound gsk932121 | 6FO0_O |
| ME | M16.974 | ubiquinol-cytochrome c reductase core protein II | cryoem structure of bovine cytochrome bc1 with no ligand bound | 6FO2_O |
| ME | M16.974 | ubiquinol-cytochrome c reductase core protein II | cryoem structure of bovine cytochrome bc1 in complex with the anti- malarial inhibitor scr0911 | 6FO6_B |
| ME | M16.974 | ubiquinol-cytochrome c reductase core protein II | crystal structure of bovine cytochrome bc1 in complex with 2-pyrazolylquinolone inhibitor wdh2g7 | 6HAW_B |
| ME | M16.974 | ubiquinol-cytochrome c reductase core protein II | rhodobacter sphaeroides mitochondrial respiratory chain complex | 6NHG_B |
| ME | M16.981 | ubiquinol-cytochrome c reductase core protein domain 2 | cryo-em structure of human respiratory complex iii (cytochrome bc1 complex) | 5XTE_L |
| ME | M16.981 | ubiquinol-cytochrome c reductase core protein domain 2 | 1BCC | |
| ME | M16.981 | ubiquinol-cytochrome c reductase core protein domain 2 | 1BE3 | |
| ME | M16.981 | ubiquinol-cytochrome c reductase core protein domain 2 | 1BGY_A | |
| ME | M16.981 | ubiquinol-cytochrome c reductase core protein domain 2 | 1L0L_A | |
| ME | M16.981 | ubiquinol-cytochrome c reductase core protein domain 2 | 1L0N_A | |
| ME | M16.981 | ubiquinol-cytochrome c reductase core protein domain 2 | mitochondrial cytochrome BC1 complex with antimycin A1 | 1NTK_A |
| ME | M16.981 | ubiquinol-cytochrome c reductase core protein domain 2 | mitochondrial cytochrome BC1 complex | 1NTM_A |
| ME | M16.981 | ubiquinol-cytochrome c reductase core protein domain 2 | mitochondrial cytochrome BC1 complex with ubiquinone | 1NTZ_A |
| ME | M16.981 | ubiquinol-cytochrome c reductase core protein domain 2 | mitochondrial cytochrome BC1 complex with 2-nonyl-4-hydroxyquinoline N-oxide | 1NU1_A |
| ME | M16.981 | ubiquinol-cytochrome c reductase core protein domain 2 | cytochrome BC1 complex with stigmatellin bound | 1PP9_A |
| ME | M16.981 | ubiquinol-cytochrome c reductase core protein domain 2 | cytochrome BC1 complex with stigmatellin and antimycin | 1PPJ_A |
| ME | M16.981 | ubiquinol-cytochrome c reductase core protein domain 2 | cytochrome BC1 complex with azoxystrobin | 1SQB_A |
| ME | M16.981 | ubiquinol-cytochrome c reductase core protein domain 2 | cytochrome BC1 complex with myxothiazol | 1SQP_A |
| ME | M16.981 | ubiquinol-cytochrome c reductase core protein domain 2 | cytochrome BC1 complex with methoxy acrylate stilbene (moas) | 1SQQ_A |
| ME | M16.981 | ubiquinol-cytochrome c reductase core protein domain 2 | cytochrome BC1 complex with UHDBT | 1SQV_A |
| ME | M16.981 | ubiquinol-cytochrome c reductase core protein domain 2 | cytochrome BC1 complex with stigmatellin A | 1SQX_A |
| ME | M16.981 | ubiquinol-cytochrome c reductase core protein domain 2 | cytochrome BC1 complex with stigmatellin bound | 2A06_A |
| ME | M16.981 | ubiquinol-cytochrome c reductase core protein domain 2 | 2BCC | |
| ME | M16.981 | ubiquinol-cytochrome c reductase core protein domain 2 | cytochrome BC1 complex with JG144 inhibitor | 2FYU_A |
| ME | M16.981 | ubiquinol-cytochrome c reductase core protein domain 2 | 2YBB_A | |
| ME | M16.981 | ubiquinol-cytochrome c reductase core protein domain 2 | cytochrome BC1 complex with stigmatellin and antimycin | 3BCC_A |
| ME | M16.981 | ubiquinol-cytochrome c reductase core protein domain 2 | 4D6T_A | |
| ME | M16.981 | ubiquinol-cytochrome c reductase core protein domain 2 | 4D6U_A | |
| ME | M16.981 | ubiquinol-cytochrome c reductase core protein domain 2 | structure of bos taurus cytochrome bc1 with fenamidone inhibited | 5KLV_A |
| ME | M16.981 | ubiquinol-cytochrome c reductase core protein domain 2 | cryo-em of bovine respirasome | 5LUF_c |
| ME | M16.981 | ubiquinol-cytochrome c reductase core protein domain 2 | cytochrome bc1 bound to the inhibitor mjm170 ***caveat 5nmi mjm c 503 has wrong chirality at atom c4 pee d 502 has wrong ***caveat 2 5nmi chirality at atom c2 pee e 502 has wrong chirality at atom ***caveat 3 5nmi c2 mjm p 404 has wrong chirality at atom | 5NMI_A |
| ME | M16.981 | ubiquinol-cytochrome c reductase core protein domain 2 | crystal structure of bovine cytochrome bc1 in complex with inhibitor scr0911. | 5OKD_A |
| ME | M16.981 | ubiquinol-cytochrome c reductase core protein domain 2 | cryoem structure of bovine cytochrome bc1 in complex with the anti- malarial compound gsk932121 | 6FO0_N |
| ME | M16.981 | ubiquinol-cytochrome c reductase core protein domain 2 | cryoem structure of bovine cytochrome bc1 with no ligand bound | 6FO2_N |
| ME | M16.981 | ubiquinol-cytochrome c reductase core protein domain 2 | cryoem structure of bovine cytochrome bc1 in complex with the anti- malarial inhibitor scr0911 | 6FO6_A |
| ME | M16.981 | ubiquinol-cytochrome c reductase core protein domain 2 | crystal structure of bovine cytochrome bc1 in complex with 2-pyrazolylquinolone inhibitor wdh2g7 | 6HAW_A |
| ME | M16.981 | ubiquinol-cytochrome c reductase core protein domain 2 | rhodobacter sphaeroides mitochondrial respiratory chain complex | 6NHG_A |
| ME | M16.982 | insulysin unit 2 | complex with bradykinin | 3CWW_A |
| ME | M16.984 | insulysin unit 3 | 2G47_A | |
| ME | M16.984 | insulysin unit 3 | complex with amylin | 2G48 |
| ME | M16.984 | insulysin unit 3 | complex with glucagon | 2G49 |
| ME | M16.984 | insulysin unit 3 | complex with oxidized insulin B chain | 2G54 |
| ME | M16.984 | insulysin unit 3 | complex with oxidized insulin B chain | 2G56 |
| ME | M16.984 | insulysin unit 3 | Glu111Gln mutant | 2JBU |
| ME | M16.984 | insulysin unit 3 | 2JG4_A | |
| ME | M16.984 | insulysin unit 3 | complex with bradykinin | 3CWW_A |
| ME | M16.986 | Fjoh_2253 protein (Flavobacterium johnsoniae) | 1KEE | |
| ME | M16.A15 | BSSC8_26020 g.p. (Bacillus subtilis) | ON HOLD | 3HDI |
| ME | M16.A20 | ymfH g.p. (Bacillus subtilis) | 4XEA_A | |
| ME | M16.UNB | subfamily M16B non-peptidase homologues | crystal structure of peptidase m16 inactive domain from pseudomonas fluorescens. northeast structural genomics target plr293l | 3GWB_A |
| ME | M16.UNW | family M16 non-peptidase homologues | predicted insulinase family protease from yersinia pestis | 3GO9_A |
| ME | M16.UNW | family M16 non-peptidase homologues | structure of ttha1265 | 5HXK_A |
| ME | M16.UNW | family M16 non-peptidase homologues | 1EZV_A | |
| ME | M16.UNW | family M16 non-peptidase homologues | 1KB9_A | |
| ME | M16.UNW | family M16 non-peptidase homologues | 1KYO_A | |
| ME | M16.UNW | family M16 non-peptidase homologues | hdbt inhibited yeast cytochrome bc1 complex | 1P84_A |
| ME | M16.UNW | family M16 non-peptidase homologues | yeast cytochrome bc1 complex with stigmatellin | 2IBZ_A |
| ME | M16.UNW | family M16 non-peptidase homologues | structure of complex iii with bound cytochrome c in reduced state and definition of a minimal core interface for electron transfer. | 3CX5_A |
| ME | M16.UNW | family M16 non-peptidase homologues | structure of yeast complex iii with isoform-2 cytochrome c bound and definition of a minimal core interface for electron transfer. | 3CXH_A |
| ME | M16.UNW | family M16 non-peptidase homologues | 4PD4_A | |
| ME | M16.UNW | family M16 non-peptidase homologues | saccharomyces cerevisiae respiratory supercomplex iii2iv | 6GIQ_A |
| ME | M16.UNW | family M16 non-peptidase homologues | iii2-iv2 mitochondrial respiratory supercomplex from s. cerevisiae | 6HU9_A |
| ME | M16.UNW | family M16 non-peptidase homologues | cytochrome bc1 complex from chicken with trifloxystrobin bound | 3L70_B |
| ME | M16.UNW | family M16 non-peptidase homologues | cytochrome bc1 complex from chicken with azoxystrobin bound | 3L71_B |
| ME | M16.UNW | family M16 non-peptidase homologues | chicken cytochrome bc1 complex with kresoxym-i-dimethyl bound | 3L72_B |
| ME | M16.UNW | family M16 non-peptidase homologues | cytochrome bc1 complex from chicken with triazolone inhibitor | 3L73_B |
| ME | M16.UNW | family M16 non-peptidase homologues | cytochrome bc1 complex from chicken with famoxadone bound | 3L74_B |
| ME | M16.UNW | family M16 non-peptidase homologues | cytochrome bc1 complex from chicken with fenamidone bound | 3L75_B |
| ME | M16.UNW | family M16 non-peptidase homologues | cytochrome bc1 complex from chicken with pfvs-designed moa inhibitor bound | 3TGU_B |
| ME | M16.UNW | family M16 non-peptidase homologues | cytochrome bc1 complex from chicken with designed inhibitor bound | 4U3F_B |
| ME | M16.UPB | subfamily M16B unassigned peptidases | complex with its substrate plant ferredoxin | 6B03_A |
| ME | M16.UPB | subfamily M16B unassigned peptidases | Glu83Ala mutant; complex with arabidopsis ferredoxin | 6B05_A |
| ME | M16.UPB | subfamily M16B unassigned peptidases | complex with arabidopsis ferredoxin, ethylmercury phosphate soaked dataset | 6BRS_A |
| ME | M16.UPB | subfamily M16B unassigned peptidases | 3EOQ | |
| ME | M16.UPB | subfamily M16B unassigned peptidases | 1HR6 | |
| ME | M16.UPB | subfamily M16B unassigned peptidases | 1HR7 | |
| ME | M16.UPB | subfamily M16B unassigned peptidases | 1HR8 | |
| ME | M16.UPB | subfamily M16B unassigned peptidases | 1HR9 | |
| ME | M16.UPW | family M16 unassigned peptidases | cytochrome BC1 complex | 1EZV_B |
| ME | M16.UPW | family M16 unassigned peptidases | ubiquinol-cystochrome C reductase complex | 1KB9_B |
| ME | M16.UPW | family M16 unassigned peptidases | cytochrome BC1 complex with bound cytochrome C | 1KYO_B |
| ME | M16.UPW | family M16 unassigned peptidases | hdbt inhibited yeast cytochrome bc1 complex | 1P84_B |
| ME | M16.UPW | family M16 unassigned peptidases | 2IBZ | |
| ME | M16.UPW | family M16 unassigned peptidases | yeast cytochrome bc1 complex with stigmatellin | 2IBZ_B |
| ME | M16.UPW | family M16 unassigned peptidases | structure of complex iii with bound cytochrome c in reduced state and definition of a minimal core interface for electron transfer. | 3CX5_B |
| ME | M16.UPW | family M16 unassigned peptidases | structure of yeast complex iii with isoform-2 cytochrome c bound and definition of a minimal core interface for electron transfer. | 3CXH_B |
| ME | M16.UPW | family M16 unassigned peptidases | 4PD4_B | |
| ME | M16.UPW | family M16 unassigned peptidases | saccharomyces cerevisiae respiratory supercomplex iii2iv | 6GIQ_B |
| ME | M16.UPW | family M16 unassigned peptidases | iii2-iv2 mitochondrial respiratory supercomplex from s. cerevisiae | 6HU9_B |
| ME | M16.UPW | family M16 unassigned peptidases | complex with beta subunit | 1HR6_A |
| ME | M16.UPW | family M16 unassigned peptidases | complex with beta subunit Glu73Gln mutant | 1HR7_A |
| ME | M16.UPW | family M16 unassigned peptidases | complex with beta subunit Glu73Gln mutant and cytochrome C oxidase IV signal peptide | 1HR8_B |
| ME | M16.UPW | family M16 unassigned peptidases | complex with beta subunit Glu73Gln mutant and malate dehydrogenase signal peptide | 1HR9_A |
| ME | M16.UPW | family M16 unassigned peptidases | cytochrome BC1 complex | 1EZV |
| ME | M16.UPW | family M16 unassigned peptidases | ubiquinol-cystochrome C reductase complex | 1KB9 |
| ME | M16.UPW | family M16 unassigned peptidases | cytochrome BC1 complex with bound cytochrome C | 1KYO |
| ME | M16.UPW | family M16 unassigned peptidases | hdbt inhibited yeast cytochrome bc1 complex | 1P84_A |
| ME | M16.UPW | family M16 unassigned peptidases | yeast cytochrome bc1 complex with stigmatellin | 2IBZ_A |
| MF | M17.001 | leucyl aminopeptidase 3 | complex with amastatin | 1BLL |
| MF | M17.001 | leucyl aminopeptidase 3 | one zinc replaced with magnesium | 1BPM |
| MF | M17.001 | leucyl aminopeptidase 3 | 1BPN | |
| MF | M17.001 | leucyl aminopeptidase 3 | 1LAM | |
| MF | M17.001 | leucyl aminopeptidase 3 | complex with L-leucinal | 1LAN |
| MF | M17.001 | leucyl aminopeptidase 3 | 1LAP | |
| MF | M17.001 | leucyl aminopeptidase 3 | complex with L-leucine phosphonic acid | 1LCP |
| MF | M17.001 | leucyl aminopeptidase 3 | complex with zofenoprilat | 2EWB_A |
| MF | M17.001 | leucyl aminopeptidase 3 | bllap in complex with microginin fr1 | 2J9A_A |
| MF | M17.002 | leucyl aminopeptidase (plant-type) | 4KSI | |
| MF | M17.002 | leucyl aminopeptidase (plant-type) | Lys354Glu mutant | 5D8N |
| MF | M17.003 | PepA aminopeptidase | 1GYT | |
| MF | M17.003 | PepA aminopeptidase | at low pH | 3H8E |
| MF | M17.003 | PepA aminopeptidase | at high pH | 3H8F |
| MF | M17.003 | PepA aminopeptidase | complex with bestatin | 3H8G |
| MF | M17.003 | PepA aminopeptidase | crystal structure of cytosol aminopeptidase from francisella tularensis | 3PEI_A |
| MF | M17.003 | PepA aminopeptidase | 3JRU | |
| MF | M17.004 | PepB aminopeptidase | 6OV8_A | |
| MF | M17.004 | PepB aminopeptidase | crystal structure of peptidase b from yersinia pestis co92 at 2.75 a resolution | 6CXD_A |
| MF | M17.008 | M17 aminopeptidase (Plasmodium spp.) | 3KQX_A | |
| MF | M17.008 | M17 aminopeptidase (Plasmodium spp.) | 3KQZ_A | |
| MF | M17.008 | M17 aminopeptidase (Plasmodium spp.) | 3KR4_A | |
| MF | M17.008 | M17 aminopeptidase (Plasmodium spp.) | 3KR5_A | |
| MF | M17.008 | M17 aminopeptidase (Plasmodium spp.) | a bestatin-based chemical biology strategy reveals distinct roles for malaria m1- and m17-family aminopeptidases | 3T8W_A |
| MF | M17.008 | M17 aminopeptidase (Plasmodium spp.) | phosphonic arginine mimetics as inhibitors of the m17 aminopeptidases from plasmodium falciparum | 4K3N_A |
| MF | M17.008 | M17 aminopeptidase (Plasmodium spp.) | complex witha hydroxamic acid-based inhibitor | 4R6T_A |
| MF | M17.008 | M17 aminopeptidase (Plasmodium spp.) | complex witha hydroxamic acid-based inhibitor | 4R7M_A |
| MF | M17.008 | M17 aminopeptidase (Plasmodium spp.) | x-ray crystal structure of the orally available aminopeptidase inhibitor, tosedostat, bound to the m17 leucyl aminopeptidase from p.falciparum | 4X2T_A |
| MF | M17.014 | LAPTc aminopeptidase | complex with actinonin | 5NTH_A |
| MF | M17.014 | LAPTc aminopeptidase | apo form | 5NSK_A |
| MF | M17.014 | LAPTc aminopeptidase | unliganded structure of leucyl aminopeptidase from trypanosoma brucei | 5NSM_A |
| MF | M17.014 | LAPTc aminopeptidase | complex with actinonin | 5NSQ_A |
| MF | M17.014 | LAPTc aminopeptidase | complex with bestatin | 5NTD_A |
| MF | M17.016 | aminopeptidase A/I (Helicobacter-type) | 4ZI6 | |
| MF | M17.016 | aminopeptidase A/I (Helicobacter-type) | complex with bestatin | 4ZLA |
| MF | M17.A05 | ZK353.6 (Caenorhabditis elegans) | structure of caenorhabditis elegans leucine aminopeptidase (lap1) | 2HB6_A |
| MF | M17.A05 | ZK353.6 (Caenorhabditis elegans) | 2HC9_A | |
| MF | M17.UPW | family M17 unassigned peptidases | crystal structure of a probable cytosol aminopeptidase (leucine aminopeptidase, lap) from chlamydia trachomatis d/uw-3/cx | 6OME_A |
| MF | M17.UPW | family M17 unassigned peptidases | 3IJ3_A | |
| MF | M17.UPW | family M17 unassigned peptidases | 5LHJ_A | |
| MF | M17.UPW | family M17 unassigned peptidases | complex with Mn | 5LHK_A |
| MH | M18.001 | aminopeptidase I | 4R8F | |
| MH | M18.001 | aminopeptidase I | crystal structure of mape1 | 5JGF_A |
| MH | M18.001 | aminopeptidase I | crystal structure of prape1 | 5JH9_A |
| MH | M18.001 | aminopeptidase I | dodecamer | 5JM9_A |
| MH | M18.002 | aspartyl aminopeptidase | 4DYO | |
| MH | M18.002 | aspartyl aminopeptidase | 3VAR | |
| MH | M18.002 | aspartyl aminopeptidase | 3VAT | |
| MH | M18.003 | aspartyl aminopeptidase (Plasmodium-type) | 4EME | |
| MH | M18.004 | apeA putative peptidase | 2GLF_A | |
| MH | M18.UPW | family M18 unassigned peptidases | 1Y7E_A | |
| MH | M18.UPW | family M18 unassigned peptidases | 2IJZ_A | |
| MH | M18.UPW | family M18 unassigned peptidases | 3WT4 | |
| MH | M18.UPW | family M18 unassigned peptidases | 4NJQ | |
| MH | M18.UPW | family M18 unassigned peptidases | 4NJR | |
| MH | M18.UPW | family M18 unassigned peptidases | 4OID | |
| MH | M18.UPW | family M18 unassigned peptidases | 4OIW | |
| MH | M18.UPW | family M18 unassigned peptidases | 2GLJ_A | |
| MH | M18.UPW | family M18 unassigned peptidases | 5JM6_A | |
| MJ | M19.001 | membrane dipeptidase | 1ITQ_A | |
| MJ | M19.001 | membrane dipeptidase | complex with cilastatin | 1ITU |
| MJ | M19.003 | dipeptidase AC | the crystal structure of the dipeptidase ac, metallo peptidase. merops family m19 | 3FDG_A |
| MJ | M19.003 | dipeptidase AC | crystal structure of metallo peptidase from rhodobacter sphaeroides liganded with phosphinate mimic of dipeptide l- ala-d-ala | 3LY0_A |
| MJ | M19.007 | thermostable dipeptidase (Brevibacillus-type) | structure of lmo2462, a listeria monocytogenes amidohydrolase family putative dipeptidase | 3LU2_A |
| MJ | M19.012 | Caul_3875-type dipeptidase | 2RAG_A | |
| MJ | M19.013 | GliJ g.p. (Aspergillus fumigatus) | space group C2 | 5LWZ |
| MJ | M19.013 | GliJ g.p. (Aspergillus fumigatus) | space group P3221 | 5LX0 |
| MJ | M19.013 | GliJ g.p. (Aspergillus fumigatus) | Asp304Ala mutant | 5LX1 |
| MJ | M19.013 | GliJ g.p. (Aspergillus fumigatus) | Asp38His mutant | 5LX4 |
| MJ | M19.013 | GliJ g.p. (Aspergillus fumigatus) | Asp38Asn mutant | 5LX7 |
| MJ | M19.013 | GliJ g.p. (Aspergillus fumigatus) | complex with Ca2+ | 5NRT |
| MJ | M19.013 | GliJ g.p. (Aspergillus fumigatus) | complex with Zn2+ | 5NRU |
| MJ | M19.013 | GliJ g.p. (Aspergillus fumigatus) | complex with Fe2+ | 5NRX |
| MJ | M19.013 | GliJ g.p. (Aspergillus fumigatus) | complex with Fe3+ | 5NRY |
| MJ | M19.013 | GliJ g.p. (Aspergillus fumigatus) | complex with Mn2+ | 5NRZ |
| MJ | M19.013 | GliJ g.p. (Aspergillus fumigatus) | complex with Ni2+ | 5NS1 |
| MJ | M19.013 | GliJ g.p. (Aspergillus fumigatus) | complex with Co2+ | 5NS2 |
| MJ | M19.013 | GliJ g.p. (Aspergillus fumigatus) | complex with Cu2+ and Zn2+ | 5NS5 |
| MJ | M19.950 | Mername-AA306 protein | 2I5G_A | |
| MJ | M19.UNW | family M19 non-peptidase homologues | 3B40_A | |
| MJ | M19.UPW | family M19 unassigned peptidases | crystal structure of renal dipeptidase from streptomyces coelicolor a3(2) | 3ID7_A |
| MJ | M19.UPW | family M19 unassigned peptidases | crystal structure of sco3058 with bound inhibitor l-ala-l-asp phosphinodipeptide | 3ISI_X |
| MJ | M19.UPW | family M19 unassigned peptidases | crystal structure of sco3058 with bound citrate and glycerol | 3ITC_A |
| MJ | M19.UPW | family M19 unassigned peptidases | complex with phosphinate pseudodipeptide l-ala-d-asp at 1.4a resolution. | 3K5X_A |
| MJ | M19.UPW | family M19 unassigned peptidases | complex with phosphinate pseudodipeptide l-leu-d-ala | 3S2J_A |
| MJ | M19.UPW | family M19 unassigned peptidases | complex with phosphinate pseudodipeptide l-leu-d-glu | 3S2L_A |
| MJ | M19.UPW | family M19 unassigned peptidases | complex with phosphinate pseudodipeptide l-phe-d-asp | 3S2M_A |
| MJ | M19.UPW | family M19 unassigned peptidases | complex with phosphinate pseudodipeptide l-tyr-d-asp | 3S2N_A |
| MH | M20.001 | glutamate carboxypeptidase | tetramer | 1CG2_A |
| MH | M20.001 | glutamate carboxypeptidase | 1CG2 | |
| MH | M20.003 | peptidase T | 1FNO_A | |
| MH | M20.003 | peptidase T | 1VIX_A | |
| MH | M20.003 | peptidase T | 3IFE | |
| MH | M20.004 | peptidase V | 1LFW_A | |
| MH | M20.005 | carnosine dipeptidase II | 4RUH | |
| MH | M20.005 | carnosine dipeptidase II | complex with manganese and bestatin | 2ZOF |
| MH | M20.005 | carnosine dipeptidase II | complex with zinc and bestatin | 2ZOG |
| MH | M20.006 | carnosine dipeptidase I | 3DLJ | |
| MH | M20.007 | Xaa-His dipeptidase | 2QYV_A | |
| MH | M20.007 | Xaa-His dipeptidase | crystal structure of aminoacylhistidine dipeptidase from vibrio alginolyticus | 3MRU_A |
| MH | M20.014 | indoleacetyl amino acid hydrolase | 1XMB | |
| MH | M20.014 | indoleacetyl amino acid hydrolase | 2Q43_A | |
| MH | M20.015 | YxeP putative peptidase | TOPSAN | 1YSJ_A |
| MH | M20.016 | BT3549 putative peptidase | TOPSAN | 3CT9 |
| MH | M20.017 | Dug1 peptidase | 4G1P | |
| MH | M20.018 | BC4143 protein | TOPSAN | 3GB0_A |
| MH | M20.019 | HMRA peptidase (Staphylococcus-type) | 3RAM | |
| MH | M20.020 | p-aminobenzoyl-glutamate hydrolase subunit A | crystal structure of aminobenzoyl-glutamate utilization protein from klebsiella pneumoniae | 3IO1_A |
| MH | M20.022 | LysK isopeptidase (Thermus thermophilus) | ON HOLD | 5XOY |
| MH | M20.973 | aminoacylase | 1Q7L | |
| MH | M20.976 | allantoate amidohydrolase | complex with allantoate | 1Z2L |
| MH | M20.976 | allantoate amidohydrolase | at pH 4.6 | 2IMO |
| MH | M20.976 | allantoate amidohydrolase | 4PXD | |
| MH | M20.A18 | DDB_G0279291 g.p. (Dictyostelium discoideum) | crystal structure of a m20a metallo peptidase (dape, lpg0809) from legionella pneumophila subsp. pneumophila str. philadelphia 1 at 1.50a resolution | 3PFE_A |
| MH | M20.UNW | family M20 non-peptidase homologues | 4PXB | |
| MH | M20.UNW | family M20 non-peptidase homologues | 4PXC | |
| MH | M20.UNW | family M20 non-peptidase homologues | 4PXE | |
| MH | M20.UNW | family M20 non-peptidase homologues | 1R3N_A | |
| MH | M20.UNW | family M20 non-peptidase homologues | selenomethionine substituted protein | 1R43_A |
| MH | M20.UNW | family M20 non-peptidase homologues | crystal structure of mutant e159a of beta-alanine synthase from saccharomyces kluyveri | 2V8D_A |
| MH | M20.UNW | family M20 non-peptidase homologues | crystal structure of beta-alanine synthase from saccharomyces kluyveri in complex with the product beta- alanine | 2V8G_A |
| MH | M20.UNW | family M20 non-peptidase homologues | crystal structure of mutant Glu159Ala of beta-alanine synthase from saccharomyces kluyveri in complex with its substrate n-carbamyl-beta-alanine | 2V8H_A |
| MH | M20.UNW | family M20 non-peptidase homologues | crystal structure of mutant r322a of beta-alanine synthase from saccharomyces kluyveri | 2V8V_A |
| MH | M20.UNW | family M20 non-peptidase homologues | crystal structure of beta-alanine synthase from saccharomyces kluyveriin complex with a gly-gly peptide | 2VL1_A |
| MH | M20.UNW | family M20 non-peptidase homologues | 4WJB_A | |
| MH | M20.UPA | subfamily M20A unassigned peptidases | 3IC1 | |
| MH | M20.UPA | subfamily M20A unassigned peptidases | 3ISZ | |
| MH | M20.UPA | subfamily M20A unassigned peptidases | 4H2K | |
| MH | M20.UPA | subfamily M20A unassigned peptidases | complex with the products succinic acid and diaminopimelic acid | 5VO3_A |
| MH | M20.UPA | subfamily M20A unassigned peptidases | 1VGY_A | |
| MH | M20.UPA | subfamily M20A unassigned peptidases | crystal structure of mono-zinc form of succinyl diaminopimelate desuccinylase from neisseria meningitidis mc58 | 4O23_A |
| MH | M20.UPA | subfamily M20A unassigned peptidases | crystal structure of zinc-bound succinyl-diaminopimelate desuccinylasefrom neisseria meningitidis mc58 | 4PPZ_A |
| MH | M20.UPA | subfamily M20A unassigned peptidases | complex with the inhibitor captopril | 4PQA_A |
| MH | M20.UPA | subfamily M20A unassigned peptidases | 5UEJ_A | |
| MH | M20.UPA | subfamily M20A unassigned peptidases | 4ONW | |
| MH | M20.UPA | subfamily M20A unassigned peptidases | 4OP4 | |
| MH | M20.UPA | subfamily M20A unassigned peptidases | apo-form | 3KHX |
| MH | M20.UPA | subfamily M20A unassigned peptidases | Arg350Ala mutant; apo-form | 3KHZ |
| MH | M20.UPA | subfamily M20A unassigned peptidases | Manganese bound form | 3KI9 |
| MH | M20.UPA | subfamily M20A unassigned peptidases | complex with one Co | 2F7V_A |
| MH | M20.UPA | subfamily M20A unassigned peptidases | crystal structure of a putative acetylornithine deacetylase (rpa2325) from rhodopseudomonas palustris cga009 at 1.90 a resolution | 3PFO_A |
| MH | M20.UPD | family M20D unassigned peptidases | crystal structure of a hydantoinase/carbamoylase family amidase from burkholderia ambifaria | 5TP4_A |
| MH | M20.UPD | family M20D unassigned peptidases | 3RAM | |
| MH | M20.UPF | subfamily M20F unassigned peptidases | the crystal structure of a m20 family metallo-carboxypeptidase sso-cp2from sulfolobus solfataricus | 4MMO_A |
| MH | M20.UPW | family M20 unassigned peptidases | crystal structure of l-n-carbamoylase from geobacillus stearothermophilus cect43 | 3N5F_A |
| MH | M20.UPW | family M20 unassigned peptidases | 3TX8 | |
| MH | M20.UPW | family M20 unassigned peptidases | TOPSAN | 2POK |
| MH | M20.UPW | family M20 unassigned peptidases | 2RB7_A | |
| MH | M20.UPW | family M20 unassigned peptidases | crystal structure of amidase, hydantoinase/carbamoylase family from burkholderia vietnamiensis | 5I4M_A |
| MH | M20.UPW | family M20 unassigned peptidases | crystal structure of an amidase (hydantoinase/carbamoylase family) from burkholderia phymatum | 6C0D_A |
| MO | M23.002 | staphylolysin | 3IT5 | |
| MO | M23.002 | staphylolysin | complex with tartaric acid | 3IT7 |
| MO | M23.004 | lysostaphin | 4LXC | |
| MO | M23.004 | lysostaphin | catalytic domain in the presence of phosphate | 4QP5 |
| MO | M23.004 | lysostaphin | catalytic domain in the absence of phosphate | 4QPB |
| MO | M23.005 | zoocin A | NMR structure | 2LS0 |
| MO | M23.008 | gp13 peptidase (bacteriophage phi-29) | 3CSQ | |
| MO | M23.008 | gp13 peptidase (bacteriophage phi-29) | 3CSR | |
| MO | M23.008 | gp13 peptidase (bacteriophage phi-29) | 3CSZ | |
| MO | M23.008 | gp13 peptidase (bacteriophage phi-29) | 3CT0 | |
| MO | M23.008 | gp13 peptidase (bacteriophage phi-29) | 3CT1 | |
| MO | M23.008 | gp13 peptidase (bacteriophage phi-29) | 3CT5 | |
| MO | M23.009 | Mername-AA292 peptidase | orthorhombic crystal | 4RNY |
| MO | M23.009 | Mername-AA292 peptidase | hexagonal crystal | 4RNZ |
| MO | M23.009 | Mername-AA292 peptidase | crystal structure of csd1-csd2 dimer i | 5J1L_A |
| MO | M23.009 | Mername-AA292 peptidase | crystal structure of csd1-csd2 dimer ii | 5J1M_A |
| MO | M23.009 | Mername-AA292 peptidase | 6MUK_A | |
| MO | M23.011 | YebA peptidase | TOPSAN | 2GU1 |
| MO | M23.012 | ALE-1 glycylglycine endopeptidase (Staphylococcus capitis) | 1R77 | |
| MO | M23.013 | LytM glycyl-glycine endopeptidase (Staphylococcus aureus) | latent form | 1QWY |
| MO | M23.013 | LytM glycyl-glycine endopeptidase (Staphylococcus aureus) | truncated form | 2B0P |
| MO | M23.013 | LytM glycyl-glycine endopeptidase (Staphylococcus aureus) | truncated form | 2B13 |
| MO | M23.013 | LytM glycyl-glycine endopeptidase (Staphylococcus aureus) | truncated form | 2B44 |
| MO | M23.013 | LytM glycyl-glycine endopeptidase (Staphylococcus aureus) | high resolution structure of m23 peptidase lytm with substrate analogue | 4ZYB_A |
| MO | M23.014 | ShyA D,D-endopeptidase (Vibrio cholerae) | open form | 6JMX |
| MO | M23.014 | ShyA D,D-endopeptidase (Vibrio cholerae) | closed form | 6JMY |
| MO | M23.014 | ShyA D,D-endopeptidase (Vibrio cholerae) | His247Ala mutant; open form | 6JMZ |
| MO | M23.014 | ShyA D,D-endopeptidase (Vibrio cholerae) | His216Ala mutant; complex with tetra-tripeptide | 6JN0 |
| MO | M23.014 | ShyA D,D-endopeptidase (Vibrio cholerae) | His216Ala mutant; complex with pentapeptide | 6JN1 |
| MO | M23.014 | ShyA D,D-endopeptidase (Vibrio cholerae) | His216Ala mutant; closed form | 6JN7 |
| MO | M23.014 | ShyA D,D-endopeptidase (Vibrio cholerae) | His216Ala mutant; open form | 6JN8 |
| MO | M23.014 | ShyA D,D-endopeptidase (Vibrio cholerae) | closed form | 6KV1 |
| MO | M23.950 | YibP g.p. (Escherichia sp.) | 4BH5 | |
| MO | M23.UNB | subfamily M23B non-peptidase homologues | crystal structure of csd2-csd2 dimer | 5J1K_A |
| MO | M23.UNB | subfamily M23B non-peptidase homologues | crystal structure of csd1-csd2 dimer i | 5J1L_B |
| MO | M23.UNB | subfamily M23B non-peptidase homologues | crystal structure of csd1-csd2 dimer ii | 5J1M_B |
| MO | M23.UNB | subfamily M23B non-peptidase homologues | 3TUF | |
| MO | M23.UNB | subfamily M23B non-peptidase homologues | 3UZ0 | |
| MO | M23.UPB | subfamily M23B unassigned peptidases | TOPSAN | 2HSI |
| MO | M23.UPB | subfamily M23B unassigned peptidases | crystal structure of a putative glycyl-glycine endopeptidase lytm (rumgna_02482) from ruminococcus gnavus atcc 29149 at 1.60 a resolution | 3NYY_A |
| MG | M24.001 | methionyl aminopeptidase 1 (Escherichia-type) | complex with methionine | 1C21 |
| MG | M24.001 | methionyl aminopeptidase 1 (Escherichia-type) | complex with trifluoromethionine | 1C22 |
| MG | M24.001 | methionyl aminopeptidase 1 (Escherichia-type) | complex with methionine phosphonate | 1C23 |
| MG | M24.001 | methionyl aminopeptidase 1 (Escherichia-type) | complex with methionine phosphinate | 1C24_A |
| MG | M24.001 | methionyl aminopeptidase 1 (Escherichia-type) | complex with norleucine phosphonate | 1C27 |
| MG | M24.001 | methionyl aminopeptidase 1 (Escherichia-type) | 1MAT | |
| MG | M24.001 | methionyl aminopeptidase 1 (Escherichia-type) | complex with 5-(2-chlorophenyl)furan-2-carboxylic acid | 1XNZ |
| MG | M24.001 | methionyl aminopeptidase 1 (Escherichia-type) | 1YVM | |
| MG | M24.001 | methionyl aminopeptidase 1 (Escherichia-type) | 2BB7 | |
| MG | M24.001 | methionyl aminopeptidase 1 (Escherichia-type) | complex with 5-(2-(trifluoromethyl)phenyl)furan-2- carboxylic acid | 2EVC_A |
| MG | M24.001 | methionyl aminopeptidase 1 (Escherichia-type) | complex with 5-(2,5-dichlorophenyl)furan-2-carboxylic acid | 2EVM_A |
| MG | M24.001 | methionyl aminopeptidase 1 (Escherichia-type) | complex with n-cyclopentyl-n-(thiazol-2-yl)oxalamide | 2EVO_A |
| MG | M24.001 | methionyl aminopeptidase 1 (Escherichia-type) | novel bacterial methionine aminopeptidase inhibitors | 2GG0_A |
| MG | M24.001 | methionyl aminopeptidase 1 (Escherichia-type) | novel bacterial methionine aminopeptidase inhibitors | 2GG2_A |
| MG | M24.001 | methionyl aminopeptidase 1 (Escherichia-type) | novel bacterial methionine aminopeptidase inhibitors | 2GG3_A |
| MG | M24.001 | methionyl aminopeptidase 1 (Escherichia-type) | novel bacterial methionine aminopeptidase inhibitors | 2GG5_A |
| MG | M24.001 | methionyl aminopeptidase 1 (Escherichia-type) | novel bacterial methionine aminopeptidase inhibitors | 2GG7_A |
| MG | M24.001 | methionyl aminopeptidase 1 (Escherichia-type) | novel bacterial methionine aminopeptidase inhibitors | 2GG8_A |
| MG | M24.001 | methionyl aminopeptidase 1 (Escherichia-type) | novel bacterial methionine aminopeptidase inhibitors | 2GG9_A |
| MG | M24.001 | methionyl aminopeptidase 1 (Escherichia-type) | novel bacterial methionine aminopeptidase inhibitors | 2GGB_A |
| MG | M24.001 | methionyl aminopeptidase 1 (Escherichia-type) | novel bacterial methionine aminopeptidase inhibitors | 2GGC_A |
| MG | M24.001 | methionyl aminopeptidase 1 (Escherichia-type) | structural basis of catalysis by mononuclear methionine aminopeptidase | 2GTX_A |
| MG | M24.001 | methionyl aminopeptidase 1 (Escherichia-type) | complex with nlep, 1: 0.5, di-metalated | 2GU4_A |
| MG | M24.001 | methionyl aminopeptidase 1 (Escherichia-type) | complex with nlep, 1: 1, di-metalated | 2GU5_A |
| MG | M24.001 | methionyl aminopeptidase 1 (Escherichia-type) | complex with nlep, 1: 2, di-metalated | 2GU6_A |
| MG | M24.001 | methionyl aminopeptidase 1 (Escherichia-type) | e. coli methionine aminopeptidase unliganded, 1:0.5 | 2GU7_A |
| MG | M24.001 | methionyl aminopeptidase 1 (Escherichia-type) | 2MAT | |
| MG | M24.001 | methionyl aminopeptidase 1 (Escherichia-type) | complex with inhibitor YE7 | 2P98 |
| MG | M24.001 | methionyl aminopeptidase 1 (Escherichia-type) | complex with inhibitor YE6 | 2P99 |
| MG | M24.001 | methionyl aminopeptidase 1 (Escherichia-type) | complex with inhibitor YE6 | 2P9A |
| MG | M24.001 | methionyl aminopeptidase 1 (Escherichia-type) | e. coli methionine aminopeptidase mn-form with inhibitor b23 | 2Q92_A |
| MG | M24.001 | methionyl aminopeptidase 1 (Escherichia-type) | e. coli methionine aminopeptidase mn-form with inhibitor b21 | 2Q93_A |
| MG | M24.001 | methionyl aminopeptidase 1 (Escherichia-type) | e. coli methionine aminopeptidase mn-form with inhibitor a04 | 2Q94_A |
| MG | M24.001 | methionyl aminopeptidase 1 (Escherichia-type) | e. coli methionine aminopeptidase mn-form with inhibitor a05 | 2Q95_A |
| MG | M24.001 | methionyl aminopeptidase 1 (Escherichia-type) | e. coli methionine aminopeptidase mn-form with inhibitor a18 | 2Q96_A |
| MG | M24.001 | methionyl aminopeptidase 1 (Escherichia-type) | e. coli methionine aminopeptidase with fe inhibitor w29 | 3D27_A |
| MG | M24.001 | methionyl aminopeptidase 1 (Escherichia-type) | Arg175Gln mutant; complex with amino-hydroxyheptanyl-Ala-Leu-Val-Phe | 3MAT |
| MG | M24.001 | methionyl aminopeptidase 1 (Escherichia-type) | x-ray structures of oxazole hydroxamate ecmetap-mn complexes | 4A6V_A |
| MG | M24.001 | methionyl aminopeptidase 1 (Escherichia-type) | x-ray structures of oxazole hydroxamate ecmetap-mn complexes | 4A6W_A |
| MG | M24.001 | methionyl aminopeptidase 1 (Escherichia-type) | His79Ala mutant | 4MAT |
| MG | M24.001 | methionyl aminopeptidase 1 (Escherichia-type) | e. coli methionine aminopeptidase in complex with inhibitor 7-methoxy-2-methylen-3,4-dihydronaphthalen-1(2h)-one | 4PNC_A |
| MG | M24.001 | methionyl aminopeptidase 1 (Escherichia-type) | novel inhibitors of bacterial methionine aminopeptidase with broad- spectrum biochemical activity | 4Z7M_A |
| MG | M24.001 | methionyl aminopeptidase 1 (Escherichia-type) | e. coli methionine aminopeptidase crystal structure fitted into the cryo-em density map of e. coli 70s ribosome in complex with methionine aminopeptidase | 6IZ7_P |
| MG | M24.001 | methionyl aminopeptidase 1 (Escherichia-type) | crystal structure of e. coli peptide deformylase and methionine aminopeptidase fitted into the cryo-em density map of the complex | 6IZI_Q |
| MG | M24.001 | methionyl aminopeptidase 1 (Escherichia-type) | crystal structure of e. coli methionine aminopeptidase enzyme and chaperone trigger factor fitted into the cryo-em density map of the complex | 6J0A_P |
| MG | M24.001 | methionyl aminopeptidase 1 (Escherichia-type) | 3MR1 | |
| MG | M24.001 | methionyl aminopeptidase 1 (Escherichia-type) | 3MX6 | |
| MG | M24.001 | methionyl aminopeptidase 1 (Escherichia-type) | pseudomonas aeruginosa metap, in mn form | 4FO7_A |
| MG | M24.001 | methionyl aminopeptidase 1 (Escherichia-type) | pseudomonas aeruginosa metap with met, in mn form | 4FO8_A |
| MG | M24.001 | methionyl aminopeptidase 1 (Escherichia-type) | pseudomonas aeruginosa metap t2n mutant, in mn form | 4JUQ_A |
| MG | M24.002 | methionyl aminopeptidase 2 | complex with ovalicin | 1B59 |
| MG | M24.002 | methionyl aminopeptidase 2 | complex with TNP-470 inhibitor | 1B6A |
| MG | M24.002 | methionyl aminopeptidase 2 | 1BN5 | |
| MG | M24.002 | methionyl aminopeptidase 2 | complex with fumagillin inhibitor | 1BOA |
| MG | M24.002 | methionyl aminopeptidase 2 | 1KQ0 | |
| MG | M24.002 | methionyl aminopeptidase 2 | 1KQ9 | |
| MG | M24.002 | methionyl aminopeptidase 2 | 1QZY | |
| MG | M24.002 | methionyl aminopeptidase 2 | 1R58 | |
| MG | M24.002 | methionyl aminopeptidase 2 | 1R5G | |
| MG | M24.002 | methionyl aminopeptidase 2 | 1R5H | |
| MG | M24.002 | methionyl aminopeptidase 2 | 1YW7 | |
| MG | M24.002 | methionyl aminopeptidase 2 | 1YW8 | |
| MG | M24.002 | methionyl aminopeptidase 2 | 1YW9 | |
| MG | M24.002 | methionyl aminopeptidase 2 | 2ADU | |
| MG | M24.002 | methionyl aminopeptidase 2 | 2EA2 | |
| MG | M24.002 | methionyl aminopeptidase 2 | 2EA4 | |
| MG | M24.002 | methionyl aminopeptidase 2 | 2GA2 | |
| MG | M24.002 | methionyl aminopeptidase 2 | 2OAZ | |
| MG | M24.002 | methionyl aminopeptidase 2 | complex with spiroepoxytriazole inhibitor (+)-31a | 5CLS_A |
| MG | M24.002 | methionyl aminopeptidase 2 | structure of human methionine aminopeptidase 2 with covalent spiroepoxytriazole inhibitor (-)-31b | 5D6E_A |
| MG | M24.002 | methionyl aminopeptidase 2 | complex with spiroepoxytriazole inhibitor (+)-31b | 5D6F_A |
| MG | M24.002 | methionyl aminopeptidase 2 | potent, reversible metap2 inhibitors via fragment based drug discovery | 5JFR_A |
| MG | M24.002 | methionyl aminopeptidase 2 | potent, reversible metap2 inhibitors via fbdd | 5JHU_A |
| MG | M24.002 | methionyl aminopeptidase 2 | potent, reversible metap2 inhibitors via fbdd | 5JI6_A |
| MG | M24.002 | methionyl aminopeptidase 2 | complex with an inhibitor 6-((r)-2-o-tolyloxymethyl-pyrrolidin-1-yl)-9h- purine | 5LYW_A |
| MG | M24.002 | methionyl aminopeptidase 2 | complex with an inhibitor 5-((r)-1-[1,2,4]triazolo[1,5-a]pyrimidin-7-yl- pyrrolidin-2-ylmethoxy)-isoquinoline | 5LYX_A |
| MG | M24.002 | methionyl aminopeptidase 2 | complex with an inhibitor (s)-3-hydroxy-2-oxo-1-(2-oxo-1,2,3,4-tetrahydro- quinolin-6-yl)-pyrrolidine-3-carboxylic acid 3-chloro-5-fluoro- benzylamide | 6QED_A |
| MG | M24.002 | methionyl aminopeptidase 2 | complex withan inhibitor (s)-3-hydroxy-2-oxo-1-phenyl-pyrrolidine-3-carboxylic acid 3-chloro-5-fluoro-benzylamide | 6QEF_A |
| MG | M24.002 | methionyl aminopeptidase 2 | complex withan inhibitor 2-oxo-1-phenyl-pyrrolidine-3-carboxylic acid (2- thiophen-2-yl-ethyl)-amide | 6QEG_A |
| MG | M24.002 | methionyl aminopeptidase 2 | complex withan inhibitor 5-chloro-quinolin-8-ol | 6QEH_A |
| MG | M24.002 | methionyl aminopeptidase 2 | complex withan inhibitor 5,6-difluoro-3-(2-isopropoxy-4-piperazin-1-yl-phenyl)- 1h-indole-2-carboxylic acid amide | 6QEI_A |
| MG | M24.002 | methionyl aminopeptidase 2 | complex withan inhibitor thiophene-2-sulfonic acid (4-fluoro-benzyl)-(4h-[1,2, 4]triazol-3-ylmethyl)-amide | 6QEJ_A |
| MG | M24.003 | Xaa-Pro dipeptidase (bacteria-type) | 4QR8 | |
| MG | M24.003 | Xaa-Pro dipeptidase (bacteria-type) | 3L24 | |
| MG | M24.003 | Xaa-Pro dipeptidase (bacteria-type) | 3L7G | |
| MG | M24.003 | Xaa-Pro dipeptidase (bacteria-type) | 4ZWO | |
| MG | M24.003 | Xaa-Pro dipeptidase (bacteria-type) | 4ZWP | |
| MG | M24.003 | Xaa-Pro dipeptidase (bacteria-type) | 4ZWU | |
| MG | M24.004 | aminopeptidase P (bacteria) | complex with inhibitor Pro-Leu | 1A16 |
| MG | M24.004 | aminopeptidase P (bacteria) | 1AZ9 | |
| MG | M24.004 | aminopeptidase P (bacteria) | low pH form | 1JAW |
| MG | M24.004 | aminopeptidase P (bacteria) | 1M35 | |
| MG | M24.004 | aminopeptidase P (bacteria) | complex with the inhibitor apstatin | 1N51_A |
| MG | M24.004 | aminopeptidase P (bacteria) | ca-substituted form of e. coli aminopeptidase p | 1W2M_A |
| MG | M24.004 | aminopeptidase P (bacteria) | znmg substituted aminopeptidase p from e. coli | 1W7V_A |
| MG | M24.004 | aminopeptidase P (bacteria) | zn mg substituted aminopeptidase p from e. coli | 1WBQ_A |
| MG | M24.004 | aminopeptidase P (bacteria) | mg-substituted form of e. coli aminopeptidase p | 1WL6_A |
| MG | M24.004 | aminopeptidase P (bacteria) | structure of aminopeptidase p from e. coli | 1WL9_A |
| MG | M24.004 | aminopeptidase P (bacteria) | apo aminopeptidase p from e. coli | 1WLR_A |
| MG | M24.004 | aminopeptidase P (bacteria) | Zn substituted; complex with product | 2BH3_A |
| MG | M24.004 | aminopeptidase P (bacteria) | complex with substrate | 2BHA_A |
| MG | M24.004 | aminopeptidase P (bacteria) | zn substituted e. coli aminopeptidase p | 2BHB_A |
| MG | M24.004 | aminopeptidase P (bacteria) | na substituted e. coli aminopeptidase p | 2BHC_A |
| MG | M24.004 | aminopeptidase P (bacteria) | Mg substituted; complex with product | 2BHD_A |
| MG | M24.004 | aminopeptidase P (bacteria) | mn substituted e. coli aminopeptidase p in complex with product and zn | 2BN7_A |
| MG | M24.004 | aminopeptidase P (bacteria) | his243ala escherichia coli aminopeptidase p | 2BWS_A |
| MG | M24.004 | aminopeptidase P (bacteria) | asp260ala escherichia coli aminopeptidase p | 2BWT_A |
| MG | M24.004 | aminopeptidase P (bacteria) | asp271ala escherichia coli aminopeptidase p | 2BWU_A |
| MG | M24.004 | aminopeptidase P (bacteria) | his361ala escherichia coli aminopeptidase p | 2BWV_A |
| MG | M24.004 | aminopeptidase P (bacteria) | his350ala escherichia coli aminopeptidase p | 2BWW_A |
| MG | M24.004 | aminopeptidase P (bacteria) | his354ala escherichia coli aminopeptidase p | 2BWX_A |
| MG | M24.004 | aminopeptidase P (bacteria) | glu383ala escherichia coli aminopeptidase p | 2BWY_A |
| MG | M24.004 | aminopeptidase P (bacteria) | His243Ala mutant; complex with substrate | 2V3X_A |
| MG | M24.004 | aminopeptidase P (bacteria) | His361Ala mutant; complex with product | 2V3Y_A |
| MG | M24.004 | aminopeptidase P (bacteria) | Glu383Ala mutant; complex with substrate | 2V3Z_A |
| MG | M24.004 | aminopeptidase P (bacteria) | the structure of pseudomonas aeruginosa aminopeptidase pepp | 5WZE_A |
| MG | M24.004 | aminopeptidase P (bacteria) | proline aminopeptidase p ii from yersinia pestis | 4PV4_A |
| MG | M24.006 | bacillus Xaa-Pro aminopeptidase | 4ZNG_C | |
| MG | M24.007 | Xaa-Pro dipeptidase (eukaryote-type) | 2IW2_A | |
| MG | M24.007 | Xaa-Pro dipeptidase (eukaryote-type) | 2OKN_A | |
| MG | M24.007 | Xaa-Pro dipeptidase (eukaryote-type) | crystal structure of wild-type human prolidase with mn ions | 5M4G_A |
| MG | M24.007 | Xaa-Pro dipeptidase (eukaryote-type) | crystal structure of wild-type human prolidase with glypro ligand | 5M4J_A |
| MG | M24.007 | Xaa-Pro dipeptidase (eukaryote-type) | crystal structure of wild-type human prolidase with mg ions and leuproligand | 5M4L_A |
| MG | M24.007 | Xaa-Pro dipeptidase (eukaryote-type) | crystal structure of wild-type human prolidase with mn ions and pro ligand | 5M4Q_A |
| MG | M24.007 | Xaa-Pro dipeptidase (eukaryote-type) | crystal structure of asp276asn mutant of human prolidase with mn ions and glypro ligand | 5MC1_A |
| MG | M24.007 | Xaa-Pro dipeptidase (eukaryote-type) | Gly278Asp mutant with Mn ions and glypro ligand | 5MC2_A |
| MG | M24.007 | Xaa-Pro dipeptidase (eukaryote-type) | Glu412Lys mutant with Mn ions and glypro ligand | 5MC3_A |
| MG | M24.007 | Xaa-Pro dipeptidase (eukaryote-type) | Gly448Arg mutant with Mn ions and glypro ligand | 5MC4_A |
| MG | M24.007 | Xaa-Pro dipeptidase (eukaryote-type) | crystal structure of delglu452 mutant of human prolidase with mn ions and glypro ligand | 5MC5_A |
| MG | M24.007 | Xaa-Pro dipeptidase (eukaryote-type) | crystal structure of arg184gln mutant of human prolidase with mn ions and cacodylate ligand | 6H2P_A |
| MG | M24.007 | Xaa-Pro dipeptidase (eukaryote-type) | crystal structure of arg184gln mutant of human prolidase with mn ions and leupro ligand | 6H2Q_A |
| MG | M24.008 | hyperthermophile prolidase | 1WY2_A | |
| MG | M24.008 | hyperthermophile prolidase | 1PV9 | |
| MG | M24.009 | aminopeptidase P1 | 3CTZ | |
| MG | M24.017 | methionyl aminopeptidase 1 (eukaryote) | third cobalt in the active site | 2B3H_A |
| MG | M24.017 | methionyl aminopeptidase 1 (eukaryote) | holo form | 2B3K_A |
| MG | M24.017 | methionyl aminopeptidase 1 (eukaryote) | apo form | 2B3L_A |
| MG | M24.017 | methionyl aminopeptidase 1 (eukaryote) | truncated form (delta 1-89); complex with pyridyl pyrimidine derivative | 2G6P_A |
| MG | M24.017 | methionyl aminopeptidase 1 (eukaryote) | human type 1 methionine aminopeptidase in complex with ovalicin at 1.1 ang | 2GZ5_A |
| MG | M24.017 | methionyl aminopeptidase 1 (eukaryote) | complex with 3-tert-butoxycarbonylaminopyridine-2- carboxylic acid thiazole-2-ylamide | 2NQ6_A |
| MG | M24.017 | methionyl aminopeptidase 1 (eukaryote) | complex with 3-(2,2-dimethylpropionylamino)pyridine-2- carboxylic acid thiazole-2-ylamide | 2NQ7_A |
| MG | M24.017 | methionyl aminopeptidase 1 (eukaryote) | complex with bengamide analog Y16 | 4FLI |
| MG | M24.017 | methionyl aminopeptidase 1 (eukaryote) | complex with bengamide analog Y08 | 4FLJ |
| MG | M24.017 | methionyl aminopeptidase 1 (eukaryote) | complex with bengamide analog Y10 | 4FLK |
| MG | M24.017 | methionyl aminopeptidase 1 (eukaryote) | complex with bengamide analog YZ6 | 4FLL |
| MG | M24.017 | methionyl aminopeptidase 1 (eukaryote) | 4HXX | |
| MG | M24.017 | methionyl aminopeptidase 1 (eukaryote) | 4IKR | |
| MG | M24.017 | methionyl aminopeptidase 1 (eukaryote) | 4IKS | |
| MG | M24.017 | methionyl aminopeptidase 1 (eukaryote) | 4IKT | |
| MG | M24.017 | methionyl aminopeptidase 1 (eukaryote) | 4IKU | |
| MG | M24.017 | methionyl aminopeptidase 1 (eukaryote) | 4IU6 | |
| MG | M24.017 | methionyl aminopeptidase 1 (eukaryote) | 4U1B | |
| MG | M24.017 | methionyl aminopeptidase 1 (eukaryote) | 4U69 | |
| MG | M24.017 | methionyl aminopeptidase 1 (eukaryote) | 4U6C | |
| MG | M24.017 | methionyl aminopeptidase 1 (eukaryote) | 4U6E | |
| MG | M24.017 | methionyl aminopeptidase 1 (eukaryote) | 4U6J | |
| MG | M24.017 | methionyl aminopeptidase 1 (eukaryote) | 4U6W | |
| MG | M24.017 | methionyl aminopeptidase 1 (eukaryote) | 4U6Z | |
| MG | M24.017 | methionyl aminopeptidase 1 (eukaryote) | 4U70 | |
| MG | M24.017 | methionyl aminopeptidase 1 (eukaryote) | 4U71 | |
| MG | M24.017 | methionyl aminopeptidase 1 (eukaryote) | 4U73 | |
| MG | M24.017 | methionyl aminopeptidase 1 (eukaryote) | 4U75 | |
| MG | M24.017 | methionyl aminopeptidase 1 (eukaryote) | 4U76 | |
| MG | M24.017 | methionyl aminopeptidase 1 (eukaryote) | Phe309Met mutant; complex with ovalicin | 5YKP_A |
| MG | M24.017 | methionyl aminopeptidase 1 (eukaryote) | Phe309Met mutant; comlex with tnp470 | 5YR4_A |
| MG | M24.017 | methionyl aminopeptidase 1 (eukaryote) | Phe309Leu mutant; complex with ovalicin | 5YR5_A |
| MG | M24.017 | methionyl aminopeptidase 1 (eukaryote) | Phe309Met mutant; complex with tnp470 | 5YR6_A |
| MG | M24.017 | methionyl aminopeptidase 1 (eukaryote) | human methionine aminopeptidase type 1b (f309l mutant) | 5YR7_A |
| MG | M24.017 | methionyl aminopeptidase 1 (eukaryote) | crystal structure of methionine aminopeptidase 1b from plasmodium falciparum, pf10_0150 | 3S6B_A |
| MG | M24.017 | methionyl aminopeptidase 1 (eukaryote) | 4FUK_A | |
| MG | M24.026 | aminopeptidase P3 | complex with apstatin | 5X49 |
| MG | M24.031 | leucine aminopeptidase (Thermotoga-type) | 2ZSG_A | |
| MG | M24.031 | leucine aminopeptidase (Thermotoga-type) | xaa-pro dipeptidase from bacillus anthracis. | 3Q6D_A |
| MG | M24.032 | Mername-AA273 peptidase | 4S2R | |
| MG | M24.032 | Mername-AA273 peptidase | complex with apstatin | 4S2T |
| MG | M24.034 | PH0974 dipeptidase | 1WN1_A | |
| MG | M24.034 | PH0974 dipeptidase | dipeptidase (ph0974) from pyrococcus horikoshii ot3 | 2HOW_A |
| MG | M24.034 | PH0974 dipeptidase | recombinant prolidase from thermococcus sibiricus | 4FKC_A |
| MG | M24.034 | PH0974 dipeptidase | crystal structure of recombinant prolidase from thermococcus sibiricusat p21221 spacegroup | 4RGZ_A |
| MG | M24.035 | methionyl aminopeptidase (archaean-type) (Pyrococcus furiosus) | the product bound form of the mn(ii)loaded methionine aminopeptidase from hyperthermophile pyrococcus furiosus | 1WKM_A |
| MG | M24.035 | methionyl aminopeptidase (archaean-type) (Pyrococcus furiosus) | dimer | 1XGM |
| MG | M24.035 | methionyl aminopeptidase (archaean-type) (Pyrococcus furiosus) | dimer | 1XGN |
| MG | M24.035 | methionyl aminopeptidase (archaean-type) (Pyrococcus furiosus) | 1XGO | |
| MG | M24.035 | methionyl aminopeptidase (archaean-type) (Pyrococcus furiosus) | dimer | 1XGS |
| MG | M24.035 | methionyl aminopeptidase (archaean-type) (Pyrococcus furiosus) | 2DFI_A | |
| MG | M24.036 | methionyl aminopeptidase 1 (Staphylococcus-type) | complex with aminoketone inhibitor 54135 | 1QXW |
| MG | M24.036 | methionyl aminopeptidase 1 (Staphylococcus-type) | complex with ketoheterocycle inhibitor 618 | 1QXY |
| MG | M24.036 | methionyl aminopeptidase 1 (Staphylococcus-type) | complex with ketoheterocycle inhibitor 119 | 1QXZ |
| MG | M24.038 | aminopeptidase P (Plasmodium falciparum-type) | ON HOLD: unliganded | 5JQK |
| MG | M24.038 | aminopeptidase P (Plasmodium falciparum-type) | ON HOLD: complex with apstatin | 5JR6 |
| MG | M24.039 | YdpF (Escherischia coli) | 5CNX | |
| MG | M24.973 | proliferation-association protein 1 | the crystal structure of ebp1 | 2Q8K_A |
| MG | M24.973 | proliferation-association protein 1 | 3J2I | |
| MG | M24.974 | FACT complex subunit SPT16 | crystal structure of human spt16 n-terminal domain | 5E5B_A |
| MG | M24.974 | FACT complex subunit SPT16 | human n-terminal domain of fact complex subunit spt16 | 5XM2_A |
| MG | M24.978 | proliferation-associated protein 2G4 | 2V6C_A | |
| MG | M24.A06 | At4g37040 (Arabidopsis thaliana)-type peptidase | identification of sh3 motif in m. tuberculosis methionine aminopeptidase suggests a mode of interaction with the ribosome | 1Y1N_A |
| MG | M24.A06 | At4g37040 (Arabidopsis thaliana)-type peptidase | product bound | 1YJ3_A |
| MG | M24.A06 | At4g37040 (Arabidopsis thaliana)-type peptidase | m. tuberculosis methionine aminopeptidase with mn inhibitor a02 | 3IU7_A |
| MG | M24.A06 | At4g37040 (Arabidopsis thaliana)-type peptidase | m. tuberculosis methionine aminopeptidase with ni inhibitor t03 | 3IU8_A |
| MG | M24.A06 | At4g37040 (Arabidopsis thaliana)-type peptidase | m. tuberculosis methionine aminopeptidase with ni inhibitor t07 | 3IU9_A |
| MG | M24.A06 | At4g37040 (Arabidopsis thaliana)-type peptidase | m. tuberculosis metap with bengamide analog y02, in mn form | 3PKA_A |
| MG | M24.A06 | At4g37040 (Arabidopsis thaliana)-type peptidase | m. tuberculosis metap with bengamide analog y16, in mn form | 3PKB_A |
| MG | M24.A06 | At4g37040 (Arabidopsis thaliana)-type peptidase | m. tuberculosis metap with bengamide analog y08, in mn form | 3PKC_A |
| MG | M24.A06 | At4g37040 (Arabidopsis thaliana)-type peptidase | m. tuberculosis metap with bengamide analog y10, in mn form | 3PKD_A |
| MG | M24.A06 | At4g37040 (Arabidopsis thaliana)-type peptidase | m. tuberculosis metap with bengamide analog y10, in ni form | 3PKE_A |
| MG | M24.A06 | At4g37040 (Arabidopsis thaliana)-type peptidase | crystal structure of c105s mutant of mycobacterium tuberculosis methionine aminopeptidase | 3ROR_A |
| MG | M24.A06 | At4g37040 (Arabidopsis thaliana)-type peptidase | mycobacterium tuberculosis methionine aminopeptidase type 1c in complex with 2-hydroxyethyl disulfide | 4IDY_A |
| MG | M24.A06 | At4g37040 (Arabidopsis thaliana)-type peptidase | cys105 covalent modification by 2-hydroxyethyl disulfide in mycobacterium tuberculosis methionine aminopeptidase type 1c | 4IEC_A |
| MG | M24.A06 | At4g37040 (Arabidopsis thaliana)-type peptidase | mycobacterium tuberculosis methionine aminopeptidase type 1c in complex with homocysteine-methyl disulfide | 4IF7_A |
| MG | M24.A06 | At4g37040 (Arabidopsis thaliana)-type peptidase | third metal bound m.tuberculosis methionine aminopeptidase | 4OOK_A |
| MG | M24.A06 | At4g37040 (Arabidopsis thaliana)-type peptidase | mycobacterium tuberculosis methionine aminopeptidase type 1c (c105m mutant) in complex with methionine | 5YOH_A |
| MG | M24.A06 | At4g37040 (Arabidopsis thaliana)-type peptidase | mycobacterium tuberculosis methionine aminopeptidase type 1c (c105t mutant) in complex with methionine | 5YOI_A |
| MG | M24.A06 | At4g37040 (Arabidopsis thaliana)-type peptidase | mycobacterium tuberculosis methionine aminopeptidase type 1c (c105n mutant) in complex with methionine | 5YPD_A |
| MG | M24.A06 | At4g37040 (Arabidopsis thaliana)-type peptidase | mycobacterium tuberculosis methionine aminopeptidase type 1c (c105n mutant). | 5YPJ_A |
| MG | M24.A06 | At4g37040 (Arabidopsis thaliana)-type peptidase | mycobacterium tuberculosis methionine aminopeptidase type 1c (c105l mutant) in complex with methionine | 5YXF_A |
| MG | M24.UNW | family M24 non-peptidase homologues | 1CHM | |
| MG | M24.UNW | family M24 non-peptidase homologues | 3CB5 | |
| MG | M24.UNW | family M24 non-peptidase homologues | 3CB6 | |
| MG | M24.UNW | family M24 non-peptidase homologues | n-terminal domain of fact complex subunit spt16 from eremothecium gossypii (ashbya gossypii) | 6A8M_A |
| MG | M24.UPA | subfamily M24A unassigned peptidases | 1O0X | |
| MG | M24.UPA | subfamily M24A unassigned peptidases | crystal structure of the enterococcus faecalis methionine aminopeptidase apo form | 3TB5_A |
| MG | M24.UPA | subfamily M24A unassigned peptidases | discovery of a novel structural motif in methionine aminopeptidase from streptococci with possible post-translational modification | 4KM3_A |
| MG | M24.UPA | subfamily M24A unassigned peptidases | 3FM3 | |
| MG | M24.UPA | subfamily M24A unassigned peptidases | complex with angiogenesis inhibitor fumagillan | 3FMQ |
| MG | M24.UPA | subfamily M24A unassigned peptidases | complex with angiogenesis inhibitor TNP470 | 3FMR |
| MG | M24.UPA | subfamily M24A unassigned peptidases | crystal structure of a methionine aminopeptidase from mycobacterium abscessus | 3TAV_A |
| MG | M24.UPB | subfamily M24B unassigned peptidases | crystal structure of icp55 from saccharomyces cerevisiae (n-terminal 58 residues deletion) | 6A9T_A |
| MG | M24.UPB | subfamily M24B unassigned peptidases | crystal strcture of icp55 from saccharomyces cerevisiae bound to apstatin inhibitor | 6A9U_A |
| MG | M24.UPB | subfamily M24B unassigned peptidases | crystal structure of icp55 from saccharomyces cerevisiae (n-terminal 42 residues deletion) | 6A9V_A |
| MG | M24.UPB | subfamily M24B unassigned peptidases | Met1Ser mutant | 5CDL |
| MG | M24.UPB | subfamily M24B unassigned peptidases | 5CDV | |
| MG | M24.UPB | subfamily M24B unassigned peptidases | 5GIQ | |
| MG | M24.UPB | subfamily M24B unassigned peptidases | metal-free | 5GIU |
| MG | M24.UPB | subfamily M24B unassigned peptidases | 4R60 | |
| MG | M24.UPB | subfamily M24B unassigned peptidases | Arg372Ala mutant | 5CDE |
| MG | M24.UPB | subfamily M24B unassigned peptidases | Met1Ser mutant | 5CIK |
| MG | M24.UPB | subfamily M24B unassigned peptidases | 5FCF | |
| MG | M24.UPB | subfamily M24B unassigned peptidases | crystal structure of xaa-pro dipeptidase from xanthomonas campestris, phosphate and zn bound | 5FCH_A |
| MG | M24.UPB | subfamily M24B unassigned peptidases | 3IG4_A | |
| MG | M24.UPB | subfamily M24B unassigned peptidases | crystal structure of dipeptidase pepe from mycobacterium ulcerans | 4EGE_A |
| MG | M24.UPW | family M24 unassigned peptidases | crystal structure of a novel xaa-pro dipeptidase from deinococcus radiodurans | 5XEV_A |
| MA | M27.001 | tentoxilysin | C-fragment | 1A8D |
| MA | M27.001 | tentoxilysin | 1AF9 | |
| MA | M27.001 | tentoxilysin | 1D0H | |
| MA | M27.001 | tentoxilysin | 1DFQ | |
| MA | M27.001 | tentoxilysin | 1DIW | |
| MA | M27.001 | tentoxilysin | 1DLL | |
| MA | M27.001 | tentoxilysin | 1FV2 | |
| MA | M27.001 | tentoxilysin | 1FV3 | |
| MA | M27.001 | tentoxilysin | structural analysis of the catalytic domain of tetanus neurotoxin | 1YVG_A |
| MA | M27.001 | tentoxilysin | 1YXW | |
| MA | M27.001 | tentoxilysin | 1YYN | |
| MA | M27.001 | tentoxilysin | light chain | 1Z7H_A |
| MA | M27.001 | tentoxilysin | 3HMY | |
| MA | M27.001 | tentoxilysin | 3HN1 | |
| MA | M27.001 | tentoxilysin | 4J1L | |
| MA | M27.001 | tentoxilysin | complex with gd1a | 5N0B_A |
| MA | M27.001 | tentoxilysin | complex with gm1a | 5N0C_A |
| MA | M27.002 | bontoxilysin | type B | 1EPW |
| MA | M27.002 | bontoxilysin | complex with a trisaccharide | 1F31 |
| MA | M27.002 | bontoxilysin | catalytic domain | 1F82_A |
| MA | M27.002 | bontoxilysin | catalytic domain; complex with cleaved form of synaptobrevin-II: SUPERCEDED BY 3G94 | 1F83 |
| MA | M27.002 | bontoxilysin | OBSOLETE; catalytic domain; complex with bis(5-amidino-benzimidazolyl)methane inhibitor: OBSOLETE | 1FQH |
| MA | M27.002 | bontoxilysin | complex with bis(5-amidino-benzimidazolyl)methane inhibitor | 1G9A |
| MA | M27.002 | bontoxilysin | complex with bis(5-amidino-benzimidazolyl)methane inhibitor | 1G9B |
| MA | M27.002 | bontoxilysin | complex with bis(5-amidino-benzimidazolyl)methane inhibitor | 1G9C |
| MA | M27.002 | bontoxilysin | complex with bis(5-amidino-benzimidazolyl)methane inhibitor | 1G9D |
| MA | M27.002 | bontoxilysin | complex with doxorubicin | 1I1E |
| MA | M27.002 | bontoxilysin | pH 4.0 | 1S0B_A |
| MA | M27.002 | bontoxilysin | pH 5.0 | 1S0C_A |
| MA | M27.002 | bontoxilysin | pH 5.5 | 1S0D_A |
| MA | M27.002 | bontoxilysin | pH 6.0 | 1S0E_A |
| MA | M27.002 | bontoxilysin | pH 7.0 | 1S0F_A |
| MA | M27.002 | bontoxilysin | apo form | 1S0G_A |
| MA | M27.002 | bontoxilysin | 1Z0H | |
| MA | M27.002 | bontoxilysin | light chain | 2ETF_A |
| MA | M27.002 | bontoxilysin | 2NM1 | |
| MA | M27.002 | bontoxilysin | complex with synaptotagamin-II ectodomain | 2NP0_A |
| MA | M27.002 | bontoxilysin | 2XHL | |
| MA | M27.002 | bontoxilysin | further refinement of botulinum neurotoxin type b catalytic domain with synaptobrevin-ii bound | 3G94_A |
| MA | M27.002 | bontoxilysin | 3ZUQ | |
| MA | M27.002 | bontoxilysin | 4KBB | |
| MA | M27.002 | bontoxilysin | Glu1191Met/Ser1199Tyr mutant; complex with human synaptotagmin 1 | 6G5F_A |
| MA | M27.002 | bontoxilysin | Glu1191Met/Ser1199Tyr mutant; complex with human synaptotagmin 2 | 6G5G_A |
| MA | M27.002 | bontoxilysin | light chain only | 1ZB7 |
| MA | M27.002 | bontoxilysin | 2VXR | |
| MA | M27.002 | bontoxilysin | 3MPP | |
| MA | M27.004 | botulinum neurotoxin X | 6F47 | |
| MA | M27.004 | botulinum neurotoxin X | apoenzyme | 6F4E |
| MA | M27.UPW | family M27 unassigned peptidases | 1E1H_A | |
| MA | M27.UPW | family M27 unassigned peptidases | 1UEE | |
| MA | M27.UPW | family M27 unassigned peptidases | Glu224Gln, Tyr366Phe double mutant | 1XTF |
| MA | M27.UPW | family M27 unassigned peptidases | complex with synaptosomal-associated protein 25 | 1XTG |
| MA | M27.UPW | family M27 unassigned peptidases | clostridium botulinum serotype a light chain inhibited by 4- chlorocinnamic hydroxamate | 2ILP_A |
| MA | M27.UPW | family M27 unassigned peptidases | clostridium botulinum neurotoxin serotype a light chain inhibited by 2,4-dichlorocinnamic hydroxamate | 2IMA_A |
| MA | M27.UPW | family M27 unassigned peptidases | clostridium botulinum neurotoxin serotype a light chain inhibited by l-arginine hydroxamate | 2IMB_A |
| MA | M27.UPW | family M27 unassigned peptidases | light chain only | 2IMC |
| MA | M27.UPW | family M27 unassigned peptidases | light chain; crystal form A | 2ISE_A |
| MA | M27.UPW | family M27 unassigned peptidases | light chain; crystal form B | 2ISG_A |
| MA | M27.UPW | family M27 unassigned peptidases | light chain; crystal form c | 2ISH_A |
| MA | M27.UPW | family M27 unassigned peptidases | complex with monoclonal antibody CR1 | 2NYY_A |
| MA | M27.UPW | family M27 unassigned peptidases | complex with monoclonal antibody AR2 | 2NZ9_A |
| MA | M27.UPW | family M27 unassigned peptidases | 2VU9 | |
| MA | M27.UPW | family M27 unassigned peptidases | 2VUA | |
| MA | M27.UPW | family M27 unassigned peptidases | 2W2D | |
| MA | M27.UPW | family M27 unassigned peptidases | apo-enzyme | 3BOK |
| MA | M27.UPW | family M27 unassigned peptidases | with zinc bound | 3BON |
| MA | M27.UPW | family M27 unassigned peptidases | complex with inhibitory peptide | 3BOO |
| MA | M27.UPW | family M27 unassigned peptidases | 3BTA | |
| MA | M27.UPW | family M27 unassigned peptidases | 3BWI | |
| MA | M27.UPW | family M27 unassigned peptidases | catalytic domain from serotype A; complex with inhibitory peptide RRGC | 3C88_A |
| MA | M27.UPW | family M27 unassigned peptidases | catalytic domain from serotype A; complex with inhibitory peptide RRGM | 3C89_A |
| MA | M27.UPW | family M27 unassigned peptidases | 3C8A | |
| MA | M27.UPW | family M27 unassigned peptidases | 3C8B | |
| MA | M27.UPW | family M27 unassigned peptidases | 3DDA | |
| MA | M27.UPW | family M27 unassigned peptidases | 3DDB | |
| MA | M27.UPW | family M27 unassigned peptidases | 3DS9 | |
| MA | M27.UPW | family M27 unassigned peptidases | a potent peptidomimetic inhibitor of botulinum neurotoxin serotype a has a very different conformation than snap-25 substrate | 3DSE_A |
| MA | M27.UPW | family M27 unassigned peptidases | 3FUO | |
| MA | M27.UPW | family M27 unassigned peptidases | catalytic domain; complex with a llama antibody | 3K3Q_B |
| MA | M27.UPW | family M27 unassigned peptidases | crystal structure of bont/a lc with jth-nb-7239 peptide | 3NF3_A |
| MA | M27.UPW | family M27 unassigned peptidases | crystal structure of bont/a lc with zinc bound | 3QIX_A |
| MA | M27.UPW | family M27 unassigned peptidases | complex with hydroxamate-based inhibitor pt-1 | 3QIY_A |
| MA | M27.UPW | family M27 unassigned peptidases | complex with hydroxamate-based inhibitor pt-2 | 3QIZ_A |
| MA | M27.UPW | family M27 unassigned peptidases | complex with hydroxamate-based inhibitor pt-3 | 3QJ0_A |
| MA | M27.UPW | family M27 unassigned peptidases | crystal structure of the protease domain of botulinum neurotoxin serotype a with a peptide inhibitor rrgf | 3QW5_A |
| MA | M27.UPW | family M27 unassigned peptidases | crystal structure of the protease domain of botulinum neurotoxin serotype a with a peptide inhibitor rygc | 3QW6_A |
| MA | M27.UPW | family M27 unassigned peptidases | crystal structure of the protease domain of botulinum neurotoxin serotype a with a peptide inhibitor rrfc | 3QW7_A |
| MA | M27.UPW | family M27 unassigned peptidases | crystal structure of the protease domain of botulinum neurotoxin serotype a with a peptide inhibitor crgc | 3QW8_A |
| MA | M27.UPW | family M27 unassigned peptidases | 3V0A | |
| MA | M27.UPW | family M27 unassigned peptidases | 3V0B | |
| MA | M27.UPW | family M27 unassigned peptidases | 3V0C | |
| MA | M27.UPW | family M27 unassigned peptidases | 3ZUR | |
| MA | M27.UPW | family M27 unassigned peptidases | 3ZUS | |
| MA | M27.UPW | family M27 unassigned peptidases | 4EJ5 | |
| MA | M27.UPW | family M27 unassigned peptidases | 4EL4 | |
| MA | M27.UPW | family M27 unassigned peptidases | 4ELC | |
| MA | M27.UPW | family M27 unassigned peptidases | 4HEV | |
| MA | M27.UPW | family M27 unassigned peptidases | 4IQP | |
| MA | M27.UPW | family M27 unassigned peptidases | 4JRA | |
| MA | M27.UPW | family M27 unassigned peptidases | crystal structure of the catalytic domain of botulinum neurotoxin bont/a c134s mutant with covalent inhibitor that modifies cys-165 causing disorder in 166-174 stretch | 4KS6_A |
| MA | M27.UPW | family M27 unassigned peptidases | crystal structure of the catalytic domain of botulinum neurotoxin bont/a c134s mutant with covalent inhibitor that modifies cys-165 causing disorder in 167-174 stretch | 4KTX_A |
| MA | M27.UPW | family M27 unassigned peptidases | crystal structure of the catalytic domain of botulinum neurotoxin bont/a c134 mutant with mtsea modified cys-165 causing stretch disorder | 4KUF_A |
| MA | M27.UPW | family M27 unassigned peptidases | crystal structure of the catalytic domain of botulinum neurotoxin serotype a with a novel cyclic peptide inhibitor | 4ZJX_A |
| MA | M27.UPW | family M27 unassigned peptidases | small molecule inhibitor abs-143 bound to the botulinum neurotoxin serotype a light chain | 5V8P_A |
| MA | M27.UPW | family M27 unassigned peptidases | small molecule inhibitor abs-143 bound to the botulinum neurotoxin serotype a light chain | 5V8R_A |
| MA | M27.UPW | family M27 unassigned peptidases | small molecule inhibitor abs-143 bound to the botulinum neurotoxin serotype a light chain | 5V8U_A |
| MA | M27.UPW | family M27 unassigned peptidases | structure of the c. botulinum neurotoxin serotype a with cu bound | 5VGV_A |
| MA | M27.UPW | family M27 unassigned peptidases | structure of the c. botulinum neurotoxin serotype a with hg bound | 5VGX_A |
| MA | M27.UPW | family M27 unassigned peptidases | structure of botulinum neurotoxin serotype c1 light chain protease | 2QN0_A |
| MA | M27.UPW | family M27 unassigned peptidases | type C; apo form (zinc removed) | 3DEB_A |
| MA | M27.UPW | family M27 unassigned peptidases | 3N7K | |
| MA | M27.UPW | family M27 unassigned peptidases | 3R4S | |
| MA | M27.UPW | family M27 unassigned peptidases | 3R4U | |
| MA | M27.UPW | family M27 unassigned peptidases | light chain only | 2FPQ |
| MA | M27.UPW | family M27 unassigned peptidases | 3N7J | |
| MA | M27.UPW | family M27 unassigned peptidases | 3OBR | |
| MA | M27.UPW | family M27 unassigned peptidases | 3OBT | |
| MA | M27.UPW | family M27 unassigned peptidases | 3OGG | |
| MA | M27.UPW | family M27 unassigned peptidases | 3RMX | |
| MA | M27.UPW | family M27 unassigned peptidases | 3RMY | |
| MA | M27.UPW | family M27 unassigned peptidases | 5BQM | |
| MA | M27.UPW | family M27 unassigned peptidases | 5BQN | |
| MA | M27.UPW | family M27 unassigned peptidases | catalytic domain | 1T3A_A |
| MA | M27.UPW | family M27 unassigned peptidases | clostridium botulinum type e catalytic domain e212q mutant | 1T3C_A |
| MA | M27.UPW | family M27 unassigned peptidases | Arg347Ala mutant; catalytic domain | 1ZKW_A |
| MA | M27.UPW | family M27 unassigned peptidases | Glu158Ala/Thr159Ala/Asn160Ala triple mutant; catalytic domain | 1ZKX_A |
| MA | M27.UPW | family M27 unassigned peptidases | Glu335Gln mutant; catalytic domain | 1ZL5_A |
| MA | M27.UPW | family M27 unassigned peptidases | Tyr350Ala mutant; catalytic domain | 1ZL6_A |
| MA | M27.UPW | family M27 unassigned peptidases | Glu335Ala mutant | 1ZN3 |
| MA | M27.UPW | family M27 unassigned peptidases | domain organization in clostridium butulinum neurotoxin type e is unique: its implication in faster translocation | 3FFZ_A |
| MA | M27.UPW | family M27 unassigned peptidases | serotype E catalytic domain; complex with snap-25 substrate peptide | 3D3X_A |
| MA | M27.UPW | family M27 unassigned peptidases | light chain | 2A8A_A |
| MA | M27.UPW | family M27 unassigned peptidases | catalytic domain | 2A97_A |
| MA | M27.UPW | family M27 unassigned peptidases | 3FIE | |
| MA | M27.UPW | family M27 unassigned peptidases | 3FII | |
| MA | M27.UPW | family M27 unassigned peptidases | light chain only | 1E1H |
| MA | M27.UPW | family M27 unassigned peptidases | structure of the light chain of botulinum neurotoxin, serotype a bound to small molecule inhibitors | 2G7K_A |
| MA | M27.UPW | family M27 unassigned peptidases | structure of the light chain of botulinum neurotoxin serotype a bound to small molecule inhibitors | 2G7N_A |
| MA | M27.UPW | family M27 unassigned peptidases | structure of the light chain of botulinum neurotoxin serotype a bound to small molecule inhibitors | 2G7P_A |
| MA | M27.UPW | family M27 unassigned peptidases | structure of the light chain of botulinum neurotoxin serotype a bound to small molecule inhibitors | 2G7Q_A |
| MH | M28.002 | aminopeptidase Ap1 | 1AMP | |
| MH | M28.002 | aminopeptidase Ap1 | complex with 1-butaneboronic acid | 1CP6 |
| MH | M28.002 | aminopeptidase Ap1 | complex with L-Leu-phosphonic acid | 1FT7 |
| MH | M28.002 | aminopeptidase Ap1 | complex with para-iodo-D-Phe hydroxamate | 1IGB |
| MH | M28.002 | aminopeptidase Ap1 | complex with Tris buffer | 1LOK |
| MH | M28.002 | aminopeptidase Ap1 | 1RTQ | |
| MH | M28.002 | aminopeptidase Ap1 | complex with bestatin | 1TXR_A |
| MH | M28.002 | aminopeptidase Ap1 | complex with bestatin | 1XRY_A |
| MH | M28.002 | aminopeptidase Ap1 | functional glutamate 151 to histidine mutant of the aminopeptidase from aeromonas proteolytica. | 2ANP_A |
| MH | M28.002 | aminopeptidase Ap1 | structure at pH 4.7. | 2DEA |
| MH | M28.002 | aminopeptidase Ap1 | complex with leucyl-leucyl-leucine. | 2IQ6_A |
| MH | M28.002 | aminopeptidase Ap1 | structure of vibrio proteolyticus aminopeptidase with a bound trp fragment of dlwcf | 2NYQ_A |
| MH | M28.002 | aminopeptidase Ap1 | Co(II) substituted Tris-bound form | 2PRQ |
| MH | M28.002 | aminopeptidase Ap1 | Met180Ala mutant | 3B35_A |
| MH | M28.002 | aminopeptidase Ap1 | Met180Ala mutant; complex with leucine phosphonic acid | 3B3C_A |
| MH | M28.002 | aminopeptidase Ap1 | Met180Ala mutant; complex with leucine | 3B3S_A |
| MH | M28.002 | aminopeptidase Ap1 | Asp118Asn mutant | 3B3T_A |
| MH | M28.002 | aminopeptidase Ap1 | Ser228Ala mutant | 3B3V_A |
| MH | M28.002 | aminopeptidase Ap1 | Ser228Ala mutant; complex with leucine | 3B3W_A |
| MH | M28.002 | aminopeptidase Ap1 | Ser228Ala mutant; complex with leucine phosphonic acid | 3B7I_A |
| MH | M28.002 | aminopeptidase Ap1 | 3FH4 | |
| MH | M28.002 | aminopeptidase Ap1 | 3VH9 | |
| MH | M28.003 | aminopeptidase S (Streptomyces-type) | 1CP7 | |
| MH | M28.003 | aminopeptidase S (Streptomyces-type) | complex with L-leucine | 1F2O |
| MH | M28.003 | aminopeptidase S (Streptomyces-type) | complex with L-phenylalanine | 1F2P |
| MH | M28.003 | aminopeptidase S (Streptomyces-type) | complex with L-methionine | 1QQ9 |
| MH | M28.003 | aminopeptidase S (Streptomyces-type) | complex with L-tryptophan | 1TF8 |
| MH | M28.003 | aminopeptidase S (Streptomyces-type) | complex with p-iodo-L-phenylalanine | 1TF9 |
| MH | M28.003 | aminopeptidase S (Streptomyces-type) | complex with D-tryptophan | 1TKF |
| MH | M28.003 | aminopeptidase S (Streptomyces-type) | complex with D-phenylalanine | 1TKH |
| MH | M28.003 | aminopeptidase S (Streptomyces-type) | complex with D-methionine | 1TKJ |
| MH | M28.003 | aminopeptidase S (Streptomyces-type) | complex with p-iodo-D-phenylalanine | 1XBU |
| MH | M28.003 | aminopeptidase S (Streptomyces-type) | 1XJO | |
| MH | M28.009 | YwaD peptidase | 6HC6 | |
| MH | M28.009 | YwaD peptidase | 6HC7 | |
| MH | M28.010 | glutamate carboxypeptidase II | 1Z8L_A | |
| MH | M28.010 | glutamate carboxypeptidase II | complex with GPI-18431 (S)-2-(4-iodobenzylphosphonomethyl)-pentanedoic acid | 2C6C |
| MH | M28.010 | glutamate carboxypeptidase II | complex with glutamate | 2C6G |
| MH | M28.010 | glutamate carboxypeptidase II | complex with phosphate anion | 2C6P |
| MH | M28.010 | glutamate carboxypeptidase II | complex with methionine | 2CIJ |
| MH | M28.010 | glutamate carboxypeptidase II | complex with 2-PMPA (2-phosphonomethyl-pentanedioic acid) | 2JBJ |
| MH | M28.010 | glutamate carboxypeptidase II | complex with quisqualic acid | 2JBK |
| MH | M28.010 | glutamate carboxypeptidase II | 2OOT | |
| MH | M28.010 | glutamate carboxypeptidase II | complex with quisqualic acid | 2OR4 |
| MH | M28.010 | glutamate carboxypeptidase II | complex with L-Ser-O-sulphate | 2PVV |
| MH | M28.010 | glutamate carboxypeptidase II | complex with 2-PMPA (2-phosphonomethyl-pentanedioic acid) | 2PVW |
| MH | M28.010 | glutamate carboxypeptidase II | complex with antibody-recruiting molecule ARM-P8 | 2XEF_A |
| MH | M28.010 | glutamate carboxypeptidase II | human glutamate carboxypeptidase ii in complex with antibody-recruiting molecule arm-p4 | 2XEG_A |
| MH | M28.010 | glutamate carboxypeptidase II | human glutamate carboxypeptidase ii in complex with antibody-recruiting molecule arm-p2 | 2XEI_A |
| MH | M28.010 | glutamate carboxypeptidase II | human glutamate carboxypeptidase ii in complex with arm-m4, urea-based inhibitor | 2XEJ_A |
| MH | M28.010 | glutamate carboxypeptidase II | complex with transition state analogue of Asp-Glu | 3BHX |
| MH | M28.010 | glutamate carboxypeptidase II | complex with transition state analogue of Asp-Glu | 3BI0 |
| MH | M28.010 | glutamate carboxypeptidase II | complex with transition state analogue of methotrexate-lu | 3BI1 |
| MH | M28.010 | glutamate carboxypeptidase II | Glu424Ala mutant; complex with N-acetyl-Asp-Glu | 3BXM |
| MH | M28.010 | glutamate carboxypeptidase II | complex with DCFBD inhibitor | 3D7D |
| MH | M28.010 | glutamate carboxypeptidase II | complex with DCIT inhibitor | 3D7F |
| MH | M28.010 | glutamate carboxypeptidase II | complex with DCMC inhibitor | 3D7G |
| MH | M28.010 | glutamate carboxypeptidase II | complex with DCIBZL inhibitor | 3D7H |
| MH | M28.010 | glutamate carboxypeptidase II | complex with dbibzl, a urea-based inhibitor | 3IWW_A |
| MH | M28.010 | glutamate carboxypeptidase II | N-terminally AviTEV-tagged form; complex with 2-PMPA | 3RBU |
| MH | M28.010 | glutamate carboxypeptidase II | Glu424Ala inactive mutant; complex with n-acetyl-aspartyl-aminononanoic acid | 3SJE_A |
| MH | M28.010 | glutamate carboxypeptidase II | complex with a urea-based inhibitor (a25) | 3SJF_A |
| MH | M28.010 | glutamate carboxypeptidase II | human glutamate carboxypeptidase ii (e424a inactive mutant ) in complex with n-acetyl-aspartyl-aminooctanoic acid | 3SJG_A |
| MH | M28.010 | glutamate carboxypeptidase II | Glu424Ala inactive mutant; complex with n-acetyl-aspartyl-methionine | 3SJX_A |
| MH | M28.010 | glutamate carboxypeptidase II | complex with ctt1057 | 4JYW_A |
| MH | M28.010 | glutamate carboxypeptidase II | complex with ctt1055 | 4JZ0_A |
| MH | M28.010 | glutamate carboxypeptidase II | complex with a phosphoramidate inhibitor ctt1056 | 4LQG_A |
| MH | M28.010 | glutamate carboxypeptidase II | complex with folyl-gamma-l-glutamic acid (pteroyldi-gamma-l-glutamic acid) | 4MCP_A |
| MH | M28.010 | glutamate carboxypeptidase II | complex with folyldi-gamma-l-glutamic acid (pteroyltri- gamma-l-glutamic acid) | 4MCQ_A |
| MH | M28.010 | glutamate carboxypeptidase II | complex with folyltri-gamma-l-glutamic acid (pteroyltetra-gamma-l-glutamic acid) | 4MCR_A |
| MH | M28.010 | glutamate carboxypeptidase II | complex with urea-based inhibitor | 4NGM_A |
| MH | M28.010 | glutamate carboxypeptidase II | complex with urea-based inhibitor | 4NGN_A |
| MH | M28.010 | glutamate carboxypeptidase II | complex with urea-based inhibitor | 4NGP_A |
| MH | M28.010 | glutamate carboxypeptidase II | complex with urea-based inhibitor | 4NGQ_A |
| MH | M28.010 | glutamate carboxypeptidase II | complex with urea-based inhibitor | 4NGR_A |
| MH | M28.010 | glutamate carboxypeptidase II | complex with urea-based inhibitor | 4NGS_A |
| MH | M28.010 | glutamate carboxypeptidase II | complex with urea-based inhibitor | 4NGT_A |
| MH | M28.010 | glutamate carboxypeptidase II | complex with ccibzl, a urea-based inhibitor n~2~-[(1- carboxycyclopropyl)carbamoyl]-n~6~-(4-iodobenzoyl)-l-lysine | 4OC0_A |
| MH | M28.010 | glutamate carboxypeptidase II | complex with coibzl, a urea-based inhibitor (2s)-2-[((1s)-1-carboxy-2-[(2s)-oxiran-2-yl]ethylcarbamoyl)amino]-6-[(4-iodobenzoyl) amino]hexanoic acid | 4OC1_A |
| MH | M28.010 | glutamate carboxypeptidase II | complex with ceibzl, a urea-based inhibitor n~2~-[(1s)-1-carboxybut-3-yn-1-yl]carbamoyl-n~6~-(4-iodobenzoyl)-l-lysine | 4OC2_A |
| MH | M28.010 | glutamate carboxypeptidase II | complex with cfibzl, a urea-based inhibitor n~2~-[(1s)-1-carboxy-2- (furan-2-yl)ethyl]carbamoyl-n~6~-(4-iodobenzoyl)-l-lysine | 4OC3_A |
| MH | M28.010 | glutamate carboxypeptidase II | complex with cpibzl, a urea-based inhibitor n~2~-[(1s)-1-carboxy-2- (pyridin-4-yl)ethyl]carbamoyl-n~6~-(4-iodobenzoyl)-l-lysine | 4OC4_A |
| MH | M28.010 | glutamate carboxypeptidase II | complex with chibzl, a urea-based inhibitor n~2~-[(s)-carboxy(4- hydroxyphenyl)methyl]carbamoyl-n~6~-(4-iodobenzoyl)-l-lysine | 4OC5_A |
| MH | M28.010 | glutamate carboxypeptidase II | complex with dccbl, a urea based inhibitor with distal carborane moiety | 4OME_A |
| MH | M28.010 | glutamate carboxypeptidase II | complex with a phosphoramidate inhibitor jrb-4-81 | 4P44_A |
| MH | M28.010 | glutamate carboxypeptidase II | complex with a phosphoramidate inhibitor jrb-4-73 | 4P45_A |
| MH | M28.010 | glutamate carboxypeptidase II | complex with a phosphoramidate inhibitor ctt54 | 4P4B_A |
| MH | M28.010 | glutamate carboxypeptidase II | complex with a phosphoramidate inhibitor mp1c | 4P4D_A |
| MH | M28.010 | glutamate carboxypeptidase II | complex with a phosphoramidate inhibitor mp1d | 4P4E_A |
| MH | M28.010 | glutamate carboxypeptidase II | complex with a phosphoramidate inhibitor nc-2-40 | 4P4F_A |
| MH | M28.010 | glutamate carboxypeptidase II | complex with a phosphoramidate inhibitor t33 | 4P4I_A |
| MH | M28.010 | glutamate carboxypeptidase II | complex with a phosphoramidate inhibitor t33d | 4P4J_A |
| MH | M28.010 | glutamate carboxypeptidase II | complex with a glutamyl sulfamide inhibitor cjc47 | 4W9Y_A |
| MH | M28.010 | glutamate carboxypeptidase II | avi-gcpii structure in complex with fitc-conjugated gcpii-specific inhibitor | 4X3R_A |
| MH | M28.010 | glutamate carboxypeptidase II | complex with a hydroxamate inhibitor jhu241 | 5D29_A |
| MH | M28.010 | glutamate carboxypeptidase II | complex with a hydroxamate inhibitor jhu242 | 5ELY_A |
| MH | M28.010 | glutamate carboxypeptidase II | inactive mutant; complex with beta-citryl glutamate | 5F09_A |
| MH | M28.010 | glutamate carboxypeptidase II | complex with a urea based inhibitor psma 1023 | 5O5R_A |
| MH | M28.010 | glutamate carboxypeptidase II | complex with a urea based inhibitor psma 1007 | 5O5T_A |
| MH | M28.010 | glutamate carboxypeptidase II | complex with a urea based inhibitor psma 1027 | 5O5U_A |
| MH | M28.010 | glutamate carboxypeptidase II | Glu424Met inactive mutant; complex with a inhibitor cfbzog | 5OF0_A |
| MH | M28.010 | glutamate carboxypeptidase II | complex with a inhibitor jhu3371 | 6ETY_A |
| MH | M28.010 | glutamate carboxypeptidase II | Glu424Met inactive mutant; complex with a inhibitor jhu3372 | 6EZ9_A |
| MH | M28.010 | glutamate carboxypeptidase II | complex with a inhibitor jhu2379 | 6F5L_A |
| MH | M28.010 | glutamate carboxypeptidase II | Glu424Met inactive mutant; complex with a inhibitor jhu 2249 | 6FE5_A |
| MH | M28.010 | glutamate carboxypeptidase II | complex with a inhibitor rna 1-79-1 | 6H7Y_A |
| MH | M28.010 | glutamate carboxypeptidase II | complex with a inhibitor rna 2-65-1 | 6H7Z_A |
| MH | M28.010 | glutamate carboxypeptidase II | complex with a inhibitor rna 2-19-1 | 6HKJ_A |
| MH | M28.010 | glutamate carboxypeptidase II | complex with a inhibitor rna 2-49-1 | 6HKZ_A |
| MH | M28.011 | NAALADASE L peptidase | 4TWE | |
| MH | M28.012 | glutamate carboxypeptidase III | 3FEC | |
| MH | M28.012 | glutamate carboxypeptidase III | complex with transition state analogue Glu-Glu | 3FED |
| MH | M28.012 | glutamate carboxypeptidase III | complex with quisqualic acid | 3FEE |
| MH | M28.012 | glutamate carboxypeptidase III | complex with Glu | 3FF3 |
| MH | M28.016 | Mername-AA103 peptidase | 3PB4 | |
| MH | M28.016 | Mername-AA103 peptidase | 3PB6 | |
| MH | M28.016 | Mername-AA103 peptidase | 3PB7 | |
| MH | M28.016 | Mername-AA103 peptidase | 3PB8 | |
| MH | M28.016 | Mername-AA103 peptidase | 3PB9 | |
| MH | M28.016 | Mername-AA103 peptidase | crystal structure of mitochondrial isoform of glutaminyl cyclase from drosophila melanogaster | 4FAI_A |
| MH | M28.016 | Mername-AA103 peptidase | crystal structure of the c136a/c164a variant of mitochondrial isoform of glutaminyl cyclase from drosophila melanogaster | 4FBE_A |
| MH | M28.020 | AM-1 aminopeptidase | aminopeptidase from aneurinibacillus sp. strain am-1 | 2EK8_A |
| MH | M28.020 | AM-1 aminopeptidase | aminopeptidase from aneurinibacillus sp. strain am-1 with bestatin | 2EK9_A |
| MH | M28.020 | AM-1 aminopeptidase | crystal structure of aminopeptidase equipped with pad from aneurinibacillus sp. am-1 | 5IB9_A |
| MH | M28.972 | transferrin receptor protein | ectodomain only | 1CX8_B |
| MH | M28.972 | transferrin receptor protein | complex with hemochromatosis protein HFE | 1DE4 |
| MH | M28.972 | transferrin receptor protein | structure of human transferrin receptor-transferrin complex | 1SUV_A |
| MH | M28.972 | transferrin receptor protein | ectodomain; complex with a cryo-em reconstruction of canine parvovirus | 2NSU_A |
| MH | M28.972 | transferrin receptor protein | 3KAS | |
| MH | M28.972 | transferrin receptor protein | complex with transferrin receptor 1 | 3S9L_C |
| MH | M28.972 | transferrin receptor protein | 3S9M_A | |
| MH | M28.972 | transferrin receptor protein | 3S9N_A | |
| MH | M28.972 | transferrin receptor protein | cryo-em structure of a plasmodium vivax invasion complex essential forentry into human reticulocytes; one molecule of parasite ligand. | 6D03_A |
| MH | M28.972 | transferrin receptor protein | cryo-em structure of a plasmodium vivax invasion complex essential forentry into human reticulocytes; two molecules of parasite ligand, subclass 1. | 6D04_A |
| MH | M28.972 | transferrin receptor protein | cryo-em structure of a plasmodium vivax invasion complex essential forentry into human reticulocytes; two molecules of parasite ligand, subclass 2. | 6D05_A |
| MH | M28.974 | glutaminyl cyclase | 1MOI | |
| MH | M28.974 | glutaminyl cyclase | 2AFM | |
| MH | M28.974 | glutaminyl cyclase | 2AFO | |
| MH | M28.974 | glutaminyl cyclase | 2AFS | |
| MH | M28.974 | glutaminyl cyclase | 2AFU | |
| MH | M28.974 | glutaminyl cyclase | 2AFW | |
| MH | M28.974 | glutaminyl cyclase | 2AFX | |
| MH | M28.974 | glutaminyl cyclase | 2AFZ | |
| MH | M28.974 | glutaminyl cyclase | 2ZED | |
| MH | M28.974 | glutaminyl cyclase | 2ZEE | |
| MH | M28.974 | glutaminyl cyclase | 2ZEF | |
| MH | M28.974 | glutaminyl cyclase | 2ZEG | |
| MH | M28.974 | glutaminyl cyclase | 2ZEH | |
| MH | M28.974 | glutaminyl cyclase | 2ZEL | |
| MH | M28.974 | glutaminyl cyclase | 2ZEM | |
| MH | M28.974 | glutaminyl cyclase | 2ZEN | |
| MH | M28.974 | glutaminyl cyclase | 2ZEO | |
| MH | M28.974 | glutaminyl cyclase | 2ZEP | |
| MH | M28.974 | glutaminyl cyclase | 3PBB | |
| MH | M28.974 | glutaminyl cyclase | 3PBE | |
| MH | M28.974 | glutaminyl cyclase | 3SI0 | |
| MH | M28.974 | glutaminyl cyclase | 4YU9 | |
| MH | M28.974 | glutaminyl cyclase | 4YWY | |
| MH | M28.974 | glutaminyl cyclase | crystal structure of human glutaminyl cyclase variant Tyr115Glu-Tyr117Glu in complex with sen177 | 6GBX_A |
| MH | M28.979 | glutaminyl-peptide cyclotransferase-like non-peptidase homologue | 3SI1 | |
| MH | M28.979 | glutaminyl-peptide cyclotransferase-like non-peptidase homologue | 3SI2 | |
| MH | M28.UNA | subfamily M28A non-peptidase homologues | 3TC8 | |
| MH | M28.UNF | subfamily M28F non-peptidase homologues | 3K9T | |
| MH | M28.UNW | family M28 non-peptidase homologues | crystal structure of a leucine aminopeptidase precursor (bt_2548) frombacteroides thetaiotaomicron vpi-5482 at 1.30 a resolution | 4FUU_A |
| MH | M28.UNW | family M28 non-peptidase homologues | crystal structure of porphyromonas gingivalis glutaminyl cyclase | 6QQL_A |
| MH | M28.UPA | subfamily M28A unassigned peptidases | structure of glycosylated glutaminyl cyclase from drosophila melanogaster | 4F9U_A |
| MH | M28.UPA | subfamily M28A unassigned peptidases | structure of c113a/c136a mutant variant of glycosylated glutaminyl cyclase from drosophila melanogaster | 4F9V_A |
| MH | M28.UPA | subfamily M28A unassigned peptidases | crystal structure of glutaminyl cyclase from drosophila melanogaster in space group i4 | 4FWU_A |
| MH | M28.UPA | subfamily M28A unassigned peptidases | crystal structure of aspartate bound peptidase e from salmonella enterica | 6A4R_A |
| MH | M28.UPA | subfamily M28A unassigned peptidases | crystal structure of peptidase e with ordered active site loop from salmonella enterica | 6A4S_A |
| MH | M28.UPD | subfamily M28D unassigned peptidases | precursor | 3IIB |
| MH | M28.UPE | subfamily M28E unassigned peptidases | crystal structure of lapb from legionella pneumophila | 5GNE_A |
| MH | M28.UPW | family M28 unassigned peptidases | 3GUX | |
| MH | M28.UPW | family M28 unassigned peptidases | crystal structure of tannerella forsythia glutaminyl cyclase | 6QRO_A |
| MQ | M29.001 | aminopeptidase T | wild-type | 2AYI_A |
| MQ | M29.005 | aminopeptidase S (Staphylococcus-type) | 1ZJC | |
| MA | M32.002 | carboxypeptidase Pfu | apoenzyme | 1K9X_A |
| MA | M32.002 | carboxypeptidase Pfu | structure of pyrococcus furiosus carboxypeptidase apo-mg | 1KA2_A |
| MA | M32.002 | carboxypeptidase Pfu | structure of pyrococcus furiosus carboxypeptidase nat-pb | 1KA4_A |
| MA | M32.003 | TcMCP1 carboxypeptidase | 3DWC | |
| MA | M32.006 | ypwA peptidase | 3HQ2 | |
| MA | M32.UPW | family M32 unassigned peptidases | crystal structure of m32 carboxypeptidase from deinococcus radioduransr1 | 5GIV_A |
| MA | M34.001 | anthrax lethal factor | precursor | 1J7N_B |
| MA | M34.001 | anthrax lethal factor | complex with N-terminus of mitogen-activated protein kinase kinase 2 | 1JKY |
| MA | M34.001 | anthrax lethal factor | complex with NSC 12155 inhibitor | 1PWP |
| MA | M34.001 | anthrax lethal factor | complex with thioacetyl-Tyr-Pro-Met-NH2 inhibitor | 1PWQ |
| MA | M34.001 | anthrax lethal factor | complex with (3-(N-hydroxycarboxamido)-2-isobutylpropanoyl-Trp-methylamide inhibitor | 1PWU |
| MA | M34.001 | anthrax lethal factor | complex with peptide substrate | 1PWV |
| MA | M34.001 | anthrax lethal factor | complex with peptide substrate in presence of zinc | 1PWW |
| MA | M34.001 | anthrax lethal factor | complex with hydroxamate inhibitor (2R)-2-[(4-fluoro-3-methylphenyl)sulfonyl]amino-N-hydroxy-2-tetrahydro-2H-pyran-4-ylacetamide | 1YQY_A |
| MA | M34.001 | anthrax lethal factor | 1ZXV | |
| MA | M34.001 | anthrax lethal factor | 2L0R | |
| MA | M34.001 | anthrax lethal factor | 3KWV | |
| MA | M34.001 | anthrax lethal factor | 4DV8 | |
| MA | M34.001 | anthrax lethal factor | 4PKQ | |
| MA | M34.001 | anthrax lethal factor | 4PKR | |
| MA | M34.001 | anthrax lethal factor | 4PKS | |
| MA | M34.001 | anthrax lethal factor | 4PKT | |
| MA | M34.001 | anthrax lethal factor | 4PKU | |
| MA | M34.001 | anthrax lethal factor | 4PKV | |
| MA | M34.001 | anthrax lethal factor | 4PKW | |
| MA | M34.001 | anthrax lethal factor | 4WF6 | |
| MA | M34.001 | anthrax lethal factor | 4XM6 | |
| MA | M34.001 | anthrax lethal factor | 4XM7 | |
| MA | M34.001 | anthrax lethal factor | 4XM8 | |
| MA | M34.001 | anthrax lethal factor | 5D1S | |
| MA | M34.001 | anthrax lethal factor | 5D1T | |
| MA | M34.001 | anthrax lethal factor | 5D1U | |
| MA | M34.002 | Pro-Pro endopeptidase 1 (Clostridium difficile-type) | precursor | 5A0P |
| MA | M34.002 | Pro-Pro endopeptidase 1 (Clostridium difficile-type) | Glu143Ala mutant; complex with product | 5A0R |
| MA | M34.002 | Pro-Pro endopeptidase 1 (Clostridium difficile-type) | Glu143Ala mutant | 5A0S |
| MA | M34.002 | Pro-Pro endopeptidase 1 (Clostridium difficile-type) | Ala143Glu, Phe178Tyr mutant | 5A0X |
| MA | M34.002 | Pro-Pro endopeptidase 1 (Clostridium difficile-type) | crystal structure of tce treated rppep-1 | 5N12_A |
| MA | M34.002 | Pro-Pro endopeptidase 1 (Clostridium difficile-type) | crystal structure of apo ppep-1(Glu143Ala/Tyr178Phe) in complex with substratepeptide ac-evnapvp-conh2 | 6R4W_A |
| MA | M34.002 | Pro-Pro endopeptidase 1 (Clostridium difficile-type) | crystal structure of ppep-1(Glu143Ala/Tyr178Phe) in complex with substrate peptide ac-evnpavp-conh2 | 6R4X_A |
| MA | M34.002 | Pro-Pro endopeptidase 1 (Clostridium difficile-type) | crystal structure of holo ppep-1(Glu143Ala/Tyr178Phe) in complex with product peptide ac-evnp-co2 (substrate peptide: ac-evnpavp-conh2) | 6R4Y_A |
| MA | M34.002 | Pro-Pro endopeptidase 1 (Clostridium difficile-type) | crystal structure of holo ppep-1Glu143Ala/Tyr178Phe) in complex with product peptide ac-evnp-co2 (substrate peptide: ac-evnppvp-conh2) | 6R4Z_A |
| MA | M34.002 | Pro-Pro endopeptidase 1 (Clostridium difficile-type) | crystal structure of holo ppep-1Glu143Ala/Tyr178Phe) in complex with substrate peptide ac-evnapvp-conh2 | 6R50_A |
| MA | M34.002 | Pro-Pro endopeptidase 1 (Clostridium difficile-type) | crystal structure of apo ppep-1(Glu143Ala/Tyr178Phe) in complex with fibrinogen-derived substrate peptide ac-slrpapp-conh2 | 6R51_B |
| MA | M34.002 | Pro-Pro endopeptidase 1 (Clostridium difficile-type) | crystal structure of ppep-1(k101a) | 6R52_A |
| MA | M34.002 | Pro-Pro endopeptidase 1 (Clostridium difficile-type) | crystal structure of ppep-1(k101r) | 6R53_A |
| MA | M34.002 | Pro-Pro endopeptidase 1 (Clostridium difficile-type) | crystal structure of ppep-1(e184a) | 6R54_A |
| MA | M34.002 | Pro-Pro endopeptidase 1 (Clostridium difficile-type) | crystal structure of ppep-1(e184k) | 6R55_A |
| MA | M34.002 | Pro-Pro endopeptidase 1 (Clostridium difficile-type) | crystal structure of ppep-1(k101e/e184k) | 6R56_A |
| MA | M34.002 | Pro-Pro endopeptidase 1 (Clostridium difficile-type) | crystal structure of ppep-1(Glu143Ala/Tyr178Phe/Glu184Ala) in complex with substrate peptide ac-evnppvp-conh2 | 6R57_A |
| MA | M34.002 | Pro-Pro endopeptidase 1 (Clostridium difficile-type) | crystal structure of ppep-1(Glu143Ala/Tyr178Phe/Glu184Ala) in complex with substrate peptide ac-evnapvp-conh2 | 6R58_A |
| MA | M34.002 | Pro-Pro endopeptidase 1 (Clostridium difficile-type) | crystal structure of ppep-1(Glu143Ala/Tyr178Phe) in complex with substrate peptide ac-evappvp-nh2 | 6R59_A |
| MA | M34.002 | Pro-Pro endopeptidase 1 (Clostridium difficile-type) | crystal structure of ppep-1(w103f) | 6R5A_A |
| MA | M34.002 | Pro-Pro endopeptidase 1 (Clostridium difficile-type) | crystal structure of ppep-1(Trp103His/Glu143Ala/Tyr178Phe) in complex with substrate peptide ac-evnppvp-conh2 | 6R5B_A |
| MA | M34.002 | Pro-Pro endopeptidase 1 (Clostridium difficile-type) | crystal structure of ppep-1(Trp103His/Glu143Ala/Tyr178Phe) in complex with substrate peptide ac-evnppvp-conh2 | 6R5C_A |
| MA | M34.003 | Pro-Pro endopeptidase 2 | 6FPC | |
| MA | M35.002 | deuterolysin | 1EB6_A | |
| MA | M35.003 | EcpA peptidase | Glu294Gln mutant | 2X3A |
| MA | M35.003 | EcpA peptidase | Glu294Ala mutant | 2X3B |
| MA | M35.003 | EcpA peptidase | Glu294Gln mutant; precursor | 2X3C |
| MA | M35.004 | peptidyl-Lys metallopeptidase | 1G12 | |
| MA | M35.004 | peptidyl-Lys metallopeptidase | 1GE5_A | |
| MA | M35.004 | peptidyl-Lys metallopeptidase | 1GE6 | |
| MA | M35.004 | peptidyl-Lys metallopeptidase | 1GE7 | |
| MA | M36.001 | fungalysin | 4K90 | |
| MJ | M38.001 | isoaspartyl dipeptidase (metallo-type) | 1ONW | |
| MJ | M38.001 | isoaspartyl dipeptidase (metallo-type) | complex with aspartate | 1ONX |
| MJ | M38.001 | isoaspartyl dipeptidase (metallo-type) | 1PO9 | |
| MJ | M38.001 | isoaspartyl dipeptidase (metallo-type) | complex with inhibitor 2-[[(1S)-1-amino-2-carboxyethyl](dihydroxy)phosphoranyl]methyl-4-methylpentanoic acid | 1POJ |
| MJ | M38.001 | isoaspartyl dipeptidase (metallo-type) | 1POK | |
| MJ | M38.001 | isoaspartyl dipeptidase (metallo-type) | Asp285Asn mutant; complex with beta-aspartylhistidine | 1YBQ_A |
| MJ | M38.001 | isoaspartyl dipeptidase (metallo-type) | Glu77Glu mutant | 2AQO_A |
| MJ | M38.001 | isoaspartyl dipeptidase (metallo-type) | Tyr137Phe mutant | 2AQV_A |
| MJ | M38.001 | isoaspartyl dipeptidase (metallo-type) | three tetrameric rings of isoaspartyl dipeptidase fitted in an em volume. | 5LP3_B |
| MJ | M38.973 | dihydropyrimidinase | crystal structure of dihydropyrimidinase from pseudomonas aeruginosa pao1 | 5E5C_A |
| MJ | M38.973 | dihydropyrimidinase | crystal structure of dihydropyrimidinase from pseudomonas aeruginosa pao1 at 2.17 angstrom resolution | 5YKD_A |
| MJ | M38.973 | dihydropyrimidinase | crystal structure of a monometallic dihydropyrimidinase from pseudomonas aeruginosa pao1 reveals no lysine carbamylation within the active site | 6AJD_A |
| MJ | M38.973 | dihydropyrimidinase | 2VR2 | |
| MJ | M38.973 | dihydropyrimidinase | 2FTW | |
| MJ | M38.974 | dihydropyrimidinase related protein-1 | 1KCX | |
| MJ | M38.974 | dihydropyrimidinase related protein-1 | 4B3Z | |
| MJ | M38.975 | dihydropyrimidinase related protein-2 | crystal structure of mouse crmp2 | 5UQC_A |
| MJ | M38.975 | dihydropyrimidinase related protein-2 | 2GSE | |
| MJ | M38.975 | dihydropyrimidinase related protein-2 | 2VM8 | |
| MJ | M38.975 | dihydropyrimidinase related protein-2 | high-resolution structure of human collapsin response mediator protein2 | 5LXX_A |
| MJ | M38.975 | dihydropyrimidinase related protein-2 | crystal structure of human dihydropyrimidinease-like 2 (dpysl2a) /collapsin response mediator protein (crmp2) residues 13-516 | 5MKV_A |
| MJ | M38.975 | dihydropyrimidinase related protein-2 | crystal structure of human dihydropyrimidinease-like 2 (dpysl2a) /collapsin response mediator protein (crmp2 13-516) mutant y479e/y499e | 5MLE_C |
| MJ | M38.975 | dihydropyrimidinase related protein-2 | 5X1A_A | |
| MJ | M38.975 | dihydropyrimidinase related protein-2 | crystal structure of human crmp-2 without c-terminal tail | 5X1C_A |
| MJ | M38.975 | dihydropyrimidinase related protein-2 | crystal structure of t246a-n247a human crmp-2 mutant | 5X1D_A |
| MJ | M38.975 | dihydropyrimidinase related protein-2 | Thr509Asp/Thr514Asp/Ser518Asp/Ser522Asp mutant | 5YZ5_A |
| MJ | M38.975 | dihydropyrimidinase related protein-2 | Ser522Asp mutant | 5YZA_A |
| MJ | M38.975 | dihydropyrimidinase related protein-2 | Ser522Asp/Thr509Asp/Thr514Asp/Ser518Asp mutant crystallized with gsk3b | 5YZB_A |
| MJ | M38.976 | dihydropyrimidinase related protein-3 | 4BKN | |
| MJ | M38.976 | dihydropyrimidinase related protein-3 | 4CNS | |
| MJ | M38.976 | dihydropyrimidinase related protein-3 | 4CNT | |
| MJ | M38.976 | dihydropyrimidinase related protein-3 | 4CNU | |
| MJ | M38.977 | dihydropyrimidinase related protein-4 | human dihydropyrimidinase-related protein 4 (dpysl4, crmp3, ulip-4) | 5NKS_A |
| MJ | M38.978 | dihydropyrimidinase related protein-5 | 4B90 | |
| MJ | M38.978 | dihydropyrimidinase related protein-5 | 4B91 | |
| MJ | M38.978 | dihydropyrimidinase related protein-5 | 4B92 | |
| MJ | M38.980 | probable imidazolonepropionase | 2GOK | |
| MJ | M38.980 | probable imidazolonepropionase | 2PUZ | |
| MJ | M38.980 | probable imidazolonepropionase | crystal structure of phenylurea hydrolase b | 4WHB_E |
| MJ | M38.981 | guanine deaminase | 2UZ9 | |
| MJ | M38.981 | guanine deaminase | 3E0L | |
| MJ | M38.981 | guanine deaminase | 4AQL | |
| MJ | M38.982 | urease | Lys217Glu mutant | 1A5K_C |
| MJ | M38.982 | urease | Lys217Cys mutant | 1A5L_C |
| MJ | M38.982 | urease | Lys217Ala mutant | 1A5M_C |
| MJ | M38.982 | urease | Lys217Ala mutant chemically rescued by formate and nickel | 1A5N_C |
| MJ | M38.982 | urease | Lys217Cys mutant chemically rescued by formate and nickel | 1A5O_C |
| MJ | M38.982 | urease | 1EF2_A | |
| MJ | M38.982 | urease | 1EJR_C | |
| MJ | M38.982 | urease | 1EJS_C | |
| MJ | M38.982 | urease | 1EJT_C | |
| MJ | M38.982 | urease | 1EJU_C | |
| MJ | M38.982 | urease | 1EJV_C | |
| MJ | M38.982 | urease | 1EJW_C | |
| MJ | M38.982 | urease | 1EJX_C | |
| MJ | M38.982 | urease | Cys319Ala mutant at pH 7.5 | 1FWA_C |
| MJ | M38.982 | urease | Cys319Ala mutant at pH 6.5 | 1FWB_C |
| MJ | M38.982 | urease | Cys319Ala mutant at pH 8.5 | 1FWC_C |
| MJ | M38.982 | urease | Cys319Ala mutant at pH 9.4 | 1FWD_C |
| MJ | M38.982 | urease | Cys319Ala mutant complex with acetohydroxamic acid | 1FWE_C |
| MJ | M38.982 | urease | Cys319Asp mutant | 1FWF_C |
| MJ | M38.982 | urease | Cys319Ser mutant | 1FWG_C |
| MJ | M38.982 | urease | Cys319Tyr mutant | 1FWH_C |
| MJ | M38.982 | urease | His134Ala mutant | 1FWI_C |
| MJ | M38.982 | urease | 1FWJ_C | |
| MJ | M38.982 | urease | apoenzyme | 1KRA_C |
| MJ | M38.982 | urease | apoenzyme | 1KRB_C |
| MJ | M38.982 | urease | apoenzyme | 1KRC_C |
| MJ | M38.982 | urease | 2KAU_C | |
| MJ | M38.982 | urease | 4EP8_C | |
| MJ | M38.982 | urease | 4EPB_C | |
| MJ | M38.982 | urease | 4EPD_C | |
| MJ | M38.982 | urease | 4EPE_C | |
| MJ | M38.982 | urease | 1E9Y | |
| MJ | M38.982 | urease | 1E9Z | |
| MJ | M38.982 | urease | 3LA4 | |
| MJ | M38.982 | urease | 4GOA | |
| MJ | M38.982 | urease | 4GY7 | |
| MJ | M38.982 | urease | 4H9M | |
| MJ | M38.982 | urease | 1IE7 | |
| MJ | M38.982 | urease | 1S3T | |
| MJ | M38.982 | urease | 1UBP | |
| MJ | M38.982 | urease | 2UBP | |
| MJ | M38.982 | urease | 3UBP | |
| MJ | M38.982 | urease | 4AC7 | |
| MJ | M38.982 | urease | 4CEU | |
| MJ | M38.982 | urease | 4CEX | |
| MJ | M38.982 | urease | 4UBP | |
| MJ | M38.982 | urease | 5A6T | |
| MJ | M38.982 | urease | complex with 2,5-dihydroxybenzensulfonate | 5FSD_C |
| MJ | M38.982 | urease | complex with 1,4-benzoquinone | 5FSE_C |
| MJ | M38.982 | urease | 1A5K_B | |
| MJ | M38.982 | urease | 1A5L_B | |
| MJ | M38.982 | urease | 1A5M_B | |
| MJ | M38.982 | urease | 1A5N_B | |
| MJ | M38.982 | urease | 1A5O_B | |
| MJ | M38.982 | urease | 1EF2_B | |
| MJ | M38.982 | urease | 1EJR_B | |
| MJ | M38.982 | urease | 1EJS_B | |
| MJ | M38.982 | urease | 1EJT_B | |
| MJ | M38.982 | urease | 1EJU_B | |
| MJ | M38.982 | urease | 1EJV_B | |
| MJ | M38.982 | urease | 1EJW_B | |
| MJ | M38.982 | urease | 1EJX_B | |
| MJ | M38.982 | urease | 1FWA_B | |
| MJ | M38.982 | urease | 1FWB_B | |
| MJ | M38.982 | urease | 1FWC_B | |
| MJ | M38.982 | urease | 1FWD_B | |
| MJ | M38.982 | urease | 1FWE_B | |
| MJ | M38.982 | urease | 1FWF_B | |
| MJ | M38.982 | urease | 1FWG_B | |
| MJ | M38.982 | urease | 1FWH_B | |
| MJ | M38.982 | urease | 1FWI_B | |
| MJ | M38.982 | urease | 1FWJ_B | |
| MJ | M38.982 | urease | 1KRA_B | |
| MJ | M38.982 | urease | 1KRB_B | |
| MJ | M38.982 | urease | 1KRC_B | |
| MJ | M38.982 | urease | 2KAU_B | |
| MJ | M38.982 | urease | 4EP8_B | |
| MJ | M38.982 | urease | 4EPB_B | |
| MJ | M38.982 | urease | 4EPD_B | |
| MJ | M38.982 | urease | 4EPE_B | |
| MJ | M38.982 | urease | 3QGA_C | |
| MJ | M38.982 | urease | 3QGK_C | |
| MJ | M38.983 | N-acetylglucosamine-6-phosphate deacetylase (Bacillus subtilis) | 2VHL | |
| MJ | M38.A02 | PyrC protein (Escherichia coli) | molecular structure of dihydroorotase: a paradigm for catalysis through the use of a binuclear metal center | 1J79_A |
| MJ | M38.A02 | PyrC protein (Escherichia coli) | dihydroorotase from escherichia coli: loop movement and cooperativity between subunits | 1XGE_A |
| MJ | M38.A02 | PyrC protein (Escherichia coli) | Thr109Ser mutant; complex with an inhibitor 5-fluoroorotate | 2E25_A |
| MJ | M38.A02 | PyrC protein (Escherichia coli) | the crystal structure of the ligand-free dihydroorotase from e. coli | 2EG6_A |
| MJ | M38.A02 | PyrC protein (Escherichia coli) | complex with hddp | 2EG7_A |
| MJ | M38.A02 | PyrC protein (Escherichia coli) | complex with 5- fluoroorotic acid | 2EG8_A |
| MJ | M38.A02 | PyrC protein (Escherichia coli) | thr110ser dihydroorotase from e. coli | 2Z24_A |
| MJ | M38.A02 | PyrC protein (Escherichia coli) | thr110val dihydroorotase from e. coli | 2Z25_A |
| MJ | M38.A02 | PyrC protein (Escherichia coli) | thr110ala dihydroorotase from e. coli ***caveat 2z26 chirality error at the ca center of gln b 319. | 2Z26_A |
| MJ | M38.A02 | PyrC protein (Escherichia coli) | thr109ser dihydroorotase from e. coli | 2Z27_A |
| MJ | M38.A02 | PyrC protein (Escherichia coli) | thr109val dihydroorotase from e. coli | 2Z28_A |
| MJ | M38.A02 | PyrC protein (Escherichia coli) | thr109ala dihydroorotase from e. coli | 2Z29_A |
| MJ | M38.A02 | PyrC protein (Escherichia coli) | thr109gly dihydroorotase from e. coli | 2Z2A_A |
| MJ | M38.A02 | PyrC protein (Escherichia coli) | deletion 107-116 mutant | 2Z2B_A |
| MJ | M38.A02 | PyrC protein (Escherichia coli) | His257Ala mutant | 3MJM_A |
| MJ | M38.A02 | PyrC protein (Escherichia coli) | hybrid dihydroorotase domain of human cad with e. coli flexible loop in apo state | 6HG1_A |
| MJ | M38.A02 | PyrC protein (Escherichia coli) | crystal structure of dihydroorotase pyrc from yersinia pestis in complex with zinc and malate at 2.4 a resolution | 6CTY_A |
| MJ | M38.A02 | PyrC protein (Escherichia coli) | crystal structure of a dihydroorotase from burkholderia cenocepacia j2315 | 4LFY_A |
| MJ | M38.UNW | family M38 non-peptidase homologues | 3E74 | |
| MJ | M38.UNW | family M38 non-peptidase homologues | 1K1D | |
| MJ | M38.UNW | family M38 non-peptidase homologues | 4V1X | |
| MJ | M38.UNW | family M38 non-peptidase homologues | 4V1Y | |
| MJ | M38.UNW | family M38 non-peptidase homologues | 2QT3 | |
| MJ | M38.UNW | family M38 non-peptidase homologues | 4CQB | |
| MJ | M38.UNW | family M38 non-peptidase homologues | 4CQC | |
| MJ | M38.UNW | family M38 non-peptidase homologues | 4CQD | |
| MJ | M38.UNW | family M38 non-peptidase homologues | 5AKQ | |
| MJ | M38.UNW | family M38 non-peptidase homologues | crystal structure of amidohydrolase from thermotoga maritima msb8 | 3OOQ_A |
| MJ | M38.UNW | family M38 non-peptidase homologues | 2FTY | |
| MJ | M38.UNW | family M38 non-peptidase homologues | 2FVK | |
| MJ | M38.UNW | family M38 non-peptidase homologues | 2FVM | |
| MJ | M38.UNW | family M38 non-peptidase homologues | 3HM7 | |
| MJ | M38.UNW | family M38 non-peptidase homologues | 3EGJ | |
| MJ | M38.UNW | family M38 non-peptidase homologues | 3IV8 | |
| MJ | M38.UNW | family M38 non-peptidase homologues | 1YMY | |
| MJ | M38.UNW | family M38 non-peptidase homologues | 1YRR | |
| MJ | M38.UNW | family M38 non-peptidase homologues | 2P50 | |
| MJ | M38.UNW | family M38 non-peptidase homologues | 2P53 | |
| MJ | M38.UNW | family M38 non-peptidase homologues | crystal structure of an adenosine deaminase from pseudomonas aeruginosa pao1 (target nysgrc-200449) with bound zn | 4DYK_A |
| MJ | M38.UNW | family M38 non-peptidase homologues | crystal structure of adenosine deaminase from pseudomonas aeruginosa pao1 with bound zn and methylthio-coformycin | 4GBD_A |
| MJ | M38.UNW | family M38 non-peptidase homologues | 1NFG | |
| MJ | M38.UNW | family M38 non-peptidase homologues | crystal structure of an adenosine deaminase from xanthomonas campestris (target nysgrc-200456) with bound zn | 4DZH_A |
| MJ | M38.UNW | family M38 non-peptidase homologues | crystal structure of an adenosine deaminase homolog from chromobacterium violaceum (target nysgrc-019589) with bound inosine. | 4F0S_A |
| MJ | M38.UNW | family M38 non-peptidase homologues | crystal structure of n-acetyl-d-glucosamine-6-phosphate deacetylase from mycobacterium smegmatis. | 6FV3_A |
| MJ | M38.UNW | family M38 non-peptidase homologues | the structure of n-acetyl-d-glucosamine-6-phosphate deacetylase d267a mutant from mycobacterium smegmatis in complex with n-acetyl-d- glucosamine-6-phosphate | 6FV4_A |
| MJ | M38.UNW | family M38 non-peptidase homologues | crystal structure of dihydropyrimidinase from brevibacillus agri nchu1002 | 3SFW_A |
| MJ | M38.UPW | family M38 unassigned peptidases | 3MPG | |
| MJ | M38.UPW | family M38 unassigned peptidases | dihydroorotase from bacillus anthracis with substrate bound | 4YIW_A |
| MJ | M38.UPW | family M38 unassigned peptidases | 3NQB | |
| MJ | M38.UPW | family M38 unassigned peptidases | 3T81 | |
| MJ | M38.UPW | family M38 unassigned peptidases | 3T8L | |
| MJ | M38.UPW | family M38 unassigned peptidases | crystal structure of putative prolidase from bifidobacterium longum | 2P9B_A |
| MJ | M38.UPW | family M38 unassigned peptidases | 1XRF_A | |
| MJ | M38.UPW | family M38 unassigned peptidases | 1XRT_A | |
| MJ | M38.UPW | family M38 unassigned peptidases | activated by aspartate transcarbamoylase | 3D6N_A |
| MJ | M38.UPW | family M38 unassigned peptidases | 4BJH | |
| MJ | M38.UPW | family M38 unassigned peptidases | dihydroorotase from aquifex aeolicus under 1200 bar of hydrostatic pressure | 6GDD_A |
| MJ | M38.UPW | family M38 unassigned peptidases | dihydroorotase from aquifex aeolicus standard (p,t) | 6GDE_A |
| MJ | M38.UPW | family M38 unassigned peptidases | dihydroorotase from aquifex aeolicus under 600 bar of hydrostatic pressure | 6GDF_A |
| MJ | M38.UPW | family M38 unassigned peptidases | 2Z00_A | |
| MJ | M38.UPW | family M38 unassigned peptidases | complex with n-methyl phosphonate derivative of l-arginine | 3MTW_A |
| MJ | M38.UPW | family M38 unassigned peptidases | isoaspartyl dipeptidase from colwellia psychrerythraea strain 34h ***caveat 5xgw thr a 93 has planar configuration at atom cb thr a 223 has ***caveat 2 5xgw planar configuration at atom cb thr b 196 has planar ***caveat 3 5xgw configuration at atom cb | 5XGW_A |
| MJ | M38.UPW | family M38 unassigned peptidases | Glu80Glnq mutant; complex with beta-isoaspartyl lysine | 5XGX_A |
| MJ | M38.UPW | family M38 unassigned peptidases | structure of imidazolonepropionase from bacillus subtilis | 2BB0_A |
| MJ | M38.UPW | family M38 unassigned peptidases | complex with imidazole-4-acetic acid sodium salt, a substrate homologue | 2G3F_A |
| MJ | M38.UPW | family M38 unassigned peptidases | 2OOF | |
| MJ | M38.UPW | family M38 unassigned peptidases | 2Q09 | |
| MJ | M38.UPW | family M38 unassigned peptidases | 1O12_A | |
| MA | M41.001 | FtsH peptidase | AAA domain only | 1LV7 |
| MA | M41.001 | FtsH peptidase | 4V0B | |
| MA | M41.004 | i-AAA peptidase | 2MV3 | |
| MA | M41.004 | i-AAA peptidase | mitochondrial atpase protease yme1 | 6AZ0_A |
| MA | M41.004 | i-AAA peptidase | atpase domain of i-aaa protease from myceliophthora thermophila | 5UBV_A |
| MA | M41.006 | paraplegin | 2QZ4 | |
| MA | M41.007 | Afg3-like protein 2 | 2LNA | |
| MA | M41.007 | Afg3-like protein 2 | human m-aaa protease afg3l2, substrate-bound | 6NYY_A |
| MA | M41.013 | Ftsh peptidase (Thermus-type) | 1IXZ | |
| MA | M41.013 | Ftsh peptidase (Thermus-type) | 1IY0 | |
| MA | M41.013 | Ftsh peptidase (Thermus-type) | 1IY1 | |
| MA | M41.013 | Ftsh peptidase (Thermus-type) | 1IY2 | |
| MA | M41.013 | Ftsh peptidase (Thermus-type) | cytosolic region | 2DHR |
| MA | M41.013 | Ftsh peptidase (Thermus-type) | 4EIW | |
| MA | M41.021 | FtsH peptidase (Thermotoga-type) | peptidase domain only | 2DI4 |
| MA | M41.021 | FtsH peptidase (Thermotoga-type) | 4WW0 | |
| MA | M41.021 | FtsH peptidase (Thermotoga-type) | 4Z8X | |
| MA | M41.021 | FtsH peptidase (Thermotoga-type) | truncated ftsh from a. aeolicus in r32 | 6GCN_A |
| MA | M41.021 | FtsH peptidase (Thermotoga-type) | truncated ftsh from a. aeolicus in p312 | 6GCO_A |
| MA | M41.021 | FtsH peptidase (Thermotoga-type) | cytoplasmic domain only | 2CE7 |
| MA | M41.021 | FtsH peptidase (Thermotoga-type) | wildtype | 2CEA_A |
| MA | M41.021 | FtsH peptidase (Thermotoga-type) | apoenzyme | 3KDS |
| MA | M41.021 | FtsH peptidase (Thermotoga-type) | 4M8A | |
| MA | M41.021 | FtsH peptidase (Thermotoga-type) | 4Q0F | |
| MA | M41.UPW | family M41 unassigned peptidases | 2R62 | |
| MA | M41.UPW | family M41 unassigned peptidases | 2R65 | |
| MH | M42.001 | glutamyl aminopeptidase (bacterium) | 3KL9 | |
| MH | M42.003 | PhTET1 aminopeptidase | pyrococcus horikoshii tet1 peptidase can assemble into a tetrahedron or a large octahedral shell | 2CF4_A |
| MH | M42.003 | PhTET1 aminopeptidase | dodecamer in the asymmetric unit | 2WYR_A |
| MH | M42.004 | PhTET2 aminopeptidase | 1XFO_A | |
| MH | M42.004 | PhTET2 aminopeptidase | 1Y0R | |
| MH | M42.004 | PhTET2 aminopeptidase | complex with amastatin | 1Y0Y |
| MH | M42.004 | PhTET2 aminopeptidase | combined solid-state nmr, solution-state nmr and em data for structuredetermination of the tetrahedral aminopeptidase tet2 from p. horikoshii | 6F3K_A |
| MH | M42.006 | FrvX putative peptidase | TOPSAN | 3CPX |
| MH | M42.007 | TM1048-type putative peptidase | 1VHO | |
| MH | M42.008 | YpdE-type putative peptidase | 1YLO_A | |
| MH | M42.009 | PhTET3 aminopeptidase | de novo crystal structure of the pyrococcus furiosus tet3 aminopeptidase | 4X8I_A |
| MH | M42.009 | PhTET3 aminopeptidase | crystal structure of frv operon protein frvx (ph1821)from pyrococcus horikoshii ot3 | 2PE3_A |
| MH | M42.009 | PhTET3 aminopeptidase | 3d structure of tet3 from pyrococcus horikoshii | 2VPU_A |
| MH | M42.009 | PhTET3 aminopeptidase | 2WZN_A | |
| MH | M42.011 | aminopeptidase I alpha chain (Bacillus-type) | 1VHE_A | |
| MH | M42.011 | aminopeptidase I alpha chain (Bacillus-type) | crystal structure of tet aminopeptidase from marine sediment archaeon thaumarchaeota archaeon scgc ab-539-e09 | 5DS0_A |
| MH | M42.UPW | family M42 unassigned peptidases | crystal structure of endoglucanase (tm1050) from thermotoga maritima at 1.40 a resolution | 3ISX_A |
| MH | M42.UPW | family M42 unassigned peptidases | crystal structure of the m42 aminopeptidase tmpep1050 from thermotoga maritima | 4P6Y_A |
| MH | M42.UPW | family M42 unassigned peptidases | crystal structure of d62a mutant of thermotoga maritima tmpep1050 aminopeptidase | 5L6Z_A |
| MH | M42.UPW | family M42 unassigned peptidases | crystal structure of dimeric tmpep1050 aminopeptidase | 5NE6_A |
| MH | M42.UPW | family M42 unassigned peptidases | crystal structure of h60a mutant of thermotoga maritima tmpep1050 aminopeptidase | 5NE7_A |
| MH | M42.UPW | family M42 unassigned peptidases | crystal structure of h307a mutant of thermotoga maritima tmpep1050 aminopeptidase | 5NE8_A |
| MH | M42.UPW | family M42 unassigned peptidases | crystal structure of h60a h307a mutant of thermotoga maritima tmpep1050 aminopeptidase | 5NE9_A |
| MH | M42.UPW | family M42 unassigned peptidases | 2FVG_A | |
| MH | M42.UPW | family M42 unassigned peptidases | 4WWV_A | |
| MA | M43.007 | ulilysin (Methanosarcina acetivorans) | structure of ulilysin, a member of the pappalysin family of metzincin metalloendopeptidases. | 2CKI_A |
| MA | M43.007 | ulilysin (Methanosarcina acetivorans) | complex with batimastat. | 2J83_A |
| MA | M43.007 | ulilysin (Methanosarcina acetivorans) | Met290Leu mutant | 3LUM |
| MA | M43.007 | ulilysin (Methanosarcina acetivorans) | Met290Cys mutant | 3LUN |
| MA | M48.001 | Ste24 peptidase | 4IL3 | |
| MA | M48.002 | HtpX peptidase | HtpX domain | 3CQB_A |
| MA | M48.003 | farnesylated-protein converting enzyme 1 | 2YPT | |
| MA | M48.003 | farnesylated-protein converting enzyme 1 | 4AW6 | |
| MA | M48.003 | farnesylated-protein converting enzyme 1 | 5SYT | |
| MA | M48.003 | farnesylated-protein converting enzyme 1 | complex with phosphoramidon | 6BH8_A |
| MA | M48.019 | GSU1437 putative peptidase | TOPSAN | 3C37 |
| MA | M48.023 | BepA (Escherichia coli) | crystal structure of e. coli bepa | 6AIT_A |
| MA | M49.001 | dipeptidyl-peptidase III | 3FVY_A | |
| MA | M49.001 | dipeptidyl-peptidase III | 3T6B | |
| MA | M49.001 | dipeptidyl-peptidase III | 3T6J | |
| MA | M49.001 | dipeptidyl-peptidase III | complex with angiotensin-ii | 5E2Q_A |
| MA | M49.001 | dipeptidyl-peptidase III | complex with met-enkephalin | 5E33_A |
| MA | M49.001 | dipeptidyl-peptidase III | complex with opioid peptide leu-enkephalin | 5E3A_A |
| MA | M49.001 | dipeptidyl-peptidase III | complex with hemorphin like opioid peptide ivypw | 5E3C_A |
| MA | M49.001 | dipeptidyl-peptidase III | structure of ligand free human dpp3 in closed form. | 5EGY_A |
| MA | M49.001 | dipeptidyl-peptidase III | complex with endomorphin-2. | 5EHH_A |
| MA | M49.003 | dipeptidyl-peptidase IIIB (Bacteroides thetaiotaomicron-type) | structure of cys-null se-met dpp iii from bacteroides thetaiotaomicron | 5NA6_A |
| MA | M49.003 | dipeptidyl-peptidase IIIB (Bacteroides thetaiotaomicron-type) | structure of dpp iii from bacteroides thetaiotaomicron | 5NA7_A |
| MA | M49.003 | dipeptidyl-peptidase IIIB (Bacteroides thetaiotaomicron-type) | structure of dpp iii from bacteroides thetaiotaomicron in closed form | 5NA8_A |
| MA | M49.004 | dipeptidyl-peptidase III (Saccharomyces-type) | 3CSK | |
| MA | M49.006 | aflatoxin oxidase (Armillariella tabescens) | ||
| MA | M49.006 | aflatoxin oxidase (Armillariella tabescens) | ON HOLD | 5YFB |
| MA | M49.006 | aflatoxin oxidase (Armillariella tabescens) | ON HOLD | 5YFC |
| MA | M49.006 | aflatoxin oxidase (Armillariella tabescens) | crystal structure of a new dpp iii family member | 5YFD_A |
| MM | M50.004 | RseP peptidase | 2ZPL | |
| MM | M50.004 | RseP peptidase | 2ZPM | |
| MM | M50.004 | RseP peptidase | 3ID1 | |
| MM | M50.004 | RseP peptidase | 3ID2 | |
| MM | M50.004 | RseP peptidase | 3ID3 | |
| MM | M50.004 | RseP peptidase | 3ID4 | |
| MM | M50.006 | MjS2P-type peptidase | 3B4R_A | |
| MM | M50.UPA | subfamily M50A unassigned peptidases | 3WKL | |
| MM | M50.UPA | subfamily M50A unassigned peptidases | 3WKM | |
| MM | M50.UPB | subfamily M50B unassigned peptidases | cbs domain tandem of site-2 protease from archaeoglobus fulgidus in complex with llama nanobody - apo form | 5G5R_A |
| MM | M50.UPB | subfamily M50B unassigned peptidases | cbs domain tandem of site-2 protease from archaeoglobus fulgidus in complex with llama nanobody - nucleotide-bound form | 5G5X_A |
| MA | M54.UPW | family M54 unassigned peptidases | complex with malonate | 3ZVS |
| MA | M54.UPW | family M54 unassigned peptidases | complex with citrate | 4A3W |
| MA | M54.UPW | family M54 unassigned peptidases | 4AXQ | |
| MA | M54.UPW | family M54 unassigned peptidases | 2X7M | |
| MA | M54.UPW | family M54 unassigned peptidases | 3LMC | |
| MN | M55.001 | D-aminopeptidase DppA | homodecamer | 1HI9 |
| MA | M56.001 | BlaR1 peptidase | 1XA1 | |
| MA | M56.001 | BlaR1 peptidase | 1XA7 | |
| MA | M56.001 | BlaR1 peptidase | 1XKZ | |
| MA | M56.001 | BlaR1 peptidase | 3Q81 | |
| MA | M56.001 | BlaR1 peptidase | 3Q82 | |
| MA | M56.001 | BlaR1 peptidase | 3UY6 | |
| MA | M56.003 | PenR1 peptidase | 1NRF | |
| MA | M60.006 | ZmpB peptidase (Clostridium perfringens) | 5KDJ | |
| MA | M60.006 | ZmpB peptidase (Clostridium perfringens) | 5KDN | |
| MA | M60.006 | ZmpB peptidase (Clostridium perfringens) | complex with an O-glycopeptide (a2,6-sialylated core-3 pentapeptide | 5KDS |
| MA | M60.006 | ZmpB peptidase (Clostridium perfringens) | complex with a2,6-Sialyl T-antigen | 5KDU |
| MA | M61.UPW | family M61 unassigned peptidases | crystal structure of the aminopeptidase n family protein q5qty1 from idiomarina loihiensis. northeast structural genomics consortium target ilr60. | 4FGM_A |
| MA | M64.UPW | family M64 unassigned peptidases | 4DF9 | |
| MA | M64.UPW | family M64 unassigned peptidases | 3P1V | |
| MA | M66.001 | StcE peptidase | 3UJZ | |
| MA | M66.001 | StcE peptidase | 4DNY | |
| MP | M67.001 | PSMD14 peptidase | 3J47_V | |
| MP | M67.001 | PSMD14 peptidase | 26s proteasome lid sub-complex | 3JCK_G |
| MP | M67.001 | PSMD14 peptidase | 4CR2_V | |
| MP | M67.001 | PSMD14 peptidase | 4CR3_V | |
| MP | M67.001 | PSMD14 peptidase | 4CR4_V | |
| MP | M67.001 | PSMD14 peptidase | 4O8X_B | |
| MP | M67.001 | PSMD14 peptidase | 4O8Y_B | |
| MP | M67.001 | PSMD14 peptidase | 4OCL_B | |
| MP | M67.001 | PSMD14 peptidase | 4OCM_B | |
| MP | M67.001 | PSMD14 peptidase | 4OCN_B | |
| MP | M67.001 | PSMD14 peptidase | 4OWP_B | |
| MP | M67.001 | PSMD14 peptidase | 5A5B_V | |
| MP | M67.001 | PSMD14 peptidase | 26s proteasome in presence of atp (s1) | 5MPD_V |
| MP | M67.001 | PSMD14 peptidase | 26s proteasome in presence of atp (s2) | 5MPE_V |
| MP | M67.001 | PSMD14 peptidase | protein-protein complex between 26s proteasome regulatory subunit rpn8, rpn11, and ubiquitin s31 | 5U4P_B |
| MP | M67.001 | PSMD14 peptidase | rpn8/rpn11 dimer complex | 5W83_B |
| MP | M67.001 | PSMD14 peptidase | yeast 26s proteasome bound to ubiquitinated substrate (4d motor state) | 6EF3_n |
| MP | M67.002 | Csn5 peptidase | 4D10_E | |
| MP | M67.002 | Csn5 peptidase | 4D18_E | |
| MP | M67.002 | Csn5 peptidase | 4F7O | |
| MP | M67.002 | Csn5 peptidase | 4WSN | |
| MP | M67.002 | Csn5 peptidase | crystal structure of csn5(2-257) in complex with cns5i-3 | 5JOG_A |
| MP | M67.002 | Csn5 peptidase | crystal structure of csn5(2-257) in complex with cns5i-1b | 5JOH_A |
| MP | M67.002 | Csn5 peptidase | cops5(2-257) in complex with a azaindole (compound 4) | 5M5Q_A |
| MP | M67.003 | STAM-binding protein-like 1 | dub domain | 2ZNR_A |
| MP | M67.003 | STAM-binding protein-like 1 | dub domain; complex with Lys63-linked ubiquitin dimer | 2ZNV_A |
| MP | M67.004 | Brcc36 isopeptidase | cryo-em structure of the human brisc-shmt2 complex | 6R8F_A |
| MP | M67.004 | Brcc36 isopeptidase | 5CW3 | |
| MP | M67.004 | Brcc36 isopeptidase | 5CW4 | |
| MP | M67.004 | Brcc36 isopeptidase | 5CW5 | |
| MP | M67.005 | histone H2A deubiquitinase MYSM1 | 2CU7 | |
| MP | M67.005 | histone H2A deubiquitinase MYSM1 | 2DCE | |
| MP | M67.006 | STAMBP isopeptidase | 2XZE | |
| MP | M67.006 | STAMBP isopeptidase | 3RZU | |
| MP | M67.006 | STAMBP isopeptidase | 3RZV | |
| MP | M67.010 | JAMM-like protein (Archaeoglobus-type) | 1OI0_A | |
| MP | M67.010 | JAMM-like protein (Archaeoglobus-type) | 1R5X_A | |
| MP | M67.971 | Mername-AA168 protein | 3J8B | |
| MP | M67.971 | Mername-AA168 protein | 3J8C | |
| MP | M67.971 | Mername-AA168 protein | structure of mammalian eif3 in the context of the 43s preinitiation complex | 5A5T_H |
| MP | M67.972 | COP9 signalosome subunit 6 | 4D10_F | |
| MP | M67.972 | COP9 signalosome subunit 6 | 4D18_F | |
| MP | M67.972 | COP9 signalosome subunit 6 | 4QFT | |
| MP | M67.972 | COP9 signalosome subunit 6 | 4R14 | |
| MP | M67.972 | COP9 signalosome subunit 6 | 4WSN | |
| MP | M67.972 | COP9 signalosome subunit 6 | 4E0Q | |
| MP | M67.973 | 26S proteasome non-ATPase regulatory subunit 7 | 2O95 | |
| MP | M67.973 | 26S proteasome non-ATPase regulatory subunit 7 | 2O96 | |
| MP | M67.973 | 26S proteasome non-ATPase regulatory subunit 7 | 26S proteasome; complex with USP14-UbAl | 5GJQ_U |
| MP | M67.973 | 26S proteasome non-ATPase regulatory subunit 7 | 26S proteasome | 5GJR_8 |
| MP | M67.973 | 26S proteasome non-ATPase regulatory subunit 7 | the human 26s proteasome lid | 5L4K_U |
| MP | M67.973 | 26S proteasome non-ATPase regulatory subunit 7 | the human 26s proteasome at 6.8 ang. ***caveat 5ln3 pro h 311 has wrong chirality at atom ca thr n 752 has wrong ***caveat 2 5ln3 chirality at atom ca | 5LN3_U |
| MP | M67.973 | 26S proteasome non-ATPase regulatory subunit 7 | 26s proteasome in complex with oprozomib | 5M32_n |
| MP | M67.973 | 26S proteasome non-ATPase regulatory subunit 7 | structural basis for dynamic regulation of the human 26s proteasome ***caveat 5t0g entry contains improper peptide linkages. | 5T0G_Z |
| MP | M67.973 | 26S proteasome non-ATPase regulatory subunit 7 | structural basis for dynamic regulation of the human 26s proteasome ***caveat 5t0h entry contains improper peptide linkages. | 5T0H_Z |
| MP | M67.973 | 26S proteasome non-ATPase regulatory subunit 7 | structural basis for dynamic regulation of the human 26s proteasome ***caveat 5t0i entry contains improper peptide linkages. residue arg k 20 ***caveat 2 5t0i is incorrectly modeled. | 5T0I_Z |
| MP | M67.973 | 26S proteasome non-ATPase regulatory subunit 7 | structural basis for dynamic regulation of the human 26s proteasome ***caveat 5t0j entry contains improper peptide linkages. | 5T0J_Z |
| MP | M67.973 | 26S proteasome non-ATPase regulatory subunit 7 | nucleotide-driven triple-state remodeling of the aaa-atpase channel inthe activated human 26s proteasome | 5VFR_Z |
| MP | M67.973 | 26S proteasome non-ATPase regulatory subunit 7 | nucleotide-driven triple-state remodeling of the aaa-atpase channel inthe activated human 26s proteasome | 5VFT_Z |
| MP | M67.973 | 26S proteasome non-ATPase regulatory subunit 7 | conformational landscape of the p28-bound human proteasome regulatory particle ***caveat 5vgz entry contains improper peptide linkages. | 5VGZ_Z |
| MP | M67.973 | 26S proteasome non-ATPase regulatory subunit 7 | conformational landscape of the p28-bound human proteasome regulatory particle ***caveat 5vhf entry contains improper peptide linkages. | 5VHF_Z |
| MP | M67.973 | 26S proteasome non-ATPase regulatory subunit 7 | conformational landscape of the p28-bound human proteasome regulatory particle ***caveat 5vhh entry contains improper peptide linkages. | 5VHH_Z |
| MP | M67.973 | 26S proteasome non-ATPase regulatory subunit 7 | conformational landscape of the p28-bound human proteasome regulatory particle ***caveat 5vhi entry contains improper peptide linkages. | 5VHI_Z |
| MP | M67.973 | 26S proteasome non-ATPase regulatory subunit 7 | conformational landscape of the p28-bound human proteasome regulatory particle ***caveat 5vhs entry contains improper peptide linkages. | 5VHS_Z |
| MP | M67.973 | 26S proteasome non-ATPase regulatory subunit 7 | 3J47_U | |
| MP | M67.973 | 26S proteasome non-ATPase regulatory subunit 7 | 26s proteasome lid sub-complex | 3JCK_E |
| MP | M67.973 | 26S proteasome non-ATPase regulatory subunit 7 | 4CR2_U | |
| MP | M67.973 | 26S proteasome non-ATPase regulatory subunit 7 | 4CR3_U | |
| MP | M67.973 | 26S proteasome non-ATPase regulatory subunit 7 | 4CR4_U | |
| MP | M67.973 | 26S proteasome non-ATPase regulatory subunit 7 | 4O8X_A | |
| MP | M67.973 | 26S proteasome non-ATPase regulatory subunit 7 | 4O8Y_A | |
| MP | M67.973 | 26S proteasome non-ATPase regulatory subunit 7 | 4OCL_A | |
| MP | M67.973 | 26S proteasome non-ATPase regulatory subunit 7 | 4OCM_A | |
| MP | M67.973 | 26S proteasome non-ATPase regulatory subunit 7 | 4OCN_A | |
| MP | M67.973 | 26S proteasome non-ATPase regulatory subunit 7 | 4OWP_A | |
| MP | M67.973 | 26S proteasome non-ATPase regulatory subunit 7 | 5A5B_U | |
| MP | M67.973 | 26S proteasome non-ATPase regulatory subunit 7 | 26s proteasome in presence of atp (s1) | 5MPD_U |
| MP | M67.973 | 26S proteasome non-ATPase regulatory subunit 7 | 26s proteasome in presence of atp (s2) | 5MPE_U |
| MP | M67.973 | 26S proteasome non-ATPase regulatory subunit 7 | protein-protein complex between 26s proteasome regulatory subunit rpn8, rpn11, and ubiquitin s31 | 5U4P_A |
| MP | M67.973 | 26S proteasome non-ATPase regulatory subunit 7 | rpn8/rpn11 dimer complex | 5W83_A |
| MP | M67.974 | eukaryotic translation initiation factor 3 subunit F | 3J8B | |
| MP | M67.974 | eukaryotic translation initiation factor 3 subunit F | 3J8C | |
| MP | M67.974 | eukaryotic translation initiation factor 3 subunit F | structure of mammalian eif3 in the context of the 43s preinitiation complex | 5A5T_F |
| MP | M67.A10 | F37A4.5 protein (Caenorhabditis elegans) | 1ZK6 | |
| MP | M67.A10 | F37A4.5 protein (Caenorhabditis elegans) | 4WO7 | |
| MP | M67.A10 | F37A4.5 protein (Caenorhabditis elegans) | 26S proteasome; complex with USP14-UbAl | 5GJQ_V |
| MP | M67.A10 | F37A4.5 protein (Caenorhabditis elegans) | 26S proteasome | 5GJR_9 |
| MP | M67.A10 | F37A4.5 protein (Caenorhabditis elegans) | the human 26s proteasome lid | 5L4K_V |
| MP | M67.A10 | F37A4.5 protein (Caenorhabditis elegans) | the human 26s proteasome at 6.8 ang. ***caveat 5ln3 pro h 311 has wrong chirality at atom ca thr n 752 has wrong ***caveat 2 5ln3 chirality at atom ca | 5LN3_V |
| MP | M67.A10 | F37A4.5 protein (Caenorhabditis elegans) | 26s proteasome in complex with oprozomib | 5M32_q |
| MP | M67.A10 | F37A4.5 protein (Caenorhabditis elegans) | structural basis for dynamic regulation of the human 26s proteasome ***caveat 5t0g entry contains improper peptide linkages. | 5T0G_c |
| MP | M67.A10 | F37A4.5 protein (Caenorhabditis elegans) | structural basis for dynamic regulation of the human 26s proteasome ***caveat 5t0h entry contains improper peptide linkages. | 5T0H_c |
| MP | M67.A10 | F37A4.5 protein (Caenorhabditis elegans) | structural basis for dynamic regulation of the human 26s proteasome ***caveat 5t0i entry contains improper peptide linkages. residue arg k 20 ***caveat 2 5t0i is incorrectly modeled. | 5T0I_c |
| MP | M67.A10 | F37A4.5 protein (Caenorhabditis elegans) | structural basis for dynamic regulation of the human 26s proteasome ***caveat 5t0j entry contains improper peptide linkages. | 5T0J_c |
| MP | M67.A10 | F37A4.5 protein (Caenorhabditis elegans) | nucleotide-driven triple-state remodeling of the aaa-atpase channel inthe activated human 26s proteasome | 5VFR_c |
| MP | M67.A10 | F37A4.5 protein (Caenorhabditis elegans) | nucleotide-driven triple-state remodeling of the aaa-atpase channel inthe activated human 26s proteasome | 5VFT_c |
| MP | M67.A10 | F37A4.5 protein (Caenorhabditis elegans) | conformational landscape of the p28-bound human proteasome regulatory particle ***caveat 5vgz entry contains improper peptide linkages. | 5VGZ_c |
| MP | M67.A10 | F37A4.5 protein (Caenorhabditis elegans) | conformational landscape of the p28-bound human proteasome regulatory particle ***caveat 5vhf entry contains improper peptide linkages. | 5VHF_c |
| MP | M67.A10 | F37A4.5 protein (Caenorhabditis elegans) | conformational landscape of the p28-bound human proteasome regulatory particle ***caveat 5vhh entry contains improper peptide linkages. | 5VHH_c |
| MP | M67.A10 | F37A4.5 protein (Caenorhabditis elegans) | conformational landscape of the p28-bound human proteasome regulatory particle ***caveat 5vhi entry contains improper peptide linkages. | 5VHI_c |
| MP | M67.A10 | F37A4.5 protein (Caenorhabditis elegans) | conformational landscape of the p28-bound human proteasome regulatory particle ***caveat 5vhs entry contains improper peptide linkages. | 5VHS_c |
| MP | M67.A10 | F37A4.5 protein (Caenorhabditis elegans) | ground state 26s proteasome (gs2) | 6EPC_V |
| MP | M67.A10 | F37A4.5 protein (Caenorhabditis elegans) | substrate processing state 26s proteasome (sps1) ***caveat 6epd pro 2 231 has wrong chirality at atom ca | 6EPD_V |
| MP | M67.A10 | F37A4.5 protein (Caenorhabditis elegans) | substrate processing state 26s proteasome (sps2) | 6EPE_V |
| MP | M67.A10 | F37A4.5 protein (Caenorhabditis elegans) | ground state 26s proteasome (gs1) | 6EPF_V |
| MP | M67.A14 | sst2 g.p. (Schizosaccharomyces pombe) | 4JXE | |
| MP | M67.A14 | sst2 g.p. (Schizosaccharomyces pombe) | 4K1R | |
| MP | M67.A14 | sst2 g.p. (Schizosaccharomyces pombe) | 4MS7 | |
| MP | M67.A14 | sst2 g.p. (Schizosaccharomyces pombe) | 4MSD | |
| MP | M67.A14 | sst2 g.p. (Schizosaccharomyces pombe) | 4MSJ | |
| MP | M67.A14 | sst2 g.p. (Schizosaccharomyces pombe) | 4MSM | |
| MP | M67.A14 | sst2 g.p. (Schizosaccharomyces pombe) | 4MSQ | |
| MP | M67.A14 | sst2 g.p. (Schizosaccharomyces pombe) | 4NQL | |
| MP | M67.A14 | sst2 g.p. (Schizosaccharomyces pombe) | 4PQT | |
| MP | M67.A14 | sst2 g.p. (Schizosaccharomyces pombe) | 4ZD4 | |
| MP | M67.A14 | sst2 g.p. (Schizosaccharomyces pombe) | 4ZD5 | |
| MP | M67.A14 | sst2 g.p. (Schizosaccharomyces pombe) | 4ZFR | |
| MP | M67.A14 | sst2 g.p. (Schizosaccharomyces pombe) | CATALYTIC DOMAIN OF SST2 F403W MUTANT BOUND TO UBIQUITIN | 4ZFT |
| MP | M67.UPA | subfamily M67A unassigned peptidases | rpn11 homolog from caldiarchaeum subterraneum | 6FJU_A |
| MP | M67.UPA | subfamily M67A unassigned peptidases | rpn11 homolog from caldiarchaeum subterraneum, truncated | 6FJV_A |
| MP | M67.UPA | subfamily M67A unassigned peptidases | caldiarchaeum subterraneum ubiquitin:rpn11-homolog complex | 6FNN_A |
| MP | M67.UPA | subfamily M67A unassigned peptidases | caldiarchaeum subterraneum ubiquitin:rpn11-homolog complex, zinc soak | 6FNO_A |
| MP | M67.UPB | subfamily M67B unassigned peptidases | structure of deubiquitinating enzyme homolog, pyrococcus furiosus jamm1. | 5LD9_A |
| MP | M67.UPB | subfamily M67B unassigned peptidases | structure of deubiquitinating enzyme homolog (pyrococcus furiosus jamm1) in complex with ubiquitin-like samp2. | 5LDA_A |
| M- | M73.A01 | spore coat-associated protein N (Bacillus subtilis) | the structural versatility of tasa in b. subtilis biofilm formation | 5OF1_A |
| M- | M73.A01 | spore coat-associated protein N (Bacillus subtilis) | the structural versatility of tasa in b. subtilis biofilm formation | 5OF2_A |
| MD | M74.001 | murein endopeptidase | zinc-free form | 1TZP |
| MD | M74.001 | murein endopeptidase | 1U10_A | |
| MS | M75.UPW | family M75 unassigned peptidases | crystal structure of a putative iron-regulated protein a precursor (bdi_2603) from parabacteroides distasonis atcc 8503 at 2.30 a resolution | 4ECG_A |
| MS | M75.UPW | family M75 unassigned peptidases | 3N8U | |
| MS | M75.UPW | family M75 unassigned peptidases | crystal structure of an imelysin peptidase (bacova_03801) from bacteroides ovatus atcc 8483 at 1.25 a resolution | 3OYV_A |
| MA | M78.002 | IrrE peptidase (Deinococcus sp.) | 3DTE | |
| MA | M78.002 | IrrE peptidase (Deinococcus sp.) | 3DTI | |
| MA | M78.002 | IrrE peptidase (Deinococcus sp.) | 3DTK | |
| MA | M80.001 | Wss1 peptidase (Saccharomyces-type) | 5XBN_A | |
| MA | M80.001 | Wss1 peptidase (Saccharomyces-type) | crystal structure of wss1 mutant from saccharomyces cerevisiae | 5XBV_A |
| MA | M80.A04 | SPCC1442.07c g.p. (Schizosaccharomyces pombe) | 5JIG_A | |
| MA | M80.A04 | SPCC1442.07c g.p. (Schizosaccharomyces pombe) | crystal structure of the wss1 e203q mutant from s. pombe | 5LN5_A |
| MT | M81.UPW | family M81 unassigned peptidases | 3IUU | |
| MA | M85.001 | NleC peptidase (Escherichia coli) | the crystal structure of non-lee encoded type iii effector c from citrobacter rodentium | 4O2I_A |
| MA | M85.001 | NleC peptidase (Escherichia coli) | n-terminal truncated nlec structure | 4LGI_A |
| MA | M85.001 | NleC peptidase (Escherichia coli) | 4LGJ_A | |
| MA | M85.001 | NleC peptidase (Escherichia coli) | 4Q3J | |
| MC | M86.001 | PghP gamma-polyglutamate hydrolase (bacteriophage) | 3A9L | |
| MA | M88.001 | IMPa peptidase (Pseudomonas aeruginosa) | 5KDV | |
| MA | M88.001 | IMPa peptidase (Pseudomonas aeruginosa) | 5KDW | |
| MA | M88.001 | IMPa peptidase (Pseudomonas aeruginosa) | complex with T-antigen | 5KDX |
| MA | M90.001 | MtfA peptidase | 3DL1 | |
| MA | M90.001 | MtfA peptidase | 3DL1_A | |
| MA | M90.001 | MtfA peptidase | 3KHI | |
| MA | M95.001 | abylysin (Pyrococcus abyssi) | 4JIU | |
| MA | M95.002 | jannalysin (Methanocaldococcus jannaschii) | 4JIX | |
| MA | M95.003 | selecase (Methanocaldococcus jannaschii) | monomer | 4QHF |
| MA | M95.003 | selecase (Methanocaldococcus jannaschii) | dimer | 4QHG |
| MA | M95.003 | selecase (Methanocaldococcus jannaschii) | tetramer | 4QHH |
| MA | M95.003 | selecase (Methanocaldococcus jannaschii) | Arg36Trp mutant | 4QHI |
| MA | M95.003 | selecase (Methanocaldococcus jannaschii) | Ile100Phe, His107Phe mutant | 4QHJ |
| MA | M97.001 | EcxAB peptidase | apo form of ab5 holotoxin | 4L63_A |
| MA | M97.001 | EcxAB peptidase | GM1 bound form of the ECX AB5 holotoxin | 4L6T_A |
| MC | M99.001 | Csd4 peptidase (Helicobacter pylori) | apo form | 4Q6M |
| MC | M99.001 | Csd4 peptidase (Helicobacter pylori) | tripeptide bound form | 4Q6N |
| MC | M99.001 | Csd4 peptidase (Helicobacter pylori) | mDAP bound form | 4Q6O |
| MC | M99.001 | Csd4 peptidase (Helicobacter pylori) | zinc form I | 4Q6P |
| MC | M99.001 | Csd4 peptidase (Helicobacter pylori) | zinc form II | 4Q6Q |
| MC | M99.001 | Csd4 peptidase (Helicobacter pylori) | apo form | 4WCK |
| MC | M99.001 | Csd4 peptidase (Helicobacter pylori) | product bound form | 4WCL |
| MC | M99.001 | Csd4 peptidase (Helicobacter pylori) | Gln46His mutant | 4WCM |
| MC | M99.001 | Csd4 peptidase (Helicobacter pylori) | tripeptide bound form | 4WCN |
| NA | N01.001 | nodavirus peptide lyase | Asn363Thr mutant | 2Q23_A |
| NA | N01.001 | nodavirus peptide lyase | Asp75Asn mutant | 2Q25_A |
| NA | N01.001 | nodavirus peptide lyase | 2Q26_A | |
| NA | N01.001 | nodavirus peptide lyase | 2Z2Q_A | |
| NA | N01.001 | nodavirus peptide lyase | calcium mutant | 3LOB |
| NA | N01.001 | nodavirus peptide lyase | 4FSJ | |
| NA | N01.001 | nodavirus peptide lyase | 4FTB | |
| NA | N01.001 | nodavirus peptide lyase | 4FTE | |
| NA | N01.001 | nodavirus peptide lyase | 4FTS | |
| NA | N01.001 | nodavirus peptide lyase | complex with duplex RNA | 2BBV |
| NA | N01.001 | nodavirus peptide lyase | 1NOV | |
| NA | N01.UPW | family N1 unassigned peptide lyases | 1F8V | |
| NA | N02.001 | tetravirus coat protein | 1OHF | |
| NA | N02.001 | tetravirus coat protein | 3S6P | |
| NA | N02.UPW | family N2 unassigned peptide lyases | 2QQP_A | |
| ND | N04.001 | Tsh-associated self-cleaving domain (Escherichia coli) and similar | Asn1100Asp mutant; integral membrane domain | 3AEH_A |
| ND | N04.002 | EspP gamma protein autotransporter domain (Escherichi-type) | autotransporter domain | 2QOM |
| ND | N04.UNW | family N4 non-lyase homologues | 2IOU | |
| ND | N04.UNW | family N4 non-lyase homologues | 1DAB | |
| NE | N05.UPW | family N5 unassigned peptide lyases | mature protein | 2VF1 |
| NB | N06.001 | YscU protein | 2ML9 | |
| NB | N06.001 | YscU protein | C-terminal domain; Asn263Ala mutant | 2JLH |
| NB | N06.001 | YscU protein | C-terminal domain | 2JLI |
| NB | N06.001 | YscU protein | C-terminal domain; Asn263Ala, Pro264Ala mutant | 2JLJ |
| NB | N06.001 | YscU protein | yersinia yscu c-terminal fragment in complex with a synthetic compound | 6EJP_A |
| NB | N06.001 | YscU protein | C-terminal domain; Asn263Ala mutant | 2V5G |
| NB | N06.001 | YscU protein | C-terminal domain; Asn263Asp mutant | 2W0R |
| NB | N06.002 | SpaS protein (Salmonella sp.) | 3C01 | |
| NB | N06.002 | SpaS protein (Salmonella sp.) | cytoplasmic domain | 2VT1 |
| NB | N06.003 | EscU protein (Escherichia coli) | cleaved C-terminal domains (215-262, 263-345) | 3BZL |
| NB | N06.003 | EscU protein (Escherichia coli) | cleaved C-terminal domains (215-262, 263-345) | 3BZO |
| NB | N06.003 | EscU protein (Escherichia coli) | Asn262Ala mutant; uncleaved C-terminal domains (215-345) | 3BZP |
| NB | N06.003 | EscU protein (Escherichia coli) | Asn262Asp mutant; uncleaved C-terminal domains (215-345) | 3BZR |
| NB | N06.003 | EscU protein (Escherichia coli) | Asn262Asp mutant; uncleaved C-terminal domains (215-345) | 3BZS |
| NB | N06.003 | EscU protein (Escherichia coli) | Pro263Ala mutant; uncleaved C-terminal domains (215-345) | 3BZT |
| NB | N06.003 | EscU protein (Escherichia coli) | Thr264Ala mutant; cleaved C-terminal domains (215-262, 263-345) | 3BZV |
| NB | N06.003 | EscU protein (Escherichia coli) | His265Ala mutant; cleaved C-terminal domains (215-262, 263-345) | 3BZX |
| NB | N06.003 | EscU protein (Escherichia coli) | Tyr316Asp mutant; cleaved C-terminal domains (215-262, 263-345) | 3BZY |
| NB | N06.003 | EscU protein (Escherichia coli) | Arg313Thr mutant; cleaved C-terminal domains (215-262, 263-345) | 3BZZ |
| NB | N06.003 | EscU protein (Escherichia coli) | Gly247Thr mutant; cleaved C-terminal domains (215-262, 263-345) | 3C00 |
| NB | N06.003 | EscU protein (Escherichia coli) | Pro263Ala mutant; cleaved and uncleaved C-terminal domains (215-262, 263-345, 215-345) | 3C03 |
| NB | N06.A01 | FlhB protein (Escherichia coli) | crystal structure of the cytoplasmic domain of flhb from aquifex aeolicus | 3B1S_A |
| NC | N07.001 | reovirus type 1 coat protein | cleaved form | 1JMU_A |
| NC | N07.001 | reovirus type 1 coat protein | 2CSE | |
| NA | N08.001 | poliovirus capsid VP0-type self-cleaving protein | 1BEV | |
| NA | N08.001 | poliovirus capsid VP0-type self-cleaving protein | crystal structure of the c147a mutant 3c from enterovirus 71 | 3SJK_A |
| NA | N08.001 | poliovirus capsid VP0-type self-cleaving protein | complex with rupintrivir (ag7088) | 3SJO_A |
| NA | N08.001 | poliovirus capsid VP0-type self-cleaving protein | 3W95 | |
| NA | N08.001 | poliovirus capsid VP0-type self-cleaving protein | structure of ev71 complex with its receptor scarb2 | 6I2K_A |
| NA | N08.001 | poliovirus capsid VP0-type self-cleaving protein | structure of ev71 complex with its receptor scarb2 | 6I2K_C |
| NA | N08.001 | poliovirus capsid VP0-type self-cleaving protein | 1D4M | |
| NA | N08.001 | poliovirus capsid VP0-type self-cleaving protein | 3J2J | |
| NA | N08.001 | poliovirus capsid VP0-type self-cleaving protein | Val1160Ile mutant | 1AL2 |
| NA | N08.001 | poliovirus capsid VP0-type self-cleaving protein | Val1160Ile, Pro1095Ser double mutant | 1AR6 |
| NA | N08.001 | poliovirus capsid VP0-type self-cleaving protein | Pro1095Ser, His2142Tyr double mutant | 1AR7 |
| NA | N08.001 | poliovirus capsid VP0-type self-cleaving protein | Pro1095Ser mutant | 1AR8 |
| NA | N08.001 | poliovirus capsid VP0-type self-cleaving protein | His2142Tyr mutant | 1AR9 |
| NA | N08.001 | poliovirus capsid VP0-type self-cleaving protein | 1ASJ | |
| NA | N08.001 | poliovirus capsid VP0-type self-cleaving protein | 1DGI | |
| NA | N08.001 | poliovirus capsid VP0-type self-cleaving protein | 1FPT | |
| NA | N08.001 | poliovirus capsid VP0-type self-cleaving protein | 1HXS | |
| NA | N08.001 | poliovirus capsid VP0-type self-cleaving protein | 1NG7 | |
| NA | N08.001 | poliovirus capsid VP0-type self-cleaving protein | complex with poliovirus receptor | 1NN8 |
| NA | N08.001 | poliovirus capsid VP0-type self-cleaving protein | complex with viral replication inhibitor R80633 | 1PO1 |
| NA | N08.001 | poliovirus capsid VP0-type self-cleaving protein | complex with viral replication inhibitor R77975 | 1PO2 |
| NA | N08.001 | poliovirus capsid VP0-type self-cleaving protein | empty capsid assembly intermediate | 1POV |
| NA | N08.001 | poliovirus capsid VP0-type self-cleaving protein | 1RA6 | |
| NA | N08.001 | poliovirus capsid VP0-type self-cleaving protein | 1RA7 | |
| NA | N08.001 | poliovirus capsid VP0-type self-cleaving protein | 1RAJ | |
| NA | N08.001 | poliovirus capsid VP0-type self-cleaving protein | 1RDR | |
| NA | N08.001 | poliovirus capsid VP0-type self-cleaving protein | 1TQL | |
| NA | N08.001 | poliovirus capsid VP0-type self-cleaving protein | complex with viral replication inhibitor R78206 | 1VBD |
| NA | N08.001 | poliovirus capsid VP0-type self-cleaving protein | electron microscopy | 1XYR |
| NA | N08.001 | poliovirus capsid VP0-type self-cleaving protein | 2BBL | |
| NA | N08.001 | poliovirus capsid VP0-type self-cleaving protein | 2BBP | |
| NA | N08.001 | poliovirus capsid VP0-type self-cleaving protein | 2IJD | |
| NA | N08.001 | poliovirus capsid VP0-type self-cleaving protein | 2IJF | |
| NA | N08.001 | poliovirus capsid VP0-type self-cleaving protein | 2ILY | |
| NA | N08.001 | poliovirus capsid VP0-type self-cleaving protein | 2ILZ | |
| NA | N08.001 | poliovirus capsid VP0-type self-cleaving protein | 2IM0 | |
| NA | N08.001 | poliovirus capsid VP0-type self-cleaving protein | 2IM1 | |
| NA | N08.001 | poliovirus capsid VP0-type self-cleaving protein | 2IM2 | |
| NA | N08.001 | poliovirus capsid VP0-type self-cleaving protein | 2IM3 | |
| NA | N08.001 | poliovirus capsid VP0-type self-cleaving protein | 2PLV | |
| NA | N08.001 | poliovirus capsid VP0-type self-cleaving protein | complex with poliovirus receptor | 3EPC |
| NA | N08.001 | poliovirus capsid VP0-type self-cleaving protein | 3IYB | |
| NA | N08.001 | poliovirus capsid VP0-type self-cleaving protein | 3IYC | |
| NA | N08.001 | poliovirus capsid VP0-type self-cleaving protein | 3J3O | |
| NA | N08.001 | poliovirus capsid VP0-type self-cleaving protein | 3J3P | |
| NA | N08.001 | poliovirus capsid VP0-type self-cleaving protein | 3J48 | |
| NA | N08.001 | poliovirus capsid VP0-type self-cleaving protein | 3J69 | |
| NA | N08.001 | poliovirus capsid VP0-type self-cleaving protein | 3J6A | |
| NA | N08.001 | poliovirus capsid VP0-type self-cleaving protein | 3J8F | |
| NA | N08.001 | poliovirus capsid VP0-type self-cleaving protein | 3J9F | |
| NA | N08.001 | poliovirus capsid VP0-type self-cleaving protein | complex of poliovirus with vhh pvsp29f | 3JBC_1 |
| NA | N08.001 | poliovirus capsid VP0-type self-cleaving protein | complex of poliovirus with vhh pvsp6a | 3JBD_1 |
| NA | N08.001 | poliovirus capsid VP0-type self-cleaving protein | complex of poliovirus with vhh pvss8a | 3JBE_1 |
| NA | N08.001 | poliovirus capsid VP0-type self-cleaving protein | complex of poliovirus with vhh pvsp19b ***caveat 3jbf residue 1 thr 177 has incorrect stereochemistry at its cb ***caveat 2 3jbf chiral center. | 3JBF_1 |
| NA | N08.001 | poliovirus capsid VP0-type self-cleaving protein | complex of poliovirus with vhh pvss21e | 3JBG_1 |
| NA | N08.001 | poliovirus capsid VP0-type self-cleaving protein | 3OL7 | |
| NA | N08.001 | poliovirus capsid VP0-type self-cleaving protein | 4DCD | |
| NA | N08.001 | poliovirus capsid VP0-type self-cleaving protein | 4K4S | |
| NA | N08.001 | poliovirus capsid VP0-type self-cleaving protein | 4K4T | |
| NA | N08.001 | poliovirus capsid VP0-type self-cleaving protein | 4K4U | |
| NA | N08.001 | poliovirus capsid VP0-type self-cleaving protein | 4K4V | |
| NA | N08.001 | poliovirus capsid VP0-type self-cleaving protein | 4K4W | |
| NA | N08.001 | poliovirus capsid VP0-type self-cleaving protein | 4NLO | |
| NA | N08.001 | poliovirus capsid VP0-type self-cleaving protein | 4NLP | |
| NA | N08.001 | poliovirus capsid VP0-type self-cleaving protein | 4NLQ | |
| NA | N08.001 | poliovirus capsid VP0-type self-cleaving protein | 4NLR | |
| NA | N08.001 | poliovirus capsid VP0-type self-cleaving protein | 4NLS | |
| NA | N08.001 | poliovirus capsid VP0-type self-cleaving protein | 4NLT | |
| NA | N08.001 | poliovirus capsid VP0-type self-cleaving protein | 4NLU | |
| NA | N08.001 | poliovirus capsid VP0-type self-cleaving protein | 4NLV | |
| NA | N08.001 | poliovirus capsid VP0-type self-cleaving protein | 4NLW | |
| NA | N08.001 | poliovirus capsid VP0-type self-cleaving protein | 4NLX | |
| NA | N08.001 | poliovirus capsid VP0-type self-cleaving protein | 4NLY | |
| NA | N08.001 | poliovirus capsid VP0-type self-cleaving protein | 4R0E | |
| NA | N08.001 | poliovirus capsid VP0-type self-cleaving protein | expanded poliovirus in complex with vhh 12b | 5KTZ_1 |
| NA | N08.001 | poliovirus capsid VP0-type self-cleaving protein | expanded poliovirus in complex with vhh 17b | 5KU0_1 |
| NA | N08.001 | poliovirus capsid VP0-type self-cleaving protein | expanded poliovirus in complex with vhh 7a | 5KU2_1 |
| NA | N08.001 | poliovirus capsid VP0-type self-cleaving protein | expanded poliovirus in complex with vhh 10e | 5KWL_1 |
| NA | N08.001 | poliovirus capsid VP0-type self-cleaving protein | cryoem structure of the native empty particle of a human rhinovirus c | 5JZG_A |
| NA | N08.001 | poliovirus capsid VP0-type self-cleaving protein | 1A3R | |
| NA | N08.001 | poliovirus capsid VP0-type self-cleaving protein | serotype 2 | 1FPN |
| NA | N08.001 | poliovirus capsid VP0-type self-cleaving protein | 1V9U | |
| NA | N08.001 | poliovirus capsid VP0-type self-cleaving protein | 2XYA | |
| NA | N08.001 | poliovirus capsid VP0-type self-cleaving protein | complex with concatamer of the VLDL receptor module V3 | 3DPR |
| NA | N08.001 | poliovirus capsid VP0-type self-cleaving protein | 3TN9 | |
| NA | N08.001 | poliovirus capsid VP0-type self-cleaving protein | 3VDD | |
| NA | N08.001 | poliovirus capsid VP0-type self-cleaving protein | 4L3B | |
| NA | N08.001 | poliovirus capsid VP0-type self-cleaving protein | novel inhibitors of human rhinovirus 3c protease | 5FX5_A |
| NA | N08.001 | poliovirus capsid VP0-type self-cleaving protein | novel inhibitors of human rhinovirus 3c protease | 5FX6_A |
| NA | N08.001 | poliovirus capsid VP0-type self-cleaving protein | structure-based design and synthesis of macrocyclic human rhinovirus 3c protease inhibitors | 6FFN_A |
| NA | N08.001 | poliovirus capsid VP0-type self-cleaving protein | structure-based design and synthesis of macrocyclic human rhinovirus 3c protease inhibitors | 6FFS_A |
| NA | N08.001 | poliovirus capsid VP0-type self-cleaving protein | 1AYM_1 | |
| NA | N08.001 | poliovirus capsid VP0-type self-cleaving protein | 1AYN_1 | |
| NA | N08.001 | poliovirus capsid VP0-type self-cleaving protein | complex with pleconaril | 1C8M |
| NA | N08.001 | poliovirus capsid VP0-type self-cleaving protein | 1D3E | |
| NA | N08.001 | poliovirus capsid VP0-type self-cleaving protein | complex with pleconaril | 1NCP |
| NA | N08.001 | poliovirus capsid VP0-type self-cleaving protein | 1NCR | |
| NA | N08.001 | poliovirus capsid VP0-type self-cleaving protein | 1ND2 | |
| NA | N08.001 | poliovirus capsid VP0-type self-cleaving protein | complex with pleconaril | 1ND3 |
| NA | N08.001 | poliovirus capsid VP0-type self-cleaving protein | complex with VP61209 | 1QJU |
| NA | N08.001 | poliovirus capsid VP0-type self-cleaving protein | complex with WIN68934 | 1QJX |
| NA | N08.001 | poliovirus capsid VP0-type self-cleaving protein | complex with VP65099 | 1QJY |
| NA | N08.001 | poliovirus capsid VP0-type self-cleaving protein | 1TP7 | |
| NA | N08.001 | poliovirus capsid VP0-type self-cleaving protein | 1XR7 | |
| NA | N08.001 | poliovirus capsid VP0-type self-cleaving protein | 4K50 | |
| NA | N08.001 | poliovirus capsid VP0-type self-cleaving protein | cryo-em structure of human rhinovirus 14 (hrv14) complex with a two-domain fragment of its cellular receptor, intercellular adhesion molecule-1 (d1d2-icam-1). implications for virus-receptor interactions. alpha carbons only | 1D3I_1 |
| NA | N08.001 | poliovirus capsid VP0-type self-cleaving protein | complex with SCH 38057 | 1HRI |
| NA | N08.001 | poliovirus capsid VP0-type self-cleaving protein | complex with SDZ 35-682 | 1HRV |
| NA | N08.001 | poliovirus capsid VP0-type self-cleaving protein | 1K5M | |
| NA | N08.001 | poliovirus capsid VP0-type self-cleaving protein | complex with pleconaril | 1NA1 |
| NA | N08.001 | poliovirus capsid VP0-type self-cleaving protein | 1NCQ | |
| NA | N08.001 | poliovirus capsid VP0-type self-cleaving protein | 1R08 | |
| NA | N08.001 | poliovirus capsid VP0-type self-cleaving protein | complex with R61837 | 1R09 |
| NA | N08.001 | poliovirus capsid VP0-type self-cleaving protein | 1RMU | |
| NA | N08.001 | poliovirus capsid VP0-type self-cleaving protein | Asn1105Ser mutant complexed with WIN 52035 | 1RUC |
| NA | N08.001 | poliovirus capsid VP0-type self-cleaving protein | Asn1105Ser mutant complexed with WIN52084 | 1RUD |
| NA | N08.001 | poliovirus capsid VP0-type self-cleaving protein | Asn1219Ala complexed with WIN52035 | 1RUE |
| NA | N08.001 | poliovirus capsid VP0-type self-cleaving protein | Asn1219Ala | 1RUF |
| NA | N08.001 | poliovirus capsid VP0-type self-cleaving protein | Asn1219Ser mutant complexed with WIN52035 | 1RUG |
| NA | N08.001 | poliovirus capsid VP0-type self-cleaving protein | 1RUH | |
| NA | N08.001 | poliovirus capsid VP0-type self-cleaving protein | Ser1223Gly mutant complexed with WIN52084 | 1RUI |
| NA | N08.001 | poliovirus capsid VP0-type self-cleaving protein | Ser1223Gly mutant | 1RUJ |
| NA | N08.001 | poliovirus capsid VP0-type self-cleaving protein | complex with FAB | 1RVF |
| NA | N08.001 | poliovirus capsid VP0-type self-cleaving protein | complex with SDZ 880-061 | 1VRH |
| NA | N08.001 | poliovirus capsid VP0-type self-cleaving protein | a comparison of the anti-rhinoviral drug binding pocket in hrv14 and hrv1a | 2HWB_1 |
| NA | N08.001 | poliovirus capsid VP0-type self-cleaving protein | 2HWC | |
| NA | N08.001 | poliovirus capsid VP0-type self-cleaving protein | 2HWR | |
| NA | N08.001 | poliovirus capsid VP0-type self-cleaving protein | 2R04 | |
| NA | N08.001 | poliovirus capsid VP0-type self-cleaving protein | 2R06 | |
| NA | N08.001 | poliovirus capsid VP0-type self-cleaving protein | 2R07 | |
| NA | N08.001 | poliovirus capsid VP0-type self-cleaving protein | 2RM2 | |
| NA | N08.001 | poliovirus capsid VP0-type self-cleaving protein | drug resistant mutant | 2RMU |
| NA | N08.001 | poliovirus capsid VP0-type self-cleaving protein | 2RR1 | |
| NA | N08.001 | poliovirus capsid VP0-type self-cleaving protein | 2RS1 | |
| NA | N08.001 | poliovirus capsid VP0-type self-cleaving protein | 2RS3 | |
| NA | N08.001 | poliovirus capsid VP0-type self-cleaving protein | 2RS5 | |
| NA | N08.001 | poliovirus capsid VP0-type self-cleaving protein | a benzonitrile analogue inhibits rhinovirus replication | 4PDW_A |
| NA | N08.001 | poliovirus capsid VP0-type self-cleaving protein | 4RHV | |
| NA | N08.001 | poliovirus capsid VP0-type self-cleaving protein | cryoem structure of rhinovirus b14 in complex with c5 fab (33 degrees celsius, molar ratio 1:3, full particle) | 5W3E_E |
| NA | N08.001 | poliovirus capsid VP0-type self-cleaving protein | cryoem structure of rhinovirus b14 in complex with c5 fab (4 degrees celsius, molar ratio 1:3, full particle) | 5W3L_A |
| NA | N08.001 | poliovirus capsid VP0-type self-cleaving protein | cryoem structure of rhinovirus b14 in complex with c5 fab (33 degrees celsius, molar ratio 1:1, full particle) | 5W3M_E |
| NA | N08.001 | poliovirus capsid VP0-type self-cleaving protein | cryoem structure of rhinovirus b14 in complex with c5 fab (33 degrees celsius, molar ratio 1:3, empty particle) | 5W3O_D |
| NA | N08.001 | poliovirus capsid VP0-type self-cleaving protein | 1RHI | |
| NA | N08.001 | poliovirus capsid VP0-type self-cleaving protein | 1Z7S | |
| NA | N08.001 | poliovirus capsid VP0-type self-cleaving protein | 1Z7Z | |
| NA | N08.001 | poliovirus capsid VP0-type self-cleaving protein | swine vesicular disease virus coat protein | 1MQT_A |
| NA | N08.001 | poliovirus capsid VP0-type self-cleaving protein | 1OOP | |
| NA | N08.001 | poliovirus capsid VP0-type self-cleaving protein | 1EV1 | |
| NA | N08.001 | poliovirus capsid VP0-type self-cleaving protein | complex with n-ethyl 4-((1- cycloheptyl-1,2-dihydropyrazol-3-one-5-yl)-amino)-4-oxo-2z-butenamide | 5IYT_A |
| NA | N08.001 | poliovirus capsid VP0-type self-cleaving protein | extracellular factors prime enterovirus particles for uncoating | 6O06_A |
| NA | N08.001 | poliovirus capsid VP0-type self-cleaving protein | echovirus 1 intact particle | 6RJF_1 |
| NA | N08.001 | poliovirus capsid VP0-type self-cleaving protein | coat protein | 4GB3_1 |
| NA | N08.001 | poliovirus capsid VP0-type self-cleaving protein | complex with the alpha- ketoamide (s)-n-benzyl-3-((s)-2-cinnamamido-3-phenylpropanamido)-2- oxo-4-((s)-2-oxopyrrolidin-3-yl)butanamide (cinnamoyl-phenylalanine- glnlactam-co-co-nh-benzyl) ***caveat 5nfs d03 a | 5NFS_A |
| NA | N08.001 | poliovirus capsid VP0-type self-cleaving protein | crystal structure echovirus 7 | 2X5I_A |
| NA | N08.001 | poliovirus capsid VP0-type self-cleaving protein | the interaction of decay-accelerating factor with echovirus 7 | 3IYP_B |
| NA | N08.001 | poliovirus capsid VP0-type self-cleaving protein | 1H8T | |
| NA | N08.001 | poliovirus capsid VP0-type self-cleaving protein | complex with domains 3 and 4 of decay accelerating factor | 1UPN |
| NA | N08.001 | poliovirus capsid VP0-type self-cleaving protein | 2C8I | |
| NA | N08.001 | poliovirus capsid VP0-type self-cleaving protein | 1Z8R_A | |
| NA | N08.001 | poliovirus capsid VP0-type self-cleaving protein | 1Q1X | |
| NA | N08.001 | poliovirus capsid VP0-type self-cleaving protein | complex with WIN51711 | 1PIV |
| NA | N08.001 | poliovirus capsid VP0-type self-cleaving protein | 1PVC | |
| NA | N08.001 | poliovirus capsid VP0-type self-cleaving protein | complex with R78206 | 1VBA |
| NA | N08.001 | poliovirus capsid VP0-type self-cleaving protein | complex with R80633 | 1VBB |
| NA | N08.001 | poliovirus capsid VP0-type self-cleaving protein | complex with antiviral drugs | 1VBC |
| NA | N08.001 | poliovirus capsid VP0-type self-cleaving protein | complex with antiviral drugs | 1VBE |
| NA | N08.001 | poliovirus capsid VP0-type self-cleaving protein | complex with poliovirus receptor | 3EPD |
| NA | N08.001 | poliovirus capsid VP0-type self-cleaving protein | poliovirus type 3 (strain saukett) stabilized virus-like particle | 5O5B_1 |
| NA | N08.001 | poliovirus capsid VP0-type self-cleaving protein | poliovirus type 3 (strain saukett) stabilized virus-like particle in complex with the pocket factor compound gpp3 | 5O5P_1 |
| NA | N08.UNW | family N8 non-lyase homologue | 1FMD | |
| NA | N08.UPW | family N8 unassigned peptide lyases | the interaction of decay-accelerating factor with echovirus 7 | 3IYP_D |
| NA | N08.UPW | family N8 unassigned peptide lyases | a benzonitrile analogue inhibits rhinovirus replication | 4PDW_D |
| PD | N09.001 | intein-containing V-type proton ATPase catalytic subunit A | endonuclease PI-SCEI domain only | 1DFA |
| PD | N09.001 | intein-containing V-type proton ATPase catalytic subunit A | endonuclease PI-SCEI miniprecursor | 1EF0 |
| PD | N09.001 | intein-containing V-type proton ATPase catalytic subunit A | endonuclease PI-SCEI domain I only | 1GPP |
| PD | N09.001 | intein-containing V-type proton ATPase catalytic subunit A | precursor | 1JVA |
| PD | N09.001 | intein-containing V-type proton ATPase catalytic subunit A | endonuclease PI-SCEI domain only; complex with its recognition sequence | 1LWS |
| PD | N09.001 | intein-containing V-type proton ATPase catalytic subunit A | endonuclease PI-SCEI domain only; complex with its substrate DNA | 1LWT |
| PD | N09.001 | intein-containing V-type proton ATPase catalytic subunit A | ligated extein segments | 1UM2 |
| PD | N09.001 | intein-containing V-type proton ATPase catalytic subunit A | endonuclease PI-SCEI domain only | 1VDE |
| PD | N09.001 | intein-containing V-type proton ATPase catalytic subunit A | 3J9T | |
| PD | N09.001 | intein-containing V-type proton ATPase catalytic subunit A | 3J9U | |
| PD | N09.001 | intein-containing V-type proton ATPase catalytic subunit A | 3J9V | |
| PD | N10.002 | intein-containing replicative DNA helicase precursor | crystal structure of npudnab intein | 4O1R_A |
| PD | N10.002 | intein-containing replicative DNA helicase precursor | intein domain only | 1MI8 |
| PD | N10.002 | intein-containing replicative DNA helicase precursor | crystal structure of g-1f/h73a mutant of ssp dnab mini-intein variant m86 | 6FRE_A |
| PD | N10.002 | intein-containing replicative DNA helicase precursor | crystal structure of g-1f mutant of ssp dnab mini-intein variant m86 | 6FRG_A |
| PD | N10.002 | intein-containing replicative DNA helicase precursor | crystal structure of ssp dnab mini-intein variant m86 | 6FRH_A |
| PD | N10.003 | intein-containing DNA polymerase III subunit alpha precursor | intein domain only | 1ZD7 |
| PD | N10.003 | intein-containing DNA polymerase III subunit alpha precursor | intein domain only | 1ZDE |
| PD | N10.003 | intein-containing DNA polymerase III subunit alpha precursor | 3NZM | |
| PD | N10.003 | intein-containing DNA polymerase III subunit alpha precursor | 4GIG | |
| PD | N10.003 | intein-containing DNA polymerase III subunit alpha precursor | crystal structure of an inactivated ssp siclopps intein with a cafhpq extein | 5OL1_A |
| PD | N10.003 | intein-containing DNA polymerase III subunit alpha precursor | crystal structure of an inactivated ssp siclopps intein with cfahpq extein | 5OL5_A |
| PD | N10.003 | intein-containing DNA polymerase III subunit alpha precursor | NMR structure; intein only | 2KEQ |
| PD | N10.003 | intein-containing DNA polymerase III subunit alpha precursor | crystal structure of npudnae intein | 4KL5_A |
| PD | N10.003 | intein-containing DNA polymerase III subunit alpha precursor | crystal structure of dimeric form of npudnae intein | 4KL6_A |
| PD | N10.003 | intein-containing DNA polymerase III subunit alpha precursor | conserved residues that modulate protein trans-splicing of npu dnae split intein | 4LX3_A |
| PD | N10.003 | intein-containing DNA polymerase III subunit alpha precursor | crystal structure of natvie npu dnae split intein | 4QFQ_A |
| PD | N10.003 | intein-containing DNA polymerase III subunit alpha precursor | crystal structure of an inactivated npu siclopps intein with cafhpq extein | 5OL6_A |
| PD | N10.003 | intein-containing DNA polymerase III subunit alpha precursor | crystal structure of an inactivated npu siclopps intein with cfahpq extein | 5OL7_A |
| PD | N10.005 | intein-containing DNA polymerase II large subunit DP2 precursor Mername-AA281 | 3O59 | |
| PD | N10.005 | intein-containing DNA polymerase II large subunit DP2 precursor Mername-AA281 | 2LCJ | |
| PD | N10.007 | intein-containing DNA-dependent DNA polymerase precursor | mini-intein | 5O9I_A |
| PD | N10.007 | intein-containing DNA-dependent DNA polymerase precursor | crystal structure of transcription factor iib mja mini-intein | 5O9J_A |
| PD | N10.007 | intein-containing DNA-dependent DNA polymerase precursor | homing endonuclease II | 2CW7 |
| PD | N10.007 | intein-containing DNA-dependent DNA polymerase precursor | homing endonuclease II | 2CW8 |
| PD | N10.008 | intein-containing DNA gyrase subunit A (Mycobacterium xenopi) | intein only | 1AM2 |
| PD | N10.008 | intein-containing DNA gyrase subunit A (Mycobacterium xenopi) | 4OZ6 | |
| PD | N10.009 | Mtu recA intein (Mycobacterium sp.) | N-terminal extein and intein | 1G18 |
| PD | N10.009 | Mtu recA intein (Mycobacterium sp.) | N-terminal extein and intein | 1G19 |
| PD | N10.009 | Mtu recA intein (Mycobacterium sp.) | extein | 1MO3 |
| PD | N10.009 | Mtu recA intein (Mycobacterium sp.) | extein | 1MO4 |
| PD | N10.009 | Mtu recA intein (Mycobacterium sp.) | extein | 1MO5 |
| PD | N10.009 | Mtu recA intein (Mycobacterium sp.) | extein | 1MO6 |
| PD | N10.009 | Mtu recA intein (Mycobacterium sp.) | intein | 2IMZ |
| PD | N10.009 | Mtu recA intein (Mycobacterium sp.) | intein | 2IN0 |
| PD | N10.009 | Mtu recA intein (Mycobacterium sp.) | intein | 2IN8 |
| PD | N10.009 | Mtu recA intein (Mycobacterium sp.) | intein | 2IN9 |
| PD | N10.009 | Mtu recA intein (Mycobacterium sp.) | intein | 3IFJ |
| PD | N10.009 | Mtu recA intein (Mycobacterium sp.) | intein | 3IGD |
| PD | N10.UPW | family N10 unassigned peptide lyases | 1UC2 | |
| PD | N10.UPW | family N10 unassigned peptide lyases | 4DWQ | |
| PD | N10.UPW | family N10 unassigned peptide lyases | 4DWR | |
| PD | N10.UPW | family N10 unassigned peptide lyases | 4ISJ | |
| PD | N10.UPW | family N10 unassigned peptide lyases | 4ISZ | |
| PD | N10.UPW | family N10 unassigned peptide lyases | 4IT0 | |
| PD | N10.UPW | family N10 unassigned peptide lyases | 1IQP | |
| PD | N10.UPW | family N10 unassigned peptide lyases | 1DQ3 | |
| PD | N10.UPW | family N10 unassigned peptide lyases | 4O1S | |
| PD | N10.UPW | family N10 unassigned peptide lyases | 1VDZ | |
| PD | N10.UPW | family N10 unassigned peptide lyases | 3I4L | |
| PD | N10.UPW | family N10 unassigned peptide lyases | 3I72 | |
| PD | N10.UPW | family N10 unassigned peptide lyases | 3I73 | |
| PD | N10.UPW | family N10 unassigned peptide lyases | 3IKJ | |
| PD | N10.UPW | family N10 unassigned peptide lyases | 3M4Y | |
| PD | N10.UPW | family N10 unassigned peptide lyases | 3MFY | |
| PD | N10.UPW | family N10 unassigned peptide lyases | 3ND8 | |
| PD | N10.UPW | family N10 unassigned peptide lyases | 3ND9 | |
| PD | N10.UPW | family N10 unassigned peptide lyases | 3P20 | |
| PD | N10.UPW | family N10 unassigned peptide lyases | 3QG1 | |
| PD | N10.UPW | family N10 unassigned peptide lyases | 3QIA | |
| PD | N10.UPW | family N10 unassigned peptide lyases | 3QJY | |
| PD | N10.UPW | family N10 unassigned peptide lyases | 3SDZ | |
| PD | N10.UPW | family N10 unassigned peptide lyases | 3SE0 | |
| PD | N10.UPW | family N10 unassigned peptide lyases | 2LQM | |
| PD | N10.UPW | family N10 unassigned peptide lyases | 4E2T | |
| PD | N10.UPW | family N10 unassigned peptide lyases | 4E2U | |
| PD | N10.UPW | family N10 unassigned peptide lyases | 1WN7 | |
| PD | N10.UPW | family N10 unassigned peptide lyases | 1WNS | |
| PD | N10.UPW | family N10 unassigned peptide lyases | 2CW7_A | |
| PD | N10.UPW | family N10 unassigned peptide lyases | 2CW8_A | |
| PE | P01.001 | DmpA aminopeptidase | 1B65_A | |
| PE | P01.002 | BapA peptidase (Sphingosinicella xenopeptidilytica) | 3N2W | |
| PE | P01.002 | BapA peptidase (Sphingosinicella xenopeptidilytica) | complex with AEBSF | 3N33 |
| PE | P01.002 | BapA peptidase (Sphingosinicella xenopeptidilytica) | Ser250Ala mutant; precursor | 3N5I |
| PE | P01.002 | BapA peptidase (Sphingosinicella xenopeptidilytica) | 3NDV | |
| PE | P01.002 | BapA peptidase (Sphingosinicella xenopeptidilytica) | 3NFB | |
| PE | P01.003 | BapF peptidase (Pseudomonas sp.) | 5TZB | |
| PE | P01.101 | pantetheinyl hydrolase ThnT precursor | Thr282Cys mutant; precursor | 3S3U |
| PE | P01.101 | pantetheinyl hydrolase ThnT precursor | 3TM1 | |
| PE | P01.101 | pantetheinyl hydrolase ThnT precursor | complex with peptide mimic | 3TM2 |
| PE | P01.101 | pantetheinyl hydrolase ThnT precursor | crystal structure of uncleaved thnt t282c, derivatized at the active site with ethg | 4IHD_A |
| PE | P01.101 | pantetheinyl hydrolase ThnT precursor | crystal structure of uncleaved thnt t282a | 4IHE_A |
| PE | P01.UPW | family P01 unassigned peptidases | 2DRH_A | |
| PB | P02.008 | GPR56 (Homo sapiens)-type protein | extracellular region; complex with fn3 monobody | 5KVM_A |
| PB | P02.010 | latrophilin-1 | GAIN and HormR domains | 4DLQ |
| PB | P02.010 | latrophilin-1 | 2JX9 | |
| PB | P02.010 | latrophilin-1 | 2JXA | |
| PB | P02.011 | latrophilin 3 | 4RMK | |
| PB | P02.011 | latrophilin 3 | 4RML | |
| PB | P02.011 | latrophilin 3 | 4YEB | |
| PB | P02.011 | latrophilin 3 | 5AFB | |
| PB | P02.011 | latrophilin 3 | 5CMN | |
| PB | P02.036 | polycystin-1 | NMR structure; PKD 1 domain only | 1B4R |
| PA | S01.001 | chymotrypsin A (cattle-type) | gamma-chymotrypsin | 1AB9 |
| PA | S01.001 | chymotrypsin A (cattle-type) | complex with eglin C | 1ACB_E |
| PA | S01.001 | chymotrypsin A (cattle-type) | complex with D-Leu-Phe-fluorobenzylamine | 1AFQ |
| PA | S01.001 | chymotrypsin A (cattle-type) | complex with inhibitor domain of Alzheimer's amyloid protein | 1CA0_ABC |
| PA | S01.001 | chymotrypsin A (cattle-type) | complex with basic pancreatic trypsin inhibitor | 1CBW_ABC |
| PA | S01.001 | chymotrypsin A (cattle-type) | complex with human pancreatic secretory trypsin inhibitor variant 3 | 1CGI_E |
| PA | S01.001 | chymotrypsin A (cattle-type) | complex with human pancreatic secretory trypsin inhibitor variant 4 | 1CGJ_E |
| PA | S01.001 | chymotrypsin A (cattle-type) | zymogen | 1CHG_A |
| PA | S01.001 | chymotrypsin A (cattle-type) | complex with turkey ovomucoid third domain | 1CHO_E |
| PA | S01.001 | chymotrypsin A (cattle-type) | delta form; complex with benzyloxycarbonyl-Gly-Gly-Phe-chloromethane | 1DLK |
| PA | S01.001 | chymotrypsin A (cattle-type) | precursor | 1EX3 |
| PA | S01.001 | chymotrypsin A (cattle-type) | complex with diethyl phosphoryl | 1GCD |
| PA | S01.001 | chymotrypsin A (cattle-type) | gamma-chymotrypsin A | 1GCT |
| PA | S01.001 | chymotrypsin A (cattle-type) | complex with N-acetyl-Phe trifluoromethyl ketone | 1GG6_A |
| PA | S01.001 | chymotrypsin A (cattle-type) | gamma form; complex with N-acetyl-Leu-Phe-aldehyde | 1GGD |
| PA | S01.001 | chymotrypsin A (cattle-type) | in 4% isopropanol | 1GHA |
| PA | S01.001 | chymotrypsin A (cattle-type) | complex with N-acetyl-D-tryptophan | 1GHB |
| PA | S01.001 | chymotrypsin A (cattle-type) | complex with PMP-D2V inhibitor from migratory locust | 1GL0_E |
| PA | S01.001 | chymotrypsin A (cattle-type) | complex with PMP-C inhibitor from migratory locust | 1GL1 |
| PA | S01.001 | chymotrypsin A (cattle-type) | gamma-chymotrypsin | 1GMC |
| PA | S01.001 | chymotrypsin A (cattle-type) | gamma-chymotrypsin | 1GMD |
| PA | S01.001 | chymotrypsin A (cattle-type) | complex with diisopropylphosphorofluoridate | 1GMH |
| PA | S01.001 | chymotrypsin A (cattle-type) | complex with turkey ovomucoid inhibitor third domain | 1HJA_ABC |
| PA | S01.001 | chymotrypsin A (cattle-type) | complex with 7-hydroxycoumarin | 1K2I_1 |
| PA | S01.001 | chymotrypsin A (cattle-type) | alpha-chymotrypsin; complex with basic pancreatic trypsin inhibitor | 1MTN_ABC |
| PA | S01.001 | chymotrypsin A (cattle-type) | complex with ecotin | 1N8O_A |
| PA | S01.001 | chymotrypsin A (cattle-type) | complex with autocatalytically produced 14-residue peptide | 1OXG_A |
| PA | S01.001 | chymotrypsin A (cattle-type) | complex with aprotinin | 1P2M_A |
| PA | S01.001 | chymotrypsin A (cattle-type) | complex with aprotinin | 1P2N_A |
| PA | S01.001 | chymotrypsin A (cattle-type) | complex with aprotinin | 1P2O_A |
| PA | S01.001 | chymotrypsin A (cattle-type) | complex with aprotinin | 1P2Q_A |
| PA | S01.001 | chymotrypsin A (cattle-type) | complex with aprotinin P1 Glu mutant | 1T7C_A |
| PA | S01.001 | chymotrypsin A (cattle-type) | complex with P1 Met mutant aprotinin | 1T8L_A |
| PA | S01.001 | chymotrypsin A (cattle-type) | complex with P1 His mutant aprotinin | 1T8M_A |
| PA | S01.001 | chymotrypsin A (cattle-type) | complex with P1 Thr mutant aprotinin | 1T8N_A |
| PA | S01.001 | chymotrypsin A (cattle-type) | complex with P1 Trp mutant aprotinin | 1T8O_A |
| PA | S01.001 | chymotrypsin A (cattle-type) | gamma-chymotrypsin; complex with L-para-chlorophenyl-1-acetamido boronic acid inhibitor | 1VGC |
| PA | S01.001 | chymotrypsin A (cattle-type) | 1YPH_A | |
| PA | S01.001 | chymotrypsin A (cattle-type) | precursor | 2CGA |
| PA | S01.001 | chymotrypsin A (cattle-type) | alpha-chymotrypsin A | 2CHA |
| PA | S01.001 | chymotrypsin A (cattle-type) | gamma-chymotrypsin A | 2GCH |
| PA | S01.001 | chymotrypsin A (cattle-type) | gamma-chymotrypsin A; pH 2.0 | 2GCT |
| PA | S01.001 | chymotrypsin A (cattle-type) | gamma-chymotrypsin A; complex with N-ac-L-Ala-L-Phe-chloroethylketone | 2GMT |
| PA | S01.001 | chymotrypsin A (cattle-type) | complex with benzohydroxamic acid/vanadate | 2P8O_A |
| PA | S01.001 | chymotrypsin A (cattle-type) | gamma-chymotrypsin; complex with D-para-chloro-1-acetamido boronic acid inhibitor | 2VGC |
| PA | S01.001 | chymotrypsin A (cattle-type) | 2Y6T | |
| PA | S01.001 | chymotrypsin A (cattle-type) | complex with guamerin | 3BG4_A |
| PA | S01.001 | chymotrypsin A (cattle-type) | gamma-chymotrypsin B; complex with trans-O-hydroxy-alpha-methyl cinnamate | 3GCH |
| PA | S01.001 | chymotrypsin A (cattle-type) | gamma-chymotrypsin A; pH 10.5 | 3GCT |
| PA | S01.001 | chymotrypsin A (cattle-type) | 3RU4_C | |
| PA | S01.001 | chymotrypsin A (cattle-type) | 3T62 | |
| PA | S01.001 | chymotrypsin A (cattle-type) | gamma-chymotrypsin; complex with D-naphthyl-1-acetamido boronic acid inhibitor | 3VGC |
| PA | S01.001 | chymotrypsin A (cattle-type) | alpha-chymotrypsin | 4CHA |
| PA | S01.001 | chymotrypsin A (cattle-type) | gamma-chymotrypsin; complex with diethylamino-O-hydroxy-alpha-methyl cinnamate | 4GCH |
| PA | S01.001 | chymotrypsin A (cattle-type) | 4Q2K | |
| PA | S01.001 | chymotrypsin A (cattle-type) | gamma-chymotrypsin; complex with D-naphthyl-1-acetamido boronic acid inhibitor | 4VGC |
| PA | S01.001 | chymotrypsin A (cattle-type) | alpha-chymotrypsin A | 5CHA |
| PA | S01.001 | chymotrypsin A (cattle-type) | photolysis product | 5GCH |
| PA | S01.001 | chymotrypsin A (cattle-type) | complex with bowman-birk inhibitor from soybean | 5J4Q_A |
| PA | S01.001 | chymotrypsin A (cattle-type) | complex with a modified bowman-birk inhibitor from soybean | 5J4S_A |
| PA | S01.001 | chymotrypsin A (cattle-type) | alpha-chymotrypsin A; complex with phenylethane boronic acid | 6CHA |
| PA | S01.001 | chymotrypsin A (cattle-type) | crystal structure of bovine alpha-chymotrypsin in space group p65 | 6DI8_A |
| PA | S01.001 | chymotrypsin A (cattle-type) | gamma-chymotrypsin; complex with N-Ac-L-Phe trifluoromethyl ketone | 6GCH |
| PA | S01.001 | chymotrypsin A (cattle-type) | gamma-chymotrypsin; complex with N-Ac-L-Leu-L-Phe trifluoromethyl ketone | 7GCH |
| PA | S01.001 | chymotrypsin A (cattle-type) | gamma-chymotrypsin; complex with Gly-Ala-Trp | 8GCH |
| PA | S01.010 | granzyme B (Homo sapiens-type) | 1FQ3 | |
| PA | S01.010 | granzyme B (Homo sapiens-type) | complex with acetyl-Ile-Glu-Pro-Asp aldehyde | 1IAU |
| PA | S01.015 | tryptase beta | tetramer | 1A0L |
| PA | S01.015 | tryptase beta | theoretical model | 1AAO |
| PA | S01.015 | tryptase beta | human beta-ii tryptase in complex with 4-(3-aminomethyl- phenyl)-piperidin-1-yl-(5-phenethyl- pyridin-3-yl)- methanone | 2BM2_A |
| PA | S01.015 | tryptase beta | human tryptase with 2-amino benzimidazole | 2FPZ_A |
| PA | S01.015 | tryptase beta | human beta-tryptase ii with inhibitor cra-29382 | 2FS8_A |
| PA | S01.015 | tryptase beta | human beta tryptase ii with inhibitor cra-28427 | 2FS9_A |
| PA | S01.015 | tryptase beta | complex with 4-piperidinebutyrate to make acylenzyme | 2FWW_A |
| PA | S01.015 | tryptase beta | complex with activated ketone inhibitor cra-29382 | 2FXR_A |
| PA | S01.015 | tryptase beta | human beta ii tryptase with inhibitor cra-27592 | 2GDD_A |
| PA | S01.015 | tryptase beta | complex with (5-(aminomethyl)-2H-spiro[benzofuran-3,4'- piperidine]-1'-yl)(5-(phenylethynyl)furan- 2-yl)methanone | 2ZA5_A |
| PA | S01.015 | tryptase beta | potent, nonpeptide inhibitors of human mast cell tryptase | 2ZEB_A |
| PA | S01.015 | tryptase beta | potent, nonpeptide inhibitors of human mast cell tryptase | 2ZEC_A |
| PA | S01.015 | tryptase beta | 3V7T | |
| PA | S01.015 | tryptase beta | complex with 5-(3-aminomethyl-phenoxymethyl)-3-[3-(2- chloro-pyridin-3-ylethynyl)-phenyl]-oxazolidin-2-one; compound with trifluoro-acetic acid | 5F03_A |
| PA | S01.017 | kallikrein-related peptidase 5 | complex with leupeptin | 2PSX |
| PA | S01.017 | kallikrein-related peptidase 5 | complex with leupeptin and zinc | 2PSY |
| PA | S01.017 | kallikrein-related peptidase 5 | complex with GSK144 | 6QFE_A |
| PA | S01.021 | DESC1 peptidase | 2OQ5 | |
| PA | S01.023 | flavoxobin | AAV-SP-I | 1OP0_A |
| PA | S01.023 | flavoxobin | AAV-SP-II | 1OP2_A |
| PA | S01.023 | flavoxobin | 4GSO | |
| PA | S01.035 | brachyurin-T | complex with locust SGPI-1 domain 1 | 2F91_A |
| PA | S01.035 | brachyurin-T | complex with crayfish trypsin | 2F91_B |
| PA | S01.091 | natural killer cell peptidase 1 (Rattus norvegicus) | Asn66Gln mutant | 1FI8_A |
| PA | S01.094 | trypsin 1 (Rattus-type) | complex with benzamidine | 1BRA |
| PA | S01.094 | trypsin 1 (Rattus-type) | variant, complex with bovine pancreatic trypsin inhibitor variant | 1BRB_E |
| PA | S01.094 | trypsin 1 (Rattus-type) | variant, complex with amyloid beta-protein precursor inhibitor domain | 1BRC_E |
| PA | S01.094 | trypsin 1 (Rattus-type) | Asn143His mutant, complex with Ala86His ecotin | 1SLU_B |
| PA | S01.094 | trypsin 1 (Rattus-type) | Asn143His mutant, complex with Ala86His ecotin | 1SLV_B |
| PA | S01.094 | trypsin 1 (Rattus-type) | Asn143His mutant, complex with Ala86His ecotin | 1SLW_B |
| PA | S01.094 | trypsin 1 (Rattus-type) | Asn143His mutant, complex with Ala86His ecotin | 1SLX_B |
| PA | S01.094 | trypsin 1 (Rattus-type) | Asp102Asn mutant; complex with benzamidine | 1TRM |
| PA | S01.094 | trypsin 1 (Rattus-type) | Asp102Asn; complex with benzamidine at pH 8 | 2TRM |
| PA | S01.101 | trypsin (Streptomyces griseus-type) | recombinant streptomyces griseus trypsin | 1OS8_A |
| PA | S01.101 | trypsin (Streptomyces griseus-type) | Thr190Pro mutant; complex with benzamidine | 1OSS_A |
| PA | S01.101 | trypsin (Streptomyces griseus-type) | 1SGT | |
| PA | S01.101 | trypsin (Streptomyces griseus-type) | 220-loop mutant of streptomyces griseus trypsin | 2FMJ_A |
| PA | S01.101 | trypsin (Streptomyces griseus-type) | na+-dependent allostery mediates coagulation factor protease active site selectivity | 3BEU_A |
| PA | S01.101 | trypsin (Streptomyces griseus-type) | 3I77 | |
| PA | S01.101 | trypsin (Streptomyces griseus-type) | 3I78 | |
| PA | S01.102 | trypsin (Streptomyces erythraeus-type) | 4M7G | |
| PA | S01.102 | trypsin (Streptomyces erythraeus-type) | s. erythraea trypsin acyl-enzyme | 5DJ7_A |
| PA | S01.102 | trypsin (Streptomyces erythraeus-type) | s. erythraea trypsin mixed catalytic intermediate | 5DK1_A |
| PA | S01.102 | trypsin (Streptomyces erythraeus-type) | s. erythraea trypsin michaelis-menten complex | 5DKM_A |
| PA | S01.102 | trypsin (Streptomyces erythraeus-type) | s. erythraea trypsin long construct apoenzyme | 5KWM_A |
| PA | S01.103 | trypsin (fungal) | complex with Gly-Ala-Arg | 1FN8 |
| PA | S01.103 | trypsin (fungal) | complex with Gly-Ala-Arg | 1FY4 |
| PA | S01.103 | trypsin (fungal) | complex with Gly-Ala-Lys | 1FY5 |
| PA | S01.103 | trypsin (fungal) | complex with Gly-Ala-Lys | 1GDN |
| PA | S01.103 | trypsin (fungal) | complex with Gly-Ala-Arg | 1GDQ |
| PA | S01.103 | trypsin (fungal) | complex with Gly-Ala-Arg | 1GDU |
| PA | S01.103 | trypsin (fungal) | 1PPZ | |
| PA | S01.103 | trypsin (fungal) | at pH 5 | 1PQ5 |
| PA | S01.103 | trypsin (fungal) | At pH 5 | 1PQ7 |
| PA | S01.103 | trypsin (fungal) | at pH 4; complex with Gly-Gly-Arg | 1PQ8 |
| PA | S01.103 | trypsin (fungal) | complex with PMSF | 1PQA |
| PA | S01.103 | trypsin (fungal) | 1TRY | |
| PA | S01.103 | trypsin (fungal) | trypsin from fusarium oxysporum- room temperature to atomic resolution | 1XVM_A |
| PA | S01.103 | trypsin (fungal) | trypsin from fusarium oxysporum at ph 6 | 1XVO_A |
| PA | S01.103 | trypsin (fungal) | anomalous substructure of trypsin (p1) | 2G51_A |
| PA | S01.103 | trypsin (fungal) | anomalous substructure of trypsin (p21) | 2G52_A |
| PA | S01.103 | trypsin (fungal) | complex with LMPI-3 inhibitor inhibitory unit 1 | 2VU8_E |
| PA | S01.109 | astrovirus serine peptidase | structural and biochemical analysis of human pathogenic astrovirus serine protease at 2.0 angstrom resolution | 2W5E_A |
| PA | S01.119 | trypsin-2 type C | Asp189Ser mutant | 1AMH |
| PA | S01.119 | trypsin-2 type C | Ser214Glu mutant | 1ANB |
| PA | S01.119 | trypsin-2 type C | Ser214Lys mutant | 1ANC |
| PA | S01.119 | trypsin-2 type C | Arg96His mutant | 1AND |
| PA | S01.119 | trypsin-2 type C | 1ANE | |
| PA | S01.119 | trypsin-2 type C | 1BRA_A | |
| PA | S01.119 | trypsin-2 type C | 1BRB | |
| PA | S01.119 | trypsin-2 type C | 1BRC | |
| PA | S01.119 | trypsin-2 type C | complex with bovine pancreatic trypsin inhibitor | 1CO7_E |
| PA | S01.119 | trypsin-2 type C | 1DPO | |
| PA | S01.119 | trypsin-2 type C | complex with ecotin inhibitor mutant | 1EZS_C |
| PA | S01.119 | trypsin-2 type C | complex with ecotin inhibitor | 1EZU_C |
| PA | S01.119 | trypsin-2 type C | engineered precursor; complex with bovine pancreatic trypsin inhibitor | 1F5R_A |
| PA | S01.119 | trypsin-2 type C | engineered precursor; complex with bovine pancreatic trypsin inhibitor | 1F7Z_A |
| PA | S01.119 | trypsin-2 type C | delta Ile16/Val17 precursor; complex with bovine pancreatic trypsin inhibitor 1 | 1FY8_E |
| PA | S01.119 | trypsin-2 type C | mutant X99RT; complex with benzamidine | 1J14_A |
| PA | S01.119 | trypsin-2 type C | mutant X99/175/190RT; complex with benzamidine | 1J15_A |
| PA | S01.119 | trypsin-2 type C | mutant X99/175/190RT; complex with benzamidine | 1J16_A |
| PA | S01.119 | trypsin-2 type C | mutant X99/175/190RT; complex with factor Xa specific inhibitor | 1J17_T |
| PA | S01.119 | trypsin-2 type C | complex with alaserpin | 1K9O_E |
| PA | S01.119 | trypsin-2 type C | Glu97Lys, Tyr99Leu mutant; complex with factor Xa inhibitor | 1QL9 |
| PA | S01.119 | trypsin-2 type C | 1SLU | |
| PA | S01.119 | trypsin-2 type C | 1SLV | |
| PA | S01.119 | trypsin-2 type C | 1SLW | |
| PA | S01.119 | trypsin-2 type C | 1SLX | |
| PA | S01.119 | trypsin-2 type C | 1TRM_A | |
| PA | S01.119 | trypsin-2 type C | complex with aprotinin mutant | 1YKT_A |
| PA | S01.119 | trypsin-2 type C | complex with aprotinin mutant | 1YLC_A |
| PA | S01.119 | trypsin-2 type C | complex with aprotinin mutant | 1YLD_A |
| PA | S01.119 | trypsin-2 type C | 2TRM_A | |
| PA | S01.119 | trypsin-2 type C | complex with bovine pancreatic trypsin inhibitor | 3FP6_E |
| PA | S01.119 | trypsin-2 type C | Ser195Ala mutant; complex with bovine pancreatic trypsin inhibitor (bpti) cleaved at the scissile bond (lys15-ala16) | 3FP7_E |
| PA | S01.119 | trypsin-2 type C | Ser195Ala mutant; complex with bovine pancreatic trypsin inhibitor | 3FP8_E |
| PA | S01.119 | trypsin-2 type C | complex with bovine pancreatic trypsin inhibitor | 3TGI_E |
| PA | S01.119 | trypsin-2 type C | Ser195Ala mutant; complex with bovine pancreatic trypsin inhibitor | 3TGJ_E |
| PA | S01.119 | trypsin-2 type C | Asp194Asn and Ile16-Val17 deletion mutant; complex with bovine pancreatic trypsin inhibitor | 3TGK_E |
| PA | S01.121 | hypodermin C | 1HYL | |
| PA | S01.121 | hypodermin C | 2HLC | |
| PA | S01.122 | brachyurin-C | complex with ecotin inhibitor | 1AZZ_A |
| PA | S01.125 | trypsin-1 (fish) | complex with benzamidine inhibitor | 1BIT |
| PA | S01.125 | trypsin-1 (fish) | complex with bovine pancreatic trypsin inhibitor | 1BZX_E |
| PA | S01.125 | trypsin-1 (fish) | 1.00 aa trypsin from atlantic salmon | 1HJ8_A |
| PA | S01.125 | trypsin-1 (fish) | complex with benzamidine | 1TBS |
| PA | S01.125 | trypsin-1 (fish) | trypsin specificity as elucidated by lie calculations, x- ray structures and association constant measurements | 1UTJ_A |
| PA | S01.125 | trypsin-1 (fish) | trypsin specificity as elucidated by lie calculations, x- ray structures and association constant measurements | 1UTK_A |
| PA | S01.125 | trypsin-1 (fish) | trypsin specificity as elucidated by lie calculations, x- ray structures and association constant measurements | 1UTL_M |
| PA | S01.125 | trypsin-1 (fish) | trypsin specificity as elucidated by lie calculations, x- ray structures and association constant measurements | 1UTM_A |
| PA | S01.125 | trypsin-1 (fish) | complex with squash seed inhibitor | 2STA_E |
| PA | S01.125 | trypsin-1 (fish) | complex with squash seed inhibitor | 2STB_E |
| PA | S01.125 | trypsin-1 (fish) | complex with benzamidine inhibitor | 2TBS |
| PA | S01.125 | trypsin-1 (fish) | complex with benzamidine | 2EEK_A |
| PA | S01.125 | trypsin-1 (fish) | 1MBQ | |
| PA | S01.125 | trypsin-1 (fish) | crystal structure of anionic trypsin isoform 1 from chum salmon | 2ZPQ_A |
| PA | S01.125 | trypsin-1 (fish) | crystal structure of anionic trypsin isoform 2 from chum salmon | 2ZPR_A |
| PA | S01.125 | trypsin-1 (fish) | crystal structure of anionic trypsin isoform 3 from chum salmon | 2ZPS_A |
| PA | S01.126 | trypsin-3 (fish) | complex with benzamidine inhibitor | 1A0J |
| PA | S01.127 | cationic trypsin (Homo sapiens-type) | chimaera with human coagulation factor Xa; complex with D-Phe-Pro-Arg-chloromethyl ketone | 1FXY_A |
| PA | S01.127 | cationic trypsin (Homo sapiens-type) | complex with DFP | 1TRN |
| PA | S01.127 | cationic trypsin (Homo sapiens-type) | complex with bovine pancreatic trypsin inhibitor | 2RA3_A |
| PA | S01.131 | elastase-2 | complex with peptidyl-pentafluoroethyl ketone MDL 101, 146 | 1B0F |
| PA | S01.131 | elastase-2 | complex with MDL 101,146 | 1BOF |
| PA | S01.131 | elastase-2 | complex with inhibitor GW475151 | 1H1B |
| PA | S01.131 | elastase-2 | complex with MeOSuc-Ala-Ala-Pro-Ala chloromethyl ketone | 1HNE |
| PA | S01.131 | elastase-2 | complex with turkey ovomucoid third domain | 1PPF_E |
| PA | S01.131 | elastase-2 | complex with MeOSuc-Ala-Ala-Pro-Val chloromethylacetone | 1PPG |
| PA | S01.131 | elastase-2 | covalent complex structure of elastase | 2RG3_A |
| PA | S01.131 | elastase-2 | complex with antileukoproteinase domain 2 | 2Z7F_E |
| PA | S01.131 | elastase-2 | 3Q76 | |
| PA | S01.131 | elastase-2 | 3Q77 | |
| PA | S01.131 | elastase-2 | complex with extracellular adherence protein (Staphylococcus aureus) | 4NZL_A |
| PA | S01.131 | elastase-2 | 4WVP | |
| PA | S01.131 | elastase-2 | 5A09 | |
| PA | S01.131 | elastase-2 | 5A0A | |
| PA | S01.131 | elastase-2 | 5A0B | |
| PA | S01.131 | elastase-2 | 5A0C | |
| PA | S01.131 | elastase-2 | complex with a dihydropyrimidone inhibitor | 5A8X_A |
| PA | S01.131 | elastase-2 | complex with a dihydropyrimidone inhibitor | 5A8Y_A |
| PA | S01.131 | elastase-2 | complex with a dihydropyrimidone inhibitor | 5A8Z_A |
| PA | S01.131 | elastase-2 | 5ABW | |
| PA | S01.131 | elastase-2 | highly glycosylated form; complex with a thiazolidinedione inhibitor | 6F5M_A |
| PA | S01.132 | mannan-binding lectin-associated serine peptidase-3 | 3DEM | |
| PA | S01.132 | mannan-binding lectin-associated serine peptidase-3 | 3GOV | |
| PA | S01.132 | mannan-binding lectin-associated serine peptidase-3 | 4AQB | |
| PA | S01.132 | mannan-binding lectin-associated serine peptidase-3 | 4DJZ | |
| PA | S01.132 | mannan-binding lectin-associated serine peptidase-3 | 4IGD | |
| PA | S01.132 | mannan-binding lectin-associated serine peptidase-3 | 4IW4 | |
| PA | S01.132 | mannan-binding lectin-associated serine peptidase-3 | 4KKD | |
| PA | S01.133 | cathepsin G | complex with phosophonate inhibitor Suc-Val-Pro-LysP-(OPh)2 | 1AU8 |
| PA | S01.133 | cathepsin G | complex with Suc-Val-Pro-PhEP inhibitor | 1CGH |
| PA | S01.133 | cathepsin G | complex with beta-ketophosphonic acid inhibitor KTP | 1KYN |
| PA | S01.133 | cathepsin G | a dual inhibitor of the leukocyte proteases cathepsin g and chymase with therapeutic efficacy in animals models of inflammation | 1T32_A |
| PA | S01.134 | myeloblastin | 1FUJ | |
| PA | S01.135 | granzyme A | theoretical model | 1HF1 |
| PA | S01.135 | granzyme A | homohexamer | 1OP8 |
| PA | S01.135 | granzyme A | complex with D-Phe-Pro-deoxo-methyl-Arg | 1ORF |
| PA | S01.136 | granzyme B, rodent-type | theoretical model | 2CP1 |
| PA | S01.137 | granzyme C | 3FZZ | |
| PA | S01.137 | granzyme C | Glu192Arg, Glu193Gly double mutant | 3G01 |
| PA | S01.139 | granzyme M | 1LZP | |
| PA | S01.139 | granzyme M | 2ZGC_A | |
| PA | S01.139 | granzyme M | complex with product | 2ZGH_A |
| PA | S01.139 | granzyme M | Asp86Asn mutant; complex with its optimal synthesized substrate | 2ZGJ_A |
| PA | S01.139 | granzyme M | structural insights into the proteolytic machinery of apoptosis-inducing granzyme m | 2ZKS_A |
| PA | S01.140 | chymase (Homo sapiens-type) | complex with PMSF | 1KLT |
| PA | S01.140 | chymase (Homo sapiens-type) | precursor | 1NN6 |
| PA | S01.140 | chymase (Homo sapiens-type) | complex with succinyl-Ala-Ala-Pro-Phe-chloromethylketone | 1PJP |
| PA | S01.140 | chymase (Homo sapiens-type) | complex with succinyl-Ala-Ala-Pro-Phe-chloromethylketone | 1T31 |
| PA | S01.140 | chymase (Homo sapiens-type) | discovery of potent, orally active, nonpeptide inhibitors of human mast cell chymase by using structure-based drug design | 2HVX_A |
| PA | S01.140 | chymase (Homo sapiens-type) | 3N7O | |
| PA | S01.140 | chymase (Homo sapiens-type) | 3S0N | |
| PA | S01.140 | chymase (Homo sapiens-type) | 4AFQ | |
| PA | S01.140 | chymase (Homo sapiens-type) | 4AFS | |
| PA | S01.140 | chymase (Homo sapiens-type) | 4AFU | |
| PA | S01.140 | chymase (Homo sapiens-type) | 4AFZ | |
| PA | S01.140 | chymase (Homo sapiens-type) | 4AG1 | |
| PA | S01.140 | chymase (Homo sapiens-type) | 4AG2 | |
| PA | S01.140 | chymase (Homo sapiens-type) | 4K2Y | |
| PA | S01.140 | chymase (Homo sapiens-type) | 4K5Z | |
| PA | S01.140 | chymase (Homo sapiens-type) | 4K60 | |
| PA | S01.140 | chymase (Homo sapiens-type) | 4K69 | |
| PA | S01.140 | chymase (Homo sapiens-type) | 4KP0 | |
| PA | S01.141 | mast cell peptidase 1 (Rattus-type) | 3RP2 | |
| PA | S01.142 | duodenase | 1EUF | |
| PA | S01.143 | tryptase alpha | tetramer | 1LTO |
| PA | S01.143 | tryptase alpha | Lys192Gln, Asp216Gly double mutant; complex with leupeptin | 2F9N |
| PA | S01.143 | tryptase alpha | Asp216Gly mutant | 2F9O |
| PA | S01.143 | tryptase alpha | Asp216Gly mutant; complex with leupeptin | 2F9P |
| PA | S01.146 | granzyme K | precursor | 1MZA |
| PA | S01.146 | granzyme K | precursor | 1MZD |
| PA | S01.147 | granzyme H | 1LXV | |
| PA | S01.147 | granzyme H | 3TJU | |
| PA | S01.147 | granzyme H | 3TJV | |
| PA | S01.147 | granzyme H | 3TK9 | |
| PA | S01.147 | granzyme H | 4GAW | |
| PA | S01.150 | mast cell peptidase 5 (mouse numbering) | hamster chymase 2 | 2RDL_A |
| PA | S01.151 | trypsin 1 | complex with aeruginosin 98-B inhibitor | 1AQ7 |
| PA | S01.151 | trypsin 1 | complex with metacyano benzylic inhibitor | 1AUJ |
| PA | S01.151 | trypsin 1 | complex with bis-phenylamidine inhibitor | 1AZ8 |
| PA | S01.151 | trypsin 1 | beta-trypsin; complex with ACPU | 1BJU |
| PA | S01.151 | trypsin 1 | beta-trypsin; complex with APPU | 1BJV |
| PA | S01.151 | trypsin 1 | 1BTP | |
| PA | S01.151 | trypsin 1 | complex with | 1BTW |
| PA | S01.151 | trypsin 1 | beta-trypsin; complex with T-butoxy-Ala-Val-boroLys ethyl ester | 1BTX |
| PA | S01.151 | trypsin 1 | beta-trypsin; complex with benzyldiamine | 1BTY |
| PA | S01.151 | trypsin 1 | beta-trypsin; complex with T-butoxy-Ala-Val-boroLys methyl ester | 1BTZ |
| PA | S01.151 | trypsin 1 | complex with benzamidine | 1C1N |
| PA | S01.151 | trypsin 1 | 1C1O | |
| PA | S01.151 | trypsin 1 | complex with (5-amidino-2-benzimidazolyl) (2-benzimidazolyl)methane | 1C1P |
| PA | S01.151 | trypsin 1 | complex with (5-amidino-2-benzimidazolyl) (2-benzimidazolyl)methane | 1C1Q |
| PA | S01.151 | trypsin 1 | complex with (5-amidino-2-benzimidazolyl) (2-benzimidazolyl)methane | 1C1R |
| PA | S01.151 | trypsin 1 | complex with bis(5-amidino-2-benzimidazolyl)methane | 1C1S |
| PA | S01.151 | trypsin 1 | complex with bis(5-amidino-2-benzimidazolyl)methane | 1C1T |
| PA | S01.151 | trypsin 1 | complex with bis(5-amidino-2-benzimidazolyl)methane ketone | 1C2D |
| PA | S01.151 | trypsin 1 | complex with bis(5-amidino-2-benzimidazolyl)methane ketone | 1C2E |
| PA | S01.151 | trypsin 1 | complex with bis(5-amidino-2-benzimidazolyl)methane ketone hydrate | 1C2F |
| PA | S01.151 | trypsin 1 | complex with bis(5-amidino-2-benzimidazolyl)methane ketone hydrate | 1C2G |
| PA | S01.151 | trypsin 1 | complex with bis(5-amidino-2-benzimidazolyl)methane ketone hydrate | 1C2H |
| PA | S01.151 | trypsin 1 | complex with bis(5-amidino-2-benzimidazolyl)methane ketone hydrate | 1C2I |
| PA | S01.151 | trypsin 1 | complex with bis(5-amidino-2-benzimidazolyl)methane ketone | 1C2J |
| PA | S01.151 | trypsin 1 | complex with 5-amidino-benzimidazole | 1C2K |
| PA | S01.151 | trypsin 1 | 1C2L | |
| PA | S01.151 | trypsin 1 | 1C2M | |
| PA | S01.151 | trypsin 1 | complex with benzamidine | 1C5P |
| PA | S01.151 | trypsin 1 | complex with 4-iodobenzo[B]thiophene-2-carboxamidine | 1C5Q |
| PA | S01.151 | trypsin 1 | complex with 4-iodobenzo[B]thiophene-2-carboxamidine | 1C5R |
| PA | S01.151 | trypsin 1 | complex with 4-iodobenzo[B]thiophene-2-carboxamidine | 1C5S |
| PA | S01.151 | trypsin 1 | complex with thieno[2,3-B]pyridine-2-carboxamidine | 1C5T |
| PA | S01.151 | trypsin 1 | complex with thieno[2,3-B]pyridine-2-carboxamidine | 1C5U |
| PA | S01.151 | trypsin 1 | 1C5V | |
| PA | S01.151 | trypsin 1 | complex with bdellastasin | 1C9T |
| PA | S01.151 | trypsin 1 | beta-trypsin; complex with benzamidine | 1CE5 |
| PA | S01.151 | trypsin 1 | NMR structure; complex with 2-[3-amino(imino)methyl phenoxy]-6-[2-(aminomethyl)phenoxy]-3,5-difluoro-4-methylpyridine | 1CU7 |
| PA | S01.151 | trypsin 1 | NMR structure; complex with 2,6-bis[3-amino(imino)methyl phenoxy]-3,5-difluoro-4-methylpyridine | 1CU8 |
| PA | S01.151 | trypsin 1 | NMR structure; complex with 2,6-bis[3-amino(imino)methyl phenoxy]-3,5-difluoro-4-methylpyridine (ZK-805623) | 1CU9 |
| PA | S01.151 | trypsin 1 | complex with soyabean Bowman-Birk inhibitor | 1D6R_A |
| PA | S01.151 | trypsin 1 | complex with inhibitor BPO | 1EB2 |
| PA | S01.151 | trypsin 1 | complex with pancreatic trypsin inhibitor Ala16Leu mutant | 1EJM_A |
| PA | S01.151 | trypsin 1 | complex with alpha-1-proteinase inhibitor | 1EZX |
| PA | S01.151 | trypsin 1 | complex with RPR131247 inhibitor | 1F0T |
| PA | S01.151 | trypsin 1 | complex with RPR128515 inhibitor | 1F0U |
| PA | S01.151 | trypsin 1 | complex with MCTI-A inhibitor from bitter gourd | 1F2S_E |
| PA | S01.151 | trypsin 1 | complex with T87 inhibitor | 1G34 |
| PA | S01.151 | trypsin 1 | complex with R11 inhibitor | 1G36 |
| PA | S01.151 | trypsin 1 | bound to meta-amidino Schiff base magnesium(II) chelate | 1G3B |
| PA | S01.151 | trypsin 1 | bound to para-amidino Schiff base iron(III) chelate | 1G3C |
| PA | S01.151 | trypsin 1 | bound to meta-amidino Schiff base copper(II) chelate | 1G3D |
| PA | S01.151 | trypsin 1 | bound to para-amidino Schiff base copper(II) chelate | 1G3E |
| PA | S01.151 | trypsin 1 | complex with engineered mung bean inhibitor | 1G9I_E |
| PA | S01.151 | trypsin 1 | guanidinobenzoylated at Ser-195 | 1GBT |
| PA | S01.151 | trypsin 1 | 1GHZ_A | |
| PA | S01.151 | trypsin 1 | 1GI0_A | |
| PA | S01.151 | trypsin 1 | 1GI1_A | |
| PA | S01.151 | trypsin 1 | 1GI2_A | |
| PA | S01.151 | trypsin 1 | 1GI3_A | |
| PA | S01.151 | trypsin 1 | complex with 2-(2-hydroxy-phenyl)-3H-benzoimidazole-5-carboxamidine | 1GI4_A |
| PA | S01.151 | trypsin 1 | 1GI5_A | |
| PA | S01.151 | trypsin 1 | 1GI6_A | |
| PA | S01.151 | trypsin 1 | engineering inhibitors highly selective for the s1 sites of ser190 trypsin-like serine protease drug targets | 1GJ6_A |
| PA | S01.151 | trypsin 1 | atomic resolution structures of trypsin provide insight into structural radiation damage | 1HJ9_A |
| PA | S01.151 | trypsin 1 | complex with benzamidine inhibitor | 1J8A |
| PA | S01.151 | trypsin 1 | complex with amylamine in cyclohexane | 1JIR |
| PA | S01.151 | trypsin 1 | complex with leupeptin | 1JRS |
| PA | S01.151 | trypsin 1 | complex with leupeptin | 1JRT |
| PA | S01.151 | trypsin 1 | complex with N-alpha-(2-naphthylsulfonyl)-N-(3-amidino-l-phenylalaninyl)-D-pipecolinic acid | 1K1I_A |
| PA | S01.151 | trypsin 1 | bovine trypsin-inhibitor complex | 1K1J_A |
| PA | S01.151 | trypsin 1 | complex with N-alpha-(2-naphthylsulfonyl)-3-amidino-l-phenylalanine piperazide | 1K1L_A |
| PA | S01.151 | trypsin 1 | complex with N-alpha-(2-naphthylsulfonyl)-N(3-amidino-l-phenylalaninyl)-4-acetyl-piperazine | 1K1M_A |
| PA | S01.151 | trypsin 1 | bovine trypsin-inhibitor complex | 1K1N_A |
| PA | S01.151 | trypsin 1 | bovine trypsin-inhibitor complex | 1K1O_A |
| PA | S01.151 | trypsin 1 | bovine trypsin-inhibitor complex | 1K1P_A |
| PA | S01.151 | trypsin 1 | complex with [4-([5-benzyloxy-1-(3-carbamimidoyl-benzyl)-1H-indole-2-carbonyl]-amino-methyl)-phenyl]-trimethyl-ammonium | 1LQE_A |
| PA | S01.151 | trypsin 1 | beta trypsin; complex with a phosphonate inhibitor ZAP | 1MAX |
| PA | S01.151 | trypsin 1 | beta trypsin; complex with a phosphonate inhibitor ZAP | 1MAY |
| PA | S01.151 | trypsin 1 | beta-trypsin; complex with MCTI-A inhibitor | 1MCU |
| PA | S01.151 | trypsin 1 | complex with factor Xa-specific inhibitor BX5633 | 1MTS |
| PA | S01.151 | trypsin 1 | complex with factor Xa-specific inhibitor BX5633 | 1MTU |
| PA | S01.151 | trypsin 1 | complex with factor Xa-specific inhibitor BX5633 | 1MTV |
| PA | S01.151 | trypsin 1 | complex with factor Xa-specific inhibitor DX9056A | 1MTW |
| PA | S01.151 | trypsin 1 | rip-phasing | 1N6X_A |
| PA | S01.151 | trypsin 1 | rip-phasing on bovine trypsin | 1N6Y_A |
| PA | S01.151 | trypsin 1 | potent, small molecule inhibitors of human mast cell tryptase. anti-asthmatic action of a dipeptide-based transition state analogue containing benzothiazole ketone | 1NC6_A |
| PA | S01.151 | trypsin 1 | modified beta-trypsin | 1NTP |
| PA | S01.151 | trypsin 1 | complex with inhibitor CRA_10433 | 1O2H_A |
| PA | S01.151 | trypsin 1 | complex with inhibitor CRA_10655 | 1O2I_A |
| PA | S01.151 | trypsin 1 | complex with inhibitor 2-5-[amino(iminio)methyl]-1H-benzimidazol-2-yl-6-isobutoxybenzenolate (CRA_10656) | 1O2J_A |
| PA | S01.151 | trypsin 1 | complex with inhibitor 2-5-[amino(iminio)methyl]-1H-benzimidazol-2-yl-6-isobutoxybenzenolate (CRA_10656) | 1O2K_A |
| PA | S01.151 | trypsin 1 | complex with inhibitor 3-5-[amino(iminio)methyl]-6-chloro-1H-benzimidazol-2-yl-1,1'-biphenyl-2-olate (CRA_10762) | 1O2L_A |
| PA | S01.151 | trypsin 1 | complex with inhibitor 3-5-[amino(iminio)methyl]-6-chloro-1H-benzimidazol-2-yl-1,1'-biphenyl-2-olate (CRA_10762) | 1O2M_A |
| PA | S01.151 | trypsin 1 | complex with inhibitor 3-5-[amino(iminio)methyl]-6-chloro-1H-benzimidazol-2-yl-1,1'-biphenyl-2-olate (CRA_10762) | 1O2N_A |
| PA | S01.151 | trypsin 1 | complex with inhibitor 2-5-[amino(iminio)methyl]-6-fluoro-1H-benzimidazol-2-yl-6-isobutoxybenzenolate (CRA_10950) | 1O2O_A |
| PA | S01.151 | trypsin 1 | 1O2P_A | |
| PA | S01.151 | trypsin 1 | 1O2Q_A | |
| PA | S01.151 | trypsin 1 | 1O2R_A | |
| PA | S01.151 | trypsin 1 | 1O2S_A | |
| PA | S01.151 | trypsin 1 | 1O2T_A | |
| PA | S01.151 | trypsin 1 | 1O2U_A | |
| PA | S01.151 | trypsin 1 | 1O2V_A | |
| PA | S01.151 | trypsin 1 | 1O2W_A | |
| PA | S01.151 | trypsin 1 | 1O2X_A | |
| PA | S01.151 | trypsin 1 | 1O2Y_A | |
| PA | S01.151 | trypsin 1 | 1O2Z_A | |
| PA | S01.151 | trypsin 1 | 1O30_A | |
| PA | S01.151 | trypsin 1 | 1O31_A | |
| PA | S01.151 | trypsin 1 | 1O32_A | |
| PA | S01.151 | trypsin 1 | 1O33_A | |
| PA | S01.151 | trypsin 1 | 1O34_A | |
| PA | S01.151 | trypsin 1 | 1O35_A | |
| PA | S01.151 | trypsin 1 | 1O36_A | |
| PA | S01.151 | trypsin 1 | 1O37_A | |
| PA | S01.151 | trypsin 1 | 1O38_A | |
| PA | S01.151 | trypsin 1 | 1O39_A | |
| PA | S01.151 | trypsin 1 | 1O3A_A | |
| PA | S01.151 | trypsin 1 | 1O3B_A | |
| PA | S01.151 | trypsin 1 | 1O3C_A | |
| PA | S01.151 | trypsin 1 | 1O3D_A | |
| PA | S01.151 | trypsin 1 | 1O3E_A | |
| PA | S01.151 | trypsin 1 | 1O3F_A | |
| PA | S01.151 | trypsin 1 | 1O3G_A | |
| PA | S01.151 | trypsin 1 | 1O3H_A | |
| PA | S01.151 | trypsin 1 | 1O3I_A | |
| PA | S01.151 | trypsin 1 | 1O3J_A | |
| PA | S01.151 | trypsin 1 | 1O3K_A | |
| PA | S01.151 | trypsin 1 | 1O3L_A | |
| PA | S01.151 | trypsin 1 | 1O3M_A | |
| PA | S01.151 | trypsin 1 | 1O3N_A | |
| PA | S01.151 | trypsin 1 | 1O3O_A | |
| PA | S01.151 | trypsin 1 | non-covalent complex between alpha-1-pi-pittsburgh and s195a trypsin | 1OPH_B |
| PA | S01.151 | trypsin 1 | complex with a synthetic 11 peptide inhibitor | 1OX1_A |
| PA | S01.151 | trypsin 1 | trypsin inhibitor complex | 1OYQ_A |
| PA | S01.151 | trypsin 1 | structural consequences of accommodation of four non- cognate amino-acid residues in the s1 pocket of bovine trypsin and chymotrypsin | 1P2I_A |
| PA | S01.151 | trypsin 1 | structural consequences of accommodation of four non- cognate amino-acid residues in the s1 pocket of bovine trypsin and chymotrypsin | 1P2J_A |
| PA | S01.151 | trypsin 1 | structural consequences of accommodation of four non- cognate amino-acid residues in the s1 pocket of bovine trypsin and chymotrypsin | 1P2K_A |
| PA | S01.151 | trypsin 1 | complex with NAPAP | 1PPC |
| PA | S01.151 | trypsin 1 | complex with squash trypsin inhibitor | 1PPE_E |
| PA | S01.151 | trypsin 1 | complex with 3-TAPAP | 1PPH |
| PA | S01.151 | trypsin 1 | complex with 2-aminobenzimidazole | 1QA0 |
| PA | S01.151 | trypsin 1 | complex with ZK-806974 inhibitor | 1QB1 |
| PA | S01.151 | trypsin 1 | complex with ZK-805623 inhibitor | 1QB6 |
| PA | S01.151 | trypsin 1 | complex with ZK-806450 inhibitor | 1QB9 |
| PA | S01.151 | trypsin 1 | complex with ZK-806688 inhibitor | 1QBN |
| PA | S01.151 | trypsin 1 | complex with ZK-806711 inhibitor | 1QBO |
| PA | S01.151 | trypsin 1 | complex with RWJ-51084 inhibitor | 1QCP |
| PA | S01.151 | trypsin 1 | complex with [4-(6-chloro-naphthalene-2-sulfonyl)-piperazin-1-yl]-(3,4,5,6-tetrahydro-2H-[1,4']bipyridinyl-4-yl)-methanone | 1QL7 |
| PA | S01.151 | trypsin 1 | complex with [4-(6-chloro-naphthalene-2-sulfonyl)-piperazin-1-yl]-(3,4,5,6-tetrahydro-2H-[1,4']bipyridinyl-4-yl)-methanone | 1QL8 |
| PA | S01.151 | trypsin 1 | complex with 1-(4-tert-butylcarbamoyl-piperazine-1-carbonyl)-3-(3-guanidino- propyl)-4-oxo-azetidine-2-carboxylic acid | 1RXP_A |
| PA | S01.151 | trypsin 1 | 1S0Q_A | |
| PA | S01.151 | trypsin 1 | complex with benzamidine | 1S0R_A |
| PA | S01.151 | trypsin 1 | beta-trypsin; complex with mung bean inhibitor lysine active fragment | 1SBW_A |
| PA | S01.151 | trypsin 1 | complex with sunflower seed serpin inhibitor | 1SFI_A |
| PA | S01.151 | trypsin 1 | complex with Bowman-Birk inhibitor | 1SMF_E |
| PA | S01.151 | trypsin 1 | complex with adzuki bean Bowman-Birk inhibitor | 1TAB_E |
| PA | S01.151 | trypsin 1 | complex with inhibitor domain from Alzheimer's amyloid beta protein precursor | 1TAW_A |
| PA | S01.151 | trypsin 1 | precursor | 1TGB |
| PA | S01.151 | trypsin 1 | precursor, in 50% methanol | 1TGC |
| PA | S01.151 | trypsin 1 | precursor | 1TGN |
| PA | S01.151 | trypsin 1 | complex with pig secretory trypsin inhibitor | 1TGS_Z |
| PA | S01.151 | trypsin 1 | precursor at 173 degrees | 1TGT |
| PA | S01.151 | trypsin 1 | beta-trypsin; high-packing density form in cyclohexane | 1TIO |
| PA | S01.151 | trypsin 1 | beta-trypsin, orthorhombic at pH 5.3 | 1TLD |
| PA | S01.151 | trypsin 1 | complex with aminomethylcyclohexane | 1TNG |
| PA | S01.151 | trypsin 1 | complex with 4-fluorobenzylamine | 1TNH |
| PA | S01.151 | trypsin 1 | complex with 4-phenylbutylamine | 1TNI |
| PA | S01.151 | trypsin 1 | complex with 2-phenylethylamine | 1TNJ |
| PA | S01.151 | trypsin 1 | complex with 3-phenylpropylamine | 1TNK |
| PA | S01.151 | trypsin 1 | complex with tranylcypromine | 1TNL |
| PA | S01.151 | trypsin 1 | anhydro-trypsin; complex with pancreatic trypsin inhibitor | 1TPA_E |
| PA | S01.151 | trypsin 1 | beta-trypsin at pH 5.0 | 1TPO |
| PA | S01.151 | trypsin 1 | beta-trypsin; complex with p-amidino-phenyl pyruvate | 1TPP |
| PA | S01.151 | trypsin 1 | complex with inhibitor A90720A | 1TPS |
| PA | S01.151 | trypsin 1 | bovine trypsin complexed with p- amidinophenylmethylphosphinic acid (ampa) | 1TX7_A |
| PA | S01.151 | trypsin 1 | bovine trypsin complexed with amso | 1TX8_A |
| PA | S01.151 | trypsin 1 | complex with cyclotheonamide A | 1TYN |
| PA | S01.151 | trypsin 1 | trypsin specificity as elucidated by lie calculations, x- ray structures and association constant measurements | 1UTN_A |
| PA | S01.151 | trypsin 1 | trypsin specificity as elucidated by lie calculations, x- ray structures and association constant measurements | 1UTO_A |
| PA | S01.151 | trypsin 1 | trypsin specificity as elucidated by lie calculations, x- ray structures and association constant measurements | 1UTP_A |
| PA | S01.151 | trypsin 1 | trypsin specificity as elucidated by lie calculations, x- ray structures and association constant measurements | 1UTQ_A |
| PA | S01.151 | trypsin 1 | benzamidine in complex with bovine trypsin variant x(ssri) bt.c1 | 1V2J_T |
| PA | S01.151 | trypsin 1 | variant X(triple.Glu)BT.D2; complex with factor Xa specific inhibitor | 1V2K_T |
| PA | S01.151 | trypsin 1 | variant X(triple.Glu)BT.D2; complex with benzamidine | 1V2L_T |
| PA | S01.151 | trypsin 1 | variant X(triple.Glu)BT.A1; complex with benzamidine | 1V2M_T |
| PA | S01.151 | trypsin 1 | potent factor xa inhibitor in complex with bovine trypsin variant x(99/175/190)bt | 1V2N_T |
| PA | S01.151 | trypsin 1 | trypsin inhibitor in complex with bovine trypsin variant x(ssyi)bt.b4 | 1V2O_T |
| PA | S01.151 | trypsin 1 | trypsin inhibitor in complex with bovine trypsin variant x(ssyi)bt.a4 | 1V2P_T |
| PA | S01.151 | trypsin 1 | trypsin inhibitor in complex with bovine trypsin variant x(sswi)bt.b4 | 1V2Q_T |
| PA | S01.151 | trypsin 1 | trypsin inhibitor in complex with bovine trypsin variant x(ssri)bt.b4 | 1V2R_T |
| PA | S01.151 | trypsin 1 | benzamidine in complex with bovine trypsin variant x(ssfi.glu)bt.d1 | 1V2S_T |
| PA | S01.151 | trypsin 1 | trypsin inhibitor in complex with bovine trypsin variant x(ssfi.glu)bt.b4 | 1V2T_T |
| PA | S01.151 | trypsin 1 | benzamidine in complex with bovine trypsin varinat x(ssai) bt.d1 | 1V2U_T |
| PA | S01.151 | trypsin 1 | benzamidine in complex with bovine trypsin variant x(ssai) bt.c1 | 1V2V_T |
| PA | S01.151 | trypsin 1 | trypsin inhibitor in complex with bovine trypsin variant x(ssai)bt.b4 | 1V2W_T |
| PA | S01.151 | trypsin 1 | complex with bis(5-amidino-benzimidazolyl) methane zinc | 1XUF |
| PA | S01.151 | trypsin 1 | complex with bis(5-amidino-benzimidazolyl) methane | 1XUG |
| PA | S01.151 | trypsin 1 | complex with bis(5-amidino-2-benzimidazolyl)methanone and cobalt, pH 8.2 | 1XUH |
| PA | S01.151 | trypsin 1 | complex with bis(5-amidino-2-benzimidazolyl)methanone, pH 8.2 | 1XUI |
| PA | S01.151 | trypsin 1 | complex with bis(5-amidino-2-benzimidazolyl)methanone zinc, pH 8.2 | 1XUJ |
| PA | S01.151 | trypsin 1 | complex with bis(5-amidino-2-benzimidazolyl)methanone, pH 5.9 | 1XUK |
| PA | S01.151 | trypsin 1 | trypsin inhibitor complex | 1Y3U_A |
| PA | S01.151 | trypsin 1 | trypsin inhibitor complex | 1Y3V_A |
| PA | S01.151 | trypsin 1 | trypsin inhibitor complex | 1Y3W_A |
| PA | S01.151 | trypsin 1 | trypsin inhibitor complex | 1Y3X_A |
| PA | S01.151 | trypsin 1 | trypsin inhibitor complex | 1Y3Y_A |
| PA | S01.151 | trypsin 1 | dianhydrosugar-based benzamidine, factor xa specific inhibitor in complex with bovine trypsin mutant | 1Y59_T |
| PA | S01.151 | trypsin 1 | dianhydrosugar-based benzamidine, factor xa specific inhibitor in complex with bovine trypsin mutant | 1Y5A_T |
| PA | S01.151 | trypsin 1 | dianhydrosugar-based benzamidine, factor xa specific inhibitor in complex with bovine trypsin mutant | 1Y5B_T |
| PA | S01.151 | trypsin 1 | dianhydrosugar-based benzamidine, factor xa specific inhibitor in complex with bovine trypsin mutant | 1Y5U_T |
| PA | S01.151 | trypsin 1 | trypsin inhibitor complex | 1YP9_A |
| PA | S01.151 | trypsin 1 | complex with 4-sulfonylbenzene-norVal-3-piperidyl-N-guanidino-L-Ala inhibitor | 1YYY |
| PA | S01.151 | trypsin 1 | complex with Kunitz domain 1 of tissue factor pathway inhibitor-2 | 1ZR0_A |
| PA | S01.151 | trypsin 1 | complex with SO2-norVal-Gly-3-piperidyl-N-guanidino-L-Ala | 1ZZZ |
| PA | S01.151 | trypsin 1 | 2A7H_A | |
| PA | S01.151 | trypsin 1 | succinyl-aapr-trypsin acyl-enzyme at 1.15 a resolution | 2AGE_X |
| PA | S01.151 | trypsin 1 | succinyl-aapk-trypsin acyl-enzyme at 1.28 a resolution | 2AGG_X |
| PA | S01.151 | trypsin 1 | complex with leupeptin | 2AGI_X |
| PA | S01.151 | trypsin 1 | guanidinobenzoyl-trypsin acyl-enzyme at 1.13 a resolution | 2AH4_X |
| PA | S01.151 | trypsin 1 | complex with 2-3'-[5'-methoxy-2'-(N-p-diaminomethylphenyl)amido]-1'-pyrido-5-(N-2''-t-butylethanol)amidobenzoic acid and benzamidine | 2AYW_A |
| PA | S01.151 | trypsin 1 | trypsin before a high dose x-ray "burn" | 2BLV_A |
| PA | S01.151 | trypsin 1 | trypsin after a high dose x-ray "burn" | 2BLW_A |
| PA | S01.151 | trypsin 1 | complex with squash seed inhibitor | 2BTC_E |
| PA | S01.151 | trypsin 1 | 2BY5_X | |
| PA | S01.151 | trypsin 1 | 2BY6_X | |
| PA | S01.151 | trypsin 1 | 2BY7_X | |
| PA | S01.151 | trypsin 1 | 2BY8_X | |
| PA | S01.151 | trypsin 1 | 2BY9_X | |
| PA | S01.151 | trypsin 1 | 2BYA_X | |
| PA | S01.151 | trypsin 1 | complex with benzylamine | 2BZA |
| PA | S01.151 | trypsin 1 | complex with Veronica trypsin inhibitor | 2CMY_A |
| PA | S01.151 | trypsin 1 | structure of hyper-vil-trypsin | 2D8W_A |
| PA | S01.151 | trypsin 1 | complex with infestin 1 | 2F3C_E |
| PA | S01.151 | trypsin 1 | complex with BPTI variant (Cys14Ser, Cys38Ser) | 2FI3_E |
| PA | S01.151 | trypsin 1 | complex with BPTI variant (Cys14Ser) | 2FI4_E |
| PA | S01.151 | trypsin 1 | complex with BPTI variant (Cys38Ser) | 2FI5_E |
| PA | S01.151 | trypsin 1 | complex with BPTI at 100K | 2FTL_E |
| PA | S01.151 | trypsin 1 | complex with the BPTI variant (Tyr35Gly) | 2FTM_A |
| PA | S01.151 | trypsin 1 | bovine trypsin bound by 4-piperidinebutyrate to make acylenzyme complex | 2FX4_A |
| PA | S01.151 | trypsin 1 | bovine trypsin complexed with 2-aminobenzamidazole | 2FX6_A |
| PA | S01.151 | trypsin 1 | anomalous substructure of trypsin (p3121) | 2G55_A |
| PA | S01.151 | trypsin 1 | complex with indole-amidine | 2G5N_A |
| PA | S01.151 | trypsin 1 | indole-amidine complexes with bovine trypsin | 2G5V_A |
| PA | S01.151 | trypsin 1 | complex with Bowman-Birk inhibitor from Vigna unguiculata seeds | 2G81_E |
| PA | S01.151 | trypsin 1 | indole-amidine complexes with bovine trypsin | 2G8T_A |
| PA | S01.151 | trypsin 1 | complex with Bowman-Birk inhibitor from snail medic | 2ILN_A |
| PA | S01.151 | trypsin 1 | complex with benzamidine containing polypeptide mediated crystal contacts | 2J9N_A |
| PA | S01.151 | trypsin 1 | the crystal structure of bovine trypsin complexed with a small inhibition peptide orb2k | 2O9Q_A |
| PA | S01.151 | trypsin 1 | complex with nicotinamide | 2OTV_A |
| PA | S01.151 | trypsin 1 | complex with benzamidine at high temperature (35 c) | 2OXS_A |
| PA | S01.151 | trypsin 1 | complex with synthetic peptide derived from Veronica trypsin inhibitor | 2PLX_A |
| PA | S01.151 | trypsin 1 | complex with pancreatic trypsin inhibitor | 2PTC_E |
| PA | S01.151 | trypsin 1 | orthorhombic | 2PTN |
| PA | S01.151 | trypsin 1 | complex with Bowman-Birk inhibitor from rice bran | 2QN5_T |
| PA | S01.151 | trypsin 1 | complex with engineered trypsin inhibitor | 2QYI_A |
| PA | S01.151 | trypsin 1 | precursor | 2TGA |
| PA | S01.151 | trypsin 1 | precursor; complex with diisopropylphosphoryl | 2TGD |
| PA | S01.151 | trypsin 1 | precursor; complex with pancreatic trypsin inhibitor | 2TGP_Z |
| PA | S01.151 | trypsin 1 | precursor at 103 degrees | 2TGT |
| PA | S01.151 | trypsin 1 | low packing density form in cyclohexane | 2TIO |
| PA | S01.151 | trypsin 1 | complex with modified Streptomyces subtilisin inhibitor | 2TLD_E |
| PA | S01.151 | trypsin 1 | precursor; complex with pancreatic trypsin inhibitor | 2TPI_Z |
| PA | S01.151 | trypsin 1 | structure of a tick tryptase inhibitor in complex with bovine trypsin | 2UUY_A |
| PA | S01.151 | trypsin 1 | 2XTT_B | |
| PA | S01.151 | trypsin 1 | exploring trypsin s3 pocket | 2ZDK_A |
| PA | S01.151 | trypsin 1 | exploring trypsin s3 pocket | 2ZDL_A |
| PA | S01.151 | trypsin 1 | exploring trypsin s3 pocket | 2ZDM_A |
| PA | S01.151 | trypsin 1 | exploring trypsin s3 pocket | 2ZDN_A |
| PA | S01.151 | trypsin 1 | exploring trypsin s3 pocket | 2ZFS_A |
| PA | S01.151 | trypsin 1 | exploring trypsin s3 pocket | 2ZFT_A |
| PA | S01.151 | trypsin 1 | exploring trypsin s3 pocket | 2ZHD_A |
| PA | S01.151 | trypsin 1 | 2ZQ1 | |
| PA | S01.151 | trypsin 1 | 2ZQ2 | |
| PA | S01.151 | trypsin 1 | 3A7T | |
| PA | S01.151 | trypsin 1 | 3A7V | |
| PA | S01.151 | trypsin 1 | 3A7W | |
| PA | S01.151 | trypsin 1 | 3A7X | |
| PA | S01.151 | trypsin 1 | 3A7Y | |
| PA | S01.151 | trypsin 1 | 3A7Z | |
| PA | S01.151 | trypsin 1 | 3A80 | |
| PA | S01.151 | trypsin 1 | 3A81 | |
| PA | S01.151 | trypsin 1 | 3A82 | |
| PA | S01.151 | trypsin 1 | 3A83 | |
| PA | S01.151 | trypsin 1 | 3A84 | |
| PA | S01.151 | trypsin 1 | 3A85 | |
| PA | S01.151 | trypsin 1 | 3A86 | |
| PA | S01.151 | trypsin 1 | 3A87 | |
| PA | S01.151 | trypsin 1 | 3A88 | |
| PA | S01.151 | trypsin 1 | 3A89 | |
| PA | S01.151 | trypsin 1 | 3A8A | |
| PA | S01.151 | trypsin 1 | 3A8B | |
| PA | S01.151 | trypsin 1 | 3A8C | |
| PA | S01.151 | trypsin 1 | 3A8D | |
| PA | S01.151 | trypsin 1 | 3AAS | |
| PA | S01.151 | trypsin 1 | 3AAU | |
| PA | S01.151 | trypsin 1 | 3AAV | |
| PA | S01.151 | trypsin 1 | 3ATI | |
| PA | S01.151 | trypsin 1 | 3ATK | |
| PA | S01.151 | trypsin 1 | 3ATL | |
| PA | S01.151 | trypsin 1 | 3ATM | |
| PA | S01.151 | trypsin 1 | complex with bovine pancreatic trypsin inhibitor Lys15Asp and Met52Leu mutant | 3BTD_E |
| PA | S01.151 | trypsin 1 | complex with bovine pancreatic trypsin inhibitor Lys50Glu and Met87Leu mutant | 3BTE_E |
| PA | S01.151 | trypsin 1 | complex with bovine pancreatic trypsin inhibitor Lys15Phe and Met52Leu mutant | 3BTF_E |
| PA | S01.151 | trypsin 1 | complex with bovine pancreatic trypsin inhibitor Lys15Gly and Met52Leu mutant | 3BTG_E |
| PA | S01.151 | trypsin 1 | complex with bovine pancreatic trypsin inhibitor Lys51His and Met52Leu mutant | 3BTH_E |
| PA | S01.151 | trypsin 1 | complex with bovine pancreatic trypsin inhibitor | 3BTK_E |
| PA | S01.151 | trypsin 1 | complex with bovine pancreatic trypsin inhibitor Lys15Met and Met52Leu mutant | 3BTM_E |
| PA | S01.151 | trypsin 1 | complex with bovine pancreatic trypsin inhibitor Lys15Gln and Met52Leu mutant | 3BTQ_E |
| PA | S01.151 | trypsin 1 | complex with bovine pancreatic trypsin inhibitor Lys15Thr and Met52Leu mutant | 3BTT_E |
| PA | S01.151 | trypsin 1 | complex with bovine pancreatic trypsin inhibitor Lys15Trp and Met52Leu mutant | 3BTW_E |
| PA | S01.151 | trypsin 1 | complex with textilinin-1 | 3D65_E |
| PA | S01.151 | trypsin 1 | 3E8L | |
| PA | S01.151 | trypsin 1 | 3GY2 | |
| PA | S01.151 | trypsin 1 | 3GY3 | |
| PA | S01.151 | trypsin 1 | 3GY4 | |
| PA | S01.151 | trypsin 1 | 3GY5 | |
| PA | S01.151 | trypsin 1 | 3GY6 | |
| PA | S01.151 | trypsin 1 | 3GY7 | |
| PA | S01.151 | trypsin 1 | 3GY8 | |
| PA | S01.151 | trypsin 1 | 3I29_A | |
| PA | S01.151 | trypsin 1 | 3ITI | |
| PA | S01.151 | trypsin 1 | 3LJJ | |
| PA | S01.151 | trypsin 1 | 3LJO | |
| PA | S01.151 | trypsin 1 | 3M35 | |
| PA | S01.151 | trypsin 1 | 3M7Q | |
| PA | S01.151 | trypsin 1 | 3MFJ | |
| PA | S01.151 | trypsin 1 | 3MI4 | |
| PA | S01.151 | trypsin 1 | 3NK8 | |
| PA | S01.151 | trypsin 1 | 3NKK | |
| PA | S01.151 | trypsin 1 | 3OTJ_E | |
| PA | S01.151 | trypsin 1 | 3PLB | |
| PA | S01.151 | trypsin 1 | 3PLK | |
| PA | S01.151 | trypsin 1 | 3PLP | |
| PA | S01.151 | trypsin 1 | 3PM3 | |
| PA | S01.151 | trypsin 1 | 3PMJ | |
| PA | S01.151 | trypsin 1 | beta-trypsin; complex with benzamidine | 3PTB |
| PA | S01.151 | trypsin 1 | trigonal | 3PTN |
| PA | S01.151 | trypsin 1 | 3PWB | |
| PA | S01.151 | trypsin 1 | 3PWC | |
| PA | S01.151 | trypsin 1 | 3PYH | |
| PA | S01.151 | trypsin 1 | 3Q00 | |
| PA | S01.151 | trypsin 1 | 3QK1 | |
| PA | S01.151 | trypsin 1 | 3RDZ | |
| PA | S01.151 | trypsin 1 | 3RU4_T | |
| PA | S01.151 | trypsin 1 | 3RXA | |
| PA | S01.151 | trypsin 1 | 3RXB | |
| PA | S01.151 | trypsin 1 | 3RXC | |
| PA | S01.151 | trypsin 1 | 3RXD | |
| PA | S01.151 | trypsin 1 | 3RXE | |
| PA | S01.151 | trypsin 1 | 3RXF | |
| PA | S01.151 | trypsin 1 | 3RXG | |
| PA | S01.151 | trypsin 1 | 3RXH | |
| PA | S01.151 | trypsin 1 | 3RXI | |
| PA | S01.151 | trypsin 1 | 3RXJ | |
| PA | S01.151 | trypsin 1 | 3RXK | |
| PA | S01.151 | trypsin 1 | 3RXL | |
| PA | S01.151 | trypsin 1 | 3RXM | |
| PA | S01.151 | trypsin 1 | 3RXO | |
| PA | S01.151 | trypsin 1 | 3RXP | |
| PA | S01.151 | trypsin 1 | 3RXQ | |
| PA | S01.151 | trypsin 1 | 3RXR | |
| PA | S01.151 | trypsin 1 | 3RXS | |
| PA | S01.151 | trypsin 1 | 3RXT | |
| PA | S01.151 | trypsin 1 | 3RXU | |
| PA | S01.151 | trypsin 1 | 3RXV | |
| PA | S01.151 | trypsin 1 | 3T25 | |
| PA | S01.151 | trypsin 1 | 3T26 | |
| PA | S01.151 | trypsin 1 | 3T27 | |
| PA | S01.151 | trypsin 1 | 3T28 | |
| PA | S01.151 | trypsin 1 | 3T29 | |
| PA | S01.151 | trypsin 1 | 3TPI | |
| PA | S01.151 | trypsin 1 | precursor; complex with pancreatic trypsin inhibitor | 3TPI_Z |
| PA | S01.151 | trypsin 1 | 3UNQ | |
| PA | S01.151 | trypsin 1 | 3UNR | |
| PA | S01.151 | trypsin 1 | 3UNS | |
| PA | S01.151 | trypsin 1 | 3UOP | |
| PA | S01.151 | trypsin 1 | 3UPE | |
| PA | S01.151 | trypsin 1 | 3UQO | |
| PA | S01.151 | trypsin 1 | 3UQV | |
| PA | S01.151 | trypsin 1 | 3UUZ | |
| PA | S01.151 | trypsin 1 | 3UWI | |
| PA | S01.151 | trypsin 1 | 3UY9 | |
| PA | S01.151 | trypsin 1 | 3V0X | |
| PA | S01.151 | trypsin 1 | 3V12 | |
| PA | S01.151 | trypsin 1 | 3V13 | |
| PA | S01.151 | trypsin 1 | 3VEQ_B | |
| PA | S01.151 | trypsin 1 | 3VPK | |
| PA | S01.151 | trypsin 1 | 4AB8 | |
| PA | S01.151 | trypsin 1 | 4AB9 | |
| PA | S01.151 | trypsin 1 | 4ABA | |
| PA | S01.151 | trypsin 1 | 4ABB | |
| PA | S01.151 | trypsin 1 | 4ABD | |
| PA | S01.151 | trypsin 1 | 4ABE | |
| PA | S01.151 | trypsin 1 | 4ABF | |
| PA | S01.151 | trypsin 1 | 4ABG | |
| PA | S01.151 | trypsin 1 | 4ABH | |
| PA | S01.151 | trypsin 1 | 4ABI_A | |
| PA | S01.151 | trypsin 1 | 4ABJ_A | |
| PA | S01.151 | trypsin 1 | complex with spinach trypsin inhibitor III (Phe14Ala mutant) | 4AOQ_A |
| PA | S01.151 | trypsin 1 | complex with cationic trypsin | 4AOR_A |
| PA | S01.151 | trypsin 1 | 4B1T_A | |
| PA | S01.151 | trypsin 1 | 4B2A_A | |
| PA | S01.151 | trypsin 1 | 4B2B_A | |
| PA | S01.151 | trypsin 1 | 4B2C_A | |
| PA | S01.151 | trypsin 1 | 4GUX_A | |
| PA | S01.151 | trypsin 1 | 4HGC_A | |
| PA | S01.151 | trypsin 1 | 4I8G | |
| PA | S01.151 | trypsin 1 | 4I8H | |
| PA | S01.151 | trypsin 1 | 4I8J | |
| PA | S01.151 | trypsin 1 | 4I8K | |
| PA | S01.151 | trypsin 1 | 4I8L | |
| PA | S01.151 | trypsin 1 | 4J2Y | |
| PA | S01.151 | trypsin 1 | 4KTS | |
| PA | S01.151 | trypsin 1 | 4KTU | |
| PA | S01.151 | trypsin 1 | 4MTB | |
| PA | S01.151 | trypsin 1 | 4NCY | |
| PA | S01.151 | trypsin 1 | 4NIV | |
| PA | S01.151 | trypsin 1 | 4NIW | |
| PA | S01.151 | trypsin 1 | 4NIX | |
| PA | S01.151 | trypsin 1 | 4NIY_A | |
| PA | S01.151 | trypsin 1 | beta-trypsin; complex with diisopropylphosphoryl | 4PTP |
| PA | S01.151 | trypsin 1 | precursor; complex with pancreatic trypsin inhibitor Arg15 analogue | 4TPI_Z |
| PA | S01.151 | trypsin 1 | 4TPY | |
| PA | S01.151 | trypsin 1 | complex with inhibitor (Huia versabilis) | 4U2W_A |
| PA | S01.151 | trypsin 1 | 4XOJ_A | |
| PA | S01.151 | trypsin 1 | 4Y0Y_E | |
| PA | S01.151 | trypsin 1 | 4Y0Z_E | |
| PA | S01.151 | trypsin 1 | 4Y10_E | |
| PA | S01.151 | trypsin 1 | 4Y11_E | |
| PA | S01.151 | trypsin 1 | 4YTA | |
| PA | S01.151 | trypsin 1 | complex with cyclic inhibitor | 5EG4_A |
| PA | S01.151 | trypsin 1 | model for comparison of diffuse scattering | 5F6M_A |
| PA | S01.151 | trypsin 1 | solved by mr from data collected by direct data collection (ddc) using the esrf robodiff goniometer | 5FXL_A |
| PA | S01.151 | trypsin 1 | succinic acid bound trypsin crystallized as dimer | 5GIB_A |
| PA | S01.151 | trypsin 1 | cationic trypsin with gol/pge as dimer at ph 4.6 | 5GXP_A |
| PA | S01.151 | trypsin 1 | complex with succinic acid | 5JYI_A |
| PA | S01.151 | trypsin 1 | 5K7R_A | |
| PA | S01.151 | trypsin 1 | trypsin inhibitors for the treatment of pancreatitis - cpd 15 | 5LGO_A |
| PA | S01.151 | trypsin 1 | trypsin inhibitors for the treatment of pancreatitis - cpd 1 | 5LH4_A |
| PA | S01.151 | trypsin 1 | trypsin inhibitors for the treatment of pancreatitis - cpd 8 | 5LH8_A |
| PA | S01.151 | trypsin 1 | complex with 2-aminopyridine (deuterated sample at100 k) | 5MN1_A |
| PA | S01.151 | trypsin 1 | complex with aniline (deuterated sample at 295 k) | 5MNA_A |
| PA | S01.151 | trypsin 1 | complex with 2-aminopyridine (deuterated sample at295 k) | 5MNB_A |
| PA | S01.151 | trypsin 1 | complex with aniline (deuterated sample at 100 k) | 5MNC_A |
| PA | S01.151 | trypsin 1 | cationic trypsin in its apo form (deuterated sample at 100 k) | 5MNE_A |
| PA | S01.151 | trypsin 1 | cationic trypsin in its apo form (deuterated sample at 295 k) | 5MNF_A |
| PA | S01.151 | trypsin 1 | complex with benzamidine (deuterated sample at 100k) | 5MNG_A |
| PA | S01.151 | trypsin 1 | complex with benzamidine (deuterated sample at 295k) | 5MNH_A |
| PA | S01.151 | trypsin 1 | complex with benzylamine (deuterated sample at 100k) | 5MNK_A |
| PA | S01.151 | trypsin 1 | complex with benzylamine (deuterated sample at 295k) | 5MNL_A |
| PA | S01.151 | trypsin 1 | complex with benzylamine (at 295 k) | 5MNM_A |
| PA | S01.151 | trypsin 1 | complex with n-amidinopiperidine (deuterated sample at 100 k) | 5MNN_A |
| PA | S01.151 | trypsin 1 | complex with n-amidinopiperidine (deuterated sample at 295 k) | 5MNO_A |
| PA | S01.151 | trypsin 1 | complex with n-amidinopiperidine (at 295 k) | 5MNP_A |
| PA | S01.151 | trypsin 1 | complex with a derivative of n-amidinopiperidine | 5MNQ_A |
| PA | S01.151 | trypsin 1 | complex with 2-aminopyridine | 5MNX_A |
| PA | S01.151 | trypsin 1 | complex with aniline | 5MNY_A |
| PA | S01.151 | trypsin 1 | neutron structure of cationic trypsin in its apo form | 5MNZ_A |
| PA | S01.151 | trypsin 1 | complex with benzamidine | 5MO0_A |
| PA | S01.151 | trypsin 1 | complex with benzylamine | 5MO1_A |
| PA | S01.151 | trypsin 1 | complex with n- amidinopiperidine | 5MO2_A |
| PA | S01.151 | trypsin 1 | complex with 2- aminopyridine | 5MON_A |
| PA | S01.151 | trypsin 1 | complex with aniline | 5MOO_A |
| PA | S01.151 | trypsin 1 | apo form | 5MOP_A |
| PA | S01.151 | trypsin 1 | complex with benzamidine | 5MOQ_A |
| PA | S01.151 | trypsin 1 | complex with benzylamine | 5MOR_A |
| PA | S01.151 | trypsin 1 | complex with n- amidinopiperidine | 5MOS_A |
| PA | S01.151 | trypsin 1 | beta-trypsin | 5PTP |
| PA | S01.151 | trypsin 1 | soaked with selenourea for 5 min | 5T3H_A |
| PA | S01.151 | trypsin 1 | orthorhombic trypsin (295 k) in the presence of 50% xylose | 6AVL_A |
| PA | S01.151 | trypsin 1 | orthorhombic trypsin (295 k) in the presence of 50% mpd | 6B6N_A |
| PA | S01.151 | trypsin 1 | orthorhombic trypsin cryocooled to 100 k with 20% xylose as cryoprotectant | 6B6O_A |
| PA | S01.151 | trypsin 1 | orthorhombic trypsin cryocooled to 100 k with 30% xylose as cryoprotectant | 6B6P_A |
| PA | S01.151 | trypsin 1 | orthorhombic trypsin cryocooled to 100 k with 50% xylose as cryoprotectant | 6B6Q_A |
| PA | S01.151 | trypsin 1 | orthorhombic trypsin cryocooled to 100 k with 50% mpd as cryoprotectant | 6B6R_A |
| PA | S01.151 | trypsin 1 | orthorhombic trypsin cryocooled to 100 k with 50% ethanol as cryoprotectant | 6B6S_A |
| PA | S01.151 | trypsin 1 | orthorhombic trypsin cryocooled to 100 k with 50% methanol as cryoprotectant | 6B6T_A |
| PA | S01.151 | trypsin 1 | complex with potent inhibitor | 6BFP_A |
| PA | S01.151 | trypsin 1 | complex with a modified sunflower trypsin inhibitor, sfti- tctr(n12,n14) | 6BVH_A |
| PA | S01.151 | trypsin 1 | complex with BBKI Leu55Arg mutant | 6DWF_A |
| PA | S01.151 | trypsin 1 | complex with BBKI | 6DWH_A |
| PA | S01.151 | trypsin 1 | complex with cyanobenzylsulfonylfluoride | 6DWR_A |
| PA | S01.151 | trypsin 1 | orthorhombic trypsin cryocooled to 100 k with 20% xylose as cryoprotectant | 6DZF_A |
| PA | S01.151 | trypsin 1 | crystallographic structure of the cyclic nonapeptide derived from the btci inhibitor bound to beta-trypsin in space group p 32 2 1 | 6E5M_A |
| PA | S01.151 | trypsin 1 | crystallographic structure of the cyclic nonapeptide derived from the btci inhibitor bound to beta-trypsin in space group p 21 21 21. | 6EAT_A |
| PA | S01.151 | trypsin 1 | 6FID_A | |
| PA | S01.151 | trypsin 1 | first active autolysate form | 1AKS |
| PA | S01.151 | trypsin 1 | complex with leech-derived tryptase inhibitor | 1AN1_E |
| PA | S01.151 | trypsin 1 | orthorhombic crystal form, complex with soybean trypsin inhibitor | 1AVW_A |
| PA | S01.151 | trypsin 1 | tetragonal crystal form, complex with soybean trypsin inhibitor | 1AVX_A |
| PA | S01.151 | trypsin 1 | complex with bdellastasin | 1C9P |
| PA | S01.151 | trypsin 1 | theoretical model; complex with inhibitor MCTI-A (Cucurbita maxima) | 1D3O |
| PA | S01.151 | trypsin 1 | theoretical model; complex with (Luffa acutangula) inhibitor | 1DF2 |
| PA | S01.151 | trypsin 1 | complex with bdellastasin | 1EJA |
| PA | S01.151 | trypsin 1 | 1EPT | |
| PA | S01.151 | trypsin 1 | 1EWU | |
| PA | S01.151 | trypsin 1 | in 0.04% polydocanol | 1FMG |
| PA | S01.151 | trypsin 1 | in 0.1% polydocanol | 1FN6 |
| PA | S01.151 | trypsin 1 | in 0.01% polydocanol | 1FNI |
| PA | S01.151 | trypsin 1 | complex with EETI-II | 1H9H_E |
| PA | S01.151 | trypsin 1 | complex with EETI-II mutant | 1H9I_E |
| PA | S01.151 | trypsin 1 | complex with a leech-derived tryptase inhibitor | 1LDT_T |
| PA | S01.151 | trypsin 1 | theoretical model; complex with Leucaena leucocephala trypsin inhibitor alpha and beta chains | 1LT2_A |
| PA | S01.151 | trypsin 1 | complex with bitter gourd inhibitor | 1MCT_A |
| PA | S01.151 | trypsin 1 | with bound acetate | 1QQU |
| PA | S01.151 | trypsin 1 | complex with turkey ovomucoid second domain | 1R0T_A |
| PA | S01.151 | trypsin 1 | complex with guanidine-3-propanol inhibitor | 1S5S_A |
| PA | S01.151 | trypsin 1 | complex with borate and guanidine-3 inhibitor | 1S6F_A |
| PA | S01.151 | trypsin 1 | complex with guanidine-3-propanol inhibitor | 1S6H_A |
| PA | S01.151 | trypsin 1 | 1S81_A | |
| PA | S01.151 | trypsin 1 | complex with borate and ethylene glycol | 1S82_A |
| PA | S01.151 | trypsin 1 | complex with 4-amino propanol | 1S83_A |
| PA | S01.151 | trypsin 1 | complex with 4-amino butanol, borate and ethylene glycol | 1S84_A |
| PA | S01.151 | trypsin 1 | complex with p-hydroxymethyl benzamidine and borate | 1S85_A |
| PA | S01.151 | trypsin 1 | complex with the second domain of tissue factor pathway inhibitor | 1TFX_A |
| PA | S01.151 | trypsin 1 | complex with barley Bowman-Birk inhibitor | 1TX6_A |
| PA | S01.151 | trypsin 1 | complex with auto catalyticaly produced native peptide | 1UHB_A |
| PA | S01.151 | trypsin 1 | complex with synthetic heterochiral peptide | 1V6D_A |
| PA | S01.151 | trypsin 1 | complex with vasopressin | 1YF4_A |
| PA | S01.151 | trypsin 1 | complex with ovomucoid turkey egg white inhibitor | 1Z7K_A |
| PA | S01.151 | trypsin 1 | complex with borate | 2A31_A |
| PA | S01.151 | trypsin 1 | complex with benzene boronic acid | 2A32_A |
| PA | S01.152 | chymotrypsin B | Ser189Asp mutant | 1KDQ_A |
| PA | S01.152 | chymotrypsin B | trypsin-like mutant (Ser189Asp, Ala226Gly) | 2JET_A |
| PA | S01.152 | chymotrypsin B | 1CBW | |
| PA | S01.152 | chymotrypsin B | 1HJA | |
| PA | S01.152 | chymotrypsin B | 3BG4 | |
| PA | S01.153 | elastase-1 | complex with peptidyl-pentafluoroethyl ketone MDL 101,146 | 1B0E |
| PA | S01.153 | elastase-1 | complex with benzyl methyl aminimide inhibitor | 1BMA |
| PA | S01.153 | elastase-1 | complex with MDL 101,146 | 1BOE |
| PA | S01.153 | elastase-1 | complex with 3S,4R-1-toluenesulphonyl-3-ethyl-azetidin-2-one-4-carboxylic acid | 1BTU |
| PA | S01.153 | elastase-1 | under xenon pressure | 1C1M |
| PA | S01.153 | elastase-1 | complex with (3S,4S)N-para-toluenesulphonyl-3-ethyl-4-(carboxylic acid) pyrrolidin-2-one at pH 9 | 1E34 |
| PA | S01.153 | elastase-1 | complex with (3S,4S)N-para-toluenesulphonyl-3-ethyl-4-(carboxylic acid) pyrrolidin-2-one at pH 9 | 1E35 |
| PA | S01.153 | elastase-1 | complex with (3S,4S)N-para-nitobenzenesulphonyl-3-ethyl-4-(carboxylic acid) pyrrolidin-2-one | 1E36 |
| PA | S01.153 | elastase-1 | complex with (3S,4S)N-para-nitobenzenesulphonyl-3-ethyl-4-(carboxylic acid) pyrrolidin-2-one | 1E37 |
| PA | S01.153 | elastase-1 | complex with (3S,4S)N-para-nitobenzenesulphonyl-3-ethyl-4-(carboxylic acid) pyrrolidin-2-one | 1E38 |
| PA | S01.153 | elastase-1 | complex with Ascaris chymotrpsin/elastase inhibitor | 1EAI_A |
| PA | S01.153 | elastase-1 | complex with 3-[[(methylamino)sulfonyl]amino]-2-oxo-6-phenyl-N-[3,3,3-trifluoro-1-(1-methylethyl)-2-oxopropyl]-1(2H)-pyridine acetamide | 1EAS |
| PA | S01.153 | elastase-1 | complex with 2-[5-methanesulfonylamino-2-(4-aminophenyl)--6-oxo-1,6-dihydro-1-pyrimidinyl]-N-(3,3,3-trifluoro-1-isopropyl-2-oxopropyl) acetamide | 1EAT |
| PA | S01.153 | elastase-1 | complex with 2-[5-amino--6-oxo-2-(2-thienyl)-1,6-dihydropyrimidin-1-yl)-N-[3,3-difluoro-1-isopropyl-2-oxo-3-(N-(2-morpholinoethyl)carbamoyl)propyl] acetamide | 1EAU |
| PA | S01.153 | elastase-1 | complex with trifluoroacetyl-L-Lys-L-Pro-isopropylanilide | 1ELA |
| PA | S01.153 | elastase-1 | complex with trifluoroacetyl-L-Lys-L-Leu-isopropylanilide | 1ELB |
| PA | S01.153 | elastase-1 | complex with trifluoroacetyl-L-Phe-P-isopropylanilide | 1ELC |
| PA | S01.153 | elastase-1 | complex with trifluoroacetyl-L-Phe-L-Ala-p-trifluoromethylanilide | 1ELD |
| PA | S01.153 | elastase-1 | complex with trifluoroacetyl-L-Val-L-Ala-p-itrifluoromethylanilide | 1ELE |
| PA | S01.153 | elastase-1 | complex with N-(tert-butoxycarbonyl-Ala-Ala)-O-(p-nitrobenzoyl) hydroxylamine | 1ELF |
| PA | S01.153 | elastase-1 | complex with N-(tert-butoxycarbonyl-Ala-Ala)-O-(p-nitrobenzoyl) hydroxylamine at pH5 | 1ELG |
| PA | S01.153 | elastase-1 | low temperature form (-45 C) | 1ESA |
| PA | S01.153 | elastase-1 | complex with N-carbobenzoxy-L-Ala-p-nitrophenol ester | 1ESB |
| PA | S01.153 | elastase-1 | TOS-elastase | 1EST |
| PA | S01.153 | elastase-1 | complex with elafin | 1FLE_E |
| PA | S01.153 | elastase-1 | complex with inhibitor ONO-6818 | 1FZZ |
| PA | S01.153 | elastase-1 | 1GVK_A | |
| PA | S01.153 | elastase-1 | triiodide derivative | 1GWA_A |
| PA | S01.153 | elastase-1 | complex with acetyl-Val-Glu-Pro-Ile-COOH | 1H9L_A |
| PA | S01.153 | elastase-1 | acyl-enzyme intermediate; complex with human beta-casomorphin-7 at pH 5 | 1HAX_B |
| PA | S01.153 | elastase-1 | acyl-enzyme intermediate; complex with human beta-casomorphin-7 jumped to pH 10 for 10 seconds | 1HAY_B |
| PA | S01.153 | elastase-1 | acyl-enzyme intermediate; complex with human beta-casomorphin-7 jumped to pH 9 for 1 minute | 1HAZ_B |
| PA | S01.153 | elastase-1 | acyl-enzyme intermediate; complex with human beta-casomorphin-7 jumped to pH 10 for 2 minutes | 1HB0_B |
| PA | S01.153 | elastase-1 | complex with N-[2-(1-formyl-2-methyl-propyl)-1-(4-piperidin-1-ylbut-2-enoyl)-pyrrolidin-3-yl]-methane sulfonoamide | 1HV7 |
| PA | S01.153 | elastase-1 | complex with benzoxazinone inhibitor | 1INC |
| PA | S01.153 | elastase-1 | complex with 3-methoxy-4-chloro-7-aminoisocoumarin inhibitor | 1JIM |
| PA | S01.153 | elastase-1 | complex with xenon and bromide, cryoprotected with dry paraffin oil | 1L0Z_A |
| PA | S01.153 | elastase-1 | complex with xenon and bromide, cryoprotected with glycerol | 1L1G_A |
| PA | S01.153 | elastase-1 | with calcium | 1LKA_A |
| PA | S01.153 | elastase-1 | without calcium | 1LKB_A |
| PA | S01.153 | elastase-1 | 1LVY | |
| PA | S01.153 | elastase-1 | complex with hybrid squash inhibitor HEI-TOE 1 | 1MCV |
| PA | S01.153 | elastase-1 | complex with inhibitor FR136706 | 1MMJ_N |
| PA | S01.153 | elastase-1 | complex with acetyl-Ala-Pro-Ala | 1NES |
| PA | S01.153 | elastase-1 | binding structure of elastase inhibitor scyptolin a | 1OKX_A |
| PA | S01.153 | elastase-1 | complex with (3R,4S)N-para-toluenesulfonyl-3-ethyl-4-(carboxylic acid)pyrrolidin-2-one | 1QGF |
| PA | S01.153 | elastase-1 | complex with human beta- casomorphin-7 | 1QIX_B |
| PA | S01.153 | elastase-1 | 1QNJ | |
| PA | S01.153 | elastase-1 | complex with macrocyclic inhibitor FR901277 | 1QR3 |
| PA | S01.153 | elastase-1 | porcine pancreatic elastase/xe-complex | 1UO6_A |
| PA | S01.153 | elastase-1 | complex with cadmium (crystal A) | 1UVO_A |
| PA | S01.153 | elastase-1 | complex with cadmium (crystal B) | 1UVP_A |
| PA | S01.153 | elastase-1 | 2A7C_A | |
| PA | S01.153 | elastase-1 | 2A7J_A | |
| PA | S01.153 | elastase-1 | complex with beta-casomorphin- 7 and Asp-Phe at pH 5.0 | 2BB4_A |
| PA | S01.153 | elastase-1 | complex with beta-casomorphin- 7 and Arg-Phe at pH 5.0 | 2BD2_A |
| PA | S01.153 | elastase-1 | complex with beta-casomorphin- 7 and Lys-Ala-NH2 at pH 5.0 | 2BD3_A |
| PA | S01.153 | elastase-1 | complex with beta-casomorphin- 7 and Lys-Ser at pH 5.0 | 2BD4_A |
| PA | S01.153 | elastase-1 | complex with beta-casomorphin- 7 and Lys-Ser at ph 5 and immersed in pH 9 buffer for 30 seconds | 2BD5_A |
| PA | S01.153 | elastase-1 | complex with beta-casomorphin- 7 and Arg-Phe at pH 5.0 (50 min soak) | 2BD7_A |
| PA | S01.153 | elastase-1 | complex with beta-casomorphin- 7 and Arg-Phe at pH 5.0 (50 min soak) and immersed in ph 9 buffer for 30 seconds | 2BD8_A |
| PA | S01.153 | elastase-1 | complex with beta-casomorphin- 7 and Arg-Phe at pH 5.0 (50 min soak) and immersed in ph 9 buffer for 28 seconds (2nd ph jump) | 2BD9_A |
| PA | S01.153 | elastase-1 | complex with N-acetyl-Asn-Pro-Ile and Ala-Ala at pH 5.0 | 2BDA_A |
| PA | S01.153 | elastase-1 | complex with Asn-Pro-Ile and Ala-Ala at pH 5.0 | 2BDB_A |
| PA | S01.153 | elastase-1 | complex with Asn-Pro-Ile at pH 5.0 | 2BDC_A |
| PA | S01.153 | elastase-1 | elastase before a high dose x-ray "burn" | 2BLO_A |
| PA | S01.153 | elastase-1 | elastase after a high dose x-ray "burn" | 2BLQ_A |
| PA | S01.153 | elastase-1 | complex with FR901451 | 2CV3_A |
| PA | S01.153 | elastase-1 | complex with alpha-1-proteinase inhibitor | 2D26_C |
| PA | S01.153 | elastase-1 | unique conformation induced by tris | 2DE8_A |
| PA | S01.153 | elastase-1 | complex with tris after soaking in a tris-free solution | 2DE9_A |
| PA | S01.153 | elastase-1 | complex with trifluoroacetyl-L-Lys-L-Ala-p-trifluoromethylphenylanilide | 2EST |
| PA | S01.153 | elastase-1 | in 95% acetone | 2FO9_A |
| PA | S01.153 | elastase-1 | in 40/50/10 % benzene | 2FOA_A |
| PA | S01.153 | elastase-1 | in 40/50/10 cyclohexane | 2FOB_A |
| PA | S01.153 | elastase-1 | in 55% dimethylformamide | 2FOC_A |
| PA | S01.153 | elastase-1 | in 80% ethanol | 2FOD_A |
| PA | S01.153 | elastase-1 | in 80% hexane | 2FOE_A |
| PA | S01.153 | elastase-1 | in 80% isopropanol | 2FOF_A |
| PA | S01.153 | elastase-1 | in 40% trifluoroethanol | 2FOG_A |
| PA | S01.153 | elastase-1 | in 40% trifluoroethanol | 2FOH_A |
| PA | S01.153 | elastase-1 | anomalous substructure | 2G4T_A |
| PA | S01.153 | elastase-1 | anomalous substructure | 2G4U_A |
| PA | S01.153 | elastase-1 | complex with Met-Phe-Leu-Glu at pH 5.0 | 2H1U_A |
| PA | S01.153 | elastase-1 | clavulanic acid bound to elastase | 2IOT_A |
| PA | S01.153 | elastase-1 | high pressure cryocooling of capillary sample cryoprotection and diffraction phasing at long wavelengths | 2OQU_A |
| PA | S01.153 | elastase-1 | sad structure solution porcine pancreatic elastase from a selenate derivative | 2V0B_A |
| PA | S01.153 | elastase-1 | complex with inhibitor JM54 | 2V35_A |
| PA | S01.153 | elastase-1 | with the magic triangle i3c | 3E3T_A |
| PA | S01.153 | elastase-1 | 3EST | |
| PA | S01.153 | elastase-1 | 3HGN | |
| PA | S01.153 | elastase-1 | 3HGP | |
| PA | S01.153 | elastase-1 | 3MNB | |
| PA | S01.153 | elastase-1 | 3MNC | |
| PA | S01.153 | elastase-1 | 3MNS | |
| PA | S01.153 | elastase-1 | 3MNX | |
| PA | S01.153 | elastase-1 | 3MO3 | |
| PA | S01.153 | elastase-1 | 3MO6 | |
| PA | S01.153 | elastase-1 | 3MO9 | |
| PA | S01.153 | elastase-1 | 3MOC | |
| PA | S01.153 | elastase-1 | 3MTY | |
| PA | S01.153 | elastase-1 | 3MU0 | |
| PA | S01.153 | elastase-1 | 3MU1 | |
| PA | S01.153 | elastase-1 | 3MU4 | |
| PA | S01.153 | elastase-1 | 3MU5 | |
| PA | S01.153 | elastase-1 | 3MU8 | |
| PA | S01.153 | elastase-1 | 3ODD | |
| PA | S01.153 | elastase-1 | 3ODF | |
| PA | S01.153 | elastase-1 | 3UOU | |
| PA | S01.153 | elastase-1 | complex with ACE-Ala-Pro-Val-difluoro-N-phenylethylacetamide | 4EST |
| PA | S01.153 | elastase-1 | 4GVU | |
| PA | S01.153 | elastase-1 | complex withthe novel inhibitor jm102 | 4YM9_A |
| PA | S01.153 | elastase-1 | 5AVD | |
| PA | S01.153 | elastase-1 | complex with carbobenzoxy-Ala-Ile boronic acid | 5EST |
| PA | S01.153 | elastase-1 | crystallized in 10% DMF | 6EST |
| PA | S01.153 | elastase-1 | complex with trifluoroacetyl-L-Leu-L-Ala-p-trifluoromethylphenylanilide | 7EST |
| PA | S01.153 | elastase-1 | complex with guanidinium isocoumarin | 8EST |
| PA | S01.153 | elastase-1 | complex with guanidinium isocoumarin | 9EST |
| PA | S01.153 | elastase-1 | 1ELT | |
| PA | S01.155 | pancreatic elastase II | complex with GR143783 inhibitor | 1BRU |
| PA | S01.156 | enteropeptidase | peptidase domain; complex with Val-Asp-Asp-Asp-Asp-Lys-chloromethyl ketone inhibitor | 1EKB |
| PA | S01.156 | enteropeptidase | 4DGJ | |
| PA | S01.156 | enteropeptidase | light chain | 3W94_A |
| PA | S01.157 | chymotrypsin C | complex with eglin C | 4H4F_A |
| PA | S01.157 | chymotrypsin C | complex of procarboxypeptidase A, proproteinase E and chymotrypsinogen C | 1PYT_C |
| PA | S01.159 | prostasin | 3DFJ | |
| PA | S01.159 | prostasin | complex with guanidinobenzoic acid | 3DFL |
| PA | S01.159 | prostasin | the x-ray structure of human prostasin in complex with dffr- chloromethyl ketone inhibitor | 3E0N_B |
| PA | S01.159 | prostasin | the x-ray structure of human prostasin in complex with a covalent benzoxazole inhibitor | 3E0P_B |
| PA | S01.159 | prostasin | complex with benzyl [(1S)-5-amino-1-[(1S)-1-((1S)-5- amino-1-[(S)-1,3-benzoxazol-2-yl(hydroxy)methyl]pentylcarbamoyl)- 3-phenylpropyl]carbamoylpentyl]carbamate | 3E16 |
| PA | S01.159 | prostasin | the crystal structure of apo prostasin at 1.7 angstroms resolution | 3E1X_B |
| PA | S01.159 | prostasin | the crystal structure of prostasin complexed with camostat at 1.6 angstroms resolution | 3FVF_B |
| PA | S01.159 | prostasin | complex with calcium | 3GYL_B |
| PA | S01.159 | prostasin | complex with aprotinin | 3GYM_A |
| PA | S01.160 | kallikrein 1 | complex with hirustasin | 1HIA_AB |
| PA | S01.160 | kallikrein 1 | complex with bovine pancreatic trypsin inhibitor | 2KAI_AB |
| PA | S01.160 | kallikrein 1 | 2PKA_A | |
| PA | S01.160 | kallikrein 1 | structure of mature human tissue kallikrein (human kallikrein 1 or klk1) at 1.70 angstrom resolution with vacant active site | 1SPJ_A |
| PA | S01.161 | kallikrein-related peptidase 2 | 4NFE | |
| PA | S01.161 | kallikrein-related peptidase 2 | 4NFF | |
| PA | S01.162 | kallikrein-related peptidase 3 | theoretical model | 1PFA |
| PA | S01.162 | kallikrein-related peptidase 3 | 2PSA | |
| PA | S01.162 | kallikrein-related peptidase 3 | 2ZCH_P | |
| PA | S01.162 | kallikrein-related peptidase 3 | crystal structure of a ternary complex between psa, a substrat-acyl intermediate and an activating antibody ***caveat 2zck there are several chirality errors in chain p, l, ** | 2ZCK_P |
| PA | S01.162 | kallikrein-related peptidase 3 | complex with an activating antibody | 2ZCL_P |
| PA | S01.162 | kallikrein-related peptidase 3 | 3QUM | |
| PA | S01.170 | kallikrein 1-related peptidase b3 | 1SGF_G | |
| PA | S01.171 | kallikrein 1 (Equus caballus) | 1GVZ | |
| PA | S01.172 | kallikrein 1-related peptidase c2 (Rattus norvegicus) | 1TON | |
| PA | S01.173 | kallikrein 13 (Mus musculus) | 1AO5 | |
| PA | S01.174 | mesotrypsin | 1H4W | |
| PA | S01.174 | mesotrypsin | complex with bovine pancreatic trypsin inhibitor | 2R9P_A |
| PA | S01.174 | mesotrypsin | complex with amyloid precursor protein inhibitor(appi) | 3L33_A |
| PA | S01.174 | mesotrypsin | complex with amyloid precursor protein inhibitor variant (appir15k) | 3L3T_A |
| PA | S01.174 | mesotrypsin | human mesotrypsin in complex with amyloid precursor protein inhibitor variant appi-m17g/i18f/f34v | 5C67_A |
| PA | S01.174 | mesotrypsin | mesotrypsin in complex with cleaved amyloid precursor like protein 2 inhibitor (aplp2) | 5JBT_A |
| PA | S01.174 | mesotrypsin | complex with diminazene | 5TP0_A |
| PA | S01.174 | mesotrypsin | complex with tissue factor pathway inhibitor variant (tfpi1-kd1-k15r-i17c-i34c) | 6BX8_A |
| PA | S01.174 | mesotrypsin | complex with appi variant t11v/m17r/i18f/f34v | 6GFI_A |
| PA | S01.174 | mesotrypsin | complex with appi-m17c/i18f/f34c | 6HAR_A |
| PA | S01.179 | bothrombin | theoretical model | 1CXM |
| PA | S01.180 | platelet-aggregating venom peptidase | theoretical model | 1CXJ |
| PA | S01.184 | factor V activator (Daboia russellii) | 2FJO | |
| PA | S01.186 | snake venom plasminogen activator | complex with Glu-Gly-Arg-chloromethylketone inhibitor | 1BQY |
| PA | S01.191 | complement factor D | complex with isatoic anhydride inhibitor | 1BIO |
| PA | S01.191 | complement factor D | complex with di-isopropyl fluorophosphate | 1DFP |
| PA | S01.191 | complement factor D | complex with 3,4-dichloroisocoumarin | 1DIC |
| PA | S01.191 | complement factor D | mutant with enhanced catalytic activity | 1DST |
| PA | S01.191 | complement factor D | 1DSU | |
| PA | S01.191 | complement factor D | precursor | 1FDP |
| PA | S01.191 | complement factor D | P21 crystal form | 1HFD |
| PA | S01.191 | complement factor D | 2XW9 | |
| PA | S01.191 | complement factor D | 2XWA | |
| PA | S01.191 | complement factor D | 2XWB_I | |
| PA | S01.191 | complement factor D | 4CBN | |
| PA | S01.191 | complement factor D | 4CBO | |
| PA | S01.191 | complement factor D | 4D9R | |
| PA | S01.191 | complement factor D | complex with compound2 | 5FBE_A |
| PA | S01.191 | complement factor D | complex with compound 3b | 5FBI_A |
| PA | S01.191 | complement factor D | complex with compound 5 | 5FCK_A |
| PA | S01.191 | complement factor D | complex with a reversible indole carboxylic acid based inhibitor | 5MT0_A |
| PA | S01.191 | complement factor D | complex with a reversible benzoic acid based inhibitor | 5MT4_A |
| PA | S01.191 | complement factor D | complex with the inhibitor (s)-pyrrolidine-1,2-dicarboxylic acid 1-[(1-carbamoyl-1h-indol-3-yl)-amide] 2-[(3- trifluoromethoxy-phenyl)-amide] | 5NAR_A |
| PA | S01.191 | complement factor D | complex with the inhibitor (s)-pyrrolidine-1,2-dicarboxylic acid 1-[(1-methyl-1h-indol-3-yl)-amide] 2-[(3- trifluoromethoxy-phenyl)-amide] | 5NAT_A |
| PA | S01.191 | complement factor D | complex with the inhibitor (1r,3s,5r)-2-aza- bicyclo[3.1.0]hexane-2,3-dicarboxylic acid 2-[(1-carbamoyl-1h-indol- 3-yl)-amide] 3-[(3-trifluoromethoxy-phenyl)-amide] | 5NAW_A |
| PA | S01.191 | complement factor D | complex with the inhibitor (2s,4s)-4-amino- pyrrolidine-1,2-dicarboxylic acid 1-[(1-carbamoyl-1h-indol-3-yl)- amide] 2-[(3-trifluoromethoxy-phenyl)-amide] | 5NB6_A |
| PA | S01.191 | complement factor D | complement factor d | 5NB7_A |
| PA | S01.191 | complement factor D | complex with the inhibitor (2s,4r)-4-fluoro- pyrrolidine-1,2-dicarboxylic acid 1-[(1-carbamoyl-1h-indol-3-yl)- amide] 2-[(3-trifluoromethoxy-phenyl)-amide] | 5NBA_A |
| PA | S01.191 | complement factor D | complement factor d inhibited with jh3 | 5TCA_A |
| PA | S01.191 | complement factor D | complement factor d inhibited with jh4 | 5TCC_A |
| PA | S01.191 | complement factor D | complex with compound 5 | 6FTY_A |
| PA | S01.191 | complement factor D | complex with compound 6 | 6FTZ_A |
| PA | S01.191 | complement factor D | complex with the inhibitor 3-((3-((3- (aminomethyl)phenyl)amino)-1h-pyrazolo[3,4-d]pyrimidin-4-yl)amino) phenol | 6FUG_A |
| PA | S01.191 | complement factor D | complex with the inhibitor (4-((3- (aminomethyl)phenyl)amino)quinazolin-2-yl)-l-valine | 6FUH_A |
| PA | S01.191 | complement factor D | complex with the inhibitor 3-((3-((3- (aminomethyl)phenyl)amino)-1h-pyrazolo[3,4-d]pyrimidin-4-yl)amino) phenol | 6FUI_A |
| PA | S01.191 | complement factor D | mouse complement factor d | 5FCR_A |
| PA | S01.191 | complement factor D | inhibiting alternative pathway complement activation by targeting the exosite on factor d | 4D9Q_A |
| PA | S01.192 | complement component activated C1r | NMR structure of EGF-like module | 1APQ |
| PA | S01.192 | complement component activated C1r | 1GPZ | |
| PA | S01.192 | complement component activated C1r | precursor | 1MD7_A |
| PA | S01.192 | complement component activated C1r | catalytic domain | 1MD8 |
| PA | S01.192 | complement component activated C1r | 2QY0 | |
| PA | S01.193 | complement component activated C1s | catalytic domain | 1ELV |
| PA | S01.193 | complement component activated C1s | zymogen | 4J1Y_A |
| PA | S01.193 | complement component activated C1s | complex with gigastasin | 5UBM_A |
| PA | S01.194 | complement component C2a | 2I6Q | |
| PA | S01.194 | complement component C2a | 2I6S | |
| PA | S01.194 | complement component C2a | catalytic component 2a only | 2ODP |
| PA | S01.194 | complement component C2a | Catalytic component C2a only | 2ODQ |
| PA | S01.194 | complement component C2a | 3ERB | |
| PA | S01.196 | complement factor Bb | catalytic domain | 1DLE_A |
| PA | S01.196 | complement factor Bb | a domain of factor b | 1Q0P_A |
| PA | S01.196 | complement factor Bb | bb segment | 1RRK_A |
| PA | S01.196 | complement factor Bb | bb segment; complex with di-isopropyl-phosphate (dip) | 1RS0_A |
| PA | S01.196 | complement factor Bb | bb segment; complex with 4-guanidinobenzoic acid | 1RTK_A |
| PA | S01.196 | complement factor Bb | 2OK5_A | |
| PA | S01.196 | complement factor Bb | c3 convertase (c3bbb) stabilized by scin | 2WIN_I |
| PA | S01.196 | complement factor Bb | complex with properdin | 5M6W_J |
| PA | S01.198 | mannan-binding lectin-associated serine peptidase 1 | catalytic domain | 3GOV_A |
| PA | S01.198 | mannan-binding lectin-associated serine peptidase 1 | 4KKD_A | |
| PA | S01.198 | mannan-binding lectin-associated serine peptidase 1 | 3POB | |
| PA | S01.198 | mannan-binding lectin-associated serine peptidase 1 | 3POE | |
| PA | S01.198 | mannan-binding lectin-associated serine peptidase 1 | 3POF | |
| PA | S01.198 | mannan-binding lectin-associated serine peptidase 1 | 3POG | |
| PA | S01.198 | mannan-binding lectin-associated serine peptidase 1 | 3POI | |
| PA | S01.198 | mannan-binding lectin-associated serine peptidase 1 | 3POJ | |
| PA | S01.199 | complement factor I | 2XRC | |
| PA | S01.199 | complement factor I | complement complex | 5O32_D |
| PA | S01.204 | prophenoloxidase-activating peptidase-I | peptidase unit only | 2OLG |
| PA | S01.211 | coagulation factor XIIa | 4BDW | |
| PA | S01.211 | coagulation factor XIIa | 4BDX | |
| PA | S01.211 | coagulation factor XIIa | peptidase domain | 4XDE |
| PA | S01.211 | coagulation factor XIIa | peptidase domain | 4XE4 |
| PA | S01.211 | coagulation factor XIIa | complex with benzamidine | 6B74 |
| PA | S01.211 | coagulation factor XIIa | complex with [3-(1-aminoisoquinolin-6-yl)phenyl]boronic acid | 6B77 |
| PA | S01.211 | coagulation factor XIIa | complex with Thr-Arg and Pro-Arg substrate mimetics | 6QF7_B |
| PA | S01.212 | plasma kallikrein | catalytic domain only | 2ANW |
| PA | S01.212 | plasma kallikrein | catalytic domain only | 2ANY |
| PA | S01.212 | plasma kallikrein | 4OGX | |
| PA | S01.212 | plasma kallikrein | 4OGY | |
| PA | S01.212 | plasma kallikrein | 4ZJ4 | |
| PA | S01.212 | plasma kallikrein | 4ZJ5 | |
| PA | S01.212 | plasma kallikrein | 4ZJ6 | |
| PA | S01.212 | plasma kallikrein | complex with peptide inhibitor pkalin-2 | 5F8T_A |
| PA | S01.212 | plasma kallikrein | complex with peptide inhibitor pkalin-3 | 5F8X_A |
| PA | S01.212 | plasma kallikrein | complex with peptide inhibitor pkalin-1 | 5F8Z_A |
| PA | S01.212 | plasma kallikrein | 5TJX_A | |
| PA | S01.212 | plasma kallikrein | allosteric activation of human prekallikrein by apple domain disc rotation | 6I44_A |
| PA | S01.212 | plasma kallikrein | complex with inhibitor | 6O1G_A |
| PA | S01.212 | plasma kallikrein | protease domain; complex with inhibitor | 6O1S_E |
| PA | S01.212 | plasma kallikrein | protease domain | 5GVT_A |
| PA | S01.213 | coagulation factor XIa | complex with ecotin mutant Mer84Arg | 1XX9_A |
| PA | S01.213 | coagulation factor XIa | complex with mutated ecotin | 1XXD_A |
| PA | S01.213 | coagulation factor XIa | complex with ecotin mutant (ecotinp) | 1XXF_A |
| PA | S01.213 | coagulation factor XIa | catalytic domain Ser434Ala, Thr475Ala, Lys437 mutant; complex with benzamidine | 1ZHM_A |
| PA | S01.213 | coagulation factor XIa | catalytic domain Ser434Ala, Thr475Ala, Lys505 mutant; complex with benzamidine | 1ZHP_A |
| PA | S01.213 | coagulation factor XIa | catalytic domain Ser434Ala/Thr475Ala/Cys482Ser/Lys437Ala mutant; complex with benzamidine | 1ZHR_A |
| PA | S01.213 | coagulation factor XIa | catalytic domain; complex with Kunitz protease inhibitor domain of protease nexin II | 1ZJD_A |
| PA | S01.213 | coagulation factor XIa | factor xi catalytic domain complexed with 2-guanidino-1-(4- (4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)ethyl nicotinate | 1ZLR_A |
| PA | S01.213 | coagulation factor XIa | catalytic domain; complex with 4-(guanidinomethyl)-phenylboronic acid | 1ZMJ_A |
| PA | S01.213 | coagulation factor XIa | catalytic domain; complex with (R)-1-(4-(4-(hydroxymethyl)-1,3,2- dioxaborolan-2-yl)phenethyl)guanidine | 1ZML_A |
| PA | S01.213 | coagulation factor XIa | catalytic domain; complex with (r)-1-(4-(4-(hydroxymethyl)-1,3, 2-dioxaborolan-2-yl)phenyl)guanidine | 1ZMN_A |
| PA | S01.213 | coagulation factor XIa | catalytic domain; complex with (S)-2-(3-((R)-1-(4-bromophenyl)ethyl)ureido)-N-((S)-1-((S)-5-guanidino-1-oxo-1-(thiazol-2-yl)pentan-2-ylamino)-3-methyl-1-oxobutan-2-yl)-5-ureidopentanamide | 1ZOM_A |
| PA | S01.213 | coagulation factor XIa | catalytic domain; complex with 4-methyl-pentanoic acid 1-[4- guanidino-1-(thiazole-2-carbonyl)-butylcarbamoyl]-2-methyl- p | 1ZPB_A |
| PA | S01.213 | coagulation factor XIa | catalytic domain; complex with 2-[2-(3-chloro-phenyl)-2-hydroxy- acetylamino]-n-[4-guanidino-1-(thiazole-2-carbonyl)-butyl] | 1ZPC_A |
| PA | S01.213 | coagulation factor XIa | factor xi catalytic domain complexed with n-((r)-1-(4- bromophenyl)ethyl)urea-asn-val-arg-alpha-ketothiazole | 1ZPZ_A |
| PA | S01.213 | coagulation factor XIa | factor xi complexed with 3-hydroxypropyl 3-(7- amidinonaphthalene-1-carboxamido)benzenesulfonate | 1ZRK_A |
| PA | S01.213 | coagulation factor XIa | catalytic domain; complex with N-(7-carbamimidoyl-naphthalen-1- yl)-3-hydroxy-2-methyl-benzamide | 1ZSJ_A |
| PA | S01.213 | coagulation factor XIa | catalytic domain; complex with 6-carbamimidoyl-4-(3-hydroxy-2- methyl-benzoylamino)-naphthalene-2-carboxylic acid methyl es | 1ZSK_A |
| PA | S01.213 | coagulation factor XIa | factor xi complexed with a pyrimidinone inhibitor | 1ZSL_A |
| PA | S01.213 | coagulation factor XIa | catalytic domain; in complex with 2-(5-benzylamino-2- methylsulfanyl-6-oxo-6h-pyrimidin-1-yl)-n-[4-guanidino-1- (thiazole-2-ca | 1ZTJ_A |
| PA | S01.213 | coagulation factor XIa | catalytic domain; in complex with 2-(5-amino-6-oxo-2-m-tolyl-6h- pyrimidin-1-yl)-n-[4-guanidino-1-(thiazole-2-carbonyl)- butyl | 1ZTK_A |
| PA | S01.213 | coagulation factor XIa | catalytic domain; complex with n-[4-guanidino-1-(thiazole-2- carbonyl)-butyl]-2-6-oxo-5-[(quinolin-8-ylmethyl)-amino]- 2-m | 1ZTL_A |
| PA | S01.213 | coagulation factor XIa | precursor | 2F83 |
| PA | S01.213 | coagulation factor XIa | catalytic domain; complex with N~2~-(aminocarbonyl)-N~1~-4-[amino(imino)methyl]amino-1-[hydroxy(1,3-thiazol-2-yl)methyl]butylvalinamide | 2FDA_A |
| PA | S01.213 | coagulation factor XIa | 2J8J | |
| PA | S01.213 | coagulation factor XIa | 2J8L | |
| PA | S01.213 | coagulation factor XIa | complex with clavatadine A | 3BG8_A |
| PA | S01.213 | coagulation factor XIa | 3SOR | |
| PA | S01.213 | coagulation factor XIa | 3SOS | |
| PA | S01.213 | coagulation factor XIa | 4CR5 | |
| PA | S01.213 | coagulation factor XIa | 4CR9 | |
| PA | S01.213 | coagulation factor XIa | 4CRA | |
| PA | S01.213 | coagulation factor XIa | 4CRB | |
| PA | S01.213 | coagulation factor XIa | 4CRC | |
| PA | S01.213 | coagulation factor XIa | 4CRD | |
| PA | S01.213 | coagulation factor XIa | 4CRE | |
| PA | S01.213 | coagulation factor XIa | 4CRF | |
| PA | S01.213 | coagulation factor XIa | 4CRG | |
| PA | S01.213 | coagulation factor XIa | human fxia in complex with small molecule inhibitors. | 4D76_A |
| PA | S01.213 | coagulation factor XIa | human fxia in complex with small molecule inhibitors. | 4D7F_A |
| PA | S01.213 | coagulation factor XIa | human fxia in complex with small molecule inhibitors. | 4D7G_A |
| PA | S01.213 | coagulation factor XIa | 4NA7 | |
| PA | S01.213 | coagulation factor XIa | 4NA8 | |
| PA | S01.213 | coagulation factor XIa | 4TY6 | |
| PA | S01.213 | coagulation factor XIa | 4TY7 | |
| PA | S01.213 | coagulation factor XIa | 4WXI | |
| PA | S01.213 | coagulation factor XIa | 4X6M | |
| PA | S01.213 | coagulation factor XIa | 4X6N | |
| PA | S01.213 | coagulation factor XIa | 4X6O | |
| PA | S01.213 | coagulation factor XIa | 4X6P | |
| PA | S01.213 | coagulation factor XIa | 4Y8X | |
| PA | S01.213 | coagulation factor XIa | 4Y8Y | |
| PA | S01.213 | coagulation factor XIa | 4Y8Z | |
| PA | S01.213 | coagulation factor XIa | 5E2O | |
| PA | S01.213 | coagulation factor XIa | 5E2P | |
| PA | S01.213 | coagulation factor XIa | human plasma coagulation fxi with peptide lp2 ***caveat 5eod lys a 8 has wrong chirality at atom ca nag a 901 has wrong ***caveat 2 5eod chirality at atom c1 nag a 902 has wrong chirality at atom ***caveat 3 5eod c1 | 5EOD_A |
| PA | S01.213 | coagulation factor XIa | human plasma coagulation factor xi in complex with peptide p39 ***caveat 5eok glu a 323 has wrong chirality at atom ca nag a 701 has wrong ***caveat 2 5eok chirality at atom c1 nag a 703 has wrong chirality at atom ***caveat 3 5eok c1 | 5EOK_A |
| PA | S01.213 | coagulation factor XIa | in complex with the inhibitor 4-(aminomethyl)-~n- [(1~s)-1-[4-(3-oxidanyl-1~h-indazol-5-yl)pyridin-2-yl]-2-phenyl- ethyl]cyclohexane-1-carboxamide | 5EXL_A |
| PA | S01.213 | coagulation factor XIa | complex with the inhibitor methyl ~n-[4-[2-[(1~s)-1-[[4-(aminomethyl)cyclohexyl]carbonylamino]-2-phenyl-ethyl]pyridin-4- yl]phenyl]carbamate | 5EXM_A |
| PA | S01.213 | coagulation factor XIa | Cys500Ser [Cys122Ser] mutant; complex with the inhibitor methyl ~n- [4-[2-[(1~s)-1-[[(~e)-3-[5-chloranyl-2-(1,2,3,4-tetrazol-1-yl) phenyl]prop-2-enoyl]amino]-2-phenyl-ethyl]pyridin-4- yl]phenyl]carbamate | 5EXN_A |
| PA | S01.213 | coagulation factor XIa | human recombinant coagulation fxi in complex with a peptide derived from human high molecular weight kininogen (hkp) | 5I25_A |
| PA | S01.213 | coagulation factor XIa | complex with the inhibitor methyl [(7s)-7-((2e)-3-[5- chloro-2-(1h-tetrazol-1-yl)phenyl]prop-2-enoylamino)-2-oxo-1,2,3,4, 5,6,7,9-octahydro-11,8-(azeno)-1,9-benzodiazacyclotridecin-14- yl]carbamate | 5Q0D_A |
| PA | S01.213 | coagulation factor XIa | complex with the inhibitor methyl [(4s,8s)-8-((2e)-3- [5-chloro-2-(1h-tetrazol-1-yl)phenyl]prop-2-enoylamino)-4-methyl-2- oxo-1,3,4,5,6,7,8,10-octahydro-2h-12,9-(azeno)-1,10- benzodiazacyclotetradecin-15-yl]carbamate | 5Q0E_A |
| PA | S01.213 | coagulation factor XIa | complex with the inhibitor methyl [(4r,5e,8s)-8-((2e)- 3-[5-chloro-2-(1h-tetrazol-1-yl)phenyl]prop-2-enoylamino)-4-methyl- 2-oxo-1,3,4,7,8,10-hexahydro-2h-12,9-(azeno)-1,10- benzodiazacyclotetradecin-15-yl]carbamate | 5Q0F_A |
| PA | S01.213 | coagulation factor XIa | complex with the inhibitor methyl [(3r,7s)-7-((2e)-3- [5-chloro-2-(1h-tetrazol-1-yl)phenyl]prop-2-enoylamino)-3-ethyl-2- oxo-1,2,3,4,5,6,7,9-octahydro-11,8-(azeno)-1,9- benzodiazacyclotridecin-14-yl]carbamate | 5Q0G_A |
| PA | S01.213 | coagulation factor XIa | complex with the inhibitor methyl [(4r,5e,8s)-11-chloro-8-[(2,6-difluoro-4-methylbenzene-1-carbonyl)amino]-4-methyl-2-oxo-1, 3,4,7,8,10-hexahydro-2h-12,9-(azeno)-1,10-benzodiazacyclotetradecin- 15-yl]carbamate | 5Q0H_A |
| PA | S01.213 | coagulation factor XIa | complex with the inhibitor 4-[[(2~s,3~r)-1-[(~e)- 3-[5-chloranyl-2-(1,2,3,4-tetrazol-1-yl)phenyl]prop-2-enoyl]-3- phenyl-pyrrolidin-2-yl]carbonylamino]benzoic acid | 5QCK_A |
| PA | S01.213 | coagulation factor XIa | complex with the inhibitor 4-[[(1~s)-2-[(~e)-3-[5- chloranyl-2-(1,2,3,4-tetrazol-1-yl)phenyl]prop-2-enoyl]-3,4-dihydro- 1~h-isoquinolin-1-yl]carbonylamino]benzoic acid | 5QCL_A |
| PA | S01.213 | coagulation factor XIa | factor xia in complex with the inhibitor methyl ~n-[4-[[(1~s)-2- [(~e)-3-[3-chloranyl-2-fluoranyl-6-(1,2,3,4-tetrazol-1-yl) phenyl]prop-2-enoyl]-3,4-dihydro-1~h-isoquinolin-1- yl]carbonylamino]phenyl]carbamate | 5QCM_A |
| PA | S01.213 | coagulation factor XIa | complex with the inhibitor 4-[[(1~s)-2-[(~e)-3-[5- chloranyl-2-(1,2,3,4-tetrazol-1-yl)phenyl]prop-2-enoyl]-5-[(3~s)-3-ethoxycarbonylpiperidin-1-yl]carbonyl-3,4-dihydro-1~h-isoquinolin- 1-yl]carbonylamino]benzoic acid | 5QCN_A |
| PA | S01.213 | coagulation factor XIa | complex with the inhibitor ((15s)-18-chloro- 15-(((2e)- 3-(5-chloro-2-(1h-tetrazol-1-yl)phenyl)-2- propenoyl)amino)-17,19- diazatricyclo[14.2.1.0~2,7~]nonadeca-1(18),2,4,6,16(19)-pentaen-5- yl)carbamate | 5TKS_A |
| PA | S01.213 | coagulation factor XIa | complex with the inhibitor methyl ((12e,15s)-15-(((2e)- 3-(5-chloro-2-(1h-tetrazol-1-yl)phenyl)-2-propenoyl)amino)-9-oxo-8, 17,19-triazatricyclo[14.2.1.0~2,7~]nonadeca-1(18),2,4,6,12,16(19)- hexaen-5-yl)carbamate | 5TKT_A |
| PA | S01.213 | coagulation factor XIa | complex with the inhibitor methyl ((15s)-15-(((2e)-3-(5-chloro-2-(1h-tetrazol-1-yl)phenyl)-2-propenoyl)amino)-9-oxo-8,17,19- triazatricyclo[14.2.1.0~2,7~]nonadeca-1(18),2,4,6,16(19)-pentaen-5- yl)carbamate | 5TKU_A |
| PA | S01.213 | coagulation factor XIa | complex with the inhibitor methyl [(11s)-11-((2e)-3-[5-chloro-2-(1h-tetrazol-1-yl)phenyl]prop-2-enoylamino)-6-fluoro-2-oxo-1,3,4,10,11,13-hexahydro-2h-5,9:15,12-di(azeno)-1,13- benzodiazacycloheptadecin-18-yl]carbamate | 5WB6_A |
| PA | S01.213 | coagulation factor XIa | fxia antibody complex | 6AOD_A |
| PA | S01.213 | coagulation factor XIa | complex with the inhibitor methyl (4-6-[(1s)-2-[(3r)-1-acetylpiperidin-3-yl]-1-((2e)-3-[5-chloro-2- (1h-tetrazol-1-yl) phenyl]prop-2-enoylamino)ethyl]-3-chloropyridazin-4-ylphenyl) carbamate | 6C0S_A |
| PA | S01.213 | coagulation factor XIa | allosteric activation of human prekallikrein by apple domain disc rotation | 6I58_A |
| PA | S01.213 | coagulation factor XIa | catalytic domain; complex with fab-portion of maa868 | 6R8X_A |
| PA | S01.214 | coagulation factor IXa | NMR; residues 1-47 | 1CFH |
| PA | S01.214 | coagulation factor IXa | NMR structure; gamma-carboxy-glutamic acid-rich domain | 1CFI |
| PA | S01.214 | coagulation factor IXa | EGF-like domain | 1EDM |
| PA | S01.214 | coagulation factor IXa | NMR; EGF-like module | 1IXA |
| PA | S01.214 | coagulation factor IXa | NMR; alpha-carbon backbone only | 1MGX |
| PA | S01.214 | coagulation factor IXa | 1NL0 | |
| PA | S01.214 | coagulation factor IXa | complex with p-amino-benzamidine | 1RFN |
| PA | S01.214 | coagulation factor IXa | 2WPH | |
| PA | S01.214 | coagulation factor IXa | 2WPI | |
| PA | S01.214 | coagulation factor IXa | 2WPJ | |
| PA | S01.214 | coagulation factor IXa | 2WPK | |
| PA | S01.214 | coagulation factor IXa | 2WPL | |
| PA | S01.214 | coagulation factor IXa | 2WPM | |
| PA | S01.214 | coagulation factor IXa | 3KCG | |
| PA | S01.214 | coagulation factor IXa | 3LC3 | |
| PA | S01.214 | coagulation factor IXa | 3LC5 | |
| PA | S01.214 | coagulation factor IXa | 4WM0 | |
| PA | S01.214 | coagulation factor IXa | 4WMA | |
| PA | S01.214 | coagulation factor IXa | 4WMB | |
| PA | S01.214 | coagulation factor IXa | 4WMI | |
| PA | S01.214 | coagulation factor IXa | 4WMK | |
| PA | S01.214 | coagulation factor IXa | 4WN2 | |
| PA | S01.214 | coagulation factor IXa | 4WNH | |
| PA | S01.214 | coagulation factor IXa | 4YZU | |
| PA | S01.214 | coagulation factor IXa | 4Z0K | |
| PA | S01.214 | coagulation factor IXa | 4ZAE | |
| PA | S01.214 | coagulation factor IXa | 5EGM | |
| PA | S01.214 | coagulation factor IXa | Lys98Thr variant; complex with egr- chloromethylketone | 5JB8_E |
| PA | S01.214 | coagulation factor IXa | Lys98Thr variant; complex with PPACK | 5JB9_E |
| PA | S01.214 | coagulation factor IXa | Val16Ile/Lys98Thr/Tyr177Thr/Ile212Val variant; complex with PPACK | 5JBA_E |
| PA | S01.214 | coagulation factor IXa | Val16Ile/Lys98Thr/Tyr177Thr/Ile213val variant; complex with egr-chloromethylketone | 5JBB_E |
| PA | S01.214 | coagulation factor IXa | Val16Ile/Lys98Thr/Tyr177Thr/Ile213val variant; complex with PPACK | 5JBC_E |
| PA | S01.214 | coagulation factor IXa | discovery of novel aminobenzisoxazole derivatives as orally available factor ixa inhibitors | 5TNO_A |
| PA | S01.214 | coagulation factor IXa | discovery of novel aminobenzisoxazole derivatives as orally available factor ixa inhibitors | 5TNT_A |
| PA | S01.214 | coagulation factor IXa | 6MV4_H | |
| PA | S01.214 | coagulation factor IXa | crystal structure of egrck-inhibited gla-domainless fixa (k148q, r150qvariant) | 6RFK_E |
| PA | S01.214 | coagulation factor IXa | 1J34 | |
| PA | S01.214 | coagulation factor IXa | 1J35 | |
| PA | S01.214 | coagulation factor IXa | complex with D-Phe-Pro-Arg | 1PFX |
| PA | S01.214 | coagulation factor IXa | porcine factor ixa complexed to 1-3-[amino(imino) methyl]phenyl-n-[4-(1h-benzimidazol-1-yl)-2-fluorophenyl]- 3-(trifluoromethyl)-1h-pyrazole-5-carboxamide | 1X7A_C |
| PA | S01.215 | coagulation factor VIIa | NMR structure; N-terminal epidermal growth factor-like domain | 1BF9 |
| PA | S01.215 | coagulation factor VIIa | complex with Glu-Gly deoxy-methyl-Arg | 1CVW |
| PA | S01.215 | coagulation factor VIIa | complex with soluble recombinant tissue factor | 1DAN |
| PA | S01.215 | coagulation factor VIIa | complex with peptide exosite inhibitor E-76 | 1DVA |
| PA | S01.215 | coagulation factor VIIa | NMR structure; first EGF-like domains | 1F7E |
| PA | S01.215 | coagulation factor VIIa | NMR structure; EGF-like domain 1 | 1F7M |
| PA | S01.215 | coagulation factor VIIa | complex with tissue factor and basic pancreatic trypsin inhibitor | 1FAK_LH |
| PA | S01.215 | coagulation factor VIIa | NMR structure; first EGF-like domain | 1FF7 |
| PA | S01.215 | coagulation factor VIIa | NMR structure; EGF-like domain 1 | 1FFM |
| PA | S01.215 | coagulation factor VIIa | complex with tissue factor | 1J9C_L |
| PA | S01.215 | coagulation factor VIIa | precursor; complex with inhibitory exosite peptide A-183 | 1JBU |
| PA | S01.215 | coagulation factor VIIa | 1KLI | |
| PA | S01.215 | coagulation factor VIIa | 1KLJ | |
| PA | S01.215 | coagulation factor VIIa | 1NL8 | |
| PA | S01.215 | coagulation factor VIIa | dissecting and designing inhibitor selectivity determinants at the s1 site using an artificial ala190 protease (ala190 upa) | 1O5D_L |
| PA | S01.215 | coagulation factor VIIa | complex with D-Phe-Phe-Arg | 1QFK |
| PA | S01.215 | coagulation factor VIIa | tf7a_3771 complex | 1W0Y_H |
| PA | S01.215 | coagulation factor VIIa | tf7a_4380 complex | 1W2K_H |
| PA | S01.215 | coagulation factor VIIa | factor7- 413 complex | 1W7X_H |
| PA | S01.215 | coagulation factor VIIa | factor7- 413 complex | 1W8B_H |
| PA | S01.215 | coagulation factor VIIa | complex with tissue factor and propylsulfonamide-D-thr-met-p-aminobenzamidine | 1WQV_L |
| PA | S01.215 | coagulation factor VIIa | human factor viia-tissue factor in complex with peprid mimetic inhibitor that has two charge groups in p2 and p4 | 1WSS_L |
| PA | S01.215 | coagulation factor VIIa | complex with tissue factor and ethylsulfonamide-D-biphenylalanine-gln-p-aminobenzamidine | 1WTG_L |
| PA | S01.215 | coagulation factor VIIa | complex with tissue factor and ethylsulfonamide-D-Trp-Gln-p-aminobenzamidine | 1WUN_L |
| PA | S01.215 | coagulation factor VIIa | complex with tissue factor and ethylsulfonamide-D-5-propoxy-trp-gln-p-aminobenzamidine | 1WV7_L |
| PA | S01.215 | coagulation factor VIIa | short factor viia with a small molecule inhibitor | 1YGC_H |
| PA | S01.215 | coagulation factor VIIa | complex with tissue factor and pyrazinone inhibitor | 1Z6J_L |
| PA | S01.215 | coagulation factor VIIa | complex of active-site inhibited human coagulation factor viia with human soluble tissue factor in the presence of ca2+, mg2+, na+, and zn2+ | 2A2Q_L |
| PA | S01.215 | coagulation factor VIIa | complex with tissue factor and 2-[[6-[3-(aminoiminomethyl)phenoxy]- 3,5-difluro-4-[(1-methyl-3-phenylpropyl)amino]-2- pyridinyl]oxy]-b | 2AEI_L |
| PA | S01.215 | coagulation factor VIIa | complex with benzamidine and soluble tissue factor | 2AER_L |
| PA | S01.215 | coagulation factor VIIa | factor viia inhibitors: chemical optimization, preclinical pharmacokinetics, pharmacodynamics, and efficacy in a baboon thrombosis model | 2B7D_L |
| PA | S01.215 | coagulation factor VIIa | complex with Glu-Gly-Arg-chloromethyl ketoneand soluble tissue factor | 2B8O_L |
| PA | S01.215 | coagulation factor VIIa | orally available factor7a inhibitor | 2BZ6_H |
| PA | S01.215 | coagulation factor VIIa | complex with PD0297121 | 2C4F_H |
| PA | S01.215 | coagulation factor VIIa | complex with BCX-3607 | 2EC9_L |
| PA | S01.215 | coagulation factor VIIa | discovery of novel heterocyclic factor viia inhibitors | 2F9B_L |
| PA | S01.215 | coagulation factor VIIa | complex with soluble tissue factor | 2FIR_L |
| PA | S01.215 | coagulation factor VIIa | discovery of a novel hydroxy pyrazole based factor ixa inhibitor | 2FLB_L |
| PA | S01.215 | coagulation factor VIIa | novel 5-azaindole factor viia inhibitors | 2FLR_L |
| PA | S01.215 | coagulation factor VIIa | active site inhibited form; complex with soluble tissue factor | 2PUQ_L |
| PA | S01.215 | coagulation factor VIIa | complex with tissue factor and benzylsulfonamide-D-Ile-Gln-p-aminobenzamidine | 2ZP0_L |
| PA | S01.215 | coagulation factor VIIa | complex with tissue factor and highly selective peptide inhibitor | 2ZWL_L |
| PA | S01.215 | coagulation factor VIIa | complex with tissue factor and ethylsulfonamide-D-5-(3-carboxybenzyloxy)-trp-gln-p- aminobenzamidine | 2ZZU_L |
| PA | S01.215 | coagulation factor VIIa | active site inhibited mutant; complex with soluble tissue factor | 3ELA_L |
| PA | S01.215 | coagulation factor VIIa | 3TH2 | |
| PA | S01.215 | coagulation factor VIIa | 3TH3 | |
| PA | S01.215 | coagulation factor VIIa | 3TH4 | |
| PA | S01.215 | coagulation factor VIIa | 4IBL | |
| PA | S01.215 | coagulation factor VIIa | 4ISH | |
| PA | S01.215 | coagulation factor VIIa | 4ISI | |
| PA | S01.215 | coagulation factor VIIa | 4JYU | |
| PA | S01.215 | coagulation factor VIIa | 4JYV | |
| PA | S01.215 | coagulation factor VIIa | 4JZD | |
| PA | S01.215 | coagulation factor VIIa | 4JZE | |
| PA | S01.215 | coagulation factor VIIa | 4JZF | |
| PA | S01.215 | coagulation factor VIIa | 4NA9 | |
| PA | S01.215 | coagulation factor VIIa | 4NG9 | |
| PA | S01.215 | coagulation factor VIIa | 4NGA | |
| PA | S01.215 | coagulation factor VIIa | 4X8S | |
| PA | S01.215 | coagulation factor VIIa | 4X8T | |
| PA | S01.215 | coagulation factor VIIa | 4X8U | |
| PA | S01.215 | coagulation factor VIIa | 4X8V | |
| PA | S01.215 | coagulation factor VIIa | 4YLQ | |
| PA | S01.215 | coagulation factor VIIa | 4YT6 | |
| PA | S01.215 | coagulation factor VIIa | 4YT7 | |
| PA | S01.215 | coagulation factor VIIa | 4Z6A | |
| PA | S01.215 | coagulation factor VIIa | 4ZMA | |
| PA | S01.215 | coagulation factor VIIa | 4ZXX | |
| PA | S01.215 | coagulation factor VIIa | 4ZXY | |
| PA | S01.215 | coagulation factor VIIa | factor viia in complex with the inhibitor (2r,15r)-2-[(1- aminoisoquinolin-6-yl)amino]-8-fluoro-7-hydroxy-4,15,17-trimethyl-13-oxa-4,11-diazatricyclo[14.2.2.1~6,10~]henicosa-1(18),6(21),7,9,16,19-hexaene-3,12-dione | 5I46_H |
| PA | S01.215 | coagulation factor VIIa | factor viia in complex with the inhibitor 1-[(2r,15r)-2-[(1-amino-4- fluoroisoquinolin-6-yl)amino]-4,15,20-trimethyl-3,12-dioxo-13-oxa-4, 11-diazatricyclo[14.2.2.1~6,10~]henicosa-1(18),6,8,10(21),16,19- hexaen-7-yl] cyclobutane-1-carboxylic acid | 5L2Y_H |
| PA | S01.215 | coagulation factor VIIa | factor viia in complex with the inhibitor 1-[(2r,15r)-2-[(1-amino-4- fluoroisoquinolin-6-yl)amino]-4,15,17-trimethyl-3,12-dioxo-13-oxa-4, 11-diazatricyclo[14.2.2.1~6,10~]henicosa-1(18),6(21),7,9,16,19- hexaen-7-yl]cyclohexane-1-carboxylic acid | 5L2Z_H |
| PA | S01.215 | coagulation factor VIIa | factor viia in complex with the inhibitor (2r,15r)-2-[(1- aminoisoquinolin-6-yl)amino]-4,15,17-trimethyl-7-[1-(1h-tetrazol-5- yl)cyclopropyl]-13-oxa-4,11-diazatricyclo[14.2.2.1~6,10~]henicosa- 1(18),6(21),7,9,16,19-hexaene-3,12-dione | 5L30_H |
| PA | S01.215 | coagulation factor VIIa | complex with cyclohexanamine | 5PA8_A |
| PA | S01.215 | coagulation factor VIIa | complex with phenylmethanamine;hydrochloride | 5PA9_A |
| PA | S01.215 | coagulation factor VIIa | complex with cyclohexylmethanamine | 5PAA_A |
| PA | S01.215 | coagulation factor VIIa | complex with 1-[[3-[2-hydroxy-3- (1h-pyrrolo[3,2-c]pyridin-2-yl)phenyl]phenyl]methyl]-3-phenylurea | 5PAB_H |
| PA | S01.215 | coagulation factor VIIa | human factor viia in complex with 5-hydroxy-n-(4-oxo-3h-quinazolin-6- yl)-1-[3-[(phenylcarbamoylamino)methyl]phenyl]pyrazole-4-carboxamide at 1.50a | 5PAC_A |
| PA | S01.215 | coagulation factor VIIa | complex with (2s)-2-hydroxy-n-[[3-[5-hydroxy-4-(1h-pyrrolo[3,2-c]pyridin-2-yl)pyrazol-1- yl]phenyl]methyl]propanamide | 5PAE_A |
| PA | S01.215 | coagulation factor VIIa | complex with n-(2-amino-1h- benzimidazol-5-yl)-2-[3-[(2-amino-2-oxoethyl)-methylsulfonylamino]-5-chlorophenyl]acetamide;2,2,2-trifluoroacetic acid | 5PAF_A |
| PA | S01.215 | coagulation factor VIIa | complex with (2r)-2-hydroxy-n-[[3-[5-hydroxy-4-(1h-pyrrolo[3,2-c]pyridin-2-yl)pyrazol-1- yl]phenyl]methyl]-3-methylbutanamide;hydrobromide | 5PAG_A |
| PA | S01.215 | coagulation factor VIIa | human factor viia in complex with n-(2-amino-1h-benzimidazol-5-yl)-1- [3-[[(3,5-dimethyl-1,2-oxazol-4-yl)carbamoylamino]methyl]phenyl]-5- hydroxypyrazole-4-carboxamide at 1.73a | 5PAI_A |
| PA | S01.215 | coagulation factor VIIa | complex with 1-(1- aminoisoquinolin-6-yl)-3-benzylurea | 5PAJ_A |
| PA | S01.215 | coagulation factor VIIa | complex with n-[[4-(aminomethyl)- 2-(2-amino-2-oxoethoxy)phenyl]methyl]-2-(4-hydroxyphenyl)-2- methoxyacetamide;hydrochloride | 5PAK_A |
| PA | S01.215 | coagulation factor VIIa | complex with 2-[(1- aminoisoquinolin-6-yl)amino]-2-(5-ethoxy-2-fluorophenyl)-1-(2- phenylpyrrolidin-1-yl)ethanone | 5PAM_A |
| PA | S01.215 | coagulation factor VIIa | complex with 5-hydroxy-n-(3-oxo-1,2-dihydroisoindol-5-yl)-1-[3-[(phenylcarbamoylamino) methyl]phenyl]pyrazole-4-carboxamide | 5PAN_A |
| PA | S01.215 | coagulation factor VIIa | complex with (2s)-2,3-dihydroxy-n-[[3-[5-hydroxy-4-(1h-pyrrolo[3,2-c]pyridin-2-yl)pyrazol-1- yl]phenyl]methyl]propanamide;hydrobromide | 5PAO_A |
| PA | S01.215 | coagulation factor VIIa | complex with 2-[(1- aminoisoquinolin-6-yl)amino]-2-(3-ethoxy-4-propan-2-yloxyphenyl)-1- (2-phenylpyrrolidin-1-yl)ethanone | 5PAQ_A |
| PA | S01.215 | coagulation factor VIIa | complex with 1h-benzimidazol-2- amine | 5PAR_A |
| PA | S01.215 | coagulation factor VIIa | complex with (2s)-2-hydroxy-n-[[3-[5-hydroxy-4-(1h-pyrrolo[3,2-c]pyridin-2-yl)pyrazol-1- yl]phenyl]methyl]-3-phenylpropanamide | 5PAS_A |
| PA | S01.215 | coagulation factor VIIa | complex with n-(2-amino-1h- benzimidazol-5-yl)-2-(3-chlorophenyl)acetamide | 5PAT_A |
| PA | S01.215 | coagulation factor VIIa | complex with n-(2-amino-1h- benzimidazol-5-yl)-2-[3-[(2-amino-2-oxoethyl)- methylsulfonylamino]phenyl]acetamide;2,2,2-trifluoroacetic acid | 5PAU_A |
| PA | S01.215 | coagulation factor VIIa | complex with n-(6-aminopyridin-3- yl)-5-hydroxy-1-phenylpyrazole-4-carboxamide | 5PAV_A |
| PA | S01.215 | coagulation factor VIIa | complex with isoquinoline-1,6- diamine | 5PAW_A |
| PA | S01.215 | coagulation factor VIIa | complex with 1-(2,6- difluorophenyl)-3-[[3-[5-hydroxy-4-(1h-pyrrolo[3,2-c]pyridin-2-yl) pyrazol-1-yl]phenyl]methyl]urea | 5PAX_A |
| PA | S01.215 | coagulation factor VIIa | complex with 1-[[3-[5-hydroxy-4- (1h-pyrrolo[3,2-c]pyridin-2-yl)pyrazol-1-yl]phenyl]methyl]-3- phenylurea | 5PAY_A |
| PA | S01.215 | coagulation factor VIIa | complex with 2-(4-ethoxy-3- methoxyphenyl)-2-(isoquinolin-6-ylamino)acetic acid | 5PB0_A |
| PA | S01.215 | coagulation factor VIIa | complex with benzenecarboximidamide | 5PB1_A |
| PA | S01.215 | coagulation factor VIIa | complex with 2-phenyl-4-(1h- pyrrolo[3,2-c]pyridin-2-yl)pyrazol-3-ol | 5PB2_A |
| PA | S01.215 | coagulation factor VIIa | complex with 1-[[3-[4-(5-amino-1h-pyrrolo[3,2-b]pyridin-2-yl)-5-hydroxypyrazol-1-yl]phenyl]methyl]-3- phenylurea | 5PB3_A |
| PA | S01.215 | coagulation factor VIIa | human factor viia in complex with 1-[[3-[5-hydroxy-3-methyl-4-(1h- pyrrolo[3,2-c]pyridin-2-yl)pyrazol-1-yl]phenyl]methyl]-3-phenylurea at 2.43a | 5PB4_A |
| PA | S01.215 | coagulation factor VIIa | human factor viia in complex with 1-[[3-[5-hydroxy-4-(7h-pyrrolo[2,3- d]pyrimidin-6-yl)pyrazol-1-yl]phenyl]methyl]-3-phenylurea at 1.84a | 5PB5_A |
| PA | S01.215 | coagulation factor VIIa | complex with n-[[3-[5-hydroxy-4- (1h-pyrrolo[3,2-c]pyridin-2-yl)pyrazol-1-yl]phenyl]methyl]pentanamide | 5PB6_A |
| PA | S01.215 | coagulation factor VIIa | factor viia in complex with the inhibitor (5r)-5-[(1-aminoisoquinolin-6-yl)amino]-19-(cyclopropylsulfonyl)-3-methyl-13-oxa-3,15- diazatricyclo[14.3.1.1~6,10~]henicosa-1(20),6(21),7,9,16,18-hexaene- 4,14-dione | 5TQE_H |
| PA | S01.215 | coagulation factor VIIa | factor viia in complex with the inhibitor (11r)-11-[(1- aminoisoquinolin-6-yl)amino]-16-(cyclopropylsulfonyl)-13-methyl-2,13-diazatricyclo[13.3.1.1~6,10~]icosa-1(19),6(20),7,9,15,17-hexaene-3, 12-dione | 5TQF_H |
| PA | S01.215 | coagulation factor VIIa | factor viia in complex with the inhibitor (5r,11r)-11-[(1-amino-4- fluoroisoquinolin-6-yl)amino]-16-(cyclopropylsulfonyl)-7-(2,2- difluoroethoxy)-5,13-dimethyl-2,13-diazatricyclo[13.3.1.1~6, 10~]icosa-1(19),6(20),7,9,15,17-hexaene-3,12-dione | 5TQG_H |
| PA | S01.215 | coagulation factor VIIa | factor viia in complex with the inhibitor 3-[(2r)-17-ethyl-4-methyl- 3,12-dioxo-7-[(propan-2-yl)sulfonyl]-13-oxa-4,11- diazatricyclo[14.2.2.1~6,10~]henicosa-1(18),6(21),7,9,16,19-hexaen-2-yl]aminobenzamide | 5U6J_H |
| PA | S01.216 | coagulation factor Xa | 1C5M | |
| PA | S01.216 | coagulation factor Xa | complex with inhibitor RPR128515 | 1EZQ |
| PA | S01.216 | coagulation factor Xa | complex with inhibitor RPR208815 | 1F0R |
| PA | S01.216 | coagulation factor Xa | complex with inhibitor RPR208707 | 1F0S |
| PA | S01.216 | coagulation factor Xa | complex with synthetic inhibitor DX-9065a | 1FAX |
| PA | S01.216 | coagulation factor Xa | complex with inhibitor ZK-807834 | 1FJS |
| PA | S01.216 | coagulation factor Xa | chimaera with human trypsin I; complex with D-Phe-Pro-Arg-chloromethyl ketone | 1FXY |
| PA | S01.216 | coagulation factor Xa | complex with inhibitor T87 | 1G2L_A |
| PA | S01.216 | coagulation factor Xa | complex with R11 inhibitor | 1G2M |
| PA | S01.216 | coagulation factor Xa | factor Xa | 1HCG |
| PA | S01.216 | coagulation factor Xa | complex with M55532 | 1IOE_A |
| PA | S01.216 | coagulation factor Xa | complex with M55590 | 1IQE_A |
| PA | S01.216 | coagulation factor Xa | complex with M55165 | 1IQF_A |
| PA | S01.216 | coagulation factor Xa | complex with M55159 | 1IQG_A |
| PA | S01.216 | coagulation factor Xa | complex with M55143 | 1IQH_A |
| PA | S01.216 | coagulation factor Xa | complex with M55125 | 1IQI_A |
| PA | S01.216 | coagulation factor Xa | complex with M55124 | 1IQJ_A |
| PA | S01.216 | coagulation factor Xa | complex with M55113 | 1IQK_A |
| PA | S01.216 | coagulation factor Xa | complex with M54476 | 1IQL_A |
| PA | S01.216 | coagulation factor Xa | complex with M54471 | 1IQM_A |
| PA | S01.216 | coagulation factor Xa | complex with M55192 | 1IQN_A |
| PA | S01.216 | coagulation factor Xa | complex with FXV673 | 1KSN_A |
| PA | S01.216 | coagulation factor Xa | complex with (R)-2-(3-adamantan-1-yl-ureido)-3- (3-carbamimidoyl-phenyl)-N-phenethyl-propionamide | 1KYE_A |
| PA | S01.216 | coagulation factor Xa | complex with [4-([5-benzyloxy-1-(3-carbamimidoyl-benzyl)-1H-indole-2-carbonyl]-amino-methyl)-phenyl]-trimethyl-ammonium | 1LPG_A |
| PA | S01.216 | coagulation factor Xa | complex with 1-(3-carbamimidoyl-benzyl)-1H-indole-2-carboxylic acid 3-carbamimidoyl-benzylester | 1LPK_A |
| PA | S01.216 | coagulation factor Xa | complex with 1-(3-carbamimidoyl-benzyl)-4-methyl-1H-indole-2-carboxylic acid 3,5-dichloro-benzylamide | 1LPZ_A |
| PA | S01.216 | coagulation factor Xa | complex with 1-(3-carbamimidoyl-benzyl)-4-methyl-1H-indole-2-carboxylic acid 3,5-dimethyl-benzylamide | 1LQD_A |
| PA | S01.216 | coagulation factor Xa | complex with 3-chloro-n-[4-chloro-2-[[(4- chlorophenyl)amino]carbonyl]phenyl]-4-[(4-methyl-1- piperazinyl)methyl]-2-thiophenecarboxamide | 1MQ5_A |
| PA | S01.216 | coagulation factor Xa | complex with 3-chloro-n-[4-chloro-2-[[(5-chloro-2- pyridinyl)amino]carbonyl]-6-methoxyphenyl]-4-[[(4,5- dihydro-2-oxazolyl)methylamino]methyl]-2- thiophenecarboxamide | 1MQ6_A |
| PA | S01.216 | coagulation factor Xa | 1MSX | |
| PA | S01.216 | coagulation factor Xa | complex with RPR132747 | 1NFU_A |
| PA | S01.216 | coagulation factor Xa | complex with RPR209685 | 1NFW_A |
| PA | S01.216 | coagulation factor Xa | complex with RPR208944 | 1NFX_A |
| PA | S01.216 | coagulation factor Xa | complex with RPR200095 | 1NFY_A |
| PA | S01.216 | coagulation factor Xa | 1NL8 | |
| PA | S01.216 | coagulation factor Xa | complex with ecotin Met84Arg mutant | 1P0S_L |
| PA | S01.216 | coagulation factor Xa | complex with the inhibitor 1-[6-methyl-4,5,6,7- tetrahydrothiazolo(5,4-c)pyridin-2-yl] carbonyl-2- carbamoyl-4-(6-chloronaphth-2-ylsulphonyl)piperazine | 1V3X_A |
| PA | S01.216 | coagulation factor Xa | factor xa in complex with the inhibitor 4-[(5-chloroindol-2- yl)sulfonyl]-2-(2-methylpropyl)-1-[[5-(pyridin-4-yl) pyrimidin-2-yl]carbonyl]piperazine | 1WU1_A |
| PA | S01.216 | coagulation factor Xa | complex with (2S)-3'-amidino-3-biphenylyl)-5-(4-pyridylamino) pentanoic acid inhibitor | 1XKA |
| PA | S01.216 | coagulation factor Xa | complex with (2S)-3'-amidino-3-biphenylyl)-5-(4-pyridylamino) pentanoic acid inhibitor | 1XKB |
| PA | S01.216 | coagulation factor Xa | complex with razaxaban | 1Z6E_A |
| PA | S01.216 | coagulation factor Xa | complex with compound 50 | 2BMG_A |
| PA | S01.216 | coagulation factor Xa | complex with compound 1 | 2BOH_A |
| PA | S01.216 | coagulation factor Xa | factor xa- cation | 2BOK_A |
| PA | S01.216 | coagulation factor Xa | complex with compound 21 | 2BQ6_A |
| PA | S01.216 | coagulation factor Xa | complex with compound 43 | 2BQ7_A |
| PA | S01.216 | coagulation factor Xa | complex with compound 45 | 2BQW_A |
| PA | S01.216 | coagulation factor Xa | complex with 6-chloro-N-(3S)-1-[(1S)-1-methyl-2-(4-morpholinyl)-2-oxoethyl]-2-oxo-3-pyrrolidinyl-2-naphthalenesulfonamide | 2CJI_A |
| PA | S01.216 | coagulation factor Xa | complex with the inhibitor 2-[[4-[(5- chloroindol-2-yl)sulfonyl]piperazin-1-yl] carbonyl]thieno[3,2-b]pyridine n-oxide | 2D1J_A |
| PA | S01.216 | coagulation factor Xa | complex with the inhibitor (-)-cis-n1-[(5- chloroindol-2-yl)carbonyl]-n2-[(5-methyl-4,5,6,7- tetrahydrothiazolo[5,4-c]pyridin-2-yl)carbonyl]-1,2- cyclohexanediami | 2EI6_A |
| PA | S01.216 | coagulation factor Xa | complex with the inhibitor trans-n1-[(5- chloroindol-2-yl)carbonyl]-n2-[(5-methyl-4,5,6,7- tetrahydrothiazolo[5,4-c]pyridin-2-yl)carbonyl]-1,2- cyclohexanediamine | 2EI7_A |
| PA | S01.216 | coagulation factor Xa | complex with the inhibitor (1s,2r,4s)-n1-[(5- chloroindol-2-yl)carbonyl]-4-(n,n-dimethylcarbamoyl)-n2- [(5-methyl-4,5,6,7-tetrahydrothiazolo[5,4-c]pyridin-2-yl) c | 2EI8_A |
| PA | S01.216 | coagulation factor Xa | 2FZZ | |
| PA | S01.216 | coagulation factor Xa | 2G00 | |
| PA | S01.216 | coagulation factor Xa | complex with antithrombin-Ser195Ala and pentasaccharide | 2GD4_L |
| PA | S01.216 | coagulation factor Xa | complex with selectide and NAPC2 | 2H9E_H |
| PA | S01.216 | coagulation factor Xa | complex with 5-chloro-N-(3S)-1-[(1S)-1-methyl-2-morpholin-4-yl-2-5-chloro-N-(3S)-1-[(1S)-1-methyl-2-morpholin-4-yl-2-sulfonamide | 2J2U_A |
| PA | S01.216 | coagulation factor Xa | complex with 6-chloro-N-(3S)-1-[(1S)-1-methyl-2-morpholin-4-yl-2-oxoethyl]-2-oxopyrrolidin-3-yl-1-benzothiophene-2-sulfonamide | 2J34_A |
| PA | S01.216 | coagulation factor Xa | complex with 5-chloro-N-(3S)-1-[(1S)-1-methyl-2-morpholin-4-yl-2-oxoethyl]-2-oxopyrrolidin-3-yl-1-benzothiophene-2-sulfonamide | 2J38_A |
| PA | S01.216 | coagulation factor Xa | complex with 1-pyrrolidineacetamide,3-[[(6-chloro-2-naphthalenyl)sulfonyl]amino]-alpha-methyl-N-(1-methylethyl)-N-[2-[(methylsulfonyl)amino]ethyl]- 2-oxo-,(alphas,3S)- | 2J4I_A |
| PA | S01.216 | coagulation factor Xa | complex with 5-(5-chloro-2-thienyl)-N-(3S)-1-[(1S)-1-methyl-2-morpholin-4-yl-2-oxoethyl]-2-oxopyrrolidin-3-yl-1H-1,2,4-triazole-3-sulfonamide | 2J94_A |
| PA | S01.216 | coagulation factor Xa | complex with 5'-chloro-N-(3S)-1-[(1S)-1-methyl-2-morpholin-4-yl-2-oxoethyl]-2-oxopyrrolidin-3-yl-2,2'-bithiophene-5-sulfonamide | 2J95_A |
| PA | S01.216 | coagulation factor Xa | factor xa - cation inhibitor complex | 2JKH_A |
| PA | S01.216 | coagulation factor Xa | complex with the inhibitor apixaban (bms- 562247) aka 1-(4-methoxyphenyl)-7-oxo-6-(4-(2-oxo-1- piperidinyl)phenyl)-4,5,6,7-tetrahydro-1h-pyrazolo[3, 4- c]pyridine | 2P16_A |
| PA | S01.216 | coagulation factor Xa | complex with NAP5 | 2P3F_H |
| PA | S01.216 | coagulation factor Xa | complex with 3- chloro-4-(2-methylamino-imidazol-1-ylmethyl)-thiophene-2- carboxylic acid [4-chloro-2-(5-chloro-pyridin-2- ylcarbamoyl)- | 2P3T_A |
| PA | S01.216 | coagulation factor Xa | complex with 3- chloro-N-(4-chloro-2-[(5-chloropyridin-2-yl) amino]carbonyl-6-methoxyphenyl)-4-[(1-methyl-1h-imidazol- 2-yl)methyl]thi | 2P3U_A |
| PA | S01.216 | coagulation factor Xa | complex with the inhibitor 5-chloro-n-(2-(4-(2- oxopyridin-1(2h)-yl)benzamido)ethyl)thiophene-2-carboxamide | 2P93_A |
| PA | S01.216 | coagulation factor Xa | complex with the inhibitor 3-chloro-n-((1r,2s)- 2-(4-(2-oxopyridin-1(2h)-yl)benzamido)cyclohexyl)-1h- indole-6-carboxamide | 2P94_A |
| PA | S01.216 | coagulation factor Xa | complex with the inhibitor 5-chloro-n-((1r,2s)- 2-(4-(2-oxopyridin-1(2h)-yl)benzamido) cyclopentyl) thiophene-2-carboxamide | 2P95_A |
| PA | S01.216 | coagulation factor Xa | an orally efficacious factor xa inhibitor | 2PHB_A |
| PA | S01.216 | coagulation factor Xa | factor xa inhibitor | 2PR3_A |
| PA | S01.216 | coagulation factor Xa | the discovery of glycine and related amino acid-based factor xa inhibitors | 2Q1J_A |
| PA | S01.216 | coagulation factor Xa | x-ray structure of fxa in complex with 7-fluoroindazole | 2RA0_A |
| PA | S01.216 | coagulation factor Xa | selective and dual action orally active inhibitors of thrombin and factor xa | 2UWL_A |
| PA | S01.216 | coagulation factor Xa | selective and dual action orally active inhibitors of thrombin and factor xa | 2UWO_A |
| PA | S01.216 | coagulation factor Xa | factor xa inhibitor complex | 2UWP_A |
| PA | S01.216 | coagulation factor Xa | structure and property based design of factor xa inhibitors: biaryl pyrrolidin-2-ones incorporating basic heterocyclic motifs | 2VH0_A |
| PA | S01.216 | coagulation factor Xa | structure and property based design of factor xa inhibitors: pyrrolidin-2-ones with biaryl p4 motifs | 2VH6_A |
| PA | S01.216 | coagulation factor Xa | 2VVC | |
| PA | S01.216 | coagulation factor Xa | 2VVU | |
| PA | S01.216 | coagulation factor Xa | 2VVV | |
| PA | S01.216 | coagulation factor Xa | 2VWL | |
| PA | S01.216 | coagulation factor Xa | 2VWM | |
| PA | S01.216 | coagulation factor Xa | 2VWN | |
| PA | S01.216 | coagulation factor Xa | 2VWO | |
| PA | S01.216 | coagulation factor Xa | complex with bay59-7939 | 2W26_A |
| PA | S01.216 | coagulation factor Xa | complex with 4,4-disubstituted pyrrolidine-1,2-dicarboxamide inhibitor 2 | 2W3I_A |
| PA | S01.216 | coagulation factor Xa | complex with 4,4-disubstituted pyrrolidine-1,2-dicarboxamide inhibitor 1 | 2W3K_A |
| PA | S01.216 | coagulation factor Xa | 2WYG | |
| PA | S01.216 | coagulation factor Xa | 2WYJ | |
| PA | S01.216 | coagulation factor Xa | 2XBV | |
| PA | S01.216 | coagulation factor Xa | 2XBW | |
| PA | S01.216 | coagulation factor Xa | 2XBX | |
| PA | S01.216 | coagulation factor Xa | 2XBY | |
| PA | S01.216 | coagulation factor Xa | 2XC0 | |
| PA | S01.216 | coagulation factor Xa | 2XC4 | |
| PA | S01.216 | coagulation factor Xa | 2XC5 | |
| PA | S01.216 | coagulation factor Xa | 2Y5F | |
| PA | S01.216 | coagulation factor Xa | 2Y5G | |
| PA | S01.216 | coagulation factor Xa | 2Y5H | |
| PA | S01.216 | coagulation factor Xa | 2Y7X | |
| PA | S01.216 | coagulation factor Xa | 2Y7Z | |
| PA | S01.216 | coagulation factor Xa | 2Y80 | |
| PA | S01.216 | coagulation factor Xa | 2Y81 | |
| PA | S01.216 | coagulation factor Xa | 2Y82 | |
| PA | S01.216 | coagulation factor Xa | factor xa in complex with the inhibitor n-(2-(((5-chloro-2- pyridinyl) amino)sulfonyl)phenyl)-4-(2-oxo-1(2h)- pyridinyl)benzamide | 3CEN_A |
| PA | S01.216 | coagulation factor Xa | factor xa in complex with the inhibitor 1-(4-methoxyphenyl)- 6-(4-(1-(pyrrolidin-1-ylmethyl)cyclopropyl)phenyl)-3- (trifluoromethyl)-5,6-dihydro-1h-pyrazolo[3,4-c]pyridin- 7(4 | 3CS7_A |
| PA | S01.216 | coagulation factor Xa | complex with methyl (2Z)- 3-[(3-chloro-1h-indol-7-yl)amino]-2-cyano-3-[(3s)-2-oxo-1- (2-oxo-2-pyrrolidin-1-ylethyl)azepan-3-yl]aminoacrylat | 3ENS_A |
| PA | S01.216 | coagulation factor Xa | 3FFG | |
| PA | S01.216 | coagulation factor Xa | 3HPT | |
| PA | S01.216 | coagulation factor Xa | 3IIT | |
| PA | S01.216 | coagulation factor Xa | 3K9X | |
| PA | S01.216 | coagulation factor Xa | 3KL6 | |
| PA | S01.216 | coagulation factor Xa | 3KQB | |
| PA | S01.216 | coagulation factor Xa | 3KQC | |
| PA | S01.216 | coagulation factor Xa | 3KQD | |
| PA | S01.216 | coagulation factor Xa | 3KQE | |
| PA | S01.216 | coagulation factor Xa | 3LIW | |
| PA | S01.216 | coagulation factor Xa | 3M36 | |
| PA | S01.216 | coagulation factor Xa | 3M37 | |
| PA | S01.216 | coagulation factor Xa | 3Q3K | |
| PA | S01.216 | coagulation factor Xa | 3SW2 | |
| PA | S01.216 | coagulation factor Xa | 3TK5 | |
| PA | S01.216 | coagulation factor Xa | 3TK6 | |
| PA | S01.216 | coagulation factor Xa | 4A7I | |
| PA | S01.216 | coagulation factor Xa | 4BTI | |
| PA | S01.216 | coagulation factor Xa | 4BTT | |
| PA | S01.216 | coagulation factor Xa | 4BTU | |
| PA | S01.216 | coagulation factor Xa | 4Y6D | |
| PA | S01.216 | coagulation factor Xa | 4Y71 | |
| PA | S01.216 | coagulation factor Xa | 4Y76 | |
| PA | S01.216 | coagulation factor Xa | 4Y79 | |
| PA | S01.216 | coagulation factor Xa | 4Y7A | |
| PA | S01.216 | coagulation factor Xa | 4Y7B | |
| PA | S01.216 | coagulation factor Xa | factor xa complex with gtc000006 | 4ZH8_A |
| PA | S01.216 | coagulation factor Xa | factor xa complex with gtc000102 | 4ZHA_A |
| PA | S01.216 | coagulation factor Xa | complex with synthetic inhibitor benzylsulfonyl- dser(benzyl)-gly-4-amidinobenzylamide | 5K0H_A |
| PA | S01.216 | coagulation factor Xa | desgla-xas195a bound to aptamer 11f7t | 5VOE_H |
| PA | S01.216 | coagulation factor Xa | desgla-xas195a bound to aptamer 11f7t and rivaroxaban ***caveat 5vof | 5VOF_H |
| PA | S01.216 | coagulation factor Xa | NMR structure of EGF-like module | 1APO |
| PA | S01.216 | coagulation factor Xa | NMR structure; N-terminal EGF-like module | 1CCF |
| PA | S01.216 | coagulation factor Xa | 1IOD | |
| PA | S01.216 | coagulation factor Xa | complex with Ornithidoros moubata inhibitor | 1KIG_H |
| PA | S01.216 | coagulation factor Xa | NMR structure; Gla and EGF-like domains | 1WHE |
| PA | S01.216 | coagulation factor Xa | NMR structure; Gla and EGF-like domains | 1WHF |
| PA | S01.217 | thrombin | complex with aeruginosin 298A inhibitor | 1A2C_H |
| PA | S01.217 | thrombin | complex with boronate form of hirudin II inhibitor | 1A3B_H |
| PA | S01.217 | thrombin | complex with boronate form of hirudin II inhibitor | 1A3E_H |
| PA | S01.217 | thrombin | complex with hirugen and (1S,7S)-7-amino-N-[(2R,3S)-7-amino-1-(cyclohexylamino)- 2-hydroxy-1-oxoheptan-3-yl]-7-benzyl-8-oxohexahydro- 1H-pyrazolo[1,2-a]pyridazine-1-carboxamide | 1A46_H |
| PA | S01.217 | thrombin | complex with hirudin I and a thiazole-containing inhibitor | 1A4W_H |
| PA | S01.217 | thrombin | complex with hirugen and (1S,7S)-7-amino-7-benzyl-N-[(1S)-4-carbamimidamido- 1-(1S)-1-hydroxy-2-oxo-2-[(2-phenylethyl)amino]ethylbutyl]- 8-oxohexahydro-1H-pyrazolo[1,2-a]pyridazine- 1-carboxamide | 1A5G_H |
| PA | S01.217 | thrombin | complex with hirudin IIIB' inhibitor | 1A61_H |
| PA | S01.217 | thrombin | complex with hirulog 3 | 1ABI_H |
| PA | S01.217 | thrombin | complex with D-Phe-Pro-Arg chloromethylketone | 1ABJ |
| PA | S01.217 | thrombin | complex with hirudin variant I | 1AD8_H |
| PA | S01.217 | thrombin | complex with hirudin I and EOC-D-Phe-Pro-azaLys-ONP inhibitor | 1AE8_H |
| PA | S01.217 | thrombin | complex with hirudin I and CBZ-Pro-azaLys-ONP inhibitor | 1AFE_H |
| PA | S01.217 | thrombin | alpha-thrombin; complex with p-amidino-Phe-pyruvate | 1AHT_H |
| PA | S01.217 | thrombin | complex with hirugen and morpholino-diphenylalanine-methoxypropylboronic acid | 1AI8_H |
| PA | S01.217 | thrombin | complex with hirugen and phenylmethylenecarboxy-(methyleneamino-formyl-diphenylmethyl)methy-pro-boroval | 1AIX_H |
| PA | S01.217 | thrombin | complex with hirugen inhibitor | 1AWF_H |
| PA | S01.217 | thrombin | 1AWH | |
| PA | S01.217 | thrombin | complex with amino(3-[(3R,5R,14S,16S,21aR)-5,14-dihydroxy-1,4,17-trioxo-16-(2-phenylethyl)icosahydro-1H-pyrrolo[1,2-d][1,4,7,11]tetraazacyclononadecin-3-yl]propylamino)methaniminium inhibitor from sponge Theonalla | 1AY6_H |
| PA | S01.217 | thrombin | complex with hirugen and [[[(4S,5S)-4-[[(3S,6S,8aR)-6-azanyl-5-oxo- 6-(phenylmethyl)-1,2,3,7,8,8a-hexahydroindolizin- 3-yl]carbonylamino]-5-(1,3-benzothiazol-2- yl)-5-hydroxy-pentyl]amino]-azanyl-methylidene]azanium | 1B5G_H |
| PA | S01.217 | thrombin | Tyr225Ile mutant; complex with D-Phe-Pro-Arg-chloromethylketone | 1B7X |
| PA | S01.217 | thrombin | complex with hirugen and benzylsulfinyl-norVal-Gly-Arg inhibitor | 1BA8_B |
| PA | S01.217 | thrombin | complex with hirugen | 1BB0_B |
| PA | S01.217 | thrombin | complex with inhibitor with rigid tripeptidyl aldehyde | 1BBO |
| PA | S01.217 | thrombin | complex with hirugen and proflavin | 1BCU_H |
| PA | S01.217 | thrombin | complex with SDZ 229-357 inhibitor | 1BHX |
| PA | S01.217 | thrombin | complex with hirudin I and BMS-186282 synthetic inhibitor | 1BMM_L |
| PA | S01.217 | thrombin | complex with hirudin I and BMS-186282 synthetic inhibitor | 1BMN_L |
| PA | S01.217 | thrombin | complex with bovine pancreatic trypsin inhibitor | 1BTH_LH |
| PA | S01.217 | thrombin | complex with acetyl-hirudin and (5-amidino-2-benzimidazolyl) (2-benzimidazolyl)methane | 1C1U_L |
| PA | S01.217 | thrombin | complex with acetyl-hirudin and bis(5-amidino-2-benzimidazolyl)methane | 1C1V_L |
| PA | S01.217 | thrombin | complex with acetyl-hirudin and bis(5-amidino-2-benzimidazolyl)methane ketone hydrate | 1C1W_L |
| PA | S01.217 | thrombin | 1C4U | |
| PA | S01.217 | thrombin | complex with 2-(2,2-diphenyl-ethyl)-7-methyl-1,3-dioxo-2,3,5,8-tetrahydro-1H-[1,2,4]triazolo [1,2-A]pyridazine-5-carboxylic acid(4-carbamimidoyl-cyclohexylmethyl)-amide | 1C4V |
| PA | S01.217 | thrombin | complex with 2-(2,2-diphenyl-ethyl)-7-methyl-1,3-dioxo-2,3,5,8-tetrahydro-1H-[1,2,4] triazolo[1,2-A]pyridazine-5-carboxylic acid [4-(2-amino-3H-imidazol-4-yl)-cyclohexyl]-amide | 1C4Y |
| PA | S01.217 | thrombin | complex with hirugen and benzylsulfinyl-norVal-Gly-3-piperidyl-N-guandino-L-alaninal | 1CA8_A |
| PA | S01.217 | thrombin | complex with 5-amidinoindole-4-benzylpiperidine inhibitor | 1D4P_A |
| PA | S01.217 | thrombin | complex with selective non-electrophilic inhibitors having cyclohexyl moieties at p1 | 1D6W_A |
| PA | S01.217 | thrombin | complex with 2-propyl-pentanoic acid divalent inhibitor | 1DIT |
| PA | S01.217 | thrombin | Ser195Ala mutant; complex with fibrinopeptide a (7-16) | 1DM4_A |
| PA | S01.217 | thrombin | complex with RWJ-51438 and hirugen | 1DOJ_A |
| PA | S01.217 | thrombin | alpha-thrombin; complex with des-Asp55 hirudin and benzamidine | 1DWB_L |
| PA | S01.217 | thrombin | alpha-thrombin; complex with des-Asp55 hirudin and MD-805 | 1DWC_L |
| PA | S01.217 | thrombin | alpha-thrombin; complex with des-Asp55 hirudin and NAPAP | 1DWD_L |
| PA | S01.217 | thrombin | alpha-thrombin; complex with des-Asp55 hirudin and D-Phe-Pro-Arg-chloromethylketone | 1DWE_L |
| PA | S01.217 | thrombin | complex with thrombomodulin | 1DX5_A |
| PA | S01.217 | thrombin | complex with haemadin | 1E0F_AD |
| PA | S01.217 | thrombin | complex with inhibitor P798 | 1EOJ |
| PA | S01.217 | thrombin | complex with inhibitor P628 | 1EOL |
| PA | S01.217 | thrombin | alpha-thrombin; complex with hirugen and dansylArg-N-(3-ethyl-1,5-pentanediyl)amide | 1FPC_L |
| PA | S01.217 | thrombin | alpha-thrombin; complex with hirudin and fibrinopeptide A | 1FPH |
| PA | S01.217 | thrombin | complex with bch-10556 andexosite-directed peptide | 1G37_A |
| PA | S01.217 | thrombin | complex with hirudin I and N-[(benzyloxy)carbonyl]-beta-phenyl-D-phenylalanyl- N-(1S,3E)-1-[dihydroxy(diphenoxy)-lambda~5~- phosphanyl]-4-methoxybut-3-en-1-yl-L-prolinamide | 1H8D_LH |
| PA | S01.217 | thrombin | complex with hirudin I and N-[(benzyloxy)carbonyl]-beta-phenyl-D-phenylalanyl- N-[(1S)-4-methoxy-1-phosphonobutyl]-L-prolinamide | 1H8I_LH |
| PA | S01.217 | thrombin | prethrombin; complex with hirugen | 1HAG_E |
| PA | S01.217 | thrombin | alpha-thrombin; complex with hirugen | 1HAH_LH |
| PA | S01.217 | thrombin | alpha-thrombin; complex with D-Phe-Pro-Arg-chloromethylketone | 1HAI |
| PA | S01.217 | thrombin | alpha-thrombin; complex with 15-mer oligonucleotide | 1HAO |
| PA | S01.217 | thrombin | alpha-thrombin; complex with 15-mer oligonucleotide | 1HAP |
| PA | S01.217 | thrombin | alpha-thrombin; complex with a peptidyl pyridinium methyl ketone | 1HBT |
| PA | S01.217 | thrombin | alpha-thrombin; complex with hirugen | 1HDT |
| PA | S01.217 | thrombin | alpha-thrombin; complex with hirugen | 1HGT |
| PA | S01.217 | thrombin | alpha-thrombin; complex with thrombomodulin and D-Phe-Pro-Arg-chloromethylketone | 1HLT |
| PA | S01.217 | thrombin | alpha-thrombin; complex with DNA and D-Phe-Pro-Arg-chloromethylketone | 1HUT |
| PA | S01.217 | thrombin | complex with hirudin variant 1 | 1HXE_L |
| PA | S01.217 | thrombin | complex with hiruden variant | 1HXF_L |
| PA | S01.217 | thrombin | alpha-thrombin; complex with hirutonin-2 | 1IHS_L |
| PA | S01.217 | thrombin | alpha-thrombin; complex with hirutonin-6 | 1IHT_L |
| PA | S01.217 | thrombin | Ser195Ala; complex with heparin cofactor II | 1JMO_L |
| PA | S01.217 | thrombin | complex with a novel bicyclic lactam inhibitor | 1JWT_A |
| PA | S01.217 | thrombin | complex with acetyl-D-Phe-Pro-boroArg-OH inhibitor | 1LHC |
| PA | S01.217 | thrombin | complex with acetyl-D-Phe-Pro-boroLys-OH inhibitor | 1LHD |
| PA | S01.217 | thrombin | complex with AC-D-Phe-Pro-boro-N-butyl-amidino-Gly-OH | 1LHE |
| PA | S01.217 | thrombin | complex with AC-D-Phe-Pro-boro-homoLys-OH | 1LHF |
| PA | S01.217 | thrombin | complex with AC-D-Phe-Pro-boroornithine-OH | 1LHG |
| PA | S01.217 | thrombin | anticoagulant slow form | 1MH0 |
| PA | S01.217 | thrombin | alpha-thrombin; non-covalent complex with receptor based peptide NRS | 1NRN |
| PA | S01.217 | thrombin | alpha-thrombin; non-covalent complex with receptor based peptide NRP | 1NRO |
| PA | S01.217 | thrombin | alpha-thrombin; non-covalent complex with receptor based peptide NR'S | 1NRP |
| PA | S01.217 | thrombin | alpha-thrombin; non-covalent complex with receptor based peptide D-FPR'S | 1NRQ |
| PA | S01.217 | thrombin | alpha-thrombin; non-covalent complex with receptor based peptide XA and D-Phe-Pro-Arg-chloromethylketone | 1NRR |
| PA | S01.217 | thrombin | alpha-thrombin; non-covalent complex with receptor based peptide NRP and hirugen | 1NRS_L |
| PA | S01.217 | thrombin | complex with staphylocoagulase | 1NU7 |
| PA | S01.217 | thrombin | staphylocoagulase-prethrombin-2 complex | 1NU9_A |
| PA | S01.217 | thrombin | d-phe-pro-arg-type thrombin inhibitor | 1NZQ_L |
| PA | S01.217 | thrombin | complex with a D-Phe-Pro-Arg-type inhibitor and a C-terminal hirudin derived exo-site inhibitor | 1O0D_L |
| PA | S01.217 | thrombin | dissecting and designing inhibitor selectivity determinants at the s1 site using an artificial Ala190 protease (ala190 upa) | 1O5G_L |
| PA | S01.217 | thrombin | complex with platelet receptor gpib-alpha | 1OOK_A |
| PA | S01.217 | thrombin | complex with a designed fluorinated inhibitor | 1OYT_L |
| PA | S01.217 | thrombin | complex with platelet receptor gpib-alpha | 1P8V_B |
| PA | S01.217 | thrombin | alpha-thrombin; complex with D-Phe-Pro-Arg chloromethylketone | 1PPB |
| PA | S01.217 | thrombin | complex with [phenylalaninyl-prolinyl]-[2-(pyridin-4-ylamino)-ethyl]-amine | 1QBV_L |
| PA | S01.217 | thrombin | complex with hirugen and Asp-Phe-Glu-Glu-Ile-Pro-Glu-Glu-sulfonated Tyr-Leu | 1QHR_A |
| PA | S01.217 | thrombin | complex with hirugen and Asp-Phe-Glu-Glu-Ile-Pro-Glu-Glu-sulfonated Tyr-Leu | 1QJ6_A |
| PA | S01.217 | thrombin | complex with hirugen and Asp-Phe-Glu-Glu-Ile-Pro-Glu-Glu-sulfonated Tyr-Leu | 1QJ7_A |
| PA | S01.217 | thrombin | complex with hirugen and Asp-Phe-Glu-Glu-Ile-Pro-Glu-Glu-sulfonated Tyr-Leu | 1QJI |
| PA | S01.217 | thrombin | complex with bivalent, benzamidine-based synthetic inhibitor BZA-2 hirulog | 1QUR |
| PA | S01.217 | thrombin | variant Glu217Lys | 1RD3_A |
| PA | S01.217 | thrombin | complex with natural product inhibitor oscillarin | 1RIW_A |
| PA | S01.217 | thrombin | fast form mutant Arg77Ala; complex with PPACK | 1SFQ_A |
| PA | S01.217 | thrombin | procoagulant fast form | 1SG8_A |
| PA | S01.217 | thrombin | anticoagulant slow form | 1SGI_A |
| PA | S01.217 | thrombin | slow form; complex with PPACK | 1SHH_A |
| PA | S01.217 | thrombin | antithrombin-anhydrothrombin-heparin ternary complex structure | 1SR5_B |
| PA | S01.217 | thrombin | complex with a novel oxyguanidine | 1T4U_L |
| PA | S01.217 | thrombin | complex with a novel oxyguanidine | 1T4V_L |
| PA | S01.217 | thrombin | complex with antithrombin and thrombin | 1TB6_L |
| PA | S01.217 | thrombin | complex with exosite-hirugen and trifluoroacetate inhibitor | 1TBZ |
| PA | S01.217 | thrombin | Tyr225Pro mutant; complex with D-Phe-Pro-Arg-chloromethylketone | 1THP |
| PA | S01.217 | thrombin | alpha-thrombin; complex with hirullin | 1THR_L |
| PA | S01.217 | thrombin | alpha-thrombin; complex with MDL-28050 | 1THS |
| PA | S01.217 | thrombin | alpha-thrombin; complex with hirugen and cyclotheonamide A | 1TMB_L |
| PA | S01.217 | thrombin | alpha-thrombin; complex with CGP 50,856 | 1TMT_L |
| PA | S01.217 | thrombin | alpha-thrombin; complex with hirudin fragment and D-Phe-Pro-Arg chloromethylketone | 1TMU_L |
| PA | S01.217 | thrombin | complex with hirugen | 1TOM |
| PA | S01.217 | thrombin | anticoagulant mutant Trp215Ala/Glu217Ala in free form | 1TQ0_A |
| PA | S01.217 | thrombin | anticoagulant mutant Trp215Ala/Glu217Ala; complex with PPACK | 1TQ7_A |
| PA | S01.217 | thrombin | complex with hirugen and NA-(N,N-dimethylcarbamoyl)-alpha-azalysine | 1UMA_L |
| PA | S01.217 | thrombin | complex with BM51.1011 | 1UVS |
| PA | S01.217 | thrombin | complex with Asp-Phe-Glu-Glu-Ile-Pro-Glu-Glu-Tyr-Leu (t-plasminogen activator loop) | 1VR1_L |
| PA | S01.217 | thrombin | complex with heparin | 1XMN_A |
| PA | S01.217 | thrombin | complex with a p2 pyridine n-oxide inhibitor | 1Z71_A |
| PA | S01.217 | thrombin | Gly193Ala mutant; complex with PPACK | 1Z8I_A |
| PA | S01.217 | thrombin | complex with an oxazolopyridine inhibitor 21 | 1ZGI_A |
| PA | S01.217 | thrombin | complex with an oxazolopyridine inhibitor 2 | 1ZGV_A |
| PA | S01.217 | thrombin | in 400 mm potassium chloride | 2A0Q_A |
| PA | S01.217 | thrombin | orally active thrombin inhibitors in complex with thrombin inh12 | 2A2X_L |
| PA | S01.217 | thrombin | complex with the central "E" region of fibrin | 2A45_A |
| PA | S01.217 | thrombin | sodium free state | 2AFQ_A |
| PA | S01.217 | thrombin | orally active thrombin inhibitors in complex with thrombin and an exosite decapeptide | 2ANK_H |
| PA | S01.217 | thrombin | ternary complex with an orally active thrombin inhibitor and a c-terminal hirudin derived exo-sit inhibitor | 2ANM_H |
| PA | S01.217 | thrombin | two Ser195Ala mutant molecules; nonproductive complex with antithrombin and synthetic heparin mimetic sr123781 | 2B5T_A |
| PA | S01.217 | thrombin | complex with inhibitor | 2BDY_A |
| PA | S01.217 | thrombin | complex with fragment-based small molecules occupying the s1 pocket | 2BVR_H |
| PA | S01.217 | thrombin | complex with fragment-based small molecules occupying the s1 pocket | 2BVS_H |
| PA | S01.217 | thrombin | design and discovery of novel, potent thrombin inhibitors with a solubilizing cationic p1-p2-linker | 2BVX_H |
| PA | S01.217 | thrombin | design and discovery of novel, potent thrombin inhibitors with a solubilizing cationic p1-p2-linker | 2BXT_H |
| PA | S01.217 | thrombin | design and discovery of novel, potent thrombin inhibitors with a solubilizing cationic p1-p2-linker | 2BXU_H |
| PA | S01.217 | thrombin | complex with a designed inhibitor | 2CN0_H |
| PA | S01.217 | thrombin | orally active thrombin inhibitors | 2FEQ_L |
| PA | S01.217 | thrombin | orally active thrombin inhibitors | 2FES_L |
| PA | S01.217 | thrombin | slow form in a self- inhibited conformation | 2GP9_A |
| PA | S01.217 | thrombin | complex with suramin | 2H9T_L |
| PA | S01.217 | thrombin | alpha-thrombin; complex with hirugen and fibrinopeptide A mimic | 2HAT |
| PA | S01.217 | thrombin | alpha-thrombin; complex with hirulog 1 | 2HGT_L |
| PA | S01.217 | thrombin | gamma-thrombin | 2HNT |
| PA | S01.217 | thrombin | alpha-thrombin; complex with D-Phe-Pro-Arg chloromethylketone and bovine prothrombin fragment 2 | 2HPP_L |
| PA | S01.217 | thrombin | alpha-thrombin; complex with D-Phe-Pro-Arg chloromethylketone and bovine prothrombin fragment 2 | 2HPQ |
| PA | S01.217 | thrombin | complex with hirugen | 2JH0_C |
| PA | S01.217 | thrombin | complex with hirugen | 2JH5_C |
| PA | S01.217 | thrombin | complex with hirugen | 2JH6_C |
| PA | S01.217 | thrombin | human thrombin chimera with human residues 184a, 186, 186a, 186b, 186cand 222 replaced by murine thrombin equivalents. | 2OD3_A |
| PA | S01.217 | thrombin | inhibitor-free human thrombin mutant c191a-c220a | 2PGB_A |
| PA | S01.217 | thrombin | Cys191Ala-Cys220Ala mutant; complex with the inhibitor PPACK | 2PGQ_A |
| PA | S01.217 | thrombin | complex with 4-([4-(3-methylbenzoyl)pyridin-2-yl]aminomethyl)benzenecarboximidamide | 2PKS_A |
| PA | S01.217 | thrombin | complex with sulfo-hirudin | 2PW8_L |
| PA | S01.217 | thrombin | Tyr225Phe mutant; complex with D-Phe-Pro-Arg-chloromethylketone | 2THF |
| PA | S01.217 | thrombin | thrombin with 3-cycle no f | 2V3H_H |
| PA | S01.217 | thrombin | complex with heparin and PCI | 3B9F_L |
| PA | S01.217 | thrombin | crystal structure of thrombin bound to the extracellular fragment of par1 | 3BEF_A |
| PA | S01.217 | thrombin | slow form in a self_inhibited conformation | 3BEI_A |
| PA | S01.217 | thrombin | thrombin:suramin complex | 3BF6_L |
| PA | S01.217 | thrombin | complex with inhibitor fm19 | 3BV9_A |
| PA | S01.217 | thrombin | complex with inhibitor 15 | 3C1K_A |
| PA | S01.217 | thrombin | cyanofluorophenylacetamides as orally efficacious thrombin inhibitors | 3C27_A |
| PA | S01.217 | thrombin | complex with inhibitor | 3DA9_A |
| PA | S01.217 | thrombin | complex with an RNA aptamer bound | 3DD2_L |
| PA | S01.217 | thrombin | meizothrombin desf1 | 3E6P_L |
| PA | S01.217 | thrombin | Trp215Ala/Glu217Ala mutant | 3EE0_A |
| PA | S01.217 | thrombin | mutant delta(146-149e) in the free form | 3GIC_A |
| PA | S01.217 | thrombin | Na-free form; complex with thrombomodulin | 3GIS_A |
| PA | S01.217 | thrombin | alpha-thrombin; complex with hirugen and fibrinopeptide A mimic | 3HAT_L |
| PA | S01.217 | thrombin | Trp215Ala/Glu217Ala mutant; complex withthe extracellular fragment of human par1 | 3HKJ_A |
| PA | S01.217 | thrombin | alpha-thrombin; complex with recombinant hirudin variant 2 | 3HTC_LH |
| PA | S01.217 | thrombin | Asn143Pro mutant in e:na+ form | 3JZ1_A |
| PA | S01.217 | thrombin | Asn143Pro mutant in e* form | 3JZ2_A |
| PA | S01.217 | thrombin | precursor; complex with fragment-2 | 3K65_A |
| PA | S01.217 | thrombin | Ser195Ala mutant; complex with the extracellular fragment of human par1 | 3LU9_A |
| PA | S01.217 | thrombin | precursor | 3NXP_A |
| PA | S01.217 | thrombin | structural basis of thrombin mediated factor v activation: essential role of the hirudin-like sequence glu666-glu672 for processing at theheavy chain-b domain junction | 3P6Z_A |
| PA | S01.217 | thrombin | structural basis of thrombin-mediated factor v activation: essential role of the hirudin-like sequence glu666-glu672 for processing at theheavy chain-b domain junction | 3P70_A |
| PA | S01.217 | thrombin | mechanism of sulfotyrosine-mediated glycoprotein ib interaction with two distinct alpha-thrombin sites | 3PMH_A |
| PA | S01.217 | thrombin | complex with benzothiazole guanidine | 3PO1_A |
| PA | S01.217 | thrombin | Asp102Asn mutant; complex with the extracellular fragment of human par4. | 3QDZ_A |
| PA | S01.217 | thrombin | the allosteric e*-e equilibrium is a key property of the trypsin fold | 3QGN_A |
| PA | S01.217 | thrombin | complex with a modified thrombin binding aptamer (mtba) | 3QLP_H |
| PA | S01.217 | thrombin | human thrombin with residues 145-150 of murine thrombin. | 3R3G_A |
| PA | S01.217 | thrombin | Tyr225Pro mutant in the e* form | 3S7H_A |
| PA | S01.217 | thrombin | Tyr225Pro mutant in the e form | 3S7K_A |
| PA | S01.217 | thrombin | prethrombin-2 mutant Ser195Ala in the alternative form | 3SQE_E |
| PA | S01.217 | thrombin | prethrombin-2 mutant Ser195Ala in the the open form | 3SQH_E |
| PA | S01.217 | thrombin | unliganded wild-type | 3U69_L |
| PA | S01.217 | thrombin | complex with D-Phe-Pro-D-Arg-D-Thr | 3U8O_L |
| PA | S01.217 | thrombin | complex with D-Phe-Pro-D-Arg-Ile | 3U8R_L |
| PA | S01.217 | thrombin | complex with D-Phe-Pro-D-Arg-Cys | 3U8T_L |
| PA | S01.217 | thrombin | complex with thrombin | 4BOH_HL |
| PA | S01.217 | thrombin | low-salt crystal structure; complex with GPIBalpha peptide | 4CH2_A |
| PA | S01.217 | thrombin | high-salt crystal structure; complex with GPIBalpha peptide | 4CH8_A |
| PA | S01.217 | thrombin | complex with thrombin binding aptamer in the presence of sodium ions | 4DIH_L |
| PA | S01.217 | thrombin | complex with thrombin binding aptamer in the presence of potassium ions | 4DII_L |
| PA | S01.217 | thrombin | complex with anophelin | 4E05_L |
| PA | S01.217 | thrombin | complex with anophelin | 4E06_L |
| PA | S01.217 | thrombin | crystal structure of thrombin mutant Glu14ea/Asp14la/Glu18Ala/Ser195Ala | 4H6S_A |
| PA | S01.217 | thrombin | crystal structure of prethrombin-2 mutant e14ea/d14la/e18a/s195a | 4H6T_A |
| PA | S01.217 | thrombin | Ser195Ala mutant; complex with argatroban | 4HFP_A |
| PA | S01.217 | thrombin | alpha-thrombin; complex with recombinant hirudin variant 2 | 4HTC_LH |
| PA | S01.217 | thrombin | recombinant Gla-domainless prothrombin mutant Ser525Ala | 4HZH_A |
| PA | S01.217 | thrombin | complex with a 27-mer aptamer bound to exosite ii | 4I7Y_H |
| PA | S01.217 | thrombin | complex with the tba deletion mutant lacking thymine 12 nucleobase | 4LZ1_L |
| PA | S01.217 | thrombin | complex with the tba deletion mutant lacking thymine 3 nucleobase | 4LZ4_A |
| PA | S01.217 | thrombin | crystal structure of ca2+-free prothrombin deletion mutant residues 146-167 | 4NZQ_A |
| PA | S01.217 | thrombin | crystal structure of ca2+ bound prothrombin deletion mutant residues 146-167 | 4O03_A |
| PA | S01.217 | thrombin | Ser195Thr mutant (free form) | 4RKJ_A |
| PA | S01.217 | thrombin | Ser195Thr mutant; complex with PPACK | 4RKO_B |
| PA | S01.217 | thrombin | Ser195Ala mutant; complex with the active site inhibitor argatroban | 4RN6_A |
| PA | S01.217 | thrombin | complex with hirunorm IV inhibitor | 4THN |
| PA | S01.217 | thrombin | complex with 4-(((1-((2s)-1-((2r)-2-( benzylsulfonylamino)-3-phenyl-propanoyl)pyrrolidin-2-yl)-1- oxo-ethyl)amino)methyl)benzamidine | 4UFD_H |
| PA | S01.217 | thrombin | complex with (2r)-2-(benzylsulfonylamino)-n-(2-( (4-carbamimidoylphenyl)methylamino)-2-oxo-butyl)-3-phenyl- propanamide | 4UFE_H |
| PA | S01.217 | thrombin | complex with (2r)-2-(benzylsulfonylamino)-n-(2-( (4-carbamimidoylphenyl)methylamino)-2-oxo-ethyl)-n-methyl- 3-phenyl-propanamide | 4UFF_H |
| PA | S01.217 | thrombin | complex with (2r)-2-(benzylsulfonylamino)-n-(( 1s)-2-((4-carbamimidoylphenyl)methylamino)-1-methyl-2-oxo- ethyl)-n-methyl-3-phenyl-propanamide ethane | 4UFG_H |
| PA | S01.217 | thrombin | thrombin inhibitor | 5A2M_H |
| PA | S01.217 | thrombin | complex with 3-chloro-benzamide | 5AFY_H |
| PA | S01.217 | thrombin | complex with (2r)-2-(benzylsulfonylamino)-n-(2-( (4-carbamimidoylphenyl)methylamino)-2-oxo-propyl)-3-phenyl- propanamide | 5AFZ_H |
| PA | S01.217 | thrombin | complex with ((4-chlorophenyl)sulfamoyl))diemethylamine | 5AHG_H |
| PA | S01.217 | thrombin | complex with a duplex/quadruplex 31-mer DNA aptamer | 5CMX_L |
| PA | S01.217 | thrombin | complex with RNA aptamer | 5DO4_L |
| PA | S01.217 | thrombin | complex with an exosite 1-specific IgA Fab | 5E8E_A |
| PA | S01.217 | thrombin | prothrombin deletion mutant residues 146-167 ( form ii ). | 5EDK_A |
| PA | S01.217 | thrombin | prothrombin deletion mutant residues 154-167 ( form i ) | 5EDM_A |
| PA | S01.217 | thrombin | sandwiched between two dna aptamers: hd22 and hd1- deltat3 | 5EW1_L |
| PA | S01.217 | thrombin | sandwiched between two dna aptamers: hd22 and hd1- deltat12 | 5EW2_L |
| PA | S01.217 | thrombin | complex with hirunorm V | 5GDS |
| PA | S01.217 | thrombin | complex with avathrin | 5GIM_A |
| PA | S01.217 | thrombin | Asp189Ala mutant | 5JDU_A |
| PA | S01.217 | thrombin | complex with (s)-n-(2-(aminomethyl)-5-chlorobenzyl)-1- ((benzylsulfonyl)-d-arginyl)pyrrolidine-2-carboxamide | 5JFD_L |
| PA | S01.217 | thrombin | complex with (s)-1-((r)-2-amino-3-cyclohexylpropanoyl)-n- (4-carbamimidoylbenzyl)pyrrolidine-2-carboxamide | 5JZY_L |
| PA | S01.217 | thrombin | complex with madanin | 5L6N_H |
| PA | S01.217 | thrombin | complex with (s)-1-((r)-2-amino-3-cyclohexylpropanoyl)-n- (5-chloro-2-(hydroxymethyl)benzy l)pyrrolidine-2-carboxamide | 5LCE_L |
| PA | S01.217 | thrombin | complex with (s)-1-((r)-2-amino-3-cyclohexylpropanoyl)-n- (2-(aminomethyl)-5-chlorobenzyl) pyrrolidine-2-carboxamide | 5LPD_L |
| PA | S01.217 | thrombin | Ala190Ser mutant; complex with (s) -1 - ((r) -2-amino-3,3- diphenylpropanoyl) -n- (3-chlorobenzyl) pyrrolidine-2-carboxamide | 5MJT_L |
| PA | S01.217 | thrombin | Ala190Ser mutant; complex with (s)-1-(d-phenylalanyl)-n-(3- chlorobenzyl)pyrrolidine-2-carboxamide | 5MLS_L |
| PA | S01.217 | thrombin | Ala190Ser mutant; complex with (s)-1-(d-phenylalanyl)-n-(4- carbamimidoylbenzyl)pyrrolidine-2-carboxamide | 5MM6_L |
| PA | S01.217 | thrombin | complex with anopheles gambiae ce5 anticoagulant | 5NHU_L |
| PA | S01.217 | thrombin | Trp215Ala/Glu217Ala mutant fused to EGF456 of thrombomodulin via a 31-residue linker; complex with PPACK | 5TO3_A |
| PA | S01.217 | thrombin | prothrombin mutant Ser101Cys/Ala470Cys | 6BJR_A |
| PA | S01.217 | thrombin | crystal structure of human prothrombin mutant s101c/a470c | 6C2W_A |
| PA | S01.217 | thrombin | reversible covalent direct thrombin inhibitors | 6CYM_A |
| PA | S01.217 | thrombin | complex with a novel glucose-conjugated potent inhibitor | 6EO8_L |
| PA | S01.217 | thrombin | complex with a novel glucose-conjugated potent inhibitor | 6EO9_H |
| PA | S01.217 | thrombin | complex with nu172,a duplex/quadruplex 26-mer dna aptamer, in the presence of potassium ions. | 6EVV_L |
| PA | S01.217 | thrombin | complex with 4-chloro-benzamidine | 6FJT_L |
| PA | S01.217 | thrombin | complex with mi2100 ((s)-n-(2-(aminomethyl)-5- chlorobenzyl)-1-((benzylsulfonyl)-l-arginyl)pyrrolidine-2- carboxamide) | 6GBW_L |
| PA | S01.217 | thrombin | complex with nu172,a duplex/quadruplex 26-mer DNA aptamer, in the presence of sodium ions. | 6GN7_L |
| PA | S01.217 | thrombin | complex with SEL2711 inhibitor | 7KME |
| PA | S01.217 | thrombin | complex with SEL2710 inhibitor | 8KME |
| PA | S01.217 | thrombin | meizothrombin desF1 | 1A0H |
| PA | S01.217 | thrombin | complex with Triatoma pallidipennis inhibitor triabin | 1AVG_H |
| PA | S01.217 | thrombin | complex with fibrinopeptide alpha | 1BBR |
| PA | S01.217 | thrombin | epsilon-thrombin; non-covalent complex with MQPA | 1ETR |
| PA | S01.217 | thrombin | epsilon-thrombin; non-covalent complex with NAPAP | 1ETS |
| PA | S01.217 | thrombin | epsilon-thrombin; non-covalent complex with 4-TAPAP | 1ETT |
| PA | S01.217 | thrombin | alpha-thrombin; complex with hirudin variant 1 | 1HRT_L |
| PA | S01.217 | thrombin | complex with ecotin | 1ID5_H |
| PA | S01.217 | thrombin | complex of alpha-thrombin and prethrombin-2 | 1MKW |
| PA | S01.217 | thrombin | complex of alpha-thrombin and prethrombin-2 | 1MKX |
| PA | S01.217 | thrombin | 1NL1 | |
| PA | S01.217 | thrombin | 1NL2 | |
| PA | S01.217 | thrombin | complex with rhodniin inhibitor | 1TBQ_H |
| PA | S01.217 | thrombin | complex with rhodniin inhibitor | 1TBR_H |
| PA | S01.217 | thrombin | complex with ornithodorin | 1TOC_B |
| PA | S01.217 | thrombin | complex with fibrinopeptide A alpha (residues 7-19) | 1UCY_E |
| PA | S01.217 | thrombin | complex with BM14.1248 | 1UVT |
| PA | S01.217 | thrombin | complex with BM12.1700 | 1UVU |
| PA | S01.217 | thrombin | complex with hirudin 51-65 | 1VIT |
| PA | S01.217 | thrombin | complex with fibrinogen-AA peptide 1-23 (Phe8Tyr mutant) | 1YCP |
| PA | S01.217 | thrombin | 2A1D | |
| PA | S01.217 | thrombin | 2HPP_P | |
| PA | S01.217 | thrombin | complex with boophilin | 2ODY_A |
| PA | S01.217 | thrombin | prothrombin fragment 1 | 2PF1 |
| PA | S01.217 | thrombin | prothrombin fragment 1; complex with calcium | 2PF2 |
| PA | S01.217 | thrombin | prothrombin fragment 1; complex with strontium | 2SPT |
| PA | S01.217 | thrombin | 3PMA | |
| PA | S01.217 | thrombin | 3PMB | |
| PA | S01.217 | thrombin | 2OCV | |
| PA | S01.217 | thrombin | 2PUX | |
| PA | S01.217 | thrombin | 2PV9 | |
| PA | S01.217 | thrombin | 3EDX | |
| PA | S01.217 | thrombin | 3HK3 | |
| PA | S01.217 | thrombin | 3HK6 | |
| PA | S01.217 | thrombin | 3HKI | |
| PA | S01.218 | protein C (activated) | complex with inhibitor beta-hydroxy-Asp-D-Phe-deoxy-methyl-Arg | 1AUT |
| PA | S01.218 | protein C (activated) | 1LQV | |
| PA | S01.218 | protein C (activated) | theoretical model | 1PCU |
| PA | S01.218 | protein C (activated) | theoretical model of catalytic domain | 2PCT |
| PA | S01.218 | protein C (activated) | complex with PPACK | 3F6U_H |
| PA | S01.218 | protein C (activated) | 3JTC | |
| PA | S01.218 | protein C (activated) | 4DT7 | |
| PA | S01.223 | acrosin | 1FIZ | |
| PA | S01.223 | acrosin | 1FIW | |
| PA | S01.224 | hepsin | dissecting and designing inhibitor selectivity determinants at the s1 site using an artificial ala190 protease (ala190 upa) ***caveat 1o5e chirality errors in residue 62 arg, | 1O5E_L |
| PA | S01.224 | hepsin | 1O5F_L | |
| PA | S01.224 | hepsin | extracellular domain | 1P57 |
| PA | S01.224 | hepsin | extracellular region; complex with covalently bound preferred substrate. | 1Z8G_A |
| PA | S01.224 | hepsin | 3T2N | |
| PA | S01.224 | hepsin | complex with inhibitor | 5CE1_A |
| PA | S01.228 | hepatocyte growth factor activator | 1YBW | |
| PA | S01.228 | hepatocyte growth factor activator | short isoform; complex with hepatocyte growth factor activator inhibitor type 1 first Kunitz domain | 1YC0_A |
| PA | S01.228 | hepatocyte growth factor activator | protease domain of hgfa with inhibitor fab58 | 2R0K_A |
| PA | S01.228 | hepatocyte growth factor activator | short form hgfa with inhibitory fab75 | 2R0L_A |
| PA | S01.228 | hepatocyte growth factor activator | 2WUB | |
| PA | S01.228 | hepatocyte growth factor activator | 2WUC | |
| PA | S01.228 | hepatocyte growth factor activator | 3K2U | |
| PA | S01.229 | mannan-binding lectin-associated serine peptidase 2 | catalytic domain only | 1Q3X |
| PA | S01.229 | mannan-binding lectin-associated serine peptidase 2 | zymogen catalytic region | 1ZJK_A |
| PA | S01.229 | mannan-binding lectin-associated serine peptidase 2 | complex with complement c4 | 4FXG_G |
| PA | S01.229 | mannan-binding lectin-associated serine peptidase 2 | complex with human complement c4 | 5JPM_G |
| PA | S01.229 | mannan-binding lectin-associated serine peptidase 2 | 1NT0 | |
| PA | S01.231 | urokinase-type plasminogen activator | 1C5W | |
| PA | S01.231 | urokinase-type plasminogen activator | 1C5X | |
| PA | S01.231 | urokinase-type plasminogen activator | 1C5Y | |
| PA | S01.231 | urokinase-type plasminogen activator | 1C5Z | |
| PA | S01.231 | urokinase-type plasminogen activator | complex with B-chain inhibitor N-(1-adamantyl)-N'-(4-guanidinobenzyl)urea | 1EJN |
| PA | S01.231 | urokinase-type plasminogen activator | complex with B-chain benzamidine inhibitor | 1F5K |
| PA | S01.231 | urokinase-type plasminogen activator | complex with 3,5-diamino-N-(aminoiminomethyl)-6-chloropyrazinecarboxamide | 1F5L |
| PA | S01.231 | urokinase-type plasminogen activator | complex with B-chain UKI-1D inhibitor | 1F92 |
| PA | S01.231 | urokinase-type plasminogen activator | microurokinase; complex with 2-amino-5-hydroxy-benzimidazole | 1FV9 |
| PA | S01.231 | urokinase-type plasminogen activator | 1GI7_A | |
| PA | S01.231 | urokinase-type plasminogen activator | 1GI8_A | |
| PA | S01.231 | urokinase-type plasminogen activator | 1GI9_A | |
| PA | S01.231 | urokinase-type plasminogen activator | engineering inhibitors highly selective for the s1 sites of ser190 trypsin-like serine protease drug targets | 1GJ7_A |
| PA | S01.231 | urokinase-type plasminogen activator | engineering inhibitors highly selective for the s1 sites of ser190 trypsin-like serine protease drug targets | 1GJ8_A |
| PA | S01.231 | urokinase-type plasminogen activator | engineering inhibitors highly selective for the s1 sites of ser190 trypsin-like serine protease drug targets | 1GJ9_A |
| PA | S01.231 | urokinase-type plasminogen activator | engineering inhibitors highly selective for the s1 sites of ser190 trypsin-like serine protease drug targets | 1GJA_A |
| PA | S01.231 | urokinase-type plasminogen activator | engineering inhibitors highly selective for the s1 sites of ser190 trypsin-like serine protease drug targets | 1GJB_A |
| PA | S01.231 | urokinase-type plasminogen activator | engineering inhibitors highly selective for the s1 sites of ser190 trypsin-like serine protease drug targets | 1GJC_A |
| PA | S01.231 | urokinase-type plasminogen activator | engineering inhibitors highly selective for the s1 sites of ser190 trypsin-like serine protease drug targets | 1GJD_A |
| PA | S01.231 | urokinase-type plasminogen activator | NMR; kringle domain | 1KDU |
| PA | S01.231 | urokinase-type plasminogen activator | peptidase domain; complex with Glu-Gly-Arg chloromethyl ketone | 1LMW |
| PA | S01.231 | urokinase-type plasminogen activator | 1O3P_A | |
| PA | S01.231 | urokinase-type plasminogen activator | dissecting and designing inhibitor selectivity determinants at the s1 site using an artificial ala190 protease (ala190 upa) | 1O5A_A |
| PA | S01.231 | urokinase-type plasminogen activator | dissecting and designing inhibitor selectivity determinants at the s1 site using an artificial ala190 protease (ala190 upa) | 1O5B_A |
| PA | S01.231 | urokinase-type plasminogen activator | dissecting and designing inhibitor selectivity determinants at the s1 site using an artificial ala190 protease (ala190 upa) | 1O5C_A |
| PA | S01.231 | urokinase-type plasminogen activator | substituted 2-naphthamidine inhibitors of urokinase | 1OWD_A |
| PA | S01.231 | urokinase-type plasminogen activator | substituted 2-naphthamidine inhibitors of urokinase | 1OWE_A |
| PA | S01.231 | urokinase-type plasminogen activator | substituted 2-naphthamidine inhibitors of urokinase | 1OWH_A |
| PA | S01.231 | urokinase-type plasminogen activator | substituted 2-naphthamidine inhibitors of urokinase | 1OWI_A |
| PA | S01.231 | urokinase-type plasminogen activator | substituted 2-naphthamidine inhibitors of urokinase | 1OWJ_A |
| PA | S01.231 | urokinase-type plasminogen activator | substituted 2-naphthamidine inhibitors of urokinase | 1OWK_A |
| PA | S01.231 | urokinase-type plasminogen activator | urokinase plasminogen activator b-chain-j435 complex | 1SC8_U |
| PA | S01.231 | urokinase-type plasminogen activator | substituted 2-naphthamidine inhibitors of urokinase | 1SQA_A |
| PA | S01.231 | urokinase-type plasminogen activator | substituted 2-naphthamidine inhibitors of urokinase | 1SQO_A |
| PA | S01.231 | urokinase-type plasminogen activator | substituted 2-naphthamidine inhibitors of urokinase | 1SQT_A |
| PA | S01.231 | urokinase-type plasminogen activator | substituted 2-naphthamadine inhibitors of urokinase | 1U6Q_A |
| PA | S01.231 | urokinase-type plasminogen activator | NMR; N-terminal fragment | 1URK |
| PA | S01.231 | urokinase-type plasminogen activator | B-chain; complex with JT464 | 1VJ9_U |
| PA | S01.231 | urokinase-type plasminogen activator | B-chain; complex with JT464 | 1VJA_U |
| PA | S01.231 | urokinase-type plasminogen activator | complex with inhibitor SI1 (N-(butylsulfonyl)-D-seryl-N-4-[amino(imino)methyl]benzyl-L-alaninamide) | 1W0Z |
| PA | S01.231 | urokinase-type plasminogen activator | complex with inhibitor SJ1 (N-(isobutoxycarbonyl)-D-seryl-N-((1S)-4-[amino(imino)methyl]amino-1-formylbutyl)-L-alaninamide ) | 1W10 |
| PA | S01.231 | urokinase-type plasminogen activator | complex with inhibitor SK1 (N-(benzylsulfonyl)-D-seryl-N-4-[amino(imino)methyl]benzyl-L-alaninamide) | 1W11 |
| PA | S01.231 | urokinase-type plasminogen activator | complex with inhibitor SL1 (N-((1S)-4-[aminomethyl]amino-1-formylbutyl)-2-(3R)-3-[(benzylsulfonyl)amino]-2-oxo-5-phenyl-2,3-dihydro-1H-1,4-benzodiazepin-1-ylacetamide) | 1W12 |
| PA | S01.231 | urokinase-type plasminogen activator | complex with inhibitor SM1 (N-(benzylsulfonyl)-D-seryl-N-(4-[amino(imino)methyl]aminobenzyl)-L-alaninamide) | 1W13 |
| PA | S01.231 | urokinase-type plasminogen activator | complex with inhibitor SH1 (N-[(2-phenylethyl)sulfonyl]-D-seryl-N-[(1S)- 4-[(diaminomethylene)amino]-1-(hydroxymethyl)butyl]-L-alaninamide) | 1W14 |
| PA | S01.231 | urokinase-type plasminogen activator | 2FD6 | |
| PA | S01.231 | urokinase-type plasminogen activator | 2I9A | |
| PA | S01.231 | urokinase-type plasminogen activator | 2I9B | |
| PA | S01.231 | urokinase-type plasminogen activator | new pharmacophore for serine protease inhibition revealed by crystal structure of human urokinase-type plasminogen activator complexed with a cyclic peptidyl inhibitor, upain- | 2NWN_A |
| PA | S01.231 | urokinase-type plasminogen activator | crystal structure and binding epitopes of urokinase-type plasminogen activator (c122a/n145q) in complex with inhibitors | 2O8T_A |
| PA | S01.231 | urokinase-type plasminogen activator | crystal structure and binding epitopes of urokinase-type plasminogen activator (c122a/n145q/s195a) in complex with inhibitors | 2O8U_A |
| PA | S01.231 | urokinase-type plasminogen activator | crystal structure and binding epitopes of urokinase-type plasminogen activator (c122a/n145q/s195a) in complex with inhibitors | 2O8W_A |
| PA | S01.231 | urokinase-type plasminogen activator | urokinase plasminogen activator b-chain-gppe complex | 2R2W_U |
| PA | S01.231 | urokinase-type plasminogen activator | fragment-based discovery of mexiletine derivatives as orally bioavailable inhibitors of urokinase-type plasminogen activator | 2VIN_A |
| PA | S01.231 | urokinase-type plasminogen activator | fragment-based discovery of mexiletine derivatives as orally bioavailable inhibitors of urokinase-type plasminogen activator | 2VIO_A |
| PA | S01.231 | urokinase-type plasminogen activator | fragment-based discovery of mexiletine derivatives as orally bioavailable inhibitors of urokinase-type plasminogen activator | 2VIP_A |
| PA | S01.231 | urokinase-type plasminogen activator | fragment-based discovery of mexiletine derivatives as orally bioavailable inhibitors of urokinase-type plasminogen activator | 2VIQ_A |
| PA | S01.231 | urokinase-type plasminogen activator | fragment-based discovery of mexiletine derivatives as orally bioavailable inhibitors of urokinase-type plasminogen activator | 2VIV_A |
| PA | S01.231 | urokinase-type plasminogen activator | fragment-based discovery of mexiletine derivatives as orally bioavailable inhibitors of urokinase-type plasminogen activator | 2VIW_A |
| PA | S01.231 | urokinase-type plasminogen activator | urokinase-type plasminogen activator inhibitor complex with a 1-(7-sulphoamidoisoquinolinyl)guanidine | 2VNT_A |
| PA | S01.231 | urokinase-type plasminogen activator | 3BT1 | |
| PA | S01.231 | urokinase-type plasminogen activator | 3BT2 | |
| PA | S01.231 | urokinase-type plasminogen activator | 3IG6 | |
| PA | S01.231 | urokinase-type plasminogen activator | 3KGP | |
| PA | S01.231 | urokinase-type plasminogen activator | 3KHV | |
| PA | S01.231 | urokinase-type plasminogen activator | 3KID | |
| PA | S01.231 | urokinase-type plasminogen activator | 3M61 | |
| PA | S01.231 | urokinase-type plasminogen activator | 3MHW | |
| PA | S01.231 | urokinase-type plasminogen activator | 3MWI | |
| PA | S01.231 | urokinase-type plasminogen activator | 3OX7 | |
| PA | S01.231 | urokinase-type plasminogen activator | 3OY5 | |
| PA | S01.231 | urokinase-type plasminogen activator | 3OY6 | |
| PA | S01.231 | urokinase-type plasminogen activator | 3PB1 | |
| PA | S01.231 | urokinase-type plasminogen activator | 3QN7 | |
| PA | S01.231 | urokinase-type plasminogen activator | 3U73 | |
| PA | S01.231 | urokinase-type plasminogen activator | 4DVA | |
| PA | S01.231 | urokinase-type plasminogen activator | 4DW2 | |
| PA | S01.231 | urokinase-type plasminogen activator | 4FU7 | |
| PA | S01.231 | urokinase-type plasminogen activator | 4FU8 | |
| PA | S01.231 | urokinase-type plasminogen activator | 4FU9 | |
| PA | S01.231 | urokinase-type plasminogen activator | 4FUB | |
| PA | S01.231 | urokinase-type plasminogen activator | 4FUC | |
| PA | S01.231 | urokinase-type plasminogen activator | 4FUD | |
| PA | S01.231 | urokinase-type plasminogen activator | 4FUE | |
| PA | S01.231 | urokinase-type plasminogen activator | 4FUF | |
| PA | S01.231 | urokinase-type plasminogen activator | 4FUG | |
| PA | S01.231 | urokinase-type plasminogen activator | 4FUH | |
| PA | S01.231 | urokinase-type plasminogen activator | 4FUI | |
| PA | S01.231 | urokinase-type plasminogen activator | 4FUJ | |
| PA | S01.231 | urokinase-type plasminogen activator | 4GLY | |
| PA | S01.231 | urokinase-type plasminogen activator | 4H42 | |
| PA | S01.231 | urokinase-type plasminogen activator | 4JK5 | |
| PA | S01.231 | urokinase-type plasminogen activator | 4JK6 | |
| PA | S01.231 | urokinase-type plasminogen activator | 4JNI | |
| PA | S01.231 | urokinase-type plasminogen activator | 4JNL | |
| PA | S01.231 | urokinase-type plasminogen activator | 4K24 | |
| PA | S01.231 | urokinase-type plasminogen activator | 4MNV | |
| PA | S01.231 | urokinase-type plasminogen activator | 4MNW | |
| PA | S01.231 | urokinase-type plasminogen activator | 4MNX | |
| PA | S01.231 | urokinase-type plasminogen activator | 4MNY | |
| PA | S01.231 | urokinase-type plasminogen activator | 4OS1 | |
| PA | S01.231 | urokinase-type plasminogen activator | 4OS2 | |
| PA | S01.231 | urokinase-type plasminogen activator | 4OS4 | |
| PA | S01.231 | urokinase-type plasminogen activator | 4OS5 | |
| PA | S01.231 | urokinase-type plasminogen activator | 4OS6 | |
| PA | S01.231 | urokinase-type plasminogen activator | 4OS7 | |
| PA | S01.231 | urokinase-type plasminogen activator | 4X0W | |
| PA | S01.231 | urokinase-type plasminogen activator | 4X1N | |
| PA | S01.231 | urokinase-type plasminogen activator | 4X1P | |
| PA | S01.231 | urokinase-type plasminogen activator | 4X1Q | |
| PA | S01.231 | urokinase-type plasminogen activator | 4X1R | |
| PA | S01.231 | urokinase-type plasminogen activator | 4X1S | |
| PA | S01.231 | urokinase-type plasminogen activator | paitrap, an upa mutant | 4XSK_U |
| PA | S01.231 | urokinase-type plasminogen activator | 4ZHL | |
| PA | S01.231 | urokinase-type plasminogen activator | 4ZHM | |
| PA | S01.231 | urokinase-type plasminogen activator | complex with upain-1-w3a at ph5.5 | 4ZKN_U |
| PA | S01.231 | urokinase-type plasminogen activator | complex with upain-1-w3a at ph7.4 | 4ZKO_U |
| PA | S01.231 | urokinase-type plasminogen activator | complex with upain-1-w3a at ph9.0 | 4ZKR_U |
| PA | S01.231 | urokinase-type plasminogen activator | Ser195Ala mutant; complex with upain-1-w3a at ph7.4 | 4ZKS_U |
| PA | S01.231 | urokinase-type plasminogen activator | complex with a camelid-derived antibody fragment | 5HGG_A |
| PA | S01.231 | urokinase-type plasminogen activator | complex with upain-2-2 | 5WXF_U |
| PA | S01.231 | urokinase-type plasminogen activator | complex with upain-2-2-w3a | 5WXO_U |
| PA | S01.231 | urokinase-type plasminogen activator | complex with upain-2-3-w3a | 5WXP_U |
| PA | S01.231 | urokinase-type plasminogen activator | complex with upain-2-4 | 5WXQ_U |
| PA | S01.231 | urokinase-type plasminogen activator | complex with upain-2-4-w3a | 5WXR_U |
| PA | S01.231 | urokinase-type plasminogen activator | complex with s2444 | 5WXS_U |
| PA | S01.231 | urokinase-type plasminogen activator | Ser195Ala mutant; complex with s2444 | 5WXT_U |
| PA | S01.231 | urokinase-type plasminogen activator | complex with quercetin | 5XG4_U |
| PA | S01.231 | urokinase-type plasminogen activator | complex with 4-bromobenzylamirne at pH4.6 | 5YC6_U |
| PA | S01.231 | urokinase-type plasminogen activator | complex with 4-bromobenzylamirne at pH7.4 | 5YC7_U |
| PA | S01.231 | urokinase-type plasminogen activator | complex with 4-iodobenzylamine at pH7.4 | 5Z1C_U |
| PA | S01.231 | urokinase-type plasminogen activator | upa-hma | 5ZA7_U |
| PA | S01.231 | urokinase-type plasminogen activator | upa-bb2-27f | 5ZA8_U |
| PA | S01.231 | urokinase-type plasminogen activator | upa-bb2-50f | 5ZA9_U |
| PA | S01.231 | urokinase-type plasminogen activator | upa-6f-hma | 5ZAE_U |
| PA | S01.231 | urokinase-type plasminogen activator | upa-bb2-28f | 5ZAF_U |
| PA | S01.231 | urokinase-type plasminogen activator | upa-bb2-94f | 5ZAG_U |
| PA | S01.231 | urokinase-type plasminogen activator | upa-bb2-30f | 5ZAH_U |
| PA | S01.231 | urokinase-type plasminogen activator | upa-31f | 5ZAJ_U |
| PA | S01.231 | urokinase-type plasminogen activator | upa-nu-09f | 5ZC5_U |
| PA | S01.231 | urokinase-type plasminogen activator | tranexamic acid is an active site inhibitor of urokinase plasminogen activator | 6NMB_A |
| PA | S01.231 | urokinase-type plasminogen activator | 3LAQ | |
| PA | S01.231 | urokinase-type plasminogen activator | catalytic domain; complex with the allosteric inhibitory nanobody nb7 | 5LHN_A |
| PA | S01.231 | urokinase-type plasminogen activator | catalytic domain; complex with p-aminobenzamidine and the allosteric inhibitory nanobody nb7 | 5LHP_A |
| PA | S01.231 | urokinase-type plasminogen activator | the egr-cmk active site inhibited catalytic domain of murine urokinase-type plasminogen activator in complex with the allosteric inhibitory nanobody nb7 | 5LHQ_A |
| PA | S01.231 | urokinase-type plasminogen activator | catalytic domain; complex with the active site binding inhibitory nanobody nb22 | 5LHR_A |
| PA | S01.231 | urokinase-type plasminogen activator | the ligand free catalytic domain of murine urokinase-type plasminogen activator | 5LHS_B |
| PA | S01.231 | urokinase-type plasminogen activator | complex with mupa-spd at ph8.5 | 6A8G_P |
| PA | S01.231 | urokinase-type plasminogen activator | complex with mupa-spd at ph8.5 | 6A8N_A |
| PA | S01.232 | t-plasminogen activator | catalytic domain; complex with bis-benzamidine inhibitor | 1A5H |
| PA | S01.232 | t-plasminogen activator | catalytic domain; complex with dansyl-Glu-Gly-Arg chloromethylketone inhibitor | 1BDA |
| PA | S01.232 | t-plasminogen activator | NMR; kringle 2 domain | 1PK2 |
| PA | S01.232 | t-plasminogen activator | kringle 2 | 1PML |
| PA | S01.232 | t-plasminogen activator | catalytic domain; complex with benzamidine | 1RTF |
| PA | S01.232 | t-plasminogen activator | NMR structure; fibronectin type I and epidermal growth factor-like modules | 1TPG |
| PA | S01.232 | t-plasminogen activator | kringle 2 | 1TPK |
| PA | S01.232 | t-plasminogen activator | NMR; fibrin-binding finger domain | 1TPM |
| PA | S01.232 | t-plasminogen activator | NMR; fibrin-binding finger domain | 1TPN |
| PA | S01.232 | t-plasminogen activator | structure of tpa and pai-1 | 5ZLZ_E |
| PA | S01.233 | plasmin | NMR structure of kringle 2 domain | 1B2I |
| PA | S01.233 | plasmin | catalytic domain; complex with streptokinase | 1BML |
| PA | S01.233 | plasmin | catalytic domain; complex with staphylokinase and Glu-Gly-deoxo-methylArg | 1BUI_A |
| PA | S01.233 | plasmin | kringle 1 domain; complex with epsilon-aminocaproic acid | 1CEA |
| PA | S01.233 | plasmin | kringle 1 domain; complex with trans-4-aminomethylcyclohexane-1-carboxylic acid | 1CEB |
| PA | S01.233 | plasmin | catalytic domain | 1DDJ |
| PA | S01.233 | plasmin | NMR structure; kringle 1 | 1HPJ |
| PA | S01.233 | plasmin | NMR structure; kringle 1 | 1HPK |
| PA | S01.233 | plasmin | 1I5K | |
| PA | S01.233 | plasmin | 1KI0 | |
| PA | S01.233 | plasmin | kringle 4 | 1KRN |
| PA | S01.233 | plasmin | microplasminogen; complex with streptokinase alpha domain | 1L4D_A |
| PA | S01.233 | plasmin | microplasminogen; complex with streptokinase alpha domain in the presence cadmium ions | 1L4Z_A |
| PA | S01.233 | plasmin | kringle 4 | 1PK4 |
| PA | S01.233 | plasmin | kringle 1 | 1PKR |
| PA | S01.233 | plasmin | kringle 4 | 1PMK |
| PA | S01.233 | plasmin | proenzyme form of catalytic domain, complex with streptokinase | 1QRZ |
| PA | S01.233 | plasmin | human plasminogen catalytic domain, k698m mutant | 1RJX_B |
| PA | S01.233 | plasmin | 2DOH | |
| PA | S01.233 | plasmin | 2DOI | |
| PA | S01.233 | plasmin | 2KNF | |
| PA | S01.233 | plasmin | 2L0S | |
| PA | S01.233 | plasmin | kringle 4 complex with epsilon-aminocaproic acid | 2PK4 |
| PA | S01.233 | plasmin | 3UIR_A | |
| PA | S01.233 | plasmin | 4A5T | |
| PA | S01.233 | plasmin | 4CIK | |
| PA | S01.233 | plasmin | 4DCB_F | |
| PA | S01.233 | plasmin | 4DUR | |
| PA | S01.233 | plasmin | 4DUU | |
| PA | S01.233 | plasmin | kringle 5 domain only | 5HPG |
| PA | S01.233 | plasmin | protease inhibitor | 5UGD_A |
| PA | S01.233 | plasmin | protease inhibitor | 5UGG_A |
| PA | S01.233 | plasmin | highly potent and selective plasmin inhibitors based on the sunflower trypsin inhibitor-1 scaffold attenuate fibrinolysis in plasma ***caveat 6d3x entry contains improper peptide linkages. | 6D3X_A |
| PA | S01.233 | plasmin | highly potent and selective plasmin inhibitors based on the sunflower trypsin inhibitor-1 scaffold attenuate fibrinolysis in plasma ***caveat 6d3y entry contains improper peptide linkages. | 6D3Y_A |
| PA | S01.233 | plasmin | protease sfti complex | 6D3Z_A |
| PA | S01.233 | plasmin | highly potent and selective plasmin inhibitors based on the sunflower trypsin inhibitor-1 scaffold attenuate fibrinolysis in plasma ***caveat 6d40 entry contains improper peptide linkages. | 6D40_A |
| PA | S01.236 | kallikrein-related peptidase 6 | precursor | 1GVL |
| PA | S01.236 | kallikrein-related peptidase 6 | complex with benzamidine inhibitor | 1L2E_A |
| PA | S01.236 | kallikrein-related peptidase 6 | complex with benzamidine inhibitor | 1LO6_A |
| PA | S01.236 | kallikrein-related peptidase 6 | 3VFE | |
| PA | S01.236 | kallikrein-related peptidase 6 | 4D8N | |
| PA | S01.236 | kallikrein-related peptidase 6 | combinatorial engineering of proteolytically resistant appi variants that selectively inhibit human kallikrein 6 for cancer therapy | 5NX1_A |
| PA | S01.236 | kallikrein-related peptidase 6 | combinatorial engineering of proteolytically resistant appi variants that selectively inhibit human kallikrein 6 for cancer therapy | 5NX3_A |
| PA | S01.236 | kallikrein-related peptidase 6 | complex with GSK144 | 6QFF_A |
| PA | S01.236 | kallikrein-related peptidase 6 | Ile218Tyr mutant; complex with GSK144 | 6QFG_A |
| PA | S01.236 | kallikrein-related peptidase 6 | Asn217Asp/Ile218Tyr/Lys224Arg mutant; complex with GSK144 | 6QFH_A |
| PA | S01.236 | kallikrein-related peptidase 6 | complex with gsk3239861a | 6QH9_A |
| PA | S01.236 | kallikrein-related peptidase 6 | complex with gsk3205388b | 6QHA_A |
| PA | S01.236 | kallikrein-related peptidase 6 | complex with gsk578724a | 6QHB_A |
| PA | S01.236 | kallikrein-related peptidase 6 | complex with gsk358180b | 6QHC_A |
| PA | S01.239 | plasminogen activator (Desmodus-type) | catalytic domain. | 1A5I |
| PA | S01.243 | lumbrokinase | two-chain form | 1YM0 |
| PA | S01.244 | kallikrein-related peptidase 8 | dimer | 1NPM |
| PA | S01.244 | kallikrein-related peptidase 8 | kallikrein-related peptidase 8 calcium complex | 5MS3_A |
| PA | S01.244 | kallikrein-related peptidase 8 | complex with leupeptin | 5MS4_A |
| PA | S01.246 | kallikrein-related peptidase 10 | kallikrein-related peptidase 10 complex with zn2+ | 5LPE_A |
| PA | S01.246 | kallikrein-related peptidase 10 | kallikrein-related peptidase 10 | 5LPF_A |
| PA | S01.251 | kallikrein-related peptidase 4 | human kallikrein 4 complex with nickel and p- aminobenzamidine | 2BDG_A |
| PA | S01.251 | kallikrein-related peptidase 4 | human kallikrein 4 complex with zinc and p-aminobenzamidine | 2BDH_A |
| PA | S01.251 | kallikrein-related peptidase 4 | human kallikrein 4 complex with cobalt and p- aminobenzamidine | 2BDI_A |
| PA | S01.251 | kallikrein-related peptidase 4 | 4K1E_A | |
| PA | S01.251 | kallikrein-related peptidase 4 | 4K8Y_A | |
| PA | S01.251 | kallikrein-related peptidase 4 | 4KEL_A | |
| PA | S01.251 | kallikrein-related peptidase 4 | 4KGA | |
| PA | S01.253 | halystase | 4E7N | |
| PA | S01.261 | streptogrisin A | complex with chymostatin | 1SGC |
| PA | S01.261 | streptogrisin A | 2SGA | |
| PA | S01.261 | streptogrisin A | complex with ACE-Pro-Ala-Pro-Phe-aldehyde | 3SGA |
| PA | S01.261 | streptogrisin A | complex with ACE-Pro-Ala-Pro-Phe | 4SGA |
| PA | S01.261 | streptogrisin A | complex with ACE-Pro-Ala-Pro-Tyr | 5SGA |
| PA | S01.262 | streptogrisin B | complex with turkey ovomucoid inhibitor third domain | 1CSO_E |
| PA | S01.262 | streptogrisin B | complex with turkey ovomucoid third domain Ser18Ile mutant | 1CT0_E |
| PA | S01.262 | streptogrisin B | complex with turkey ovomucoid inhibitor third domain The18I variant | 1CT2_E |
| PA | S01.262 | streptogrisin B | complex with turkey ovomucoid inhibitor third domain Val18I variant | 1CT4_E |
| PA | S01.262 | streptogrisin B | complex with turkey ovomucoid inhibitor third domain Ser18I variant | 1CTO |
| PA | S01.262 | streptogrisin B | complex with turkey ovomucoid third domain Leu18Ile mutant | 1DS2_E |
| PA | S01.262 | streptogrisin B | complex with turkey ovomucoid third domain Asp18 variant at pH 6.5 | 1SGD_E |
| PA | S01.262 | streptogrisin B | complex with turkey ovomucoid third domain Glu18 variant | 1SGE_E |
| PA | S01.262 | streptogrisin B | complex with turkey ovomucoid third domain Asn18 variant | 1SGN_E |
| PA | S01.262 | streptogrisin B | complex with turkey ovomucoid third domain | 1SGP_E |
| PA | S01.262 | streptogrisin B | complex with turkey ovomucoid third domain Gly18 variant | 1SGQ_E |
| PA | S01.262 | streptogrisin B | complex with turkey ovomucoid third domain Leu18 variant | 1SGR_E |
| PA | S01.262 | streptogrisin B | complex with turkey ovomucoid third domain Tyr18 variant at pH 6.5 | 1SGY_E |
| PA | S01.262 | streptogrisin B | 2GKV_E | |
| PA | S01.262 | streptogrisin B | molecular structures of the complexes of sgpb with omtky3 aromatic p1 variants trp18i, his18i, phe18i, and tyr18i | 2NU0_E |
| PA | S01.262 | streptogrisin B | molecular structures of the complexes of sgpb with omtky3 aromatic p1 variants trp18i, his18i, phe18i and tyr18i | 2NU1_E |
| PA | S01.262 | streptogrisin B | complex with turkey ovomucoid third domain variants Lys18Ile and Arg18Ile | 2NU2_E |
| PA | S01.262 | streptogrisin B | complex with turkey ovomucoid third domain variants Lys18Ile and Arg18Ile | 2NU3_E |
| PA | S01.262 | streptogrisin B | complex with turkey ovomucoid third domain variants Lys18Ile and Arg18Ile | 2NU4_E |
| PA | S01.262 | streptogrisin B | 2QA9 | |
| PA | S01.262 | streptogrisin B | 2QAA | |
| PA | S01.262 | streptogrisin B | complex with turkey ovomucoid third domain Asp18 variant at pH 10.7 | 2SGD_E |
| PA | S01.262 | streptogrisin B | glu 18 variant of turkey ovomucoid inhibitor third domain complexed with streptomyces griseus proteinase b at ph 10.7 | 2SGE_E |
| PA | S01.262 | streptogrisin B | complex with turkey ovomucoid third domain Phe18 variant | 2SGF_E |
| PA | S01.262 | streptogrisin B | complex with turkey ovomucoid third domain Pro18 variant | 2SGP_E |
| PA | S01.262 | streptogrisin B | complex with turkey ovomucoid third domain Gln18 variant at pH 6.5 | 2SGQ_E |
| PA | S01.262 | streptogrisin B | complex with turkey ovomucoid third domain | 3SGB_E |
| PA | S01.262 | streptogrisin B | complex with turkey ovomucoid third domain Gln18 variant at pH 10.7 | 3SGQ_E |
| PA | S01.262 | streptogrisin B | complex with potato inhibitor PCI-1 | 4SGB_E |
| PA | S01.267 | streptogrisin E | complex with tetrapeptide ligand | 1HPG |
| PA | S01.268 | alpha-lytic endopeptidase | Val167Ile mutant | 1BOQ |
| PA | S01.268 | alpha-lytic endopeptidase | Met190Ala and Gly216Ala mutant | 1GBA |
| PA | S01.268 | alpha-lytic endopeptidase | Met190Ala and Gly216Ala mutant; complex with MeOSuc-Ala-Ala-Pro-Ala boronic acid | 1GBB |
| PA | S01.268 | alpha-lytic endopeptidase | Met190Ala and Gly216Ala mutant; complex with MeOSuc-Ala-Ala-Pro-Leu boronic acid | 1GBC |
| PA | S01.268 | alpha-lytic endopeptidase | Met190Ala and Gly216Ala mutant; complex with MeOSuc-Ala-Ala-Pro-Phe boronic acid | 1GBD |
| PA | S01.268 | alpha-lytic endopeptidase | Met190Ala and Gly216Leu mutant | 1GBE |
| PA | S01.268 | alpha-lytic endopeptidase | Met190Ala and Gly216Leu mutant; complex with MeOSuc-Ala-Ala-Pro-Ala boronic acid | 1GBF |
| PA | S01.268 | alpha-lytic endopeptidase | Met190Ala and Gly216Leu mutant; complex with MeOSuc-Ala-Ala-Pro-Leu boronic acid | 1GBH |
| PA | S01.268 | alpha-lytic endopeptidase | Met190Ala and Gly216Leu mutant; complex with MeOSuc-Ala-Ala-Pro-Phe boronic acid | 1GBI |
| PA | S01.268 | alpha-lytic endopeptidase | Met190Ala mutant | 1GBJ |
| PA | S01.268 | alpha-lytic endopeptidase | Met190Ala mutant; complex with MeOSuc-Ala-Ala-Pro-Ala boronic acid | 1GBK |
| PA | S01.268 | alpha-lytic endopeptidase | Met190Ala mutant; complex with MeOSuc-Ala-Ala-Pro-Leu boronic acid | 1GBL |
| PA | S01.268 | alpha-lytic endopeptidase | Met190Ala mutant; complex with MeOSuc-Ala-Ala-Pro-Phe boronic acid | 1GBM |
| PA | S01.268 | alpha-lytic endopeptidase | complex with BOC-Ala-Pro-Val boronic acid | 1P01 |
| PA | S01.268 | alpha-lytic endopeptidase | complex with MeOSuc-Ala-Ala-Pro-Ala boronic acid | 1P02 |
| PA | S01.268 | alpha-lytic endopeptidase | complex with MeOSuc-Ala-Ala-Pro-Val boronic acid | 1P03 |
| PA | S01.268 | alpha-lytic endopeptidase | complex with MeOSuc-Ala-Ala-Pro-Ile boronic acid | 1P04 |
| PA | S01.268 | alpha-lytic endopeptidase | complex with MeOSuc-Ala-Ala-Pro-Nle boronic acid | 1P05 |
| PA | S01.268 | alpha-lytic endopeptidase | complex with MeOSuc-Ala-Ala-Pro-Phe boronic acid | 1P06 |
| PA | S01.268 | alpha-lytic endopeptidase | Met213Ala mutant | 1P09 |
| PA | S01.268 | alpha-lytic endopeptidase | Met213Ala mutant; complex with MeOSuc-Ala-Ala-Pro-Val boronic acid | 1P10 |
| PA | S01.268 | alpha-lytic endopeptidase | complex with N-[(2S)-2-(phenoxy(1-R-(N-T-butyloxycarbonyl-L-Ala-Pro)-1-amino-2-methylpropyl)phosphinyloxy)-propanoyl]-L-Ala methyl ester | 1P11 |
| PA | S01.268 | alpha-lytic endopeptidase | complex with N-[(2S)-2-(phenoxy(1-R-(N-T-butyloxycarbonyl-L-Ala-Pro)-1-amino-2-methylpropyl)phosphinyloxy)-propanoyl]-L-Ala methyl ester | 1P12 |
| PA | S01.268 | alpha-lytic endopeptidase | Arg102His, Gly134Ser mutant | 1QQ4_A |
| PA | S01.268 | alpha-lytic endopeptidase | Arg102His, Gly134Ser mutant, pH 8 | 1QRW |
| PA | S01.268 | alpha-lytic endopeptidase | pH 5.14 | 1QRX |
| PA | S01.268 | alpha-lytic endopeptidase | 1SSX | |
| PA | S01.268 | alpha-lytic endopeptidase | single structure model | 1TAL |
| PA | S01.268 | alpha-lytic endopeptidase | 2ALP | |
| PA | S01.268 | alpha-lytic endopeptidase | 2H5C | |
| PA | S01.268 | alpha-lytic endopeptidase | 2H5D | |
| PA | S01.268 | alpha-lytic endopeptidase | Met190Ala mutant; complex with MeOSuc-Ala-Ala-Pro-Val boronic acid | 2LPR |
| PA | S01.268 | alpha-lytic endopeptidase | propeptide | 2PRO |
| PA | S01.268 | alpha-lytic endopeptidase | mature peptidase, multiconformer model | 2ULL |
| PA | S01.268 | alpha-lytic endopeptidase | Met190Ala mutant; complex with MeOSuc-Ala-Ala-Pro-Nle boronic acid | 3LPR |
| PA | S01.268 | alpha-lytic endopeptidase | 3M7T | |
| PA | S01.268 | alpha-lytic endopeptidase | 3M7U | |
| PA | S01.268 | alpha-lytic endopeptidase | Met213Ala mutant; complex with propeptide truncated C-terminally | 3PRO |
| PA | S01.268 | alpha-lytic endopeptidase | 3QGJ | |
| PA | S01.268 | alpha-lytic endopeptidase | 3URC | |
| PA | S01.268 | alpha-lytic endopeptidase | 3URD | |
| PA | S01.268 | alpha-lytic endopeptidase | 3URE | |
| PA | S01.268 | alpha-lytic endopeptidase | Met213Ala mutant; complex with propeptide | 4PRO |
| PA | S01.268 | alpha-lytic endopeptidase | Met213Ala mutant; complex with MeOSuc-Ala-Ala-Pro-Ala boronic acid | 5LPR |
| PA | S01.268 | alpha-lytic endopeptidase | Met213Ala mutant; complex with MeOSuc-Ala-Ala-Pro-Nle boronic acid | 6LPR |
| PA | S01.268 | alpha-lytic endopeptidase | Met213Ala mutant; complex with MeOSuc-Ala-Ala-Pro-Leu boronic acid | 7LPR |
| PA | S01.268 | alpha-lytic endopeptidase | Met213Ala mutant; complex with MeOSuc-Ala-Ala-Pro-Phe boronic acid | 8LPR |
| PA | S01.268 | alpha-lytic endopeptidase | complex with MeoSuc-Ala-Ala-Pro-Leu boronic acid | 9LPR |
| PA | S01.268 | alpha-lytic endopeptidase | crystal structure of l5 protease lysobacter sp. xl1 | 5MRT_A |
| PA | S01.268 | alpha-lytic endopeptidase | crystal structure of l1 protease of lysobacter sp. xl1 | 5MRR_A |
| PA | S01.268 | alpha-lytic endopeptidase | complex with aebsf | 5MRS_A |
| PA | S01.269 | glutamyl endopeptidase I | 1QY6 | |
| PA | S01.269 | glutamyl endopeptidase I | alkaline form | 1WCZ_A |
| PA | S01.269 | glutamyl endopeptidase I | structure of v8 protease from staphylococcus aureus | 2O8L_A |
| PA | S01.270 | exfoliatin A | dimer | 1AGJ_A |
| PA | S01.270 | exfoliatin A | 1DUA | |
| PA | S01.270 | exfoliatin A | Ser195Ala mutant | 1DUE |
| PA | S01.270 | exfoliatin A | 1EXF | |
| PA | S01.270 | exfoliatin A | 2EXF | |
| PA | S01.270 | exfoliatin A | 1DT2 | |
| PA | S01.270 | exfoliatin A | 1QTF | |
| PA | S01.273 | DegP peptidase | dimer | 1KY9_A |
| PA | S01.273 | DegP peptidase | 2ZLE | |
| PA | S01.273 | DegP peptidase | 3CS0 | |
| PA | S01.273 | DegP peptidase | 3MH4 | |
| PA | S01.273 | DegP peptidase | 3MH5 | |
| PA | S01.273 | DegP peptidase | 3MH6 | |
| PA | S01.273 | DegP peptidase | 3MH7 | |
| PA | S01.273 | DegP peptidase | 3OTP | |
| PA | S01.273 | DegP peptidase | 3OU0 | |
| PA | S01.273 | DegP peptidase | 4A8D | |
| PA | S01.274 | DegQ peptidase | 3STI | |
| PA | S01.274 | DegQ peptidase | 3STJ | |
| PA | S01.274 | DegQ peptidase | 4A8A | |
| PA | S01.274 | DegQ peptidase | 4A8B | |
| PA | S01.274 | DegQ peptidase | 4A8C | |
| PA | S01.274 | DegQ peptidase | 4A9G | |
| PA | S01.275 | DegS peptidase | 1SOT | |
| PA | S01.275 | DegS peptidase | complex with activating decapeptide | 1SOZ |
| PA | S01.275 | DegS peptidase | 1TE0 | |
| PA | S01.275 | DegS peptidase | 1VCW | |
| PA | S01.275 | DegS peptidase | 2QF0 | |
| PA | S01.275 | DegS peptidase | 2QF3 | |
| PA | S01.275 | DegS peptidase | 2QGR | |
| PA | S01.275 | DegS peptidase | 2R3U | |
| PA | S01.275 | DegS peptidase | 2R3Y | |
| PA | S01.275 | DegS peptidase | 2RCE | |
| PA | S01.275 | DegS peptidase | 3B8J | |
| PA | S01.275 | DegS peptidase | 3GCN | |
| PA | S01.275 | DegS peptidase | 3GCO | |
| PA | S01.275 | DegS peptidase | 3GDS | |
| PA | S01.275 | DegS peptidase | 3GDU | |
| PA | S01.275 | DegS peptidase | 3GDV | |
| PA | S01.275 | DegS peptidase | 3LGI | |
| PA | S01.275 | DegS peptidase | 3LGT | |
| PA | S01.275 | DegS peptidase | 3LGU | |
| PA | S01.275 | DegS peptidase | 3LGV | |
| PA | S01.275 | DegS peptidase | 3LGW | |
| PA | S01.275 | DegS peptidase | 3LGY | |
| PA | S01.275 | DegS peptidase | 3LH1 | |
| PA | S01.275 | DegS peptidase | 3LH3 | |
| PA | S01.275 | DegS peptidase | 4RQY | |
| PA | S01.275 | DegS peptidase | 4RQZ | |
| PA | S01.275 | DegS peptidase | 4RR0 | |
| PA | S01.275 | DegS peptidase | 4RR1 | |
| PA | S01.275 | DegS peptidase | complex with activating dnrlglvyqf peptide | 6EW9_A |
| PA | S01.277 | HtrA1 peptidase (Homo sapiens-type) | 2JOA | |
| PA | S01.277 | HtrA1 peptidase (Homo sapiens-type) | 2YTW | |
| PA | S01.277 | HtrA1 peptidase (Homo sapiens-type) | 3NUM | |
| PA | S01.277 | HtrA1 peptidase (Homo sapiens-type) | 3NWU | |
| PA | S01.277 | HtrA1 peptidase (Homo sapiens-type) | 3NZI | |
| PA | S01.277 | HtrA1 peptidase (Homo sapiens-type) | 3TJN | |
| PA | S01.277 | HtrA1 peptidase (Homo sapiens-type) | 3TJO | |
| PA | S01.277 | HtrA1 peptidase (Homo sapiens-type) | 3TJQ | |
| PA | S01.278 | HtrA2 peptidase | 1LCY_A | |
| PA | S01.278 | HtrA2 peptidase | 2PZD | |
| PA | S01.278 | HtrA2 peptidase | htra2 protease mutant v226k | 5FHT_A |
| PA | S01.278 | HtrA2 peptidase | htra2 wild-type structure | 5M3N_A |
| PA | S01.278 | HtrA2 peptidase | htra2 a141s mutant structure | 5M3O_A |
| PA | S01.278 | HtrA2 peptidase | htra2 g399s mutant | 5TNY_A |
| PA | S01.278 | HtrA2 peptidase | htra2 s142d mutant | 5TNZ_A |
| PA | S01.278 | HtrA2 peptidase | htra2 s276c mutant | 5TO0_A |
| PA | S01.278 | HtrA2 peptidase | htra2 exposed (l266r, f303a) mutant | 5TO1_A |
| PA | S01.278 | HtrA2 peptidase | htra2 pathogenic mutant | 5WYN_A |
| PA | S01.279 | Deg2 chloroplast peptidase | 4FLN | |
| PA | S01.279 | Deg2 chloroplast peptidase | crystal structure of protease domain of deg2 linked with the pdz domain of deg9 | 5ILB_A |
| PA | S01.280 | lysyl endopeptidase (bacteria) | 1ARB | |
| PA | S01.280 | lysyl endopeptidase (bacteria) | complex with N(alpha)-p-tosyl-L-Lys chloromethylketone | 1ARC |
| PA | S01.280 | lysyl endopeptidase (bacteria) | 4GPG | |
| PA | S01.280 | lysyl endopeptidase (bacteria) | Lys30Arg mutant; complex with TLCK | 4NSV |
| PA | S01.280 | lysyl endopeptidase (bacteria) | complex with TLCK | 4NSY |
| PA | S01.282 | SplB peptidase (Staphylococcus aureus) | 2VID | |
| PA | S01.282 | SplB peptidase (Staphylococcus aureus) | gly-ser-splb protease from staphylococcus aureus at 1.96 a resolution | 4K1S_A |
| PA | S01.282 | SplB peptidase (Staphylococcus aureus) | gly-ser-splb protease from staphylococcus aureus at 1.60 a resolution | 4K1T_A |
| PA | S01.283 | SplC peptidase (Staphylococcus aureus) | functional and structural characterization of spl proteases from staphylococcus aureus | 2AS9_A |
| PA | S01.284 | HtrA3 peptidase | 2P3W | |
| PA | S01.284 | HtrA3 peptidase | 4RI0 | |
| PA | S01.300 | kallikrein-related peptidase 7 | complex with Ala-Ala-Phe-chloromethylketone | 2QXG_A |
| PA | S01.300 | kallikrein-related peptidase 7 | complex with Suc-Ala-Ala-Pro-Phe-chloromethylketone | 2QXH_A |
| PA | S01.300 | kallikrein-related peptidase 7 | high resolution structure of human kallikrein 7 in complex with suc-ala-ala-pro-phe-chloromethylketone | 2QXI_A |
| PA | S01.300 | kallikrein-related peptidase 7 | complex with Suc-Ala-Ala-Pro-Phe-chloromethylketone and copper | 2QXJ_A |
| PA | S01.300 | kallikrein-related peptidase 7 | produced as a secretion protein in E. coli | 3BSQ_A |
| PA | S01.300 | kallikrein-related peptidase 7 | kallikrein-7 in complex with compound1 | 5FAH_A |
| PA | S01.300 | kallikrein-related peptidase 7 | human kallikrein 7 in complex with 1,3,6-trisubstituted 1,4-diazepane-7-one | 5Y9L_A |
| PA | S01.300 | kallikrein-related peptidase 7 | human kallikrein 7 in complex with 1,4-diazepane-7-one 1-acetamide derivative | 5YJK_A |
| PA | S01.300 | kallikrein-related peptidase 7 | mouse kallikrein 7 | 5ZFH_A |
| PA | S01.300 | kallikrein-related peptidase 7 | mouse kallikrein 7 in complex with 6-benzyl-1,4-diazepan-7-one derivative | 5ZFI_A |
| PA | S01.300 | kallikrein-related peptidase 7 | mouse kallikrein 7 in complex with imidazolinylindole derivative | 6AHS_A |
| PA | S01.302 | matriptase | complex with bovine pancreatic trypsin inhibitor | 1EAW_A |
| PA | S01.302 | matriptase | fragment: peptidase unit only | 1EAX |
| PA | S01.302 | matriptase | 2FMV | |
| PA | S01.302 | matriptase | 2GV6_A | |
| PA | S01.302 | matriptase | complex with inhibitor CJ-672 | 2GV7_A |
| PA | S01.302 | matriptase | complex with FAB inhibitor E2 | 3BN9_B |
| PA | S01.302 | matriptase | 3NCL | |
| PA | S01.302 | matriptase | 3NPS | |
| PA | S01.302 | matriptase | 3P8F | |
| PA | S01.302 | matriptase | 3P8G | |
| PA | S01.302 | matriptase | 3SO3 | |
| PA | S01.302 | matriptase | 4IS5 | |
| PA | S01.302 | matriptase | complex with hepatocyte growth factor activator inhibitor-1 | 4ISL_A |
| PA | S01.302 | matriptase | complex with hepatocyte growth factor activator inhibitor-1 | 4ISN_A |
| PA | S01.302 | matriptase | peptidase domain only; complex with Kunitz inhibitor | 4ISO_A |
| PA | S01.302 | matriptase | 4JYT | |
| PA | S01.302 | matriptase | 4JZ1 | |
| PA | S01.302 | matriptase | 4JZI | |
| PA | S01.302 | matriptase | 4O97 | |
| PA | S01.302 | matriptase | 4O9V | |
| PA | S01.302 | matriptase | complex with inhibitor | 4R0I_A |
| PA | S01.302 | matriptase | crystal structure of the zymogen matriptase catalytic domain | 5LYO_A |
| PA | S01.312 | SplE peptidase (Staphylococcus aureus) | atomic resolution structure of sple protease from staphylococcus aureus | 5MM8_A |
| PA | S01.319 | neutrophil serine peptidase 4 | apo form 1 | 4Q7X |
| PA | S01.319 | neutrophil serine peptidase 4 | apo form 2 | 4Q7Y |
| PA | S01.319 | neutrophil serine peptidase 4 | complex with Phe-Phe-Arg-chloromethylketone | 4Q7Z |
| PA | S01.319 | neutrophil serine peptidase 4 | complex with Val-Leu-Lys-chloromethylketone | 4Q80 |
| PA | S01.347 | contortrixobin | 3S69 | |
| PA | S01.393 | NAPase (Nocardiopsis alba) | 2OUA | |
| PA | S01.422 | fibrinolytic enzyme A (Annelida-type) | 1M9U | |
| PA | S01.429 | factor V activating enzyme (Vipera lebetina) and similar | 2FJQ | |
| PA | S01.431 | SFase-2 endopeptidase | 2SFA | |
| PA | S01.438 | fire ant chymotrypsin | complex with PMSF | 1EQ9 |
| PA | S01.441 | Deg5 chloroplast peptidase | crystal structure of deg5 | 4IC5_A |
| PA | S01.443 | glutamyl peptidase BI | 1P3C | |
| PA | S01.443 | glutamyl peptidase BI | complex with 2-methyl-2,4-pentanediol | 1P3E |
| PA | S01.446 | pseutarin C | prothrombinase complex | 4BXS_A |
| PA | S01.446 | pseutarin C | prothrombinase complex | 4BXW_A |
| PA | S01.466 | ACC-C peptidase | 2AIP_A | |
| PA | S01.466 | ACC-C peptidase | benzamidine-inhibited | 2AIQ_A |
| PA | S01.470 | cellulomonadin | 2EA3 | |
| PA | S01.472 | Deg1 chloroplast peptidase | 3QO6 | |
| PA | S01.474 | Deg8 chloroplast peptidase | 4IC6 | |
| PA | S01.482 | HtrA peptidase (Synechocystis-type) | 5B6L | |
| PA | S01.482 | HtrA peptidase (Synechocystis-type) | 5GND | |
| PA | S01.482 | HtrA peptidase (Synechocystis-type) | 5T63 | |
| PA | S01.482 | HtrA peptidase (Synechocystis-type) | Ser237Ala mutant | 5T69 |
| PA | S01.491 | HtrA peptidase (Thermotoga maritima-type) | peptidase domain only. | 1L1J |
| PA | S01.494 | Htra2 peptidase (Mycobacterium-type) | proteolytically active form | 1Y8T_A |
| PA | S01.494 | Htra2 peptidase (Mycobacterium-type) | crystal structure of rv0983 from mycobacterium tuberculosis- proteolytically active form ***caveat 2z9i chirality error at the ca center of asp a 238. | 2Z9I_A |
| PA | S01.499 | alkaline endopeptidase (Nesterenkonia sp.) | 3CP7 | |
| PA | S01.500 | HtrA peptidase (Helicobacter-type) | crystal structure of h. pylori htra with pdz2 deletion | 5Y28_A |
| PA | S01.500 | HtrA peptidase (Helicobacter-type) | crystal structure of h. pylori htra | 5Y2D_A |
| PA | S01.502 | Grass peptidase (Insecta) | 2XXL | |
| PA | S01.503 | SplA peptidase (Staphylococcus aureus) | ON HOLD | 2W7S |
| PA | S01.503 | SplA peptidase (Staphylococcus aureus) | ON HOLD | 2W7U |
| PA | S01.503 | SplA peptidase (Staphylococcus aureus) | complex with a specific phosphonate inhibitor | 3UFA_A |
| PA | S01.503 | SplA peptidase (Staphylococcus aureus) | complex with a specific phosphonate inhibitor | 4MVN_A |
| PA | S01.516 | VesB peptidase (Vibrio cholerae) | structure of vibrio cholerae vesb protease | 4LK4_A |
| PA | S01.522 | ESP peptidase (Staphylococcus-type) | 4JCN | |
| PA | S01.526 | SplD peptidase (Staphylococcus aureus) | 4INK | |
| PA | S01.526 | SplD peptidase (Staphylococcus aureus) | 4INL | |
| PA | S01.931 | kallikrein 1-related peptidase b4 (Mus musculus) | complex with beta and gamma chains | 1SGF_A |
| PA | S01.971 | azurocidin | 1A7S | |
| PA | S01.971 | azurocidin | 1AE5 | |
| PA | S01.971 | azurocidin | Arg23Ser, Phe25Glu mutant | 1FY1 |
| PA | S01.971 | azurocidin | Gly175Gln mutant | 1FY3 |
| PA | S01.972 | haptoglobin-1 | structure of t. brucei haptoglobin-hemoglobin receptor binding to human haptoglobin-hemoglobin | 4WJG_C |
| PA | S01.972 | haptoglobin-1 | complex with haemoglobin | 4X0L_C |
| PA | S01.972 | haptoglobin-1 | structure of the t. brucei haptoglobin-haemoglobin receptor bound to human haptolgobin-haemoglobin | 5HU6_C |
| PA | S01.972 | haptoglobin-1 | 4F4O | |
| PA | S01.975 | macrophage-stimulating protein | beta-chain | 2ASU_A |
| PA | S01.975 | macrophage-stimulating protein | 4QT8 | |
| PA | S01.976 | hepatocyte growth factor | complex with SemA domain of the Met receptor | 1SHY_A |
| PA | S01.976 | hepatocyte growth factor | protease-like domain from 2-chain hepatocyte growth factor | 1SI5_H |
| PA | S01.976 | hepatocyte growth factor | crystal structure of onartuzumab fab in complex with met and hgf-beta | 4K3J_A |
| PA | S01.976 | hepatocyte growth factor | zymogen hgf-beta/met with zymogen activator peptide zap.14 | 4O3T_A |
| PA | S01.976 | hepatocyte growth factor | zymogen hgf-beta/met with zymogen activator peptide zap2.3 | 4O3U_A |
| PA | S01.979 | protein Z | 3F1S_B | |
| PA | S01.979 | protein Z | 3H5C_B | |
| PA | S01.982 | fibroblast-derived mammary growth factor | 2QJ4 | |
| PA | S01.982 | fibroblast-derived mammary growth factor | 3HMR | |
| PA | S01.982 | fibroblast-derived mammary growth factor | 4IUA | |
| PA | S01.983 | carboxypeptidase A complex component III | 1FON | |
| PA | S01.983 | carboxypeptidase A complex component III | complex of procarboxypeptidase A, proproteinase E and chymotrypsinogen C | 1PYT_B |
| PA | S01.999 | apolipoprotein | 1I71 | |
| PA | S01.999 | apolipoprotein | 1JFN | |
| PA | S01.999 | apolipoprotein | 1KIV | |
| PA | S01.999 | apolipoprotein | 2FEB | |
| PA | S01.999 | apolipoprotein | 3KIV | |
| PA | S01.999 | apolipoprotein | 4BV5 | |
| PA | S01.999 | apolipoprotein | 4BV7 | |
| PA | S01.999 | apolipoprotein | 4BVC | |
| PA | S01.999 | apolipoprotein | 4BVD | |
| PA | S01.999 | apolipoprotein | 4BVV | |
| PA | S01.999 | apolipoprotein | 4BVW | |
| PA | S01.999 | apolipoprotein | 4KIV | |
| PA | S01.A05 | DEGP9 g.p. (Arabidopsis thaliana) | crystal structure of deg9 | 5IL9_A |
| PA | S01.A05 | DEGP9 g.p. (Arabidopsis thaliana) | deg9 protease domain | 5ILA_A |
| PA | S01.A05 | DEGP9 g.p. (Arabidopsis thaliana) | crystal structure of protease domain of deg2 linked with the pdz domain of deg9 | 5ILB_A |
| PA | S01.A05 | DEGP9 g.p. (Arabidopsis thaliana) | deg9 crystal under 289k | 5JYK_A |
| PA | S01.A05 | DEGP9 g.p. (Arabidopsis thaliana) | crystal structure of deg9 at 295 k | 5Y09_A |
| PA | S01.UNA | subfamily S1A non-peptidase homologues | 3H7T | |
| PA | S01.UNC | subfamily S1C non-peptidase homologues | apo form | 5HM9 |
| PA | S01.UNC | subfamily S1C non-peptidase homologues | nickel-bound form | 5HMA |
| PA | S01.UPA | subfamily S1A unassigned peptidases | 2E7V | |
| PA | S01.UPA | subfamily S1A unassigned peptidases | Gln111Asn, Gln174Asn, Gln218Asn triple mutant | 3H7O |
| PA | S01.UPA | subfamily S1A unassigned peptidases | crystal structure of da-36, a thrombin-like enzyme from deinagkistrodon acutus | 5XRF_A |
| PA | S01.UPC | subfamily S1C unassigned peptidases | crystal structure of mycobacterium tuberculosis htra1 (rv1223) in regulated conformation | 6IEO_A |
| PA | S01.UPC | subfamily S1C unassigned peptidases | structure of legionella pneumophila degq (s190a variant) | 4YNN_A |
| PA | S01.UPC | subfamily S1C unassigned peptidases | structure of legionella pneumophila degq (delta pdz2 variant) | 4YO1_A |
| PA | S01.UPC | subfamily S1C unassigned peptidases | 5ZVJ | |
| PA | S01.UPE | subfamily S1E unassigned peptidases | 2PFE | |
| PA | S03.001 | togavirin | 1KXA | |
| PA | S03.001 | togavirin | Ser215Ala mutant | 1KXB |
| PA | S03.001 | togavirin | Asn190Lys mutant | 1KXC |
| PA | S03.001 | togavirin | Asn222Leu mutant | 1KXD |
| PA | S03.001 | togavirin | Tyr180Ser and Glu183Gly double mutant | 1KXE |
| PA | S03.001 | togavirin | tetragonal crystal form II | 1KXF |
| PA | S03.001 | togavirin | complete virion | 1LD4 |
| PA | S03.001 | togavirin | 1SNW | |
| PA | S03.001 | togavirin | Ser215Ala mutant | 1SVP_A |
| PA | S03.001 | togavirin | 1WYK | |
| PA | S03.001 | togavirin | mapping the E2 glycoprotein of alphaviruses | 1Z8Y_A |
| PA | S03.001 | togavirin | 2SNV | |
| PA | S03.001 | togavirin | type III crystal form | 2SNW |
| PA | S03.001 | togavirin | 3J0F | |
| PA | S03.001 | togavirin | 3MUU | |
| PA | S03.001 | togavirin | 3MUW | |
| PA | S03.001 | togavirin | conserved core domain of capsid protein | 1EP5_B |
| PA | S03.001 | togavirin | conserved core domain of capsid protein | 1EP6_A |
| PA | S03.001 | togavirin | 3J0C | |
| PA | S03.001 | togavirin | 3J0G | |
| PA | S03.001 | togavirin | complete virion | 1DYL |
| PA | S03.001 | togavirin | trimer | 1VCP |
| PA | S03.001 | togavirin | dimer | 1VCQ |
| PA | S03.001 | togavirin | cryoem structure of chimeric eastern equine encephalitis virus | 6MX4_C |
| PA | S03.001 | togavirin | cryoem structure of chimeric eastern equine encephalitis virus: genome-binding capsid n-terminal domain | 6MX7_C |
| PA | S03.001 | togavirin | 2RSW | |
| PA | S03.001 | togavirin | electron cryo-microscopy of chikungunya virus ***caveat 3j2w numerous residues are not properly linked. this entry ***caveat 2 3j2w contains numerous unrealistic interatomic distances. | 3J2W_A |
| PA | S03.001 | togavirin | electron cryo-microscopy of chikungunya virus ***caveat 3j2w numerous residues are not properly linked. this entry ***caveat 2 3j2w contains numerous unrealistic interatomic distances. | 3J2W_E |
| PA | S03.001 | togavirin | electron cryo-microscopy of "immature" chikungunya vlp | 5VU2_I |
| PA | S03.001 | togavirin | electron cryo-microscopy of chikungunya vlp | 6NK5_A |
| PA | S03.001 | togavirin | electron cryo-microscopy of chikungunya vlp in complex with mouse mxra8 receptor | 6NK6_A |
| PA | S03.001 | togavirin | electron cryo-microscopy of chikungunya in complex with mouse mxra8 receptor | 6NK7_A |
| PA | S03.001 | togavirin | 1DYL_A | |
| PA | S03.001 | togavirin | 1I9W | |
| PA | S03.001 | togavirin | 1RER | |
| PA | S03.001 | togavirin | 1VCP_A | |
| PA | S03.001 | togavirin | 1VCQ_A | |
| PA | S03.001 | togavirin | 2ALA | |
| PA | S03.001 | togavirin | 2V33 | |
| PA | S03.001 | togavirin | 4AGJ | |
| PA | S03.001 | togavirin | 4AGK | |
| PA | S03.001 | togavirin | 4UON | |
| PA | S03.001 | togavirin | capsid protein; complex with piperazine. | 5G4B_A |
| PA | S03.001 | togavirin | 2YEW | |
| PA | S06.002 | EspP peptidase (Escherichia coli) | 2QOM_A | |
| PA | S06.002 | EspP peptidase (Escherichia coli) | 3SLJ | |
| PA | S06.002 | EspP peptidase (Escherichia coli) | 3SLO | |
| PA | S06.002 | EspP peptidase (Escherichia coli) | 3SLT | |
| PA | S06.002 | EspP peptidase (Escherichia coli) | 3SZE | |
| PA | S06.003 | Tsh peptidase | 1WXR | |
| PA | S06.003 | Tsh peptidase | hemoglobin protease (hbp) passenger missing domain-2 | 3AK5_A |
| PA | S06.004 | Sat peptidase | 4OM9 | |
| PA | S06.006 | Hap serine peptidase | 3SYJ | |
| PA | S06.013 | SepA peptidase (Shigellai-type) | crystal structure of the secreted extracellular protein a (sepa) from shigella flexneri | 5J44_A |
| PA | S06.UPW | family S6 unassigned peptidases | the structure of haemophilus influenzae iga1 protease | 3H09_A |
| PA | S07.001 | flavivirin | 1BEF_A | |
| PA | S07.001 | flavivirin | dengue virus RNA helicase | 2BHR_A |
| PA | S07.001 | flavivirin | dengue virus rna helicase at 2.4a | 2BMF_A |
| PA | S07.001 | flavivirin | dengue virus ns2b/ns3 protease | 2FOM_A |
| PA | S07.001 | flavivirin | 3IXY | |
| PA | S07.001 | flavivirin | dengue virus ns2b-ns3 protease a125c variant at ph 8.5 | 4M9F_A |
| PA | S07.001 | flavivirin | Ala125Cys mutant | 4M9I_A |
| PA | S07.001 | flavivirin | ns2b-ns3 protease from dengue virus at ph 5.5 | 4M9K_A |
| PA | S07.001 | flavivirin | ns2b-ns3 protease from dengue virus at ph 8.5 | 4M9M_A |
| PA | S07.001 | flavivirin | ns2b-ns3 protease from dengue virus in the presence of dtnb, a covalent allosteric inhibitor | 4M9T_A |
| PA | S07.001 | flavivirin | structure of dengue virus protease with an allosteric inhibitor that blocks replication | 6MO0_A |
| PA | S07.001 | flavivirin | structure of dengue virus protease with an allosteric inhibitor that blocks replication | 6MO1_A |
| PA | S07.001 | flavivirin | structure of dengue virus protease with an allosteric inhibitor that blocks replication | 6MO2_A |
| PA | S07.001 | flavivirin | dengue virus 4 ns3 helicase structure, apo enzyme. | 2JLQ_A |
| PA | S07.001 | flavivirin | dengue virus 4 ns3 helicase in complex with amppnp | 2JLR_A |
| PA | S07.001 | flavivirin | dengue virus 4 ns3 helicase in complex with adp | 2JLS_A |
| PA | S07.001 | flavivirin | dengue virus 4 ns3 helicase in complex with ssrna | 2JLU_A |
| PA | S07.001 | flavivirin | dengue virus 4 ns3 helicase in complex with ssrna and amppnp | 2JLV_A |
| PA | S07.001 | flavivirin | dengue virus 4 ns3 helicase in complex with ssrna2 | 2JLW_A |
| PA | S07.001 | flavivirin | dengue virus 4 ns3 helicase in complex with ssrna and adp- vanadate | 2JLX_A |
| PA | S07.001 | flavivirin | dengue virus 4 ns3 helicase in complex with ssrna and adp- phosphate | 2JLY_A |
| PA | S07.001 | flavivirin | dengue virus 4 ns3 helicase in complex with ssrna and adp | 2JLZ_A |
| PA | S07.001 | flavivirin | 2VBC_A | |
| PA | S07.001 | flavivirin | 2WHX | |
| PA | S07.001 | flavivirin | 2WZQ | |
| PA | S07.001 | flavivirin | 3UYP | |
| PA | S07.001 | flavivirin | crystal structure of full length ns2b47-ns3 (gd4ns2bns3) from dengue virus 4 in open conformation | 5YVJ_C |
| PA | S07.001 | flavivirin | crystal structure of dengue virus 1 ns2b/ns3 protease | 3L6P_A |
| PA | S07.001 | flavivirin | crystal structure of dengue virus 1 ns2b/ns3 protease active site mutant | 3LKW_A |
| PA | S07.001 | flavivirin | dengue virus protease covalently bound to a peptide | 3U1I_A |
| PA | S07.001 | flavivirin | kokobera virus helicase | 2V6I_A |
| PA | S07.001 | flavivirin | kokobera virus helicase: mutant met47thr | 2V6J_A |
| PA | S07.003 | Zika virus NS2B-NS3 peptidase | 1SFK | |
| PA | S07.003 | Zika virus NS2B-NS3 peptidase | 2HCN | |
| PA | S07.003 | Zika virus NS2B-NS3 peptidase | 2HCS | |
| PA | S07.003 | Zika virus NS2B-NS3 peptidase | 2HFZ | |
| PA | S07.003 | Zika virus NS2B-NS3 peptidase | 2OF6 | |
| PA | S07.003 | Zika virus NS2B-NS3 peptidase | 2QEQ | |
| PA | S07.003 | Zika virus NS2B-NS3 peptidase | complex with Bz-Nle-Lys- Arg-Arg-H | 2FP7 |
| PA | S07.003 | Zika virus NS2B-NS3 peptidase | 2G05 | |
| PA | S07.003 | Zika virus NS2B-NS3 peptidase | 2G2G | |
| PA | S07.003 | Zika virus NS2B-NS3 peptidase | His51Ala mutant | 2GGV |
| PA | S07.003 | Zika virus NS2B-NS3 peptidase | complex with bovine pancreatic trypsin inhibitor | 2IJO_A |
| PA | S07.003 | Zika virus NS2B-NS3 peptidase | 2P5P | |
| PA | S07.003 | Zika virus NS2B-NS3 peptidase | 2YOL | |
| PA | S07.003 | Zika virus NS2B-NS3 peptidase | 3E90 | |
| PA | S07.003 | Zika virus NS2B-NS3 peptidase | 3I50 | |
| PA | S07.003 | Zika virus NS2B-NS3 peptidase | complex witha capped dipeptide boronate inhibitor | 5IDK_A |
| PA | S07.003 | Zika virus NS2B-NS3 peptidase | 2PX2 | |
| PA | S07.003 | Zika virus NS2B-NS3 peptidase | 2PX4 | |
| PA | S07.003 | Zika virus NS2B-NS3 peptidase | 2PX5 | |
| PA | S07.003 | Zika virus NS2B-NS3 peptidase | 2PX8 | |
| PA | S07.003 | Zika virus NS2B-NS3 peptidase | 2PXA | |
| PA | S07.003 | Zika virus NS2B-NS3 peptidase | 2PXC | |
| PA | S07.003 | Zika virus NS2B-NS3 peptidase | structure of the murray valley encephalitis virus rna helicase to 1.9a resolution | 2V8O_A |
| PA | S07.003 | Zika virus NS2B-NS3 peptidase | 2WV9 | |
| PA | S07.003 | Zika virus NS2B-NS3 peptidase | catalytic domain | 2Z83_A |
| PA | S07.003 | Zika virus NS2B-NS3 peptidase | 3P54 | |
| PA | S07.003 | Zika virus NS2B-NS3 peptidase | 4HDG | |
| PA | S07.003 | Zika virus NS2B-NS3 peptidase | 4HDH | |
| PA | S07.003 | Zika virus NS2B-NS3 peptidase | 4K6M | |
| PA | S07.003 | Zika virus NS2B-NS3 peptidase | 4MTP | |
| PA | S07.003 | Zika virus NS2B-NS3 peptidase | structure of jev protease | 4R8T_B |
| PA | S07.003 | Zika virus NS2B-NS3 peptidase | 4FG0 | |
| PA | S07.003 | Zika virus NS2B-NS3 peptidase | after self-cleavage | 5GJ4 |
| PA | S07.003 | Zika virus NS2B-NS3 peptidase | complex with a reverse peptide inhibitor | 5GPI |
| PA | S07.003 | Zika virus NS2B-NS3 peptidase | comolex with a compound fragment | 5H4I |
| PA | S07.003 | Zika virus NS2B-NS3 peptidase | complex with a dipeptide inhibitor | 5H6V_A |
| PA | S07.003 | Zika virus NS2B-NS3 peptidase | complex with a boronate inhibitor | 5LC0 |
| PA | S07.003 | Zika virus NS2B-NS3 peptidase | apo-form | 5T1V |
| PA | S07.003 | Zika virus NS2B-NS3 peptidase | crystal structure of the zika virus ns2b-ns3 protease in super-open conformation | 5TFN_A |
| PA | S07.003 | Zika virus NS2B-NS3 peptidase | crystal structure of the zika virus ns2b-ns3 protease with a deletion v76-l86 in ns2b | 5TFO_A |
| PA | S07.003 | Zika virus NS2B-NS3 peptidase | crystal structure of zika ns3 protease with phenylacetyl-lys-lys-arg- cooh inhibitor | 5ZMQ_A |
| PA | S07.003 | Zika virus NS2B-NS3 peptidase | crystal structure of zika ns3 protease with phenylacetyl-lys-lys-arg- cooh inhibitor | 5ZMQ_B |
| PA | S07.003 | Zika virus NS2B-NS3 peptidase | complex with 4- guanidinomethyl-phenylacetyl-lys-lys-arg-h | 5ZMS_A |
| PA | S07.003 | Zika virus NS2B-NS3 peptidase | complex with 4- guanidinomethyl-phenylacetyl-lys-lys-arg-h | 5ZMS_B |
| PA | S07.003 | Zika virus NS2B-NS3 peptidase | crystal structure of zika ns3 protease with 4-guanidinomethyl- phenylacetyl-arg-arg-arg-4-amidinobenzylamide | 5ZOB_A |
| PA | S07.003 | Zika virus NS2B-NS3 peptidase | crystal structure of zika ns2b-ns3 protease with compound 1c | 6JPW_A |
| PA | S07.UPW | family S7 unassigned peptidases | 1N6G | |
| PA | S07.UPW | family S7 unassigned peptidases | 1NA4 | |
| PA | S07.UPW | family S7 unassigned peptidases | 1SVB | |
| PA | S07.UPW | family S7 unassigned peptidases | 1URZ | |
| PA | S07.UPW | family S7 unassigned peptidases | 1Z66 | |
| PA | S07.UPW | family S7 unassigned peptidases | 2GG1 | |
| SB | S08.001 | subtilisin Carlsberg | complex with barley chymotrypsin inhibitor CI-2A(M59P): OBSOLETE ENTRY | 1A10 |
| SB | S08.001 | subtilisin Carlsberg | complex with chymotrypsin inhibitor CI-2A: OBSOLETE ENTRY | 1A1Y |
| SB | S08.001 | subtilisin Carlsberg | 1AF4 | |
| SB | S08.001 | subtilisin Carlsberg | complex with L-naphthyl-1-acetamido boronic acid inhibitor | 1AV7 |
| SB | S08.001 | subtilisin Carlsberg | complex with D-para-chlorophenyl-1-acetamido boronic acid inhibitor | 1AVT |
| SB | S08.001 | subtilisin Carlsberg | trans-cinnamoyl-subtilisin in andhydrous acetonitrile | 1BE6 |
| SB | S08.001 | subtilisin Carlsberg | trans-cinnamoyl-subtilisin in water | 1BE8 |
| SB | S08.001 | subtilisin Carlsberg | in 40% acetonitrile | 1BFK |
| SB | S08.001 | subtilisin Carlsberg | in 20% dioxane | 1BFU |
| SB | S08.001 | subtilisin Carlsberg | under xenon pressure | 1C3L |
| SB | S08.001 | subtilisin Carlsberg | NMR structure; complex with barley chymotrypsin inhibitor-2 | 1CIS |
| SB | S08.001 | subtilisin Carlsberg | complex with eglin C | 1CSE_E |
| SB | S08.001 | subtilisin Carlsberg | complex with tomato inhibitor-II | 1OYV_A |
| SB | S08.001 | subtilisin Carlsberg | complex with inhibitor turkey ovomucoid third domain | 1R0R_E |
| SB | S08.001 | subtilisin Carlsberg | 1SBC | |
| SB | S08.001 | subtilisin Carlsberg | 1SCA | |
| SB | S08.001 | subtilisin Carlsberg | acetonitrile soaked crystals | 1SCB |
| SB | S08.001 | subtilisin Carlsberg | 1SCD | |
| SB | S08.001 | subtilisin Carlsberg | complex with N-tert-butoxycarbonyl-Ala-Pro-Phe-O-benzoyl hydroxylamine | 1SCN |
| SB | S08.001 | subtilisin Carlsberg | complex with L-para-chlorophenyl-1-acetamido boronic acid inhibitor | 1VSB |
| SB | S08.001 | subtilisin Carlsberg | complex with turkey ovomucoid third domain | 1YU6_A |
| SB | S08.001 | subtilisin Carlsberg | complex with N-acetyl eglin C | 2SEC_E |
| SB | S08.001 | subtilisin Carlsberg | crystallographic analysis of counter-ion effects in acetonitrile | 2WUV_A |
| SB | S08.001 | subtilisin Carlsberg | crystallographic analysis of counter-ion effects in acetonitrile (native data) | 2WUW_E |
| SB | S08.001 | subtilisin Carlsberg | complex with horseshoe crab Kazal-type serine protease inhibitor | 3QTL_A |
| SB | S08.001 | subtilisin Carlsberg | bond length analysis of Asp, Glu and His residues | 3UNX_A |
| SB | S08.001 | subtilisin Carlsberg | complex with D-naphthyl-1-acetamido boronic acid inhibitor | 3VSB |
| SB | S08.001 | subtilisin Carlsberg | extensive counter-ion interactions in aqueous medium, cs derivative | 4C3U_A |
| SB | S08.001 | subtilisin Carlsberg | extensive counter-ion interactions in aqueous medium, no cs soak | 4C3V_A |
| SB | S08.001 | subtilisin Carlsberg | complex with Streptomyces caespitosus sermetstatin | 4HX2_A |
| SB | S08.001 | subtilisin Carlsberg | subtilisin serine protease modified with the protease inhibitor cyanobenzylsulfonylfluoride | 6DWQ_A |
| SB | S08.002 | mesentericopeptidase | complex with eglin-C | 1MEE_A |
| SB | S08.003 | subtilisin lentus | 1ST3 | |
| SB | S08.003 | subtilisin lentus | 1C13 | |
| SB | S08.003 | subtilisin lentus | Lys27Arg, Asn87Ser, Val104Tyr, Asn123Ser, Thr274Ala mutant | 1C9J |
| SB | S08.003 | subtilisin lentus | Asn76Asp, Ser103Ala, Val104Ile mutant | 1C9M |
| SB | S08.003 | subtilisin lentus | Ser87 variant | 1C9N |
| SB | S08.003 | subtilisin lentus | 1GCI | |
| SB | S08.003 | subtilisin lentus | 1IAV | |
| SB | S08.003 | subtilisin lentus | 1JEA | |
| SB | S08.003 | subtilisin lentus | 1NDQ_A | |
| SB | S08.003 | subtilisin lentus | variant Ser101Gly/Val104Asn | 1NDU_A |
| SB | S08.003 | subtilisin lentus | s156e/s166d variant of Bacillus lentus subtilisin | 1Q5P_A |
| SB | S08.003 | subtilisin lentus | 1SVN | |
| SB | S08.003 | subtilisin lentus | complex with gramicidin S | 1TK2_A |
| SB | S08.003 | subtilisin lentus | 3BX1 | |
| SB | S08.003 | subtilisin lentus | complex with barley subtilisin inhibitor | 3BX1_A |
| SB | S08.003 | subtilisin lentus | 4CFY | |
| SB | S08.003 | subtilisin lentus | 4CFZ | |
| SB | S08.003 | subtilisin lentus | 4CG0 | |
| SB | S08.003 | subtilisin lentus | 5AQE | |
| SB | S08.003 | subtilisin lentus | cooperative bio-metallic selectivity in a tailored protease enables creation of a c-c cross-coupling heckase | 5ARB_A |
| SB | S08.003 | subtilisin lentus | cooperative bio-metallic selectivity in a tailored protease enables creation of a c-c cross-coupling heckase | 5ARC_A |
| SB | S08.003 | subtilisin lentus | cooperative bio-metallic selectivity in a tailored protease enables creation of a c-c cross-coupling heckase | 5ARD_A |
| SB | S08.007 | thermitase | complex with eglin C | 1TEC_E |
| SB | S08.007 | thermitase | 1THM | |
| SB | S08.007 | thermitase | complex with eglin C | 2TEC_E |
| SB | S08.007 | thermitase | complex with eglin C | 3TEC_E |
| SB | S08.009 | subtilisin Ak1 | 1DBI | |
| SB | S08.010 | M-peptidase | 1MPT | |
| SB | S08.010 | M-peptidase | form I | 1WSD_A |
| SB | S08.012 | PfSUB1 peptidase | crystal structure of pfsub1-prodomain-nimp.m7 fab complex | 4LVN_A |
| SB | S08.012 | PfSUB1 peptidase | crystal structure of pfsub1-prodomain-nimp.m7 fab complex with added cacl2 | 4LVO_A |
| SB | S08.012 | PfSUB1 peptidase | crystal structure of pvsub1 | 4TR2_A |
| SB | S08.020 | C5a peptidase | 1XF1_A | |
| SB | S08.020 | C5a peptidase | 3EIF | |
| SB | S08.020 | C5a peptidase | 1XF1 | |
| SB | S08.021 | fervidolysin | 1R6V | |
| SB | S08.022 | bpr peptidase (Dichelobacter nodosus) | 3TI7 | |
| SB | S08.022 | bpr peptidase (Dichelobacter nodosus) | 3TI9 | |
| SB | S08.027 | cell envelope peptidase A (Streptococcus-type) | crystal structure of a serine protease from streptococcus species | 5XXZ_A |
| SB | S08.027 | cell envelope peptidase A (Streptococcus-type) | crystal structure of a serine protease from streptococcus species | 5XYA_A |
| SB | S08.027 | cell envelope peptidase A (Streptococcus-type) | crystal structure of a serine protease from streptococcus species | 5XYR_A |
| SB | S08.030 | IspA peptidase | precursor | 2WV7 |
| SB | S08.030 | IspA peptidase | precursor | 2WWT |
| SB | S08.030 | IspA peptidase | precursor | 2X8J |
| SB | S08.030 | IspA peptidase | processed intracellular subtilisin from b. clausii | 2XRM_A |
| SB | S08.030 | IspA peptidase | processed form | 2XRN |
| SB | S08.034 | subtilisin BPN' | mutant 7186 (Thr22Cys, Ser87Cys, Gly169Ala, Asn218Ser)) | 1A2Q |
| SB | S08.034 | subtilisin BPN' | engineered mutant | 1AK9 |
| SB | S08.034 | subtilisin BPN' | mutant form | 1AQN |
| SB | S08.034 | subtilisin BPN' | mutant form | 1AU9 |
| SB | S08.034 | subtilisin BPN' | engineered mutant | 1DUI |
| SB | S08.034 | subtilisin BPN' | 1GNS | |
| SB | S08.034 | subtilisin BPN' | engineered mutant | 1GNV |
| SB | S08.034 | subtilisin BPN' | complex with barley inhibitor CI-2A | 1LW6_E |
| SB | S08.034 | subtilisin BPN' | mutant | 1S01 |
| SB | S08.034 | subtilisin BPN' | 1S02 | |
| SB | S08.034 | subtilisin BPN' | mutant form | 1SBH |
| SB | S08.034 | subtilisin BPN' | engineered mutant | 1SBI |
| SB | S08.034 | subtilisin BPN' | complex with eglin C Leu45Arg | 1SBN_E |
| SB | S08.034 | subtilisin BPN' | 1SBT | |
| SB | S08.034 | subtilisin BPN' | complex with eglin C Arg53Lys | 1SIB_E |
| SB | S08.034 | subtilisin BPN' | prosegment; complex with mutant subtilisin BPN | 1SPB_S |
| SB | S08.034 | subtilisin BPN' | peroxide inactivated | 1ST2 |
| SB | S08.034 | subtilisin BPN' | engineered mutant; complex with Ala-Leu-Ala-Leu | 1SUA |
| SB | S08.034 | subtilisin BPN' | mutant Asn218Ser, Ser221Cys | 1SUB |
| SB | S08.034 | subtilisin BPN' | mutant Met50Phe, Tyr217Lys, Asn218Ser, Ser221Cys, 75-83 deleted | 1SUC |
| SB | S08.034 | subtilisin BPN' | mutant Met50Phe, Tyr217Lys, Asn218Ser, Ser221Cys | 1SUD |
| SB | S08.034 | subtilisin BPN' | engineered mutant; complex with di(isopropyl)phosphate | 1SUE |
| SB | S08.034 | subtilisin BPN' | complex with phenyl methyl sulfonate inhibitor | 1SUP |
| SB | S08.034 | subtilisin BPN' | complex with chymotrypsin inhibitor 2 | 1TM1_E |
| SB | S08.034 | subtilisin BPN' | complex with chymotrypsin inhibitor 2 Met59Lys mutant | 1TM3_E |
| SB | S08.034 | subtilisin BPN' | complex with chymotrypsin inhibitor 2 Met59Gly mutant | 1TM4_E |
| SB | S08.034 | subtilisin BPN' | complex with chymotrypsin inhibitor 2 Met59Ala mutant | 1TM5 _E |
| SB | S08.034 | subtilisin BPN' | complex with chymotrypsin inhibitor 2 Met59Tyr mutant | 1TM7_E |
| SB | S08.034 | subtilisin BPN' | complex with chymotrypsin inhibitor 2 Met59Phe mutant | 1TMG_E |
| SB | S08.034 | subtilisin BPN' | complex with chymotrypsin inhibitor 2 Tyr61Ala mutant | 1TO1_E |
| SB | S08.034 | subtilisin BPN' | complex with chymotrypsin inhibitor 2 Met59Lys mutant at pH 9 | 1TO2_E |
| SB | S08.034 | subtilisin BPN' | selenosubtilisin BPN | 1UBN |
| SB | S08.034 | subtilisin BPN' | complex with inhibitor POIA1 | 1V5I_A |
| SB | S08.034 | subtilisin BPN' | complex with barley chymotrypsin inhibitor 2 Thr58Ala mutant | 1Y1K_E |
| SB | S08.034 | subtilisin BPN' | complex with barley chymotrypsin inhibitor 2 Thr58Pro mutant | 1Y33_E |
| SB | S08.034 | subtilisin BPN' | complex with barley chymotrypsin inhibitor 2 Glu60Ala mutant | 1Y34_E |
| SB | S08.034 | subtilisin BPN' | complex with barley chymotrypsin inhibitor 2 Glu60Ser mutant | 1Y3B_E |
| SB | S08.034 | subtilisin BPN' | complex with barley chymotrypsin inhibitor 2 Arg62Ala mutant | 1Y3C_E |
| SB | S08.034 | subtilisin BPN' | complex with barley chymotrypsin inhibitor 2 Arg67Ala mutant | 1Y3D_E |
| SB | S08.034 | subtilisin BPN' | complex with barley chymotrypsin inhibitor 2 Phe69Ala mutant | 1Y3F_E |
| SB | S08.034 | subtilisin BPN' | complex with barley chymotrypsin inhibitor 2 Arg65Ala mutant | 1Y48_E |
| SB | S08.034 | subtilisin BPN' | complex with barley chymotrypsin inhibitor 2 Met59Arg, Glu60Ser mutant | 1Y4A_E |
| SB | S08.034 | subtilisin BPN' | engineered mutant | 1YJA |
| SB | S08.034 | subtilisin BPN' | engineered mutant | 1YJB |
| SB | S08.034 | subtilisin BPN' | engineered mutant | 1YJC |
| SB | S08.034 | subtilisin BPN' | 2SBT | |
| SB | S08.034 | subtilisin BPN' | complex with Streptomyces subtilisin inhibitor | 2SIC_E |
| SB | S08.034 | subtilisin BPN' | complex with chymotrypsin inhibitor 2 | 2SNI_E |
| SB | S08.034 | subtilisin BPN' | recombinant | 2ST1 |
| SB | S08.034 | subtilisin BPN' | complex with Streptomyces subtilisin inhibitor Met73Lys | 3SIC_E |
| SB | S08.034 | subtilisin BPN' | 5OX2_A | |
| SB | S08.034 | subtilisin BPN' | complex with Streptomyces subtilisin inhibitor Met70Gly, Met73Lys | 5SIC_E |
| SB | S08.036 | subtilisin E | Ser221Cys mutant; complex with propeptide | 1SCJ_A |
| SB | S08.036 | subtilisin E | Ser221selenocysteine mutant | 1SEL |
| SB | S08.036 | subtilisin E | 3WHI | |
| SB | S08.037 | subtilisin DY | complex with N-Bz-Ala-Pro-Phe-choromethyl ketone inhibitor | 1BH6 |
| SB | S08.038 | alkaline peptidase (Bacillus alcalophilus) | NMR structure | 1AH2 |
| SB | S08.039 | PCSK9 peptidase | 2P4E_P | |
| SB | S08.039 | PCSK9 peptidase | 2PMW_A | |
| SB | S08.039 | PCSK9 peptidase | the crystal structure of pcsk9 at 1.9 angstroms resolution reveals structural homology to resistin within the c- terminal domain | 2QTW_A |
| SB | S08.039 | PCSK9 peptidase | wt pcsk9-deltac bound to wt egf-a of ldlr | 2W2M_P |
| SB | S08.039 | PCSK9 peptidase | wt pcsk9-deltac bound to egf-a h306y mutant of ldlr | 2W2N_P |
| SB | S08.039 | PCSK9 peptidase | pcsk9-deltac d374y mutant bound to wt egf-a of ldlr | 2W2O_P |
| SB | S08.039 | PCSK9 peptidase | pcsk9-deltac d374a mutant bound to wt egf-a of ldlr | 2W2P_P |
| SB | S08.039 | PCSK9 peptidase | pcsk9-deltac d374h mutant bound to wt egf-a of ldlr | 2W2Q_P |
| SB | S08.039 | PCSK9 peptidase | pcsk9:egf-a complex | 3BPS_P |
| SB | S08.039 | PCSK9 peptidase | pcsk9:egfa(h306y) | 3GCW_P |
| SB | S08.039 | PCSK9 peptidase | pcsk9:egfa (ph 7.4) | 3GCX_P |
| SB | S08.039 | PCSK9 peptidase | complex with FAB from ldlr competitive antibody | 3H42_A |
| SB | S08.040 | apr2 peptidase (Dichelobacter nodosus) | crystal structure of a subtilisin-like protease | 3LPA_A |
| SB | S08.040 | apr2 peptidase (Dichelobacter nodosus) | crystal structure of a subtilisin-like protease | 3LPD_A |
| SB | S08.044 | subtilisin NAT | 3VYV_A | |
| SB | S08.044 | subtilisin NAT | 4DWW | |
| SB | S08.044 | subtilisin NAT | 5GL8_A | |
| SB | S08.050 | secreted peptidase A | 1S2N_A | |
| SB | S08.050 | secreted peptidase A | 1SH7_A | |
| SB | S08.051 | aqualysin 1 | 4DZT | |
| SB | S08.054 | endopeptidase K | complex with lactoferrin fragment | 1BJR |
| SB | S08.054 | endopeptidase K | in anhydrous organic solvent at 70 celsius | 1CNM |
| SB | S08.054 | endopeptidase K | enhanced activity through three-phase partitioning | 1EGQ |
| SB | S08.054 | endopeptidase K | complex with Hg2+ | 1HT3 |
| SB | S08.054 | endopeptidase K | 1IC6 | |
| SB | S08.054 | endopeptidase K | complex with melanin monomers | 1OYO_A |
| SB | S08.054 | endopeptidase K | complex with heptapeptide inhibitor Pro-Ala-Pro-Phe-Ala-Ala-Ala | 1P7V_A |
| SB | S08.054 | endopeptidase K | complex with a designed heptapeptide inhibitor Pro-Ala-Pro-Phe-Ala-Ser-Ala | 1P7W_A |
| SB | S08.054 | endopeptidase K | complex with N-Ac-Pro-Ala-Pro-Phe-D-Ala-Ala-NH2 | 1PEK |
| SB | S08.054 | endopeptidase K | strategy to design inhibitors: structure of a complex of proteinase k with a designed octapeptide inhibitor n-ac- pro-ala-pro-phe-dala-ala-ala-ala-nh2 at 2.5a resolution | 1PFG_A |
| SB | S08.054 | endopeptidase K | structure of a ternary complex of proteinase k, mercury and a substrate-analogue hexapeptide at 2.2 a resolution | 1PJ8_A |
| SB | S08.054 | endopeptidase K | complex with mercury | 1PTK |
| SB | S08.054 | endopeptidase K | complex with human lactoferrin fragment | 2DP4_E |
| SB | S08.054 | endopeptidase K | complex with a specific lactoferrin peptide Val-Leu-Leu-His | 2DQK_A |
| SB | S08.054 | endopeptidase K | complex with a synthetic peptide Leu-Leu-Phe-Asn-Asp | 2DUJ_A |
| SB | S08.054 | endopeptidase K | anomalous substructure of proteinase k | 2G4V_A |
| SB | S08.054 | endopeptidase K | complex with inhibitory lactoferrin octapeptide Gly-Asp-Glu-Gln-Gly-Glu-Asn-Lys | 2HD4_A |
| SB | S08.054 | endopeptidase K | complex with a synthetic peptide Lys-Leu-Lys-Leu-Leu-Val-Val-Ile-Arg-Leu-Lys | 2HPZ_A |
| SB | S08.054 | endopeptidase K | 2ID8_A | |
| SB | S08.054 | endopeptidase K | calcium-free form | 2PKC |
| SB | S08.054 | endopeptidase K | structure of serine proteinase k complex with a highly flexible hydrophobic peptide at 1.8a resolution | 2PQ2_A |
| SB | S08.054 | endopeptidase K | 2PRK | |
| SB | S08.054 | endopeptidase K | complex with alanine boronic acid | 2PWA_A |
| SB | S08.054 | endopeptidase K | complex with coumarin | 2PWB_A |
| SB | S08.054 | endopeptidase K | complex with auramine | 2PYZ_A |
| SB | S08.054 | endopeptidase K | sad structure solution of proteinase k grown in selenate solution | 2V8B_A |
| SB | S08.054 | endopeptidase K | 3AJ8 | |
| SB | S08.054 | endopeptidase K | 3AJ9 | |
| SB | S08.054 | endopeptidase K | proteinase k by lb nanotemplate method before high x-ray dose on esrf id23-1 beamline | 3D9Q_X |
| SB | S08.054 | endopeptidase K | proteinase k by lb nanotemplate method after the first step of high x-ray dose on esrf id23-1 beamline | 3DDZ_X |
| SB | S08.054 | endopeptidase K | proteinase k by lb nanotemplate method after the second step of high x-ray dose on esrf id23-1 beamline | 3DE0_X |
| SB | S08.054 | endopeptidase K | proteinase k by lb nanotemplate method after the third step of high x-ray dose on esrf id23-1 beamline | 3DE1_X |
| SB | S08.054 | endopeptidase K | proteinase k by lb nanotemplate method after the fourth step of high x-ray dose on esrf id23-1 beamline | 3DE2_X |
| SB | S08.054 | endopeptidase K | proteinase k by classical hanging drop method before high x- ray dose on esrf id23-1 beamline | 3DE3_X |
| SB | S08.054 | endopeptidase K | proteinase k by classical hanging drop method after the first step of high x-ray dose on esrf id23-1 beamline | 3DE4_X |
| SB | S08.054 | endopeptidase K | roteinase k by classical hanging drop method after the second step of high x-ray dose on esrf id23-1 beamline | 3DE5_X |
| SB | S08.054 | endopeptidase K | proteinase k by classical hanging drop method after the third step of high x-ray dose on esrf id23-1 beamline | 3DE6_X |
| SB | S08.054 | endopeptidase K | proteinase k by classical hanging drop method after the fourth step of high x-ray dose on esrf id23-1 beamline | 3DE7_X |
| SB | S08.054 | endopeptidase K | 3DVQ | |
| SB | S08.054 | endopeptidase K | 3DVR | |
| SB | S08.054 | endopeptidase K | 3DVS | |
| SB | S08.054 | endopeptidase K | 3DW1 | |
| SB | S08.054 | endopeptidase K | 3DW3 | |
| SB | S08.054 | endopeptidase K | 3DWE | |
| SB | S08.054 | endopeptidase K | complex with digalacturonic acid | 3DYB |
| SB | S08.054 | endopeptidase K | complex with the mad triangle b3c | 3GT3_A |
| SB | S08.054 | endopeptidase K | complex with the magic triangle i3c | 3GT4_A |
| SB | S08.054 | endopeptidase K | 3I2Y | |
| SB | S08.054 | endopeptidase K | 3I30 | |
| SB | S08.054 | endopeptidase K | 3I34 | |
| SB | S08.054 | endopeptidase K | 3I37 | |
| SB | S08.054 | endopeptidase K | 3L1K | |
| SB | S08.054 | endopeptidase K | 3OSZ | |
| SB | S08.054 | endopeptidase K | complex with inhibitor MeOSuc-Ala-Ala-Pro-Ala-chloromethyl ketone | 3PRK |
| SB | S08.054 | endopeptidase K | 3PTL | |
| SB | S08.054 | endopeptidase K | 3Q40 | |
| SB | S08.054 | endopeptidase K | 3Q5G | |
| SB | S08.054 | endopeptidase K | 3QMP | |
| SB | S08.054 | endopeptidase K | 4B5L | |
| SB | S08.054 | endopeptidase K | 4DJ5 | |
| SB | S08.054 | endopeptidase K | 4FON | |
| SB | S08.054 | endopeptidase K | 4WOB | |
| SB | S08.054 | endopeptidase K | 4WOC | |
| SB | S08.054 | endopeptidase K | 4ZAR | |
| SB | S08.054 | endopeptidase K | crystal structure of proteinase k processed with the crystaldirect automated mounting and cryo-cooling technology | 5AMX_A |
| SB | S08.054 | endopeptidase K | 5AVJ_A | |
| SB | S08.054 | endopeptidase K | 5AVK_A | |
| SB | S08.054 | endopeptidase K | 5B1D_A | |
| SB | S08.054 | endopeptidase K | 5B1E_A | |
| SB | S08.054 | endopeptidase K | 5CW1 | |
| SB | S08.054 | endopeptidase K | 5I9S_A | |
| SB | S08.054 | endopeptidase K | microed structure of proteinase k at 1.6 a resolution | 5K7S_A |
| SB | S08.054 | endopeptidase K | 5KXU | |
| SB | S08.054 | endopeptidase K | 5KXV | |
| SB | S08.054 | endopeptidase K | single-shot pink beam serial crystallography: proteinase k | 5MJL_A |
| SB | S08.054 | endopeptidase K | serial millisecond crystallography of membrane and soluble protein micro-crystals using synchrotron radiation | 5UVL_A |
| SB | S08.054 | endopeptidase K | using sound pulses to solve the crystal harvesting bottleneck | 5WHW_A |
| SB | S08.054 | endopeptidase K | using sound pulses to solve the crystal harvesting bottleneck | 5WJG_A |
| SB | S08.054 | endopeptidase K | using sound pulses to solve the crystal harvesting bottleneck | 5WJH_A |
| SB | S08.054 | endopeptidase K | crystal structure of proteinase k from engyodontium album | 5WRC_A |
| SB | S08.054 | endopeptidase K | 6CL7_A | |
| SB | S08.054 | endopeptidase K | 6CL8_A | |
| SB | S08.054 | endopeptidase K | 6CL9_A | |
| SB | S08.054 | endopeptidase K | 6CLA_A | |
| SB | S08.054 | endopeptidase K | 6CLB_A | |
| SB | S08.054 | endopeptidase K | proteinase~k siras phased structure of room-temperature, serially collected synchrotron data | 6FJS_A |
| SB | S08.054 | endopeptidase K | high-viscosity injector-based pink beam serial crystallography of micro-crystals at a synchrotron radiation source. | 6MH6_A |
| SB | S08.054 | endopeptidase K | microed structure of proteinase k at 2.75a resolution from a single milled crystal. | 6N4U_A |
| SB | S08.056 | cuticle-degrading peptidase of parasitic fungus | 3F7O_A | |
| SB | S08.056 | cuticle-degrading peptidase of parasitic fungus | 3F7M_A | |
| SB | S08.059 | NisP (Lactococcus lactis)-type lantibiotic leader peptidase | 4MZD | |
| SB | S08.062 | antigen Pen c 1-type peptidase | 4TST | |
| SB | S08.070 | kexin | complex with N-acetyl-L-alanyl-6-ammonio-N-[(1R)-4-carbamimidamido-1-(dihydroxyboranyl)butyl]-L-norleucinamide | 1OT5_A |
| SB | S08.070 | kexin | complex with Ac-Arg-Glu-Lys-boroArg peptidyl boronic acid inhibitor | 1R64_A |
| SB | S08.070 | kexin | complex with N~2~-acetyl-N~5~-[amino(iminio)methyl]-L-ornithyl-L-alpha-glutamyl-N-[(1S)-5-amino-1-(chloroacetyl)pentyl]-N~5~-[amino(iminio)methyl]-L-ornithinamide | 2ID4 |
| SB | S08.071 | furin | 4OMC | |
| SB | S08.071 | furin | 4OMD | |
| SB | S08.071 | furin | 4RYD | |
| SB | S08.071 | furin | crystal structure of unglycosylated apo human furin @1.89a | 4Z2A_A |
| SB | S08.071 | furin | complex with the inhibitory antibody nb14 | 5JMO_A |
| SB | S08.071 | furin | structure of the unliganded form of the proprotein convertase furin. | 5JXG_A |
| SB | S08.071 | furin | complex with meta- guanidinomethyl-phac-rvr-amba | 5JXH_A |
| SB | S08.071 | furin | structure of the unliganded form of the proprotein convertase furin inpresence of edta. | 5JXI_A |
| SB | S08.071 | furin | complex to meta- guanidinomethyl-phac-rvr-amba in presence of edta | 5JXJ_A |
| SB | S08.071 | furin | complex with the 2,5-dideoxystreptamine derived small molecule inhibitor 1n | 5MIM_A |
| SB | S08.071 | furin | complex with the competitive inhibitor phac-cit-val-arg-amba | 6EQV_A |
| SB | S08.071 | furin | complex with the competitive inhibitor 4-aminomethyl-phenylacetyl-arg-val-arg-amba | 6EQW_A |
| SB | S08.071 | furin | complex with the competitive inhibitor arg-arg-arg-val-arg-amba | 6EQX_A |
| SB | S08.071 | furin | complex with the cyclic peptide c[succinyl-phe-2-nal-(arg)4-lys]-arg-4-amba | 6HLB_A |
| SB | S08.071 | furin | complex with the cyclic peptide c[succinyl-phe-2-nal-(arg)3-lys]-lys-4-amba | 6HLD_A |
| SB | S08.071 | furin | complex with the p6-p2-cyclized peptide h-lys-arg-arg-tle-lys-4-amba | 6HLE_A |
| SB | S08.071 | furin | complex with the cyclic peptide c[glutaryl-arg-arg-lys]-arg-4-amba | 6HZA_A |
| SB | S08.071 | furin | complex with the cyclic inhibitor c[glutaryl-arg-arg-lys]-lys-4-amba | 6HZB_A |
| SB | S08.071 | furin | complex with the cyclic inhibitor c[glutaryl-bvk-lys-arg-arg-tle-lys]-4-amba | 6HZC_A |
| SB | S08.071 | furin | complex with the cyclic inhibitor c[glutaryl-arg-arg-arg-lys]-arg-4-amba | 6HZD_A |
| SB | S08.071 | furin | homooctomer | 1P8J |
| SB | S08.072 | PCSK1 peptidase | 1KN6 | |
| SB | S08.072 | PCSK1 peptidase | 2KDT | |
| SB | S08.072 | PCSK1 peptidase | 2KE3 | |
| SB | S08.086 | CylA lantibiotic leader peptidase | crystal structure of a lanthipeptide protease | 4ZOQ_A |
| SB | S08.090 | tripeptidyl-peptidase II | 3LXU | |
| SB | S08.092 | cucumisin | 3VTA | |
| SB | S08.092 | cucumisin | complex with propeptide | 4YN3 |
| SB | S08.108 | CspB peptidase (Clostridium sp.) | 4I0W | |
| SB | S08.113 | sfericase | 1EA7 | |
| SB | S08.113 | sfericase | 2IXT | |
| SB | S08.113 | sfericase | the crystal structure of sph at 0.8a | 3D43_A |
| SB | S08.121 | cytotoxin SubAB | crystal structure of the a-subunit of the ab5 toxin from e. coli | 2IY9_A |
| SB | S08.121 | cytotoxin SubAB | structural basis of subtilase cytotoxin subab assembly | 4BWG_A |
| SB | S08.123 | KP-43 peptidase | 1WMD_A | |
| SB | S08.123 | KP-43 peptidase | 1WME | |
| SB | S08.123 | KP-43 peptidase | oxidized form | 1WMF |
| SB | S08.125 | AspA (Aeromonas sobria)-type peptidase | 3HJR | |
| SB | S08.125 | AspA (Aeromonas sobria)-type peptidase | complex with chaperone (orf2) | 3WQB_A |
| SB | S08.129 | Tk-subtilisin | precursor | 2E1P |
| SB | S08.129 | Tk-subtilisin | mature form | 2Z2X_A |
| SB | S08.129 | Tk-subtilisin | autoprocessed form | 2Z2Y_A |
| SB | S08.129 | Tk-subtilisin | unautoprocessed form soaked by 10mm CaCL2 | 2Z2Z_A |
| SB | S08.129 | Tk-subtilisin | complex with Tk-propeptide | 2Z30_A |
| SB | S08.129 | Tk-subtilisin | Ser324Alamutant; complex with Gly56Ser-propeptide mutant | 2Z56_A |
| SB | S08.129 | Tk-subtilisin | Ser324Alamutant; complex with Gly56Glu-propeptide mutant | 2Z57_A |
| SB | S08.129 | Tk-subtilisin | Ser324Alamutant; complex with Gly56Trp-propeptide mutant | 2Z58_A |
| SB | S08.129 | Tk-subtilisin | Ser324Ala mutant | 2ZRQ_A |
| SB | S08.129 | Tk-subtilisin | 2ZWO | |
| SB | S08.129 | Tk-subtilisin | 2ZWP | |
| SB | S08.129 | Tk-subtilisin | 3A3N | |
| SB | S08.129 | Tk-subtilisin | 3A3O | |
| SB | S08.129 | Tk-subtilisin | 3A3P | |
| SB | S08.129 | Tk-subtilisin | 3VHQ | |
| SB | S08.129 | Tk-subtilisin | 3VV2 | |
| SB | S08.129 | Tk-subtilisin | 3WIU | |
| SB | S08.129 | Tk-subtilisin | 3WIV | |
| SB | S08.129 | Tk-subtilisin | 4JP8 | |
| SB | S08.130 | MCP-01 peptidase | crystal structure of deseasin mcp-01 from pseudoalteromonas sp. sm9913 | 3VV3_A |
| SB | S08.131 | mycosin-1 | 4J94 | |
| SB | S08.131 | mycosin-1 | crystal structure of mycp1 from mycobacterium smegmatis | 4KB5_A |
| SB | S08.131 | mycosin-1 | crystal structure of mycp1 from the esx-1 type vii secretion system | 4KPG_A |
| SB | S08.131 | mycosin-1 | crystal structure of mycp1 with the n-terminal propeptide removed | 4M1Z_A |
| SB | S08.131 | mycosin-1 | structure of mycp3 protease from the type vii (esx-3) secretion system. | 4KG7_A |
| SB | S08.140 | subtilisin S41 | 2GKO | |
| SB | S08.146 | PatG peptidase | patg macrocyclase domain | 4AKS_A |
| SB | S08.146 | PatG peptidase | patg macrocyclase in complex with peptide | 4AKT_A |
| SB | S08.146 | PatG peptidase | 4H6X | |
| SB | S08.146 | PatG peptidase | patg domain of unknown function | 4UVQ_A |
| SB | S08.151 | SlSBT3 g.p. (Solanum lycopersicum) | 3I6S | |
| SB | S08.151 | SlSBT3 g.p. (Solanum lycopersicum) | complex with a chloromthylketone inhibitor | 3I74 |
| SB | S08.156 | PatA peptidase (Prochloron didemni ) | structure of self-cleaved protease domain of pata | 3ZXX_A |
| SB | S08.156 | PatA peptidase (Prochloron didemni ) | structure of s218a mutant of the protease domain of pata | 3ZXY_A |
| SB | S08.156 | PatA peptidase (Prochloron didemni ) | 4H6V | |
| SB | S08.156 | PatA peptidase (Prochloron didemni ) | 4H6W | |
| SB | S08.160 | NalP g.p. (Neisseria meningitidis) | translocator domain (776-1083) | 1UYN |
| SB | S08.160 | NalP g.p. (Neisseria meningitidis) | translocator domain (776-1083) | 1UYO |
| SB | S08.UNA | subfamily S8A non-peptidase homologues | structure of pseudoprotease cspc from clostridioides difficile | 6MW4_A |
| SB | S08.UPA | subfamily S8A unassigned peptidases | 3AFG | |
| SB | S08.UPA | subfamily S8A unassigned peptidases | 2B6N_A | |
| SB | S08.UPA | subfamily S8A unassigned peptidases | 1V6C_A | |
| SB | S08.UPA | subfamily S8A unassigned peptidases | complex with chymostatin | 1WVM_A |
| SB | S08.UPA | subfamily S8A unassigned peptidases | structure of a serine protease mycp1, an essential component of the type vii (esx-1) secretion system | 4HVL_A |
| SC | S09.001 | prolyl oligopeptidase | mutant form | 1E5T |
| SC | S09.001 | prolyl oligopeptidase | mutant; complex with N-[(benzyloxy)carbonyl]glycyl-L-proline | 1E8M_A |
| SC | S09.001 | prolyl oligopeptidase | mutant; complex with peptide | 1E8N_A |
| SC | S09.001 | prolyl oligopeptidase | 1H2W_A | |
| SC | S09.001 | prolyl oligopeptidase | Tyr473Phe mutant | 1H2X_A |
| SC | S09.001 | prolyl oligopeptidase | Tyr473Phe mutant; complex with inhibitor Z-Pro-prolinal | 1H2Y_A |
| SC | S09.001 | prolyl oligopeptidase | Ser554Ala mutant; complex with peptide ligand Suc-Gly-Pro | 1H2Z_A |
| SC | S09.001 | prolyl oligopeptidase | Asp641Ala mutant; complex with bound peptide ligand Suc-Gly-Pro | 1O6F_A |
| SC | S09.001 | prolyl oligopeptidase | Asp641Asn mutant; complex with bound peptide ligand Suc-Gly-Pro | 1O6G_A |
| SC | S09.001 | prolyl oligopeptidase | 1QFM_A | |
| SC | S09.001 | prolyl oligopeptidase | complex with Z-Pro-prolinal inhibitor | 1QFS |
| SC | S09.001 | prolyl oligopeptidase | prolyl oligopeptidase from porcine brain, s554a mutant with bound peptide ligand gly-phe-arg-pro | 1UOO_A |
| SC | S09.001 | prolyl oligopeptidase | prolyl oligopeptidase from porcine brain, s554a mutant with bound peptide ligand gly-phe-glu-pro | 1UOP_A |
| SC | S09.001 | prolyl oligopeptidase | prolyl oligopeptidase from porcine brain, s554a mutant with bound peptide ligand glu-phe-ser-pro | 1UOQ_A |
| SC | S09.001 | prolyl oligopeptidase | Tyr73Cys, Val427Cys and Cys255Thr mutant | 1VZ2 |
| SC | S09.001 | prolyl oligopeptidase | Thr597Cys mutant | 1VZ3 |
| SC | S09.001 | prolyl oligopeptidase | 2XDW | |
| SC | S09.001 | prolyl oligopeptidase | 3EQ7 | |
| SC | S09.001 | prolyl oligopeptidase | 3EQ8 | |
| SC | S09.001 | prolyl oligopeptidase | 3EQ9 | |
| SC | S09.001 | prolyl oligopeptidase | 4AMY | |
| SC | S09.001 | prolyl oligopeptidase | 4AMZ | |
| SC | S09.001 | prolyl oligopeptidase | 4AN0 | |
| SC | S09.001 | prolyl oligopeptidase | 4AN1 | |
| SC | S09.001 | prolyl oligopeptidase | 4AX4 | |
| SC | S09.001 | prolyl oligopeptidase | 4BCB | |
| SC | S09.001 | prolyl oligopeptidase | 4BCC | |
| SC | S09.001 | prolyl oligopeptidase | 4BCD | |
| SC | S09.001 | prolyl oligopeptidase | prolyl oligopeptidase with gsk552 | 3DDU_A |
| SC | S09.002 | prolyl oligopeptidase homologue (Pyrococcus-type) | prolyl oligopeptidase from pyrococcus furiosus | 5T88_A |
| SC | S09.002 | prolyl oligopeptidase homologue (Pyrococcus-type) | prolyl oligopeptidase mutant s477c from pyrococcus furiosus | 6CAN_A |
| SC | S09.003 | dipeptidyl-peptidase IV (eukaryote) | native dpp-iv (cd26) from rat | 2GBC_A |
| SC | S09.003 | dipeptidyl-peptidase IV (eukaryote) | rat dpp-iv with alkynyl cyanopyrrolidine #1 | 2GBF_A |
| SC | S09.003 | dipeptidyl-peptidase IV (eukaryote) | rat dpp-iv with alkynyl cyanopyrrolidine #2 | 2GBG_A |
| SC | S09.003 | dipeptidyl-peptidase IV (eukaryote) | rat dpp-iv with xanthine inhibitor 4 | 2GBI_A |
| SC | S09.003 | dipeptidyl-peptidase IV (eukaryote) | rat dpp-iv with xanthine mimetic inhibitor #7 | 2I3Z_A |
| SC | S09.003 | dipeptidyl-peptidase IV (eukaryote) | complex with thiazole-based peptide mimetic number 31 | 2OAE_A |
| SC | S09.003 | dipeptidyl-peptidase IV (eukaryote) | 4FFV | |
| SC | S09.003 | dipeptidyl-peptidase IV (eukaryote) | 4FFW | |
| SC | S09.003 | dipeptidyl-peptidase IV (eukaryote) | complex with a chemibody inhibitor | 5VTA_A |
| SC | S09.003 | dipeptidyl-peptidase IV (eukaryote) | 1J2E_A | |
| SC | S09.003 | dipeptidyl-peptidase IV (eukaryote) | complex with inhibitor 2-amino-3-methyl-1-pyrrolidin-1-yl-butan-1-one | 1N1M_A |
| SC | S09.003 | dipeptidyl-peptidase IV (eukaryote) | 1NU6 | |
| SC | S09.003 | dipeptidyl-peptidase IV (eukaryote) | complex with diprotin A | 1NU8 |
| SC | S09.003 | dipeptidyl-peptidase IV (eukaryote) | apo form | 1PFQ_A |
| SC | S09.003 | dipeptidyl-peptidase IV (eukaryote) | 1R9M_A | |
| SC | S09.003 | dipeptidyl-peptidase IV (eukaryote) | complex with a decapeptide (TNPY) | 1R9N_A |
| SC | S09.003 | dipeptidyl-peptidase IV (eukaryote) | complex with 5-aminomethyl- 6-(2,4-dichloro-phenyl)-2-(3,5-dimethoxy-phenyl)-pyrimidin- 4-ylamine | 1RWQ_A |
| SC | S09.003 | dipeptidyl-peptidase IV (eukaryote) | apo form | 1TK3_A |
| SC | S09.003 | dipeptidyl-peptidase IV (eukaryote) | human dipeptidyl peptidase iv/cd26 inhibited with diisopropyl fluorophosphate | 1TKR_A |
| SC | S09.003 | dipeptidyl-peptidase IV (eukaryote) | human dipeptidyl peptidase iv/cd26 mutant y547f | 1U8E_A |
| SC | S09.003 | dipeptidyl-peptidase IV (eukaryote) | complex with adenosine deaminase | 1W1I_A |
| SC | S09.003 | dipeptidyl-peptidase IV (eukaryote) | complex with diprotin A | 1WCY_A |
| SC | S09.003 | dipeptidyl-peptidase IV (eukaryote) | complex with sitagliptin | 1X70_A |
| SC | S09.003 | dipeptidyl-peptidase IV (eukaryote) | x-ray structure of novel biaryl-based dipeptidyl peptidase iv inhibitor | 2AJL_I |
| SC | S09.003 | dipeptidyl-peptidase IV (eukaryote) | hiv-1 tat protein derived n-terminal nonapeptide trp2-tat (1-9) bound to the active site of dipeptidyl peptidase iv (cd26) | 2BGN_A |
| SC | S09.003 | dipeptidyl-peptidase IV (eukaryote) | complex with HIV-1TAT derived nonapeptides TAT(1- 9) | 2BGR_A |
| SC | S09.003 | dipeptidyl-peptidase IV (eukaryote) | complex with N-((2S)-1-[(3R)-3-amino-4-(2-fluorophenyl)butanoyl]pyrrolidin-2-ylmethyl)benzamide | 2BUB_A |
| SC | S09.003 | dipeptidyl-peptidase IV (eukaryote) | complex with 6-(4-(1S,2S)-2-amino-1-[(dimethylamino)carbonyl]-3-[(3S)-3-fluoropyrrolidin-1-yl]-3-oxopropylphenyl)-1H-[1,2,4]triazolo[1,5-A]pyridin-4-ium | 2FJP_A |
| SC | S09.003 | dipeptidyl-peptidase IV (eukaryote) | complex with cyanopyrrolidine (C5-Pro-Pro) inhibitor 21AC | 2G5P_A |
| SC | S09.003 | dipeptidyl-peptidase IV (eukaryote) | complex with cyanopyrrolidine (C5-Pro-Pro) inhibitor 21AG | 2G5T_A |
| SC | S09.003 | dipeptidyl-peptidase IV (eukaryote) | complex with cyanopyrrolidine (C5-Pro-Pro) inhibitor 24B | 2G63_A |
| SC | S09.003 | dipeptidyl-peptidase IV (eukaryote) | complex with (2S,3S)-3-3-[4-(methylsulfonyl)phenyl]-1,2,4-oxadiazol-5-yl-1-oxo-1-pyrrolidin-1-ylbutan-2-amine | 2HHA_A |
| SC | S09.003 | dipeptidyl-peptidase IV (eukaryote) | complex with potent alkynyl cyanopyrrolidine (ABT-279) | 2I03_A |
| SC | S09.003 | dipeptidyl-peptidase IV (eukaryote) | complex with ABT-341, a cyclohexene-constrained phenethylamine inhibitor | 2I78_A |
| SC | S09.003 | dipeptidyl-peptidase IV (eukaryote) | complex with (3R)-4-[(3R)-3-amino-4-(2,4,5-trifluorophenyl)butanoyl]-3-(2,2,2-trifluoroethyl)-1,4-diazepan-2-one | 2IIT_A |
| SC | S09.003 | dipeptidyl-peptidase IV (eukaryote) | complex with (3R)-4-[(3R)-3-amino-4-(2,4,5-trifluorophenyl)butanoyl]-3-methyl-1,4-diazepan-2-one | 2IIV_A |
| SC | S09.003 | dipeptidyl-peptidase IV (eukaryote) | complex with 1-(3,4- dimethoxy-phenyl)-3-m-tolyl-piperidine-4-ylamine | 2JID_A |
| SC | S09.003 | dipeptidyl-peptidase IV (eukaryote) | complex with pyrrolidine-constrained phenethylamine 29G | 2OAG_A |
| SC | S09.003 | dipeptidyl-peptidase IV (eukaryote) | complex with Lilly aryl ketone inhibitor 4-[(3R)-3-[2-(4-fluorophenyl)-2-oxoethyl]aminobutyl]benzamide | 2OGZ_A |
| SC | S09.003 | dipeptidyl-peptidase IV (eukaryote) | complex with cyclic hydrazine (2R)-4-(2-benzoyl-1,2-diazepan-1-yl)-4-oxo-1-(2,4,5-trifluorophenyl)butan-2-amine | 2OLE_A |
| SC | S09.003 | dipeptidyl-peptidase IV (eukaryote) | 2ONC_A | |
| SC | S09.003 | dipeptidyl-peptidase IV (eukaryote) | complex with alpha amino acid inhibitor N-(trans-4-(1S,2S)-2-amino-3-[(3S)-3-fluoropyrrolidin- 1-yl]-1-methyl-3-oxopropylcyclohexyl)-N-methylacetamide | 2OPH_A |
| SC | S09.003 | dipeptidyl-peptidase IV (eukaryote) | human dipeptidyl peptidase iv (dpp4) with piperidinone- constrained phenethylamine | 2OQI_A |
| SC | S09.003 | dipeptidyl-peptidase IV (eukaryote) | human dipeptidyl peptidase iv (dpp4) with piperidine- constrained phenethylamine | 2OQV_A |
| SC | S09.003 | dipeptidyl-peptidase IV (eukaryote) | complex with cyclohexalamine inhibitor (1S,2R,5S)-5-[3-(trifluoromethyl)-5,6-dihydro[1,2,4]triazolo[4,3-A]pyrazin-7(8H)-yl]-2-(2,4,5-trifluorophenyl)cyclohexanamine | 2P8S_A |
| SC | S09.003 | dipeptidyl-peptidase IV (eukaryote) | complex with inhibitor pzf | 2QJR_A |
| SC | S09.003 | dipeptidyl-peptidase IV (eukaryote) | complex structure of dipeptidyl peptidase iv and a oxadiazolyl ketone | 2QKY_A |
| SC | S09.003 | dipeptidyl-peptidase IV (eukaryote) | complex with a triazolopiperazine-based beta amino acid inhibitor | 2QOE_A |
| SC | S09.003 | dipeptidyl-peptidase IV (eukaryote) | complex with (2S,3S)-3-amino-4-[(3S)-3-fluoropyrrolidin-1-yl]-N,N-dimethyl-4-oxo-2-(trans-4-[1,2,4]triazolo[1,5-A]pyridin-5-ylcyclohexyl)butanamide | 2QT9_A |
| SC | S09.003 | dipeptidyl-peptidase IV (eukaryote) | complex with (2S,3S)-3-amino-4-(3,3-difluoropyrrolidin-1-yl)-N,N-dimethyl-4-oxo-2-(trans-4-[1,2,4]triazolo[1,5-A]pyridin-6-ylcyclohexyl)butanamide | 2QTB_A |
| SC | S09.003 | dipeptidyl-peptidase IV (eukaryote) | complex with 8-[(3R)-3-aminopiperidin-1-yl]-7-but-2-yn- 1-yl-3-methyl-1-[(4-methylquinazolin-2-yl)methyl]- 3,7-dihydro-1H-purine-2,6-dione | 2RGU_A |
| SC | S09.003 | dipeptidyl-peptidase IV (eukaryote) | complex with (3R,4R)-4-(pyrrolidin-1-ylcarbonyl)-1-(quinoxalin- 2-ylcarbonyl)pyrrolidin-3-amine | 2RIP_A |
| SC | S09.003 | dipeptidyl-peptidase IV (eukaryote) | complex with (1S,3S, 5S)-2-[(2S)-2-amino-2-(3-hydroxytricyclo[3.3.1.13,7]dec-1- yl)acetyl]-2-azabicyclo[3.1.0]hexane-3-carbonitrile | 3BJM_A |
| SC | S09.003 | dipeptidyl-peptidase IV (eukaryote) | complex with (2S,3S)-4-cyclopropyl-3-(3R,5R)-3-[2-fluoro- 4-(methylsulfonyl)phenyl]-1,2,4-oxadiazolidin- 5-yl-1-[(3S)-3-fluoropyrrolidin-1-yl]-1- oxobutan-2-amine | 3C43_A |
| SC | S09.003 | dipeptidyl-peptidase IV (eukaryote) | complex with (2S,3S)-3-3-[2-chloro-4-(methylsulfonyl)phenyl]- 1,2,4-oxadiazol-5-yl-1-cyclopentylidene- 4-cyclopropyl-1-fluorobutan-2-amine | 3C45_A |
| SC | S09.003 | dipeptidyl-peptidase IV (eukaryote) | complex with 1-biphenyl-2-ylmethanamine | 3CCB_A |
| SC | S09.003 | dipeptidyl-peptidase IV (eukaryote) | complex with 7-(aminomethyl)-6-(2-chlorophenyl)-1-methyl- 1H-benzimidazole-5-carbonitrile | 3CCC_A |
| SC | S09.003 | dipeptidyl-peptidase IV (eukaryote) | 4'-[(1R)-1-amino-2-(2,5-difluorophenyl)ethyl]biphenyl- 3-carboxamide | 3D4L_A |
| SC | S09.003 | dipeptidyl-peptidase IV (eukaryote) | crystal structure analysis of dppiv inhibitor | 3EIO_A |
| SC | S09.003 | dipeptidyl-peptidase IV (eukaryote) | 3F8S | |
| SC | S09.003 | dipeptidyl-peptidase IV (eukaryote) | 3G0B | |
| SC | S09.003 | dipeptidyl-peptidase IV (eukaryote) | 3G0C | |
| SC | S09.003 | dipeptidyl-peptidase IV (eukaryote) | 3G0D | |
| SC | S09.003 | dipeptidyl-peptidase IV (eukaryote) | 3G0G | |
| SC | S09.003 | dipeptidyl-peptidase IV (eukaryote) | complex with a reversed amide inhibitor | 3H0C_A |
| SC | S09.003 | dipeptidyl-peptidase IV (eukaryote) | 3HAB | |
| SC | S09.003 | dipeptidyl-peptidase IV (eukaryote) | 3HAC | |
| SC | S09.003 | dipeptidyl-peptidase IV (eukaryote) | 3KWF | |
| SC | S09.003 | dipeptidyl-peptidase IV (eukaryote) | 3KWJ | |
| SC | S09.003 | dipeptidyl-peptidase IV (eukaryote) | 3NOX | |
| SC | S09.003 | dipeptidyl-peptidase IV (eukaryote) | 3O95 | |
| SC | S09.003 | dipeptidyl-peptidase IV (eukaryote) | 3O9V | |
| SC | S09.003 | dipeptidyl-peptidase IV (eukaryote) | 3OC0 | |
| SC | S09.003 | dipeptidyl-peptidase IV (eukaryote) | 3OPM | |
| SC | S09.003 | dipeptidyl-peptidase IV (eukaryote) | 3Q0T | |
| SC | S09.003 | dipeptidyl-peptidase IV (eukaryote) | 3Q8W | |
| SC | S09.003 | dipeptidyl-peptidase IV (eukaryote) | 3QBJ | |
| SC | S09.003 | dipeptidyl-peptidase IV (eukaryote) | 3SWW | |
| SC | S09.003 | dipeptidyl-peptidase IV (eukaryote) | 3SX4 | |
| SC | S09.003 | dipeptidyl-peptidase IV (eukaryote) | 3VJK | |
| SC | S09.003 | dipeptidyl-peptidase IV (eukaryote) | 3VJL | |
| SC | S09.003 | dipeptidyl-peptidase IV (eukaryote) | 3VJM | |
| SC | S09.003 | dipeptidyl-peptidase IV (eukaryote) | 3W2T | |
| SC | S09.003 | dipeptidyl-peptidase IV (eukaryote) | 3WQH | |
| SC | S09.003 | dipeptidyl-peptidase IV (eukaryote) | 4A5S | |
| SC | S09.003 | dipeptidyl-peptidase IV (eukaryote) | 4DSA | |
| SC | S09.003 | dipeptidyl-peptidase IV (eukaryote) | 4DSZ | |
| SC | S09.003 | dipeptidyl-peptidase IV (eukaryote) | 4DTC | |
| SC | S09.003 | dipeptidyl-peptidase IV (eukaryote) | 4G1F | |
| SC | S09.003 | dipeptidyl-peptidase IV (eukaryote) | 4J3J | |
| SC | S09.003 | dipeptidyl-peptidase IV (eukaryote) | 4JH0 | |
| SC | S09.003 | dipeptidyl-peptidase IV (eukaryote) | 4KR0 | |
| SC | S09.003 | dipeptidyl-peptidase IV (eukaryote) | 4L72 | |
| SC | S09.003 | dipeptidyl-peptidase IV (eukaryote) | 4LKO | |
| SC | S09.003 | dipeptidyl-peptidase IV (eukaryote) | 4N8D | |
| SC | S09.003 | dipeptidyl-peptidase IV (eukaryote) | 4N8E | |
| SC | S09.003 | dipeptidyl-peptidase IV (eukaryote) | 4PNZ | |
| SC | S09.003 | dipeptidyl-peptidase IV (eukaryote) | 4PV7 | |
| SC | S09.003 | dipeptidyl-peptidase IV (eukaryote) | 4QZV | |
| SC | S09.003 | dipeptidyl-peptidase IV (eukaryote) | complex with a novel tricyclic hetero-cycle inhibitor | 5I7U_A |
| SC | S09.003 | dipeptidyl-peptidase IV (eukaryote) | human dpp4 in complex with a novel 5,5,6-tricyclic pyrrolidine inhibitor | 5ISM_A |
| SC | S09.003 | dipeptidyl-peptidase IV (eukaryote) | complex with hl1 | 5J3J_A |
| SC | S09.003 | dipeptidyl-peptidase IV (eukaryote) | complex with syr-472 | 5KBY_A |
| SC | S09.003 | dipeptidyl-peptidase IV (eukaryote) | human dpp4 in complex with a ligand 34a | 5T4B_A |
| SC | S09.003 | dipeptidyl-peptidase IV (eukaryote) | human dpp4 in complex with ligand 19a | 5T4E_A |
| SC | S09.003 | dipeptidyl-peptidase IV (eukaryote) | human dpp4 in complex with ligand 34p | 5T4F_A |
| SC | S09.003 | dipeptidyl-peptidase IV (eukaryote) | human dpp4 in complex with ligand 34n | 5T4H_A |
| SC | S09.003 | dipeptidyl-peptidase IV (eukaryote) | complex with inhibitor3 | 5Y7H_A |
| SC | S09.003 | dipeptidyl-peptidase IV (eukaryote) | complex with inhibitor2 | 5Y7J_A |
| SC | S09.003 | dipeptidyl-peptidase IV (eukaryote) | complex with inhibitor1 | 5Y7K_A |
| SC | S09.003 | dipeptidyl-peptidase IV (eukaryote) | complex with hl2 | 5ZID_A |
| SC | S09.003 | dipeptidyl-peptidase IV (eukaryote) | complex with vildagliptin | 6B1E_A |
| SC | S09.003 | dipeptidyl-peptidase IV (eukaryote) | complex with vildagliptin analog | 6B1O_A |
| SC | S09.003 | dipeptidyl-peptidase IV (eukaryote) | 1ORV | |
| SC | S09.003 | dipeptidyl-peptidase IV (eukaryote) | complex with peptidomimetic inhibitor (2S)-pyrrolidin-2-ylmethylamine | 1ORW |
| SC | S09.003 | dipeptidyl-peptidase IV (eukaryote) | complex with 7- benzyl-1,3-dimethyl-8-piperazin-1-yl-3,7-dihydro-purine-2, 6-dione (BDPX) | 2AJ8_A |
| SC | S09.003 | dipeptidyl-peptidase IV (eukaryote) | complex with the tripeptide tert-butyl-Gly-L-Pro-L-Ile (tbu-GPI) | 2AJB_A |
| SC | S09.003 | dipeptidyl-peptidase IV (eukaryote) | complex with 4-(2- aminoethyl)-benzene sulphonyl fluoride (AEBSF) | 2AJC_A |
| SC | S09.003 | dipeptidyl-peptidase IV (eukaryote) | complex with L- Pro-boro-L-Pro (boroPro) | 2AJD_A |
| SC | S09.003 | dipeptidyl-peptidase IV (eukaryote) | complex with 1-methylamine-1-benzyl-cyclopentane | 2BUA_A |
| SC | S09.003 | dipeptidyl-peptidase IV (eukaryote) | complex with (S)-2-[(R)-3-amino-4-(2-fluoro-phenyl)-butyryl]-1,2,3,4-tetrahydro-isoquinoline-3-carboxylic acid amide | 2BUC_A |
| SC | S09.003 | dipeptidyl-peptidase IV (eukaryote) | porcine dipeptidyl peptidase iv in complex with 8-(3-aminopiperidin-1-yl)-7-[(2-bromophenyl)methyl]-1,3-dimethyl-2,3,6,7-tetrahydro-1h- purine-2,6-dione | 5LLS_A |
| SC | S09.006 | dipeptidyl aminopeptidase B (fungus) | 3KL4 | |
| SC | S09.006 | dipeptidyl aminopeptidase B (fungus) | 3ZN8 | |
| SC | S09.007 | fibroblast activation protein alpha subunit | 1Z68_A | |
| SC | S09.009 | dipeptidyl-peptidase 4 (bacteria-type 1) | 2ECF | |
| SC | S09.009 | dipeptidyl-peptidase 4 (bacteria-type 1) | 5YP1 | |
| SC | S09.009 | dipeptidyl-peptidase 4 (bacteria-type 1) | complex with inhibitor-1c | 5YP2 |
| SC | S09.009 | dipeptidyl-peptidase 4 (bacteria-type 1) | complex with Ile-Pro | 5YP3 |
| SC | S09.009 | dipeptidyl-peptidase 4 (bacteria-type 1) | complex with Lys-Pro | 5YP4 |
| SC | S09.010 | oligopeptidase B | structure of oligopeptidase b from leishmania major ***caveat 2xe4 pgo a 1743 has wrong chirality at atom c2 | 2XE4_A |
| SC | S09.010 | oligopeptidase B | oligopeptidase b from trypanosoma brucei - open form | 4BP8_A |
| SC | S09.010 | oligopeptidase B | oligopeptidase b from trypanosoma brucei with covalently bound antipain - closed form ***caveat 4bp9 oar g 4 has wrong chirality at atom ca oar h 4 has wrong ***caveat 2 4bp9 chirality at atom ca oar i 4 has wrong chirality at atom ca ***caveat 3 4bp9 oar | 4BP9_A |
| SC | S09.013 | dipeptidyl-peptidase 4 (bacteria-type 2) | crystal structure of porphyromonas gingivalis dipeptidyl peptidase 4 | 5OLJ_A |
| SC | S09.017 | prolyl tripeptidyl peptidase | 2D5L_A | |
| SC | S09.017 | prolyl tripeptidyl peptidase | Ser603Ala mutant; complex with substrate | 2DCM_A |
| SC | S09.017 | prolyl tripeptidyl peptidase | prolyl tripeptidyl aminopeptidase complexed with an inhibitor | 2EEP_A |
| SC | S09.017 | prolyl tripeptidyl peptidase | prolyl tripeptidyl aminopeptidase mutant e636a | 2Z3W_A |
| SC | S09.017 | prolyl tripeptidyl peptidase | prolyl tripeptidyl aminopeptidase mutant e636a complexd with an inhibitor | 2Z3Z_A |
| SC | S09.017 | prolyl tripeptidyl peptidase | crystal structure of a putative dipeptidyl aminopeptidase iv (bacova_01349) from bacteroides ovatus atcc 8483 at 2.48 a resolution | 4Q1V_A |
| SC | S09.018 | dipeptidyl-peptidase 8 | dpp8 - apo, space group 20 | 6EOO_A |
| SC | S09.018 | dipeptidyl-peptidase 8 | dpp8 - slrflyeg, space group 20 | 6EOP_A |
| SC | S09.018 | dipeptidyl-peptidase 8 | dpp8 - apo, space group 19 | 6EOS_A |
| SC | S09.018 | dipeptidyl-peptidase 8 | dpp8 - slrflyeg, space group 19 | 6EOT_A |
| SC | S09.019 | dipeptidyl-peptidase 9 | dpp9 - apo | 6EOQ_A |
| SC | S09.019 | dipeptidyl-peptidase 9 | dpp9 - 1g244 | 6EOR_A |
| SC | S09.024 | Mername-AA264 putative peptidase (LP_1002 protein) (Lactobacillus plantarum) | TOPSAN | 3BJR |
| SC | S09.035 | lasso peptide isopeptidase (Asticcacaulis-type) | 5TXC | |
| SC | S09.035 | lasso peptide isopeptidase (Asticcacaulis-type) | Ser527Ala mutant; complex with astexin3-dC4 | 5TXE |
| SC | S09.070 | acylaminoacyl peptidase (Aeropyrum-type) | 1VE6 | |
| SC | S09.070 | acylaminoacyl peptidase (Aeropyrum-type) | 1VE7 | |
| SC | S09.070 | acylaminoacyl peptidase (Aeropyrum-type) | binding of inhibitors by acylaminoacyl-peptidase | 2HU5_A |
| SC | S09.070 | acylaminoacyl peptidase (Aeropyrum-type) | binding of inhibitors by acylaminoacyl peptidase | 2HU7_A |
| SC | S09.070 | acylaminoacyl peptidase (Aeropyrum-type) | binding of inhibitors by acylaminoacyl peptidase | 2HU8_A |
| SC | S09.070 | acylaminoacyl peptidase (Aeropyrum-type) | aeropyrum pernix acylaminoacyl peptidase, h367a mutant | 2QR5_A |
| SC | S09.070 | acylaminoacyl peptidase (Aeropyrum-type) | 2QZP_A | |
| SC | S09.070 | acylaminoacyl peptidase (Aeropyrum-type) | 3O4G | |
| SC | S09.070 | acylaminoacyl peptidase (Aeropyrum-type) | 3O4H | |
| SC | S09.070 | acylaminoacyl peptidase (Aeropyrum-type) | 3O4I | |
| SC | S09.070 | acylaminoacyl peptidase (Aeropyrum-type) | 3O4J | |
| SC | S09.070 | acylaminoacyl peptidase (Aeropyrum-type) | complex with Z-Gly-Gly-Phe chloromethylketone inhibitor | 4RE5 |
| SC | S09.070 | acylaminoacyl peptidase (Aeropyrum-type) | complex with Z-Gly-Gly-Phe chloromethylketone inhibitor | 4RE6 |
| SC | S09.071 | trilobed protease | 4HXE | |
| SC | S09.071 | trilobed protease | complex with Z-Gly-Gly-Phe-chloromethyl ketone | 4HXF |
| SC | S09.071 | trilobed protease | orthorhombic crystal form | 4HXG |
| SC | S09.072 | puromycin hydrolase | 3AZO | |
| SC | S09.072 | puromycin hydrolase | Ser511Ala mutant | 3AZP |
| SC | S09.072 | puromycin hydrolase | Ser511Ala mutant; complex with PGG | 3AZQ |
| SC | S09.076 | prolyl oligopeptidase (Myxococcus xanthus) | 2BKL | |
| SC | S09.077 | prolyl oligopeptidase B (Galerina marginata) | prolyl oligopeptidase b from galerina marginata bound to 25mer macrocyclization substrate - s577a mutant | 5N4B_A |
| SC | S09.077 | prolyl oligopeptidase B (Galerina marginata) | prolyl oligopeptidase b from galerina marginata bound to 35mer hydrolysis and macrocyclization substrate - s577a mutant | 5N4C_A |
| SC | S09.077 | prolyl oligopeptidase B (Galerina marginata) | prolyl oligopeptidase b from galerina marginata bound to 25mer macrocyclization substrate - d661a mutant | 5N4D_A |
| SC | S09.077 | prolyl oligopeptidase B (Galerina marginata) | prolyl oligopeptidase b from galerina marginata bound to 35mer hydrolysis and macrocyclization substrate - h698a mutant | 5N4E_A |
| SC | S09.077 | prolyl oligopeptidase B (Galerina marginata) | prolyl oligopeptidase b from galerina marginata - apo protein | 5N4F_A |
| SC | S09.078 | peptide cyclase 1 | structural characterization of the fast and promiscuous macrocyclase from plant - pcy1-s562a bound to presegetalin f1 | 5O3U_A |
| SC | S09.078 | peptide cyclase 1 | structural characterization of the fast and promiscuous macrocyclase from plant - pcy1-s562a bound to presegetalin b1 | 5O3V_A |
| SC | S09.078 | peptide cyclase 1 | structural characterization of the fast and promiscuous macrocyclase from plant - pcy1-s562a bound to presegetalin a1 | 5O3W_A |
| SC | S09.078 | peptide cyclase 1 | structural characterization of the fast and promiscuous macrocyclase from plant - apo pcy1 | 5O3X_A |
| SC | S09.078 | peptide cyclase 1 | pcy1 in complex with follower peptide | 5UW3_A |
| SC | S09.078 | peptide cyclase 1 | pcy1 h695a variant in complex with follower peptide | 5UW5_A |
| SC | S09.078 | peptide cyclase 1 | pcy1 in complex with follower peptide and covalent inhibitor zpp | 5UW6_A |
| SC | S09.078 | peptide cyclase 1 | pcy1 y481f variant in complex with follower peptide | 5UW7_A |
| SC | S09.078 | peptide cyclase 1 | pcy1 g696insertion variant in complex with follower peptide and the covalent inhibitor zpp | 5UZW_A |
| SC | S09.079 | S9dr carboxypeptidase (Deinococcus radiodurans) | inactive form | 5YZM |
| SC | S09.079 | S9dr carboxypeptidase (Deinococcus radiodurans) | active form | 5YZN |
| SC | S09.079 | S9dr carboxypeptidase (Deinococcus radiodurans) | Ser514Ala mutant | 5YZO |
| SC | S09.079 | S9dr carboxypeptidase (Deinococcus radiodurans) | inactive form | 6IGP |
| SC | S09.079 | S9dr carboxypeptidase (Deinococcus radiodurans) | inactive form; PMSF-treated | 6IGQ |
| SC | S09.079 | S9dr carboxypeptidase (Deinococcus radiodurans) | Ser514Ala mutant; inactive form | 6IGR |
| SC | S09.079 | S9dr carboxypeptidase (Deinococcus radiodurans) | Ser514Ala mutant; substrate-bound form | 6IKG |
| SC | S09.940 | S-formylglutathione hydrolase FrmB (Escherichi coli) | structural and kinetic study of an s-formylglutathione hydrolase from agrobacterium tumefaciens | 3E4D_A |
| SC | S09.940 | S-formylglutathione hydrolase FrmB (Escherichi coli) | the crystal structure of the neisserial esterase d. | 4B6G_A |
| SC | S09.940 | S-formylglutathione hydrolase FrmB (Escherichi coli) | bromide soaked | 3S8Y_A |
| SC | S09.941 | highly similar to acyl-protein thioesterase 1 (Homo sapiens) | 1FJ2 | |
| SC | S09.941 | highly similar to acyl-protein thioesterase 1 (Homo sapiens) | complex with an isoform-selective inhibitor, ml348 | 5SYM_A |
| SC | S09.942 | esterase/lipase (Homo sapiens) | 3HLK | |
| SC | S09.943 | acyl-CoA thioesterase 4 (Homo sapiens) | 3K2I | |
| SC | S09.946 | BSU33620 g.p. (Bacillus subtilis) and similar | 1R1D | |
| SC | S09.946 | BSU33620 g.p. (Bacillus subtilis) and similar | 1TQH | |
| SC | S09.947 | esterase 6 (Drosophila melanogaster) | esterase-6 from drosophila melanogaster | 5THM_A |
| SC | S09.948 | para-nitrobenzyl esterase (Bacillus subtilis) | 1C7I | |
| SC | S09.948 | para-nitrobenzyl esterase (Bacillus subtilis) | 1C7J | |
| SC | S09.948 | para-nitrobenzyl esterase (Bacillus subtilis) | 1QE3 | |
| SC | S09.948 | para-nitrobenzyl esterase (Bacillus subtilis) | crystal structure of the geobacillus stearothermophilus carboxylesterase est55 at ph 6.2 | 2OGS_A |
| SC | S09.948 | para-nitrobenzyl esterase (Bacillus subtilis) | crystal structure of the geobacillus stearothermophilus carboxylesterase est55 at ph 6.8 | 2OGT_A |
| SC | S09.949 | cephalosporin C deacetylase | 1L7A | |
| SC | S09.949 | cephalosporin C deacetylase | 1ODS | |
| SC | S09.949 | cephalosporin C deacetylase | 1ODT | |
| SC | S09.949 | cephalosporin C deacetylase | crystal structure of acetyl xylan esterase 1 from thermoanaerobacterium sp. jw/sl ys485 | 3FCY_A |
| SC | S09.951 | brefeldin A esterase | 1JKM | |
| SC | S09.951 | brefeldin A esterase | crystal structure of est25 - a bacterial homolog of hormone-sensitive lipase from a metagenomic library | 4J7A_A |
| SC | S09.951 | brefeldin A esterase | crystal structure of esterase mutant - f72g | 5IQ0_A |
| SC | S09.951 | brefeldin A esterase | crystal structure of esterase mutant - l255w | 5IQ2_A |
| SC | S09.951 | brefeldin A esterase | crystal structure of esterase mutant - f72g/l255w | 5IQ3_A |
| SC | S09.973 | dipeptidylpeptidase homologue DPP6 | 1XFD | |
| SC | S09.974 | dipeptidylpeptidase homologue DPP10 | 4WJL | |
| SC | S09.979 | acetylcholinesterase | complex with green mamba venom peptide fasciculin-II | 1B41 |
| SC | S09.979 | acetylcholinesterase | Glu202Gln mutant; complex with green mamba venom peptide fasciculin-II | 1F8U |
| SC | S09.979 | acetylcholinesterase | theoretical model | 2CLJ |
| SC | S09.979 | acetylcholinesterase | inhibited by aged tabun and complex with fasciculin-ii | 2X8B_A |
| SC | S09.979 | acetylcholinesterase | recombinant human acetylcholinesterase | 3LII_A |
| SC | S09.979 | acetylcholinesterase | complex with huprine w and fasciculin 2 | 4BDT_A |
| SC | S09.979 | acetylcholinesterase | crystal structure of recombinant human acetylcholinesterase in the apostate | 4EY4_A |
| SC | S09.979 | acetylcholinesterase | complex with (-)-huperzine a | 4EY5_A |
| SC | S09.979 | acetylcholinesterase | complex with (-)-galantamine | 4EY6_A |
| SC | S09.979 | acetylcholinesterase | complex with donepezil | 4EY7_A |
| SC | S09.979 | acetylcholinesterase | complex with fasciculin-2 | 4EY8_A |
| SC | S09.979 | acetylcholinesterase | complex with dihydrotanshinone i | 4M0E_A |
| SC | S09.979 | acetylcholinesterase | complex with territrem b | 4M0F_A |
| SC | S09.979 | acetylcholinesterase | 4PQE_A | |
| SC | S09.979 | acetylcholinesterase | structure of homo sapiens acetylcholinesterase phosphonylated by sarin. | 5FPQ_A |
| SC | S09.979 | acetylcholinesterase | complex with paraoxon in the unaged state (predominant acyl loop conformation) | 5HF5_A |
| SC | S09.979 | acetylcholinesterase | complex with paraoxon in the aged state | 5HF6_A |
| SC | S09.979 | acetylcholinesterase | complex with paraoxon (alternative acyl loop conformation) | 5HF8_A |
| SC | S09.979 | acetylcholinesterase | complex with paraoxon and hi6 | 5HF9_A |
| SC | S09.979 | acetylcholinesterase | complex with paraoxon and 2-pam | 5HFA_A |
| SC | S09.979 | acetylcholinesterase | stable, high-expression variant of human acetylcholinesterase | 5HQ3_A |
| SC | S09.979 | acetylcholinesterase | crystal structure of recombinant human acetylcholinesterase inhibited by (-) stereoisomer of vx | 6CQT_A |
| SC | S09.979 | acetylcholinesterase | crystal structure of recombinant human acetylcholinesterase with reactivator hi-6 ***caveat 6cqu nag a 603 has wrong chirality at atom c1 | 6CQU_A |
| SC | S09.979 | acetylcholinesterase | complex with vx(+) and hi-6 | 6CQV_A |
| SC | S09.979 | acetylcholinesterase | complex with vx(-) and hi-6 | 6CQW_A |
| SC | S09.979 | acetylcholinesterase | crystal structure of recombinant human acetylcholinesterase inhibited by vx(+) | 6CQX_A |
| SC | S09.979 | acetylcholinesterase | complex with empa and hi-6 | 6CQY_A |
| SC | S09.979 | acetylcholinesterase | crystal structure of recombinant human acetylcholinesterase inhibited by vx | 6CQZ_A |
| SC | S09.979 | acetylcholinesterase | complex with c35. | 6F25_A |
| SC | S09.979 | acetylcholinesterase | complex with reactivator, hlo7 | 6NEA_A |
| SC | S09.979 | acetylcholinesterase | binary complex of native hache with donepezil | 6O4W_A |
| SC | S09.979 | acetylcholinesterase | binary complex of native hache with 9-aminoacridine | 6O4X_A |
| SC | S09.979 | acetylcholinesterase | binary complex of native hache with bw284c51 | 6O50_A |
| SC | S09.979 | acetylcholinesterase | room temperature structure of binary complex of native hache with bw284c51 | 6O52_A |
| SC | S09.979 | acetylcholinesterase | room temperature structure of binary complex of native hache with oxime reactivator rs-170b | 6O5R_A |
| SC | S09.979 | acetylcholinesterase | room temperature structure of vx-phosphonylated hache in complex with oxime reactivator rs-170b | 6O5S_A |
| SC | S09.979 | acetylcholinesterase | binary complex of native hache with oxime reactivator rs-170b | 6O5V_A |
| SC | S09.979 | acetylcholinesterase | complex with oxime reactivatorrs-170b | 6O66_A |
| SC | S09.979 | acetylcholinesterase | crystal structure of double mutant l380r/f535k of human acetylcholinesterase | 6O69_A |
| SC | S09.979 | acetylcholinesterase | 1C2B | |
| SC | S09.979 | acetylcholinesterase | 1C2O | |
| SC | S09.979 | acetylcholinesterase | 1J06 | |
| SC | S09.979 | acetylcholinesterase | 1J07 | |
| SC | S09.979 | acetylcholinesterase | 1KU6 | |
| SC | S09.979 | acetylcholinesterase | 1MAA | |
| SC | S09.979 | acetylcholinesterase | 1MAH | |
| SC | S09.979 | acetylcholinesterase | 1N5M | |
| SC | S09.979 | acetylcholinesterase | 1N5R | |
| SC | S09.979 | acetylcholinesterase | 1Q83 | |
| SC | S09.979 | acetylcholinesterase | 1Q84 | |
| SC | S09.979 | acetylcholinesterase | 2C0P | |
| SC | S09.979 | acetylcholinesterase | 2C0Q | |
| SC | S09.979 | acetylcholinesterase | 2GYU | |
| SC | S09.979 | acetylcholinesterase | 2GYV | |
| SC | S09.979 | acetylcholinesterase | 2GYW | |
| SC | S09.979 | acetylcholinesterase | 2H9Y | |
| SC | S09.979 | acetylcholinesterase | 2HA0 | |
| SC | S09.979 | acetylcholinesterase | 2HA2 | |
| SC | S09.979 | acetylcholinesterase | 2HA3 | |
| SC | S09.979 | acetylcholinesterase | 2HA4 | |
| SC | S09.979 | acetylcholinesterase | 2HA5 | |
| SC | S09.979 | acetylcholinesterase | 2HA6 | |
| SC | S09.979 | acetylcholinesterase | 2HA7 | |
| SC | S09.979 | acetylcholinesterase | 2JEY | |
| SC | S09.979 | acetylcholinesterase | 2JEZ | |
| SC | S09.979 | acetylcholinesterase | 2JF0 | |
| SC | S09.979 | acetylcholinesterase | 2JGE | |
| SC | S09.979 | acetylcholinesterase | 2JGF | |
| SC | S09.979 | acetylcholinesterase | 2JGI | |
| SC | S09.979 | acetylcholinesterase | 2JGJ | |
| SC | S09.979 | acetylcholinesterase | 2JGK | |
| SC | S09.979 | acetylcholinesterase | 2JGL | |
| SC | S09.979 | acetylcholinesterase | 2JGM | |
| SC | S09.979 | acetylcholinesterase | 2WHP | |
| SC | S09.979 | acetylcholinesterase | 2WHQ | |
| SC | S09.979 | acetylcholinesterase | 2WHR | |
| SC | S09.979 | acetylcholinesterase | 2WLS | |
| SC | S09.979 | acetylcholinesterase | 2WU3 | |
| SC | S09.979 | acetylcholinesterase | 2WU4 | |
| SC | S09.979 | acetylcholinesterase | 2XUD | |
| SC | S09.979 | acetylcholinesterase | 2XUF | |
| SC | S09.979 | acetylcholinesterase | 2XUG | |
| SC | S09.979 | acetylcholinesterase | 2XUH | |
| SC | S09.979 | acetylcholinesterase | 2XUI | |
| SC | S09.979 | acetylcholinesterase | 2XUJ | |
| SC | S09.979 | acetylcholinesterase | 2XUK | |
| SC | S09.979 | acetylcholinesterase | 2XUO | |
| SC | S09.979 | acetylcholinesterase | 2XUP | |
| SC | S09.979 | acetylcholinesterase | 2XUQ | |
| SC | S09.979 | acetylcholinesterase | 2Y2U | |
| SC | S09.979 | acetylcholinesterase | 2Y2V | |
| SC | S09.979 | acetylcholinesterase | 3DL4 | |
| SC | S09.979 | acetylcholinesterase | 3DL7 | |
| SC | S09.979 | acetylcholinesterase | 3ZLT | |
| SC | S09.979 | acetylcholinesterase | 3ZLU | |
| SC | S09.979 | acetylcholinesterase | 3ZLV | |
| SC | S09.979 | acetylcholinesterase | 4A16 | |
| SC | S09.979 | acetylcholinesterase | 4A23 | |
| SC | S09.979 | acetylcholinesterase | 4ARA | |
| SC | S09.979 | acetylcholinesterase | 4ARB | |
| SC | S09.979 | acetylcholinesterase | 4B7Z | |
| SC | S09.979 | acetylcholinesterase | 4B80 | |
| SC | S09.979 | acetylcholinesterase | 4B81 | |
| SC | S09.979 | acetylcholinesterase | 4B82 | |
| SC | S09.979 | acetylcholinesterase | 4B83 | |
| SC | S09.979 | acetylcholinesterase | 4B84 | |
| SC | S09.979 | acetylcholinesterase | 4B85 | |
| SC | S09.979 | acetylcholinesterase | 4BC0 | |
| SC | S09.979 | acetylcholinesterase | 4BC1 | |
| SC | S09.979 | acetylcholinesterase | 4BTL | |
| SC | S09.979 | acetylcholinesterase | 5DTG | |
| SC | S09.979 | acetylcholinesterase | 5DTI | |
| SC | S09.979 | acetylcholinesterase | 5DTJ | |
| SC | S09.979 | acetylcholinesterase | mache-syn tz2pa5 complex | 5EHN_A |
| SC | S09.979 | acetylcholinesterase | mache-anti tz2pa5 complex | 5EHQ_A |
| SC | S09.979 | acetylcholinesterase | mache-syn tz2pa5 complex from an equimolar mixture of the syn/anti isomers | 5EHZ_A |
| SC | S09.979 | acetylcholinesterase | mache-anti tz2pa5 complex from a 1:6 mixture of the syn/anti isomers | 5EIA_A |
| SC | S09.979 | acetylcholinesterase | mache-tz2 complex | 5EIE_A |
| SC | S09.979 | acetylcholinesterase | mache-tz2/pa5 complex | 5EIH_A |
| SC | S09.979 | acetylcholinesterase | complex with c-547,an alkyl ammonium derivative of 6-methyl uracil | 5FKJ_A |
| SC | S09.979 | acetylcholinesterase | structure of a pre-reaction ternary complex between sarin- acetylcholinesterase and hi-6 | 5FPP_A |
| SC | S09.979 | acetylcholinesterase | mus musculus acetylcholinesterase in complex with al200 | 5FUM_A |
| SC | S09.979 | acetylcholinesterase | inhibited by DFP | 5HCU_A |
| SC | S09.979 | acetylcholinesterase | complex with crystal violet | 5OV9_A |
| SC | S09.979 | acetylcholinesterase | mus musculus acetylcholinesterase in complex with 2-(4-biphenylyloxy)-n-[3-(1-piperidinyl)propyl]-acetamide hydrochloride (10) | 6FSD_A |
| SC | S09.979 | acetylcholinesterase | 4QWW | |
| SC | S09.980 | cholinesterase | 1ACJ | |
| SC | S09.980 | cholinesterase | 1ACL | |
| SC | S09.980 | cholinesterase | 1AMN | |
| SC | S09.980 | cholinesterase | 1AX9 | |
| SC | S09.980 | cholinesterase | 1CFJ | |
| SC | S09.980 | cholinesterase | 1DX6 | |
| SC | S09.980 | cholinesterase | 1E3Q | |
| SC | S09.980 | cholinesterase | 1E66 | |
| SC | S09.980 | cholinesterase | 1EA5 | |
| SC | S09.980 | cholinesterase | 1EEA | |
| SC | S09.980 | cholinesterase | 1EVE | |
| SC | S09.980 | cholinesterase | 1FSS | |
| SC | S09.980 | cholinesterase | 1GPK | |
| SC | S09.980 | cholinesterase | 1GPN | |
| SC | S09.980 | cholinesterase | 1GQR | |
| SC | S09.980 | cholinesterase | 1GQS | |
| SC | S09.980 | cholinesterase | 1H22 | |
| SC | S09.980 | cholinesterase | 1H23 | |
| SC | S09.980 | cholinesterase | 1HBJ | |
| SC | S09.980 | cholinesterase | 1JGA | |
| SC | S09.980 | cholinesterase | 1JGB | |
| SC | S09.980 | cholinesterase | 1JJB | |
| SC | S09.980 | cholinesterase | 1OCE | |
| SC | S09.980 | cholinesterase | 1ODC | |
| SC | S09.980 | cholinesterase | 1QID | |
| SC | S09.980 | cholinesterase | 1QIE | |
| SC | S09.980 | cholinesterase | 1QIF | |
| SC | S09.980 | cholinesterase | 1QIG | |
| SC | S09.980 | cholinesterase | 1QIH | |
| SC | S09.980 | cholinesterase | 1QII | |
| SC | S09.980 | cholinesterase | 1QIJ | |
| SC | S09.980 | cholinesterase | 1QIK | |
| SC | S09.980 | cholinesterase | 1QIM | |
| SC | S09.980 | cholinesterase | 1QTI | |
| SC | S09.980 | cholinesterase | 1SOM | |
| SC | S09.980 | cholinesterase | 1U65 | |
| SC | S09.980 | cholinesterase | 1UT6 | |
| SC | S09.980 | cholinesterase | 1VOT | |
| SC | S09.980 | cholinesterase | 1VXO | |
| SC | S09.980 | cholinesterase | 1VXR | |
| SC | S09.980 | cholinesterase | 1W4L | |
| SC | S09.980 | cholinesterase | 1W6R | |
| SC | S09.980 | cholinesterase | 1W75 | |
| SC | S09.980 | cholinesterase | 1W76 | |
| SC | S09.980 | cholinesterase | 1ZGB | |
| SC | S09.980 | cholinesterase | 1ZGC | |
| SC | S09.980 | cholinesterase | 2ACE | |
| SC | S09.980 | cholinesterase | 2ACK | |
| SC | S09.980 | cholinesterase | 2BAG | |
| SC | S09.980 | cholinesterase | 2C4H | |
| SC | S09.980 | cholinesterase | 2C58 | |
| SC | S09.980 | cholinesterase | 2C5F | |
| SC | S09.980 | cholinesterase | 2C5G | |
| SC | S09.980 | cholinesterase | 2CEK | |
| SC | S09.980 | cholinesterase | 2CKM | |
| SC | S09.980 | cholinesterase | 2CMF | |
| SC | S09.980 | cholinesterase | 2DFP | |
| SC | S09.980 | cholinesterase | 2J3D | |
| SC | S09.980 | cholinesterase | 2J3Q | |
| SC | S09.980 | cholinesterase | 2J4F | |
| SC | S09.980 | cholinesterase | 2V96 | |
| SC | S09.980 | cholinesterase | 2V97 | |
| SC | S09.980 | cholinesterase | 2V98 | |
| SC | S09.980 | cholinesterase | 2VA9 | |
| SC | S09.980 | cholinesterase | 2VJA | |
| SC | S09.980 | cholinesterase | 2VJB | |
| SC | S09.980 | cholinesterase | 2VJC | |
| SC | S09.980 | cholinesterase | 2VJD | |
| SC | S09.980 | cholinesterase | 2VQ6 | |
| SC | S09.980 | cholinesterase | 2VT6 | |
| SC | S09.980 | cholinesterase | 2VT7 | |
| SC | S09.980 | cholinesterase | 2W6C | |
| SC | S09.980 | cholinesterase | 2W9I | |
| SC | S09.980 | cholinesterase | 2WFZ | |
| SC | S09.980 | cholinesterase | 2WG0 | |
| SC | S09.980 | cholinesterase | 2WG1 | |
| SC | S09.980 | cholinesterase | 2WG2 | |
| SC | S09.980 | cholinesterase | 2XI4 | |
| SC | S09.980 | cholinesterase | 3ACE | |
| SC | S09.980 | cholinesterase | 3GEL | |
| SC | S09.980 | cholinesterase | 3I6M | |
| SC | S09.980 | cholinesterase | 3I6Z | |
| SC | S09.980 | cholinesterase | 3M3D | |
| SC | S09.980 | cholinesterase | 3ZV7 | |
| SC | S09.980 | cholinesterase | 4ACE | |
| SC | S09.980 | cholinesterase | 4TVK | |
| SC | S09.980 | cholinesterase | 4W63 | |
| SC | S09.980 | cholinesterase | 4X3C | |
| SC | S09.980 | cholinesterase | 5BWB | |
| SC | S09.980 | cholinesterase | 5BWC | |
| SC | S09.980 | cholinesterase | acetylcholinesterase methylene blue no peg | 5DLP_A |
| SC | S09.980 | cholinesterase | 5E2I_A | |
| SC | S09.980 | cholinesterase | acetylcholinesterase methylene blue no peg | 5E4J_A |
| SC | S09.980 | cholinesterase | acetylcholinesterase methylene blue with peg | 5E4T_A |
| SC | S09.980 | cholinesterase | crystal structure of msf-aged torpedo californica acetylcholinesterase | 5EHX_A |
| SC | S09.980 | cholinesterase | complex with alkylene-linked bis-tacrine dimer (7 carbon linker) | 5EI5_A |
| SC | S09.980 | cholinesterase | complex with the n- methyl-indoxylacetate hydrolysis products | 5IH7_A |
| SC | S09.980 | cholinesterase | torpedo californica acetylcholinesterase in complex with a non-chiral donepezil-like inhibitor 17 | 5NAP_A |
| SC | S09.980 | cholinesterase | torpedo californica acetylcholinesterase in complex with a non-chiral donepezil-like compound 20 | 5NAU_A |
| SC | S09.980 | cholinesterase | torpedo californica acetylcholinesterase in complex with a chlorotacrine-tryptophan hybrid inhibitor | 5NUU_A |
| SC | S09.980 | cholinesterase | rivastigmine analogue bound to tc ache. | 6EUE_A |
| SC | S09.980 | cholinesterase | t. californica ache in complex with a 3-hydroxy-2-pyridine aldoxime. | 6EWK_A |
| SC | S09.980 | cholinesterase | torpedo californica ache in complex with indolic multi-target directedligand | 6EZG_A |
| SC | S09.980 | cholinesterase | torpedo californica ache in complex with indolic multi-target directedligand ***caveat 6ezh nag a 601 has wrong chirality at atom c1 | 6EZH_A |
| SC | S09.980 | cholinesterase | carbamylated t. californica acetylcholineterase bound to uncharged hybrid reactivator 1 | 6FLD_A |
| SC | S09.980 | cholinesterase | carbamylated t. californica acetylcholineterase bound to uncharged hybrid reactivator 2 | 6FQN_A |
| SC | S09.980 | cholinesterase | non-aged form of torpedo californica acetylcholinesterase inhibited bynerve agent tabun | 6G17_A |
| SC | S09.980 | cholinesterase | complex with 9-amino-6-chloro-1,2,3,4-tetrahydro-10-methylacridin-10-ium | 6G1U_A |
| SC | S09.980 | cholinesterase | complex with 12-amino-3-chloro-6,7,10,11-tetrahydro-5,9-dimethyl-7, 11-methanocycloocta[b]quinolin-5-ium | 6G1V_A |
| SC | S09.980 | cholinesterase | complex with 2-1-[2-(6-chloro-1,2,3,4-tetrahydroacridin-9-ylamino) ethyl]-1h-1,2,3-triazol-4-yl-n-[4-(hydroxy)-3- methoxybenzyl]acetamide | 6G1W_A |
| SC | S09.980 | cholinesterase | torpedo californica acetylcholinesterase bound to uncharged hybrid reactivator 1 | 6G4M_A |
| SC | S09.980 | cholinesterase | torpedo californica acetylcholinesterase bound to uncharged hybrid reactivator 2 | 6G4N_A |
| SC | S09.980 | cholinesterase | non-aged form of torpedo californica acetylcholinesterase inhibited bytabun analog nedpa bound to uncharged reactivator 1 | 6G4O_A |
| SC | S09.980 | cholinesterase | non-aged form of torpedo californica acetylcholinesterase inhibited bytabun analog nedpa bound to uncharged reactivator 2 | 6G4P_A |
| SC | S09.980 | cholinesterase | complex to 1-(6-oxo-1,2,3,4,6,10b- hexahydropyrido[2,1-a]isoindol-10-yl)-3-(4-(((1-(2-((1,2,3,4- tetrahydroacridin-9-yl)amino)ethyl)-1h-1,2,3-triazol-4-yl)methoxy) methyl)pyridin-2-yl)urea ***caveat 6h12 fjk a 626 has wrong c | 6H12_A |
| SC | S09.980 | cholinesterase | complex to1-(4-((methyl((1-(2-((1,2,3,4-tetrahydroacridin-9-yl)amino)ethyl)-1h-1,2,3-triazol-4-yl)methyl) amino)methyl)pyridin-2-yl)-3-(6-oxo-1,2,3,4,6,10b-hexahydropyrido[2, 1-a]isoindol-10-yl)urea ***caveat 6h13 nag a 602 h | 6H13_A |
| SC | S09.980 | cholinesterase | complex to 1-(6-oxo-1,2,3,4,6,10b- hexahydropyrido[2,1-a]isoindol-10-yl)-3-(4-(1-(2-((1,2,3,4- tetrahydroacridin-9-yl)amino)ethyl)-1h-1,2,3-triazol-4-yl)pyridin-2- yl)urea | 6H14_A |
| SC | S09.980 | cholinesterase | 1EHO | |
| SC | S09.980 | cholinesterase | 1EHQ | |
| SC | S09.980 | cholinesterase | 1KCJ | |
| SC | S09.980 | cholinesterase | 1P0I | |
| SC | S09.980 | cholinesterase | 1P0M | |
| SC | S09.980 | cholinesterase | 1P0P | |
| SC | S09.980 | cholinesterase | 1P0Q | |
| SC | S09.980 | cholinesterase | 1XLU | |
| SC | S09.980 | cholinesterase | 1XLV | |
| SC | S09.980 | cholinesterase | 1XLW | |
| SC | S09.980 | cholinesterase | 2J4C | |
| SC | S09.980 | cholinesterase | 2PM8 | |
| SC | S09.980 | cholinesterase | 2WID | |
| SC | S09.980 | cholinesterase | 2WIF | |
| SC | S09.980 | cholinesterase | 2WIG | |
| SC | S09.980 | cholinesterase | 2WIJ | |
| SC | S09.980 | cholinesterase | 2WIK | |
| SC | S09.980 | cholinesterase | 2WIL | |
| SC | S09.980 | cholinesterase | 2WSL | |
| SC | S09.980 | cholinesterase | 2XMB | |
| SC | S09.980 | cholinesterase | 2XMC | |
| SC | S09.980 | cholinesterase | 2XMD | |
| SC | S09.980 | cholinesterase | 2XMG | |
| SC | S09.980 | cholinesterase | 2XQF | |
| SC | S09.980 | cholinesterase | 2XQG | |
| SC | S09.980 | cholinesterase | 2XQI | |
| SC | S09.980 | cholinesterase | 2XQJ | |
| SC | S09.980 | cholinesterase | 2XQK | |
| SC | S09.980 | cholinesterase | 2Y1K | |
| SC | S09.980 | cholinesterase | 3DJY | |
| SC | S09.980 | cholinesterase | 3DKK | |
| SC | S09.980 | cholinesterase | 3O9M | |
| SC | S09.980 | cholinesterase | 4AQD | |
| SC | S09.980 | cholinesterase | 4AXB | |
| SC | S09.980 | cholinesterase | 4B0O | |
| SC | S09.980 | cholinesterase | 4B0P | |
| SC | S09.980 | cholinesterase | 4BBZ | |
| SC | S09.980 | cholinesterase | 4BDS | |
| SC | S09.980 | cholinesterase | 4TPK | |
| SC | S09.980 | cholinesterase | 4XII | |
| SC | S09.980 | cholinesterase | complex with n- ((1-benzylpiperidin-3-yl)methyl)-n-methylnaphthalene-2-sulfonamide ***caveat 5dyt nag a 606 has wrong chirality at atom c1 nag a 607 has wrong ***caveat 2 5dyt chirality at atom c1 nag a | 5DYT_A |
| SC | S09.980 | cholinesterase | complex with n- ((1-benzylpiperidin-3-yl)methyl)-n-(2-methoxyethyl)naphthalene-2- sulfonamide ***caveat 5dyw 5hf a 601 has wrong chirality at atom c07 nag a 621 has ***caveat 2 5dyw wrong chirality at at | 5DYW_A |
| SC | S09.980 | cholinesterase | complex with n- ((1-benzylpiperidin-3-yl)methyl)naphthalene-2-sulfonamide ***caveat 5dyy nag a 611 has wrong chirality at atom c1 nag a 612 has wrong ***caveat 2 5dyy chirality at atom c1 ful a 613 has w | 5DYY_A |
| SC | S09.980 | cholinesterase | discovery and structure-activity relationships of a highly selective butyrylcholinesterase inhibitor by structure-based virtual screening | 5K5E_A |
| SC | S09.980 | cholinesterase | complex with N-propargyliperidines | 5LKR_A |
| SC | S09.980 | cholinesterase | crystal structure of hubche with n-((1-(2,3-dihydro-1h-inden-2-yl) piperidin-3-yl)methyl)-n-(2-(dimethylamino)ethyl)-2-naphthamide. ***caveat 5nn0 fuc a 605 has wrong chirality at atom c1 nag a 608 has wrong ***caveat 2 5nn0 chirality at atom c1 | 5NN0_A |
| SC | S09.980 | cholinesterase | crystal structure of a variant of human butyrylcholinesterase expressed in bacteria. | 6EMI_A |
| SC | S09.980 | cholinesterase | complex with decamethonium | 6EP4_A |
| SC | S09.980 | cholinesterase | complex with ethopropazine | 6EQP_A |
| SC | S09.980 | cholinesterase | complex with huprine 19 | 6EQQ_A |
| SC | S09.980 | cholinesterase | complex with propidium | 6ESJ_A |
| SC | S09.980 | cholinesterase | complex with thioflavine t | 6ESY_A |
| SC | S09.980 | cholinesterase | butyrylcolinesterase expressed in cho cells co-crystallised with a rivastigmine analogue | 6EUL_A |
| SC | S09.980 | cholinesterase | butyrylcolinesterase expressed in cho cells co-crystallised with a rivastigmine analogue | 6EYF_A |
| SC | S09.980 | cholinesterase | human butyrylcholinesterase carbamylated. | 6EZ2_A |
| SC | S09.980 | cholinesterase | complex with n-propargyliperidines | 6F7Q_A |
| SC | S09.980 | cholinesterase | complex with the s enantiomer of a chlorotacrine-tryptophan multi-target inhibitor. | 6I0B_A |
| SC | S09.980 | cholinesterase | complex with the r enantiomer of a chlorotacrine-tryptophan multi-target inhibitor. | 6I0C_A |
| SC | S09.980 | cholinesterase | cryoem reconstruction of full-length, fully-glycosylated human butyrylcholinesterase tetramer | 6I2T_B |
| SC | S09.980 | cholinesterase | complex with (s)-2-(butylamino)-n-(2- cycloheptylethyl)-3-(1h-indol-3-yl)propanamide | 6QAA_A |
| SC | S09.980 | cholinesterase | complex with (s)-n-(1-((2- cycloheptylethyl)amino)-3-(1h-indol-3-yl)-1-oxopropan-2-yl)-n,n- dimethylbutan-1-aminium | 6QAB_A |
| SC | S09.980 | cholinesterase | complex with (s)-2-(butylamino)-n-(3- cycloheptylpropyl)-3-(1h-indol-3-yl)propanamide | 6QAC_A |
| SC | S09.980 | cholinesterase | complex with ((s)-2-(butylamino)-n-(2- (4-(dimethylamino)cyclohexyl)ethyl)-3-(1h-indol-3-yl)propanamide | 6QAD_A |
| SC | S09.980 | cholinesterase | complex with (s)-n2-butyl-n1-(2- cycloheptylethyl)-3-(1h-indol-3-yl)-n1,n2-dimethylpropane-1,2-diamine | 6QAE_A |
| SC | S09.980 | cholinesterase | 1DX4 | |
| SC | S09.980 | cholinesterase | 1QO9 | |
| SC | S09.980 | cholinesterase | 1QON | |
| SC | S09.982 | liver carboxylesterase | complex with tacrine | 1MX1_A |
| SC | S09.982 | liver carboxylesterase | complex with homatropine, a cocaine analogue | 1MX5_A |
| SC | S09.982 | liver carboxylesterase | complex with naloxone methiodide, a heroin analogue | 1MX9_A |
| SC | S09.982 | liver carboxylesterase | complex with tamoxifen | 1YA4_A |
| SC | S09.982 | liver carboxylesterase | complex with cleavage products of mevastatin | 1YA8_A |
| SC | S09.982 | liver carboxylesterase | complex to etyl acetate; a fatty acid ethyl ester analogue | 1YAH_A |
| SC | S09.982 | liver carboxylesterase | complex with benzil | 1YAJ_A |
| SC | S09.982 | liver carboxylesterase | complex with cholate and palmitate | 2DQY_A |
| SC | S09.982 | liver carboxylesterase | complex with homatropine, coenzyme a, and palmitate | 2DQZ_A |
| SC | S09.982 | liver carboxylesterase | complex with taurocholate | 2DR0_A |
| SC | S09.982 | liver carboxylesterase | complex with coenzyme a | 2H7C_A |
| SC | S09.982 | liver carboxylesterase | complex with the nerve agent cyclosarin (gf) | 3K9B_A |
| SC | S09.982 | liver carboxylesterase | recombinant human carboxylesterase 1 from whole cabbage loopers | 4AB1_A |
| SC | S09.982 | liver carboxylesterase | comparison of the structure and activity of glycosylated and aglycosylated human carboxylesterase 1 | 5A7G_A |
| SC | S09.982 | liver carboxylesterase | comparison of the structure and activity of glycosylated and aglycosylated human carboxylesterase 1 | 5A7H_A |
| SC | S09.985 | bile salt-dependent lipase | 1F6W | |
| SC | S09.985 | bile salt-dependent lipase | 1JMY | |
| SC | S09.985 | bile salt-dependent lipase | crystal structure of native recombinant human bile salt activated lipase | 6H0T_A |
| SC | S09.985 | bile salt-dependent lipase | crystal structure of tabun surrogate nedpa inhibited recombinant humanbile salt activated lipase | 6H0V_A |
| SC | S09.985 | bile salt-dependent lipase | crystal structure of sarin surrogate nimp inhibited recombinant human bile salt activated lipase | 6H18_A |
| SC | S09.985 | bile salt-dependent lipase | crystal structure of ethyl-paraoxon inhibited recombinant human bile salt activated lipase (aged form) | 6H19_A |
| SC | S09.985 | bile salt-dependent lipase | crystal structure of vx surrogate nemp inhibited recombinant human bile salt activated lipase | 6H1A_A |
| SC | S09.985 | bile salt-dependent lipase | 1AKN | |
| SC | S09.985 | bile salt-dependent lipase | 1AQL | |
| SC | S09.985 | bile salt-dependent lipase | 2BCE | |
| SC | S09.988 | neuroligin 4, X-linked | 2WQZ | |
| SC | S09.988 | neuroligin 4, X-linked | 2XB6 | |
| SC | S09.988 | neuroligin 4, X-linked | 3BE8 | |
| SC | S09.990 | esterase D | 3FCX | |
| SC | S09.994 | neuroligin 1 | crystal structure of the chicken mdga1 ectodomain in complex with the human neuroligin 1 (nl1(-a-b)) cholinesterase domain. | 5OJ6_A |
| SC | S09.994 | neuroligin 1 | crystal structure of the human neuroligin 1 cholinesterase domain containing spliced sequence b (ssb) (nl1(-a+b)) | 5OJK_A |
| SC | S09.994 | neuroligin 1 | 3B3Q | |
| SC | S09.994 | neuroligin 1 | 3BIW | |
| SC | S09.994 | neuroligin 1 | 3BIX | |
| SC | S09.994 | neuroligin 1 | 3VKF | |
| SC | S09.995 | neuroligin 2 | crystal structure of human mdga1 and human neuroligin-2 complex | 5XEQ_A |
| SC | S09.995 | neuroligin 2 | complex of nlgn2 with mdga1 ig1-ig2 ***caveat 5v5v residue ser 246 and residue glu 247 that are next to each ***caveat 2 5v5v other in the sample sequence are not properly linked: ***caveat 3 5v5v distance between c and n atoms is 2.87a. | 5V5V_A |
| SC | S09.A10 | At5g23530 (Arabidopsis thaliana) | 2ZSH | |
| SC | S09.A10 | At5g23530 (Arabidopsis thaliana) | 2ZSI | |
| SC | S09.A40 | YqiA protein (Escherichi coli) | crystal structure of the esterase yqia (ye3661) from yersinia enterocolitica, northeast structural genomics consortium target yer85 | 4FLE_A |
| SC | S09.A47 | aes protein (acetyl esterase) (Escherichi coli) | 3GA7 | |
| SC | S09.A47 | aes protein (acetyl esterase) (Escherichi coli) | structure of aes from e. coli | 4KRX_A |
| SC | S09.A47 | aes protein (acetyl esterase) (Escherichi coli) | complex with pms | 4KRY_A |
| SC | S09.A56 | At5G20060 protein (Arabidopsis thaliana) | crystal structure of zea mays acyl-protein thioesterase 2 | 6AVY_A |
| SC | S09.A72 | CG9542 protein (Drosophila melanogaster) | 4E11 | |
| SC | S09.A72 | CG9542 protein (Drosophila melanogaster) | 4E14 | |
| SC | S09.A72 | CG9542 protein (Drosophila melanogaster) | 4E15 | |
| SC | S09.A77 | dpf-6 g.p. (Caenorhabditis elegans) | 2JBW | |
| SC | S09.A77 | dpf-6 g.p. (Caenorhabditis elegans) | the crystal structure of a cold-adapted acylaminoacyl peptidase reveals a novel quaternary architecture based on the arm-exchange mechanism | 5L8S_A |
| SC | S09.UNC | subfamily S9C non-peptidase homologues | 3EEB_A | |
| SC | S09.UNC | subfamily S9C non-peptidase homologues | 3FZY_A | |
| SC | S09.UNC | subfamily S9C non-peptidase homologues | 3GCD_A | |
| SC | S09.UNC | subfamily S9C non-peptidase homologues | complex with g2 oligosaccharide. | 6EN3_A |
| SC | S09.UNW | family S9 non-peptidase homologues | 2HDW | |
| SC | S09.UNW | family S9 non-peptidase homologues | 3EBL | |
| SC | S09.UNW | family S9 non-peptidase homologues | 3ED1 | |
| SC | S09.UNW | family S9 non-peptidase homologues | the alpha-esterase-7 carboxylesterase, e3, from the blowfly lucilia cuprina | 4FNG_A |
| SC | S09.UNW | family S9 non-peptidase homologues | the alpha-esterase-7 carboxylesterase, e3, from the blowfly lucilia cuprina | 4FNM_A |
| SC | S09.UNW | family S9 non-peptidase homologues | absorbed x-ray dose 1.85 mgy | 4QWM_A |
| SC | S09.UNW | family S9 non-peptidase homologues | absorbed x-ray dose 3.70 mgy at 100k | 4UBI_A |
| SC | S09.UNW | family S9 non-peptidase homologues | absorbed x-ray dose 5.55 mgy at 100k | 4UBJ_A |
| SC | S09.UNW | family S9 non-peptidase homologues | absorbed x-ray dose 7.40 mgy at 100k | 4UBK_A |
| SC | S09.UNW | family S9 non-peptidase homologues | absorbed x-ray dose 9.26 mgy | 4UBL_A |
| SC | S09.UNW | family S9 non-peptidase homologues | absorbed x-ray dose 11.11 mgy at 100k | 4UBM_A |
| SC | S09.UNW | family S9 non-peptidase homologues | absorbed x-ray dose 1.85 mgy temp 150k | 4UBN_A |
| SC | S09.UNW | family S9 non-peptidase homologues | absorbed x-ray dose 3.70 mgy temp 150k | 4UBO_A |
| SC | S09.UNW | family S9 non-peptidase homologues | absorbed x-ray dose 5.54 mgy temp 150k | 4W1P_A |
| SC | S09.UNW | family S9 non-peptidase homologues | absorbed x-ray dose 7.39 mgy temp 150k | 4W1Q_A |
| SC | S09.UNW | family S9 non-peptidase homologues | absorbed x-ray dose 9.24 mgy temp 150k | 4W1R_A |
| SC | S09.UNW | family S9 non-peptidase homologues | absorbed x-ray dose 11.09 mgy temp 150k | 4W1S_A |
| SC | S09.UNW | family S9 non-peptidase homologues | lucilia cuprina alpha esterase 7: gly137asp | 5C8V_A |
| SC | S09.UNW | family S9 non-peptidase homologues | 5CH3_A | |
| SC | S09.UNW | family S9 non-peptidase homologues | 5CH5_A | |
| SC | S09.UNW | family S9 non-peptidase homologues | crystal structure of the alpha-esterase-7 carboxyl esterase (dimer), e3, from lucilia cuprina | 5IKX_A |
| SC | S09.UNW | family S9 non-peptidase homologues | apo-enzyme qfit multi-conformer model | 5IVD_A |
| SC | S09.UNW | family S9 non-peptidase homologues | apo-enzyme ensemble refinement | 5IVH_A |
| SC | S09.UNW | family S9 non-peptidase homologues | phosphorylated enzyme qfit multi-conformer model | 5IVI_A |
| SC | S09.UNW | family S9 non-peptidase homologues | phosphorylated-enzyme ensemble refinement | 5IVK_A |
| SC | S09.UNW | family S9 non-peptidase homologues | complex with (3-bromo-5-phenoxylphenyl)boronic acid | 5TYJ_A |
| SC | S09.UNW | family S9 non-peptidase homologues | complex with 3-chloro-4-[(2-fluorophenyl) methoxy]phenylborinic acid | 5TYK_A |
| SC | S09.UNW | family S9 non-peptidase homologues | complex with naphthalen-2-ylboronic acid | 5TYL_A |
| SC | S09.UNW | family S9 non-peptidase homologues | complex with [3-bromo-5-(pyrrolidin-1-yl) phenyl]borinic acid | 5TYM_A |
| SC | S09.UNW | family S9 non-peptidase homologues | complex with [3-bromo-5-(pyrrolidin-1-yl) phenyl]borinic acid | 5TYN_A |
| SC | S09.UNW | family S9 non-peptidase homologues | complex with [3-(benzyloxy)-4-methylphenyl]borinicacid | 5TYO_A |
| SC | S09.UNW | family S9 non-peptidase homologues | complex with (3-bromo-4-methylphenyl)boronic acid | 5TYP_A |
| SC | S09.UNW | family S9 non-peptidase homologues | crystal structure of a putative thioesterase (tm1040_2492) from silicibacter sp. tm1040 at 1.79 a resolution | 2PBL_A |
| SC | S09.UNW | family S9 non-peptidase homologues | 1R88 | |
| SC | S09.UNW | family S9 non-peptidase homologues | crystal structure hormone-sensitive lipase from a metagenome library | 3DNM_A |
| SC | S09.UNW | family S9 non-peptidase homologues | crystal structure at 2.2 angstrom of hsl-homolog este7 from a metagenome library | 3K6K_A |
| SC | S09.UPA | subfamily S9A unassigned peptidases | 1YR2 | |
| SC | S09.UPA | subfamily S9A unassigned peptidases | appep_wt2 opened state | 3IUJ_A |
| SC | S09.UPA | subfamily S9A unassigned peptidases | appep_wt1 opened state | 3IUL_A |
| SC | S09.UPA | subfamily S9A unassigned peptidases | appep_wtx opened state | 3IUM_A |
| SC | S09.UPA | subfamily S9A unassigned peptidases | appep_d622n opened state | 3IUN_A |
| SC | S09.UPA | subfamily S9A unassigned peptidases | appep_d622n+pp closed state | 3IUQ_A |
| SC | S09.UPA | subfamily S9A unassigned peptidases | appep_d266nx+h2h3 opened state | 3IUR_A |
| SC | S09.UPA | subfamily S9A unassigned peptidases | appep_wt+pp closed state | 3IVM_A |
| SC | S09.UPA | subfamily S9A unassigned peptidases | appep_pepclose closed state | 3MUN_A |
| SC | S09.UPA | subfamily S9A unassigned peptidases | appep_pepclose+pp closed state | 3MUO_A |
| SC | S09.UPA | subfamily S9A unassigned peptidases | 4HVT_A | |
| SC | S09.UPW | family S9 unassigned peptidases | the crystal structure of a hyper-thermophilic carboxylesterase from the archaeon archaeoglobus fulgidus | 1JJI_A |
| SC | S09.UPW | family S9 unassigned peptidases | 2AZG | |
| SC | S09.UPW | family S9 unassigned peptidases | crystal structure of acetylcholinesterase catalytic subunit of the malaria vector anopheles gambiae, 3.4 a | 5X61_B |
| SC | S09.UPW | family S9 unassigned peptidases | crystal structure of acetylcholinesterase catalytic subunits of the malaria vector anopheles gambiae, 3.2 a | 5YDH_A |
| SC | S09.UPW | family S9 unassigned peptidases | crystal structure of acetylcholinesterase catalytic subunits of the malaria vector anopheles gambiae, new crystal packing | 5YDI_A |
| SC | S09.UPW | family S9 unassigned peptidases | complex with PMSF | 5YDJ_A |
| SC | S09.UPW | family S9 unassigned peptidases | crystal structure of an insecticide-resistant acetylcholinesterase mutant from the malaria vector anopheles gambiae in the ligand-free state | 6ARX_A |
| SC | S09.UPW | family S9 unassigned peptidases | insecticide-resistant mutant; complex with a difluoromethyl ketone inhibitor | 6ARY_A |
| SC | S09.UPW | family S9 unassigned peptidases | 1K4Y | |
| SC | S09.UPW | family S9 unassigned peptidases | pyrobaculum calidifontis esterase monoclinic form | 2YH2_A |
| SC | S09.UPW | family S9 unassigned peptidases | hyperthermophilic esterase from the archeon pyrobaculum calidifontis | 3ZWQ_A |
| SC | S09.UPW | family S9 unassigned peptidases | crystal structure of a hsl-like carboxylesterase from sulfolobus tokodaii | 3AIK_A |
| SC | S09.UPW | family S9 unassigned peptidases | complex with paraoxon | 3AIL_A |
| SC | S09.UPW | family S9 unassigned peptidases | r267e mutant of a hsl-like carboxylesterase from sulfolobus tokodaii | 3AIM_A |
| SC | S09.UPW | family S9 unassigned peptidases | r267g mutant of a hsl-like carboxylesterase from sulfolobus tokodaii | 3AIN_A |
| SC | S09.UPW | family S9 unassigned peptidases | r267k mutant of a hsl-like carboxylesterase from sulfolobus tokodaii | 3AIO_A |
| SC | S09.UPW | family S9 unassigned peptidases | complex with transition state analog dimethylarsenic acid | 1LZK_A |
| SC | S09.UPW | family S9 unassigned peptidases | bacterial heroin esterase | 1LZL_A |
| SC | S09.UPW | family S9 unassigned peptidases | 1THG | |
| SC | S09.UPW | family S9 unassigned peptidases | crystal structure of juvenile hormone esterase from manduca sexta, with otfp covalently attached | 2FJ0_A |
| SC | S09.UPW | family S9 unassigned peptidases | crystal structure of a sugar hydrolase (yeeb) from lactococcus lactis,northeast structural genomics consortium target kr108 | 3HXK_A |
| SC | S09.UPW | family S9 unassigned peptidases | 1CLE | |
| SC | S09.UPW | family S9 unassigned peptidases | 1LLF | |
| SC | S09.UPW | family S9 unassigned peptidases | 1THG_A | |
| SC | S09.UPW | family S9 unassigned peptidases | 1CRL | |
| SC | S09.UPW | family S9 unassigned peptidases | 1LPM | |
| SC | S09.UPW | family S9 unassigned peptidases | 1LPN | |
| SC | S09.UPW | family S9 unassigned peptidases | 1LPO | |
| SC | S09.UPW | family S9 unassigned peptidases | 1LPP | |
| SC | S09.UPW | family S9 unassigned peptidases | 1LPS | |
| SC | S09.UPW | family S9 unassigned peptidases | 1TRH | |
| SC | S09.UPW | family S9 unassigned peptidases | 3RAR | |
| SC | S09.UPW | family S9 unassigned peptidases | 1GZ7 | |
| SC | S09.UPW | family S9 unassigned peptidases | complex with paraoxon | 3DOI_A |
| SC | S09.UPW | family S9 unassigned peptidases | crystal structure of esterase lipw from mycobacterium marinum | 3QH4_A |
| SC | S09.UPW | family S9 unassigned peptidases | crystal structure of the esterase domain from rhodothermus marinus rmar_1206 protein | 5CML_A |
| SC | S09.UPW | family S9 unassigned peptidases | crystal structure of a lipase carboxylesterase from sulfolobus islandicus | 5LK6_A |
| SC | S09.UPW | family S9 unassigned peptidases | crystal structure of acetyl ester-xyloside bifunctional hydrolase fromcaldicellulosiruptor lactoaceticus | 6A6O_A |
| SC | S09.UPW | family S9 unassigned peptidases | crystal structure of an s-formylglutathione hydrolase from pseudoalteromonas haloplanktis tac125 | 3LS2_A |
| SC | S10.001 | carboxypeptidase Y | 1CPY | |
| SC | S10.001 | carboxypeptidase Y | complex with carboxypeptidase Y inhibitor | 1WPX_A |
| SC | S10.001 | carboxypeptidase Y | 1YSC | |
| SC | S10.002 | serine carboxypeptidase A | physiological dimer of precursor | 1IVY_A |
| SC | S10.002 | serine carboxypeptidase A | 3BP4 | |
| SC | S10.002 | serine carboxypeptidase A | 3BP7 | |
| SC | S10.002 | serine carboxypeptidase A | 3BXN | |
| SC | S10.002 | serine carboxypeptidase A | 4AZ0 | |
| SC | S10.002 | serine carboxypeptidase A | 4AZ3 | |
| SC | S10.002 | serine carboxypeptidase A | 4CI9 | |
| SC | S10.002 | serine carboxypeptidase A | 4CIA | |
| SC | S10.002 | serine carboxypeptidase A | 4CIB | |
| SC | S10.002 | serine carboxypeptidase A | 4MWS | |
| SC | S10.002 | serine carboxypeptidase A | 4MWT | |
| SC | S10.005 | serine carboxypeptidase D | complex with antipain | 1BCR |
| SC | S10.005 | serine carboxypeptidase D | complex with chymostatin | 1BCS |
| SC | S10.005 | serine carboxypeptidase D | 1WHS | |
| SC | S10.005 | serine carboxypeptidase D | complex with L-benzylsuccinate | 1WHT_B |
| SC | S10.005 | serine carboxypeptidase D | 3SC2 | |
| SC | S10.005 | serine carboxypeptidase D | complex with inhibitor benzoic acid | 1GXS_A |
| SC | S10.007 | kex carboxypeptidase | 1AC5 | |
| SC | S10.A14 | At2g22990 (Arabidopsis thaliana) | 2DRF | |
| SC | S10.A18 | At5g09640 (Arabidopsis thaliana) | 2DRG | |
| SC | S10.A43 | At2g35780 (Arabidopsis thaliana) | 1BCR_A | |
| SC | S10.A43 | At2g35780 (Arabidopsis thaliana) | 1BCS_A | |
| SC | S10.A43 | At2g35780 (Arabidopsis thaliana) | 1WHS_A | |
| SC | S10.A43 | At2g35780 (Arabidopsis thaliana) | 1WHT | |
| SC | S10.A43 | At2g35780 (Arabidopsis thaliana) | 3SC2_A | |
| SE | S11.003 | penicillin-binding protein 6 | 3IT9 | |
| SE | S11.003 | penicillin-binding protein 6 | complex with ampicillin | 3ITA |
| SE | S11.003 | penicillin-binding protein 6 | complex with a substrate fragment | 3ITB |
| SE | S11.004 | K15-type DD-transpeptidase | Ser96Ala mutant | 1ES2 |
| SE | S11.004 | K15-type DD-transpeptidase | Cys98Ala mutant | 1ES3 |
| SE | S11.004 | K15-type DD-transpeptidase | Cys98Asn mutant | 1ES4 |
| SE | S11.004 | K15-type DD-transpeptidase | Ser216Ala mutant | 1ES5 |
| SE | S11.004 | K15-type DD-transpeptidase | Arg248Leu mutant | 1ESI |
| SE | S11.004 | K15-type DD-transpeptidase | Lys38His mutant | 1J9M |
| SE | S11.004 | K15-type DD-transpeptidase | 1SKF | |
| SE | S11.004 | K15-type DD-transpeptidase | 3MFD | |
| SE | S11.006 | D,D-carboxypeptidase PBP3 (Streptococcus-type) | 1XP4_A | |
| SE | S11.008 | penicillin-binding protein 5-type peptidase | deacylation defective mutant | 1HD8_A |
| SE | S11.008 | penicillin-binding protein 5-type peptidase | Asp105Gly deacylation defective mutant | 1NJ4 |
| SE | S11.008 | penicillin-binding protein 5-type peptidase | 1NZO | |
| SE | S11.008 | penicillin-binding protein 5-type peptidase | 1NZU | |
| SE | S11.008 | penicillin-binding protein 5-type peptidase | 1SDN | |
| SE | S11.008 | penicillin-binding protein 5-type peptidase | 1Z6F | |
| SE | S11.008 | penicillin-binding protein 5-type peptidase | complex with peptide-mimetic penicillin | 3BEB |
| SE | S11.008 | penicillin-binding protein 5-type peptidase | complex with peptide-mimetic penicillin | 3BEC |
| SE | S11.008 | penicillin-binding protein 5-type peptidase | 3MZD | |
| SE | S11.008 | penicillin-binding protein 5-type peptidase | 3MZE | |
| SE | S11.008 | penicillin-binding protein 5-type peptidase | 3MZF | |
| SE | S11.008 | penicillin-binding protein 5-type peptidase | crystal structure of e. coli pbp5 with 2c | 5J8X_A |
| SE | S11.009 | penicillin-binding protein 6b-type peptidase | 5FSR_A | |
| SE | S11.010 | penicillin-binding protein 4 (Staphylococcus-type) peptidase | 1TVF_A | |
| SE | S11.A01 | penP g.p. (Bacillus subtilis) | promiscuous protein self-assembly as a function of protein stability | 5NPO_B |
| SE | S11.A01 | penP g.p. (Bacillus subtilis) | crystal structure of class a beta-lactamase from clostridium kluyveri dsm 555 | 6NJ1_A |
| SE | S11.A01 | penP g.p. (Bacillus subtilis) | beta-lactamase penicillinase from bacillus megaterium | 6MU9_A |
| SE | S11.UNW | family S11 non-peptidase homologues | crystal structure of a halotolerant bacterial beta-lactamase | 3LEZ_A |
| SE | S11.UPW | family S11 unassigned peptidases | 3A3J | |
| SE | S11.UPW | family S11 unassigned peptidases | crystal structure of penicillin-binding protein d2 from listeria monocytogenes in the apo form | 5ZQA_A |
| SE | S11.UPW | family S11 unassigned peptidases | crystal structure of penicillin-binding protein d2 from listeria monocytogenes in the penicillin g bound form | 5ZQB_A |
| SE | S11.UPW | family S11 unassigned peptidases | crystal structure of penicillin-binding protein d2 from listeria monocytogenes in the ampicillin bound form | 5ZQC_A |
| SE | S11.UPW | family S11 unassigned peptidases | crystal structure of penicillin-binding protein d2 from listeria monocytogenes in the cefotaxime bound form | 5ZQD_A |
| SE | S11.UPW | family S11 unassigned peptidases | crystal structure of penicillin-binding protein d2 from listeria monocytogenes in the cefuroxime bound form | 5ZQE_A |
| SE | S11.UPW | family S11 unassigned peptidases | complex with meropenem | 4PPR_A |
| SE | S11.UPW | family S11 unassigned peptidases | crystal structure of an evolved putative penicillin-binding protein homolog, rv2911, from mycobacterium tuberculosis | 4P0M_A |
| SE | S11.UPW | family S11 unassigned peptidases | the crystal structure of d-alanyl-d-alanine carboxypeptidase from mycobacterium tuberculosis h37rv | 4RYE_A |
| SE | S11.UPW | family S11 unassigned peptidases | crystal structure of the d-alanyl-d-alanine carboxypeptidase dacd fromfrancisella tularensis | 6OSU_A |
| SE | S11.UPW | family S11 unassigned peptidases | structural, thermodynamic and kinetic analysis of the picomolar binding affinity interaction of the beta-lactamase inhibitor protein-ii (blip-ii) with class a beta-lactamases | 3QHY_A |
| SE | S11.UPW | family S11 unassigned peptidases | complex with isocitrate | 1W7F_A |
| SE | S11.UPW | family S11 unassigned peptidases | crystal structure of the class a beta-lactamase bs3 inhibited by 6-beta-iodopenicillanate. | 2WK0_A |
| SE | S11.UPW | family S11 unassigned peptidases | structural basis for the interaction of lactivicins with serine beta-lactamases | 2X71_A |
| SE | S11.UPW | family S11 unassigned peptidases | crystal structure of class a beta-lactamase from bacillus licheniformis bs3 with clavulanic acid | 2Y91_A |
| SE | S11.UPW | family S11 unassigned peptidases | crystal structure of class a beta-lactamase of bacillus licheniformis bs3 with aminocitrate | 3B3X_A |
| SE | S11.UPW | family S11 unassigned peptidases | crystal structure of class a beta-lactamase from bacillus licheniformis bs3 with tazobactam | 4A5R_A |
| SE | S12.001 | D-Ala-D-Ala carboxypeptidase B | 1CEF | |
| SE | S12.001 | D-Ala-D-Ala carboxypeptidase B | complex with cephalothin | 1CEG |
| SE | S12.001 | D-Ala-D-Ala carboxypeptidase B | complex with a cephalosporin analogue of cell wall peptidoglycan | 1HVB |
| SE | S12.001 | D-Ala-D-Ala carboxypeptidase B | complex with a specific peptidoglycan substrate fragment | 1IKG_A |
| SE | S12.001 | D-Ala-D-Ala carboxypeptidase B | complex with the products of a specific peptidoglycan substrate fragment | 1IKI_A |
| SE | S12.001 | D-Ala-D-Ala carboxypeptidase B | phosphonate-inhibited | 1MPL_A |
| SE | S12.001 | D-Ala-D-Ala carboxypeptidase B | complex with penicillin | 1PW1 |
| SE | S12.001 | D-Ala-D-Ala carboxypeptidase B | complex with cephalosporin | 1PW8 |
| SE | S12.001 | D-Ala-D-Ala carboxypeptidase B | complex with penicillin G | 1PWC |
| SE | S12.001 | D-Ala-D-Ala carboxypeptidase B | complex with cephalosporin C | 1PWD |
| SE | S12.001 | D-Ala-D-Ala carboxypeptidase B | complex with penicillin | 1PWG |
| SE | S12.001 | D-Ala-D-Ala carboxypeptidase B | complex with monocyclic phosphate inhibitor (2Z)-3-[oxido(oxo)phosphino]oxy-2-phenylacrylate | 1SCW_A |
| SE | S12.001 | D-Ala-D-Ala carboxypeptidase B | complex with bicyclic phosphate inhibitor 2-[(dioxidophosphino)oxy]benzoate | 1SDE_A |
| SE | S12.001 | D-Ala-D-Ala carboxypeptidase B | inhibition of the r61 dd-peptidase by n-benzoyl-beta-sultam | 1YQS_A |
| SE | S12.001 | D-Ala-D-Ala carboxypeptidase B | 2PTE | |
| SE | S12.001 | D-Ala-D-Ala carboxypeptidase B | 3PTE | |
| SE | S12.001 | D-Ala-D-Ala carboxypeptidase B | 1CEF_A | |
| SE | S12.001 | D-Ala-D-Ala carboxypeptidase B | 1CEG_A | |
| SE | S12.001 | D-Ala-D-Ala carboxypeptidase B | 1HVB_A | |
| SE | S12.001 | D-Ala-D-Ala carboxypeptidase B | 1IKG | |
| SE | S12.001 | D-Ala-D-Ala carboxypeptidase B | 1IKI | |
| SE | S12.001 | D-Ala-D-Ala carboxypeptidase B | 1MPL | |
| SE | S12.001 | D-Ala-D-Ala carboxypeptidase B | 1PW1_A | |
| SE | S12.001 | D-Ala-D-Ala carboxypeptidase B | 1PW8_A | |
| SE | S12.001 | D-Ala-D-Ala carboxypeptidase B | 1PWC_A | |
| SE | S12.001 | D-Ala-D-Ala carboxypeptidase B | 1PWD_A | |
| SE | S12.001 | D-Ala-D-Ala carboxypeptidase B | 1PWG_A | |
| SE | S12.001 | D-Ala-D-Ala carboxypeptidase B | 1SCW | |
| SE | S12.001 | D-Ala-D-Ala carboxypeptidase B | 1SDE | |
| SE | S12.001 | D-Ala-D-Ala carboxypeptidase B | 1YQS | |
| SE | S12.001 | D-Ala-D-Ala carboxypeptidase B | 3PTE_A | |
| SE | S12.002 | aminopeptidase DmpB | 1EI5_A | |
| SE | S12.003 | alkaline D-peptidase | 4Y7P | |
| SE | S12.003 | alkaline D-peptidase | crystal structure of d-stereospecific amidohydrolase from streptomycessp. 82f2 | 3WWX_A |
| SE | S12.006 | class C beta-lactamase | complex with (p-iodophenylacetylamino)methylphosphinic acid | 1BLS |
| SE | S12.006 | class C beta-lactamase | complex with a cephalosporin sulfone inhibitor | 1GA0_A |
| SE | S12.006 | class C beta-lactamase | 1GCE_A | |
| SE | S12.006 | class C beta-lactamase | gc1 beta-lactamase with a penem inhibitor | 1ONH_A |
| SE | S12.006 | class C beta-lactamase | complex with penem way185229 | 1Q2Q_A |
| SE | S12.006 | class C beta-lactamase | 1RGZ | |
| SE | S12.006 | class C beta-lactamase | complex with iodo-acetamido-phenyl boronic acid | 1S6R_A |
| SE | S12.006 | class C beta-lactamase | 1XX2 | |
| SE | S12.006 | class C beta-lactamase | 1Y54 | |
| SE | S12.006 | class C beta-lactamase | homodimer | 2BLT |
| SE | S12.006 | class C beta-lactamase | 2Q9M | |
| SE | S12.006 | class C beta-lactamase | 2Q9N | |
| SE | S12.006 | class C beta-lactamase | 3S4X | |
| SE | S12.006 | class C beta-lactamase | 4XUX | |
| SE | S12.006 | class C beta-lactamase | Ser64Gly mutant | 5HAI_A |
| SE | S12.006 | class C beta-lactamase | complex with a penicillin derivative mpc-1 | 5XHR_A |
| SE | S12.006 | class C beta-lactamase | 1C3B | |
| SE | S12.006 | class C beta-lactamase | 1FCM | |
| SE | S12.006 | class C beta-lactamase | 1FCN | |
| SE | S12.006 | class C beta-lactamase | 1FCO | |
| SE | S12.006 | class C beta-lactamase | 1FSW | |
| SE | S12.006 | class C beta-lactamase | 1FSY | |
| SE | S12.006 | class C beta-lactamase | 1GA9 | |
| SE | S12.006 | class C beta-lactamase | 1I5Q | |
| SE | S12.006 | class C beta-lactamase | 1IEL | |
| SE | S12.006 | class C beta-lactamase | 1IEM | |
| SE | S12.006 | class C beta-lactamase | 1KDS | |
| SE | S12.006 | class C beta-lactamase | 1KDW | |
| SE | S12.006 | class C beta-lactamase | 1KE0 | |
| SE | S12.006 | class C beta-lactamase | 1KE3 | |
| SE | S12.006 | class C beta-lactamase | 1KE4 | |
| SE | S12.006 | class C beta-lactamase | 1KVL | |
| SE | S12.006 | class C beta-lactamase | 1KVM | |
| SE | S12.006 | class C beta-lactamase | 1L0D | |
| SE | S12.006 | class C beta-lactamase | 1L0E | |
| SE | S12.006 | class C beta-lactamase | 1L0F | |
| SE | S12.006 | class C beta-lactamase | 1L0G | |
| SE | S12.006 | class C beta-lactamase | 1L2S | |
| SE | S12.006 | class C beta-lactamase | 1LL5 | |
| SE | S12.006 | class C beta-lactamase | 1LL9 | |
| SE | S12.006 | class C beta-lactamase | 1LLB | |
| SE | S12.006 | class C beta-lactamase | 1MXO | |
| SE | S12.006 | class C beta-lactamase | 1MY8 | |
| SE | S12.006 | class C beta-lactamase | 1O07 | |
| SE | S12.006 | class C beta-lactamase | 1PI4 | |
| SE | S12.006 | class C beta-lactamase | 1PI5 | |
| SE | S12.006 | class C beta-lactamase | 1XGI | |
| SE | S12.006 | class C beta-lactamase | 1XGJ | |
| SE | S12.006 | class C beta-lactamase | 2BLS | |
| SE | S12.006 | class C beta-lactamase | 2FFY | |
| SE | S12.006 | class C beta-lactamase | 2HDQ | |
| SE | S12.006 | class C beta-lactamase | 2HDR | |
| SE | S12.006 | class C beta-lactamase | 2HDS | |
| SE | S12.006 | class C beta-lactamase | 2HDU | |
| SE | S12.006 | class C beta-lactamase | 2I72 | |
| SE | S12.006 | class C beta-lactamase | 2P9V | |
| SE | S12.006 | class C beta-lactamase | 2PU2 | |
| SE | S12.006 | class C beta-lactamase | 2PU4 | |
| SE | S12.006 | class C beta-lactamase | 2R9W | |
| SE | S12.006 | class C beta-lactamase | 2R9X | |
| SE | S12.006 | class C beta-lactamase | 2RCX | |
| SE | S12.006 | class C beta-lactamase | tripeptide deletion (Gly286 Ser287 Asp288) on the h10 helix | 2ZJ9_A |
| SE | S12.006 | class C beta-lactamase | 3BLS | |
| SE | S12.006 | class C beta-lactamase | 3BM6 | |
| SE | S12.006 | class C beta-lactamase | 3FKV | |
| SE | S12.006 | class C beta-lactamase | 3FKW | |
| SE | S12.006 | class C beta-lactamase | 3GQZ | |
| SE | S12.006 | class C beta-lactamase | 3GR2 | |
| SE | S12.006 | class C beta-lactamase | 3GRJ | |
| SE | S12.006 | class C beta-lactamase | 3GSG | |
| SE | S12.006 | class C beta-lactamase | 3GTC | |
| SE | S12.006 | class C beta-lactamase | 3GV9 | |
| SE | S12.006 | class C beta-lactamase | 3GVB | |
| SE | S12.006 | class C beta-lactamase | 3IWI | |
| SE | S12.006 | class C beta-lactamase | 3IWO | |
| SE | S12.006 | class C beta-lactamase | 3IWQ | |
| SE | S12.006 | class C beta-lactamase | 3IXB | |
| SE | S12.006 | class C beta-lactamase | 3IXD | |
| SE | S12.006 | class C beta-lactamase | 3IXG | |
| SE | S12.006 | class C beta-lactamase | 3IXH | |
| SE | S12.006 | class C beta-lactamase | 3O86 | |
| SE | S12.006 | class C beta-lactamase | 3O87 | |
| SE | S12.006 | class C beta-lactamase | 3O88 | |
| SE | S12.006 | class C beta-lactamase | 4E3I | |
| SE | S12.006 | class C beta-lactamase | 4E3J | |
| SE | S12.006 | class C beta-lactamase | 4E3K | |
| SE | S12.006 | class C beta-lactamase | 4E3L | |
| SE | S12.006 | class C beta-lactamase | 4E3M | |
| SE | S12.006 | class C beta-lactamase | 4E3N | |
| SE | S12.006 | class C beta-lactamase | 4E3O | |
| SE | S12.006 | class C beta-lactamase | 4JXG | |
| SE | S12.006 | class C beta-lactamase | 4JXS | |
| SE | S12.006 | class C beta-lactamase | 4JXV | |
| SE | S12.006 | class C beta-lactamase | 4JXW | |
| SE | S12.006 | class C beta-lactamase | 4KEN | |
| SE | S12.006 | class C beta-lactamase | 4KG2 | |
| SE | S12.006 | class C beta-lactamase | 4KG5 | |
| SE | S12.006 | class C beta-lactamase | 4KG6 | |
| SE | S12.006 | class C beta-lactamase | 4KZ3 | |
| SE | S12.006 | class C beta-lactamase | 4KZ4 | |
| SE | S12.006 | class C beta-lactamase | 4KZ5 | |
| SE | S12.006 | class C beta-lactamase | 4KZ6 | |
| SE | S12.006 | class C beta-lactamase | 4KZ7 | |
| SE | S12.006 | class C beta-lactamase | 4KZ8 | |
| SE | S12.006 | class C beta-lactamase | 4KZ9 | |
| SE | S12.006 | class C beta-lactamase | 4KZA | |
| SE | S12.006 | class C beta-lactamase | 4KZB | |
| SE | S12.006 | class C beta-lactamase | 4LV0 | |
| SE | S12.006 | class C beta-lactamase | 4LV1 | |
| SE | S12.006 | class C beta-lactamase | 4LV2 | |
| SE | S12.006 | class C beta-lactamase | 4LV3 | |
| SE | S12.006 | class C beta-lactamase | 4OKP | |
| SE | S12.006 | class C beta-lactamase | 4OLD | |
| SE | S12.006 | class C beta-lactamase | 4OLG | |
| SE | S12.006 | class C beta-lactamase | crystal structure of a class c beta lactamase | 5F1G_A |
| SE | S12.006 | class C beta-lactamase | crystal structure of class c beta-lactamase | 5GGW_A |
| SE | S12.006 | class C beta-lactamase | crystal structure of ampc ber | 5GZW_A |
| SE | S12.006 | class C beta-lactamase | crystal structure of the s61a mutant of ampc ber | 5JOC_A |
| SE | S12.006 | class C beta-lactamase | complex with nanomolar inhibitor | 6DPT_A |
| SE | S12.006 | class C beta-lactamase | complex with inhibitor | 6DPX_A |
| SE | S12.006 | class C beta-lactamase | complex with inhibitor | 6DPY_A |
| SE | S12.006 | class C beta-lactamase | complex with inhibitor | 6DPZ_A |
| SE | S12.006 | class C beta-lactamase | beta-lactamase from escherichia coli str. sakai | 6N9K_A |
| SE | S12.006 | class C beta-lactamase | 1FR1_A | |
| SE | S12.006 | class C beta-lactamase | 1FR6_A | |
| SE | S12.006 | class C beta-lactamase | 1RGY | |
| SE | S12.006 | class C beta-lactamase | crystal structure of class c beta-lactamase mox-1 | 3W8K_A |
| SE | S12.006 | class C beta-lactamase | complex with aztorenam | 4WBG_A |
| SE | S12.006 | class C beta-lactamase | complex with a boronic acid transition state inhibitor s02030 | 5ZYB_A |
| SE | S12.006 | class C beta-lactamase | crystal structure of cmy-136 class c beta-lactamase | 6G9T_A |
| SE | S12.006 | class C beta-lactamase | crystal structure of fox-4 cephamycinase | 5CGS_A |
| SE | S12.006 | class C beta-lactamase | crystal structure of fox-4 cephamycinase mutant y150f | 5CGW_A |
| SE | S12.006 | class C beta-lactamase | Tyr150Phe mutant; complex with cefoxitin | 5CGX_A |
| SE | S12.006 | class C beta-lactamase | complex with cephalothin batsi (sm23) | 5CHJ_A |
| SE | S12.006 | class C beta-lactamase | complex with ceftazidime batsi (lp06) | 5CHM_A |
| SE | S12.006 | class C beta-lactamase | complex with sulfate | 5CHU_A |
| SE | S12.006 | class C beta-lactamase | complex with avibactam | 5ZA2_A |
| SE | S12.006 | class C beta-lactamase | crystal structure of class c beta-lactamase act-1 | 2ZC7_A |
| SE | S12.006 | class C beta-lactamase | complex with a citrate molecule | 1ZC2_A |
| SE | S12.006 | class C beta-lactamase | structural basis for the extended substrate spectrum of cmy- 10, a plasmid-encoded class c beta-lactamase | 1ZKJ_A |
| SE | S12.006 | class C beta-lactamase | crystal structure of a class c beta lactamase | 5F1F_A |
| SE | S12.006 | class C beta-lactamase | crystal structure of a class c beta lactamase of apo form | 5GSC_A |
| SE | S12.006 | class C beta-lactamase | complex with compound1 | 5K1D_A |
| SE | S12.006 | class C beta-lactamase | complex with compound2 | 5K1F_A |
| SE | S12.006 | class C beta-lactamase | crystal structure of adc-1 beta-lactamase | 4NET_A |
| SE | S12.006 | class C beta-lactamase | structure of adc-68, a novel carbapenem-hydrolyzing class c extended- spectrum -lactamase from acinetobacter baumannii | 4QD4_A |
| SE | S12.006 | class C beta-lactamase | crystal structure of adc-7 beta-lactamase | 4U0T_A |
| SE | S12.006 | class C beta-lactamase | complex with boronic acid inhibitor s02030 | 4U0X_B |
| SE | S12.006 | class C beta-lactamase | complex with boronic acid transition state inhibitor ec04 | 5W12_A |
| SE | S12.006 | class C beta-lactamase | complex with boronic acid transition state inhibitor sm23 | 5W13_A |
| SE | S12.006 | class C beta-lactamase | complex with boronic acid transition state inhibitor s03043 | 5W14_A |
| SE | S12.006 | class C beta-lactamase | complex with boronic acid transition state inhibitor cr157 | 5WAC_A |
| SE | S12.006 | class C beta-lactamase | complex with boronic acid transition state inhibitor cr161 | 5WAD_A |
| SE | S12.006 | class C beta-lactamase | complex with boronic acid transition state inhibitor cr167 | 5WAE_A |
| SE | S12.006 | class C beta-lactamase | complex with boronic acid transition state inhibitor cr192 | 5WAF_A |
| SE | S12.006 | class C beta-lactamase | complex with boronic acid transition state inhibitor s06017 | 5WAG_B |
| SE | S12.006 | class C beta-lactamase | crystal structure of beta-lactamase/d-alanine carboxypeptidase from pseudomonas syringae | 5EVI_A |
| SE | S12.006 | class C beta-lactamase | crystal structure of beta-lactamase/d-alanine carboxypeptidase from chromobacterium violaceum | 5EVL_A |
| SE | S12.006 | class C beta-lactamase | crystal structure of d-alanine carboxypeptidase ampc from burkholderiacenocepacia | 5E2G_A |
| SE | S12.006 | class C beta-lactamase | crystal structure of d-alanine carboxypeptidase ampc from mycobacterium smegmatis | 5E2H_A |
| SE | S12.006 | class C beta-lactamase | wild type beta-lactamase derived from chromohalobacter sp.560 | 3WRT_A |
| SE | S12.006 | class C beta-lactamase | n288q-n321q mutant beta-lactamase derived from chromohalobacter sp.560(without soaking) | 3WRZ_A |
| SE | S12.006 | class C beta-lactamase | n288q-n321q mutant beta-lactamase derived from chromohalobacter sp.560(condition-1a) | 3WS0_A |
| SE | S12.006 | class C beta-lactamase | n288q-n321q mutant beta-lactamase derived from chromohalobacter sp.560(condition-1b) | 3WS1_A |
| SE | S12.006 | class C beta-lactamase | n288q-n321q mutant beta-lactamase derived from chromohalobacter sp.560(condition-1c) | 3WS2_A |
| SE | S12.006 | class C beta-lactamase | n288q-n321q mutant beta-lactamase derived from chromohalobacter sp.560(condition-2a) | 3WS4_A |
| SE | S12.006 | class C beta-lactamase | n288q-n321q mutant beta-lactamase derived from chromohalobacter sp.560(condition-2b) | 3WS5_A |
| SE | S12.006 | class C beta-lactamase | crystal structure of the class c beta-lactamase tru-1 from aeromonas enteropelogenes | 6FM6_A |
| SE | S12.006 | class C beta-lactamase | complex with avibactam | 6FM7_A |
| SE | S12.008 | Pab87 peptidase | 2QMI | |
| SE | S12.010 | colibactin peptidase (Escherichia-type) | 3O3V | |
| SE | S12.011 | XcnG peptidase (Xenorhabdus nematophila) | structure of fmta-like protein | 4GDN_A |
| SE | S12.012 | AmpH protein (Escherichia-type) | crystal structure of beta-lactamase/d-alanine carboxypeptidase from yersinia pestis | 3OZH_A |
| SE | S12.012 | AmpH protein (Escherichia-type) | complex with citrate | 3RJU_A |
| SE | S12.950 | esterase EstB | 1CI8_A | |
| SE | S12.950 | esterase EstB | DFP-inhibited | 1CI9_A |
| SE | S12.951 | D-amino acid amidase (Ochrobactrum anthropi-type) | complex with D-Phe | 2DNS_A |
| SE | S12.951 | D-amino acid amidase (Ochrobactrum anthropi-type) | 2DRW_A | |
| SE | S12.951 | D-amino acid amidase (Ochrobactrum anthropi-type) | complex with L-Phe | 2EFU_A |
| SE | S12.951 | D-amino acid amidase (Ochrobactrum anthropi-type) | complex with L-Phe-NH2 | 2EFX_A |
| SE | S12.UPW | family S12 unassigned peptidases | 2WZX | |
| SE | S12.UPW | family S12 unassigned peptidases | 2WZZ | |
| SE | S12.UPW | family S12 unassigned peptidases | 3S1Y | |
| SE | S12.UPW | family S12 unassigned peptidases | 3S22 | |
| SE | S12.UPW | family S12 unassigned peptidases | 4GZB | |
| SE | S12.UPW | family S12 unassigned peptidases | 4HEF | |
| SE | S12.UPW | family S12 unassigned peptidases | 4NK3 | |
| SE | S12.UPW | family S12 unassigned peptidases | 4OOY | |
| SE | S12.UPW | family S12 unassigned peptidases | 4WYY | |
| SE | S12.UPW | family S12 unassigned peptidases | 4WZ4 | |
| SE | S12.UPW | family S12 unassigned peptidases | 4X68 | |
| SE | S12.UPW | family S12 unassigned peptidases | the crystal structure of penicillin binding protein from bacillus halodurans | 3TG9_A |
| SE | S12.UPW | family S12 unassigned peptidases | putative 6-aminohexanoate-dimer hydrolase from bacillus anthracis | 4GB7_A |
| SE | S12.UPW | family S12 unassigned peptidases | 3HL9 | |
| SE | S12.UPW | family S12 unassigned peptidases | 3HLB | |
| SE | S12.UPW | family S12 unassigned peptidases | 3HLC | |
| SE | S12.UPW | family S12 unassigned peptidases | 3HLD | |
| SE | S12.UPW | family S12 unassigned peptidases | 3HLE | |
| SE | S12.UPW | family S12 unassigned peptidases | 3HLF | |
| SE | S12.UPW | family S12 unassigned peptidases | 3HLG | |
| SE | S12.UPW | family S12 unassigned peptidases | 4LCL | |
| SE | S12.UPW | family S12 unassigned peptidases | 4LCM | |
| SE | S12.UPW | family S12 unassigned peptidases | structure determination of esta from arthrobacter nitroguajacolicus rue61a | 3ZYT_A |
| SE | S12.UPW | family S12 unassigned peptidases | 1WYB | |
| SE | S12.UPW | family S12 unassigned peptidases | 1WYC | |
| SE | S12.UPW | family S12 unassigned peptidases | 2DCF | |
| SE | S12.UPW | family S12 unassigned peptidases | 2E8I_A | |
| SE | S12.UPW | family S12 unassigned peptidases | 2ZLY_A | |
| SE | S12.UPW | family S12 unassigned peptidases | 2ZM0_A | |
| SE | S12.UPW | family S12 unassigned peptidases | 2ZM2_A | |
| SE | S12.UPW | family S12 unassigned peptidases | 2ZM7_A | |
| SE | S12.UPW | family S12 unassigned peptidases | 2ZM8_A | |
| SE | S12.UPW | family S12 unassigned peptidases | 2ZM9_A | |
| SE | S12.UPW | family S12 unassigned peptidases | 2ZMA_A | |
| SE | S12.UPW | family S12 unassigned peptidases | 3A65_A | |
| SE | S12.UPW | family S12 unassigned peptidases | 3A66_A | |
| SE | S12.UPW | family S12 unassigned peptidases | 3VWL | |
| SE | S12.UPW | family S12 unassigned peptidases | 3VWM | |
| SE | S12.UPW | family S12 unassigned peptidases | 3VWN | |
| SE | S12.UPW | family S12 unassigned peptidases | 3VWP | |
| SE | S12.UPW | family S12 unassigned peptidases | 3VWQ | |
| SE | S12.UPW | family S12 unassigned peptidases | 3VWR | |
| SE | S12.UPW | family S12 unassigned peptidases | crystal structure of a family viii carboxylesterase. | 4IVI_A |
| SE | S12.UPW | family S12 unassigned peptidases | complex with cephalothin. | 4IVK_A |
| SE | S12.UPW | family S12 unassigned peptidases | crystal structure of a novel penicillin-binding protein (pbp) homolog from caulobacter crescentus | 5GKV_A |
| SE | S12.UPW | family S12 unassigned peptidases | crystal structure of putative beta-lactamase from bacteroides dorei dsm 17855 | 5TGF_A |
| SE | S12.UPW | family S12 unassigned peptidases | 3VWL_A | |
| SE | S12.UPW | family S12 unassigned peptidases | 3VWM_A | |
| SE | S12.UPW | family S12 unassigned peptidases | 3VWN_X | |
| SE | S12.UPW | family S12 unassigned peptidases | 3VWP_A | |
| SE | S12.UPW | family S12 unassigned peptidases | 3VWQ_A | |
| SE | S12.UPW | family S12 unassigned peptidases | 3VWR_A | |
| SE | S13.001 | D-Ala-D-Ala peptidase C | 2EX2_A | |
| SE | S13.001 | D-Ala-D-Ala peptidase C | complex with ampicillin | 2EX6_A |
| SE | S13.001 | D-Ala-D-Ala peptidase C | complex with penicillin-G | 2EX8_A |
| SE | S13.001 | D-Ala-D-Ala peptidase C | complex with penicillin-V | 2EX9_A |
| SE | S13.001 | D-Ala-D-Ala peptidase C | complex with Farom | 2EXA_A |
| SE | S13.001 | D-Ala-D-Ala peptidase C | complex with Flomox | 2EXB_A |
| SE | S13.001 | D-Ala-D-Ala peptidase C | 3A3D | |
| SE | S13.001 | D-Ala-D-Ala peptidase C | 3A3E | |
| SE | S13.001 | D-Ala-D-Ala peptidase C | 3A3F | |
| SE | S13.001 | D-Ala-D-Ala peptidase C | 3A3I | |
| SE | S13.002 | D-Ala-D-Ala carboxypeptidase (Actinomadura-type) | 1W79 | |
| SE | S13.002 | D-Ala-D-Ala carboxypeptidase (Actinomadura-type) | 1W8Q | |
| SE | S13.002 | D-Ala-D-Ala carboxypeptidase (Actinomadura-type) | 1W8Y_A | |
| SE | S13.002 | D-Ala-D-Ala carboxypeptidase (Actinomadura-type) | complex with peptidoglycan-mimetic cephalosporin | 2VGJ |
| SE | S13.002 | D-Ala-D-Ala carboxypeptidase (Actinomadura-type) | complex with peptidoglycan-mimetic cephalosporin | 2VGK |
| SE | S13.002 | D-Ala-D-Ala carboxypeptidase (Actinomadura-type) | 2WKE | |
| SE | S13.002 | D-Ala-D-Ala carboxypeptidase (Actinomadura-type) | 2XDM | |
| SE | S13.002 | D-Ala-D-Ala carboxypeptidase (Actinomadura-type) | 2XK1 | |
| SE | S13.002 | D-Ala-D-Ala carboxypeptidase (Actinomadura-type) | 2XLN | |
| SE | S13.002 | D-Ala-D-Ala carboxypeptidase (Actinomadura-type) | 2Y4A | |
| SE | S13.002 | D-Ala-D-Ala carboxypeptidase (Actinomadura-type) | 2Y55 | |
| SE | S13.002 | D-Ala-D-Ala carboxypeptidase (Actinomadura-type) | 2Y59 | |
| SE | S13.002 | D-Ala-D-Ala carboxypeptidase (Actinomadura-type) | 3ZCZ | |
| SE | S13.002 | D-Ala-D-Ala carboxypeptidase (Actinomadura-type) | 3ZVT | |
| SE | S13.002 | D-Ala-D-Ala carboxypeptidase (Actinomadura-type) | 3ZVW | |
| SE | S13.002 | D-Ala-D-Ala carboxypeptidase (Actinomadura-type) | 4B4X | |
| SE | S13.002 | D-Ala-D-Ala carboxypeptidase (Actinomadura-type) | 4B4Z | |
| SE | S13.002 | D-Ala-D-Ala carboxypeptidase (Actinomadura-type) | 4BEN | |
| SE | S13.002 | D-Ala-D-Ala carboxypeptidase (Actinomadura-type) | 1W5D_A | |
| SE | S13.002 | D-Ala-D-Ala carboxypeptidase (Actinomadura-type) | complex with a peptidoglycan mimetic peptide. | 2J9P_A |
| SE | S13.005 | Bd3459 D-alanyl-D-alanine carboxypeptidase (Bdellovibrio bacteriovorus) | complex with immunity protein bd3460 | 5CER_A |
| SE | S13.005 | Bd3459 D-alanyl-D-alanine carboxypeptidase (Bdellovibrio bacteriovorus) | bd3459, a predatory peptidoglycan endopeptidase from bdellovibrio bacteriovorus | 3V39_A |
| SE | S13.005 | Bd3459 D-alanyl-D-alanine carboxypeptidase (Bdellovibrio bacteriovorus) | bd3459 predatory endopeptidase from bdellovibrio bacteriovorus, k38m form | 5CEB_A |
| SE | S13.005 | Bd3459 D-alanyl-D-alanine carboxypeptidase (Bdellovibrio bacteriovorus) | complex with immunity protein bd3460 | 5CEC_A |
| SE | S13.005 | Bd3459 D-alanyl-D-alanine carboxypeptidase (Bdellovibrio bacteriovorus) | penicillin g acylated bd3459 predatory endopeptidase from bdellovibriobacteriovorus in complex with immunity protein bd3460 ***caveat 5ced pnm a 501 has wrong chirality at atom c6 | 5CED_A |
| SK | S14.001 | peptidase Clp (type 1) | homotetradecamer | 1TYF_A |
| SK | S14.001 | peptidase Clp (type 1) | clpp | 1YG6_A |
| SK | S14.001 | peptidase Clp (type 1) | crystal structure of e. coli clpp with a peptide chloromethyl ketone covalently bound at the active site | 2FZS_A |
| SK | S14.001 | peptidase Clp (type 1) | crystal structure of clpp a153c mutant with inter-heptamer disulfide bonds | 3HLN_A |
| SK | S14.001 | peptidase Clp (type 1) | complex with adep1 | 3MT6_R |
| SK | S14.001 | peptidase Clp (type 1) | 3KTG | |
| SK | S14.001 | peptidase Clp (type 1) | 3KTH | |
| SK | S14.001 | peptidase Clp (type 1) | 3KTI | |
| SK | S14.001 | peptidase Clp (type 1) | 3KTJ | |
| SK | S14.001 | peptidase Clp (type 1) | 3KTK | |
| SK | S14.001 | peptidase Clp (type 1) | 3TT6 | |
| SK | S14.001 | peptidase Clp (type 1) | 3TT7 | |
| SK | S14.001 | peptidase Clp (type 1) | 2ZL0_A | |
| SK | S14.001 | peptidase Clp (type 1) | complex with the peptide NVLGFTQ | 2ZL2_A |
| SK | S14.001 | peptidase Clp (type 1) | Ser99Ala mutant | 2ZL3_A |
| SK | S14.001 | peptidase Clp (type 1) | Ser99Ala mutant; complex with the peptide (Ala)4 | 2ZL4_A |
| SK | S14.001 | peptidase Clp (type 1) | 4JCT | |
| SK | S14.001 | peptidase Clp (type 1) | complex with ClpP1 | 4RYF_H |
| SK | S14.001 | peptidase Clp (type 1) | complex with agonist adepa54556. | 5DKP_A |
| SK | S14.001 | peptidase Clp (type 1) | crystal structure of clpp from staphylococcus aureus | 3QWD_A |
| SK | S14.001 | peptidase Clp (type 1) | 3ST9 | |
| SK | S14.001 | peptidase Clp (type 1) | 3STA | |
| SK | S14.001 | peptidase Clp (type 1) | crystal structure of clpp from staphylococcus aureus in the active, extended conformation | 3V5E_A |
| SK | S14.001 | peptidase Clp (type 1) | the crystal structure of the mutant clpp s98a (staphylococcus aureus) | 3V5I_A |
| SK | S14.001 | peptidase Clp (type 1) | 4EMM | |
| SK | S14.001 | peptidase Clp (type 1) | 4EMP | |
| SK | S14.001 | peptidase Clp (type 1) | clpp ser98dha | 4MXI_A |
| SK | S14.001 | peptidase Clp (type 1) | staphylococcus aureus clpp mutant - y63a | 5C90_A |
| SK | S14.001 | peptidase Clp (type 1) | complex with av145 | 5DL1_A |
| SK | S14.001 | peptidase Clp (type 1) | complex with acyldepsipeptide | 5VZ2_A |
| SK | S14.001 | peptidase Clp (type 1) | Val7Ala mutant | 6DKF_B |
| SK | S14.001 | peptidase Clp (type 1) | s. aureus clpp bound to anti-4a | 6N80_A |
| SK | S14.001 | peptidase Clp (type 1) | Ala153Pro mutant | 1Y7O |
| SK | S14.001 | peptidase Clp (type 1) | 4JCQ | |
| SK | S14.001 | peptidase Clp (type 1) | complex with ClpP2 | 4RYF_A |
| SK | S14.001 | peptidase Clp (type 1) | 3Q7H | |
| SK | S14.001 | peptidase Clp (type 1) | crystal structure of atp-dependent clp protease subunit p from francisella tularensis | 3P2L_A |
| SK | S14.001 | peptidase Clp (type 1) | compressed conformation of francisella tularensis clpp at 2.84 a | 5G1Q_A |
| SK | S14.001 | peptidase Clp (type 1) | open conformation of francisella tularensis clpp at 1.9 a | 5G1R_A |
| SK | S14.001 | peptidase Clp (type 1) | 1R99 | |
| SK | S14.001 | peptidase Clp (type 1) | crystal structure of clpp1 from clostridium difficile 630. | 6MX2_A |
| SK | S14.002 | peptidase Clp (type 2) | 1R8Z | |
| SK | S14.003 | peptidase Clp (type 3) | 1TG6_A | |
| SK | S14.003 | peptidase Clp (type 3) | complex with acyldepsipeptide adep-28 | 6BBA_A |
| SK | S14.003 | peptidase Clp (type 3) | complex with onc201 (tic10) | 6DL7_A |
| SK | S14.003 | peptidase Clp (type 3) | crystal structure of the hclpp y118a mutant with an activating small molecule | 6H23_A |
| SK | S14.006 | peptidase Clp (type 6) | 1R93 | |
| SK | S14.008 | ClpP1 peptidase (Streptomyces-type) | the 3.0 a resolution structure of caseinolytic clp protease 1 from mycobacterium tuberculosis | 2C8T_A |
| SK | S14.008 | ClpP1 peptidase (Streptomyces-type) | peptidase subunit only | 2CBY |
| SK | S14.008 | ClpP1 peptidase (Streptomyces-type) | peptidase subunit only | 2CE3 |
| SK | S14.008 | ClpP1 peptidase (Streptomyces-type) | crystal structure of m. tuberculosis clpp1p2 bound to adep and agonist | 4U0G_H |
| SK | S14.008 | ClpP1 peptidase (Streptomyces-type) | crystal structure of m. tuberculosis clpp1p1 | 4U0H_A |
| SK | S14.008 | ClpP1 peptidase (Streptomyces-type) | crystal structure of the active form of the proteolytic complex clpp1 and clpp2 | 5DZK_U |
| SK | S14.008 | ClpP1 peptidase (Streptomyces-type) | crystal structure of the active form of the proteolytic complex clpp1 and clpp2 | 5E0S_H |
| SK | S14.009 | ClpP2 peptidase (Streptomyces-type) | crystal structure of the active form of the proteolytic complex clpp1 and clpp2 | 5DZK_A |
| SK | S14.009 | ClpP2 peptidase (Streptomyces-type) | crystal structure of the active form of the proteolytic complex clpp1 and clpp2 | 5E0S_A |
| SK | S14.010 | ClpP4 peptidase (plant) | 1R91 | |
| SK | S14.011 | PFC0310c peptidase | catalytic domain | 2F6I_A |
| SK | S14.A01 | At1g02560 (Arabidopsis thaliana)-type peptidase | 1R92 | |
| SK | S14.A02 | At5g23140 (Arabidopsis thaliana)-type peptidase | 1R8V | |
| SK | S14.A03 | At1g66670 (Arabidopsis thaliana)-type peptidase | 1R90 | |
| SK | S14.UNW | family S14 non-peptidase homologues | 1R98 | |
| SK | S14.UNW | family S14 non-peptidase homologues | 1R97 | |
| SK | S14.UNW | family S14 non-peptidase homologues | 1R96 | |
| SK | S14.UPW | family S14 unassigned peptidases | 2K77 | |
| SK | S14.UPW | family S14 unassigned peptidases | 2Y1Q | |
| SK | S14.UPW | family S14 unassigned peptidases | 2Y1R | |
| SK | S14.UPW | family S14 unassigned peptidases | 3J3R | |
| SK | S14.UPW | family S14 unassigned peptidases | 3J3S | |
| SK | S14.UPW | family S14 unassigned peptidases | 3J3T | |
| SK | S14.UPW | family S14 unassigned peptidases | 3J3U | |
| SK | S14.UPW | family S14 unassigned peptidases | 3PXG | |
| SK | S14.UPW | family S14 unassigned peptidases | 3PXI | |
| SC | S15.001 | Xaa-Pro dipeptidyl-peptidase | 1LNS_A | |
| SC | S15.UNW | family S15 non-peptidase homologues | space group p3121 | 5G59_A |
| SC | S15.UNW | family S15 non-peptidase homologues | space group c2221 | 5G5C_A |
| SC | S15.UNW | family S15 non-peptidase homologues | space group p21 | 5G5M_A |
| SC | S15.UNW | family S15 non-peptidase homologues | structure of the pyrococcus furiosus esterase pf2001 with space group p212121 | 5LCN_A |
| SC | S15.UPW | family S15 unassigned peptidases | 1JU3 | |
| SC | S15.UPW | family S15 unassigned peptidases | 1JU4 | |
| SC | S15.UPW | family S15 unassigned peptidases | 1L7Q | |
| SC | S15.UPW | family S15 unassigned peptidases | 1L7R | |
| SC | S15.UPW | family S15 unassigned peptidases | 3I2F | |
| SC | S15.UPW | family S15 unassigned peptidases | 3I2G | |
| SC | S15.UPW | family S15 unassigned peptidases | 3I2H | |
| SC | S15.UPW | family S15 unassigned peptidases | 3I2I | |
| SC | S15.UPW | family S15 unassigned peptidases | 3I2J | |
| SC | S15.UPW | family S15 unassigned peptidases | 3I2K | |
| SC | S15.UPW | family S15 unassigned peptidases | 3IDA | |
| SC | S15.UPW | family S15 unassigned peptidases | 3PUH | |
| SC | S15.UPW | family S15 unassigned peptidases | 3PUI | |
| SC | S15.UPW | family S15 unassigned peptidases | 4P08 | |
| SJ | S16.001 | Lon-A peptidase | alpha-domain of atpase | 1QZM_A |
| SJ | S16.001 | Lon-A peptidase | catalytic domain only | 1RR9_A |
| SJ | S16.001 | Lon-A peptidase | proteolytic domain | 1RRE_A |
| SJ | S16.001 | Lon-A peptidase | 2ANE | |
| SJ | S16.001 | Lon-A peptidase | 3LJC | |
| SJ | S16.001 | Lon-A peptidase | 1X37 | |
| SJ | S16.001 | Lon-A peptidase | N-terminal domain | 3M65 |
| SJ | S16.001 | Lon-A peptidase | C-terminal domain | 3M6A |
| SJ | S16.001 | Lon-A peptidase | crystal structure of alpha sub-domain of lon protease from brevibacillus thermoruber | 4GIT_A |
| SJ | S16.002 | PIM1 peptidase | ON HOLD | 2X36 |
| SJ | S16.005 | Lon-B peptidase | proteolytic domain Glu506Ala mutant | 1Z0B_A |
| SJ | S16.005 | Lon-B peptidase | proteolytic domain Asp508Ala mutant | 1Z0C_A |
| SJ | S16.005 | Lon-B peptidase | proteolytic domain | 1Z0E_A |
| SJ | S16.005 | Lon-B peptidase | proteolytic domain | 1Z0G_A |
| SJ | S16.005 | Lon-B peptidase | proteolytic domain | 1Z0T_A |
| SJ | S16.005 | Lon-B peptidase | proteolytic domain | 1Z0V_A |
| SJ | S16.005 | Lon-B peptidase | proteolytic domain | 1Z0W_A |
| SJ | S16.007 | LonC peptidase | Leu91Met/Ile359Met mutant | 4FW9 |
| SJ | S16.007 | LonC peptidase | complex with N-[(1R)-1-(dihydroxyboryl)-3-methylbutyl]-N-(pyrazin-2-ylcarbonyl)-L-phenylalaninamide | 4FWD |
| SJ | S16.007 | LonC peptidase | complex with lactacystin | 4FWG |
| SJ | S16.007 | LonC peptidase | complex with N-[(benzyloxy)carbonyl]-L-leucyl-N-[(1R)- 1-(dihydroxyboranyl)-3-methylbutyl]-L-leucinamide | 4FWH |
| SJ | S16.008 | protease La (Methanocaldococcus-type) | 1XHK_A | |
| SJ | S16.012 | SepM peptidase (Streptococcus mutans) | 2KJP | |
| SJ | S16.A04 | DNA repair protein RadA (Escherichia coli) | crystal structure of the c-terminal lon protease-like domain of thermus thermophilus rada/sms | 5H45_A |
| SJ | S16.A11 | PF0467 (Pyrococcus furiosus) | 3K1J | |
| SH | S21.001 | assemblin | with di-isopropyl phosphate covalently bound to active site Ser129 | 1AT3_A |
| SH | S21.001 | assemblin | 4CX8 | |
| SH | S21.001 | assemblin | 4V07 | |
| SH | S21.001 | assemblin | 4V08 | |
| SH | S21.001 | assemblin | 4V0T | |
| SH | S21.002 | cytomegalovirus assemblin | 1CMV | |
| SH | S21.002 | cytomegalovirus assemblin | active site His157Gln mutant | 1ID4 |
| SH | S21.002 | cytomegalovirus assemblin | active site His157Ala mutant | 1IEC |
| SH | S21.002 | cytomegalovirus assemblin | active site His157Glu mutant | 1IED |
| SH | S21.002 | cytomegalovirus assemblin | active site Ser134Ala mutant | 1IEF |
| SH | S21.002 | cytomegalovirus assemblin | active site Ser134Ala/His157Ala double mutant | 1IEG |
| SH | S21.002 | cytomegalovirus assemblin | dimer interface Ser225Tyr mutant | 1JQ6 |
| SH | S21.002 | cytomegalovirus assemblin | dimer interface Ser225Tyr mutant; complex with BILC 408 inhibitor | 1JQ7 |
| SH | S21.002 | cytomegalovirus assemblin | Ala143Val mutant | 1LAY |
| SH | S21.002 | cytomegalovirus assemblin | complex with N-acetyl-L-valyl-3,3-dimethyl-L-alpha-aspartyl-N~4~,N~4~-dimethyl-N~1~-[(1R)-3,3,3-trifluoro-1-methyl-2-oxopropyl]-L-aspartamide | 1NJT |
| SH | S21.002 | cytomegalovirus assemblin | complex with N-(6-aminohexanoyl)-3-methyl-L-valyl-3-methyl- L-valyl-N~1~-[(2S,3S)-3-hydroxy-4-oxo-4-[(1R)- 1-phenylpropyl]aminobutan-2-yl]-N~4~,N~4~- dimethyl-L-aspartamide | 1NJU |
| SH | S21.002 | cytomegalovirus assemblin | complex with N-acetyl-L-valyl-3,3-dimethyl-L-alpha-aspartyl-N~4~,N~4~-dimethyl-N~1~-[(1R)-3,3,3-trifluoro-1-methyl-2-oxopropyl]-L-aspartamide | 1NKK |
| SH | S21.002 | cytomegalovirus assemblin | complex with N-(6-aminohexanoyl)-3-methyl-L-valyl-3-methyl-L-valyl-N~4~,N~4~-dimethyl-N~1~-[(1R)-1-methyl-2,3-dioxo-3-[(1S)-1- phenylpropyl]aminopropyl]-L-aspartamide | 1NKM |
| SH | S21.002 | cytomegalovirus assemblin | dimer | 1WPO |
| SH | S21.002 | cytomegalovirus assemblin | complex with des-amino-t-butyl-Gly-t-butyl-Gly-phenylAsn-Ala-BAC inhibitor | 2WPO |
| SH | S21.003 | Epstein-Barr virus-type assemblin | 1O6E | |
| SH | S21.005 | Varicella zoster assemblin | residues 10-236; Cys10Met mutant | 1VZV |
| SH | S21.006 | herpesvirus 8-type assemblin | 1FL1_A | |
| SH | S21.006 | herpesvirus 8-type assemblin | complex with hexapeptide phosphonate inhibitor | 2PBK |
| SH | S21.006 | herpesvirus 8-type assemblin | 4P2T | |
| SF | S24.001 | repressor LexA | lexa s119a c-terminal tryptic fragment | 1JHC_A |
| SF | S24.001 | repressor LexA | Leu89Pro, Gln92Trp, Glu152Ala and Lys156Ala mutant | 1JHE |
| SF | S24.001 | repressor LexA | Gly85Asp mutant | 1JHF_A |
| SF | S24.001 | repressor LexA | Ser119Ala mutant | 1JHH |
| SF | S24.001 | repressor LexA | 1LEA | |
| SF | S24.001 | repressor LexA | 1LEB | |
| SF | S24.001 | repressor LexA | theoretical model; dimer in complex with recA operator | 1MVD |
| SF | S24.001 | repressor LexA | theoretical model; complex with DNA | 1QAA |
| SF | S24.001 | repressor LexA | 3JSO | |
| SF | S24.001 | repressor LexA | 3JSP | |
| SF | S24.001 | repressor LexA | 3K3R | |
| SF | S24.001 | repressor LexA | 3K2Z | |
| SF | S24.002 | phage lambda repressor protein | C-terminal domain | 1F39 |
| SF | S24.002 | phage lambda repressor protein | 1GFX | |
| SF | S24.002 | phage lambda repressor protein | 1J5G | |
| SF | S24.002 | phage lambda repressor protein | 1KCA | |
| SF | S24.002 | phage lambda repressor protein | 1LLI | |
| SF | S24.002 | phage lambda repressor protein | 1LMB | |
| SF | S24.002 | phage lambda repressor protein | 1LRP | |
| SF | S24.002 | phage lambda repressor protein | 1LWQ | |
| SF | S24.002 | phage lambda repressor protein | 1RIO | |
| SF | S24.002 | phage lambda repressor protein | 3BDN | |
| SF | S24.002 | phage lambda repressor protein | 3KZ3 | |
| SF | S24.002 | phage lambda repressor protein | 3WOA | |
| SF | S24.002 | phage lambda repressor protein | 1ADR | |
| SF | S24.002 | phage lambda repressor protein | 1QAR | |
| SF | S24.002 | phage lambda repressor protein | 2R1J | |
| SF | S24.002 | phage lambda repressor protein | 3JXB | |
| SF | S24.002 | phage lambda repressor protein | 3JXC | |
| SF | S24.002 | phage lambda repressor protein | 3JXD | |
| SF | S24.002 | phage lambda repressor protein | structure of a hyper-cleavable monomeric fragment of phage lambda repressor containing the cleavage site region | 2HNF_A |
| SF | S24.002 | phage lambda repressor protein | structure of a hyper-cleavable monomeric fragment of phage lambda repressor containing the cleavage site region | 2HO0_A |
| SF | S24.003 | UmuD protein | UmuD'; selenomethionyl derivative | 1AY9 |
| SF | S24.003 | UmuD protein | NMR structure; Umud' homodimer | 1I4V |
| SF | S24.003 | UmuD protein | UmuD'; selenomethionyl derivative | 1UMU |
| SF | S24.UPW | family S24 unassigned peptidases | mycobacterium tuberculosis lexa c-domain i | 6A2Q_A |
| SF | S24.UPW | family S24 unassigned peptidases | mycobacterium tuberculosis lexa c-domain ii | 6A2R_A |
| SF | S24.UPW | family S24 unassigned peptidases | mycobacterium tuberculosis lexa c-domain s160a | 6A2S_A |
| SF | S24.UPW | family S24 unassigned peptidases | mycobacterium tuberculosis lexa c-domain k197a | 6A2T_A |
| SF | S26.001 | signal peptidase I | complex with beta-lactam inhibitor (5S,6S)-6-[(R)acetoxyeth-2-yl]-penem-3-carboxylatepropane | 1B12_A |
| SF | S26.001 | signal peptidase I | apoenzyme | 1KN9 |
| SF | S26.001 | signal peptidase I | complex with lipopeptide inhibitor arylomycin A2 | 1T7D_A |
| SF | S26.001 | signal peptidase I | complex with arylomycin A2 and a beta-sultam inhibitor | 3IIQ |
| SF | S26.001 | signal peptidase I | complex with an arylomycin lipoglycopeptide antibiotic | 3S04 |
| SF | S26.001 | signal peptidase I | e. coli lepb in complex with gne0775 ((4s,7s,10s)-10-((s)-4-amino-2- (2-(4-(tert-butyl)phenyl)-4-methylpyrimidine-5-carboxamido)-n- methylbutanamido)-16,26-bis(2-aminoethoxy)-n-(2-iminoethyl)-7-methyl-6,9-dioxo-5,8-diaza-1,2(1,3)-dibenzenacyclodecaphane-4 | 6B88_A |
| SF | S26.016 | SpsB signal peptidase | fusion protein with maltose-binding periplasmic protein | 4WVG |
| SF | S26.016 | SpsB signal peptidase | crystal structure of the type-i signal peptidase from staphylococcus aureus (spsb) in complex with a substrate peptide (pep1). | 4WVH_A |
| SF | S26.016 | SpsB signal peptidase | fusion protein with maltose-binding periplasmic protein | 4WVI |
| SF | S26.016 | SpsB signal peptidase | fusion protein with maltose-binding periplasmic protein | 4WVJ |
| SF | S26.UNW | family S26 non-peptidase homologues | an arm-swapped dimer of the s. pyogenes pilin specific assembly factors ipa | 4K8W_A |
| SF | S26.UNW | family S26 non-peptidase homologues | 4N31 | |
| SF | S26.UPA | subfamily S26A unassigned peptidases | 4NV4_A | |
| SF | S26.UPA | subfamily S26A unassigned peptidases | crystal structure of a signal peptidase i (ef3073) from enterococcus faecalis v583 at 2.27 a resolution | 4ME8_A |
| SC | S28.001 | lysosomal Pro-Xaa carboxypeptidase | 3N2Z | |
| SC | S28.002 | dipeptidyl-peptidase II | 3JYH | |
| SC | S28.002 | dipeptidyl-peptidase II | 3N0T | |
| SC | S28.002 | dipeptidyl-peptidase II | 4EBB | |
| PA | S29.001 | hepacivirin | monomer | 1A1Q |
| PA | S29.001 | hepacivirin | complex with NS4A peptide | 1A1R |
| PA | S29.001 | hepacivirin | helicase domain | 1A1V |
| PA | S29.001 | hepacivirin | NMR structure | 1BT7 |
| PA | S29.001 | hepacivirin | 1CU1 | |
| PA | S29.001 | hepacivirin | complex with a fragment of NS4 protein | 1DXP |
| PA | S29.001 | hepacivirin | NMR structure; complex with Glu-Leu-(di-fluoro-2-keto-pantan-1-oic) acid | 1DXW |
| PA | S29.001 | hepacivirin | complex with a fragment of NS4 protein and CBz-Ile-Leu-5,5-di-fluoro-2-keto-3-aminopentanoic acid | 1DY8 |
| PA | S29.001 | hepacivirin | complex with a fragment of NS4 protein and Boc-Glu-Leu-5,5-di-fluoro-2-keto-3-aminopentanoic acid | 1DY9 |
| PA | S29.001 | hepacivirin | helicase domain | 1HEI |
| PA | S29.001 | hepacivirin | complex with NS4A | 1JXP_A |
| PA | S29.001 | hepacivirin | NS3 protease domain:NS4a peptide complex with covalently bound inhibitor (GW472467X) | 1N1L_A |
| PA | S29.001 | hepacivirin | 1NS3 | |
| PA | S29.001 | hepacivirin | complex with pentapeptide keto-amide N-(pyrazin-2-ylcarbonyl)leucylisoleucyl-N~1~-1-[2-(1-carboxy-2-[4-(phosphonooxy)phenyl]ethylamino)-1,1-dihydroxy-2-oxoethyl]but-3-enyl-3-cyclohexylalaninamide | 1RGQ |
| PA | S29.001 | hepacivirin | NS3 protease domain: NS4a peptide complex with N-[(2R,3S)-1-((2S)-2-[(cyclopentylamino)carbonyl]amino-3-methylbutanoyl)-2-(1-formyl-1-cyclobutyl)pyrrolidinyl]cyclopropanecarboxamide | 1RTL_A |
| PA | S29.001 | hepacivirin | hcv ns3 protease with ns4a peptide and a covalently bound macrocyclic ketoamide compound. | 2A4Q_A |
| PA | S29.001 | hepacivirin | hcv ns3 protease domain with a ketoamide inhibitor covalently bound. | 2A4R_A |
| PA | S29.001 | hepacivirin | hcv ns3 protease domain with ns4a peptide and a ketoamide inhibitor with a p2 norborane | 2F9U_A |
| PA | S29.001 | hepacivirin | NMR structure; complex with phenethylamide inhibitor | 2K1Q |
| PA | S29.001 | hepacivirin | Ser139Ala mutant | 2O8M_A |
| PA | S29.001 | hepacivirin | Ser139Ala mutant | 2O8M_C |
| PA | S29.001 | hepacivirin | discovery of the hcv ns3/4a protease inhibitor sch503034. key steps in structure-based optimization | 2OBO_A |
| PA | S29.001 | hepacivirin | discovery of the hcv ns3/4a protease inhibitor sch503034. key steps in structure-based optimization | 2OBO_B |
| PA | S29.001 | hepacivirin | discovery of the hcv ns3/4a protease inhibitor sch503034. key steps in structure-based optimization | 2OBQ_A |
| PA | S29.001 | hepacivirin | discovery of the hcv ns3/4a protease inhibitor sch503034. key steps in structure-based optimization | 2OBQ_B |
| PA | S29.001 | hepacivirin | complex with ketoamide inhibitor SCH491762 | 2OC0_A |
| PA | S29.001 | hepacivirin | complex with ketoamide inhibitor SCH491762 | 2OC0_B |
| PA | S29.001 | hepacivirin | structure of the hcv ns3/4a protease inhibitor cvs4819 | 2OC1_A |
| PA | S29.001 | hepacivirin | structure of the hcv ns3/4a protease inhibitor cvs4819 | 2OC1_B |
| PA | S29.001 | hepacivirin | structure of hepatitis c viral ns3 protease domain complexed with ns4a peptide and ketoamide sch571696 | 2OC7_A |
| PA | S29.001 | hepacivirin | structure of hepatitis c viral ns3 protease domain complexed with ns4a peptide and ketoamide sch571696 | 2OC7_B |
| PA | S29.001 | hepacivirin | structure of hepatitis c viral ns3 protease domain complexed with ns4a peptide and ketoamide sch503034 | 2OC8_A |
| PA | S29.001 | hepacivirin | structure of hepatitis c viral ns3 protease domain complexed with ns4a peptide and ketoamide sch503034 | 2OC8_B |
| PA | S29.001 | hepacivirin | NS3-4a Arg155Lys mutant | 2OIN_A |
| PA | S29.001 | hepacivirin | 2P59_A | |
| PA | S29.001 | hepacivirin | Val36Met mutant | 2QV1_A |
| PA | S29.001 | hepacivirin | crystal structure of hcv ns3 protease with a boronate inhibitor | 2XCN_A |
| PA | S29.001 | hepacivirin | crystal structure of hepatitis c virus ns3 helicase with a novel inhibitor | 2ZJO_A |
| PA | S29.001 | hepacivirin | structure of hcv ns3-4a protease with an inhibitor derived from a boronic acid | 3EYD_A |
| PA | S29.001 | hepacivirin | complex with non-covalent macrocyclic compound tmc435 | 3KEE_A |
| PA | S29.001 | hepacivirin | complex with non-covalent macrocyclic compound tmc435 | 3KEE_E |
| PA | S29.001 | hepacivirin | the hcv ns3/ns4a protease apo structure | 3KF2_A |
| PA | S29.001 | hepacivirin | the hcv ns3/ns4a protease apo structure | 3KF2_C |
| PA | S29.001 | hepacivirin | hcv ns3 protease domain with p1-p3 macrocyclic ketoamide inhibitor | 3KNX_A |
| PA | S29.001 | hepacivirin | hcv ns3-4a protease domain with ketoamide inhibitor narlaprevir | 3LON_A |
| PA | S29.001 | hepacivirin | hcv ns3-4a protease domain with a ketoamide inhibitor derivative of boceprevir bound | 3LOX_A |
| PA | S29.001 | hepacivirin | complex with itmn-191 | 3M5L_A |
| PA | S29.001 | hepacivirin | avoiding drug resistance against hcv ns3/4a protease inhibitors | 3M5M_A |
| PA | S29.001 | hepacivirin | complex with n-terminal product 4b5a | 3M5N_A |
| PA | S29.001 | hepacivirin | complex with n-terminal product 4b5a | 3M5N_F |
| PA | S29.001 | hepacivirin | complex with n-terminal product 5a5b | 3M5O_A |
| PA | S29.001 | hepacivirin | complex with n-terminal product 5a5b | 3M5O_C |
| PA | S29.001 | hepacivirin | hcv ns3/4a in complex with ligand 3 | 3OYP_A |
| PA | S29.001 | hepacivirin | complex with bi 201335 | 3P8N_A |
| PA | S29.001 | hepacivirin | complex with des-bromine analogue of bi 201335 | 3P8O_A |
| PA | S29.001 | hepacivirin | molecular mechanisms of viral and host-cell substrate recognition by hcv ns3/4a protease | 3RC6_A |
| PA | S29.001 | hepacivirin | the structure of hcv ns3 helicase (heli-80) bound with inhibitor itmn-3479 | 3RVB_A |
| PA | S29.001 | hepacivirin | Arg155Lys variant; complex with danoprevir | 3SU0_A |
| PA | S29.001 | hepacivirin | Asp168Ala variant; complex with danoprevir | 3SU1_A |
| PA | S29.001 | hepacivirin | Ala156Thr variant; complex with danoprevir | 3SU2_A |
| PA | S29.001 | hepacivirin | complex with vaniprevir | 3SU3_A |
| PA | S29.001 | hepacivirin | Arg155Lys variant; complex with vaniprevir | 3SU4_A |
| PA | S29.001 | hepacivirin | Asp168Ala variant; complex with vaniprevir | 3SU5_A |
| PA | S29.001 | hepacivirin | Ala156Thr variant; complex with vaniprevir | 3SU6_A |
| PA | S29.001 | hepacivirin | complex with mk-5172 | 3SUD_A |
| PA | S29.001 | hepacivirin | Arg155Lys variant; complex with mk-5172 | 3SUE_A |
| PA | S29.001 | hepacivirin | Asp168Ala variant; complex with mk-5172 | 3SUF_A |
| PA | S29.001 | hepacivirin | Ala156Thr variant; complex with mk-5172 | 3SUG_A |
| PA | S29.001 | hepacivirin | complex with telaprevir | 3SV6_A |
| PA | S29.001 | hepacivirin | Arg155Lys variant; complex with telaprevir | 3SV7_A |
| PA | S29.001 | hepacivirin | Asp168Ala variant; complex with telaprevir | 3SV8_A |
| PA | S29.001 | hepacivirin | Ala156Thr variant; complex with telaprevir | 3SV9_A |
| PA | S29.001 | hepacivirin | co-complex of the of ns3-4a protease with the inhibitory peptide cp5- 46-a (in-house data) | 4A1T_A |
| PA | S29.001 | hepacivirin | complex with the optimized inhibitory peptide cp5-46a-4d5e | 4A1V_A |
| PA | S29.001 | hepacivirin | complex with the inhibitory peptide cp5-46-a (synchrotron data) | 4A1X_A |
| PA | S29.001 | hepacivirin | full-length hcv ns3-4a protease-helicase in complex with a macrocyclicprotease inhibitor. | 4A92_A |
| PA | S29.001 | hepacivirin | discovery of an allosteric mechanism for the regulation of hcv ns3 protein function | 4B6E_A |
| PA | S29.001 | hepacivirin | discovery of an allosteric mechanism for the regulation of hcv ns3 protein function | 4B6F_A |
| PA | S29.001 | hepacivirin | discovery of an allosteric mechanism for the regulation of hcv ns3 protein function | 4B71_A |
| PA | S29.001 | hepacivirin | discovery of an allosteric mechanism for the regulation of hcv ns3 protein function | 4B73_A |
| PA | S29.001 | hepacivirin | discovery of an allosteric mechanism for the regulation of hcv ns3 protein function | 4B74_A |
| PA | S29.001 | hepacivirin | discovery of an allosteric mechanism for the regulation of hcv ns3 protein function | 4B75_A |
| PA | S29.001 | hepacivirin | discovery of an allosteric mechanism for the regulation of hcv ns3 protein function | 4B76_A |
| PA | S29.001 | hepacivirin | complex with compound 4 | 4I31_A |
| PA | S29.001 | hepacivirin | Asp168Val mutant; complex with compound4 | 4I32_A |
| PA | S29.001 | hepacivirin | Arg155Lys mutant; complex with compound4 | 4I33_A |
| PA | S29.001 | hepacivirin | complex with ddivpc peptide | 4JMY_A |
| PA | S29.001 | hepacivirin | complex with inhibitor | 4K8B_A |
| PA | S29.001 | hepacivirin | complex with inhibitor | 4K8B_C |
| PA | S29.001 | hepacivirin | ns3/ns4a protease with inhibitor | 4KTC_A |
| PA | S29.001 | hepacivirin | complex with bms-605339 aka n-(tert-butoxycarbonyl)-3-me thyl-l-valyl-(4r)-n-((1r,2s)-1-((cyclopropylsulfonyl)carba moyl)-2-vinylcyclopropyl)-4-((6- methoxy-1-isoquinolinyl)ox y)-l-prolinamide | 4NWK_A |
| PA | S29.001 | hepacivirin | complex with bms-650032 aka n-(tert-butoxycarbonyl)-3-me thyl-l-valyl-(4r)-4-((7- chloro-4-methoxy-1-isoquinolinyl)o xy)-n-((1r,2s)-1- ((cyclopropylsulfonyl)carbamoyl)-2-vinylc yclopropyl)-l-prolinamid | 4NWL_A |
| PA | S29.001 | hepacivirin | structure-based design of a novel series of azetidine inhibitors of the hepatitis c virus ns3/4a serine protease | 4TYD_A |
| PA | S29.001 | hepacivirin | hcv ns3/4a serine protease in complex with 6570 | 4U01_A |
| PA | S29.001 | hepacivirin | variant Arg155Lys; complex with asunaprevir | 4WH6_A |
| PA | S29.001 | hepacivirin | complex with an asunaprevir p1-p3 macrocyclic analog. | 4WH8_A |
| PA | S29.001 | hepacivirin | complex with with a bound inhibitor | 4WXR_A |
| PA | S29.001 | hepacivirin | the spring alpha-helix coordinates multiple modes of hcv ns3 helicase action | 5E4F_A |
| PA | S29.001 | hepacivirin | structure of hepatitis c virus (hcv) full-length ns3 complex with small-molecule ligand 3-aminobenzene-1,2- dicarboxylic acid (at1246) in an alternate binding site. | 5FPS_A |
| PA | S29.001 | hepacivirin | structure of hepatitis c virus (hcv) full-length ns3 complex with small-molecule ligand 2-(1-methyl-1h-indol-3- yl)acetic acid (at3437) in an alternate binding site. | 5FPT_A |
| PA | S29.001 | hepacivirin | structure of hepatitis c virus (hcv) full-length ns3 complex with small-molecule ligand 5-bromo-1-methyl-1h-indole-2- carboxylic acid (at21457) in an alternate binding site. | 5FPY_A |
| PA | S29.001 | hepacivirin | complex with jz01-15, an analogue of 5172-mcp1p3 | 5VOJ_A |
| PA | S29.001 | hepacivirin | complex with am-07, an analogue of 5172-mcp1p3 | 5VP9_A |
| PA | S29.001 | hepacivirin | Tyr56His/Asp168Ala double mutant; complex with danoprevir | 6C2N_A |
| PA | S29.001 | hepacivirin | RNA helicase from genotype 1B | 8OHM_A |
| PA | S29.UPW | family S29 unassigned peptidases | 2M6X | |
| PA | S29.UPW | family S29 unassigned peptidases | crystal structure of hcv ns3 protease with a boronate inhibitor | 2XCF_A |
| PA | S29.UPW | family S29 unassigned peptidases | protein-ligand complex of a novel macrocyclic hcv ns3 protease inhibitor derived from amino cyclic boronates | 2XNI_A |
| PA | S31.001 | pestivirus NS3 polyprotein peptidase | Ser163Ala mutant | 5WX1 |
| PA | S31.001 | pestivirus NS3 polyprotein peptidase | 2YQ2 | |
| PA | S31.001 | pestivirus NS3 polyprotein peptidase | 2YQ3 | |
| PA | S32.001 | equine arteritis virus serine peptidase | 1MBM_A | |
| PA | S32.002 | porcine reproductive and respiratory syndrome virus nsp4 peptidase | ON HOLD | 3FAN |
| PA | S32.002 | porcine reproductive and respiratory syndrome virus nsp4 peptidase | ON HOLD: Ser118Ala mutant | 3FAO |
| PA | S32.002 | porcine reproductive and respiratory syndrome virus nsp4 peptidase | prrsv nsp4 | 5Y4L_B |
| SC | S33.001 | prolyl aminopeptidase | 1QTR_A | |
| SC | S33.001 | prolyl aminopeptidase | complex with Pro-TBODA | 1WM1_A |
| SC | S33.001 | prolyl aminopeptidase | complex with sar-TBODA | 1X2B_A |
| SC | S33.001 | prolyl aminopeptidase | complex with Ala-TBODA | 1X2E_A |
| SC | S33.001 | prolyl aminopeptidase | 1AZW | |
| SC | S33.005 | tricorn interacting factor F1 | Methionine residues modified to selenomethionine. | 1MT3_A |
| SC | S33.005 | tricorn interacting factor F1 | 1MTZ | |
| SC | S33.005 | tricorn interacting factor F1 | complex with 3-amino-1-chloro-4-phenyl-butanol-2-yl. | 1MU0 |
| SC | S33.005 | tricorn interacting factor F1 | inactive F1-mutant Gly37Ala | 1XQV_A |
| SC | S33.005 | tricorn interacting factor F1 | F1-mutant Ser105Ala complex with Phe-Leu | 1XQW_A |
| SC | S33.005 | tricorn interacting factor F1 | F1-mutant Ser105Ala; complex with PCK | 1XQX_A |
| SC | S33.005 | tricorn interacting factor F1 | Ser105Ala mutant; complex with Pro-Leu-Gly-Gly | 1XQY_A |
| SC | S33.005 | tricorn interacting factor F1 | active site F1-mutant Tyr205Phe complex with inhibitor PCK | 1XRL_A |
| SC | S33.005 | tricorn interacting factor F1 | active site F1-mutant Glu213Gln soaked with peptide Ala-Phe | 1XRM_A |
| SC | S33.005 | tricorn interacting factor F1 | active site F1-mutant Glu213Gln soaked with peptide Phe-Ala | 1XRN_A |
| SC | S33.005 | tricorn interacting factor F1 | active site F1-mutant Glu213Gln soaked with peptide Phe-Leu | 1XRO_A |
| SC | S33.005 | tricorn interacting factor F1 | active site F1-mutant Glu213Gln soaked with peptide Pro-Leu-Gly-Gly | 1XRP_A |
| SC | S33.005 | tricorn interacting factor F1 | active site F1-mutant Glu245Gln soaked with peptide Phe-Leu | 1XRQ_A |
| SC | S33.005 | tricorn interacting factor F1 | active site F1-mutant Glu245Gln soaked with peptide Pro-Pro | 1XRR_A |
| SC | S33.016 | 2-hydroxy-6-oxo-6-phenylhexa-2,4-dienoate hydrolase (Burkholderia-type) | crystal structure of hsad bound to 3,5-dichloro-4- hydroxybenzenesulphonic acid | 5JZ9_A |
| SC | S33.016 | 2-hydroxy-6-oxo-6-phenylhexa-2,4-dienoate hydrolase (Burkholderia-type) | 2HC3 | |
| SC | S33.016 | 2-hydroxy-6-oxo-6-phenylhexa-2,4-dienoate hydrolase (Burkholderia-type) | 2OG1_A | |
| SC | S33.016 | 2-hydroxy-6-oxo-6-phenylhexa-2,4-dienoate hydrolase (Burkholderia-type) | 2PU5_A | |
| SC | S33.016 | 2-hydroxy-6-oxo-6-phenylhexa-2,4-dienoate hydrolase (Burkholderia-type) | Ser112Ala mutant | 2PU6_A |
| SC | S33.016 | 2-hydroxy-6-oxo-6-phenylhexa-2,4-dienoate hydrolase (Burkholderia-type) | 2PU7 | |
| SC | S33.016 | 2-hydroxy-6-oxo-6-phenylhexa-2,4-dienoate hydrolase (Burkholderia-type) | Ser112Ala mutant; complex with its substrate HopDA | 2PUH_A |
| SC | S33.016 | 2-hydroxy-6-oxo-6-phenylhexa-2,4-dienoate hydrolase (Burkholderia-type) | 2PUJ | |
| SC | S33.016 | 2-hydroxy-6-oxo-6-phenylhexa-2,4-dienoate hydrolase (Burkholderia-type) | Ser112Ala mutant; complex with 3- cl hopda | 2RHT_A |
| SC | S33.016 | 2-hydroxy-6-oxo-6-phenylhexa-2,4-dienoate hydrolase (Burkholderia-type) | Ser112Ala mutant; complex with 3, 10-di-fluoro hopda | 2RHW_A |
| SC | S33.016 | 2-hydroxy-6-oxo-6-phenylhexa-2,4-dienoate hydrolase (Burkholderia-type) | Ser112Ala mutant | 2RI6_A |
| SC | S33.016 | 2-hydroxy-6-oxo-6-phenylhexa-2,4-dienoate hydrolase (Burkholderia-type) | 3V1K | |
| SC | S33.016 | 2-hydroxy-6-oxo-6-phenylhexa-2,4-dienoate hydrolase (Burkholderia-type) | 3V1L | |
| SC | S33.016 | 2-hydroxy-6-oxo-6-phenylhexa-2,4-dienoate hydrolase (Burkholderia-type) | 3V1M | |
| SC | S33.016 | 2-hydroxy-6-oxo-6-phenylhexa-2,4-dienoate hydrolase (Burkholderia-type) | 3V1N | |
| SC | S33.022 | Lpx1 peptidase (Saccharomyces cerevisiae) | 2Y6U | |
| SC | S33.022 | Lpx1 peptidase (Saccharomyces cerevisiae) | 2Y6V | |
| SC | S33.023 | Hip1 peptidase (Mycobacterium tuberculosis) | 5UGQ | |
| SC | S33.023 | Hip1 peptidase (Mycobacterium tuberculosis) | 5UNO | |
| SC | S33.023 | Hip1 peptidase (Mycobacterium tuberculosis) | Thr466Ala mutant | 5UOH |
| SC | S33.971 | epoxide hydrolase | 2E3J_A | |
| SC | S33.971 | epoxide hydrolase | complex with an inhibitor | 2ZJF_A |
| SC | S33.971 | epoxide hydrolase | 4QLA | |
| SC | S33.973 | cytosolic epoxide hydrolase | 1S8O_A | |
| SC | S33.973 | cytosolic epoxide hydrolase | complex with 4-(3-cyclohexyluriedo)-ethanoic acid | 1ZD2_P |
| SC | S33.973 | cytosolic epoxide hydrolase | complex with 4-(3-cyclohexyluriedo)-butyric acid | 1ZD3_A |
| SC | S33.973 | cytosolic epoxide hydrolase | complex with 4-(3-cyclohexyluriedo)-hexanoic acid | 1ZD4_A |
| SC | S33.973 | cytosolic epoxide hydrolase | complex with 4-(3-cyclohexyluriedo)-heptanoic acid | 1ZD5_A |
| SC | S33.973 | cytosolic epoxide hydrolase | complex with a synthetic inhibitor | 3ANS_A |
| SC | S33.973 | cytosolic epoxide hydrolase | complex with a synthetic inhibitor | 3ANT_A |
| SC | S33.973 | cytosolic epoxide hydrolase | crystal structure of soluble epoxide hydrolase | 3I1Y_A |
| SC | S33.973 | cytosolic epoxide hydrolase | crystal structure of soluble epoxide hydrolase | 3I28_A |
| SC | S33.973 | cytosolic epoxide hydrolase | 3KOO_A | |
| SC | S33.973 | cytosolic epoxide hydrolase | soluble epoxide hydrolase in complex with pyrazole antagonist | 3OTQ_A |
| SC | S33.973 | cytosolic epoxide hydrolase | hydrolase domain; complex with a benzoxazole inhibitor | 3PDC_A |
| SC | S33.973 | cytosolic epoxide hydrolase | complex with fragment inhibitor | 3WK4_A |
| SC | S33.973 | cytosolic epoxide hydrolase | complex with fragment inhibitor | 3WK5_A |
| SC | S33.973 | cytosolic epoxide hydrolase | complex with fragment inhibitor | 3WK6_A |
| SC | S33.973 | cytosolic epoxide hydrolase | complex with fragment inhibitor | 3WK7_A |
| SC | S33.973 | cytosolic epoxide hydrolase | complex with fragment inhibitor | 3WK8_A |
| SC | S33.973 | cytosolic epoxide hydrolase | complex with fragment inhibitor | 3WK9_A |
| SC | S33.973 | cytosolic epoxide hydrolase | complex with fragment inhibitor | 3WKA_A |
| SC | S33.973 | cytosolic epoxide hydrolase | complex with fragment inhibitor | 3WKB_A |
| SC | S33.973 | cytosolic epoxide hydrolase | complex with fragment inhibitor | 3WKC_A |
| SC | S33.973 | cytosolic epoxide hydrolase | complex with fragment inhibitor | 3WKD_A |
| SC | S33.973 | cytosolic epoxide hydrolase | complex with t-aucb | 3WKE_A |
| SC | S33.973 | cytosolic epoxide hydrolase | complex with c9 | 4C4X_A |
| SC | S33.973 | cytosolic epoxide hydrolase | complex with a4 | 4C4Y_A |
| SC | S33.973 | cytosolic epoxide hydrolase | complex with a8 | 4C4Z_A |
| SC | S33.973 | cytosolic epoxide hydrolase | complex with n-cycloheptyl-1-(mesitylsulfonyl)piperidine-4-carboxamide. | 4HAI_A |
| SC | S33.973 | cytosolic epoxide hydrolase | complex with fulvestrant | 4J03_A |
| SC | S33.973 | cytosolic epoxide hydrolase | complex with a carboxamide inhibitor | 4JNC_A |
| SC | S33.973 | cytosolic epoxide hydrolase | complex with 1-(1-isobutyrylpiperidin-4-yl)-3-(4-(trifluoromethyl)phenyl)urea | 4OCZ_A |
| SC | S33.973 | cytosolic epoxide hydrolase | complex with 1-(1-propanoylpiperidin-4-yl)-3-[4-(trifluoromethoxy)phenyl]urea | 4OD0_A |
| SC | S33.973 | cytosolic epoxide hydrolase | complex with a three substituted cyclopropane derivative | 4X6X_A |
| SC | S33.973 | cytosolic epoxide hydrolase | complex with a cyclopropyl urea derivative | 4X6Y_A |
| SC | S33.973 | cytosolic epoxide hydrolase | complex with n-[(1-methyl- 1h-pyrazol-3-yl)methyl]-2-phenylethanamine | 4Y2J_A |
| SC | S33.973 | cytosolic epoxide hydrolase | complex with n-methyl-1-[3- (pyridin-3-yl)phenyl]methanamine | 4Y2P_A |
| SC | S33.973 | cytosolic epoxide hydrolase | complex with 1-[3- (trifluoromethyl)pyridin-2-yl]piperazine | 4Y2Q_A |
| SC | S33.973 | cytosolic epoxide hydrolase | complex with 2-(piperazin-1-yl)nicotinonitrile | 4Y2R_A |
| SC | S33.973 | cytosolic epoxide hydrolase | complex with 1-[3- (trifluoromethyl)phenyl]-1h-pyrazol-4-ol | 4Y2S_A |
| SC | S33.973 | cytosolic epoxide hydrolase | complex with 3-[4- (benzyloxy)phenyl]propan-1-ol | 4Y2T_A |
| SC | S33.973 | cytosolic epoxide hydrolase | complex with tert-butyl 1,2,3,4-tetrahydroquinolin-3-ylcarbamate | 4Y2U_A |
| SC | S33.973 | cytosolic epoxide hydrolase | complex with (4-bromo-3- cyclopropyl-1h-pyrazol-1-yl)acetic acid | 4Y2V_A |
| SC | S33.973 | cytosolic epoxide hydrolase | complex with 2-([2- (adamantan-1-yl)ethyl]aminomethyl)phenol | 4Y2X_A |
| SC | S33.973 | cytosolic epoxide hydrolase | structure of soluble epoxide hydrolase in complex with 2-(2- fluorophenyl)-n-[(5-methyl-2-thienyl)methyl]ethanamine | 4Y2Y_A |
| SC | S33.973 | cytosolic epoxide hydrolase | apo form | 5AHX_A |
| SC | S33.973 | cytosolic epoxide hydrolase | ligand complex structure of soluble epoxide hydrolase | 5AI0_A |
| SC | S33.973 | cytosolic epoxide hydrolase | ligand complex structure of soluble epoxide hydrolase | 5AI4_A |
| SC | S33.973 | cytosolic epoxide hydrolase | ligand complex structure of soluble epoxide hydrolase | 5AI5_A |
| SC | S33.973 | cytosolic epoxide hydrolase | ligand complex structure of soluble epoxide hydrolase | 5AI6_A |
| SC | S33.973 | cytosolic epoxide hydrolase | ligand complex structure of soluble epoxide hydrolase | 5AI8_A |
| SC | S33.973 | cytosolic epoxide hydrolase | ligand complex structure of soluble epoxide hydrolase | 5AI9_A |
| SC | S33.973 | cytosolic epoxide hydrolase | ligand complex structure of soluble epoxide hydrolase | 5AIA_A |
| SC | S33.973 | cytosolic epoxide hydrolase | ligand complex structure of soluble epoxide hydrolase | 5AIB_A |
| SC | S33.973 | cytosolic epoxide hydrolase | ligand complex structure of soluble epoxide hydrolase | 5AIC_A |
| SC | S33.973 | cytosolic epoxide hydrolase | ligand complex structure of soluble epoxide hydrolase | 5AK3_A |
| SC | S33.973 | cytosolic epoxide hydrolase | ligand complex structure of soluble epoxide hydrolase | 5AK4_A |
| SC | S33.973 | cytosolic epoxide hydrolase | ligand complex structure of soluble epoxide hydrolase | 5AK5_A |
| SC | S33.973 | cytosolic epoxide hydrolase | ligand complex structure of soluble epoxide hydrolase | 5AK6_A |
| SC | S33.973 | cytosolic epoxide hydrolase | ligand complex structure of soluble epoxide hydrolase | 5AKE_A |
| SC | S33.973 | cytosolic epoxide hydrolase | ligand complex structure of soluble epoxide hydrolase | 5AKG_A |
| SC | S33.973 | cytosolic epoxide hydrolase | ligand complex structure of soluble epoxide hydrolase | 5AKH_A |
| SC | S33.973 | cytosolic epoxide hydrolase | ligand complex structure of soluble epoxide hydrolase | 5AKI_A |
| SC | S33.973 | cytosolic epoxide hydrolase | ligand complex structure of soluble epoxide hydrolase | 5AKJ_A |
| SC | S33.973 | cytosolic epoxide hydrolase | ligand complex structure of soluble epoxide hydrolase | 5AKK_A |
| SC | S33.973 | cytosolic epoxide hydrolase | ligand complex structure of soluble epoxide hydrolase | 5AKL_A |
| SC | S33.973 | cytosolic epoxide hydrolase | ligand complex structure of soluble epoxide hydrolase | 5AKX_A |
| SC | S33.973 | cytosolic epoxide hydrolase | ligand complex structure of soluble epoxide hydrolase | 5AKY_A |
| SC | S33.973 | cytosolic epoxide hydrolase | ligand complex structure of soluble epoxide hydrolase | 5AKZ_A |
| SC | S33.973 | cytosolic epoxide hydrolase | ligand complex structure of soluble epoxide hydrolase | 5ALD_A |
| SC | S33.973 | cytosolic epoxide hydrolase | ligand complex structure of soluble epoxide hydrolase | 5ALE_A |
| SC | S33.973 | cytosolic epoxide hydrolase | ligand complex structure of soluble epoxide hydrolase | 5ALF_A |
| SC | S33.973 | cytosolic epoxide hydrolase | ligand complex structure of soluble epoxide hydrolase | 5ALG_A |
| SC | S33.973 | cytosolic epoxide hydrolase | ligand complex structure of soluble epoxide hydrolase | 5ALH_A |
| SC | S33.973 | cytosolic epoxide hydrolase | ligand complex structure of soluble epoxide hydrolase | 5ALI_A |
| SC | S33.973 | cytosolic epoxide hydrolase | ligand complex structure of soluble epoxide hydrolase | 5ALJ_A |
| SC | S33.973 | cytosolic epoxide hydrolase | ligand complex structure of soluble epoxide hydrolase | 5ALK_A |
| SC | S33.973 | cytosolic epoxide hydrolase | ligand complex structure of soluble epoxide hydrolase | 5ALL_A |
| SC | S33.973 | cytosolic epoxide hydrolase | ligand complex structure of soluble epoxide hydrolase | 5ALM_A |
| SC | S33.973 | cytosolic epoxide hydrolase | ligand complex structure of soluble epoxide hydrolase | 5ALN_A |
| SC | S33.973 | cytosolic epoxide hydrolase | ligand complex structure of soluble epoxide hydrolase | 5ALO_A |
| SC | S33.973 | cytosolic epoxide hydrolase | ligand complex structure of soluble epoxide hydrolase | 5ALP_A |
| SC | S33.973 | cytosolic epoxide hydrolase | ligand complex structure of soluble epoxide hydrolase | 5ALQ_A |
| SC | S33.973 | cytosolic epoxide hydrolase | ligand complex structure of soluble epoxide hydrolase | 5ALR_A |
| SC | S33.973 | cytosolic epoxide hydrolase | ligand complex structure of soluble epoxide hydrolase | 5ALS_A |
| SC | S33.973 | cytosolic epoxide hydrolase | ligand complex structure of soluble epoxide hydrolase | 5ALT_A |
| SC | S33.973 | cytosolic epoxide hydrolase | ligand complex structure of soluble epoxide hydrolase | 5ALU_A |
| SC | S33.973 | cytosolic epoxide hydrolase | ligand complex structure of soluble epoxide hydrolase | 5ALV_A |
| SC | S33.973 | cytosolic epoxide hydrolase | ligand complex structure of soluble epoxide hydrolase | 5ALW_A |
| SC | S33.973 | cytosolic epoxide hydrolase | ligand complex structure of soluble epoxide hydrolase | 5ALX_A |
| SC | S33.973 | cytosolic epoxide hydrolase | ligand complex structure of soluble epoxide hydrolase | 5ALY_A |
| SC | S33.973 | cytosolic epoxide hydrolase | ligand complex structure of soluble epoxide hydrolase | 5ALZ_A |
| SC | S33.973 | cytosolic epoxide hydrolase | ligand complex structure of soluble epoxide hydrolase | 5AM0_A |
| SC | S33.973 | cytosolic epoxide hydrolase | ligand complex structure of soluble epoxide hydrolase | 5AM1_A |
| SC | S33.973 | cytosolic epoxide hydrolase | ligand complex structure of soluble epoxide hydrolase | 5AM2_A |
| SC | S33.973 | cytosolic epoxide hydrolase | ligand complex structure of soluble epoxide hydrolase | 5AM3_A |
| SC | S33.973 | cytosolic epoxide hydrolase | ligand complex structure of soluble epoxide hydrolase | 5AM4_A |
| SC | S33.973 | cytosolic epoxide hydrolase | ligand complex structure of soluble epoxide hydrolase | 5AM5_A |
| SC | S33.973 | cytosolic epoxide hydrolase | ligand complex structure of soluble epoxide hydrolase | 5FP0_A |
| SC | S33.973 | cytosolic epoxide hydrolase | complex with trans-4-[4-(3-trifluoromethoxyphenyl-l-ureido)-cyclohexyloxy]-benzoicacid. | 6AUM_A |
| SC | S33.973 | cytosolic epoxide hydrolase | complex with lk864 | 6FR2_A |
| SC | S33.973 | cytosolic epoxide hydrolase | soluble epoxide hydrolase in complex with talinolol | 6HGV_A |
| SC | S33.973 | cytosolic epoxide hydrolase | soluble epoxide hydrolase in complex with 1-(4-((4-(tert-butyl) morpholin-2-yl)methoxy)phenyl)-3-cyclohexylurea | 6HGX_A |
| SC | S33.973 | cytosolic epoxide hydrolase | apo form C-terminal domain (hseh ctd) | 6I5E_A |
| SC | S33.973 | cytosolic epoxide hydrolase | C-terminal domain (hseh ctd); complex with 15d-pgj2 | 6I5G_A |
| SC | S33.973 | cytosolic epoxide hydrolase | 1CQZ | |
| SC | S33.973 | cytosolic epoxide hydrolase | 1CR6 | |
| SC | S33.973 | cytosolic epoxide hydrolase | 1EK1 | |
| SC | S33.973 | cytosolic epoxide hydrolase | 1EK2 | |
| SC | S33.975 | 1-acylglycerol-3-phosphate O-acyltransferase ABHD5 | 5A4H | |
| SC | S33.979 | monoglyceride lipase | 3HJU | |
| SC | S33.979 | monoglyceride lipase | 3JW8 | |
| SC | S33.979 | monoglyceride lipase | 3JWE | |
| SC | S33.979 | monoglyceride lipase | 3PE6 | |
| SC | S33.979 | monoglyceride lipase | 4UUQ | |
| SC | S33.979 | monoglyceride lipase | complex with compound 3l | 5ZUN_A |
| SC | S33.979 | monoglyceride lipase | structure of human monoacylglycerol lipase bound to a covalent inhibitor | 6AX1_A |
| SC | S33.979 | monoglyceride lipase | structure of human monoacylglycerol lipase bound to a covalent inhibitor | 6BQ0_A |
| SC | S33.982 | valacyclovir hydrolase | 2OCG | |
| SC | S33.982 | valacyclovir hydrolase | 2OCI | |
| SC | S33.982 | valacyclovir hydrolase | 2OCK | |
| SC | S33.982 | valacyclovir hydrolase | 2OCL | |
| SC | S33.983 | Ccg1-interacting factor b | 1IMJ | |
| SC | S33.984 | protein phosphatase methylesterase 1 | 3C5V | |
| SC | S33.984 | protein phosphatase methylesterase 1 | 3C5W | |
| SC | S33.990 | haloalkane dehalogenase | 1B6G | |
| SC | S33.990 | haloalkane dehalogenase | 1BE0 | |
| SC | S33.990 | haloalkane dehalogenase | 1BEE | |
| SC | S33.990 | haloalkane dehalogenase | 1BEZ | |
| SC | S33.990 | haloalkane dehalogenase | 1CIJ | |
| SC | S33.990 | haloalkane dehalogenase | complex with chloride at pH 6.2 | 1EDB |
| SC | S33.990 | haloalkane dehalogenase | complex with chloride at pH 8 | 1EDD |
| SC | S33.990 | haloalkane dehalogenase | at pH 8.2 | 1EDE |
| SC | S33.990 | haloalkane dehalogenase | 1HDE | |
| SC | S33.990 | haloalkane dehalogenase | complex with 1,2-dichloroethane at pH 5 | 2DHC |
| SC | S33.990 | haloalkane dehalogenase | complex with 1,2-dichloroethane at pH 5 | 2DHD |
| SC | S33.990 | haloalkane dehalogenase | at pH 6 | 2DHE |
| SC | S33.990 | haloalkane dehalogenase | complex with iodide | 2EDA |
| SC | S33.990 | haloalkane dehalogenase | 2EDC | |
| SC | S33.990 | haloalkane dehalogenase | at pH 6.2 | 2HAD |
| SC | S33.990 | haloalkane dehalogenase | 2PKY | |
| SC | S33.990 | haloalkane dehalogenase | 2YXP | |
| SC | S33.990 | haloalkane dehalogenase | crystal structure of cold-adapted haloalkane dehalogenase dpca from psychrobacter cryohalolentis k5 | 6F9O_A |
| SC | S33.991 | CPO-A2 (Streptomyces aureofaciens)-type chloroperoxidase | 1A7U | |
| SC | S33.991 | CPO-A2 (Streptomyces aureofaciens)-type chloroperoxidase | complex with benzoate | 1A8U |
| SC | S33.991 | CPO-A2 (Streptomyces aureofaciens)-type chloroperoxidase | 1BRO | |
| SC | S33.991 | CPO-A2 (Streptomyces aureofaciens)-type chloroperoxidase | Met99Thr mutant | 1BRT |
| SC | S33.991 | CPO-A2 (Streptomyces aureofaciens)-type chloroperoxidase | structure of a 16 nm protein cage designed by fusing symmetric oligomeric domains | 3VDX_A |
| SC | S33.991 | CPO-A2 (Streptomyces aureofaciens)-type chloroperoxidase | structure of a 16 nm protein cage designed by fusing symmetric oligomeric domains | 4D9J_A |
| SC | S33.991 | CPO-A2 (Streptomyces aureofaciens)-type chloroperoxidase | structure of a 16 nm protein cage designed by fusing symmetric oligomeric domains, triple mutant, p21212 form | 4IQ4_A |
| SC | S33.991 | CPO-A2 (Streptomyces aureofaciens)-type chloroperoxidase | structure of a 16 nm protein cage designed by fusing symmetric oligomeric domains, triple mutant, p212121 form | 4ITV_A |
| SC | S33.991 | CPO-A2 (Streptomyces aureofaciens)-type chloroperoxidase | structure of a 16 nm protein cage designed by fusing symmetric oligomeric domains, triple mutant, i222 form | 4IVJ_A |
| SC | S33.991 | CPO-A2 (Streptomyces aureofaciens)-type chloroperoxidase | structure of a 16 nm protein cage designed by fusing symmetric oligomeric domains, quadruple mutant, i222 form | 4QES_A |
| SC | S33.991 | CPO-A2 (Streptomyces aureofaciens)-type chloroperoxidase | structure of a 16 nm protein cage designed by fusing symmetric oligomeric domains, quadruple mutant, p21212 form | 4QF0_A |
| SC | S33.991 | CPO-A2 (Streptomyces aureofaciens)-type chloroperoxidase | structure of a 16 nm protein cage designed by fusing symmetric oligomeric domains, quadruple mutant, p212121 form | 4QFF_A |
| SC | S33.992 | chloroperoxidase 1 (Streptomyces lividans-type) | chloroperoxidase l | 1A88_A |
| SC | S33.993 | YJU3 (Saccharomyces cerevisiae) | crystal structure of a soluble variant of the monoglyceride lipase from saccharomyces cerevisiae | 4ZWN_A |
| SC | S33.993 | YJU3 (Saccharomyces cerevisiae) | crystal structure of a soluble variant of monoglyceride lipase from saccharomyces cerevisiae in complex with a substrate analog | 4ZXF_A |
| SC | S33.994 | BioH protein (Escherichi coli) | 1M33 | |
| SC | S33.995 | MhpC protein (Escherichi coli) | 1U2E | |
| SC | S33.996 | YfbB protein (Escherichi coli) | 4GDM | |
| SC | S33.996 | YfbB protein (Escherichi coli) | 4GEC | |
| SC | S33.996 | YfbB protein (Escherichi coli) | 4GEG | |
| SC | S33.996 | YfbB protein (Escherichi coli) | 4MXD | |
| SC | S33.996 | YfbB protein (Escherichi coli) | 4MYD | |
| SC | S33.996 | YfbB protein (Escherichi coli) | 4MYS | |
| SC | S33.A18 | At3g03990 (Arabidopsis thaliana)-type peptidase | 4IH4 | |
| SC | S33.A18 | At3g03990 (Arabidopsis thaliana)-type peptidase | the crystal structure of the strigolactone-induced atd14-d3-ask1 complex | 5HZG_A |
| SC | S33.A18 | At3g03990 (Arabidopsis thaliana)-type peptidase | crystal structure of osd14 | 3VXK_A |
| SC | S33.A18 | At3g03990 (Arabidopsis thaliana)-type peptidase | crystal structure of oryza sativa dwarf14 (d14) | 3W04_A |
| SC | S33.A18 | At3g03990 (Arabidopsis thaliana)-type peptidase | crystal structure of oryza sativa dwarf14 (d14) in complex with PMSF | 3W05_A |
| SC | S33.A18 | At3g03990 (Arabidopsis thaliana)-type peptidase | crystal structure of osd14 in complex with hydroxy d-ring | 3WIO_A |
| SC | S33.A18 | At3g03990 (Arabidopsis thaliana)-type peptidase | crystal structure of rice dwarf14 (d14) | 4IH9_A |
| SC | S33.A18 | At3g03990 (Arabidopsis thaliana)-type peptidase | crystal structure of rice dwarf14 (d14) in complex with a gr24 hydrolysis intermediate | 4IHA_A |
| SC | S33.A18 | At3g03990 (Arabidopsis thaliana)-type peptidase | crystal structure of rice dwarf14 in complex with synthetic strigolactone gr24 | 5DJ5_A |
| SC | S33.A18 | At3g03990 (Arabidopsis thaliana)-type peptidase | crystal structure of osd14 in complex with covalently bound kk094 | 5ZHR_A |
| SC | S33.A18 | At3g03990 (Arabidopsis thaliana)-type peptidase | crystal structure of osd14 in complex with covalently bound kk052 | 5ZHS_A |
| SC | S33.A18 | At3g03990 (Arabidopsis thaliana)-type peptidase | crystal structure of osd14 in complex with covalently bound kk073 | 5ZHT_A |
| SC | S33.A18 | At3g03990 (Arabidopsis thaliana)-type peptidase | crystal structure of rice d14 bound to 2-(2-methyl-3-nitroanilino) benzoic acid | 6AP8_A |
| SC | S33.A18 | At3g03990 (Arabidopsis thaliana)-type peptidase | oryza sativa dwarf14 | 6ELX_A |
| SC | S33.A29 | At4g37470 (Arabidopsis thaliana)-type peptidase | 3W06 | |
| SC | S33.A29 | At4g37470 (Arabidopsis thaliana)-type peptidase | 4HRX | |
| SC | S33.A29 | At4g37470 (Arabidopsis thaliana)-type peptidase | 4HRY | |
| SC | S33.A29 | At4g37470 (Arabidopsis thaliana)-type peptidase | 4HTA | |
| SC | S33.A29 | At4g37470 (Arabidopsis thaliana)-type peptidase | 4IH1 | |
| SC | S33.A29 | At4g37470 (Arabidopsis thaliana)-type peptidase | 4JYM | |
| SC | S33.A29 | At4g37470 (Arabidopsis thaliana)-type peptidase | 4JYP | |
| SC | S33.A29 | At4g37470 (Arabidopsis thaliana)-type peptidase | crystal structure of kai2 | 5Z9G_A |
| SC | S33.A29 | At4g37470 (Arabidopsis thaliana)-type peptidase | crystal structure of kai2_ply2(a219v) | 5Z9H_A |
| SC | S33.A29 | At4g37470 (Arabidopsis thaliana)-type peptidase | crystal structure of physcomitrella patens kai2-like e | 6AZB_A |
| SC | S33.A29 | At4g37470 (Arabidopsis thaliana)-type peptidase | crystal structure of physcomitrella patens kai2-like e s166a | 6AZC_A |
| SC | S33.A29 | At4g37470 (Arabidopsis thaliana)-type peptidase | crystal structure of physcomitrella patens kai2-like c | 6ATX_A |
| SC | S33.A57 | PLN02872 protein (Mus musculus) | complex with a phosphonate inhibitor | 1K8Q_A |
| SC | S33.UNW | family S33 non-peptidase homologues | crystal structure of alr0039, a putative alpha/beta hydrolase from nostoc sp pcc 7120. | 3QYJ_A |
| SC | S33.UNW | family S33 non-peptidase homologues | structure of the rhodococcus haloalkane dehalogenase mutant with enhanced enantioselectivity | 2V9Z_A |
| SC | S33.UNW | family S33 non-peptidase homologues | 3FBW | |
| SC | S33.UNW | family S33 non-peptidase homologues | 3RK4 | |
| SC | S33.UNW | family S33 non-peptidase homologues | 3SK0 | |
| SC | S33.UNW | family S33 non-peptidase homologues | 4E46 | |
| SC | S33.UNW | family S33 non-peptidase homologues | 4F5Z | |
| SC | S33.UNW | family S33 non-peptidase homologues | 4F60 | |
| SC | S33.UNW | family S33 non-peptidase homologues | 4FWB | |
| SC | S33.UNW | family S33 non-peptidase homologues | 4WCV | |
| SC | S33.UNW | family S33 non-peptidase homologues | structure of haloalkane dehalogenase variant dhaa101 | 5FLK_A |
| SC | S33.UNW | family S33 non-peptidase homologues | halotag bound to the p9 benzothiadiazole fluorogenic ligand | 5UXZ_A |
| SC | S33.UNW | family S33 non-peptidase homologues | apo halotag | 5UY1_A |
| SC | S33.UNW | family S33 non-peptidase homologues | halotag bound to the p1 benzoxadiazole fluorogenic ligand | 5VNP_A |
| SC | S33.UNW | family S33 non-peptidase homologues | 1CV2 | |
| SC | S33.UNW | family S33 non-peptidase homologues | 1D07 | |
| SC | S33.UNW | family S33 non-peptidase homologues | 1G42 | |
| SC | S33.UNW | family S33 non-peptidase homologues | 1G4H | |
| SC | S33.UNW | family S33 non-peptidase homologues | 1G5F | |
| SC | S33.UNW | family S33 non-peptidase homologues | 1IZ7 | |
| SC | S33.UNW | family S33 non-peptidase homologues | 1IZ8 | |
| SC | S33.UNW | family S33 non-peptidase homologues | 1K5P | |
| SC | S33.UNW | family S33 non-peptidase homologues | 1K63 | |
| SC | S33.UNW | family S33 non-peptidase homologues | 1K6E | |
| SC | S33.UNW | family S33 non-peptidase homologues | 1MJ5 | |
| SC | S33.UNW | family S33 non-peptidase homologues | 2BFN | |
| SC | S33.UNW | family S33 non-peptidase homologues | 4WDQ | |
| SC | S33.UNW | family S33 non-peptidase homologues | 1EHY_A | |
| SC | S33.UNW | family S33 non-peptidase homologues | the crystal structure of an epoxide hydrolase from streptomyces carzinostaticus subsp. neocarzinostaticus. | 4I19_A |
| SC | S33.UNW | family S33 non-peptidase homologues | ensemble refinement of an epoxide hydrolase from streptomyces carzinostaticus subsp. neocarzinostaticus. | 4QA9_A |
| SC | S33.UNW | family S33 non-peptidase homologues | 4CCY | |
| SC | S33.UNW | family S33 non-peptidase homologues | crystal structure of the putative alpha/beta hydrolase rutd from e.coli | 3V48_A |
| SC | S33.UNW | family S33 non-peptidase homologues | 3BF7 | |
| SC | S33.UNW | family S33 non-peptidase homologues | 3BF8 | |
| SC | S33.UNW | family S33 non-peptidase homologues | structure of a putative epoxide hydrolase from pseudomonas aeruginosa. | 4B9A_A |
| SC | S33.UNW | family S33 non-peptidase homologues | structure of a putative epoxide hydrolase from pseudomonas aeruginosa, with bound mfa. | 4B9E_A |
| SC | S33.UNW | family S33 non-peptidase homologues | structure of a putative epoxide hydrolase t131d mutant from pseudomonas aeruginosa. | 4BAT_A |
| SC | S33.UNW | family S33 non-peptidase homologues | structure of a putative epoxide hydrolase t131d mutant from pseudomonas aeruginosa, with bound mfa | 4BAU_A |
| SC | S33.UNW | family S33 non-peptidase homologues | structure of a putative epoxide hydrolase q244e mutant from pseudomonas aeruginosa. | 4BAZ_A |
| SC | S33.UNW | family S33 non-peptidase homologues | structure of a putative epoxide hydrolase q244e mutant from pseudomonas aeruginosa, with bound mfa. | 4BB0_A |
| SC | S33.UNW | family S33 non-peptidase homologues | 3KXP | |
| SC | S33.UNW | family S33 non-peptidase homologues | structure of potato (solanum tuberosum) epoxide hydrolase i (steh1) | 2CJP_A |
| SC | S33.UNW | family S33 non-peptidase homologues | structure of a y149f mutant of epoxide hydrolase from solanum tuberosum | 3CXU_A |
| SC | S33.UNW | family S33 non-peptidase homologues | laboratory evolved variant r-c1b1 of potato epoxide hydrolase steh1 | 4UFN_A |
| SC | S33.UNW | family S33 non-peptidase homologues | laboratory evolved variant r-c1b1d33e6 of potato epoxide hydrolase steh1 | 4UFO_A |
| SC | S33.UNW | family S33 non-peptidase homologues | laboratory evolved variant r-c1b1d33 of potato epoxide hydrolase steh1 | 4UFP_A |
| SC | S33.UNW | family S33 non-peptidase homologues | laboratory evolved variant r-c1 of potato epoxide hydrolase steh1 | 4UHB_A |
| SC | S33.UNW | family S33 non-peptidase homologues | structure of an h300n mutant of potato epoxide hydrolase, steh1 | 4Y9S_A |
| SC | S33.UNW | family S33 non-peptidase homologues | 2PSD | |
| SC | S33.UNW | family S33 non-peptidase homologues | 2PSE | |
| SC | S33.UNW | family S33 non-peptidase homologues | 2PSF | |
| SC | S33.UNW | family S33 non-peptidase homologues | 2PSH | |
| SC | S33.UNW | family S33 non-peptidase homologues | 2PSJ | |
| SC | S33.UNW | family S33 non-peptidase homologues | 1BN6_A | |
| SC | S33.UNW | family S33 non-peptidase homologues | 1BN7_A | |
| SC | S33.UNW | family S33 non-peptidase homologues | 1CQW_A | |
| SC | S33.UNW | family S33 non-peptidase homologues | 2YYS_A | |
| SC | S33.UNW | family S33 non-peptidase homologues | crystal structure of haloalkane dehalogenase (dcca) from caulobacter crescentus | 5ESR_A |
| SC | S33.UNW | family S33 non-peptidase homologues | 3WI7 | |
| SC | S33.UNW | family S33 non-peptidase homologues | 3WIB | |
| SC | S33.UNW | family S33 non-peptidase homologues | 3R3U | |
| SC | S33.UNW | family S33 non-peptidase homologues | 3R3V | |
| SC | S33.UNW | family S33 non-peptidase homologues | 3R3W | |
| SC | S33.UNW | family S33 non-peptidase homologues | 3R3X | |
| SC | S33.UNW | family S33 non-peptidase homologues | 3R3Y | |
| SC | S33.UNW | family S33 non-peptidase homologues | 3R3Z | |
| SC | S33.UNW | family S33 non-peptidase homologues | 3R40 | |
| SC | S33.UNW | family S33 non-peptidase homologues | 3R41 | |
| SC | S33.UNW | family S33 non-peptidase homologues | crystal structure of the fluoroacetate dehalogenase rpa1163 - his280asn/fluoroacetate - cocrystallized - both protomers reacted with ligand | 5K3A_A |
| SC | S33.UNW | family S33 non-peptidase homologues | crystal structure of the fluoroacetate dehalogenase rpa1163 - asp110asn/chloroacetate - cocrystallized | 5K3B_A |
| SC | S33.UNW | family S33 non-peptidase homologues | crystal structure of the fluoroacetate dehalogenase rpa1163 - wt/5- fluorotryptophan | 5K3C_A |
| SC | S33.UNW | family S33 non-peptidase homologues | crystal structure of the fluoroacetate dehalogenase rpa1163 - wt/apo -no halide | 5K3D_A |
| SC | S33.UNW | family S33 non-peptidase homologues | crystal structure of the fluoroacetate dehalogenase rpa1163 - asp110asn/glycolate - cocrystallized | 5K3E_A |
| SC | S33.UNW | family S33 non-peptidase homologues | crystal structure of the fluoroacetate dehalogenase rpa1163 - his280asn/fluoroacetate - cocrystallized - single protomer reacted with ligand | 5K3F_A |
| SC | S33.UNW | family S33 non-peptidase homologues | crystal structure determination from picosecond infrared laser ablatedprotein crystals by serial synchrotron crystallography | 5NYV_A |
| SC | S33.UNW | family S33 non-peptidase homologues | crystal structure determination from picosecond infrared laser ablatedprotein crystals by serial synchrotron crystallography | 5O2G_A |
| SC | S33.UNW | family S33 non-peptidase homologues | an efficient setup for fixed-target, time-resolved serial crystallography with optical excitation | 5O2I_A |
| SC | S33.UNW | family S33 non-peptidase homologues | crystal structure of the fluoroacetate dehalogenase rpa1163 - asp110asn/fluoroacetate - cocrystallized | 5SWN_A |
| SC | S33.UNW | family S33 non-peptidase homologues | crystal structure of the fluoroacetate dehalogenase rpa1163 - asp110asn - apo no halide | 5T4T_B |
| SC | S33.UNW | family S33 non-peptidase homologues | the hit-and-return system enables efficient time-resolved serial synchrotron crystallography | 6FSX_A |
| SC | S33.UNW | family S33 non-peptidase homologues | the hit-and-return system enables efficient time-resolved serial synchrotron crystallography: facd752ms after reaction initiation | 6GXD_A |
| SC | S33.UNW | family S33 non-peptidase homologues | the hit-and-return system enables efficient time-resolved serial synchrotron crystallography: raddam1 | 6GXF_A |
| SC | S33.UNW | family S33 non-peptidase homologues | the hit-and-return system enables efficient time-resolved serial synchrotron crystallography: facd 0ms after reaction initiation | 6GXH_A |
| SC | S33.UNW | family S33 non-peptidase homologues | the hit-and-return system enables efficient time-resolved serial synchrotron crystallography: raddam2 | 6GXL_A |
| SC | S33.UNW | family S33 non-peptidase homologues | the hit-and-return system enables efficient time-resolved serial synchrotron crystallography: facd2052ms after reaction initiation | 6GXT_A |
| SC | S33.UNW | family S33 non-peptidase homologues | fluoroacetate dehalogenase, room temperature structure solved by serial 1 degree oscillation crystallography | 6MUH_A |
| SC | S33.UNW | family S33 non-peptidase homologues | fluoroacetate dehalogenase, room temperature structure solved by serial 3 degree oscillation crystallography | 6MUY_A |
| SC | S33.UNW | family S33 non-peptidase homologues | fluoroacetate dehalogenase, room temperature structure, using first 1 degree of total 3 degree oscillation | 6MZZ_A |
| SC | S33.UNW | family S33 non-peptidase homologues | fluoroacetate dehalogenase, room temperature structure, using last 1 degree of total 3 degree oscillation and 144 kgy dose | 6N00_A |
| SC | S33.UNW | family S33 non-peptidase homologues | crystal structure of dbja (mutant dbja delta) | 3A2L_A |
| SC | S33.UNW | family S33 non-peptidase homologues | crystal structure of dbja (wild type type i) | 3A2M_A |
| SC | S33.UNW | family S33 non-peptidase homologues | crystal structure of dbja (wild type type ii p21) | 3A2N_A |
| SC | S33.UNW | family S33 non-peptidase homologues | crystal structure of dbja (his-dbja) | 3AFI_E |
| SC | S33.UNW | family S33 non-peptidase homologues | crystal structure of an alpha/beta hydrolase fold protein from burkholderia ambifaria. | 5W15_A |
| SC | S33.UNW | family S33 non-peptidase homologues | 4NVR_A | |
| SC | S33.UNW | family S33 non-peptidase homologues | crystal structure of a putative epoxide hydrolase (kpn_01808) from klebsiella pneumoniae subsp. pneumoniae mgh 78578 at 1.60 a resolution | 5BOV_A |
| SC | S33.UNW | family S33 non-peptidase homologues | crystal structure of haloalkane dehalogenase linb 140a+143l+177w+211l mutant (linb86) from sphingobium japonicum ut26 | 4WDR_A |
| SC | S33.UNW | family S33 non-peptidase homologues | crystal structure of haloalkane dehalogenase linb 140a+143l+177w+211l mutant (linb86) from sphingobium japonicum ut26 at 1.3 a resolution | 5LKA_A |
| SC | S33.UPW | family S33 unassigned peptidases | crystal structure of a probable hydrolytic enzyme (pa3053) from pseudomonas aeruginosa pao1 at 1.50 a resolution | 4F0J_A |
| SC | S33.UPW | family S33 unassigned peptidases | 2J2X | |
| SC | S33.UPW | family S33 unassigned peptidases | 4NMW | |
| SC | S33.UPW | family S33 unassigned peptidases | crystal structure of bromoperoxidase from bacillus anthracis | 3FOB_A |
| SC | S33.UPW | family S33 unassigned peptidases | the structure of an alpha/beta fold family hydrolase from bacillus anthracis str. sterne | 3OOS_A |
| SC | S33.UPW | family S33 unassigned peptidases | 1HKH_A | |
| SC | S33.UPW | family S33 unassigned peptidases | complex with 3a,4,7,7a-tetrahydro-benzo [1,3] dioxol-2-one | 1HL7_A |
| SC | S33.UPW | family S33 unassigned peptidases | the crystal structure of an epoxide hydrolase from streptomyces carzinostaticus subsp. neocarzinostaticus | 5F4Z_A |
| SC | S33.UPW | family S33 unassigned peptidases | structure of a thermophilic esterase | 5FRD_A |
| SC | S33.UPW | family S33 unassigned peptidases | 3I1I_A | |
| SC | S33.UPW | family S33 unassigned peptidases | 2R11 | |
| SC | S33.UPW | family S33 unassigned peptidases | crystal structure of naproxen esterase (carboxylesterase np) from bacillus subtilis | 4CCW_A |
| SC | S33.UPW | family S33 unassigned peptidases | crystal structure of a novel esterase rv0045c from mycobacterium tuberculosis | 3P2M_A |
| SC | S33.UPW | family S33 unassigned peptidases | 1R3D_A | |
| SC | S33.UPW | family S33 unassigned peptidases | the crystal structure of a hydrolase from pseudomonas aeruginosa pa01 | 3OM8_A |
| SC | S33.UPW | family S33 unassigned peptidases | 4ETW | |
| SC | S33.UPW | family S33 unassigned peptidases | 1J1I_A | |
| SC | S33.UPW | family S33 unassigned peptidases | 1C4X_A | |
| SC | S33.UPW | family S33 unassigned peptidases | structure of aspergillus niger epoxide hydrolase | 1QO7_A |
| SC | S33.UPW | family S33 unassigned peptidases | structure of enantioselective mutant of epoxide hydrolase from aspergillus niger generated by directed evolution | 3G02_A |
| SC | S33.UPW | family S33 unassigned peptidases | complex with valpromide (2- propylpentanamide) | 3G0I_A |
| SC | S33.UPW | family S33 unassigned peptidases | 1A8Q | |
| SC | S33.UPW | family S33 unassigned peptidases | crystal structure of predicted cib-like hydrolase (np_393672.1) from thermoplasma acidophilum at 1.45 a resolution | 3BDI_A |
| SC | S33.UPW | family S33 unassigned peptidases | 1Q0R | |
| SC | S33.UPW | family S33 unassigned peptidases | 1Q0Z | |
| SC | S33.UPW | family S33 unassigned peptidases | 4OSE_A | |
| SC | S33.UPW | family S33 unassigned peptidases | crystal structure of vinj | 3WMR_A |
| SC | S33.UPW | family S33 unassigned peptidases | 2PL5 | |
| SC | S33.UPW | family S33 unassigned peptidases | crystal structure of alpha/beta hydrolase from rhodopseudomonas palustris cga009 | 4PSU_A |
| SC | S33.UPW | family S33 unassigned peptidases | orthorhombic crystal structure of an acetylester hydrolase from corynebacterium glutamicum | 5D6O_A |
| SC | S33.UPW | family S33 unassigned peptidases | trigonal crystal structure of an acetylester hydrolase from corynebacterium glutamicum | 5D7B_A |
| SC | S33.UPW | family S33 unassigned peptidases | crystal structure of dxnb2, a carbon - carbon bond hydrolase from sphingomonas wittichii rw1 | 4LXG_A |
| SC | S33.UPW | family S33 unassigned peptidases | crystal structure of the Ser105Ala mutant of a carbon-carbon bond hydrolase, dxnb2 from sphingomonas wittichii rw1, in complex with 3- cl hopda | 4LXH_A |
| SC | S33.UPW | family S33 unassigned peptidases | crystal structure of the Ser105Ala mutant of a carbon-carbon bond hydrolase, dxnb2 from sphingomonas wittichii rw1, in complex with 5, 8-dif hopda ***caveat 4lxi chiral center atom ca5 has sp2 hybridization instead of sp3 | 4LXI_A |
| SC | S33.UPW | family S33 unassigned peptidases | crystal structure of the s105a mutant of a c-c hydrolase, dxnb2 from sphingomonas wittichii rw1 | 4LYD_A |
| SC | S33.UPW | family S33 unassigned peptidases | crystal structure of the Ser105Ala mutant of a c-c hydrolase, dxnb2 from sphingomonas wittichii rw1, in complex with substrate hopda | 4LYE_A |
| SC | S33.UPW | family S33 unassigned peptidases | crystal strukture of rv0183, a monoglyceride lipase from mycobacteriumtuberculosis | 6EIC_C |
| SC | S33.UPW | family S33 unassigned peptidases | crystal structure of the enol-lactonase from burkholderia xenovorans lb400 | 2XUA_A |
| SC | S33.UPW | family S33 unassigned peptidases | crystal structure of rsbq | 1WOM_A |
| SC | S33.UPW | family S33 unassigned peptidases | crystal structure of rsbq inhibited by PMSF | 1WPR_A |
| SC | S33.UPW | family S33 unassigned peptidases | crystal structure of homoserine transacetylase | 2B61_A |
| SC | S33.UPW | family S33 unassigned peptidases | crystal structure of alpha/beta superfamily hydrolase from oenococcus oeni psu-1 | 3FSG_A |
| SC | S33.UPW | family S33 unassigned peptidases | crystal structure of proline iminopeptidase mycobacterium smegmatis | 3NWO_A |
| SC | S33.UPW | family S33 unassigned peptidases | homoserine transacetylase meta from mycobacterium abscessus | 5W8P_A |
| SC | S33.UPW | family S33 unassigned peptidases | crystal structure of non-heme chloroperoxidase from burkholderia cenocepacia | 4DGQ_A |
| SC | S33.UPW | family S33 unassigned peptidases | 4X00_A | |
| SC | S33.UPW | family S33 unassigned peptidases | thioesterase domain from curacin biosynthetic pathway | 3QIT_A |
| SC | S33.UPW | family S33 unassigned peptidases | crystal structures of n-acyl homoserine lactonase aidh | 4G5X_A |
| SC | S33.UPW | family S33 unassigned peptidases | Ser102Gly mutant; complex with n-hexanoyl homoserine lactone | 4G8B_A |
| SC | S33.UPW | family S33 unassigned peptidases | Glu219Gly mutant; complex with n-hexanoyl homoserine | 4G8C_A |
| SC | S33.UPW | family S33 unassigned peptidases | crystal structures of n-acyl homoserine lactonase aidh s102g mutant | 4G8D_A |
| SC | S33.UPW | family S33 unassigned peptidases | complex with n-butanoyl homoserine | 4G9E_A |
| SC | S33.UPW | family S33 unassigned peptidases | crystal structures of n-acyl homoserine lactonase aidh e219g mutant | 4G9G_A |
| SC | S33.UPW | family S33 unassigned peptidases | 3VVL | |
| SC | S33.UPW | family S33 unassigned peptidases | 3VVM | |
| SC | S33.UPW | family S33 unassigned peptidases | crystal structure of pyth_h230a | 5Y51_A |
| SC | S33.UPW | family S33 unassigned peptidases | crystal structure of a novel pyrethroid hydrolase from sphingobium faniae jz-2 | 5Y57_A |
| SC | S33.UPW | family S33 unassigned peptidases | crystal structure of a novel pyrethroid hydrolase pyth with bif | 5Y5R_A |
| SC | S33.UPW | family S33 unassigned peptidases | crystal structure of a novel pyrethroid hydrolase pyth (s78a) | 5Y5V_A |
| SC | S33.UPW | family S33 unassigned peptidases | 1XKL | |
| SC | S33.UPW | family S33 unassigned peptidases | 1Y7H | |
| SC | S33.UPW | family S33 unassigned peptidases | 1Y7I | |
| SC | S33.UPW | family S33 unassigned peptidases | crystal structure of the n-fopmylmaleamic acid deformylase nfo(s94a) from pseudomonas putida s16 | 4L0C_A |
| PA | S39.001 | sobemovirus peptidase | peptidase domain only | 1ZYO |
| PA | S39.UPA | subfamily S39A unassigned peptidases | ryegrass mottle virus protease domain | 6FEZ_A |
| PA | S39.UPA | subfamily S39A unassigned peptidases | ryegrass mottle virus serine protease domain fused with vpg domain | 6FF0_A |
| SK | S41.001 | C-terminal processing peptidase-1 | complex with a substrate-binding adaptor | 5WQL_C |
| SK | S41.002 | C-terminal processing peptidase-2 | 1FC6_A | |
| SK | S41.002 | C-terminal processing peptidase-2 | 1FC7 | |
| SK | S41.002 | C-terminal processing peptidase-2 | 1FC9 | |
| SK | S41.002 | C-terminal processing peptidase-2 | 1FCF | |
| SK | S41.005 | tricorn core peptidase (archaea) | 1K32 | |
| SK | S41.005 | tricorn core peptidase (archaea) | complex with tetrapeptide chloromethyl ketone derivative | 1N6D |
| SK | S41.005 | tricorn core peptidase (archaea) | complex with tridecapeptide chloromethyl ketone derivative | 1N6E |
| SK | S41.005 | tricorn core peptidase (archaea) | complex with Z-Phe-diketo-Arg-Glu-Phe | 1N6F |
| SK | S41.007 | ctpB peptidase | 4C2C | |
| SK | S41.007 | ctpB peptidase | 4C2D | |
| SK | S41.007 | ctpB peptidase | 4C2E | |
| SK | S41.007 | ctpB peptidase | 4C2F | |
| SK | S41.007 | ctpB peptidase | 4C2G | |
| SK | S41.007 | ctpB peptidase | 4C2H | |
| SK | S41.011 | chlamydial protease-like activity factor | 3DJA | |
| SK | S41.011 | chlamydial protease-like activity factor | 3DOR | |
| SK | S41.011 | chlamydial protease-like activity factor | 3DPM | |
| SK | S41.011 | chlamydial protease-like activity factor | 3DPN | |
| SK | S41.012 | Pep putative peptidase (Vibrio-type) | crystal structure of putative s41 protease (yp_211611.1) from bacteroides fragilis nctc 9343 at 2.00 a resolution | 3K50_A |
| SK | S41.951 | interphotoreceptor retinoid-binding protein unit 2 | 1J7X | |
| SK | S41.UNA | subfamily S41A non-peptidase homologues | crystal structure of a putative peptidase (parmer_02772) from parabacteroides merdae atcc 43184 at 2.26 a resolution | 4L8K_A |
| SK | S41.UNA | subfamily S41A non-peptidase homologues | crystal structure of a putative protease (bacuni_00178) from bacteroides uniformis atcc 8492 at 1.50 a resolution | 4GHN_A |
| PB | S45.001 | penicillin G acylase precursor | complex with 3,4-dihydroxyphenylacetic acid | 1AI4_A |
| PB | S45.001 | penicillin G acylase precursor | complex with m-nitrophenylacetic acid | 1AI5_A |
| PB | S45.001 | penicillin G acylase precursor | complex with p-hydroxyphenylacetic acid | 1AI6_A |
| PB | S45.001 | penicillin G acylase precursor | complex with phenol | 1AI7_A |
| PB | S45.001 | penicillin G acylase precursor | complex with p-nitrophenylacetic acid | 1AJN_A |
| PB | S45.001 | penicillin G acylase precursor | complex with 2,5-dihydroxyphenylacetic acid | 1AJP_A |
| PB | S45.001 | penicillin G acylase precursor | complex with thiopheneacetic acid | 1AJQ_A |
| PB | S45.001 | penicillin G acylase precursor | slow processing precursor | 1E3A_A |
| PB | S45.001 | penicillin G acylase precursor | mutant; complex with phenylacetic acid | 1FXH_A |
| PB | S45.001 | penicillin G acylase precursor | mutant; complex with penicillin G | 1FXV_A |
| PB | S45.001 | penicillin G acylase precursor | complex with substrate | 1GK9_A |
| PB | S45.001 | penicillin G acylase precursor | complex with substrate | 1GKF_A |
| PB | S45.001 | penicillin G acylase precursor | complex with substrate | 1GM7_A |
| PB | S45.001 | penicillin G acylase precursor | complex with substrate | 1GM8_A |
| PB | S45.001 | penicillin G acylase precursor | complex with substrate | 1GM9_A |
| PB | S45.001 | penicillin G acylase precursor | altered substrate specificity mutant of penicillin acylase | 1H2G_A |
| PB | S45.001 | penicillin G acylase precursor | penicillin acylase, mutant | 1JX9_A |
| PB | S45.001 | penicillin G acylase precursor | penicillin acylase, mutant complexed with paa | 1K5Q_A |
| PB | S45.001 | penicillin G acylase precursor | penicillin acylase, mutant complexed with ppa | 1K5S_A |
| PB | S45.001 | penicillin G acylase precursor | penicillin acylase mutant with phenyl proprionic acid | 1K7D_A |
| PB | S45.001 | penicillin G acylase precursor | mutant; complex with phenyl proprionic acid | 1KEC_A |
| PB | S45.001 | penicillin G acylase precursor | complex with calcium | 1PNK |
| PB | S45.001 | penicillin G acylase precursor | complex with 2-phenylacetic acid and calcium | 1PNL |
| PB | S45.001 | penicillin G acylase precursor | complex with benzylsulfinic acid and calcium | 1PNM |
| PB | S45.001 | penicillin G acylase precursor | 4PEL | |
| PB | S45.001 | penicillin G acylase precursor | crystal structure of penicillin g acylase from bacillus megaterium | 6NVW_A |
| PB | S45.001 | penicillin G acylase precursor | 1CP9_A | |
| PB | S45.001 | penicillin G acylase precursor | thermostable penicillin g acylase from alcaligenes faecalis in orthorhombic form | 3K3W_A |
| PB | S45.001 | penicillin G acylase precursor | thermostable penicillin g acylase from alcaligenes faecalis in tetragonal form | 3ML0_A |
| PB | S45.002 | cephalosporin acylase precursor | 1FM2_A | |
| PB | S45.002 | cephalosporin acylase precursor | 1JVZ | |
| PB | S45.002 | cephalosporin acylase precursor | 1JW0 | |
| PB | S45.002 | cephalosporin acylase precursor | 1KEH_A | |
| PB | S45.002 | cephalosporin acylase precursor | 1GHD_A | |
| PB | S45.002 | cephalosporin acylase precursor | crystal structure of spacer removed cephalosporin acylase mutant | 4E55_A |
| PB | S45.002 | cephalosporin acylase precursor | crystal structure of spacer 8aa-shortened cephalosporin acylase mutant | 4E56_A |
| PB | S45.002 | cephalosporin acylase precursor | crystal structure of spacer 6aa-shortened cephalosporin acylase mutant | 4E57_A |
| PB | S45.002 | cephalosporin acylase precursor | 1GK0 | |
| PB | S45.002 | cephalosporin acylase precursor | 1GK1 | |
| PB | S45.002 | cephalosporin acylase precursor | 1OR0 | |
| PB | S45.002 | cephalosporin acylase precursor | 2ADV_A | |
| PB | S45.002 | cephalosporin acylase precursor | 2AE3 | |
| PB | S45.002 | cephalosporin acylase precursor | 2AE4 | |
| PB | S45.002 | cephalosporin acylase precursor | 2AE5 | |
| PB | S45.002 | cephalosporin acylase precursor | 3S8R | |
| PB | S45.002 | cephalosporin acylase precursor | Tyr33Leu mutant | 2ADV |
| PB | S45.002 | cephalosporin acylase precursor | mutations in cephalosporin acylase affecting stability and autoproteolysis | 3JTQ_A |
| PB | S45.002 | cephalosporin acylase precursor | mutations in cephalosporin acylase affecting stability and autoproteolysis | 3JTR_A |
| PB | S45.003 | cephalosporin C acylase precursor | mature enzyme. | 1FM2 |
| PB | S45.003 | cephalosporin C acylase precursor | precursor. | 1KEH |
| PB | S45.004 | acyl-homoserine lactone acylase | 2WYB | |
| PB | S45.004 | acyl-homoserine lactone acylase | 2WYC | |
| PB | S45.004 | acyl-homoserine lactone acylase | 2WYD | |
| PB | S45.004 | acyl-homoserine lactone acylase | 2WYE | |
| PB | S45.004 | acyl-homoserine lactone acylase | 3L91 | |
| PB | S45.004 | acyl-homoserine lactone acylase | 3L94 | |
| PB | S45.004 | acyl-homoserine lactone acylase | 3SRA | |
| PB | S45.004 | acyl-homoserine lactone acylase | 3SRB | |
| PB | S45.004 | acyl-homoserine lactone acylase | 3SRC | |
| PB | S45.004 | acyl-homoserine lactone acylase | 4BTH | |
| PB | S45.004 | acyl-homoserine lactone acylase | 4K2F | |
| PB | S45.004 | acyl-homoserine lactone acylase | 4K2G | |
| PB | S45.004 | acyl-homoserine lactone acylase | 4M1J | |
| PB | S45.004 | acyl-homoserine lactone acylase | 4WKS | |
| PB | S45.004 | acyl-homoserine lactone acylase | 4WKT | |
| PB | S45.004 | acyl-homoserine lactone acylase | 4WKU | |
| PB | S45.004 | acyl-homoserine lactone acylase | 4WKV | |
| PB | S45.004 | acyl-homoserine lactone acylase | inactive s1a/n269d-cppvdq mutant in complex with the pyoverdine precursor pvdiq reveals a specific binding pocket for the d-tyr of this substrate | 5UBK_A |
| PB | S45.004 | acyl-homoserine lactone acylase | circularly permuted version | 5UBL_A |
| PB | S45.004 | acyl-homoserine lactone acylase | 4YF9 | |
| PB | S45.004 | acyl-homoserine lactone acylase | complex with decanoic acid | 4YFA |
| PB | S45.004 | acyl-homoserine lactone acylase | complex with phenylacetic acid | 4YFB |
| PB | S45.004 | acyl-homoserine lactone acylase | delta202-208 mutant | 5C9I |
| PA | S46.002 | dipeptidyl-peptidase 11 (Porphyromonas gingivalis-type) | 4XZY | |
| PA | S46.002 | dipeptidyl-peptidase 11 (Porphyromonas gingivalis-type) | 4Y01 | |
| PA | S46.002 | dipeptidyl-peptidase 11 (Porphyromonas gingivalis-type) | 4Y02 | |
| PA | S46.002 | dipeptidyl-peptidase 11 (Porphyromonas gingivalis-type) | 4Y04 | |
| PA | S46.002 | dipeptidyl-peptidase 11 (Porphyromonas gingivalis-type) | crystal structure of porphyromonas gingivalis dpp11 | 5JWF_A |
| PA | S46.002 | dipeptidyl-peptidase 11 (Porphyromonas gingivalis-type) | complex with dipeptide Arg-Asp | 5JXF_A |
| PA | S46.002 | dipeptidyl-peptidase 11 (Porphyromonas gingivalis-type) | complex with dipeptide Arg-Asp | 5JWG_A |
| PA | S46.002 | dipeptidyl-peptidase 11 (Porphyromonas gingivalis-type) | complex with dipeptide Arg-Glu | 5JWI_A |
| PA | S46.002 | dipeptidyl-peptidase 11 (Porphyromonas gingivalis-type) | crystal structure of porphyromonas endodontalis dpp11 | 5JXK_A |
| PA | S46.002 | dipeptidyl-peptidase 11 (Porphyromonas gingivalis-type) | crystal structure of porphyromonas endodontalis dpp11 in alternate conformation | 5JXP_A |
| PA | S46.002 | dipeptidyl-peptidase 11 (Porphyromonas gingivalis-type) | complex with substrate | 5JY0_A |
| PA | S46.003 | dipeptidyl-peptidase BII (Pseudoxanthomonas mexicana) | 3WOI | |
| PA | S46.003 | dipeptidyl-peptidase BII (Pseudoxanthomonas mexicana) | 3WOJ | |
| PA | S46.003 | dipeptidyl-peptidase BII (Pseudoxanthomonas mexicana) | 3WOK | |
| PA | S46.003 | dipeptidyl-peptidase BII (Pseudoxanthomonas mexicana) | 3WOL | |
| PA | S46.003 | dipeptidyl-peptidase BII (Pseudoxanthomonas mexicana) | 3WOM | |
| PA | S46.003 | dipeptidyl-peptidase BII (Pseudoxanthomonas mexicana) | 3WON | |
| PA | S46.003 | dipeptidyl-peptidase BII (Pseudoxanthomonas mexicana) | 3WOO_A | |
| PA | S46.003 | dipeptidyl-peptidase BII (Pseudoxanthomonas mexicana) | 3WOP | |
| PA | S46.003 | dipeptidyl-peptidase BII (Pseudoxanthomonas mexicana) | 3WOQ | |
| PA | S46.003 | dipeptidyl-peptidase BII (Pseudoxanthomonas mexicana) | 3WOR_A | |
| PA | S46.003 | dipeptidyl-peptidase BII (Pseudoxanthomonas mexicana) | 4Y06 | |
| S- | S48.001 | HetR putative peptidase | crystal structure of heterocyst differentiation protein, hetr from fischerella mv11 | 3QOD_A |
| S- | S48.001 | HetR putative peptidase | crystal structure of heterocyst differentiation protein, hetr from fischerella mv11 | 3QOE_A |
| S- | S48.001 | HetR putative peptidase | complex with DNA | 4IZZ |
| S- | S48.001 | HetR putative peptidase | complex with 24mer DNA target | 4J00 |
| S- | S48.001 | HetR putative peptidase | complex with 294mer DNA target | 4J01 |
| S- | S48.001 | HetR putative peptidase | 4HRI | |
| S- | S48.001 | HetR putative peptidase | 4LH9 | |
| S- | S48.001 | HetR putative peptidase | 4YNL | |
| S- | S48.001 | HetR putative peptidase | 4YRV | |
| SK | S49.001 | signal peptide peptidase A (Pseudomonas aeruginosa) | Methionines replaced with selenomethionine | 3BEZ |
| SK | S49.001 | signal peptide peptidase A (Pseudomonas aeruginosa) | native crystals | 3BF0 |
| SK | S49.005 | archaean signal peptide peptidase 1 | 2DEO | |
| SK | S49.005 | archaean signal peptide peptidase 1 | 3BPP | |
| SK | S49.005 | archaean signal peptide peptidase 1 | 3VIV | |
| SK | S49.005 | archaean signal peptide peptidase 1 | 3WG5 | |
| SK | S49.005 | archaean signal peptide peptidase 1 | 3WWV | |
| SK | S49.008 | signal peptide peptidase (Bacillus-type) | 3RST | |
| SK | S49.008 | signal peptide peptidase (Bacillus-type) | 4KWB | |
| SJ | S50.001 | infectious pancreatic necrosis birnavirus Vp4 peptidase | 2PNL | |
| SJ | S50.001 | infectious pancreatic necrosis birnavirus Vp4 peptidase | 2PNM | |
| SJ | S50.001 | infectious pancreatic necrosis birnavirus Vp4 peptidase | 4IZJ | |
| SJ | S50.001 | infectious pancreatic necrosis birnavirus Vp4 peptidase | Lys674Ala mutant | 4IZK |
| SJ | S50.004 | blotched snakehead birnavirus Vp4 peptidase | 2GEF | |
| PC | S51.001 | dipeptidase E | ON HOLD | 1EOZ |
| PC | S51.001 | dipeptidase E | 1FY2 | |
| PC | S51.001 | dipeptidase E | 1FYE_A | |
| PC | S51.003 | cyanophycinase | 3EN0 | |
| PC | S51.UNW | family S51 non-peptidase homologues | crystal structure of peptidase e from deinococcus radiodurans r1 | 6A4T_A |
| PC | S51.UNW | family S51 non-peptidase homologues | 3L4E | |
| SB | S53.001 | sedolisin | complex with a fragment of iodotyrostatin | 1GA1_A |
| SB | S53.001 | sedolisin | complex with pseudoiodotyrostatin inhibitor | 1GA4 |
| SB | S53.001 | sedolisin | complex with a fragment of tyrostatin | 1GA6 |
| SB | S53.001 | sedolisin | complex with the inhibitor AIAF | 1KDV_A |
| SB | S53.001 | sedolisin | complex with the inhibitor AIPF | 1KDY_A |
| SB | S53.001 | sedolisin | complex with the inhibitor tyrostatin | 1KDZ_A |
| SB | S53.001 | sedolisin | complex with the inhibitor pseudotyrostatin | 1KE1_A |
| SB | S53.001 | sedolisin | complex with chymostatin | 1KE2_A |
| SB | S53.001 | sedolisin | complex with two molecules of pseudo-iodotyrostatin | 1NLU_A |
| SB | S53.001 | sedolisin | complex with the inhibitor aiaf | 6M8W_A |
| SB | S53.001 | sedolisin | complex with the inhibitor aipf | 6M8Y_A |
| SB | S53.001 | sedolisin | complex with the inhibitor pseudotyrostatin | 6M9C_A |
| SB | S53.001 | sedolisin | complex with the inhibitor chymostatin | 6M9D_A |
| SB | S53.001 | sedolisin | complex with the inhibitor tyrostatin | 6M9F_A |
| SB | S53.003 | tripeptidyl-peptidase I | precursor | 3EDY |
| SB | S53.003 | tripeptidyl-peptidase I | 3EE6 | |
| SB | S53.003 | tripeptidyl-peptidase I | 1R60 | |
| SB | S53.003 | tripeptidyl-peptidase I | 3EDY_A | |
| SB | S53.003 | tripeptidyl-peptidase I | 3EE6_A | |
| SB | S53.004 | kumamolisin | 1GT9 | |
| SB | S53.004 | kumamolisin | 1GTG | |
| SB | S53.004 | kumamolisin | complex with Ac-Ile-Ala-Phe-Cho | 1GTJ |
| SB | S53.004 | kumamolisin | complex with Ac-Ile-Ala-Phe-Cho | 1GTL |
| SB | S53.004 | kumamolisin | precursor | 1T1E_A |
| SB | S53.004 | kumamolisin | Glu23Ala mutant | 1T1G_A |
| SB | S53.004 | kumamolisin | Trp129Ala mutant | 1T1I_A |
| SB | S53.009 | kumamolisin-As | complex with inhibitor Ace-Ile-Pro-PHL | 1SIO |
| SB | S53.009 | kumamolisin-As | kumamolisin-as e78h mutant | 1SIU_A |
| SB | S53.009 | kumamolisin-As | kumamolisin-as, apoenzyme | 1SN7_A |
| SB | S53.009 | kumamolisin-As | Asp164Asn mutant | 1ZVJ |
| SB | S53.009 | kumamolisin-As | Asp164Asn, Glu78His double mutant | 1ZVK |
| ST | S54.016 | GlpG peptidase (Escherichia-type) | 2IC8 | |
| ST | S54.016 | GlpG peptidase (Escherichia-type) | 2IRV | |
| ST | S54.016 | GlpG peptidase (Escherichia-type) | 2LEP | |
| ST | S54.016 | GlpG peptidase (Escherichia-type) | 2NRF | |
| ST | S54.016 | GlpG peptidase (Escherichia-type) | open-cap conformation | 2O7L |
| ST | S54.016 | GlpG peptidase (Escherichia-type) | 2XOV | |
| ST | S54.016 | GlpG peptidase (Escherichia-type) | complex with isocoumarin inhibitor | 2XOW |
| ST | S54.016 | GlpG peptidase (Escherichia-type) | 2XTU | |
| ST | S54.016 | GlpG peptidase (Escherichia-type) | 2XTV | |
| ST | S54.016 | GlpG peptidase (Escherichia-type) | 3B44 | |
| ST | S54.016 | GlpG peptidase (Escherichia-type) | 3B45 | |
| ST | S54.016 | GlpG peptidase (Escherichia-type) | 3TXT | |
| ST | S54.016 | GlpG peptidase (Escherichia-type) | 3UBB | |
| ST | S54.016 | GlpG peptidase (Escherichia-type) | 3ZEB | |
| ST | S54.016 | GlpG peptidase (Escherichia-type) | 3ZMH | |
| ST | S54.016 | GlpG peptidase (Escherichia-type) | 3ZMI | |
| ST | S54.016 | GlpG peptidase (Escherichia-type) | 3ZMJ | |
| ST | S54.016 | GlpG peptidase (Escherichia-type) | 3ZOT | |
| ST | S54.016 | GlpG peptidase (Escherichia-type) | 4H1D | |
| ST | S54.016 | GlpG peptidase (Escherichia-type) | 4HDD | |
| ST | S54.016 | GlpG peptidase (Escherichia-type) | 4NJN | |
| ST | S54.016 | GlpG peptidase (Escherichia-type) | 4NJP | |
| ST | S54.016 | GlpG peptidase (Escherichia-type) | complex with peptide derived inhibitor ac-rvrha-phenylethyl-ketoamide | 5MT6_A |
| ST | S54.016 | GlpG peptidase (Escherichia-type) | complex with peptide derived inhibitor ac-vrha-cmk | 5MT7_A |
| ST | S54.016 | GlpG peptidase (Escherichia-type) | complex with peptide derived inhibitor ac-rvrha-cmk | 5MT8_A |
| ST | S54.016 | GlpG peptidase (Escherichia-type) | a modular route to novel potent and selective inhibitors of rhomboid intramembrane proteases | 5MTF_A |
| ST | S54.024 | GlpG peptidase (Haemophilus-type) | 2NR9 | |
| ST | S54.024 | GlpG peptidase (Haemophilus-type) | 3ODJ | |
| ST | S54.UPW | family S54 unassigned peptidases | 1VG5 | |
| SP | S59.001 | nucleoporin 145 | autoproteolytic domain | 1KO6 |
| SP | S59.001 | nucleoporin 145 | C-terminal domain | 2Q5X |
| SP | S59.001 | nucleoporin 145 | C-terminal domain | 2Q5Y |
| SP | S59.001 | nucleoporin 145 | 3MMY | |
| SP | S59.001 | nucleoporin 145 | 4OWR | |
| SP | S59.001 | nucleoporin 145 | 5A9Q | |
| SP | S59.001 | nucleoporin 145 | 3TKN | |
| SP | S59.002 | nuclear pore complex component Nup145 (Saccharomyces-type) | 3BG0 | |
| SP | S59.002 | nuclear pore complex component Nup145 (Saccharomyces-type) | 3BG1 | |
| SP | S59.002 | nuclear pore complex component Nup145 (Saccharomyces-type) | 3IKO | |
| SP | S59.002 | nuclear pore complex component Nup145 (Saccharomyces-type) | autoproteolytic domain | 3KEP |
| SP | S59.002 | nuclear pore complex component Nup145 (Saccharomyces-type) | autoproteolytic domain | 3KES |
| SP | S59.002 | nuclear pore complex component Nup145 (Saccharomyces-type) | 4XMM | |
| SP | S59.002 | nuclear pore complex component Nup145 (Saccharomyces-type) | 4XMN | |
| SP | S59.951 | nup 36 protein | 2AIV | |
| SP | S59.951 | nup 36 protein | 3PBP | |
| SP | S59.952 | Nup100p (Saccharomyces cerevisiae) | crystal structure of the c-terminal domain of nuclear pore complex component nup116 from candida glabrata | 3NF5_A |
| SP | S59.A07 | nup189 (Schizosaccharomyces pombe) | 5CWW | |
| SP | S59.A07 | nup189 (Schizosaccharomyces pombe) | crystal structure of chaetomium thermophilum nup145n apd | 5HB5_A |
| SP | S59.A07 | nup189 (Schizosaccharomyces pombe) | crystal structure of chaetomium thermophilum nup145n apd t994a mutant fused to nup145c n | 5HB6_A |
| SP | S59.UPW | family S59 unassigned peptidases | crystal structure of the nup98 c-terminal domain bound to nanobody tp377 | 5E0Q_A |
| SR | S60.001 | lactoferrin | diferric form | 1B0L |
| SR | S60.001 | lactoferrin | oxalate substituted diferric form | 1BKA |
| SR | S60.001 | lactoferrin | apo form | 1CB6_A |
| SR | S60.001 | lactoferrin | N-terminal half molecule; Asp60Ser mutant | 1DSN |
| SR | S60.001 | lactoferrin | Arg210Lys mutant; N-terminal lobe | 1EH3_A |
| SR | S60.001 | lactoferrin | diceric form | 1FCK_A |
| SR | S60.001 | lactoferrin | Arg210Glu mutant; N-terminal lobe | 1H43_A |
| SR | S60.001 | lactoferrin | Arg210Ile mutant; N-terminal lobe | 1H44_A |
| SR | S60.001 | lactoferrin | Arg210Gly mutant; N-terminal lobe | 1H45_A |
| SR | S60.001 | lactoferrin | N-terminal half molecule; His253Met mutant | 1HSE |
| SR | S60.001 | lactoferrin | domain-opened mutant (Arg121Asp); N-terminal lobe | 1L5T_A |
| SR | S60.001 | lactoferrin | copper form | 1LCF |
| SR | S60.001 | lactoferrin | N-terminal half molecule | 1LCT |
| SR | S60.001 | lactoferrin | diferric form | 1LFG |
| SR | S60.001 | lactoferrin | apo form | 1LFH |
| SR | S60.001 | lactoferrin | copper form | 1LFI |
| SR | S60.001 | lactoferrin | N2 fragment; complex with legume isolectin II | 1LGB |
| SR | S60.001 | lactoferrin | 1N76_A | |
| SR | S60.001 | lactoferrin | N-terminal half molecule; Arg121Glu mutant | 1VFD |
| SR | S60.001 | lactoferrin | N-terminal half molecule; Arg121Ser mutant | 1VFE |
| SR | S60.001 | lactoferrin | recombinant form | 2BJJ_X |
| SR | S60.001 | lactoferrin | 1BLF_A | |
| SR | S60.001 | lactoferrin | 1JW1_A | |
| SR | S60.001 | lactoferrin | 1DTZ_A | |
| SR | S60.001 | lactoferrin | 1I6Q_A | |
| SR | S60.001 | lactoferrin | complex with Escherichia coli OmpC | 2J4U_S |
| SR | S60.001 | lactoferrin | structure of diferric mare lactoferrin at 2.62a resolution | 1B1X_A |
| SR | S60.001 | lactoferrin | structure of mare apolactoferrin: the n and c lobes are in the closed form | 1B7U_A |
| SR | S60.001 | lactoferrin | structure of oxalate substituted diferric mare lactoferrin from colostrum | 1B7Z_A |
| SR | S60.001 | lactoferrin | melanin protein interaction: x-ray structure of the complex of mare lactoferrin with melanin monomers | 1F9B_A |
| SR | S60.001 | lactoferrin | apolactoferrin | 1I6B_A |
| SR | S60.001 | lactoferrin | complex with a lanthanide ion (Sm3+) | 1QJM_A |
| SR | S60.001 | lactoferrin | complex with 6- (hydroxymethyl)oxane-2,3,4,5-tetrol | 3CR9_A |
| SR | S60.001 | lactoferrin | 1CE2_A | |
| SR | S60.970 | lactotransferrin precursor, domain 2 | 1BLF_A | |
| SR | S60.970 | lactotransferrin precursor, domain 2 | 1LFC | |
| SR | S60.970 | lactotransferrin precursor, domain 2 | proteolytically generated functional monoferric C-terminal lobe | 1NKX_A |
| SR | S60.970 | lactotransferrin precursor, domain 2 | zinc saturated C-terminal lobe | 1SDX_A |
| SR | S60.970 | lactotransferrin precursor, domain 2 | 1Y58 | |
| SR | S60.970 | lactotransferrin precursor, domain 2 | C-terminal lobe; complex with indomethacin | 2ALT_A |
| SR | S60.970 | lactotransferrin precursor, domain 2 | C-terminal lobe; complex with tetrasaccharide | 2ALU_A |
| SR | S60.970 | lactotransferrin precursor, domain 2 | C-terminal lobe; complex with N-acetyl galactosamine | 2AYS_A |
| SR | S60.970 | lactotransferrin precursor, domain 2 | C-terminal lobe; complex with maltose | 2B65_A |
| SR | S60.970 | lactotransferrin precursor, domain 2 | C-terminal lobe; complex with diclofenac | 2B6D_A |
| SR | S60.970 | lactotransferrin precursor, domain 2 | C-terminal lobe; complex with adenosine | 2DOJ_A |
| SR | S60.970 | lactotransferrin precursor, domain 2 | C-terminal lobe; complex with trisaccharide | 2DP8_A |
| SR | S60.970 | lactotransferrin precursor, domain 2 | C-terminal lobe; complex with galactose | 2DQV_A |
| SR | S60.970 | lactotransferrin precursor, domain 2 | C-terminal lobe; complex with mannose | 2DS9_A |
| SR | S60.970 | lactotransferrin precursor, domain 2 | C-terminal lobe; complex with xylose | 2DSF_A |
| SR | S60.970 | lactotransferrin precursor, domain 2 | C-terminal lobe; complex with sucrose | 2DVC_A |
| SR | S60.970 | lactotransferrin precursor, domain 2 | C-terminal lobe; complex with fucose | 2DWA_A |
| SR | S60.970 | lactotransferrin precursor, domain 2 | C-terminal lobe; complex with N-acetylglucosamine | 2DWH_A |
| SR | S60.970 | lactotransferrin precursor, domain 2 | C-terminal lobe; complex with cellobiose | 2DWI_A |
| SR | S60.970 | lactotransferrin precursor, domain 2 | C-terminal lobe; complex with raffinose | 2DWJ_A |
| SR | S60.970 | lactotransferrin precursor, domain 2 | C-terminal lobe; complex with sorbitol | 2DXR_A |
| SR | S60.970 | lactotransferrin precursor, domain 2 | C-terminal lobe; complex with trehalose | 2DXY_A |
| SR | S60.970 | lactotransferrin precursor, domain 2 | structure of the complex of lactoferrin c-lobe with melibiose at 2.0 a resolution | 2DYX_A |
| SR | S60.970 | lactotransferrin precursor, domain 2 | C-terminal lobe; complex with rhamnose | 2E0S_A |
| SR | S60.970 | lactotransferrin precursor, domain 2 | C-terminal lobe; complex with arabinose | 2E1S_A |
| SR | S60.970 | lactotransferrin precursor, domain 2 | C-terminal lobe; complex with a pentasaccharide | 2FA7_A |
| SR | S60.970 | lactotransferrin precursor, domain 2 | C-terminal lobe; complex with acetyl salicylic acid | 2G5J_A |
| SR | S60.970 | lactotransferrin precursor, domain 2 | C-terminal lobe; complex with methyl alpha-d-mannopyranoside | 2G93_A |
| SR | S60.970 | lactotransferrin precursor, domain 2 | C-terminal lobe; complex with lactose | 2H4I_A |
| SR | S60.970 | lactotransferrin precursor, domain 2 | C-terminal lobe; complex with glucose | 2HCA_A |
| SR | S60.970 | lactotransferrin precursor, domain 2 | 2MD1 | |
| SR | S60.970 | lactotransferrin precursor, domain 2 | 2MD2 | |
| SR | S60.970 | lactotransferrin precursor, domain 2 | 2MD3 | |
| SR | S60.970 | lactotransferrin precursor, domain 2 | 2MD4 | |
| SR | S60.970 | lactotransferrin precursor, domain 2 | C-terminal lobe; complex with atenolol | 2NUV_A |
| SR | S60.970 | lactotransferrin precursor, domain 2 | C-terminal lobe; complex with disaccharide | 2NWJ_A |
| SR | S60.970 | lactotransferrin precursor, domain 2 | C-terminal lobe; complex with disaccharide | 2O1L_A |
| SR | S60.970 | lactotransferrin precursor, domain 2 | C-terminal lobe; complex with fructose | 2O51_A |
| SR | S60.970 | lactotransferrin precursor, domain 2 | C-terminal lobe; complex with N-(4-hydroxyphenyl) acetamide | 2OCU_A |
| SR | S60.970 | lactotransferrin precursor, domain 2 | C-terminal lobe; complex with O-alpha-D-glucopyranosyl-(1 3)- alpha-d-fructofuranosyl- (2 1)- alpha-D-glucopyranoside | 2P1S_A |
| SR | S60.970 | lactotransferrin precursor, domain 2 | C-terminal lobe; complex with ribose | 2PX1_A |
| SR | S60.970 | lactotransferrin precursor, domain 2 | C-terminal lobe; complex with mannitol and mannose | 2Q8J_A |
| SR | S60.970 | lactotransferrin precursor, domain 2 | C-lobe; complex with amygdalin | 2QJE_A |
| SR | S60.970 | lactotransferrin precursor, domain 2 | C-lobe; complex with inositol | 2R71_A |
| SR | S60.970 | lactotransferrin precursor, domain 2 | ligand recognition in c-lobe: the crystal structure of the complex of lactoferrin c-lobe with nicotinamide at 2.5 a resolution | 2R9J_A |
| SR | S60.970 | lactotransferrin precursor, domain 2 | C-terminal lobe; complex with parecoxib | 2ZMB_A |
| SR | S60.970 | lactotransferrin precursor, domain 2 | 3CFL | |
| SR | S60.970 | lactotransferrin precursor, domain 2 | C-lobe; complex with vitamin B3 (niacin) | 3CI8_A |
| SR | S60.970 | lactotransferrin precursor, domain 2 | C-lobe; complex with 2-chromenone | 3CRB_A |
| SR | S60.970 | lactotransferrin precursor, domain 2 | C-lobe; complex with nimesulide | 3E9X_A |
| SR | S60.970 | lactotransferrin precursor, domain 2 | structure of the complex of c-terminal half (c-lobe) of bovine lactoferrin with alpha-methyl-4-(2-methylpropyl) benzene acetic acid | 3FKX_A |
| SR | S60.970 | lactotransferrin precursor, domain 2 | 3IAZ | |
| SR | S60.970 | lactotransferrin precursor, domain 2 | 3IB0 | |
| SR | S60.970 | lactotransferrin precursor, domain 2 | 3IB1 | |
| SR | S60.970 | lactotransferrin precursor, domain 2 | 3IB2 | |
| SR | S60.970 | lactotransferrin precursor, domain 2 | 3K0V | |
| SR | S60.970 | lactotransferrin precursor, domain 2 | 3KJ7 | |
| SR | S60.970 | lactotransferrin precursor, domain 2 | 3MJN | |
| SR | S60.970 | lactotransferrin precursor, domain 2 | 3O97 | |
| SR | S60.970 | lactotransferrin precursor, domain 2 | 3RGY | |
| SR | S60.970 | lactotransferrin precursor, domain 2 | 3SDF | |
| SR | S60.970 | lactotransferrin precursor, domain 2 | 3TAJ | |
| SR | S60.970 | lactotransferrin precursor, domain 2 | 3TOD | |
| SR | S60.970 | lactotransferrin precursor, domain 2 | 3TTR | |
| SR | S60.970 | lactotransferrin precursor, domain 2 | 3TUS | |
| SR | S60.970 | lactotransferrin precursor, domain 2 | 3U72 | |
| SR | S60.970 | lactotransferrin precursor, domain 2 | 3U8Q | |
| SR | S60.970 | lactotransferrin precursor, domain 2 | 3UGW | |
| SR | S60.970 | lactotransferrin precursor, domain 2 | 3UK4 | |
| SR | S60.970 | lactotransferrin precursor, domain 2 | 3USD | |
| SR | S60.970 | lactotransferrin precursor, domain 2 | 3V5A | |
| SR | S60.970 | lactotransferrin precursor, domain 2 | 3VDF | |
| SR | S60.970 | lactotransferrin precursor, domain 2 | 4DIG | |
| SR | S60.970 | lactotransferrin precursor, domain 2 | 4DXU | |
| SR | S60.970 | lactotransferrin precursor, domain 2 | 4FIM | |
| SR | S60.970 | lactotransferrin precursor, domain 2 | 4FJP | |
| SR | S60.970 | lactotransferrin precursor, domain 2 | 4FOR | |
| SR | S60.970 | lactotransferrin precursor, domain 2 | 4G2Z | |
| SR | S60.970 | lactotransferrin precursor, domain 2 | 4G77 | |
| SR | S60.970 | lactotransferrin precursor, domain 2 | 4G8H | |
| SR | S60.970 | lactotransferrin precursor, domain 2 | 4GRK | |
| SR | S60.970 | lactotransferrin precursor, domain 2 | 4N6P | |
| SR | S60.970 | lactotransferrin precursor, domain 2 | 4NED | |
| SR | S60.970 | lactotransferrin precursor, domain 2 | 4OQO | |
| SR | S60.970 | lactotransferrin precursor, domain 2 | 5CRY | |
| SR | S60.970 | lactotransferrin precursor, domain 2 | intermediate structure of iron-saturated c-lobe of bovine lactoferrin at 2.79 angstrom resolution indicates the softening of iron coordination | 5HBC_A |
| SR | S60.970 | lactotransferrin precursor, domain 2 | diceric form | 1FCK_A |
| SR | S60.970 | lactotransferrin precursor, domain 2 | 1N76_A | |
| SR | S60.970 | lactotransferrin precursor, domain 2 | crystals grown at pH 6.5 | 1SQY_A |
| SR | S60.970 | lactotransferrin precursor, domain 2 | recombinant form | 2BJJ_X |
| SR | S60.970 | lactotransferrin precursor, domain 2 | fragment; complex with proteinase K and a human lactoferrin | 2DP4_I |
| SR | S60.970 | lactotransferrin precursor, domain 2 | N-terminal lobe; complex with a lactoferrin-binding domain of pneumococcal surface protein A | 2PMS_A |
| SR | S60.970 | lactotransferrin precursor, domain 2 | apo form | 1AIV_A |
| SR | S60.970 | lactotransferrin precursor, domain 2 | C-terminal lobe, apo form | 1IQ7_A |
| SR | S60.970 | lactotransferrin precursor, domain 2 | 1N04_A | |
| SR | S60.970 | lactotransferrin precursor, domain 2 | 1OVT_A | |
| SR | S60.970 | lactotransferrin precursor, domain 2 | apo- form | 1RYX_A |
| SR | S60.970 | lactotransferrin precursor, domain 2 | aluminum-bound form | 2D3I_A |
| SR | S60.970 | lactotransferrin precursor, domain 2 | 1BIY_A | |
| SR | S60.970 | lactotransferrin precursor, domain 2 | 1CE2_A | |
| SR | S60.970 | lactotransferrin precursor, domain 2 | 1H76_A | |
| SR | S60.970 | lactotransferrin precursor, domain 2 | 1D9K | |
| SR | S60.970 | lactotransferrin precursor, domain 2 | N-terminal lobe, holo form | 1IEJ_A |
| SR | S60.970 | lactotransferrin precursor, domain 2 | 1JL4 | |
| SR | S60.970 | lactotransferrin precursor, domain 2 | N-terminal lobe, iron loaded open form | 1NFT_A |
| SR | S60.970 | lactotransferrin precursor, domain 2 | N-terminal lobe | 1NNT_A |
| SR | S60.970 | lactotransferrin precursor, domain 2 | N-terminal lobe, apo form | 1TFA_A |
| SR | S60.970 | lactotransferrin precursor, domain 2 | 1DTZ_A | |
| SR | S60.970 | lactotransferrin precursor, domain 2 | 1I6Q_A | |
| SR | S60.972 | serotransferrin precursor (domain 1) | N-terminal lobe | 1A8E_A |
| SR | S60.972 | serotransferrin precursor (domain 1) | N-terminal lobe | 1A8F_A |
| SR | S60.972 | serotransferrin precursor (domain 1) | N-terminal lobe | 1B3E_A |
| SR | S60.972 | serotransferrin precursor (domain 1) | N-terminal lobe, apo form | 1BP5_A |
| SR | S60.972 | serotransferrin precursor (domain 1) | N-terminal lobe, apo form, crystal form 2 | 1BTJ_A |
| SR | S60.972 | serotransferrin precursor (domain 1) | 1D3K_A | |
| SR | S60.972 | serotransferrin precursor (domain 1) | 1D4N_A | |
| SR | S60.972 | serotransferrin precursor (domain 1) | N-terminal lobe His249Glu mutant | 1DTG_A |
| SR | S60.972 | serotransferrin precursor (domain 1) | N-terminal lobe Lys206Ala mutant | 1FQE_A |
| SR | S60.972 | serotransferrin precursor (domain 1) | N-terminal lobe Lys296Ala mutant | 1FQF_A |
| SR | S60.972 | serotransferrin precursor (domain 1) | N-terminal lobe His249Gln mutant | 1JQF_A |
| SR | S60.972 | serotransferrin precursor (domain 1) | N-terminal lobe Ile66Trp mutant | 1N7W_A |
| SR | S60.972 | serotransferrin precursor (domain 1) | N-terminal lobe Tyr45Glu mutant | 1N7X_A |
| SR | S60.972 | serotransferrin precursor (domain 1) | N-terminal lobe | 1N84_A |
| SR | S60.972 | serotransferrin precursor (domain 1) | N-terminal lobe Asp63Glu mutant | 1OQG_A |
| SR | S60.972 | serotransferrin precursor (domain 1) | N-terminal lobe Arg124Ala mutant | 1OQH_A |
| SR | S60.972 | serotransferrin precursor (domain 1) | N-terminal lobe; complex with oxalate | 1RYO_A |
| SR | S60.972 | serotransferrin precursor (domain 1) | complex with human transferrin receptor | 1SUV_C |
| SR | S60.972 | serotransferrin precursor (domain 1) | apo-form (non-glycosylated) | 2HAU_A |
| SR | S60.972 | serotransferrin precursor (domain 1) | apo-form (glycosylated) | 2HAV_A |
| SR | S60.972 | serotransferrin precursor (domain 1) | N-terminal lobe Lys206Glu/Lys296Glu mutant | 2O7U_B |
| SR | S60.972 | serotransferrin precursor (domain 1) | N-terminal lobe Lys206Glu mutant | 2O84_X |
| SR | S60.972 | serotransferrin precursor (domain 1) | 1JNF_A | |
| SR | S60.972 | serotransferrin precursor (domain 1) | high-resolution x-ray studies on rabbit serum transferrin: preliminary structure analysis of the n-terminal half- molecule at 2.3 angstroms resolution | 1TFD_A |
| SR | S60.975 | serotransferrin precursor (domain 2) | apo-form (non-glycosylated) | 2HAU_A |
| SR | S60.975 | serotransferrin precursor (domain 2) | apo-form (glycosylated) | 2HAV_A |
| SR | S60.975 | serotransferrin precursor (domain 2) | N-lobe; Gly65Arg/Lys206Glu double mutant | 3FGS_A |
| SR | S60.975 | serotransferrin precursor (domain 2) | 1H76_A | |
| SR | S60.977 | 1300017J02Rik protein | 3MC2 | |
| S- | S62.001 | influenza A PA peptidase | crystal structure of pa-pb1 complex form influenza virus rna polymerase | 2ZNL_A |
| S- | S62.001 | influenza A PA peptidase | RNA polymerase subunit | 3CM8_A |
| S- | S62.001 | influenza A PA peptidase | N-terminal, non-peptidase domain | 3EBJ_A |
| S- | S62.001 | influenza A PA peptidase | the crystal structure of avian influenza virus pa_n in complex with ump | 3HW3_A |
| S- | S62.001 | influenza A PA peptidase | crystal structure of avian influenza a virus in complex with tmp | 3HW4_A |
| S- | S62.001 | influenza A PA peptidase | crystal structure of avian influenza virus pa_n in complex with amp | 3HW5_A |
| S- | S62.001 | influenza A PA peptidase | crystal structure of avian influenza virus pa_n in complex with mn | 3HW6_A |
| S- | S62.001 | influenza A PA peptidase | electron cryo-microscopy of an rna polymerase | 3J9B_A |
| S- | S62.001 | influenza A PA peptidase | crystal structure of avian influenza virus pan apo | 4E5E_A |
| S- | S62.001 | influenza A PA peptidase | crystal structure of avian influenza virus pan bound to compound 1 | 4E5F_A |
| S- | S62.001 | influenza A PA peptidase | crystal structure of avian influenza virus pan bound to compound 2 | 4E5G_A |
| S- | S62.001 | influenza A PA peptidase | crystal structure of avian influenza virus pan bound to compound 3 | 4E5H_A |
| S- | S62.001 | influenza A PA peptidase | crystal structure of avian influenza virus pan bound to compound 4 | 4E5I_A |
| S- | S62.001 | influenza A PA peptidase | crystal structure of avian influenza virus pan bound to compound 5 | 4E5J_A |
| S- | S62.001 | influenza A PA peptidase | crystal structure of avian influenza virus pan bound to compound 6 | 4E5L_A |
| S- | S62.001 | influenza A PA peptidase | structure of polymerase acid protein (pa) from influenzavirus a influenza a virus a, wilson-smith/1933 (h1n1) | 4IUJ_A |
| S- | S62.001 | influenza A PA peptidase | 2-(4-(1h-tetrazol-5-yl)phenyl)-5-hydroxypyrimidin-4(3h)-one bound to influenza 2009 h1n1 endonuclease | 4W9S_A |
| S- | S62.001 | influenza A PA peptidase | phenolic acid derivative bound to influenza strain h1n1 polymerase subunit pa endonuclease | 4YYL_A |
| S- | S62.001 | influenza A PA peptidase | endonuclease inhibitor bound to influenza strain h1n1 polymerase acidic subunit n-terminal region with expelling one of the metal ionsin the active site | 4ZHZ_A |
| S- | S62.001 | influenza A PA peptidase | endonuclease inhibitor bound to influenza strain h1n1 polymerase acidic subunit n-terminal region without a chelation to the metal ions in the active site | 4ZI0_A |
| S- | S62.001 | influenza A PA peptidase | apo form of influenza strain h1n1 polymerase acidic subunit n-terminal region | 4ZQQ_A |
| S- | S62.001 | influenza A PA peptidase | endonuclease inhibitor 1 bound to influenza strain h1n1 polymerase acidic subunit n-terminal region at ph 7.0 | 5FDD_A |
| S- | S62.001 | influenza A PA peptidase | endonuclease inhibitor 3 bound to influenza strain h1n1 polymerase acidic subunit n-terminal region at ph 7.0 | 5FDG_A |
| S- | S62.001 | influenza A PA peptidase | endonuclease inhibitor 2 bound to influenza strain h1n1 polymerase acidic subunit n-terminal region at ph 7.0 | 5I13_A |
| S- | S62.001 | influenza A PA peptidase | crystal structure of polymerase acid protein (pa) from influenza a virus, wilson-smith/1933 (h1n1) bound to fragment hit ebsi-747 1-(4- chlorophenyl)-1h-imidazole | 5IEQ_A |
| S- | S62.001 | influenza A PA peptidase | crystal structure of polymerase acid protein (pa) from influenza a virus, wilson-smith/1933 (h1n1) bound to fragment hit ebsi-576 (5,6- dichloro-1h-1,3-benzodiazol-2-yl)methanol | 5IF2_A |
| S- | S62.001 | influenza A PA peptidase | crystal structure of polymerase acid protein (pa) from influenza a virus, wilson-smith/1933 (h1n1) bound to ebsi-39 (2,3- dichlorophenyl)methanol | 5IF5_A |
| S- | S62.001 | influenza A PA peptidase | crystal structure of polymerase acid protein (pa) from influenza a virus, wilson-smith/1933 (h1n1) bound to fragment hit ebsi-279 n-[(4-chlorophenyl)methyl]-1-methyl-1h-pyrazolo[3,4-d]pyrimidin-4-amine | 5IF7_A |
| S- | S62.001 | influenza A PA peptidase | crystal structure of polymerase acid protein (pa) from influenza a virus, wilson-smith/1933 (h1n1) bound to fragment hit ebsi-2643 5- [(4-chlorophenyl)methyl]-1,3,4-oxadiazol-2-amine | 5IF8_A |
| S- | S62.001 | influenza A PA peptidase | crystal structure of polymerase acid protein (pa) from influenza a virus, wilson-smith/1933 (h1n1) bound to follow on fragment ebsi-47195-chloro-2-(1h-imidazol-1-yl)aniline | 5IFB_A |
| S- | S62.001 | influenza A PA peptidase | crystal structure of polymerase acid protein (pa) from influenza a virus, wilson-smith/1933 (h1n1) bound to follow on fragment ebsi-47201-(4-bromophenyl)-1h-imidazole | 5IFC_A |
| S- | S62.001 | influenza A PA peptidase | crystal structure of polymerase acid protein (pa) from influenza a virus, wilson-smith/1933 (h1n1) bound to follow on fragment ebsi-47211-(4-fluorophenyl)-1h-imidazole | 5IFD_A |
| S- | S62.001 | influenza A PA peptidase | apo form of influenza strain h1n1 polymerase acidic subunit n-terminalregion crystallized with potassium sodium tartrate | 5JHT_A |
| S- | S62.001 | influenza A PA peptidase | apo form of influenza strain h1n1 polymerase acidic subunit n-terminalregion crystallized with polyethylene glycol 8000 | 5JHV_A |
| S- | S62.001 | influenza A PA peptidase | crystal structure of polymerase acid protein (pa) from influenza a virus, wilson-smith/1933 (h1n1) bound to follow on fragment ebsi-47234-(5-chlorothiophen-2-yl)-1h-pyrazole | 5V0U_A |
| S- | S62.001 | influenza A PA peptidase | crystal structure of polymerase acid protein (pa) from influenza a virus, wilson-smith/1933 (h1n1) bound to fragment hit bsi-70565 1-1-[4-fluorophenyl)methyl]-2-methyl-1h-imidazol-4-ylethan-1-one | 6CFP_A |
| S- | S62.UNW | family S62 non-peptidase homologues | influenza c virus rna-dependent rna polymerase - space group p43212 | 5D98_A |
| S- | S62.UNW | family S62 non-peptidase homologues | influenza c virus rna-dependent rna polymerase - space group p212121 | 5D9A_A |
| S- | S62.UNW | family S62 non-peptidase homologues | a mechanism for the activation of the influenza virus transcriptase | 6F5P_A |
| S- | S62.UNW | family S62 non-peptidase homologues | crystal structure of influenza b polymerase with bound vrna promoter (form flub2) | 4WRT_R |
| S- | S62.UNW | family S62 non-peptidase homologues | crystal structure of influenza b polymerase bound to the vrna promoter(flub1 form) | 4WSA_R |
| S- | S62.UNW | family S62 non-peptidase homologues | influenza b polymerase bound to four heptad repeats of serine 5 phosphorylated pol ii ctd | 5M3J_A |
| S- | S62.UNW | family S62 non-peptidase homologues | influenza b polymerase bound to vrna promoter and capped rna primer | 5MSG_A |
| S- | S62.UNW | family S62 non-peptidase homologues | a mechanism for the activation of the influenza virus transcriptase | 6F5O_A |
| S- | S62.UNW | family S62 non-peptidase homologues | influenza b polymerase pre-initiation complex | 6QCS_A |
| S- | S62.UNW | family S62 non-peptidase homologues | crystal structure of influenza b polymerase initiation state with capped 14-mer rna primer and ctp | 6QCV_A |
| S- | S62.UNW | family S62 non-peptidase homologues | crystal structure of influenza b polymerase initiation state with capped 14-mer rna primer | 6QCW_A |
| S- | S62.UNW | family S62 non-peptidase homologues | crystal structure of influenza b polymerase initiation state with capped 15-mer rna primer | 6QCX_A |
| S- | S62.UPW | family S62 unassigned peptidases | 4-(2-(4-fluorophenyl)-5-hydroxy-6-oxo-1,6-dihydropyridin-3-yl)benzoic acid bound to influenza 2009 ph1n1 endonuclease | 6NEL_A |
| S- | S62.UPW | family S62 unassigned peptidases | 3-hydroxy-5-[(naphthalen-1-yl)methyl]-6-[4-(1h-tetrazol-5-yl) phenyl]pyridin-2(1h)-one bound to influenza 2009 ph1n1 endonuclease ***caveat 6nem a hg cys 8 - a o hoh 510; dist = 0.98 a | 6NEM_A |
| SS | S66.001 | murein tetrapeptidase LD-carboxypeptidase (Pseudomonas-type) | 1ZL0 | |
| SS | S66.001 | murein tetrapeptidase LD-carboxypeptidase (Pseudomonas-type) | 1ZRS | |
| SS | S66.001 | murein tetrapeptidase LD-carboxypeptidase (Pseudomonas-type) | Ser115Ala mutant | 2AUM |
| SS | S66.001 | murein tetrapeptidase LD-carboxypeptidase (Pseudomonas-type) | His285Ala mutant | 2AUN |
| SS | S66.002 | murein tetrapeptidase LD-carboxypeptidase (Escherichia-type) | native escherichia coli l,d-carboxypeptidase a (ldca) | 5Z01_A |
| SS | S66.002 | murein tetrapeptidase LD-carboxypeptidase (Escherichia-type) | mutant (s106a) escherichia coli l,d-carboxypeptidase a (ldca) | 5Z03_A |
| SS | S66.003 | microcin C7 immunity protein | 3TLA | |
| SS | S66.003 | microcin C7 immunity protein | 3TLB | |
| SS | S66.003 | microcin C7 immunity protein | 3TLC | |
| SS | S66.003 | microcin C7 immunity protein | 3TLE | |
| SS | S66.003 | microcin C7 immunity protein | 3TLG | |
| SS | S66.003 | microcin C7 immunity protein | 3TLY | |
| SS | S66.003 | microcin C7 immunity protein | 3TLZ | |
| SS | S66.003 | microcin C7 immunity protein | 4IIX | |
| SS | S66.003 | microcin C7 immunity protein | 4IIY | |
| SS | S66.003 | microcin C7 immunity protein | crystal structure of mccf homolog from listeria monocytogenes egd-e | 4H1H_A |
| SS | S66.003 | microcin C7 immunity protein | crystal structure of the s111a mutant of member of mccf clade from listeria monocytogenes egd-e with product | 4INJ_A |
| SS | S66.003 | microcin C7 immunity protein | 3GJZ_A | |
| SS | S66.003 | microcin C7 immunity protein | crystal structure of the w180a mutant of microcin immunity protein mccf from bacillus anthracis shows the active site loop in the open conformation. | 3SR3_A |
| SS | S66.003 | microcin C7 immunity protein | crystal structure of the s112a mutant of mycrocine immunity protein (mccf) with amp | 3T5M_A |
| SS | S66.003 | microcin C7 immunity protein | crystal structure of the s238r mutant of mycrocine immunity protein (mccf) with amp | 3U1B_A |
| SS | S66.003 | microcin C7 immunity protein | crystal structure of the double mutant (s112a, h303a) of b.anthracis mycrocine immunity protein (mccf) with alanyl sulfamoyl adenylates | 4JVO_A |
| SS | S66.003 | microcin C7 immunity protein | crystal structure of the double mutant (s112a, h303a) of b.anthracis mycrocine immunity protein (mccf) with aspartyl sulfamoyl adenylates | 4MI1_A |
| SS | S66.003 | microcin C7 immunity protein | crystal structure of the double mutant (s112a, h303a) of b.anthracis mycrocine immunity protein (mccf) | 4MJX_A |
| SS | S66.003 | microcin C7 immunity protein | crystal structure of microcin immunity protein mccf from bacillus anthracis in complex with mcc | 5K99_A |
| SS | S66.003 | microcin C7 immunity protein | crystal structure of mccflike protein (ba_5613) from bacillus anthracis str. ames | 4E5S_A |
| SS | S66.003 | microcin C7 immunity protein | crystal structure of mccf-like protein (ba_5613) in complex with asa (alanyl sulfamoyl adenylates) | 5FD8_A |
| SS | S66.003 | microcin C7 immunity protein | crystal structure of mccf-like protein (ba_5613) in the complex with aspartyl sulfamoyl adenylate | 5USD_A |
| SS | S66.UPW | family S66 unassigned peptidases | TOPSAN | 3G23 |
| SS | S66.UPW | family S66 unassigned peptidases | crystal structure of ba3275, the member of s66 family of serine peptidases | 5F1Y_A |
| SS | S66.UPW | family S66 unassigned peptidases | crystal structure of s116a ba3275 with amp bound | 5F5X_A |
| SS | S66.UPW | family S66 unassigned peptidases | crystal structure of native b3275, member of mccf family of enzymes | 5F9M_A |
| SS | S66.UPW | family S66 unassigned peptidases | crystal structure of 3 mutant of ba3275 (s116a, e243a, h313a), the member of s66 family of serine peptidases | 5JYB_A |
| SJ | S69.001 | Tellina virus 1 VP4 peptidase | 3P06 | |
| S- | S71.001 | MUC1 self-cleaving mucin | NMR structure | 2ACM |
| S- | S71.001 | MUC1 self-cleaving mucin | crystal structure of the mucin-1 sea domain, l1105m mutant, selenium- derivative | 6BSB_A |
| S- | S71.001 | MUC1 self-cleaving mucin | crystal structure of the mucin-1 sea domain | 6BSC_A |
| S- | S72.001 | dystroglycan | peptide 881-895; complex with a WW domain fragment | 1EG4 |
| S- | S72.001 | dystroglycan | 2MK7 | |
| S- | S72.001 | dystroglycan | 1U2C | |
| S- | S72.001 | dystroglycan | 4WIQ | |
| SO | S74.001 | Escherichia coli phage K1F endosialidase CIMCD self-cleaving protein | 1V0E | |
| SO | S74.001 | Escherichia coli phage K1F endosialidase CIMCD self-cleaving protein | 3GW6 | |
| SO | S74.002 | Bacillus subtilis phage GA-1 neck appendage CIMCD self-cleaving protein | 3GUD | |
| SO | S74.003 | myelin regulatory factor | 5YHU | |
| SO | S74.003 | myelin regulatory factor | 5ZHU | |
| SH | S77.001 | prohead peptidase gp21 (bacteriophage T4) | 5JBL | |
| S- | S79.001 | CARD8 self-cleaving protein | 4IKM | |
| S- | S81.001 | destabilase | 2DQA | |
| S- | S85.UPW | family S85 unassigned peptidases | 1Y0G | |
| PB | T01.002 | archaean proteasome, beta component | 1PMA_B | |
| PB | T01.002 | archaean proteasome, beta component | implications for interactions of proteasome with pan and pa700 from the 1.9 a structure of a proteasome-11s activator complex | 1YA7_H |
| PB | T01.002 | archaean proteasome, beta component | 20s proteasome Asp9Ser mutant; complex with PA26 | 1YAR_H |
| PB | T01.002 | archaean proteasome, beta component | 20s proteasome; complex with pa26 | 1YAU_H |
| PB | T01.002 | archaean proteasome, beta component | 20s proteasome with an open gate | 3C91_H |
| PB | T01.002 | archaean proteasome, beta component | 20s proteasome with a closed gate | 3C92_H |
| PB | T01.002 | archaean proteasome, beta component | 3IPM_H | |
| PB | T01.002 | archaean proteasome, beta component | 3J9I_Z | |
| PB | T01.002 | archaean proteasome, beta component | 3JRM_H | |
| PB | T01.002 | archaean proteasome, beta component | 3JSE_H | |
| PB | T01.002 | archaean proteasome, beta component | 3JTL_H | |
| PB | T01.002 | archaean proteasome, beta component | thermoplasma acidophilum 20s proteasome using 200kev with stage position | 5VY3_B |
| PB | T01.002 | archaean proteasome, beta component | thermoplasma acidophilum 20s proteasome using 200kev with image shift | 5VY4_B |
| PB | T01.002 | archaean proteasome, beta component | 20s proteasome using cryo-electron microscopy | 6BDF_B |
| PB | T01.002 | archaean proteasome, beta component | proteasome 20s core particle | 3H4P_A |
| PB | T01.002 | archaean proteasome, beta component | 20S proteasome complex with calpain inhibitor I | 1J2Q_H |
| PB | T01.002 | archaean proteasome, beta component | 20s core particle of pan-proteasomes | 6HE5_1 |
| PB | T01.002 | archaean proteasome, beta component | 20s proteasome | 6HE7_1 |
| PB | T01.002 | archaean proteasome, beta component | pan-proteasome in state 1 | 6HE8_1 |
| PB | T01.002 | archaean proteasome, beta component | pan-proteasome in state 2 | 6HE9_1 |
| PB | T01.002 | archaean proteasome, beta component | pan-proteasome in state 3 | 6HEA_1 |
| PB | T01.002 | archaean proteasome, beta component | pan-proteasome in state 4 | 6HEC_1 |
| PB | T01.002 | archaean proteasome, beta component | pan-proteasome in state 5 | 6HED_1 |
| PB | T01.005 | bacterial proteasome, beta component | 1Q5Q | |
| PB | T01.005 | bacterial proteasome, beta component | 1Q5R_H | |
| PB | T01.005 | bacterial proteasome, beta component | 2H6J_H | |
| PB | T01.005 | bacterial proteasome, beta component | 20S proteasome complex | 1Q5Q_H |
| PB | T01.005 | bacterial proteasome, beta component | 2FHG | |
| PB | T01.005 | bacterial proteasome, beta component | complex with peptidyl boronate inhbitor MLN-273 | 2FHH |
| PB | T01.005 | bacterial proteasome, beta component | complex with n,c-capped dipeptide inhibitor pks2205 | 5THO_H |
| PB | T01.005 | bacterial proteasome, beta component | complex with n, c-capped dipeptide dplg-2 | 5TRG_H |
| PB | T01.005 | bacterial proteasome, beta component | complex with n, c-capped dipeptide pks2169 | 5TRR_H |
| PB | T01.005 | bacterial proteasome, beta component | complex with n, c-capped dipeptide pks2144 | 5TRS_H |
| PB | T01.005 | bacterial proteasome, beta component | complex with n, c-capped dipeptide pks2206 | 5TRY_H |
| PB | T01.005 | bacterial proteasome, beta component | complex with n, c-capped dipeptide pks2208 | 5TS0_H |
| PB | T01.005 | bacterial proteasome, beta component | doubly pafe-capped 20s core particle in mycobacterium tuberculosis | 6BGL_P |
| PB | T01.005 | bacterial proteasome, beta component | singly pafe-capped 20s cp in mycobacterium tuberculosis | 6BGO_P |
| PB | T01.006 | HslV component of HslUV peptidase | complex with HslU protein | 1E94 |
| PB | T01.006 | HslV component of HslUV peptidase | complex with HslU | 1G4A |
| PB | T01.006 | HslV component of HslUV peptidase | complex with HslU | 1G4B |
| PB | T01.006 | HslV component of HslUV peptidase | complex with HslU protein | 1HQY |
| PB | T01.006 | HslV component of HslUV peptidase | complex with HslU protein | 1HT1 |
| PB | T01.006 | HslV component of HslUV peptidase | complex with HslU protein | 1HT2 |
| PB | T01.006 | HslV component of HslUV peptidase | 1NED_A | |
| PB | T01.006 | HslV component of HslUV peptidase | crystal structure of the l88a mutant of hslv from escherichia coli | 4G4E_A |
| PB | T01.006 | HslV component of HslUV peptidase | hslu l199q in hsluv complex | 5JI2_A |
| PB | T01.006 | HslV component of HslUV peptidase | hsluv complex | 5JI3_A |
| PB | T01.006 | HslV component of HslUV peptidase | complex with HslU | 1G3I_G |
| PB | T01.006 | HslV component of HslUV peptidase | 1G3K | |
| PB | T01.006 | HslV component of HslUV peptidase | 1JJW | |
| PB | T01.006 | HslV component of HslUV peptidase | complex with HslU protein | 1KYI_G |
| PB | T01.006 | HslV component of HslUV peptidase | complex with I-domain deletion mutant | 1OFH_G |
| PB | T01.006 | HslV component of HslUV peptidase | asymmetric complex between hslv and i-domain deleted hslu (h. influenzae) | 1OFI_G |
| PB | T01.006 | HslV component of HslUV peptidase | 1M4Y | |
| PB | T01.007 | CodW component of CodWX peptidase | complex with HslU | 1YYF_C |
| PB | T01.007 | CodW component of CodWX peptidase | 2Z3A | |
| PB | T01.007 | CodW component of CodWX peptidase | 2Z3B | |
| PB | T01.007 | CodW component of CodWX peptidase | 3TY6 | |
| PB | T01.010 | proteasome subunit beta1c | ground state 26s proteasome (gs2) | 6EPC_1 |
| PB | T01.010 | proteasome subunit beta1c | substrate processing state 26s proteasome (sps1) ***caveat 6epd pro 2 231 has wrong chirality at atom ca | 6EPD_1 |
| PB | T01.010 | proteasome subunit beta1c | substrate processing state 26s proteasome (sps2) | 6EPE_1 |
| PB | T01.010 | proteasome subunit beta1c | ground state 26s proteasome (gs1) | 6EPF_1 |
| PB | T01.010 | proteasome subunit beta1c | 20S proteasome | 4R3O_H |
| PB | T01.010 | proteasome subunit beta1c | 20S proteasome; complex with carfilzomib | 4R67_H |
| PB | T01.010 | proteasome subunit beta1c | cryo-em reveals the conformation of a substrate analogue in the human 20s proteasome core | 5A0Q_H |
| PB | T01.010 | proteasome subunit beta1c | 26S proteasome; complex with USP14-UbAl | 5GJQ_a |
| PB | T01.010 | proteasome subunit beta1c | 26S proteasome | 5GJR_a |
| PB | T01.010 | proteasome subunit beta1c | native human 20s proteasome at 1.8 angstrom ***caveat 5le5 6v1 u 47 has wrong chirality at atom c1 | 5LE5_N |
| PB | T01.010 | proteasome subunit beta1c | native human 20s proteasome in mg-acetate at 2.2 angstrom ***caveat 5lex 6v1 u 47 has wrong chirality at atom c1 | 5LEX_N |
| PB | T01.010 | proteasome subunit beta1c | 20s proteasome; complex with oprozomib | 5LEY_N |
| PB | T01.010 | proteasome subunit beta1c | 20s proteasome; complex with oprozomib in mg-acetate | 5LEZ_N |
| PB | T01.010 | proteasome subunit beta1c | human 20s proteasome complex with epoxomicin at 2.4 angstrom ***caveat 5lf0 6v1 u 47 has wrong chirality at atom c1 iml c 2 has wrong ***caveat 2 5lf0 chirality at atom cb iml d 2 has wrong chirality at atom ca ***caveat 3 5lf0 iml d 2 has wrong chirality | 5LF0_N |
| PB | T01.010 | proteasome subunit beta1c | human 20s proteasome complex with dihydroeponemycin at 2.0 angstrom ***caveat 5lf1 6v1 u 47 has wrong chirality at atom c1 | 5LF1_N |
| PB | T01.010 | proteasome subunit beta1c | human 20s proteasome complex with bortezomib at 2.1 angstrom ***caveat 5lf3 6v1 u 47 has wrong chirality at atom c1 | 5LF3_N |
| PB | T01.010 | proteasome subunit beta1c | 20s proteasome; complex with delanzomib | 5LF4_N |
| PB | T01.010 | proteasome subunit beta1c | human 20s proteasome complex with z-lly-ketoaldehyde at 2.1 angstrom ***caveat 5lf6 6v1 u 47 has wrong chirality at atom c1 | 5LF6_N |
| PB | T01.010 | proteasome subunit beta1c | human 20s proteasome complex with ixazomib at 2.0 angstrom ***caveat 5lf7 6v1 u 47 has wrong chirality at atom c1 | 5LF7_N |
| PB | T01.010 | proteasome subunit beta1c | the human 26s proteasome at 6.8 ang. ***caveat 5ln3 pro h 311 has wrong chirality at atom ca thr n 752 has wrong ***caveat 2 5ln3 chirality at atom ca | 5LN3_1 |
| PB | T01.010 | proteasome subunit beta1c | 26s proteasome in complex with oprozomib | 5M32_n |
| PB | T01.010 | proteasome subunit beta1c | structural basis for dynamic regulation of the human 26s proteasome ***caveat 5t0g entry contains improper peptide linkages. | 5T0G_N |
| PB | T01.010 | proteasome subunit beta1c | structural basis for dynamic regulation of the human 26s proteasome ***caveat 5t0h entry contains improper peptide linkages. | 5T0H_N |
| PB | T01.010 | proteasome subunit beta1c | structural basis for dynamic regulation of the human 26s proteasome ***caveat 5t0i entry contains improper peptide linkages. residue arg k 20 ***caveat 2 5t0i is incorrectly modeled. | 5T0I_N |
| PB | T01.010 | proteasome subunit beta1c | structural basis for dynamic regulation of the human 26s proteasome ***caveat 5t0j entry contains improper peptide linkages. | 5T0J_N |
| PB | T01.010 | proteasome subunit beta1c | nucleotide-driven triple-state remodeling of the aaa-atpase channel inthe activated human 26s proteasome | 5VFO_N |
| PB | T01.010 | proteasome subunit beta1c | nucleotide-driven triple-state remodeling of the aaa-atpase channel inthe activated human 26s proteasome | 5VFR_N |
| PB | T01.010 | proteasome subunit beta1c | nucleotide-driven triple-state remodeling of the aaa-atpase channel inthe activated human 26s proteasome | 5VFT_N |
| PB | T01.010 | proteasome subunit beta1c | endogeneous native human 20s proteasome | 6R70_N |
| PB | T01.010 | proteasome subunit beta1c | 20S proteasome in complex with activator PA26 (Trypanosoma brucei) | 1FNT_H |
| PB | T01.010 | proteasome subunit beta1c | complete proteasome | 1G0U_N |
| PB | T01.010 | proteasome subunit beta1c | complex with epoxomicin | 1G65_N |
| PB | T01.010 | proteasome subunit beta1c | proteasome complex bound to TMC-95A inhibitor | 1JD2_N |
| PB | T01.010 | proteasome subunit beta1c | 20S proteasome | 1RYP_H |
| PB | T01.010 | proteasome subunit beta1c | 20S proteasome; complex with the proteasome activator PA26 from Trypanosoma brucei | 1Z7Q_H |
| PB | T01.010 | proteasome subunit beta1c | 20S proteasome;complex with bortezomib | 2F16_N |
| PB | T01.010 | proteasome subunit beta1c | 20S proteasome; complex with salinosporamide A | 2FAK_N |
| PB | T01.010 | proteasome subunit beta1c | 20S proteasome; complex with homobelactosin C | 2FNY_N |
| PB | T01.010 | proteasome subunit beta1c | 20S proteasome; complex with TMC-95 based biphenyl-ether macrocycle | 2GPL_N |
| PB | T01.010 | proteasome subunit beta1c | 20S proteasome; complex with syringolin A | 2ZCY_N |
| PB | T01.010 | proteasome subunit beta1c | 20S proteasome; complex with glidobactin A | 3BDM_N |
| PB | T01.010 | proteasome subunit beta1c | 20S proteasome; complex with fellutamide B | 3D29_N |
| PB | T01.010 | proteasome subunit beta1c | 20s proteasome; complex with the epimer form of spirolactacystin | 3DY3_N |
| PB | T01.010 | proteasome subunit beta1c | 20s proteasome; complex with spirolactacystin | 3DY4_N |
| PB | T01.010 | proteasome subunit beta1c | 20s proteasome; complex with homobelactosin c | 3E47_N |
| PB | T01.010 | proteasome subunit beta1c | 20s proteasome; complex with syringolin b | 3GPJ_N |
| PB | T01.010 | proteasome subunit beta1c | 20S proteasome; complex with salinosporamide derivative | 3GPT_N |
| PB | T01.010 | proteasome subunit beta1c | 20S proteasome; complex with salinosporamide derivative | 3GPW_N |
| PB | T01.010 | proteasome subunit beta1c | 20S proteasome; complex with hyroxylated salinosporamide | 3HYE_N |
| PB | T01.010 | proteasome subunit beta1c | 20S proteasome; complex with bortezomib | 3MG0_N |
| PB | T01.010 | proteasome subunit beta1c | 20S proteasome; complex with compound 1 | 3MG4_N |
| PB | T01.010 | proteasome subunit beta1c | 20S proteasome; complex with compound 6 | 3MG6_N |
| PB | T01.010 | proteasome subunit beta1c | 20S open-gate proteasome; complex with compound 6 | 3MG7_N |
| PB | T01.010 | proteasome subunit beta1c | 20S open-gate proteasome; complex with compound 16 | 3MG8_N |
| PB | T01.010 | proteasome subunit beta1c | 20S proteasome; complex with ligand 2a | 3NZJ_N |
| PB | T01.010 | proteasome subunit beta1c | 20S proteasome; complex with ligand 2b | 3NZW_N |
| PB | T01.010 | proteasome subunit beta1c | 20S proteasome; complex with ligand 2c | 3NZX_N |
| PB | T01.010 | proteasome subunit beta1c | 20S open-gate proteasome; complex with compound 24 | 3OEU_N |
| PB | T01.010 | proteasome subunit beta1c | 20S open-gate proteasome; complex with compound 25 | 3OEV_N |
| PB | T01.010 | proteasome subunit beta1c | 20S proteasome; complex with alpha-keto-aldehyde | 3OKJ_N |
| PB | T01.010 | proteasome subunit beta1c | 20S open-gate proteasome; complex with compound 20 | 3SDI_N |
| PB | T01.010 | proteasome subunit beta1c | 20S open-gate proteasome; complex with compound 34 | 3SDK_N |
| PB | T01.010 | proteasome subunit beta1c | 20S proteasome; complex with hydroxyurea derivative HU10 | 3SHJ_N |
| PB | T01.010 | proteasome subunit beta1c | 20S proteasome; complex with homobelactosin C | 3TDD_N |
| PB | T01.010 | proteasome subunit beta1c | 20S open-gate proteasome; complex with PR-957 (morpholine) | 3UN4_N |
| PB | T01.010 | proteasome subunit beta1c | 20S proteasome; complex with PR-957 (epoxide) | 3UN8_N |
| PB | T01.010 | proteasome subunit beta1c | 26S proteasome | 3WXR_H |
| PB | T01.010 | proteasome subunit beta1c | 26S proteasome | 4CR2 |
| PB | T01.010 | proteasome subunit beta1c | 4CR3 | |
| PB | T01.010 | proteasome subunit beta1c | 26S proteasome | 4CR4 |
| PB | T01.010 | proteasome subunit beta1c | 20S proteasome; complex with K-7174 | 4EU2_H |
| PB | T01.010 | proteasome subunit beta1c | 20S proteasome; complex with cepafungin I | 4FZC_N |
| PB | T01.010 | proteasome subunit beta1c | 20S proteasome; complex with glidobactin | 4FZG_N |
| PB | T01.010 | proteasome subunit beta1c | 20S proteasome; complex with Syringolin-Glidobactin chimera | 4G4S_H |
| PB | T01.010 | proteasome subunit beta1c | 20S proteasome; complex with Syringolin-Glidobactin chimera | 4GK7_N |
| PB | T01.010 | proteasome subunit beta1c | 20S proteasome; complex with vinylketone carmaphycin analogue VNK1 | 4HNP_N |
| PB | T01.010 | proteasome subunit beta1c | 20S proteasome; complex with epoxyketone carmaphycin analogue 3 | 4HRC_N |
| PB | T01.010 | proteasome subunit beta1c | 20S proteasome; complex with carmaphycin A | 4HRD_N |
| PB | T01.010 | proteasome subunit beta1c | 20S proteasome; complex with vinyl sulfone LU102 | 4INR_N |
| PB | T01.010 | proteasome subunit beta1c | 20S proteasome; complex with vinyl sulfone LU122 | 4INT_N |
| PB | T01.010 | proteasome subunit beta1c | 20S proteasome; complex with vinyl sulfone LU112 | 4INU_N |
| PB | T01.010 | proteasome subunit beta1c | 20S proteasome; complex with belactosin derivative 3E | 4J70_N |
| PB | T01.010 | proteasome subunit beta1c | 20S proteasome; complex with dimerized linear mimetic of TMC-95A | 4JSQ_N |
| PB | T01.010 | proteasome subunit beta1c | 20S proteasome; complex with dimerized linear mimetic of TMC-95A | 4JSU_N |
| PB | T01.010 | proteasome subunit beta1c | 20S proteasome; complex with dimerized linear mimetic of TMC-95A | 4JT0_N |
| PB | T01.010 | proteasome subunit beta1c | 20S proteasome; complex with vibralactone | 4LQI_N |
| PB | T01.010 | proteasome subunit beta1c | 20S proteasome; complex with enone carmaphycin analogue 6 | 4LTC_N |
| PB | T01.010 | proteasome subunit beta1c | 20S proteasome; complex with MG132 | 4NNN_N |
| PB | T01.010 | proteasome subunit beta1c | 20S proteasome; complex with Z-Leu-Leu-Leu-ketoaldehyde | 4NNW_N |
| PB | T01.010 | proteasome subunit beta1c | 20S proteasome; complex with Z-Leu-Leu-Leu-B(OH)2 | 4NO1_N |
| PB | T01.010 | proteasome subunit beta1c | 20S proteasome; complex with Z-Leu-Leu-Leu-vinylsulfone | 4NO6_N |
| PB | T01.010 | proteasome subunit beta1c | 20S proteasome; complex with Z-Leu-Leu-Leu-ketoamide | 4NO8_N |
| PB | T01.010 | proteasome subunit beta1c | 20S proteasome; complex with Z-Leu-Leu-Leu-epoxyketone | 4NO9_N |
| PB | T01.010 | proteasome subunit beta1c | 20S proteasome; complex with kendomycin | 4Q1S_N |
| PB | T01.010 | proteasome subunit beta1c | 20S proteasome; complex with Boc-Ala-Ala-Ala-CHO | 4QBY_N |
| PB | T01.010 | proteasome subunit beta1c | 20S proteasome; complex with epoxyketone inhibitor 8 | 4QLQ_N |
| PB | T01.010 | proteasome subunit beta1c | 20S proteasome; complex with epoxyketone inhibitor 11 | 4QLS_N |
| PB | T01.010 | proteasome subunit beta1c | 20S proteasome; complex with tripeptidic epoxyketone inhibitor 2 | 4QLT_N |
| PB | T01.010 | proteasome subunit beta1c | 20S proteasome; complex with tripeptidic epoxyketone inhibitor 9 | 4QLU_N |
| PB | T01.010 | proteasome subunit beta1c | 20S proteasome; complex with tripeptidic epoxyketone inhibitor 17 | 4QLV_N |
| PB | T01.010 | proteasome subunit beta1c | 20S proteasome | 4QUX_N |
| PB | T01.010 | proteasome subunit beta1c | 20S proteasome | 4QUY_N |
| PB | T01.010 | proteasome subunit beta1c | 20S proteasome | 4QV0_N |
| PB | T01.010 | proteasome subunit beta1c | 20S proteasome | 4QV1_N |
| PB | T01.010 | proteasome subunit beta1c | 20S proteasome | 4QV3_N |
| PB | T01.010 | proteasome subunit beta1c | 20S proteasome beta5 Met45Thr mutant | 4QV4_N |
| PB | T01.010 | proteasome subunit beta1c | 20S proteasome beta5 Met45Ile mutant | 4QV5_N |
| PB | T01.010 | proteasome subunit beta1c | 20S proteasome | 4QV6_N |
| PB | T01.010 | proteasome subunit beta1c | 20S proteasome | 4QV7_N |
| PB | T01.010 | proteasome subunit beta1c | 20S proteasome | 4QV8_N |
| PB | T01.010 | proteasome subunit beta1c | 20S proteasome | 4QV9_N |
| PB | T01.010 | proteasome subunit beta1c | 20S proteasome; complex with bortezomib | 4QVL_N |
| PB | T01.010 | proteasome subunit beta1c | 20S proteasome beta5 Met45Ala mutant; complex with bortezomib | 4QVM_N |
| PB | T01.010 | proteasome subunit beta1c | 20S proteasome beta5 Met45Val mutant; complex with bortezomib | 4QVN_N |
| PB | T01.010 | proteasome subunit beta1c | 20S proteasome beta5 Met45Thr mutant; complex with bortezomib | 4QVP_N |
| PB | T01.010 | proteasome subunit beta1c | 20S proteasome beta5 Met45Ile mutant; complex with bortezomib | 4QVQ_N |
| PB | T01.010 | proteasome subunit beta1c | 20S proteasome beta5 Ala49Val mutant; complex with bortezomib | 4QVV_N |
| PB | T01.010 | proteasome subunit beta1c | 20S proteasome beta5 Ala49Ser mutant; complex with bortezomib | 4QVW_N |
| PB | T01.010 | proteasome subunit beta1c | 20S proteasome beta5 Ala49Thr mutant; complex with bortezomib | 4QVY_N |
| PB | T01.010 | proteasome subunit beta1c | 20S proteasome beta5 Ala49Thr,Ala50Val mutant; complex with bortezomib | 4QW0_N |
| PB | T01.010 | proteasome subunit beta1c | 20S proteasome beta5 Ala50Val mutant; complex with bortezomib | 4QW1_N |
| PB | T01.010 | proteasome subunit beta1c | 20S proteasome beta5 Cys63Phe mutant; complex with bortezomib | 4QW3_N |
| PB | T01.010 | proteasome subunit beta1c | 20S proteasome; complex with carfilzomib | 4QW4_N |
| PB | T01.010 | proteasome subunit beta1c | 20S proteasome beta5 Met45Ala mutant; complex with carfilzomib | 4QW5_N |
| PB | T01.010 | proteasome subunit beta1c | 20S proteasome beta5 Met45Val mutant; complex with carfilzomib | 4QW6_N |
| PB | T01.010 | proteasome subunit beta1c | 20S proteasome beta5 Met45Thr mutant; complex with carfilzomib | 4QW7_N |
| PB | T01.010 | proteasome subunit beta1c | 20S proteasome beta5 Met45Ile mutant; complex with carfilzomib | 4QWF_N |
| PB | T01.010 | proteasome subunit beta1c | 20S proteasome beta5 Ala49Val mutant; complex with carfilzomib | 4QWG_N |
| PB | T01.010 | proteasome subunit beta1c | 20S proteasome beta5 Ala49Ser mutant; complex with carfilzomib | 4QWI_N |
| PB | T01.010 | proteasome subunit beta1c | 20S proteasome beta5 Ala49Thr mutant; complex with carfilzomib | 4QWJ_N |
| PB | T01.010 | proteasome subunit beta1c | 20S proteasome beta5 Ala49Thr, Ala50Val mutant; complex with carfilzomib | 4QWK_N |
| PB | T01.010 | proteasome subunit beta1c | 20S proteasome beta5 Ala50Val mutant; complex with carfilzomib | 4QWL_N |
| PB | T01.010 | proteasome subunit beta1c | 20S proteasome beta5 Cys52Phe mutant; complex with carfilzomib | 4QWR_N |
| PB | T01.010 | proteasome subunit beta1c | 20S proteasome beta5 Cys63Phe mutant; complex with carfilzomib | 4QWS_N |
| PB | T01.010 | proteasome subunit beta1c | 20S proteasome beta5 Cys52Phe mutant; complex with bortezomib | 4QWU_N |
| PB | T01.010 | proteasome subunit beta1c | 20S proteasome; complex with epoxyketone inhibitor ONX 0914 | 4QWX_N |
| PB | T01.010 | proteasome subunit beta1c | 20S proteasome beta 5 Met45Ala mutant; complex with epoxyketone inhibitor ONX 0914 | 4QXJ_N |
| PB | T01.010 | proteasome subunit beta1c | complete proteasome; complex with epoxyketone inhibitor ONX 0914 | 4QZ0_N |
| PB | T01.010 | proteasome subunit beta1c | 20S proteasome beta 5 Met45Thr mutant; complex with epoxyketone inhibitor ONX 0914 | 4QZ1_N |
| PB | T01.010 | proteasome subunit beta1c | 20S proteasome beta 5 Met45Ile mutant; complex with epoxyketone inhibitor ONX 0914 | 4QZ2_N |
| PB | T01.010 | proteasome subunit beta1c | 20S proteasome beta 5 Ala49Val mutant; complex with epoxyketone inhibitor ONX 0914 | 4QZ3_N |
| PB | T01.010 | proteasome subunit beta1c | 20S proteasome beta 5 Ala49Ser mutant; complex with epoxyketone inhibitor ONX 0914 | 4QZ4_N |
| PB | T01.010 | proteasome subunit beta1c | 20S proteasome beta 5 Ala49Thr mutant; complex with epoxyketone inhibitor ONX 0914 | 4QZ5_N |
| PB | T01.010 | proteasome subunit beta1c | 20S proteasome beta 5 Ala49Thr, Ala50Val mutant; complex with epoxyketone inhibitor ONX 0914 | 4QZ6_N |
| PB | T01.010 | proteasome subunit beta1c | 20S proteasome beta 5 Ala50Val mutant; complex with epoxyketone inhibitor ONX 0914 | 4QZ7_N |
| PB | T01.010 | proteasome subunit beta1c | 20S proteasome beta 5 Cys52Phe mutant; complex with epoxyketone inhibitor ONX 0914 | 4QZW_N |
| PB | T01.010 | proteasome subunit beta1c | complete proteasome; complex with epoxyketone inhibitor ONX 0914 | 4QZX_N |
| PB | T01.010 | proteasome subunit beta1c | 20S proteasome; complex with omuralide | 4QZZ_N |
| PB | T01.010 | proteasome subunit beta1c | 20S proteasome beta 5 Cys52Phe mutant; complex with omuralide | 4R00_N |
| PB | T01.010 | proteasome subunit beta1c | 20S proteasome; complex with BSC4999 | 4R02_N |
| PB | T01.010 | proteasome subunit beta1c | 20S proteasome; ligand induced aziridine-formation in beta5 | 4R17_N |
| PB | T01.010 | proteasome subunit beta1c | 20S proteasome; ligand induced Lys33-Thr1 cross-linking in beta5 | 4R18_N |
| PB | T01.010 | proteasome subunit beta1c | 20S proteasome; complex with alkaloid indolo-phakellin | 4RUR_N |
| PB | T01.010 | proteasome subunit beta1c | 4V7O | |
| PB | T01.010 | proteasome subunit beta1c | 20S proteasome; complex with PR-VI modulator | 4X6Z_H |
| PB | T01.010 | proteasome subunit beta1c | 20S proteasome; complex with Ac-Pro-Ala-Asp-EP | 4Y69_N |
| PB | T01.010 | proteasome subunit beta1c | 20S proteasome beta2 His114Asp mutant; complex with Ac-Pro-Ala-Asp-EP | 4Y6A_N |
| PB | T01.010 | proteasome subunit beta1c | 20S proteasome; complex with Ac-Pro-Ala-Glu-EP | 4Y6V_N |
| PB | T01.010 | proteasome subunit beta1c | 20S proteasome; complex with Ac-Pro-Ala-Leu-EP | 4Y6Z_N |
| PB | T01.010 | proteasome subunit beta1c | 20S proteasome; complex with Ac-Leu-Ala-Val-EP | 4Y70_N |
| PB | T01.010 | proteasome subunit beta1c | 20S proteasome; complex with Ac-Leu-Ala-Leu-EP | 4Y74_N |
| PB | T01.010 | proteasome subunit beta1c | 20S proteasome; complex with Ac-Pro-Ala-Phe-EP | 4Y75_N |
| PB | T01.010 | proteasome subunit beta1c | 20S proteasome; complex with Ac-Leu-Ala-Phe-EP | 4Y77_N |
| PB | T01.010 | proteasome subunit beta1c | 20S proteasome; complex with Ac-Leu-Ala-Asp-EP | 4Y78_N |
| PB | T01.010 | proteasome subunit beta1c | 20S proteasome; complex with Ac-Leu-Ala-Glu-EP | 4Y7W_N |
| PB | T01.010 | proteasome subunit beta1c | complete proteasome; complex with Ac-PAA-ep | 4Y7X_N |
| PB | T01.010 | proteasome subunit beta1c | 20S proteasome; complex with Ac-Leu-Ala-Ala-EP | 4Y7Y_N |
| PB | T01.010 | proteasome subunit beta1c | 20S proteasome; complex with Ac-Leu-Ala-Ile-EP | 4Y80_N |
| PB | T01.010 | proteasome subunit beta1c | 20S proteasome; complex with Ac-Pro-Ala-Tyr-EP | 4Y81_N |
| PB | T01.010 | proteasome subunit beta1c | 20S proteasome; complex with Ac-Leu-Ala-Tyr-EP | 4Y82_N |
| PB | T01.010 | proteasome subunit beta1c | 20S proteasome; complex with N3-Ala(4,4-F2P)-Asn-Leu-Leu-EP | 4Y84_N |
| PB | T01.010 | proteasome subunit beta1c | 20S proteasome; complex with N3-Ala-Pro-Asn-Leu-Leu-EP | 4Y8G_N |
| PB | T01.010 | proteasome subunit beta1c | 20S proteasome; complex with N3-Ala-Pro-Ala-Leu-EP | 4Y8H_N |
| PB | T01.010 | proteasome subunit beta1c | 20S proteasome; complex with Ac-Pro-Leu-Leu-EP | 4Y8I_N |
| PB | T01.010 | proteasome subunit beta1c | 20S proteasome; complex with Ac-Leu-Leu-Leu-EP | 4Y8J_N |
| PB | T01.010 | proteasome subunit beta1c | 20S proteasome; complex with H-Ala-Pro-Leu-Leu-EP | 4Y8K_N |
| PB | T01.010 | proteasome subunit beta1c | 20S proteasome; complex with Ac-Ala-Pro-Leu-Leu-EP | 4Y8L_N |
| PB | T01.010 | proteasome subunit beta1c | 20S proteasome beta7-delta7 C-terminal mutant | 4Y8M_N |
| PB | T01.010 | proteasome subunit beta1c | 20S proteasome beta7-delta7 C-terminal mutant; complex with Ac-Pro-Ala-Glu-EP | 4Y8N_N |
| PB | T01.010 | proteasome subunit beta1c | 20S proteasome beta 7-delta 7 C-terminal mutant; complex with Ac-Pro-Ala-Phe-EP | 4Y8O_N |
| PB | T01.010 | proteasome subunit beta1c | 20S proteasome beta 7-delta 7 C-terminal mutant; complex with Ac-Pro-Ala-Leu-EP | 4Y8P_N |
| PB | T01.010 | proteasome subunit beta1c | 20S proteasome beta 7-delta 7 C-terminal mutant; complex with Ac-Pro-Ala-Tyr-EP | 4Y8Q_N |
| PB | T01.010 | proteasome subunit beta1c | 20S proteasome beta 2 His116Asp mutant | 4Y8R_N |
| PB | T01.010 | proteasome subunit beta1c | 20S proteasome beta 2 His116Asp mutant; complex with Ac-Leu-Ala-Glu-EP | 4Y8S_N |
| PB | T01.010 | proteasome subunit beta1c | 20S proteasome beta 2 His116Asp mutant; complex with Ac-Pro-Ala-Glu-EP | 4Y8T_N |
| PB | T01.010 | proteasome subunit beta1c | 20S proteasome beta 2 His116Asp mutant; complex with Ac-Pro-Ala-Asp-EP | 4Y8U_N |
| PB | T01.010 | proteasome subunit beta1c | 20S proteasome beta 2 His116Glu mutant | 4Y9Y_N |
| PB | T01.010 | proteasome subunit beta1c | 20S proteasome beta 2 His116Glu mutant; complex with Ac-Leu-Ala-Glu-EP | 4Y9Z_N |
| PB | T01.010 | proteasome subunit beta1c | 20S proteasome beta 2 His116Glu mutant; complex with Ac-Pro-Ala-Glu-EP | 4YA0_N |
| PB | T01.010 | proteasome subunit beta1c | 20S proteasome beta 2 His116Asn mutant | 4YA1_N |
| PB | T01.010 | proteasome subunit beta1c | 20S proteasome beta 2 His116Asn mutant; complex with Ac-Leu-Ala-Glu-EP | 4YA2_N |
| PB | T01.010 | proteasome subunit beta1c | 20S proteasome beta 2 His116Asn mutant; complex with Ac-Pro-Ala-Glu-EP | 4YA3_N |
| PB | T01.010 | proteasome subunit beta1c | 20S proteasome beta 2 His114Asp mutant | 4YA4_N |
| PB | T01.010 | proteasome subunit beta1c | 20S proteasome beta 2 His114Asp mutant; complex with Ac-Pro-Ala-Glu-EP | 4YA5_N |
| PB | T01.010 | proteasome subunit beta1c | 20S proteasome beta 2 His114Asp mutant; complex with Ac-Leu-Ala-Glu-EP | 4YA7_N |
| PB | T01.010 | proteasome subunit beta1c | 20S proteasome beta 2 His114Asp mutant; complex with AC-Leu-Ala-Asp-EP | 4YA9_N |
| PB | T01.010 | proteasome subunit beta1c | 20S proteasome; complex with belactosin C derivative 3 | 4Z1L_N |
| PB | T01.010 | proteasome subunit beta1c | 5A5B | |
| PB | T01.010 | proteasome subunit beta1c | 20S proteasome; complex with macyranone A | 5AHJ_N |
| PB | T01.010 | proteasome subunit beta1c | 20S proteasome; complex with beta1/beta2 nonspecifici sulfonamide ligand | 5BOU_N |
| PB | T01.010 | proteasome subunit beta1c | yeast 20s proteasome beta2-g170a mutant | 5BXL_N |
| PB | T01.010 | proteasome subunit beta1c | yeast 20s proteasome beta2-g170a mutant in complex with bortezomib | 5BXN_N |
| PB | T01.010 | proteasome subunit beta1c | 20S proteasome beta5 Gly48Cys mutant | 5CGF_N |
| PB | T01.010 | proteasome subunit beta1c | 20S proteasome beta5 Gly48Cys mutant; complex with alpha-chloroacetamide 1 | 5CGG_N |
| PB | T01.010 | proteasome subunit beta1c | 20S proteasome beta5 Gly48Cys mutant; complex with alpha-chloroacetamide 5 | 5CGH_N |
| PB | T01.010 | proteasome subunit beta1c | 20S proteasome beta5 Gly48Cys mutant; complex with ONX 0914 | 5CGI_N |
| PB | T01.010 | proteasome subunit beta1c | yeast 20s proteasome at 2.3 a resolution | 5CZ4_N |
| PB | T01.010 | proteasome subunit beta1c | yeast 20s proteasome beta1-t1a mutant in complex with carfilzomib | 5CZ5_N |
| PB | T01.010 | proteasome subunit beta1c | yeast 20s proteasome beta5-t1a mutant in complex with syringolin a, propeptide expressed in trans | 5CZ6_N |
| PB | T01.010 | proteasome subunit beta1c | yeast 20s proteasome beta5-t1a beta5-k81r double mutant in complex with bortezomib, propeptide expressed in cis | 5CZ7_N |
| PB | T01.010 | proteasome subunit beta1c | yeast 20s proteasome beta5-l(-49)s-k33a mutant in complex with carfilzomib | 5CZ8_N |
| PB | T01.010 | proteasome subunit beta1c | yeast 20s proteasome beta5-d17n mutant in complex with carfilzomib; propeptide expressed in trans | 5CZ9_N |
| PB | T01.010 | proteasome subunit beta1c | yeast 20s proteasome beta5-d166n mutant | 5CZA_N |
| PB | T01.010 | proteasome subunit beta1c | yeast 20s proteasome beta5-d166n mutant in complex with carfilzomib | 5D0S_N |
| PB | T01.010 | proteasome subunit beta1c | 20s proteasome beta5-Asp166Asn mutant; complex with MG132 | 5D0T_N |
| PB | T01.010 | proteasome subunit beta1c | yeast 20s proteasome beta5-t1c mutant in complex with carfilzomib | 5D0V_N |
| PB | T01.010 | proteasome subunit beta1c | yeast 20s proteasome beta5-t1s mutant | 5D0W_N |
| PB | T01.010 | proteasome subunit beta1c | yeast 20s proteasome beta5-t1s mutant in complex with bortezomib | 5D0X_N |
| PB | T01.010 | proteasome subunit beta1c | yeast 20s proteasome beta5-t1s mutant in complex with carfilzomib | 5D0Z_N |
| PB | T01.010 | proteasome subunit beta1c | 20S proteasome; complex with alkyne-PI | 5DKI_N |
| PB | T01.010 | proteasome subunit beta1c | 20S proteasome; complex with octreotide-PI | 5DKJ_N |
| PB | T01.010 | proteasome subunit beta1c | yeast 20s proteasome beta2-t1a mutant | 5FG7_N |
| PB | T01.010 | proteasome subunit beta1c | yeast 20s proteasome beta2-t(-2)v mutant | 5FG9_N |
| PB | T01.010 | proteasome subunit beta1c | yeast 20s proteasome beta5-k33a mutant (propeptide expressed in trans) | 5FGA_N |
| PB | T01.010 | proteasome subunit beta1c | yeast 20s proteasome beta5-h(-2)l-t1a double mutant in complex with carfilzomib | 5FGD_N |
| PB | T01.010 | proteasome subunit beta1c | yeast 20s proteasome beta5-h(-2)t-t1a double mutant in complex with carfilzomib | 5FGE_N |
| PB | T01.010 | proteasome subunit beta1c | yeast 20s proteasome beta5-h(-2)a-t1a-k81r triple mutant in complex with carfilzomib | 5FGF_N |
| PB | T01.010 | proteasome subunit beta1c | yeast 20s proteasome beta5-l(-49s)_d17n double mutant in complex with carfilzomib | 5FGG_N |
| PB | T01.010 | proteasome subunit beta1c | 20s proteasome beta5-Lys33Ala mutant (propeptide expressed in trans); complex with MG132 | 5FGH_N |
| PB | T01.010 | proteasome subunit beta1c | yeast 20s proteasome beta1-t1a beta2-t1a double mutant in complex withcarfilzomib | 5FGI_N |
| PB | T01.010 | proteasome subunit beta1c | yeast 20s proteasome beta5-k33a mutant (propeptide expressed in trans)in complex with carfilzomib | 5FHS_N |
| PB | T01.010 | proteasome subunit beta1c | 20s proteasome; complex with the peptidic epoxyketone inhibitor 27 | 5JHR_N |
| PB | T01.010 | proteasome subunit beta1c | 20s proteasome; complex with the peptidic epoxyketone inhibitor 15 | 5JHS_N |
| PB | T01.010 | proteasome subunit beta1c | 20s proteasome; complex with epoxyketone inhibitor 14 | 5L52_N |
| PB | T01.010 | proteasome subunit beta1c | 20s proteasome; complex with epoxyketone inhibitor 16 | 5L54_N |
| PB | T01.010 | proteasome subunit beta1c | 20s proteasome; complex with epoxyketone inhibitor 18 | 5L55_N |
| PB | T01.010 | proteasome subunit beta1c | yeast 20s proteasome with human beta5i (1-138; r57t) | 5L5A_N |
| PB | T01.010 | proteasome subunit beta1c | yeast 20s proteasome with human beta5i (1-138) and human beta6 (97- 111; 118-133) | 5L5B_N |
| PB | T01.010 | proteasome subunit beta1c | yeast 20s proteasome with human beta5i (1-138) and human beta6 (97- 111; 118-133) in complex with onx 0914 | 5L5D_N |
| PB | T01.010 | proteasome subunit beta1c | yeast 20s proteasome with human beta5i (1-138) and human beta6 (97- 111; 118-133) in complex with carfilzomib | 5L5E_N |
| PB | T01.010 | proteasome subunit beta1c | yeast 20s proteasome with human beta5i (1-138) and human beta6 (97- 111; 118-133) in complex with bortezomib | 5L5F_N |
| PB | T01.010 | proteasome subunit beta1c | yeast 20s proteasome with human beta5i (1-138) and human beta6 (97- 111; 118-133); complex with PR-924 | 5L5H_N |
| PB | T01.010 | proteasome subunit beta1c | yeast 20s proteasome with human beta5i (1-138) and human beta6 (97- 111; 118-133) in complex with epoxyketone inhibitor 9 | 5L5I_N |
| PB | T01.010 | proteasome subunit beta1c | yeast 20s proteasome with human beta5i (1-138) and human beta6 (97- 111; 118-133) in complex with epoxyketone inhibitor 14 | 5L5J_N |
| PB | T01.010 | proteasome subunit beta1c | yeast 20s proteasome with human beta5i (1-138) and human beta6 (97- 111; 118-133) in complex with epoxyketone inhibitor 16 | 5L5O_N |
| PB | T01.010 | proteasome subunit beta1c | yeast 20s proteasome with human beta5i (1-138) and human beta6 (97- 111; 118-133) in complex with epoxyketone inhibitor 17 | 5L5P_N |
| PB | T01.010 | proteasome subunit beta1c | yeast 20s proteasome with human beta5i (1-138) and human beta6 (97- 111; 118-133) in complex with epoxyketone 18 | 5L5Q_N |
| PB | T01.010 | proteasome subunit beta1c | yeast 20s proteasome with human beta5i (1-138;v31m) and human beta6 (97-111; 118-133) | 5L5R_N |
| PB | T01.010 | proteasome subunit beta1c | yeast 20s proteasome with human beta5i (1-138; Val31Met mutant) and human beta6 (97-111; 118-133); complex with PR-924 | 5L5S_N |
| PB | T01.010 | proteasome subunit beta1c | yeast 20s proteasome with human beta5i (1-138; v31m) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 16 | 5L5T_N |
| PB | T01.010 | proteasome subunit beta1c | yeast 20s proteasome with human beta5i (1-138; v31m) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 17 ***caveat 5l5u 04c h 301 has wrong chirality at atom c27 04c k 301 has ***caveat 2 5l5u wrong chirality at atom c27 04c v 301 h | 5L5U_N |
| PB | T01.010 | proteasome subunit beta1c | yeast 20s proteasome with human beta5c (1-138) and human beta6 (97- 111; 118-133) | 5L5W_N |
| PB | T01.010 | proteasome subunit beta1c | yeast 20s proteasome with human beta5c (1-138) and human beta6 (97- 111; 118-133) in complex with onx 0914 | 5L5X_N |
| PB | T01.010 | proteasome subunit beta1c | yeast 20s proteasome with human beta5c (1-138) and human beta6 (97- 111; 118-133) in complex with carfilzomib | 5L5Y_N |
| PB | T01.010 | proteasome subunit beta1c | yeast 20s proteasome with human beta5c (1-138) and human beta6 (97- 111; 118-133) in complex with bortezomib | 5L5Z_N |
| PB | T01.010 | proteasome subunit beta1c | yeast 20s proteasome with human beta5c (1-138) and human beta6 (97- 111; 118-133); complex with PR-924 | 5L60_N |
| PB | T01.010 | proteasome subunit beta1c | yeast 20s proteasome with human beta5c (1-138) and human beta6 (99- 132) in complex with epoxyketone inhibitor 14 | 5L61_N |
| PB | T01.010 | proteasome subunit beta1c | yeast 20s proteasome with human beta5c (1-138) and human beta6 (97- 111; 118-133) in complex with epoxyketone inhibitor 16 | 5L62_N |
| PB | T01.010 | proteasome subunit beta1c | yeast 20s proteasome with human beta5c (1-138) and human beta6 (97- 111; 118-133) in complex with epoxyketone inhibitor 17 ***caveat 5l63 04c h 301 has wrong chirality at atom c27 04c k 301 has ***caveat 2 5l63 wrong chirality at atom c27 04c v 301 has wr | 5L63_N |
| PB | T01.010 | proteasome subunit beta1c | yeast 20s proteasome with human beta5c (1-138) and human beta6 (97- 111; 118-133) in complex with epoxyketone inhibitor 18 | 5L64_N |
| PB | T01.010 | proteasome subunit beta1c | yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97- 111; 118-133) in complex with carfilzomib | 5L65_N |
| PB | T01.010 | proteasome subunit beta1c | yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97- 111; 118-133) in complex with bortezomib | 5L66_N |
| PB | T01.010 | proteasome subunit beta1c | yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97- 111; 118-133); complex with PR-924 | 5L67_N |
| PB | T01.010 | proteasome subunit beta1c | yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97- 111; 118-133) in complex with epoxyketone inhibitor 14 | 5L68_N |
| PB | T01.010 | proteasome subunit beta1c | yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97- 111; 118-133) in complex with epoxyketone inhibitor 16 | 5L69_N |
| PB | T01.010 | proteasome subunit beta1c | yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97- 111; 118-133) in complex with epoxyketone inhibitor 17 | 5L6A_N |
| PB | T01.010 | proteasome subunit beta1c | yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97- 111; 118-133) in complex with onx 0914 | 5L6B_N |
| PB | T01.010 | proteasome subunit beta1c | yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97- 111; 118-133) in complex with epoxyketone inhibitor 18 | 5L6C_N |
| PB | T01.010 | proteasome subunit beta1c | ligand-induced aziridine-formation at the yeast proteasomal subunit beta5 by sulfonate esters | 5LAI_N |
| PB | T01.010 | proteasome subunit beta1c | ligand-induced lys33-thr1 crosslinking at the yeast proteasomal subunit beta5 by sulfonate esters | 5LAJ_N |
| PB | T01.010 | proteasome subunit beta1c | yeast 20s proteasome with human beta5i (1-138; Arg57Thr mutant)in complex with PR-924 | 5LTT_N |
| PB | T01.010 | proteasome subunit beta1c | yeast 20s proteasome with human beta5i (1-138) and human beta6 (97- 111; 118-133) in complex with thiazole based inhibitor ro19 | 5M2B_N |
| PB | T01.010 | proteasome subunit beta1c | 26s proteasome in presence of atp (s1) | 5MP9_h |
| PB | T01.010 | proteasome subunit beta1c | 26s proteasome in presence of atp (s2) | 5MPA_h |
| PB | T01.010 | proteasome subunit beta1c | yeast 20s proteasome in complex with blm-pep activator | 5NIF_H |
| PB | T01.010 | proteasome subunit beta1c | yeast 26s proteasome bound to ubiquitinated substrate (4d motor state) | 6EF3_1 |
| PB | T01.010 | proteasome subunit beta1c | yeast 20s proteasome in complex with cystargolide B | 6G7F_N |
| PB | T01.010 | proteasome subunit beta1c | yeast 20s proteasome in complex with cystargolide B derivative 1 | 6G8M_N |
| PB | T01.010 | proteasome subunit beta1c | yeast 20s proteasome in complex with cystargolide B derivative 2 | 6G8N_N |
| PB | T01.010 | proteasome subunit beta1c | yeast 20s proteasome in complex with homosalinosporamide a | 6GOP_N |
| PB | T01.010 | proteasome subunit beta1c | yeast 20s proteasome in complex with the peptidic non-covalent bindinginhibitor rts-v5 | 6H39_N |
| PB | T01.010 | proteasome subunit beta1c | yeast 20s proteasome with human beta2c (s171g) | 6HTB_N |
| PB | T01.010 | proteasome subunit beta1c | yeast 20s proteasome with human beta2c (s171g) in complex with onx 0914 | 6HTC_N |
| PB | T01.010 | proteasome subunit beta1c | yeast 20s proteasome with human beta2c (s171g) in complex with 4 | 6HTD_N |
| PB | T01.010 | proteasome subunit beta1c | yeast 20s proteasome with human beta2c (s171g) in complex with 7 | 6HTP_N |
| PB | T01.010 | proteasome subunit beta1c | yeast 20s proteasome with human beta2c (s171g) in complex with 13 | 6HTR_N |
| PB | T01.010 | proteasome subunit beta1c | yeast 20s proteasome with human beta2c (s171g) in complex with 16 | 6HUB_N |
| PB | T01.010 | proteasome subunit beta1c | yeast 20s proteasome with human beta2c (s171g) in complex with 18 | 6HUC_N |
| PB | T01.010 | proteasome subunit beta1c | yeast 20s proteasome with human beta2c (s171g) in complex with 20 | 6HUQ_N |
| PB | T01.010 | proteasome subunit beta1c | yeast 20s proteasome with human beta2c (s171g) in complex with 29 | 6HUU_N |
| PB | T01.010 | proteasome subunit beta1c | yeast 20s proteasome with human beta2c (s171g) in complex with 39 | 6HUV_N |
| PB | T01.010 | proteasome subunit beta1c | yeast 20s proteasome with human beta2i (1-53) | 6HV3_N |
| PB | T01.010 | proteasome subunit beta1c | yeast 20s proteasome with human beta2i (1-53) in complex with onx 0914 | 6HV4_N |
| PB | T01.010 | proteasome subunit beta1c | yeast 20s proteasome with human beta2i (1-53) in complex with 4 | 6HV5_N |
| PB | T01.010 | proteasome subunit beta1c | yeast 20s proteasome with human beta2i (1-53) in complex with 7 | 6HV7_N |
| PB | T01.010 | proteasome subunit beta1c | yeast 20s proteasome with human beta2i (1-53) in complex with 13 | 6HVA_N |
| PB | T01.010 | proteasome subunit beta1c | yeast 20s proteasome with human beta2i (1-53) in complex with 16 | 6HVR_N |
| PB | T01.010 | proteasome subunit beta1c | yeast 20s proteasome with human beta2i (1-53) in complex with 18 | 6HVS_N |
| PB | T01.010 | proteasome subunit beta1c | yeast 20s proteasome with human beta2i (1-53) in complex with 20 | 6HVT_N |
| PB | T01.010 | proteasome subunit beta1c | yeast 20s proteasome with human beta2i (1-53) in complex with 29 | 6HVU_N |
| PB | T01.010 | proteasome subunit beta1c | yeast 20s proteasome with human beta2i (1-53) in complex with 39 | 6HVV_N |
| PB | T01.010 | proteasome subunit beta1c | yeast 20s proteasome with human beta2i (1-53) in complex with 43 | 6HVW_N |
| PB | T01.010 | proteasome subunit beta1c | yeast 20s proteasome in complex with 4 | 6HVX_N |
| PB | T01.010 | proteasome subunit beta1c | yeast 20s proteasome in complex with 5 (7- and 6-membered ring) | 6HVY_N |
| PB | T01.010 | proteasome subunit beta1c | yeast 20s proteasome in complex with 7 | 6HW0_N |
| PB | T01.010 | proteasome subunit beta1c | yeast 20s proteasome in complex with 13 | 6HW3_N |
| PB | T01.010 | proteasome subunit beta1c | yeast 20s proteasome in complex with 16 | 6HW4_N |
| PB | T01.010 | proteasome subunit beta1c | yeast 20s proteasome in complex with 18 | 6HW5_N |
| PB | T01.010 | proteasome subunit beta1c | yeast 20s proteasome in complex with 20 | 6HW6_N |
| PB | T01.010 | proteasome subunit beta1c | yeast 20s proteasome in complex with 29 | 6HW7_N |
| PB | T01.010 | proteasome subunit beta1c | yeast 20s proteasome in complex with 39 | 6HW8_N |
| PB | T01.010 | proteasome subunit beta1c | yeast 20s proteasome in complex with 41b | 6HW9_N |
| PB | T01.010 | proteasome subunit beta1c | yeast 20s proteasome in complex with 43 | 6HWA_N |
| PB | T01.010 | proteasome subunit beta1c | yeast 20s proteasome in complex with 44b | 6HWB_N |
| PB | T01.010 | proteasome subunit beta1c | yeast 20s proteasome beta2-g45a mutant | 6HWC_N |
| PB | T01.010 | proteasome subunit beta1c | yeast 20s proteasome beta2-g45a mutant in complex with bortezomib | 6HWD_N |
| PB | T01.010 | proteasome subunit beta1c | yeast 20s proteasome beta2-g45a mutant in complex with carfilzomib | 6HWE_N |
| PB | T01.010 | proteasome subunit beta1c | yeast 20s proteasome beta2-g45a mutant in complex with onx 0914 | 6HWF_N |
| PB | T01.010 | proteasome subunit beta1c | 20S proteasome; complex with PR-957 | 3UNB_N |
| PB | T01.010 | proteasome subunit beta1c | 20S proteasome | 3UNE_N |
| PB | T01.010 | proteasome subunit beta1c | 20S proteasome complex | 5FMG_H |
| PB | T01.011 | proteasome subunit beta2c | 20S proteasome in complex with activator PA26 (Trypanosoma brucei) | 1FNT_I |
| PB | T01.011 | proteasome subunit beta2c | complete proteasome | 1G0U_H |
| PB | T01.011 | proteasome subunit beta2c | complex with epoxomicin | 1G65_H |
| PB | T01.011 | proteasome subunit beta2c | proteasome complex bound to TMC-95A inhibitor | 1JD2_H |
| PB | T01.011 | proteasome subunit beta2c | 20S proteasome | 1RYP_I |
| PB | T01.011 | proteasome subunit beta2c | 20S proteasome; complex with the proteasome activator PA26 from Trypanosoma brucei | 1Z7Q_I |
| PB | T01.011 | proteasome subunit beta2c | 20S proteasome;complex with bortezomib | 2F16_H |
| PB | T01.011 | proteasome subunit beta2c | 20S proteasome; complex with salinosporamide A | 2FAK_H |
| PB | T01.011 | proteasome subunit beta2c | 20S proteasome; complex with homobelactosin C | 2FNY_H |
| PB | T01.011 | proteasome subunit beta2c | 20S proteasome; complex with TMC-95 based biphenyl-ether macrocycle | 2GPL_H |
| PB | T01.011 | proteasome subunit beta2c | 20S proteasome; complex with syringolin A | 2ZCY_H |
| PB | T01.011 | proteasome subunit beta2c | 20S proteasome; complex with glidobactin A | 3BDM_H |
| PB | T01.011 | proteasome subunit beta2c | 20S proteasome; complex with fellutamide B | 3D29_H |
| PB | T01.011 | proteasome subunit beta2c | 20s proteasome; complex with the epimer form of spirolactacystin | 3DY3_H |
| PB | T01.011 | proteasome subunit beta2c | 20s proteasome; complex with spirolactacystin | 3DY4_H |
| PB | T01.011 | proteasome subunit beta2c | 20s proteasome; complex with homobelactosin c | 3E47_H |
| PB | T01.011 | proteasome subunit beta2c | 20s proteasome; complex with syringolin b | 3GPJ_H |
| PB | T01.011 | proteasome subunit beta2c | 20S proteasome; complex with salinosporamide derivative | 3GPT_H |
| PB | T01.011 | proteasome subunit beta2c | 20S proteasome; complex with salinosporamide derivative | 3GPW_H |
| PB | T01.011 | proteasome subunit beta2c | 20S proteasome; complex with hyroxylated salinosporamide | 3HYE_H |
| PB | T01.011 | proteasome subunit beta2c | 20S proteasome; complex with bortezomib | 3MG0_H |
| PB | T01.011 | proteasome subunit beta2c | 20S proteasome; complex with compound 1 | 3MG4_H |
| PB | T01.011 | proteasome subunit beta2c | 20S proteasome; complex with compound 6 | 3MG6_H |
| PB | T01.011 | proteasome subunit beta2c | 20S open-gate proteasome; complex with compound 6 | 3MG7_H |
| PB | T01.011 | proteasome subunit beta2c | 20S open-gate proteasome; complex with compound 16 | 3MG8_H |
| PB | T01.011 | proteasome subunit beta2c | 20S proteasome; complex with ligand 2a | 3NZJ_H |
| PB | T01.011 | proteasome subunit beta2c | 20S proteasome; complex with ligand 2b | 3NZW_H |
| PB | T01.011 | proteasome subunit beta2c | 20S proteasome; complex with ligand 2c | 3NZX_H |
| PB | T01.011 | proteasome subunit beta2c | 20S open-gate proteasome; complex with compound 24 | 3OEU_H |
| PB | T01.011 | proteasome subunit beta2c | 20S open-gate proteasome; complex with compound 25 | 3OEV_H |
| PB | T01.011 | proteasome subunit beta2c | 20S proteasome; complex with alpha-keto-aldehyde | 3OKJ_H |
| PB | T01.011 | proteasome subunit beta2c | 20S open-gate proteasome; complex with compound 20 | 3SDI_H |
| PB | T01.011 | proteasome subunit beta2c | 20S open-gate proteasome; complex with compound 34 | 3SDK_H |
| PB | T01.011 | proteasome subunit beta2c | 20S proteasome; complex with hydroxyurea derivative HU10 | 3SHJ_H |
| PB | T01.011 | proteasome subunit beta2c | 20S proteasome; complex with homobelactosin C | 3TDD_H |
| PB | T01.011 | proteasome subunit beta2c | 20S open-gate proteasome; complex with PR-957 (morpholine) | 3UN4_H |
| PB | T01.011 | proteasome subunit beta2c | 20S proteasome; complex with PR-957 (epoxide) | 3UN8_H |
| PB | T01.011 | proteasome subunit beta2c | 26S proteasome | 3WXR_I |
| PB | T01.011 | proteasome subunit beta2c | 26S proteasome | 4CR2 |
| PB | T01.011 | proteasome subunit beta2c | 4CR3 | |
| PB | T01.011 | proteasome subunit beta2c | 26S proteasome | 4CR4 |
| PB | T01.011 | proteasome subunit beta2c | 20S proteasome; complex with K-7174 | 4EU2_I |
| PB | T01.011 | proteasome subunit beta2c | 20S proteasome; complex with cepafungin I | 4FZC_H |
| PB | T01.011 | proteasome subunit beta2c | 20S proteasome; complex with glidobactin | 4FZG_H |
| PB | T01.011 | proteasome subunit beta2c | 20S proteasome; complex with Syringolin-Glidobactin chimera | 4G4S_I |
| PB | T01.011 | proteasome subunit beta2c | 20S proteasome; complex with Syringolin-Glidobactin chimera | 4GK7_H |
| PB | T01.011 | proteasome subunit beta2c | 20S proteasome; complex with vinylketone carmaphycin analogue VNK1 | 4HNP_H |
| PB | T01.011 | proteasome subunit beta2c | 20S proteasome; complex with epoxyketone carmaphycin analogue 3 | 4HRC_H |
| PB | T01.011 | proteasome subunit beta2c | 20S proteasome; complex with carmaphycin A | 4HRD_H |
| PB | T01.011 | proteasome subunit beta2c | 20S proteasome; complex with vinyl sulfone LU102 | 4INR_H |
| PB | T01.011 | proteasome subunit beta2c | 20S proteasome; complex with vinyl sulfone LU122 | 4INT_H |
| PB | T01.011 | proteasome subunit beta2c | 20S proteasome; complex with vinyl sulfone LU112 | 4INU_H |
| PB | T01.011 | proteasome subunit beta2c | 20S proteasome; complex with belactosin derivative 3E | 4J70_H |
| PB | T01.011 | proteasome subunit beta2c | 20S proteasome; complex with dimerized linear mimetic of TMC-95A | 4JSQ_H |
| PB | T01.011 | proteasome subunit beta2c | 20S proteasome; complex with dimerized linear mimetic of TMC-95A | 4JSU_H |
| PB | T01.011 | proteasome subunit beta2c | 20S proteasome; complex with dimerized linear mimetic of TMC-95A | 4JT0_H |
| PB | T01.011 | proteasome subunit beta2c | 20S proteasome; complex with vibralactone | 4LQI_H |
| PB | T01.011 | proteasome subunit beta2c | 20S proteasome; complex with enone carmaphycin analogue 6 | 4LTC_H |
| PB | T01.011 | proteasome subunit beta2c | 20S proteasome; complex with MG132 | 4NNN_H |
| PB | T01.011 | proteasome subunit beta2c | 20S proteasome; complex with Z-Leu-Leu-Leu-ketoaldehyde | 4NNW_H |
| PB | T01.011 | proteasome subunit beta2c | 20S proteasome; complex with Z-Leu-Leu-Leu-B(OH)2 | 4NO1_H |
| PB | T01.011 | proteasome subunit beta2c | 20S proteasome; complex with Z-Leu-Leu-Leu-vinylsulfone | 4NO6_H |
| PB | T01.011 | proteasome subunit beta2c | 20S proteasome; complex with Z-Leu-Leu-Leu-ketoamide | 4NO8_H |
| PB | T01.011 | proteasome subunit beta2c | 20S proteasome; complex with Z-Leu-Leu-Leu-epoxyketone | 4NO9_H |
| PB | T01.011 | proteasome subunit beta2c | 20S proteasome; complex with kendomycin | 4Q1S_H |
| PB | T01.011 | proteasome subunit beta2c | 20S proteasome; complex with Boc-Ala-Ala-Ala-CHO | 4QBY_H |
| PB | T01.011 | proteasome subunit beta2c | 20S proteasome; complex with epoxyketone inhibitor 8 | 4QLQ_H |
| PB | T01.011 | proteasome subunit beta2c | 20S proteasome; complex with epoxyketone inhibitor 11 | 4QLS_H |
| PB | T01.011 | proteasome subunit beta2c | 20S proteasome; complex with tripeptidic epoxyketone inhibitor 2 | 4QLT_H |
| PB | T01.011 | proteasome subunit beta2c | 20S proteasome; complex with tripeptidic epoxyketone inhibitor 9 | 4QLU_H |
| PB | T01.011 | proteasome subunit beta2c | 20S proteasome; complex with tripeptidic epoxyketone inhibitor 17 | 4QLV_H |
| PB | T01.011 | proteasome subunit beta2c | 20S proteasome | 4QUX_H |
| PB | T01.011 | proteasome subunit beta2c | 20S proteasome | 4QUY_H |
| PB | T01.011 | proteasome subunit beta2c | 20S proteasome | 4QV0_H |
| PB | T01.011 | proteasome subunit beta2c | 20S proteasome | 4QV1_H |
| PB | T01.011 | proteasome subunit beta2c | 20S proteasome | 4QV3_H |
| PB | T01.011 | proteasome subunit beta2c | 20S proteasome beta5 Met45Thr mutant | 4QV4_H |
| PB | T01.011 | proteasome subunit beta2c | 20S proteasome beta5 Met45Ile mutant | 4QV5_H |
| PB | T01.011 | proteasome subunit beta2c | 20S proteasome | 4QV6_H |
| PB | T01.011 | proteasome subunit beta2c | 20S proteasome | 4QV7_H |
| PB | T01.011 | proteasome subunit beta2c | 20S proteasome | 4QV8_H |
| PB | T01.011 | proteasome subunit beta2c | 20S proteasome | 4QV9_H |
| PB | T01.011 | proteasome subunit beta2c | 20S proteasome; complex with bortezomib | 4QVL_H |
| PB | T01.011 | proteasome subunit beta2c | 20S proteasome beta5 Met45Ala mutant; complex with bortezomib | 4QVM_H |
| PB | T01.011 | proteasome subunit beta2c | 20S proteasome beta5 Met45Val mutant; complex with bortezomib | 4QVN_H |
| PB | T01.011 | proteasome subunit beta2c | 20S proteasome beta5 Met45Thr mutant; complex with bortezomib | 4QVP_H |
| PB | T01.011 | proteasome subunit beta2c | 20S proteasome beta5 Met45Ile mutant; complex with bortezomib | 4QVQ_H |
| PB | T01.011 | proteasome subunit beta2c | 20S proteasome beta5 Ala49Val mutant; complex with bortezomib | 4QVV_H |
| PB | T01.011 | proteasome subunit beta2c | 20S proteasome beta5 Ala49Ser mutant; complex with bortezomib | 4QVW_H |
| PB | T01.011 | proteasome subunit beta2c | 20S proteasome beta5 Ala49Thr mutant; complex with bortezomib | 4QVY_H |
| PB | T01.011 | proteasome subunit beta2c | 20S proteasome beta5 Ala49Thr,Ala50Val mutant; complex with bortezomib | 4QW0_H |
| PB | T01.011 | proteasome subunit beta2c | 20S proteasome beta5 Ala50Val mutant; complex with bortezomib | 4QW1_H |
| PB | T01.011 | proteasome subunit beta2c | 20S proteasome beta5 Cys63Phe mutant; complex with bortezomib | 4QW3_H |
| PB | T01.011 | proteasome subunit beta2c | 20S proteasome; complex with carfilzomib | 4QW4_H |
| PB | T01.011 | proteasome subunit beta2c | 20S proteasome beta5 Met45Ala mutant; complex with carfilzomib | 4QW5_H |
| PB | T01.011 | proteasome subunit beta2c | 20S proteasome beta5 Met45Val mutant; complex with carfilzomib | 4QW6_H |
| PB | T01.011 | proteasome subunit beta2c | 20S proteasome beta5 Met45Thr mutant; complex with carfilzomib | 4QW7_H |
| PB | T01.011 | proteasome subunit beta2c | 20S proteasome beta5 Met45Ile mutant; complex with carfilzomib | 4QWF_H |
| PB | T01.011 | proteasome subunit beta2c | 20S proteasome beta5 Ala49Val mutant; complex with carfilzomib | 4QWG_H |
| PB | T01.011 | proteasome subunit beta2c | 20S proteasome beta5 Ala49Ser mutant; complex with carfilzomib | 4QWI_H |
| PB | T01.011 | proteasome subunit beta2c | 20S proteasome beta5 Ala49Thr mutant; complex with carfilzomib | 4QWJ_H |
| PB | T01.011 | proteasome subunit beta2c | 20S proteasome beta5 Ala49Thr, Ala50Val mutant; complex with carfilzomib | 4QWK_H |
| PB | T01.011 | proteasome subunit beta2c | 20S proteasome beta5 Ala50Val mutant; complex with carfilzomib | 4QWL_H |
| PB | T01.011 | proteasome subunit beta2c | 20S proteasome beta5 Cys52Phe mutant; complex with carfilzomib | 4QWR_H |
| PB | T01.011 | proteasome subunit beta2c | 20S proteasome beta5 Cys63Phe mutant; complex with carfilzomib | 4QWS_H |
| PB | T01.011 | proteasome subunit beta2c | 20S proteasome beta5 Cys52Phe mutant; complex with bortezomib | 4QWU_H |
| PB | T01.011 | proteasome subunit beta2c | 20S proteasome; complex with epoxyketone inhibitor ONX 0914 | 4QWX_H |
| PB | T01.011 | proteasome subunit beta2c | 20S proteasome beta 5 Met45Ala mutant; complex with epoxyketone inhibitor ONX 0914 | 4QXJ_H |
| PB | T01.011 | proteasome subunit beta2c | complete proteasome; complex with epoxyketone inhibitor ONX 0914 | 4QZ0_H |
| PB | T01.011 | proteasome subunit beta2c | 20S proteasome beta 5 Met45Thr mutant; complex with epoxyketone inhibitor ONX 0914 | 4QZ1_H |
| PB | T01.011 | proteasome subunit beta2c | 20S proteasome beta 5 Met45Ile mutant; complex with epoxyketone inhibitor ONX 0914 | 4QZ2_H |
| PB | T01.011 | proteasome subunit beta2c | 20S proteasome beta 5 Ala49Val mutant; complex with epoxyketone inhibitor ONX 0914 | 4QZ3_H |
| PB | T01.011 | proteasome subunit beta2c | 20S proteasome beta 5 Ala49Ser mutant; complex with epoxyketone inhibitor ONX 0914 | 4QZ4_H |
| PB | T01.011 | proteasome subunit beta2c | 20S proteasome beta 5 Ala49Thr mutant; complex with epoxyketone inhibitor ONX 0914 | 4QZ5_H |
| PB | T01.011 | proteasome subunit beta2c | 20S proteasome beta 5 Ala49Thr, Ala50Val mutant; complex with epoxyketone inhibitor ONX 0914 | 4QZ6_H |
| PB | T01.011 | proteasome subunit beta2c | 20S proteasome beta 5 Ala50Val mutant; complex with epoxyketone inhibitor ONX 0914 | 4QZ7_H |
| PB | T01.011 | proteasome subunit beta2c | 20S proteasome beta 5 Cys52Phe mutant; complex with epoxyketone inhibitor ONX 0914 | 4QZW_H |
| PB | T01.011 | proteasome subunit beta2c | complete proteasome; complex with epoxyketone inhibitor ONX 0914 | 4QZX_H |
| PB | T01.011 | proteasome subunit beta2c | 20S proteasome; complex with omuralide | 4QZZ_H |
| PB | T01.011 | proteasome subunit beta2c | 20S proteasome beta 5 Cys52Phe mutant; complex with omuralide | 4R00_H |
| PB | T01.011 | proteasome subunit beta2c | 20S proteasome; complex with BSC4999 | 4R02_H |
| PB | T01.011 | proteasome subunit beta2c | 20S proteasome; ligand induced aziridine-formation in beta5 | 4R17_H |
| PB | T01.011 | proteasome subunit beta2c | 20S proteasome; ligand induced Lys33-Thr1 cross-linking in beta5 | 4R18_H |
| PB | T01.011 | proteasome subunit beta2c | 20S proteasome; complex with alkaloid indolo-phakellin | 4RUR_H |
| PB | T01.011 | proteasome subunit beta2c | 4V7O | |
| PB | T01.011 | proteasome subunit beta2c | 20S proteasome; complex with PR-VI modulator | 4X6Z_I |
| PB | T01.011 | proteasome subunit beta2c | 20S proteasome; complex with Ac-Pro-Ala-Asp-EP | 4Y69_H |
| PB | T01.011 | proteasome subunit beta2c | 20S proteasome beta2 His114Asp mutant; complex with Ac-Pro-Ala-Asp-EP | 4Y6A_H |
| PB | T01.011 | proteasome subunit beta2c | 20S proteasome; complex with Ac-Pro-Ala-Glu-EP | 4Y6V_H |
| PB | T01.011 | proteasome subunit beta2c | 20S proteasome; complex with Ac-Pro-Ala-Leu-EP | 4Y6Z_H |
| PB | T01.011 | proteasome subunit beta2c | 20S proteasome; complex with Ac-Leu-Ala-Val-EP | 4Y70_H |
| PB | T01.011 | proteasome subunit beta2c | 20S proteasome; complex with Ac-Leu-Ala-Leu-EP | 4Y74_H |
| PB | T01.011 | proteasome subunit beta2c | 20S proteasome; complex with Ac-Pro-Ala-Phe-EP | 4Y75_H |
| PB | T01.011 | proteasome subunit beta2c | 20S proteasome; complex with Ac-Leu-Ala-Phe-EP | 4Y77_H |
| PB | T01.011 | proteasome subunit beta2c | 20S proteasome; complex with Ac-Leu-Ala-Asp-EP | 4Y78_H |
| PB | T01.011 | proteasome subunit beta2c | 20S proteasome; complex with Ac-Leu-Ala-Glu-EP | 4Y7W_H |
| PB | T01.011 | proteasome subunit beta2c | complete proteasome; complex with Ac-PAA-ep | 4Y7X_H |
| PB | T01.011 | proteasome subunit beta2c | 20S proteasome; complex with Ac-Leu-Ala-Ala-EP | 4Y7Y_H |
| PB | T01.011 | proteasome subunit beta2c | 20S proteasome; complex with Ac-Leu-Ala-Ile-EP | 4Y80_H |
| PB | T01.011 | proteasome subunit beta2c | 20S proteasome; complex with Ac-Pro-Ala-Tyr-EP | 4Y81_H |
| PB | T01.011 | proteasome subunit beta2c | 20S proteasome; complex with Ac-Leu-Ala-Tyr-EP | 4Y82_H |
| PB | T01.011 | proteasome subunit beta2c | 20S proteasome; complex with N3-Ala(4,4-F2P)-Asn-Leu-Leu-EP | 4Y84_H |
| PB | T01.011 | proteasome subunit beta2c | 20S proteasome; complex with N3-Ala-Pro-Asn-Leu-Leu-EP | 4Y8G_H |
| PB | T01.011 | proteasome subunit beta2c | 20S proteasome; complex with N3-Ala-Pro-Ala-Leu-EP | 4Y8H_H |
| PB | T01.011 | proteasome subunit beta2c | 20S proteasome; complex with Ac-Pro-Leu-Leu-EP | 4Y8I_H |
| PB | T01.011 | proteasome subunit beta2c | 20S proteasome; complex with Ac-Leu-Leu-Leu-EP | 4Y8J_H |
| PB | T01.011 | proteasome subunit beta2c | 20S proteasome; complex with H-Ala-Pro-Leu-Leu-EP | 4Y8K_H |
| PB | T01.011 | proteasome subunit beta2c | 20S proteasome; complex with Ac-Ala-Pro-Leu-Leu-EP | 4Y8L_H |
| PB | T01.011 | proteasome subunit beta2c | 20S proteasome beta7-delta7 C-terminal mutant | 4Y8M_H |
| PB | T01.011 | proteasome subunit beta2c | 20S proteasome beta7-delta7 C-terminal mutant; complex with Ac-Pro-Ala-Glu-EP | 4Y8N_H |
| PB | T01.011 | proteasome subunit beta2c | 20S proteasome beta 7-delta 7 C-terminal mutant; complex with Ac-Pro-Ala-Phe-EP | 4Y8O_H |
| PB | T01.011 | proteasome subunit beta2c | 20S proteasome beta 7-delta 7 C-terminal mutant; complex with Ac-Pro-Ala-Leu-EP | 4Y8P_H |
| PB | T01.011 | proteasome subunit beta2c | 20S proteasome beta 7-delta 7 C-terminal mutant; complex with Ac-Pro-Ala-Tyr-EP | 4Y8Q_H |
| PB | T01.011 | proteasome subunit beta2c | 20S proteasome beta 2 His116Asp mutant | 4Y8R_H |
| PB | T01.011 | proteasome subunit beta2c | 20S proteasome beta 2 His116Asp mutant; complex with Ac-Leu-Ala-Glu-EP | 4Y8S_H |
| PB | T01.011 | proteasome subunit beta2c | 20S proteasome beta 2 His116Asp mutant; complex with Ac-Pro-Ala-Glu-EP | 4Y8T_H |
| PB | T01.011 | proteasome subunit beta2c | 20S proteasome beta 2 His116Asp mutant; complex with Ac-Pro-Ala-Asp-EP | 4Y8U_H |
| PB | T01.011 | proteasome subunit beta2c | 20S proteasome beta 2 His116Glu mutant | 4Y9Y_H |
| PB | T01.011 | proteasome subunit beta2c | 20S proteasome beta 2 His116Glu mutant; complex with Ac-Leu-Ala-Glu-EP | 4Y9Z_H |
| PB | T01.011 | proteasome subunit beta2c | 20S proteasome beta 2 His116Glu mutant; complex with Ac-Pro-Ala-Glu-EP | 4YA0_H |
| PB | T01.011 | proteasome subunit beta2c | 20S proteasome beta 2 His116Asn mutant | 4YA1_H |
| PB | T01.011 | proteasome subunit beta2c | 20S proteasome beta 2 His116Asn mutant; complex with Ac-Leu-Ala-Glu-EP | 4YA2_H |
| PB | T01.011 | proteasome subunit beta2c | 20S proteasome beta 2 His116Asn mutant; complex with Ac-Pro-Ala-Glu-EP | 4YA3_H |
| PB | T01.011 | proteasome subunit beta2c | 20S proteasome beta 2 His114Asp mutant | 4YA4_H |
| PB | T01.011 | proteasome subunit beta2c | 20S proteasome beta 2 His114Asp mutant; complex with Ac-Pro-Ala-Glu-EP | 4YA5_H |
| PB | T01.011 | proteasome subunit beta2c | 20S proteasome beta 2 His114Asp mutant; complex with Ac-Leu-Ala-Glu-EP | 4YA7_H |
| PB | T01.011 | proteasome subunit beta2c | 20S proteasome beta 2 His114Asp mutant; complex with AC-Leu-Ala-Asp-EP | 4YA9_H |
| PB | T01.011 | proteasome subunit beta2c | 20S proteasome; complex with belactosin C derivative 3 | 4Z1L_H |
| PB | T01.011 | proteasome subunit beta2c | 5A5B | |
| PB | T01.011 | proteasome subunit beta2c | 20S proteasome; complex with macyranone A | 5AHJ_H |
| PB | T01.011 | proteasome subunit beta2c | 20S proteasome; complex with beta1/beta2 nonspecifici sulfonamide ligand | 5BOU_H |
| PB | T01.011 | proteasome subunit beta2c | yeast 20s proteasome beta2-g170a mutant | 5BXL_H |
| PB | T01.011 | proteasome subunit beta2c | yeast 20s proteasome beta2-g170a mutant in complex with bortezomib | 5BXN_H |
| PB | T01.011 | proteasome subunit beta2c | 20S proteasome beta5 Gly48Cys mutant | 5CGF_H |
| PB | T01.011 | proteasome subunit beta2c | 20S proteasome beta5 Gly48Cys mutant; complex with alpha-chloroacetamide 1 | 5CGG_H |
| PB | T01.011 | proteasome subunit beta2c | 20S proteasome beta5 Gly48Cys mutant; complex with alpha-chloroacetamide 5 | 5CGH_H |
| PB | T01.011 | proteasome subunit beta2c | 20S proteasome beta5 Gly48Cys mutant; complex with ONX 0914 | 5CGI_H |
| PB | T01.011 | proteasome subunit beta2c | yeast 20s proteasome at 2.3 a resolution | 5CZ4_H |
| PB | T01.011 | proteasome subunit beta2c | yeast 20s proteasome beta1-t1a mutant in complex with carfilzomib | 5CZ5_H |
| PB | T01.011 | proteasome subunit beta2c | yeast 20s proteasome beta5-t1a mutant in complex with syringolin a, propeptide expressed in trans | 5CZ6_H |
| PB | T01.011 | proteasome subunit beta2c | yeast 20s proteasome beta5-t1a beta5-k81r double mutant in complex with bortezomib, propeptide expressed in cis | 5CZ7_H |
| PB | T01.011 | proteasome subunit beta2c | yeast 20s proteasome beta5-l(-49)s-k33a mutant in complex with carfilzomib | 5CZ8_H |
| PB | T01.011 | proteasome subunit beta2c | yeast 20s proteasome beta5-d17n mutant in complex with carfilzomib; propeptide expressed in trans | 5CZ9_H |
| PB | T01.011 | proteasome subunit beta2c | yeast 20s proteasome beta5-d166n mutant | 5CZA_H |
| PB | T01.011 | proteasome subunit beta2c | yeast 20s proteasome beta5-d166n mutant in complex with carfilzomib | 5D0S_H |
| PB | T01.011 | proteasome subunit beta2c | 20s proteasome beta5-Asp166Asn mutant; complex with MG132 | 5D0T_H |
| PB | T01.011 | proteasome subunit beta2c | yeast 20s proteasome beta5-t1c mutant in complex with carfilzomib | 5D0V_H |
| PB | T01.011 | proteasome subunit beta2c | yeast 20s proteasome beta5-t1s mutant | 5D0W_H |
| PB | T01.011 | proteasome subunit beta2c | yeast 20s proteasome beta5-t1s mutant in complex with bortezomib | 5D0X_H |
| PB | T01.011 | proteasome subunit beta2c | yeast 20s proteasome beta5-t1s mutant in complex with carfilzomib | 5D0Z_H |
| PB | T01.011 | proteasome subunit beta2c | 20S proteasome; complex with alkyne-PI | 5DKI_H |
| PB | T01.011 | proteasome subunit beta2c | 20S proteasome; complex with octreotide-PI | 5DKJ_H |
| PB | T01.011 | proteasome subunit beta2c | yeast 20s proteasome beta2-t1a mutant | 5FG7_H |
| PB | T01.011 | proteasome subunit beta2c | yeast 20s proteasome beta2-t(-2)v mutant | 5FG9_H |
| PB | T01.011 | proteasome subunit beta2c | yeast 20s proteasome beta5-k33a mutant (propeptide expressed in trans) | 5FGA_H |
| PB | T01.011 | proteasome subunit beta2c | yeast 20s proteasome beta5-h(-2)l-t1a double mutant in complex with carfilzomib | 5FGD_H |
| PB | T01.011 | proteasome subunit beta2c | yeast 20s proteasome beta5-h(-2)t-t1a double mutant in complex with carfilzomib | 5FGE_H |
| PB | T01.011 | proteasome subunit beta2c | yeast 20s proteasome beta5-h(-2)a-t1a-k81r triple mutant in complex with carfilzomib | 5FGF_H |
| PB | T01.011 | proteasome subunit beta2c | yeast 20s proteasome beta5-l(-49s)_d17n double mutant in complex with carfilzomib | 5FGG_H |
| PB | T01.011 | proteasome subunit beta2c | 20s proteasome beta5-Lys33Ala mutant (propeptide expressed in trans); complex with MG132 | 5FGH_H |
| PB | T01.011 | proteasome subunit beta2c | yeast 20s proteasome beta1-t1a beta2-t1a double mutant in complex withcarfilzomib | 5FGI_H |
| PB | T01.011 | proteasome subunit beta2c | yeast 20s proteasome beta5-k33a mutant (propeptide expressed in trans)in complex with carfilzomib | 5FHS_H |
| PB | T01.011 | proteasome subunit beta2c | 20s proteasome; complex with the peptidic epoxyketone inhibitor 27 | 5JHR_H |
| PB | T01.011 | proteasome subunit beta2c | 20s proteasome; complex with the peptidic epoxyketone inhibitor 15 | 5JHS_H |
| PB | T01.011 | proteasome subunit beta2c | 20s proteasome; complex with epoxyketone inhibitor 14 | 5L52_H |
| PB | T01.011 | proteasome subunit beta2c | 20s proteasome; complex with epoxyketone inhibitor 16 | 5L54_H |
| PB | T01.011 | proteasome subunit beta2c | 20s proteasome; complex with epoxyketone inhibitor 18 | 5L55_H |
| PB | T01.011 | proteasome subunit beta2c | yeast 20s proteasome with human beta5i (1-138; r57t) | 5L5A_H |
| PB | T01.011 | proteasome subunit beta2c | yeast 20s proteasome with human beta5i (1-138) and human beta6 (97- 111; 118-133) | 5L5B_H |
| PB | T01.011 | proteasome subunit beta2c | yeast 20s proteasome with human beta5i (1-138) and human beta6 (97- 111; 118-133) in complex with onx 0914 | 5L5D_H |
| PB | T01.011 | proteasome subunit beta2c | yeast 20s proteasome with human beta5i (1-138) and human beta6 (97- 111; 118-133) in complex with carfilzomib | 5L5E_H |
| PB | T01.011 | proteasome subunit beta2c | yeast 20s proteasome with human beta5i (1-138) and human beta6 (97- 111; 118-133) in complex with bortezomib | 5L5F_H |
| PB | T01.011 | proteasome subunit beta2c | yeast 20s proteasome with human beta5i (1-138) and human beta6 (97- 111; 118-133); complex with PR-924 | 5L5H_H |
| PB | T01.011 | proteasome subunit beta2c | yeast 20s proteasome with human beta5i (1-138) and human beta6 (97- 111; 118-133) in complex with epoxyketone inhibitor 9 | 5L5I_H |
| PB | T01.011 | proteasome subunit beta2c | yeast 20s proteasome with human beta5i (1-138) and human beta6 (97- 111; 118-133) in complex with epoxyketone inhibitor 14 | 5L5J_H |
| PB | T01.011 | proteasome subunit beta2c | yeast 20s proteasome with human beta5i (1-138) and human beta6 (97- 111; 118-133) in complex with epoxyketone inhibitor 16 | 5L5O_H |
| PB | T01.011 | proteasome subunit beta2c | yeast 20s proteasome with human beta5i (1-138) and human beta6 (97- 111; 118-133) in complex with epoxyketone inhibitor 17 | 5L5P_H |
| PB | T01.011 | proteasome subunit beta2c | yeast 20s proteasome with human beta5i (1-138) and human beta6 (97- 111; 118-133) in complex with epoxyketone 18 | 5L5Q_H |
| PB | T01.011 | proteasome subunit beta2c | yeast 20s proteasome with human beta5i (1-138;v31m) and human beta6 (97-111; 118-133) | 5L5R_H |
| PB | T01.011 | proteasome subunit beta2c | yeast 20s proteasome with human beta5i (1-138; Val31Met mutant) and human beta6 (97-111; 118-133); complex with PR-924 | 5L5S_H |
| PB | T01.011 | proteasome subunit beta2c | yeast 20s proteasome with human beta5i (1-138; v31m) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 16 | 5L5T_H |
| PB | T01.011 | proteasome subunit beta2c | yeast 20s proteasome with human beta5i (1-138; v31m) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 17 ***caveat 5l5u 04c h 301 has wrong chirality at atom c27 04c k 301 has ***caveat 2 5l5u wrong chirality at atom c27 04c v 301 h | 5L5U_H |
| PB | T01.011 | proteasome subunit beta2c | yeast 20s proteasome with human beta5c (1-138) and human beta6 (97- 111; 118-133) | 5L5W_H |
| PB | T01.011 | proteasome subunit beta2c | yeast 20s proteasome with human beta5c (1-138) and human beta6 (97- 111; 118-133) in complex with onx 0914 | 5L5X_H |
| PB | T01.011 | proteasome subunit beta2c | yeast 20s proteasome with human beta5c (1-138) and human beta6 (97- 111; 118-133) in complex with carfilzomib | 5L5Y_H |
| PB | T01.011 | proteasome subunit beta2c | yeast 20s proteasome with human beta5c (1-138) and human beta6 (97- 111; 118-133) in complex with bortezomib | 5L5Z_H |
| PB | T01.011 | proteasome subunit beta2c | yeast 20s proteasome with human beta5c (1-138) and human beta6 (97- 111; 118-133); complex with PR-924 | 5L60_H |
| PB | T01.011 | proteasome subunit beta2c | yeast 20s proteasome with human beta5c (1-138) and human beta6 (99- 132) in complex with epoxyketone inhibitor 14 | 5L61_H |
| PB | T01.011 | proteasome subunit beta2c | yeast 20s proteasome with human beta5c (1-138) and human beta6 (97- 111; 118-133) in complex with epoxyketone inhibitor 16 | 5L62_H |
| PB | T01.011 | proteasome subunit beta2c | yeast 20s proteasome with human beta5c (1-138) and human beta6 (97- 111; 118-133) in complex with epoxyketone inhibitor 17 ***caveat 5l63 04c h 301 has wrong chirality at atom c27 04c k 301 has ***caveat 2 5l63 wrong chirality at atom c27 04c v 301 has wr | 5L63_H |
| PB | T01.011 | proteasome subunit beta2c | yeast 20s proteasome with human beta5c (1-138) and human beta6 (97- 111; 118-133) in complex with epoxyketone inhibitor 18 | 5L64_H |
| PB | T01.011 | proteasome subunit beta2c | yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97- 111; 118-133) in complex with carfilzomib | 5L65_H |
| PB | T01.011 | proteasome subunit beta2c | yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97- 111; 118-133) in complex with bortezomib | 5L66_H |
| PB | T01.011 | proteasome subunit beta2c | yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97- 111; 118-133); complex with PR-924 | 5L67_H |
| PB | T01.011 | proteasome subunit beta2c | yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97- 111; 118-133) in complex with epoxyketone inhibitor 14 | 5L68_H |
| PB | T01.011 | proteasome subunit beta2c | yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97- 111; 118-133) in complex with epoxyketone inhibitor 16 | 5L69_H |
| PB | T01.011 | proteasome subunit beta2c | yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97- 111; 118-133) in complex with epoxyketone inhibitor 17 | 5L6A_H |
| PB | T01.011 | proteasome subunit beta2c | yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97- 111; 118-133) in complex with onx 0914 | 5L6B_H |
| PB | T01.011 | proteasome subunit beta2c | yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97- 111; 118-133) in complex with epoxyketone inhibitor 18 | 5L6C_H |
| PB | T01.011 | proteasome subunit beta2c | ligand-induced aziridine-formation at the yeast proteasomal subunit beta5 by sulfonate esters | 5LAI_H |
| PB | T01.011 | proteasome subunit beta2c | ligand-induced lys33-thr1 crosslinking at the yeast proteasomal subunit beta5 by sulfonate esters | 5LAJ_H |
| PB | T01.011 | proteasome subunit beta2c | yeast 20s proteasome with human beta5i (1-138; Arg57Thr mutant)in complex with PR-924 | 5LTT_H |
| PB | T01.011 | proteasome subunit beta2c | yeast 20s proteasome with human beta5i (1-138) and human beta6 (97- 111; 118-133) in complex with thiazole based inhibitor ro19 | 5M2B_H |
| PB | T01.011 | proteasome subunit beta2c | 26s proteasome in presence of atp (s1) | 5MP9_i |
| PB | T01.011 | proteasome subunit beta2c | 26s proteasome in presence of atp (s2) | 5MPA_i |
| PB | T01.011 | proteasome subunit beta2c | yeast 20s proteasome in complex with blm-pep activator | 5NIF_I |
| PB | T01.011 | proteasome subunit beta2c | yeast 26s proteasome bound to ubiquitinated substrate (4d motor state) | 6EF3_2 |
| PB | T01.011 | proteasome subunit beta2c | yeast 20s proteasome in complex with cystargolide B | 6G7F_H |
| PB | T01.011 | proteasome subunit beta2c | yeast 20s proteasome in complex with cystargolide B derivative 1 | 6G8M_H |
| PB | T01.011 | proteasome subunit beta2c | yeast 20s proteasome in complex with cystargolide B derivative 2 | 6G8N_H |
| PB | T01.011 | proteasome subunit beta2c | yeast 20s proteasome in complex with homosalinosporamide a | 6GOP_H |
| PB | T01.011 | proteasome subunit beta2c | yeast 20s proteasome in complex with the peptidic non-covalent bindinginhibitor rts-v5 | 6H39_H |
| PB | T01.011 | proteasome subunit beta2c | yeast 20s proteasome with human beta2i (1-53) | 6HV3_H |
| PB | T01.011 | proteasome subunit beta2c | yeast 20s proteasome with human beta2i (1-53) in complex with onx 0914 | 6HV4_H |
| PB | T01.011 | proteasome subunit beta2c | yeast 20s proteasome with human beta2i (1-53) in complex with 4 | 6HV5_H |
| PB | T01.011 | proteasome subunit beta2c | yeast 20s proteasome with human beta2i (1-53) in complex with 7 | 6HV7_H |
| PB | T01.011 | proteasome subunit beta2c | yeast 20s proteasome with human beta2i (1-53) in complex with 13 | 6HVA_H |
| PB | T01.011 | proteasome subunit beta2c | yeast 20s proteasome with human beta2i (1-53) in complex with 16 | 6HVR_H |
| PB | T01.011 | proteasome subunit beta2c | yeast 20s proteasome with human beta2i (1-53) in complex with 18 | 6HVS_H |
| PB | T01.011 | proteasome subunit beta2c | yeast 20s proteasome with human beta2i (1-53) in complex with 20 | 6HVT_H |
| PB | T01.011 | proteasome subunit beta2c | yeast 20s proteasome with human beta2i (1-53) in complex with 29 | 6HVU_H |
| PB | T01.011 | proteasome subunit beta2c | yeast 20s proteasome with human beta2i (1-53) in complex with 39 | 6HVV_H |
| PB | T01.011 | proteasome subunit beta2c | yeast 20s proteasome with human beta2i (1-53) in complex with 43 | 6HVW_H |
| PB | T01.011 | proteasome subunit beta2c | yeast 20s proteasome in complex with 4 | 6HVX_H |
| PB | T01.011 | proteasome subunit beta2c | yeast 20s proteasome in complex with 5 (7- and 6-membered ring) | 6HVY_H |
| PB | T01.011 | proteasome subunit beta2c | yeast 20s proteasome in complex with 7 | 6HW0_H |
| PB | T01.011 | proteasome subunit beta2c | yeast 20s proteasome in complex with 13 | 6HW3_H |
| PB | T01.011 | proteasome subunit beta2c | yeast 20s proteasome in complex with 16 | 6HW4_H |
| PB | T01.011 | proteasome subunit beta2c | yeast 20s proteasome in complex with 18 | 6HW5_H |
| PB | T01.011 | proteasome subunit beta2c | yeast 20s proteasome in complex with 20 | 6HW6_H |
| PB | T01.011 | proteasome subunit beta2c | yeast 20s proteasome in complex with 29 | 6HW7_H |
| PB | T01.011 | proteasome subunit beta2c | yeast 20s proteasome in complex with 39 | 6HW8_H |
| PB | T01.011 | proteasome subunit beta2c | yeast 20s proteasome in complex with 41b | 6HW9_H |
| PB | T01.011 | proteasome subunit beta2c | yeast 20s proteasome in complex with 43 | 6HWA_H |
| PB | T01.011 | proteasome subunit beta2c | yeast 20s proteasome in complex with 44b | 6HWB_H |
| PB | T01.011 | proteasome subunit beta2c | yeast 20s proteasome beta2-g45a mutant | 6HWC_H |
| PB | T01.011 | proteasome subunit beta2c | yeast 20s proteasome beta2-g45a mutant in complex with bortezomib | 6HWD_H |
| PB | T01.011 | proteasome subunit beta2c | yeast 20s proteasome beta2-g45a mutant in complex with carfilzomib | 6HWE_H |
| PB | T01.011 | proteasome subunit beta2c | yeast 20s proteasome beta2-g45a mutant in complex with onx 0914 | 6HWF_H |
| PB | T01.011 | proteasome subunit beta2c | 26S proteasome; complex with USP14-UbAl | 5GJQ_b |
| PB | T01.011 | proteasome subunit beta2c | 26S proteasome | 5GJR_b |
| PB | T01.011 | proteasome subunit beta2c | 20S proteasome; complex with PR-957 | 3UNB_H |
| PB | T01.011 | proteasome subunit beta2c | 20S proteasome | 3UNE_H |
| PB | T01.011 | proteasome subunit beta2c | ground state 26s proteasome (gs2) | 6EPC_2 |
| PB | T01.011 | proteasome subunit beta2c | substrate processing state 26s proteasome (sps1) ***caveat 6epd pro 2 231 has wrong chirality at atom ca | 6EPD_2 |
| PB | T01.011 | proteasome subunit beta2c | substrate processing state 26s proteasome (sps2) | 6EPE_2 |
| PB | T01.011 | proteasome subunit beta2c | ground state 26s proteasome (gs1) | 6EPF_2 |
| PB | T01.012 | proteasome subunit beta5c | 3UNF | |
| PB | T01.012 | proteasome subunit beta5c | 20S immunoproteasome | 3UNH_K |
| PB | T01.012 | proteasome subunit beta5c | yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97- 111; 118-133) in complex with carfilzomib | 5L65_K |
| PB | T01.012 | proteasome subunit beta5c | yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97- 111; 118-133) in complex with bortezomib | 5L66_K |
| PB | T01.012 | proteasome subunit beta5c | yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97- 111; 118-133); complex with PR-924 | 5L67_K |
| PB | T01.012 | proteasome subunit beta5c | yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97- 111; 118-133) in complex with epoxyketone inhibitor 14 | 5L68_K |
| PB | T01.012 | proteasome subunit beta5c | yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97- 111; 118-133) in complex with epoxyketone inhibitor 16 | 5L69_K |
| PB | T01.012 | proteasome subunit beta5c | yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97- 111; 118-133) in complex with epoxyketone inhibitor 17 | 5L6A_K |
| PB | T01.012 | proteasome subunit beta5c | yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97- 111; 118-133) in complex with onx 0914 | 5L6B_K |
| PB | T01.012 | proteasome subunit beta5c | yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97- 111; 118-133) in complex with epoxyketone inhibitor 18 | 5L6C_K |
| PB | T01.012 | proteasome subunit beta5c | 20S proteasome in complex with activator PA26 (Trypanosoma brucei) | 1FNT_L |
| PB | T01.012 | proteasome subunit beta5c | complete proteasome | 1G0U_K |
| PB | T01.012 | proteasome subunit beta5c | complex with epoxomicin | 1G65_K |
| PB | T01.012 | proteasome subunit beta5c | proteasome complex bound to TMC-95A inhibitor | 1JD2_K |
| PB | T01.012 | proteasome subunit beta5c | 20S proteasome | 1RYP_L |
| PB | T01.012 | proteasome subunit beta5c | 20S proteasome; complex with the proteasome activator PA26 from Trypanosoma brucei | 1Z7Q_L |
| PB | T01.012 | proteasome subunit beta5c | 20S proteasome;complex with bortezomib | 2F16_K |
| PB | T01.012 | proteasome subunit beta5c | 20S proteasome; complex with salinosporamide A | 2FAK_K |
| PB | T01.012 | proteasome subunit beta5c | 20S proteasome; complex with homobelactosin C | 2FNY_K |
| PB | T01.012 | proteasome subunit beta5c | 20S proteasome; complex with TMC-95 based biphenyl-ether macrocycle | 2GPL_K |
| PB | T01.012 | proteasome subunit beta5c | 20S proteasome; complex with syringolin A | 2ZCY_K |
| PB | T01.012 | proteasome subunit beta5c | 20S proteasome; complex with glidobactin A | 3BDM_K |
| PB | T01.012 | proteasome subunit beta5c | 20S proteasome; complex with fellutamide B | 3D29_K |
| PB | T01.012 | proteasome subunit beta5c | 20s proteasome; complex with the epimer form of spirolactacystin | 3DY3_K |
| PB | T01.012 | proteasome subunit beta5c | 20s proteasome; complex with spirolactacystin | 3DY4_K |
| PB | T01.012 | proteasome subunit beta5c | 20s proteasome; complex with homobelactosin c | 3E47_K |
| PB | T01.012 | proteasome subunit beta5c | 20s proteasome; complex with syringolin b | 3GPJ_K |
| PB | T01.012 | proteasome subunit beta5c | 20S proteasome; complex with salinosporamide derivative | 3GPT_K |
| PB | T01.012 | proteasome subunit beta5c | 20S proteasome; complex with salinosporamide derivative | 3GPW_K |
| PB | T01.012 | proteasome subunit beta5c | 20S proteasome; complex with hyroxylated salinosporamide | 3HYE_K |
| PB | T01.012 | proteasome subunit beta5c | 20S proteasome; complex with bortezomib | 3MG0_K |
| PB | T01.012 | proteasome subunit beta5c | 20S proteasome; complex with compound 1 | 3MG4_K |
| PB | T01.012 | proteasome subunit beta5c | 20S proteasome; complex with compound 6 | 3MG6_K |
| PB | T01.012 | proteasome subunit beta5c | 20S open-gate proteasome; complex with compound 6 | 3MG7_K |
| PB | T01.012 | proteasome subunit beta5c | 20S open-gate proteasome; complex with compound 16 | 3MG8_K |
| PB | T01.012 | proteasome subunit beta5c | 20S proteasome; complex with ligand 2a | 3NZJ_K |
| PB | T01.012 | proteasome subunit beta5c | 20S proteasome; complex with ligand 2b | 3NZW_K |
| PB | T01.012 | proteasome subunit beta5c | 20S proteasome; complex with ligand 2c | 3NZX_K |
| PB | T01.012 | proteasome subunit beta5c | 20S open-gate proteasome; complex with compound 24 | 3OEU_K |
| PB | T01.012 | proteasome subunit beta5c | 20S open-gate proteasome; complex with compound 25 | 3OEV_K |
| PB | T01.012 | proteasome subunit beta5c | 20S proteasome; complex with alpha-keto-aldehyde | 3OKJ_K |
| PB | T01.012 | proteasome subunit beta5c | 20S open-gate proteasome; complex with compound 20 | 3SDI_K |
| PB | T01.012 | proteasome subunit beta5c | 20S open-gate proteasome; complex with compound 34 | 3SDK_K |
| PB | T01.012 | proteasome subunit beta5c | 20S proteasome; complex with hydroxyurea derivative HU10 | 3SHJ_K |
| PB | T01.012 | proteasome subunit beta5c | 20S proteasome; complex with homobelactosin C | 3TDD_K |
| PB | T01.012 | proteasome subunit beta5c | 20S open-gate proteasome; complex with PR-957 (morpholine) | 3UN4_K |
| PB | T01.012 | proteasome subunit beta5c | 20S proteasome; complex with PR-957 (epoxide) | 3UN8_K |
| PB | T01.012 | proteasome subunit beta5c | 26S proteasome | 3WXR_L |
| PB | T01.012 | proteasome subunit beta5c | 26S proteasome | 4CR2 |
| PB | T01.012 | proteasome subunit beta5c | 4CR3 | |
| PB | T01.012 | proteasome subunit beta5c | 26S proteasome | 4CR4 |
| PB | T01.012 | proteasome subunit beta5c | 20S proteasome; complex with K-7174 | 4EU2_L |
| PB | T01.012 | proteasome subunit beta5c | 20S proteasome; complex with cepafungin I | 4FZC_K |
| PB | T01.012 | proteasome subunit beta5c | 20S proteasome; complex with glidobactin | 4FZG_K |
| PB | T01.012 | proteasome subunit beta5c | 20S proteasome; complex with Syringolin-Glidobactin chimera | 4G4S_L |
| PB | T01.012 | proteasome subunit beta5c | 20S proteasome; complex with Syringolin-Glidobactin chimera | 4GK7_K |
| PB | T01.012 | proteasome subunit beta5c | 20S proteasome; complex with vinylketone carmaphycin analogue VNK1 | 4HNP_K |
| PB | T01.012 | proteasome subunit beta5c | 20S proteasome; complex with epoxyketone carmaphycin analogue 3 | 4HRC_K |
| PB | T01.012 | proteasome subunit beta5c | 20S proteasome; complex with carmaphycin A | 4HRD_K |
| PB | T01.012 | proteasome subunit beta5c | 20S proteasome; complex with vinyl sulfone LU102 | 4INR_K |
| PB | T01.012 | proteasome subunit beta5c | 20S proteasome; complex with vinyl sulfone LU122 | 4INT_K |
| PB | T01.012 | proteasome subunit beta5c | 20S proteasome; complex with vinyl sulfone LU112 | 4INU_K |
| PB | T01.012 | proteasome subunit beta5c | 20S proteasome; complex with belactosin derivative 3E | 4J70_K |
| PB | T01.012 | proteasome subunit beta5c | 20S proteasome; complex with dimerized linear mimetic of TMC-95A | 4JSQ_K |
| PB | T01.012 | proteasome subunit beta5c | 20S proteasome; complex with dimerized linear mimetic of TMC-95A | 4JSU_K |
| PB | T01.012 | proteasome subunit beta5c | 20S proteasome; complex with dimerized linear mimetic of TMC-95A | 4JT0_K |
| PB | T01.012 | proteasome subunit beta5c | 20S proteasome; complex with vibralactone | 4LQI_K |
| PB | T01.012 | proteasome subunit beta5c | 20S proteasome; complex with enone carmaphycin analogue 6 | 4LTC_K |
| PB | T01.012 | proteasome subunit beta5c | 20S proteasome; complex with MG132 | 4NNN_K |
| PB | T01.012 | proteasome subunit beta5c | 20S proteasome; complex with Z-Leu-Leu-Leu-ketoaldehyde | 4NNW_K |
| PB | T01.012 | proteasome subunit beta5c | 20S proteasome; complex with Z-Leu-Leu-Leu-B(OH)2 | 4NO1_K |
| PB | T01.012 | proteasome subunit beta5c | 20S proteasome; complex with Z-Leu-Leu-Leu-vinylsulfone | 4NO6_K |
| PB | T01.012 | proteasome subunit beta5c | 20S proteasome; complex with Z-Leu-Leu-Leu-ketoamide | 4NO8_K |
| PB | T01.012 | proteasome subunit beta5c | 20S proteasome; complex with Z-Leu-Leu-Leu-epoxyketone | 4NO9_K |
| PB | T01.012 | proteasome subunit beta5c | 20S proteasome; complex with kendomycin | 4Q1S_K |
| PB | T01.012 | proteasome subunit beta5c | 20S proteasome; complex with Boc-Ala-Ala-Ala-CHO | 4QBY_K |
| PB | T01.012 | proteasome subunit beta5c | 20S proteasome; complex with epoxyketone inhibitor 8 | 4QLQ_K |
| PB | T01.012 | proteasome subunit beta5c | 20S proteasome; complex with epoxyketone inhibitor 11 | 4QLS_K |
| PB | T01.012 | proteasome subunit beta5c | 20S proteasome; complex with tripeptidic epoxyketone inhibitor 2 | 4QLT_K |
| PB | T01.012 | proteasome subunit beta5c | 20S proteasome; complex with tripeptidic epoxyketone inhibitor 9 | 4QLU_K |
| PB | T01.012 | proteasome subunit beta5c | 20S proteasome; complex with tripeptidic epoxyketone inhibitor 17 | 4QLV_K |
| PB | T01.012 | proteasome subunit beta5c | 20S proteasome; Ala49Thr mutant | 4QUX_K |
| PB | T01.012 | proteasome subunit beta5c | 20S proteasome; Ala49Ser mutant | 4QUY_K |
| PB | T01.012 | proteasome subunit beta5c | 20S proteasome; Ala49Thr, Ala50Val mutant | 4QV0_K |
| PB | T01.012 | proteasome subunit beta5c | 20S proteasome; Met45Ala mutant | 4QV1_K |
| PB | T01.012 | proteasome subunit beta5c | 20S proteasome; Met45Val mutant | 4QV3_K |
| PB | T01.012 | proteasome subunit beta5c | 20S proteasome beta5 Met45Thr mutant | 4QV4_K |
| PB | T01.012 | proteasome subunit beta5c | 20S proteasome beta5 Met45Ile mutant | 4QV5_K |
| PB | T01.012 | proteasome subunit beta5c | 20S proteasome; Ala49Val mutant | 4QV6_K |
| PB | T01.012 | proteasome subunit beta5c | 20S proteasome; Ala50Val mutant | 4QV7_K |
| PB | T01.012 | proteasome subunit beta5c | 20S proteasome; Cys52Phe mutant | 4QV8_K |
| PB | T01.012 | proteasome subunit beta5c | 20S proteasome; Cys63Phe mutant | 4QV9_K |
| PB | T01.012 | proteasome subunit beta5c | 20S proteasome; complex with bortezomib | 4QVL_K |
| PB | T01.012 | proteasome subunit beta5c | 20S proteasome beta5 Met45Ala mutant; complex with bortezomib | 4QVM_K |
| PB | T01.012 | proteasome subunit beta5c | 20S proteasome beta5 Met45Val mutant; complex with bortezomib | 4QVN_K |
| PB | T01.012 | proteasome subunit beta5c | 20S proteasome beta5 Met45Thr mutant; complex with bortezomib | 4QVP_K |
| PB | T01.012 | proteasome subunit beta5c | 20S proteasome beta5 Met45Ile mutant; complex with bortezomib | 4QVQ_K |
| PB | T01.012 | proteasome subunit beta5c | 20S proteasome beta5 Ala49Val mutant; complex with bortezomib | 4QVV_K |
| PB | T01.012 | proteasome subunit beta5c | 20S proteasome beta5 Ala49Ser mutant; complex with bortezomib | 4QVW_K |
| PB | T01.012 | proteasome subunit beta5c | 20S proteasome beta5 Ala49Thr mutant; complex with bortezomib | 4QVY_K |
| PB | T01.012 | proteasome subunit beta5c | 20S proteasome beta5 Ala49Thr,Ala50Val mutant; complex with bortezomib | 4QW0_K |
| PB | T01.012 | proteasome subunit beta5c | 20S proteasome beta5 Ala50Val mutant; complex with bortezomib | 4QW1_K |
| PB | T01.012 | proteasome subunit beta5c | 20S proteasome beta5 Cys63Phe mutant; complex with bortezomib | 4QW3_K |
| PB | T01.012 | proteasome subunit beta5c | 20S proteasome; complex with carfilzomib | 4QW4_K |
| PB | T01.012 | proteasome subunit beta5c | 20S proteasome beta5 Met45Ala mutant; complex with carfilzomib | 4QW5_K |
| PB | T01.012 | proteasome subunit beta5c | 20S proteasome beta5 Met45Val mutant; complex with carfilzomib | 4QW6_K |
| PB | T01.012 | proteasome subunit beta5c | 20S proteasome beta5 Met45Thr mutant; complex with carfilzomib | 4QW7_K |
| PB | T01.012 | proteasome subunit beta5c | 20S proteasome beta5 Met45Ile mutant; complex with carfilzomib | 4QWF_K |
| PB | T01.012 | proteasome subunit beta5c | 20S proteasome beta5 Ala49Val mutant; complex with carfilzomib | 4QWG_K |
| PB | T01.012 | proteasome subunit beta5c | 20S proteasome beta5 Ala49Ser mutant; complex with carfilzomib | 4QWI_K |
| PB | T01.012 | proteasome subunit beta5c | 20S proteasome beta5 Ala49Thr mutant; complex with carfilzomib | 4QWJ_K |
| PB | T01.012 | proteasome subunit beta5c | 20S proteasome beta5 Ala49Thr, Ala50Val mutant; complex with carfilzomib | 4QWK_K |
| PB | T01.012 | proteasome subunit beta5c | 20S proteasome beta5 Ala50Val mutant; complex with carfilzomib | 4QWL_K |
| PB | T01.012 | proteasome subunit beta5c | 20S proteasome beta5 Cys52Phe mutant; complex with carfilzomib | 4QWR_K |
| PB | T01.012 | proteasome subunit beta5c | 20S proteasome beta5 Cys63Phe mutant; complex with carfilzomib | 4QWS_K |
| PB | T01.012 | proteasome subunit beta5c | 20S proteasome beta5 Cys52Phe mutant; complex with bortezomib | 4QWU_K |
| PB | T01.012 | proteasome subunit beta5c | 20S proteasome; complex with epoxyketone inhibitor ONX 0914 | 4QWX_K |
| PB | T01.012 | proteasome subunit beta5c | 20S proteasome beta 5 Met45Ala mutant; complex with epoxyketone inhibitor ONX 0914 | 4QXJ_K |
| PB | T01.012 | proteasome subunit beta5c | complete proteasome; complex with epoxyketone inhibitor ONX 0914 | 4QZ0_K |
| PB | T01.012 | proteasome subunit beta5c | 20S proteasome beta 5 Met45Thr mutant; complex with epoxyketone inhibitor ONX 0914 | 4QZ1_K |
| PB | T01.012 | proteasome subunit beta5c | 20S proteasome beta 5 Met45Ile mutant; complex with epoxyketone inhibitor ONX 0914 | 4QZ2_K |
| PB | T01.012 | proteasome subunit beta5c | 20S proteasome beta 5 Ala49Val mutant; complex with epoxyketone inhibitor ONX 0914 | 4QZ3_K |
| PB | T01.012 | proteasome subunit beta5c | 20S proteasome beta 5 Ala49Ser mutant; complex with epoxyketone inhibitor ONX 0914 | 4QZ4_K |
| PB | T01.012 | proteasome subunit beta5c | 20S proteasome beta 5 Ala49Thr mutant; complex with epoxyketone inhibitor ONX 0914 | 4QZ5_K |
| PB | T01.012 | proteasome subunit beta5c | 20S proteasome beta 5 Ala49Thr, Ala50Val mutant; complex with epoxyketone inhibitor ONX 0914 | 4QZ6_K |
| PB | T01.012 | proteasome subunit beta5c | 20S proteasome beta 5 Ala50Val mutant; complex with epoxyketone inhibitor ONX 0914 | 4QZ7_K |
| PB | T01.012 | proteasome subunit beta5c | 20S proteasome beta 5 Cys52Phe mutant; complex with epoxyketone inhibitor ONX 0914 | 4QZW_K |
| PB | T01.012 | proteasome subunit beta5c | complete proteasome; complex with epoxyketone inhibitor ONX 0914 | 4QZX_K |
| PB | T01.012 | proteasome subunit beta5c | 20S proteasome; complex with omuralide | 4QZZ_K |
| PB | T01.012 | proteasome subunit beta5c | 20S proteasome beta 5 Cys52Phe mutant; complex with omuralide | 4R00_K |
| PB | T01.012 | proteasome subunit beta5c | 20S proteasome; complex with BSC4999 | 4R02_K |
| PB | T01.012 | proteasome subunit beta5c | 20S proteasome; ligand induced aziridine-formation in beta5 | 4R17_K |
| PB | T01.012 | proteasome subunit beta5c | 20S proteasome; ligand induced Lys33-Thr1 cross-linking in beta5 | 4R18_K |
| PB | T01.012 | proteasome subunit beta5c | 20S proteasome; complex with alkaloid indolo-phakellin | 4RUR_K |
| PB | T01.012 | proteasome subunit beta5c | 4V7O | |
| PB | T01.012 | proteasome subunit beta5c | 20S proteasome; complex with PR-VI modulator | 4X6Z_L |
| PB | T01.012 | proteasome subunit beta5c | 20S proteasome; complex with Ac-Pro-Ala-Asp-EP | 4Y69_K |
| PB | T01.012 | proteasome subunit beta5c | 20S proteasome beta2 His114Asp mutant; complex with Ac-Pro-Ala-Asp-EP | 4Y6A_K |
| PB | T01.012 | proteasome subunit beta5c | 20S proteasome; complex with Ac-Pro-Ala-Glu-EP | 4Y6V_K |
| PB | T01.012 | proteasome subunit beta5c | 20S proteasome; complex with Ac-Pro-Ala-Leu-EP | 4Y6Z_K |
| PB | T01.012 | proteasome subunit beta5c | 20S proteasome; complex with Ac-Leu-Ala-Val-EP | 4Y70_K |
| PB | T01.012 | proteasome subunit beta5c | 20S proteasome; complex with Ac-Leu-Ala-Leu-EP | 4Y74_K |
| PB | T01.012 | proteasome subunit beta5c | 20S proteasome; complex with Ac-Pro-Ala-Phe-EP | 4Y75_K |
| PB | T01.012 | proteasome subunit beta5c | 20S proteasome; complex with Ac-Leu-Ala-Phe-EP | 4Y77_K |
| PB | T01.012 | proteasome subunit beta5c | 20S proteasome; complex with Ac-Leu-Ala-Asp-EP | 4Y78_K |
| PB | T01.012 | proteasome subunit beta5c | 20S proteasome; complex with Ac-Leu-Ala-Glu-EP | 4Y7W_K |
| PB | T01.012 | proteasome subunit beta5c | complete proteasome; complex with Ac-PAA-ep | 4Y7X_K |
| PB | T01.012 | proteasome subunit beta5c | 20S proteasome; complex with Ac-Leu-Ala-Ala-EP | 4Y7Y_K |
| PB | T01.012 | proteasome subunit beta5c | 20S proteasome; complex with Ac-Leu-Ala-Ile-EP | 4Y80_K |
| PB | T01.012 | proteasome subunit beta5c | 20S proteasome; complex with Ac-Pro-Ala-Tyr-EP | 4Y81_K |
| PB | T01.012 | proteasome subunit beta5c | 20S proteasome; complex with Ac-Leu-Ala-Tyr-EP | 4Y82_K |
| PB | T01.012 | proteasome subunit beta5c | 20S proteasome; complex with N3-Ala(4,4-F2P)-Asn-Leu-Leu-EP | 4Y84_K |
| PB | T01.012 | proteasome subunit beta5c | 20S proteasome; complex with N3-Ala-Pro-Asn-Leu-Leu-EP | 4Y8G_K |
| PB | T01.012 | proteasome subunit beta5c | 20S proteasome; complex with N3-Ala-Pro-Ala-Leu-EP | 4Y8H_K |
| PB | T01.012 | proteasome subunit beta5c | 20S proteasome; complex with Ac-Pro-Leu-Leu-EP | 4Y8I_K |
| PB | T01.012 | proteasome subunit beta5c | 20S proteasome; complex with Ac-Leu-Leu-Leu-EP | 4Y8J_K |
| PB | T01.012 | proteasome subunit beta5c | 20S proteasome; complex with H-Ala-Pro-Leu-Leu-EP | 4Y8K_K |
| PB | T01.012 | proteasome subunit beta5c | 20S proteasome; complex with Ac-Ala-Pro-Leu-Leu-EP | 4Y8L_K |
| PB | T01.012 | proteasome subunit beta5c | 20S proteasome beta7-delta7 C-terminal mutant | 4Y8M_K |
| PB | T01.012 | proteasome subunit beta5c | 20S proteasome beta7-delta7 C-terminal mutant; complex with Ac-Pro-Ala-Glu-EP | 4Y8N_K |
| PB | T01.012 | proteasome subunit beta5c | 20S proteasome beta 7-delta 7 C-terminal mutant; complex with Ac-Pro-Ala-Phe-EP | 4Y8O_K |
| PB | T01.012 | proteasome subunit beta5c | 20S proteasome beta 7-delta 7 C-terminal mutant; complex with Ac-Pro-Ala-Leu-EP | 4Y8P_K |
| PB | T01.012 | proteasome subunit beta5c | 20S proteasome beta 7-delta 7 C-terminal mutant; complex with Ac-Pro-Ala-Tyr-EP | 4Y8Q_K |
| PB | T01.012 | proteasome subunit beta5c | 20S proteasome beta 2 His116Asp mutant | 4Y8R_K |
| PB | T01.012 | proteasome subunit beta5c | 20S proteasome beta 2 His116Asp mutant; complex with Ac-Leu-Ala-Glu-EP | 4Y8S_K |
| PB | T01.012 | proteasome subunit beta5c | 20S proteasome beta 2 His116Asp mutant; complex with Ac-Pro-Ala-Glu-EP | 4Y8T_K |
| PB | T01.012 | proteasome subunit beta5c | 20S proteasome beta 2 His116Asp mutant; complex with Ac-Pro-Ala-Asp-EP | 4Y8U_K |
| PB | T01.012 | proteasome subunit beta5c | 20S proteasome beta 2 His116Glu mutant | 4Y9Y_K |
| PB | T01.012 | proteasome subunit beta5c | 20S proteasome beta 2 His116Glu mutant; complex with Ac-Leu-Ala-Glu-EP | 4Y9Z_K |
| PB | T01.012 | proteasome subunit beta5c | 20S proteasome beta 2 His116Glu mutant; complex with Ac-Pro-Ala-Glu-EP | 4YA0_K |
| PB | T01.012 | proteasome subunit beta5c | 20S proteasome beta 2 His116Asn mutant | 4YA1_K |
| PB | T01.012 | proteasome subunit beta5c | 20S proteasome beta 2 His116Asn mutant; complex with Ac-Leu-Ala-Glu-EP | 4YA2_K |
| PB | T01.012 | proteasome subunit beta5c | 20S proteasome beta 2 His116Asn mutant; complex with Ac-Pro-Ala-Glu-EP | 4YA3_K |
| PB | T01.012 | proteasome subunit beta5c | 20S proteasome beta 2 His114Asp mutant | 4YA4_K |
| PB | T01.012 | proteasome subunit beta5c | 20S proteasome beta 2 His114Asp mutant; complex with Ac-Pro-Ala-Glu-EP | 4YA5_K |
| PB | T01.012 | proteasome subunit beta5c | 20S proteasome beta 2 His114Asp mutant; complex with Ac-Leu-Ala-Glu-EP | 4YA7_K |
| PB | T01.012 | proteasome subunit beta5c | 20S proteasome beta 2 His114Asp mutant; complex with AC-Leu-Ala-Asp-EP | 4YA9_K |
| PB | T01.012 | proteasome subunit beta5c | 20S proteasome; complex with belactosin C derivative 3 | 4Z1L_K |
| PB | T01.012 | proteasome subunit beta5c | 5A5B | |
| PB | T01.012 | proteasome subunit beta5c | 20S proteasome; complex with macyranone A | 5AHJ_K |
| PB | T01.012 | proteasome subunit beta5c | 20S proteasome; complex with beta1/beta2 nonspecifici sulfonamide ligand | 5BOU_K |
| PB | T01.012 | proteasome subunit beta5c | yeast 20s proteasome beta2-g170a mutant | 5BXL_K |
| PB | T01.012 | proteasome subunit beta5c | yeast 20s proteasome beta2-g170a mutant in complex with bortezomib | 5BXN_K |
| PB | T01.012 | proteasome subunit beta5c | 20S proteasome beta5 Gly48Cys mutant | 5CGF_K |
| PB | T01.012 | proteasome subunit beta5c | 20S proteasome beta5 Gly48Cys mutant; complex with alpha-chloroacetamide 1 | 5CGG_K |
| PB | T01.012 | proteasome subunit beta5c | 20S proteasome beta5 Gly48Cys mutant; complex with alpha-chloroacetamide 5 | 5CGH_K |
| PB | T01.012 | proteasome subunit beta5c | 20S proteasome beta5 Gly48Cys mutant; complex with ONX 0914 | 5CGI_K |
| PB | T01.012 | proteasome subunit beta5c | yeast 20s proteasome at 2.3 a resolution | 5CZ4_K |
| PB | T01.012 | proteasome subunit beta5c | yeast 20s proteasome beta1-t1a mutant in complex with carfilzomib | 5CZ5_K |
| PB | T01.012 | proteasome subunit beta5c | yeast 20s proteasome beta5-t1a mutant in complex with syringolin a, propeptide expressed in trans | 5CZ6_K |
| PB | T01.012 | proteasome subunit beta5c | yeast 20s proteasome beta5-t1a beta5-k81r double mutant in complex with bortezomib, propeptide expressed in cis | 5CZ7_K |
| PB | T01.012 | proteasome subunit beta5c | yeast 20s proteasome beta5-l(-49)s-k33a mutant in complex with carfilzomib | 5CZ8_K |
| PB | T01.012 | proteasome subunit beta5c | yeast 20s proteasome beta5-d17n mutant in complex with carfilzomib; propeptide expressed in trans | 5CZ9_K |
| PB | T01.012 | proteasome subunit beta5c | yeast 20s proteasome beta5-d166n mutant | 5CZA_K |
| PB | T01.012 | proteasome subunit beta5c | yeast 20s proteasome beta5-d166n mutant in complex with carfilzomib | 5D0S_K |
| PB | T01.012 | proteasome subunit beta5c | 20s proteasome beta5-Asp166Asn mutant; complex with MG132 | 5D0T_K |
| PB | T01.012 | proteasome subunit beta5c | yeast 20s proteasome beta5-t1c mutant in complex with carfilzomib | 5D0V_K |
| PB | T01.012 | proteasome subunit beta5c | yeast 20s proteasome beta5-t1s mutant | 5D0W_K |
| PB | T01.012 | proteasome subunit beta5c | yeast 20s proteasome beta5-t1s mutant in complex with bortezomib | 5D0X_K |
| PB | T01.012 | proteasome subunit beta5c | yeast 20s proteasome beta5-t1s mutant in complex with carfilzomib | 5D0Z_K |
| PB | T01.012 | proteasome subunit beta5c | 20S proteasome; complex with alkyne-PI | 5DKI_K |
| PB | T01.012 | proteasome subunit beta5c | 20S proteasome; complex with octreotide-PI | 5DKJ_K |
| PB | T01.012 | proteasome subunit beta5c | yeast 20s proteasome beta2-t1a mutant | 5FG7_K |
| PB | T01.012 | proteasome subunit beta5c | yeast 20s proteasome beta2-t(-2)v mutant | 5FG9_K |
| PB | T01.012 | proteasome subunit beta5c | yeast 20s proteasome beta5-k33a mutant (propeptide expressed in trans) | 5FGA_K |
| PB | T01.012 | proteasome subunit beta5c | yeast 20s proteasome beta5-h(-2)l-t1a double mutant in complex with carfilzomib | 5FGD_K |
| PB | T01.012 | proteasome subunit beta5c | yeast 20s proteasome beta5-h(-2)t-t1a double mutant in complex with carfilzomib | 5FGE_K |
| PB | T01.012 | proteasome subunit beta5c | yeast 20s proteasome beta5-h(-2)a-t1a-k81r triple mutant in complex with carfilzomib | 5FGF_K |
| PB | T01.012 | proteasome subunit beta5c | yeast 20s proteasome beta5-l(-49s)_d17n double mutant in complex with carfilzomib | 5FGG_K |
| PB | T01.012 | proteasome subunit beta5c | 20s proteasome beta5-Lys33Ala mutant (propeptide expressed in trans); complex with MG132 | 5FGH_K |
| PB | T01.012 | proteasome subunit beta5c | yeast 20s proteasome beta1-t1a beta2-t1a double mutant in complex withcarfilzomib | 5FGI_K |
| PB | T01.012 | proteasome subunit beta5c | yeast 20s proteasome beta5-k33a mutant (propeptide expressed in trans)in complex with carfilzomib | 5FHS_K |
| PB | T01.012 | proteasome subunit beta5c | 20s proteasome; complex with the peptidic epoxyketone inhibitor 27 | 5JHR_K |
| PB | T01.012 | proteasome subunit beta5c | 20s proteasome; complex with the peptidic epoxyketone inhibitor 15 | 5JHS_K |
| PB | T01.012 | proteasome subunit beta5c | 20s proteasome; complex with epoxyketone inhibitor 14 | 5L52_K |
| PB | T01.012 | proteasome subunit beta5c | 20s proteasome; complex with epoxyketone inhibitor 16 | 5L54_K |
| PB | T01.012 | proteasome subunit beta5c | 20s proteasome; complex with epoxyketone inhibitor 18 | 5L55_K |
| PB | T01.012 | proteasome subunit beta5c | yeast 20s proteasome with human beta5i (1-138; r57t) | 5L5A_K |
| PB | T01.012 | proteasome subunit beta5c | yeast 20s proteasome with human beta5i (1-138) and human beta6 (97- 111; 118-133) | 5L5B_K |
| PB | T01.012 | proteasome subunit beta5c | yeast 20s proteasome with human beta5i (1-138) and human beta6 (97- 111; 118-133) in complex with onx 0914 | 5L5D_K |
| PB | T01.012 | proteasome subunit beta5c | yeast 20s proteasome with human beta5i (1-138) and human beta6 (97- 111; 118-133) in complex with carfilzomib | 5L5E_K |
| PB | T01.012 | proteasome subunit beta5c | yeast 20s proteasome with human beta5i (1-138) and human beta6 (97- 111; 118-133) in complex with bortezomib | 5L5F_K |
| PB | T01.012 | proteasome subunit beta5c | yeast 20s proteasome with human beta5i (1-138) and human beta6 (97- 111; 118-133); complex with PR-924 | 5L5H_K |
| PB | T01.012 | proteasome subunit beta5c | yeast 20s proteasome with human beta5i (1-138) and human beta6 (97- 111; 118-133) in complex with epoxyketone inhibitor 9 | 5L5I_K |
| PB | T01.012 | proteasome subunit beta5c | yeast 20s proteasome with human beta5i (1-138) and human beta6 (97- 111; 118-133) in complex with epoxyketone inhibitor 14 | 5L5J_K |
| PB | T01.012 | proteasome subunit beta5c | yeast 20s proteasome with human beta5i (1-138) and human beta6 (97- 111; 118-133) in complex with epoxyketone inhibitor 16 | 5L5O_K |
| PB | T01.012 | proteasome subunit beta5c | yeast 20s proteasome with human beta5i (1-138) and human beta6 (97- 111; 118-133) in complex with epoxyketone inhibitor 17 | 5L5P_K |
| PB | T01.012 | proteasome subunit beta5c | yeast 20s proteasome with human beta5i (1-138) and human beta6 (97- 111; 118-133) in complex with epoxyketone 18 | 5L5Q_K |
| PB | T01.012 | proteasome subunit beta5c | yeast 20s proteasome with human beta5i (1-138;v31m) and human beta6 (97-111; 118-133) | 5L5R_K |
| PB | T01.012 | proteasome subunit beta5c | yeast 20s proteasome with human beta5i (1-138; Val31Met mutant) and human beta6 (97-111; 118-133); complex with PR-924 | 5L5S_K |
| PB | T01.012 | proteasome subunit beta5c | yeast 20s proteasome with human beta5i (1-138; v31m) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 16 | 5L5T_K |
| PB | T01.012 | proteasome subunit beta5c | yeast 20s proteasome with human beta5i (1-138; v31m) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 17 ***caveat 5l5u 04c h 301 has wrong chirality at atom c27 04c k 301 has ***caveat 2 5l5u wrong chirality at atom c27 04c v 301 h | 5L5U_K |
| PB | T01.012 | proteasome subunit beta5c | yeast 20s proteasome with human beta5c (1-138) and human beta6 (97- 111; 118-133) | 5L5W_K |
| PB | T01.012 | proteasome subunit beta5c | yeast 20s proteasome with human beta5c (1-138) and human beta6 (97- 111; 118-133) in complex with onx 0914 | 5L5X_K |
| PB | T01.012 | proteasome subunit beta5c | yeast 20s proteasome with human beta5c (1-138) and human beta6 (97- 111; 118-133) in complex with carfilzomib | 5L5Y_K |
| PB | T01.012 | proteasome subunit beta5c | yeast 20s proteasome with human beta5c (1-138) and human beta6 (97- 111; 118-133) in complex with bortezomib | 5L5Z_K |
| PB | T01.012 | proteasome subunit beta5c | yeast 20s proteasome with human beta5c (1-138) and human beta6 (97- 111; 118-133); complex with PR-924 | 5L60_K |
| PB | T01.012 | proteasome subunit beta5c | yeast 20s proteasome with human beta5c (1-138) and human beta6 (99- 132) in complex with epoxyketone inhibitor 14 | 5L61_K |
| PB | T01.012 | proteasome subunit beta5c | yeast 20s proteasome with human beta5c (1-138) and human beta6 (97- 111; 118-133) in complex with epoxyketone inhibitor 16 | 5L62_K |
| PB | T01.012 | proteasome subunit beta5c | yeast 20s proteasome with human beta5c (1-138) and human beta6 (97- 111; 118-133) in complex with epoxyketone inhibitor 17 ***caveat 5l63 04c h 301 has wrong chirality at atom c27 04c k 301 has ***caveat 2 5l63 wrong chirality at atom c27 04c v 301 has wr | 5L63_K |
| PB | T01.012 | proteasome subunit beta5c | yeast 20s proteasome with human beta5c (1-138) and human beta6 (97- 111; 118-133) in complex with epoxyketone inhibitor 18 | 5L64_K |
| PB | T01.012 | proteasome subunit beta5c | ligand-induced aziridine-formation at the yeast proteasomal subunit beta5 by sulfonate esters | 5LAI_K |
| PB | T01.012 | proteasome subunit beta5c | ligand-induced lys33-thr1 crosslinking at the yeast proteasomal subunit beta5 by sulfonate esters | 5LAJ_K |
| PB | T01.012 | proteasome subunit beta5c | yeast 20s proteasome with human beta5i (1-138; Arg57Thr mutant)in complex with PR-924 | 5LTT_K |
| PB | T01.012 | proteasome subunit beta5c | yeast 20s proteasome with human beta5i (1-138) and human beta6 (97- 111; 118-133) in complex with thiazole based inhibitor ro19 | 5M2B_K |
| PB | T01.012 | proteasome subunit beta5c | 26s proteasome in presence of atp (s1) | 5MP9_l |
| PB | T01.012 | proteasome subunit beta5c | 26s proteasome in presence of atp (s2) | 5MPA_l |
| PB | T01.012 | proteasome subunit beta5c | yeast 20s proteasome in complex with blm-pep activator | 5NIF_L |
| PB | T01.012 | proteasome subunit beta5c | yeast 26s proteasome bound to ubiquitinated substrate (4d motor state) | 6EF3_5 |
| PB | T01.012 | proteasome subunit beta5c | yeast 20s proteasome in complex with cystargolide B | 6G7F_K |
| PB | T01.012 | proteasome subunit beta5c | yeast 20s proteasome in complex with cystargolide B derivative 1 | 6G8M_K |
| PB | T01.012 | proteasome subunit beta5c | yeast 20s proteasome in complex with cystargolide B derivative 2 | 6G8N_K |
| PB | T01.012 | proteasome subunit beta5c | yeast 20s proteasome in complex with homosalinosporamide a | 6GOP_K |
| PB | T01.012 | proteasome subunit beta5c | yeast 20s proteasome in complex with the peptidic non-covalent bindinginhibitor rts-v5 | 6H39_K |
| PB | T01.012 | proteasome subunit beta5c | yeast 20s proteasome with human beta2c (s171g) | 6HTB_K |
| PB | T01.012 | proteasome subunit beta5c | yeast 20s proteasome with human beta2c (s171g) in complex with onx 0914 | 6HTC_K |
| PB | T01.012 | proteasome subunit beta5c | yeast 20s proteasome with human beta2c (s171g) in complex with 4 | 6HTD_K |
| PB | T01.012 | proteasome subunit beta5c | yeast 20s proteasome with human beta2c (s171g) in complex with 7 | 6HTP_K |
| PB | T01.012 | proteasome subunit beta5c | yeast 20s proteasome with human beta2c (s171g) in complex with 13 | 6HTR_K |
| PB | T01.012 | proteasome subunit beta5c | yeast 20s proteasome with human beta2c (s171g) in complex with 16 | 6HUB_K |
| PB | T01.012 | proteasome subunit beta5c | yeast 20s proteasome with human beta2c (s171g) in complex with 18 | 6HUC_K |
| PB | T01.012 | proteasome subunit beta5c | yeast 20s proteasome with human beta2c (s171g) in complex with 20 | 6HUQ_K |
| PB | T01.012 | proteasome subunit beta5c | yeast 20s proteasome with human beta2c (s171g) in complex with 29 | 6HUU_K |
| PB | T01.012 | proteasome subunit beta5c | yeast 20s proteasome with human beta2c (s171g) in complex with 39 | 6HUV_K |
| PB | T01.012 | proteasome subunit beta5c | yeast 20s proteasome with human beta2i (1-53) | 6HV3_K |
| PB | T01.012 | proteasome subunit beta5c | yeast 20s proteasome with human beta2i (1-53) in complex with onx 0914 | 6HV4_K |
| PB | T01.012 | proteasome subunit beta5c | yeast 20s proteasome with human beta2i (1-53) in complex with 4 | 6HV5_K |
| PB | T01.012 | proteasome subunit beta5c | yeast 20s proteasome with human beta2i (1-53) in complex with 7 | 6HV7_K |
| PB | T01.012 | proteasome subunit beta5c | yeast 20s proteasome with human beta2i (1-53) in complex with 13 | 6HVA_K |
| PB | T01.012 | proteasome subunit beta5c | yeast 20s proteasome with human beta2i (1-53) in complex with 16 | 6HVR_K |
| PB | T01.012 | proteasome subunit beta5c | yeast 20s proteasome with human beta2i (1-53) in complex with 18 | 6HVS_K |
| PB | T01.012 | proteasome subunit beta5c | yeast 20s proteasome with human beta2i (1-53) in complex with 20 | 6HVT_K |
| PB | T01.012 | proteasome subunit beta5c | yeast 20s proteasome with human beta2i (1-53) in complex with 29 | 6HVU_K |
| PB | T01.012 | proteasome subunit beta5c | yeast 20s proteasome with human beta2i (1-53) in complex with 39 | 6HVV_K |
| PB | T01.012 | proteasome subunit beta5c | yeast 20s proteasome with human beta2i (1-53) in complex with 43 | 6HVW_K |
| PB | T01.012 | proteasome subunit beta5c | yeast 20s proteasome in complex with 4 | 6HVX_K |
| PB | T01.012 | proteasome subunit beta5c | yeast 20s proteasome in complex with 5 (7- and 6-membered ring) | 6HVY_K |
| PB | T01.012 | proteasome subunit beta5c | yeast 20s proteasome in complex with 7 | 6HW0_K |
| PB | T01.012 | proteasome subunit beta5c | yeast 20s proteasome in complex with 13 | 6HW3_K |
| PB | T01.012 | proteasome subunit beta5c | yeast 20s proteasome in complex with 16 | 6HW4_K |
| PB | T01.012 | proteasome subunit beta5c | yeast 20s proteasome in complex with 18 | 6HW5_K |
| PB | T01.012 | proteasome subunit beta5c | yeast 20s proteasome in complex with 20 | 6HW6_K |
| PB | T01.012 | proteasome subunit beta5c | yeast 20s proteasome in complex with 29 | 6HW7_K |
| PB | T01.012 | proteasome subunit beta5c | yeast 20s proteasome in complex with 39 | 6HW8_K |
| PB | T01.012 | proteasome subunit beta5c | yeast 20s proteasome in complex with 41b | 6HW9_K |
| PB | T01.012 | proteasome subunit beta5c | yeast 20s proteasome in complex with 43 | 6HWA_K |
| PB | T01.012 | proteasome subunit beta5c | yeast 20s proteasome in complex with 44b | 6HWB_K |
| PB | T01.012 | proteasome subunit beta5c | yeast 20s proteasome beta2-g45a mutant | 6HWC_K |
| PB | T01.012 | proteasome subunit beta5c | yeast 20s proteasome beta2-g45a mutant in complex with bortezomib | 6HWD_K |
| PB | T01.012 | proteasome subunit beta5c | yeast 20s proteasome beta2-g45a mutant in complex with carfilzomib | 6HWE_K |
| PB | T01.012 | proteasome subunit beta5c | yeast 20s proteasome beta2-g45a mutant in complex with onx 0914 | 6HWF_K |
| PB | T01.012 | proteasome subunit beta5c | ground state 26s proteasome (gs2) | 6EPC_5 |
| PB | T01.012 | proteasome subunit beta5c | substrate processing state 26s proteasome (sps1) ***caveat 6epd pro 2 231 has wrong chirality at atom ca | 6EPD_5 |
| PB | T01.012 | proteasome subunit beta5c | substrate processing state 26s proteasome (sps2) | 6EPE_5 |
| PB | T01.012 | proteasome subunit beta5c | ground state 26s proteasome (gs1) | 6EPF_5 |
| PB | T01.012 | proteasome subunit beta5c | cryo-em reveals the conformation of a substrate analogue in the human 20s proteasome core | 5A0Q_L |
| PB | T01.012 | proteasome subunit beta5c | 26S proteasome; complex with USP14-UbAl | 5GJQ_e |
| PB | T01.012 | proteasome subunit beta5c | 26S proteasome | 5GJR_e |
| PB | T01.012 | proteasome subunit beta5c | native human 20s proteasome at 1.8 angstrom ***caveat 5le5 6v1 u 47 has wrong chirality at atom c1 | 5LE5_K |
| PB | T01.012 | proteasome subunit beta5c | native human 20s proteasome in mg-acetate at 2.2 angstrom ***caveat 5lex 6v1 u 47 has wrong chirality at atom c1 | 5LEX_K |
| PB | T01.012 | proteasome subunit beta5c | 20s proteasome; complex with oprozomib | 5LEY_K |
| PB | T01.012 | proteasome subunit beta5c | 20s proteasome; complex with oprozomib in mg-acetate | 5LEZ_K |
| PB | T01.012 | proteasome subunit beta5c | human 20s proteasome complex with epoxomicin at 2.4 angstrom ***caveat 5lf0 6v1 u 47 has wrong chirality at atom c1 iml c 2 has wrong ***caveat 2 5lf0 chirality at atom cb iml d 2 has wrong chirality at atom ca ***caveat 3 5lf0 iml d 2 has wrong chirality | 5LF0_K |
| PB | T01.012 | proteasome subunit beta5c | human 20s proteasome complex with dihydroeponemycin at 2.0 angstrom ***caveat 5lf1 6v1 u 47 has wrong chirality at atom c1 | 5LF1_K |
| PB | T01.012 | proteasome subunit beta5c | human 20s proteasome complex with bortezomib at 2.1 angstrom ***caveat 5lf3 6v1 u 47 has wrong chirality at atom c1 | 5LF3_K |
| PB | T01.012 | proteasome subunit beta5c | 20s proteasome; complex with delanzomib | 5LF4_K |
| PB | T01.012 | proteasome subunit beta5c | human 20s proteasome complex with z-lly-ketoaldehyde at 2.1 angstrom ***caveat 5lf6 6v1 u 47 has wrong chirality at atom c1 | 5LF6_c |
| PB | T01.012 | proteasome subunit beta5c | human 20s proteasome complex with ixazomib at 2.0 angstrom ***caveat 5lf7 6v1 u 47 has wrong chirality at atom c1 | 5LF7_K |
| PB | T01.012 | proteasome subunit beta5c | the human 26s proteasome at 6.8 ang. ***caveat 5ln3 pro h 311 has wrong chirality at atom ca thr n 752 has wrong ***caveat 2 5ln3 chirality at atom ca | 5LN3_5 |
| PB | T01.012 | proteasome subunit beta5c | 26s proteasome in complex with oprozomib | 5M32_K |
| PB | T01.012 | proteasome subunit beta5c | structural basis for dynamic regulation of the human 26s proteasome ***caveat 5t0g entry contains improper peptide linkages. | 5T0G_R |
| PB | T01.012 | proteasome subunit beta5c | structural basis for dynamic regulation of the human 26s proteasome ***caveat 5t0h entry contains improper peptide linkages. | 5T0H_R |
| PB | T01.012 | proteasome subunit beta5c | structural basis for dynamic regulation of the human 26s proteasome ***caveat 5t0i entry contains improper peptide linkages. residue arg k 20 ***caveat 2 5t0i is incorrectly modeled. | 5T0I_R |
| PB | T01.012 | proteasome subunit beta5c | structural basis for dynamic regulation of the human 26s proteasome ***caveat 5t0j entry contains improper peptide linkages. | 5T0J_R |
| PB | T01.012 | proteasome subunit beta5c | nucleotide-driven triple-state remodeling of the aaa-atpase channel inthe activated human 26s proteasome | 5VFO_R |
| PB | T01.012 | proteasome subunit beta5c | nucleotide-driven triple-state remodeling of the aaa-atpase channel inthe activated human 26s proteasome | 5VFR_R |
| PB | T01.012 | proteasome subunit beta5c | nucleotide-driven triple-state remodeling of the aaa-atpase channel inthe activated human 26s proteasome | 5VFT_R |
| PB | T01.012 | proteasome subunit beta5c | endogeneous native human 20s proteasome | 6R70_K |
| PB | T01.012 | proteasome subunit beta5c | 20S proteasome; complex with PR-957 | 3UNB_K |
| PB | T01.012 | proteasome subunit beta5c | 20S proteasome | 3UNE_K |
| PB | T01.012 | proteasome subunit beta5c | 20S proteasome complex | 1IRU_L |
| PB | T01.013 | proteasome subunit beta1i | cryo-em structure of human immunoproteasome with a novel noncompetitive inhibitor that selectively inhibits activated lymphocytes | 6AVO_A |
| PB | T01.013 | proteasome subunit beta1i | 3UNF | |
| PB | T01.013 | proteasome subunit beta1i | 20S immunoproteasome | 3UNH_N |
| PB | T01.014 | proteasome subunit beta2i | cryo-em structure of human immunoproteasome with a novel noncompetitive inhibitor that selectively inhibits activated lymphocytes | 6AVO_B |
| PB | T01.014 | proteasome subunit beta2i | yeast 20s proteasome with human beta2i (1-53) | 6HV3_H |
| PB | T01.014 | proteasome subunit beta2i | yeast 20s proteasome with human beta2i (1-53) in complex with onx 0914 | 6HV4_H |
| PB | T01.014 | proteasome subunit beta2i | yeast 20s proteasome with human beta2i (1-53) in complex with 4 | 6HV5_H |
| PB | T01.014 | proteasome subunit beta2i | yeast 20s proteasome with human beta2i (1-53) in complex with 7 | 6HV7_H |
| PB | T01.014 | proteasome subunit beta2i | yeast 20s proteasome with human beta2i (1-53) in complex with 13 | 6HVA_H |
| PB | T01.014 | proteasome subunit beta2i | yeast 20s proteasome with human beta2i (1-53) in complex with 16 | 6HVR_H |
| PB | T01.014 | proteasome subunit beta2i | yeast 20s proteasome with human beta2i (1-53) in complex with 18 | 6HVS_H |
| PB | T01.014 | proteasome subunit beta2i | yeast 20s proteasome with human beta2i (1-53) in complex with 20 | 6HVT_H |
| PB | T01.014 | proteasome subunit beta2i | yeast 20s proteasome with human beta2i (1-53) in complex with 29 | 6HVU_H |
| PB | T01.014 | proteasome subunit beta2i | yeast 20s proteasome with human beta2i (1-53) in complex with 39 | 6HVV_H |
| PB | T01.014 | proteasome subunit beta2i | yeast 20s proteasome with human beta2i (1-53) in complex with 43 | 6HVW_H |
| PB | T01.014 | proteasome subunit beta2i | 3UNF | |
| PB | T01.014 | proteasome subunit beta2i | 20S immunoproteasome | 3UNH_H |
| PB | T01.015 | proteasome subunit beta5i | yeast 20s proteasome with human beta5i (1-138; r57t) | 5L5A_K |
| PB | T01.015 | proteasome subunit beta5i | yeast 20s proteasome with human beta5i (1-138) and human beta6 (97- 111; 118-133) | 5L5B_K |
| PB | T01.015 | proteasome subunit beta5i | yeast 20s proteasome with human beta5i (1-138) and human beta6 (97- 111; 118-133) in complex with onx 0914 | 5L5D_K |
| PB | T01.015 | proteasome subunit beta5i | yeast 20s proteasome with human beta5i (1-138) and human beta6 (97- 111; 118-133) in complex with carfilzomib | 5L5E_K |
| PB | T01.015 | proteasome subunit beta5i | yeast 20s proteasome with human beta5i (1-138) and human beta6 (97- 111; 118-133) in complex with bortezomib | 5L5F_K |
| PB | T01.015 | proteasome subunit beta5i | yeast 20s proteasome with human beta5i (1-138) and human beta6 (97- 111; 118-133); complex with PR-924 | 5L5H_K |
| PB | T01.015 | proteasome subunit beta5i | yeast 20s proteasome with human beta5i (1-138) and human beta6 (97- 111; 118-133) in complex with epoxyketone inhibitor 9 | 5L5I_K |
| PB | T01.015 | proteasome subunit beta5i | yeast 20s proteasome with human beta5i (1-138) and human beta6 (97- 111; 118-133) in complex with epoxyketone inhibitor 14 | 5L5J_K |
| PB | T01.015 | proteasome subunit beta5i | yeast 20s proteasome with human beta5i (1-138) and human beta6 (97- 111; 118-133) in complex with epoxyketone inhibitor 16 | 5L5O_K |
| PB | T01.015 | proteasome subunit beta5i | yeast 20s proteasome with human beta5i (1-138) and human beta6 (97- 111; 118-133) in complex with epoxyketone inhibitor 17 | 5L5P_K |
| PB | T01.015 | proteasome subunit beta5i | yeast 20s proteasome with human beta5i (1-138) and human beta6 (97- 111; 118-133) in complex with epoxyketone 18 | 5L5Q_K |
| PB | T01.015 | proteasome subunit beta5i | yeast 20s proteasome with human beta5i (1-138;v31m) and human beta6 (97-111; 118-133) | 5L5R_K |
| PB | T01.015 | proteasome subunit beta5i | yeast 20s proteasome with human beta5i (1-138; Val31Met mutant) and human beta6 (97-111; 118-133); complex with PR-924 | 5L5S_K |
| PB | T01.015 | proteasome subunit beta5i | yeast 20s proteasome with human beta5i (1-138; v31m) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 16 | 5L5T_K |
| PB | T01.015 | proteasome subunit beta5i | yeast 20s proteasome with human beta5i (1-138; v31m) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 17 ***caveat 5l5u 04c h 301 has wrong chirality at atom c27 04c k 301 has ***caveat 2 5l5u wrong chirality at atom c27 04c v 301 h | 5L5U_K |
| PB | T01.015 | proteasome subunit beta5i | yeast 20s proteasome with human beta5i (1-138; Arg57Thr mutant)in complex with PR-924 | 5LTT_K |
| PB | T01.015 | proteasome subunit beta5i | yeast 20s proteasome with human beta5i (1-138) and human beta6 (97- 111; 118-133) in complex with thiazole based inhibitor ro19 | 5M2B_K |
| PB | T01.015 | proteasome subunit beta5i | cryo-em structure of human immunoproteasome with a novel noncompetitive inhibitor that selectively inhibits activated lymphocytes | 6AVO_C |
| PB | T01.017 | protein serine kinase c17 | 20S proteasome | 4R3O_I |
| PB | T01.017 | protein serine kinase c17 | 20S proteasome; complex with carfilzomib | 4R67_I |
| PB | T01.017 | protein serine kinase c17 | cryo-em reveals the conformation of a substrate analogue in the human 20s proteasome core | 5A0Q_I |
| PB | T01.017 | protein serine kinase c17 | native human 20s proteasome at 1.8 angstrom ***caveat 5le5 6v1 u 47 has wrong chirality at atom c1 | 5LE5_H |
| PB | T01.017 | protein serine kinase c17 | native human 20s proteasome in mg-acetate at 2.2 angstrom ***caveat 5lex 6v1 u 47 has wrong chirality at atom c1 | 5LEX_H |
| PB | T01.017 | protein serine kinase c17 | 20s proteasome; complex with oprozomib | 5LEY_H |
| PB | T01.017 | protein serine kinase c17 | 20s proteasome; complex with oprozomib in mg-acetate | 5LEZ_H |
| PB | T01.017 | protein serine kinase c17 | human 20s proteasome complex with epoxomicin at 2.4 angstrom ***caveat 5lf0 6v1 u 47 has wrong chirality at atom c1 iml c 2 has wrong ***caveat 2 5lf0 chirality at atom cb iml d 2 has wrong chirality at atom ca ***caveat 3 5lf0 iml d 2 has wrong chirality | 5LF0_H |
| PB | T01.017 | protein serine kinase c17 | human 20s proteasome complex with dihydroeponemycin at 2.0 angstrom ***caveat 5lf1 6v1 u 47 has wrong chirality at atom c1 | 5LF1_H |
| PB | T01.017 | protein serine kinase c17 | human 20s proteasome complex with bortezomib at 2.1 angstrom ***caveat 5lf3 6v1 u 47 has wrong chirality at atom c1 | 5LF3_H |
| PB | T01.017 | protein serine kinase c17 | 20s proteasome; complex with delanzomib | 5LF4_H |
| PB | T01.017 | protein serine kinase c17 | human 20s proteasome complex with z-lly-ketoaldehyde at 2.1 angstrom ***caveat 5lf6 6v1 u 47 has wrong chirality at atom c1 | 5LF6_H |
| PB | T01.017 | protein serine kinase c17 | human 20s proteasome complex with ixazomib at 2.0 angstrom ***caveat 5lf7 6v1 u 47 has wrong chirality at atom c1 | 5LF7_H |
| PB | T01.017 | protein serine kinase c17 | the human 26s proteasome at 6.8 ang. ***caveat 5ln3 pro h 311 has wrong chirality at atom ca thr n 752 has wrong ***caveat 2 5ln3 chirality at atom ca | 5LN3_2 |
| PB | T01.017 | protein serine kinase c17 | 26s proteasome in complex with oprozomib | 5M32_H |
| PB | T01.017 | protein serine kinase c17 | structural basis for dynamic regulation of the human 26s proteasome ***caveat 5t0g entry contains improper peptide linkages. | 5T0G_O |
| PB | T01.017 | protein serine kinase c17 | structural basis for dynamic regulation of the human 26s proteasome ***caveat 5t0h entry contains improper peptide linkages. | 5T0H_O |
| PB | T01.017 | protein serine kinase c17 | structural basis for dynamic regulation of the human 26s proteasome ***caveat 5t0i entry contains improper peptide linkages. residue arg k 20 ***caveat 2 5t0i is incorrectly modeled. | 5T0I_O |
| PB | T01.017 | protein serine kinase c17 | structural basis for dynamic regulation of the human 26s proteasome ***caveat 5t0j entry contains improper peptide linkages. | 5T0J_O |
| PB | T01.017 | protein serine kinase c17 | nucleotide-driven triple-state remodeling of the aaa-atpase channel inthe activated human 26s proteasome | 5VFO_O |
| PB | T01.017 | protein serine kinase c17 | nucleotide-driven triple-state remodeling of the aaa-atpase channel inthe activated human 26s proteasome | 5VFR_O |
| PB | T01.017 | protein serine kinase c17 | nucleotide-driven triple-state remodeling of the aaa-atpase channel inthe activated human 26s proteasome | 5VFT_O |
| PB | T01.017 | protein serine kinase c17 | yeast 20s proteasome with human beta2c (s171g) | 6HTB_H |
| PB | T01.017 | protein serine kinase c17 | yeast 20s proteasome with human beta2c (s171g) in complex with onx 0914 | 6HTC_H |
| PB | T01.017 | protein serine kinase c17 | yeast 20s proteasome with human beta2c (s171g) in complex with 4 | 6HTD_H |
| PB | T01.017 | protein serine kinase c17 | yeast 20s proteasome with human beta2c (s171g) in complex with 7 | 6HTP_H |
| PB | T01.017 | protein serine kinase c17 | yeast 20s proteasome with human beta2c (s171g) in complex with 13 | 6HTR_H |
| PB | T01.017 | protein serine kinase c17 | yeast 20s proteasome with human beta2c (s171g) in complex with 16 | 6HUB_H |
| PB | T01.017 | protein serine kinase c17 | yeast 20s proteasome with human beta2c (s171g) in complex with 18 | 6HUC_H |
| PB | T01.017 | protein serine kinase c17 | yeast 20s proteasome with human beta2c (s171g) in complex with 20 | 6HUQ_H |
| PB | T01.017 | protein serine kinase c17 | yeast 20s proteasome with human beta2c (s171g) in complex with 29 | 6HUU_H |
| PB | T01.017 | protein serine kinase c17 | yeast 20s proteasome with human beta2c (s171g) in complex with 39 | 6HUV_H |
| PB | T01.017 | protein serine kinase c17 | endogeneous native human 20s proteasome | 6R70_H |
| PB | T01.020 | similar to proteasome subunit beta type 6 (Rattus norvegicus) (but not T01.019) | 20S proteasome complex | 1IRU_H |
| PB | T01.021 | TbHslUV peptidase | 4HNZ | |
| PB | T01.021 | TbHslUV peptidase | 4HO7 | |
| PB | T01.022 | Anbu protein | Anbu Complex | 5LOX |
| PB | T01.022 | Anbu protein | 5NYW | |
| PB | T01.022 | Anbu protein | 5NYF | |
| PB | T01.022 | Anbu protein | 5NYG | |
| PB | T01.022 | Anbu protein | 5NYJ | |
| PB | T01.022 | Anbu protein | 5NYP | |
| PB | T01.022 | Anbu protein | 5NYQ | |
| PB | T01.022 | Anbu protein | 5NYR | |
| PB | T01.023 | BPH protein | 5OVS | |
| PB | T01.023 | BPH protein | complex with epoxomicin | 5OVT |
| PB | T01.970 | archaean proteasome, alpha subunit | 1PMA_A | |
| PB | T01.970 | archaean proteasome, alpha subunit | implications for interactions of proteasome with pan and pa700 from the 1.9 a structure of a proteasome-11s activator complex | 1YA7_A |
| PB | T01.970 | archaean proteasome, alpha subunit | 20s proteasome Asp9Ser mutant; complex with PA26 | 1YAR_A |
| PB | T01.970 | archaean proteasome, alpha subunit | 20s proteasome; complex with pa26 | 1YAU_A |
| PB | T01.970 | archaean proteasome, alpha subunit | 2KU1 | |
| PB | T01.970 | archaean proteasome, alpha subunit | 2KU2 | |
| PB | T01.970 | archaean proteasome, alpha subunit | 20s proteasome with an open gate | 3C91_A |
| PB | T01.970 | archaean proteasome, alpha subunit | 20s proteasome with a closed gate | 3C92_A |
| PB | T01.970 | archaean proteasome, alpha subunit | 3IPM_A | |
| PB | T01.970 | archaean proteasome, alpha subunit | 3J9I_S | |
| PB | T01.970 | archaean proteasome, alpha subunit | 3JRM_A | |
| PB | T01.970 | archaean proteasome, alpha subunit | 3JSE_A | |
| PB | T01.970 | archaean proteasome, alpha subunit | 3JTL_A | |
| PB | T01.970 | archaean proteasome, alpha subunit | thermoplasma acidophilum 20s proteasome using 200kev with stage position | 5VY3_A |
| PB | T01.970 | archaean proteasome, alpha subunit | thermoplasma acidophilum 20s proteasome using 200kev with image shift | 5VY4_A |
| PB | T01.970 | archaean proteasome, alpha subunit | 20s proteasome using cryo-electron microscopy | 6BDF_A |
| PB | T01.970 | archaean proteasome, alpha subunit | alpha ring homoheptamer | 1J2P |
| PB | T01.970 | archaean proteasome, alpha subunit | 20S proteasome complex with calpain inhibitor I | 1J2Q_A |
| PB | T01.970 | archaean proteasome, alpha subunit | 20s core particle of pan-proteasomes | 6HE5_A |
| PB | T01.970 | archaean proteasome, alpha subunit | 20s proteasome | 6HE7_A |
| PB | T01.970 | archaean proteasome, alpha subunit | pan-proteasome in state 1 | 6HE8_A |
| PB | T01.970 | archaean proteasome, alpha subunit | pan-proteasome in state 2 | 6HE9_A |
| PB | T01.970 | archaean proteasome, alpha subunit | pan-proteasome in state 3 | 6HEA_A |
| PB | T01.970 | archaean proteasome, alpha subunit | pan-proteasome in state 4 | 6HEC_A |
| PB | T01.970 | archaean proteasome, alpha subunit | pan-proteasome in state 5 | 6HED_A |
| PB | T01.971 | proteasome subunit alpha 6 | ground state 26s proteasome (gs2) | 6EPC_A |
| PB | T01.971 | proteasome subunit alpha 6 | substrate processing state 26s proteasome (sps1) ***caveat 6epd pro 2 231 has wrong chirality at atom ca | 6EPD_A |
| PB | T01.971 | proteasome subunit alpha 6 | substrate processing state 26s proteasome (sps2) | 6EPE_A |
| PB | T01.971 | proteasome subunit alpha 6 | ground state 26s proteasome (gs1) | 6EPF_A |
| PB | T01.971 | proteasome subunit alpha 6 | 20S proteasome in complex with activator PA26 (Trypanosoma brucei) | 1FNT_A |
| PB | T01.971 | proteasome subunit alpha 6 | complete proteasome | 1G0U_G |
| PB | T01.971 | proteasome subunit alpha 6 | complex with epoxomicin | 1G65_G |
| PB | T01.971 | proteasome subunit alpha 6 | proteasome complex bound to TMC-95A inhibitor | 1JD2_G |
| PB | T01.971 | proteasome subunit alpha 6 | 20S proteasome | 1RYP_A |
| PB | T01.971 | proteasome subunit alpha 6 | 20S proteasome; complex with the proteasome activator PA26 from Trypanosoma brucei | 1Z7Q_A |
| PB | T01.971 | proteasome subunit alpha 6 | 20S proteasome;complex with bortezomib | 2F16_G |
| PB | T01.971 | proteasome subunit alpha 6 | 20S proteasome; complex with salinosporamide A | 2FAK_G |
| PB | T01.971 | proteasome subunit alpha 6 | 20S proteasome; complex with homobelactosin C | 2FNY_G |
| PB | T01.971 | proteasome subunit alpha 6 | 20S proteasome; complex with TMC-95 based biphenyl-ether macrocycle | 2GPL_G |
| PB | T01.971 | proteasome subunit alpha 6 | 20S proteasome; complex with syringolin A | 2ZCY_G |
| PB | T01.971 | proteasome subunit alpha 6 | 20S proteasome; complex with glidobactin A | 3BDM_G |
| PB | T01.971 | proteasome subunit alpha 6 | 20S proteasome; complex with fellutamide B | 3D29_G |
| PB | T01.971 | proteasome subunit alpha 6 | 20s proteasome; complex with the epimer form of spirolactacystin | 3DY3_G |
| PB | T01.971 | proteasome subunit alpha 6 | 20s proteasome; complex with spirolactacystin | 3DY4_G |
| PB | T01.971 | proteasome subunit alpha 6 | 20s proteasome; complex with homobelactosin c | 3E47_G |
| PB | T01.971 | proteasome subunit alpha 6 | 20s proteasome; complex with syringolin b | 3GPJ_G |
| PB | T01.971 | proteasome subunit alpha 6 | 20S proteasome; complex with salinosporamide derivative | 3GPT_G |
| PB | T01.971 | proteasome subunit alpha 6 | 20S proteasome; complex with salinosporamide derivative | 3GPW_G |
| PB | T01.971 | proteasome subunit alpha 6 | 20S proteasome; complex with hyroxylated salinosporamide | 3HYE_G |
| PB | T01.971 | proteasome subunit alpha 6 | 20S proteasome; complex with bortezomib | 3MG0_G |
| PB | T01.971 | proteasome subunit alpha 6 | 20S proteasome; complex with compound 1 | 3MG4_G |
| PB | T01.971 | proteasome subunit alpha 6 | 20S proteasome; complex with compound 6 | 3MG6_G |
| PB | T01.971 | proteasome subunit alpha 6 | 20S open-gate proteasome; complex with compound 6 | 3MG7_G |
| PB | T01.971 | proteasome subunit alpha 6 | 20S open-gate proteasome; complex with compound 16 | 3MG8_G |
| PB | T01.971 | proteasome subunit alpha 6 | 20S proteasome; complex with ligand 2a | 3NZJ_G |
| PB | T01.971 | proteasome subunit alpha 6 | 20S proteasome; complex with ligand 2b | 3NZW_G |
| PB | T01.971 | proteasome subunit alpha 6 | 20S proteasome; complex with ligand 2c | 3NZX_G |
| PB | T01.971 | proteasome subunit alpha 6 | 20S open-gate proteasome; complex with compound 24 | 3OEU_G |
| PB | T01.971 | proteasome subunit alpha 6 | 20S open-gate proteasome; complex with compound 25 | 3OEV_G |
| PB | T01.971 | proteasome subunit alpha 6 | 20S proteasome; complex with alpha-keto-aldehyde | 3OKJ_G |
| PB | T01.971 | proteasome subunit alpha 6 | 20S open-gate proteasome; complex with compound 20 | 3SDI_G |
| PB | T01.971 | proteasome subunit alpha 6 | 20S open-gate proteasome; complex with compound 34 | 3SDK_G |
| PB | T01.971 | proteasome subunit alpha 6 | 20S proteasome; complex with hydroxyurea derivative HU10 | 3SHJ_G |
| PB | T01.971 | proteasome subunit alpha 6 | 20S proteasome; complex with homobelactosin C | 3TDD_G |
| PB | T01.971 | proteasome subunit alpha 6 | 20S open-gate proteasome; complex with PR-957 (morpholine) | 3UN4_G |
| PB | T01.971 | proteasome subunit alpha 6 | 20S proteasome; complex with PR-957 (epoxide) | 3UN8_G |
| PB | T01.971 | proteasome subunit alpha 6 | 26S proteasome | 3WXR_A |
| PB | T01.971 | proteasome subunit alpha 6 | 26S proteasome | 4CR2_A |
| PB | T01.971 | proteasome subunit alpha 6 | 26S proteasome | 4CR3_A |
| PB | T01.971 | proteasome subunit alpha 6 | 26S proteasome | 4CR4_A |
| PB | T01.971 | proteasome subunit alpha 6 | 20S proteasome; complex with K-7174 | 4EU2_A |
| PB | T01.971 | proteasome subunit alpha 6 | 20S proteasome; complex with cepafungin I | 4FZC_G |
| PB | T01.971 | proteasome subunit alpha 6 | 20S proteasome; complex with glidobactin | 4FZG_G |
| PB | T01.971 | proteasome subunit alpha 6 | 20S proteasome; complex with Syringolin-Glidobactin chimera | 4G4S_A |
| PB | T01.971 | proteasome subunit alpha 6 | 20S proteasome; complex with Syringolin-Glidobactin chimera | 4GK7_G |
| PB | T01.971 | proteasome subunit alpha 6 | 20S proteasome; complex with vinylketone carmaphycin analogue VNK1 | 4HNP_G |
| PB | T01.971 | proteasome subunit alpha 6 | 20S proteasome; complex with epoxyketone carmaphycin analogue 3 | 4HRC_G |
| PB | T01.971 | proteasome subunit alpha 6 | 20S proteasome; complex with carmaphycin A | 4HRD_G |
| PB | T01.971 | proteasome subunit alpha 6 | 20S proteasome; complex with vinyl sulfone LU102 | 4INR_G |
| PB | T01.971 | proteasome subunit alpha 6 | 20S proteasome; complex with vinyl sulfone LU122 | 4INT_G |
| PB | T01.971 | proteasome subunit alpha 6 | 20S proteasome; complex with vinyl sulfone LU112 | 4INU_G |
| PB | T01.971 | proteasome subunit alpha 6 | 20S proteasome; complex with belactosin derivative 3E | 4J70_G |
| PB | T01.971 | proteasome subunit alpha 6 | 20S proteasome; complex with dimerized linear mimetic of TMC-95A | 4JSQ_G |
| PB | T01.971 | proteasome subunit alpha 6 | 20S proteasome; complex with dimerized linear mimetic of TMC-95A | 4JSU_G |
| PB | T01.971 | proteasome subunit alpha 6 | 20S proteasome; complex with dimerized linear mimetic of TMC-95A | 4JT0_G |
| PB | T01.971 | proteasome subunit alpha 6 | 20S proteasome; complex with vibralactone | 4LQI_G |
| PB | T01.971 | proteasome subunit alpha 6 | 20S proteasome; complex with enone carmaphycin analogue 6 | 4LTC_G |
| PB | T01.971 | proteasome subunit alpha 6 | 20S proteasome; complex with MG132 | 4NNN_G |
| PB | T01.971 | proteasome subunit alpha 6 | 20S proteasome; complex with Z-Leu-Leu-Leu-ketoaldehyde | 4NNW_G |
| PB | T01.971 | proteasome subunit alpha 6 | 20S proteasome; complex with Z-Leu-Leu-Leu-B(OH)2 | 4NO1_G |
| PB | T01.971 | proteasome subunit alpha 6 | 20S proteasome; complex with Z-Leu-Leu-Leu-vinylsulfone | 4NO6_G |
| PB | T01.971 | proteasome subunit alpha 6 | 20S proteasome; complex with Z-Leu-Leu-Leu-ketoamide | 4NO8_G |
| PB | T01.971 | proteasome subunit alpha 6 | 20S proteasome; complex with Z-Leu-Leu-Leu-epoxyketone | 4NO9_G |
| PB | T01.971 | proteasome subunit alpha 6 | 20S proteasome; complex with kendomycin | 4Q1S_G |
| PB | T01.971 | proteasome subunit alpha 6 | 20S proteasome; complex with Boc-Ala-Ala-Ala-CHO | 4QBY_G |
| PB | T01.971 | proteasome subunit alpha 6 | 20S proteasome; complex with epoxyketone inhibitor 8 | 4QLQ_G |
| PB | T01.971 | proteasome subunit alpha 6 | 20S proteasome; complex with epoxyketone inhibitor 11 | 4QLS_G |
| PB | T01.971 | proteasome subunit alpha 6 | 20S proteasome; complex with tripeptidic epoxyketone inhibitor 2 | 4QLT_G |
| PB | T01.971 | proteasome subunit alpha 6 | 20S proteasome; complex with tripeptidic epoxyketone inhibitor 9 | 4QLU_G |
| PB | T01.971 | proteasome subunit alpha 6 | 20S proteasome; complex with tripeptidic epoxyketone inhibitor 17 | 4QLV_G |
| PB | T01.971 | proteasome subunit alpha 6 | 20S proteasome | 4QUX_G |
| PB | T01.971 | proteasome subunit alpha 6 | 20S proteasome | 4QUY_G |
| PB | T01.971 | proteasome subunit alpha 6 | 20S proteasome | 4QV0_G |
| PB | T01.971 | proteasome subunit alpha 6 | 20S proteasome | 4QV1_G |
| PB | T01.971 | proteasome subunit alpha 6 | 20S proteasome | 4QV3_G |
| PB | T01.971 | proteasome subunit alpha 6 | 20S proteasome beta5 Met45Thr mutant | 4QV4_G |
| PB | T01.971 | proteasome subunit alpha 6 | 20S proteasome beta5 Met45Ile mutant | 4QV5_G |
| PB | T01.971 | proteasome subunit alpha 6 | 20S proteasome | 4QV6_G |
| PB | T01.971 | proteasome subunit alpha 6 | 20S proteasome | 4QV7_G |
| PB | T01.971 | proteasome subunit alpha 6 | 20S proteasome | 4QV8_G |
| PB | T01.971 | proteasome subunit alpha 6 | 20S proteasome | 4QV9_G |
| PB | T01.971 | proteasome subunit alpha 6 | 20S proteasome; complex with bortezomib | 4QVL_G |
| PB | T01.971 | proteasome subunit alpha 6 | 20S proteasome beta5 Met45Ala mutant; complex with bortezomib | 4QVM_G |
| PB | T01.971 | proteasome subunit alpha 6 | 20S proteasome beta5 Met45Val mutant; complex with bortezomib | 4QVN_G |
| PB | T01.971 | proteasome subunit alpha 6 | 20S proteasome beta5 Met45Thr mutant; complex with bortezomib | 4QVP_G |
| PB | T01.971 | proteasome subunit alpha 6 | 20S proteasome beta5 Met45Ile mutant; complex with bortezomib | 4QVQ_G |
| PB | T01.971 | proteasome subunit alpha 6 | 20S proteasome beta5 Ala49Val mutant; complex with bortezomib | 4QVV_G |
| PB | T01.971 | proteasome subunit alpha 6 | 20S proteasome beta5 Ala49Ser mutant; complex with bortezomib | 4QVW_G |
| PB | T01.971 | proteasome subunit alpha 6 | 20S proteasome beta5 Ala49Thr mutant; complex with bortezomib | 4QVY_G |
| PB | T01.971 | proteasome subunit alpha 6 | 20S proteasome beta5 Ala49Thr,Ala50Val mutant; complex with bortezomib | 4QW0_G |
| PB | T01.971 | proteasome subunit alpha 6 | 20S proteasome beta5 Ala50Val mutant; complex with bortezomib | 4QW1_G |
| PB | T01.971 | proteasome subunit alpha 6 | 20S proteasome beta5 Cys63Phe mutant; complex with bortezomib | 4QW3_G |
| PB | T01.971 | proteasome subunit alpha 6 | 20S proteasome; complex with carfilzomib | 4QW4_G |
| PB | T01.971 | proteasome subunit alpha 6 | 20S proteasome beta5 Met45Ala mutant; complex with carfilzomib | 4QW5_G |
| PB | T01.971 | proteasome subunit alpha 6 | 20S proteasome beta5 Met45Val mutant; complex with carfilzomib | 4QW6_G |
| PB | T01.971 | proteasome subunit alpha 6 | 20S proteasome beta5 Met45Thr mutant; complex with carfilzomib | 4QW7_G |
| PB | T01.971 | proteasome subunit alpha 6 | 20S proteasome beta5 Met45Ile mutant; complex with carfilzomib | 4QWF_G |
| PB | T01.971 | proteasome subunit alpha 6 | 20S proteasome beta5 Ala49Val mutant; complex with carfilzomib | 4QWG_G |
| PB | T01.971 | proteasome subunit alpha 6 | 20S proteasome beta5 Ala49Ser mutant; complex with carfilzomib | 4QWI_G |
| PB | T01.971 | proteasome subunit alpha 6 | 20S proteasome beta5 Ala49Thr mutant; complex with carfilzomib | 4QWJ_G |
| PB | T01.971 | proteasome subunit alpha 6 | 20S proteasome beta5 Ala49Thr, Ala50Val mutant; complex with carfilzomib | 4QWK_G |
| PB | T01.971 | proteasome subunit alpha 6 | 20S proteasome beta5 Ala50Val mutant; complex with carfilzomib | 4QWL_G |
| PB | T01.971 | proteasome subunit alpha 6 | 20S proteasome beta5 Cys52Phe mutant; complex with carfilzomib | 4QWR_G |
| PB | T01.971 | proteasome subunit alpha 6 | 20S proteasome beta5 Cys63Phe mutant; complex with carfilzomib | 4QWS_G |
| PB | T01.971 | proteasome subunit alpha 6 | 20S proteasome beta5 Cys52Phe mutant; complex with bortezomib | 4QWU_G |
| PB | T01.971 | proteasome subunit alpha 6 | 20S proteasome; complex with epoxyketone inhibitor ONX 0914 | 4QWX_G |
| PB | T01.971 | proteasome subunit alpha 6 | 20S proteasome beta 5 Met45Ala mutant; complex with epoxyketone inhibitor ONX 0914 | 4QXJ_G |
| PB | T01.971 | proteasome subunit alpha 6 | complete proteasome; complex with epoxyketone inhibitor ONX 0914 | 4QZ0_G |
| PB | T01.971 | proteasome subunit alpha 6 | 20S proteasome beta 5 Met45Thr mutant; complex with epoxyketone inhibitor ONX 0914 | 4QZ1_G |
| PB | T01.971 | proteasome subunit alpha 6 | 20S proteasome beta 5 Met45Ile mutant; complex with epoxyketone inhibitor ONX 0914 | 4QZ2_G |
| PB | T01.971 | proteasome subunit alpha 6 | 20S proteasome beta 5 Ala49Val mutant; complex with epoxyketone inhibitor ONX 0914 | 4QZ3_G |
| PB | T01.971 | proteasome subunit alpha 6 | 20S proteasome beta 5 Ala49Ser mutant; complex with epoxyketone inhibitor ONX 0914 | 4QZ4_G |
| PB | T01.971 | proteasome subunit alpha 6 | 20S proteasome beta 5 Ala49Thr mutant; complex with epoxyketone inhibitor ONX 0914 | 4QZ5_G |
| PB | T01.971 | proteasome subunit alpha 6 | 20S proteasome beta 5 Ala49Thr, Ala50Val mutant; complex with epoxyketone inhibitor ONX 0914 | 4QZ6_G |
| PB | T01.971 | proteasome subunit alpha 6 | 20S proteasome beta 5 Ala50Val mutant; complex with epoxyketone inhibitor ONX 0914 | 4QZ7_G |
| PB | T01.971 | proteasome subunit alpha 6 | 20S proteasome beta 5 Cys52Phe mutant; complex with epoxyketone inhibitor ONX 0914 | 4QZW_G |
| PB | T01.971 | proteasome subunit alpha 6 | complete proteasome; complex with epoxyketone inhibitor ONX 0914 | 4QZX_G |
| PB | T01.971 | proteasome subunit alpha 6 | 20S proteasome; complex with omuralide | 4QZZ_G |
| PB | T01.971 | proteasome subunit alpha 6 | 20S proteasome beta 5 Cys52Phe mutant; complex with omuralide | 4R00_G |
| PB | T01.971 | proteasome subunit alpha 6 | 20S proteasome; complex with BSC4999 | 4R02_G |
| PB | T01.971 | proteasome subunit alpha 6 | 20S proteasome; ligand induced aziridine-formation in beta5 | 4R17_G |
| PB | T01.971 | proteasome subunit alpha 6 | 20S proteasome; ligand induced Lys33-Thr1 cross-linking in beta5 | 4R18_G |
| PB | T01.971 | proteasome subunit alpha 6 | 20S proteasome; complex with alkaloid indolo-phakellin | 4RUR_G |
| PB | T01.971 | proteasome subunit alpha 6 | 4V7O | |
| PB | T01.971 | proteasome subunit alpha 6 | 20S proteasome; complex with PR-VI modulator | 4X6Z_A |
| PB | T01.971 | proteasome subunit alpha 6 | 20S proteasome; complex with Ac-Pro-Ala-Asp-EP | 4Y69_G |
| PB | T01.971 | proteasome subunit alpha 6 | 20S proteasome beta2 His114Asp mutant; complex with Ac-Pro-Ala-Asp-EP | 4Y6A_G |
| PB | T01.971 | proteasome subunit alpha 6 | 20S proteasome; complex with Ac-Pro-Ala-Glu-EP | 4Y6V_G |
| PB | T01.971 | proteasome subunit alpha 6 | 20S proteasome; complex with Ac-Pro-Ala-Leu-EP | 4Y6Z_G |
| PB | T01.971 | proteasome subunit alpha 6 | 20S proteasome; complex with Ac-Leu-Ala-Val-EP | 4Y70_G |
| PB | T01.971 | proteasome subunit alpha 6 | 20S proteasome; complex with Ac-Leu-Ala-Leu-EP | 4Y74_G |
| PB | T01.971 | proteasome subunit alpha 6 | 20S proteasome; complex with Ac-Pro-Ala-Phe-EP | 4Y75_G |
| PB | T01.971 | proteasome subunit alpha 6 | 20S proteasome; complex with Ac-Leu-Ala-Phe-EP | 4Y77_G |
| PB | T01.971 | proteasome subunit alpha 6 | 20S proteasome; complex with Ac-Leu-Ala-Asp-EP | 4Y78_G |
| PB | T01.971 | proteasome subunit alpha 6 | 20S proteasome; complex with Ac-Leu-Ala-Glu-EP | 4Y7W_G |
| PB | T01.971 | proteasome subunit alpha 6 | complete proteasome; complex with Ac-PAA-ep | 4Y7X_G |
| PB | T01.971 | proteasome subunit alpha 6 | 20S proteasome; complex with Ac-Leu-Ala-Ala-EP | 4Y7Y_G |
| PB | T01.971 | proteasome subunit alpha 6 | 20S proteasome; complex with Ac-Leu-Ala-Ile-EP | 4Y80_G |
| PB | T01.971 | proteasome subunit alpha 6 | 20S proteasome; complex with Ac-Pro-Ala-Tyr-EP | 4Y81_G |
| PB | T01.971 | proteasome subunit alpha 6 | 20S proteasome; complex with Ac-Leu-Ala-Tyr-EP | 4Y82_G |
| PB | T01.971 | proteasome subunit alpha 6 | 20S proteasome; complex with N3-Ala(4,4-F2P)-Asn-Leu-Leu-EP | 4Y84_G |
| PB | T01.971 | proteasome subunit alpha 6 | 20S proteasome; complex with N3-Ala-Pro-Asn-Leu-Leu-EP | 4Y8G_G |
| PB | T01.971 | proteasome subunit alpha 6 | 20S proteasome; complex with N3-Ala-Pro-Ala-Leu-EP | 4Y8H_G |
| PB | T01.971 | proteasome subunit alpha 6 | 20S proteasome; complex with Ac-Pro-Leu-Leu-EP | 4Y8I_G |
| PB | T01.971 | proteasome subunit alpha 6 | 20S proteasome; complex with Ac-Leu-Leu-Leu-EP | 4Y8J_G |
| PB | T01.971 | proteasome subunit alpha 6 | 20S proteasome; complex with H-Ala-Pro-Leu-Leu-EP | 4Y8K_G |
| PB | T01.971 | proteasome subunit alpha 6 | 20S proteasome; complex with Ac-Ala-Pro-Leu-Leu-EP | 4Y8L_G |
| PB | T01.971 | proteasome subunit alpha 6 | 20S proteasome beta7-delta7 C-terminal mutant | 4Y8M_G |
| PB | T01.971 | proteasome subunit alpha 6 | 20S proteasome beta7-delta7 C-terminal mutant; complex with Ac-Pro-Ala-Glu-EP | 4Y8N_G |
| PB | T01.971 | proteasome subunit alpha 6 | 20S proteasome beta 7-delta 7 C-terminal mutant; complex with Ac-Pro-Ala-Phe-EP | 4Y8O_G |
| PB | T01.971 | proteasome subunit alpha 6 | 20S proteasome beta 7-delta 7 C-terminal mutant; complex with Ac-Pro-Ala-Leu-EP | 4Y8P_G |
| PB | T01.971 | proteasome subunit alpha 6 | 20S proteasome beta 7-delta 7 C-terminal mutant; complex with Ac-Pro-Ala-Tyr-EP | 4Y8Q_G |
| PB | T01.971 | proteasome subunit alpha 6 | 20S proteasome beta 2 His116Asp mutant | 4Y8R_G |
| PB | T01.971 | proteasome subunit alpha 6 | 20S proteasome beta 2 His116Asp mutant; complex with Ac-Leu-Ala-Glu-EP | 4Y8S_G |
| PB | T01.971 | proteasome subunit alpha 6 | 20S proteasome beta 2 His116Asp mutant; complex with Ac-Pro-Ala-Glu-EP | 4Y8T_G |
| PB | T01.971 | proteasome subunit alpha 6 | 20S proteasome beta 2 His116Asp mutant; complex with Ac-Pro-Ala-Asp-EP | 4Y8U_G |
| PB | T01.971 | proteasome subunit alpha 6 | 20S proteasome beta 2 His116Glu mutant | 4Y9Y_G |
| PB | T01.971 | proteasome subunit alpha 6 | 20S proteasome beta 2 His116Glu mutant; complex with Ac-Leu-Ala-Glu-EP | 4Y9Z_G |
| PB | T01.971 | proteasome subunit alpha 6 | 20S proteasome beta 2 His116Glu mutant; complex with Ac-Pro-Ala-Glu-EP | 4YA0_G |
| PB | T01.971 | proteasome subunit alpha 6 | 20S proteasome beta 2 His116Asn mutant | 4YA1_G |
| PB | T01.971 | proteasome subunit alpha 6 | 20S proteasome beta 2 His116Asn mutant; complex with Ac-Leu-Ala-Glu-EP | 4YA2_G |
| PB | T01.971 | proteasome subunit alpha 6 | 20S proteasome beta 2 His116Asn mutant; complex with Ac-Pro-Ala-Glu-EP | 4YA3_G |
| PB | T01.971 | proteasome subunit alpha 6 | 20S proteasome beta 2 His114Asp mutant | 4YA4_G |
| PB | T01.971 | proteasome subunit alpha 6 | 20S proteasome beta 2 His114Asp mutant; complex with Ac-Pro-Ala-Glu-EP | 4YA5_G |
| PB | T01.971 | proteasome subunit alpha 6 | 20S proteasome beta 2 His114Asp mutant; complex with Ac-Leu-Ala-Glu-EP | 4YA7_G |
| PB | T01.971 | proteasome subunit alpha 6 | 20S proteasome beta 2 His114Asp mutant; complex with AC-Leu-Ala-Asp-EP | 4YA9_G |
| PB | T01.971 | proteasome subunit alpha 6 | 20S proteasome; complex with belactosin C derivative 3 | 4Z1L_G |
| PB | T01.971 | proteasome subunit alpha 6 | 26S protease-UBP6 complex | 5A5B_A |
| PB | T01.971 | proteasome subunit alpha 6 | 20S proteasome; complex with macyranone A | 5AHJ_G |
| PB | T01.971 | proteasome subunit alpha 6 | 20S proteasome; complex with beta1/beta2 nonspecifici sulfonamide ligand | 5BOU_G |
| PB | T01.971 | proteasome subunit alpha 6 | yeast 20s proteasome beta2-g170a mutant | 5BXL_G |
| PB | T01.971 | proteasome subunit alpha 6 | yeast 20s proteasome beta2-g170a mutant in complex with bortezomib | 5BXN_G |
| PB | T01.971 | proteasome subunit alpha 6 | 20S proteasome beta5 Gly48Cys mutant | 5CGF_G |
| PB | T01.971 | proteasome subunit alpha 6 | 20S proteasome beta5 Gly48Cys mutant; complex with alpha-chloroacetamide 1 | 5CGG_G |
| PB | T01.971 | proteasome subunit alpha 6 | 20S proteasome beta5 Gly48Cys mutant; complex with alpha-chloroacetamide 5 | 5CGH_G |
| PB | T01.971 | proteasome subunit alpha 6 | 20S proteasome beta5 Gly48Cys mutant; complex with ONX 0914 | 5CGI_G |
| PB | T01.971 | proteasome subunit alpha 6 | yeast 20s proteasome at 2.3 a resolution | 5CZ4_G |
| PB | T01.971 | proteasome subunit alpha 6 | yeast 20s proteasome beta1-t1a mutant in complex with carfilzomib | 5CZ5_G |
| PB | T01.971 | proteasome subunit alpha 6 | yeast 20s proteasome beta5-t1a mutant in complex with syringolin a, propeptide expressed in trans | 5CZ6_G |
| PB | T01.971 | proteasome subunit alpha 6 | yeast 20s proteasome beta5-t1a beta5-k81r double mutant in complex with bortezomib, propeptide expressed in cis | 5CZ7_G |
| PB | T01.971 | proteasome subunit alpha 6 | yeast 20s proteasome beta5-l(-49)s-k33a mutant in complex with carfilzomib | 5CZ8_G |
| PB | T01.971 | proteasome subunit alpha 6 | yeast 20s proteasome beta5-d17n mutant in complex with carfilzomib; propeptide expressed in trans | 5CZ9_G |
| PB | T01.971 | proteasome subunit alpha 6 | yeast 20s proteasome beta5-d166n mutant | 5CZA_G |
| PB | T01.971 | proteasome subunit alpha 6 | yeast 20s proteasome beta5-d166n mutant in complex with carfilzomib | 5D0S_G |
| PB | T01.971 | proteasome subunit alpha 6 | yeast 20s proteasome beta5-d166n mutant in complex with mg132 | 5D0T_G |
| PB | T01.971 | proteasome subunit alpha 6 | yeast 20s proteasome beta5-t1c mutant in complex with carfilzomib | 5D0V_G |
| PB | T01.971 | proteasome subunit alpha 6 | yeast 20s proteasome beta5-t1s mutant | 5D0W_G |
| PB | T01.971 | proteasome subunit alpha 6 | yeast 20s proteasome beta5-t1s mutant in complex with bortezomib | 5D0X_G |
| PB | T01.971 | proteasome subunit alpha 6 | yeast 20s proteasome beta5-t1s mutant in complex with carfilzomib | 5D0Z_G |
| PB | T01.971 | proteasome subunit alpha 6 | 20S proteasome; complex with alkyne-PI | 5DKI_G |
| PB | T01.971 | proteasome subunit alpha 6 | 20S proteasome; complex with octreotide-PI | 5DKJ_G |
| PB | T01.971 | proteasome subunit alpha 6 | yeast 20s proteasome beta2-t1a mutant | 5FG7_G |
| PB | T01.971 | proteasome subunit alpha 6 | yeast 20s proteasome beta2-t(-2)v mutant | 5FG9_G |
| PB | T01.971 | proteasome subunit alpha 6 | yeast 20s proteasome beta5-k33a mutant (propeptide expressed in trans) | 5FGA_G |
| PB | T01.971 | proteasome subunit alpha 6 | yeast 20s proteasome beta5-h(-2)l-t1a double mutant in complex with carfilzomib | 5FGD_G |
| PB | T01.971 | proteasome subunit alpha 6 | yeast 20s proteasome beta5-h(-2)t-t1a double mutant in complex with carfilzomib | 5FGE_G |
| PB | T01.971 | proteasome subunit alpha 6 | yeast 20s proteasome beta5-h(-2)a-t1a-k81r triple mutant in complex with carfilzomib | 5FGF_G |
| PB | T01.971 | proteasome subunit alpha 6 | yeast 20s proteasome beta5-l(-49s)_d17n double mutant in complex with carfilzomib | 5FGG_G |
| PB | T01.971 | proteasome subunit alpha 6 | yeast 20s proteasome beta5-k33a mutant (propeptide expressed in trans)in complex with mg132 | 5FGH_G |
| PB | T01.971 | proteasome subunit alpha 6 | yeast 20s proteasome beta1-t1a beta2-t1a double mutant in complex withcarfilzomib | 5FGI_G |
| PB | T01.971 | proteasome subunit alpha 6 | yeast 20s proteasome beta5-k33a mutant (propeptide expressed in trans)in complex with carfilzomib | 5FHS_G |
| PB | T01.971 | proteasome subunit alpha 6 | 20s proteasome; complex with the peptidic epoxyketone inhibitor 27 | 5JHR_G |
| PB | T01.971 | proteasome subunit alpha 6 | 20s proteasome; complex with the peptidic epoxyketone inhibitor 15 | 5JHS_G |
| PB | T01.971 | proteasome subunit alpha 6 | yeast 20s proteasome in complex with epoxyketone inhibitor 14 | 5L52_G |
| PB | T01.971 | proteasome subunit alpha 6 | yeast 20s proteasome in complex with epoxyketone inhibitor 16 | 5L54_G |
| PB | T01.971 | proteasome subunit alpha 6 | yeast 20s proteasome in complex with epoxyketone inhibitor 18 | 5L55_G |
| PB | T01.971 | proteasome subunit alpha 6 | yeast 20s proteasome with human beta5i (1-138; r57t) | 5L5A_G |
| PB | T01.971 | proteasome subunit alpha 6 | yeast 20s proteasome with human beta5i (1-138) and human beta6 (97- 111; 118-133) | 5L5B_G |
| PB | T01.971 | proteasome subunit alpha 6 | yeast 20s proteasome with human beta5i (1-138) and human beta6 (97- 111; 118-133) in complex with onx 0914 | 5L5D_G |
| PB | T01.971 | proteasome subunit alpha 6 | yeast 20s proteasome with human beta5i (1-138) and human beta6 (97- 111; 118-133) in complex with carfilzomib | 5L5E_G |
| PB | T01.971 | proteasome subunit alpha 6 | yeast 20s proteasome with human beta5i (1-138) and human beta6 (97- 111; 118-133) in complex with bortezomib | 5L5F_G |
| PB | T01.971 | proteasome subunit alpha 6 | yeast 20s proteasome with human beta5i (1-138) and human beta6 (97- 111; 118-133) in complex with pr-924 | 5L5H_G |
| PB | T01.971 | proteasome subunit alpha 6 | yeast 20s proteasome with human beta5i (1-138) and human beta6 (97- 111; 118-133) in complex with epoxyketone inhibitor 9 | 5L5I_G |
| PB | T01.971 | proteasome subunit alpha 6 | yeast 20s proteasome with human beta5i (1-138) and human beta6 (97- 111; 118-133) in complex with epoxyketone inhibitor 14 | 5L5J_G |
| PB | T01.971 | proteasome subunit alpha 6 | yeast 20s proteasome with human beta5i (1-138) and human beta6 (97- 111; 118-133) in complex with epoxyketone inhibitor 16 | 5L5O_G |
| PB | T01.971 | proteasome subunit alpha 6 | yeast 20s proteasome with human beta5i (1-138) and human beta6 (97- 111; 118-133) in complex with epoxyketone inhibitor 17 | 5L5P_G |
| PB | T01.971 | proteasome subunit alpha 6 | yeast 20s proteasome with human beta5i (1-138) and human beta6 (97- 111; 118-133) in complex with epoxyketone 18 | 5L5Q_G |
| PB | T01.971 | proteasome subunit alpha 6 | yeast 20s proteasome with human beta5i (1-138;v31m) and human beta6 (97-111; 118-133) | 5L5R_G |
| PB | T01.971 | proteasome subunit alpha 6 | yeast 20s proteasome with human beta5i (1-138; v31m) and human beta6 (97-111; 118-133) in complex with pr-924 | 5L5S_G |
| PB | T01.971 | proteasome subunit alpha 6 | yeast 20s proteasome with human beta5i (1-138; v31m) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 16 | 5L5T_G |
| PB | T01.971 | proteasome subunit alpha 6 | yeast 20s proteasome with human beta5i (1-138; v31m) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 17 ***caveat 5l5u 04c h 301 has wrong chirality at atom c27 04c k 301 has ***caveat 2 5l5u wrong chirality at atom c27 04c v 301 h | 5L5U_G |
| PB | T01.971 | proteasome subunit alpha 6 | yeast 20s proteasome with human beta5c (1-138) and human beta6 (97- 111; 118-133) | 5L5W_G |
| PB | T01.971 | proteasome subunit alpha 6 | yeast 20s proteasome with human beta5c (1-138) and human beta6 (97- 111; 118-133) in complex with onx 0914 | 5L5X_G |
| PB | T01.971 | proteasome subunit alpha 6 | yeast 20s proteasome with human beta5c (1-138) and human beta6 (97- 111; 118-133) in complex with carfilzomib | 5L5Y_G |
| PB | T01.971 | proteasome subunit alpha 6 | yeast 20s proteasome with human beta5c (1-138) and human beta6 (97- 111; 118-133) in complex with bortezomib | 5L5Z_G |
| PB | T01.971 | proteasome subunit alpha 6 | yeast 20s proteasome with human beta5c (1-138) and human beta6 (97- 111; 118-133) in complex with pr-924 | 5L60_G |
| PB | T01.971 | proteasome subunit alpha 6 | yeast 20s proteasome with human beta5c (1-138) and human beta6 (99- 132) in complex with epoxyketone inhibitor 14 | 5L61_G |
| PB | T01.971 | proteasome subunit alpha 6 | yeast 20s proteasome with human beta5c (1-138) and human beta6 (97- 111; 118-133) in complex with epoxyketone inhibitor 16 | 5L62_G |
| PB | T01.971 | proteasome subunit alpha 6 | yeast 20s proteasome with human beta5c (1-138) and human beta6 (97- 111; 118-133) in complex with epoxyketone inhibitor 17 ***caveat 5l63 04c h 301 has wrong chirality at atom c27 04c k 301 has ***caveat 2 5l63 wrong chirality at atom c27 04c v 301 has wr | 5L63_G |
| PB | T01.971 | proteasome subunit alpha 6 | yeast 20s proteasome with human beta5c (1-138) and human beta6 (97- 111; 118-133) in complex with epoxyketone inhibitor 18 | 5L64_G |
| PB | T01.971 | proteasome subunit alpha 6 | yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97- 111; 118-133) in complex with carfilzomib | 5L65_G |
| PB | T01.971 | proteasome subunit alpha 6 | yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97- 111; 118-133) in complex with bortezomib | 5L66_G |
| PB | T01.971 | proteasome subunit alpha 6 | yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97- 111; 118-133) in complex with pr-924 | 5L67_G |
| PB | T01.971 | proteasome subunit alpha 6 | yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97- 111; 118-133) in complex with epoxyketone inhibitor 14 | 5L68_G |
| PB | T01.971 | proteasome subunit alpha 6 | yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97- 111; 118-133) in complex with epoxyketone inhibitor 16 | 5L69_G |
| PB | T01.971 | proteasome subunit alpha 6 | yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97- 111; 118-133) in complex with epoxyketone inhibitor 17 | 5L6A_G |
| PB | T01.971 | proteasome subunit alpha 6 | yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97- 111; 118-133) in complex with onx 0914 | 5L6B_G |
| PB | T01.971 | proteasome subunit alpha 6 | yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97- 111; 118-133) in complex with epoxyketone inhibitor 18 | 5L6C_G |
| PB | T01.971 | proteasome subunit alpha 6 | ligand-induced aziridine-formation at the yeast proteasomal subunit beta5 by sulfonate esters | 5LAI_G |
| PB | T01.971 | proteasome subunit alpha 6 | ligand-induced lys33-thr1 crosslinking at the yeast proteasomal subunit beta5 by sulfonate esters | 5LAJ_G |
| PB | T01.971 | proteasome subunit alpha 6 | yeast 20s proteasome with human beta5i (1-138; r57t)in complex with pr-924 | 5LTT_G |
| PB | T01.971 | proteasome subunit alpha 6 | yeast 20s proteasome with human beta5i (1-138) and human beta6 (97- 111; 118-133) in complex with thiazole based inhibitor ro19 | 5M2B_G |
| PB | T01.971 | proteasome subunit alpha 6 | 26s proteasome in presence of atp (s1) | 5MP9_a |
| PB | T01.971 | proteasome subunit alpha 6 | 26s proteasome in presence of atp (s2) | 5MPA_a |
| PB | T01.971 | proteasome subunit alpha 6 | yeast 20s proteasome in complex with blm-pep activator | 5NIF_A |
| PB | T01.971 | proteasome subunit alpha 6 | yeast 26s proteasome bound to ubiquitinated substrate (1d* motor state) | 6EF0_A |
| PB | T01.971 | proteasome subunit alpha 6 | yeast 26s proteasome bound to ubiquitinated substrate (5d motor state) | 6EF1_A |
| PB | T01.971 | proteasome subunit alpha 6 | yeast 26s proteasome bound to ubiquitinated substrate (5t motor state) | 6EF2_A |
| PB | T01.971 | proteasome subunit alpha 6 | yeast 26s proteasome bound to ubiquitinated substrate (4d motor state) | 6EF3_A |
| PB | T01.971 | proteasome subunit alpha 6 | yeast 20s proteasome in complex with cystargolide b | 6G7F_G |
| PB | T01.971 | proteasome subunit alpha 6 | yeast 20s proteasome in complex with cystargolide b derivative 1 | 6G8M_G |
| PB | T01.971 | proteasome subunit alpha 6 | yeast 20s proteasome in complex with cystargolide b derivative 2 | 6G8N_G |
| PB | T01.971 | proteasome subunit alpha 6 | yeast 20s proteasome in complex with homosalinosporamide a | 6GOP_G |
| PB | T01.971 | proteasome subunit alpha 6 | yeast 20s proteasome in complex with the peptidic non-covalent bindinginhibitor rts-v5 | 6H39_G |
| PB | T01.971 | proteasome subunit alpha 6 | yeast 20s proteasome with human beta2c (s171g) | 6HTB_G |
| PB | T01.971 | proteasome subunit alpha 6 | yeast 20s proteasome with human beta2c (s171g) in complex with onx 0914 | 6HTC_G |
| PB | T01.971 | proteasome subunit alpha 6 | yeast 20s proteasome with human beta2c (s171g) in complex with 4 | 6HTD_G |
| PB | T01.971 | proteasome subunit alpha 6 | yeast 20s proteasome with human beta2c (s171g) in complex with 7 | 6HTP_G |
| PB | T01.971 | proteasome subunit alpha 6 | yeast 20s proteasome with human beta2c (s171g) in complex with 13 | 6HTR_G |
| PB | T01.971 | proteasome subunit alpha 6 | yeast 20s proteasome with human beta2c (s171g) in complex with 16 | 6HUB_G |
| PB | T01.971 | proteasome subunit alpha 6 | yeast 20s proteasome with human beta2c (s171g) in complex with 18 | 6HUC_G |
| PB | T01.971 | proteasome subunit alpha 6 | yeast 20s proteasome with human beta2c (s171g) in complex with 20 | 6HUQ_G |
| PB | T01.971 | proteasome subunit alpha 6 | yeast 20s proteasome with human beta2c (s171g) in complex with 29 | 6HUU_G |
| PB | T01.971 | proteasome subunit alpha 6 | yeast 20s proteasome with human beta2c (s171g) in complex with 39 | 6HUV_G |
| PB | T01.971 | proteasome subunit alpha 6 | yeast 20s proteasome with human beta2i (1-53) | 6HV3_G |
| PB | T01.971 | proteasome subunit alpha 6 | yeast 20s proteasome with human beta2i (1-53) in complex with onx 0914 | 6HV4_G |
| PB | T01.971 | proteasome subunit alpha 6 | yeast 20s proteasome with human beta2i (1-53) in complex with 4 | 6HV5_G |
| PB | T01.971 | proteasome subunit alpha 6 | yeast 20s proteasome with human beta2i (1-53) in complex with 7 | 6HV7_G |
| PB | T01.971 | proteasome subunit alpha 6 | yeast 20s proteasome with human beta2i (1-53) in complex with 13 | 6HVA_G |
| PB | T01.971 | proteasome subunit alpha 6 | yeast 20s proteasome with human beta2i (1-53) in complex with 16 | 6HVR_G |
| PB | T01.971 | proteasome subunit alpha 6 | yeast 20s proteasome with human beta2i (1-53) in complex with 18 | 6HVS_G |
| PB | T01.971 | proteasome subunit alpha 6 | yeast 20s proteasome with human beta2i (1-53) in complex with 20 | 6HVT_G |
| PB | T01.971 | proteasome subunit alpha 6 | yeast 20s proteasome with human beta2i (1-53) in complex with 29 | 6HVU_G |
| PB | T01.971 | proteasome subunit alpha 6 | yeast 20s proteasome with human beta2i (1-53) in complex with 39 | 6HVV_G |
| PB | T01.971 | proteasome subunit alpha 6 | yeast 20s proteasome with human beta2i (1-53) in complex with 43 | 6HVW_G |
| PB | T01.971 | proteasome subunit alpha 6 | yeast 20s proteasome in complex with 4 | 6HVX_G |
| PB | T01.971 | proteasome subunit alpha 6 | yeast 20s proteasome in complex with 5 (7- and 6-membered ring) | 6HVY_G |
| PB | T01.971 | proteasome subunit alpha 6 | yeast 20s proteasome in complex with 7 | 6HW0_G |
| PB | T01.971 | proteasome subunit alpha 6 | yeast 20s proteasome in complex with 13 | 6HW3_G |
| PB | T01.971 | proteasome subunit alpha 6 | yeast 20s proteasome in complex with 16 | 6HW4_G |
| PB | T01.971 | proteasome subunit alpha 6 | yeast 20s proteasome in complex with 18 | 6HW5_G |
| PB | T01.971 | proteasome subunit alpha 6 | yeast 20s proteasome in complex with 20 | 6HW6_G |
| PB | T01.971 | proteasome subunit alpha 6 | yeast 20s proteasome in complex with 29 | 6HW7_G |
| PB | T01.971 | proteasome subunit alpha 6 | yeast 20s proteasome in complex with 39 | 6HW8_G |
| PB | T01.971 | proteasome subunit alpha 6 | yeast 20s proteasome in complex with 41b | 6HW9_G |
| PB | T01.971 | proteasome subunit alpha 6 | yeast 20s proteasome in complex with 43 | 6HWA_G |
| PB | T01.971 | proteasome subunit alpha 6 | yeast 20s proteasome in complex with 44b | 6HWB_G |
| PB | T01.971 | proteasome subunit alpha 6 | yeast 20s proteasome beta2-g45a mutant | 6HWC_G |
| PB | T01.971 | proteasome subunit alpha 6 | yeast 20s proteasome beta2-g45a mutant in complex with bortezomib | 6HWD_G |
| PB | T01.971 | proteasome subunit alpha 6 | yeast 20s proteasome beta2-g45a mutant in complex with carfilzomib | 6HWE_G |
| PB | T01.971 | proteasome subunit alpha 6 | yeast 20s proteasome beta2-g45a mutant in complex with onx 0914 | 6HWF_G |
| PB | T01.971 | proteasome subunit alpha 6 | 20S proteasome | 4R3O_A |
| PB | T01.971 | proteasome subunit alpha 6 | 20S proteasome; complex with carfilzomib | 4R67_A |
| PB | T01.971 | proteasome subunit alpha 6 | cryo-em reveals the conformation of a substrate analogue in the human 20s proteasome core | 5A0Q_A |
| PB | T01.971 | proteasome subunit alpha 6 | 26S proteasome; complex with USP14-UbAl | 5GJQ_b |
| PB | T01.971 | proteasome subunit alpha 6 | 26S proteasome | 5GJR_b |
| PB | T01.971 | proteasome subunit alpha 6 | native human 20s proteasome at 1.8 angstrom ***caveat 5le5 6v1 u 47 has wrong chirality at atom c1 | 5LE5_G |
| PB | T01.971 | proteasome subunit alpha 6 | native human 20s proteasome in mg-acetate at 2.2 angstrom ***caveat 5lex 6v1 u 47 has wrong chirality at atom c1 | 5LEX_G |
| PB | T01.971 | proteasome subunit alpha 6 | 20s proteasome; complex with oprozomib | 5LEY_G |
| PB | T01.971 | proteasome subunit alpha 6 | 20s proteasome; complex with oprozomib in mg-acetate | 5LEZ_G |
| PB | T01.971 | proteasome subunit alpha 6 | human 20s proteasome complex with epoxomicin at 2.4 angstrom ***caveat 5lf0 6v1 u 47 has wrong chirality at atom c1 iml c 2 has wrong ***caveat 2 5lf0 chirality at atom cb iml d 2 has wrong chirality at atom ca ***caveat 3 5lf0 iml d 2 has wrong chirality | 5LF0_G |
| PB | T01.971 | proteasome subunit alpha 6 | human 20s proteasome complex with dihydroeponemycin at 2.0 angstrom ***caveat 5lf1 6v1 u 47 has wrong chirality at atom c1 | 5LF1_G |
| PB | T01.971 | proteasome subunit alpha 6 | human 20s proteasome complex with bortezomib at 2.1 angstrom ***caveat 5lf3 6v1 u 47 has wrong chirality at atom c1 | 5LF3_G |
| PB | T01.971 | proteasome subunit alpha 6 | human 20s proteasome complex with delanzomib at 2.0 angstrom ***caveat 5lf4 6v1 u 47 has wrong chirality at atom c1 6v7 n 307 has wrong ***caveat 2 5lf4 chirality at atom c9 6v7 y 306 has wrong chirality at atom ***caveat 3 5lf4 c9 | 5LF4_G |
| PB | T01.971 | proteasome subunit alpha 6 | human 20s proteasome complex with z-lly-ketoaldehyde at 2.1 angstrom ***caveat 5lf6 6v1 u 47 has wrong chirality at atom c1 | 5LF6_G |
| PB | T01.971 | proteasome subunit alpha 6 | human 20s proteasome complex with ixazomib at 2.0 angstrom ***caveat 5lf7 6v1 u 47 has wrong chirality at atom c1 | 5LF7_G |
| PB | T01.971 | proteasome subunit alpha 6 | the human 26s proteasome at 6.8 ang. ***caveat 5ln3 pro h 311 has wrong chirality at atom ca thr n 752 has wrong ***caveat 2 5ln3 chirality at atom ca | 5LN3_A |
| PB | T01.971 | proteasome subunit alpha 6 | 26s proteasome in complex with oprozomib | 5M32_G |
| PB | T01.971 | proteasome subunit alpha 6 | structural basis for dynamic regulation of the human 26s proteasome ***caveat 5t0g entry contains improper peptide linkages. | 5T0G_G |
| PB | T01.971 | proteasome subunit alpha 6 | structural basis for dynamic regulation of the human 26s proteasome ***caveat 5t0h entry contains improper peptide linkages. | 5T0H_G |
| PB | T01.971 | proteasome subunit alpha 6 | structural basis for dynamic regulation of the human 26s proteasome ***caveat 5t0i entry contains improper peptide linkages. residue arg k 20 ***caveat 2 5t0i is incorrectly modeled. | 5T0I_G |
| PB | T01.971 | proteasome subunit alpha 6 | structural basis for dynamic regulation of the human 26s proteasome ***caveat 5t0j entry contains improper peptide linkages. | 5T0J_G |
| PB | T01.971 | proteasome subunit alpha 6 | nucleotide-driven triple-state remodeling of the aaa-atpase channel inthe activated human 26s proteasome | 5VFO_G |
| PB | T01.971 | proteasome subunit alpha 6 | nucleotide-driven triple-state remodeling of the aaa-atpase channel inthe activated human 26s proteasome | 5VFR_e |
| PB | T01.971 | proteasome subunit alpha 6 | nucleotide-driven triple-state remodeling of the aaa-atpase channel inthe activated human 26s proteasome | 5VFT_G |
| PB | T01.971 | proteasome subunit alpha 6 | cryo-em structure of human immunoproteasome with a novel noncompetitive inhibitor that selectively inhibits activated lymphocytes | 6AVO_K |
| PB | T01.971 | proteasome subunit alpha 6 | endogeneous native human 20s proteasome | 6R70_G |
| PB | T01.971 | proteasome subunit alpha 6 | 20S proteasome; complex with PR-957 | 3UNB_G |
| PB | T01.971 | proteasome subunit alpha 6 | 20S proteasome | 3UNE_G |
| PB | T01.971 | proteasome subunit alpha 6 | 20S immunoproteasome; complex with PR-957 | 3UNF_G |
| PB | T01.971 | proteasome subunit alpha 6 | 20S immunoproteasome | 3UNH_G |
| PB | T01.971 | proteasome subunit alpha 6 | 20S proteasome complex | 1IRU_A |
| PB | T01.972 | proteasome subunit alpha 2 | ground state 26s proteasome (gs2) | 6EPC_B |
| PB | T01.972 | proteasome subunit alpha 2 | substrate processing state 26s proteasome (sps1) ***caveat 6epd pro 2 231 has wrong chirality at atom ca | 6EPD_B |
| PB | T01.972 | proteasome subunit alpha 2 | substrate processing state 26s proteasome (sps2) | 6EPE_B |
| PB | T01.972 | proteasome subunit alpha 2 | ground state 26s proteasome (gs1) | 6EPF_B |
| PB | T01.972 | proteasome subunit alpha 2 | 20S proteasome | 4R3O_B |
| PB | T01.972 | proteasome subunit alpha 2 | 20S proteasome; complex with carfilzomib | 4R67_B |
| PB | T01.972 | proteasome subunit alpha 2 | cryo-em reveals the conformation of a substrate analogue in the human 20s proteasome core | 5A0Q_B |
| PB | T01.972 | proteasome subunit alpha 2 | 26S proteasome; complex with USP14-UbAl | 5GJQ_C |
| PB | T01.972 | proteasome subunit alpha 2 | 26S proteasome | 5GJR_C |
| PB | T01.972 | proteasome subunit alpha 2 | native human 20s proteasome at 1.8 angstrom ***caveat 5le5 6v1 u 47 has wrong chirality at atom c1 | 5LE5_A |
| PB | T01.972 | proteasome subunit alpha 2 | native human 20s proteasome in mg-acetate at 2.2 angstrom ***caveat 5lex 6v1 u 47 has wrong chirality at atom c1 | 5LEX_A |
| PB | T01.972 | proteasome subunit alpha 2 | 20s proteasome; complex with oprozomib | 5LEY_A |
| PB | T01.972 | proteasome subunit alpha 2 | 20s proteasome; complex with oprozomib in mg-acetate | 5LEZ_A |
| PB | T01.972 | proteasome subunit alpha 2 | human 20s proteasome complex with epoxomicin at 2.4 angstrom ***caveat 5lf0 6v1 u 47 has wrong chirality at atom c1 iml c 2 has wrong ***caveat 2 5lf0 chirality at atom cb iml d 2 has wrong chirality at atom ca ***caveat 3 5lf0 iml d 2 has wrong chirality | 5LF0_A |
| PB | T01.972 | proteasome subunit alpha 2 | human 20s proteasome complex with dihydroeponemycin at 2.0 angstrom ***caveat 5lf1 6v1 u 47 has wrong chirality at atom c1 | 5LF1_A |
| PB | T01.972 | proteasome subunit alpha 2 | human 20s proteasome complex with bortezomib at 2.1 angstrom ***caveat 5lf3 6v1 u 47 has wrong chirality at atom c1 | 5LF3_A |
| PB | T01.972 | proteasome subunit alpha 2 | human 20s proteasome complex with delanzomib at 2.0 angstrom ***caveat 5lf4 6v1 u 47 has wrong chirality at atom c1 6v7 n 307 has wrong ***caveat 2 5lf4 chirality at atom c9 6v7 y 306 has wrong chirality at atom ***caveat 3 5lf4 c9 | 5LF4_A |
| PB | T01.972 | proteasome subunit alpha 2 | human 20s proteasome complex with z-lly-ketoaldehyde at 2.1 angstrom ***caveat 5lf6 6v1 u 47 has wrong chirality at atom c1 | 5LF6_A |
| PB | T01.972 | proteasome subunit alpha 2 | human 20s proteasome complex with ixazomib at 2.0 angstrom ***caveat 5lf7 6v1 u 47 has wrong chirality at atom c1 | 5LF7_A |
| PB | T01.972 | proteasome subunit alpha 2 | the human 26s proteasome at 6.8 ang. ***caveat 5ln3 pro h 311 has wrong chirality at atom ca thr n 752 has wrong ***caveat 2 5ln3 chirality at atom ca | 5LN3_B |
| PB | T01.972 | proteasome subunit alpha 2 | 26s proteasome in complex with oprozomib | 5M32_A |
| PB | T01.972 | proteasome subunit alpha 2 | structural basis for dynamic regulation of the human 26s proteasome ***caveat 5t0g entry contains improper peptide linkages. | 5T0G_H |
| PB | T01.972 | proteasome subunit alpha 2 | structural basis for dynamic regulation of the human 26s proteasome ***caveat 5t0h entry contains improper peptide linkages. | 5T0H_H |
| PB | T01.972 | proteasome subunit alpha 2 | structural basis for dynamic regulation of the human 26s proteasome ***caveat 5t0i entry contains improper peptide linkages. residue arg k 20 ***caveat 2 5t0i is incorrectly modeled. | 5T0I_H |
| PB | T01.972 | proteasome subunit alpha 2 | structural basis for dynamic regulation of the human 26s proteasome ***caveat 5t0j entry contains improper peptide linkages. | 5T0J_H |
| PB | T01.972 | proteasome subunit alpha 2 | nucleotide-driven triple-state remodeling of the aaa-atpase channel inthe activated human 26s proteasome | 5VFO_H |
| PB | T01.972 | proteasome subunit alpha 2 | nucleotide-driven triple-state remodeling of the aaa-atpase channel inthe activated human 26s proteasome | 5VFR_H |
| PB | T01.972 | proteasome subunit alpha 2 | nucleotide-driven triple-state remodeling of the aaa-atpase channel inthe activated human 26s proteasome | 5VFT_H |
| PB | T01.972 | proteasome subunit alpha 2 | cryo-em structure of human immunoproteasome with a novel noncompetitive inhibitor that selectively inhibits activated lymphocytes | 6AVO_P |
| PB | T01.972 | proteasome subunit alpha 2 | endogeneous native human 20s proteasome | 6R70_A |
| PB | T01.972 | proteasome subunit alpha 2 | 20S proteasome; complex with PR-957 | 3UNB_A |
| PB | T01.972 | proteasome subunit alpha 2 | 20S proteasome | 3UNE_A |
| PB | T01.972 | proteasome subunit alpha 2 | 20S immunoproteasome; complex with PR-957 | 3UNF_A |
| PB | T01.972 | proteasome subunit alpha 2 | 20S immunoproteasome | 3UNH_A |
| PB | T01.972 | proteasome subunit alpha 2 | 20S proteasome complex | 5FMG_B |
| PB | T01.972 | proteasome subunit alpha 2 | 20S proteasome complex | 1IRU_B |
| PB | T01.973 | proteasome subunit alpha 4 | ground state 26s proteasome (gs2) | 6EPC_C |
| PB | T01.973 | proteasome subunit alpha 4 | substrate processing state 26s proteasome (sps1) ***caveat 6epd pro 2 231 has wrong chirality at atom ca | 6EPD_C |
| PB | T01.973 | proteasome subunit alpha 4 | substrate processing state 26s proteasome (sps2) | 6EPE_C |
| PB | T01.973 | proteasome subunit alpha 4 | ground state 26s proteasome (gs1) | 6EPF_C |
| PB | T01.973 | proteasome subunit alpha 4 | 20S proteasome in complex with activator PA26 (Trypanosoma brucei) | 1FNT_C |
| PB | T01.973 | proteasome subunit alpha 4 | complete proteasome | 1G0U_B |
| PB | T01.973 | proteasome subunit alpha 4 | complex with epoxomicin | 1G65_B |
| PB | T01.973 | proteasome subunit alpha 4 | proteasome complex bound to TMC-95A inhibitor | 1JD2_B |
| PB | T01.973 | proteasome subunit alpha 4 | 20S proteasome | 1RYP_C |
| PB | T01.973 | proteasome subunit alpha 4 | 20S proteasome; complex with the proteasome activator PA26 from Trypanosoma brucei | 1Z7Q_C |
| PB | T01.973 | proteasome subunit alpha 4 | 20S proteasome;complex with bortezomib | 2F16_B |
| PB | T01.973 | proteasome subunit alpha 4 | 20S proteasome; complex with salinosporamide A | 2FAK_B |
| PB | T01.973 | proteasome subunit alpha 4 | 20S proteasome; complex with homobelactosin C | 2FNY_B |
| PB | T01.973 | proteasome subunit alpha 4 | 20S proteasome; complex with TMC-95 based biphenyl-ether macrocycle | 2GPL_B |
| PB | T01.973 | proteasome subunit alpha 4 | 20S proteasome; complex with syringolin A | 2ZCY_B |
| PB | T01.973 | proteasome subunit alpha 4 | 20S proteasome; complex with glidobactin A | 3BDM_B |
| PB | T01.973 | proteasome subunit alpha 4 | 20S proteasome; complex with fellutamide B | 3D29_B |
| PB | T01.973 | proteasome subunit alpha 4 | 20s proteasome; complex with the epimer form of spirolactacystin | 3DY3_B |
| PB | T01.973 | proteasome subunit alpha 4 | 20s proteasome; complex with spirolactacystin | 3DY4_B |
| PB | T01.973 | proteasome subunit alpha 4 | 20s proteasome; complex with homobelactosin c | 3E47_B |
| PB | T01.973 | proteasome subunit alpha 4 | 20s proteasome; complex with syringolin b | 3GPJ_B |
| PB | T01.973 | proteasome subunit alpha 4 | 20S proteasome; complex with salinosporamide derivative | 3GPT_B |
| PB | T01.973 | proteasome subunit alpha 4 | 20S proteasome; complex with salinosporamide derivative | 3GPW_B |
| PB | T01.973 | proteasome subunit alpha 4 | 20S proteasome; complex with hyroxylated salinosporamide | 3HYE_B |
| PB | T01.973 | proteasome subunit alpha 4 | 20S proteasome; complex with bortezomib | 3MG0_B |
| PB | T01.973 | proteasome subunit alpha 4 | 20S proteasome; complex with compound 1 | 3MG4_B |
| PB | T01.973 | proteasome subunit alpha 4 | 20S proteasome; complex with compound 6 | 3MG6_B |
| PB | T01.973 | proteasome subunit alpha 4 | 20S open-gate proteasome; complex with compound 6 | 3MG7_B |
| PB | T01.973 | proteasome subunit alpha 4 | 20S open-gate proteasome; complex with compound 16 | 3MG8_B |
| PB | T01.973 | proteasome subunit alpha 4 | 20S proteasome; complex with ligand 2a | 3NZJ_B |
| PB | T01.973 | proteasome subunit alpha 4 | 20S proteasome; complex with ligand 2b | 3NZW_B |
| PB | T01.973 | proteasome subunit alpha 4 | 20S proteasome; complex with ligand 2c | 3NZX_B |
| PB | T01.973 | proteasome subunit alpha 4 | 20S open-gate proteasome; complex with compound 24 | 3OEU_B |
| PB | T01.973 | proteasome subunit alpha 4 | 20S open-gate proteasome; complex with compound 25 | 3OEV_B |
| PB | T01.973 | proteasome subunit alpha 4 | 20S proteasome; complex with alpha-keto-aldehyde | 3OKJ_B |
| PB | T01.973 | proteasome subunit alpha 4 | 20S open-gate proteasome; complex with compound 20 | 3SDI_B |
| PB | T01.973 | proteasome subunit alpha 4 | 20S open-gate proteasome; complex with compound 34 | 3SDK_B |
| PB | T01.973 | proteasome subunit alpha 4 | 20S proteasome; complex with hydroxyurea derivative HU10 | 3SHJ_B |
| PB | T01.973 | proteasome subunit alpha 4 | 20S proteasome; complex with homobelactosin C | 3TDD_B |
| PB | T01.973 | proteasome subunit alpha 4 | 20S open-gate proteasome; complex with PR-957 (morpholine) | 3UN4_B |
| PB | T01.973 | proteasome subunit alpha 4 | 20S proteasome; complex with PR-957 (epoxide) | 3UN8_B |
| PB | T01.973 | proteasome subunit alpha 4 | 26S proteasome | 3WXR_C |
| PB | T01.973 | proteasome subunit alpha 4 | 26S proteasome | 4CR2_C |
| PB | T01.973 | proteasome subunit alpha 4 | 26S proteasome | 4CR3_C |
| PB | T01.973 | proteasome subunit alpha 4 | 26S proteasome | 4CR4_C |
| PB | T01.973 | proteasome subunit alpha 4 | 20S proteasome; complex with K-7174 | 4EU2_C |
| PB | T01.973 | proteasome subunit alpha 4 | 20S proteasome; complex with cepafungin I | 4FZC_B |
| PB | T01.973 | proteasome subunit alpha 4 | 20S proteasome; complex with glidobactin | 4FZG_B |
| PB | T01.973 | proteasome subunit alpha 4 | 20S proteasome; complex with Syringolin-Glidobactin chimera | 4G4S_C |
| PB | T01.973 | proteasome subunit alpha 4 | 20S proteasome; complex with Syringolin-Glidobactin chimera | 4GK7_B |
| PB | T01.973 | proteasome subunit alpha 4 | 20S proteasome; complex with vinylketone carmaphycin analogue VNK1 | 4HNP_B |
| PB | T01.973 | proteasome subunit alpha 4 | 20S proteasome; complex with epoxyketone carmaphycin analogue 3 | 4HRC_B |
| PB | T01.973 | proteasome subunit alpha 4 | 20S proteasome; complex with carmaphycin A | 4HRD_B |
| PB | T01.973 | proteasome subunit alpha 4 | 20S proteasome; complex with vinyl sulfone LU102 | 4INR_B |
| PB | T01.973 | proteasome subunit alpha 4 | 20S proteasome; complex with vinyl sulfone LU122 | 4INT_B |
| PB | T01.973 | proteasome subunit alpha 4 | 20S proteasome; complex with vinyl sulfone LU112 | 4INU_B |
| PB | T01.973 | proteasome subunit alpha 4 | 20S proteasome; complex with belactosin derivative 3E | 4J70_B |
| PB | T01.973 | proteasome subunit alpha 4 | 20S proteasome; complex with dimerized linear mimetic of TMC-95A | 4JSQ_B |
| PB | T01.973 | proteasome subunit alpha 4 | 20S proteasome; complex with dimerized linear mimetic of TMC-95A | 4JSU_B |
| PB | T01.973 | proteasome subunit alpha 4 | 20S proteasome; complex with dimerized linear mimetic of TMC-95A | 4JT0_B |
| PB | T01.973 | proteasome subunit alpha 4 | 20S proteasome; complex with vibralactone | 4LQI_B |
| PB | T01.973 | proteasome subunit alpha 4 | 20S proteasome; complex with enone carmaphycin analogue 6 | 4LTC_B |
| PB | T01.973 | proteasome subunit alpha 4 | 20S proteasome; complex with MG132 | 4NNN_B |
| PB | T01.973 | proteasome subunit alpha 4 | 20S proteasome; complex with Z-Leu-Leu-Leu-ketoaldehyde | 4NNW_B |
| PB | T01.973 | proteasome subunit alpha 4 | 20S proteasome; complex with Z-Leu-Leu-Leu-B(OH)2 | 4NO1_B |
| PB | T01.973 | proteasome subunit alpha 4 | 20S proteasome; complex with Z-Leu-Leu-Leu-vinylsulfone | 4NO6_B |
| PB | T01.973 | proteasome subunit alpha 4 | 20S proteasome; complex with Z-Leu-Leu-Leu-ketoamide | 4NO8_B |
| PB | T01.973 | proteasome subunit alpha 4 | 20S proteasome; complex with Z-Leu-Leu-Leu-epoxyketone | 4NO9_B |
| PB | T01.973 | proteasome subunit alpha 4 | 20S proteasome; complex with kendomycin | 4Q1S_B |
| PB | T01.973 | proteasome subunit alpha 4 | 20S proteasome; complex with Boc-Ala-Ala-Ala-CHO | 4QBY_B |
| PB | T01.973 | proteasome subunit alpha 4 | 20S proteasome; complex with epoxyketone inhibitor 8 | 4QLQ_B |
| PB | T01.973 | proteasome subunit alpha 4 | 20S proteasome; complex with epoxyketone inhibitor 11 | 4QLS_B |
| PB | T01.973 | proteasome subunit alpha 4 | 20S proteasome; complex with tripeptidic epoxyketone inhibitor 2 | 4QLT_B |
| PB | T01.973 | proteasome subunit alpha 4 | 20S proteasome; complex with tripeptidic epoxyketone inhibitor 9 | 4QLU_B |
| PB | T01.973 | proteasome subunit alpha 4 | 20S proteasome; complex with tripeptidic epoxyketone inhibitor 17 | 4QLV_B |
| PB | T01.973 | proteasome subunit alpha 4 | 20S proteasome | 4QUX_B |
| PB | T01.973 | proteasome subunit alpha 4 | 20S proteasome | 4QUY_B |
| PB | T01.973 | proteasome subunit alpha 4 | 20S proteasome | 4QV0_B |
| PB | T01.973 | proteasome subunit alpha 4 | 20S proteasome | 4QV1_B |
| PB | T01.973 | proteasome subunit alpha 4 | 20S proteasome | 4QV3_B |
| PB | T01.973 | proteasome subunit alpha 4 | 20S proteasome beta5 Met45Thr mutant | 4QV4_B |
| PB | T01.973 | proteasome subunit alpha 4 | 20S proteasome beta5 Met45Ile mutant | 4QV5_B |
| PB | T01.973 | proteasome subunit alpha 4 | 20S proteasome | 4QV6_B |
| PB | T01.973 | proteasome subunit alpha 4 | 20S proteasome | 4QV7_B |
| PB | T01.973 | proteasome subunit alpha 4 | 20S proteasome | 4QV8_B |
| PB | T01.973 | proteasome subunit alpha 4 | 20S proteasome | 4QV9_B |
| PB | T01.973 | proteasome subunit alpha 4 | 20S proteasome; complex with bortezomib | 4QVL_B |
| PB | T01.973 | proteasome subunit alpha 4 | 20S proteasome beta5 Met45Ala mutant; complex with bortezomib | 4QVM_B |
| PB | T01.973 | proteasome subunit alpha 4 | 20S proteasome beta5 Met45Val mutant; complex with bortezomib | 4QVN_B |
| PB | T01.973 | proteasome subunit alpha 4 | 20S proteasome beta5 Met45Thr mutant; complex with bortezomib | 4QVP_B |
| PB | T01.973 | proteasome subunit alpha 4 | 20S proteasome beta5 Met45Ile mutant; complex with bortezomib | 4QVQ_B |
| PB | T01.973 | proteasome subunit alpha 4 | 20S proteasome beta5 Ala49Val mutant; complex with bortezomib | 4QVV_B |
| PB | T01.973 | proteasome subunit alpha 4 | 20S proteasome beta5 Ala49Ser mutant; complex with bortezomib | 4QVW_B |
| PB | T01.973 | proteasome subunit alpha 4 | 20S proteasome beta5 Ala49Thr mutant; complex with bortezomib | 4QVY_B |
| PB | T01.973 | proteasome subunit alpha 4 | 20S proteasome beta5 Ala49Thr,Ala50Val mutant; complex with bortezomib | 4QW0_B |
| PB | T01.973 | proteasome subunit alpha 4 | 20S proteasome beta5 Ala50Val mutant; complex with bortezomib | 4QW1_B |
| PB | T01.973 | proteasome subunit alpha 4 | 20S proteasome beta5 Cys63Phe mutant; complex with bortezomib | 4QW3_B |
| PB | T01.973 | proteasome subunit alpha 4 | 20S proteasome; complex with carfilzomib | 4QW4_B |
| PB | T01.973 | proteasome subunit alpha 4 | 20S proteasome beta5 Met45Ala mutant; complex with carfilzomib | 4QW5_B |
| PB | T01.973 | proteasome subunit alpha 4 | 20S proteasome beta5 Met45Val mutant; complex with carfilzomib | 4QW6_B |
| PB | T01.973 | proteasome subunit alpha 4 | 20S proteasome beta5 Met45Thr mutant; complex with carfilzomib | 4QW7_B |
| PB | T01.973 | proteasome subunit alpha 4 | 20S proteasome beta5 Met45Ile mutant; complex with carfilzomib | 4QWF_B |
| PB | T01.973 | proteasome subunit alpha 4 | 20S proteasome beta5 Ala49Val mutant; complex with carfilzomib | 4QWG_B |
| PB | T01.973 | proteasome subunit alpha 4 | 20S proteasome beta5 Ala49Ser mutant; complex with carfilzomib | 4QWI_B |
| PB | T01.973 | proteasome subunit alpha 4 | 20S proteasome beta5 Ala49Thr mutant; complex with carfilzomib | 4QWJ_B |
| PB | T01.973 | proteasome subunit alpha 4 | 20S proteasome beta5 Ala49Thr, Ala50Val mutant; complex with carfilzomib | 4QWK_B |
| PB | T01.973 | proteasome subunit alpha 4 | 20S proteasome beta5 Ala50Val mutant; complex with carfilzomib | 4QWL_B |
| PB | T01.973 | proteasome subunit alpha 4 | 20S proteasome beta5 Cys52Phe mutant; complex with carfilzomib | 4QWR_B |
| PB | T01.973 | proteasome subunit alpha 4 | 20S proteasome beta5 Cys63Phe mutant; complex with carfilzomib | 4QWS_B |
| PB | T01.973 | proteasome subunit alpha 4 | 20S proteasome beta5 Cys52Phe mutant; complex with bortezomib | 4QWU_B |
| PB | T01.973 | proteasome subunit alpha 4 | 20S proteasome; complex with epoxyketone inhibitor ONX 0914 | 4QWX_B |
| PB | T01.973 | proteasome subunit alpha 4 | 20S proteasome beta 5 Met45Ala mutant; complex with epoxyketone inhibitor ONX 0914 | 4QXJ_B |
| PB | T01.973 | proteasome subunit alpha 4 | complete proteasome; complex with epoxyketone inhibitor ONX 0914 | 4QZ0_B |
| PB | T01.973 | proteasome subunit alpha 4 | 20S proteasome beta 5 Met45Thr mutant; complex with epoxyketone inhibitor ONX 0914 | 4QZ1_B |
| PB | T01.973 | proteasome subunit alpha 4 | 20S proteasome beta 5 Met45Ile mutant; complex with epoxyketone inhibitor ONX 0914 | 4QZ2_B |
| PB | T01.973 | proteasome subunit alpha 4 | 20S proteasome beta 5 Ala49Val mutant; complex with epoxyketone inhibitor ONX 0914 | 4QZ3_B |
| PB | T01.973 | proteasome subunit alpha 4 | 20S proteasome beta 5 Ala49Ser mutant; complex with epoxyketone inhibitor ONX 0914 | 4QZ4_B |
| PB | T01.973 | proteasome subunit alpha 4 | 20S proteasome beta 5 Ala49Thr mutant; complex with epoxyketone inhibitor ONX 0914 | 4QZ5_B |
| PB | T01.973 | proteasome subunit alpha 4 | 20S proteasome beta 5 Ala49Thr, Ala50Val mutant; complex with epoxyketone inhibitor ONX 0914 | 4QZ6_B |
| PB | T01.973 | proteasome subunit alpha 4 | 20S proteasome beta 5 Ala50Val mutant; complex with epoxyketone inhibitor ONX 0914 | 4QZ7_B |
| PB | T01.973 | proteasome subunit alpha 4 | 20S proteasome beta 5 Cys52Phe mutant; complex with epoxyketone inhibitor ONX 0914 | 4QZW_B |
| PB | T01.973 | proteasome subunit alpha 4 | complete proteasome; complex with epoxyketone inhibitor ONX 0914 | 4QZX_B |
| PB | T01.973 | proteasome subunit alpha 4 | 20S proteasome; complex with omuralide | 4QZZ_B |
| PB | T01.973 | proteasome subunit alpha 4 | 20S proteasome beta 5 Cys52Phe mutant; complex with omuralide | 4R00_B |
| PB | T01.973 | proteasome subunit alpha 4 | 20S proteasome; complex with BSC4999 | 4R02_B |
| PB | T01.973 | proteasome subunit alpha 4 | 20S proteasome; ligand induced aziridine-formation in beta5 | 4R17_B |
| PB | T01.973 | proteasome subunit alpha 4 | 20S proteasome; ligand induced Lys33-Thr1 cross-linking in beta5 | 4R18_B |
| PB | T01.973 | proteasome subunit alpha 4 | 20S proteasome; complex with alkaloid indolo-phakellin | 4RUR_B |
| PB | T01.973 | proteasome subunit alpha 4 | 4V7O | |
| PB | T01.973 | proteasome subunit alpha 4 | 20S proteasome; complex with PR-VI modulator | 4X6Z_C |
| PB | T01.973 | proteasome subunit alpha 4 | 20S proteasome; complex with Ac-Pro-Ala-Asp-EP | 4Y69_B |
| PB | T01.973 | proteasome subunit alpha 4 | 20S proteasome beta2 His114Asp mutant; complex with Ac-Pro-Ala-Asp-EP | 4Y6A_B |
| PB | T01.973 | proteasome subunit alpha 4 | 20S proteasome; complex with Ac-Pro-Ala-Glu-EP | 4Y6V_B |
| PB | T01.973 | proteasome subunit alpha 4 | 20S proteasome; complex with Ac-Pro-Ala-Leu-EP | 4Y6Z_B |
| PB | T01.973 | proteasome subunit alpha 4 | 20S proteasome; complex with Ac-Leu-Ala-Val-EP | 4Y70_B |
| PB | T01.973 | proteasome subunit alpha 4 | 20S proteasome; complex with Ac-Leu-Ala-Leu-EP | 4Y74_B |
| PB | T01.973 | proteasome subunit alpha 4 | 20S proteasome; complex with Ac-Pro-Ala-Phe-EP | 4Y75_B |
| PB | T01.973 | proteasome subunit alpha 4 | 20S proteasome; complex with Ac-Leu-Ala-Phe-EP | 4Y77_B |
| PB | T01.973 | proteasome subunit alpha 4 | 20S proteasome; complex with Ac-Leu-Ala-Asp-EP | 4Y78_B |
| PB | T01.973 | proteasome subunit alpha 4 | 20S proteasome; complex with Ac-Leu-Ala-Glu-EP | 4Y7W_B |
| PB | T01.973 | proteasome subunit alpha 4 | complete proteasome; complex with Ac-PAA-ep | 4Y7X_B |
| PB | T01.973 | proteasome subunit alpha 4 | 20S proteasome; complex with Ac-Leu-Ala-Ala-EP | 4Y7Y_B |
| PB | T01.973 | proteasome subunit alpha 4 | 20S proteasome; complex with Ac-Leu-Ala-Ile-EP | 4Y80_B |
| PB | T01.973 | proteasome subunit alpha 4 | 20S proteasome; complex with Ac-Pro-Ala-Tyr-EP | 4Y81_B |
| PB | T01.973 | proteasome subunit alpha 4 | 20S proteasome; complex with Ac-Leu-Ala-Tyr-EP | 4Y82_B |
| PB | T01.973 | proteasome subunit alpha 4 | 20S proteasome; complex with N3-Ala(4,4-F2P)-Asn-Leu-Leu-EP | 4Y84_B |
| PB | T01.973 | proteasome subunit alpha 4 | 20S proteasome; complex with N3-Ala-Pro-Asn-Leu-Leu-EP | 4Y8G_B |
| PB | T01.973 | proteasome subunit alpha 4 | 20S proteasome; complex with N3-Ala-Pro-Ala-Leu-EP | 4Y8H_B |
| PB | T01.973 | proteasome subunit alpha 4 | 20S proteasome; complex with Ac-Pro-Leu-Leu-EP | 4Y8I_B |
| PB | T01.973 | proteasome subunit alpha 4 | 20S proteasome; complex with Ac-Leu-Leu-Leu-EP | 4Y8J_B |
| PB | T01.973 | proteasome subunit alpha 4 | 20S proteasome; complex with H-Ala-Pro-Leu-Leu-EP | 4Y8K_B |
| PB | T01.973 | proteasome subunit alpha 4 | 20S proteasome; complex with Ac-Ala-Pro-Leu-Leu-EP | 4Y8L_B |
| PB | T01.973 | proteasome subunit alpha 4 | 20S proteasome beta7-delta7 C-terminal mutant | 4Y8M_B |
| PB | T01.973 | proteasome subunit alpha 4 | 20S proteasome beta7-delta7 C-terminal mutant; complex with Ac-Pro-Ala-Glu-EP | 4Y8N_B |
| PB | T01.973 | proteasome subunit alpha 4 | 20S proteasome beta 7-delta 7 C-terminal mutant; complex with Ac-Pro-Ala-Phe-EP | 4Y8O_B |
| PB | T01.973 | proteasome subunit alpha 4 | 20S proteasome beta 7-delta 7 C-terminal mutant; complex with Ac-Pro-Ala-Leu-EP | 4Y8P_B |
| PB | T01.973 | proteasome subunit alpha 4 | 20S proteasome beta 7-delta 7 C-terminal mutant; complex with Ac-Pro-Ala-Tyr-EP | 4Y8Q_B |
| PB | T01.973 | proteasome subunit alpha 4 | 20S proteasome beta 2 His116Asp mutant | 4Y8R_B |
| PB | T01.973 | proteasome subunit alpha 4 | 20S proteasome beta 2 His116Asp mutant; complex with Ac-Leu-Ala-Glu-EP | 4Y8S_B |
| PB | T01.973 | proteasome subunit alpha 4 | 20S proteasome beta 2 His116Asp mutant; complex with Ac-Pro-Ala-Glu-EP | 4Y8T_B |
| PB | T01.973 | proteasome subunit alpha 4 | 20S proteasome beta 2 His116Asp mutant; complex with Ac-Pro-Ala-Asp-EP | 4Y8U_B |
| PB | T01.973 | proteasome subunit alpha 4 | 20S proteasome beta 2 His116Glu mutant | 4Y9Y_B |
| PB | T01.973 | proteasome subunit alpha 4 | 20S proteasome beta 2 His116Glu mutant; complex with Ac-Leu-Ala-Glu-EP | 4Y9Z_B |
| PB | T01.973 | proteasome subunit alpha 4 | 20S proteasome beta 2 His116Glu mutant; complex with Ac-Pro-Ala-Glu-EP | 4YA0_B |
| PB | T01.973 | proteasome subunit alpha 4 | 20S proteasome beta 2 His116Asn mutant | 4YA1_B |
| PB | T01.973 | proteasome subunit alpha 4 | 20S proteasome beta 2 His116Asn mutant; complex with Ac-Leu-Ala-Glu-EP | 4YA2_B |
| PB | T01.973 | proteasome subunit alpha 4 | 20S proteasome beta 2 His116Asn mutant; complex with Ac-Pro-Ala-Glu-EP | 4YA3_B |
| PB | T01.973 | proteasome subunit alpha 4 | 20S proteasome beta 2 His114Asp mutant | 4YA4_B |
| PB | T01.973 | proteasome subunit alpha 4 | 20S proteasome beta 2 His114Asp mutant; complex with Ac-Pro-Ala-Glu-EP | 4YA5_B |
| PB | T01.973 | proteasome subunit alpha 4 | 20S proteasome beta 2 His114Asp mutant; complex with Ac-Leu-Ala-Glu-EP | 4YA7_B |
| PB | T01.973 | proteasome subunit alpha 4 | 20S proteasome beta 2 His114Asp mutant; complex with AC-Leu-Ala-Asp-EP | 4YA9_B |
| PB | T01.973 | proteasome subunit alpha 4 | 20S proteasome; complex with belactosin C derivative 3 | 4Z1L_B |
| PB | T01.973 | proteasome subunit alpha 4 | 26S protease-UBP6 complex | 5A5B_C |
| PB | T01.973 | proteasome subunit alpha 4 | 20S proteasome; complex with macyranone A | 5AHJ_B |
| PB | T01.973 | proteasome subunit alpha 4 | 20S proteasome; complex with beta1/beta2 nonspecifici sulfonamide ligand | 5BOU_B |
| PB | T01.973 | proteasome subunit alpha 4 | yeast 20s proteasome beta2-g170a mutant | 5BXL_B |
| PB | T01.973 | proteasome subunit alpha 4 | yeast 20s proteasome beta2-g170a mutant in complex with bortezomib | 5BXN_B |
| PB | T01.973 | proteasome subunit alpha 4 | 20S proteasome beta5 Gly48Cys mutant | 5CGF_B |
| PB | T01.973 | proteasome subunit alpha 4 | 20S proteasome beta5 Gly48Cys mutant; complex with alpha-chloroacetamide 1 | 5CGG_B |
| PB | T01.973 | proteasome subunit alpha 4 | 20S proteasome beta5 Gly48Cys mutant; complex with alpha-chloroacetamide 5 | 5CGH_B |
| PB | T01.973 | proteasome subunit alpha 4 | 20S proteasome beta5 Gly48Cys mutant; complex with ONX 0914 | 5CGI_B |
| PB | T01.973 | proteasome subunit alpha 4 | yeast 20s proteasome at 2.3 a resolution | 5CZ4_B |
| PB | T01.973 | proteasome subunit alpha 4 | yeast 20s proteasome beta1-t1a mutant in complex with carfilzomib | 5CZ5_B |
| PB | T01.973 | proteasome subunit alpha 4 | yeast 20s proteasome beta5-t1a mutant in complex with syringolin a, propeptide expressed in trans | 5CZ6_B |
| PB | T01.973 | proteasome subunit alpha 4 | yeast 20s proteasome beta5-t1a beta5-k81r double mutant in complex with bortezomib, propeptide expressed in cis | 5CZ7_B |
| PB | T01.973 | proteasome subunit alpha 4 | yeast 20s proteasome beta5-l(-49)s-k33a mutant in complex with carfilzomib | 5CZ8_B |
| PB | T01.973 | proteasome subunit alpha 4 | yeast 20s proteasome beta5-d17n mutant in complex with carfilzomib; propeptide expressed in trans | 5CZ9_B |
| PB | T01.973 | proteasome subunit alpha 4 | yeast 20s proteasome beta5-d166n mutant | 5CZA_B |
| PB | T01.973 | proteasome subunit alpha 4 | yeast 20s proteasome beta5-d166n mutant in complex with carfilzomib | 5D0S_B |
| PB | T01.973 | proteasome subunit alpha 4 | yeast 20s proteasome beta5-d166n mutant in complex with mg132 | 5D0T_B |
| PB | T01.973 | proteasome subunit alpha 4 | yeast 20s proteasome beta5-t1c mutant in complex with carfilzomib | 5D0V_B |
| PB | T01.973 | proteasome subunit alpha 4 | yeast 20s proteasome beta5-t1s mutant | 5D0W_B |
| PB | T01.973 | proteasome subunit alpha 4 | yeast 20s proteasome beta5-t1s mutant in complex with bortezomib | 5D0X_B |
| PB | T01.973 | proteasome subunit alpha 4 | yeast 20s proteasome beta5-t1s mutant in complex with carfilzomib | 5D0Z_B |
| PB | T01.973 | proteasome subunit alpha 4 | 20S proteasome; complex with alkyne-PI | 5DKI_B |
| PB | T01.973 | proteasome subunit alpha 4 | 20S proteasome; complex with octreotide-PI | 5DKJ_B |
| PB | T01.973 | proteasome subunit alpha 4 | yeast 20s proteasome beta2-t1a mutant | 5FG7_B |
| PB | T01.973 | proteasome subunit alpha 4 | yeast 20s proteasome beta2-t(-2)v mutant | 5FG9_B |
| PB | T01.973 | proteasome subunit alpha 4 | yeast 20s proteasome beta5-k33a mutant (propeptide expressed in trans) | 5FGA_B |
| PB | T01.973 | proteasome subunit alpha 4 | yeast 20s proteasome beta5-h(-2)l-t1a double mutant in complex with carfilzomib | 5FGD_B |
| PB | T01.973 | proteasome subunit alpha 4 | yeast 20s proteasome beta5-h(-2)t-t1a double mutant in complex with carfilzomib | 5FGE_B |
| PB | T01.973 | proteasome subunit alpha 4 | yeast 20s proteasome beta5-h(-2)a-t1a-k81r triple mutant in complex with carfilzomib | 5FGF_B |
| PB | T01.973 | proteasome subunit alpha 4 | yeast 20s proteasome beta5-l(-49s)_d17n double mutant in complex with carfilzomib | 5FGG_B |
| PB | T01.973 | proteasome subunit alpha 4 | yeast 20s proteasome beta5-k33a mutant (propeptide expressed in trans)in complex with mg132 | 5FGH_B |
| PB | T01.973 | proteasome subunit alpha 4 | yeast 20s proteasome beta1-t1a beta2-t1a double mutant in complex withcarfilzomib | 5FGI_B |
| PB | T01.973 | proteasome subunit alpha 4 | yeast 20s proteasome beta5-k33a mutant (propeptide expressed in trans)in complex with carfilzomib | 5FHS_B |
| PB | T01.973 | proteasome subunit alpha 4 | 20s proteasome; complex with the peptidic epoxyketone inhibitor 27 | 5JHR_B |
| PB | T01.973 | proteasome subunit alpha 4 | 20s proteasome; complex with the peptidic epoxyketone inhibitor 15 | 5JHS_B |
| PB | T01.973 | proteasome subunit alpha 4 | 20s proteasome; complex with epoxyketone inhibitor 14 | 5L52_B |
| PB | T01.973 | proteasome subunit alpha 4 | yeast 20s proteasome in complex with epoxyketone inhibitor 16 | 5L54_B |
| PB | T01.973 | proteasome subunit alpha 4 | yeast 20s proteasome in complex with epoxyketone inhibitor 18 | 5L55_B |
| PB | T01.973 | proteasome subunit alpha 4 | yeast 20s proteasome with human beta5i (1-138; r57t) | 5L5A_B |
| PB | T01.973 | proteasome subunit alpha 4 | yeast 20s proteasome with human beta5i (1-138) and human beta6 (97- 111; 118-133) | 5L5B_B |
| PB | T01.973 | proteasome subunit alpha 4 | yeast 20s proteasome with human beta5i (1-138) and human beta6 (97- 111; 118-133) in complex with onx 0914 | 5L5D_B |
| PB | T01.973 | proteasome subunit alpha 4 | yeast 20s proteasome with human beta5i (1-138) and human beta6 (97- 111; 118-133) in complex with carfilzomib | 5L5E_B |
| PB | T01.973 | proteasome subunit alpha 4 | yeast 20s proteasome with human beta5i (1-138) and human beta6 (97- 111; 118-133) in complex with bortezomib | 5L5F_B |
| PB | T01.973 | proteasome subunit alpha 4 | yeast 20s proteasome with human beta5i (1-138) and human beta6 (97- 111; 118-133) in complex with pr-924 | 5L5H_B |
| PB | T01.973 | proteasome subunit alpha 4 | yeast 20s proteasome with human beta5i (1-138) and human beta6 (97- 111; 118-133) in complex with epoxyketone inhibitor 9 | 5L5I_B |
| PB | T01.973 | proteasome subunit alpha 4 | yeast 20s proteasome with human beta5i (1-138) and human beta6 (97- 111; 118-133) in complex with epoxyketone inhibitor 14 | 5L5J_B |
| PB | T01.973 | proteasome subunit alpha 4 | yeast 20s proteasome with human beta5i (1-138) and human beta6 (97- 111; 118-133) in complex with epoxyketone inhibitor 16 | 5L5O_B |
| PB | T01.973 | proteasome subunit alpha 4 | yeast 20s proteasome with human beta5i (1-138) and human beta6 (97- 111; 118-133) in complex with epoxyketone inhibitor 17 | 5L5P_B |
| PB | T01.973 | proteasome subunit alpha 4 | yeast 20s proteasome with human beta5i (1-138) and human beta6 (97- 111; 118-133) in complex with epoxyketone 18 | 5L5Q_B |
| PB | T01.973 | proteasome subunit alpha 4 | yeast 20s proteasome with human beta5i (1-138;v31m) and human beta6 (97-111; 118-133) | 5L5R_B |
| PB | T01.973 | proteasome subunit alpha 4 | yeast 20s proteasome with human beta5i (1-138; v31m) and human beta6 (97-111; 118-133) in complex with pr-924 | 5L5S_B |
| PB | T01.973 | proteasome subunit alpha 4 | yeast 20s proteasome with human beta5i (1-138; v31m) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 16 | 5L5T_B |
| PB | T01.973 | proteasome subunit alpha 4 | yeast 20s proteasome with human beta5i (1-138; v31m) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 17 ***caveat 5l5u 04c h 301 has wrong chirality at atom c27 04c k 301 has ***caveat 2 5l5u wrong chirality at atom c27 04c v 301 h | 5L5U_B |
| PB | T01.973 | proteasome subunit alpha 4 | yeast 20s proteasome with human beta5c (1-138) and human beta6 (97- 111; 118-133) | 5L5W_B |
| PB | T01.973 | proteasome subunit alpha 4 | yeast 20s proteasome with human beta5c (1-138) and human beta6 (97- 111; 118-133) in complex with onx 0914 | 5L5X_B |
| PB | T01.973 | proteasome subunit alpha 4 | yeast 20s proteasome with human beta5c (1-138) and human beta6 (97- 111; 118-133) in complex with carfilzomib | 5L5Y_B |
| PB | T01.973 | proteasome subunit alpha 4 | yeast 20s proteasome with human beta5c (1-138) and human beta6 (97- 111; 118-133) in complex with bortezomib | 5L5Z_B |
| PB | T01.973 | proteasome subunit alpha 4 | yeast 20s proteasome with human beta5c (1-138) and human beta6 (97- 111; 118-133) in complex with pr-924 | 5L60_B |
| PB | T01.973 | proteasome subunit alpha 4 | yeast 20s proteasome with human beta5c (1-138) and human beta6 (99- 132) in complex with epoxyketone inhibitor 14 | 5L61_B |
| PB | T01.973 | proteasome subunit alpha 4 | yeast 20s proteasome with human beta5c (1-138) and human beta6 (97- 111; 118-133) in complex with epoxyketone inhibitor 16 | 5L62_B |
| PB | T01.973 | proteasome subunit alpha 4 | yeast 20s proteasome with human beta5c (1-138) and human beta6 (97- 111; 118-133) in complex with epoxyketone inhibitor 17 ***caveat 5l63 04c h 301 has wrong chirality at atom c27 04c k 301 has ***caveat 2 5l63 wrong chirality at atom c27 04c v 301 has wr | 5L63_B |
| PB | T01.973 | proteasome subunit alpha 4 | yeast 20s proteasome with human beta5c (1-138) and human beta6 (97- 111; 118-133) in complex with epoxyketone inhibitor 18 | 5L64_B |
| PB | T01.973 | proteasome subunit alpha 4 | yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97- 111; 118-133) in complex with carfilzomib | 5L65_B |
| PB | T01.973 | proteasome subunit alpha 4 | yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97- 111; 118-133) in complex with bortezomib | 5L66_B |
| PB | T01.973 | proteasome subunit alpha 4 | yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97- 111; 118-133) in complex with pr-924 | 5L67_B |
| PB | T01.973 | proteasome subunit alpha 4 | yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97- 111; 118-133) in complex with epoxyketone inhibitor 14 | 5L68_B |
| PB | T01.973 | proteasome subunit alpha 4 | yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97- 111; 118-133) in complex with epoxyketone inhibitor 16 | 5L69_B |
| PB | T01.973 | proteasome subunit alpha 4 | yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97- 111; 118-133) in complex with epoxyketone inhibitor 17 | 5L6A_B |
| PB | T01.973 | proteasome subunit alpha 4 | yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97- 111; 118-133) in complex with onx 0914 | 5L6B_B |
| PB | T01.973 | proteasome subunit alpha 4 | yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97- 111; 118-133) in complex with epoxyketone inhibitor 18 | 5L6C_B |
| PB | T01.973 | proteasome subunit alpha 4 | ligand-induced aziridine-formation at the yeast proteasomal subunit beta5 by sulfonate esters | 5LAI_B |
| PB | T01.973 | proteasome subunit alpha 4 | ligand-induced lys33-thr1 crosslinking at the yeast proteasomal subunit beta5 by sulfonate esters | 5LAJ_B |
| PB | T01.973 | proteasome subunit alpha 4 | yeast 20s proteasome with human beta5i (1-138; r57t)in complex with pr-924 | 5LTT_B |
| PB | T01.973 | proteasome subunit alpha 4 | yeast 20s proteasome with human beta5i (1-138) and human beta6 (97- 111; 118-133) in complex with thiazole based inhibitor ro19 | 5M2B_B |
| PB | T01.973 | proteasome subunit alpha 4 | 26s proteasome in presence of atp (s1) | 5MP9_c |
| PB | T01.973 | proteasome subunit alpha 4 | 26s proteasome in presence of atp (s2) | 5MPA_c |
| PB | T01.973 | proteasome subunit alpha 4 | 20s proteasome; complex with blm-pep activator | 5NIF_C |
| PB | T01.973 | proteasome subunit alpha 4 | yeast 26s proteasome bound to ubiquitinated substrate (1d* motor state) | 6EF0_C |
| PB | T01.973 | proteasome subunit alpha 4 | yeast 26s proteasome bound to ubiquitinated substrate (5d motor state) | 6EF1_C |
| PB | T01.973 | proteasome subunit alpha 4 | yeast 26s proteasome bound to ubiquitinated substrate (5t motor state) | 6EF2_C |
| PB | T01.973 | proteasome subunit alpha 4 | yeast 26s proteasome bound to ubiquitinated substrate (4d motor state) | 6EF3_C |
| PB | T01.973 | proteasome subunit alpha 4 | 20s proteasome in complex with cystargolide B | 6G7F_B |
| PB | T01.973 | proteasome subunit alpha 4 | 20s proteasome in complex with cystargolide B derivative 1 | 6G8M_B |
| PB | T01.973 | proteasome subunit alpha 4 | 20s proteasome in complex with cystargolide B derivative 2 | 6G8N_B |
| PB | T01.973 | proteasome subunit alpha 4 | yeast 20s proteasome in complex with homosalinosporamide a | 6GOP_B |
| PB | T01.973 | proteasome subunit alpha 4 | yeast 20s proteasome in complex with the peptidic non-covalent bindinginhibitor rts-v5 | 6H39_B |
| PB | T01.973 | proteasome subunit alpha 4 | yeast 20s proteasome with human beta2c (s171g) | 6HTB_B |
| PB | T01.973 | proteasome subunit alpha 4 | yeast 20s proteasome with human beta2c (s171g) in complex with onx 0914 | 6HTC_B |
| PB | T01.973 | proteasome subunit alpha 4 | yeast 20s proteasome with human beta2c (s171g) in complex with 4 | 6HTD_B |
| PB | T01.973 | proteasome subunit alpha 4 | yeast 20s proteasome with human beta2c (s171g) in complex with 7 | 6HTP_B |
| PB | T01.973 | proteasome subunit alpha 4 | yeast 20s proteasome with human beta2c (s171g) in complex with 13 | 6HTR_B |
| PB | T01.973 | proteasome subunit alpha 4 | yeast 20s proteasome with human beta2c (s171g) in complex with 16 | 6HUB_B |
| PB | T01.973 | proteasome subunit alpha 4 | yeast 20s proteasome with human beta2c (s171g) in complex with 18 | 6HUC_B |
| PB | T01.973 | proteasome subunit alpha 4 | yeast 20s proteasome with human beta2c (s171g) in complex with 20 | 6HUQ_B |
| PB | T01.973 | proteasome subunit alpha 4 | yeast 20s proteasome with human beta2c (s171g) in complex with 29 | 6HUU_B |
| PB | T01.973 | proteasome subunit alpha 4 | yeast 20s proteasome with human beta2c (s171g) in complex with 39 | 6HUV_B |
| PB | T01.973 | proteasome subunit alpha 4 | yeast 20s proteasome with human beta2i (1-53) | 6HV3_B |
| PB | T01.973 | proteasome subunit alpha 4 | yeast 20s proteasome with human beta2i (1-53) in complex with onx 0914 | 6HV4_B |
| PB | T01.973 | proteasome subunit alpha 4 | yeast 20s proteasome with human beta2i (1-53) in complex with 4 | 6HV5_B |
| PB | T01.973 | proteasome subunit alpha 4 | yeast 20s proteasome with human beta2i (1-53) in complex with 7 | 6HV7_B |
| PB | T01.973 | proteasome subunit alpha 4 | yeast 20s proteasome with human beta2i (1-53) in complex with 13 | 6HVA_B |
| PB | T01.973 | proteasome subunit alpha 4 | yeast 20s proteasome with human beta2i (1-53) in complex with 16 | 6HVR_B |
| PB | T01.973 | proteasome subunit alpha 4 | yeast 20s proteasome with human beta2i (1-53) in complex with 18 | 6HVS_B |
| PB | T01.973 | proteasome subunit alpha 4 | yeast 20s proteasome with human beta2i (1-53) in complex with 20 | 6HVT_B |
| PB | T01.973 | proteasome subunit alpha 4 | yeast 20s proteasome with human beta2i (1-53) in complex with 29 | 6HVU_B |
| PB | T01.973 | proteasome subunit alpha 4 | yeast 20s proteasome with human beta2i (1-53) in complex with 39 | 6HVV_B |
| PB | T01.973 | proteasome subunit alpha 4 | yeast 20s proteasome with human beta2i (1-53) in complex with 43 | 6HVW_B |
| PB | T01.973 | proteasome subunit alpha 4 | yeast 20s proteasome in complex with 4 | 6HVX_B |
| PB | T01.973 | proteasome subunit alpha 4 | yeast 20s proteasome in complex with 5 (7- and 6-membered ring) | 6HVY_B |
| PB | T01.973 | proteasome subunit alpha 4 | yeast 20s proteasome in complex with 7 | 6HW0_B |
| PB | T01.973 | proteasome subunit alpha 4 | yeast 20s proteasome in complex with 13 | 6HW3_B |
| PB | T01.973 | proteasome subunit alpha 4 | yeast 20s proteasome in complex with 16 | 6HW4_B |
| PB | T01.973 | proteasome subunit alpha 4 | yeast 20s proteasome in complex with 18 | 6HW5_B |
| PB | T01.973 | proteasome subunit alpha 4 | yeast 20s proteasome in complex with 20 | 6HW6_B |
| PB | T01.973 | proteasome subunit alpha 4 | yeast 20s proteasome in complex with 29 | 6HW7_B |
| PB | T01.973 | proteasome subunit alpha 4 | yeast 20s proteasome in complex with 39 | 6HW8_B |
| PB | T01.973 | proteasome subunit alpha 4 | yeast 20s proteasome in complex with 41b | 6HW9_B |
| PB | T01.973 | proteasome subunit alpha 4 | yeast 20s proteasome in complex with 43 | 6HWA_B |
| PB | T01.973 | proteasome subunit alpha 4 | yeast 20s proteasome in complex with 44b | 6HWB_B |
| PB | T01.973 | proteasome subunit alpha 4 | yeast 20s proteasome beta2-g45a mutant | 6HWC_B |
| PB | T01.973 | proteasome subunit alpha 4 | yeast 20s proteasome beta2-g45a mutant in complex with bortezomib | 6HWD_B |
| PB | T01.973 | proteasome subunit alpha 4 | yeast 20s proteasome beta2-g45a mutant in complex with carfilzomib | 6HWE_B |
| PB | T01.973 | proteasome subunit alpha 4 | yeast 20s proteasome beta2-g45a mutant in complex with onx 0914 | 6HWF_B |
| PB | T01.973 | proteasome subunit alpha 4 | 20S proteasome | 4R3O_C |
| PB | T01.973 | proteasome subunit alpha 4 | 20S proteasome; complex with carfilzomib | 4R67_C |
| PB | T01.973 | proteasome subunit alpha 4 | cryo-em reveals the conformation of a substrate analogue in the human 20s proteasome core | 5A0Q_C |
| PB | T01.973 | proteasome subunit alpha 4 | 26S proteasome; complex with USP14-UbAl | 5GJQ_D |
| PB | T01.973 | proteasome subunit alpha 4 | 26S proteasome | 5GJR_D |
| PB | T01.973 | proteasome subunit alpha 4 | native human 20s proteasome at 1.8 angstrom ***caveat 5le5 6v1 u 47 has wrong chirality at atom c1 | 5LE5_B |
| PB | T01.973 | proteasome subunit alpha 4 | native human 20s proteasome in mg-acetate at 2.2 angstrom ***caveat 5lex 6v1 u 47 has wrong chirality at atom c1 | 5LEX_B |
| PB | T01.973 | proteasome subunit alpha 4 | 20s proteasome; complex with oprozomib | 5LEY_B |
| PB | T01.973 | proteasome subunit alpha 4 | 20s proteasome; complex with oprozomib in mg-acetate | 5LEZ_B |
| PB | T01.973 | proteasome subunit alpha 4 | human 20s proteasome complex with epoxomicin at 2.4 angstrom ***caveat 5lf0 6v1 u 47 has wrong chirality at atom c1 iml c 2 has wrong ***caveat 2 5lf0 chirality at atom cb iml d 2 has wrong chirality at atom ca ***caveat 3 5lf0 iml d 2 has wrong chirality | 5LF0_B |
| PB | T01.973 | proteasome subunit alpha 4 | human 20s proteasome complex with dihydroeponemycin at 2.0 angstrom ***caveat 5lf1 6v1 u 47 has wrong chirality at atom c1 | 5LF1_B |
| PB | T01.973 | proteasome subunit alpha 4 | human 20s proteasome complex with bortezomib at 2.1 angstrom ***caveat 5lf3 6v1 u 47 has wrong chirality at atom c1 | 5LF3_B |
| PB | T01.973 | proteasome subunit alpha 4 | human 20s proteasome complex with delanzomib at 2.0 angstrom ***caveat 5lf4 6v1 u 47 has wrong chirality at atom c1 6v7 n 307 has wrong ***caveat 2 5lf4 chirality at atom c9 6v7 y 306 has wrong chirality at atom ***caveat 3 5lf4 c9 | 5LF4_B |
| PB | T01.973 | proteasome subunit alpha 4 | human 20s proteasome complex with z-lly-ketoaldehyde at 2.1 angstrom ***caveat 5lf6 6v1 u 47 has wrong chirality at atom c1 | 5LF6_B |
| PB | T01.973 | proteasome subunit alpha 4 | human 20s proteasome complex with ixazomib at 2.0 angstrom ***caveat 5lf7 6v1 u 47 has wrong chirality at atom c1 | 5LF7_B |
| PB | T01.973 | proteasome subunit alpha 4 | the human 26s proteasome at 6.8 ang. ***caveat 5ln3 pro h 311 has wrong chirality at atom ca thr n 752 has wrong ***caveat 2 5ln3 chirality at atom ca | 5LN3_C |
| PB | T01.973 | proteasome subunit alpha 4 | 26s proteasome in complex with oprozomib | 5M32_B |
| PB | T01.973 | proteasome subunit alpha 4 | structural basis for dynamic regulation of the human 26s proteasome ***caveat 5t0g entry contains improper peptide linkages. | 5T0G_I |
| PB | T01.973 | proteasome subunit alpha 4 | structural basis for dynamic regulation of the human 26s proteasome ***caveat 5t0h entry contains improper peptide linkages. | 5T0H_I |
| PB | T01.973 | proteasome subunit alpha 4 | structural basis for dynamic regulation of the human 26s proteasome ***caveat 5t0i entry contains improper peptide linkages. residue arg k 20 ***caveat 2 5t0i is incorrectly modeled. | 5T0I_I |
| PB | T01.973 | proteasome subunit alpha 4 | structural basis for dynamic regulation of the human 26s proteasome ***caveat 5t0j entry contains improper peptide linkages. | 5T0J_I |
| PB | T01.973 | proteasome subunit alpha 4 | nucleotide-driven triple-state remodeling of the aaa-atpase channel inthe activated human 26s proteasome | 5VFO_I |
| PB | T01.973 | proteasome subunit alpha 4 | nucleotide-driven triple-state remodeling of the aaa-atpase channel inthe activated human 26s proteasome | 5VFR_I |
| PB | T01.973 | proteasome subunit alpha 4 | nucleotide-driven triple-state remodeling of the aaa-atpase channel inthe activated human 26s proteasome | 5VFT_I |
| PB | T01.973 | proteasome subunit alpha 4 | cryo-em structure of human immunoproteasome with a novel noncompetitive inhibitor that selectively inhibits activated lymphocytes | 6AVO_O |
| PB | T01.973 | proteasome subunit alpha 4 | endogeneous native human 20s proteasome | 6R70_B |
| PB | T01.973 | proteasome subunit alpha 4 | 20S proteasome; complex with PR-957 | 3UNB_B |
| PB | T01.973 | proteasome subunit alpha 4 | 20S proteasome | 3UNE_B |
| PB | T01.973 | proteasome subunit alpha 4 | 20S immunoproteasome; complex with PR-957 | 3UNF_B |
| PB | T01.973 | proteasome subunit alpha 4 | 20S immunoproteasome | 3UNH_B |
| PB | T01.973 | proteasome subunit alpha 4 | 20S proteasome complex | 1IRU_C |
| PB | T01.973 | proteasome subunit alpha 4 | 20S proteasome complex | 5FMG_C |
| PB | T01.974 | proteasome subunit alpha 7 | 20S proteasome | 4R3O_D |
| PB | T01.974 | proteasome subunit alpha 7 | 20S proteasome; complex with carfilzomib | 4R67_D |
| PB | T01.974 | proteasome subunit alpha 7 | cryo-em reveals the conformation of a substrate analogue in the human 20s proteasome core | 5A0Q_D |
| PB | T01.974 | proteasome subunit alpha 7 | 26S proteasome; complex with USP14-UbAl | 5GJQ_e |
| PB | T01.974 | proteasome subunit alpha 7 | 26S proteasome | 5GJR_e |
| PB | T01.974 | proteasome subunit alpha 7 | native human 20s proteasome at 1.8 angstrom ***caveat 5le5 6v1 u 47 has wrong chirality at atom c1 | 5LE5_C |
| PB | T01.974 | proteasome subunit alpha 7 | native human 20s proteasome in mg-acetate at 2.2 angstrom ***caveat 5lex 6v1 u 47 has wrong chirality at atom c1 | 5LEX_C |
| PB | T01.974 | proteasome subunit alpha 7 | 20s proteasome; complex with oprozomib | 5LEY_C |
| PB | T01.974 | proteasome subunit alpha 7 | 20s proteasome; complex with oprozomib in mg-acetate | 5LEZ_C |
| PB | T01.974 | proteasome subunit alpha 7 | human 20s proteasome complex with epoxomicin at 2.4 angstrom ***caveat 5lf0 6v1 u 47 has wrong chirality at atom c1 iml c 2 has wrong ***caveat 2 5lf0 chirality at atom cb iml d 2 has wrong chirality at atom ca ***caveat 3 5lf0 iml d 2 has wrong chirality | 5LF0_C |
| PB | T01.974 | proteasome subunit alpha 7 | human 20s proteasome complex with dihydroeponemycin at 2.0 angstrom ***caveat 5lf1 6v1 u 47 has wrong chirality at atom c1 | 5LF1_C |
| PB | T01.974 | proteasome subunit alpha 7 | human 20s proteasome complex with bortezomib at 2.1 angstrom ***caveat 5lf3 6v1 u 47 has wrong chirality at atom c1 | 5LF3_C |
| PB | T01.974 | proteasome subunit alpha 7 | human 20s proteasome complex with delanzomib at 2.0 angstrom ***caveat 5lf4 6v1 u 47 has wrong chirality at atom c1 6v7 n 307 has wrong ***caveat 2 5lf4 chirality at atom c9 6v7 y 306 has wrong chirality at atom ***caveat 3 5lf4 c9 | 5LF4_C |
| PB | T01.974 | proteasome subunit alpha 7 | human 20s proteasome complex with z-lly-ketoaldehyde at 2.1 angstrom ***caveat 5lf6 6v1 u 47 has wrong chirality at atom c1 | 5LF6_c |
| PB | T01.974 | proteasome subunit alpha 7 | human 20s proteasome complex with ixazomib at 2.0 angstrom ***caveat 5lf7 6v1 u 47 has wrong chirality at atom c1 | 5LF7_C |
| PB | T01.974 | proteasome subunit alpha 7 | the human 26s proteasome at 6.8 ang. ***caveat 5ln3 pro h 311 has wrong chirality at atom ca thr n 752 has wrong ***caveat 2 5ln3 chirality at atom ca | 5LN3_D |
| PB | T01.974 | proteasome subunit alpha 7 | 26s proteasome; complex with oprozomib | 5M32_C |
| PB | T01.974 | proteasome subunit alpha 7 | structural basis for dynamic regulation of the human 26s proteasome ***caveat 5t0g entry contains improper peptide linkages. | 5T0G_J |
| PB | T01.974 | proteasome subunit alpha 7 | structural basis for dynamic regulation of the human 26s proteasome ***caveat 5t0h entry contains improper peptide linkages. | 5T0H_J |
| PB | T01.974 | proteasome subunit alpha 7 | structural basis for dynamic regulation of the human 26s proteasome ***caveat 5t0i entry contains improper peptide linkages. residue arg k 20 ***caveat 2 5t0i is incorrectly modeled. | 5T0I_J |
| PB | T01.974 | proteasome subunit alpha 7 | structural basis for dynamic regulation of the human 26s proteasome ***caveat 5t0j entry contains improper peptide linkages. | 5T0J_J |
| PB | T01.974 | proteasome subunit alpha 7 | nucleotide-driven triple-state remodeling of the aaa-atpase channel inthe activated human 26s proteasome | 5VFO_J |
| PB | T01.974 | proteasome subunit alpha 7 | nucleotide-driven triple-state remodeling of the aaa-atpase channel inthe activated human 26s proteasome | 5VFR_J |
| PB | T01.974 | proteasome subunit alpha 7 | nucleotide-driven triple-state remodeling of the aaa-atpase channel inthe activated human 26s proteasome | 5VFT_J |
| PB | T01.974 | proteasome subunit alpha 7 | cryo-em structure of human immunoproteasome with a novel noncompetitive inhibitor that selectively inhibits activated lymphocytes | 6AVO_I |
| PB | T01.974 | proteasome subunit alpha 7 | endogeneous native human 20s proteasome | 6R70_C |
| PB | T01.974 | proteasome subunit alpha 7 | 20S proteasome; complex with PR-957 | 3UNB_C |
| PB | T01.974 | proteasome subunit alpha 7 | 20S proteasome | 3UNE_C |
| PB | T01.974 | proteasome subunit alpha 7 | 20S immunoproteasome; complex with PR-957 | 3UNF_C |
| PB | T01.974 | proteasome subunit alpha 7 | 20S immunoproteasome | 3UNH_C |
| PB | T01.974 | proteasome subunit alpha 7 | 20S proteasome complex | 1IRU_D |
| PB | T01.974 | proteasome subunit alpha 7 | 20S proteasome complex | 5FMG_D |
| PB | T01.975 | proteasome subunit alpha 5 | ground state 26s proteasome (gs2) | 6EPC_E |
| PB | T01.975 | proteasome subunit alpha 5 | substrate processing state 26s proteasome (sps1) ***caveat 6epd pro 2 231 has wrong chirality at atom ca | 6EPD_E |
| PB | T01.975 | proteasome subunit alpha 5 | substrate processing state 26s proteasome (sps2) | 6EPE_E |
| PB | T01.975 | proteasome subunit alpha 5 | ground state 26s proteasome (gs1) | 6EPF_E |
| PB | T01.975 | proteasome subunit alpha 5 | 20S proteasome | 4R3O_E |
| PB | T01.975 | proteasome subunit alpha 5 | 20S proteasome; complex with carfilzomib | 4R67_E |
| PB | T01.975 | proteasome subunit alpha 5 | cryo-em reveals the conformation of a substrate analogue in the human 20s proteasome core | 5A0Q_E |
| PB | T01.975 | proteasome subunit alpha 5 | 26S proteasome; complex with USP14-UbAl | 5GJQ_F |
| PB | T01.975 | proteasome subunit alpha 5 | 26S proteasome | 5GJR_F |
| PB | T01.975 | proteasome subunit alpha 5 | native human 20s proteasome at 1.8 angstrom ***caveat 5le5 6v1 u 47 has wrong chirality at atom c1 | 5LE5_D |
| PB | T01.975 | proteasome subunit alpha 5 | native human 20s proteasome in mg-acetate at 2.2 angstrom ***caveat 5lex 6v1 u 47 has wrong chirality at atom c1 | 5LEX_D |
| PB | T01.975 | proteasome subunit alpha 5 | 20s proteasome; complex with oprozomib | 5LEY_D |
| PB | T01.975 | proteasome subunit alpha 5 | 20s proteasome; complex with oprozomib in mg-acetate | 5LEZ_D |
| PB | T01.975 | proteasome subunit alpha 5 | human 20s proteasome complex with epoxomicin at 2.4 angstrom ***caveat 5lf0 6v1 u 47 has wrong chirality at atom c1 iml c 2 has wrong ***caveat 2 5lf0 chirality at atom cb iml d 2 has wrong chirality at atom ca ***caveat 3 5lf0 iml d 2 has wrong chirality | 5LF0_D |
| PB | T01.975 | proteasome subunit alpha 5 | human 20s proteasome complex with dihydroeponemycin at 2.0 angstrom ***caveat 5lf1 6v1 u 47 has wrong chirality at atom c1 | 5LF1_D |
| PB | T01.975 | proteasome subunit alpha 5 | human 20s proteasome complex with bortezomib at 2.1 angstrom ***caveat 5lf3 6v1 u 47 has wrong chirality at atom c1 | 5LF3_D |
| PB | T01.975 | proteasome subunit alpha 5 | human 20s proteasome complex with delanzomib at 2.0 angstrom ***caveat 5lf4 6v1 u 47 has wrong chirality at atom c1 6v7 n 307 has wrong ***caveat 2 5lf4 chirality at atom c9 6v7 y 306 has wrong chirality at atom ***caveat 3 5lf4 c9 | 5LF4_D |
| PB | T01.975 | proteasome subunit alpha 5 | human 20s proteasome complex with z-lly-ketoaldehyde at 2.1 angstrom ***caveat 5lf6 6v1 u 47 has wrong chirality at atom c1 | 5LF6_D |
| PB | T01.975 | proteasome subunit alpha 5 | human 20s proteasome complex with ixazomib at 2.0 angstrom ***caveat 5lf7 6v1 u 47 has wrong chirality at atom c1 | 5LF7_D |
| PB | T01.975 | proteasome subunit alpha 5 | the human 26s proteasome at 6.8 ang. ***caveat 5ln3 pro h 311 has wrong chirality at atom ca thr n 752 has wrong ***caveat 2 5ln3 chirality at atom ca | 5LN3_E |
| PB | T01.975 | proteasome subunit alpha 5 | 26s proteasome; complex with oprozomib | 5M32_D |
| PB | T01.975 | proteasome subunit alpha 5 | structural basis for dynamic regulation of the human 26s proteasome ***caveat 5t0g entry contains improper peptide linkages. | 5T0G_K |
| PB | T01.975 | proteasome subunit alpha 5 | structural basis for dynamic regulation of the human 26s proteasome ***caveat 5t0h entry contains improper peptide linkages. | 5T0H_K |
| PB | T01.975 | proteasome subunit alpha 5 | structural basis for dynamic regulation of the human 26s proteasome ***caveat 5t0i entry contains improper peptide linkages. residue arg k 20 ***caveat 2 5t0i is incorrectly modeled. | 5T0I_K |
| PB | T01.975 | proteasome subunit alpha 5 | structural basis for dynamic regulation of the human 26s proteasome ***caveat 5t0j entry contains improper peptide linkages. | 5T0J_K |
| PB | T01.975 | proteasome subunit alpha 5 | nucleotide-driven triple-state remodeling of the aaa-atpase channel inthe activated human 26s proteasome | 5VFO_K |
| PB | T01.975 | proteasome subunit alpha 5 | nucleotide-driven triple-state remodeling of the aaa-atpase channel inthe activated human 26s proteasome | 5VFR_K |
| PB | T01.975 | proteasome subunit alpha 5 | nucleotide-driven triple-state remodeling of the aaa-atpase channel inthe activated human 26s proteasome | 5VFT_K |
| PB | T01.975 | proteasome subunit alpha 5 | cryo-em structure of human immunoproteasome with a novel noncompetitive inhibitor that selectively inhibits activated lymphocytes | 6AVO_H |
| PB | T01.975 | proteasome subunit alpha 5 | endogeneous native human 20s proteasome | 6R70_D |
| PB | T01.975 | proteasome subunit alpha 5 | 20S proteasome complex | 1IRU_E |
| PB | T01.976 | proteasome subunit alpha 1 | 20S proteasome in complex with activator PA26 (Trypanosoma brucei) | 1FNT_F |
| PB | T01.976 | proteasome subunit alpha 1 | complete proteasome | 1G0U_E |
| PB | T01.976 | proteasome subunit alpha 1 | complex with epoxomicin | 1G65_E |
| PB | T01.976 | proteasome subunit alpha 1 | proteasome complex bound to TMC-95A inhibitor | 1JD2_E |
| PB | T01.976 | proteasome subunit alpha 1 | 20S proteasome | 1RYP_F |
| PB | T01.976 | proteasome subunit alpha 1 | 20S proteasome; complex with the proteasome activator PA26 from Trypanosoma brucei | 1Z7Q_F |
| PB | T01.976 | proteasome subunit alpha 1 | 20S proteasome; complex with bortezomib | 2F16_E |
| PB | T01.976 | proteasome subunit alpha 1 | 20S proteasome; complex with salinosporamide A | 2FAK_E |
| PB | T01.976 | proteasome subunit alpha 1 | 20S proteasome; complex with homobelactosin C | 2FNY_E |
| PB | T01.976 | proteasome subunit alpha 1 | 20S proteasome; complex with TMC-95 based biphenyl-ether macrocycle | 2GPL_E |
| PB | T01.976 | proteasome subunit alpha 1 | 20S proteasome; complex with syringolin A | 2ZCY_E |
| PB | T01.976 | proteasome subunit alpha 1 | 20S proteasome; complex with glidobactin A | 3BDM_E |
| PB | T01.976 | proteasome subunit alpha 1 | 20S proteasome; complex with fellutamide B | 3D29_E |
| PB | T01.976 | proteasome subunit alpha 1 | 20s proteasome; complex with the epimer form of spirolactacystin | 3DY3_E |
| PB | T01.976 | proteasome subunit alpha 1 | 20s proteasome; complex with spirolactacystin | 3DY4_E |
| PB | T01.976 | proteasome subunit alpha 1 | 20s proteasome; complex with homobelactosin C | 3E47_E |
| PB | T01.976 | proteasome subunit alpha 1 | 20s proteasome; complex with syringolin B | 3GPJ_E |
| PB | T01.976 | proteasome subunit alpha 1 | 20S proteasome; complex with salinosporamide derivative | 3GPT_E |
| PB | T01.976 | proteasome subunit alpha 1 | 20S proteasome; complex with salinosporamide derivative | 3GPW_E |
| PB | T01.976 | proteasome subunit alpha 1 | 20S proteasome; complex with hyroxylated salinosporamide | 3HYE_E |
| PB | T01.976 | proteasome subunit alpha 1 | 20S proteasome; complex with bortezomib | 3MG0_E |
| PB | T01.976 | proteasome subunit alpha 1 | 20S proteasome; complex with compound 1 | 3MG4_E |
| PB | T01.976 | proteasome subunit alpha 1 | 20S proteasome; complex with compound 6 | 3MG6_E |
| PB | T01.976 | proteasome subunit alpha 1 | 20S open-gate proteasome; complex with compound 6 | 3MG7_E |
| PB | T01.976 | proteasome subunit alpha 1 | 20S open-gate proteasome; complex with compound 16 | 3MG8_E |
| PB | T01.976 | proteasome subunit alpha 1 | 20S proteasome; complex with ligand 2a | 3NZJ_E |
| PB | T01.976 | proteasome subunit alpha 1 | 20S proteasome; complex with ligand 2b | 3NZW_E |
| PB | T01.976 | proteasome subunit alpha 1 | 20S proteasome; complex with ligand 2c | 3NZX_E |
| PB | T01.976 | proteasome subunit alpha 1 | 20S open-gate proteasome; complex with compound 24 | 3OEU_E |
| PB | T01.976 | proteasome subunit alpha 1 | 20S open-gate proteasome; complex with compound 25 | 3OEV_E |
| PB | T01.976 | proteasome subunit alpha 1 | 20S proteasome; complex with alpha-keto-aldehyde | 3OKJ_E |
| PB | T01.976 | proteasome subunit alpha 1 | 20S open-gate proteasome; complex with compound 20 | 3SDI_E |
| PB | T01.976 | proteasome subunit alpha 1 | 20S open-gate proteasome; complex with compound 34 | 3SDK_E |
| PB | T01.976 | proteasome subunit alpha 1 | 20S proteasome; complex with hydroxyurea derivative HU10 | 3SHJ_E |
| PB | T01.976 | proteasome subunit alpha 1 | 20S proteasome; complex with homobelactosin C | 3TDD_E |
| PB | T01.976 | proteasome subunit alpha 1 | 20S open-gate proteasome; complex with PR-957 (morpholine) | 3UN4_E |
| PB | T01.976 | proteasome subunit alpha 1 | 20S proteasome; complex with PR-957 (epoxide) | 3UN8_E |
| PB | T01.976 | proteasome subunit alpha 1 | 26S proteasome | 3WXR_F |
| PB | T01.976 | proteasome subunit alpha 1 | 26S proteasome | 4CR2_F |
| PB | T01.976 | proteasome subunit alpha 1 | 26S proteasome | 4CR3_F |
| PB | T01.976 | proteasome subunit alpha 1 | 26S proteasome | 4CR4_F |
| PB | T01.976 | proteasome subunit alpha 1 | 20S proteasome; complex with K-7174 | 4EU2_F |
| PB | T01.976 | proteasome subunit alpha 1 | 20S proteasome; complex with cepafungin I | 4FZC_E |
| PB | T01.976 | proteasome subunit alpha 1 | 20S proteasome; complex with glidobactin | 4FZG_E |
| PB | T01.976 | proteasome subunit alpha 1 | 20S proteasome; complex with Syringolin-Glidobactin chimera | 4G4S_F |
| PB | T01.976 | proteasome subunit alpha 1 | 20S proteasome; complex with Syringolin-Glidobactin chimera | 4GK7_E |
| PB | T01.976 | proteasome subunit alpha 1 | 20S proteasome; complex with vinylketone carmaphycin analogue VNK1 | 4HNP_E |
| PB | T01.976 | proteasome subunit alpha 1 | 20S proteasome; complex with epoxyketone carmaphycin analogue 3 | 4HRC_E |
| PB | T01.976 | proteasome subunit alpha 1 | 20S proteasome; complex with carmaphycin A | 4HRD_E |
| PB | T01.976 | proteasome subunit alpha 1 | 20S proteasome; complex with vinyl sulfone LU102 | 4INR_E |
| PB | T01.976 | proteasome subunit alpha 1 | 20S proteasome; complex with vinyl sulfone LU122 | 4INT_E |
| PB | T01.976 | proteasome subunit alpha 1 | 20S proteasome; complex with vinyl sulfone LU112 | 4INU_E |
| PB | T01.976 | proteasome subunit alpha 1 | 20S proteasome; complex with belactosin derivative 3E | 4J70_E |
| PB | T01.976 | proteasome subunit alpha 1 | 20S proteasome; complex with dimerized linear mimetic of TMC-95A | 4JSQ_E |
| PB | T01.976 | proteasome subunit alpha 1 | 20S proteasome; complex with dimerized linear mimetic of TMC-95A | 4JSU_E |
| PB | T01.976 | proteasome subunit alpha 1 | 20S proteasome; complex with dimerized linear mimetic of TMC-95A | 4JT0_E |
| PB | T01.976 | proteasome subunit alpha 1 | 20S proteasome; complex with vibralactone | 4LQI_E |
| PB | T01.976 | proteasome subunit alpha 1 | 20S proteasome; complex with enone carmaphycin analogue 6 | 4LTC_E |
| PB | T01.976 | proteasome subunit alpha 1 | 20S proteasome; complex with MG132 | 4NNN_E |
| PB | T01.976 | proteasome subunit alpha 1 | 20S proteasome; complex with Z-Leu-Leu-Leu-ketoaldehyde | 4NNW_E |
| PB | T01.976 | proteasome subunit alpha 1 | 20S proteasome; complex with Z-Leu-Leu-Leu-B(OH)2 | 4NO1_E |
| PB | T01.976 | proteasome subunit alpha 1 | 20S proteasome; complex with Z-Leu-Leu-Leu-vinylsulfone | 4NO6_E |
| PB | T01.976 | proteasome subunit alpha 1 | 20S proteasome; complex with Z-Leu-Leu-Leu-ketoamide | 4NO8_E |
| PB | T01.976 | proteasome subunit alpha 1 | 20S proteasome; complex with Z-Leu-Leu-Leu-epoxyketone | 4NO9_E |
| PB | T01.976 | proteasome subunit alpha 1 | 20S proteasome; complex with kendomycin | 4Q1S_E |
| PB | T01.976 | proteasome subunit alpha 1 | 20S proteasome; complex with Boc-Ala-Ala-Ala-CHO | 4QBY_E |
| PB | T01.976 | proteasome subunit alpha 1 | 20S proteasome; complex with epoxyketone inhibitor 8 | 4QLQ_E |
| PB | T01.976 | proteasome subunit alpha 1 | 20S proteasome; complex with epoxyketone inhibitor 11 | 4QLS_E |
| PB | T01.976 | proteasome subunit alpha 1 | 20S proteasome; complex with tripeptidic epoxyketone inhibitor 2 | 4QLT_E |
| PB | T01.976 | proteasome subunit alpha 1 | 20S proteasome; complex with tripeptidic epoxyketone inhibitor 9 | 4QLU_E |
| PB | T01.976 | proteasome subunit alpha 1 | 20S proteasome; complex with tripeptidic epoxyketone inhibitor 17 | 4QLV_E |
| PB | T01.976 | proteasome subunit alpha 1 | 20S proteasome | 4QUX_E |
| PB | T01.976 | proteasome subunit alpha 1 | 20S proteasome | 4QUY_E |
| PB | T01.976 | proteasome subunit alpha 1 | 20S proteasome | 4QV0_E |
| PB | T01.976 | proteasome subunit alpha 1 | 20S proteasome | 4QV1_E |
| PB | T01.976 | proteasome subunit alpha 1 | 20S proteasome | 4QV3_E |
| PB | T01.976 | proteasome subunit alpha 1 | 20S proteasome beta5 Met45Thr mutant | 4QV4_E |
| PB | T01.976 | proteasome subunit alpha 1 | 20S proteasome beta5 Met45Ile mutant | 4QV5_E |
| PB | T01.976 | proteasome subunit alpha 1 | 20S proteasome | 4QV6_E |
| PB | T01.976 | proteasome subunit alpha 1 | 20S proteasome | 4QV7_E |
| PB | T01.976 | proteasome subunit alpha 1 | 20S proteasome | 4QV8_E |
| PB | T01.976 | proteasome subunit alpha 1 | 20S proteasome | 4QV9_E |
| PB | T01.976 | proteasome subunit alpha 1 | 20S proteasome; complex with bortezomib | 4QVL_E |
| PB | T01.976 | proteasome subunit alpha 1 | 20S proteasome beta5 Met45Ala mutant; complex with bortezomib | 4QVM_E |
| PB | T01.976 | proteasome subunit alpha 1 | 20S proteasome beta5 Met45Val mutant; complex with bortezomib | 4QVN_E |
| PB | T01.976 | proteasome subunit alpha 1 | 20S proteasome beta5 Met45Thr mutant; complex with bortezomib | 4QVP_E |
| PB | T01.976 | proteasome subunit alpha 1 | 20S proteasome beta5 Met45Ile mutant; complex with bortezomib | 4QVQ_E |
| PB | T01.976 | proteasome subunit alpha 1 | 20S proteasome beta5 Ala49Val mutant; complex with bortezomib | 4QVV_E |
| PB | T01.976 | proteasome subunit alpha 1 | 20S proteasome beta5 Ala49Ser mutant; complex with bortezomib | 4QVW_E |
| PB | T01.976 | proteasome subunit alpha 1 | 20S proteasome beta5 Ala49Thr mutant; complex with bortezomib | 4QVY_E |
| PB | T01.976 | proteasome subunit alpha 1 | 20S proteasome beta5 Ala49Thr,Ala50Val mutant; complex with bortezomib | 4QW0_E |
| PB | T01.976 | proteasome subunit alpha 1 | 20S proteasome beta5 Ala50Val mutant; complex with bortezomib | 4QW1_E |
| PB | T01.976 | proteasome subunit alpha 1 | 20S proteasome beta5 Cys63Phe mutant; complex with bortezomib | 4QW3_E |
| PB | T01.976 | proteasome subunit alpha 1 | 20S proteasome; complex with carfilzomib | 4QW4_E |
| PB | T01.976 | proteasome subunit alpha 1 | 20S proteasome beta5 Met45Ala mutant; complex with carfilzomib | 4QW5_E |
| PB | T01.976 | proteasome subunit alpha 1 | 20S proteasome beta5 Met45Val mutant; complex with carfilzomib | 4QW6_E |
| PB | T01.976 | proteasome subunit alpha 1 | 20S proteasome beta5 Met45Thr mutant; complex with carfilzomib | 4QW7_E |
| PB | T01.976 | proteasome subunit alpha 1 | 20S proteasome beta5 Met45Ile mutant; complex with carfilzomib | 4QWF_E |
| PB | T01.976 | proteasome subunit alpha 1 | 20S proteasome beta5 Ala49Val mutant; complex with carfilzomib | 4QWG_E |
| PB | T01.976 | proteasome subunit alpha 1 | 20S proteasome beta5 Ala49Ser mutant; complex with carfilzomib | 4QWI_E |
| PB | T01.976 | proteasome subunit alpha 1 | 20S proteasome beta5 Ala49Thr mutant; complex with carfilzomib | 4QWJ_E |
| PB | T01.976 | proteasome subunit alpha 1 | 20S proteasome beta5 Ala49Thr, Ala50Val mutant; complex with carfilzomib | 4QWK_E |
| PB | T01.976 | proteasome subunit alpha 1 | 20S proteasome beta5 Ala50Val mutant; complex with carfilzomib | 4QWL_E |
| PB | T01.976 | proteasome subunit alpha 1 | 20S proteasome beta5 Cys52Phe mutant; complex with carfilzomib | 4QWR_E |
| PB | T01.976 | proteasome subunit alpha 1 | 20S proteasome beta5 Cys63Phe mutant; complex with carfilzomib | 4QWS_E |
| PB | T01.976 | proteasome subunit alpha 1 | 20S proteasome beta5 Cys52Phe mutant; complex with bortezomib | 4QWU_E |
| PB | T01.976 | proteasome subunit alpha 1 | 20S proteasome; complex with epoxyketone inhibitor ONX 0914 | 4QWX_E |
| PB | T01.976 | proteasome subunit alpha 1 | 20S proteasome beta 5 Met45Ala mutant; complex with epoxyketone inhibitor ONX 0914 | 4QXJ_E |
| PB | T01.976 | proteasome subunit alpha 1 | complete proteasome; complex with epoxyketone inhibitor ONX 0914 | 4QZ0_E |
| PB | T01.976 | proteasome subunit alpha 1 | 20S proteasome beta 5 Met45Thr mutant; complex with epoxyketone inhibitor ONX 0914 | 4QZ1_E |
| PB | T01.976 | proteasome subunit alpha 1 | 20S proteasome beta 5 Met45Ile mutant; complex with epoxyketone inhibitor ONX 0914 | 4QZ2_E |
| PB | T01.976 | proteasome subunit alpha 1 | 20S proteasome beta 5 Ala49Val mutant; complex with epoxyketone inhibitor ONX 0914 | 4QZ3_E |
| PB | T01.976 | proteasome subunit alpha 1 | 20S proteasome beta 5 Ala49Ser mutant; complex with epoxyketone inhibitor ONX 0914 | 4QZ4_E |
| PB | T01.976 | proteasome subunit alpha 1 | 20S proteasome beta 5 Ala49Thr mutant; complex with epoxyketone inhibitor ONX 0914 | 4QZ5_E |
| PB | T01.976 | proteasome subunit alpha 1 | 20S proteasome beta 5 Ala49Thr, Ala50Val mutant; complex with epoxyketone inhibitor ONX 0914 | 4QZ6_E |
| PB | T01.976 | proteasome subunit alpha 1 | 20S proteasome beta 5 Ala50Val mutant; complex with epoxyketone inhibitor ONX 0914 | 4QZ7_E |
| PB | T01.976 | proteasome subunit alpha 1 | 20S proteasome beta 5 Cys52Phe mutant; complex with epoxyketone inhibitor ONX 0914 | 4QZW_E |
| PB | T01.976 | proteasome subunit alpha 1 | complete proteasome; complex with epoxyketone inhibitor ONX 0914 | 4QZX_E |
| PB | T01.976 | proteasome subunit alpha 1 | 20S proteasome; complex with omuralide | 4QZZ_E |
| PB | T01.976 | proteasome subunit alpha 1 | 20S proteasome beta 5 Cys52Phe mutant; complex with omuralide | 4R00_E |
| PB | T01.976 | proteasome subunit alpha 1 | 20S proteasome; complex with BSC4999 | 4R02_E |
| PB | T01.976 | proteasome subunit alpha 1 | 20S proteasome; ligand induced aziridine-formation in beta5 | 4R17_E |
| PB | T01.976 | proteasome subunit alpha 1 | 20S proteasome; ligand induced Lys33-Thr1 cross-linking in beta5 | 4R18_E |
| PB | T01.976 | proteasome subunit alpha 1 | 20S proteasome; complex with alkaloid indolo-phakellin | 4RUR_E |
| PB | T01.976 | proteasome subunit alpha 1 | 4V7O | |
| PB | T01.976 | proteasome subunit alpha 1 | 20S proteasome; complex with PR-VI modulator | 4X6Z_F |
| PB | T01.976 | proteasome subunit alpha 1 | 20S proteasome; complex with Ac-Pro-Ala-Asp-EP | 4Y69_E |
| PB | T01.976 | proteasome subunit alpha 1 | 20S proteasome beta2 His114Asp mutant; complex with Ac-Pro-Ala-Asp-EP | 4Y6A_E |
| PB | T01.976 | proteasome subunit alpha 1 | 20S proteasome; complex with Ac-Pro-Ala-Glu-EP | 4Y6V_E |
| PB | T01.976 | proteasome subunit alpha 1 | 20S proteasome; complex with Ac-Pro-Ala-Leu-EP | 4Y6Z_E |
| PB | T01.976 | proteasome subunit alpha 1 | 20S proteasome; complex with Ac-Leu-Ala-Val-EP | 4Y70_E |
| PB | T01.976 | proteasome subunit alpha 1 | 20S proteasome; complex with Ac-Leu-Ala-Leu-EP | 4Y74_E |
| PB | T01.976 | proteasome subunit alpha 1 | 20S proteasome; complex with Ac-Pro-Ala-Phe-EP | 4Y75_E |
| PB | T01.976 | proteasome subunit alpha 1 | 20S proteasome; complex with Ac-Leu-Ala-Phe-EP | 4Y77_E |
| PB | T01.976 | proteasome subunit alpha 1 | 20S proteasome; complex with Ac-Leu-Ala-Asp-EP | 4Y78_E |
| PB | T01.976 | proteasome subunit alpha 1 | 20S proteasome; complex with Ac-Leu-Ala-Glu-EP | 4Y7W_E |
| PB | T01.976 | proteasome subunit alpha 1 | complete proteasome; complex with Ac-PAA-ep | 4Y7X_E |
| PB | T01.976 | proteasome subunit alpha 1 | 20S proteasome; complex with Ac-Leu-Ala-Ala-EP | 4Y7Y_E |
| PB | T01.976 | proteasome subunit alpha 1 | 20S proteasome; complex with Ac-Leu-Ala-Ile-EP | 4Y80_E |
| PB | T01.976 | proteasome subunit alpha 1 | 20S proteasome; complex with Ac-Pro-Ala-Tyr-EP | 4Y81_E |
| PB | T01.976 | proteasome subunit alpha 1 | 20S proteasome; complex with Ac-Leu-Ala-Tyr-EP | 4Y82_E |
| PB | T01.976 | proteasome subunit alpha 1 | 20S proteasome; complex with N3-Ala(4,4-F2P)-Asn-Leu-Leu-EP | 4Y84_E |
| PB | T01.976 | proteasome subunit alpha 1 | 20S proteasome; complex with N3-Ala-Pro-Asn-Leu-Leu-EP | 4Y8G_E |
| PB | T01.976 | proteasome subunit alpha 1 | 20S proteasome; complex with N3-Ala-Pro-Ala-Leu-EP | 4Y8H_E |
| PB | T01.976 | proteasome subunit alpha 1 | 20S proteasome; complex with Ac-Pro-Leu-Leu-EP | 4Y8I_E |
| PB | T01.976 | proteasome subunit alpha 1 | 20S proteasome; complex with Ac-Leu-Leu-Leu-EP | 4Y8J_E |
| PB | T01.976 | proteasome subunit alpha 1 | 20S proteasome; complex with H-Ala-Pro-Leu-Leu-EP | 4Y8K_E |
| PB | T01.976 | proteasome subunit alpha 1 | 20S proteasome; complex with Ac-Ala-Pro-Leu-Leu-EP | 4Y8L_E |
| PB | T01.976 | proteasome subunit alpha 1 | 20S proteasome beta7-delta7 C-terminal mutant | 4Y8M_E |
| PB | T01.976 | proteasome subunit alpha 1 | 20S proteasome beta7-delta7 C-terminal mutant; complex with Ac-Pro-Ala-Glu-EP | 4Y8N_E |
| PB | T01.976 | proteasome subunit alpha 1 | 20S proteasome beta 7-delta 7 C-terminal mutant; complex with Ac-Pro-Ala-Phe-EP | 4Y8O_E |
| PB | T01.976 | proteasome subunit alpha 1 | 20S proteasome beta 7-delta 7 C-terminal mutant; complex with Ac-Pro-Ala-Leu-EP | 4Y8P_E |
| PB | T01.976 | proteasome subunit alpha 1 | 20S proteasome beta 7-delta 7 C-terminal mutant; complex with Ac-Pro-Ala-Tyr-EP | 4Y8Q_E |
| PB | T01.976 | proteasome subunit alpha 1 | 20S proteasome beta 2 His116Asp mutant | 4Y8R_E |
| PB | T01.976 | proteasome subunit alpha 1 | 20S proteasome beta 2 His116Asp mutant; complex with Ac-Leu-Ala-Glu-EP | 4Y8S_E |
| PB | T01.976 | proteasome subunit alpha 1 | 20S proteasome beta 2 His116Asp mutant; complex with Ac-Pro-Ala-Glu-EP | 4Y8T_E |
| PB | T01.976 | proteasome subunit alpha 1 | 20S proteasome beta 2 His116Asp mutant; complex with Ac-Pro-Ala-Asp-EP | 4Y8U_E |
| PB | T01.976 | proteasome subunit alpha 1 | 20S proteasome beta 2 His116Glu mutant | 4Y9Y_E |
| PB | T01.976 | proteasome subunit alpha 1 | 20S proteasome beta 2 His116Glu mutant; complex with Ac-Leu-Ala-Glu-EP | 4Y9Z_E |
| PB | T01.976 | proteasome subunit alpha 1 | 20S proteasome beta 2 His116Glu mutant; complex with Ac-Pro-Ala-Glu-EP | 4YA0_E |
| PB | T01.976 | proteasome subunit alpha 1 | 20S proteasome beta 2 His116Asn mutant | 4YA1_E |
| PB | T01.976 | proteasome subunit alpha 1 | 20S proteasome beta 2 His116Asn mutant; complex with Ac-Leu-Ala-Glu-EP | 4YA2_E |
| PB | T01.976 | proteasome subunit alpha 1 | 20S proteasome beta 2 His116Asn mutant; complex with Ac-Pro-Ala-Glu-EP | 4YA3_E |
| PB | T01.976 | proteasome subunit alpha 1 | 20S proteasome beta 2 His114Asp mutant | 4YA4_E |
| PB | T01.976 | proteasome subunit alpha 1 | 20S proteasome beta 2 His114Asp mutant; complex with Ac-Pro-Ala-Glu-EP | 4YA5_E |
| PB | T01.976 | proteasome subunit alpha 1 | 20S proteasome beta 2 His114Asp mutant; complex with Ac-Leu-Ala-Glu-EP | 4YA7_E |
| PB | T01.976 | proteasome subunit alpha 1 | 20S proteasome beta 2 His114Asp mutant; complex with AC-Leu-Ala-Asp-EP | 4YA9_E |
| PB | T01.976 | proteasome subunit alpha 1 | 20S proteasome; complex with belactosin C derivative 3 | 4Z1L_E |
| PB | T01.976 | proteasome subunit alpha 1 | 26S protease-UBP6 complex | 5A5B_F |
| PB | T01.976 | proteasome subunit alpha 1 | 20S proteasome; complex with macyranone A | 5AHJ_E |
| PB | T01.976 | proteasome subunit alpha 1 | 20S proteasome; complex with beta1/beta2 nonspecifici sulfonamide ligand | 5BOU_E |
| PB | T01.976 | proteasome subunit alpha 1 | yeast 20s proteasome beta2-g170a mutant | 5BXL_E |
| PB | T01.976 | proteasome subunit alpha 1 | yeast 20s proteasome beta2-g170a mutant in complex with bortezomib | 5BXN_E |
| PB | T01.976 | proteasome subunit alpha 1 | 20S proteasome beta5 Gly48Cys mutant | 5CGF_E |
| PB | T01.976 | proteasome subunit alpha 1 | 20S proteasome beta5 Gly48Cys mutant; complex with alpha-chloroacetamide 1 | 5CGG_E |
| PB | T01.976 | proteasome subunit alpha 1 | 20S proteasome beta5 Gly48Cys mutant; complex with alpha-chloroacetamide 5 | 5CGH_E |
| PB | T01.976 | proteasome subunit alpha 1 | 20S proteasome beta5 Gly48Cys mutant; complex with ONX 0914 | 5CGI_E |
| PB | T01.976 | proteasome subunit alpha 1 | yeast 20s proteasome at 2.3 a resolution | 5CZ4_E |
| PB | T01.976 | proteasome subunit alpha 1 | yeast 20s proteasome beta1-t1a mutant in complex with carfilzomib | 5CZ5_E |
| PB | T01.976 | proteasome subunit alpha 1 | yeast 20s proteasome beta5-t1a mutant in complex with syringolin a, propeptide expressed in trans | 5CZ6_E |
| PB | T01.976 | proteasome subunit alpha 1 | yeast 20s proteasome beta5-t1a beta5-k81r double mutant in complex with bortezomib, propeptide expressed in cis | 5CZ7_E |
| PB | T01.976 | proteasome subunit alpha 1 | yeast 20s proteasome beta5-l(-49)s-k33a mutant in complex with carfilzomib | 5CZ8_E |
| PB | T01.976 | proteasome subunit alpha 1 | yeast 20s proteasome beta5-d17n mutant in complex with carfilzomib; propeptide expressed in trans | 5CZ9_E |
| PB | T01.976 | proteasome subunit alpha 1 | yeast 20s proteasome beta5-d166n mutant | 5CZA_E |
| PB | T01.976 | proteasome subunit alpha 1 | yeast 20s proteasome beta5-d166n mutant in complex with carfilzomib | 5D0S_E |
| PB | T01.976 | proteasome subunit alpha 1 | yeast 20s proteasome beta5-d166n mutant in complex with mg132 | 5D0T_E |
| PB | T01.976 | proteasome subunit alpha 1 | yeast 20s proteasome beta5-t1c mutant in complex with carfilzomib | 5D0V_E |
| PB | T01.976 | proteasome subunit alpha 1 | yeast 20s proteasome beta5-t1s mutant | 5D0W_E |
| PB | T01.976 | proteasome subunit alpha 1 | yeast 20s proteasome beta5-t1s mutant in complex with bortezomib | 5D0X_E |
| PB | T01.976 | proteasome subunit alpha 1 | yeast 20s proteasome beta5-t1s mutant in complex with carfilzomib | 5D0Z_E |
| PB | T01.976 | proteasome subunit alpha 1 | 20S proteasome; complex with alkyne-PI | 5DKI_E |
| PB | T01.976 | proteasome subunit alpha 1 | 20S proteasome; complex with octreotide-PI | 5DKJ_E |
| PB | T01.976 | proteasome subunit alpha 1 | yeast 20s proteasome beta2-t1a mutant | 5FG7_E |
| PB | T01.976 | proteasome subunit alpha 1 | yeast 20s proteasome beta2-t(-2)v mutant | 5FG9_E |
| PB | T01.976 | proteasome subunit alpha 1 | yeast 20s proteasome beta5-k33a mutant (propeptide expressed in trans) | 5FGA_E |
| PB | T01.976 | proteasome subunit alpha 1 | yeast 20s proteasome beta5-h(-2)l-t1a double mutant in complex with carfilzomib | 5FGD_E |
| PB | T01.976 | proteasome subunit alpha 1 | yeast 20s proteasome beta5-h(-2)t-t1a double mutant in complex with carfilzomib | 5FGE_E |
| PB | T01.976 | proteasome subunit alpha 1 | yeast 20s proteasome beta5-h(-2)a-t1a-k81r triple mutant in complex with carfilzomib | 5FGF_E |
| PB | T01.976 | proteasome subunit alpha 1 | yeast 20s proteasome beta5-l(-49s)_d17n double mutant in complex with carfilzomib | 5FGG_E |
| PB | T01.976 | proteasome subunit alpha 1 | yeast 20s proteasome beta5-k33a mutant (propeptide expressed in trans)in complex with mg132 | 5FGH_E |
| PB | T01.976 | proteasome subunit alpha 1 | yeast 20s proteasome beta1-t1a beta2-t1a double mutant in complex withcarfilzomib | 5FGI_E |
| PB | T01.976 | proteasome subunit alpha 1 | yeast 20s proteasome beta5-k33a mutant (propeptide expressed in trans)in complex with carfilzomib | 5FHS_E |
| PB | T01.976 | proteasome subunit alpha 1 | 20s proteasome; complex with the peptidic epoxyketone inhibitor 27 | 5JHR_E |
| PB | T01.976 | proteasome subunit alpha 1 | 20s proteasome; complex with the peptidic epoxyketone inhibitor 15 | 5JHS_E |
| PB | T01.976 | proteasome subunit alpha 1 | yeast 20s proteasome in complex with epoxyketone inhibitor 14 | 5L52_E |
| PB | T01.976 | proteasome subunit alpha 1 | yeast 20s proteasome in complex with epoxyketone inhibitor 16 | 5L54_E |
| PB | T01.976 | proteasome subunit alpha 1 | yeast 20s proteasome in complex with epoxyketone inhibitor 18 | 5L55_E |
| PB | T01.976 | proteasome subunit alpha 1 | yeast 20s proteasome with human beta5i (1-138; r57t) | 5L5A_E |
| PB | T01.976 | proteasome subunit alpha 1 | yeast 20s proteasome with human beta5i (1-138) and human beta6 (97- 111; 118-133) | 5L5B_E |
| PB | T01.976 | proteasome subunit alpha 1 | yeast 20s proteasome with human beta5i (1-138) and human beta6 (97- 111; 118-133) in complex with onx 0914 | 5L5D_E |
| PB | T01.976 | proteasome subunit alpha 1 | yeast 20s proteasome with human beta5i (1-138) and human beta6 (97- 111; 118-133) in complex with carfilzomib | 5L5E_E |
| PB | T01.976 | proteasome subunit alpha 1 | yeast 20s proteasome with human beta5i (1-138) and human beta6 (97- 111; 118-133) in complex with bortezomib | 5L5F_E |
| PB | T01.976 | proteasome subunit alpha 1 | yeast 20s proteasome with human beta5i (1-138) and human beta6 (97- 111; 118-133) in complex with pr-924 | 5L5H_E |
| PB | T01.976 | proteasome subunit alpha 1 | yeast 20s proteasome with human beta5i (1-138) and human beta6 (97- 111; 118-133) in complex with epoxyketone inhibitor 9 | 5L5I_E |
| PB | T01.976 | proteasome subunit alpha 1 | yeast 20s proteasome with human beta5i (1-138) and human beta6 (97- 111; 118-133) in complex with epoxyketone inhibitor 14 | 5L5J_E |
| PB | T01.976 | proteasome subunit alpha 1 | yeast 20s proteasome with human beta5i (1-138) and human beta6 (97- 111; 118-133) in complex with epoxyketone inhibitor 16 | 5L5O_E |
| PB | T01.976 | proteasome subunit alpha 1 | yeast 20s proteasome with human beta5i (1-138) and human beta6 (97- 111; 118-133) in complex with epoxyketone inhibitor 17 | 5L5P_E |
| PB | T01.976 | proteasome subunit alpha 1 | yeast 20s proteasome with human beta5i (1-138) and human beta6 (97- 111; 118-133) in complex with epoxyketone 18 | 5L5Q_E |
| PB | T01.976 | proteasome subunit alpha 1 | yeast 20s proteasome with human beta5i (1-138;v31m) and human beta6 (97-111; 118-133) | 5L5R_E |
| PB | T01.976 | proteasome subunit alpha 1 | yeast 20s proteasome with human beta5i (1-138; v31m) and human beta6 (97-111; 118-133) in complex with pr-924 | 5L5S_E |
| PB | T01.976 | proteasome subunit alpha 1 | yeast 20s proteasome with human beta5i (1-138; v31m) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 16 | 5L5T_E |
| PB | T01.976 | proteasome subunit alpha 1 | yeast 20s proteasome with human beta5i (1-138; v31m) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 17 ***caveat 5l5u 04c h 301 has wrong chirality at atom c27 04c k 301 has ***caveat 2 5l5u wrong chirality at atom c27 04c v 301 h | 5L5U_E |
| PB | T01.976 | proteasome subunit alpha 1 | yeast 20s proteasome with human beta5c (1-138) and human beta6 (97- 111; 118-133) | 5L5W_E |
| PB | T01.976 | proteasome subunit alpha 1 | yeast 20s proteasome with human beta5c (1-138) and human beta6 (97- 111; 118-133) in complex with onx 0914 | 5L5X_E |
| PB | T01.976 | proteasome subunit alpha 1 | yeast 20s proteasome with human beta5c (1-138) and human beta6 (97- 111; 118-133) in complex with carfilzomib | 5L5Y_E |
| PB | T01.976 | proteasome subunit alpha 1 | yeast 20s proteasome with human beta5c (1-138) and human beta6 (97- 111; 118-133) in complex with bortezomib | 5L5Z_E |
| PB | T01.976 | proteasome subunit alpha 1 | yeast 20s proteasome with human beta5c (1-138) and human beta6 (97- 111; 118-133) in complex with pr-924 | 5L60_E |
| PB | T01.976 | proteasome subunit alpha 1 | yeast 20s proteasome with human beta5c (1-138) and human beta6 (99- 132) in complex with epoxyketone inhibitor 14 | 5L61_E |
| PB | T01.976 | proteasome subunit alpha 1 | yeast 20s proteasome with human beta5c (1-138) and human beta6 (97- 111; 118-133) in complex with epoxyketone inhibitor 16 | 5L62_E |
| PB | T01.976 | proteasome subunit alpha 1 | yeast 20s proteasome with human beta5c (1-138) and human beta6 (97- 111; 118-133) in complex with epoxyketone inhibitor 17 ***caveat 5l63 04c h 301 has wrong chirality at atom c27 04c k 301 has ***caveat 2 5l63 wrong chirality at atom c27 04c v 301 has wr | 5L63_E |
| PB | T01.976 | proteasome subunit alpha 1 | yeast 20s proteasome with human beta5c (1-138) and human beta6 (97- 111; 118-133) in complex with epoxyketone inhibitor 18 | 5L64_E |
| PB | T01.976 | proteasome subunit alpha 1 | yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97- 111; 118-133) in complex with carfilzomib | 5L65_E |
| PB | T01.976 | proteasome subunit alpha 1 | yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97- 111; 118-133) in complex with bortezomib | 5L66_E |
| PB | T01.976 | proteasome subunit alpha 1 | yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97- 111; 118-133) in complex with pr-924 | 5L67_E |
| PB | T01.976 | proteasome subunit alpha 1 | yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97- 111; 118-133) in complex with epoxyketone inhibitor 14 | 5L68_E |
| PB | T01.976 | proteasome subunit alpha 1 | yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97- 111; 118-133) in complex with epoxyketone inhibitor 16 | 5L69_E |
| PB | T01.976 | proteasome subunit alpha 1 | yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97- 111; 118-133) in complex with epoxyketone inhibitor 17 | 5L6A_E |
| PB | T01.976 | proteasome subunit alpha 1 | yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97- 111; 118-133) in complex with onx 0914 | 5L6B_E |
| PB | T01.976 | proteasome subunit alpha 1 | yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97- 111; 118-133) in complex with epoxyketone inhibitor 18 | 5L6C_E |
| PB | T01.976 | proteasome subunit alpha 1 | ligand-induced aziridine-formation at the yeast proteasomal subunit beta5 by sulfonate esters | 5LAI_E |
| PB | T01.976 | proteasome subunit alpha 1 | ligand-induced lys33-thr1 crosslinking at the yeast proteasomal subunit beta5 by sulfonate esters | 5LAJ_E |
| PB | T01.976 | proteasome subunit alpha 1 | yeast 20s proteasome with human beta5i (1-138; r57t)in complex with pr-924 | 5LTT_E |
| PB | T01.976 | proteasome subunit alpha 1 | yeast 20s proteasome with human beta5i (1-138) and human beta6 (97- 111; 118-133) in complex with thiazole based inhibitor ro19 | 5M2B_E |
| PB | T01.976 | proteasome subunit alpha 1 | 26s proteasome in presence of atp (s1) | 5MP9_f |
| PB | T01.976 | proteasome subunit alpha 1 | 26s proteasome in presence of atp (s2) | 5MPA_f |
| PB | T01.976 | proteasome subunit alpha 1 | yeast 20s proteasome in complex with blm-pep activator | 5NIF_F |
| PB | T01.976 | proteasome subunit alpha 1 | yeast 26s proteasome bound to ubiquitinated substrate (1d* motor state) | 6EF0_F |
| PB | T01.976 | proteasome subunit alpha 1 | yeast 26s proteasome bound to ubiquitinated substrate (5d motor state) | 6EF1_F |
| PB | T01.976 | proteasome subunit alpha 1 | yeast 26s proteasome bound to ubiquitinated substrate (5t motor state) | 6EF2_F |
| PB | T01.976 | proteasome subunit alpha 1 | yeast 26s proteasome bound to ubiquitinated substrate (4d motor state) | 6EF3_F |
| PB | T01.976 | proteasome subunit alpha 1 | yeast 20s proteasome in complex with cystargolide b | 6G7F_E |
| PB | T01.976 | proteasome subunit alpha 1 | yeast 20s proteasome in complex with cystargolide b derivative 1 | 6G8M_E |
| PB | T01.976 | proteasome subunit alpha 1 | yeast 20s proteasome in complex with cystargolide b derivative 2 | 6G8N_E |
| PB | T01.976 | proteasome subunit alpha 1 | yeast 20s proteasome in complex with homosalinosporamide a | 6GOP_E |
| PB | T01.976 | proteasome subunit alpha 1 | yeast 20s proteasome in complex with the peptidic non-covalent bindinginhibitor rts-v5 | 6H39_E |
| PB | T01.976 | proteasome subunit alpha 1 | yeast 20s proteasome with human beta2c (s171g) | 6HTB_E |
| PB | T01.976 | proteasome subunit alpha 1 | yeast 20s proteasome with human beta2c (s171g) in complex with onx 0914 | 6HTC_E |
| PB | T01.976 | proteasome subunit alpha 1 | yeast 20s proteasome with human beta2c (s171g) in complex with 4 | 6HTD_E |
| PB | T01.976 | proteasome subunit alpha 1 | yeast 20s proteasome with human beta2c (s171g) in complex with 7 | 6HTP_E |
| PB | T01.976 | proteasome subunit alpha 1 | yeast 20s proteasome with human beta2c (s171g) in complex with 13 | 6HTR_E |
| PB | T01.976 | proteasome subunit alpha 1 | yeast 20s proteasome with human beta2c (s171g) in complex with 16 | 6HUB_E |
| PB | T01.976 | proteasome subunit alpha 1 | yeast 20s proteasome with human beta2c (s171g) in complex with 18 | 6HUC_E |
| PB | T01.976 | proteasome subunit alpha 1 | yeast 20s proteasome with human beta2c (s171g) in complex with 20 | 6HUQ_E |
| PB | T01.976 | proteasome subunit alpha 1 | yeast 20s proteasome with human beta2c (s171g) in complex with 29 | 6HUU_E |
| PB | T01.976 | proteasome subunit alpha 1 | yeast 20s proteasome with human beta2c (s171g) in complex with 39 | 6HUV_E |
| PB | T01.976 | proteasome subunit alpha 1 | yeast 20s proteasome with human beta2i (1-53) | 6HV3_E |
| PB | T01.976 | proteasome subunit alpha 1 | yeast 20s proteasome with human beta2i (1-53) in complex with onx 0914 | 6HV4_E |
| PB | T01.976 | proteasome subunit alpha 1 | yeast 20s proteasome with human beta2i (1-53) in complex with 4 | 6HV5_E |
| PB | T01.976 | proteasome subunit alpha 1 | yeast 20s proteasome with human beta2i (1-53) in complex with 7 | 6HV7_E |
| PB | T01.976 | proteasome subunit alpha 1 | yeast 20s proteasome with human beta2i (1-53) in complex with 13 | 6HVA_E |
| PB | T01.976 | proteasome subunit alpha 1 | yeast 20s proteasome with human beta2i (1-53) in complex with 16 | 6HVR_E |
| PB | T01.976 | proteasome subunit alpha 1 | yeast 20s proteasome with human beta2i (1-53) in complex with 18 | 6HVS_E |
| PB | T01.976 | proteasome subunit alpha 1 | yeast 20s proteasome with human beta2i (1-53) in complex with 20 | 6HVT_E |
| PB | T01.976 | proteasome subunit alpha 1 | yeast 20s proteasome with human beta2i (1-53) in complex with 29 | 6HVU_E |
| PB | T01.976 | proteasome subunit alpha 1 | yeast 20s proteasome with human beta2i (1-53) in complex with 39 | 6HVV_E |
| PB | T01.976 | proteasome subunit alpha 1 | yeast 20s proteasome with human beta2i (1-53) in complex with 43 | 6HVW_E |
| PB | T01.976 | proteasome subunit alpha 1 | yeast 20s proteasome in complex with 4 | 6HVX_E |
| PB | T01.976 | proteasome subunit alpha 1 | yeast 20s proteasome in complex with 5 (7- and 6-membered ring) | 6HVY_E |
| PB | T01.976 | proteasome subunit alpha 1 | yeast 20s proteasome in complex with 7 | 6HW0_E |
| PB | T01.976 | proteasome subunit alpha 1 | yeast 20s proteasome in complex with 13 | 6HW3_E |
| PB | T01.976 | proteasome subunit alpha 1 | yeast 20s proteasome in complex with 16 | 6HW4_E |
| PB | T01.976 | proteasome subunit alpha 1 | yeast 20s proteasome in complex with 18 | 6HW5_E |
| PB | T01.976 | proteasome subunit alpha 1 | yeast 20s proteasome in complex with 20 | 6HW6_E |
| PB | T01.976 | proteasome subunit alpha 1 | yeast 20s proteasome in complex with 29 | 6HW7_E |
| PB | T01.976 | proteasome subunit alpha 1 | yeast 20s proteasome in complex with 39 | 6HW8_E |
| PB | T01.976 | proteasome subunit alpha 1 | yeast 20s proteasome in complex with 41b | 6HW9_E |
| PB | T01.976 | proteasome subunit alpha 1 | yeast 20s proteasome in complex with 43 | 6HWA_E |
| PB | T01.976 | proteasome subunit alpha 1 | yeast 20s proteasome in complex with 44b | 6HWB_E |
| PB | T01.976 | proteasome subunit alpha 1 | yeast 20s proteasome beta2-g45a mutant | 6HWC_E |
| PB | T01.976 | proteasome subunit alpha 1 | yeast 20s proteasome beta2-g45a mutant in complex with bortezomib | 6HWD_E |
| PB | T01.976 | proteasome subunit alpha 1 | yeast 20s proteasome beta2-g45a mutant in complex with carfilzomib | 6HWE_E |
| PB | T01.976 | proteasome subunit alpha 1 | yeast 20s proteasome beta2-g45a mutant in complex with onx 0914 | 6HWF_E |
| PB | T01.976 | proteasome subunit alpha 1 | 20S proteasome | 4R3O_F |
| PB | T01.976 | proteasome subunit alpha 1 | 20S proteasome; complex with carfilzomib | 4R67_F |
| PB | T01.976 | proteasome subunit alpha 1 | cryo-em reveals the conformation of a substrate analogue in the human 20s proteasome core | 5A0Q_F |
| PB | T01.976 | proteasome subunit alpha 1 | 26S proteasome; complex with USP14-UbAl | 5GJQ_G |
| PB | T01.976 | proteasome subunit alpha 1 | 26S proteasome | 5GJR_G |
| PB | T01.976 | proteasome subunit alpha 1 | native human 20s proteasome at 1.8 angstrom ***caveat 5le5 6v1 u 47 has wrong chirality at atom c1 | 5LE5_E |
| PB | T01.976 | proteasome subunit alpha 1 | native human 20s proteasome in mg-acetate at 2.2 angstrom ***caveat 5lex 6v1 u 47 has wrong chirality at atom c1 | 5LEX_E |
| PB | T01.976 | proteasome subunit alpha 1 | 20s proteasome; complex with oprozomib | 5LEY_E |
| PB | T01.976 | proteasome subunit alpha 1 | 20s proteasome; complex with oprozomib in mg-acetate | 5LEZ_E |
| PB | T01.976 | proteasome subunit alpha 1 | human 20s proteasome complex with epoxomicin at 2.4 angstrom ***caveat 5lf0 6v1 u 47 has wrong chirality at atom c1 iml c 2 has wrong ***caveat 2 5lf0 chirality at atom cb iml d 2 has wrong chirality at atom ca ***caveat 3 5lf0 iml d 2 has wrong chirality | 5LF0_E |
| PB | T01.976 | proteasome subunit alpha 1 | human 20s proteasome complex with dihydroeponemycin at 2.0 angstrom ***caveat 5lf1 6v1 u 47 has wrong chirality at atom c1 | 5LF1_E |
| PB | T01.976 | proteasome subunit alpha 1 | human 20s proteasome complex with bortezomib at 2.1 angstrom ***caveat 5lf3 6v1 u 47 has wrong chirality at atom c1 | 5LF3_E |
| PB | T01.976 | proteasome subunit alpha 1 | human 20s proteasome complex with delanzomib at 2.0 angstrom ***caveat 5lf4 6v1 u 47 has wrong chirality at atom c1 6v7 n 307 has wrong ***caveat 2 5lf4 chirality at atom c9 6v7 y 306 has wrong chirality at atom ***caveat 3 5lf4 c9 | 5LF4_E |
| PB | T01.976 | proteasome subunit alpha 1 | human 20s proteasome complex with z-lly-ketoaldehyde at 2.1 angstrom ***caveat 5lf6 6v1 u 47 has wrong chirality at atom c1 | 5LF6_E |
| PB | T01.976 | proteasome subunit alpha 1 | human 20s proteasome complex with ixazomib at 2.0 angstrom ***caveat 5lf7 6v1 u 47 has wrong chirality at atom c1 | 5LF7_E |
| PB | T01.976 | proteasome subunit alpha 1 | the human 26s proteasome at 6.8 ang. ***caveat 5ln3 pro h 311 has wrong chirality at atom ca thr n 752 has wrong ***caveat 2 5ln3 chirality at atom ca | 5LN3_F |
| PB | T01.976 | proteasome subunit alpha 1 | 26s proteasome in complex with oprozomib | 5M32_E |
| PB | T01.976 | proteasome subunit alpha 1 | structural basis for dynamic regulation of the human 26s proteasome ***caveat 5t0g entry contains improper peptide linkages. | 5T0G_L |
| PB | T01.976 | proteasome subunit alpha 1 | structural basis for dynamic regulation of the human 26s proteasome ***caveat 5t0h entry contains improper peptide linkages. | 5T0H_L |
| PB | T01.976 | proteasome subunit alpha 1 | structural basis for dynamic regulation of the human 26s proteasome ***caveat 5t0i entry contains improper peptide linkages. residue arg k 20 ***caveat 2 5t0i is incorrectly modeled. | 5T0I_L |
| PB | T01.976 | proteasome subunit alpha 1 | structural basis for dynamic regulation of the human 26s proteasome ***caveat 5t0j entry contains improper peptide linkages. | 5T0J_L |
| PB | T01.976 | proteasome subunit alpha 1 | nucleotide-driven triple-state remodeling of the aaa-atpase channel inthe activated human 26s proteasome | 5VFO_L |
| PB | T01.976 | proteasome subunit alpha 1 | nucleotide-driven triple-state remodeling of the aaa-atpase channel inthe activated human 26s proteasome | 5VFR_L |
| PB | T01.976 | proteasome subunit alpha 1 | nucleotide-driven triple-state remodeling of the aaa-atpase channel inthe activated human 26s proteasome | 5VFT_L |
| PB | T01.976 | proteasome subunit alpha 1 | cryo-em structure of human immunoproteasome with a novel noncompetitive inhibitor that selectively inhibits activated lymphocytes | 6AVO_G |
| PB | T01.976 | proteasome subunit alpha 1 | endogeneous native human 20s proteasome | 6R70_E |
| PB | T01.976 | proteasome subunit alpha 1 | 20S proteasome; complex with PR-957 | 3UNB_E |
| PB | T01.976 | proteasome subunit alpha 1 | 20S proteasome | 3UNE_E |
| PB | T01.976 | proteasome subunit alpha 1 | 20S immunoproteasome; complex with PR-957 | 3UNF_E |
| PB | T01.976 | proteasome subunit alpha 1 | 20S immunoproteasome | 3UNH_E |
| PB | T01.976 | proteasome subunit alpha 1 | 20S proteasome complex | 1IRU_F |
| PB | T01.977 | proteasome subunit alpha 3 | 20S proteasome | 4R3O_G |
| PB | T01.977 | proteasome subunit alpha 3 | 20S proteasome; complex with carfilzomib | 4R67_G |
| PB | T01.977 | proteasome subunit alpha 3 | cryo-em reveals the conformation of a substrate analogue in the human 20s proteasome core | 5A0Q_G |
| PB | T01.977 | proteasome subunit alpha 3 | 5DSV | |
| PB | T01.977 | proteasome subunit alpha 3 | 26S proteasome; complex with USP14-UbAl | 5GJQ_x |
| PB | T01.977 | proteasome subunit alpha 3 | 26S proteasome | 5GJR_X |
| PB | T01.977 | proteasome subunit alpha 3 | native human 20s proteasome at 1.8 angstrom ***caveat 5le5 6v1 u 47 has wrong chirality at atom c1 | 5LE5_F |
| PB | T01.977 | proteasome subunit alpha 3 | native human 20s proteasome in mg-acetate at 2.2 angstrom ***caveat 5lex 6v1 u 47 has wrong chirality at atom c1 | 5LEX_F |
| PB | T01.977 | proteasome subunit alpha 3 | 20s proteasome; complex with oprozomib | 5LEY_F |
| PB | T01.977 | proteasome subunit alpha 3 | 20s proteasome; complex with oprozomib in mg-acetate | 5LEZ_F |
| PB | T01.977 | proteasome subunit alpha 3 | human 20s proteasome complex with epoxomicin at 2.4 angstrom ***caveat 5lf0 6v1 u 47 has wrong chirality at atom c1 iml c 2 has wrong ***caveat 2 5lf0 chirality at atom cb iml d 2 has wrong chirality at atom ca ***caveat 3 5lf0 iml d 2 has wrong chirality | 5LF0_F |
| PB | T01.977 | proteasome subunit alpha 3 | human 20s proteasome complex with dihydroeponemycin at 2.0 angstrom ***caveat 5lf1 6v1 u 47 has wrong chirality at atom c1 | 5LF1_F |
| PB | T01.977 | proteasome subunit alpha 3 | human 20s proteasome complex with bortezomib at 2.1 angstrom ***caveat 5lf3 6v1 u 47 has wrong chirality at atom c1 | 5LF3_F |
| PB | T01.977 | proteasome subunit alpha 3 | human 20s proteasome complex with delanzomib at 2.0 angstrom ***caveat 5lf4 6v1 u 47 has wrong chirality at atom c1 6v7 n 307 has wrong ***caveat 2 5lf4 chirality at atom c9 6v7 y 306 has wrong chirality at atom ***caveat 3 5lf4 c9 | 5LF4_F |
| PB | T01.977 | proteasome subunit alpha 3 | human 20s proteasome complex with z-lly-ketoaldehyde at 2.1 angstrom ***caveat 5lf6 6v1 u 47 has wrong chirality at atom c1 | 5LF6_F |
| PB | T01.977 | proteasome subunit alpha 3 | human 20s proteasome complex with ixazomib at 2.0 angstrom ***caveat 5lf7 6v1 u 47 has wrong chirality at atom c1 | 5LF7_F |
| PB | T01.977 | proteasome subunit alpha 3 | the human 26s proteasome at 6.8 ang. ***caveat 5ln3 pro h 311 has wrong chirality at atom ca thr n 752 has wrong ***caveat 2 5ln3 chirality at atom ca | 5LN3_G |
| PB | T01.977 | proteasome subunit alpha 3 | 26s proteasome in complex with oprozomib | 5M32_F |
| PB | T01.977 | proteasome subunit alpha 3 | structural basis for dynamic regulation of the human 26s proteasome ***caveat 5t0g entry contains improper peptide linkages. | 5T0G_M |
| PB | T01.977 | proteasome subunit alpha 3 | structural basis for dynamic regulation of the human 26s proteasome ***caveat 5t0h entry contains improper peptide linkages. | 5T0H_M |
| PB | T01.977 | proteasome subunit alpha 3 | structural basis for dynamic regulation of the human 26s proteasome ***caveat 5t0i entry contains improper peptide linkages. residue arg k 20 ***caveat 2 5t0i is incorrectly modeled. | 5T0I_M |
| PB | T01.977 | proteasome subunit alpha 3 | structural basis for dynamic regulation of the human 26s proteasome ***caveat 5t0j entry contains improper peptide linkages. | 5T0J_M |
| PB | T01.977 | proteasome subunit alpha 3 | nucleotide-driven triple-state remodeling of the aaa-atpase channel inthe activated human 26s proteasome | 5VFO_M |
| PB | T01.977 | proteasome subunit alpha 3 | nucleotide-driven triple-state remodeling of the aaa-atpase channel inthe activated human 26s proteasome | 5VFR_M |
| PB | T01.977 | proteasome subunit alpha 3 | nucleotide-driven triple-state remodeling of the aaa-atpase channel inthe activated human 26s proteasome | 5VFT_M |
| PB | T01.977 | proteasome subunit alpha 3 | cryo-em structure of human immunoproteasome with a novel noncompetitive inhibitor that selectively inhibits activated lymphocytes | 6AVO_J |
| PB | T01.977 | proteasome subunit alpha 3 | endogeneous native human 20s proteasome | 6R70_F |
| PB | T01.983 | proteasome subunit beta 3 | ground state 26s proteasome (gs2) | 6EPC_3 |
| PB | T01.983 | proteasome subunit beta 3 | substrate processing state 26s proteasome (sps1) ***caveat 6epd pro 2 231 has wrong chirality at atom ca | 6EPD_3 |
| PB | T01.983 | proteasome subunit beta 3 | substrate processing state 26s proteasome (sps2) | 6EPE_3 |
| PB | T01.983 | proteasome subunit beta 3 | ground state 26s proteasome (gs1) | 6EPF_3 |
| PB | T01.983 | proteasome subunit beta 3 | 20S proteasome | 4R3O_J |
| PB | T01.983 | proteasome subunit beta 3 | 20S proteasome; complex with carfilzomib | 4R67_J |
| PB | T01.983 | proteasome subunit beta 3 | cryo-em reveals the conformation of a substrate analogue in the human 20s proteasome core | 5A0Q_J |
| PB | T01.983 | proteasome subunit beta 3 | 26S proteasome; complex with USP14-UbAl | 5GJQ_C |
| PB | T01.983 | proteasome subunit beta 3 | 26S proteasome | 5GJR_C |
| PB | T01.983 | proteasome subunit beta 3 | native human 20s proteasome at 1.8 angstrom ***caveat 5le5 6v1 u 47 has wrong chirality at atom c1 | 5LE5_I |
| PB | T01.983 | proteasome subunit beta 3 | native human 20s proteasome in mg-acetate at 2.2 angstrom ***caveat 5lex 6v1 u 47 has wrong chirality at atom c1 | 5LEX_I |
| PB | T01.983 | proteasome subunit beta 3 | 20s proteasome; complex with oprozomib | 5LEY_I |
| PB | T01.983 | proteasome subunit beta 3 | 20s proteasome; complex with oprozomib in mg-acetate | 5LEZ_I |
| PB | T01.983 | proteasome subunit beta 3 | human 20s proteasome complex with epoxomicin at 2.4 angstrom ***caveat 5lf0 6v1 u 47 has wrong chirality at atom c1 iml c 2 has wrong ***caveat 2 5lf0 chirality at atom cb iml d 2 has wrong chirality at atom ca ***caveat 3 5lf0 iml d 2 has wrong chirality | 5LF0_I |
| PB | T01.983 | proteasome subunit beta 3 | human 20s proteasome complex with dihydroeponemycin at 2.0 angstrom ***caveat 5lf1 6v1 u 47 has wrong chirality at atom c1 | 5LF1_I |
| PB | T01.983 | proteasome subunit beta 3 | human 20s proteasome complex with bortezomib at 2.1 angstrom ***caveat 5lf3 6v1 u 47 has wrong chirality at atom c1 | 5LF3_I |
| PB | T01.983 | proteasome subunit beta 3 | human 20s proteasome complex with delanzomib at 2.0 angstrom ***caveat 5lf4 6v1 u 47 has wrong chirality at atom c1 6v7 n 307 has wrong ***caveat 2 5lf4 chirality at atom c9 6v7 y 306 has wrong chirality at atom ***caveat 3 5lf4 c9 | 5LF4_I |
| PB | T01.983 | proteasome subunit beta 3 | human 20s proteasome complex with z-lly-ketoaldehyde at 2.1 angstrom ***caveat 5lf6 6v1 u 47 has wrong chirality at atom c1 | 5LF6_I |
| PB | T01.983 | proteasome subunit beta 3 | human 20s proteasome complex with ixazomib at 2.0 angstrom ***caveat 5lf7 6v1 u 47 has wrong chirality at atom c1 | 5LF7_I |
| PB | T01.983 | proteasome subunit beta 3 | the human 26s proteasome at 6.8 ang. ***caveat 5ln3 pro h 311 has wrong chirality at atom ca thr n 752 has wrong ***caveat 2 5ln3 chirality at atom ca | 5LN3_3 |
| PB | T01.983 | proteasome subunit beta 3 | 26s proteasome; complex with oprozomib | 5M32_I |
| PB | T01.983 | proteasome subunit beta 3 | structural basis for dynamic regulation of the human 26s proteasome ***caveat 5t0g entry contains improper peptide linkages. | 5T0G_P |
| PB | T01.983 | proteasome subunit beta 3 | structural basis for dynamic regulation of the human 26s proteasome ***caveat 5t0h entry contains improper peptide linkages. | 5T0H_P |
| PB | T01.983 | proteasome subunit beta 3 | structural basis for dynamic regulation of the human 26s proteasome ***caveat 5t0i entry contains improper peptide linkages. residue arg k 20 ***caveat 2 5t0i is incorrectly modeled. | 5T0I_P |
| PB | T01.983 | proteasome subunit beta 3 | structural basis for dynamic regulation of the human 26s proteasome ***caveat 5t0j entry contains improper peptide linkages. | 5T0J_P |
| PB | T01.983 | proteasome subunit beta 3 | nucleotide-driven triple-state remodeling of the aaa-atpase channel inthe activated human 26s proteasome | 5VFO_P |
| PB | T01.983 | proteasome subunit beta 3 | nucleotide-driven triple-state remodeling of the aaa-atpase channel inthe activated human 26s proteasome | 5VFR_P |
| PB | T01.983 | proteasome subunit beta 3 | nucleotide-driven triple-state remodeling of the aaa-atpase channel inthe activated human 26s proteasome | 5VFT_P |
| PB | T01.983 | proteasome subunit beta 3 | cryo-em structure of human immunoproteasome with a novel noncompetitive inhibitor that selectively inhibits activated lymphocytes | 6AVO_U |
| PB | T01.983 | proteasome subunit beta 3 | endogeneous native human 20s proteasome | 6R70_I |
| PB | T01.983 | proteasome subunit beta 3 | 20S proteasome; complex with PR-957 | 3UNB_I |
| PB | T01.983 | proteasome subunit beta 3 | 20S proteasome | 3UNE_I |
| PB | T01.983 | proteasome subunit beta 3 | 20S immunoproteasome; complex with PR-957 | 3UNF_I |
| PB | T01.983 | proteasome subunit beta 3 | 20S immunoproteasome | 3UNH_I |
| PB | T01.984 | proteasome subunit beta 2 | ground state 26s proteasome (gs2) | 6EPC_4 |
| PB | T01.984 | proteasome subunit beta 2 | substrate processing state 26s proteasome (sps1) ***caveat 6epd pro 2 231 has wrong chirality at atom ca | 6EPD_4 |
| PB | T01.984 | proteasome subunit beta 2 | substrate processing state 26s proteasome (sps2) | 6EPE_4 |
| PB | T01.984 | proteasome subunit beta 2 | ground state 26s proteasome (gs1) | 6EPF_4 |
| PB | T01.984 | proteasome subunit beta 2 | 20S proteasome in complex with activator PA26 (Trypanosoma brucei) | 1FNT_K |
| PB | T01.984 | proteasome subunit beta 2 | complete proteasome | 1G0U_J |
| PB | T01.984 | proteasome subunit beta 2 | complex with epoxomicin | 1G65_J |
| PB | T01.984 | proteasome subunit beta 2 | proteasome complex bound to TMC-95A inhibitor | 1JD2_J |
| PB | T01.984 | proteasome subunit beta 2 | 20S proteasome | 1RYP_K |
| PB | T01.984 | proteasome subunit beta 2 | 20S proteasome; complex with the proteasome activator PA26 from Trypanosoma brucei | 1Z7Q_K |
| PB | T01.984 | proteasome subunit beta 2 | 20S proteasome;complex with bortezomib | 2F16_J |
| PB | T01.984 | proteasome subunit beta 2 | 20S proteasome; complex with salinosporamide A | 2FAK_J |
| PB | T01.984 | proteasome subunit beta 2 | 20S proteasome; complex with homobelactosin C | 2FNY_J |
| PB | T01.984 | proteasome subunit beta 2 | 20S proteasome; complex with TMC-95 based biphenyl-ether macrocycle | 2GPL_J |
| PB | T01.984 | proteasome subunit beta 2 | 20S proteasome; complex with syringolin A | 2ZCY_J |
| PB | T01.984 | proteasome subunit beta 2 | 20S proteasome; complex with glidobactin A | 3BDM_J |
| PB | T01.984 | proteasome subunit beta 2 | 20S proteasome; complex with fellutamide B | 3D29_J |
| PB | T01.984 | proteasome subunit beta 2 | 20s proteasome; complex with the epimer form of spirolactacystin | 3DY3_J |
| PB | T01.984 | proteasome subunit beta 2 | 20s proteasome; complex with spirolactacystin | 3DY4_J |
| PB | T01.984 | proteasome subunit beta 2 | 20s proteasome; complex with homobelactosin c | 3E47_J |
| PB | T01.984 | proteasome subunit beta 2 | 20s proteasome; complex with syringolin b | 3GPJ_J |
| PB | T01.984 | proteasome subunit beta 2 | 20S proteasome; complex with salinosporamide derivative | 3GPT_J |
| PB | T01.984 | proteasome subunit beta 2 | 20S proteasome; complex with salinosporamide derivative | 3GPW_J |
| PB | T01.984 | proteasome subunit beta 2 | 20S proteasome; complex with hyroxylated salinosporamide | 3HYE_J |
| PB | T01.984 | proteasome subunit beta 2 | 20S proteasome; complex with bortezomib | 3MG0_J |
| PB | T01.984 | proteasome subunit beta 2 | 20S proteasome; complex with compound 1 | 3MG4_J |
| PB | T01.984 | proteasome subunit beta 2 | 20S proteasome; complex with compound 6 | 3MG6_J |
| PB | T01.984 | proteasome subunit beta 2 | 20S open-gate proteasome; complex with compound 6 | 3MG7_J |
| PB | T01.984 | proteasome subunit beta 2 | 20S open-gate proteasome; complex with compound 16 | 3MG8_J |
| PB | T01.984 | proteasome subunit beta 2 | 20S proteasome; complex with ligand 2a | 3NZJ_J |
| PB | T01.984 | proteasome subunit beta 2 | 20S proteasome; complex with ligand 2b | 3NZW_J |
| PB | T01.984 | proteasome subunit beta 2 | 20S proteasome; complex with ligand 2c | 3NZX_J |
| PB | T01.984 | proteasome subunit beta 2 | 20S open-gate proteasome; complex with compound 24 | 3OEU_J |
| PB | T01.984 | proteasome subunit beta 2 | 20S open-gate proteasome; complex with compound 25 | 3OEV_J |
| PB | T01.984 | proteasome subunit beta 2 | 20S proteasome; complex with alpha-keto-aldehyde | 3OKJ_J |
| PB | T01.984 | proteasome subunit beta 2 | 20S open-gate proteasome; complex with compound 20 | 3SDI_J |
| PB | T01.984 | proteasome subunit beta 2 | 20S open-gate proteasome; complex with compound 34 | 3SDK_J |
| PB | T01.984 | proteasome subunit beta 2 | 20S proteasome; complex with hydroxyurea derivative HU10 | 3SHJ_J |
| PB | T01.984 | proteasome subunit beta 2 | 20S proteasome; complex with homobelactosin C | 3TDD_J |
| PB | T01.984 | proteasome subunit beta 2 | 20S open-gate proteasome; complex with PR-957 (morpholine) | 3UN4_J |
| PB | T01.984 | proteasome subunit beta 2 | 20S proteasome; complex with PR-957 (epoxide) | 3UN8_J |
| PB | T01.984 | proteasome subunit beta 2 | 26S proteasome | 3WXR_K |
| PB | T01.984 | proteasome subunit beta 2 | 26S proteasome | 4CR2 |
| PB | T01.984 | proteasome subunit beta 2 | 4CR3 | |
| PB | T01.984 | proteasome subunit beta 2 | 26S proteasome | 4CR4 |
| PB | T01.984 | proteasome subunit beta 2 | 20S proteasome; complex with K-7174 | 4EU2_K |
| PB | T01.984 | proteasome subunit beta 2 | 20S proteasome; complex with cepafungin I | 4FZC_J |
| PB | T01.984 | proteasome subunit beta 2 | 20S proteasome; complex with glidobactin | 4FZG_J |
| PB | T01.984 | proteasome subunit beta 2 | 20S proteasome; complex with Syringolin-Glidobactin chimera | 4G4S_K |
| PB | T01.984 | proteasome subunit beta 2 | 20S proteasome; complex with Syringolin-Glidobactin chimera | 4GK7_J |
| PB | T01.984 | proteasome subunit beta 2 | 20S proteasome; complex with vinylketone carmaphycin analogue VNK1 | 4HNP_J |
| PB | T01.984 | proteasome subunit beta 2 | 20S proteasome; complex with epoxyketone carmaphycin analogue 3 | 4HRC_J |
| PB | T01.984 | proteasome subunit beta 2 | 20S proteasome; complex with carmaphycin A | 4HRD_J |
| PB | T01.984 | proteasome subunit beta 2 | 20S proteasome; complex with vinyl sulfone LU102 | 4INR_J |
| PB | T01.984 | proteasome subunit beta 2 | 20S proteasome; complex with vinyl sulfone LU122 | 4INT_J |
| PB | T01.984 | proteasome subunit beta 2 | 20S proteasome; complex with vinyl sulfone LU112 | 4INU_J |
| PB | T01.984 | proteasome subunit beta 2 | 20S proteasome; complex with belactosin derivative 3E | 4J70_J |
| PB | T01.984 | proteasome subunit beta 2 | 20S proteasome; complex with dimerized linear mimetic of TMC-95A20S proteasome; complex with dimerized linear mimetic of TMC-95A | 4JSQ_J |
| PB | T01.984 | proteasome subunit beta 2 | 20S proteasome; complex with dimerized linear mimetic of TMC-95A | 4JSU_J |
| PB | T01.984 | proteasome subunit beta 2 | 20S proteasome; complex with dimerized linear mimetic of TMC-95A | 4JT0_J |
| PB | T01.984 | proteasome subunit beta 2 | 20S proteasome; complex with vibralactone | 4LQI_J |
| PB | T01.984 | proteasome subunit beta 2 | 20S proteasome; complex with enone carmaphycin analogue 6 | 4LTC_J |
| PB | T01.984 | proteasome subunit beta 2 | 20S proteasome; complex with MG132 | 4NNN_J |
| PB | T01.984 | proteasome subunit beta 2 | 20S proteasome; complex with Z-Leu-Leu-Leu-ketoaldehyde | 4NNW_J |
| PB | T01.984 | proteasome subunit beta 2 | 20S proteasome; complex with Z-Leu-Leu-Leu-B(OH)2 | 4NO1_J |
| PB | T01.984 | proteasome subunit beta 2 | 20S proteasome; complex with Z-Leu-Leu-Leu-vinylsulfone | 4NO6_J |
| PB | T01.984 | proteasome subunit beta 2 | 20S proteasome; complex with Z-Leu-Leu-Leu-ketoamide | 4NO8_J |
| PB | T01.984 | proteasome subunit beta 2 | 20S proteasome; complex with Z-Leu-Leu-Leu-epoxyketone | 4NO9_J |
| PB | T01.984 | proteasome subunit beta 2 | 20S proteasome; complex with kendomycin | 4Q1S_J |
| PB | T01.984 | proteasome subunit beta 2 | 20S proteasome; complex with Boc-Ala-Ala-Ala-CHO | 4QBY_J |
| PB | T01.984 | proteasome subunit beta 2 | 20S proteasome; complex with epoxyketone inhibitor 8 | 4QLQ_J |
| PB | T01.984 | proteasome subunit beta 2 | 20S proteasome; complex with epoxyketone inhibitor 11 | 4QLS_J |
| PB | T01.984 | proteasome subunit beta 2 | 20S proteasome; complex with tripeptidic epoxyketone inhibitor 2 | 4QLT_J |
| PB | T01.984 | proteasome subunit beta 2 | 20S proteasome; complex with tripeptidic epoxyketone inhibitor 9 | 4QLU_J |
| PB | T01.984 | proteasome subunit beta 2 | 20S proteasome; complex with tripeptidic epoxyketone inhibitor 17 | 4QLV_J |
| PB | T01.984 | proteasome subunit beta 2 | 20S proteasome | 4QUX_J |
| PB | T01.984 | proteasome subunit beta 2 | 20S proteasome | 4QUY_J |
| PB | T01.984 | proteasome subunit beta 2 | 20S proteasome | 4QV0_J |
| PB | T01.984 | proteasome subunit beta 2 | 20S proteasome | 4QV1_J |
| PB | T01.984 | proteasome subunit beta 2 | 20S proteasome | 4QV3_J |
| PB | T01.984 | proteasome subunit beta 2 | 20S proteasome beta5 Met45Thr mutant | 4QV4_J |
| PB | T01.984 | proteasome subunit beta 2 | 20S proteasome beta5 Met45Ile mutant | 4QV5_J |
| PB | T01.984 | proteasome subunit beta 2 | 20S proteasome | 4QV6_J |
| PB | T01.984 | proteasome subunit beta 2 | 20S proteasome | 4QV7_J |
| PB | T01.984 | proteasome subunit beta 2 | 20S proteasome | 4QV8_J |
| PB | T01.984 | proteasome subunit beta 2 | 20S proteasome | 4QV9_J |
| PB | T01.984 | proteasome subunit beta 2 | 20S proteasome; complex with bortezomib | 4QVL_J |
| PB | T01.984 | proteasome subunit beta 2 | 20S proteasome beta5 Met45Ala mutant; complex with bortezomib | 4QVM_J |
| PB | T01.984 | proteasome subunit beta 2 | 20S proteasome beta5 Met45Val mutant; complex with bortezomib | 4QVN_J |
| PB | T01.984 | proteasome subunit beta 2 | 20S proteasome beta5 Met45Thr mutant; complex with bortezomib | 4QVP_J |
| PB | T01.984 | proteasome subunit beta 2 | 20S proteasome beta5 Met45Ile mutant; complex with bortezomib | 4QVQ_J |
| PB | T01.984 | proteasome subunit beta 2 | 20S proteasome beta5 Ala49Val mutant; complex with bortezomib | 4QVV_J |
| PB | T01.984 | proteasome subunit beta 2 | 20S proteasome beta5 Ala49Ser mutant; complex with bortezomib | 4QVW_J |
| PB | T01.984 | proteasome subunit beta 2 | 20S proteasome beta5 Ala49Thr mutant; complex with bortezomib | 4QVY_J |
| PB | T01.984 | proteasome subunit beta 2 | 20S proteasome beta5 Ala49Thr,Ala50Val mutant; complex with bortezomib | 4QW0_J |
| PB | T01.984 | proteasome subunit beta 2 | 20S proteasome beta5 Ala50Val mutant; complex with bortezomib | 4QW1_J |
| PB | T01.984 | proteasome subunit beta 2 | 20S proteasome beta5 Cys63Phe mutant; complex with bortezomib | 4QW3_J |
| PB | T01.984 | proteasome subunit beta 2 | 20S proteasome; complex with carfilzomib | 4QW4_J |
| PB | T01.984 | proteasome subunit beta 2 | 20S proteasome beta5 Met45Ala mutant; complex with carfilzomib | 4QW5_J |
| PB | T01.984 | proteasome subunit beta 2 | 20S proteasome beta5 Met45Val mutant; complex with carfilzomib | 4QW6_J |
| PB | T01.984 | proteasome subunit beta 2 | 20S proteasome beta5 Met45Thr mutant; complex with carfilzomib | 4QW7_J |
| PB | T01.984 | proteasome subunit beta 2 | 20S proteasome beta5 Met45Ile mutant; complex with carfilzomib | 4QWF_J |
| PB | T01.984 | proteasome subunit beta 2 | 20S proteasome beta5 Ala49Val mutant; complex with carfilzomib | 4QWG_J |
| PB | T01.984 | proteasome subunit beta 2 | 20S proteasome beta5 Ala49Ser mutant; complex with carfilzomib | 4QWI_J |
| PB | T01.984 | proteasome subunit beta 2 | 20S proteasome beta5 Ala49Thr mutant; complex with carfilzomib | 4QWJ_J |
| PB | T01.984 | proteasome subunit beta 2 | 20S proteasome beta5 Ala49Thr, Ala50Val mutant; complex with carfilzomib | 4QWK_J |
| PB | T01.984 | proteasome subunit beta 2 | 20S proteasome beta5 Ala50Val mutant; complex with carfilzomib | 4QWL_J |
| PB | T01.984 | proteasome subunit beta 2 | 20S proteasome beta5 Cys52Phe mutant; complex with carfilzomib | 4QWR_J |
| PB | T01.984 | proteasome subunit beta 2 | 20S proteasome beta5 Cys63Phe mutant; complex with carfilzomib | 4QWS_J |
| PB | T01.984 | proteasome subunit beta 2 | 20S proteasome beta5 Cys52Phe mutant; complex with bortezomib | 4QWU_J |
| PB | T01.984 | proteasome subunit beta 2 | 20S proteasome; complex with epoxyketone inhibitor ONX 0914 | 4QWX_J |
| PB | T01.984 | proteasome subunit beta 2 | 20S proteasome beta 5 Met45Ala mutant; complex with epoxyketone inhibitor ONX 0914 | 4QXJ_J |
| PB | T01.984 | proteasome subunit beta 2 | complete proteasome; complex with epoxyketone inhibitor ONX 0914 | 4QZ0_J |
| PB | T01.984 | proteasome subunit beta 2 | 20S proteasome beta 5 Met45Thr mutant; complex with epoxyketone inhibitor ONX 0914 | 4QZ1_J |
| PB | T01.984 | proteasome subunit beta 2 | 20S proteasome beta 5 Met45Ile mutant; complex with epoxyketone inhibitor ONX 0914 | 4QZ2_J |
| PB | T01.984 | proteasome subunit beta 2 | 20S proteasome beta 5 Ala49Val mutant; complex with epoxyketone inhibitor ONX 0914 | 4QZ3_J |
| PB | T01.984 | proteasome subunit beta 2 | 20S proteasome beta 5 Ala49Ser mutant; complex with epoxyketone inhibitor ONX 0914 | 4QZ4_J |
| PB | T01.984 | proteasome subunit beta 2 | 20S proteasome beta 5 Ala49Thr mutant; complex with epoxyketone inhibitor ONX 0914 | 4QZ5_J |
| PB | T01.984 | proteasome subunit beta 2 | 20S proteasome beta 5 Ala49Thr, Ala50Val mutant; complex with epoxyketone inhibitor ONX 0914 | 4QZ6_J |
| PB | T01.984 | proteasome subunit beta 2 | 20S proteasome beta 5 Ala50Val mutant; complex with epoxyketone inhibitor ONX 0914 | 4QZ7_J |
| PB | T01.984 | proteasome subunit beta 2 | 20S proteasome beta 5 Cys52Phe mutant; complex with epoxyketone inhibitor ONX 0914 | 4QZW_J |
| PB | T01.984 | proteasome subunit beta 2 | complete proteasome; complex with epoxyketone inhibitor ONX 0914 | 4QZX_J |
| PB | T01.984 | proteasome subunit beta 2 | 20S proteasome; complex with omuralide | 4QZZ_J |
| PB | T01.984 | proteasome subunit beta 2 | 20S proteasome beta 5 Cys52Phe mutant; complex with omuralide | 4R00_J |
| PB | T01.984 | proteasome subunit beta 2 | 20S proteasome; complex with BSC4999 | 4R02_J |
| PB | T01.984 | proteasome subunit beta 2 | 20S proteasome; ligand induced aziridine-formation in beta5 | 4R17_J |
| PB | T01.984 | proteasome subunit beta 2 | 20S proteasome; ligand induced Lys33-Thr1 cross-linking in beta5 | 4R18_J |
| PB | T01.984 | proteasome subunit beta 2 | 20S proteasome; complex with alkaloid indolo-phakellin | 4RUR_J |
| PB | T01.984 | proteasome subunit beta 2 | 4V7O | |
| PB | T01.984 | proteasome subunit beta 2 | 20S proteasome; complex with PR-VI modulator | 4X6Z_K |
| PB | T01.984 | proteasome subunit beta 2 | 20S proteasome; complex with Ac-Pro-Ala-Asp-EP | 4Y69_J |
| PB | T01.984 | proteasome subunit beta 2 | 20S proteasome beta2 His114Asp mutant; complex with Ac-Pro-Ala-Asp-EP | 4Y6A_J |
| PB | T01.984 | proteasome subunit beta 2 | 20S proteasome; complex with Ac-Pro-Ala-Glu-EP | 4Y6V_J |
| PB | T01.984 | proteasome subunit beta 2 | 20S proteasome; complex with Ac-Pro-Ala-Leu-EP | 4Y6Z_J |
| PB | T01.984 | proteasome subunit beta 2 | 20S proteasome; complex with Ac-Leu-Ala-Val-EP | 4Y70_J |
| PB | T01.984 | proteasome subunit beta 2 | 20S proteasome; complex with Ac-Leu-Ala-Leu-EP | 4Y74_J |
| PB | T01.984 | proteasome subunit beta 2 | 20S proteasome; complex with Ac-Pro-Ala-Phe-EP | 4Y75_J |
| PB | T01.984 | proteasome subunit beta 2 | 20S proteasome; complex with Ac-Leu-Ala-Phe-EP | 4Y77_J |
| PB | T01.984 | proteasome subunit beta 2 | 20S proteasome; complex with Ac-Leu-Ala-Asp-EP | 4Y78_J |
| PB | T01.984 | proteasome subunit beta 2 | 20S proteasome; complex with Ac-Leu-Ala-Glu-EP | 4Y7W_J |
| PB | T01.984 | proteasome subunit beta 2 | complete proteasome; complex with Ac-PAA-ep | 4Y7X_J |
| PB | T01.984 | proteasome subunit beta 2 | 20S proteasome; complex with Ac-Leu-Ala-Ala-EP | 4Y7Y_J |
| PB | T01.984 | proteasome subunit beta 2 | 20S proteasome; complex with Ac-Leu-Ala-Ile-EP | 4Y80_J |
| PB | T01.984 | proteasome subunit beta 2 | 20S proteasome; complex with Ac-Pro-Ala-Tyr-EP | 4Y81_J |
| PB | T01.984 | proteasome subunit beta 2 | 20S proteasome; complex with Ac-Leu-Ala-Tyr-EP | 4Y82_J |
| PB | T01.984 | proteasome subunit beta 2 | 20S proteasome; complex with N3-Ala(4,4-F2P)-Asn-Leu-Leu-EP | 4Y84_J |
| PB | T01.984 | proteasome subunit beta 2 | 20S proteasome; complex with N3-Ala-Pro-Asn-Leu-Leu-EP | 4Y8G_J |
| PB | T01.984 | proteasome subunit beta 2 | 20S proteasome; complex with N3-Ala-Pro-Ala-Leu-EP | 4Y8H_J |
| PB | T01.984 | proteasome subunit beta 2 | 20S proteasome; complex with Ac-Pro-Leu-Leu-EP | 4Y8I_J |
| PB | T01.984 | proteasome subunit beta 2 | 20S proteasome; complex with Ac-Leu-Leu-Leu-EP | 4Y8J_J |
| PB | T01.984 | proteasome subunit beta 2 | 20S proteasome; complex with H-Ala-Pro-Leu-Leu-EP | 4Y8K_J |
| PB | T01.984 | proteasome subunit beta 2 | 20S proteasome; complex with Ac-Ala-Pro-Leu-Leu-EP | 4Y8L_J |
| PB | T01.984 | proteasome subunit beta 2 | 20S proteasome beta7-delta7 C-terminal mutant | 4Y8M_J |
| PB | T01.984 | proteasome subunit beta 2 | 20S proteasome beta7-delta7 C-terminal mutant; complex with Ac-Pro-Ala-Glu-EP | 4Y8N_J |
| PB | T01.984 | proteasome subunit beta 2 | 20S proteasome beta 7-delta 7 C-terminal mutant; complex with Ac-Pro-Ala-Phe-EP | 4Y8O_J |
| PB | T01.984 | proteasome subunit beta 2 | 20S proteasome beta 7-delta 7 C-terminal mutant; complex with Ac-Pro-Ala-Leu-EP | 4Y8P_J |
| PB | T01.984 | proteasome subunit beta 2 | 20S proteasome beta 7-delta 7 C-terminal mutant; complex with Ac-Pro-Ala-Tyr-EP | 4Y8Q_J |
| PB | T01.984 | proteasome subunit beta 2 | 20S proteasome beta 2 His116Asp mutant | 4Y8R_J |
| PB | T01.984 | proteasome subunit beta 2 | 20S proteasome beta 2 His116Asp mutant; complex with Ac-Leu-Ala-Glu-EP | 4Y8S_J |
| PB | T01.984 | proteasome subunit beta 2 | 20S proteasome beta 2 His116Asp mutant; complex with Ac-Pro-Ala-Glu-EP | 4Y8T_J |
| PB | T01.984 | proteasome subunit beta 2 | 20S proteasome beta 2 His116Asp mutant; complex with Ac-Pro-Ala-Asp-EP | 4Y8U_J |
| PB | T01.984 | proteasome subunit beta 2 | 20S proteasome beta 2 His116Glu mutant | 4Y9Y_J |
| PB | T01.984 | proteasome subunit beta 2 | 20S proteasome beta 2 His116Glu mutant; complex with Ac-Leu-Ala-Glu-EP | 4Y9Z_J |
| PB | T01.984 | proteasome subunit beta 2 | 20S proteasome beta 2 His116Glu mutant; complex with Ac-Pro-Ala-Glu-EP | 4YA0_J |
| PB | T01.984 | proteasome subunit beta 2 | 20S proteasome beta 2 His116Asn mutant | 4YA1_J |
| PB | T01.984 | proteasome subunit beta 2 | 20S proteasome beta 2 His116Asn mutant; complex with Ac-Leu-Ala-Glu-EP | 4YA2_J |
| PB | T01.984 | proteasome subunit beta 2 | 20S proteasome beta 2 His116Asn mutant; complex with Ac-Pro-Ala-Glu-EP | 4YA3_J |
| PB | T01.984 | proteasome subunit beta 2 | 20S proteasome beta 2 His114Asp mutant | 4YA4_J |
| PB | T01.984 | proteasome subunit beta 2 | 20S proteasome beta 2 His114Asp mutant; complex with Ac-Pro-Ala-Glu-EP | 4YA5_J |
| PB | T01.984 | proteasome subunit beta 2 | 20S proteasome beta 2 His114Asp mutant; complex with Ac-Leu-Ala-Glu-EP | 4YA7_J |
| PB | T01.984 | proteasome subunit beta 2 | 20S proteasome beta 2 His114Asp mutant; complex with AC-Leu-Ala-Asp-EP | 4YA9_J |
| PB | T01.984 | proteasome subunit beta 2 | 20S proteasome; complex with belactosin C derivative 3 | 4Z1L_J |
| PB | T01.984 | proteasome subunit beta 2 | 5A5B | |
| PB | T01.984 | proteasome subunit beta 2 | 20S proteasome; complex with macyranone A | 5AHJ_J |
| PB | T01.984 | proteasome subunit beta 2 | 20S proteasome; complex with beta1/beta2 nonspecifici sulfonamide ligand | 5BOU_J |
| PB | T01.984 | proteasome subunit beta 2 | yeast 20s proteasome beta2-g170a mutant | 5BXL_J |
| PB | T01.984 | proteasome subunit beta 2 | yeast 20s proteasome beta2-g170a mutant in complex with bortezomib | 5BXN_J |
| PB | T01.984 | proteasome subunit beta 2 | 20S proteasome beta5 Gly48Cys mutant | 5CGF_J |
| PB | T01.984 | proteasome subunit beta 2 | 20S proteasome beta5 Gly48Cys mutant; complex with alpha-chloroacetamide 1 | 5CGG_J |
| PB | T01.984 | proteasome subunit beta 2 | 20S proteasome beta5 Gly48Cys mutant; complex with alpha-chloroacetamide 5 | 5CGH_J |
| PB | T01.984 | proteasome subunit beta 2 | 20S proteasome beta5 Gly48Cys mutant; complex with ONX 0914 | 5CGI_J |
| PB | T01.984 | proteasome subunit beta 2 | yeast 20s proteasome at 2.3 a resolution | 5CZ4_J |
| PB | T01.984 | proteasome subunit beta 2 | yeast 20s proteasome beta1-t1a mutant in complex with carfilzomib | 5CZ5_J |
| PB | T01.984 | proteasome subunit beta 2 | yeast 20s proteasome beta5-t1a mutant in complex with syringolin a, propeptide expressed in trans | 5CZ6_J |
| PB | T01.984 | proteasome subunit beta 2 | yeast 20s proteasome beta5-t1a beta5-k81r double mutant in complex with bortezomib, propeptide expressed in cis | 5CZ7_J |
| PB | T01.984 | proteasome subunit beta 2 | yeast 20s proteasome beta5-l(-49)s-k33a mutant in complex with carfilzomib | 5CZ8_J |
| PB | T01.984 | proteasome subunit beta 2 | yeast 20s proteasome beta5-d17n mutant in complex with carfilzomib; propeptide expressed in trans | 5CZ9_J |
| PB | T01.984 | proteasome subunit beta 2 | yeast 20s proteasome beta5-d166n mutant | 5CZA_J |
| PB | T01.984 | proteasome subunit beta 2 | yeast 20s proteasome beta5-d166n mutant in complex with carfilzomib | 5D0S_J |
| PB | T01.984 | proteasome subunit beta 2 | yeast 20s proteasome beta5-d166n mutant in complex with mg132 | 5D0T_J |
| PB | T01.984 | proteasome subunit beta 2 | yeast 20s proteasome beta5-t1c mutant in complex with carfilzomib | 5D0V_J |
| PB | T01.984 | proteasome subunit beta 2 | yeast 20s proteasome beta5-t1s mutant | 5D0W_J |
| PB | T01.984 | proteasome subunit beta 2 | yeast 20s proteasome beta5-t1s mutant in complex with bortezomib | 5D0X_J |
| PB | T01.984 | proteasome subunit beta 2 | yeast 20s proteasome beta5-t1s mutant in complex with carfilzomib | 5D0Z_J |
| PB | T01.984 | proteasome subunit beta 2 | 20S proteasome; complex with alkyne-PI | 5DKI_J |
| PB | T01.984 | proteasome subunit beta 2 | 20S proteasome; complex with octreotide-PI | 5DKJ_J |
| PB | T01.984 | proteasome subunit beta 2 | yeast 20s proteasome beta2-t1a mutant | 5FG7_J |
| PB | T01.984 | proteasome subunit beta 2 | yeast 20s proteasome beta2-t(-2)v mutant | 5FG9_J |
| PB | T01.984 | proteasome subunit beta 2 | yeast 20s proteasome beta5-k33a mutant (propeptide expressed in trans) | 5FGA_J |
| PB | T01.984 | proteasome subunit beta 2 | yeast 20s proteasome beta5-h(-2)l-t1a double mutant in complex with carfilzomib | 5FGD_J |
| PB | T01.984 | proteasome subunit beta 2 | yeast 20s proteasome beta5-h(-2)t-t1a double mutant in complex with carfilzomib | 5FGE_J |
| PB | T01.984 | proteasome subunit beta 2 | yeast 20s proteasome beta5-h(-2)a-t1a-k81r triple mutant in complex with carfilzomib | 5FGF_J |
| PB | T01.984 | proteasome subunit beta 2 | yeast 20s proteasome beta5-l(-49s)_d17n double mutant in complex with carfilzomib | 5FGG_J |
| PB | T01.984 | proteasome subunit beta 2 | yeast 20s proteasome beta5-k33a mutant (propeptide expressed in trans)in complex with mg132 | 5FGH_J |
| PB | T01.984 | proteasome subunit beta 2 | yeast 20s proteasome beta1-t1a beta2-t1a double mutant in complex withcarfilzomib | 5FGI_J |
| PB | T01.984 | proteasome subunit beta 2 | yeast 20s proteasome beta5-k33a mutant (propeptide expressed in trans)in complex with carfilzomib | 5FHS_J |
| PB | T01.984 | proteasome subunit beta 2 | 20s proteasome; complex with the peptidic epoxyketone inhibitor 27 | 5JHR_J |
| PB | T01.984 | proteasome subunit beta 2 | 20s proteasome; complex with the peptidic epoxyketone inhibitor 15 | 5JHS_J |
| PB | T01.984 | proteasome subunit beta 2 | yeast 20s proteasome in complex with epoxyketone inhibitor 14 | 5L52_J |
| PB | T01.984 | proteasome subunit beta 2 | yeast 20s proteasome in complex with epoxyketone inhibitor 16 | 5L54_J |
| PB | T01.984 | proteasome subunit beta 2 | yeast 20s proteasome in complex with epoxyketone inhibitor 18 | 5L55_J |
| PB | T01.984 | proteasome subunit beta 2 | yeast 20s proteasome with human beta5i (1-138; r57t) | 5L5A_J |
| PB | T01.984 | proteasome subunit beta 2 | yeast 20s proteasome with human beta5i (1-138) and human beta6 (97- 111; 118-133) | 5L5B_J |
| PB | T01.984 | proteasome subunit beta 2 | yeast 20s proteasome with human beta5i (1-138) and human beta6 (97- 111; 118-133) in complex with onx 0914 | 5L5D_J |
| PB | T01.984 | proteasome subunit beta 2 | yeast 20s proteasome with human beta5i (1-138) and human beta6 (97- 111; 118-133) in complex with carfilzomib | 5L5E_J |
| PB | T01.984 | proteasome subunit beta 2 | yeast 20s proteasome with human beta5i (1-138) and human beta6 (97- 111; 118-133) in complex with bortezomib | 5L5F_J |
| PB | T01.984 | proteasome subunit beta 2 | yeast 20s proteasome with human beta5i (1-138) and human beta6 (97- 111; 118-133) in complex with pr-924 | 5L5H_J |
| PB | T01.984 | proteasome subunit beta 2 | yeast 20s proteasome with human beta5i (1-138) and human beta6 (97- 111; 118-133) in complex with epoxyketone inhibitor 9 | 5L5I_J |
| PB | T01.984 | proteasome subunit beta 2 | yeast 20s proteasome with human beta5i (1-138) and human beta6 (97- 111; 118-133) in complex with epoxyketone inhibitor 14 | 5L5J_J |
| PB | T01.984 | proteasome subunit beta 2 | yeast 20s proteasome with human beta5i (1-138) and human beta6 (97- 111; 118-133) in complex with epoxyketone inhibitor 16 | 5L5O_J |
| PB | T01.984 | proteasome subunit beta 2 | yeast 20s proteasome with human beta5i (1-138) and human beta6 (97- 111; 118-133) in complex with epoxyketone inhibitor 17 | 5L5P_J |
| PB | T01.984 | proteasome subunit beta 2 | yeast 20s proteasome with human beta5i (1-138) and human beta6 (97- 111; 118-133) in complex with epoxyketone 18 | 5L5Q_J |
| PB | T01.984 | proteasome subunit beta 2 | yeast 20s proteasome with human beta5i (1-138;v31m) and human beta6 (97-111; 118-133) | 5L5R_J |
| PB | T01.984 | proteasome subunit beta 2 | yeast 20s proteasome with human beta5i (1-138; v31m) and human beta6 (97-111; 118-133) in complex with pr-924 | 5L5S_J |
| PB | T01.984 | proteasome subunit beta 2 | yeast 20s proteasome with human beta5i (1-138; v31m) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 16 | 5L5T_J |
| PB | T01.984 | proteasome subunit beta 2 | yeast 20s proteasome with human beta5i (1-138; v31m) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 17 ***caveat 5l5u 04c h 301 has wrong chirality at atom c27 04c k 301 has ***caveat 2 5l5u wrong chirality at atom c27 04c v 301 h | 5L5U_J |
| PB | T01.984 | proteasome subunit beta 2 | yeast 20s proteasome with human beta5c (1-138) and human beta6 (97- 111; 118-133) | 5L5W_J |
| PB | T01.984 | proteasome subunit beta 2 | yeast 20s proteasome with human beta5c (1-138) and human beta6 (97- 111; 118-133) in complex with onx 0914 | 5L5X_J |
| PB | T01.984 | proteasome subunit beta 2 | yeast 20s proteasome with human beta5c (1-138) and human beta6 (97- 111; 118-133) in complex with carfilzomib | 5L5Y_J |
| PB | T01.984 | proteasome subunit beta 2 | yeast 20s proteasome with human beta5c (1-138) and human beta6 (97- 111; 118-133) in complex with bortezomib | 5L5Z_J |
| PB | T01.984 | proteasome subunit beta 2 | yeast 20s proteasome with human beta5c (1-138) and human beta6 (97- 111; 118-133) in complex with pr-924 | 5L60_J |
| PB | T01.984 | proteasome subunit beta 2 | yeast 20s proteasome with human beta5c (1-138) and human beta6 (99- 132) in complex with epoxyketone inhibitor 14 | 5L61_J |
| PB | T01.984 | proteasome subunit beta 2 | yeast 20s proteasome with human beta5c (1-138) and human beta6 (97- 111; 118-133) in complex with epoxyketone inhibitor 16 | 5L62_J |
| PB | T01.984 | proteasome subunit beta 2 | yeast 20s proteasome with human beta5c (1-138) and human beta6 (97- 111; 118-133) in complex with epoxyketone inhibitor 17 ***caveat 5l63 04c h 301 has wrong chirality at atom c27 04c k 301 has ***caveat 2 5l63 wrong chirality at atom c27 04c v 301 has wr | 5L63_J |
| PB | T01.984 | proteasome subunit beta 2 | yeast 20s proteasome with human beta5c (1-138) and human beta6 (97- 111; 118-133) in complex with epoxyketone inhibitor 18 | 5L64_J |
| PB | T01.984 | proteasome subunit beta 2 | yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97- 111; 118-133) in complex with carfilzomib | 5L65_J |
| PB | T01.984 | proteasome subunit beta 2 | yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97- 111; 118-133) in complex with bortezomib | 5L66_J |
| PB | T01.984 | proteasome subunit beta 2 | yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97- 111; 118-133) in complex with pr-924 | 5L67_J |
| PB | T01.984 | proteasome subunit beta 2 | yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97- 111; 118-133) in complex with epoxyketone inhibitor 14 | 5L68_J |
| PB | T01.984 | proteasome subunit beta 2 | yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97- 111; 118-133) in complex with epoxyketone inhibitor 16 | 5L69_J |
| PB | T01.984 | proteasome subunit beta 2 | yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97- 111; 118-133) in complex with epoxyketone inhibitor 17 | 5L6A_J |
| PB | T01.984 | proteasome subunit beta 2 | yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97- 111; 118-133) in complex with onx 0914 | 5L6B_J |
| PB | T01.984 | proteasome subunit beta 2 | yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97- 111; 118-133) in complex with epoxyketone inhibitor 18 | 5L6C_J |
| PB | T01.984 | proteasome subunit beta 2 | ligand-induced aziridine-formation at the yeast proteasomal subunit beta5 by sulfonate esters | 5LAI_J |
| PB | T01.984 | proteasome subunit beta 2 | ligand-induced lys33-thr1 crosslinking at the yeast proteasomal subunit beta5 by sulfonate esters | 5LAJ_J |
| PB | T01.984 | proteasome subunit beta 2 | yeast 20s proteasome with human beta5i (1-138; r57t)in complex with pr-924 | 5LTT_J |
| PB | T01.984 | proteasome subunit beta 2 | yeast 20s proteasome with human beta5i (1-138) and human beta6 (97- 111; 118-133) in complex with thiazole based inhibitor ro19 | 5M2B_J |
| PB | T01.984 | proteasome subunit beta 2 | 26s proteasome in presence of atp (s1) | 5MP9_k |
| PB | T01.984 | proteasome subunit beta 2 | 26s proteasome in presence of atp (s2) | 5MPA_k |
| PB | T01.984 | proteasome subunit beta 2 | yeast 20s proteasome in complex with blm-pep activator | 5NIF_K |
| PB | T01.984 | proteasome subunit beta 2 | yeast 26s proteasome bound to ubiquitinated substrate (4d motor state) | 6EF3_4 |
| PB | T01.984 | proteasome subunit beta 2 | yeast 20s proteasome in complex with cystargolide b | 6G7F_J |
| PB | T01.984 | proteasome subunit beta 2 | yeast 20s proteasome in complex with cystargolide b derivative 1 | 6G8M_J |
| PB | T01.984 | proteasome subunit beta 2 | yeast 20s proteasome in complex with cystargolide b derivative 2 | 6G8N_J |
| PB | T01.984 | proteasome subunit beta 2 | yeast 20s proteasome in complex with homosalinosporamide a | 6GOP_J |
| PB | T01.984 | proteasome subunit beta 2 | yeast 20s proteasome in complex with the peptidic non-covalent bindinginhibitor rts-v5 | 6H39_J |
| PB | T01.984 | proteasome subunit beta 2 | yeast 20s proteasome with human beta2c (s171g) | 6HTB_J |
| PB | T01.984 | proteasome subunit beta 2 | yeast 20s proteasome with human beta2c (s171g) in complex with onx 0914 | 6HTC_J |
| PB | T01.984 | proteasome subunit beta 2 | yeast 20s proteasome with human beta2c (s171g) in complex with 4 | 6HTD_J |
| PB | T01.984 | proteasome subunit beta 2 | yeast 20s proteasome with human beta2c (s171g) in complex with 7 | 6HTP_J |
| PB | T01.984 | proteasome subunit beta 2 | yeast 20s proteasome with human beta2c (s171g) in complex with 13 | 6HTR_J |
| PB | T01.984 | proteasome subunit beta 2 | yeast 20s proteasome with human beta2c (s171g) in complex with 16 | 6HUB_J |
| PB | T01.984 | proteasome subunit beta 2 | yeast 20s proteasome with human beta2c (s171g) in complex with 18 | 6HUC_J |
| PB | T01.984 | proteasome subunit beta 2 | yeast 20s proteasome with human beta2c (s171g) in complex with 20 | 6HUQ_J |
| PB | T01.984 | proteasome subunit beta 2 | yeast 20s proteasome with human beta2c (s171g) in complex with 29 | 6HUU_J |
| PB | T01.984 | proteasome subunit beta 2 | yeast 20s proteasome with human beta2c (s171g) in complex with 39 | 6HUV_J |
| PB | T01.984 | proteasome subunit beta 2 | yeast 20s proteasome with human beta2i (1-53) | 6HV3_J |
| PB | T01.984 | proteasome subunit beta 2 | yeast 20s proteasome with human beta2i (1-53) in complex with onx 0914 | 6HV4_J |
| PB | T01.984 | proteasome subunit beta 2 | yeast 20s proteasome with human beta2i (1-53) in complex with 4 | 6HV5_J |
| PB | T01.984 | proteasome subunit beta 2 | yeast 20s proteasome with human beta2i (1-53) in complex with 7 | 6HV7_J |
| PB | T01.984 | proteasome subunit beta 2 | yeast 20s proteasome with human beta2i (1-53) in complex with 13 | 6HVA_J |
| PB | T01.984 | proteasome subunit beta 2 | yeast 20s proteasome with human beta2i (1-53) in complex with 16 | 6HVR_J |
| PB | T01.984 | proteasome subunit beta 2 | yeast 20s proteasome with human beta2i (1-53) in complex with 18 | 6HVS_J |
| PB | T01.984 | proteasome subunit beta 2 | yeast 20s proteasome with human beta2i (1-53) in complex with 20 | 6HVT_J |
| PB | T01.984 | proteasome subunit beta 2 | yeast 20s proteasome with human beta2i (1-53) in complex with 29 | 6HVU_J |
| PB | T01.984 | proteasome subunit beta 2 | yeast 20s proteasome with human beta2i (1-53) in complex with 39 | 6HVV_J |
| PB | T01.984 | proteasome subunit beta 2 | yeast 20s proteasome with human beta2i (1-53) in complex with 43 | 6HVW_J |
| PB | T01.984 | proteasome subunit beta 2 | yeast 20s proteasome in complex with 4 | 6HVX_J |
| PB | T01.984 | proteasome subunit beta 2 | yeast 20s proteasome in complex with 5 (7- and 6-membered ring) | 6HVY_J |
| PB | T01.984 | proteasome subunit beta 2 | yeast 20s proteasome in complex with 7 | 6HW0_J |
| PB | T01.984 | proteasome subunit beta 2 | yeast 20s proteasome in complex with 13 | 6HW3_J |
| PB | T01.984 | proteasome subunit beta 2 | yeast 20s proteasome in complex with 16 | 6HW4_J |
| PB | T01.984 | proteasome subunit beta 2 | yeast 20s proteasome in complex with 18 | 6HW5_J |
| PB | T01.984 | proteasome subunit beta 2 | yeast 20s proteasome in complex with 20 | 6HW6_J |
| PB | T01.984 | proteasome subunit beta 2 | yeast 20s proteasome in complex with 29 | 6HW7_J |
| PB | T01.984 | proteasome subunit beta 2 | yeast 20s proteasome in complex with 39 | 6HW8_J |
| PB | T01.984 | proteasome subunit beta 2 | yeast 20s proteasome in complex with 41b | 6HW9_J |
| PB | T01.984 | proteasome subunit beta 2 | yeast 20s proteasome in complex with 43 | 6HWA_J |
| PB | T01.984 | proteasome subunit beta 2 | yeast 20s proteasome in complex with 44b | 6HWB_J |
| PB | T01.984 | proteasome subunit beta 2 | yeast 20s proteasome beta2-g45a mutant | 6HWC_J |
| PB | T01.984 | proteasome subunit beta 2 | yeast 20s proteasome beta2-g45a mutant in complex with bortezomib | 6HWD_J |
| PB | T01.984 | proteasome subunit beta 2 | yeast 20s proteasome beta2-g45a mutant in complex with carfilzomib | 6HWE_J |
| PB | T01.984 | proteasome subunit beta 2 | yeast 20s proteasome beta2-g45a mutant in complex with onx 0914 | 6HWF_J |
| PB | T01.984 | proteasome subunit beta 2 | 20S proteasome | 4R3O_K |
| PB | T01.984 | proteasome subunit beta 2 | 20S proteasome; complex with carfilzomib | 4R67_K |
| PB | T01.984 | proteasome subunit beta 2 | cryo-em reveals the conformation of a substrate analogue in the human 20s proteasome core | 5A0Q_K |
| PB | T01.984 | proteasome subunit beta 2 | 26S proteasome; complex with USP14-UbAl | 5GJQ_D |
| PB | T01.984 | proteasome subunit beta 2 | 26S proteasome | 5GJR_D |
| PB | T01.984 | proteasome subunit beta 2 | native human 20s proteasome at 1.8 angstrom ***caveat 5le5 6v1 u 47 has wrong chirality at atom c1 | 5LE5_J |
| PB | T01.984 | proteasome subunit beta 2 | native human 20s proteasome in mg-acetate at 2.2 angstrom ***caveat 5lex 6v1 u 47 has wrong chirality at atom c1 | 5LEX_J |
| PB | T01.984 | proteasome subunit beta 2 | 20s proteasome; complex with oprozomib | 5LEY_J |
| PB | T01.984 | proteasome subunit beta 2 | 20s proteasome; complex with oprozomib in mg-acetate | 5LEZ_J |
| PB | T01.984 | proteasome subunit beta 2 | human 20s proteasome complex with epoxomicin at 2.4 angstrom ***caveat 5lf0 6v1 u 47 has wrong chirality at atom c1 iml c 2 has wrong ***caveat 2 5lf0 chirality at atom cb iml d 2 has wrong chirality at atom ca ***caveat 3 5lf0 iml d 2 has wrong chirality | 5LF0_J |
| PB | T01.984 | proteasome subunit beta 2 | human 20s proteasome complex with dihydroeponemycin at 2.0 angstrom ***caveat 5lf1 6v1 u 47 has wrong chirality at atom c1 | 5LF1_J |
| PB | T01.984 | proteasome subunit beta 2 | human 20s proteasome complex with bortezomib at 2.1 angstrom ***caveat 5lf3 6v1 u 47 has wrong chirality at atom c1 | 5LF3_J |
| PB | T01.984 | proteasome subunit beta 2 | human 20s proteasome complex with delanzomib at 2.0 angstrom ***caveat 5lf4 6v1 u 47 has wrong chirality at atom c1 6v7 n 307 has wrong ***caveat 2 5lf4 chirality at atom c9 6v7 y 306 has wrong chirality at atom ***caveat 3 5lf4 c9 | 5LF4_J |
| PB | T01.984 | proteasome subunit beta 2 | human 20s proteasome complex with z-lly-ketoaldehyde at 2.1 angstrom ***caveat 5lf6 6v1 u 47 has wrong chirality at atom c1 | 5LF6_J |
| PB | T01.984 | proteasome subunit beta 2 | human 20s proteasome complex with ixazomib at 2.0 angstrom ***caveat 5lf7 6v1 u 47 has wrong chirality at atom c1 | 5LF7_J |
| PB | T01.984 | proteasome subunit beta 2 | the human 26s proteasome at 6.8 ang. ***caveat 5ln3 pro h 311 has wrong chirality at atom ca thr n 752 has wrong ***caveat 2 5ln3 chirality at atom ca | 5LN3_4 |
| PB | T01.984 | proteasome subunit beta 2 | 26s proteasome; complex with oprozomib | 5M32_J |
| PB | T01.984 | proteasome subunit beta 2 | structural basis for dynamic regulation of the human 26s proteasome ***caveat 5t0g entry contains improper peptide linkages. | 5T0G_Q |
| PB | T01.984 | proteasome subunit beta 2 | structural basis for dynamic regulation of the human 26s proteasome ***caveat 5t0h entry contains improper peptide linkages. | 5T0H_Q |
| PB | T01.984 | proteasome subunit beta 2 | structural basis for dynamic regulation of the human 26s proteasome ***caveat 5t0i entry contains improper peptide linkages. residue arg k 20 ***caveat 2 5t0i is incorrectly modeled. | 5T0I_Q |
| PB | T01.984 | proteasome subunit beta 2 | structural basis for dynamic regulation of the human 26s proteasome ***caveat 5t0j entry contains improper peptide linkages. | 5T0J_Q |
| PB | T01.984 | proteasome subunit beta 2 | nucleotide-driven triple-state remodeling of the aaa-atpase channel inthe activated human 26s proteasome | 5VFO_Q |
| PB | T01.984 | proteasome subunit beta 2 | nucleotide-driven triple-state remodeling of the aaa-atpase channel inthe activated human 26s proteasome | 5VFR_Q |
| PB | T01.984 | proteasome subunit beta 2 | nucleotide-driven triple-state remodeling of the aaa-atpase channel inthe activated human 26s proteasome | 5VFT_Q |
| PB | T01.984 | proteasome subunit beta 2 | cryo-em structure of human immunoproteasome with a novel noncompetitive inhibitor that selectively inhibits activated lymphocytes | 6AVO_T |
| PB | T01.984 | proteasome subunit beta 2 | endogeneous native human 20s proteasome | 6R70_J |
| PB | T01.984 | proteasome subunit beta 2 | 20S proteasome; complex with PR-957 | 3UNB_J |
| PB | T01.984 | proteasome subunit beta 2 | 20S proteasome | 3UNE_J |
| PB | T01.984 | proteasome subunit beta 2 | 20S immunoproteasome; complex with PR-957 | 3UNF_J |
| PB | T01.984 | proteasome subunit beta 2 | 20S immunoproteasome | 3UNH_J |
| PB | T01.984 | proteasome subunit beta 2 | 20S proteasome complex | 1IRU_K |
| PB | T01.986 | proteasome subunit beta 1 | ground state 26s proteasome (gs2) | 6EPC_6 |
| PB | T01.986 | proteasome subunit beta 1 | substrate processing state 26s proteasome (sps1) ***caveat 6epd pro 2 231 has wrong chirality at atom ca | 6EPD_6 |
| PB | T01.986 | proteasome subunit beta 1 | substrate processing state 26s proteasome (sps2) | 6EPE_6 |
| PB | T01.986 | proteasome subunit beta 1 | ground state 26s proteasome (gs1) | 6EPF_6 |
| PB | T01.986 | proteasome subunit beta 1 | 20S proteasome | 4R3O_M |
| PB | T01.986 | proteasome subunit beta 1 | 20S proteasome; complex with carfilzomib | 4R67_M |
| PB | T01.986 | proteasome subunit beta 1 | cryo-em reveals the conformation of a substrate analogue in the human 20s proteasome core | 5A0Q_M |
| PB | T01.986 | proteasome subunit beta 1 | 26S proteasome; complex with USP14-UbAl | 5GJQ_F |
| PB | T01.986 | proteasome subunit beta 1 | 26S proteasome | 5GJR_F |
| PB | T01.986 | proteasome subunit beta 1 | yeast 20s proteasome with human beta5i (1-138) and human beta6 (97- 111; 118-133) | 5L5B_L |
| PB | T01.986 | proteasome subunit beta 1 | yeast 20s proteasome with human beta5i (1-138) and human beta6 (97- 111; 118-133) in complex with onx 0914 | 5L5D_L |
| PB | T01.986 | proteasome subunit beta 1 | yeast 20s proteasome with human beta5i (1-138) and human beta6 (97- 111; 118-133) in complex with carfilzomib | 5L5E_L |
| PB | T01.986 | proteasome subunit beta 1 | yeast 20s proteasome with human beta5i (1-138) and human beta6 (97- 111; 118-133) in complex with bortezomib | 5L5F_L |
| PB | T01.986 | proteasome subunit beta 1 | yeast 20s proteasome with human beta5i (1-138) and human beta6 (97- 111; 118-133) in complex with pr-924 | 5L5H_L |
| PB | T01.986 | proteasome subunit beta 1 | yeast 20s proteasome with human beta5i (1-138) and human beta6 (97- 111; 118-133) in complex with epoxyketone inhibitor 9 | 5L5I_L |
| PB | T01.986 | proteasome subunit beta 1 | yeast 20s proteasome with human beta5i (1-138) and human beta6 (97- 111; 118-133) in complex with epoxyketone inhibitor 14 | 5L5J_L |
| PB | T01.986 | proteasome subunit beta 1 | yeast 20s proteasome with human beta5i (1-138) and human beta6 (97- 111; 118-133) in complex with epoxyketone inhibitor 16 | 5L5O_L |
| PB | T01.986 | proteasome subunit beta 1 | yeast 20s proteasome with human beta5i (1-138) and human beta6 (97- 111; 118-133) in complex with epoxyketone inhibitor 17 | 5L5P_L |
| PB | T01.986 | proteasome subunit beta 1 | yeast 20s proteasome with human beta5i (1-138) and human beta6 (97- 111; 118-133) in complex with epoxyketone 18 | 5L5Q_L |
| PB | T01.986 | proteasome subunit beta 1 | yeast 20s proteasome with human beta5i (1-138;v31m) and human beta6 (97-111; 118-133) | 5L5R_L |
| PB | T01.986 | proteasome subunit beta 1 | yeast 20s proteasome with human beta5i (1-138; v31m) and human beta6 (97-111; 118-133) in complex with pr-924 | 5L5S_L |
| PB | T01.986 | proteasome subunit beta 1 | yeast 20s proteasome with human beta5i (1-138; v31m) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 16 | 5L5T_L |
| PB | T01.986 | proteasome subunit beta 1 | yeast 20s proteasome with human beta5i (1-138; v31m) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 17 ***caveat 5l5u 04c h 301 has wrong chirality at atom c27 04c k 301 has ***caveat 2 5l5u wrong chirality at atom c27 04c v 301 h | 5L5U_L |
| PB | T01.986 | proteasome subunit beta 1 | yeast 20s proteasome with human beta5c (1-138) and human beta6 (97- 111; 118-133) | 5L5W_L |
| PB | T01.986 | proteasome subunit beta 1 | yeast 20s proteasome with human beta5c (1-138) and human beta6 (97- 111; 118-133) in complex with onx 0914 | 5L5X_L |
| PB | T01.986 | proteasome subunit beta 1 | yeast 20s proteasome with human beta5c (1-138) and human beta6 (97- 111; 118-133) in complex with carfilzomib | 5L5Y_L |
| PB | T01.986 | proteasome subunit beta 1 | yeast 20s proteasome with human beta5c (1-138) and human beta6 (97- 111; 118-133) in complex with bortezomib | 5L5Z_L |
| PB | T01.986 | proteasome subunit beta 1 | yeast 20s proteasome with human beta5c (1-138) and human beta6 (97- 111; 118-133) in complex with pr-924 | 5L60_L |
| PB | T01.986 | proteasome subunit beta 1 | yeast 20s proteasome with human beta5c (1-138) and human beta6 (99- 132) in complex with epoxyketone inhibitor 14 | 5L61_L |
| PB | T01.986 | proteasome subunit beta 1 | yeast 20s proteasome with human beta5c (1-138) and human beta6 (97- 111; 118-133) in complex with epoxyketone inhibitor 16 | 5L62_L |
| PB | T01.986 | proteasome subunit beta 1 | yeast 20s proteasome with human beta5c (1-138) and human beta6 (97- 111; 118-133) in complex with epoxyketone inhibitor 17 ***caveat 5l63 04c h 301 has wrong chirality at atom c27 04c k 301 has ***caveat 2 5l63 wrong chirality at atom c27 04c v 301 has wr | 5L63_L |
| PB | T01.986 | proteasome subunit beta 1 | yeast 20s proteasome with human beta5c (1-138) and human beta6 (97- 111; 118-133) in complex with epoxyketone inhibitor 18 | 5L64_L |
| PB | T01.986 | proteasome subunit beta 1 | native human 20s proteasome at 1.8 angstrom ***caveat 5le5 6v1 u 47 has wrong chirality at atom c1 | 5LE5_L |
| PB | T01.986 | proteasome subunit beta 1 | native human 20s proteasome in mg-acetate at 2.2 angstrom ***caveat 5lex 6v1 u 47 has wrong chirality at atom c1 | 5LEX_L |
| PB | T01.986 | proteasome subunit beta 1 | 20s proteasome; complex with oprozomib | 5LEY_L |
| PB | T01.986 | proteasome subunit beta 1 | 20s proteasome; complex with oprozomib in mg-acetate | 5LEZ_L |
| PB | T01.986 | proteasome subunit beta 1 | human 20s proteasome complex with epoxomicin at 2.4 angstrom ***caveat 5lf0 6v1 u 47 has wrong chirality at atom c1 iml c 2 has wrong ***caveat 2 5lf0 chirality at atom cb iml d 2 has wrong chirality at atom ca ***caveat 3 5lf0 iml d 2 has wrong chirality | 5LF0_L |
| PB | T01.986 | proteasome subunit beta 1 | human 20s proteasome complex with dihydroeponemycin at 2.0 angstrom ***caveat 5lf1 6v1 u 47 has wrong chirality at atom c1 | 5LF1_L |
| PB | T01.986 | proteasome subunit beta 1 | human 20s proteasome complex with bortezomib at 2.1 angstrom ***caveat 5lf3 6v1 u 47 has wrong chirality at atom c1 | 5LF3_L |
| PB | T01.986 | proteasome subunit beta 1 | human 20s proteasome complex with delanzomib at 2.0 angstrom ***caveat 5lf4 6v1 u 47 has wrong chirality at atom c1 6v7 n 307 has wrong ***caveat 2 5lf4 chirality at atom c9 6v7 y 306 has wrong chirality at atom ***caveat 3 5lf4 c9 | 5LF4_L |
| PB | T01.986 | proteasome subunit beta 1 | human 20s proteasome complex with z-lly-ketoaldehyde at 2.1 angstrom ***caveat 5lf6 6v1 u 47 has wrong chirality at atom c1 | 5LF6_L |
| PB | T01.986 | proteasome subunit beta 1 | human 20s proteasome complex with ixazomib at 2.0 angstrom ***caveat 5lf7 6v1 u 47 has wrong chirality at atom c1 | 5LF7_L |
| PB | T01.986 | proteasome subunit beta 1 | the human 26s proteasome at 6.8 ang. ***caveat 5ln3 pro h 311 has wrong chirality at atom ca thr n 752 has wrong ***caveat 2 5ln3 chirality at atom ca | 5LN3_6 |
| PB | T01.986 | proteasome subunit beta 1 | yeast 20s proteasome with human beta5i (1-138) and human beta6 (97- 111; 118-133) in complex with thiazole based inhibitor ro19 | 5M2B_L |
| PB | T01.986 | proteasome subunit beta 1 | 26s proteasome; complex with oprozomib | 5M32_L |
| PB | T01.986 | proteasome subunit beta 1 | structural basis for dynamic regulation of the human 26s proteasome ***caveat 5t0g entry contains improper peptide linkages. | 5T0G_S |
| PB | T01.986 | proteasome subunit beta 1 | structural basis for dynamic regulation of the human 26s proteasome ***caveat 5t0h entry contains improper peptide linkages. | 5T0H_S |
| PB | T01.986 | proteasome subunit beta 1 | structural basis for dynamic regulation of the human 26s proteasome ***caveat 5t0i entry contains improper peptide linkages. residue arg k 20 ***caveat 2 5t0i is incorrectly modeled. | 5T0I_S |
| PB | T01.986 | proteasome subunit beta 1 | structural basis for dynamic regulation of the human 26s proteasome ***caveat 5t0j entry contains improper peptide linkages. | 5T0J_S |
| PB | T01.986 | proteasome subunit beta 1 | nucleotide-driven triple-state remodeling of the aaa-atpase channel inthe activated human 26s proteasome | 5VFO_S |
| PB | T01.986 | proteasome subunit beta 1 | nucleotide-driven triple-state remodeling of the aaa-atpase channel inthe activated human 26s proteasome | 5VFR_S |
| PB | T01.986 | proteasome subunit beta 1 | nucleotide-driven triple-state remodeling of the aaa-atpase channel inthe activated human 26s proteasome | 5VFT_S |
| PB | T01.986 | proteasome subunit beta 1 | cryo-em structure of human immunoproteasome with a novel noncompetitive inhibitor that selectively inhibits activated lymphocytes | 6AVO_S |
| PB | T01.986 | proteasome subunit beta 1 | endogeneous native human 20s proteasome | 6R70_L |
| PB | T01.987 | proteasome subunit beta 4 | ground state 26s proteasome (gs2) | 6EPC_7 |
| PB | T01.987 | proteasome subunit beta 4 | substrate processing state 26s proteasome (sps1) ***caveat 6epd pro 2 231 has wrong chirality at atom ca | 6EPD_7 |
| PB | T01.987 | proteasome subunit beta 4 | substrate processing state 26s proteasome (sps2) | 6EPE_7 |
| PB | T01.987 | proteasome subunit beta 4 | ground state 26s proteasome (gs1) | 6EPF_7 |
| PB | T01.987 | proteasome subunit beta 4 | 20S proteasome | 4R3O_N |
| PB | T01.987 | proteasome subunit beta 4 | 20S proteasome; complex with carfilzomib | 4R67_N |
| PB | T01.987 | proteasome subunit beta 4 | cryo-em reveals the conformation of a substrate analogue in the human 20s proteasome core | 5A0Q_N |
| PB | T01.987 | proteasome subunit beta 4 | 26S proteasome; complex with USP14-UbAl | 5GJQ_G |
| PB | T01.987 | proteasome subunit beta 4 | 26S proteasome | 5GJR_G |
| PB | T01.987 | proteasome subunit beta 4 | native human 20s proteasome at 1.8 angstrom ***caveat 5le5 6v1 u 47 has wrong chirality at atom c1 | 5LE5_M |
| PB | T01.987 | proteasome subunit beta 4 | native human 20s proteasome in mg-acetate at 2.2 angstrom ***caveat 5lex 6v1 u 47 has wrong chirality at atom c1 | 5LEX_M |
| PB | T01.987 | proteasome subunit beta 4 | 20s proteasome; complex with oprozomib | 5LEY_M |
| PB | T01.987 | proteasome subunit beta 4 | 20s proteasome; complex with oprozomib in mg-acetate | 5LEZ_M |
| PB | T01.987 | proteasome subunit beta 4 | human 20s proteasome complex with epoxomicin at 2.4 angstrom ***caveat 5lf0 6v1 u 47 has wrong chirality at atom c1 iml c 2 has wrong ***caveat 2 5lf0 chirality at atom cb iml d 2 has wrong chirality at atom ca ***caveat 3 5lf0 iml d 2 has wrong chirality | 5LF0_M |
| PB | T01.987 | proteasome subunit beta 4 | human 20s proteasome complex with dihydroeponemycin at 2.0 angstrom ***caveat 5lf1 6v1 u 47 has wrong chirality at atom c1 | 5LF1_M |
| PB | T01.987 | proteasome subunit beta 4 | human 20s proteasome complex with bortezomib at 2.1 angstrom ***caveat 5lf3 6v1 u 47 has wrong chirality at atom c1 | 5LF3_M |
| PB | T01.987 | proteasome subunit beta 4 | human 20s proteasome complex with delanzomib at 2.0 angstrom ***caveat 5lf4 6v1 u 47 has wrong chirality at atom c1 6v7 n 307 has wrong ***caveat 2 5lf4 chirality at atom c9 6v7 y 306 has wrong chirality at atom ***caveat 3 5lf4 c9 | 5LF4_M |
| PB | T01.987 | proteasome subunit beta 4 | human 20s proteasome complex with z-lly-ketoaldehyde at 2.1 angstrom ***caveat 5lf6 6v1 u 47 has wrong chirality at atom c1 | 5LF6_M |
| PB | T01.987 | proteasome subunit beta 4 | human 20s proteasome complex with ixazomib at 2.0 angstrom ***caveat 5lf7 6v1 u 47 has wrong chirality at atom c1 | 5LF7_M |
| PB | T01.987 | proteasome subunit beta 4 | the human 26s proteasome at 6.8 ang. ***caveat 5ln3 pro h 311 has wrong chirality at atom ca thr n 752 has wrong ***caveat 2 5ln3 chirality at atom ca | 5LN3_7 |
| PB | T01.987 | proteasome subunit beta 4 | 26s proteasome; complex with oprozomib | 5M32_M |
| PB | T01.987 | proteasome subunit beta 4 | structural basis for dynamic regulation of the human 26s proteasome ***caveat 5t0g entry contains improper peptide linkages. | 5T0G_T |
| PB | T01.987 | proteasome subunit beta 4 | structural basis for dynamic regulation of the human 26s proteasome ***caveat 5t0h entry contains improper peptide linkages. | 5T0H_T |
| PB | T01.987 | proteasome subunit beta 4 | structural basis for dynamic regulation of the human 26s proteasome ***caveat 5t0i entry contains improper peptide linkages. residue arg k 20 ***caveat 2 5t0i is incorrectly modeled. | 5T0I_T |
| PB | T01.987 | proteasome subunit beta 4 | structural basis for dynamic regulation of the human 26s proteasome ***caveat 5t0j entry contains improper peptide linkages. | 5T0J_T |
| PB | T01.987 | proteasome subunit beta 4 | nucleotide-driven triple-state remodeling of the aaa-atpase channel inthe activated human 26s proteasome | 5VFO_T |
| PB | T01.987 | proteasome subunit beta 4 | nucleotide-driven triple-state remodeling of the aaa-atpase channel inthe activated human 26s proteasome | 5VFR_T |
| PB | T01.987 | proteasome subunit beta 4 | nucleotide-driven triple-state remodeling of the aaa-atpase channel inthe activated human 26s proteasome | 5VFT_T |
| PB | T01.987 | proteasome subunit beta 4 | cryo-em structure of human immunoproteasome with a novel noncompetitive inhibitor that selectively inhibits activated lymphocytes | 6AVO_W |
| PB | T01.987 | proteasome subunit beta 4 | endogeneous native human 20s proteasome | 6R70_M |
| PB | T01.987 | proteasome subunit beta 4 | 20S proteasome; complex with PR-957 | 3UNB_M |
| PB | T01.987 | proteasome subunit beta 4 | 20S proteasome | 3UNE_M |
| PB | T01.987 | proteasome subunit beta 4 | 20S immunoproteasome; complex with PR-957 | 3UNF_M |
| PB | T01.987 | proteasome subunit beta 4 | 20S immunoproteasome | 3UNH_M |
| PB | T01.987 | proteasome subunit beta 4 | 20S proteasome complex | 1IRU_N |
| PB | T01.990 | similar to splicing factor U2AF homolog (Mus musculus) | 20S proteasome complex | 1IRU_M |
| PB | T01.997 | Mername-AA244 peptidase homologue | 20S proteasome complex | 5FMG_J |
| PB | T01.A02 | proteasome subunit beta2 (Drosophila melanogaster) | 20S proteasome complex | 1IRU_I |
| PB | T01.A02 | proteasome subunit beta2 (Drosophila melanogaster) | 20S proteasome complex | 5FMG_I |
| PB | T01.A12 | 20S proteasome component beta 6 | 20S proteasome in complex with activator PA26 (Trypanosoma brucei) | 1FNT_M |
| PB | T01.A12 | 20S proteasome component beta 6 | complete proteasome | 1G0U_L |
| PB | T01.A12 | 20S proteasome component beta 6 | complex with epoxomicin | 1G65_L |
| PB | T01.A12 | 20S proteasome component beta 6 | proteasome complex bound to TMC-95A inhibitor | 1JD2_L |
| PB | T01.A12 | 20S proteasome component beta 6 | 20S proteasome | 1RYP_M |
| PB | T01.A12 | 20S proteasome component beta 6 | 20S proteasome; complex with the proteasome activator PA26 from Trypanosoma brucei | 1Z7Q_M |
| PB | T01.A12 | 20S proteasome component beta 6 | 20S proteasome;complex with bortezomib | 2F16_L |
| PB | T01.A12 | 20S proteasome component beta 6 | 20S proteasome; complex with salinosporamide A | 2FAK_L |
| PB | T01.A12 | 20S proteasome component beta 6 | 20S proteasome; complex with homobelactosin C | 2FNY_L |
| PB | T01.A12 | 20S proteasome component beta 6 | 20S proteasome; complex with TMC-95 based biphenyl-ether macrocycle | 2GPL_L |
| PB | T01.A12 | 20S proteasome component beta 6 | 20S proteasome; complex with syringolin A | 2ZCY_L |
| PB | T01.A12 | 20S proteasome component beta 6 | 20S proteasome; complex with glidobactin A | 3BDM_L |
| PB | T01.A12 | 20S proteasome component beta 6 | 20S proteasome; complex with fellutamide B | 3D29_L |
| PB | T01.A12 | 20S proteasome component beta 6 | 20s proteasome; complex with the epimer form of spirolactacystin | 3DY3_L |
| PB | T01.A12 | 20S proteasome component beta 6 | 20s proteasome; complex with spirolactacystin | 3DY4_L |
| PB | T01.A12 | 20S proteasome component beta 6 | 20s proteasome; complex with homobelactosin c | 3E47_L |
| PB | T01.A12 | 20S proteasome component beta 6 | 20s proteasome; complex with syringolin b | 3GPJ_L |
| PB | T01.A12 | 20S proteasome component beta 6 | 20S proteasome; complex with salinosporamide derivative | 3GPT_L |
| PB | T01.A12 | 20S proteasome component beta 6 | 20S proteasome; complex with salinosporamide derivative | 3GPW_L |
| PB | T01.A12 | 20S proteasome component beta 6 | 20S proteasome; complex with hyroxylated salinosporamide | 3HYE_L |
| PB | T01.A12 | 20S proteasome component beta 6 | 20S proteasome; complex with bortezomib | 3MG0_L |
| PB | T01.A12 | 20S proteasome component beta 6 | 20S proteasome; complex with compound 1 | 3MG4_L |
| PB | T01.A12 | 20S proteasome component beta 6 | 20S proteasome; complex with compound 6 | 3MG6_L |
| PB | T01.A12 | 20S proteasome component beta 6 | 20S open-gate proteasome; complex with compound 6 | 3MG7_L |
| PB | T01.A12 | 20S proteasome component beta 6 | 20S open-gate proteasome; complex with compound 16 | 3MG8_L |
| PB | T01.A12 | 20S proteasome component beta 6 | 20S proteasome; complex with ligand 2a | 3NZJ_L |
| PB | T01.A12 | 20S proteasome component beta 6 | 20S proteasome; complex with ligand 2b | 3NZW_L |
| PB | T01.A12 | 20S proteasome component beta 6 | 20S proteasome; complex with ligand 2c | 3NZX_L |
| PB | T01.A12 | 20S proteasome component beta 6 | 20S open-gate proteasome; complex with compound 24 | 3OEU_L |
| PB | T01.A12 | 20S proteasome component beta 6 | 20S open-gate proteasome; complex with compound 25 | 3OEV_L |
| PB | T01.A12 | 20S proteasome component beta 6 | 20S proteasome; complex with alpha-keto-aldehyde | 3OKJ_L |
| PB | T01.A12 | 20S proteasome component beta 6 | 20S open-gate proteasome; complex with compound 20 | 3SDI_L |
| PB | T01.A12 | 20S proteasome component beta 6 | 20S open-gate proteasome; complex with compound 34 | 3SDK_L |
| PB | T01.A12 | 20S proteasome component beta 6 | 20S proteasome; complex with hydroxyurea derivative HU10 | 3SHJ_L |
| PB | T01.A12 | 20S proteasome component beta 6 | 20S proteasome; complex with homobelactosin C | 3TDD_L |
| PB | T01.A12 | 20S proteasome component beta 6 | 20S open-gate proteasome; complex with PR-957 (morpholine) | 3UN4_L |
| PB | T01.A12 | 20S proteasome component beta 6 | 20S proteasome; complex with PR-957 (epoxide) | 3UN8_L |
| PB | T01.A12 | 20S proteasome component beta 6 | 26S proteasome | 3WXR_M |
| PB | T01.A12 | 20S proteasome component beta 6 | 26S proteasome | 4CR2 |
| PB | T01.A12 | 20S proteasome component beta 6 | 4CR3 | |
| PB | T01.A12 | 20S proteasome component beta 6 | 26S proteasome | 4CR4 |
| PB | T01.A12 | 20S proteasome component beta 6 | 20S proteasome; complex with K-7174 | 4EU2_M |
| PB | T01.A12 | 20S proteasome component beta 6 | 20S proteasome; complex with cepafungin I | 4FZC_L |
| PB | T01.A12 | 20S proteasome component beta 6 | 20S proteasome; complex with glidobactin | 4FZG_L |
| PB | T01.A12 | 20S proteasome component beta 6 | 20S proteasome; complex with Syringolin-Glidobactin chimera | 4G4S_M |
| PB | T01.A12 | 20S proteasome component beta 6 | 20S proteasome; complex with Syringolin-Glidobactin chimera | 4GK7_L |
| PB | T01.A12 | 20S proteasome component beta 6 | 20S proteasome; complex with vinylketone carmaphycin analogue VNK1 | 4HNP_L |
| PB | T01.A12 | 20S proteasome component beta 6 | 20S proteasome; complex with epoxyketone carmaphycin analogue 3 | 4HRC_L |
| PB | T01.A12 | 20S proteasome component beta 6 | 20S proteasome; complex with carmaphycin A | 4HRD_L |
| PB | T01.A12 | 20S proteasome component beta 6 | 20S proteasome; complex with vinyl sulfone LU102 | 4INR_L |
| PB | T01.A12 | 20S proteasome component beta 6 | 20S proteasome; complex with vinyl sulfone LU122 | 4INT_L |
| PB | T01.A12 | 20S proteasome component beta 6 | 20S proteasome; complex with vinyl sulfone LU112 | 4INU_L |
| PB | T01.A12 | 20S proteasome component beta 6 | 20S proteasome; complex with belactosin derivative 3E | 4J70_L |
| PB | T01.A12 | 20S proteasome component beta 6 | 20S proteasome; complex with dimerized linear mimetic of TMC-95A | 4JSQ_L |
| PB | T01.A12 | 20S proteasome component beta 6 | 20S proteasome; complex with dimerized linear mimetic of TMC-95A | 4JSU_L |
| PB | T01.A12 | 20S proteasome component beta 6 | 20S proteasome; complex with dimerized linear mimetic of TMC-95A | 4JT0_L |
| PB | T01.A12 | 20S proteasome component beta 6 | 20S proteasome; complex with vibralactone | 4LQI_L |
| PB | T01.A12 | 20S proteasome component beta 6 | 20S proteasome; complex with enone carmaphycin analogue 6 | 4LTC_L |
| PB | T01.A12 | 20S proteasome component beta 6 | 20S proteasome; complex with MG132 | 4NNN_L |
| PB | T01.A12 | 20S proteasome component beta 6 | 20S proteasome; complex with Z-Leu-Leu-Leu-ketoaldehyde | 4NNW_L |
| PB | T01.A12 | 20S proteasome component beta 6 | 20S proteasome; complex with Z-Leu-Leu-Leu-B(OH)2 | 4NO1_L |
| PB | T01.A12 | 20S proteasome component beta 6 | 20S proteasome; complex with Z-Leu-Leu-Leu-vinylsulfone | 4NO6_L |
| PB | T01.A12 | 20S proteasome component beta 6 | 20S proteasome; complex with Z-Leu-Leu-Leu-ketoamide | 4NO8_L |
| PB | T01.A12 | 20S proteasome component beta 6 | 20S proteasome; complex with Z-Leu-Leu-Leu-epoxyketone | 4NO9_L |
| PB | T01.A12 | 20S proteasome component beta 6 | 20S proteasome; complex with kendomycin | 4Q1S_L |
| PB | T01.A12 | 20S proteasome component beta 6 | 20S proteasome; complex with Boc-Ala-Ala-Ala-CHO | 4QBY_L |
| PB | T01.A12 | 20S proteasome component beta 6 | 20S proteasome; complex with epoxyketone inhibitor 8 | 4QLQ_L |
| PB | T01.A12 | 20S proteasome component beta 6 | 20S proteasome; complex with epoxyketone inhibitor 11 | 4QLS_L |
| PB | T01.A12 | 20S proteasome component beta 6 | 20S proteasome; complex with tripeptidic epoxyketone inhibitor 2 | 4QLT_L |
| PB | T01.A12 | 20S proteasome component beta 6 | 20S proteasome; complex with tripeptidic epoxyketone inhibitor 9 | 4QLU_L |
| PB | T01.A12 | 20S proteasome component beta 6 | 20S proteasome; complex with tripeptidic epoxyketone inhibitor 17 | 4QLV_L |
| PB | T01.A12 | 20S proteasome component beta 6 | 20S proteasome | 4QUX_L |
| PB | T01.A12 | 20S proteasome component beta 6 | 20S proteasome | 4QUY_L |
| PB | T01.A12 | 20S proteasome component beta 6 | 20S proteasome | 4QV0_L |
| PB | T01.A12 | 20S proteasome component beta 6 | 20S proteasome | 4QV1_L |
| PB | T01.A12 | 20S proteasome component beta 6 | 20S proteasome | 4QV3_L |
| PB | T01.A12 | 20S proteasome component beta 6 | 20S proteasome beta5 Met45Thr mutant | 4QV4_L |
| PB | T01.A12 | 20S proteasome component beta 6 | 20S proteasome beta5 Met45Ile mutant | 4QV5_L |
| PB | T01.A12 | 20S proteasome component beta 6 | 20S proteasome | 4QV6_L |
| PB | T01.A12 | 20S proteasome component beta 6 | 20S proteasome | 4QV7_L |
| PB | T01.A12 | 20S proteasome component beta 6 | 20S proteasome | 4QV8_L |
| PB | T01.A12 | 20S proteasome component beta 6 | 20S proteasome | 4QV9_L |
| PB | T01.A12 | 20S proteasome component beta 6 | 20S proteasome; complex with bortezomib | 4QVL_L |
| PB | T01.A12 | 20S proteasome component beta 6 | 20S proteasome beta5 Met45Ala mutant; complex with bortezomib | 4QVM_L |
| PB | T01.A12 | 20S proteasome component beta 6 | 20S proteasome beta5 Met45Val mutant; complex with bortezomib | 4QVN_L |
| PB | T01.A12 | 20S proteasome component beta 6 | 20S proteasome beta5 Met45Thr mutant; complex with bortezomib | 4QVP_L |
| PB | T01.A12 | 20S proteasome component beta 6 | 20S proteasome beta5 Met45Ile mutant; complex with bortezomib | 4QVQ_L |
| PB | T01.A12 | 20S proteasome component beta 6 | 20S proteasome beta5 Ala49Val mutant; complex with bortezomib | 4QVV_L |
| PB | T01.A12 | 20S proteasome component beta 6 | 20S proteasome beta5 Ala49Ser mutant; complex with bortezomib | 4QVW_L |
| PB | T01.A12 | 20S proteasome component beta 6 | 20S proteasome beta5 Ala49Thr mutant; complex with bortezomib | 4QVY_L |
| PB | T01.A12 | 20S proteasome component beta 6 | 20S proteasome beta5 Ala49Thr,Ala50Val mutant; complex with bortezomib | 4QW0_L |
| PB | T01.A12 | 20S proteasome component beta 6 | 20S proteasome beta5 Ala50Val mutant; complex with bortezomib | 4QW1_L |
| PB | T01.A12 | 20S proteasome component beta 6 | 20S proteasome beta5 Cys63Phe mutant; complex with bortezomib | 4QW3_L |
| PB | T01.A12 | 20S proteasome component beta 6 | 20S proteasome; complex with carfilzomib | 4QW4_L |
| PB | T01.A12 | 20S proteasome component beta 6 | 20S proteasome beta5 Met45Ala mutant; complex with carfilzomib | 4QW5_L |
| PB | T01.A12 | 20S proteasome component beta 6 | 20S proteasome beta5 Met45Val mutant; complex with carfilzomib | 4QW6_L |
| PB | T01.A12 | 20S proteasome component beta 6 | 20S proteasome beta5 Met45Thr mutant; complex with carfilzomib | 4QW7_L |
| PB | T01.A12 | 20S proteasome component beta 6 | 20S proteasome beta5 Met45Ile mutant; complex with carfilzomib | 4QWF_L |
| PB | T01.A12 | 20S proteasome component beta 6 | 20S proteasome beta5 Ala49Val mutant; complex with carfilzomib | 4QWG_L |
| PB | T01.A12 | 20S proteasome component beta 6 | 20S proteasome beta5 Ala49Ser mutant; complex with carfilzomib | 4QWI_L |
| PB | T01.A12 | 20S proteasome component beta 6 | 20S proteasome beta5 Ala49Thr mutant; complex with carfilzomib | 4QWJ_L |
| PB | T01.A12 | 20S proteasome component beta 6 | 20S proteasome beta5 Ala49Thr, Ala50Val mutant; complex with carfilzomib | 4QWK_L |
| PB | T01.A12 | 20S proteasome component beta 6 | 20S proteasome beta5 Ala50Val mutant; complex with carfilzomib | 4QWL_L |
| PB | T01.A12 | 20S proteasome component beta 6 | 20S proteasome beta5 Cys52Phe mutant; complex with carfilzomib | 4QWR_L |
| PB | T01.A12 | 20S proteasome component beta 6 | 20S proteasome beta5 Cys63Phe mutant; complex with carfilzomib | 4QWS_L |
| PB | T01.A12 | 20S proteasome component beta 6 | 20S proteasome beta5 Cys52Phe mutant; complex with bortezomib | 4QWU_L |
| PB | T01.A12 | 20S proteasome component beta 6 | 20S proteasome; complex with epoxyketone inhibitor ONX 0914 | 4QWX_L |
| PB | T01.A12 | 20S proteasome component beta 6 | 20S proteasome beta 5 Met45Ala mutant; complex with epoxyketone inhibitor ONX 0914 | 4QXJ_L |
| PB | T01.A12 | 20S proteasome component beta 6 | complete proteasome; complex with epoxyketone inhibitor ONX 0914 | 4QZ0_L |
| PB | T01.A12 | 20S proteasome component beta 6 | 20S proteasome beta 5 Met45Thr mutant; complex with epoxyketone inhibitor ONX 0914 | 4QZ1_L |
| PB | T01.A12 | 20S proteasome component beta 6 | 20S proteasome beta 5 Met45Ile mutant; complex with epoxyketone inhibitor ONX 0914 | 4QZ2_L |
| PB | T01.A12 | 20S proteasome component beta 6 | 20S proteasome beta 5 Ala49Val mutant; complex with epoxyketone inhibitor ONX 0914 | 4QZ3_L |
| PB | T01.A12 | 20S proteasome component beta 6 | 20S proteasome beta 5 Ala49Ser mutant; complex with epoxyketone inhibitor ONX 0914 | 4QZ4_L |
| PB | T01.A12 | 20S proteasome component beta 6 | 20S proteasome beta 5 Ala49Thr mutant; complex with epoxyketone inhibitor ONX 0914 | 4QZ5_L |
| PB | T01.A12 | 20S proteasome component beta 6 | 20S proteasome beta 5 Ala49Thr, Ala50Val mutant; complex with epoxyketone inhibitor ONX 0914 | 4QZ6_L |
| PB | T01.A12 | 20S proteasome component beta 6 | 20S proteasome beta 5 Ala50Val mutant; complex with epoxyketone inhibitor ONX 0914 | 4QZ7_L |
| PB | T01.A12 | 20S proteasome component beta 6 | 20S proteasome beta 5 Cys52Phe mutant; complex with epoxyketone inhibitor ONX 0914 | 4QZW_L |
| PB | T01.A12 | 20S proteasome component beta 6 | complete proteasome; complex with epoxyketone inhibitor ONX 0914 | 4QZX_L |
| PB | T01.A12 | 20S proteasome component beta 6 | 20S proteasome; complex with omuralide | 4QZZ_L |
| PB | T01.A12 | 20S proteasome component beta 6 | 20S proteasome beta 5 Cys52Phe mutant; complex with omuralide | 4R00_L |
| PB | T01.A12 | 20S proteasome component beta 6 | 20S proteasome; complex with BSC4999 | 4R02_L |
| PB | T01.A12 | 20S proteasome component beta 6 | 20S proteasome; ligand induced aziridine-formation in beta5 | 4R17_L |
| PB | T01.A12 | 20S proteasome component beta 6 | 20S proteasome; ligand induced Lys33-Thr1 cross-linking in beta5 | 4R18_L |
| PB | T01.A12 | 20S proteasome component beta 6 | 20S proteasome; complex with alkaloid indolo-phakellin | 4RUR_L |
| PB | T01.A12 | 20S proteasome component beta 6 | 4V7O | |
| PB | T01.A12 | 20S proteasome component beta 6 | 20S proteasome; complex with PR-VI modulator | 4X6Z_M |
| PB | T01.A12 | 20S proteasome component beta 6 | 20S proteasome; complex with Ac-Pro-Ala-Asp-EP | 4Y69_L |
| PB | T01.A12 | 20S proteasome component beta 6 | 20S proteasome beta2 His114Asp mutant; complex with Ac-Pro-Ala-Asp-EP | 4Y6A_L |
| PB | T01.A12 | 20S proteasome component beta 6 | 20S proteasome; complex with Ac-Pro-Ala-Glu-EP | 4Y6V_L |
| PB | T01.A12 | 20S proteasome component beta 6 | 20S proteasome; complex with Ac-Pro-Ala-Leu-EP | 4Y6Z_L |
| PB | T01.A12 | 20S proteasome component beta 6 | 20S proteasome; complex with Ac-Leu-Ala-Val-EP | 4Y70_L |
| PB | T01.A12 | 20S proteasome component beta 6 | 20S proteasome; complex with Ac-Leu-Ala-Leu-EP | 4Y74_L |
| PB | T01.A12 | 20S proteasome component beta 6 | 20S proteasome; complex with Ac-Pro-Ala-Phe-EP | 4Y75_L |
| PB | T01.A12 | 20S proteasome component beta 6 | 20S proteasome; complex with Ac-Leu-Ala-Phe-EP | 4Y77_L |
| PB | T01.A12 | 20S proteasome component beta 6 | 20S proteasome; complex with Ac-Leu-Ala-Asp-EP | 4Y78_L |
| PB | T01.A12 | 20S proteasome component beta 6 | 20S proteasome; complex with Ac-Leu-Ala-Glu-EP | 4Y7W_L |
| PB | T01.A12 | 20S proteasome component beta 6 | complete proteasome; complex with Ac-PAA-ep | 4Y7X_L |
| PB | T01.A12 | 20S proteasome component beta 6 | 20S proteasome; complex with Ac-Leu-Ala-Ala-EP | 4Y7Y_L |
| PB | T01.A12 | 20S proteasome component beta 6 | 20S proteasome; complex with Ac-Leu-Ala-Ile-EP | 4Y80_L |
| PB | T01.A12 | 20S proteasome component beta 6 | 20S proteasome; complex with Ac-Pro-Ala-Tyr-EP | 4Y81_L |
| PB | T01.A12 | 20S proteasome component beta 6 | 20S proteasome; complex with Ac-Leu-Ala-Tyr-EP | 4Y82_L |
| PB | T01.A12 | 20S proteasome component beta 6 | 20S proteasome; complex with N3-Ala(4,4-F2P)-Asn-Leu-Leu-EP | 4Y84_L |
| PB | T01.A12 | 20S proteasome component beta 6 | 20S proteasome; complex with N3-Ala-Pro-Asn-Leu-Leu-EP | 4Y8G_L |
| PB | T01.A12 | 20S proteasome component beta 6 | 20S proteasome; complex with N3-Ala-Pro-Ala-Leu-EP | 4Y8H_L |
| PB | T01.A12 | 20S proteasome component beta 6 | 20S proteasome; complex with Ac-Pro-Leu-Leu-EP | 4Y8I_L |
| PB | T01.A12 | 20S proteasome component beta 6 | 20S proteasome; complex with Ac-Leu-Leu-Leu-EP | 4Y8J_L |
| PB | T01.A12 | 20S proteasome component beta 6 | 20S proteasome; complex with H-Ala-Pro-Leu-Leu-EP | 4Y8K_L |
| PB | T01.A12 | 20S proteasome component beta 6 | 20S proteasome; complex with Ac-Ala-Pro-Leu-Leu-EP | 4Y8L_L |
| PB | T01.A12 | 20S proteasome component beta 6 | 20S proteasome beta7-delta7 C-terminal mutant | 4Y8M_L |
| PB | T01.A12 | 20S proteasome component beta 6 | 20S proteasome beta7-delta7 C-terminal mutant; complex with Ac-Pro-Ala-Glu-EP | 4Y8N_L |
| PB | T01.A12 | 20S proteasome component beta 6 | 20S proteasome beta 7-delta 7 C-terminal mutant; complex with Ac-Pro-Ala-Phe-EP | 4Y8O_L |
| PB | T01.A12 | 20S proteasome component beta 6 | 20S proteasome beta 7-delta 7 C-terminal mutant; complex with Ac-Pro-Ala-Leu-EP | 4Y8P_L |
| PB | T01.A12 | 20S proteasome component beta 6 | 20S proteasome beta 7-delta 7 C-terminal mutant; complex with Ac-Pro-Ala-Tyr-EP | 4Y8Q_L |
| PB | T01.A12 | 20S proteasome component beta 6 | 20S proteasome beta 2 His116Asp mutant | 4Y8R_L |
| PB | T01.A12 | 20S proteasome component beta 6 | 20S proteasome beta 2 His116Asp mutant; complex with Ac-Leu-Ala-Glu-EP | 4Y8S_L |
| PB | T01.A12 | 20S proteasome component beta 6 | 20S proteasome beta 2 His116Asp mutant; complex with Ac-Pro-Ala-Glu-EP | 4Y8T_L |
| PB | T01.A12 | 20S proteasome component beta 6 | 20S proteasome beta 2 His116Asp mutant; complex with Ac-Pro-Ala-Asp-EP | 4Y8U_L |
| PB | T01.A12 | 20S proteasome component beta 6 | 20S proteasome beta 2 His116Glu mutant | 4Y9Y_L |
| PB | T01.A12 | 20S proteasome component beta 6 | 20S proteasome beta 2 His116Glu mutant; complex with Ac-Leu-Ala-Glu-EP | 4Y9Z_L |
| PB | T01.A12 | 20S proteasome component beta 6 | 20S proteasome beta 2 His116Glu mutant; complex with Ac-Pro-Ala-Glu-EP | 4YA0_L |
| PB | T01.A12 | 20S proteasome component beta 6 | 20S proteasome beta 2 His116Asn mutant | 4YA1_L |
| PB | T01.A12 | 20S proteasome component beta 6 | 20S proteasome beta 2 His116Asn mutant; complex with Ac-Leu-Ala-Glu-EP | 4YA2_L |
| PB | T01.A12 | 20S proteasome component beta 6 | 20S proteasome beta 2 His116Asn mutant; complex with Ac-Pro-Ala-Glu-EP | 4YA3_L |
| PB | T01.A12 | 20S proteasome component beta 6 | 20S proteasome beta 2 His114Asp mutant | 4YA4_L |
| PB | T01.A12 | 20S proteasome component beta 6 | 20S proteasome beta 2 His114Asp mutant; complex with Ac-Pro-Ala-Glu-EP | 4YA5_L |
| PB | T01.A12 | 20S proteasome component beta 6 | 20S proteasome beta 2 His114Asp mutant; complex with Ac-Leu-Ala-Glu-EP | 4YA7_L |
| PB | T01.A12 | 20S proteasome component beta 6 | 20S proteasome beta 2 His114Asp mutant; complex with AC-Leu-Ala-Asp-EP | 4YA9_L |
| PB | T01.A12 | 20S proteasome component beta 6 | 20S proteasome; complex with belactosin C derivative 3 | 4Z1L_L |
| PB | T01.A12 | 20S proteasome component beta 6 | 5A5B | |
| PB | T01.A12 | 20S proteasome component beta 6 | 20S proteasome; complex with macyranone A | 5AHJ_L |
| PB | T01.A12 | 20S proteasome component beta 6 | 20S proteasome; complex with beta1/beta2 nonspecifici sulfonamide ligand | 5BOU_L |
| PB | T01.A12 | 20S proteasome component beta 6 | yeast 20s proteasome beta2-g170a mutant | 5BXL_L |
| PB | T01.A12 | 20S proteasome component beta 6 | yeast 20s proteasome beta2-g170a mutant in complex with bortezomib | 5BXN_L |
| PB | T01.A12 | 20S proteasome component beta 6 | 20S proteasome beta5 Gly48Cys mutant | 5CGF_L |
| PB | T01.A12 | 20S proteasome component beta 6 | 20S proteasome beta5 Gly48Cys mutant; complex with alpha-chloroacetamide 1 | 5CGG_L |
| PB | T01.A12 | 20S proteasome component beta 6 | 20S proteasome beta5 Gly48Cys mutant; complex with alpha-chloroacetamide 5 | 5CGH_L |
| PB | T01.A12 | 20S proteasome component beta 6 | 20S proteasome beta5 Gly48Cys mutant; complex with ONX 0914 | 5CGI_L |
| PB | T01.A12 | 20S proteasome component beta 6 | yeast 20s proteasome at 2.3 a resolution | 5CZ4_L |
| PB | T01.A12 | 20S proteasome component beta 6 | yeast 20s proteasome beta1-t1a mutant in complex with carfilzomib | 5CZ5_L |
| PB | T01.A12 | 20S proteasome component beta 6 | yeast 20s proteasome beta5-t1a mutant in complex with syringolin a, propeptide expressed in trans | 5CZ6_L |
| PB | T01.A12 | 20S proteasome component beta 6 | yeast 20s proteasome beta5-t1a beta5-k81r double mutant in complex with bortezomib, propeptide expressed in cis | 5CZ7_L |
| PB | T01.A12 | 20S proteasome component beta 6 | yeast 20s proteasome beta5-l(-49)s-k33a mutant in complex with carfilzomib | 5CZ8_L |
| PB | T01.A12 | 20S proteasome component beta 6 | yeast 20s proteasome beta5-d17n mutant in complex with carfilzomib; propeptide expressed in trans | 5CZ9_L |
| PB | T01.A12 | 20S proteasome component beta 6 | yeast 20s proteasome beta5-d166n mutant | 5CZA_L |
| PB | T01.A12 | 20S proteasome component beta 6 | yeast 20s proteasome beta5-d166n mutant in complex with carfilzomib | 5D0S_L |
| PB | T01.A12 | 20S proteasome component beta 6 | 20s proteasome beta5-Asp166Asn mutant; complex with MG132 | 5D0T_L |
| PB | T01.A12 | 20S proteasome component beta 6 | yeast 20s proteasome beta5-t1c mutant in complex with carfilzomib | 5D0V_L |
| PB | T01.A12 | 20S proteasome component beta 6 | yeast 20s proteasome beta5-t1s mutant | 5D0W_L |
| PB | T01.A12 | 20S proteasome component beta 6 | yeast 20s proteasome beta5-t1s mutant in complex with bortezomib | 5D0X_L |
| PB | T01.A12 | 20S proteasome component beta 6 | yeast 20s proteasome beta5-t1s mutant in complex with carfilzomib | 5D0Z_L |
| PB | T01.A12 | 20S proteasome component beta 6 | 20S proteasome; complex with alkyne-PI | 5DKI_L |
| PB | T01.A12 | 20S proteasome component beta 6 | 20S proteasome; complex with octreotide-PI | 5DKJ_L |
| PB | T01.A12 | 20S proteasome component beta 6 | yeast 20s proteasome beta2-t1a mutant | 5FG7_L |
| PB | T01.A12 | 20S proteasome component beta 6 | yeast 20s proteasome beta2-t(-2)v mutant | 5FG9_L |
| PB | T01.A12 | 20S proteasome component beta 6 | yeast 20s proteasome beta5-k33a mutant (propeptide expressed in trans) | 5FGA_L |
| PB | T01.A12 | 20S proteasome component beta 6 | yeast 20s proteasome beta5-h(-2)l-t1a double mutant in complex with carfilzomib | 5FGD_L |
| PB | T01.A12 | 20S proteasome component beta 6 | yeast 20s proteasome beta5-h(-2)t-t1a double mutant in complex with carfilzomib | 5FGE_L |
| PB | T01.A12 | 20S proteasome component beta 6 | yeast 20s proteasome beta5-h(-2)a-t1a-k81r triple mutant in complex with carfilzomib | 5FGF_L |
| PB | T01.A12 | 20S proteasome component beta 6 | yeast 20s proteasome beta5-l(-49s)_d17n double mutant in complex with carfilzomib | 5FGG_L |
| PB | T01.A12 | 20S proteasome component beta 6 | 20s proteasome beta5-Lys33Ala mutant (propeptide expressed in trans); complex with MG132 | 5FGH_L |
| PB | T01.A12 | 20S proteasome component beta 6 | yeast 20s proteasome beta1-t1a beta2-t1a double mutant in complex withcarfilzomib | 5FGI_L |
| PB | T01.A12 | 20S proteasome component beta 6 | yeast 20s proteasome beta5-k33a mutant (propeptide expressed in trans)in complex with carfilzomib | 5FHS_L |
| PB | T01.A12 | 20S proteasome component beta 6 | 20s proteasome; complex with the peptidic epoxyketone inhibitor 27 | 5JHR_L |
| PB | T01.A12 | 20S proteasome component beta 6 | 20s proteasome; complex with the peptidic epoxyketone inhibitor 15 | 5JHS_L |
| PB | T01.A12 | 20S proteasome component beta 6 | 20s proteasome; complex with epoxyketone inhibitor 14 | 5L52_L |
| PB | T01.A12 | 20S proteasome component beta 6 | 20s proteasome; complex with epoxyketone inhibitor 16 | 5L54_L |
| PB | T01.A12 | 20S proteasome component beta 6 | 20s proteasome; complex with epoxyketone inhibitor 18 | 5L55_L |
| PB | T01.A12 | 20S proteasome component beta 6 | yeast 20s proteasome with human beta5i (1-138; r57t) | 5L5A_L |
| PB | T01.A12 | 20S proteasome component beta 6 | yeast 20s proteasome with human beta5i (1-138) and human beta6 (97- 111; 118-133) | 5L5B_L |
| PB | T01.A12 | 20S proteasome component beta 6 | yeast 20s proteasome with human beta5i (1-138) and human beta6 (97- 111; 118-133) in complex with onx 0914 | 5L5D_L |
| PB | T01.A12 | 20S proteasome component beta 6 | yeast 20s proteasome with human beta5i (1-138) and human beta6 (97- 111; 118-133) in complex with carfilzomib | 5L5E_L |
| PB | T01.A12 | 20S proteasome component beta 6 | yeast 20s proteasome with human beta5i (1-138) and human beta6 (97- 111; 118-133) in complex with bortezomib | 5L5F_L |
| PB | T01.A12 | 20S proteasome component beta 6 | yeast 20s proteasome with human beta5i (1-138) and human beta6 (97- 111; 118-133) in complex with pr-924 | 5L5H_L |
| PB | T01.A12 | 20S proteasome component beta 6 | yeast 20s proteasome with human beta5i (1-138) and human beta6 (97- 111; 118-133) in complex with epoxyketone inhibitor 9 | 5L5I_L |
| PB | T01.A12 | 20S proteasome component beta 6 | yeast 20s proteasome with human beta5i (1-138) and human beta6 (97- 111; 118-133) in complex with epoxyketone inhibitor 14 | 5L5J_L |
| PB | T01.A12 | 20S proteasome component beta 6 | yeast 20s proteasome with human beta5i (1-138) and human beta6 (97- 111; 118-133) in complex with epoxyketone inhibitor 16 | 5L5O_L |
| PB | T01.A12 | 20S proteasome component beta 6 | yeast 20s proteasome with human beta5i (1-138) and human beta6 (97- 111; 118-133) in complex with epoxyketone inhibitor 17 | 5L5P_L |
| PB | T01.A12 | 20S proteasome component beta 6 | yeast 20s proteasome with human beta5i (1-138) and human beta6 (97- 111; 118-133) in complex with epoxyketone 18 | 5L5Q_L |
| PB | T01.A12 | 20S proteasome component beta 6 | yeast 20s proteasome with human beta5i (1-138;v31m) and human beta6 (97-111; 118-133) | 5L5R_L |
| PB | T01.A12 | 20S proteasome component beta 6 | yeast 20s proteasome with human beta5i (1-138; v31m) and human beta6 (97-111; 118-133) in complex with pr-924 | 5L5S_L |
| PB | T01.A12 | 20S proteasome component beta 6 | yeast 20s proteasome with human beta5i (1-138; v31m) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 16 | 5L5T_L |
| PB | T01.A12 | 20S proteasome component beta 6 | yeast 20s proteasome with human beta5i (1-138; v31m) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 17 ***caveat 5l5u 04c h 301 has wrong chirality at atom c27 04c k 301 has ***caveat 2 5l5u wrong chirality at atom c27 04c v 301 h | 5L5U_L |
| PB | T01.A12 | 20S proteasome component beta 6 | yeast 20s proteasome with human beta5c (1-138) and human beta6 (97- 111; 118-133) | 5L5W_L |
| PB | T01.A12 | 20S proteasome component beta 6 | yeast 20s proteasome with human beta5c (1-138) and human beta6 (97- 111; 118-133) in complex with onx 0914 | 5L5X_L |
| PB | T01.A12 | 20S proteasome component beta 6 | yeast 20s proteasome with human beta5c (1-138) and human beta6 (97- 111; 118-133) in complex with carfilzomib | 5L5Y_L |
| PB | T01.A12 | 20S proteasome component beta 6 | yeast 20s proteasome with human beta5c (1-138) and human beta6 (97- 111; 118-133) in complex with bortezomib | 5L5Z_L |
| PB | T01.A12 | 20S proteasome component beta 6 | yeast 20s proteasome with human beta5c (1-138) and human beta6 (97- 111; 118-133) in complex with pr-924 | 5L60_L |
| PB | T01.A12 | 20S proteasome component beta 6 | yeast 20s proteasome with human beta5c (1-138) and human beta6 (99- 132) in complex with epoxyketone inhibitor 14 | 5L61_L |
| PB | T01.A12 | 20S proteasome component beta 6 | yeast 20s proteasome with human beta5c (1-138) and human beta6 (97- 111; 118-133) in complex with epoxyketone inhibitor 16 | 5L62_L |
| PB | T01.A12 | 20S proteasome component beta 6 | yeast 20s proteasome with human beta5c (1-138) and human beta6 (97- 111; 118-133) in complex with epoxyketone inhibitor 17 ***caveat 5l63 04c h 301 has wrong chirality at atom c27 04c k 301 has ***caveat 2 5l63 wrong chirality at atom c27 04c v 301 has wr | 5L63_L |
| PB | T01.A12 | 20S proteasome component beta 6 | yeast 20s proteasome with human beta5c (1-138) and human beta6 (97- 111; 118-133) in complex with epoxyketone inhibitor 18 | 5L64_L |
| PB | T01.A12 | 20S proteasome component beta 6 | yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97- 111; 118-133) in complex with carfilzomib | 5L65_L |
| PB | T01.A12 | 20S proteasome component beta 6 | yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97- 111; 118-133) in complex with bortezomib | 5L66_L |
| PB | T01.A12 | 20S proteasome component beta 6 | yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97- 111; 118-133); complex with PR-924 | 5L67_L |
| PB | T01.A12 | 20S proteasome component beta 6 | yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97- 111; 118-133) in complex with epoxyketone inhibitor 14 | 5L68_L |
| PB | T01.A12 | 20S proteasome component beta 6 | yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97- 111; 118-133) in complex with epoxyketone inhibitor 16 | 5L69_L |
| PB | T01.A12 | 20S proteasome component beta 6 | yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97- 111; 118-133) in complex with epoxyketone inhibitor 17 | 5L6A_L |
| PB | T01.A12 | 20S proteasome component beta 6 | yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97- 111; 118-133) in complex with onx 0914 | 5L6B_L |
| PB | T01.A12 | 20S proteasome component beta 6 | yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97- 111; 118-133) in complex with epoxyketone inhibitor 18 | 5L6C_L |
| PB | T01.A12 | 20S proteasome component beta 6 | ligand-induced aziridine-formation at the yeast proteasomal subunit beta5 by sulfonate esters | 5LAI_L |
| PB | T01.A12 | 20S proteasome component beta 6 | ligand-induced lys33-thr1 crosslinking at the yeast proteasomal subunit beta5 by sulfonate esters | 5LAJ_L |
| PB | T01.A12 | 20S proteasome component beta 6 | yeast 20s proteasome with human beta5i (1-138; Arg57Thr mutant)in complex with PR-924 | 5LTT_L |
| PB | T01.A12 | 20S proteasome component beta 6 | yeast 20s proteasome with human beta5i (1-138) and human beta6 (97- 111; 118-133) in complex with thiazole based inhibitor ro19 | 5M2B_L |
| PB | T01.A12 | 20S proteasome component beta 6 | 26s proteasome in presence of atp (s1) | 5MP9_m |
| PB | T01.A12 | 20S proteasome component beta 6 | 26s proteasome in presence of atp (s2) | 5MPA_m |
| PB | T01.A12 | 20S proteasome component beta 6 | yeast 20s proteasome in complex with blm-pep activator | 5NIF_M |
| PB | T01.A12 | 20S proteasome component beta 6 | yeast 26s proteasome bound to ubiquitinated substrate (4d motor state) | 6EF3_6 |
| PB | T01.A12 | 20S proteasome component beta 6 | yeast 20s proteasome in complex with cystargolide B | 6G7F_L |
| PB | T01.A12 | 20S proteasome component beta 6 | yeast 20s proteasome in complex with cystargolide B derivative 1 | 6G8M_L |
| PB | T01.A12 | 20S proteasome component beta 6 | yeast 20s proteasome in complex with cystargolide B derivative 2 | 6G8N_L |
| PB | T01.A12 | 20S proteasome component beta 6 | yeast 20s proteasome in complex with homosalinosporamide a | 6GOP_L |
| PB | T01.A12 | 20S proteasome component beta 6 | yeast 20s proteasome in complex with the peptidic non-covalent bindinginhibitor rts-v5 | 6H39_L |
| PB | T01.A12 | 20S proteasome component beta 6 | yeast 20s proteasome with human beta2c (s171g) | 6HTB_L |
| PB | T01.A12 | 20S proteasome component beta 6 | yeast 20s proteasome with human beta2c (s171g) in complex with onx 0914 | 6HTC_L |
| PB | T01.A12 | 20S proteasome component beta 6 | yeast 20s proteasome with human beta2c (s171g) in complex with 4 | 6HTD_L |
| PB | T01.A12 | 20S proteasome component beta 6 | yeast 20s proteasome with human beta2c (s171g) in complex with 7 | 6HTP_L |
| PB | T01.A12 | 20S proteasome component beta 6 | yeast 20s proteasome with human beta2c (s171g) in complex with 13 | 6HTR_L |
| PB | T01.A12 | 20S proteasome component beta 6 | yeast 20s proteasome with human beta2c (s171g) in complex with 16 | 6HUB_L |
| PB | T01.A12 | 20S proteasome component beta 6 | yeast 20s proteasome with human beta2c (s171g) in complex with 18 | 6HUC_L |
| PB | T01.A12 | 20S proteasome component beta 6 | yeast 20s proteasome with human beta2c (s171g) in complex with 20 | 6HUQ_L |
| PB | T01.A12 | 20S proteasome component beta 6 | yeast 20s proteasome with human beta2c (s171g) in complex with 29 | 6HUU_L |
| PB | T01.A12 | 20S proteasome component beta 6 | yeast 20s proteasome with human beta2c (s171g) in complex with 39 | 6HUV_L |
| PB | T01.A12 | 20S proteasome component beta 6 | yeast 20s proteasome with human beta2i (1-53) | 6HV3_L |
| PB | T01.A12 | 20S proteasome component beta 6 | yeast 20s proteasome with human beta2i (1-53) in complex with onx 0914 | 6HV4_L |
| PB | T01.A12 | 20S proteasome component beta 6 | yeast 20s proteasome with human beta2i (1-53) in complex with 4 | 6HV5_L |
| PB | T01.A12 | 20S proteasome component beta 6 | yeast 20s proteasome with human beta2i (1-53) in complex with 7 | 6HV7_L |
| PB | T01.A12 | 20S proteasome component beta 6 | yeast 20s proteasome with human beta2i (1-53) in complex with 13 | 6HVA_L |
| PB | T01.A12 | 20S proteasome component beta 6 | yeast 20s proteasome with human beta2i (1-53) in complex with 16 | 6HVR_L |
| PB | T01.A12 | 20S proteasome component beta 6 | yeast 20s proteasome with human beta2i (1-53) in complex with 18 | 6HVS_L |
| PB | T01.A12 | 20S proteasome component beta 6 | yeast 20s proteasome with human beta2i (1-53) in complex with 20 | 6HVT_L |
| PB | T01.A12 | 20S proteasome component beta 6 | yeast 20s proteasome with human beta2i (1-53) in complex with 29 | 6HVU_L |
| PB | T01.A12 | 20S proteasome component beta 6 | yeast 20s proteasome with human beta2i (1-53) in complex with 39 | 6HVV_L |
| PB | T01.A12 | 20S proteasome component beta 6 | yeast 20s proteasome with human beta2i (1-53) in complex with 43 | 6HVW_L |
| PB | T01.A12 | 20S proteasome component beta 6 | yeast 20s proteasome in complex with 4 | 6HVX_L |
| PB | T01.A12 | 20S proteasome component beta 6 | yeast 20s proteasome in complex with 5 (7- and 6-membered ring) | 6HVY_L |
| PB | T01.A12 | 20S proteasome component beta 6 | yeast 20s proteasome in complex with 7 | 6HW0_L |
| PB | T01.A12 | 20S proteasome component beta 6 | yeast 20s proteasome in complex with 13 | 6HW3_L |
| PB | T01.A12 | 20S proteasome component beta 6 | yeast 20s proteasome in complex with 16 | 6HW4_L |
| PB | T01.A12 | 20S proteasome component beta 6 | yeast 20s proteasome in complex with 18 | 6HW5_L |
| PB | T01.A12 | 20S proteasome component beta 6 | yeast 20s proteasome in complex with 20 | 6HW6_L |
| PB | T01.A12 | 20S proteasome component beta 6 | yeast 20s proteasome in complex with 29 | 6HW7_L |
| PB | T01.A12 | 20S proteasome component beta 6 | yeast 20s proteasome in complex with 39 | 6HW8_L |
| PB | T01.A12 | 20S proteasome component beta 6 | yeast 20s proteasome in complex with 41b | 6HW9_L |
| PB | T01.A12 | 20S proteasome component beta 6 | yeast 20s proteasome in complex with 43 | 6HWA_L |
| PB | T01.A12 | 20S proteasome component beta 6 | yeast 20s proteasome in complex with 44b | 6HWB_L |
| PB | T01.A12 | 20S proteasome component beta 6 | yeast 20s proteasome beta2-g45a mutant | 6HWC_L |
| PB | T01.A12 | 20S proteasome component beta 6 | yeast 20s proteasome beta2-g45a mutant in complex with bortezomib | 6HWD_L |
| PB | T01.A12 | 20S proteasome component beta 6 | yeast 20s proteasome beta2-g45a mutant in complex with carfilzomib | 6HWE_L |
| PB | T01.A12 | 20S proteasome component beta 6 | yeast 20s proteasome beta2-g45a mutant in complex with onx 0914 | 6HWF_L |
| PB | T01.A13 | psmB4-2 g.p. (Dictyostelium discoideum) | 20S proteasome in complex with activator PA26 (Trypanosoma brucei) | 1FNT_N |
| PB | T01.A13 | psmB4-2 g.p. (Dictyostelium discoideum) | complete proteasome | 1G0U_M |
| PB | T01.A13 | psmB4-2 g.p. (Dictyostelium discoideum) | complex with epoxomicin | 1G65_M |
| PB | T01.A13 | psmB4-2 g.p. (Dictyostelium discoideum) | proteasome complex bound to TMC-95A inhibitor | 1JD2_M |
| PB | T01.A13 | psmB4-2 g.p. (Dictyostelium discoideum) | 20S proteasome | 1RYP_N |
| PB | T01.A13 | psmB4-2 g.p. (Dictyostelium discoideum) | 20S proteasome; complex with the proteasome activator PA26 from Trypanosoma brucei | 1Z7Q_N |
| PB | T01.A13 | psmB4-2 g.p. (Dictyostelium discoideum) | 2F16 | |
| PB | T01.A13 | psmB4-2 g.p. (Dictyostelium discoideum) | 20S proteasome;complex with bortezomib | 2F16_M |
| PB | T01.A13 | psmB4-2 g.p. (Dictyostelium discoideum) | 2FAK | |
| PB | T01.A13 | psmB4-2 g.p. (Dictyostelium discoideum) | 20S proteasome; complex with salinosporamide A | 2FAK_M |
| PB | T01.A13 | psmB4-2 g.p. (Dictyostelium discoideum) | 20S proteasome; complex with homobelactosin C | 2FNY_M |
| PB | T01.A13 | psmB4-2 g.p. (Dictyostelium discoideum) | 2GPL | |
| PB | T01.A13 | psmB4-2 g.p. (Dictyostelium discoideum) | 20S proteasome; complex with TMC-95 based biphenyl-ether macrocycle | 2GPL_M |
| PB | T01.A13 | psmB4-2 g.p. (Dictyostelium discoideum) | 2ZCY | |
| PB | T01.A13 | psmB4-2 g.p. (Dictyostelium discoideum) | 20S proteasome; complex with syringolin A | 2ZCY_M |
| PB | T01.A13 | psmB4-2 g.p. (Dictyostelium discoideum) | 3BDM | |
| PB | T01.A13 | psmB4-2 g.p. (Dictyostelium discoideum) | 20S proteasome; complex with glidobactin A | 3BDM_M |
| PB | T01.A13 | psmB4-2 g.p. (Dictyostelium discoideum) | 3D29 | |
| PB | T01.A13 | psmB4-2 g.p. (Dictyostelium discoideum) | 20S proteasome; complex with fellutamide B | 3D29_M |
| PB | T01.A13 | psmB4-2 g.p. (Dictyostelium discoideum) | 3DY3 | |
| PB | T01.A13 | psmB4-2 g.p. (Dictyostelium discoideum) | 20s proteasome; complex with the epimer form of spirolactacystin | 3DY3_M |
| PB | T01.A13 | psmB4-2 g.p. (Dictyostelium discoideum) | 3DY4 | |
| PB | T01.A13 | psmB4-2 g.p. (Dictyostelium discoideum) | 20s proteasome; complex with spirolactacystin | 3DY4_M |
| PB | T01.A13 | psmB4-2 g.p. (Dictyostelium discoideum) | 20s proteasome; complex with homobelactosin c | 3E47 |
| PB | T01.A13 | psmB4-2 g.p. (Dictyostelium discoideum) | 20s proteasome; complex with homobelactosin c | 3E47_M |
| PB | T01.A13 | psmB4-2 g.p. (Dictyostelium discoideum) | 20s proteasome; complex with syringolin b | 3GPJ |
| PB | T01.A13 | psmB4-2 g.p. (Dictyostelium discoideum) | 20s proteasome; complex with syringolin b | 3GPJ_M |
| PB | T01.A13 | psmB4-2 g.p. (Dictyostelium discoideum) | 20S proteasome; complex with salinosporamide derivative | 3GPT_M |
| PB | T01.A13 | psmB4-2 g.p. (Dictyostelium discoideum) | 20S proteasome; complex with salinosporamide derivative | 3GPW_M |
| PB | T01.A13 | psmB4-2 g.p. (Dictyostelium discoideum) | 20S proteasome; complex with hyroxylated salinosporamide | 3HYE_M |
| PB | T01.A13 | psmB4-2 g.p. (Dictyostelium discoideum) | 20S proteasome; complex with bortezomib | 3MG0_M |
| PB | T01.A13 | psmB4-2 g.p. (Dictyostelium discoideum) | 20S proteasome; complex with compound 1 | 3MG4_M |
| PB | T01.A13 | psmB4-2 g.p. (Dictyostelium discoideum) | 20S proteasome; complex with compound 6 | 3MG6_M |
| PB | T01.A13 | psmB4-2 g.p. (Dictyostelium discoideum) | 20S open-gate proteasome; complex with compound 6 | 3MG7_M |
| PB | T01.A13 | psmB4-2 g.p. (Dictyostelium discoideum) | 20S open-gate proteasome; complex with compound 16 | 3MG8_M |
| PB | T01.A13 | psmB4-2 g.p. (Dictyostelium discoideum) | 20S proteasome; complex with ligand 2a | 3NZJ_M |
| PB | T01.A13 | psmB4-2 g.p. (Dictyostelium discoideum) | 20S proteasome; complex with ligand 2b | 3NZW_M |
| PB | T01.A13 | psmB4-2 g.p. (Dictyostelium discoideum) | 20S proteasome; complex with ligand 2c | 3NZX_M |
| PB | T01.A13 | psmB4-2 g.p. (Dictyostelium discoideum) | 20S open-gate proteasome; complex with compound 24 | 3OEU_M |
| PB | T01.A13 | psmB4-2 g.p. (Dictyostelium discoideum) | 20S open-gate proteasome; complex with compound 25 | 3OEV_M |
| PB | T01.A13 | psmB4-2 g.p. (Dictyostelium discoideum) | 20S proteasome; complex with alpha-keto-aldehyde | 3OKJ_M |
| PB | T01.A13 | psmB4-2 g.p. (Dictyostelium discoideum) | 20S open-gate proteasome; complex with compound 20 | 3SDI_M |
| PB | T01.A13 | psmB4-2 g.p. (Dictyostelium discoideum) | 20S open-gate proteasome; complex with compound 34 | 3SDK_M |
| PB | T01.A13 | psmB4-2 g.p. (Dictyostelium discoideum) | 20S proteasome; complex with hydroxyurea derivative HU10 | 3SHJ_M |
| PB | T01.A13 | psmB4-2 g.p. (Dictyostelium discoideum) | 20S proteasome; complex with homobelactosin C | 3TDD_M |
| PB | T01.A13 | psmB4-2 g.p. (Dictyostelium discoideum) | 20S open-gate proteasome; complex with PR-957 (morpholine) | 3UN4_M |
| PB | T01.A13 | psmB4-2 g.p. (Dictyostelium discoideum) | 20S proteasome; complex with PR-957 (epoxide) | 3UN8_M |
| PB | T01.A13 | psmB4-2 g.p. (Dictyostelium discoideum) | 26S proteasome | 3WXR_N |
| PB | T01.A13 | psmB4-2 g.p. (Dictyostelium discoideum) | 26S proteasome | 4CR2 |
| PB | T01.A13 | psmB4-2 g.p. (Dictyostelium discoideum) | 4CR3 | |
| PB | T01.A13 | psmB4-2 g.p. (Dictyostelium discoideum) | 26S proteasome | 4CR4 |
| PB | T01.A13 | psmB4-2 g.p. (Dictyostelium discoideum) | 20S proteasome; complex with K-7174 | 4EU2_N |
| PB | T01.A13 | psmB4-2 g.p. (Dictyostelium discoideum) | 20S proteasome; complex with cepafungin I | 4FZC_M |
| PB | T01.A13 | psmB4-2 g.p. (Dictyostelium discoideum) | 20S proteasome; complex with glidobactin | 4FZG_M |
| PB | T01.A13 | psmB4-2 g.p. (Dictyostelium discoideum) | 20S proteasome; complex with Syringolin-Glidobactin chimera | 4G4S_N |
| PB | T01.A13 | psmB4-2 g.p. (Dictyostelium discoideum) | 20S proteasome; complex with Syringolin-Glidobactin chimera | 4GK7_M |
| PB | T01.A13 | psmB4-2 g.p. (Dictyostelium discoideum) | 20S proteasome; complex with vinylketone carmaphycin analogue VNK1 | 4HNP_M |
| PB | T01.A13 | psmB4-2 g.p. (Dictyostelium discoideum) | 20S proteasome; complex with epoxyketone carmaphycin analogue 3 | 4HRC_M |
| PB | T01.A13 | psmB4-2 g.p. (Dictyostelium discoideum) | 20S proteasome; complex with carmaphycin A | 4HRD_M |
| PB | T01.A13 | psmB4-2 g.p. (Dictyostelium discoideum) | 20S proteasome; complex with vinyl sulfone LU102 | 4INR_M |
| PB | T01.A13 | psmB4-2 g.p. (Dictyostelium discoideum) | 20S proteasome; complex with vinyl sulfone LU122 | 4INT_M |
| PB | T01.A13 | psmB4-2 g.p. (Dictyostelium discoideum) | 20S proteasome; complex with vinyl sulfone LU112 | 4INU_M |
| PB | T01.A13 | psmB4-2 g.p. (Dictyostelium discoideum) | 20S proteasome; complex with belactosin derivative 3E | 4J70_M |
| PB | T01.A13 | psmB4-2 g.p. (Dictyostelium discoideum) | 20S proteasome; complex with dimerized linear mimetic of TMC-95A | 4JSQ_M |
| PB | T01.A13 | psmB4-2 g.p. (Dictyostelium discoideum) | 20S proteasome; complex with dimerized linear mimetic of TMC-95A | 4JSU_M |
| PB | T01.A13 | psmB4-2 g.p. (Dictyostelium discoideum) | 20S proteasome; complex with dimerized linear mimetic of TMC-95A | 4JT0_M |
| PB | T01.A13 | psmB4-2 g.p. (Dictyostelium discoideum) | 20S proteasome; complex with vibralactone | 4LQI_M |
| PB | T01.A13 | psmB4-2 g.p. (Dictyostelium discoideum) | 20S proteasome; complex with enone carmaphycin analogue 6 | 4LTC_M |
| PB | T01.A13 | psmB4-2 g.p. (Dictyostelium discoideum) | 20S proteasome; complex with MG132 | 4NNN_M |
| PB | T01.A13 | psmB4-2 g.p. (Dictyostelium discoideum) | 20S proteasome; complex with Z-Leu-Leu-Leu-ketoaldehyde | 4NNW_M |
| PB | T01.A13 | psmB4-2 g.p. (Dictyostelium discoideum) | 20S proteasome; complex with Z-Leu-Leu-Leu-B(OH)2 | 4NO1_M |
| PB | T01.A13 | psmB4-2 g.p. (Dictyostelium discoideum) | 20S proteasome; complex with Z-Leu-Leu-Leu-vinylsulfone | 4NO6_M |
| PB | T01.A13 | psmB4-2 g.p. (Dictyostelium discoideum) | 20S proteasome; complex with Z-Leu-Leu-Leu-ketoamide | 4NO8_M |
| PB | T01.A13 | psmB4-2 g.p. (Dictyostelium discoideum) | 20S proteasome; complex with Z-Leu-Leu-Leu-epoxyketone | 4NO9_M |
| PB | T01.A13 | psmB4-2 g.p. (Dictyostelium discoideum) | 20S proteasome; complex with kendomycin | 4Q1S_M |
| PB | T01.A13 | psmB4-2 g.p. (Dictyostelium discoideum) | 20S proteasome; complex with Boc-Ala-Ala-Ala-CHO | 4QBY_M |
| PB | T01.A13 | psmB4-2 g.p. (Dictyostelium discoideum) | 20S proteasome; complex with epoxyketone inhibitor 8 | 4QLQ_M |
| PB | T01.A13 | psmB4-2 g.p. (Dictyostelium discoideum) | 20S proteasome; complex with epoxyketone inhibitor 11 | 4QLS_M |
| PB | T01.A13 | psmB4-2 g.p. (Dictyostelium discoideum) | 20S proteasome; complex with tripeptidic epoxyketone inhibitor 2 | 4QLT_M |
| PB | T01.A13 | psmB4-2 g.p. (Dictyostelium discoideum) | 20S proteasome; complex with tripeptidic epoxyketone inhibitor 9 | 4QLU_M |
| PB | T01.A13 | psmB4-2 g.p. (Dictyostelium discoideum) | 20S proteasome; complex with tripeptidic epoxyketone inhibitor 17 | 4QLV_M |
| PB | T01.A13 | psmB4-2 g.p. (Dictyostelium discoideum) | 20S proteasome | 4QUX_M |
| PB | T01.A13 | psmB4-2 g.p. (Dictyostelium discoideum) | 20S proteasome | 4QUY_M |
| PB | T01.A13 | psmB4-2 g.p. (Dictyostelium discoideum) | 20S proteasome | 4QV0_M |
| PB | T01.A13 | psmB4-2 g.p. (Dictyostelium discoideum) | 20S proteasome | 4QV1_M |
| PB | T01.A13 | psmB4-2 g.p. (Dictyostelium discoideum) | 20S proteasome | 4QV3_M |
| PB | T01.A13 | psmB4-2 g.p. (Dictyostelium discoideum) | 20S proteasome beta5 Met45Thr mutant | 4QV4_M |
| PB | T01.A13 | psmB4-2 g.p. (Dictyostelium discoideum) | 20S proteasome beta5 Met45Ile mutant | 4QV5_M |
| PB | T01.A13 | psmB4-2 g.p. (Dictyostelium discoideum) | 20S proteasome | 4QV6_M |
| PB | T01.A13 | psmB4-2 g.p. (Dictyostelium discoideum) | 20S proteasome | 4QV7_M |
| PB | T01.A13 | psmB4-2 g.p. (Dictyostelium discoideum) | 20S proteasome | 4QV8_M |
| PB | T01.A13 | psmB4-2 g.p. (Dictyostelium discoideum) | 20S proteasome | 4QV9_M |
| PB | T01.A13 | psmB4-2 g.p. (Dictyostelium discoideum) | 20S proteasome; complex with bortezomib | 4QVL_M |
| PB | T01.A13 | psmB4-2 g.p. (Dictyostelium discoideum) | 20S proteasome beta5 Met45Ala mutant; complex with bortezomib | 4QVM_M |
| PB | T01.A13 | psmB4-2 g.p. (Dictyostelium discoideum) | 20S proteasome beta5 Met45Val mutant; complex with bortezomib | 4QVN_M |
| PB | T01.A13 | psmB4-2 g.p. (Dictyostelium discoideum) | 20S proteasome beta5 Met45Thr mutant; complex with bortezomib | 4QVP_M |
| PB | T01.A13 | psmB4-2 g.p. (Dictyostelium discoideum) | 20S proteasome beta5 Met45Ile mutant; complex with bortezomib | 4QVQ_M |
| PB | T01.A13 | psmB4-2 g.p. (Dictyostelium discoideum) | 20S proteasome beta5 Ala49Val mutant; complex with bortezomib | 4QVV_M |
| PB | T01.A13 | psmB4-2 g.p. (Dictyostelium discoideum) | 20S proteasome beta5 Ala49Ser mutant; complex with bortezomib | 4QVW_M |
| PB | T01.A13 | psmB4-2 g.p. (Dictyostelium discoideum) | 20S proteasome beta5 Ala49Thr mutant; complex with bortezomib | 4QVY_M |
| PB | T01.A13 | psmB4-2 g.p. (Dictyostelium discoideum) | 20S proteasome beta5 Ala49Thr,Ala50Val mutant; complex with bortezomib | 4QW0_M |
| PB | T01.A13 | psmB4-2 g.p. (Dictyostelium discoideum) | 20S proteasome beta5 Ala50Val mutant; complex with bortezomib | 4QW1_M |
| PB | T01.A13 | psmB4-2 g.p. (Dictyostelium discoideum) | 20S proteasome beta5 Cys63Phe mutant; complex with bortezomib | 4QW3_M |
| PB | T01.A13 | psmB4-2 g.p. (Dictyostelium discoideum) | 20S proteasome; complex with carfilzomib | 4QW4_M |
| PB | T01.A13 | psmB4-2 g.p. (Dictyostelium discoideum) | 20S proteasome beta5 Met45Ala mutant; complex with carfilzomib | 4QW5_M |
| PB | T01.A13 | psmB4-2 g.p. (Dictyostelium discoideum) | 20S proteasome beta5 Met45Val mutant; complex with carfilzomib | 4QW6_M |
| PB | T01.A13 | psmB4-2 g.p. (Dictyostelium discoideum) | 20S proteasome beta5 Met45Thr mutant; complex with carfilzomib | 4QW7_M |
| PB | T01.A13 | psmB4-2 g.p. (Dictyostelium discoideum) | 20S proteasome beta5 Met45Ile mutant; complex with carfilzomib | 4QWF_M |
| PB | T01.A13 | psmB4-2 g.p. (Dictyostelium discoideum) | 20S proteasome beta5 Ala49Val mutant; complex with carfilzomib | 4QWG_M |
| PB | T01.A13 | psmB4-2 g.p. (Dictyostelium discoideum) | 20S proteasome beta5 Ala49Ser mutant; complex with carfilzomib | 4QWI_M |
| PB | T01.A13 | psmB4-2 g.p. (Dictyostelium discoideum) | 20S proteasome beta5 Ala49Thr mutant; complex with carfilzomib | 4QWJ_M |
| PB | T01.A13 | psmB4-2 g.p. (Dictyostelium discoideum) | 20S proteasome beta5 Ala49Thr, Ala50Val mutant; complex with carfilzomib | 4QWK_M |
| PB | T01.A13 | psmB4-2 g.p. (Dictyostelium discoideum) | 20S proteasome beta5 Ala50Val mutant; complex with carfilzomib | 4QWL_M |
| PB | T01.A13 | psmB4-2 g.p. (Dictyostelium discoideum) | 20S proteasome beta5 Cys52Phe mutant; complex with carfilzomib | 4QWR_M |
| PB | T01.A13 | psmB4-2 g.p. (Dictyostelium discoideum) | 20S proteasome beta5 Cys63Phe mutant; complex with carfilzomib | 4QWS_M |
| PB | T01.A13 | psmB4-2 g.p. (Dictyostelium discoideum) | 20S proteasome beta5 Cys52Phe mutant; complex with bortezomib | 4QWU_M |
| PB | T01.A13 | psmB4-2 g.p. (Dictyostelium discoideum) | 20S proteasome; complex with epoxyketone inhibitor ONX 0914 | 4QWX_M |
| PB | T01.A13 | psmB4-2 g.p. (Dictyostelium discoideum) | 20S proteasome beta 5 Met45Ala mutant; complex with epoxyketone inhibitor ONX 0914 | 4QXJ_M |
| PB | T01.A13 | psmB4-2 g.p. (Dictyostelium discoideum) | complete proteasome; complex with epoxyketone inhibitor ONX 0914 | 4QZ0_M |
| PB | T01.A13 | psmB4-2 g.p. (Dictyostelium discoideum) | 20S proteasome beta 5 Met45Thr mutant; complex with epoxyketone inhibitor ONX 0914 | 4QZ1_M |
| PB | T01.A13 | psmB4-2 g.p. (Dictyostelium discoideum) | 20S proteasome beta 5 Met45Ile mutant; complex with epoxyketone inhibitor ONX 0914 | 4QZ2_M |
| PB | T01.A13 | psmB4-2 g.p. (Dictyostelium discoideum) | 20S proteasome beta 5 Ala49Val mutant; complex with epoxyketone inhibitor ONX 0914 | 4QZ3_M |
| PB | T01.A13 | psmB4-2 g.p. (Dictyostelium discoideum) | 20S proteasome beta 5 Ala49Ser mutant; complex with epoxyketone inhibitor ONX 0914 | 4QZ4_M |
| PB | T01.A13 | psmB4-2 g.p. (Dictyostelium discoideum) | 20S proteasome beta 5 Ala49Thr mutant; complex with epoxyketone inhibitor ONX 0914 | 4QZ5_M |
| PB | T01.A13 | psmB4-2 g.p. (Dictyostelium discoideum) | 20S proteasome beta 5 Ala49Thr, Ala50Val mutant; complex with epoxyketone inhibitor ONX 0914 | 4QZ6_M |
| PB | T01.A13 | psmB4-2 g.p. (Dictyostelium discoideum) | 20S proteasome beta 5 Ala50Val mutant; complex with epoxyketone inhibitor ONX 0914 | 4QZ7_M |
| PB | T01.A13 | psmB4-2 g.p. (Dictyostelium discoideum) | 20S proteasome beta 5 Cys52Phe mutant; complex with epoxyketone inhibitor ONX 0914 | 4QZW_M |
| PB | T01.A13 | psmB4-2 g.p. (Dictyostelium discoideum) | complete proteasome; complex with epoxyketone inhibitor ONX 0914 | 4QZX_M |
| PB | T01.A13 | psmB4-2 g.p. (Dictyostelium discoideum) | 20S proteasome; complex with omuralide | 4QZZ_M |
| PB | T01.A13 | psmB4-2 g.p. (Dictyostelium discoideum) | 20S proteasome beta 5 Cys52Phe mutant; complex with omuralide | 4R00_M |
| PB | T01.A13 | psmB4-2 g.p. (Dictyostelium discoideum) | 20S proteasome; complex with BSC4999 | 4R02_M |
| PB | T01.A13 | psmB4-2 g.p. (Dictyostelium discoideum) | 20S proteasome; ligand induced aziridine-formation in beta5 | 4R17_M |
| PB | T01.A13 | psmB4-2 g.p. (Dictyostelium discoideum) | 20S proteasome; ligand induced Lys33-Thr1 cross-linking in beta5 | 4R18_M |
| PB | T01.A13 | psmB4-2 g.p. (Dictyostelium discoideum) | 20S proteasome; complex with alkaloid indolo-phakellin | 4RUR_M |
| PB | T01.A13 | psmB4-2 g.p. (Dictyostelium discoideum) | 4V7O | |
| PB | T01.A13 | psmB4-2 g.p. (Dictyostelium discoideum) | 20S proteasome; complex with PR-VI modulator | 4X6Z_N |
| PB | T01.A13 | psmB4-2 g.p. (Dictyostelium discoideum) | 20S proteasome; complex with Ac-Pro-Ala-Asp-EP | 4Y69_M |
| PB | T01.A13 | psmB4-2 g.p. (Dictyostelium discoideum) | 20S proteasome beta2 His114Asp mutant; complex with Ac-Pro-Ala-Asp-EP | 4Y6A_M |
| PB | T01.A13 | psmB4-2 g.p. (Dictyostelium discoideum) | 20S proteasome; complex with Ac-Pro-Ala-Glu-EP | 4Y6V_M |
| PB | T01.A13 | psmB4-2 g.p. (Dictyostelium discoideum) | 20S proteasome; complex with Ac-Pro-Ala-Leu-EP | 4Y6Z_M |
| PB | T01.A13 | psmB4-2 g.p. (Dictyostelium discoideum) | 20S proteasome; complex with Ac-Leu-Ala-Val-EP | 4Y70_M |
| PB | T01.A13 | psmB4-2 g.p. (Dictyostelium discoideum) | 20S proteasome; complex with Ac-Leu-Ala-Leu-EP | 4Y74_M |
| PB | T01.A13 | psmB4-2 g.p. (Dictyostelium discoideum) | 20S proteasome; complex with Ac-Pro-Ala-Phe-EP | 4Y75_M |
| PB | T01.A13 | psmB4-2 g.p. (Dictyostelium discoideum) | 20S proteasome; complex with Ac-Leu-Ala-Phe-EP | 4Y77_M |
| PB | T01.A13 | psmB4-2 g.p. (Dictyostelium discoideum) | 20S proteasome; complex with Ac-Leu-Ala-Asp-EP | 4Y78_M |
| PB | T01.A13 | psmB4-2 g.p. (Dictyostelium discoideum) | 20S proteasome; complex with Ac-Leu-Ala-Glu-EP | 4Y7W_M |
| PB | T01.A13 | psmB4-2 g.p. (Dictyostelium discoideum) | complete proteasome; complex with Ac-PAA-ep | 4Y7X_M |
| PB | T01.A13 | psmB4-2 g.p. (Dictyostelium discoideum) | 20S proteasome; complex with Ac-Leu-Ala-Ala-EP | 4Y7Y_M |
| PB | T01.A13 | psmB4-2 g.p. (Dictyostelium discoideum) | 20S proteasome; complex with Ac-Leu-Ala-Ile-EP | 4Y80_M |
| PB | T01.A13 | psmB4-2 g.p. (Dictyostelium discoideum) | 20S proteasome; complex with Ac-Pro-Ala-Tyr-EP | 4Y81_M |
| PB | T01.A13 | psmB4-2 g.p. (Dictyostelium discoideum) | 20S proteasome; complex with Ac-Leu-Ala-Tyr-EP | 4Y82_M |
| PB | T01.A13 | psmB4-2 g.p. (Dictyostelium discoideum) | 20S proteasome; complex with N3-Ala(4,4-F2P)-Asn-Leu-Leu-EP | 4Y84_M |
| PB | T01.A13 | psmB4-2 g.p. (Dictyostelium discoideum) | 20S proteasome; complex with N3-Ala-Pro-Asn-Leu-Leu-EP | 4Y8G_M |
| PB | T01.A13 | psmB4-2 g.p. (Dictyostelium discoideum) | 20S proteasome; complex with N3-Ala-Pro-Ala-Leu-EP | 4Y8H_M |
| PB | T01.A13 | psmB4-2 g.p. (Dictyostelium discoideum) | 20S proteasome; complex with Ac-Pro-Leu-Leu-EP | 4Y8I_M |
| PB | T01.A13 | psmB4-2 g.p. (Dictyostelium discoideum) | 20S proteasome; complex with Ac-Leu-Leu-Leu-EP | 4Y8J_M |
| PB | T01.A13 | psmB4-2 g.p. (Dictyostelium discoideum) | 20S proteasome; complex with H-Ala-Pro-Leu-Leu-EP | 4Y8K_M |
| PB | T01.A13 | psmB4-2 g.p. (Dictyostelium discoideum) | 20S proteasome; complex with Ac-Ala-Pro-Leu-Leu-EP | 4Y8L_M |
| PB | T01.A13 | psmB4-2 g.p. (Dictyostelium discoideum) | 20S proteasome beta7-delta7 C-terminal mutant | 4Y8M_M |
| PB | T01.A13 | psmB4-2 g.p. (Dictyostelium discoideum) | 20S proteasome beta7-delta7 C-terminal mutant; complex with Ac-Pro-Ala-Glu-EP | 4Y8N_M |
| PB | T01.A13 | psmB4-2 g.p. (Dictyostelium discoideum) | 20S proteasome beta 7-delta 7 C-terminal mutant; complex with Ac-Pro-Ala-Phe-EP | 4Y8O_M |
| PB | T01.A13 | psmB4-2 g.p. (Dictyostelium discoideum) | 20S proteasome beta 7-delta 7 C-terminal mutant; complex with Ac-Pro-Ala-Leu-EP | 4Y8P_M |
| PB | T01.A13 | psmB4-2 g.p. (Dictyostelium discoideum) | 20S proteasome beta 7-delta 7 C-terminal mutant; complex with Ac-Pro-Ala-Tyr-EP | 4Y8Q_M |
| PB | T01.A13 | psmB4-2 g.p. (Dictyostelium discoideum) | 20S proteasome beta 2 His116Asp mutant | 4Y8R_M |
| PB | T01.A13 | psmB4-2 g.p. (Dictyostelium discoideum) | 20S proteasome beta 2 His116Asp mutant; complex with Ac-Leu-Ala-Glu-EP | 4Y8S_M |
| PB | T01.A13 | psmB4-2 g.p. (Dictyostelium discoideum) | 20S proteasome beta 2 His116Asp mutant; complex with Ac-Pro-Ala-Glu-EP | 4Y8T_M |
| PB | T01.A13 | psmB4-2 g.p. (Dictyostelium discoideum) | 20S proteasome beta 2 His116Asp mutant; complex with Ac-Pro-Ala-Asp-EP | 4Y8U_M |
| PB | T01.A13 | psmB4-2 g.p. (Dictyostelium discoideum) | 20S proteasome beta 2 His116Glu mutant | 4Y9Y_M |
| PB | T01.A13 | psmB4-2 g.p. (Dictyostelium discoideum) | 20S proteasome beta 2 His116Glu mutant; complex with Ac-Leu-Ala-Glu-EP | 4Y9Z_M |
| PB | T01.A13 | psmB4-2 g.p. (Dictyostelium discoideum) | 20S proteasome beta 2 His116Glu mutant; complex with Ac-Pro-Ala-Glu-EP | 4YA0_M |
| PB | T01.A13 | psmB4-2 g.p. (Dictyostelium discoideum) | 20S proteasome beta 2 His116Asn mutant | 4YA1_M |
| PB | T01.A13 | psmB4-2 g.p. (Dictyostelium discoideum) | 20S proteasome beta 2 His116Asn mutant; complex with Ac-Leu-Ala-Glu-EP | 4YA2_M |
| PB | T01.A13 | psmB4-2 g.p. (Dictyostelium discoideum) | 20S proteasome beta 2 His116Asn mutant; complex with Ac-Pro-Ala-Glu-EP | 4YA3_M |
| PB | T01.A13 | psmB4-2 g.p. (Dictyostelium discoideum) | 20S proteasome beta 2 His114Asp mutant | 4YA4_M |
| PB | T01.A13 | psmB4-2 g.p. (Dictyostelium discoideum) | 20S proteasome beta 2 His114Asp mutant; complex with Ac-Pro-Ala-Glu-EP | 4YA5_M |
| PB | T01.A13 | psmB4-2 g.p. (Dictyostelium discoideum) | 20S proteasome beta 2 His114Asp mutant; complex with Ac-Leu-Ala-Glu-EP | 4YA7_M |
| PB | T01.A13 | psmB4-2 g.p. (Dictyostelium discoideum) | 20S proteasome beta 2 His114Asp mutant; complex with AC-Leu-Ala-Asp-EP | 4YA9_M |
| PB | T01.A13 | psmB4-2 g.p. (Dictyostelium discoideum) | 20S proteasome; complex with belactosin C derivative 3 | 4Z1L_M |
| PB | T01.A13 | psmB4-2 g.p. (Dictyostelium discoideum) | 5A5B | |
| PB | T01.A13 | psmB4-2 g.p. (Dictyostelium discoideum) | 20S proteasome; complex with macyranone A | 5AHJ_M |
| PB | T01.A13 | psmB4-2 g.p. (Dictyostelium discoideum) | 20S proteasome; complex with beta1/beta2 nonspecifici sulfonamide ligand | 5BOU_M |
| PB | T01.A13 | psmB4-2 g.p. (Dictyostelium discoideum) | yeast 20s proteasome beta2-g170a mutant | 5BXL_M |
| PB | T01.A13 | psmB4-2 g.p. (Dictyostelium discoideum) | yeast 20s proteasome beta2-g170a mutant in complex with bortezomib | 5BXN_M |
| PB | T01.A13 | psmB4-2 g.p. (Dictyostelium discoideum) | 20S proteasome beta5 Gly48Cys mutant | 5CGF_M |
| PB | T01.A13 | psmB4-2 g.p. (Dictyostelium discoideum) | 20S proteasome beta5 Gly48Cys mutant; complex with alpha-chloroacetamide 1 | 5CGG_M |
| PB | T01.A13 | psmB4-2 g.p. (Dictyostelium discoideum) | 20S proteasome beta5 Gly48Cys mutant; complex with alpha-chloroacetamide 5 | 5CGH_M |
| PB | T01.A13 | psmB4-2 g.p. (Dictyostelium discoideum) | 20S proteasome beta5 Gly48Cys mutant; complex with ONX 0914 | 5CGI_M |
| PB | T01.A13 | psmB4-2 g.p. (Dictyostelium discoideum) | yeast 20s proteasome at 2.3 a resolution | 5CZ4_M |
| PB | T01.A13 | psmB4-2 g.p. (Dictyostelium discoideum) | yeast 20s proteasome beta1-t1a mutant in complex with carfilzomib | 5CZ5_M |
| PB | T01.A13 | psmB4-2 g.p. (Dictyostelium discoideum) | yeast 20s proteasome beta5-t1a mutant in complex with syringolin a, propeptide expressed in trans | 5CZ6_M |
| PB | T01.A13 | psmB4-2 g.p. (Dictyostelium discoideum) | yeast 20s proteasome beta5-t1a beta5-k81r double mutant in complex with bortezomib, propeptide expressed in cis | 5CZ7_M |
| PB | T01.A13 | psmB4-2 g.p. (Dictyostelium discoideum) | yeast 20s proteasome beta5-l(-49)s-k33a mutant in complex with carfilzomib | 5CZ8_M |
| PB | T01.A13 | psmB4-2 g.p. (Dictyostelium discoideum) | yeast 20s proteasome beta5-d17n mutant in complex with carfilzomib; propeptide expressed in trans | 5CZ9_M |
| PB | T01.A13 | psmB4-2 g.p. (Dictyostelium discoideum) | yeast 20s proteasome beta5-d166n mutant | 5CZA_M |
| PB | T01.A13 | psmB4-2 g.p. (Dictyostelium discoideum) | yeast 20s proteasome beta5-d166n mutant in complex with carfilzomib | 5D0S_M |
| PB | T01.A13 | psmB4-2 g.p. (Dictyostelium discoideum) | 20s proteasome beta5-Asp166Asn mutant; complex with MG132 | 5D0T_M |
| PB | T01.A13 | psmB4-2 g.p. (Dictyostelium discoideum) | yeast 20s proteasome beta5-t1c mutant in complex with carfilzomib | 5D0V_M |
| PB | T01.A13 | psmB4-2 g.p. (Dictyostelium discoideum) | yeast 20s proteasome beta5-t1s mutant | 5D0W_M |
| PB | T01.A13 | psmB4-2 g.p. (Dictyostelium discoideum) | yeast 20s proteasome beta5-t1s mutant in complex with bortezomib | 5D0X_M |
| PB | T01.A13 | psmB4-2 g.p. (Dictyostelium discoideum) | yeast 20s proteasome beta5-t1s mutant in complex with carfilzomib | 5D0Z_M |
| PB | T01.A13 | psmB4-2 g.p. (Dictyostelium discoideum) | 20S proteasome; complex with alkyne-PI | 5DKI_M |
| PB | T01.A13 | psmB4-2 g.p. (Dictyostelium discoideum) | 20S proteasome; complex with octreotide-PI | 5DKJ_M |
| PB | T01.A13 | psmB4-2 g.p. (Dictyostelium discoideum) | yeast 20s proteasome beta2-t1a mutant | 5FG7_M |
| PB | T01.A13 | psmB4-2 g.p. (Dictyostelium discoideum) | yeast 20s proteasome beta2-t(-2)v mutant | 5FG9_M |
| PB | T01.A13 | psmB4-2 g.p. (Dictyostelium discoideum) | yeast 20s proteasome beta5-k33a mutant (propeptide expressed in trans) | 5FGA_M |
| PB | T01.A13 | psmB4-2 g.p. (Dictyostelium discoideum) | yeast 20s proteasome beta5-h(-2)l-t1a double mutant in complex with carfilzomib | 5FGD_M |
| PB | T01.A13 | psmB4-2 g.p. (Dictyostelium discoideum) | yeast 20s proteasome beta5-h(-2)t-t1a double mutant in complex with carfilzomib | 5FGE_M |
| PB | T01.A13 | psmB4-2 g.p. (Dictyostelium discoideum) | yeast 20s proteasome beta5-h(-2)a-t1a-k81r triple mutant in complex with carfilzomib | 5FGF_M |
| PB | T01.A13 | psmB4-2 g.p. (Dictyostelium discoideum) | yeast 20s proteasome beta5-l(-49s)_d17n double mutant in complex with carfilzomib | 5FGG_M |
| PB | T01.A13 | psmB4-2 g.p. (Dictyostelium discoideum) | 20s proteasome beta5-Lys33Ala mutant (propeptide expressed in trans); complex with MG132 | 5FGH_M |
| PB | T01.A13 | psmB4-2 g.p. (Dictyostelium discoideum) | yeast 20s proteasome beta1-t1a beta2-t1a double mutant in complex withcarfilzomib | 5FGI_M |
| PB | T01.A13 | psmB4-2 g.p. (Dictyostelium discoideum) | yeast 20s proteasome beta5-k33a mutant (propeptide expressed in trans)in complex with carfilzomib | 5FHS_M |
| PB | T01.A13 | psmB4-2 g.p. (Dictyostelium discoideum) | 20s proteasome; complex with the peptidic epoxyketone inhibitor 27 | 5JHR_M |
| PB | T01.A13 | psmB4-2 g.p. (Dictyostelium discoideum) | 20s proteasome; complex with the peptidic epoxyketone inhibitor 15 | 5JHS_M |
| PB | T01.A13 | psmB4-2 g.p. (Dictyostelium discoideum) | 20s proteasome; complex with epoxyketone inhibitor 14 | 5L52_M |
| PB | T01.A13 | psmB4-2 g.p. (Dictyostelium discoideum) | 20s proteasome; complex with epoxyketone inhibitor 16 | 5L54_M |
| PB | T01.A13 | psmB4-2 g.p. (Dictyostelium discoideum) | 20s proteasome; complex with epoxyketone inhibitor 18 | 5L55_M |
| PB | T01.A13 | psmB4-2 g.p. (Dictyostelium discoideum) | yeast 20s proteasome with human beta5i (1-138; r57t) | 5L5A_M |
| PB | T01.A13 | psmB4-2 g.p. (Dictyostelium discoideum) | yeast 20s proteasome with human beta5i (1-138) and human beta6 (97- 111; 118-133) | 5L5B_M |
| PB | T01.A13 | psmB4-2 g.p. (Dictyostelium discoideum) | yeast 20s proteasome with human beta5i (1-138) and human beta6 (97- 111; 118-133) in complex with onx 0914 | 5L5D_M |
| PB | T01.A13 | psmB4-2 g.p. (Dictyostelium discoideum) | yeast 20s proteasome with human beta5i (1-138) and human beta6 (97- 111; 118-133) in complex with carfilzomib | 5L5E_M |
| PB | T01.A13 | psmB4-2 g.p. (Dictyostelium discoideum) | yeast 20s proteasome with human beta5i (1-138) and human beta6 (97- 111; 118-133) in complex with bortezomib | 5L5F_M |
| PB | T01.A13 | psmB4-2 g.p. (Dictyostelium discoideum) | yeast 20s proteasome with human beta5i (1-138) and human beta6 (97- 111; 118-133); complex with PR-924 | 5L5H_M |
| PB | T01.A13 | psmB4-2 g.p. (Dictyostelium discoideum) | yeast 20s proteasome with human beta5i (1-138) and human beta6 (97- 111; 118-133) in complex with epoxyketone inhibitor 9 | 5L5I_M |
| PB | T01.A13 | psmB4-2 g.p. (Dictyostelium discoideum) | yeast 20s proteasome with human beta5i (1-138) and human beta6 (97- 111; 118-133) in complex with epoxyketone inhibitor 14 | 5L5J_M |
| PB | T01.A13 | psmB4-2 g.p. (Dictyostelium discoideum) | yeast 20s proteasome with human beta5i (1-138) and human beta6 (97- 111; 118-133) in complex with epoxyketone inhibitor 16 | 5L5O_M |
| PB | T01.A13 | psmB4-2 g.p. (Dictyostelium discoideum) | yeast 20s proteasome with human beta5i (1-138) and human beta6 (97- 111; 118-133) in complex with epoxyketone inhibitor 17 | 5L5P_M |
| PB | T01.A13 | psmB4-2 g.p. (Dictyostelium discoideum) | yeast 20s proteasome with human beta5i (1-138) and human beta6 (97- 111; 118-133) in complex with epoxyketone 18 | 5L5Q_M |
| PB | T01.A13 | psmB4-2 g.p. (Dictyostelium discoideum) | yeast 20s proteasome with human beta5i (1-138;v31m) and human beta6 (97-111; 118-133) | 5L5R_M |
| PB | T01.A13 | psmB4-2 g.p. (Dictyostelium discoideum) | yeast 20s proteasome with human beta5i (1-138; Val31Met mutant) and human beta6 (97-111; 118-133); complex with PR-924 | 5L5S_M |
| PB | T01.A13 | psmB4-2 g.p. (Dictyostelium discoideum) | yeast 20s proteasome with human beta5i (1-138; v31m) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 16 | 5L5T_M |
| PB | T01.A13 | psmB4-2 g.p. (Dictyostelium discoideum) | yeast 20s proteasome with human beta5i (1-138; v31m) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 17 ***caveat 5l5u 04c h 301 has wrong chirality at atom c27 04c k 301 has ***caveat 2 5l5u wrong chirality at atom c27 04c v 301 h | 5L5U_M |
| PB | T01.A13 | psmB4-2 g.p. (Dictyostelium discoideum) | yeast 20s proteasome with human beta5c (1-138) and human beta6 (97- 111; 118-133) | 5L5W_M |
| PB | T01.A13 | psmB4-2 g.p. (Dictyostelium discoideum) | yeast 20s proteasome with human beta5c (1-138) and human beta6 (97- 111; 118-133) in complex with onx 0914 | 5L5X_M |
| PB | T01.A13 | psmB4-2 g.p. (Dictyostelium discoideum) | yeast 20s proteasome with human beta5c (1-138) and human beta6 (97- 111; 118-133) in complex with carfilzomib | 5L5Y_M |
| PB | T01.A13 | psmB4-2 g.p. (Dictyostelium discoideum) | yeast 20s proteasome with human beta5c (1-138) and human beta6 (97- 111; 118-133) in complex with bortezomib | 5L5Z_M |
| PB | T01.A13 | psmB4-2 g.p. (Dictyostelium discoideum) | yeast 20s proteasome with human beta5c (1-138) and human beta6 (97- 111; 118-133); complex with PR-924 | 5L60_M |
| PB | T01.A13 | psmB4-2 g.p. (Dictyostelium discoideum) | yeast 20s proteasome with human beta5c (1-138) and human beta6 (99- 132) in complex with epoxyketone inhibitor 14 | 5L61_M |
| PB | T01.A13 | psmB4-2 g.p. (Dictyostelium discoideum) | yeast 20s proteasome with human beta5c (1-138) and human beta6 (97- 111; 118-133) in complex with epoxyketone inhibitor 16 | 5L62_M |
| PB | T01.A13 | psmB4-2 g.p. (Dictyostelium discoideum) | yeast 20s proteasome with human beta5c (1-138) and human beta6 (97- 111; 118-133) in complex with epoxyketone inhibitor 17 ***caveat 5l63 04c h 301 has wrong chirality at atom c27 04c k 301 has ***caveat 2 5l63 wrong chirality at atom c27 04c v 301 has wr | 5L63_M |
| PB | T01.A13 | psmB4-2 g.p. (Dictyostelium discoideum) | yeast 20s proteasome with human beta5c (1-138) and human beta6 (97- 111; 118-133) in complex with epoxyketone inhibitor 18 | 5L64_M |
| PB | T01.A13 | psmB4-2 g.p. (Dictyostelium discoideum) | yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97- 111; 118-133) in complex with carfilzomib | 5L65_M |
| PB | T01.A13 | psmB4-2 g.p. (Dictyostelium discoideum) | yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97- 111; 118-133) in complex with bortezomib | 5L66_M |
| PB | T01.A13 | psmB4-2 g.p. (Dictyostelium discoideum) | yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97- 111; 118-133); complex with PR-924 | 5L67_M |
| PB | T01.A13 | psmB4-2 g.p. (Dictyostelium discoideum) | yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97- 111; 118-133) in complex with epoxyketone inhibitor 14 | 5L68_M |
| PB | T01.A13 | psmB4-2 g.p. (Dictyostelium discoideum) | yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97- 111; 118-133) in complex with epoxyketone inhibitor 16 | 5L69_M |
| PB | T01.A13 | psmB4-2 g.p. (Dictyostelium discoideum) | yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97- 111; 118-133) in complex with epoxyketone inhibitor 17 | 5L6A_M |
| PB | T01.A13 | psmB4-2 g.p. (Dictyostelium discoideum) | yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97- 111; 118-133) in complex with onx 0914 | 5L6B_M |
| PB | T01.A13 | psmB4-2 g.p. (Dictyostelium discoideum) | yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97- 111; 118-133) in complex with epoxyketone inhibitor 18 | 5L6C_M |
| PB | T01.A13 | psmB4-2 g.p. (Dictyostelium discoideum) | ligand-induced aziridine-formation at the yeast proteasomal subunit beta5 by sulfonate esters | 5LAI_M |
| PB | T01.A13 | psmB4-2 g.p. (Dictyostelium discoideum) | ligand-induced lys33-thr1 crosslinking at the yeast proteasomal subunit beta5 by sulfonate esters | 5LAJ_M |
| PB | T01.A13 | psmB4-2 g.p. (Dictyostelium discoideum) | yeast 20s proteasome with human beta5i (1-138; Arg57Thr mutant)in complex with PR-924 | 5LTT_M |
| PB | T01.A13 | psmB4-2 g.p. (Dictyostelium discoideum) | yeast 20s proteasome with human beta5i (1-138) and human beta6 (97- 111; 118-133) in complex with thiazole based inhibitor ro19 | 5M2B_M |
| PB | T01.A13 | psmB4-2 g.p. (Dictyostelium discoideum) | 26s proteasome in presence of atp (s1) | 5MP9_n |
| PB | T01.A13 | psmB4-2 g.p. (Dictyostelium discoideum) | 26s proteasome in presence of atp (s2) | 5MPA_n |
| PB | T01.A13 | psmB4-2 g.p. (Dictyostelium discoideum) | yeast 20s proteasome in complex with blm-pep activator | 5NIF_N |
| PB | T01.A13 | psmB4-2 g.p. (Dictyostelium discoideum) | yeast 26s proteasome bound to ubiquitinated substrate (4d motor state) | 6EF3_7 |
| PB | T01.A13 | psmB4-2 g.p. (Dictyostelium discoideum) | yeast 20s proteasome in complex with cystargolide B | 6G7F_M |
| PB | T01.A13 | psmB4-2 g.p. (Dictyostelium discoideum) | yeast 20s proteasome in complex with cystargolide B derivative 1 | 6G8M_M |
| PB | T01.A13 | psmB4-2 g.p. (Dictyostelium discoideum) | yeast 20s proteasome in complex with cystargolide B derivative 2 | 6G8N_M |
| PB | T01.A13 | psmB4-2 g.p. (Dictyostelium discoideum) | yeast 20s proteasome in complex with homosalinosporamide a | 6GOP_M |
| PB | T01.A13 | psmB4-2 g.p. (Dictyostelium discoideum) | yeast 20s proteasome in complex with the peptidic non-covalent bindinginhibitor rts-v5 | 6H39_M |
| PB | T01.A13 | psmB4-2 g.p. (Dictyostelium discoideum) | yeast 20s proteasome with human beta2c (s171g) | 6HTB_M |
| PB | T01.A13 | psmB4-2 g.p. (Dictyostelium discoideum) | yeast 20s proteasome with human beta2c (s171g) in complex with onx 0914 | 6HTC_M |
| PB | T01.A13 | psmB4-2 g.p. (Dictyostelium discoideum) | yeast 20s proteasome with human beta2c (s171g) in complex with 4 | 6HTD_M |
| PB | T01.A13 | psmB4-2 g.p. (Dictyostelium discoideum) | yeast 20s proteasome with human beta2c (s171g) in complex with 7 | 6HTP_M |
| PB | T01.A13 | psmB4-2 g.p. (Dictyostelium discoideum) | yeast 20s proteasome with human beta2c (s171g) in complex with 13 | 6HTR_M |
| PB | T01.A13 | psmB4-2 g.p. (Dictyostelium discoideum) | yeast 20s proteasome with human beta2c (s171g) in complex with 16 | 6HUB_M |
| PB | T01.A13 | psmB4-2 g.p. (Dictyostelium discoideum) | yeast 20s proteasome with human beta2c (s171g) in complex with 18 | 6HUC_M |
| PB | T01.A13 | psmB4-2 g.p. (Dictyostelium discoideum) | yeast 20s proteasome with human beta2c (s171g) in complex with 20 | 6HUQ_M |
| PB | T01.A13 | psmB4-2 g.p. (Dictyostelium discoideum) | yeast 20s proteasome with human beta2c (s171g) in complex with 29 | 6HUU_M |
| PB | T01.A13 | psmB4-2 g.p. (Dictyostelium discoideum) | yeast 20s proteasome with human beta2c (s171g) in complex with 39 | 6HUV_M |
| PB | T01.A13 | psmB4-2 g.p. (Dictyostelium discoideum) | yeast 20s proteasome with human beta2i (1-53) | 6HV3_M |
| PB | T01.A13 | psmB4-2 g.p. (Dictyostelium discoideum) | yeast 20s proteasome with human beta2i (1-53) in complex with onx 0914 | 6HV4_M |
| PB | T01.A13 | psmB4-2 g.p. (Dictyostelium discoideum) | yeast 20s proteasome with human beta2i (1-53) in complex with 4 | 6HV5_M |
| PB | T01.A13 | psmB4-2 g.p. (Dictyostelium discoideum) | yeast 20s proteasome with human beta2i (1-53) in complex with 7 | 6HV7_M |
| PB | T01.A13 | psmB4-2 g.p. (Dictyostelium discoideum) | yeast 20s proteasome with human beta2i (1-53) in complex with 13 | 6HVA_M |
| PB | T01.A13 | psmB4-2 g.p. (Dictyostelium discoideum) | yeast 20s proteasome with human beta2i (1-53) in complex with 16 | 6HVR_M |
| PB | T01.A13 | psmB4-2 g.p. (Dictyostelium discoideum) | yeast 20s proteasome with human beta2i (1-53) in complex with 18 | 6HVS_M |
| PB | T01.A13 | psmB4-2 g.p. (Dictyostelium discoideum) | yeast 20s proteasome with human beta2i (1-53) in complex with 20 | 6HVT_M |
| PB | T01.A13 | psmB4-2 g.p. (Dictyostelium discoideum) | yeast 20s proteasome with human beta2i (1-53) in complex with 29 | 6HVU_M |
| PB | T01.A13 | psmB4-2 g.p. (Dictyostelium discoideum) | yeast 20s proteasome with human beta2i (1-53) in complex with 39 | 6HVV_M |
| PB | T01.A13 | psmB4-2 g.p. (Dictyostelium discoideum) | yeast 20s proteasome with human beta2i (1-53) in complex with 43 | 6HVW_M |
| PB | T01.A13 | psmB4-2 g.p. (Dictyostelium discoideum) | yeast 20s proteasome in complex with 4 | 6HVX_M |
| PB | T01.A13 | psmB4-2 g.p. (Dictyostelium discoideum) | yeast 20s proteasome in complex with 5 (7- and 6-membered ring) | 6HVY_M |
| PB | T01.A13 | psmB4-2 g.p. (Dictyostelium discoideum) | yeast 20s proteasome in complex with 7 | 6HW0_M |
| PB | T01.A13 | psmB4-2 g.p. (Dictyostelium discoideum) | yeast 20s proteasome in complex with 13 | 6HW3_M |
| PB | T01.A13 | psmB4-2 g.p. (Dictyostelium discoideum) | yeast 20s proteasome in complex with 16 | 6HW4_M |
| PB | T01.A13 | psmB4-2 g.p. (Dictyostelium discoideum) | yeast 20s proteasome in complex with 18 | 6HW5_M |
| PB | T01.A13 | psmB4-2 g.p. (Dictyostelium discoideum) | yeast 20s proteasome in complex with 20 | 6HW6_M |
| PB | T01.A13 | psmB4-2 g.p. (Dictyostelium discoideum) | yeast 20s proteasome in complex with 29 | 6HW7_M |
| PB | T01.A13 | psmB4-2 g.p. (Dictyostelium discoideum) | yeast 20s proteasome in complex with 39 | 6HW8_M |
| PB | T01.A13 | psmB4-2 g.p. (Dictyostelium discoideum) | yeast 20s proteasome in complex with 41b | 6HW9_M |
| PB | T01.A13 | psmB4-2 g.p. (Dictyostelium discoideum) | yeast 20s proteasome in complex with 43 | 6HWA_M |
| PB | T01.A13 | psmB4-2 g.p. (Dictyostelium discoideum) | yeast 20s proteasome in complex with 44b | 6HWB_M |
| PB | T01.A13 | psmB4-2 g.p. (Dictyostelium discoideum) | yeast 20s proteasome beta2-g45a mutant | 6HWC_M |
| PB | T01.A13 | psmB4-2 g.p. (Dictyostelium discoideum) | yeast 20s proteasome beta2-g45a mutant in complex with bortezomib | 6HWD_M |
| PB | T01.A13 | psmB4-2 g.p. (Dictyostelium discoideum) | yeast 20s proteasome beta2-g45a mutant in complex with carfilzomib | 6HWE_M |
| PB | T01.A13 | psmB4-2 g.p. (Dictyostelium discoideum) | yeast 20s proteasome beta2-g45a mutant in complex with onx 0914 | 6HWF_M |
| PB | T01.A14 | PFE0915c g.p. (Plasmodium falciparum) | 20S proteasome complex | 5FMG_M |
| PB | T01.A15 | PF10_0111 g.p. (Plasmodium falciparum) | 20S proteasome complex | 5FMG_L |
| PB | T01.A16 | PF14_0716 g.p. (Plasmodium falciparum) | 20S proteasome complex | 5FMG_F |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | ground state 26s proteasome (gs2) | 6EPC_F |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | substrate processing state 26s proteasome (sps1) ***caveat 6epd pro 2 231 has wrong chirality at atom ca | 6EPD_F |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | substrate processing state 26s proteasome (sps2) | 6EPE_F |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | ground state 26s proteasome (gs1) | 6EPF_F |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S proteasome in complex with activator PA26 (Trypanosoma brucei) | 1FNT_D |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | complete proteasome | 1G0U_C |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | complex with epoxomicin | 1G65_C |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | proteasome complex bound to TMC-95A inhibitor | 1JD2_C |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S proteasome | 1RYP_D |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S proteasome; complex with the proteasome activator PA26 from Trypanosoma brucei | 1Z7Q_D |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S proteasome;complex with bortezomib | 2F16_C |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S proteasome; complex with salinosporamide A | 2FAK_C |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S proteasome; complex with homobelactosin C | 2FNY_C |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S proteasome; complex with TMC-95 based biphenyl-ether macrocycle | 2GPL_C |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S proteasome; complex with syringolin A | 2ZCY_C |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S proteasome; complex with glidobactin A | 3BDM_C |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S proteasome; complex with fellutamide B | 3D29_C |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20s proteasome; complex with the epimer form of spirolactacystin | 3DY3_C |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20s proteasome; complex with spirolactacystin | 3DY4_C |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20s proteasome; complex with homobelactosin c | 3E47_C |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20s proteasome; complex with syringolin b | 3GPJ_C |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S proteasome; complex with salinosporamide derivative | 3GPT_C |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S proteasome; complex with salinosporamide derivative | 3GPW_C |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S proteasome; complex with hyroxylated salinosporamide | 3HYE_C |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S proteasome; complex with bortezomib | 3MG0_C |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S proteasome; complex with compound 1 | 3MG4_C |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S proteasome; complex with compound 6 | 3MG6_C |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S open-gate proteasome; complex with compound 6 | 3MG7_C |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S open-gate proteasome; complex with compound 16 | 3MG8_C |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S proteasome; complex with ligand 2a | 3NZJ_C |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S proteasome; complex with ligand 2b | 3NZW_C |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S proteasome; complex with ligand 2c | 3NZX_C |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S open-gate proteasome; complex with compound 24 | 3OEU_C |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S open-gate proteasome; complex with compound 25 | 3OEV_C |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S proteasome; complex with alpha-keto-aldehyde | 3OKJ_C |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S open-gate proteasome; complex with compound 20 | 3SDI_C |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S open-gate proteasome; complex with compound 34 | 3SDK_C |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S proteasome; complex with hydroxyurea derivative HU10 | 3SHJ_C |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S proteasome; complex with homobelactosin C | 3TDD_C |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S open-gate proteasome; complex with PR-957 (morpholine) | 3UN4_C |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S proteasome; complex with PR-957 (epoxide) | 3UN8_C |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 26S proteasome; mutant | 3WXR_D |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 26S proteasome | 4CR2_D |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 26S proteasome | 4CR3_D |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 26S proteasome | 4CR4_D |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S proteasome; complex with K-7174 | 4EU2_D |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S proteasome; complex with cepafungin I | 4FZC_C |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S proteasome; complex with glidobactin | 4FZG_C |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S proteasome; complex with Syringolin-Glidobactin chimera | 4G4S_D |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S proteasome; complex with Syringolin-Glidobactin chimera | 4GK7_C |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S proteasome; complex with vinylketone carmaphycin analogue VNK1 | 4HNP_C |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S proteasome; complex with epoxyketone carmaphycin analogue 3 | 4HRC_C |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S proteasome; complex with carmaphycin A | 4HRD_C |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S proteasome; complex with vinyl sulfone LU102 | 4INR_C |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S proteasome; complex with vinyl sulfone LU122 | 4INT_C |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S proteasome; complex with vinyl sulfone LU112 | 4INU_C |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S proteasome; complex with belactosin derivative 3E | 4J70_C |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S proteasome; complex with dimerized linear mimetic of TMC-95A | 4JSQ_C |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S proteasome; complex with dimerized linear mimetic of TMC-95A | 4JSU_C |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S proteasome; complex with dimerized linear mimetic of TMC-95A | 4JT0_C |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S proteasome; complex with vibralactone | 4LQI_C |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S proteasome; complex with enone carmaphycin analogue 6 | 4LTC_C |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S proteasome; complex with MG132 | 4NNN_C |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S proteasome; complex with Z-Leu-Leu-Leu-ketoaldehyde | 4NNW_C |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S proteasome; complex with Z-Leu-Leu-Leu-B(OH)2 | 4NO1_C |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S proteasome; complex with Z-Leu-Leu-Leu-vinylsulfone | 4NO6_C |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S proteasome; complex with Z-Leu-Leu-Leu-ketoamide | 4NO8_C |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S proteasome; complex with Z-Leu-Leu-Leu-epoxyketone | 4NO9_C |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S proteasome; complex with kendomycin | 4Q1S_C |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S proteasome; complex with Boc-Ala-Ala-Ala-CHO | 4QBY_C |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S proteasome; complex with epoxyketone inhibitor 8 | 4QLQ_C |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S proteasome; complex with epoxyketone inhibitor 11 | 4QLS_C |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S proteasome; complex with tripeptidic epoxyketone inhibitor 2 | 4QLT_C |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S proteasome; complex with tripeptidic epoxyketone inhibitor 9 | 4QLU_C |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S proteasome; complex with tripeptidic epoxyketone inhibitor 17 | 4QLV_C |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S proteasome | 4QUX_C |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S proteasome | 4QUY_C |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S proteasome | 4QV0_C |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S proteasome | 4QV1_C |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S proteasome | 4QV3_C |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S proteasome beta5 Met45Thr mutant | 4QV4_C |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S proteasome beta5 Met45Ile mutant | 4QV5_C |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S proteasome | 4QV6_C |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S proteasome | 4QV7_C |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S proteasome | 4QV8_C |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S proteasome | 4QV9_C |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S proteasome; complex with bortezomib | 4QVL_C |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S proteasome beta5 Met45Ala mutant; complex with bortezomib | 4QVM_C |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S proteasome beta5 Met45Val mutant; complex with bortezomib | 4QVN_C |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S proteasome beta5 Met45Thr mutant; complex with bortezomib | 4QVP_C |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S proteasome beta5 Met45Ile mutant; complex with bortezomib | 4QVQ_C |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S proteasome beta5 Ala49Val mutant; complex with bortezomib | 4QVV_C |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S proteasome beta5 Ala49Ser mutant; complex with bortezomib | 4QVW_C |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S proteasome beta5 Ala49Thr mutant; complex with bortezomib | 4QVY_C |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S proteasome beta5 Ala49Thr,Ala50Val mutant; complex with bortezomib | 4QW0_C |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S proteasome beta5 Ala50Val mutant; complex with bortezomib | 4QW1_C |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S proteasome beta5 Cys63Phe mutant; complex with bortezomib | 4QW3_C |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S proteasome; complex with carfilzomib | 4QW4_C |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S proteasome beta5 Met45Ala mutant; complex with carfilzomib | 4QW5_C |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S proteasome beta5 Met45Val mutant; complex with carfilzomib | 4QW6_C |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S proteasome beta5 Met45Thr mutant; complex with carfilzomib | 4QW7_C |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S proteasome beta5 Met45Ile mutant; complex with carfilzomib | 4QWF_C |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S proteasome beta5 Ala49Val mutant; complex with carfilzomib | 4QWG_C |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S proteasome beta5 Ala49Ser mutant; complex with carfilzomib | 4QWI_C |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S proteasome beta5 Ala49Thr mutant; complex with carfilzomib | 4QWJ_C |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S proteasome beta5 Ala49Thr, Ala50Val mutant; complex with carfilzomib | 4QWK_C |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S proteasome beta5 Ala50Val mutant; complex with carfilzomib | 4QWL_C |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S proteasome beta5 Cys52Phe mutant; complex with carfilzomib | 4QWR_C |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S proteasome beta5 Cys63Phe mutant; complex with carfilzomib | 4QWS_C |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S proteasome beta5 Cys52Phe mutant; complex with bortezomib | 4QWU_C |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S proteasome; complex with epoxyketone inhibitor ONX 0914 | 4QWX_C |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S proteasome beta 5 Met45Ala mutant; complex with epoxyketone inhibitor ONX 0914 | 4QXJ_C |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | complete proteasome; complex with epoxyketone inhibitor ONX 0914 | 4QZ0_C |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S proteasome beta 5 Met45Thr mutant; complex with epoxyketone inhibitor ONX 0914 | 4QZ1_C |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S proteasome beta 5 Met45Ile mutant; complex with epoxyketone inhibitor ONX 0914 | 4QZ2_C |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S proteasome beta 5 Ala49Val mutant; complex with epoxyketone inhibitor ONX 0914 | 4QZ3_C |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S proteasome beta 5 Ala49Ser mutant; complex with epoxyketone inhibitor ONX 0914 | 4QZ4_C |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S proteasome beta 5 Ala49Thr mutant; complex with epoxyketone inhibitor ONX 0914 | 4QZ5_C |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S proteasome beta 5 Ala49Thr, Ala50Val mutant; complex with epoxyketone inhibitor ONX 0914 | 4QZ6_C |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S proteasome beta 5 Ala50Val mutant; complex with epoxyketone inhibitor ONX 0914 | 4QZ7_C |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S proteasome beta 5 Cys52Phe mutant; complex with epoxyketone inhibitor ONX 0914 | 4QZW_C |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | complete proteasome; complex with epoxyketone inhibitor ONX 0914 | 4QZX_C |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S proteasome; complex with omuralide | 4QZZ_C |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S proteasome beta 5 Cys52Phe mutant; complex with omuralide | 4R00_C |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S proteasome; complex with BSC4999 | 4R02_C |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S proteasome; ligand induced aziridine-formation in beta5 | 4R17_C |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S proteasome; ligand induced Lys33-Thr1 cross-linking in beta5 | 4R18_C |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S proteasome; complex with alkaloid indolo-phakellin | 4RUR_C |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 4V7O | |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S proteasome; complex with PR-VI modulator | 4X6Z_D |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S proteasome; complex with Ac-Pro-Ala-Asp-EP | 4Y69_C |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S proteasome beta2 His114Asp mutant; complex with Ac-Pro-Ala-Asp-EP | 4Y6A_C |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S proteasome; complex with Ac-Pro-Ala-Glu-EP | 4Y6V_C |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S proteasome; complex with Ac-Pro-Ala-Leu-EP | 4Y6Z_C |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S proteasome; complex with Ac-Leu-Ala-Val-EP | 4Y70_C |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S proteasome; complex with Ac-Leu-Ala-Leu-EP | 4Y74_C |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S proteasome; complex with Ac-Pro-Ala-Phe-EP | 4Y75_C |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S proteasome; complex with Ac-Leu-Ala-Phe-EP | 4Y77_C |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S proteasome; complex with Ac-Leu-Ala-Asp-EP | 4Y78_C |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S proteasome; complex with Ac-Leu-Ala-Glu-EP | 4Y7W_C |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | complete proteasome; complex with Ac-PAA-ep | 4Y7X_C |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S proteasome; complex with Ac-Leu-Ala-Ala-EP | 4Y7Y_C |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S proteasome; complex with Ac-Leu-Ala-Ile-EP | 4Y80_C |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S proteasome; complex with Ac-Pro-Ala-Tyr-EP | 4Y81_C |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S proteasome; complex with Ac-Leu-Ala-Tyr-EP | 4Y82_C |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S proteasome; complex with N3-Ala(4,4-F2P)-Asn-Leu-Leu-EP | 4Y84_C |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S proteasome; complex with N3-Ala-Pro-Asn-Leu-Leu-EP | 4Y8G_C |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S proteasome; complex with N3-Ala-Pro-Ala-Leu-EP | 4Y8H_C |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S proteasome; complex with Ac-Pro-Leu-Leu-EP | 4Y8I_C |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S proteasome; complex with Ac-Leu-Leu-Leu-EP | 4Y8J_C |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S proteasome; complex with H-Ala-Pro-Leu-Leu-EP | 4Y8K_C |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S proteasome; complex with Ac-Ala-Pro-Leu-Leu-EP | 4Y8L_C |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S proteasome beta7-delta7 C-terminal mutant | 4Y8M_C |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S proteasome beta7-delta7 C-terminal mutant; complex with Ac-Pro-Ala-Glu-EP | 4Y8N_C |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S proteasome beta 7-delta 7 C-terminal mutant; complex with Ac-Pro-Ala-Phe-EP | 4Y8O_C |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S proteasome beta 7-delta 7 C-terminal mutant; complex with Ac-Pro-Ala-Leu-EP | 4Y8P_C |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S proteasome beta 7-delta 7 C-terminal mutant; complex with Ac-Pro-Ala-Tyr-EP | 4Y8Q_C |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S proteasome beta 2 His116Asp mutant | 4Y8R_C |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S proteasome beta 2 His116Asp mutant; complex with Ac-Leu-Ala-Glu-EP | 4Y8S_C |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S proteasome beta 2 His116Asp mutant; complex with Ac-Pro-Ala-Glu-EP | 4Y8T_C |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S proteasome beta 2 His116Asp mutant; complex with Ac-Pro-Ala-Asp-EP | 4Y8U_C |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S proteasome beta 2 His116Glu mutant | 4Y9Y_C |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S proteasome beta 2 His116Glu mutant; complex with Ac-Leu-Ala-Glu-EP | 4Y9Z_C |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S proteasome beta 2 His116Glu mutant; complex with Ac-Pro-Ala-Glu-EP | 4YA0_C |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S proteasome beta 2 His116Asn mutant | 4YA1_C |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S proteasome beta 2 His116Asn mutant; complex with Ac-Leu-Ala-Glu-EP | 4YA2_C |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S proteasome beta 2 His116Asn mutant; complex with Ac-Pro-Ala-Glu-EP | 4YA3_C |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S proteasome beta 2 His114Asp mutant | 4YA4_C |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S proteasome beta 2 His114Asp mutant; complex with Ac-Pro-Ala-Glu-EP | 4YA5_C |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S proteasome beta 2 His114Asp mutant; complex with Ac-Leu-Ala-Glu-EP | 4YA7_C |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S proteasome beta 2 His114Asp mutant; complex with AC-Leu-Ala-Asp-EP | 4YA9_C |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S proteasome; complex with belactosin C derivative 3 | 4Z1L_C |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 26S protease-UBP6 complex | 5A5B_D |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S proteasome; complex with macyranone A | 5AHJ_C |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S proteasome; complex with beta1/beta2 nonspecifici sulfonamide ligand | 5BOU_C |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | yeast 20s proteasome beta2-g170a mutant | 5BXL_C |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | yeast 20s proteasome beta2-g170a mutant in complex with bortezomib | 5BXN_C |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S proteasome beta5 Gly48Cys mutant | 5CGF_C |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S proteasome beta5 Gly48Cys mutant; complex with alpha-chloroacetamide 1 | 5CGG_C |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S proteasome beta5 Gly48Cys mutant; complex with alpha-chloroacetamide 5 | 5CGH_C |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S proteasome beta5 Gly48Cys mutant; complex with ONX 0914 | 5CGI_C |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | yeast 20s proteasome at 2.3 a resolution | 5CZ4_C |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | yeast 20s proteasome beta1-t1a mutant in complex with carfilzomib | 5CZ5_C |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | yeast 20s proteasome beta5-t1a mutant in complex with syringolin a, propeptide expressed in trans | 5CZ6_C |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | yeast 20s proteasome beta5-t1a beta5-k81r double mutant in complex with bortezomib, propeptide expressed in cis | 5CZ7_C |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | yeast 20s proteasome beta5-l(-49)s-k33a mutant in complex with carfilzomib | 5CZ8_C |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | yeast 20s proteasome beta5-d17n mutant in complex with carfilzomib; propeptide expressed in trans | 5CZ9_C |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | yeast 20s proteasome beta5-d166n mutant | 5CZA_C |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | yeast 20s proteasome beta5-d166n mutant in complex with carfilzomib | 5D0S_C |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20s proteasome beta5-Asp166Asn mutant; complex with MG132 | 5D0T_C |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | yeast 20s proteasome beta5-t1c mutant in complex with carfilzomib | 5D0V_C |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | yeast 20s proteasome beta5-t1s mutant | 5D0W_C |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | yeast 20s proteasome beta5-t1s mutant in complex with bortezomib | 5D0X_C |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | yeast 20s proteasome beta5-t1s mutant in complex with carfilzomib | 5D0Z_C |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S proteasome; complex with alkyne-PI | 5DKI_C |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S proteasome; complex with octreotide-PI | 5DKJ_C |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | yeast 20s proteasome beta2-t1a mutant | 5FG7_C |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | yeast 20s proteasome beta2-t(-2)v mutant | 5FG9_C |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | yeast 20s proteasome beta5-k33a mutant (propeptide expressed in trans) | 5FGA_C |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | yeast 20s proteasome beta5-h(-2)l-t1a double mutant in complex with carfilzomib | 5FGD_C |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | yeast 20s proteasome beta5-h(-2)t-t1a double mutant in complex with carfilzomib | 5FGE_C |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | yeast 20s proteasome beta5-h(-2)a-t1a-k81r triple mutant in complex with carfilzomib | 5FGF_C |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | yeast 20s proteasome beta5-l(-49s)_d17n double mutant in complex with carfilzomib | 5FGG_C |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20s proteasome beta5-Lys33Ala mutant (propeptide expressed in trans); complex with MG132 | 5FGH_C |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | yeast 20s proteasome beta1-t1a beta2-t1a double mutant in complex withcarfilzomib | 5FGI_C |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | yeast 20s proteasome beta5-k33a mutant (propeptide expressed in trans)in complex with carfilzomib | 5FHS_C |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20s proteasome; complex with the peptidic epoxyketone inhibitor 27 | 5JHR_C |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20s proteasome; complex with the peptidic epoxyketone inhibitor 15 | 5JHS_C |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | yeast 20s proteasome in complex with epoxyketone inhibitor 14 | 5L52_C |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | yeast 20s proteasome in complex with epoxyketone inhibitor 16 | 5L54_C |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | yeast 20s proteasome in complex with epoxyketone inhibitor 18 | 5L55_C |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | yeast 20s proteasome with human beta5i (1-138; r57t) | 5L5A_C |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | yeast 20s proteasome with human beta5i (1-138) and human beta6 (97- 111; 118-133) | 5L5B_C |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | yeast 20s proteasome with human beta5i (1-138) and human beta6 (97- 111; 118-133) in complex with onx 0914 | 5L5D_C |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | yeast 20s proteasome with human beta5i (1-138) and human beta6 (97- 111; 118-133) in complex with carfilzomib | 5L5E_C |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | yeast 20s proteasome with human beta5i (1-138) and human beta6 (97- 111; 118-133) in complex with bortezomib | 5L5F_C |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | yeast 20s proteasome with human beta5i (1-138) and human beta6 (97- 111; 118-133) in complex with pr-924 | 5L5H_C |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | yeast 20s proteasome with human beta5i (1-138) and human beta6 (97- 111; 118-133) in complex with epoxyketone inhibitor 9 | 5L5I_C |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | yeast 20s proteasome with human beta5i (1-138) and human beta6 (97- 111; 118-133) in complex with epoxyketone inhibitor 14 | 5L5J_C |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | yeast 20s proteasome with human beta5i (1-138) and human beta6 (97- 111; 118-133) in complex with epoxyketone inhibitor 16 | 5L5O_C |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | yeast 20s proteasome with human beta5i (1-138) and human beta6 (97- 111; 118-133) in complex with epoxyketone inhibitor 17 | 5L5P_C |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | yeast 20s proteasome with human beta5i (1-138) and human beta6 (97- 111; 118-133) in complex with epoxyketone 18 | 5L5Q_C |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | yeast 20s proteasome with human beta5i (1-138;v31m) and human beta6 (97-111; 118-133) | 5L5R_C |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | yeast 20s proteasome with human beta5i (1-138; v31m) and human beta6 (97-111; 118-133) in complex with pr-924 | 5L5S_C |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | yeast 20s proteasome with human beta5i (1-138; v31m) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 16 | 5L5T_C |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | yeast 20s proteasome with human beta5i (1-138; v31m) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 17 ***caveat 5l5u 04c h 301 has wrong chirality at atom c27 04c k 301 has ***caveat 2 5l5u wrong chirality at atom c27 04c v 301 h | 5L5U_C |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | yeast 20s proteasome with human beta5c (1-138) and human beta6 (97- 111; 118-133) | 5L5W_C |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | yeast 20s proteasome with human beta5c (1-138) and human beta6 (97- 111; 118-133) in complex with onx 0914 | 5L5X_C |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | yeast 20s proteasome with human beta5c (1-138) and human beta6 (97- 111; 118-133) in complex with carfilzomib | 5L5Y_C |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | yeast 20s proteasome with human beta5c (1-138) and human beta6 (97- 111; 118-133) in complex with bortezomib | 5L5Z_C |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | yeast 20s proteasome with human beta5c (1-138) and human beta6 (97- 111; 118-133) in complex with pr-924 | 5L60_C |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | yeast 20s proteasome with human beta5c (1-138) and human beta6 (99- 132) in complex with epoxyketone inhibitor 14 | 5L61_C |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | yeast 20s proteasome with human beta5c (1-138) and human beta6 (97- 111; 118-133) in complex with epoxyketone inhibitor 16 | 5L62_C |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | yeast 20s proteasome with human beta5c (1-138) and human beta6 (97- 111; 118-133) in complex with epoxyketone inhibitor 17 ***caveat 5l63 04c h 301 has wrong chirality at atom c27 04c k 301 has ***caveat 2 5l63 wrong chirality at atom c27 04c v 301 has wr | 5L63_C |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | yeast 20s proteasome with human beta5c (1-138) and human beta6 (97- 111; 118-133) in complex with epoxyketone inhibitor 18 | 5L64_C |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97- 111; 118-133) in complex with carfilzomib | 5L65_C |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97- 111; 118-133) in complex with bortezomib | 5L66_C |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97- 111; 118-133) in complex with pr-924 | 5L67_C |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97- 111; 118-133) in complex with epoxyketone inhibitor 14 | 5L68_C |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97- 111; 118-133) in complex with epoxyketone inhibitor 16 | 5L69_C |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97- 111; 118-133) in complex with epoxyketone inhibitor 17 | 5L6A_C |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97- 111; 118-133) in complex with onx 0914 | 5L6B_C |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97- 111; 118-133) in complex with epoxyketone inhibitor 18 | 5L6C_C |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | ligand-induced aziridine-formation at the yeast proteasomal subunit beta5 by sulfonate esters | 5LAI_C |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | ligand-induced lys33-thr1 crosslinking at the yeast proteasomal subunit beta5 by sulfonate esters | 5LAJ_C |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | yeast 20s proteasome with human beta5i (1-138; r57t)in complex with pr-924 | 5LTT_C |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | yeast 20s proteasome with human beta5i (1-138) and human beta6 (97- 111; 118-133) in complex with thiazole based inhibitor ro19 | 5M2B_C |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 26s proteasome in presence of atp (s1) | 5MP9_d |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 26s proteasome in presence of atp (s2) | 5MPA_d |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | yeast 20s proteasome in complex with blm-pep activator | 5NIF_D |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | yeast 26s proteasome bound to ubiquitinated substrate (1d* motor state) | 6EF0_D |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | yeast 26s proteasome bound to ubiquitinated substrate (5d motor state) | 6EF1_D |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | yeast 26s proteasome bound to ubiquitinated substrate (5t motor state) | 6EF2_D |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | yeast 26s proteasome bound to ubiquitinated substrate (4d motor state) | 6EF3_D |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | yeast 20s proteasome in complex with cystargolide b | 6G7F_C |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | yeast 20s proteasome in complex with cystargolide b derivative 1 | 6G8M_C |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | yeast 20s proteasome in complex with cystargolide b derivative 2 | 6G8N_C |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | yeast 20s proteasome in complex with homosalinosporamide a | 6GOP_C |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | yeast 20s proteasome in complex with the peptidic non-covalent bindinginhibitor rts-v5 | 6H39_C |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | yeast 20s proteasome with human beta2c (s171g) | 6HTB_C |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | yeast 20s proteasome with human beta2c (s171g) in complex with onx 0914 | 6HTC_C |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | yeast 20s proteasome with human beta2c (s171g) in complex with 4 | 6HTD_C |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | yeast 20s proteasome with human beta2c (s171g) in complex with 7 | 6HTP_C |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | yeast 20s proteasome with human beta2c (s171g) in complex with 13 | 6HTR_C |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | yeast 20s proteasome with human beta2c (s171g) in complex with 16 | 6HUB_C |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | yeast 20s proteasome with human beta2c (s171g) in complex with 18 | 6HUC_C |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | yeast 20s proteasome with human beta2c (s171g) in complex with 20 | 6HUQ_C |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | yeast 20s proteasome with human beta2c (s171g) in complex with 29 | 6HUU_C |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | yeast 20s proteasome with human beta2c (s171g) in complex with 39 | 6HUV_C |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | yeast 20s proteasome with human beta2i (1-53) | 6HV3_C |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | yeast 20s proteasome with human beta2i (1-53) in complex with onx 0914 | 6HV4_C |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | yeast 20s proteasome with human beta2i (1-53) in complex with 4 | 6HV5_C |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | yeast 20s proteasome with human beta2i (1-53) in complex with 7 | 6HV7_C |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | yeast 20s proteasome with human beta2i (1-53) in complex with 13 | 6HVA_C |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | yeast 20s proteasome with human beta2i (1-53) in complex with 16 | 6HVR_C |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | yeast 20s proteasome with human beta2i (1-53) in complex with 18 | 6HVS_C |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | yeast 20s proteasome with human beta2i (1-53) in complex with 20 | 6HVT_C |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | yeast 20s proteasome with human beta2i (1-53) in complex with 29 | 6HVU_C |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | yeast 20s proteasome with human beta2i (1-53) in complex with 39 | 6HVV_C |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | yeast 20s proteasome with human beta2i (1-53) in complex with 43 | 6HVW_C |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | yeast 20s proteasome in complex with 4 | 6HVX_C |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | yeast 20s proteasome in complex with 5 (7- and 6-membered ring) | 6HVY_C |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | yeast 20s proteasome in complex with 7 | 6HW0_C |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | yeast 20s proteasome in complex with 13 | 6HW3_C |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | yeast 20s proteasome in complex with 16 | 6HW4_C |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | yeast 20s proteasome in complex with 18 | 6HW5_C |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | yeast 20s proteasome in complex with 20 | 6HW6_C |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | yeast 20s proteasome in complex with 29 | 6HW7_C |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | yeast 20s proteasome in complex with 39 | 6HW8_C |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | yeast 20s proteasome in complex with 41b | 6HW9_C |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | yeast 20s proteasome in complex with 43 | 6HWA_C |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | yeast 20s proteasome in complex with 44b | 6HWB_C |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | yeast 20s proteasome beta2-g45a mutant | 6HWC_C |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | yeast 20s proteasome beta2-g45a mutant in complex with bortezomib | 6HWD_C |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | yeast 20s proteasome beta2-g45a mutant in complex with carfilzomib | 6HWE_C |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | yeast 20s proteasome beta2-g45a mutant in complex with onx 0914 | 6HWF_C |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S proteasome in complex with activator PA26 (Trypanosoma brucei) | 1FNT_J |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | complete proteasome | 1G0U_I |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | complex with epoxomicin | 1G65_I |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | proteasome complex bound to TMC-95A inhibitor | 1JD2_I |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S proteasome | 1RYP_J |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S proteasome; complex with the proteasome activator PA26 from Trypanosoma brucei | 1Z7Q_J |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S proteasome;complex with bortezomib | 2F16_I |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S proteasome; complex with salinosporamide A | 2FAK_I |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S proteasome; complex with homobelactosin C | 2FNY_I |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S proteasome; complex with TMC-95 based biphenyl-ether macrocycle | 2GPL_I |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S proteasome; complex with syringolin A | 2ZCY_I |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S proteasome; complex with glidobactin A | 3BDM_I |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S proteasome; complex with fellutamide B | 3D29_I |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20s proteasome; complex with the epimer form of spirolactacystin | 3DY3_I |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20s proteasome; complex with spirolactacystin | 3DY4_I |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20s proteasome; complex with homobelactosin c | 3E47_I |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20s proteasome; complex with syringolin b | 3GPJ_I |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S proteasome; complex with salinosporamide derivative | 3GPT_I |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S proteasome; complex with salinosporamide derivative | 3GPW_I |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S proteasome; complex with hyroxylated salinosporamide | 3HYE_I |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S proteasome; complex with bortezomib | 3MG0_I |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S proteasome; complex with compound 1 | 3MG4_I |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S proteasome; complex with compound 6 | 3MG6_I |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S open-gate proteasome; complex with compound 6 | 3MG7_I |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S open-gate proteasome; complex with compound 16 | 3MG8_I |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S proteasome; complex with ligand 2a | 3NZJ_I |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S proteasome; complex with ligand 2b | 3NZW_I |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S proteasome; complex with ligand 2c | 3NZX_I |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S open-gate proteasome; complex with compound 24 | 3OEU_I |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S open-gate proteasome; complex with compound 25 | 3OEV_I |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S proteasome; complex with alpha-keto-aldehyde | 3OKJ_I |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S open-gate proteasome; complex with compound 20 | 3SDI_I |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S open-gate proteasome; complex with compound 34 | 3SDK_I |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S proteasome; complex with hydroxyurea derivative HU10 | 3SHJ_I |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S proteasome; complex with homobelactosin C | 3TDD_I |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S open-gate proteasome; complex with PR-957 (morpholine) | 3UN4_I |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S proteasome; complex with PR-957 (epoxide) | 3UN8_I |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 26S proteasome | 3WXR_J |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 26S proteasome | 4CR2 |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 4CR3 | |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 26S proteasome | 4CR4 |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S proteasome; complex with K-7174 | 4EU2_J |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S proteasome; complex with cepafungin I | 4FZC_I |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S proteasome; complex with glidobactin | 4FZG_I |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S proteasome; complex with Syringolin-Glidobactin chimera | 4G4S_J |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S proteasome; complex with Syringolin-Glidobactin chimera | 4GK7_I |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S proteasome; complex with vinylketone carmaphycin analogue VNK1 | 4HNP_I |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S proteasome; complex with epoxyketone carmaphycin analogue 3 | 4HRC_I |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S proteasome; complex with carmaphycin A | 4HRD_I |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S proteasome; complex with vinyl sulfone LU102 | 4INR_I |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S proteasome; complex with vinyl sulfone LU122 | 4INT_I |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S proteasome; complex with vinyl sulfone LU112 | 4INU_I |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S proteasome; complex with belactosin derivative 3E | 4J70_I |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S proteasome; complex with dimerized linear mimetic of TMC-95A | 4JSQ_I |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S proteasome; complex with dimerized linear mimetic of TMC-95A | 4JSU_I |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S proteasome; complex with dimerized linear mimetic of TMC-95A | 4JT0_I |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S proteasome; complex with vibralactone | 4LQI_I |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S proteasome; complex with enone carmaphycin analogue 6 | 4LTC_I |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S proteasome; complex with MG132 | 4NNN_I |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S proteasome; complex with Z-Leu-Leu-Leu-ketoaldehyde | 4NNW_I |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S proteasome; complex with Z-Leu-Leu-Leu-B(OH)2 | 4NO1_I |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S proteasome; complex with Z-Leu-Leu-Leu-vinylsulfone | 4NO6_I |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S proteasome; complex with Z-Leu-Leu-Leu-ketoamide | 4NO8_I |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S proteasome; complex with Z-Leu-Leu-Leu-epoxyketone | 4NO9_I |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S proteasome; complex with kendomycin | 4Q1S_I |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S proteasome; complex with Boc-Ala-Ala-Ala-CHO | 4QBY_I |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S proteasome; complex with epoxyketone inhibitor 8 | 4QLQ_I |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S proteasome; complex with epoxyketone inhibitor 11 | 4QLS_I |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S proteasome; complex with tripeptidic epoxyketone inhibitor 2 | 4QLT_I |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S proteasome; complex with tripeptidic epoxyketone inhibitor 9 | 4QLU_I |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S proteasome; complex with tripeptidic epoxyketone inhibitor 17 | 4QLV_I |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S proteasome | 4QUX_I |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S proteasome | 4QUY_I |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S proteasome | 4QV0_I |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S proteasome | 4QV1_I |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S proteasome | 4QV3_I |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S proteasome beta5 Met45Thr mutant | 4QV4_I |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S proteasome beta5 Met45Ile mutant | 4QV5_I |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S proteasome | 4QV6_I |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S proteasome | 4QV7_I |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S proteasome | 4QV8_I |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S proteasome | 4QV9_I |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S proteasome; complex with bortezomib | 4QVL_I |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S proteasome beta5 Met45Ala mutant; complex with bortezomib | 4QVM_I |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S proteasome beta5 Met45Val mutant; complex with bortezomib | 4QVN_I |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S proteasome beta5 Met45Thr mutant; complex with bortezomib | 4QVP_I |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S proteasome beta5 Met45Ile mutant; complex with bortezomib | 4QVQ_I |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S proteasome beta5 Ala49Val mutant; complex with bortezomib | 4QVV_I |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S proteasome beta5 Ala49Ser mutant; complex with bortezomib | 4QVW_I |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S proteasome beta5 Ala49Thr mutant; complex with bortezomib | 4QVY_I |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S proteasome beta5 Ala49Thr,Ala50Val mutant; complex with bortezomib | 4QW0_I |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S proteasome beta5 Ala50Val mutant; complex with bortezomib | 4QW1_I |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S proteasome beta5 Cys63Phe mutant; complex with bortezomib | 4QW3_I |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S proteasome; complex with carfilzomib | 4QW4_I |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S proteasome beta5 Met45Ala mutant; complex with carfilzomib | 4QW5_I |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S proteasome beta5 Met45Val mutant; complex with carfilzomib | 4QW6_I |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S proteasome beta5 Met45Thr mutant; complex with carfilzomib | 4QW7_I |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S proteasome beta5 Met45Ile mutant; complex with carfilzomib | 4QWF_I |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S proteasome beta5 Ala49Val mutant; complex with carfilzomib | 4QWG_I |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S proteasome beta5 Ala49Ser mutant; complex with carfilzomib | 4QWI_I |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S proteasome beta5 Ala49Thr mutant; complex with carfilzomib | 4QWJ_I |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S proteasome beta5 Ala49Thr, Ala50Val mutant; complex with carfilzomib | 4QWK_I |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S proteasome beta5 Ala50Val mutant; complex with carfilzomib | 4QWL_I |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S proteasome beta5 Cys52Phe mutant; complex with carfilzomib | 4QWR_I |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S proteasome beta5 Cys63Phe mutant; complex with carfilzomib | 4QWS_I |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S proteasome beta5 Cys52Phe mutant; complex with bortezomib | 4QWU_I |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S proteasome; complex with epoxyketone inhibitor ONX 0914 | 4QWX_I |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S proteasome beta 5 Met45Ala mutant; complex with epoxyketone inhibitor ONX 0914 | 4QXJ_I |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | complete proteasome; complex with epoxyketone inhibitor ONX 0914 | 4QZ0_I |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S proteasome beta 5 Met45Thr mutant; complex with epoxyketone inhibitor ONX 0914 | 4QZ1_I |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S proteasome beta 5 Met45Ile mutant; complex with epoxyketone inhibitor ONX 0914 | 4QZ2_I |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S proteasome beta 5 Ala49Val mutant; complex with epoxyketone inhibitor ONX 0914 | 4QZ3_I |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S proteasome beta 5 Ala49Ser mutant; complex with epoxyketone inhibitor ONX 0914 | 4QZ4_I |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S proteasome beta 5 Ala49Thr mutant; complex with epoxyketone inhibitor ONX 0914 | 4QZ5_I |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S proteasome beta 5 Ala49Thr, Ala50Val mutant; complex with epoxyketone inhibitor ONX 0914 | 4QZ6_I |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S proteasome beta 5 Ala50Val mutant; complex with epoxyketone inhibitor ONX 0914 | 4QZ7_I |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S proteasome beta 5 Cys52Phe mutant; complex with epoxyketone inhibitor ONX 0914 | 4QZW_I |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | complete proteasome; complex with epoxyketone inhibitor ONX 0914 | 4QZX_I |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S proteasome; complex with omuralide | 4QZZ_I |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S proteasome beta 5 Cys52Phe mutant; complex with omuralide | 4R00_I |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S proteasome; complex with BSC4999 | 4R02_I |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S proteasome; ligand induced aziridine-formation in beta5 | 4R17_I |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S proteasome; ligand induced Lys33-Thr1 cross-linking in beta5 | 4R18_I |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S proteasome; complex with alkaloid indolo-phakellin | 4RUR_I |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S proteasome; complex with PR-VI modulator | 4X6Z_J |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S proteasome; complex with Ac-Pro-Ala-Asp-EP | 4Y69_I |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S proteasome beta2 His114Asp mutant; complex with Ac-Pro-Ala-Asp-EP | 4Y6A_I |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S proteasome; complex with Ac-Pro-Ala-Glu-EP | 4Y6V_I |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S proteasome; complex with Ac-Pro-Ala-Leu-EP | 4Y6Z_I |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S proteasome; complex with Ac-Leu-Ala-Val-EP | 4Y70_I |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S proteasome; complex with Ac-Leu-Ala-Leu-EP | 4Y74_I |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S proteasome; complex with Ac-Pro-Ala-Phe-EP | 4Y75_I |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S proteasome; complex with Ac-Leu-Ala-Phe-EP | 4Y77_I |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S proteasome; complex with Ac-Leu-Ala-Asp-EP | 4Y78_I |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S proteasome; complex with Ac-Leu-Ala-Glu-EP | 4Y7W_I |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | complete proteasome; complex with Ac-PAA-ep | 4Y7X_I |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S proteasome; complex with Ac-Leu-Ala-Ala-EP | 4Y7Y_I |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S proteasome; complex with Ac-Leu-Ala-Ile-EP | 4Y80_I |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S proteasome; complex with Ac-Pro-Ala-Tyr-EP | 4Y81_I |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S proteasome; complex with Ac-Leu-Ala-Tyr-EP | 4Y82_I |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S proteasome; complex with N3-Ala(4,4-F2P)-Asn-Leu-Leu-EP | 4Y84_I |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S proteasome; complex with N3-Ala-Pro-Asn-Leu-Leu-EP | 4Y8G_I |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S proteasome; complex with N3-Ala-Pro-Ala-Leu-EP | 4Y8H_I |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S proteasome; complex with Ac-Pro-Leu-Leu-EP | 4Y8I_I |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S proteasome; complex with Ac-Leu-Leu-Leu-EP | 4Y8J_I |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S proteasome; complex with H-Ala-Pro-Leu-Leu-EP | 4Y8K_I |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S proteasome; complex with Ac-Ala-Pro-Leu-Leu-EP | 4Y8L_I |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S proteasome beta7-delta7 C-terminal mutant | 4Y8M_I |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S proteasome beta7-delta7 C-terminal mutant; complex with Ac-Pro-Ala-Glu-EP | 4Y8N_I |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S proteasome beta 7-delta 7 C-terminal mutant; complex with Ac-Pro-Ala-Phe-EP | 4Y8O_I |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S proteasome beta 7-delta 7 C-terminal mutant; complex with Ac-Pro-Ala-Leu-EP | 4Y8P_I |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S proteasome beta 7-delta 7 C-terminal mutant; complex with Ac-Pro-Ala-Tyr-EP | 4Y8Q_I |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S proteasome beta 2 His116Asp mutant | 4Y8R_I |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S proteasome beta 2 His116Asp mutant; complex with Ac-Leu-Ala-Glu-EP | 4Y8S_I |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S proteasome beta 2 His116Asp mutant; complex with Ac-Pro-Ala-Glu-EP | 4Y8T_I |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S proteasome beta 2 His116Asp mutant; complex with Ac-Pro-Ala-Asp-EP | 4Y8U_I |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S proteasome beta 2 His116Glu mutant | 4Y9Y_I |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S proteasome beta 2 His116Glu mutant; complex with Ac-Leu-Ala-Glu-EP | 4Y9Z_I |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S proteasome beta 2 His116Glu mutant; complex with Ac-Pro-Ala-Glu-EP | 4YA0_I |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S proteasome beta 2 His116Asn mutant | 4YA1_I |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S proteasome beta 2 His116Asn mutant; complex with Ac-Leu-Ala-Glu-EP | 4YA2_I |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S proteasome beta 2 His116Asn mutant; complex with Ac-Pro-Ala-Glu-EP | 4YA3_I |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S proteasome beta 2 His114Asp mutant | 4YA4_I |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S proteasome beta 2 His114Asp mutant; complex with Ac-Pro-Ala-Glu-EP | 4YA5_I |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S proteasome beta 2 His114Asp mutant; complex with Ac-Leu-Ala-Glu-EP | 4YA7_I |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S proteasome beta 2 His114Asp mutant; complex with AC-Leu-Ala-Asp-EP | 4YA9_I |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S proteasome; complex with belactosin C derivative 3 | 4Z1L_I |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 5A5B | |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S proteasome; complex with macyranone A | 5AHJ_I |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S proteasome; complex with beta1/beta2 nonspecifici sulfonamide ligand | 5BOU_I |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | yeast 20s proteasome beta2-g170a mutant | 5BXL_I |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | yeast 20s proteasome beta2-g170a mutant in complex with bortezomib | 5BXN_I |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S proteasome beta5 Gly48Cys mutant | 5CGF_I |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S proteasome beta5 Gly48Cys mutant; complex with alpha-chloroacetamide 1 | 5CGG_I |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S proteasome beta5 Gly48Cys mutant; complex with alpha-chloroacetamide 5 | 5CGH_I |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S proteasome beta5 Gly48Cys mutant; complex with ONX 0914 | 5CGI_I |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | yeast 20s proteasome at 2.3 a resolution | 5CZ4_I |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | yeast 20s proteasome beta1-t1a mutant in complex with carfilzomib | 5CZ5_I |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | yeast 20s proteasome beta5-t1a mutant in complex with syringolin a, propeptide expressed in trans | 5CZ6_I |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | yeast 20s proteasome beta5-t1a beta5-k81r double mutant in complex with bortezomib, propeptide expressed in cis | 5CZ7_I |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | yeast 20s proteasome beta5-l(-49)s-k33a mutant in complex with carfilzomib | 5CZ8_I |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | yeast 20s proteasome beta5-d17n mutant in complex with carfilzomib; propeptide expressed in trans | 5CZ9_I |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | yeast 20s proteasome beta5-d166n mutant | 5CZA_I |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | yeast 20s proteasome beta5-d166n mutant in complex with carfilzomib | 5D0S_I |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20s proteasome beta5-Asp166Asn mutant; complex with MG132 | 5D0T_I |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | yeast 20s proteasome beta5-t1c mutant in complex with carfilzomib | 5D0V_I |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | yeast 20s proteasome beta5-t1s mutant | 5D0W_I |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | yeast 20s proteasome beta5-t1s mutant in complex with bortezomib | 5D0X_I |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | yeast 20s proteasome beta5-t1s mutant in complex with carfilzomib | 5D0Z_I |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S proteasome; complex with alkyne-PI | 5DKI_I |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20S proteasome; complex with octreotide-PI | 5DKJ_I |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | yeast 20s proteasome beta2-t1a mutant | 5FG7_I |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | yeast 20s proteasome beta2-t(-2)v mutant | 5FG9_I |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | yeast 20s proteasome beta5-k33a mutant (propeptide expressed in trans) | 5FGA_I |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | yeast 20s proteasome beta5-h(-2)l-t1a double mutant in complex with carfilzomib | 5FGD_I |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | yeast 20s proteasome beta5-h(-2)t-t1a double mutant in complex with carfilzomib | 5FGE_I |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | yeast 20s proteasome beta5-h(-2)a-t1a-k81r triple mutant in complex with carfilzomib | 5FGF_I |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | yeast 20s proteasome beta5-l(-49s)_d17n double mutant in complex with carfilzomib | 5FGG_I |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20s proteasome beta5-Lys33Ala mutant (propeptide expressed in trans); complex with MG132 | 5FGH_I |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | yeast 20s proteasome beta1-t1a beta2-t1a double mutant in complex withcarfilzomib | 5FGI_I |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | yeast 20s proteasome beta5-k33a mutant (propeptide expressed in trans)in complex with carfilzomib | 5FHS_I |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20s proteasome; complex with the peptidic epoxyketone inhibitor 27 | 5JHR_I |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 20s proteasome; complex with the peptidic epoxyketone inhibitor 15 | 5JHS_I |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | yeast 20s proteasome in complex with epoxyketone inhibitor 14 | 5L52_I |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | yeast 20s proteasome in complex with epoxyketone inhibitor 16 | 5L54_I |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | yeast 20s proteasome in complex with epoxyketone inhibitor 18 | 5L55_I |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | yeast 20s proteasome with human beta5i (1-138; r57t) | 5L5A_I |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | yeast 20s proteasome with human beta5i (1-138) and human beta6 (97- 111; 118-133) | 5L5B_I |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | yeast 20s proteasome with human beta5i (1-138) and human beta6 (97- 111; 118-133) in complex with onx 0914 | 5L5D_I |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | yeast 20s proteasome with human beta5i (1-138) and human beta6 (97- 111; 118-133) in complex with carfilzomib | 5L5E_I |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | yeast 20s proteasome with human beta5i (1-138) and human beta6 (97- 111; 118-133) in complex with bortezomib | 5L5F_I |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | yeast 20s proteasome with human beta5i (1-138) and human beta6 (97- 111; 118-133) in complex with pr-924 | 5L5H_I |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | yeast 20s proteasome with human beta5i (1-138) and human beta6 (97- 111; 118-133) in complex with epoxyketone inhibitor 9 | 5L5I_I |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | yeast 20s proteasome with human beta5i (1-138) and human beta6 (97- 111; 118-133) in complex with epoxyketone inhibitor 14 | 5L5J_I |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | yeast 20s proteasome with human beta5i (1-138) and human beta6 (97- 111; 118-133) in complex with epoxyketone inhibitor 16 | 5L5O_I |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | yeast 20s proteasome with human beta5i (1-138) and human beta6 (97- 111; 118-133) in complex with epoxyketone inhibitor 17 | 5L5P_I |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | yeast 20s proteasome with human beta5i (1-138) and human beta6 (97- 111; 118-133) in complex with epoxyketone 18 | 5L5Q_I |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | yeast 20s proteasome with human beta5i (1-138;v31m) and human beta6 (97-111; 118-133) | 5L5R_I |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | yeast 20s proteasome with human beta5i (1-138; v31m) and human beta6 (97-111; 118-133) in complex with pr-924 | 5L5S_I |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | yeast 20s proteasome with human beta5i (1-138; v31m) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 16 | 5L5T_I |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | yeast 20s proteasome with human beta5i (1-138; v31m) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 17 ***caveat 5l5u 04c h 301 has wrong chirality at atom c27 04c k 301 has ***caveat 2 5l5u wrong chirality at atom c27 04c v 301 h | 5L5U_I |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | yeast 20s proteasome with human beta5c (1-138) and human beta6 (97- 111; 118-133) | 5L5W_I |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | yeast 20s proteasome with human beta5c (1-138) and human beta6 (97- 111; 118-133) in complex with onx 0914 | 5L5X_I |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | yeast 20s proteasome with human beta5c (1-138) and human beta6 (97- 111; 118-133) in complex with carfilzomib | 5L5Y_I |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | yeast 20s proteasome with human beta5c (1-138) and human beta6 (97- 111; 118-133) in complex with bortezomib | 5L5Z_I |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | yeast 20s proteasome with human beta5c (1-138) and human beta6 (97- 111; 118-133) in complex with pr-924 | 5L60_I |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | yeast 20s proteasome with human beta5c (1-138) and human beta6 (99- 132) in complex with epoxyketone inhibitor 14 | 5L61_I |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | yeast 20s proteasome with human beta5c (1-138) and human beta6 (97- 111; 118-133) in complex with epoxyketone inhibitor 16 | 5L62_I |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | yeast 20s proteasome with human beta5c (1-138) and human beta6 (97- 111; 118-133) in complex with epoxyketone inhibitor 17 ***caveat 5l63 04c h 301 has wrong chirality at atom c27 04c k 301 has ***caveat 2 5l63 wrong chirality at atom c27 04c v 301 has wr | 5L63_I |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | yeast 20s proteasome with human beta5c (1-138) and human beta6 (97- 111; 118-133) in complex with epoxyketone inhibitor 18 | 5L64_I |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97- 111; 118-133) in complex with carfilzomib | 5L65_I |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97- 111; 118-133) in complex with bortezomib | 5L66_I |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97- 111; 118-133) in complex with pr-924 | 5L67_I |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97- 111; 118-133) in complex with epoxyketone inhibitor 14 | 5L68_I |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97- 111; 118-133) in complex with epoxyketone inhibitor 16 | 5L69_I |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97- 111; 118-133) in complex with epoxyketone inhibitor 17 | 5L6A_I |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97- 111; 118-133) in complex with onx 0914 | 5L6B_I |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97- 111; 118-133) in complex with epoxyketone inhibitor 18 | 5L6C_I |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | ligand-induced aziridine-formation at the yeast proteasomal subunit beta5 by sulfonate esters | 5LAI_I |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | ligand-induced lys33-thr1 crosslinking at the yeast proteasomal subunit beta5 by sulfonate esters | 5LAJ_I |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | yeast 20s proteasome with human beta5i (1-138; r57t)in complex with pr-924 | 5LTT_I |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | yeast 20s proteasome with human beta5i (1-138) and human beta6 (97- 111; 118-133) in complex with thiazole based inhibitor ro19 | 5M2B_I |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 26s proteasome in presence of atp (s1) | 5MP9_j |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | 26s proteasome in presence of atp (s2) | 5MPA_j |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | yeast 20s proteasome in complex with blm-pep activator | 5NIF_J |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | yeast 26s proteasome bound to ubiquitinated substrate (4d motor state) | 6EF3_3 |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | yeast 20s proteasome in complex with cystargolide b | 6G7F_I |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | yeast 20s proteasome in complex with cystargolide b derivative 1 | 6G8M_I |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | yeast 20s proteasome in complex with cystargolide b derivative 2 | 6G8N_I |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | yeast 20s proteasome in complex with homosalinosporamide a | 6GOP_I |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | yeast 20s proteasome in complex with the peptidic non-covalent bindinginhibitor rts-v5 | 6H39_I |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | yeast 20s proteasome with human beta2c (s171g) | 6HTB_I |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | yeast 20s proteasome with human beta2c (s171g) in complex with onx 0914 | 6HTC_I |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | yeast 20s proteasome with human beta2c (s171g) in complex with 4 | 6HTD_I |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | yeast 20s proteasome with human beta2c (s171g) in complex with 7 | 6HTP_I |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | yeast 20s proteasome with human beta2c (s171g) in complex with 13 | 6HTR_I |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | yeast 20s proteasome with human beta2c (s171g) in complex with 16 | 6HUB_I |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | yeast 20s proteasome with human beta2c (s171g) in complex with 18 | 6HUC_I |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | yeast 20s proteasome with human beta2c (s171g) in complex with 20 | 6HUQ_I |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | yeast 20s proteasome with human beta2c (s171g) in complex with 29 | 6HUU_I |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | yeast 20s proteasome with human beta2c (s171g) in complex with 39 | 6HUV_I |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | yeast 20s proteasome with human beta2i (1-53) | 6HV3_I |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | yeast 20s proteasome with human beta2i (1-53) in complex with onx 0914 | 6HV4_I |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | yeast 20s proteasome with human beta2i (1-53) in complex with 4 | 6HV5_I |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | yeast 20s proteasome with human beta2i (1-53) in complex with 7 | 6HV7_I |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | yeast 20s proteasome with human beta2i (1-53) in complex with 13 | 6HVA_I |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | yeast 20s proteasome with human beta2i (1-53) in complex with 16 | 6HVR_I |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | yeast 20s proteasome with human beta2i (1-53) in complex with 18 | 6HVS_I |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | yeast 20s proteasome with human beta2i (1-53) in complex with 20 | 6HVT_I |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | yeast 20s proteasome with human beta2i (1-53) in complex with 29 | 6HVU_I |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | yeast 20s proteasome with human beta2i (1-53) in complex with 39 | 6HVV_I |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | yeast 20s proteasome with human beta2i (1-53) in complex with 43 | 6HVW_I |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | yeast 20s proteasome in complex with 4 | 6HVX_I |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | yeast 20s proteasome in complex with 5 (7- and 6-membered ring) | 6HVY_I |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | yeast 20s proteasome in complex with 7 | 6HW0_I |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | yeast 20s proteasome in complex with 13 | 6HW3_I |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | yeast 20s proteasome in complex with 16 | 6HW4_I |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | yeast 20s proteasome in complex with 18 | 6HW5_I |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | yeast 20s proteasome in complex with 20 | 6HW6_I |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | yeast 20s proteasome in complex with 29 | 6HW7_I |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | yeast 20s proteasome in complex with 39 | 6HW8_I |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | yeast 20s proteasome in complex with 41b | 6HW9_I |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | yeast 20s proteasome in complex with 43 | 6HWA_I |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | yeast 20s proteasome in complex with 44b | 6HWB_I |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | yeast 20s proteasome beta2-g45a mutant | 6HWC_I |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | yeast 20s proteasome beta2-g45a mutant in complex with bortezomib | 6HWD_I |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | yeast 20s proteasome beta2-g45a mutant in complex with carfilzomib | 6HWE_I |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | yeast 20s proteasome beta2-g45a mutant in complex with onx 0914 | 6HWF_I |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | ground state 26s proteasome (gs2) | 6EPC_D |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | substrate processing state 26s proteasome (sps1) ***caveat 6epd pro 2 231 has wrong chirality at atom ca | 6EPD_D |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | substrate processing state 26s proteasome (sps2) | 6EPE_D |
| PB | T01.UNA | subfamily T1A non-peptidase homologues | ground state 26s proteasome (gs1) | 6EPF_D |
| PB | T01.UPA | subfamily T1A unassigned peptidases | ground state 26s proteasome (gs2) | 6EPC_G |
| PB | T01.UPA | subfamily T1A unassigned peptidases | substrate processing state 26s proteasome (sps1) ***caveat 6epd pro 2 231 has wrong chirality at atom ca | 6EPD_G |
| PB | T01.UPA | subfamily T1A unassigned peptidases | substrate processing state 26s proteasome (sps2) | 6EPE_G |
| PB | T01.UPA | subfamily T1A unassigned peptidases | ground state 26s proteasome (gs1) | 6EPF_G |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S proteasome in complex with activator PA26 (Trypanosoma brucei) | 1FNT_B |
| PB | T01.UPA | subfamily T1A unassigned peptidases | complete proteasome | 1G0U_A |
| PB | T01.UPA | subfamily T1A unassigned peptidases | complex with epoxomicin | 1G65_A |
| PB | T01.UPA | subfamily T1A unassigned peptidases | proteasome complex bound to TMC-95A inhibitor | 1JD2_A |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S proteasome | 1RYP_B |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S proteasome; complex with the proteasome activator PA26 from Trypanosoma brucei | 1Z7Q_B |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S proteasome; complex with bortezomib | 2F16_A |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S proteasome; complex with salinosporamide A | 2FAK_A |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S proteasome; complex with homobelactosin C | 2FNY_A |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S proteasome; complex with TMC-95 based biphenyl-ether macrocycle | 2GPL_A |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S proteasome; complex with syringolin A | 2ZCY_A |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S proteasome; complex with glidobactin A | 3BDM_A |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S proteasome; complex with fellutamide B | 3D29_A |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20s proteasome; complex with the epimer form of spirolactacystin | 3DY3_A |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20s proteasome; complex with spirolactacystin | 3DY4_A |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20s proteasome; complex with homobelactosin c | 3E47_A |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20s proteasome; complex with syringolin b | 3GPJ_A |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S proteasome; complex with salinosporamide derivative | 3GPT_A |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S proteasome; complex with salinosporamide derivative | 3GPW_A |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S proteasome; complex with hyroxylated salinosporamide | 3HYE_A |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S proteasome; complex with bortezomib | 3MG0_A |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S proteasome; complex with compound 1 | 3MG4_A |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S proteasome; complex with compound 6 | 3MG6_A |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S open-gate proteasome; complex with compound 6 | 3MG7_A |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S open-gate proteasome; complex with compound 16 | 3MG8_A |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S proteasome; complex with ligand 2a | 3NZJ_A |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S proteasome; complex with ligand 2b | 3NZW_A |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S proteasome; complex with ligand 2c | 3NZX_A |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S open-gate proteasome; complex with compound 24 | 3OEU_A |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S open-gate proteasome; complex with compound 25 | 3OEV_A |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S proteasome; complex with alpha-keto-aldehyde | 3OKJ_A |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S open-gate proteasome; complex with compound 20 | 3SDI_A |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S open-gate proteasome; complex with compound 34 | 3SDK_A |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S proteasome; complex with hydroxyurea derivative HU10 | 3SHJ_A |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S proteasome; complex with homobelactosin C | 3TDD_A |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S open-gate proteasome; complex with PR-957 (morpholine) | 3UN4_A |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S proteasome; complex with PR-957 (epoxide) | 3UN8_A |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 26S proteasome | 3WXR_B |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 26S proteasome | 4CR2_B |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 26S proteasome | 4CR3_B |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 26S proteasome | 4CR4_B |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S proteasome; complex with K-7174 | 4EU2_B |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S proteasome; complex with cepafungin I | 4FZC_A |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S proteasome; complex with glidobactin | 4FZG_A |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S proteasome; complex with Syringolin-Glidobactin chimera | 4G4S_B |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S proteasome; complex with Syringolin-Glidobactin chimera | 4GK7_A |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S proteasome; complex with vinylketone carmaphycin analogue VNK1 | 4HNP_A |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S proteasome; complex with epoxyketone carmaphycin analogue 3 | 4HRC_A |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S proteasome; complex with carmaphycin A | 4HRD_A |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S proteasome; complex with vinyl sulfone LU102 | 4INR_A |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S proteasome; complex with vinyl sulfone LU122 | 4INT_A |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S proteasome; complex with vinyl sulfone LU112 | 4INU_A |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S proteasome; complex with belactosin derivative 3E | 4J70_A |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S proteasome; complex with dimerized linear mimetic of TMC-95A | 4JSQ_A |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S proteasome; complex with dimerized linear mimetic of TMC-95A | 4JSU_A |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S proteasome; complex with dimerized linear mimetic of TMC-95A | 4JT0_A |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S proteasome; complex with vibralactone | 4LQI_A |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S proteasome; complex with enone carmaphycin analogue 6 | 4LTC_A |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S proteasome; complex with MG132 | 4NNN_A |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S proteasome; complex with Z-Leu-Leu-Leu-ketoaldehyde | 4NNW_A |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S proteasome; complex with Z-Leu-Leu-Leu-B(OH)2 | 4NO1_A |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S proteasome; complex with Z-Leu-Leu-Leu-vinylsulfone | 4NO6_A |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S proteasome; complex with Z-Leu-Leu-Leu-ketoamide | 4NO8_A |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S proteasome; complex with Z-Leu-Leu-Leu-epoxyketone | 4NO9_A |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S proteasome; complex with kendomycin | 4Q1S_A |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S proteasome; complex with Boc-Ala-Ala-Ala-CHO | 4QBY_A |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S proteasome; complex with epoxyketone inhibitor 8 | 4QLQ_A |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S proteasome; complex with epoxyketone inhibitor 11 | 4QLS_A |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S proteasome; complex with tripeptidic epoxyketone inhibitor 2 | 4QLT_A |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S proteasome; complex with tripeptidic epoxyketone inhibitor 9 | 4QLU_A |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S proteasome; complex with tripeptidic epoxyketone inhibitor 17 | 4QLV_A |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S proteasome | 4QUX_A |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S proteasome | 4QUY_A |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S proteasome | 4QV0_A |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S proteasome | 4QV1_A |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S proteasome | 4QV3_A |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S proteasome beta5 Met45Thr mutant | 4QV4_A |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S proteasome beta5 Met45Ile mutant | 4QV5_A |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S proteasome | 4QV6_A |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S proteasome | 4QV7_A |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S proteasome | 4QV8_A |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S proteasome | 4QV9_A |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S proteasome; complex with bortezomib | 4QVL_A |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S proteasome beta5 Met45Ala mutant; complex with bortezomib | 4QVM_A |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S proteasome beta5 Met45Val mutant; complex with bortezomib | 4QVN_A |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S proteasome beta5 Met45Thr mutant; complex with bortezomib | 4QVP_A |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S proteasome beta5 Met45Ile mutant; complex with bortezomib | 4QVQ_A |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S proteasome beta5 Ala49Val mutant; complex with bortezomib | 4QVV_A |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S proteasome beta5 Ala49Ser mutant; complex with bortezomib | 4QVW_A |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S proteasome beta5 Ala49Thr mutant; complex with bortezomib | 4QVY_A |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S proteasome beta5 Ala49Thr,Ala50Val mutant; complex with bortezomib | 4QW0_A |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S proteasome beta5 Ala50Val mutant; complex with bortezomib | 4QW1_A |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S proteasome beta5 Cys63Phe mutant; complex with bortezomib | 4QW3_A |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S proteasome; complex with carfilzomib | 4QW4_A |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S proteasome beta5 Met45Ala mutant; complex with carfilzomib | 4QW5_A |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S proteasome beta5 Met45Val mutant; complex with carfilzomib | 4QW6_A |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S proteasome beta5 Met45Thr mutant; complex with carfilzomib | 4QW7_A |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S proteasome beta5 Met45Ile mutant; complex with carfilzomib | 4QWF_A |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S proteasome beta5 Ala49Val mutant; complex with carfilzomib | 4QWG_A |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S proteasome beta5 Ala49Ser mutant; complex with carfilzomib | 4QWI_A |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S proteasome beta5 Ala49Thr mutant; complex with carfilzomib | 4QWJ_A |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S proteasome beta5 Ala49Thr, Ala50Val mutant; complex with carfilzomib | 4QWK_A |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S proteasome beta5 Ala50Val mutant; complex with carfilzomib | 4QWL_A |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S proteasome beta5 Cys52Phe mutant; complex with carfilzomib | 4QWR_A |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S proteasome beta5 Cys63Phe mutant; complex with carfilzomib | 4QWS_A |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S proteasome beta5 Cys52Phe mutant; complex with bortezomib | 4QWU_A |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S proteasome; complex with epoxyketone inhibitor ONX 0914 | 4QWX_A |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S proteasome beta 5 Met45Ala mutant; complex with epoxyketone inhibitor ONX 0914 | 4QXJ_A |
| PB | T01.UPA | subfamily T1A unassigned peptidases | complete proteasome; complex with epoxyketone inhibitor ONX 0914 | 4QZ0_A |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S proteasome beta 5 Met45Thr mutant; complex with epoxyketone inhibitor ONX 0914 | 4QZ1_A |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S proteasome beta 5 Met45Ile mutant; complex with epoxyketone inhibitor ONX 0914 | 4QZ2_A |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S proteasome beta 5 Ala49Val mutant; complex with epoxyketone inhibitor ONX 0914 | 4QZ3_A |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S proteasome beta 5 Ala49Ser mutant; complex with epoxyketone inhibitor ONX 0914 | 4QZ4_A |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S proteasome beta 5 Ala49Thr mutant; complex with epoxyketone inhibitor ONX 0914 | 4QZ5_A |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S proteasome beta 5 Ala49Thr, Ala50Val mutant; complex with epoxyketone inhibitor ONX 0914 | 4QZ6_A |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S proteasome beta 5 Ala50Val mutant; complex with epoxyketone inhibitor ONX 0914 | 4QZ7_A |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S proteasome beta 5 Cys52Phe mutant; complex with epoxyketone inhibitor ONX 0914 | 4QZW_A |
| PB | T01.UPA | subfamily T1A unassigned peptidases | complete proteasome; complex with epoxyketone inhibitor ONX 0914 | 4QZX_A |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S proteasome; complex with omuralide | 4QZZ_A |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S proteasome beta 5 Cys52Phe mutant; complex with omuralide | 4R00_A |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S proteasome; complex with BSC4999 | 4R02_A |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S proteasome; ligand induced aziridine-formation in beta5 | 4R17_A |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S proteasome; ligand induced Lys33-Thr1 cross-linking in beta5 | 4R18_A |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S proteasome; complex with alkaloid indolo-phakellin | 4RUR_A |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 4V7O | |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S proteasome; complex with PR-VI modulator | 4X6Z_B |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S proteasome; complex with Ac-Pro-Ala-Asp-EP | 4Y69_A |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S proteasome beta2 His114Asp mutant; complex with Ac-Pro-Ala-Asp-EP | 4Y6A_A |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S proteasome; complex with Ac-Pro-Ala-Glu-EP | 4Y6V_A |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S proteasome; complex with Ac-Pro-Ala-Leu-EP | 4Y6Z_A |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S proteasome; complex with Ac-Leu-Ala-Val-EP | 4Y70_A |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S proteasome; complex with Ac-Leu-Ala-Leu-EP | 4Y74_A |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S proteasome; complex with Ac-Pro-Ala-Phe-EP | 4Y75_A |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S proteasome; complex with Ac-Leu-Ala-Phe-EP | 4Y77_A |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S proteasome; complex with Ac-Leu-Ala-Asp-EP | 4Y78_A |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S proteasome; complex with Ac-Leu-Ala-Glu-EP | 4Y7W_A |
| PB | T01.UPA | subfamily T1A unassigned peptidases | complete proteasome; complex with Ac-PAA-ep | 4Y7X_A |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S proteasome; complex with Ac-Leu-Ala-Ala-EP | 4Y7Y_A |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S proteasome; complex with Ac-Leu-Ala-Ile-EP | 4Y80_A |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S proteasome; complex with Ac-Pro-Ala-Tyr-EP | 4Y81_A |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S proteasome; complex with Ac-Leu-Ala-Tyr-EP | 4Y82_A |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S proteasome; complex with N3-Ala(4,4-F2P)-Asn-Leu-Leu-EP | 4Y84_A |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S proteasome; complex with N3-Ala-Pro-Asn-Leu-Leu-EP | 4Y8G_A |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S proteasome; complex with N3-Ala-Pro-Ala-Leu-EP | 4Y8H_A |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S proteasome; complex with Ac-Pro-Leu-Leu-EP | 4Y8I_A |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S proteasome; complex with Ac-Leu-Leu-Leu-EP | 4Y8J_A |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S proteasome; complex with H-Ala-Pro-Leu-Leu-EP | 4Y8K_A |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S proteasome; complex with Ac-Ala-Pro-Leu-Leu-EP | 4Y8L_A |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S proteasome beta7-delta7 C-terminal mutant | 4Y8M_A |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S proteasome beta7-delta7 C-terminal mutant; complex with Ac-Pro-Ala-Glu-EP | 4Y8N_A |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S proteasome beta 7-delta 7 C-terminal mutant; complex with Ac-Pro-Ala-Phe-EP | 4Y8O_A |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S proteasome beta 7-delta 7 C-terminal mutant; complex with Ac-Pro-Ala-Leu-EP | 4Y8P_A |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S proteasome beta 7-delta 7 C-terminal mutant; complex with Ac-Pro-Ala-Tyr-EP | 4Y8Q_A |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S proteasome beta 2 His116Asp mutant | 4Y8R_A |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S proteasome beta 2 His116Asp mutant; complex with Ac-Leu-Ala-Glu-EP | 4Y8S_A |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S proteasome beta 2 His116Asp mutant; complex with Ac-Pro-Ala-Glu-EP | 4Y8T_A |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S proteasome beta 2 His116Asp mutant; complex with Ac-Pro-Ala-Asp-EP | 4Y8U_A |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S proteasome beta 2 His116Glu mutant | 4Y9Y_A |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S proteasome beta 2 His116Glu mutant; complex with Ac-Leu-Ala-Glu-EP | 4Y9Z_A |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S proteasome beta 2 His116Glu mutant; complex with Ac-Pro-Ala-Glu-EP | 4YA0_A |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S proteasome beta 2 His116Asn mutant | 4YA1_A |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S proteasome beta 2 His116Asn mutant; complex with Ac-Leu-Ala-Glu-EP | 4YA2_A |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S proteasome beta 2 His116Asn mutant; complex with Ac-Pro-Ala-Glu-EP | 4YA3_A |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S proteasome beta 2 His114Asp mutant | 4YA4_A |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S proteasome beta 2 His114Asp mutant; complex with Ac-Pro-Ala-Glu-EP | 4YA5_A |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S proteasome beta 2 His114Asp mutant; complex with Ac-Leu-Ala-Glu-EP | 4YA7_A |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S proteasome beta 2 His114Asp mutant; complex with AC-Leu-Ala-Asp-EP | 4YA9_A |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S proteasome; complex with belactosin C derivative 3 | 4Z1L_A |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 26S protease-UBP6 complex | 5A5B_B |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S proteasome; complex with macyranone A | 5AHJ_A |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S proteasome; complex with beta1/beta2 nonspecifici sulfonamide ligand | 5BOU_A |
| PB | T01.UPA | subfamily T1A unassigned peptidases | yeast 20s proteasome beta2-g170a mutant | 5BXL_A |
| PB | T01.UPA | subfamily T1A unassigned peptidases | yeast 20s proteasome beta2-g170a mutant in complex with bortezomib | 5BXN_A |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S proteasome beta5 Gly48Cys mutant | 5CGF_A |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S proteasome beta5 Gly48Cys mutant; complex with alpha-chloroacetamide 1 | 5CGG_A |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S proteasome beta5 Gly48Cys mutant; complex with alpha-chloroacetamide 5 | 5CGH_A |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S proteasome beta5 Gly48Cys mutant; complex with ONX 0914 | 5CGI_A |
| PB | T01.UPA | subfamily T1A unassigned peptidases | yeast 20s proteasome at 2.3 a resolution | 5CZ4_A |
| PB | T01.UPA | subfamily T1A unassigned peptidases | yeast 20s proteasome beta1-t1a mutant in complex with carfilzomib | 5CZ5_A |
| PB | T01.UPA | subfamily T1A unassigned peptidases | yeast 20s proteasome beta5-t1a mutant in complex with syringolin a, propeptide expressed in trans | 5CZ6_A |
| PB | T01.UPA | subfamily T1A unassigned peptidases | yeast 20s proteasome beta5-t1a beta5-k81r double mutant in complex with bortezomib, propeptide expressed in cis | 5CZ7_A |
| PB | T01.UPA | subfamily T1A unassigned peptidases | yeast 20s proteasome beta5-l(-49)s-k33a mutant in complex with carfilzomib | 5CZ8_A |
| PB | T01.UPA | subfamily T1A unassigned peptidases | yeast 20s proteasome beta5-d17n mutant in complex with carfilzomib; propeptide expressed in trans | 5CZ9_A |
| PB | T01.UPA | subfamily T1A unassigned peptidases | yeast 20s proteasome beta5-d166n mutant | 5CZA_A |
| PB | T01.UPA | subfamily T1A unassigned peptidases | yeast 20s proteasome beta5-d166n mutant in complex with carfilzomib | 5D0S_A |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20s proteasome beta5-Asp166Asn mutant; complex with MG132 | 5D0T_A |
| PB | T01.UPA | subfamily T1A unassigned peptidases | yeast 20s proteasome beta5-t1c mutant in complex with carfilzomib | 5D0V_A |
| PB | T01.UPA | subfamily T1A unassigned peptidases | yeast 20s proteasome beta5-t1s mutant | 5D0W_A |
| PB | T01.UPA | subfamily T1A unassigned peptidases | yeast 20s proteasome beta5-t1s mutant in complex with bortezomib | 5D0X_A |
| PB | T01.UPA | subfamily T1A unassigned peptidases | yeast 20s proteasome beta5-t1s mutant in complex with carfilzomib | 5D0Z_A |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S proteasome; complex with alkyne-PI | 5DKI_A |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S proteasome; complex with octreotide-PI | 5DKJ_A |
| PB | T01.UPA | subfamily T1A unassigned peptidases | yeast 20s proteasome beta2-t1a mutant | 5FG7_A |
| PB | T01.UPA | subfamily T1A unassigned peptidases | yeast 20s proteasome beta2-t(-2)v mutant | 5FG9_A |
| PB | T01.UPA | subfamily T1A unassigned peptidases | yeast 20s proteasome beta5-k33a mutant (propeptide expressed in trans) | 5FGA_A |
| PB | T01.UPA | subfamily T1A unassigned peptidases | yeast 20s proteasome beta5-h(-2)l-t1a double mutant in complex with carfilzomib | 5FGD_A |
| PB | T01.UPA | subfamily T1A unassigned peptidases | yeast 20s proteasome beta5-h(-2)t-t1a double mutant in complex with carfilzomib | 5FGE_A |
| PB | T01.UPA | subfamily T1A unassigned peptidases | yeast 20s proteasome beta5-h(-2)a-t1a-k81r triple mutant in complex with carfilzomib | 5FGF_A |
| PB | T01.UPA | subfamily T1A unassigned peptidases | yeast 20s proteasome beta5-l(-49s)_d17n double mutant in complex with carfilzomib | 5FGG_A |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20s proteasome beta5-Lys33Ala mutant (propeptide expressed in trans); complex with MG132 | 5FGH_A |
| PB | T01.UPA | subfamily T1A unassigned peptidases | yeast 20s proteasome beta1-t1a beta2-t1a double mutant in complex withcarfilzomib | 5FGI_A |
| PB | T01.UPA | subfamily T1A unassigned peptidases | yeast 20s proteasome beta5-k33a mutant (propeptide expressed in trans)in complex with carfilzomib | 5FHS_A |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20s proteasome; complex with the peptidic epoxyketone inhibitor 27 | 5JHR_A |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20s proteasome; complex with the peptidic epoxyketone inhibitor 15 | 5JHS_A |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20s proteasome; complex with epoxyketone inhibitor 14 | 5L52_A |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20s proteasome; complex with epoxyketone inhibitor 16 | 5L54_A |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20s proteasome; complex with epoxyketone inhibitor 18 | 5L55_A |
| PB | T01.UPA | subfamily T1A unassigned peptidases | yeast 20s proteasome with human beta5i (1-138; r57t) | 5L5A_A |
| PB | T01.UPA | subfamily T1A unassigned peptidases | yeast 20s proteasome with human beta5i (1-138) and human beta6 (97- 111; 118-133) | 5L5B_A |
| PB | T01.UPA | subfamily T1A unassigned peptidases | yeast 20s proteasome with human beta5i (1-138) and human beta6 (97- 111; 118-133) in complex with onx 0914 | 5L5D_A |
| PB | T01.UPA | subfamily T1A unassigned peptidases | yeast 20s proteasome with human beta5i (1-138) and human beta6 (97- 111; 118-133) in complex with carfilzomib | 5L5E_A |
| PB | T01.UPA | subfamily T1A unassigned peptidases | yeast 20s proteasome with human beta5i (1-138) and human beta6 (97- 111; 118-133) in complex with bortezomib | 5L5F_A |
| PB | T01.UPA | subfamily T1A unassigned peptidases | yeast 20s proteasome with human beta5i (1-138) and human beta6 (97- 111; 118-133); complex with PR-924 | 5L5H_A |
| PB | T01.UPA | subfamily T1A unassigned peptidases | yeast 20s proteasome with human beta5i (1-138) and human beta6 (97- 111; 118-133) in complex with epoxyketone inhibitor 9 | 5L5I_A |
| PB | T01.UPA | subfamily T1A unassigned peptidases | yeast 20s proteasome with human beta5i (1-138) and human beta6 (97- 111; 118-133) in complex with epoxyketone inhibitor 14 | 5L5J_A |
| PB | T01.UPA | subfamily T1A unassigned peptidases | yeast 20s proteasome with human beta5i (1-138) and human beta6 (97- 111; 118-133) in complex with epoxyketone inhibitor 16 | 5L5O_A |
| PB | T01.UPA | subfamily T1A unassigned peptidases | yeast 20s proteasome with human beta5i (1-138) and human beta6 (97- 111; 118-133) in complex with epoxyketone inhibitor 17 | 5L5P_A |
| PB | T01.UPA | subfamily T1A unassigned peptidases | yeast 20s proteasome with human beta5i (1-138) and human beta6 (97- 111; 118-133) in complex with epoxyketone 18 | 5L5Q_A |
| PB | T01.UPA | subfamily T1A unassigned peptidases | yeast 20s proteasome with human beta5i (1-138;v31m) and human beta6 (97-111; 118-133) | 5L5R_A |
| PB | T01.UPA | subfamily T1A unassigned peptidases | yeast 20s proteasome with human beta5i (1-138; Val31Met mutant) and human beta6 (97-111; 118-133); complex with PR-924 | 5L5S_A |
| PB | T01.UPA | subfamily T1A unassigned peptidases | yeast 20s proteasome with human beta5i (1-138; v31m) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 16 | 5L5T_A |
| PB | T01.UPA | subfamily T1A unassigned peptidases | yeast 20s proteasome with human beta5i (1-138; v31m) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 17 ***caveat 5l5u 04c h 301 has wrong chirality at atom c27 04c k 301 has ***caveat 2 5l5u wrong chirality at atom c27 04c v 301 h | 5L5U_A |
| PB | T01.UPA | subfamily T1A unassigned peptidases | yeast 20s proteasome with human beta5c (1-138) and human beta6 (97- 111; 118-133) | 5L5W_A |
| PB | T01.UPA | subfamily T1A unassigned peptidases | yeast 20s proteasome with human beta5c (1-138) and human beta6 (97- 111; 118-133) in complex with onx 0914 | 5L5X_A |
| PB | T01.UPA | subfamily T1A unassigned peptidases | yeast 20s proteasome with human beta5c (1-138) and human beta6 (97- 111; 118-133) in complex with carfilzomib | 5L5Y_A |
| PB | T01.UPA | subfamily T1A unassigned peptidases | yeast 20s proteasome with human beta5c (1-138) and human beta6 (97- 111; 118-133) in complex with bortezomib | 5L5Z_A |
| PB | T01.UPA | subfamily T1A unassigned peptidases | yeast 20s proteasome with human beta5c (1-138) and human beta6 (97- 111; 118-133); complex with PR-924 | 5L60_A |
| PB | T01.UPA | subfamily T1A unassigned peptidases | yeast 20s proteasome with human beta5c (1-138) and human beta6 (99- 132) in complex with epoxyketone inhibitor 14 | 5L61_A |
| PB | T01.UPA | subfamily T1A unassigned peptidases | yeast 20s proteasome with human beta5c (1-138) and human beta6 (97- 111; 118-133) in complex with epoxyketone inhibitor 16 | 5L62_A |
| PB | T01.UPA | subfamily T1A unassigned peptidases | yeast 20s proteasome with human beta5c (1-138) and human beta6 (97- 111; 118-133) in complex with epoxyketone inhibitor 17 ***caveat 5l63 04c h 301 has wrong chirality at atom c27 04c k 301 has ***caveat 2 5l63 wrong chirality at atom c27 04c v 301 has wr | 5L63_A |
| PB | T01.UPA | subfamily T1A unassigned peptidases | yeast 20s proteasome with human beta5c (1-138) and human beta6 (97- 111; 118-133) in complex with epoxyketone inhibitor 18 | 5L64_A |
| PB | T01.UPA | subfamily T1A unassigned peptidases | yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97- 111; 118-133) in complex with carfilzomib | 5L65_A |
| PB | T01.UPA | subfamily T1A unassigned peptidases | yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97- 111; 118-133) in complex with bortezomib | 5L66_A |
| PB | T01.UPA | subfamily T1A unassigned peptidases | yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97- 111; 118-133); complex with PR-924 | 5L67_A |
| PB | T01.UPA | subfamily T1A unassigned peptidases | yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97- 111; 118-133) in complex with epoxyketone inhibitor 14 | 5L68_A |
| PB | T01.UPA | subfamily T1A unassigned peptidases | yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97- 111; 118-133) in complex with epoxyketone inhibitor 16 | 5L69_A |
| PB | T01.UPA | subfamily T1A unassigned peptidases | yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97- 111; 118-133) in complex with epoxyketone inhibitor 17 | 5L6A_A |
| PB | T01.UPA | subfamily T1A unassigned peptidases | yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97- 111; 118-133) in complex with onx 0914 | 5L6B_A |
| PB | T01.UPA | subfamily T1A unassigned peptidases | yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97- 111; 118-133) in complex with epoxyketone inhibitor 18 | 5L6C_A |
| PB | T01.UPA | subfamily T1A unassigned peptidases | ligand-induced aziridine-formation at the yeast proteasomal subunit beta5 by sulfonate esters | 5LAI_A |
| PB | T01.UPA | subfamily T1A unassigned peptidases | ligand-induced lys33-thr1 crosslinking at the yeast proteasomal subunit beta5 by sulfonate esters | 5LAJ_A |
| PB | T01.UPA | subfamily T1A unassigned peptidases | yeast 20s proteasome with human beta5i (1-138; Arg57Thr mutant)in complex with PR-924 | 5LTT_A |
| PB | T01.UPA | subfamily T1A unassigned peptidases | yeast 20s proteasome with human beta5i (1-138) and human beta6 (97- 111; 118-133) in complex with thiazole based inhibitor ro19 | 5M2B_A |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 26s proteasome in presence of atp (s1) | 5MP9_b |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 26s proteasome in presence of atp (s2) | 5MPA_b |
| PB | T01.UPA | subfamily T1A unassigned peptidases | yeast 20s proteasome in complex with blm-pep activator | 5NIF_B |
| PB | T01.UPA | subfamily T1A unassigned peptidases | yeast 26s proteasome bound to ubiquitinated substrate (1d* motor state) | 6EF0_B |
| PB | T01.UPA | subfamily T1A unassigned peptidases | yeast 26s proteasome bound to ubiquitinated substrate (5d motor state) | 6EF1_B |
| PB | T01.UPA | subfamily T1A unassigned peptidases | yeast 26s proteasome bound to ubiquitinated substrate (5t motor state) | 6EF2_B |
| PB | T01.UPA | subfamily T1A unassigned peptidases | yeast 26s proteasome bound to ubiquitinated substrate (4d motor state) | 6EF3_B |
| PB | T01.UPA | subfamily T1A unassigned peptidases | yeast 20s proteasome in complex with cystargolide B | 6G7F_A |
| PB | T01.UPA | subfamily T1A unassigned peptidases | yeast 20s proteasome in complex with cystargolide B derivative 1 | 6G8M_A |
| PB | T01.UPA | subfamily T1A unassigned peptidases | yeast 20s proteasome in complex with cystargolide B derivative 2 | 6G8N_A |
| PB | T01.UPA | subfamily T1A unassigned peptidases | yeast 20s proteasome in complex with homosalinosporamide a | 6GOP_A |
| PB | T01.UPA | subfamily T1A unassigned peptidases | yeast 20s proteasome in complex with the peptidic non-covalent bindinginhibitor rts-v5 | 6H39_A |
| PB | T01.UPA | subfamily T1A unassigned peptidases | yeast 20s proteasome with human beta2c (s171g) | 6HTB_A |
| PB | T01.UPA | subfamily T1A unassigned peptidases | yeast 20s proteasome with human beta2c (s171g) in complex with onx 0914 | 6HTC_A |
| PB | T01.UPA | subfamily T1A unassigned peptidases | yeast 20s proteasome with human beta2c (s171g) in complex with 4 | 6HTD_A |
| PB | T01.UPA | subfamily T1A unassigned peptidases | yeast 20s proteasome with human beta2c (s171g) in complex with 7 | 6HTP_A |
| PB | T01.UPA | subfamily T1A unassigned peptidases | yeast 20s proteasome with human beta2c (s171g) in complex with 13 | 6HTR_A |
| PB | T01.UPA | subfamily T1A unassigned peptidases | yeast 20s proteasome with human beta2c (s171g) in complex with 16 | 6HUB_A |
| PB | T01.UPA | subfamily T1A unassigned peptidases | yeast 20s proteasome with human beta2c (s171g) in complex with 18 | 6HUC_A |
| PB | T01.UPA | subfamily T1A unassigned peptidases | yeast 20s proteasome with human beta2c (s171g) in complex with 20 | 6HUQ_A |
| PB | T01.UPA | subfamily T1A unassigned peptidases | yeast 20s proteasome with human beta2c (s171g) in complex with 29 | 6HUU_A |
| PB | T01.UPA | subfamily T1A unassigned peptidases | yeast 20s proteasome with human beta2c (s171g) in complex with 39 | 6HUV_A |
| PB | T01.UPA | subfamily T1A unassigned peptidases | yeast 20s proteasome with human beta2i (1-53) | 6HV3_A |
| PB | T01.UPA | subfamily T1A unassigned peptidases | yeast 20s proteasome with human beta2i (1-53) in complex with onx 0914 | 6HV4_A |
| PB | T01.UPA | subfamily T1A unassigned peptidases | yeast 20s proteasome with human beta2i (1-53) in complex with 4 | 6HV5_A |
| PB | T01.UPA | subfamily T1A unassigned peptidases | yeast 20s proteasome with human beta2i (1-53) in complex with 7 | 6HV7_A |
| PB | T01.UPA | subfamily T1A unassigned peptidases | yeast 20s proteasome with human beta2i (1-53) in complex with 13 | 6HVA_A |
| PB | T01.UPA | subfamily T1A unassigned peptidases | yeast 20s proteasome with human beta2i (1-53) in complex with 16 | 6HVR_A |
| PB | T01.UPA | subfamily T1A unassigned peptidases | yeast 20s proteasome with human beta2i (1-53) in complex with 18 | 6HVS_A |
| PB | T01.UPA | subfamily T1A unassigned peptidases | yeast 20s proteasome with human beta2i (1-53) in complex with 20 | 6HVT_A |
| PB | T01.UPA | subfamily T1A unassigned peptidases | yeast 20s proteasome with human beta2i (1-53) in complex with 29 | 6HVU_A |
| PB | T01.UPA | subfamily T1A unassigned peptidases | yeast 20s proteasome with human beta2i (1-53) in complex with 39 | 6HVV_A |
| PB | T01.UPA | subfamily T1A unassigned peptidases | yeast 20s proteasome with human beta2i (1-53) in complex with 43 | 6HVW_A |
| PB | T01.UPA | subfamily T1A unassigned peptidases | yeast 20s proteasome in complex with 4 | 6HVX_A |
| PB | T01.UPA | subfamily T1A unassigned peptidases | yeast 20s proteasome in complex with 5 (7- and 6-membered ring) | 6HVY_A |
| PB | T01.UPA | subfamily T1A unassigned peptidases | yeast 20s proteasome in complex with 7 | 6HW0_A |
| PB | T01.UPA | subfamily T1A unassigned peptidases | yeast 20s proteasome in complex with 13 | 6HW3_A |
| PB | T01.UPA | subfamily T1A unassigned peptidases | yeast 20s proteasome in complex with 16 | 6HW4_A |
| PB | T01.UPA | subfamily T1A unassigned peptidases | yeast 20s proteasome in complex with 18 | 6HW5_A |
| PB | T01.UPA | subfamily T1A unassigned peptidases | yeast 20s proteasome in complex with 20 | 6HW6_A |
| PB | T01.UPA | subfamily T1A unassigned peptidases | yeast 20s proteasome in complex with 29 | 6HW7_A |
| PB | T01.UPA | subfamily T1A unassigned peptidases | yeast 20s proteasome in complex with 39 | 6HW8_A |
| PB | T01.UPA | subfamily T1A unassigned peptidases | yeast 20s proteasome in complex with 41b | 6HW9_A |
| PB | T01.UPA | subfamily T1A unassigned peptidases | yeast 20s proteasome in complex with 43 | 6HWA_A |
| PB | T01.UPA | subfamily T1A unassigned peptidases | yeast 20s proteasome in complex with 44b | 6HWB_A |
| PB | T01.UPA | subfamily T1A unassigned peptidases | yeast 20s proteasome beta2-g45a mutant | 6HWC_A |
| PB | T01.UPA | subfamily T1A unassigned peptidases | yeast 20s proteasome beta2-g45a mutant in complex with bortezomib | 6HWD_A |
| PB | T01.UPA | subfamily T1A unassigned peptidases | yeast 20s proteasome beta2-g45a mutant in complex with carfilzomib | 6HWE_A |
| PB | T01.UPA | subfamily T1A unassigned peptidases | yeast 20s proteasome beta2-g45a mutant in complex with onx 0914 | 6HWF_A |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S proteasome in complex with activator PA26 (Trypanosoma brucei) | 1FNT_E |
| PB | T01.UPA | subfamily T1A unassigned peptidases | complete proteasome | 1G0U_D |
| PB | T01.UPA | subfamily T1A unassigned peptidases | complex with epoxomicin | 1G65_D |
| PB | T01.UPA | subfamily T1A unassigned peptidases | proteasome complex bound to TMC-95A inhibitor | 1JD2_D |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S proteasome | 1RYP_E |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S proteasome; complex with the proteasome activator PA26 from Trypanosoma brucei | 1Z7Q_E |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S proteasome;complex with bortezomib | 2F16_D |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S proteasome; complex with salinosporamide A | 2FAK_D |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S proteasome; complex with homobelactosin C | 2FNY_D |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S proteasome; complex with TMC-95 based biphenyl-ether macrocycle | 2GPL_D |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 2Z5C | |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S proteasome; complex with syringolin A | 2ZCY_D |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S proteasome; complex with glidobactin A | 3BDM_D |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S proteasome; complex with fellutamide B | 3D29_D |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20s proteasome; complex with the epimer form of spirolactacystin | 3DY3_D |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20s proteasome; complex with spirolactacystin | 3DY4_D |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20s proteasome; complex with homobelactosin c | 3E47_D |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20s proteasome; complex with syringolin b | 3GPJ_D |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S proteasome; complex with salinosporamide derivative | 3GPT_D |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S proteasome; complex with salinosporamide derivative | 3GPW_D |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S proteasome; complex with hyroxylated salinosporamide | 3HYE_D |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S proteasome; complex with bortezomib | 3MG0_D |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S proteasome; complex with compound 1 | 3MG4_D |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S proteasome; complex with compound 6 | 3MG6_D |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S open-gate proteasome; complex with compound 6 | 3MG7_D |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S open-gate proteasome; complex with compound 16 | 3MG8_D |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S proteasome; complex with ligand 2a | 3NZJ_D |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S proteasome; complex with ligand 2b | 3NZW_D |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S proteasome; complex with ligand 2c | 3NZX_D |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S open-gate proteasome; complex with compound 24 | 3OEU_D |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S open-gate proteasome; complex with compound 25 | 3OEV_D |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S proteasome; complex with alpha-keto-aldehyde | 3OKJ_D |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S open-gate proteasome; complex with compound 20 | 3SDI_D |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S open-gate proteasome; complex with compound 34 | 3SDK_D |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S proteasome; complex with hydroxyurea derivative HU10 | 3SHJ_D |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S proteasome; complex with homobelactosin C | 3TDD_D |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S open-gate proteasome; complex with PR-957 (morpholine) | 3UN4_D |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S proteasome; complex with PR-957 (epoxide) | 3UN8_D |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 26S proteasome | 3WXR_E |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 26S proteasome | 4CR2_E |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 26S proteasome | 4CR3_E |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 26S proteasome | 4CR4_E |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S proteasome; complex with K-7174 | 4EU2_E |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S proteasome; complex with cepafungin I | 4FZC_D |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S proteasome; complex with glidobactin | 4FZG_D |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S proteasome; complex with Syringolin-Glidobactin chimera | 4G4S_E |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S proteasome; complex with Syringolin-Glidobactin chimera | 4GK7_D |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S proteasome; complex with vinylketone carmaphycin analogue VNK1 | 4HNP_D |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S proteasome; complex with epoxyketone carmaphycin analogue 3 | 4HRC_D |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S proteasome; complex with carmaphycin A | 4HRD_D |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S proteasome; complex with vinyl sulfone LU102 | 4INR_D |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S proteasome; complex with vinyl sulfone LU122 | 4INT_D |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S proteasome; complex with vinyl sulfone LU112 | 4INU_D |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S proteasome; complex with belactosin derivative 3E | 4J70_D |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S proteasome; complex with dimerized linear mimetic of TMC-95A | 4JSQ_D |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S proteasome; complex with dimerized linear mimetic of TMC-95A | 4JSU_D |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S proteasome; complex with dimerized linear mimetic of TMC-95A | 4JT0_D |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S proteasome; complex with vibralactone | 4LQI_D |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S proteasome; complex with enone carmaphycin analogue 6 | 4LTC_D |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S proteasome; complex with MG132 | 4NNN_D |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S proteasome; complex with Z-Leu-Leu-Leu-ketoaldehyde | 4NNW_D |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S proteasome; complex with Z-Leu-Leu-Leu-B(OH)2 | 4NO1_D |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S proteasome; complex with Z-Leu-Leu-Leu-vinylsulfone | 4NO6_D |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S proteasome; complex with Z-Leu-Leu-Leu-ketoamide | 4NO8_D |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S proteasome; complex with Z-Leu-Leu-Leu-epoxyketone | 4NO9_D |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S proteasome; complex with kendomycin | 4Q1S_D |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S proteasome; complex with Boc-Ala-Ala-Ala-CHO | 4QBY_D |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S proteasome; complex with epoxyketone inhibitor 8 | 4QLQ_D |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S proteasome; complex with epoxyketone inhibitor 11 | 4QLS_D |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S proteasome; complex with tripeptidic epoxyketone inhibitor 2 | 4QLT_D |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S proteasome; complex with tripeptidic epoxyketone inhibitor 9 | 4QLU_D |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S proteasome; complex with tripeptidic epoxyketone inhibitor 17 | 4QLV_D |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S proteasome | 4QUX_D |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S proteasome | 4QUY_D |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S proteasome | 4QV0_D |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S proteasome | 4QV1_D |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S proteasome | 4QV3_D |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S proteasome beta5 Met45Thr mutant | 4QV4_D |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S proteasome beta5 Met45Ile mutant | 4QV5_D |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S proteasome | 4QV6_D |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S proteasome | 4QV7_D |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S proteasome | 4QV8_D |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S proteasome | 4QV9_D |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S proteasome; complex with bortezomib | 4QVL_D |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S proteasome beta5 Met45Ala mutant; complex with bortezomib | 4QVM_D |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S proteasome beta5 Met45Val mutant; complex with bortezomib | 4QVN_D |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S proteasome beta5 Met45Thr mutant; complex with bortezomib | 4QVP_D |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S proteasome beta5 Met45Ile mutant; complex with bortezomib | 4QVQ_D |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S proteasome beta5 Ala49Val mutant; complex with bortezomib | 4QVV_D |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S proteasome beta5 Ala49Ser mutant; complex with bortezomib | 4QVW_D |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S proteasome beta5 Ala49Thr mutant; complex with bortezomib | 4QVY_D |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S proteasome beta5 Ala49Thr,Ala50Val mutant; complex with bortezomib | 4QW0_D |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S proteasome beta5 Ala50Val mutant; complex with bortezomib | 4QW1_D |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S proteasome beta5 Cys63Phe mutant; complex with bortezomib | 4QW3_D |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S proteasome; complex with carfilzomib | 4QW4_D |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S proteasome beta5 Met45Ala mutant; complex with carfilzomib | 4QW5_D |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S proteasome beta5 Met45Val mutant; complex with carfilzomib | 4QW6_D |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S proteasome beta5 Met45Thr mutant; complex with carfilzomib | 4QW7_D |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S proteasome beta5 Met45Ile mutant; complex with carfilzomib | 4QWF_D |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S proteasome beta5 Ala49Val mutant; complex with carfilzomib | 4QWG_D |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S proteasome beta5 Ala49Ser mutant; complex with carfilzomib | 4QWI_D |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S proteasome beta5 Ala49Thr mutant; complex with carfilzomib | 4QWJ_D |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S proteasome beta5 Ala49Thr, Ala50Val mutant; complex with carfilzomib | 4QWK_D |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S proteasome beta5 Ala50Val mutant; complex with carfilzomib | 4QWL_D |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S proteasome beta5 Cys52Phe mutant; complex with carfilzomib | 4QWR_D |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S proteasome beta5 Cys63Phe mutant; complex with carfilzomib | 4QWS_D |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S proteasome beta5 Cys52Phe mutant; complex with bortezomib | 4QWU_D |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S proteasome; complex with epoxyketone inhibitor ONX 0914 | 4QWX_D |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S proteasome beta 5 Met45Ala mutant; complex with epoxyketone inhibitor ONX 0914 | 4QXJ_D |
| PB | T01.UPA | subfamily T1A unassigned peptidases | complete proteasome; complex with epoxyketone inhibitor ONX 0914 | 4QZ0_D |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S proteasome beta 5 Met45Thr mutant; complex with epoxyketone inhibitor ONX 0914 | 4QZ1_D |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S proteasome beta 5 Met45Ile mutant; complex with epoxyketone inhibitor ONX 0914 | 4QZ2_D |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S proteasome beta 5 Ala49Val mutant; complex with epoxyketone inhibitor ONX 0914 | 4QZ3_D |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S proteasome beta 5 Ala49Ser mutant; complex with epoxyketone inhibitor ONX 0914 | 4QZ4_D |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S proteasome beta 5 Ala49Thr mutant; complex with epoxyketone inhibitor ONX 0914 | 4QZ5_D |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S proteasome beta 5 Ala49Thr, Ala50Val mutant; complex with epoxyketone inhibitor ONX 0914 | 4QZ6_D |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S proteasome beta 5 Ala50Val mutant; complex with epoxyketone inhibitor ONX 0914 | 4QZ7_D |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S proteasome beta 5 Cys52Phe mutant; complex with epoxyketone inhibitor ONX 0914 | 4QZW_D |
| PB | T01.UPA | subfamily T1A unassigned peptidases | complete proteasome; complex with epoxyketone inhibitor ONX 0914 | 4QZX_D |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S proteasome; complex with omuralide | 4QZZ_D |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S proteasome beta 5 Cys52Phe mutant; complex with omuralide | 4R00_D |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S proteasome; complex with BSC4999 | 4R02_D |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S proteasome; ligand induced aziridine-formation in beta5 | 4R17_D |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S proteasome; ligand induced Lys33-Thr1 cross-linking in beta5 | 4R18_D |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S proteasome; complex with alkaloid indolo-phakellin | 4RUR_D |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S proteasome; complex with PR-VI modulator | 4X6Z_E |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S proteasome; complex with Ac-Pro-Ala-Asp-EP | 4Y69_D |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S proteasome beta2 His114Asp mutant; complex with Ac-Pro-Ala-Asp-EP | 4Y6A_D |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S proteasome; complex with Ac-Pro-Ala-Glu-EP | 4Y6V_D |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S proteasome; complex with Ac-Pro-Ala-Leu-EP | 4Y6Z_D |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S proteasome; complex with Ac-Leu-Ala-Val-EP | 4Y70_D |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S proteasome; complex with Ac-Leu-Ala-Leu-EP | 4Y74_D |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S proteasome; complex with Ac-Pro-Ala-Phe-EP | 4Y75_D |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S proteasome; complex with Ac-Leu-Ala-Phe-EP | 4Y77_D |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S proteasome; complex with Ac-Leu-Ala-Asp-EP | 4Y78_D |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S proteasome; complex with Ac-Leu-Ala-Glu-EP | 4Y7W_D |
| PB | T01.UPA | subfamily T1A unassigned peptidases | complete proteasome; complex with Ac-PAA-ep | 4Y7X_D |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S proteasome; complex with Ac-Leu-Ala-Ala-EP | 4Y7Y_D |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S proteasome; complex with Ac-Leu-Ala-Ile-EP | 4Y80_D |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S proteasome; complex with Ac-Pro-Ala-Tyr-EP | 4Y81_D |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S proteasome; complex with Ac-Leu-Ala-Tyr-EP | 4Y82_D |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S proteasome; complex with N3-Ala(4,4-F2P)-Asn-Leu-Leu-EP | 4Y84_D |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S proteasome; complex with N3-Ala-Pro-Asn-Leu-Leu-EP | 4Y8G_D |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S proteasome; complex with N3-Ala-Pro-Ala-Leu-EP | 4Y8H_D |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S proteasome; complex with Ac-Pro-Leu-Leu-EP | 4Y8I_D |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S proteasome; complex with Ac-Leu-Leu-Leu-EP | 4Y8J_D |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S proteasome; complex with H-Ala-Pro-Leu-Leu-EP | 4Y8K_D |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S proteasome; complex with Ac-Ala-Pro-Leu-Leu-EP | 4Y8L_D |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S proteasome beta7-delta7 C-terminal mutant | 4Y8M_D |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S proteasome beta7-delta7 C-terminal mutant; complex with Ac-Pro-Ala-Glu-EP | 4Y8N_D |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S proteasome beta 7-delta 7 C-terminal mutant; complex with Ac-Pro-Ala-Phe-EP | 4Y8O_D |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S proteasome beta 7-delta 7 C-terminal mutant; complex with Ac-Pro-Ala-Leu-EP | 4Y8P_D |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S proteasome beta 7-delta 7 C-terminal mutant; complex with Ac-Pro-Ala-Tyr-EP | 4Y8Q_D |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S proteasome beta 2 His116Asp mutant | 4Y8R_D |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S proteasome beta 2 His116Asp mutant; complex with Ac-Leu-Ala-Glu-EP | 4Y8S_D |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S proteasome beta 2 His116Asp mutant; complex with Ac-Pro-Ala-Glu-EP | 4Y8T_D |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S proteasome beta 2 His116Asp mutant; complex with Ac-Pro-Ala-Asp-EP | 4Y8U_D |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S proteasome beta 2 His116Glu mutant | 4Y9Y_D |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S proteasome beta 2 His116Glu mutant; complex with Ac-Leu-Ala-Glu-EP | 4Y9Z_D |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S proteasome beta 2 His116Glu mutant; complex with Ac-Pro-Ala-Glu-EP | 4YA0_D |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S proteasome beta 2 His116Asn mutant | 4YA1_D |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S proteasome beta 2 His116Asn mutant; complex with Ac-Leu-Ala-Glu-EP | 4YA2_D |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S proteasome beta 2 His116Asn mutant; complex with Ac-Pro-Ala-Glu-EP | 4YA3_D |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S proteasome beta 2 His114Asp mutant | 4YA4_D |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S proteasome beta 2 His114Asp mutant; complex with Ac-Pro-Ala-Glu-EP | 4YA5_D |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S proteasome beta 2 His114Asp mutant; complex with Ac-Leu-Ala-Glu-EP | 4YA7_D |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S proteasome beta 2 His114Asp mutant; complex with AC-Leu-Ala-Asp-EP | 4YA9_D |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S proteasome; complex with belactosin C derivative 3 | 4Z1L_D |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 26S protease-UBP6 complex | 5A5B_E |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S proteasome; complex with macyranone A | 5AHJ_D |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S proteasome; complex with beta1/beta2 nonspecifici sulfonamide ligand | 5BOU_D |
| PB | T01.UPA | subfamily T1A unassigned peptidases | yeast 20s proteasome beta2-g170a mutant | 5BXL_D |
| PB | T01.UPA | subfamily T1A unassigned peptidases | yeast 20s proteasome beta2-g170a mutant in complex with bortezomib | 5BXN_D |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S proteasome beta5 Gly48Cys mutant | 5CGF_D |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S proteasome beta5 Gly48Cys mutant; complex with alpha-chloroacetamide 1 | 5CGG_D |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S proteasome beta5 Gly48Cys mutant; complex with alpha-chloroacetamide 5 | 5CGH_D |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S proteasome beta5 Gly48Cys mutant; complex with ONX 0914 | 5CGI_D |
| PB | T01.UPA | subfamily T1A unassigned peptidases | yeast 20s proteasome at 2.3 a resolution | 5CZ4_D |
| PB | T01.UPA | subfamily T1A unassigned peptidases | yeast 20s proteasome beta1-t1a mutant in complex with carfilzomib | 5CZ5_D |
| PB | T01.UPA | subfamily T1A unassigned peptidases | yeast 20s proteasome beta5-t1a mutant in complex with syringolin a, propeptide expressed in trans | 5CZ6_D |
| PB | T01.UPA | subfamily T1A unassigned peptidases | yeast 20s proteasome beta5-t1a beta5-k81r double mutant in complex with bortezomib, propeptide expressed in cis | 5CZ7_D |
| PB | T01.UPA | subfamily T1A unassigned peptidases | yeast 20s proteasome beta5-l(-49)s-k33a mutant in complex with carfilzomib | 5CZ8_D |
| PB | T01.UPA | subfamily T1A unassigned peptidases | yeast 20s proteasome beta5-d17n mutant in complex with carfilzomib; propeptide expressed in trans | 5CZ9_D |
| PB | T01.UPA | subfamily T1A unassigned peptidases | yeast 20s proteasome beta5-d166n mutant | 5CZA_D |
| PB | T01.UPA | subfamily T1A unassigned peptidases | yeast 20s proteasome beta5-d166n mutant in complex with carfilzomib | 5D0S_D |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20s proteasome beta5-Asp166Asn mutant; complex with MG132 | 5D0T_D |
| PB | T01.UPA | subfamily T1A unassigned peptidases | yeast 20s proteasome beta5-t1c mutant in complex with carfilzomib | 5D0V_D |
| PB | T01.UPA | subfamily T1A unassigned peptidases | yeast 20s proteasome beta5-t1s mutant | 5D0W_D |
| PB | T01.UPA | subfamily T1A unassigned peptidases | yeast 20s proteasome beta5-t1s mutant in complex with bortezomib | 5D0X_D |
| PB | T01.UPA | subfamily T1A unassigned peptidases | yeast 20s proteasome beta5-t1s mutant in complex with carfilzomib | 5D0Z_D |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S proteasome; complex with alkyne-PI | 5DKI_D |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S proteasome; complex with octreotide-PI | 5DKJ_D |
| PB | T01.UPA | subfamily T1A unassigned peptidases | yeast 20s proteasome beta2-t1a mutant | 5FG7_D |
| PB | T01.UPA | subfamily T1A unassigned peptidases | yeast 20s proteasome beta2-t(-2)v mutant | 5FG9_D |
| PB | T01.UPA | subfamily T1A unassigned peptidases | yeast 20s proteasome beta5-k33a mutant (propeptide expressed in trans) | 5FGA_D |
| PB | T01.UPA | subfamily T1A unassigned peptidases | yeast 20s proteasome beta5-h(-2)l-t1a double mutant in complex with carfilzomib | 5FGD_D |
| PB | T01.UPA | subfamily T1A unassigned peptidases | yeast 20s proteasome beta5-h(-2)t-t1a double mutant in complex with carfilzomib | 5FGE_D |
| PB | T01.UPA | subfamily T1A unassigned peptidases | yeast 20s proteasome beta5-h(-2)a-t1a-k81r triple mutant in complex with carfilzomib | 5FGF_D |
| PB | T01.UPA | subfamily T1A unassigned peptidases | yeast 20s proteasome beta5-l(-49s)_d17n double mutant in complex with carfilzomib | 5FGG_D |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20s proteasome beta5-Lys33Ala mutant (propeptide expressed in trans); complex with MG132 | 5FGH_D |
| PB | T01.UPA | subfamily T1A unassigned peptidases | yeast 20s proteasome beta1-t1a beta2-t1a double mutant in complex withcarfilzomib | 5FGI_D |
| PB | T01.UPA | subfamily T1A unassigned peptidases | yeast 20s proteasome beta5-k33a mutant (propeptide expressed in trans)in complex with carfilzomib | 5FHS_D |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20s proteasome; complex with the peptidic epoxyketone inhibitor 27 | 5JHR_D |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20s proteasome; complex with the peptidic epoxyketone inhibitor 15 | 5JHS_D |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20s proteasome; complex with epoxyketone inhibitor 14 | 5L52_D |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20s proteasome; complex with epoxyketone inhibitor 16 | 5L54_D |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20s proteasome; complex with epoxyketone inhibitor 18 | 5L55_D |
| PB | T01.UPA | subfamily T1A unassigned peptidases | yeast 20s proteasome with human beta5i (1-138; r57t) | 5L5A_D |
| PB | T01.UPA | subfamily T1A unassigned peptidases | yeast 20s proteasome with human beta5i (1-138) and human beta6 (97- 111; 118-133) | 5L5B_D |
| PB | T01.UPA | subfamily T1A unassigned peptidases | yeast 20s proteasome with human beta5i (1-138) and human beta6 (97- 111; 118-133) in complex with onx 0914 | 5L5D_D |
| PB | T01.UPA | subfamily T1A unassigned peptidases | yeast 20s proteasome with human beta5i (1-138) and human beta6 (97- 111; 118-133) in complex with carfilzomib | 5L5E_D |
| PB | T01.UPA | subfamily T1A unassigned peptidases | yeast 20s proteasome with human beta5i (1-138) and human beta6 (97- 111; 118-133) in complex with bortezomib | 5L5F_D |
| PB | T01.UPA | subfamily T1A unassigned peptidases | yeast 20s proteasome with human beta5i (1-138) and human beta6 (97- 111; 118-133); complex with PR-924 | 5L5H_D |
| PB | T01.UPA | subfamily T1A unassigned peptidases | yeast 20s proteasome with human beta5i (1-138) and human beta6 (97- 111; 118-133) in complex with epoxyketone inhibitor 9 | 5L5I_D |
| PB | T01.UPA | subfamily T1A unassigned peptidases | yeast 20s proteasome with human beta5i (1-138) and human beta6 (97- 111; 118-133) in complex with epoxyketone inhibitor 14 | 5L5J_D |
| PB | T01.UPA | subfamily T1A unassigned peptidases | yeast 20s proteasome with human beta5i (1-138) and human beta6 (97- 111; 118-133) in complex with epoxyketone inhibitor 16 | 5L5O_D |
| PB | T01.UPA | subfamily T1A unassigned peptidases | yeast 20s proteasome with human beta5i (1-138) and human beta6 (97- 111; 118-133) in complex with epoxyketone inhibitor 17 | 5L5P_D |
| PB | T01.UPA | subfamily T1A unassigned peptidases | yeast 20s proteasome with human beta5i (1-138) and human beta6 (97- 111; 118-133) in complex with epoxyketone 18 | 5L5Q_D |
| PB | T01.UPA | subfamily T1A unassigned peptidases | yeast 20s proteasome with human beta5i (1-138;v31m) and human beta6 (97-111; 118-133) | 5L5R_D |
| PB | T01.UPA | subfamily T1A unassigned peptidases | yeast 20s proteasome with human beta5i (1-138; Val31Met mutant) and human beta6 (97-111; 118-133); complex with PR-924 | 5L5S_D |
| PB | T01.UPA | subfamily T1A unassigned peptidases | yeast 20s proteasome with human beta5i (1-138; v31m) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 16 | 5L5T_D |
| PB | T01.UPA | subfamily T1A unassigned peptidases | yeast 20s proteasome with human beta5i (1-138; v31m) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 17 ***caveat 5l5u 04c h 301 has wrong chirality at atom c27 04c k 301 has ***caveat 2 5l5u wrong chirality at atom c27 04c v 301 h | 5L5U_D |
| PB | T01.UPA | subfamily T1A unassigned peptidases | yeast 20s proteasome with human beta5c (1-138) and human beta6 (97- 111; 118-133) | 5L5W_D |
| PB | T01.UPA | subfamily T1A unassigned peptidases | yeast 20s proteasome with human beta5c (1-138) and human beta6 (97- 111; 118-133) in complex with onx 0914 | 5L5X_D |
| PB | T01.UPA | subfamily T1A unassigned peptidases | yeast 20s proteasome with human beta5c (1-138) and human beta6 (97- 111; 118-133) in complex with carfilzomib | 5L5Y_D |
| PB | T01.UPA | subfamily T1A unassigned peptidases | yeast 20s proteasome with human beta5c (1-138) and human beta6 (97- 111; 118-133) in complex with bortezomib | 5L5Z_D |
| PB | T01.UPA | subfamily T1A unassigned peptidases | yeast 20s proteasome with human beta5c (1-138) and human beta6 (97- 111; 118-133); complex with PR-924 | 5L60_D |
| PB | T01.UPA | subfamily T1A unassigned peptidases | yeast 20s proteasome with human beta5c (1-138) and human beta6 (99- 132) in complex with epoxyketone inhibitor 14 | 5L61_D |
| PB | T01.UPA | subfamily T1A unassigned peptidases | yeast 20s proteasome with human beta5c (1-138) and human beta6 (97- 111; 118-133) in complex with epoxyketone inhibitor 16 | 5L62_D |
| PB | T01.UPA | subfamily T1A unassigned peptidases | yeast 20s proteasome with human beta5c (1-138) and human beta6 (97- 111; 118-133) in complex with epoxyketone inhibitor 17 ***caveat 5l63 04c h 301 has wrong chirality at atom c27 04c k 301 has ***caveat 2 5l63 wrong chirality at atom c27 04c v 301 has wr | 5L63_D |
| PB | T01.UPA | subfamily T1A unassigned peptidases | yeast 20s proteasome with human beta5c (1-138) and human beta6 (97- 111; 118-133) in complex with epoxyketone inhibitor 18 | 5L64_D |
| PB | T01.UPA | subfamily T1A unassigned peptidases | yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97- 111; 118-133) in complex with carfilzomib | 5L65_D |
| PB | T01.UPA | subfamily T1A unassigned peptidases | yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97- 111; 118-133) in complex with bortezomib | 5L66_D |
| PB | T01.UPA | subfamily T1A unassigned peptidases | yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97- 111; 118-133); complex with PR-924 | 5L67_D |
| PB | T01.UPA | subfamily T1A unassigned peptidases | yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97- 111; 118-133) in complex with epoxyketone inhibitor 14 | 5L68_D |
| PB | T01.UPA | subfamily T1A unassigned peptidases | yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97- 111; 118-133) in complex with epoxyketone inhibitor 16 | 5L69_D |
| PB | T01.UPA | subfamily T1A unassigned peptidases | yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97- 111; 118-133) in complex with epoxyketone inhibitor 17 | 5L6A_D |
| PB | T01.UPA | subfamily T1A unassigned peptidases | yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97- 111; 118-133) in complex with onx 0914 | 5L6B_D |
| PB | T01.UPA | subfamily T1A unassigned peptidases | yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97- 111; 118-133) in complex with epoxyketone inhibitor 18 | 5L6C_D |
| PB | T01.UPA | subfamily T1A unassigned peptidases | ligand-induced aziridine-formation at the yeast proteasomal subunit beta5 by sulfonate esters | 5LAI_D |
| PB | T01.UPA | subfamily T1A unassigned peptidases | ligand-induced lys33-thr1 crosslinking at the yeast proteasomal subunit beta5 by sulfonate esters | 5LAJ_D |
| PB | T01.UPA | subfamily T1A unassigned peptidases | yeast 20s proteasome with human beta5i (1-138; Arg57Thr mutant)in complex with PR-924 | 5LTT_D |
| PB | T01.UPA | subfamily T1A unassigned peptidases | yeast 20s proteasome with human beta5i (1-138) and human beta6 (97- 111; 118-133) in complex with thiazole based inhibitor ro19 | 5M2B_D |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 26s proteasome in presence of atp (s1) | 5MP9_e |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 26s proteasome in presence of atp (s2) | 5MPA_e |
| PB | T01.UPA | subfamily T1A unassigned peptidases | yeast 20s proteasome in complex with blm-pep activator | 5NIF_E |
| PB | T01.UPA | subfamily T1A unassigned peptidases | yeast 26s proteasome bound to ubiquitinated substrate (1d* motor state) | 6EF0_E |
| PB | T01.UPA | subfamily T1A unassigned peptidases | yeast 26s proteasome bound to ubiquitinated substrate (5d motor state) | 6EF1_E |
| PB | T01.UPA | subfamily T1A unassigned peptidases | yeast 26s proteasome bound to ubiquitinated substrate (5t motor state) | 6EF2_E |
| PB | T01.UPA | subfamily T1A unassigned peptidases | yeast 26s proteasome bound to ubiquitinated substrate (4d motor state) | 6EF3_E |
| PB | T01.UPA | subfamily T1A unassigned peptidases | yeast 20s proteasome in complex with cystargolide B | 6G7F_D |
| PB | T01.UPA | subfamily T1A unassigned peptidases | yeast 20s proteasome in complex with cystargolide B derivative 1 | 6G8M_D |
| PB | T01.UPA | subfamily T1A unassigned peptidases | yeast 20s proteasome in complex with cystargolide B derivative 2 | 6G8N_D |
| PB | T01.UPA | subfamily T1A unassigned peptidases | yeast 20s proteasome in complex with homosalinosporamide a | 6GOP_D |
| PB | T01.UPA | subfamily T1A unassigned peptidases | yeast 20s proteasome in complex with the peptidic non-covalent bindinginhibitor rts-v5 | 6H39_D |
| PB | T01.UPA | subfamily T1A unassigned peptidases | yeast 20s proteasome with human beta2c (s171g) | 6HTB_D |
| PB | T01.UPA | subfamily T1A unassigned peptidases | yeast 20s proteasome with human beta2c (s171g) in complex with onx 0914 | 6HTC_D |
| PB | T01.UPA | subfamily T1A unassigned peptidases | yeast 20s proteasome with human beta2c (s171g) in complex with 4 | 6HTD_D |
| PB | T01.UPA | subfamily T1A unassigned peptidases | yeast 20s proteasome with human beta2c (s171g) in complex with 7 | 6HTP_D |
| PB | T01.UPA | subfamily T1A unassigned peptidases | yeast 20s proteasome with human beta2c (s171g) in complex with 13 | 6HTR_D |
| PB | T01.UPA | subfamily T1A unassigned peptidases | yeast 20s proteasome with human beta2c (s171g) in complex with 16 | 6HUB_D |
| PB | T01.UPA | subfamily T1A unassigned peptidases | yeast 20s proteasome with human beta2c (s171g) in complex with 18 | 6HUC_D |
| PB | T01.UPA | subfamily T1A unassigned peptidases | yeast 20s proteasome with human beta2c (s171g) in complex with 20 | 6HUQ_D |
| PB | T01.UPA | subfamily T1A unassigned peptidases | yeast 20s proteasome with human beta2c (s171g) in complex with 29 | 6HUU_D |
| PB | T01.UPA | subfamily T1A unassigned peptidases | yeast 20s proteasome with human beta2c (s171g) in complex with 39 | 6HUV_D |
| PB | T01.UPA | subfamily T1A unassigned peptidases | yeast 20s proteasome with human beta2i (1-53) | 6HV3_D |
| PB | T01.UPA | subfamily T1A unassigned peptidases | yeast 20s proteasome with human beta2i (1-53) in complex with onx 0914 | 6HV4_D |
| PB | T01.UPA | subfamily T1A unassigned peptidases | yeast 20s proteasome with human beta2i (1-53) in complex with 4 | 6HV5_D |
| PB | T01.UPA | subfamily T1A unassigned peptidases | yeast 20s proteasome with human beta2i (1-53) in complex with 7 | 6HV7_D |
| PB | T01.UPA | subfamily T1A unassigned peptidases | yeast 20s proteasome with human beta2i (1-53) in complex with 13 | 6HVA_D |
| PB | T01.UPA | subfamily T1A unassigned peptidases | yeast 20s proteasome with human beta2i (1-53) in complex with 16 | 6HVR_D |
| PB | T01.UPA | subfamily T1A unassigned peptidases | yeast 20s proteasome with human beta2i (1-53) in complex with 18 | 6HVS_D |
| PB | T01.UPA | subfamily T1A unassigned peptidases | yeast 20s proteasome with human beta2i (1-53) in complex with 20 | 6HVT_D |
| PB | T01.UPA | subfamily T1A unassigned peptidases | yeast 20s proteasome with human beta2i (1-53) in complex with 29 | 6HVU_D |
| PB | T01.UPA | subfamily T1A unassigned peptidases | yeast 20s proteasome with human beta2i (1-53) in complex with 39 | 6HVV_D |
| PB | T01.UPA | subfamily T1A unassigned peptidases | yeast 20s proteasome with human beta2i (1-53) in complex with 43 | 6HVW_D |
| PB | T01.UPA | subfamily T1A unassigned peptidases | yeast 20s proteasome in complex with 4 | 6HVX_D |
| PB | T01.UPA | subfamily T1A unassigned peptidases | yeast 20s proteasome in complex with 5 (7- and 6-membered ring) | 6HVY_D |
| PB | T01.UPA | subfamily T1A unassigned peptidases | yeast 20s proteasome in complex with 7 | 6HW0_D |
| PB | T01.UPA | subfamily T1A unassigned peptidases | yeast 20s proteasome in complex with 13 | 6HW3_D |
| PB | T01.UPA | subfamily T1A unassigned peptidases | yeast 20s proteasome in complex with 16 | 6HW4_D |
| PB | T01.UPA | subfamily T1A unassigned peptidases | yeast 20s proteasome in complex with 18 | 6HW5_D |
| PB | T01.UPA | subfamily T1A unassigned peptidases | yeast 20s proteasome in complex with 20 | 6HW6_D |
| PB | T01.UPA | subfamily T1A unassigned peptidases | yeast 20s proteasome in complex with 29 | 6HW7_D |
| PB | T01.UPA | subfamily T1A unassigned peptidases | yeast 20s proteasome in complex with 39 | 6HW8_D |
| PB | T01.UPA | subfamily T1A unassigned peptidases | yeast 20s proteasome in complex with 41b | 6HW9_D |
| PB | T01.UPA | subfamily T1A unassigned peptidases | yeast 20s proteasome in complex with 43 | 6HWA_D |
| PB | T01.UPA | subfamily T1A unassigned peptidases | yeast 20s proteasome in complex with 44b | 6HWB_D |
| PB | T01.UPA | subfamily T1A unassigned peptidases | yeast 20s proteasome beta2-g45a mutant | 6HWC_D |
| PB | T01.UPA | subfamily T1A unassigned peptidases | yeast 20s proteasome beta2-g45a mutant in complex with bortezomib | 6HWD_D |
| PB | T01.UPA | subfamily T1A unassigned peptidases | yeast 20s proteasome beta2-g45a mutant in complex with carfilzomib | 6HWE_D |
| PB | T01.UPA | subfamily T1A unassigned peptidases | yeast 20s proteasome beta2-g45a mutant in complex with onx 0914 | 6HWF_D |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S proteasome; complex with PR-957 | 3UNB_L |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S proteasome | 3UNE_L |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S immunoproteasome; complex with PR-957 | 3UNF_L |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S immunoproteasome | 3UNH_L |
| PB | T01.UPA | subfamily T1A unassigned peptidases | yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97- 111; 118-133) in complex with carfilzomib | 5L65_L |
| PB | T01.UPA | subfamily T1A unassigned peptidases | yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97- 111; 118-133) in complex with bortezomib | 5L66_L |
| PB | T01.UPA | subfamily T1A unassigned peptidases | yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97- 111; 118-133); complex with PR-924 | 5L67_L |
| PB | T01.UPA | subfamily T1A unassigned peptidases | yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97- 111; 118-133) in complex with epoxyketone inhibitor 14 | 5L68_L |
| PB | T01.UPA | subfamily T1A unassigned peptidases | yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97- 111; 118-133) in complex with epoxyketone inhibitor 16 | 5L69_L |
| PB | T01.UPA | subfamily T1A unassigned peptidases | yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97- 111; 118-133) in complex with epoxyketone inhibitor 17 | 5L6A_L |
| PB | T01.UPA | subfamily T1A unassigned peptidases | yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97- 111; 118-133) in complex with onx 0914 | 5L6B_L |
| PB | T01.UPA | subfamily T1A unassigned peptidases | yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97- 111; 118-133) in complex with epoxyketone inhibitor 18 | 5L6C_L |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S proteasome complex | 1Q5Q_A |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 1Q5R_A | |
| PB | T01.UPA | subfamily T1A unassigned peptidases | Phe145Ala mutant | 2H6J_A |
| PB | T01.UPA | subfamily T1A unassigned peptidases | complex with n,c-capped dipeptide inhibitor pks2205 | 5THO_A |
| PB | T01.UPA | subfamily T1A unassigned peptidases | complex with n, c-capped dipeptide dplg-2 | 5TRG_A |
| PB | T01.UPA | subfamily T1A unassigned peptidases | complex with n, c-capped dipeptide pks2169 | 5TRR_A |
| PB | T01.UPA | subfamily T1A unassigned peptidases | complex with n, c-capped dipeptide pks2144 | 5TRS_A |
| PB | T01.UPA | subfamily T1A unassigned peptidases | complex with n, c-capped dipeptide pks2206 | 5TRY_A |
| PB | T01.UPA | subfamily T1A unassigned peptidases | complex with n, c-capped dipeptide pks2208 | 5TS0_A |
| PB | T01.UPA | subfamily T1A unassigned peptidases | doubly pafe-capped 20s core particle in mycobacterium tuberculosis | 6BGL_A |
| PB | T01.UPA | subfamily T1A unassigned peptidases | singly pafe-capped 20s cp in mycobacterium tuberculosis | 6BGO_A |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S proteasome; complex with PR-957 | 3UNB_F |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S proteasome | 3UNE_F |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S immunoproteasome; complex with PR-957 | 3UNF_F |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S immunoproteasome | 3UNH_F |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S proteasome; complex with PR-957 | 3UNB_D |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S proteasome | 3UNE_D |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S immunoproteasome; complex with PR-957 | 3UNF_D |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S immunoproteasome | 3UNH_D |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S proteasome complex | 1IRU_G |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S proteasome complex | 5FMG_E |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S proteasome complex | 5FMG_G |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S proteasome complex | 5FMG_K |
| PB | T01.UPA | subfamily T1A unassigned peptidases | 20S proteasome complex | 5FMG_A |
| PB | T01.UPB | subfamily T1B unassigned peptidases | 1DO2 | |
| PB | T01.UPW | family T1 unassigned peptidases | 20S proteasome in complex with activator PA26 (Trypanosoma brucei) | 1FNT_G |
| PB | T01.UPW | family T1 unassigned peptidases | complete proteasome | 1G0U_F |
| PB | T01.UPW | family T1 unassigned peptidases | complex with epoxomicin | 1G65_F |
| PB | T01.UPW | family T1 unassigned peptidases | proteasome complex bound to TMC-95A inhibitor | 1JD2_F |
| PB | T01.UPW | family T1 unassigned peptidases | 20S proteasome | 1RYP_G |
| PB | T01.UPW | family T1 unassigned peptidases | 20S proteasome; complex with the proteasome activator PA26 from Trypanosoma brucei | 1Z7Q_G |
| PB | T01.UPW | family T1 unassigned peptidases | 20S proteasome;complex with bortezomib | 2F16_F |
| PB | T01.UPW | family T1 unassigned peptidases | 20S proteasome; complex with salinosporamide A | 2FAK_F |
| PB | T01.UPW | family T1 unassigned peptidases | 20S proteasome; complex with homobelactosin C | 2FNY_F |
| PB | T01.UPW | family T1 unassigned peptidases | 20S proteasome; complex with TMC-95 based biphenyl-ether macrocycle | 2GPL_F |
| PB | T01.UPW | family T1 unassigned peptidases | 20S proteasome; complex with syringolin A | 2ZCY_F |
| PB | T01.UPW | family T1 unassigned peptidases | 20S proteasome; complex with glidobactin A | 3BDM_F |
| PB | T01.UPW | family T1 unassigned peptidases | 20S proteasome; complex with fellutamide B | 3D29_F |
| PB | T01.UPW | family T1 unassigned peptidases | 20s proteasome; complex with the epimer form of spirolactacystin | 3DY3_F |
| PB | T01.UPW | family T1 unassigned peptidases | 20s proteasome; complex with spirolactacystin | 3DY4_F |
| PB | T01.UPW | family T1 unassigned peptidases | 20s proteasome; complex with homobelactosin c | 3E47_F |
| PB | T01.UPW | family T1 unassigned peptidases | 20s proteasome; complex with syringolin b | 3GPJ_F |
| PB | T01.UPW | family T1 unassigned peptidases | 20S proteasome; complex with salinosporamide derivative | 3GPT_F |
| PB | T01.UPW | family T1 unassigned peptidases | 20S proteasome; complex with salinosporamide derivative | 3GPW_F |
| PB | T01.UPW | family T1 unassigned peptidases | 20S proteasome; complex with hyroxylated salinosporamide | 3HYE_F |
| PB | T01.UPW | family T1 unassigned peptidases | 20S proteasome; complex with bortezomib | 3MG0_F |
| PB | T01.UPW | family T1 unassigned peptidases | 20S proteasome; complex with compound 1 | 3MG4_F |
| PB | T01.UPW | family T1 unassigned peptidases | 20S proteasome; complex with compound 6 | 3MG6_F |
| PB | T01.UPW | family T1 unassigned peptidases | 20S open-gate proteasome; complex with compound 6 | 3MG7_F |
| PB | T01.UPW | family T1 unassigned peptidases | 20S open-gate proteasome; complex with compound 16 | 3MG8_F |
| PB | T01.UPW | family T1 unassigned peptidases | 20S proteasome; complex with ligand 2a | 3NZJ_F |
| PB | T01.UPW | family T1 unassigned peptidases | 20S proteasome; complex with ligand 2b | 3NZW_F |
| PB | T01.UPW | family T1 unassigned peptidases | 20S proteasome; complex with ligand 2c | 3NZX_F |
| PB | T01.UPW | family T1 unassigned peptidases | 20S open-gate proteasome; complex with compound 24 | 3OEU_F |
| PB | T01.UPW | family T1 unassigned peptidases | 20S open-gate proteasome; complex with compound 25 | 3OEV_F |
| PB | T01.UPW | family T1 unassigned peptidases | 20S proteasome; complex with alpha-keto-aldehyde | 3OKJ_F |
| PB | T01.UPW | family T1 unassigned peptidases | 20S open-gate proteasome; complex with compound 20 | 3SDI_F |
| PB | T01.UPW | family T1 unassigned peptidases | 20S open-gate proteasome; complex with compound 34 | 3SDK_F |
| PB | T01.UPW | family T1 unassigned peptidases | 20S proteasome; complex with hydroxyurea derivative HU10 | 3SHJ_F |
| PB | T01.UPW | family T1 unassigned peptidases | 20S proteasome; complex with homobelactosin C | 3TDD_F |
| PB | T01.UPW | family T1 unassigned peptidases | 20S open-gate proteasome; complex with PR-957 (morpholine) | 3UN4_F |
| PB | T01.UPW | family T1 unassigned peptidases | 20S proteasome; complex with PR-957 (epoxide) | 3UN8_F |
| PB | T01.UPW | family T1 unassigned peptidases | 26S proteasome | 3WXR_G |
| PB | T01.UPW | family T1 unassigned peptidases | 26S proteasome | 4CR2_G |
| PB | T01.UPW | family T1 unassigned peptidases | 26S proteasome | 4CR3_G |
| PB | T01.UPW | family T1 unassigned peptidases | 26S proteasome | 4CR4_G |
| PB | T01.UPW | family T1 unassigned peptidases | 20S proteasome; complex with K-7174 | 4EU2_G |
| PB | T01.UPW | family T1 unassigned peptidases | 20S proteasome; complex with cepafungin I | 4FZC_F |
| PB | T01.UPW | family T1 unassigned peptidases | 20S proteasome; complex with glidobactin | 4FZG_F |
| PB | T01.UPW | family T1 unassigned peptidases | 20S proteasome; complex with Syringolin-Glidobactin chimera | 4G4S_G |
| PB | T01.UPW | family T1 unassigned peptidases | 20S proteasome; complex with Syringolin-Glidobactin chimera | 4GK7_F |
| PB | T01.UPW | family T1 unassigned peptidases | 20S proteasome; complex with vinylketone carmaphycin analogue VNK1 | 4HNP_F |
| PB | T01.UPW | family T1 unassigned peptidases | 20S proteasome; complex with epoxyketone carmaphycin analogue 3 | 4HRC_F |
| PB | T01.UPW | family T1 unassigned peptidases | 20S proteasome; complex with carmaphycin A | 4HRD_F |
| PB | T01.UPW | family T1 unassigned peptidases | 20S proteasome; complex with vinyl sulfone LU102 | 4INR_F |
| PB | T01.UPW | family T1 unassigned peptidases | 20S proteasome; complex with vinyl sulfone LU122 | 4INT_F |
| PB | T01.UPW | family T1 unassigned peptidases | 20S proteasome; complex with vinyl sulfone LU112 | 4INU_F |
| PB | T01.UPW | family T1 unassigned peptidases | 20S proteasome; complex with belactosin derivative 3E | 4J70_F |
| PB | T01.UPW | family T1 unassigned peptidases | 20S proteasome; complex with dimerized linear mimetic of TMC-95A | 4JSQ_F |
| PB | T01.UPW | family T1 unassigned peptidases | 20S proteasome; complex with dimerized linear mimetic of TMC-95A | 4JSU_F |
| PB | T01.UPW | family T1 unassigned peptidases | 20S proteasome; complex with dimerized linear mimetic of TMC-95A | 4JT0_F |
| PB | T01.UPW | family T1 unassigned peptidases | 20S proteasome; complex with vibralactone | 4LQI_F |
| PB | T01.UPW | family T1 unassigned peptidases | 20S proteasome; complex with enone carmaphycin analogue 6 | 4LTC_F |
| PB | T01.UPW | family T1 unassigned peptidases | 20S proteasome; complex with MG132 | 4NNN_F |
| PB | T01.UPW | family T1 unassigned peptidases | 20S proteasome; complex with Z-Leu-Leu-Leu-ketoaldehyde | 4NNW_F |
| PB | T01.UPW | family T1 unassigned peptidases | 20S proteasome; complex with Z-Leu-Leu-Leu-B(OH)2 | 4NO1_F |
| PB | T01.UPW | family T1 unassigned peptidases | 20S proteasome; complex with Z-Leu-Leu-Leu-vinylsulfone | 4NO6_F |
| PB | T01.UPW | family T1 unassigned peptidases | 20S proteasome; complex with Z-Leu-Leu-Leu-ketoamide | 4NO8_F |
| PB | T01.UPW | family T1 unassigned peptidases | 20S proteasome; complex with Z-Leu-Leu-Leu-epoxyketone | 4NO9_F |
| PB | T01.UPW | family T1 unassigned peptidases | 20S proteasome; complex with kendomycin | 4Q1S_F |
| PB | T01.UPW | family T1 unassigned peptidases | 20S proteasome; complex with Boc-Ala-Ala-Ala-CHO | 4QBY_F |
| PB | T01.UPW | family T1 unassigned peptidases | 20S proteasome; complex with epoxyketone inhibitor 8 | 4QLQ_F |
| PB | T01.UPW | family T1 unassigned peptidases | 20S proteasome; complex with epoxyketone inhibitor 11 | 4QLS_F |
| PB | T01.UPW | family T1 unassigned peptidases | 20S proteasome; complex with tripeptidic epoxyketone inhibitor 2 | 4QLT_F |
| PB | T01.UPW | family T1 unassigned peptidases | 20S proteasome; complex with tripeptidic epoxyketone inhibitor 9 | 4QLU_F |
| PB | T01.UPW | family T1 unassigned peptidases | 20S proteasome; complex with tripeptidic epoxyketone inhibitor 17 | 4QLV_F |
| PB | T01.UPW | family T1 unassigned peptidases | 20S proteasome | 4QUX_F |
| PB | T01.UPW | family T1 unassigned peptidases | 20S proteasome | 4QUY_F |
| PB | T01.UPW | family T1 unassigned peptidases | 20S proteasome | 4QV0_F |
| PB | T01.UPW | family T1 unassigned peptidases | 20S proteasome | 4QV1_F |
| PB | T01.UPW | family T1 unassigned peptidases | 20S proteasome | 4QV3_F |
| PB | T01.UPW | family T1 unassigned peptidases | 20S proteasome beta5 Met45Thr mutant | 4QV4_F |
| PB | T01.UPW | family T1 unassigned peptidases | 20S proteasome beta5 Met45Ile mutant | 4QV5_F |
| PB | T01.UPW | family T1 unassigned peptidases | 20S proteasome | 4QV6_F |
| PB | T01.UPW | family T1 unassigned peptidases | 20S proteasome | 4QV7_F |
| PB | T01.UPW | family T1 unassigned peptidases | 20S proteasome | 4QV8_F |
| PB | T01.UPW | family T1 unassigned peptidases | 20S proteasome | 4QV9_F |
| PB | T01.UPW | family T1 unassigned peptidases | 20S proteasome; complex with bortezomib | 4QVL_F |
| PB | T01.UPW | family T1 unassigned peptidases | 20S proteasome beta5 Met45Ala mutant; complex with bortezomib | 4QVM_F |
| PB | T01.UPW | family T1 unassigned peptidases | 20S proteasome beta5 Met45Val mutant; complex with bortezomib | 4QVN_F |
| PB | T01.UPW | family T1 unassigned peptidases | 20S proteasome beta5 Met45Thr mutant; complex with bortezomib | 4QVP_F |
| PB | T01.UPW | family T1 unassigned peptidases | 20S proteasome beta5 Met45Ile mutant; complex with bortezomib | 4QVQ_F |
| PB | T01.UPW | family T1 unassigned peptidases | 20S proteasome beta5 Ala49Val mutant; complex with bortezomib | 4QVV_F |
| PB | T01.UPW | family T1 unassigned peptidases | 20S proteasome beta5 Ala49Ser mutant; complex with bortezomib | 4QVW_F |
| PB | T01.UPW | family T1 unassigned peptidases | 20S proteasome beta5 Ala49Thr mutant; complex with bortezomib | 4QVY_F |
| PB | T01.UPW | family T1 unassigned peptidases | 20S proteasome beta5 Ala49Thr,Ala50Val mutant; complex with bortezomib | 4QW0_F |
| PB | T01.UPW | family T1 unassigned peptidases | 20S proteasome beta5 Ala50Val mutant; complex with bortezomib | 4QW1_F |
| PB | T01.UPW | family T1 unassigned peptidases | 20S proteasome beta5 Cys63Phe mutant; complex with bortezomib | 4QW3_F |
| PB | T01.UPW | family T1 unassigned peptidases | 20S proteasome; complex with carfilzomib | 4QW4_F |
| PB | T01.UPW | family T1 unassigned peptidases | 20S proteasome beta5 Met45Ala mutant; complex with carfilzomib | 4QW5_F |
| PB | T01.UPW | family T1 unassigned peptidases | 20S proteasome beta5 Met45Val mutant; complex with carfilzomib | 4QW6_F |
| PB | T01.UPW | family T1 unassigned peptidases | 20S proteasome beta5 Met45Thr mutant; complex with carfilzomib | 4QW7_F |
| PB | T01.UPW | family T1 unassigned peptidases | 20S proteasome beta5 Met45Ile mutant; complex with carfilzomib | 4QWF_F |
| PB | T01.UPW | family T1 unassigned peptidases | 20S proteasome beta5 Ala49Val mutant; complex with carfilzomib | 4QWG_F |
| PB | T01.UPW | family T1 unassigned peptidases | 20S proteasome beta5 Ala49Ser mutant; complex with carfilzomib | 4QWI_F |
| PB | T01.UPW | family T1 unassigned peptidases | 20S proteasome beta5 Ala49Thr mutant; complex with carfilzomib | 4QWJ_F |
| PB | T01.UPW | family T1 unassigned peptidases | 20S proteasome beta5 Ala49Thr, Ala50Val mutant; complex with carfilzomib | 4QWK_F |
| PB | T01.UPW | family T1 unassigned peptidases | 20S proteasome beta5 Ala50Val mutant; complex with carfilzomib | 4QWL_F |
| PB | T01.UPW | family T1 unassigned peptidases | 20S proteasome beta5 Cys52Phe mutant; complex with carfilzomib | 4QWR_F |
| PB | T01.UPW | family T1 unassigned peptidases | 20S proteasome beta5 Cys63Phe mutant; complex with carfilzomib | 4QWS_F |
| PB | T01.UPW | family T1 unassigned peptidases | 20S proteasome beta5 Cys52Phe mutant; complex with bortezomib | 4QWU_F |
| PB | T01.UPW | family T1 unassigned peptidases | 20S proteasome; complex with epoxyketone inhibitor ONX 0914 | 4QWX_F |
| PB | T01.UPW | family T1 unassigned peptidases | 20S proteasome beta 5 Met45Ala mutant; complex with epoxyketone inhibitor ONX 0914 | 4QXJ_F |
| PB | T01.UPW | family T1 unassigned peptidases | complete proteasome; complex with epoxyketone inhibitor ONX 0914 | 4QZ0_F |
| PB | T01.UPW | family T1 unassigned peptidases | 20S proteasome beta 5 Met45Thr mutant; complex with epoxyketone inhibitor ONX 0914 | 4QZ1_F |
| PB | T01.UPW | family T1 unassigned peptidases | 20S proteasome beta 5 Met45Ile mutant; complex with epoxyketone inhibitor ONX 0914 | 4QZ2_F |
| PB | T01.UPW | family T1 unassigned peptidases | 20S proteasome beta 5 Ala49Val mutant; complex with epoxyketone inhibitor ONX 0914 | 4QZ3_F |
| PB | T01.UPW | family T1 unassigned peptidases | 20S proteasome beta 5 Ala49Ser mutant; complex with epoxyketone inhibitor ONX 0914 | 4QZ4_F |
| PB | T01.UPW | family T1 unassigned peptidases | 20S proteasome beta 5 Ala49Thr mutant; complex with epoxyketone inhibitor ONX 0914 | 4QZ5_F |
| PB | T01.UPW | family T1 unassigned peptidases | 20S proteasome beta 5 Ala49Thr, Ala50Val mutant; complex with epoxyketone inhibitor ONX 0914 | 4QZ6_F |
| PB | T01.UPW | family T1 unassigned peptidases | 20S proteasome beta 5 Ala50Val mutant; complex with epoxyketone inhibitor ONX 0914 | 4QZ7_F |
| PB | T01.UPW | family T1 unassigned peptidases | 20S proteasome beta 5 Cys52Phe mutant; complex with epoxyketone inhibitor ONX 0914 | 4QZW_F |
| PB | T01.UPW | family T1 unassigned peptidases | complete proteasome; complex with epoxyketone inhibitor ONX 0914 | 4QZX_F |
| PB | T01.UPW | family T1 unassigned peptidases | 20S proteasome; complex with omuralide | 4QZZ_F |
| PB | T01.UPW | family T1 unassigned peptidases | 20S proteasome beta 5 Cys52Phe mutant; complex with omuralide | 4R00_F |
| PB | T01.UPW | family T1 unassigned peptidases | 20S proteasome; complex with BSC4999 | 4R02_F |
| PB | T01.UPW | family T1 unassigned peptidases | 20S proteasome; ligand induced aziridine-formation in beta5 | 4R17_F |
| PB | T01.UPW | family T1 unassigned peptidases | 20S proteasome; ligand induced Lys33-Thr1 cross-linking in beta5 | 4R18_F |
| PB | T01.UPW | family T1 unassigned peptidases | 20S proteasome; complex with alkaloid indolo-phakellin | 4RUR_F |
| PB | T01.UPW | family T1 unassigned peptidases | 4V7O | |
| PB | T01.UPW | family T1 unassigned peptidases | 20S proteasome; complex with PR-VI modulator | 4X6Z_G |
| PB | T01.UPW | family T1 unassigned peptidases | 20S proteasome; complex with Ac-Pro-Ala-Asp-EP | 4Y69_F |
| PB | T01.UPW | family T1 unassigned peptidases | 20S proteasome beta2 His114Asp mutant; complex with Ac-Pro-Ala-Asp-EP | 4Y6A_F |
| PB | T01.UPW | family T1 unassigned peptidases | 20S proteasome; complex with Ac-Pro-Ala-Glu-EP | 4Y6V_F |
| PB | T01.UPW | family T1 unassigned peptidases | 20S proteasome; complex with Ac-Pro-Ala-Leu-EP | 4Y6Z_F |
| PB | T01.UPW | family T1 unassigned peptidases | 20S proteasome; complex with Ac-Leu-Ala-Val-EP | 4Y70_F |
| PB | T01.UPW | family T1 unassigned peptidases | 20S proteasome; complex with Ac-Leu-Ala-Leu-EP | 4Y74_F |
| PB | T01.UPW | family T1 unassigned peptidases | 20S proteasome; complex with Ac-Pro-Ala-Phe-EP | 4Y75_F |
| PB | T01.UPW | family T1 unassigned peptidases | 20S proteasome; complex with Ac-Leu-Ala-Phe-EP | 4Y77_F |
| PB | T01.UPW | family T1 unassigned peptidases | 20S proteasome; complex with Ac-Leu-Ala-Asp-EP | 4Y78_F |
| PB | T01.UPW | family T1 unassigned peptidases | 20S proteasome; complex with Ac-Leu-Ala-Glu-EP | 4Y7W_F |
| PB | T01.UPW | family T1 unassigned peptidases | complete proteasome; complex with Ac-PAA-ep | 4Y7X_F |
| PB | T01.UPW | family T1 unassigned peptidases | 20S proteasome; complex with Ac-Leu-Ala-Ala-EP | 4Y7Y_F |
| PB | T01.UPW | family T1 unassigned peptidases | 20S proteasome; complex with Ac-Leu-Ala-Ile-EP | 4Y80_F |
| PB | T01.UPW | family T1 unassigned peptidases | 20S proteasome; complex with Ac-Pro-Ala-Tyr-EP | 4Y81_F |
| PB | T01.UPW | family T1 unassigned peptidases | 20S proteasome; complex with Ac-Leu-Ala-Tyr-EP | 4Y82_F |
| PB | T01.UPW | family T1 unassigned peptidases | 20S proteasome; complex with N3-Ala(4,4-F2P)-Asn-Leu-Leu-EP | 4Y84_F |
| PB | T01.UPW | family T1 unassigned peptidases | 20S proteasome; complex with N3-Ala-Pro-Asn-Leu-Leu-EP | 4Y8G_F |
| PB | T01.UPW | family T1 unassigned peptidases | 20S proteasome; complex with N3-Ala-Pro-Ala-Leu-EP | 4Y8H_F |
| PB | T01.UPW | family T1 unassigned peptidases | 20S proteasome; complex with Ac-Pro-Leu-Leu-EP | 4Y8I_F |
| PB | T01.UPW | family T1 unassigned peptidases | 20S proteasome; complex with Ac-Leu-Leu-Leu-EP | 4Y8J_F |
| PB | T01.UPW | family T1 unassigned peptidases | 20S proteasome; complex with H-Ala-Pro-Leu-Leu-EP | 4Y8K_F |
| PB | T01.UPW | family T1 unassigned peptidases | 20S proteasome; complex with Ac-Ala-Pro-Leu-Leu-EP | 4Y8L_F |
| PB | T01.UPW | family T1 unassigned peptidases | 20S proteasome beta7-delta7 C-terminal mutant | 4Y8M_F |
| PB | T01.UPW | family T1 unassigned peptidases | 20S proteasome beta7-delta7 C-terminal mutant; complex with Ac-Pro-Ala-Glu-EP | 4Y8N_F |
| PB | T01.UPW | family T1 unassigned peptidases | 20S proteasome beta 7-delta 7 C-terminal mutant; complex with Ac-Pro-Ala-Phe-EP | 4Y8O_F |
| PB | T01.UPW | family T1 unassigned peptidases | 20S proteasome beta 7-delta 7 C-terminal mutant; complex with Ac-Pro-Ala-Leu-EP | 4Y8P_F |
| PB | T01.UPW | family T1 unassigned peptidases | 20S proteasome beta 7-delta 7 C-terminal mutant; complex with Ac-Pro-Ala-Tyr-EP | 4Y8Q_F |
| PB | T01.UPW | family T1 unassigned peptidases | 20S proteasome beta 2 His116Asp mutant | 4Y8R_F |
| PB | T01.UPW | family T1 unassigned peptidases | 20S proteasome beta 2 His116Asp mutant; complex with Ac-Leu-Ala-Glu-EP | 4Y8S_F |
| PB | T01.UPW | family T1 unassigned peptidases | 20S proteasome beta 2 His116Asp mutant; complex with Ac-Pro-Ala-Glu-EP | 4Y8T_F |
| PB | T01.UPW | family T1 unassigned peptidases | 20S proteasome beta 2 His116Asp mutant; complex with Ac-Pro-Ala-Asp-EP | 4Y8U_F |
| PB | T01.UPW | family T1 unassigned peptidases | 20S proteasome beta 2 His116Glu mutant | 4Y9Y_F |
| PB | T01.UPW | family T1 unassigned peptidases | 20S proteasome beta 2 His116Glu mutant; complex with Ac-Leu-Ala-Glu-EP | 4Y9Z_F |
| PB | T01.UPW | family T1 unassigned peptidases | 20S proteasome beta 2 His116Glu mutant; complex with Ac-Pro-Ala-Glu-EP | 4YA0_F |
| PB | T01.UPW | family T1 unassigned peptidases | 20S proteasome beta 2 His116Asn mutant | 4YA1_F |
| PB | T01.UPW | family T1 unassigned peptidases | 20S proteasome beta 2 His116Asn mutant; complex with Ac-Leu-Ala-Glu-EP | 4YA2_F |
| PB | T01.UPW | family T1 unassigned peptidases | 20S proteasome beta 2 His116Asn mutant; complex with Ac-Pro-Ala-Glu-EP | 4YA3_F |
| PB | T01.UPW | family T1 unassigned peptidases | 20S proteasome beta 2 His114Asp mutant | 4YA4_F |
| PB | T01.UPW | family T1 unassigned peptidases | 20S proteasome beta 2 His114Asp mutant; complex with Ac-Pro-Ala-Glu-EP | 4YA5_F |
| PB | T01.UPW | family T1 unassigned peptidases | 20S proteasome beta 2 His114Asp mutant; complex with Ac-Leu-Ala-Glu-EP | 4YA7_F |
| PB | T01.UPW | family T1 unassigned peptidases | 20S proteasome beta 2 His114Asp mutant; complex with AC-Leu-Ala-Asp-EP | 4YA9_F |
| PB | T01.UPW | family T1 unassigned peptidases | 20S proteasome; complex with belactosin C derivative 3 | 4Z1L_F |
| PB | T01.UPW | family T1 unassigned peptidases | 26S protease-UBP6 complex | 5A5B_G |
| PB | T01.UPW | family T1 unassigned peptidases | 20S proteasome; complex with macyranone A | 5AHJ_F |
| PB | T01.UPW | family T1 unassigned peptidases | 20S proteasome; complex with beta1/beta2 nonspecifici sulfonamide ligand | 5BOU_F |
| PB | T01.UPW | family T1 unassigned peptidases | yeast 20s proteasome beta2-g170a mutant | 5BXL_F |
| PB | T01.UPW | family T1 unassigned peptidases | yeast 20s proteasome beta2-g170a mutant in complex with bortezomib | 5BXN_F |
| PB | T01.UPW | family T1 unassigned peptidases | 20S proteasome beta5 Gly48Cys mutant | 5CGF_F |
| PB | T01.UPW | family T1 unassigned peptidases | 20S proteasome beta5 Gly48Cys mutant; complex with alpha-chloroacetamide 1 | 5CGG_F |
| PB | T01.UPW | family T1 unassigned peptidases | 20S proteasome beta5 Gly48Cys mutant; complex with alpha-chloroacetamide 5 | 5CGH_F |
| PB | T01.UPW | family T1 unassigned peptidases | 20S proteasome beta5 Gly48Cys mutant; complex with ONX 0914 | 5CGI_F |
| PB | T01.UPW | family T1 unassigned peptidases | yeast 20s proteasome at 2.3 a resolution | 5CZ4_F |
| PB | T01.UPW | family T1 unassigned peptidases | yeast 20s proteasome beta1-t1a mutant in complex with carfilzomib | 5CZ5_F |
| PB | T01.UPW | family T1 unassigned peptidases | yeast 20s proteasome beta5-t1a mutant in complex with syringolin a, propeptide expressed in trans | 5CZ6_F |
| PB | T01.UPW | family T1 unassigned peptidases | yeast 20s proteasome beta5-t1a beta5-k81r double mutant in complex with bortezomib, propeptide expressed in cis | 5CZ7_F |
| PB | T01.UPW | family T1 unassigned peptidases | yeast 20s proteasome beta5-l(-49)s-k33a mutant in complex with carfilzomib | 5CZ8_F |
| PB | T01.UPW | family T1 unassigned peptidases | yeast 20s proteasome beta5-d17n mutant in complex with carfilzomib; propeptide expressed in trans | 5CZ9_F |
| PB | T01.UPW | family T1 unassigned peptidases | yeast 20s proteasome beta5-d166n mutant | 5CZA_F |
| PB | T01.UPW | family T1 unassigned peptidases | yeast 20s proteasome beta5-d166n mutant in complex with carfilzomib | 5D0S_F |
| PB | T01.UPW | family T1 unassigned peptidases | 20s proteasome beta5-Asp166Asn mutant; complex with MG132 | 5D0T_F |
| PB | T01.UPW | family T1 unassigned peptidases | yeast 20s proteasome beta5-t1c mutant in complex with carfilzomib | 5D0V_F |
| PB | T01.UPW | family T1 unassigned peptidases | yeast 20s proteasome beta5-t1s mutant | 5D0W_F |
| PB | T01.UPW | family T1 unassigned peptidases | yeast 20s proteasome beta5-t1s mutant in complex with bortezomib | 5D0X_F |
| PB | T01.UPW | family T1 unassigned peptidases | yeast 20s proteasome beta5-t1s mutant in complex with carfilzomib | 5D0Z_F |
| PB | T01.UPW | family T1 unassigned peptidases | 20S proteasome; complex with alkyne-PI | 5DKI_F |
| PB | T01.UPW | family T1 unassigned peptidases | 20S proteasome; complex with octreotide-PI | 5DKJ_F |
| PB | T01.UPW | family T1 unassigned peptidases | yeast 20s proteasome beta2-t1a mutant | 5FG7_F |
| PB | T01.UPW | family T1 unassigned peptidases | yeast 20s proteasome beta2-t(-2)v mutant | 5FG9_F |
| PB | T01.UPW | family T1 unassigned peptidases | yeast 20s proteasome beta5-k33a mutant (propeptide expressed in trans) | 5FGA_F |
| PB | T01.UPW | family T1 unassigned peptidases | yeast 20s proteasome beta5-h(-2)l-t1a double mutant in complex with carfilzomib | 5FGD_F |
| PB | T01.UPW | family T1 unassigned peptidases | yeast 20s proteasome beta5-h(-2)t-t1a double mutant in complex with carfilzomib | 5FGE_F |
| PB | T01.UPW | family T1 unassigned peptidases | yeast 20s proteasome beta5-h(-2)a-t1a-k81r triple mutant in complex with carfilzomib | 5FGF_F |
| PB | T01.UPW | family T1 unassigned peptidases | yeast 20s proteasome beta5-l(-49s)_d17n double mutant in complex with carfilzomib | 5FGG_F |
| PB | T01.UPW | family T1 unassigned peptidases | 20s proteasome beta5-Lys33Ala mutant (propeptide expressed in trans); complex with MG132 | 5FGH_F |
| PB | T01.UPW | family T1 unassigned peptidases | yeast 20s proteasome beta1-t1a beta2-t1a double mutant in complex withcarfilzomib | 5FGI_F |
| PB | T01.UPW | family T1 unassigned peptidases | yeast 20s proteasome beta5-k33a mutant (propeptide expressed in trans)in complex with carfilzomib | 5FHS_F |
| PB | T01.UPW | family T1 unassigned peptidases | 20s proteasome; complex with the peptidic epoxyketone inhibitor 27 | 5JHR_F |
| PB | T01.UPW | family T1 unassigned peptidases | 20s proteasome; complex with the peptidic epoxyketone inhibitor 15 | 5JHS_F |
| PB | T01.UPW | family T1 unassigned peptidases | 20s proteasome; complex with epoxyketone inhibitor 14 | 5L52_F |
| PB | T01.UPW | family T1 unassigned peptidases | 20s proteasome; complex with epoxyketone inhibitor 16 | 5L54_F |
| PB | T01.UPW | family T1 unassigned peptidases | 20s proteasome; complex with epoxyketone inhibitor 18 | 5L55_F |
| PB | T01.UPW | family T1 unassigned peptidases | yeast 20s proteasome with human beta5i (1-138; r57t) | 5L5A_F |
| PB | T01.UPW | family T1 unassigned peptidases | yeast 20s proteasome with human beta5i (1-138) and human beta6 (97- 111; 118-133) | 5L5B_F |
| PB | T01.UPW | family T1 unassigned peptidases | yeast 20s proteasome with human beta5i (1-138) and human beta6 (97- 111; 118-133) in complex with onx 0914 | 5L5D_F |
| PB | T01.UPW | family T1 unassigned peptidases | yeast 20s proteasome with human beta5i (1-138) and human beta6 (97- 111; 118-133) in complex with carfilzomib | 5L5E_F |
| PB | T01.UPW | family T1 unassigned peptidases | yeast 20s proteasome with human beta5i (1-138) and human beta6 (97- 111; 118-133) in complex with bortezomib | 5L5F_F |
| PB | T01.UPW | family T1 unassigned peptidases | yeast 20s proteasome with human beta5i (1-138) and human beta6 (97- 111; 118-133); complex with PR-924 | 5L5H_F |
| PB | T01.UPW | family T1 unassigned peptidases | yeast 20s proteasome with human beta5i (1-138) and human beta6 (97- 111; 118-133) in complex with epoxyketone inhibitor 9 | 5L5I_F |
| PB | T01.UPW | family T1 unassigned peptidases | yeast 20s proteasome with human beta5i (1-138) and human beta6 (97- 111; 118-133) in complex with epoxyketone inhibitor 14 | 5L5J_F |
| PB | T01.UPW | family T1 unassigned peptidases | yeast 20s proteasome with human beta5i (1-138) and human beta6 (97- 111; 118-133) in complex with epoxyketone inhibitor 16 | 5L5O_F |
| PB | T01.UPW | family T1 unassigned peptidases | yeast 20s proteasome with human beta5i (1-138) and human beta6 (97- 111; 118-133) in complex with epoxyketone inhibitor 17 | 5L5P_F |
| PB | T01.UPW | family T1 unassigned peptidases | yeast 20s proteasome with human beta5i (1-138) and human beta6 (97- 111; 118-133) in complex with epoxyketone 18 | 5L5Q_F |
| PB | T01.UPW | family T1 unassigned peptidases | yeast 20s proteasome with human beta5i (1-138;v31m) and human beta6 (97-111; 118-133) | 5L5R_F |
| PB | T01.UPW | family T1 unassigned peptidases | yeast 20s proteasome with human beta5i (1-138; Val31Met mutant) and human beta6 (97-111; 118-133); complex with PR-924 | 5L5S_F |
| PB | T01.UPW | family T1 unassigned peptidases | yeast 20s proteasome with human beta5i (1-138; v31m) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 16 | 5L5T_F |
| PB | T01.UPW | family T1 unassigned peptidases | yeast 20s proteasome with human beta5i (1-138; v31m) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 17 ***caveat 5l5u 04c h 301 has wrong chirality at atom c27 04c k 301 has ***caveat 2 5l5u wrong chirality at atom c27 04c v 301 h | 5L5U_F |
| PB | T01.UPW | family T1 unassigned peptidases | yeast 20s proteasome with human beta5c (1-138) and human beta6 (97- 111; 118-133) | 5L5W_F |
| PB | T01.UPW | family T1 unassigned peptidases | yeast 20s proteasome with human beta5c (1-138) and human beta6 (97- 111; 118-133) in complex with onx 0914 | 5L5X_F |
| PB | T01.UPW | family T1 unassigned peptidases | yeast 20s proteasome with human beta5c (1-138) and human beta6 (97- 111; 118-133) in complex with carfilzomib | 5L5Y_F |
| PB | T01.UPW | family T1 unassigned peptidases | yeast 20s proteasome with human beta5c (1-138) and human beta6 (97- 111; 118-133) in complex with bortezomib | 5L5Z_F |
| PB | T01.UPW | family T1 unassigned peptidases | yeast 20s proteasome with human beta5c (1-138) and human beta6 (97- 111; 118-133); complex with PR-924 | 5L60_F |
| PB | T01.UPW | family T1 unassigned peptidases | yeast 20s proteasome with human beta5c (1-138) and human beta6 (99- 132) in complex with epoxyketone inhibitor 14 | 5L61_F |
| PB | T01.UPW | family T1 unassigned peptidases | yeast 20s proteasome with human beta5c (1-138) and human beta6 (97- 111; 118-133) in complex with epoxyketone inhibitor 16 | 5L62_F |
| PB | T01.UPW | family T1 unassigned peptidases | yeast 20s proteasome with human beta5c (1-138) and human beta6 (97- 111; 118-133) in complex with epoxyketone inhibitor 17 ***caveat 5l63 04c h 301 has wrong chirality at atom c27 04c k 301 has ***caveat 2 5l63 wrong chirality at atom c27 04c v 301 has wr | 5L63_F |
| PB | T01.UPW | family T1 unassigned peptidases | yeast 20s proteasome with human beta5c (1-138) and human beta6 (97- 111; 118-133) in complex with epoxyketone inhibitor 18 | 5L64_F |
| PB | T01.UPW | family T1 unassigned peptidases | yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97- 111; 118-133) in complex with carfilzomib | 5L65_F |
| PB | T01.UPW | family T1 unassigned peptidases | yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97- 111; 118-133) in complex with bortezomib | 5L66_F |
| PB | T01.UPW | family T1 unassigned peptidases | yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97- 111; 118-133); complex with PR-924 | 5L67_F |
| PB | T01.UPW | family T1 unassigned peptidases | yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97- 111; 118-133) in complex with epoxyketone inhibitor 14 | 5L68_F |
| PB | T01.UPW | family T1 unassigned peptidases | yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97- 111; 118-133) in complex with epoxyketone inhibitor 16 | 5L69_F |
| PB | T01.UPW | family T1 unassigned peptidases | yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97- 111; 118-133) in complex with epoxyketone inhibitor 17 | 5L6A_F |
| PB | T01.UPW | family T1 unassigned peptidases | yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97- 111; 118-133) in complex with onx 0914 | 5L6B_F |
| PB | T01.UPW | family T1 unassigned peptidases | yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97- 111; 118-133) in complex with epoxyketone inhibitor 18 | 5L6C_F |
| PB | T01.UPW | family T1 unassigned peptidases | ligand-induced aziridine-formation at the yeast proteasomal subunit beta5 by sulfonate esters | 5LAI_F |
| PB | T01.UPW | family T1 unassigned peptidases | ligand-induced lys33-thr1 crosslinking at the yeast proteasomal subunit beta5 by sulfonate esters | 5LAJ_F |
| PB | T01.UPW | family T1 unassigned peptidases | yeast 20s proteasome with human beta5i (1-138; Arg57Thr mutant)in complex with PR-924 | 5LTT_F |
| PB | T01.UPW | family T1 unassigned peptidases | yeast 20s proteasome with human beta5i (1-138) and human beta6 (97- 111; 118-133) in complex with thiazole based inhibitor ro19 | 5M2B_F |
| PB | T01.UPW | family T1 unassigned peptidases | 26s proteasome in presence of atp (s1) | 5MP9_g |
| PB | T01.UPW | family T1 unassigned peptidases | 26s proteasome in presence of atp (s2) | 5MPA_g |
| PB | T01.UPW | family T1 unassigned peptidases | yeast 20s proteasome in complex with blm-pep activator | 5NIF_G |
| PB | T01.UPW | family T1 unassigned peptidases | yeast 26s proteasome bound to ubiquitinated substrate (1d* motor state) | 6EF0_G |
| PB | T01.UPW | family T1 unassigned peptidases | yeast 26s proteasome bound to ubiquitinated substrate (5d motor state) | 6EF1_G |
| PB | T01.UPW | family T1 unassigned peptidases | yeast 26s proteasome bound to ubiquitinated substrate (5t motor state) | 6EF2_G |
| PB | T01.UPW | family T1 unassigned peptidases | yeast 26s proteasome bound to ubiquitinated substrate (4d motor state) | 6EF3_G |
| PB | T01.UPW | family T1 unassigned peptidases | yeast 20s proteasome in complex with cystargolide B | 6G7F_F |
| PB | T01.UPW | family T1 unassigned peptidases | yeast 20s proteasome in complex with cystargolide B derivative 1 | 6G8M_F |
| PB | T01.UPW | family T1 unassigned peptidases | yeast 20s proteasome in complex with cystargolide B derivative 2 | 6G8N_F |
| PB | T01.UPW | family T1 unassigned peptidases | yeast 20s proteasome in complex with homosalinosporamide a | 6GOP_F |
| PB | T01.UPW | family T1 unassigned peptidases | yeast 20s proteasome in complex with the peptidic non-covalent bindinginhibitor rts-v5 | 6H39_F |
| PB | T01.UPW | family T1 unassigned peptidases | yeast 20s proteasome with human beta2c (s171g) | 6HTB_F |
| PB | T01.UPW | family T1 unassigned peptidases | yeast 20s proteasome with human beta2c (s171g) in complex with onx 0914 | 6HTC_F |
| PB | T01.UPW | family T1 unassigned peptidases | yeast 20s proteasome with human beta2c (s171g) in complex with 4 | 6HTD_F |
| PB | T01.UPW | family T1 unassigned peptidases | yeast 20s proteasome with human beta2c (s171g) in complex with 7 | 6HTP_F |
| PB | T01.UPW | family T1 unassigned peptidases | yeast 20s proteasome with human beta2c (s171g) in complex with 13 | 6HTR_F |
| PB | T01.UPW | family T1 unassigned peptidases | yeast 20s proteasome with human beta2c (s171g) in complex with 16 | 6HUB_F |
| PB | T01.UPW | family T1 unassigned peptidases | yeast 20s proteasome with human beta2c (s171g) in complex with 18 | 6HUC_F |
| PB | T01.UPW | family T1 unassigned peptidases | yeast 20s proteasome with human beta2c (s171g) in complex with 20 | 6HUQ_F |
| PB | T01.UPW | family T1 unassigned peptidases | yeast 20s proteasome with human beta2c (s171g) in complex with 29 | 6HUU_F |
| PB | T01.UPW | family T1 unassigned peptidases | yeast 20s proteasome with human beta2c (s171g) in complex with 39 | 6HUV_F |
| PB | T01.UPW | family T1 unassigned peptidases | yeast 20s proteasome with human beta2i (1-53) | 6HV3_F |
| PB | T01.UPW | family T1 unassigned peptidases | yeast 20s proteasome with human beta2i (1-53) in complex with onx 0914 | 6HV4_F |
| PB | T01.UPW | family T1 unassigned peptidases | yeast 20s proteasome with human beta2i (1-53) in complex with 4 | 6HV5_F |
| PB | T01.UPW | family T1 unassigned peptidases | yeast 20s proteasome with human beta2i (1-53) in complex with 7 | 6HV7_F |
| PB | T01.UPW | family T1 unassigned peptidases | yeast 20s proteasome with human beta2i (1-53) in complex with 13 | 6HVA_F |
| PB | T01.UPW | family T1 unassigned peptidases | yeast 20s proteasome with human beta2i (1-53) in complex with 16 | 6HVR_F |
| PB | T01.UPW | family T1 unassigned peptidases | yeast 20s proteasome with human beta2i (1-53) in complex with 18 | 6HVS_F |
| PB | T01.UPW | family T1 unassigned peptidases | yeast 20s proteasome with human beta2i (1-53) in complex with 20 | 6HVT_F |
| PB | T01.UPW | family T1 unassigned peptidases | yeast 20s proteasome with human beta2i (1-53) in complex with 29 | 6HVU_F |
| PB | T01.UPW | family T1 unassigned peptidases | yeast 20s proteasome with human beta2i (1-53) in complex with 39 | 6HVV_F |
| PB | T01.UPW | family T1 unassigned peptidases | yeast 20s proteasome with human beta2i (1-53) in complex with 43 | 6HVW_F |
| PB | T01.UPW | family T1 unassigned peptidases | yeast 20s proteasome in complex with 4 | 6HVX_F |
| PB | T01.UPW | family T1 unassigned peptidases | yeast 20s proteasome in complex with 5 (7- and 6-membered ring) | 6HVY_F |
| PB | T01.UPW | family T1 unassigned peptidases | yeast 20s proteasome in complex with 7 | 6HW0_F |
| PB | T01.UPW | family T1 unassigned peptidases | yeast 20s proteasome in complex with 13 | 6HW3_F |
| PB | T01.UPW | family T1 unassigned peptidases | yeast 20s proteasome in complex with 16 | 6HW4_F |
| PB | T01.UPW | family T1 unassigned peptidases | yeast 20s proteasome in complex with 18 | 6HW5_F |
| PB | T01.UPW | family T1 unassigned peptidases | yeast 20s proteasome in complex with 20 | 6HW6_F |
| PB | T01.UPW | family T1 unassigned peptidases | yeast 20s proteasome in complex with 29 | 6HW7_F |
| PB | T01.UPW | family T1 unassigned peptidases | yeast 20s proteasome in complex with 39 | 6HW8_F |
| PB | T01.UPW | family T1 unassigned peptidases | yeast 20s proteasome in complex with 41b | 6HW9_F |
| PB | T01.UPW | family T1 unassigned peptidases | yeast 20s proteasome in complex with 43 | 6HWA_F |
| PB | T01.UPW | family T1 unassigned peptidases | yeast 20s proteasome in complex with 44b | 6HWB_F |
| PB | T01.UPW | family T1 unassigned peptidases | yeast 20s proteasome beta2-g45a mutant | 6HWC_F |
| PB | T01.UPW | family T1 unassigned peptidases | yeast 20s proteasome beta2-g45a mutant in complex with bortezomib | 6HWD_F |
| PB | T01.UPW | family T1 unassigned peptidases | yeast 20s proteasome beta2-g45a mutant in complex with carfilzomib | 6HWE_F |
| PB | T01.UPW | family T1 unassigned peptidases | yeast 20s proteasome beta2-g45a mutant in complex with onx 0914 | 6HWF_F |
| PB | T01.UPW | family T1 unassigned peptidases | proteasome 20s core particle | 3H4P |
| PB | T01.UPW | family T1 unassigned peptidases | 20S proteasome complex | 5FMG_N |
| PB | T02.001 | glycosylasparaginase precursor | 1APY_A | |
| PB | T02.001 | glycosylasparaginase precursor | complex with reaction product | 1APZ |
| PB | T02.002 | isoaspartyl dipeptidase (threonine type) | structure of putative asparaginase encoded by escherichia coli ybik gene | 1JN9_A |
| PB | T02.002 | isoaspartyl dipeptidase (threonine type) | 1K2X_A | |
| PB | T02.002 | isoaspartyl dipeptidase (threonine type) | complex with L-aspartate | 1SEO_A |
| PB | T02.002 | isoaspartyl dipeptidase (threonine type) | 1T3M | |
| PB | T02.002 | isoaspartyl dipeptidase (threonine type) | orthorhombic crystal structure of precursor e. coli isoaspartyl peptidase/l-asparaginase (ecaiii) with active- site t179a mutation | 2ZAK_A |
| PB | T02.002 | isoaspartyl dipeptidase (threonine type) | complex with L-aspartate | 2ZAL_A |
| PB | T02.002 | isoaspartyl dipeptidase (threonine type) | hexagonal crystal structure of precursor e. coli isoaspartyl peptidase/l-asparaginase (ecaiii) with active- site t179a mutation | 3C17_A |
| PB | T02.002 | isoaspartyl dipeptidase (threonine type) | 3TKJ | |
| PB | T02.002 | isoaspartyl dipeptidase (threonine type) | 4ET0 | |
| PB | T02.002 | isoaspartyl dipeptidase (threonine type) | 4O0C | |
| PB | T02.002 | isoaspartyl dipeptidase (threonine type) | 4O0D | |
| PB | T02.002 | isoaspartyl dipeptidase (threonine type) | 4O0E | |
| PB | T02.002 | isoaspartyl dipeptidase (threonine type) | 4O0F | |
| PB | T02.002 | isoaspartyl dipeptidase (threonine type) | 4O0G | |
| PB | T02.002 | isoaspartyl dipeptidase (threonine type) | 4O0H | |
| PB | T02.002 | isoaspartyl dipeptidase (threonine type) | 4OSX | |
| PB | T02.002 | isoaspartyl dipeptidase (threonine type) | 4OSY | |
| PB | T02.002 | isoaspartyl dipeptidase (threonine type) | 4PVP | |
| PB | T02.002 | isoaspartyl dipeptidase (threonine type) | 4PVQ | |
| PB | T02.002 | isoaspartyl dipeptidase (threonine type) | 4PVR | |
| PB | T02.002 | isoaspartyl dipeptidase (threonine type) | 4PVS | |
| PB | T02.002 | isoaspartyl dipeptidase (threonine type) | circularly permuted | 4ZM9_A |
| PB | T02.004 | taspase-1 | 2A8I | |
| PB | T02.004 | taspase-1 | activated form | 2A8J |
| PB | T02.004 | taspase-1 | Thr234Ala mutant | 2A8L |
| PB | T02.004 | taspase-1 | Thr234Ser mutant | 2A8M |
| PB | T02.007 | Chryseobacterium meningosepticum-type N4-(beta-N-acetylglucosaminyl)-L-asparaginase | 1AYY_A | |
| PB | T02.007 | Chryseobacterium meningosepticum-type N4-(beta-N-acetylglucosaminyl)-L-asparaginase | precursor Asp151Asn mutant | 1P4K |
| PB | T02.007 | Chryseobacterium meningosepticum-type N4-(beta-N-acetylglucosaminyl)-L-asparaginase | precursor Asp151Asn mutant;complex with glycine | 1P4V |
| PB | T02.007 | Chryseobacterium meningosepticum-type N4-(beta-N-acetylglucosaminyl)-L-asparaginase | Thr152Cys mutant | 2GAC |
| PB | T02.007 | Chryseobacterium meningosepticum-type N4-(beta-N-acetylglucosaminyl)-L-asparaginase | 2GAW | |
| PB | T02.007 | Chryseobacterium meningosepticum-type N4-(beta-N-acetylglucosaminyl)-L-asparaginase | complex with substrate | 2GL9_A |
| PB | T02.007 | Chryseobacterium meningosepticum-type N4-(beta-N-acetylglucosaminyl)-L-asparaginase | 3LJQ | |
| PB | T02.007 | Chryseobacterium meningosepticum-type N4-(beta-N-acetylglucosaminyl)-L-asparaginase | 4R4Y | |
| PB | T02.007 | Chryseobacterium meningosepticum-type N4-(beta-N-acetylglucosaminyl)-L-asparaginase | precursor Thr152Ala mutant | 9GAA |
| PB | T02.007 | Chryseobacterium meningosepticum-type N4-(beta-N-acetylglucosaminyl)-L-asparaginase | precursor Thr152Cys mutant | 9GAC |
| PB | T02.007 | Chryseobacterium meningosepticum-type N4-(beta-N-acetylglucosaminyl)-L-asparaginase | precursor | 9GAF |
| PB | T02.A01 | At5g08100 (Arabidopsis thaliana) | potassium-independent form | 2GEZ_A |
| PB | T02.A02 | At3g16150 (Arabidopsis thaliana) | complex with K+ cations | 4PU6_A |
| PB | T02.A02 | At3g16150 (Arabidopsis thaliana) | complex with K+ and Na+ cations | 4PV2_A |
| PB | T02.A02 | At3g16150 (Arabidopsis thaliana) | complex with Na+ cations | 4PV3_A |
| PB | T03.001 | gamma-glutamyltransferase 1 (bacterial-type) | 2DBU_A | |
| PB | T03.001 | gamma-glutamyltransferase 1 (bacterial-type) | acyl-enzyme intermediate | 2DBW_A |
| PB | T03.001 | gamma-glutamyltransferase 1 (bacterial-type) | complex with L-glutamate | 2DBX_A |
| PB | T03.001 | gamma-glutamyltransferase 1 (bacterial-type) | complex with hydrolyzed glutathione | 2DG5_A |
| PB | T03.001 | gamma-glutamyltransferase 1 (bacterial-type) | t391a precursor mutant protein of gamma- glutamyltranspeptidase from escherichia coli | 2E0W_A |
| PB | T03.001 | gamma-glutamyltransferase 1 (bacterial-type) | monoclinic form | 2E0X_A |
| PB | T03.001 | gamma-glutamyltransferase 1 (bacterial-type) | samarium derivative | 2E0Y_A |
| PB | T03.001 | gamma-glutamyltransferase 1 (bacterial-type) | complex with azaserine | 2Z8I_A |
| PB | T03.001 | gamma-glutamyltransferase 1 (bacterial-type) | complex with azaserine prepared in the dark | 2Z8J_A |
| PB | T03.001 | gamma-glutamyltransferase 1 (bacterial-type) | complex with acivicin | 2Z8K_A |
| PB | T03.001 | gamma-glutamyltransferase 1 (bacterial-type) | complex with peptidyl phosphonate inhibitor 1b | 5B5T_A |
| PB | T03.001 | gamma-glutamyltransferase 1 (bacterial-type) | 2V36_A | |
| PB | T03.001 | gamma-glutamyltransferase 1 (bacterial-type) | 3A75 | |
| PB | T03.001 | gamma-glutamyltransferase 1 (bacterial-type) | 3WHQ | |
| PB | T03.001 | gamma-glutamyltransferase 1 (bacterial-type) | 3WHR | |
| PB | T03.001 | gamma-glutamyltransferase 1 (bacterial-type) | 3WHS | |
| PB | T03.001 | gamma-glutamyltransferase 1 (bacterial-type) | 2NQO_A | |
| PB | T03.001 | gamma-glutamyltransferase 1 (bacterial-type) | complex with glutamate | 2QM6_A |
| PB | T03.001 | gamma-glutamyltransferase 1 (bacterial-type) | Thr380Ala mutant | 2QMC_A |
| PB | T03.001 | gamma-glutamyltransferase 1 (bacterial-type) | complex with acivicin | 3FNM_A |
| PB | T03.001 | gamma-glutamyltransferase 1 (bacterial-type) | varying binding modes of inhibitors and structural differences in the binding pockets of different gamma-glutamyltranspeptidases | 5BPK_A |
| PB | T03.001 | gamma-glutamyltransferase 1 (bacterial-type) | 4OTT_A | |
| PB | T03.001 | gamma-glutamyltransferase 1 (bacterial-type) | 4OTT_B | |
| PB | T03.001 | gamma-glutamyltransferase 1 (bacterial-type) | complex with l-glutamate | 4OTU_A |
| PB | T03.001 | gamma-glutamyltransferase 1 (bacterial-type) | complex with l-glutamate | 4OTU_B |
| PB | T03.001 | gamma-glutamyltransferase 1 (bacterial-type) | Thr399Ala precursor mutant | 4Y23_A |
| PB | T03.006 | gamma-glutamyltransferase 1 (mammalian-type) | 4GDX | |
| PB | T03.006 | gamma-glutamyltransferase 1 (mammalian-type) | 4GG2 | |
| PB | T03.006 | gamma-glutamyltransferase 1 (mammalian-type) | 4Z9O | |
| PB | T03.006 | gamma-glutamyltransferase 1 (mammalian-type) | 4ZBK | |
| PB | T03.006 | gamma-glutamyltransferase 1 (mammalian-type) | 4ZC6 | |
| PB | T03.006 | gamma-glutamyltransferase 1 (mammalian-type) | 4ZCG | |
| PB | T03.006 | gamma-glutamyltransferase 1 (mammalian-type) | complex with don | 5V4Q_A |
| PB | T03.023 | CapD poly-gamma-glutamate hydrolase | 3G9K_L | |
| PB | T03.023 | CapD poly-gamma-glutamate hydrolase | crystal form II | 3GA9_L |
| PB | T03.025 | oxamate amidohydrolase proenzyme (Klebsiella pneumonia) | 2NLZ_A | |
| PB | T03.025 | oxamate amidohydrolase proenzyme (Klebsiella pneumonia) | 2I3O_A | |
| PB | T03.025 | oxamate amidohydrolase proenzyme (Klebsiella pneumonia) | crystal structure of hpxw | 5HFT_A |
| PE | T05.002 | ArgJ protein (archea) | processed heterodimer | 1VRA |
| PE | T05.UPW | family T5 unassigned peptidases | ornithine acetyltransferase (orf6 gene product- clavulanic acid biosynthesis) from streptomyces clavuligerus | 1VZ6_A |
| PE | T05.UPW | family T5 unassigned peptidases | ornithine acetyltransferase (orf6 gene product- clavulanic acid biosynthesis) from streptomyces clavuligerus | 1VZ7_A |
| PE | T05.UPW | family T5 unassigned peptidases | ornithine acetyltransferase (orf6 gene product- clavulanic acid biosynthesis) from streptomyces clavuligerus (semet structure) | 1VZ8_A |
| PE | T05.UPW | family T5 unassigned peptidases | structure of a novel n-acyl-enzyme intermediate of an n- terminal nucleophile (ntn) hydrolase, oat2 | 2V4I_A |
| PE | T05.UPW | family T5 unassigned peptidases | structure of the acyl-enzyme complex of an n-terminal nucleophile (ntn) hydrolase, oat2 | 2VZK_A |
| PE | T05.UPW | family T5 unassigned peptidases | complex with glutamate | 2YEP_A |
| U- | U32.001 | collagenase (Porphyromonas-type) | 1LK8 | |
| U- | U32.UPW | family U32 unassigned peptidases | on hold | 5D88 |
| U- | U40.001 | protein P5 murein endopeptidase (bacteriophage phi-6) | 4DQ5_A | |
| U- | U40.001 | protein P5 murein endopeptidase (bacteriophage phi-6) | Val207Phe mutant | 4DQ7_A |
| U- | U40.001 | protein P5 murein endopeptidase (bacteriophage phi-6) | in complex with chitotetraose | 4DQJ_A |
| U- | U56.001 | homomultimeric peptidase | 3DKT | |
| U- | U56.UPW | family U56 unassigned peptidases | 4PT2_P | |
| U- | U69.001 | AIDA-I self-cleaving autotransporter protein (Escherichia coli) | 4MEE | |
| U- | U69.UPW | family U69 unassigned peptidases | crystal structure of the icsa autochaperone region | 3ML3_A |
| U- | U69.UPW | family U69 unassigned peptidases | C-terminal fragment of the icsa/virg passenger-domain | 5KE1_A |
| U- | U69.UPW | family U69 unassigned peptidases | 3QQ2 | |
| U- | U69.UPW | family U69 unassigned peptidases | 4EHC | |
| U- | U72.001 | Dop isopeptidase | structure of the deamidase-depupylase dop of the prokaryotic ubiquitin-like modification pathway | 4B0R_A |
| U- | U72.001 | Dop isopeptidase | structure of the deamidase-depupylase dop of the prokaryotic ubiquitin-like modification pathway in complex with atp | 4B0S_A |
| U- | U72.001 | Dop isopeptidase | structure of the deamidase-depupylase dop of the prokaryotic ubiquitin-like modification pathway in complex with adp and phosphate | 5LRT_A |
| U- | U72.UPW | family U72 unassigned peptidases | structure of the pup ligase pafa of the prokaryotic ubiquitin-like modification pathway in complex with adp | 4B0T_A |
| U- | U72.UPW | family U72 unassigned peptidases | complex between prokaryotic ubiquitin-like protein pup and its ligase pafa | 4BJR_A |
